Citrus Sinensis ID: 042568
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 983 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZUI0 | 980 | Putative leucine-rich rep | yes | no | 0.929 | 0.932 | 0.708 | 0.0 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.853 | 0.813 | 0.357 | 1e-140 | |
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.896 | 0.872 | 0.343 | 1e-139 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.924 | 0.886 | 0.354 | 1e-136 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.872 | 0.731 | 0.343 | 1e-122 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.928 | 0.804 | 0.310 | 1e-116 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.852 | 0.703 | 0.334 | 1e-114 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.853 | 0.671 | 0.325 | 1e-114 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.853 | 0.734 | 0.314 | 1e-113 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.860 | 0.752 | 0.318 | 1e-113 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 1255 bits (3248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/918 (70%), Positives = 761/918 (82%), Gaps = 4/918 (0%)
Query: 62 VHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAEL 121
V VCNWSGVKCN +V+ELD+S R + G ISP++ANL+ L VLDLS+NFF G IP E+
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 122 GSLIR-LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQY 180
GSL LKQLSLS N L G IP +LG L++L YLDLG+N+L G IP+ +FC+ SS+SLQY
Sbjct: 111 GSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQY 170
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
IDLSNNSLTGEIPL C L+ LRFLLLWSN+L G VP +L+NS+ L+W+DLESNM SGE
Sbjct: 171 IDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGE 230
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
LPS++ISKMPQLQFLYLSYN FVSH+ NTNLEPFFASLANSS+ QELELAGN+LGG I S
Sbjct: 231 LPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITS 290
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360
+ LS NLVQIHLD N I+G IPP ISNL+NLTLLNLSSNLL+G IP ELC +SKLERV
Sbjct: 291 SVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERV 350
Query: 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420
YLSNN L+GEIP GDIP LGLLD+S+N LSGSIPDSF NLSQLRRLLLYGNHLSGT+P
Sbjct: 351 YLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVP 410
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSD-VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
SLGKC+NLEILDLSHN ++G IP + V+ LR+LKLYLNLSSNHL GP+PLELSKMDMVL
Sbjct: 411 QSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVL 470
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
++DLS N LSG IPPQLGSCIALE LNLS N LP S+GQLPYLK+ DVS NRL G
Sbjct: 471 SVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGA 530
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHT 599
IP SFQ S TLK LNFSFN SGN+S+KG+FS LTI SF G+ LCG IKG+Q CKK+H
Sbjct: 531 IPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHK 590
Query: 600 HHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKE-EAKNPRVS 658
+ V+L +LLSL A +L +FG LV RS+FGK+L+V ++EDEEK+ + + K PR+S
Sbjct: 591 YPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRIS 650
Query: 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQIL 718
Y+QLI ATGGF SSLIGSGRFGHVYKGVL++NT++AVKVLD T E +GSFKRECQIL
Sbjct: 651 YQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQIL 710
Query: 719 KRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVA 778
KR RHRNLIRIIT CSKP F ALVLPLM NGSLE HLYP S LDLIQLV ICSDVA
Sbjct: 711 KRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVA 770
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
EG+AYLHH+SP+KVVHCDLKPSNILLD+++TALV DFGI++LV+G++E+V+ +DS+SF
Sbjct: 771 EGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS-TDDSVSFG 829
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV+GRRPTDVL ++GSSLHE++
Sbjct: 830 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFM 889
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
K HYP L+ I+E+A++++ PQ P K+W +V+LE+IELGL+CTQYNPSTRP MLDV
Sbjct: 890 KSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDV 949
Query: 959 AHEMGRLKQYLSSPSSLI 976
AHEMGRLK+YL + SL+
Sbjct: 950 AHEMGRLKEYLFACPSLL 967
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-140, Method: Compositional matrix adjust.
Identities = 337/942 (35%), Positives = 495/942 (52%), Gaps = 103/942 (10%)
Query: 35 DRASLVTFMSSII-SAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTI 93
D +L+ F S + + L SWN + CNW GV C R +V+ L+L + G I
Sbjct: 31 DMQALLEFKSQVSENNKREVLASWNHSS-PFCNWIGVTCGRRRERVISLNLGGFKLTGVI 89
Query: 94 SPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI------------ 141
SP++ NLS L +L+L+ N F IP ++G L RL+ L++S+N L+G+I
Sbjct: 90 SPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSRLST 149
Query: 142 ------------PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
PS+LGSL +L LDL N L G P + + TSLQ +D + N +
Sbjct: 150 VDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASL---GNLTSLQKLDFAYNQMR 206
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
GEIP L + F + N G P AL N S LE L L N FSG L ++ +
Sbjct: 207 GEIP-DEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLL 265
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS--- 306
P L+ L L N F T LAN S+ + +++ N L G IP G L
Sbjct: 266 PNLRRLLLGTNQFTGAIPKT--------LANISSLERFDISSNYLSGSIPLSFGKLRNLW 317
Query: 307 --------------------------TNLVQIHLDCNLIYGKIPPHISNL-VNLTLLNLS 339
T L + + N + G++P I+NL LT L L
Sbjct: 318 WLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLG 377
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSF 399
NL++GTIPH++ + L+ + L N LSGE+P +FG + +L ++DL N +SG IP F
Sbjct: 378 QNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYF 437
Query: 400 ANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459
N+++L++L L N G IP SLG+C L L + N+++G IP ++ + SL Y++L
Sbjct: 438 GNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDL 496
Query: 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519
S+N L G P E+ K+++++ + S+N LSG +P +G C+++E L + GNS +G +P
Sbjct: 497 SNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIP-D 555
Query: 520 VGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQ 579
+ +L LK D S+N L G IP+ + P+L+ LN S NKF G + G F + T S
Sbjct: 556 ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVF 615
Query: 580 GNDGLCGEIKGLQ--TC---------KKEHTHHLVILSILLSLFAMSLLFIFGNFLVLRS 628
GN +CG ++ +Q C K V+ I + + ++ L+ I +
Sbjct: 616 GNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMK 675
Query: 629 KFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVL 688
+ K+ N +D + + +VSY++L AT F ++LIGSG FG+V+KG+L
Sbjct: 676 RKKKN----NASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLL 731
Query: 689 -QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-----PDFKALV 742
+N +AVKVL+L G T SF EC+ K IRHRNL+++IT+CS DF+ALV
Sbjct: 732 GPENKLVAVKVLNLLKHGA-TKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALV 790
Query: 743 LPLMSNGSLE-----NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL 797
M GSL+ L + S L + + I DVA + YLH H V HCD+
Sbjct: 791 YEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDI 850
Query: 798 KPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM 857
KPSNILLD+DLTA V+DFG+A+L+ D +S + + G++GY APEYGM
Sbjct: 851 KPSNILLDDDLTAHVSDFGLAQLLYKYDR------ESFLNQFSSAGVRGTIGYAAPEYGM 904
Query: 858 GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
G + S GDVYSFG+LLLE+ +G++PTD F +LH + K
Sbjct: 905 GGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTK 946
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 353/1027 (34%), Positives = 513/1027 (49%), Gaps = 146/1027 (14%)
Query: 35 DRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTIS 94
DR +L+ F S + L SWN + +CNW GV C +V L+L + G IS
Sbjct: 25 DRQALLQFKSQVSEDKRVVLSSWNHS-FPLCNWKGVTCGRKNKRVTHLELGRLQLGGVIS 83
Query: 95 PALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI------------- 141
P++ NLS L+ LDL +NFF G IP E+G L RL+ L + N L+G I
Sbjct: 84 PSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNL 143
Query: 142 -----------PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG 190
PS+LGSL L L+L N + G++P + + T L+ + LS+N+L G
Sbjct: 144 RLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL---GNLTLLEQLALSHNNLEG 200
Query: 191 EIP--------------------------LKNECELR----------------------N 202
EIP L N L+ N
Sbjct: 201 EIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPN 260
Query: 203 LRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDF 262
L + N G +P L+N S LE L + N +G +P+ +P L+ L+L N
Sbjct: 261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT--FGNVPNLKLLFLHTNSL 318
Query: 263 VSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGK 322
S D + +LE F SL N + + L + N LGG +P I +LS LV + L LI G
Sbjct: 319 GS-DSSRDLE-FLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGS 376
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
IP I NL+NL L L N+L+G +P L + L + L +N LSG IP+ G++ L
Sbjct: 377 IPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLE 436
Query: 383 LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442
LDLS N G +P S N S L L + N L+GTIP + K L LD+S N + G
Sbjct: 437 TLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGS 496
Query: 443 IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIAL 502
+P D+ L++L + L N LSG +P LG+C+ +
Sbjct: 497 LPQDIGALQNLG-------------------------TLSLGDNKLSGKLPQTLGNCLTM 531
Query: 503 ESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSG 562
ESL L GN G +P G L +K+ D+S+N L G IP+ F + L+ LN SFN G
Sbjct: 532 ESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEG 590
Query: 563 NISNKGAFSSLTIASFQGNDGLCGEIKGLQ---------TCKKEHTHHL--VILSILLSL 611
+ KG F + T S GN+ LCG I G Q + K+H+ L V++ + + +
Sbjct: 591 KVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGI 650
Query: 612 FAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCP 671
+ LLF+ L+ K K+ + + E + ++SY L AT GF
Sbjct: 651 TLLLLLFMASVTLIWLRKRKKN------KETNNPTPSTLEVLHEKISYGDLRNATNGFSS 704
Query: 672 SSLIGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
S+++GSG FG VYK +L + +AVKVL++ G + SF EC+ LK IRHRNL++++
Sbjct: 705 SNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK-SFMAECESLKDIRHRNLVKLL 763
Query: 731 TICSKPD-----FKALVLPLMSNGSLENHLYPS-----HGLSHGLDLIQLVKICSDVAEG 780
T CS D F+AL+ M NGSL+ L+P H S L L++ + I DVA
Sbjct: 764 TACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASV 823
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ YLH H + HCDLKPSN+LLD+DLTA V+DFG+A+L+ DE +S +
Sbjct: 824 LDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE------ESFFNQLS 877
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
+ G++GY APEYG+G + S +GDVYSFG+LLLE+ TG+RPT+ LF +L+ + K
Sbjct: 878 SAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKS 937
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
P R+ IV+++I H+ + + + + E+GL C + +P R + V
Sbjct: 938 ALPERILDIVDESIL-----HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVK 992
Query: 961 EMGRLKQ 967
E+ +++
Sbjct: 993 ELISIRE 999
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 360/1015 (35%), Positives = 530/1015 (52%), Gaps = 106/1015 (10%)
Query: 31 QIIR-----DRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLS 85
Q IR D+ +L+ F S + L SWN + + +C+W+GVKC +V +DL
Sbjct: 31 QTIRLTEETDKQALLEFKSQVSETSRVVLGSWNDS-LPLCSWTGVKCGLKHRRVTGVDLG 89
Query: 86 ARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLS------------ 133
+ G +SP + NLS L L+L+ NFF G IP+E+G+L RL+ L++S
Sbjct: 90 GLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVL 149
Query: 134 ------------WNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181
N L+ +P + GSL +L L LG N L G+ P + + TSLQ +
Sbjct: 150 SNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASL---GNLTSLQML 206
Query: 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGEL 241
D N + GEIP + L+ + F + N+ G P + N S L +L + N FSG L
Sbjct: 207 DFIYNQIEGEIP-GDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTL 265
Query: 242 PSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP-- 299
+ S +P LQ LY+ N F T L+N S+ ++L++ N+L G IP
Sbjct: 266 RPDFGSLLPNLQILYMGINSFTGTIPET--------LSNISSLRQLDIPSNHLTGKIPLS 317
Query: 300 -------------------------SIIGDLS--TNLVQIHLDCNLIYGKIPPHISNL-V 331
+G L+ + L +++ N + G++P I+NL
Sbjct: 318 FGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLST 377
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
LT L+L NL++G+IPH + + L+ + L N L+G++P + G++ L + L N L
Sbjct: 378 QLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGL 437
Query: 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLR 451
SG IP S N+S L L L N G+IPSSLG C L L+L NK++G IP ++ L
Sbjct: 438 SGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELP 497
Query: 452 SLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNS 511
SL + LN+S N L GPL ++ K+ +LA+D+S+N LSG IP L +C++LE L L GNS
Sbjct: 498 SL-VVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNS 556
Query: 512 LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFS 571
G +P + L L+ D+S N L G IP+ L+ LN S N F G + +G F
Sbjct: 557 FVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFR 615
Query: 572 SLTIASFQGNDGLCGEIKG--LQTCKKE----HTHHLVILSILLSLFAMSLLFIFGNFLV 625
+ + S GN LCG I LQ C E H+ I++I +S +LL + +
Sbjct: 616 NTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVY 675
Query: 626 LRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYK 685
L + SV + D ++ ++SY +L + TGGF S+LIGSG FG V+K
Sbjct: 676 LCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFK 735
Query: 686 GVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-----DFK 739
G L N +A+KVL+L G SF EC+ L IRHRNL++++TICS DF+
Sbjct: 736 GFLGSKNKAVAIKVLNLCKRGA-AKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFR 794
Query: 740 ALVLPLMSNGSLENHLYP-----SHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
ALV M NG+L+ L+P + S L L + I DVA + YLH + + H
Sbjct: 795 ALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAH 854
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
CD+KPSNILLD+DLTA V+DFG+A+L+ D D+ + + G++GY APE
Sbjct: 855 CDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR------DTFHIQFSSAGVRGTIGYAAPE 908
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR--LDPIVEK 912
YGMG S GDVYSFG++LLEI TG+RPT+ LF DG +LH + K R LD E
Sbjct: 909 YGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDET 968
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
+ QH +N V + + + +G+ C++ +P R SM + ++ +++
Sbjct: 969 ILRGAYAQH----FNMV--ECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRE 1017
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 333/970 (34%), Positives = 488/970 (50%), Gaps = 112/970 (11%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
+ +LDLS + G I NL +L L L++N +G IPAE+G+ L QL L N L
Sbjct: 218 LTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLT 277
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
GKIP++LG+L QL+ L + NKL IP +F T L ++ LS N L G P+ E
Sbjct: 278 GKIPAELGNLVQLQALRIYKNKLTSSIPSSLF---RLTQLTHLGLSENHLVG--PISEEI 332
Query: 199 E-LRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI------------ 245
L +L L L SN G+ PQ++ N L L + N SGELP+++
Sbjct: 333 GFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAH 392
Query: 246 -----------ISKMPQLQFLYLSYNDFVSH--DGNTNLEPFFASLA------------- 279
IS L+ L LS+N G + F S+
Sbjct: 393 DNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFTGEIPDDIF 452
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLS 339
N SN + L +A NNL G + +IG L L + + N + G IP I NL +L +L L
Sbjct: 453 NCSNLETLSVADNNLTGTLKPLIGKLQ-KLRILQVSYNSLTGPIPREIGNLKDLNILYLH 511
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSF 399
SN G IP E+ ++ L+ + + +N L G IP D+ L +LDLS NK SG IP F
Sbjct: 512 SNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALF 571
Query: 400 ANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLN 458
+ L L L L GN +G+IP+SL L D+S N ++G IP ++ A L++++LYLN
Sbjct: 572 SKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLN 631
Query: 459 LSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC---IALE------------ 503
S+N L G +P EL K++MV IDLS N SGSIP L +C L+
Sbjct: 632 FSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPD 691
Query: 504 ----------SLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQL 553
SLNLS NS G +P S G + +L D+SSN L GEIP+S TLK L
Sbjct: 692 EVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHL 751
Query: 554 NFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCK-KEHTHHL-----VILSI 607
+ N G++ G F ++ + GN LCG K L+ C K+ + H VIL I
Sbjct: 752 KLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILII 811
Query: 608 LLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATG 667
L S A+ L+ + L K K + + + L D + K R K+L +AT
Sbjct: 812 LGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDS---ALKLKRFEPKELEQATD 868
Query: 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNL 726
F +++IGS VYKG L+D T IAVKVL+L + E F E + L +++HRNL
Sbjct: 869 SFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNL 928
Query: 727 IRIITIC-SKPDFKALVLPLMSNGSLENHLYPSHGLSHGL-DLIQLVKICSDVAEGVAYL 784
++I+ KALVLP M NG+LE+ + HG + + L++ + +C +A G+ YL
Sbjct: 929 VKILGFAWESGKTKALVLPFMENGNLEDTI---HGSAAPIGSLLEKIDLCVHIASGIDYL 985
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H +VHCDLKP+NILLD D A V+DFG A+++ G E + + +F
Sbjct: 986 HSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARIL-GFREDGSTTASTSAFE------ 1038
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
G++GY+APE+ ++ +T DV+SFG++++E++T +RPT + D +
Sbjct: 1039 -GTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDM---------- 1087
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVV--------LELIELGLLCTQYNPSTRPSML 956
L +VEK+I + + ++ +V + ++L L CT P RP M
Sbjct: 1088 TLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMN 1147
Query: 957 DVAHEMGRLK 966
++ + +L+
Sbjct: 1148 EILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 342/1101 (31%), Positives = 519/1101 (47%), Gaps = 188/1101 (17%)
Query: 7 SLFCFLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCN 66
S F S+ + F +S + ++ ++L++++ S S P WN +D C
Sbjct: 16 SHFSITLSLFLAFFISSTSASTNEV-----SALISWLHSSNSPPPSVFSGWNPSDSDPCQ 70
Query: 67 WSGVKCNNSRNKVV-------------------------ELDLSARSIYGTISPALANLS 101
W + C++S NK+V +L +S ++ G IS + + S
Sbjct: 71 WPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCS 130
Query: 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKL 161
LIV+DLS N G IP+ LG L L++L L+ N L GKIP +LG L+ L++ +N L
Sbjct: 131 ELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYL 190
Query: 162 VGEIPIPIFCSNSSTSLQYIDLSNNS-LTGEIPLK-NECELRNLRFLLLWSNRLVGQVPQ 219
+P+ + ++L+ I NS L+G+IP + C RNL+ L L + ++ G +P
Sbjct: 191 SENLPLEL---GKISTLESIRAGGNSELSGKIPEEIGNC--RNLKVLGLAATKISGSLPV 245
Query: 220 ALANSSKLEWLDLESNMFSGELPSEI-----------------------ISKMPQLQFLY 256
+L SKL+ L + S M SGE+P E+ + K+ L+ +
Sbjct: 246 SLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKML 305
Query: 257 LSYND----------FVSHDGNTNLE-PFFA-----SLANSSNFQELELAGNNLGGMIPS 300
L N+ F+ +L +F+ S N SN QEL L+ NN+ G IPS
Sbjct: 306 LWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPS 365
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360
I+ + T LVQ +D N I G IPP I L L + N L G IP EL L+ +
Sbjct: 366 ILSN-CTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQAL 424
Query: 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420
LS N L+G +P+ + +L L L N +SG IP N + L RL L N ++G IP
Sbjct: 425 DLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIP 484
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480
+G NL LDLS N +SG +P +++ R L++ LNLS+N L G LPL LS + +
Sbjct: 485 KGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQM-LNLSNNTLQGYLPLSLSSLTKLQV 543
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540
+D+S N+L+G IP LG I+L L LS NS G +P S+G L+ D+SSN + G I
Sbjct: 544 LDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTI 603
Query: 541 PQ------------------------------------------------SFQASPTLKQ 552
P+ + L
Sbjct: 604 PEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVS 663
Query: 553 LNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTC-----------KKEHTHH 601
LN S N+FSG + + F L A +GN+GLC KG ++C + H+H
Sbjct: 664 LNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCFVSNSSQLTTQRGVHSHR 721
Query: 602 LVI-LSILLSLFAMSLLFIFGNFLVLRSK--FGKDLSVLNGADLEDEEKEKEEAKNPRVS 658
L I + +L+S+ A+ L + G V+R+K D G +L + + N V
Sbjct: 722 LRIAIGLLISVTAV--LAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVE 779
Query: 659 Y--KQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVL---------DLTTTGEI 707
+ K L+E ++IG G G VYK + + IAVK L + T + +
Sbjct: 780 HVLKCLVEG-------NVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGV 832
Query: 708 TGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGL-SHGLD 766
SF E + L IRH+N++R + C + + L+ MSNGSL + L+ G+ S G +
Sbjct: 833 RDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWE 892
Query: 767 LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826
+ KI A+G+AYLHH +VH D+K +NIL+ D + DFG+AKLV
Sbjct: 893 V--RYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLV----- 945
Query: 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886
D F + + GS GYIAPEYG + + DVYS+GV++LE++TG++P D
Sbjct: 946 ------DDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDP 999
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
DG + +WVK+ I + + Q P + + +++ + + LLC
Sbjct: 1000 TIPDGLHIVDWVKK--------IRDIQVIDQGLQARP----ESEVEEMMQTLGVALLCIN 1047
Query: 947 YNPSTRPSMLDVAHEMGRLKQ 967
P RP+M DVA + + Q
Sbjct: 1048 PIPEDRPTMKDVAAMLSEICQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-114, Method: Compositional matrix adjust.
Identities = 322/962 (33%), Positives = 461/962 (47%), Gaps = 124/962 (12%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141
L+L + + G I P L N SL L LS N G +P EL S I L S N L G +
Sbjct: 263 LNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLEL-SEIPLLTFSAERNQLSGSL 321
Query: 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPI----------FCSN-----------SSTSLQY 180
PS +G L+ L L NN+ GEIP I SN S SL+
Sbjct: 322 PSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEA 381
Query: 181 IDLSNNSLTGEIP-LKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
IDLS N L+G I + + C +L LLL +N++ G +P+ L L LDL+SN F+G
Sbjct: 382 IDLSGNLLSGTIEEVFDGCS--SLGELLLTNNQINGSIPEDLWKL-PLMALDLDSNNFTG 438
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFF-ASLANSSNFQELELAGNNLGGMI 298
E+P + ++F SYN LE + A + N+++ + L L+ N L G I
Sbjct: 439 EIPKSLWKSTNLMEFTA-SYN---------RLEGYLPAEIGNAASLKRLVLSDNQLTGEI 488
Query: 299 PSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
P IG L T+L ++L+ N+ GKIP + + +LT L+L SN L G IP ++ +++L+
Sbjct: 489 PREIGKL-TSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQ 547
Query: 359 RVYLSNNSLSGEIPSA------------FGDIPHLGLLDLSKNKLSGSIPDSFANLSQLR 406
+ LS N+LSG IPS + H G+ DLS N+LSG IP+ L
Sbjct: 548 CLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLV 607
Query: 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVA------------------ 448
+ L NHLSG IP+SL + NL ILDLS N ++G IP ++
Sbjct: 608 EISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGH 667
Query: 449 -----GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALE 503
GL + LNL+ N LDGP+P L + + +DLSFNNLSG + +L + L
Sbjct: 668 IPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLV 727
Query: 504 SLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563
L + N G +P +G L L+ DVS N L GEIP P L+ LN + N G
Sbjct: 728 GLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGE 787
Query: 564 ISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTHHLVILSILLSLFAMSLLFIFGNF 623
+ + G + A GN LCG + G CK E T I + +++ F
Sbjct: 788 VPSDGVCQDPSKALLSGNKELCGRVVG-SDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVF 846
Query: 624 LVLRSKFGKDLSVLNGADLEDEEKEK------------EEAKNP-------------RVS 658
+ R K + + + +E + K ++ P +V
Sbjct: 847 SLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVR 906
Query: 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQIL 718
++EAT F ++IG G FG VYK L +AVK L T + F E + L
Sbjct: 907 LGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKT-QGNREFMAEMETL 965
Query: 719 KRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVA 778
+++H NL+ ++ CS + K LV M NGSL++ L G+ LD + +KI A
Sbjct: 966 GKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAA 1025
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
G+A+LHH ++H D+K SNILLD D VADFG+A+L+ + V+
Sbjct: 1026 RGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVST-------- 1077
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH--DGSSLHE 896
++ G+ GYI PEYG RA+T GDVYSFGV+LLE+VTG+ PT F +G +L
Sbjct: 1078 ----VIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVG 1133
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
W I + K P+ + + L L+++ +LC P+ RP+ML
Sbjct: 1134 WA----------IQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNML 1183
Query: 957 DV 958
DV
Sbjct: 1184 DV 1185
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1059), Expect = e-114, Method: Compositional matrix adjust.
Identities = 316/970 (32%), Positives = 467/970 (48%), Gaps = 131/970 (13%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSL-IRLKQLSLSWNSLQGK 140
LDLSA ++ G I N+S L+ L L+ N G +P + S L+QL LS L G+
Sbjct: 292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIF---------CSNSS------------TSLQ 179
IP +L L+ LDL NN L G IP +F N++ T+LQ
Sbjct: 352 IPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQ 411
Query: 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
++ L +N+L G++P K LR L L L+ NR G++PQ + N + L+ +D+ N F G
Sbjct: 412 WLVLYHNNLEGKLP-KEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEG 470
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
E+P I ++ +L L+L N+ V ASL N L+LA N L G IP
Sbjct: 471 EIPPSI-GRLKELNLLHLRQNELVGG--------LPASLGNCHQLNILDLADNQLSGSIP 521
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTI------------ 347
S G L L Q+ L N + G +P + +L NLT +NLS N LNGTI
Sbjct: 522 SSFGFLK-GLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSF 580
Query: 348 -----------PHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP 396
P EL L+R+ L N L+G+IP G I L LLD+S N L+G+IP
Sbjct: 581 DVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIP 640
Query: 397 DSFANLSQLRRLLLYGNHLSGTIPSSLGK------------------------CVNLEIL 432
+L + L N LSG IP LGK C L +L
Sbjct: 641 LQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVL 700
Query: 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI 492
L N ++G IP ++ L +L + LNL N G LP + K+ + + LS N+L+G I
Sbjct: 701 SLDGNSLNGSIPQEIGNLGALNV-LNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEI 759
Query: 493 PPQLGSCIALES-LNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLK 551
P ++G L+S L+LS N+ G +P ++G L L+ D+S N+L GE+P S +L
Sbjct: 760 PVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLG 819
Query: 552 QLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTHH---------L 602
LN SFN G + K FS SF GN GLCG L C + +++ +
Sbjct: 820 YLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSV 875
Query: 603 VILSILLSLFAMSLL-FIFGNFLVLRSKFGKDL----SVLNGADLEDEEKEKEEAKN--- 654
VI+S + +L A+ L+ + F R F K + + + + K +N
Sbjct: 876 VIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGAS 935
Query: 655 -PRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKR 713
+ ++ ++EAT +IGSG G VYK L++ +AVK + SF R
Sbjct: 936 KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSR 995
Query: 714 ECQILKRIRHRNLIRIITICSKPD--FKALVLPLMSNGSLENHLYPSHGLSHG----LDL 767
E + L RIRHR+L++++ CS L+ M NGS+ + L+ + LD
Sbjct: 996 EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055
Query: 768 IQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827
++I +A+GV YLHH +VH D+K SN+LLD ++ A + DFG+AK++ +
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVL-----T 1110
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887
NC + T ++ S GYIAPEY +A+ DVYS G++L+EIVTG+ PTD +
Sbjct: 1111 ENCDTN----TDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSV 1166
Query: 888 FHDGSSLHEWVKRHYP---HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLC 944
F + WV+ H D +++ + P D +++E+ L C
Sbjct: 1167 FGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE---------EDAACQVLEIALQC 1217
Query: 945 TQYNPSTRPS 954
T+ +P RPS
Sbjct: 1218 TKTSPQERPS 1227
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 317/1009 (31%), Positives = 481/1009 (47%), Gaps = 170/1009 (16%)
Query: 75 SRNKVVELDLSARSIYGTISP---ALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLS 131
S K+ LDLS +I G IS L++ S+ LD S N G+I L + LK L+
Sbjct: 175 SSKKLQTLDLSYNNITGPISGLTIPLSSCVSMTYLDFSGNSISGYISDSLINCTNLKSLN 234
Query: 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
LS+N+ G+IP G L KL LQ +DLS+N LTG
Sbjct: 235 LSYNNFDGQIPKSFGEL-----------KL----------------LQSLDLSHNRLTGW 267
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ 251
IP + R+L+ L L N G +P++L++ S L+ LDL +N SG P+ I+
Sbjct: 268 IPPEIGDTCRSLQNLRLSYNNFTGVIPESLSSCSWLQSLDLSNNNISGPFPNTILRSFGS 327
Query: 252 LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQ 311
LQ L LS N+ +S D F S++ + + + + N G+IP + + +L +
Sbjct: 328 LQILLLS-NNLISGD-------FPTSISACKSLRIADFSSNRFSGVIPPDLCPGAASLEE 379
Query: 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER------------ 359
+ L NL+ G+IPP IS L ++LS N LNGTIP E+ + KLE+
Sbjct: 380 LRLPDNLVTGEIPPAISQCSELRTIDLSLNYLNGTIPPEIGNLQKLEQFIAWYNNIAGEI 439
Query: 360 ------------VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRR 407
+ L+NN L+GEIP F + ++ + + N+L+G +P F LS+L
Sbjct: 440 PPEIGKLQNLKDLILNNNQLTGEIPPEFFNCSNIEWVSFTSNRLTGEVPKDFGILSRLAV 499
Query: 408 LLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS---------------------- 445
L L N+ +G IP LGKC L LDL+ N ++G IP
Sbjct: 500 LQLGNNNFTGEIPPELGKCTTLVWLDLNTNHLTGEIPPRLGRQPGSKALSGLLSGNTMAF 559
Query: 446 ---------------DVAGLRSLKLYLNLSSNHLD------GPLPLELSKMDMVLAIDLS 484
+ +G+R +L S D GP+ ++ + +DLS
Sbjct: 560 VRNVGNSCKGVGGLVEFSGIRPERLLQIPSLKSCDFTRMYSGPILSLFTRYQTIEYLDLS 619
Query: 485 FNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544
+N L G IP ++G IAL+ L LS N L G +P ++GQL L FD S NRL G+IP+SF
Sbjct: 620 YNQLRGKIPDEIGEMIALQVLELSHNQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESF 679
Query: 545 QASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCK--------- 595
L Q++ S N+ +G I +G S+L + N GLCG L CK
Sbjct: 680 SNLSFLVQIDLSNNELTGPIPQRGQLSTLPATQYANNPGLCG--VPLPECKNGNNQLPAG 737
Query: 596 ----KEHTH--------HLVILSILLSLFAMSLLFIFG------NFLVLRSKFGKDLSVL 637
K H + ++L +L+S ++ +L ++ +K L +
Sbjct: 738 TEEGKRAKHGTRAASWANSIVLGVLISAASVCILIVWAIAVRARRRDADDAKMLHSLQAV 797
Query: 638 NGADLEDEEKEKE---------EAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVL 688
N A EKEKE + + ++ + QLIEAT GF +S+IG G FG V+K L
Sbjct: 798 NSATTWKIEKEKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATL 857
Query: 689 QDNTRIAV-KVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747
+D + +A+ K++ L+ G+ F E + L +I+HRNL+ ++ C + + LV M
Sbjct: 858 KDGSSVAIKKLIRLSCQGD--REFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQ 915
Query: 748 NGSLENHLYPSHGLSHG-----LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNI 802
GSLE L HG G L + KI A+G+ +LHH+ ++H D+K SN+
Sbjct: 916 YGSLEEVL---HGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNV 972
Query: 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS 862
LLD+D+ A V+DFG+A+L+ +D ++ + L G+ GY+ PEY R +
Sbjct: 973 LLDQDMEARVSDFGMARLISALDTHLSVST-----------LAGTPGYVPPEYYQSFRCT 1021
Query: 863 THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK---RHYPHR--LDPIVEKAIAKY 917
GDVYS GV++LEI++G+RPTD ++L W K R H +D + K +
Sbjct: 1022 AKGDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWSKMKAREGKHMEVIDEDLLKEGSSE 1081
Query: 918 APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
+ + V +L +E+ L C PS RP+ML V + L+
Sbjct: 1082 SLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLRELR 1130
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-113, Method: Compositional matrix adjust.
Identities = 301/945 (31%), Positives = 463/945 (48%), Gaps = 99/945 (10%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
EL ++ G + +L NL+ L +N F G+IP E+G + LK L L+ N + G+
Sbjct: 185 ELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGE 244
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+P ++G L +L+ + L NK G IP I + TSL+ + L NSL G IP +
Sbjct: 245 LPKEIGMLVKLQEVILWQNKFSGFIPKDI---GNLTSLETLALYGNSLVGPIP-SEIGNM 300
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
++L+ L L+ N+L G +P+ L SK+ +D N+ SGE+P E+ SK+ +L+ LYL N
Sbjct: 301 KSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVEL-SKISELRLLYLFQN 359
Query: 261 DFVSHDGN-----TNLE-----------PFFASLANSSNFQELELAGNNLGGMIPSIIG- 303
N NL P N ++ ++L+L N+L G+IP +G
Sbjct: 360 KLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGL 419
Query: 304 -------DLS---------------TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341
D S +NL+ ++L N I+G IPP + +L L + N
Sbjct: 420 YSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGN 479
Query: 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN 401
L G P ELC + L + L N SG +P G L L L+ N+ S ++P+ +
Sbjct: 480 RLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISK 539
Query: 402 LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSS 461
LS L + N L+G IPS + C L+ LDLS N G +P ++ L L++ L LS
Sbjct: 540 LSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEI-LRLSE 598
Query: 462 NHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALE-SLNLSGNSLEGLLPVSV 520
N G +P + + + + + N SGSIPPQLG +L+ ++NLS N G +P +
Sbjct: 599 NRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEI 658
Query: 521 GQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQG 580
G L L +++N L GEIP +F+ +L NFS+N +G + + F ++T+ SF G
Sbjct: 659 GNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLG 718
Query: 581 NDGLCGEIKGLQTCKKEHTHHLVILSI--------------LLSLFAMSLLFIFGNFLVL 626
N GLCG L++C H+ I S+ + +SLL I L
Sbjct: 719 NKGLCG--GHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL 776
Query: 627 RSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKG 686
R+ ++ + +E + R + K ++EAT GF S ++G G G VYK
Sbjct: 777 RNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKA 836
Query: 687 VLQDNTRIAVKVLD------LTTTGEITGSFKRECQILKRIRHRNLIRIITIC--SKPDF 738
V+ IAVK L+ + SF+ E L +IRHRN++R+ + C +
Sbjct: 837 VMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNS 896
Query: 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLK 798
L+ MS GSL L+ G SH +D I AEG+AYLHH +++H D+K
Sbjct: 897 NLLLYEYMSRGSLGELLH--GGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIK 954
Query: 799 PSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG 858
+NIL+DE+ A V DFG+AK++ M + + + GS GYIAPEY
Sbjct: 955 SNNILIDENFEAHVGDFGLAKVI------------DMPLSKSVSAVAGSYGYIAPEYAYT 1002
Query: 859 KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYA 918
+ + D+YSFGV+LLE++TG+ P L G L W + H I + ++
Sbjct: 1003 MKVTEKCDIYSFGVVLLELLTGKAPVQPL-EQGGDLATWTRNH-------IRDHSLTS-- 1052
Query: 919 PQHMPIYYNKVWSDVVLE----LIELGLLCTQYNPSTRPSMLDVA 959
+ + Y KV DV+L + ++ +LCT+ +PS RP+M +V
Sbjct: 1053 -EILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 983 | ||||||
| 224091833 | 981 | predicted protein [Populus trichocarpa] | 0.994 | 0.996 | 0.763 | 0.0 | |
| 359484856 | 975 | PREDICTED: putative leucine-rich repeat | 0.988 | 0.996 | 0.733 | 0.0 | |
| 255575000 | 960 | Receptor protein kinase CLAVATA1 precurs | 0.969 | 0.992 | 0.726 | 0.0 | |
| 297821685 | 987 | predicted protein [Arabidopsis lyrata su | 0.981 | 0.977 | 0.681 | 0.0 | |
| 356514411 | 981 | PREDICTED: putative leucine-rich repeat | 0.963 | 0.965 | 0.683 | 0.0 | |
| 356498777 | 973 | PREDICTED: putative leucine-rich repeat | 0.969 | 0.979 | 0.674 | 0.0 | |
| 15224094 | 980 | putative leucine-rich repeat transmembra | 0.929 | 0.932 | 0.708 | 0.0 | |
| 356564889 | 975 | PREDICTED: putative leucine-rich repeat | 0.969 | 0.977 | 0.663 | 0.0 | |
| 449457969 | 992 | PREDICTED: putative leucine-rich repeat | 0.971 | 0.962 | 0.644 | 0.0 | |
| 357479973 | 1053 | Receptor-like protein kinase [Medicago t | 0.849 | 0.792 | 0.682 | 0.0 |
| >gi|224091833|ref|XP_002309364.1| predicted protein [Populus trichocarpa] gi|222855340|gb|EEE92887.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1463 bits (3788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 751/984 (76%), Positives = 861/984 (87%), Gaps = 6/984 (0%)
Query: 1 MGSCKFSLFCFLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNST 60
MG+CK S+F FLC +II VVSGE++ Q+++DR SL++F S I+ PE ALESWNS+
Sbjct: 1 MGACKLSMFSFLCLIIILVVVSGEESP---QLVKDRISLLSFRSGIVLDPEGALESWNSS 57
Query: 61 DVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE 120
HVC+W+GVKC+N+ ++V++LDLS S++G ISP LANLSSL+VLDLS+NFF+GHIPAE
Sbjct: 58 SNHVCHWTGVKCDNASDRVIQLDLSGLSLHGRISPILANLSSLLVLDLSRNFFEGHIPAE 117
Query: 121 LGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQY 180
LG L +L+QLSLSWN L G IP +LG LHQL YLDLG+N+L G+IP P+FC N S+SL+Y
Sbjct: 118 LGYLFQLRQLSLSWNLLGGNIPEELGFLHQLVYLDLGSNRLAGDIPAPLFC-NGSSSLEY 176
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
+DLSNNSLTG+IPLKNECEL LRFLLLWSNRLVG+VP+AL+ S+ L+WLDLESNM +GE
Sbjct: 177 MDLSNNSLTGKIPLKNECELSALRFLLLWSNRLVGRVPRALSKSTNLKWLDLESNMLTGE 236
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
LPSEI+ KMP+LQFLYLSYNDFVSHDGNTNLEPFFASL NSS+ QELELAGNNL G IP
Sbjct: 237 LPSEIVRKMPKLQFLYLSYNDFVSHDGNTNLEPFFASLVNSSDLQELELAGNNLRGEIPP 296
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360
I+G+LSTN VQIHLD NL+YG IPPHISNLVNLTLLNLSSNLLNGTIP ELC M KLERV
Sbjct: 297 IVGNLSTNFVQIHLDENLLYGSIPPHISNLVNLTLLNLSSNLLNGTIPLELCRMGKLERV 356
Query: 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420
YLSNNSLSGEIP+A +I HLGLLDLSKNKL+G IPDSFANLSQLRRLLLY N LSGTIP
Sbjct: 357 YLSNNSLSGEIPAALANISHLGLLDLSKNKLTGPIPDSFANLSQLRRLLLYENQLSGTIP 416
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480
SLG+CVNLEILDLS N ISGIIPS+VAGL+SLKLYLNLSSNHL GPLPLELSKMDMVLA
Sbjct: 417 PSLGQCVNLEILDLSRNTISGIIPSEVAGLKSLKLYLNLSSNHLHGPLPLELSKMDMVLA 476
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540
IDLS NNLSGSIPPQLGSCIALE LNLSGN LEGLLP ++GQLPYLK+ DVSSN+L G I
Sbjct: 477 IDLSSNNLSGSIPPQLGSCIALEHLNLSGNVLEGLLPATIGQLPYLKELDVSSNQLSGNI 536
Query: 541 PQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTH 600
PQS +ASPTLK LNFSFNKFSGN SNKGAFSSLTI SF GN+GLCGEIKG+ C+++H H
Sbjct: 537 PQSLEASPTLKHLNFSFNKFSGNTSNKGAFSSLTIDSFLGNEGLCGEIKGMPNCRRKHAH 596
Query: 601 HLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYK 660
H ++L +LLSLFA +LL IF L LRSKF + + + N DLEDE+KE ++ K+PR+SY+
Sbjct: 597 HSLVLPVLLSLFATTLLCIFAYPLALRSKFRRQMVIFNRGDLEDEDKETKDLKHPRISYR 656
Query: 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKR 720
QLIEATGGF SSLIGSG+FGHVYKGVLQDNTRIAVKVLD T GEI+GSFKRECQ+LKR
Sbjct: 657 QLIEATGGFSASSLIGSGQFGHVYKGVLQDNTRIAVKVLDTKTAGEISGSFKRECQVLKR 716
Query: 721 IRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
+HRNLI+IITICSKPDFKALVLPLMSNGSLE HLYPSHGL+ GLDLIQLV IC+DVAEG
Sbjct: 717 AKHRNLIKIITICSKPDFKALVLPLMSNGSLERHLYPSHGLNTGLDLIQLVSICNDVAEG 776
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
VAYLHH+SP++VVHCDLKPSNILLDED+TALV DFGIA+L+KG D+S N +DS+SF+ST
Sbjct: 777 VAYLHHYSPVRVVHCDLKPSNILLDEDMTALVTDFGIARLIKGADDS-NPTDDSVSFSST 835
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
DGLLCGSVGYIAPEYGMGKRAST GDVYSFGVLLLEI+TGRRPTDVLFH+GSSLH W+K
Sbjct: 836 DGLLCGSVGYIAPEYGMGKRASTQGDVYSFGVLLLEIITGRRPTDVLFHEGSSLHGWIKS 895
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
HYPH + PIV++A+ ++AP MP+Y NK+WSDV+LELIELGL+CTQ NPSTRPSML+VA+
Sbjct: 896 HYPHNVKPIVDQAVLRFAPSGMPVYCNKIWSDVILELIELGLICTQNNPSTRPSMLEVAN 955
Query: 961 EMGRLKQYLSSPSS-LIEEAALKG 983
EMG LKQYLSSP LI+EA K
Sbjct: 956 EMGSLKQYLSSPPPLLIDEAYPKA 979
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484856|ref|XP_002274639.2| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1414 bits (3661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 720/982 (73%), Positives = 838/982 (85%), Gaps = 10/982 (1%)
Query: 1 MGSCKFS-LFCFL-CSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWN 58
MG +FS L FL C + + V E+NA +I DRASL+ F+S ++ PE+ L+SWN
Sbjct: 1 MGLSRFSPLISFLYCFIAVLVGVYSEENA---RIFHDRASLLAFLSGVVLDPENTLKSWN 57
Query: 59 STDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIP 118
S+ VHVCNWSGV+CNN R++V+ELDL ++++ GTISPA++NLS L VLDLS NFF+G IP
Sbjct: 58 SSGVHVCNWSGVRCNNGRDQVIELDLRSQALRGTISPAISNLSFLRVLDLSGNFFEGEIP 117
Query: 119 AELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSL 178
AE+G+L RL+QLSLS N L+GKIP++LG L +L YL+LG+N+LVGEIP+ +FC+ SST L
Sbjct: 118 AEIGALFRLQQLSLSSNLLRGKIPAELGLLRELVYLNLGSNQLVGEIPVSLFCNGSST-L 176
Query: 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFS 238
+Y+D SNNSL+GEIPLKN CEL+ LRFLLLWSNRLVG VPQAL+NS+KLEWLD+ESN+ S
Sbjct: 177 EYVDFSNNSLSGEIPLKN-CELKELRFLLLWSNRLVGHVPQALSNSTKLEWLDVESNLLS 235
Query: 239 GELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMI 298
GELPS I+ KMP LQ LYLSYNDFVSHDGNTNLEPFFASL N SNFQELEL GNNLGG I
Sbjct: 236 GELPSGIVQKMPNLQILYLSYNDFVSHDGNTNLEPFFASLVNCSNFQELELGGNNLGGEI 295
Query: 299 PSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
PSIIGDLST+L QIHLD NLIYG IP IS LVNLTLLNLSSNLLNG+IP EL M +LE
Sbjct: 296 PSIIGDLSTSLAQIHLDENLIYGPIPADISRLVNLTLLNLSSNLLNGSIPSELSPMGRLE 355
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
RVY SNNSLSGEIPSAFGDIPHLGLLDLS+NKLSGSIPDSFANLSQLRRLLLY N LSGT
Sbjct: 356 RVYFSNNSLSGEIPSAFGDIPHLGLLDLSENKLSGSIPDSFANLSQLRRLLLYENQLSGT 415
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478
IP SLGKC+NLEILDLSHN+ISG+IPS+VAGLRSLKLYLNLSSNHL GP+PLELSKMDM+
Sbjct: 416 IPPSLGKCINLEILDLSHNRISGMIPSEVAGLRSLKLYLNLSSNHLQGPIPLELSKMDML 475
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG 538
LA+DLS NNLSG+IP QL SCIALE LNLSGN L+G LPVS+GQLPYL++ DVSSN+L G
Sbjct: 476 LAMDLSSNNLSGTIPTQLRSCIALEYLNLSGNVLQGPLPVSIGQLPYLQELDVSSNQLIG 535
Query: 539 EIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEH 598
EIPQS QAS TLK LNFSFN FSGNISNKG+FSSLT+ SF GN GLCG IKG+ C+++H
Sbjct: 536 EIPQSLQASSTLKYLNFSFNNFSGNISNKGSFSSLTMDSFLGNVGLCGSIKGMPNCRRKH 595
Query: 599 THHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVS 658
+HLV+L ILLS+FA +L IFG + +S + L++ NG D+E+ E+E++E K PR++
Sbjct: 596 AYHLVLLPILLSIFATPILCIFGYPFMHKSGIRRPLAIFNGTDMEEGEQERKELKYPRIT 655
Query: 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQIL 718
++QL+EATGGF SSLIGSGRFGHVYKGVL+DNTRIAVKVLD EI+GSFKRECQ+L
Sbjct: 656 HRQLVEATGGFSSSSLIGSGRFGHVYKGVLRDNTRIAVKVLDSRIAAEISGSFKRECQVL 715
Query: 719 KRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVA 778
KR RHRNLIRIITICSKPDFKALVLPLMSNG LE HLYP L HGL+L+QLV ICSDVA
Sbjct: 716 KRTRHRNLIRIITICSKPDFKALVLPLMSNGCLERHLYPGRDLGHGLNLVQLVSICSDVA 775
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
EGVAYLHH+SP++VVHCDLKPSNILLDED+TALV DFGIAKLV G DE + ANDS S++
Sbjct: 776 EGVAYLHHYSPVRVVHCDLKPSNILLDEDMTALVTDFGIAKLVSG-DEGTS-ANDSTSYS 833
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
STDGLLCGS+GYIAPEYG+GKRAST GDVYSFGVLLLEIVTG+RPTDVLFHDGSSLHEWV
Sbjct: 834 STDGLLCGSIGYIAPEYGLGKRASTQGDVYSFGVLLLEIVTGKRPTDVLFHDGSSLHEWV 893
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
K YP++L+PIVE+A+ + P P+ +++W D +LELIELGL+CTQY P+TRPSMLDV
Sbjct: 894 KSQYPNKLEPIVEQALTRATPPATPVNCSRIWRDAILELIELGLICTQYIPATRPSMLDV 953
Query: 959 AHEMGRLKQYLSSPSS-LIEEA 979
A+EM RLKQYL + SS +IEEA
Sbjct: 954 ANEMVRLKQYLCNHSSQMIEEA 975
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575000|ref|XP_002528406.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223532194|gb|EEF33999.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1390 bits (3597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 717/987 (72%), Positives = 831/987 (84%), Gaps = 34/987 (3%)
Query: 1 MGSCKFSLFCFLCSVIIFFVV-SGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNS 59
MGSCKFS+F FLC ++I +V S ++N++ + SL+ F + I+S P+ ALESW S
Sbjct: 1 MGSCKFSMFSFLCLLVICLLVVSAKENSE-------KISLLAFKTGIVSDPQGALESWKS 53
Query: 60 TDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPA 119
+ +HVCNW+GVKC+N + VV+LDLS S+ G ISPALANLSSL +LDLS+N F+G+IPA
Sbjct: 54 SGIHVCNWTGVKCSNVSHHVVKLDLSGLSLRGRISPALANLSSLAILDLSRNLFEGYIPA 113
Query: 120 ELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179
ELG+L +L+++SLSWN L+GKIP +LG L +L YLDL +NKL G+IP P+FC+ +S+SL+
Sbjct: 114 ELGNLFQLQEISLSWNHLEGKIPFELGFLGKLVYLDLASNKLTGDIPAPLFCNGTSSSLE 173
Query: 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
YIDLSNNSLTG IPLKNECEL++LRFLLLWSN+LVGQ+P+AL+NS KL+WLDLESNM SG
Sbjct: 174 YIDLSNNSLTGSIPLKNECELKDLRFLLLWSNKLVGQIPRALSNSKKLQWLDLESNMLSG 233
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
ELPSEI++KMP+LQFLYLSYNDFVSH+GNTNLEPF +SL NSSNFQELELAGNNLGG IP
Sbjct: 234 ELPSEIVNKMPELQFLYLSYNDFVSHEGNTNLEPFLSSLVNSSNFQELELAGNNLGGKIP 293
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
IIGDLS HL ISNLVNLTLLNLSSNLLNG+IP ELC M KLER
Sbjct: 294 PIIGDLS------HL------------ISNLVNLTLLNLSSNLLNGSIPPELCRMGKLER 335
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
VYLSNNSLSGEIP+A GD PHLGLLDLSKNKLSGSIPD+FANLSQL RLLLY N LSGTI
Sbjct: 336 VYLSNNSLSGEIPAALGDTPHLGLLDLSKNKLSGSIPDTFANLSQLGRLLLYDNQLSGTI 395
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
P SLGKC+NLEILDLSHN+ISG+IPS VA LRSLKLYLNLSSNHL GPLPLELSKMDMVL
Sbjct: 396 PPSLGKCINLEILDLSHNQISGLIPSPVAALRSLKLYLNLSSNHLQGPLPLELSKMDMVL 455
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
AIDLS NNLS +IPPQLGSCIALE LNLSGN L+G LP S+G+LPYLKQ DVS N+L G+
Sbjct: 456 AIDLSSNNLSSTIPPQLGSCIALEYLNLSGNILDGPLPDSIGKLPYLKQLDVSLNQLHGK 515
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHT 599
IP+S QASPTLK LNFSFN FSGN+S GAFSSLT+ SF GNDGLCG I G++ C+K+H
Sbjct: 516 IPESLQASPTLKHLNFSFNNFSGNVSKTGAFSSLTMDSFLGNDGLCGTINGMKRCRKKHA 575
Query: 600 HHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSY 659
+H IL LLSLFA L + F VLR K+ K L++ N ++EDEEKE +E K PR+SY
Sbjct: 576 YHSFILPALLSLFATPFLCV---FFVLRYKYRKQLAIFNQGNMEDEEKETKELKYPRISY 632
Query: 660 KQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILK 719
+QL++ATGGF SSLIGSGRFGHVYKGVLQDNTRIAVKVLD T G I+GSFKRECQ+LK
Sbjct: 633 QQLVDATGGFSASSLIGSGRFGHVYKGVLQDNTRIAVKVLDSKTAGAISGSFKRECQVLK 692
Query: 720 RIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE 779
R RHRNLIRIITICSKPDFKALVLPLMSNGSLE +LYPSHGL+ GLDL+QLV ICSDVAE
Sbjct: 693 RARHRNLIRIITICSKPDFKALVLPLMSNGSLERYLYPSHGLNSGLDLVQLVSICSDVAE 752
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID-----ESVNCANDS 834
GVAYLHH+SP++VVHCDLKPSNI+LD+D+TALV DFGIA+L+KGID + ANDS
Sbjct: 753 GVAYLHHYSPVRVVHCDLKPSNIVLDDDMTALVTDFGIARLIKGIDYENNNSNNTPANDS 812
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894
+SF+STD LLCGS+GYIAPEYGMGKRAST GDVYSFGVLLLEI+ G+RPTD+LFH+GSSL
Sbjct: 813 VSFSSTDCLLCGSLGYIAPEYGMGKRASTQGDVYSFGVLLLEIIAGKRPTDLLFHEGSSL 872
Query: 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
HEWVK HYPH+L+ IV++AI + AP MP Y NK+W DV+LELIELGL+CTQ NPSTRPS
Sbjct: 873 HEWVKSHYPHKLENIVKQAILRCAPSAMPSYCNKIWGDVILELIELGLMCTQNNPSTRPS 932
Query: 955 MLDVAHEMGRLKQYLSSPSSLIEEAAL 981
MLDVA EMGRLKQ+LS+P SL+ E A
Sbjct: 933 MLDVAQEMGRLKQFLSNPPSLLTEEAF 959
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297821685|ref|XP_002878725.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297324564|gb|EFH54984.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1270 bits (3286), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/985 (68%), Positives = 801/985 (81%), Gaps = 20/985 (2%)
Query: 1 MGSCKFSLFCFLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNST 60
M SC F FL +V+ V++ ++N D+ SL++F SSI+S P ++L SW S
Sbjct: 1 MDSCSLLFFLFLITVMT--VLASKEN--------DQISLLSFKSSIVSDPHNSLSSWVSL 50
Query: 61 DVHVCN------WSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQ 114
+ WSGVKCN +V+ELD+S + + G ISP++A L++L VLDLS+NFF
Sbjct: 51 SSSSSSLVDVCSWSGVKCNKESTQVIELDISGKDLGGEISPSIAKLTALTVLDLSRNFFV 110
Query: 115 GHIPAELGSLIR-LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173
G IP E+GSL + LKQLSLS N LQG IP +LGSL++L YLDLG+N+L G IP+ +FC+
Sbjct: 111 GKIPPEIGSLHKTLKQLSLSENLLQGDIPQELGSLNRLVYLDLGSNRLTGSIPVQLFCNG 170
Query: 174 SSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLE 233
SS SLQYIDLSNNSLTGEIPLKN C+L+ LRFLLLWSN+L G VP +L+NS+ L+W+DLE
Sbjct: 171 SSLSLQYIDLSNNSLTGEIPLKNHCQLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLE 230
Query: 234 SNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN 293
SN+ +GELPS++ISKMP LQFLYLSYN F+SH+ NTNLEPFFASLANSS+ +ELELAGN+
Sbjct: 231 SNLLTGELPSQVISKMPHLQFLYLSYNHFISHNNNTNLEPFFASLANSSDLEELELAGNS 290
Query: 294 LGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCL 353
LGG I S + LS NLVQIHLD N I+G IPP ISNL+NLTLLNLSSNLL+G IP ELC
Sbjct: 291 LGGEISSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCK 350
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
+SKLERVYLSNN L+GEIP GDIP LGLLD+S+NKLSGSIPDSFANLSQLRRLLLYGN
Sbjct: 351 LSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNKLSGSIPDSFANLSQLRRLLLYGN 410
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSD-VAGLRSLKLYLNLSSNHLDGPLPLEL 472
HLSGT+P SLGKC+NLEILDLSHN +SG IP + V+ LR+LKLYLNLSSNHL GP+PLEL
Sbjct: 411 HLSGTVPQSLGKCINLEILDLSHNNLSGNIPVEVVSNLRNLKLYLNLSSNHLSGPIPLEL 470
Query: 473 SKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVS 532
SKMDMVL++DLS N LSG IPPQLGSCIALE LNLS NS LP S+GQLPYLK+ DVS
Sbjct: 471 SKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNSFSSTLPASLGQLPYLKELDVS 530
Query: 533 SNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQ 592
SNRL G IP SFQ S TLK LNFSFN FSGN+S+KG+FS LTI SF G+ LCG IKG+Q
Sbjct: 531 SNRLNGAIPPSFQQSSTLKHLNFSFNLFSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ 590
Query: 593 TCKKEHTHHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKE-KEE 651
CKK+H + VIL +LLSL L +FG LV RS+FGK+L+V + ++EDEEK+ + +
Sbjct: 591 ACKKKHKYPSVILPVLLSLIVTPFLCVFGYPLVQRSRFGKNLTVYDKEEVEDEEKQNRND 650
Query: 652 AKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSF 711
K PR+SY+QLI ATGGF SSLIGSGRFGHVYKGVL++NT+IAVKVLD T E +GSF
Sbjct: 651 PKYPRISYQQLITATGGFNASSLIGSGRFGHVYKGVLRNNTKIAVKVLDPKTALEFSGSF 710
Query: 712 KRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLV 771
KRECQILKR RHRNLIRIIT C KP FKALVLPLM NGSLE HLYP LS LDLIQLV
Sbjct: 711 KRECQILKRTRHRNLIRIITTCRKPGFKALVLPLMPNGSLERHLYPGEYLSKNLDLIQLV 770
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831
ICSDVAEG+AYLHH+SP+KV+HCDLKPSNILLD+++TALV DFGI++LV+G++E+V+
Sbjct: 771 YICSDVAEGIAYLHHYSPVKVIHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS-T 829
Query: 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891
+DS+SF STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV+GRRPTDVL ++G
Sbjct: 830 DDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEG 889
Query: 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
S+LHE++K HYP+ L+ I+E+A+ ++ PQ P K+W +V+LE+IELGL+CTQYNPST
Sbjct: 890 SNLHEFMKSHYPNSLEEIIEQALIRWKPQGKPERCEKLWREVILEMIELGLICTQYNPST 949
Query: 952 RPSMLDVAHEMGRLKQYLSSPSSLI 976
RP MLDVAHEMGRLK+YL + SL+
Sbjct: 950 RPDMLDVAHEMGRLKEYLFACPSLL 974
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514411|ref|XP_003525899.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1263 bits (3268), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 661/967 (68%), Positives = 770/967 (79%), Gaps = 20/967 (2%)
Query: 11 FLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGV 70
FL I+ V GE+N ++ ++ SLV+FMS I S P++ L+SW S VHVCNW GV
Sbjct: 4 FLFITIVHSGVYGEENV---TLVSEKESLVSFMSGIFSDPKNVLKSWKSPSVHVCNWYGV 60
Query: 71 KCNN-SRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQ 129
+CNN S NK++EL L+ S+ GTISPALANLS L +LDLS NF GHIP ELG LI+L+Q
Sbjct: 61 RCNNASDNKIIELALNGSSLGGTISPALANLSYLQILDLSDNFLVGHIPKELGYLIQLQQ 120
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
LSLS N LQG+IPS+LGS H L YL++G+N+L GE+P +FC+ SST L+YIDLSNNSL
Sbjct: 121 LSLSGNFLQGEIPSELGSFHNLYYLNMGSNQLEGEVPPSLFCNGSST-LRYIDLSNNSLG 179
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
G+IPL NEC L+ LRFLLLWSN VG VP AL+NS +L+W D+ESN SGELPSEI+S
Sbjct: 180 GQIPLSNECILKELRFLLLWSNNFVGHVPLALSNSRELKWFDVESNRLSGELPSEIVSNW 239
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL-STN 308
PQLQFLYLSYN FVSHDGNT LEPFF+SL N SN Q LELAGNNLGG +P IGDL ++
Sbjct: 240 PQLQFLYLSYNGFVSHDGNTKLEPFFSSLMNLSNMQGLELAGNNLGGKLPQNIGDLLPSS 299
Query: 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLS 368
L+Q+HL+ NLI+G IP +I+NLVNLTLLN SSNLLNG+IPH LC M KLER+YLSNNSLS
Sbjct: 300 LLQLHLEDNLIHGSIPSNIANLVNLTLLNFSSNLLNGSIPHSLCQMGKLERIYLSNNSLS 359
Query: 369 GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVN 428
GEIPS G I LGLLDLS+NKLSGSIPD+FANL+QLRRLLLY N LSGTIP SLGKCVN
Sbjct: 360 GEIPSTLGGIRRLGLLDLSRNKLSGSIPDTFANLTQLRRLLLYDNQLSGTIPPSLGKCVN 419
Query: 429 LEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488
LEILDLSHNKISG+IP +VA SLKLYLNLSSN+LDGPLPLELSKMDMVLAIDLS NNL
Sbjct: 420 LEILDLSHNKISGLIPKEVAAFTSLKLYLNLSSNNLDGPLPLELSKMDMVLAIDLSMNNL 479
Query: 489 SGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS- 547
SG IPPQL SCIALE LNLSGNSLEG LP S+G+L Y++ DVSSN+L G IPQS Q S
Sbjct: 480 SGRIPPQLESCIALEYLNLSGNSLEGPLPDSLGKLDYIQALDVSSNQLTGVIPQSLQLSL 539
Query: 548 PTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTHHLVILSI 607
TLK++NFS NKFSG+ISNKGAFSS TI SF GNDGLCG +KG+Q C + +HLV+L +
Sbjct: 540 STLKKVNFSSNKFSGSISNKGAFSSFTIDSFLGNDGLCGSVKGMQNCHTKPRYHLVLLLL 599
Query: 608 LLSLFAMSLLFIF---GNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIE 664
+ L + L G + SK +++++ D +DE++E +E K PR+SY+QLIE
Sbjct: 600 IPVLLIGTPLLCLCMQGYPTIKCSKERMQMAIVSKGDFDDEDEETKELKYPRISYRQLIE 659
Query: 665 ATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRH 723
ATGGF SS IGSGRFG VYKG+L+DNTRIAVKVLD T G+ I+GSF+RECQIL R+RH
Sbjct: 660 ATGGFSASSRIGSGRFGQVYKGILRDNTRIAVKVLDTATAGDIISGSFRRECQILTRMRH 719
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
RNLIRIITICSK +FKALVLPLM NGSLE HLYP S LD++QLV+ICSDVAEG+AY
Sbjct: 720 RNLIRIITICSKKEFKALVLPLMPNGSLERHLYP----SQRLDMVQLVRICSDVAEGMAY 775
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LHH+SP++VVHCDLKPSNILLD+D TALV DFGIA+LVK D N SF ST GL
Sbjct: 776 LHHYSPVRVVHCDLKPSNILLDDDFTALVTDFGIARLVKSDD---NMPTSDSSFCSTHGL 832
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
LCGS+GYIAPEYGMGK AST GDVYSFGVL+LEIVTGRRPTDVL H+GS LHEWVK+ YP
Sbjct: 833 LCGSLGYIAPEYGMGKIASTQGDVYSFGVLVLEIVTGRRPTDVLVHEGSCLHEWVKKQYP 892
Query: 904 HRLDPIVEKAIAK--YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961
H L IVE+A+ + +P MP Y+K DV+LELIELGLLCT +NPSTRPSMLDVA E
Sbjct: 893 HELGNIVEQAMQRCCSSPSGMPNQYHKFGQDVMLELIELGLLCTHHNPSTRPSMLDVAQE 952
Query: 962 MGRLKQY 968
MG+LK Y
Sbjct: 953 MGKLKDY 959
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498777|ref|XP_003518225.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1260 bits (3261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 660/979 (67%), Positives = 791/979 (80%), Gaps = 26/979 (2%)
Query: 4 CKFSLFCFLCSVIIFF--------VVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALE 55
C F +F + V++FF V+ G++NA I+ + SL++FMS I+S P++AL+
Sbjct: 2 CLFRIFRSI--VLLFFFLGTVQSRVLHGKENAG---IVNGKNSLISFMSGIVSDPQNALK 56
Query: 56 SWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQG 115
SW S VHVC+WSGV+CNN+ + ++ELDLS S+ GTISPALAN+SSL +LDLS N+F G
Sbjct: 57 SWKSPGVHVCDWSGVRCNNASDMIIELDLSGGSLGGTISPALANISSLQILDLSGNYFVG 116
Query: 116 HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
HIP ELG L++L QLSLS N LQG IPS+ GSLH L YL+LG+N L GEIP +FC+
Sbjct: 117 HIPKELGYLVQLGQLSLSGNFLQGHIPSEFGSLHNLYYLNLGSNHLEGEIPPSLFCN--G 174
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
TSL Y+DLSNNSL GEIPL EC L++LRFLLLWSN+LVGQVP ALA S+KL+WLDLE N
Sbjct: 175 TSLSYVDLSNNSLGGEIPLNKECILKDLRFLLLWSNKLVGQVPLALAYSTKLKWLDLELN 234
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
M SGELP +I+S PQLQFLYLSYN+F SHDGNTNLEPFFASL N S+FQELELAGNNLG
Sbjct: 235 MLSGELPFKIVSNWPQLQFLYLSYNNFTSHDGNTNLEPFFASLVNLSHFQELELAGNNLG 294
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
G +P IGDL T+L Q+HL+ NLIYG IPP I NLVNLT L LSSNLLNG+IP L M+
Sbjct: 295 GKLPHNIGDLPTSLQQLHLEKNLIYGSIPPQIGNLVNLTFLKLSSNLLNGSIPPSLGHMN 354
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
+LER+YLSNNSLSG+IPS GDI HLGLLDLS+NKLSG IPDSFANLSQLRRLLLY N L
Sbjct: 355 RLERIYLSNNSLSGDIPSILGDIKHLGLLDLSRNKLSGPIPDSFANLSQLRRLLLYDNQL 414
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475
SGTIP SLGKCVNLEILDLSHNKI+G+IP++VA L SLKLYLNLS+N+L G LPLELSKM
Sbjct: 415 SGTIPPSLGKCVNLEILDLSHNKITGLIPAEVAALDSLKLYLNLSNNNLHGSLPLELSKM 474
Query: 476 DMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535
DMVLAID+S NNLSGS+PPQL SC ALE LNLSGNS EG LP S+G+L Y++ DVSSN+
Sbjct: 475 DMVLAIDVSMNNLSGSVPPQLESCTALEYLNLSGNSFEGPLPYSLGKLLYIRALDVSSNQ 534
Query: 536 LFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCK 595
L G+IP+S Q S +LK+LNFSFNKFSG +S+KGAFS+LTI SF GNDGLCG KG+Q C
Sbjct: 535 LTGKIPESMQLSSSLKELNFSFNKFSGRVSHKGAFSNLTIDSFLGNDGLCGRFKGMQHCH 594
Query: 596 KEHTHHLVILSILLSLFAMSLLFIFGNF--LVLRSKFGKDLSVLNGADLEDEEKEKEEAK 653
K+ +HLV L I + LF LL + + + ++SK ++V+ DLED E+ E+ K
Sbjct: 595 KKRGYHLVFLLIPVLLFGTPLLCMLFRYSMVTIKSKVRNRIAVVRRGDLEDVEEGTEDHK 654
Query: 654 NPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKR 713
PR+SYKQL EATGGF SSLIGSGRFG VY+G+LQDNTR+AVKVLD TT GEI+ SF+R
Sbjct: 655 YPRISYKQLREATGGFSASSLIGSGRFGQVYEGMLQDNTRVAVKVLD-TTHGEISRSFRR 713
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E QILK+IRHRNLIRIITIC +P+F ALV PLM NGSLE +LYP S LD++QLV+I
Sbjct: 714 EYQILKKIRHRNLIRIITICCRPEFNALVFPLMPNGSLEKYLYP----SQRLDVVQLVRI 769
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
CSDVAEG++YLHH+SP+KVVHCDLKPSNILLDED+TALV DFGI++LV+ DE+ + N+
Sbjct: 770 CSDVAEGMSYLHHYSPVKVVHCDLKPSNILLDEDMTALVTDFGISRLVQS-DENTSI-NE 827
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
S SF+ST GLLCGSVGYIAPEYGMGK AST GDVYSFGVL+LE+V+GRRPTDVL H+GSS
Sbjct: 828 SASFSSTHGLLCGSVGYIAPEYGMGKHASTEGDVYSFGVLVLEMVSGRRPTDVLSHEGSS 887
Query: 894 LHEWVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
L EW+K+ Y H+L+ VE+A+ +++P +P + NK+W DV+LELIELGL+CTQYNPST
Sbjct: 888 LCEWIKKQYTHQHQLENFVEQALQRFSPCGVPNHRNKIWKDVILELIELGLVCTQYNPST 947
Query: 952 RPSMLDVAHEMGRLKQYLS 970
RPSM D+A EM RLK YL+
Sbjct: 948 RPSMHDIAQEMERLKDYLT 966
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15224094|ref|NP_179990.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75339043|sp|Q9ZUI0.1|Y2241_ARATH RecName: Full=Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130; Flags: Precursor gi|4115373|gb|AAD03374.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|330252438|gb|AEC07532.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1255 bits (3248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/918 (70%), Positives = 761/918 (82%), Gaps = 4/918 (0%)
Query: 62 VHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAEL 121
V VCNWSGVKCN +V+ELD+S R + G ISP++ANL+ L VLDLS+NFF G IP E+
Sbjct: 51 VDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEI 110
Query: 122 GSLIR-LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQY 180
GSL LKQLSLS N L G IP +LG L++L YLDLG+N+L G IP+ +FC+ SS+SLQY
Sbjct: 111 GSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQY 170
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
IDLSNNSLTGEIPL C L+ LRFLLLWSN+L G VP +L+NS+ L+W+DLESNM SGE
Sbjct: 171 IDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGE 230
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
LPS++ISKMPQLQFLYLSYN FVSH+ NTNLEPFFASLANSS+ QELELAGN+LGG I S
Sbjct: 231 LPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITS 290
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360
+ LS NLVQIHLD N I+G IPP ISNL+NLTLLNLSSNLL+G IP ELC +SKLERV
Sbjct: 291 SVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERV 350
Query: 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420
YLSNN L+GEIP GDIP LGLLD+S+N LSGSIPDSF NLSQLRRLLLYGNHLSGT+P
Sbjct: 351 YLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVP 410
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSD-VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
SLGKC+NLEILDLSHN ++G IP + V+ LR+LKLYLNLSSNHL GP+PLELSKMDMVL
Sbjct: 411 QSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVL 470
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
++DLS N LSG IPPQLGSCIALE LNLS N LP S+GQLPYLK+ DVS NRL G
Sbjct: 471 SVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGA 530
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHT 599
IP SFQ S TLK LNFSFN SGN+S+KG+FS LTI SF G+ LCG IKG+Q CKK+H
Sbjct: 531 IPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHK 590
Query: 600 HHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEEKEKE-EAKNPRVS 658
+ V+L +LLSL A +L +FG LV RS+FGK+L+V ++EDEEK+ + + K PR+S
Sbjct: 591 YPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRIS 650
Query: 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQIL 718
Y+QLI ATGGF SSLIGSGRFGHVYKGVL++NT++AVKVLD T E +GSFKRECQIL
Sbjct: 651 YQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQIL 710
Query: 719 KRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVA 778
KR RHRNLIRIIT CSKP F ALVLPLM NGSLE HLYP S LDLIQLV ICSDVA
Sbjct: 711 KRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVA 770
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
EG+AYLHH+SP+KVVHCDLKPSNILLD+++TALV DFGI++LV+G++E+V+ +DS+SF
Sbjct: 771 EGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS-TDDSVSFG 829
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV+GRRPTDVL ++GSSLHE++
Sbjct: 830 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFM 889
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
K HYP L+ I+E+A++++ PQ P K+W +V+LE+IELGL+CTQYNPSTRP MLDV
Sbjct: 890 KSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDV 949
Query: 959 AHEMGRLKQYLSSPSSLI 976
AHEMGRLK+YL + SL+
Sbjct: 950 AHEMGRLKEYLFACPSLL 967
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564889|ref|XP_003550679.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 648/976 (66%), Positives = 779/976 (79%), Gaps = 23/976 (2%)
Query: 6 FSLFCFLCSVIIFF------VVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNS 59
F++F +I F V+ G++NA I+ + SL++FMS I+S P++ALESW S
Sbjct: 4 FTIFRLTVFLIFFLGTVQSRVLHGKENAG---IVNGKKSLISFMSGIVSDPQNALESWKS 60
Query: 60 TDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPA 119
VHVC+WSGV+CNN+ + ++ELDLS S+ GTISPALAN+SSL +LDLS N GHIP
Sbjct: 61 PGVHVCDWSGVRCNNASDMIIELDLSGSSLGGTISPALANISSLQILDLSGNCLVGHIPK 120
Query: 120 ELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179
ELG L++L+QLSLS N LQG IPS+ GSLH L YLDLG+N L GEIP +FC+ TSL
Sbjct: 121 ELGYLVQLRQLSLSGNFLQGHIPSEFGSLHNLYYLDLGSNHLEGEIPPSLFCN--GTSLS 178
Query: 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
Y+DLSNNSL G+IP C L++LRFLLLWSN+LVGQVP ALANS++L+WLDLE NM SG
Sbjct: 179 YVDLSNNSLGGQIPFNKGCILKDLRFLLLWSNKLVGQVPLALANSTRLKWLDLELNMLSG 238
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
ELPS+I+S PQLQFLYLSYN+F SHDGNTNLEPFFASL N S+FQELELAGNNLGG +P
Sbjct: 239 ELPSKIVSNWPQLQFLYLSYNNFTSHDGNTNLEPFFASLVNLSHFQELELAGNNLGGKLP 298
Query: 300 SIIGDL-STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
IGDL T+L Q+HL+ NLIYG IP I NLVNLT L LSSNL+NG+IP L M++LE
Sbjct: 299 HNIGDLIPTSLQQLHLEKNLIYGSIPSQIGNLVNLTFLKLSSNLINGSIPPSLSNMNRLE 358
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
R+YLSNNSLSGEIPS G I HLGLLDLS+NKLSGSIPDSFANLSQLRRLLLY N LSGT
Sbjct: 359 RIYLSNNSLSGEIPSTLGAIKHLGLLDLSRNKLSGSIPDSFANLSQLRRLLLYDNQLSGT 418
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478
IP SLGKCVNLEILDLSHNKI+G+IP +VA L LKLYLNLS+N+L G LPLELSKMDMV
Sbjct: 419 IPPSLGKCVNLEILDLSHNKITGLIPEEVADLSGLKLYLNLSNNNLHGSLPLELSKMDMV 478
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG 538
LAID+S NNLSGSIPPQL SC ALE LNLSGNS EG LP S+G+L Y++ DVSSN+L G
Sbjct: 479 LAIDVSMNNLSGSIPPQLESCTALEYLNLSGNSFEGPLPYSLGKLLYIRSLDVSSNQLTG 538
Query: 539 EIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEH 598
+IP+S Q S +LK+LNFSFNKFSG +SNKGAFS+LT+ SF GNDGLCG KG+Q C K+
Sbjct: 539 KIPESMQLSSSLKELNFSFNKFSGKVSNKGAFSNLTVDSFLGNDGLCGWSKGMQHCHKKR 598
Query: 599 THHLVILSILLSLFAMSLLFI-FGNFLV-LRSKFGKDLSVLNGADLEDEEKEKEEAKNPR 656
+HLV L I + LF LL + F F+V ++SK ++V+ DLED E+ ++ K PR
Sbjct: 599 GYHLVFLLIPVLLFGTPLLCMPFRYFMVTIKSKLRNRIAVVRRGDLEDVEEGTKDHKYPR 658
Query: 657 VSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQ 716
+SYKQL EATGGF SSLIGSGRFG VY+G+LQDNTR+AVKVLD TT GEI+ SF+RE Q
Sbjct: 659 ISYKQLREATGGFTASSLIGSGRFGQVYEGMLQDNTRVAVKVLD-TTHGEISRSFRREYQ 717
Query: 717 ILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSD 776
ILK+IRHRNLIRIITIC +P+F ALV PLM NGSLE HLYP S L+++QLV+ICSD
Sbjct: 718 ILKKIRHRNLIRIITICCRPEFNALVFPLMPNGSLEKHLYP----SQRLNVVQLVRICSD 773
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
VAEG++YLHH+SP+KVVHCDLKPSNILLDED+TALV DFGI++LV + + +DS S
Sbjct: 774 VAEGMSYLHHYSPVKVVHCDLKPSNILLDEDMTALVTDFGISRLV--LSDENTSTSDSAS 831
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
F+ST GLLCGSVGYIAPEYGMGK ST GDVYSFGVL+LE+V+GRRPTDVL H+GSSL +
Sbjct: 832 FSSTHGLLCGSVGYIAPEYGMGKHVSTEGDVYSFGVLVLEMVSGRRPTDVLSHEGSSLCD 891
Query: 897 WVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
W+K+ Y H+L+ VE+A+ +++ +P + K+W DV+LEL+E+GL+CTQYNPSTRP+
Sbjct: 892 WIKKQYTHQHQLENFVEQALHRFSHCGVPNHRVKIWKDVILELVEVGLVCTQYNPSTRPT 951
Query: 955 MLDVAHEMGRLKQYLS 970
M D+A EM RLK L+
Sbjct: 952 MHDIAQEMERLKDNLT 967
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457969|ref|XP_004146720.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/989 (64%), Positives = 775/989 (78%), Gaps = 34/989 (3%)
Query: 6 FSLFCFLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNSTD-VHV 64
F F +V S E+ + + ++A+L++F + I+S P + L+ W S+ +H
Sbjct: 4 FKFFPLFLTVFFLNKASAEEQSSINAA-SEKAALLSFRNGIVSDPHNFLKDWESSSAIHF 62
Query: 65 CNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSL 124
CNW+G+KCNNS +V +LDLS +S+ GTISP+L+NLS+L +LDLS+N F+G IP ELG L
Sbjct: 63 CNWAGIKCNNSTQQVEKLDLSEKSLKGTISPSLSNLSALTILDLSRNSFEGSIPMELGFL 122
Query: 125 IRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLS 184
+ L+QLSLSWN L G IP ++G L +L++LDLG+NKL GEIP+ FC+ S+ SL+YIDLS
Sbjct: 123 VNLQQLSLSWNHLNGNIPKEIGFLQKLKFLDLGSNKLQGEIPL--FCNGSNLSLKYIDLS 180
Query: 185 NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSE 244
NNSL GEIPLKNEC L+NL LLLWSN+LVG++P AL+NS+ L+WLDL SN +GELPS+
Sbjct: 181 NNSLGGEIPLKNECPLKNLMCLLLWSNKLVGKIPLALSNSTNLKWLDLGSNKLNGELPSD 240
Query: 245 IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD 304
I+ KMP LQ+LYLS N+F+SHDGN+NL+PFFASL NSSN QELELAGN L G IPSIIGD
Sbjct: 241 IVLKMPLLQYLYLSDNEFISHDGNSNLQPFFASLVNSSNLQELELAGNQLSGEIPSIIGD 300
Query: 305 LSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364
L NL Q+HLD NLIYG IPP ISNL NLTLLNLSSNLLNG+IP EL + LER YLSN
Sbjct: 301 LHVNLSQLHLDDNLIYGSIPPSISNLRNLTLLNLSSNLLNGSIPSELSRLRNLERFYLSN 360
Query: 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLG 424
NSLSGEIPS+ G+IPHLGLLDLS+NKLSG IP++ ANL+QLR+LLLY N+LSGTIPSSLG
Sbjct: 361 NSLSGEIPSSLGEIPHLGLLDLSRNKLSGLIPEALANLTQLRKLLLYSNNLSGTIPSSLG 420
Query: 425 KCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLS 484
KC+NLEILDLS+N+ISG++PS+VAGLRSLKLYLNLS NHL GPLPLELSKMDMVLAIDLS
Sbjct: 421 KCINLEILDLSNNQISGVLPSEVAGLRSLKLYLNLSRNHLHGPLPLELSKMDMVLAIDLS 480
Query: 485 FNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544
NNLSGSIP QLG+CIALE+LNLS NS +G LP+S+GQLPYL+ DVS N L G IP+S
Sbjct: 481 SNNLSGSIPSQLGNCIALENLNLSDNSFDGSLPISIGQLPYLQSLDVSLNHLTGNIPESL 540
Query: 545 QASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCG----EIKGLQTCKKEHTH 600
+ SPTLK+LN SFN FSG I + G FS LTI+SF GN GLCG IKGL CK++H H
Sbjct: 541 ENSPTLKKLNLSFNNFSGKIPDNGVFSWLTISSFLGNKGLCGSSSSSIKGLPKCKEKHKH 600
Query: 601 HLVILSILLSLFAMSLLFIFG-NFLVLRSKFGKDLSVLNGADLEDEEKEKEEA-KNPRVS 658
H ILSIL+S A + + G + LRSK K +V N DLE+ +E+EE K PR+S
Sbjct: 601 H--ILSILMSSSAAFVFCMIGISLAALRSKMRKRFAVCNRRDLEEANEEEEEEMKYPRIS 658
Query: 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLD-LTTTGEITGSFKRECQI 717
Y QL+EAT GF S+LIGSGRFG VYKG+L DNT+IAVKVL+ + T GEI+ SFKRECQ+
Sbjct: 659 YGQLVEATNGFSSSNLIGSGRFGDVYKGILSDNTKIAVKVLNPMRTAGEISRSFKRECQV 718
Query: 718 LKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDV 777
LKR RHRNLI+IIT CS+PDFKALVLPLM NGSLE+HLYPS +DL+QLV IC DV
Sbjct: 719 LKRTRHRNLIKIITTCSRPDFKALVLPLMGNGSLESHLYPSQ-----IDLVQLVSICRDV 773
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA------ 831
AEGVAYLHHHS ++VVHCDLKPSNILLDED+TALV DFGIA+LV G N
Sbjct: 774 AEGVAYLHHHSHVRVVHCDLKPSNILLDEDMTALVTDFGIARLVSGGGGEDNHNNNNNNG 833
Query: 832 -----NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886
+DS S +ST GLLCGSVGYIAPEYG+GK+AST GDV+SFGVLLLE++TG+RPTD
Sbjct: 834 GGGGQDDSTSISSTHGLLCGSVGYIAPEYGLGKQASTEGDVFSFGVLLLELITGKRPTDH 893
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKY-----APQHMPIYYNKVWSDVVLELIELG 941
F G+ LHEWVK YPH+LDPIV+ A+ +Y A + P ++W +V++E+IE+G
Sbjct: 894 FFEQGAGLHEWVKSQYPHQLDPIVDDAMDRYCTAAAARRGGPRPCKRLWREVIVEVIEMG 953
Query: 942 LLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970
L+CTQ++P+ RPSM+DVA EM RL++YLS
Sbjct: 954 LMCTQFSPALRPSMVDVAQEMTRLQEYLS 982
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479973|ref|XP_003610272.1| Receptor-like protein kinase [Medicago truncatula] gi|355511327|gb|AES92469.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1109 bits (2869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 577/846 (68%), Positives = 689/846 (81%), Gaps = 11/846 (1%)
Query: 15 VIIFFVVSGEDNADDDQ---IIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVK 71
++ +F+V D++ ++ D+ SLV+FMS IIS PE+AL+SW T VHVC+WSGVK
Sbjct: 2 LLFYFLVLVHSRVHDEENIGLMNDKNSLVSFMSYIISDPENALKSWKLTVVHVCDWSGVK 61
Query: 72 CNNSRN--KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQ 129
CNN N +++ELDLS +S+ GTISPALANLS L +LDLS N GHIP ELG L+ L+Q
Sbjct: 62 CNNESNNKRIIELDLSGKSLGGTISPALANLSLLQILDLSGNLLVGHIPRELGYLVHLEQ 121
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
LSLSWN LQG IP + GSLH L YLDLG+N+L GEIP P+ C+ TSL YIDLSNNSL
Sbjct: 122 LSLSWNLLQGDIPLEFGSLHNLYYLDLGSNQLEGEIPPPLLCN--VTSLSYIDLSNNSLG 179
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
G+IPL N+C ++ L+F LLWSN+LVGQVP AL+NS+KL+WLDLESNM SGELPS+II
Sbjct: 180 GKIPLNNKCIIKELKFFLLWSNKLVGQVPLALSNSTKLKWLDLESNMLSGELPSKIICNF 239
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNL 309
PQLQFLYLSYN+FVSHDGNTNLEPFFASL NSSNFQELELAGN+LGG +P IIG+L ++L
Sbjct: 240 PQLQFLYLSYNNFVSHDGNTNLEPFFASLMNSSNFQELELAGNSLGGRLPHIIGNLPSSL 299
Query: 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
+HL+ NLI+G IPPHI+NL NLT L LSSN +NGTIPH LC +++LER+YLS N LSG
Sbjct: 300 QHLHLEENLIHGSIPPHIANLANLTFLKLSSNRINGTIPHSLCKINRLERMYLSKNYLSG 359
Query: 370 EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429
EIPS GDI HLGLLDLSKNKLSGSIPDSFA L+QLRRLLL+ NHLSGTIP +LGKCVNL
Sbjct: 360 EIPSTLGDIQHLGLLDLSKNKLSGSIPDSFAKLAQLRRLLLHENHLSGTIPPTLGKCVNL 419
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489
EILDLSHNKI+G+IPS+VA L SLKLYLNLS+N L G LPLELSKMDMVLAID+S NN S
Sbjct: 420 EILDLSHNKITGMIPSEVAALTSLKLYLNLSNNELQGILPLELSKMDMVLAIDVSMNNFS 479
Query: 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549
G IPPQL +CIALE LNLSGN EG LP ++GQLPY++ D+SSN+L G IP+S Q
Sbjct: 480 GGIPPQLENCIALEYLNLSGNFFEGPLPYTLGQLPYIQSLDISSNQLNGTIPESLQLCSY 539
Query: 550 LKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTHHLVILSILL 609
LK LNFSFNKFSGN+SNKGAFSSLTI SF GN+ LCG KG+Q C ++ ++HLV L + +
Sbjct: 540 LKALNFSFNKFSGNVSNKGAFSSLTIDSFLGNNNLCGPFKGMQQCHRKKSYHLVFLLVPV 599
Query: 610 SLFAMSLLFIFGNFLVLRSKFGKDL-SVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGG 668
LF ++ + + ++++SK K L +V N DLEDEE E +E K+PR+SY+QL EATGG
Sbjct: 600 LLFGTPVICMCRDSIIIKSKVKKKLQAVSNRCDLEDEEVETKEIKHPRISYRQLREATGG 659
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
F SSLIGSG+FG VYKGVL DNTR+AVKVLD T EI+ SF+RECQILK+IRHRNLIR
Sbjct: 660 FNASSLIGSGQFGRVYKGVLLDNTRVAVKVLDATKDNEISWSFRRECQILKKIRHRNLIR 719
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLY-PSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
IITIC+K +FKA+VLPLMSNGSLE +LY P+H LSH LD+IQLV+ICSDVAEG+ YLHH+
Sbjct: 720 IITICNKQEFKAIVLPLMSNGSLERNLYDPNHELSHRLDVIQLVRICSDVAEGMCYLHHY 779
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
SP+KVVHCDLKPSNILLD+D TALV+DFGI++L+KG + C +S SF+ST GLLCGS
Sbjct: 780 SPVKVVHCDLKPSNILLDDDFTALVSDFGISRLLKGDANTSTC--NSTSFSSTHGLLCGS 837
Query: 848 VGYIAP 853
VGYIAP
Sbjct: 838 VGYIAP 843
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 983 | ||||||
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.980 | 0.983 | 0.643 | 0.0 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.804 | 0.767 | 0.353 | 2.4e-127 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.887 | 0.850 | 0.352 | 1.3e-123 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.859 | 0.837 | 0.336 | 5e-115 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.856 | 0.821 | 0.349 | 2.2e-112 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.840 | 0.823 | 0.326 | 1.3e-111 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.864 | 0.841 | 0.336 | 3.3e-111 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.869 | 0.845 | 0.319 | 1.1e-108 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.790 | 0.705 | 0.322 | 1.3e-105 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.796 | 0.699 | 0.318 | 4e-104 |
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3149 (1113.6 bits), Expect = 0., P = 0.
Identities = 630/979 (64%), Positives = 747/979 (76%)
Query: 1 MGSCKFSLFCFLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNST 60
M C + FL +V+ V++ ++N D + I + SL +++SS S+ +S
Sbjct: 1 MDYCSLLVVSFLITVMT--VLASKEN-DHELIKNPQNSLSSWISSSSSS--------SSM 49
Query: 61 DVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE 120
V VCNWSGVKCN +V+ELD+S R + G ISP++ANL+ L VLDLS+NFF G IP E
Sbjct: 50 LVDVCNWSGVKCNKESTQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPE 109
Query: 121 LGSLIR-LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179
+GSL LKQLSLS N L G IP +LG L++L YLDLG+N+L G IP+ +FC+ SS+SLQ
Sbjct: 110 IGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQ 169
Query: 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
YIDLSNNSLTGEIPL C L+ LRFLLLWSN+L G VP +L+NS+ L+W+DLESNM SG
Sbjct: 170 YIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSG 229
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
ELPS++ISKMPQLQFLYLSYN FVSH+ NTNLEPFFASLANSS+ QELELAGN+LGG I
Sbjct: 230 ELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEIT 289
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHIXXXXXXXXXXXXXXXXXGTIPHELCLMSKLER 359
S + LS NLVQIHLD N I+G IPP I G IP ELC +SKLER
Sbjct: 290 SSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLER 349
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
VYLSNN L+GEIP GDIP LGLLD+S+N LSGSIPDSF NLSQLRRLLLYGNHLSGT+
Sbjct: 350 VYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTV 409
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478
P SLGKC+NLEILDLSHN ++G IP +V + LR+LKLYLNLSSNHL GP+PLELSKMDMV
Sbjct: 410 PQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMV 469
Query: 479 LAIDLSFNNLSGSIPPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFG 538
L++DLS N LSG IPPQLGSCIA P S+GQLPYLK+ DVS NRL G
Sbjct: 470 LSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTG 529
Query: 539 EIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEH 598
IP SFQ S TLK LNFSFN SGN+S+KG+FS LTI SF G+ LCG IKG+Q CKK+H
Sbjct: 530 AIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKH 589
Query: 599 TXXXXXXXXXXXXFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXN-PRV 657
A +L +FG LV RS+FGK+L+V ++ PR+
Sbjct: 590 KYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRI 649
Query: 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI 717
SY+QLI ATGGF SSLIGSGRFGHVYKGVL++NT++AVKVLD T E +GSFKRECQI
Sbjct: 650 SYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQI 709
Query: 718 LKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDV 777
LKR RHRNLIRIIT CSKP F ALVLPLM NGSLE HLYP S LDLIQLV ICSDV
Sbjct: 710 LKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDV 769
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
AEG+AYLHH+SP+KVVHCDLKPSNILLD+++TALV DFGI++LV+G++E+V+ +DS+SF
Sbjct: 770 AEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVS-TDDSVSF 828
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897
STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV+GRRPTDVL ++GSSLHE+
Sbjct: 829 GSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEF 888
Query: 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957
+K HYP L+ I+E+A++++ PQ P K+W +V+LE+IELGL+CTQYNPSTRP MLD
Sbjct: 889 MKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLD 948
Query: 958 VAHEMGRLKQYLSSPSSLI 976
VAHEMGRLK+YL + SL+
Sbjct: 949 VAHEMGRLKEYLFACPSLL 967
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 2.4e-127, Sum P(2) = 2.4e-127
Identities = 300/848 (35%), Positives = 444/848 (52%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGH-IPAELGSLIRLKQLSLSWNSLQGK 140
L++S + G I +L+N S L +DLS N GH +P+ELGSL +L L LS N+L G
Sbjct: 126 LNMSYNLLEGRIPSSLSNCSRLSTVDLSSNHL-GHGVPSELGSLSKLAILDLSKNNLTGN 184
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNEC 198
P+ LG+L L+ LD N++ GEIP + T + + ++ NS +G P L N
Sbjct: 185 FPASLGNLTSLQKLDFAYNQMRGEIPDEVA---RLTQMVFFQIALNSFSGGFPPALYNIS 241
Query: 199 ELRNLRFL-LLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L +L +S L L N L L L +N F+G +P + ++ + L+ +
Sbjct: 242 SLESLSLADNSFSGNLRADFGYLLPN---LRRLLLGTNQFTGAIP-KTLANISSLERFDI 297
Query: 258 SYNDFVSHDGNTNLEPFFASLANS--SNFQELELAGNNLGGMIPSIIGDLSTNLVQI-HL 314
S N ++S G+ L F L N + L N+ G+ IG ++ N Q+ +L
Sbjct: 298 SSN-YLS--GSIPLS--FGKLRNLWWLGIRNNSLGNNSSSGL--EFIGAVA-NCTQLEYL 349
Query: 315 DC--NLIYGKIPPHIXXXXXXXXXXXXXXXX-XGTIPHELCLMSKLERVYLSNNSLSGEI 371
D N + G++P I GTIPH++ + L+ + L N LSGE+
Sbjct: 350 DVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGEL 409
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431
P +FG + +L ++DL N +SG IP F N+++L++L L N G IP SLG+C L
Sbjct: 410 PVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLD 469
Query: 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491
L + N+++G IP ++ + SL Y++LS+N L G P E+ K+++++ + S+N LSG
Sbjct: 470 LWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGK 528
Query: 492 IPPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLK 551
+P +G C++ P + +L LK D S+N L G IP+ + P+L+
Sbjct: 529 MPQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLR 587
Query: 552 QLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQT--C-------KKEHTXXX 602
LN S NKF G + G F + T S GN +CG ++ +Q C K++
Sbjct: 588 NLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVR 647
Query: 603 XXXXXXXXXFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRVSYKQL 662
SLL I + F K N +D + +VSY++L
Sbjct: 648 KKVVSGICIGIASLLLII--IVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEEL 705
Query: 663 IEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI 721
AT F ++LIGSG FG+V+KG+L +N +AVKVL+L G T SF EC+ K I
Sbjct: 706 HSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGA-TKSFMAECETFKGI 764
Query: 722 RHRNLIRIITICSK-----PDFKALVLPLMSNGSLE-----NHLYPSHGLSHGLDLIQLV 771
RHRNL+++IT+CS DF+ALV M GSL+ L + S L + +
Sbjct: 765 RHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKL 824
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831
I DVA + YLH H V HCD+KPSNILLD+DLTA V+DFG+A+L+ D +
Sbjct: 825 NIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE-SFL 883
Query: 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891
N F+S G+ G++GY APEYGMG + S GDVYSFG+LLLE+ +G++PTD F
Sbjct: 884 NQ---FSSA-GVR-GTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGD 938
Query: 892 SSLHEWVK 899
+LH + K
Sbjct: 939 YNLHSYTK 946
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 325/922 (35%), Positives = 479/922 (51%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELG-SLIRLKQLSLSWNSLQGK 140
L+LS SI G+I A+ + L LDLS N +G IP E+G SL L L L N L G+
Sbjct: 132 LELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGE 191
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
IPS LG+L L+ DL N+L G IP + +SL ++L N+L+G IP + L
Sbjct: 192 IPSALGNLTSLQEFDLSFNRLSGAIPSSL---GQLSSLLTMNLGQNNLSGMIP-NSIWNL 247
Query: 201 RNLRFLLLWSNRLVGQVP-QALANSSKLEWLDLESNMFSGELPSEII--SKMPQLQFLYL 257
+LR + N+L G +P A LE +D+ +N F G++P+ + S + +Q
Sbjct: 248 SSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGN 307
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS--TNLVQIHLD 315
++ ++ G L + FQ E ++ G I DL+ + L ++L
Sbjct: 308 LFSGIIT-SGFGRLRNLTELYLWRNLFQTREQ--DDWG-----FISDLTNCSKLQTLNLG 359
Query: 316 CNLIYGKIPPHIXXXXXXXXXXXXXXXX-XGTIPHELCLMSKLERVYLSNNSLSGEIPSA 374
N + G +P G+IP ++ + L+ +YL NN+ G +PS+
Sbjct: 360 ENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSS 419
Query: 375 FGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434
G + +LG+L +N LSGSIP + NL++L LLL N SG IP +L NL L L
Sbjct: 420 LGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGL 479
Query: 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPP 494
S N +SG IPS++ +++L + +N+S N+L+G +P E+ + ++ N LSG IP
Sbjct: 480 STNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPN 539
Query: 495 QLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554
LG C P ++GQL L+ D+SSN L G+IP S L LN
Sbjct: 540 TLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLN 599
Query: 555 FSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGL---QTCKKEHTXXXXXXXXXXXX 611
SFN F G + GAF++ + S QGN LCG I L + C
Sbjct: 600 LSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVS 659
Query: 612 FAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRVSYKQLIEATGGFCP 671
A +L + +L++ + K GA +P VSY QL++AT GF P
Sbjct: 660 LAAALAILSSLYLLIT--WHKRTK--KGAP-----SRTSMKGHPLVSYSQLVKATDGFAP 710
Query: 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
++L+GSG FG VYKG L +AVKVL L + SF EC+ L+ +RHRNL++I+T
Sbjct: 711 TNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALK-SFTAECEALRNMRHRNLVKIVT 769
Query: 732 ICSK-----PDFKALVLPLMSNGSLENHLYPS---HGLSHGLDLIQLVKICSDVAEGVAY 783
ICS DFKA+V M NGSLE+ ++P L+L + V I DVA + Y
Sbjct: 770 ICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDY 829
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH H P VVHCD+K SN+LLD D+ A V DFG+A+++ +D + S TS+ G
Sbjct: 830 LHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARIL--VD-GTSLIQQS---TSSMGF 883
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
+ G++GY APEYG+G ASTHGD+YS+G+L+LEIVTG+RPTD F L ++V+
Sbjct: 884 I-GTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLH 942
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVW---SDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
R+ +V+ + + + N ++ ++ L+ LGL C+Q PS+R D+
Sbjct: 943 GRVTDVVDTKLILDSENWLNSTNNSPCRRITECIVWLLRLGLSCSQELPSSRTPTGDIID 1002
Query: 961 EMGRLKQYLSSPSSLIEEAALK 982
E+ +KQ LS + E +L+
Sbjct: 1003 ELNAIKQNLSGLFPVCEGGSLE 1024
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 5.0e-115, P = 5.0e-115
Identities = 304/903 (33%), Positives = 461/903 (51%)
Query: 91 GTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQ 150
G I +L+N S L+ LDL N +P+ELGSL +L L L N L+GK P + +L
Sbjct: 128 GEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTS 187
Query: 151 LEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNECELRNLRFLLL 208
L L+LG N L GEIP I + SL L+ N+ +G P N L NL +LL
Sbjct: 188 LIVLNLGYNHLEGEIPDDIAMLSQMVSLT---LTMNNFSGVFPPAFYNLSSLENL-YLL- 242
Query: 209 WSNRLVGQVPQALANS-SKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDG 267
N G + N + L L N +G +P+ + + + L+ + N
Sbjct: 243 -GNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTL-ANISTLEMFGIGKNRMTG--- 297
Query: 268 NTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIG--DLSTNLVQIH---LDCNLIYGK 322
++ P F L N LELA N+LG + D TN +H + N + G
Sbjct: 298 --SISPNFGKL---ENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGA 352
Query: 323 IPPHIXXXXXXXXXXXXXXXXX-GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHL 381
+P I G+IPH++ + L+ + L++N L+G +P++ G++ L
Sbjct: 353 LPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGL 412
Query: 382 GLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441
G L L N+ SG IP NL+QL +L L N G +P SLG C ++ L + +NK++G
Sbjct: 413 GELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNG 472
Query: 442 IIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA 501
IP ++ + +L ++LN+ SN L G LP ++ ++ ++ + L NNLSG +P LG C++
Sbjct: 473 TIPKEIMQIPTL-VHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLS 531
Query: 502 XXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561
P G L +K D+S+N L G I + F+ L+ LN S N F
Sbjct: 532 MEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFE 590
Query: 562 GNISNKGAFSSLTIASFQGNDGLCGEIKGLQT--CKKE----HTXXXXXXXXXXXXFAMS 615
G + +G F + T+ S GN LCG IK L+ C + T ++
Sbjct: 591 GRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVG 650
Query: 616 LLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRVSYKQLIEATGGFCPSSLI 675
+ + F+V S F K N + + ++SY L AT GF S+++
Sbjct: 651 IALLLLLFIVSLSWFKKRK---NNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIV 707
Query: 676 GSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
GSG FG V+K +LQ +N +AVKVL++ G + SF EC+ LK IRHRNL++++T C+
Sbjct: 708 GSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMK-SFMAECESLKDIRHRNLVKLLTACA 766
Query: 735 KPDF-----KALVLPLMSNGSLENHLYPS-----HGLSHGLDLIQLVKICSDVAEGVAYL 784
DF +AL+ M NGSL+ L+P H S L L++ + I DVA + YL
Sbjct: 767 SIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYL 826
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H H + HCDLKPSNILLD+DLTA V+DFG+A+L+ D+ + S+ G+
Sbjct: 827 HVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQE-----SFFNQLSSAGVR 881
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
G++GY APEYGMG + S HGDVYSFGVL+LE+ TG+RPT+ LF +L+ + K P
Sbjct: 882 -GTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPE 940
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964
R+ I +K+I H + + + ++++GL C + +P R + + A E+
Sbjct: 941 RVLDIADKSIL-----HSGLRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELIS 995
Query: 965 LKQ 967
+++
Sbjct: 996 IRE 998
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 324/928 (34%), Positives = 463/928 (49%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141
L++S G I L+N SSL LDLS N + +P E GSL +L LSL N+L GK
Sbjct: 134 LNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKF 193
Query: 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELR 201
P+ LG+L L+ LD N++ GEIP I + + ++ N G P L
Sbjct: 194 PASLGNLTSLQMLDFIYNQIEGEIPGDIA---RLKQMIFFRIALNKFNGVFP-PPIYNLS 249
Query: 202 NLRFLLLWSNRLVGQV-PQALANSSKLEWLDLESNMFSGELPSEI--ISKMPQLQF---- 254
+L FL + N G + P + L+ L + N F+G +P + IS + QL
Sbjct: 250 SLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNH 309
Query: 255 ----LYLSY----NDFVSHDGNTNLE-------PFFASLANSSNFQELELAGNNLGGMIP 299
+ LS+ N + N +L F +L N S Q L + N LGG +P
Sbjct: 310 LTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP 369
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHIXXXXXXXXXXXXXXXXXGTIPHELCLMSKLER 359
I +LST L ++ L NLI G+IPH + + L+
Sbjct: 370 VFIANLSTQLTELSLGGNLI------------------------SGSIPHGIGNLVSLQT 405
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
+ L N L+G++P + G++ L + L N LSG IP S N+S L L L N G+I
Sbjct: 406 LDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSI 465
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
PSSLG C L L+L NK++G IP ++ L SL + LN+S N L GPL ++ K+ +L
Sbjct: 466 PSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFLL 524
Query: 480 AIDLSFNNLSGSIPPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGE 539
A+D+S+N LSG IP L +C++ P + L L+ D+S N L G
Sbjct: 525 ALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGT 583
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQT--CKKE 597
IP+ L+ LN S N F G + +G F + + S GN LCG I LQ C E
Sbjct: 584 IPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVE 643
Query: 598 ----HTXXXXXXXXXXXXFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXX 653
H+ +LL + + L + SV +
Sbjct: 644 LPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSF 703
Query: 654 NPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFK 712
++SY +L + TGGF S+LIGSG FG V+KG L N +A+KVL+L G SF
Sbjct: 704 YEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAK-SFI 762
Query: 713 RECQILKRIRHRNLIRIITICSKPDF-----KALVLPLMSNGSLENHLYPSH-----GLS 762
EC+ L IRHRNL++++TICS DF +ALV M NG+L+ L+P S
Sbjct: 763 AECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPS 822
Query: 763 HGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822
L L + I DVA + YLH + + HCD+KPSNILLD+DLTA V+DFG+A+L+
Sbjct: 823 RTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLL 882
Query: 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR 882
D + F+S G+ G++GY APEYGMG S GDVYSFG++LLEI TG+R
Sbjct: 883 KFDRDTF----HIQFSSA-GVR-GTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKR 936
Query: 883 PTDVLFHDGSSLHEWVKRHYPHR--LDPIVEKAIAKYA-PQHMPIYYNKVWSDVVLELIE 939
PT+ LF DG +LH + K R LD I ++ I + A QH +N V + + +
Sbjct: 937 PTNKLFVDGLTLHSFTKSALQKRQALD-ITDETILRGAYAQH----FNMV--ECLTLVFR 989
Query: 940 LGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
+G+ C++ +P R SM + ++ +++
Sbjct: 990 VGVSCSEESPVNRISMAEAISKLVSIRE 1017
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 1.3e-111, Sum P(2) = 1.3e-111
Identities = 287/878 (32%), Positives = 412/878 (46%)
Query: 59 STDVHVCNWSGVKCNN-SRNKVVE-LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGH 116
S D+ N SG + S ++++ L L+ I G I P +++LS L L+LS N F G
Sbjct: 73 SLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGS 132
Query: 117 IPAELGS-LIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
P E+ S L+ L+ L + N+L G +P + +L QL +L LG N G+IP P + S
Sbjct: 133 FPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIP-PSY--GSW 189
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLL-WSNRLVGQVPQALANSSKLEWLDLES 234
++Y+ +S N L G+IP + L LR L + + N +P + N S+L D +
Sbjct: 190 PVIEYLAVSGNELVGKIPPEIG-NLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGAN 248
Query: 235 NMFSGELPSEIISKMPQLQFLYLSYNDFV--------------SHDGNTNL--EPFFASL 278
+GE+P EI K+ +L L+L N F S D + N+ AS
Sbjct: 249 CGLTGEIPPEI-GKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASF 307
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHIXXXXXXXXXXX 338
A N L L N L G IP IGDL L + L N G IP +
Sbjct: 308 AELKNLTLLNLFRNKLHGEIPEFIGDLP-ELEVLQLWENNFTGSIPQKLGENGKLNLVDL 366
Query: 339 XXXXXXGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398
GT+P +C +KLE + N L G IP + G L + + +N L+GSIP
Sbjct: 367 SSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKG 426
Query: 399 FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLN 458
L +L ++ L N+LSG +P + G VNL + LS+N++SG +P + ++ L
Sbjct: 427 LFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLL- 485
Query: 459 LSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIAXXXXXXXXXXXXXXXPV 518
L N GP+P E+ K+ + ID S N SG I P++ C P
Sbjct: 486 LDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPN 545
Query: 519 SVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASF 578
+ + L ++S N L G IP S + +L L+FS+N SG + G FS SF
Sbjct: 546 EITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSF 605
Query: 579 QGNDGLCGEIKGLQTCKKEHTXXXXXXXXXXXXFA-MSLLFIFGNFLVLRSKFGKDLSVL 637
GN LCG G CK A M LL + G LV F ++++
Sbjct: 606 LGNPDLCGPYLG--PCKDGVAKGGHQSHSKGPLSASMKLLLVLG-LLVCSIAFAV-VAII 661
Query: 638 NGADLXXXXXXXXXXXNP--RVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIA 695
L R+ + + ++IG G G VYKGV+ + +A
Sbjct: 662 KARSLKKASESRAWRLTAFQRLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVA 720
Query: 696 VKVLDLTTTGEITG-SFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENH 754
VK L + G F E Q L RIRHR+++R++ CS + LV M NGSL
Sbjct: 721 VKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEV 780
Query: 755 LYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVA 813
L+ G H L KI + A+G+ YLHH SP+ +VH D+K +NILLD + A VA
Sbjct: 781 LHGKKG-GH-LHWDTRYKIALEAAKGLCYLHHDCSPL-IVHRDVKSNNILLDSNFEAHVA 837
Query: 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 873
DFG+AK ++ S C MS + GS GYIAPEY + DVYSFGV+
Sbjct: 838 DFGLAKFLQDSGTS-EC----MS------AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVV 886
Query: 874 LLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
LLE+VTGR+P F DG + +WV++ D +++
Sbjct: 887 LLELVTGRKPVGE-FGDGVDIVQWVRKMTDSNKDSVLK 923
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 309/917 (33%), Positives = 466/917 (50%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141
LD+ + G I L N S L+ L L N G +P+ELGSL L QL+L N+++GK+
Sbjct: 119 LDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKL 178
Query: 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNECE 199
P+ LG+L LE L L +N L GEIP + SLQ + +NN +G P L N
Sbjct: 179 PTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLV--ANN-FSGVFPPALYN--- 232
Query: 200 LRNLRFLLLWSNRLVGQV-PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
L +L+ L + N G++ P L ++ N F+G +P+ + S + L+ L ++
Sbjct: 233 LSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTL-SNISTLERLGMN 291
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS--TNLVQIH--- 313
N+ T P F N N + L L N+LG + L+ TN Q+
Sbjct: 292 ENNL------TGSIPTFG---NVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLG 342
Query: 314 LDCNLIYGKIPPHIXXXXXXXXXXXXXXXX-XGTIPHELCLMSKLERVYLSNNSLSGEIP 372
+ N + G +P I G+IP+++ + L+++ L N LSG +P
Sbjct: 343 IGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLP 402
Query: 373 SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEIL 432
++ G + +L L L N+LSG IP N++ L L L N G +P+SLG C +L L
Sbjct: 403 TSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLEL 462
Query: 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI 492
+ NK++G IP ++ ++ L L L++S N L G LP ++ + + + L N LSG +
Sbjct: 463 WIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKL 521
Query: 493 PPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQ 552
P LG+C+ P G L +K+ D+S+N L G IP+ F + L+
Sbjct: 522 PQTLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEY 580
Query: 553 LNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQT--CK-------KEHTXXXX 603
LN SFN G + KG F + T S GN+ LCG I G Q C K+H+
Sbjct: 581 LNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK 640
Query: 604 XXXXXXXX--FAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRVSYKQ 661
+ LLF+ L+ K K+ N + ++SY
Sbjct: 641 KVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTP------STLEVLHEKISYGD 694
Query: 662 LIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKR 720
L AT GF S+++GSG FG VYK +L ++ AVKVL++ G + SF EC+ LK
Sbjct: 695 LRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMK-SFMAECESLKD 753
Query: 721 IRHRNLIRIITICSKPDF-----KALVLPLMSNGSLENHLYPS-----HGLSHGLDLIQL 770
IRHRNL++++T CS DF +AL+ M NGSL+ L+P H S L L++
Sbjct: 754 IRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLER 813
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830
+ I DVA + YLH H + HCDLKPSN+LLD+DLTA V+DFG+A+L+ DE
Sbjct: 814 LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE--- 870
Query: 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890
+ S+ G+ G++GY APEYG+G + S +GDVYSFG+LLLE+ TG+RPT+ LF
Sbjct: 871 --SFFNQLSSAGVR-GTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGG 927
Query: 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
+L+ + K P R+ IV+++I H+ + + + + E+GL C + +P
Sbjct: 928 NFTLNSYTKSALPERILDIVDESIL-----HIGLRVGFPVVECLTMVFEVGLRCCEESPM 982
Query: 951 TRPSMLDVAHEMGRLKQ 967
R + V E+ +++
Sbjct: 983 NRLATSIVVKELISIRE 999
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1074 (383.1 bits), Expect = 1.1e-108, P = 1.1e-108
Identities = 294/921 (31%), Positives = 461/921 (50%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
++ L ++ S+ G I L+N S L+ LDL N + +P+ELGSL +L L L N+L
Sbjct: 115 RLEHLYMAFNSLEGGIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNL 174
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
+GK+P LG+L L+ L +N + GE+P + + L LS N G P
Sbjct: 175 KGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGL---GLSMNKFFGVFP-PAI 230
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANS-SKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
L L L L+ + G + N + L+L N G +P+ + S + LQ
Sbjct: 231 YNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTL-SNISTLQKFG 289
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS-----TNLVQ 311
++ N + P F + + Q L+L+ N LG GDL TN
Sbjct: 290 INKNMMTG-----GIYPNFGKVPS---LQYLDLSENPLGSYT---FGDLEFIDSLTNCTH 338
Query: 312 IHL---DCNLIYGKIPPHIXXXXXXXXXXXXXXXXX-GTIPHELCLMSKLERVYLSNNSL 367
+ L + G +P I G+IP ++ + L+R+ L N L
Sbjct: 339 LQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNML 398
Query: 368 SGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV 427
+G +P++ G + LGLL L N++SG IP NL+QL L L N G +P SLGKC
Sbjct: 399 TGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCS 458
Query: 428 NLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487
++ L + +NK++G IP ++ + +L + L++ N L G LP ++ + ++ + L N
Sbjct: 459 HMLDLRIGYNKLNGTIPKEIMQIPTL-VNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNK 517
Query: 488 LSGSIPPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS 547
SG +P LG+C+A P ++ L +++ D+S+N L G IP+ F
Sbjct: 518 FSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANF 576
Query: 548 PTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQT--C--------KKE 597
L+ LN S N F+G + +KG F + TI GN LCG IK L+ C K
Sbjct: 577 SKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKH 636
Query: 598 HTXXXXXXXXXXXXFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRV 657
+ A+ LL + + ++ + + N + ++
Sbjct: 637 SSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNL-----VPSKLEIFHEKI 691
Query: 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQ 716
SY L AT GF S+++GSG FG V+K +L ++I AVKVL++ G + SF EC+
Sbjct: 692 SYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMK-SFMAECE 750
Query: 717 ILKRIRHRNLIRIITICSKPDF-----KALVLPLMSNGSLENHLYPSHGLS-----HGLD 766
LK RHRNL++++T C+ DF +AL+ + NGS++ L+P L
Sbjct: 751 SLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLT 810
Query: 767 LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826
L++ + I DVA + YLH H + HCDLKPSN+LL++DLTA V+DFG+A+L+ D+
Sbjct: 811 LLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDK 870
Query: 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886
++ S+ G+ G++GY APEYGMG + S HGDVYSFGVLLLE+ TG+RPTD
Sbjct: 871 E-----SFLNQLSSAGVR-GTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDE 924
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
LF +LH + K P ++ I +KAI H+ + ++ + ++E+GL C +
Sbjct: 925 LFGGNLTLHSYTKLALPEKVFEIADKAIL-----HIGLRVGFRTAECLTLVLEVGLRCCE 979
Query: 947 YNPSTRPSMLDVAHEMGRLKQ 967
P+ R + +VA E+ +++
Sbjct: 980 EYPTNRLATSEVAKELISIRE 1000
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 1.3e-105, Sum P(2) = 1.3e-105
Identities = 277/859 (32%), Positives = 410/859 (47%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
+V L L+ + G + + L L + L +N F G IP E+ + L+ L+L N L
Sbjct: 219 LVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLV 278
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
G IP +LG L LE+L L N L G IP I N S +++ ID S N+LTGEIPL+
Sbjct: 279 GPIPKELGDLQSLEFLYLYRNGLNGTIPREI--GNLSYAIE-IDFSENALTGEIPLELG- 334
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS--EIISKMPQLQFLY 256
+ L L L+ N+L G +P L+ L LDL N +G +P + + + LQ
Sbjct: 335 NIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQ 394
Query: 257 LS-----------YNDFVSHDGNTN-LEPFFAS-LANSSNFQELELAGNNLGGMIPSIIG 303
S Y+D D + N L S L SN L L NNL G IP+ I
Sbjct: 395 NSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGIT 454
Query: 304 DLSTNLVQIHLDCNLIYGKIPPHIXXXXXXXXXXXXXXXXXGTIPHELCLMSKLERVYLS 363
T LVQ+ L N + G+ P ++ G+IP E+ S L+R+ L+
Sbjct: 455 TCKT-LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLA 513
Query: 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSL 423
+N +GE+P G + LG L++S NKL+G +P N L+RL + N+ SGT+PS +
Sbjct: 514 DNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEV 573
Query: 424 GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD-MVLAID 482
G LE+L LS+N +SG IP + L L L + N +G +P EL + + +A++
Sbjct: 574 GSLYQLELLKLSNNNLSGTIPVALGNLSRLT-ELQMGGNLFNGSIPRELGSLTGLQIALN 632
Query: 483 LSFNNLSGSIPPQLGSCIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQ 542
LS+N L+G IPP+L + + L +L +++N L GEIP
Sbjct: 633 LSYNKLTGEIPPELSNLV---------------------MLEFLL---LNNNNLSGEIPS 668
Query: 543 SFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKG--LQT--CKKEH 598
SF +L NFS+N +G I +++++SF GN+GLCG +QT
Sbjct: 669 SFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQ 725
Query: 599 TXXXXXXXXXXXXFAMSLLFIFGNFLVLRSKFGKDL-----SVLNGA-DLXXXXXXXXXX 652
+ A++ I G L+L + + +V + A D
Sbjct: 726 STGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIY 785
Query: 653 XNPR--VSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG----E 706
P+ +++ L+ AT F S ++G G G VYK VL +AVK L G
Sbjct: 786 FPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNN 845
Query: 707 ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLD 766
+ SF+ E L IRHRN++++ C+ L+ M GSL L H S LD
Sbjct: 846 VDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEIL---HDPSCNLD 902
Query: 767 LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826
+ KI A+G+AYLHH ++ H D+K +NILLD+ A V DFG+AK++
Sbjct: 903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI----- 957
Query: 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886
M + + + GS GYIAPEY + + D+YS+GV+LLE++TG+ P
Sbjct: 958 -------DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP 1010
Query: 887 LFHDGSSLHEWVKRHYPHR 905
+ G + WV R Y R
Sbjct: 1011 I-DQGGDVVNWV-RSYIRR 1027
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 897 (320.8 bits), Expect = 4.0e-104, Sum P(2) = 4.0e-104
Identities = 263/826 (31%), Positives = 386/826 (46%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
+ L LS + G+I +L NL +L +L L +N+ G IP +LG++ + L LS N L
Sbjct: 272 MTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLT 331
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
G IPS LG+L L L L N L G IP + S LQ L+NN LTG IP +
Sbjct: 332 GSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQ---LNNNKLTGSIP-SSFG 387
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
L+NL +L L+ N L G +PQ L N + LDL N +G +P +L+ LYL
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSF-GNFTKLESLYLR 446
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNL 318
N H + P +ANSS+ L L NN G P + L I LD N
Sbjct: 447 VN----HLSGA-IPP---GVANSSHLTTLILDTNNFTGFFPETVCK-GRKLQNISLDYNH 497
Query: 319 IYGKIPPHIXXXXXXXXXXXXXXXXXGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI 378
+ G IP + G I + L + S+N GEI S +
Sbjct: 498 LEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKS 557
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
P LG L +S N ++G+IP N++QL L L N+L G +P ++G NL L L+ N+
Sbjct: 558 PKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQ 617
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGS 498
+SG +P+ ++ L +L+ L+LSSN+ +P + ++LS N GSIP +L
Sbjct: 618 LSGRVPAGLSFLTNLES-LDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSK 675
Query: 499 CIAXXXXXXXXXXXXXXXPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
P + L L + D+S N L G IP +F+ L ++ S N
Sbjct: 676 LTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNN 735
Query: 559 KFSGNISNKGAFSSLTIASFQGNDGLCGEI--KGLQTC----KKEHTXXXXXXXXXXXXF 612
K G + + F T + + N GLC I + L+ C K +
Sbjct: 736 KLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILG 795
Query: 613 AMSLLFIFGNFLVLRSKFGKDLSVLNGADLXXXXXXXXXXXNPRVSYKQLIEATGGFCPS 672
+ +L I N + K L D + + Y+ +IE+T F P+
Sbjct: 796 VLVILSICANTFTYCIRKRK-LQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPT 854
Query: 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITG-----SFKRECQILKRIRHRNLI 727
LIG+G + VY+ LQD T IAVK L T EI+ F E + L IRHRN++
Sbjct: 855 HLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVV 913
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
++ CS L+ M GSL N L + + L + + + VA ++Y+HH
Sbjct: 914 KLFGFCSHRRHTFLIYEYMEKGSL-NKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHD 972
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+VH D+ NILLD D TA ++DFG AKL+K DS ++++ + G+
Sbjct: 973 RITPIVHRDISSGNILLDNDYTAKISDFGTAKLLK---------TDSSNWSA----VAGT 1019
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
GY+APE+ + + DVYSFGVL+LE++ G+ P D++ SS
Sbjct: 1020 YGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSS 1065
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ZUI0 | Y2241_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7080 | 0.9298 | 0.9326 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 983 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-111 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-36 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-30 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-26 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 8e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 1e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 1e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 367 bits (943), Expect = e-111
Identities = 308/1017 (30%), Positives = 463/1017 (45%), Gaps = 124/1017 (12%)
Query: 11 FLCSVIIFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGV 70
+ + F+ +A++ ++ L++F SSI + P L +WNS+ VC W G+
Sbjct: 12 LIFMLFFLFLNFSMLHAEELEL------LLSFKSSI-NDPLKYLSNWNSS-ADVCLWQGI 63
Query: 71 KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLI-RLKQ 129
CNNS ++VV +DLS ++I G IS A+ L + ++LS N G IP ++ + L+
Sbjct: 64 TCNNS-SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
L+LS N+ G IP GS+ LE LDL NN L GEIP I S +SL+ +DL N L
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI---GSFSSLKVLDLGGNVLV 177
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
G+IP + L +L FL L SN+LVGQ+P+ L L+W+ L N SGE+P E I +
Sbjct: 178 GKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE-IGGL 235
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNL 309
L L L YN+ P +SL N N Q L L N L G IP I L L
Sbjct: 236 TSLNHLDLVYNNLTG--------PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL-QKL 286
Query: 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
+ + L N + G+IP + L NL +L+L SN G IP L + +L+ + L +N SG
Sbjct: 287 ISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG 346
Query: 370 EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429
EIP G +L +LDLS N L+G IP+ + L +L+L+ N L G IP SLG C +L
Sbjct: 347 EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSL 406
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489
+ L N SG +PS+ L L +L++S+N+L G + M + + L+ N
Sbjct: 407 RRVRLQDNSFSGELPSEFTKL-PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF 465
Query: 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549
G +P GS LE+L+LS N G +P +G L L Q +S N+L GEIP +
Sbjct: 466 GGLPDSFGSK-RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 550 LKQLNFSFNKFSG---------------------------------------NISNK--- 567
L L+ S N+ SG NIS+
Sbjct: 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH 584
Query: 568 ------GAFSSLTIASFQGNDGLCGEIK--GLQTCKKEHTHHLVILSILLSLFAMSLLFI 619
GAF ++ ++ GN LCG GL CK+ I +L A +L +
Sbjct: 585 GSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLAL 644
Query: 620 FGNFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEAT-GGFCPSSLIGSG 678
V G++ L + ED E + + +VS I ++I G
Sbjct: 645 VAFGFVFIR--GRNNLELKRVENEDGTWEL-QFFDSKVSKSITINDILSSLKEENVISRG 701
Query: 679 RFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738
+ G YKG N + V ++ I S + + +++H N++++I +C
Sbjct: 702 KKGASYKGKSIKNG-MQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKG 757
Query: 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLK 798
L+ + +L L L + KI +A+ + +LH VV +L
Sbjct: 758 AYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 799 PSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG 858
P I++D G DE + TD S Y+APE
Sbjct: 811 PEKIIID-----------------GKDEPHLRLSLPGLLC-TDTKCFISSAYVAPETRET 852
Query: 859 KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH-RLDPIVEKAIAKY 917
K + D+Y FG++L+E++TG+ P D F S+ EW + Y LD ++ +I
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG- 911
Query: 918 APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSS 974
+ + N+ ++E++ L L CT +P+ RP DV L+ S SS
Sbjct: 912 ---DVSVNQNE-----IVEVMNLALHCTATDPTARPCANDVLKT---LESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 675 IGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG VYKG L T++AVK L + E F E I+K++ H N++R+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +C++ + +V M G L + L L L L+++ +A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VH DL N L+ E+L ++DFG+++ + D G L +
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---------KRGGGKLP--IK 169
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
++APE + ++ DV+SFGVLL EI T G +P + + E ++ Y RL
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLELLEDGY--RLPR 225
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
P++ P EL EL L C Y+P RP+ ++ ++
Sbjct: 226 ----------PENCPD-----------ELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 9e-47
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG VY + +A+KV+ + RE +ILK+++H N++R+ +
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
D LV+ G L + L LS + + + YLH +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED----EARFYLRQILSALEYLHSK---GI 118
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
VH DLKP NILLDED +ADFG+A+ + + T+ G+ Y+A
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL----------DPGEKLTT----FVGTPEYMA 164
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE +GK D++S GV+L E++TG+ P F L E K+ I +
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKK--------IGK- 211
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
P+ S +LI LL +P R + +
Sbjct: 212 ------PKPPFPPPEWDISPEAKDLIR-KLL--VKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VY + ++A+K++ + + RE +ILK++ H N++++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ LV+ GSL++ L L ++++I + EG+ YLH + ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 794 HCDLKPSNILLDED-LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
H DLKP NILLD D +ADFG++KL+ S S + G+ Y+A
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT-------------SDKSLLKTIVGTPAYMA 161
Query: 853 PEYGMGKR-ASTHGDVYSFGVLLLEI 877
PE +GK S D++S GV+L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 9e-43
Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 49/294 (16%)
Query: 675 IGSGRFGHVYKGVL---QDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG VYKG L ++ AVK L + + F RE +I++++ H N++++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +C++ + +V+ M G L ++L L L L+ +A G+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+H DL N L+ E+L ++DFG+++ + D+ +
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLY--DDDYYRKRGGKL----------PIR 168
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
++APE + ++ DV+SFGVLL EI T G +P + + E++K Y RL
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKNGY--RLPQ 224
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
P + P EL +L L C +P RP+ ++ +
Sbjct: 225 ----------PPNCP-----------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 84/294 (28%), Positives = 129/294 (43%), Gaps = 44/294 (14%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITG-SFKRECQILKRIRHRNL 726
+ +GSG FG VYK + +AVK+L + + +RE +IL+R+ H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLH 785
+R+I D LV+ G L ++L G L + KI + G+ YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ ++H DLKP NILLDE+ +ADFG+AK + S T+
Sbjct: 116 SNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS---------SLTT----FV 159
Query: 846 GSVGYIAPE-YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
G+ Y+APE G DV+S GV+L E++TG+ P F + L + +
Sbjct: 160 GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQ--LQLIRR 213
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
L P +E + WS E +L C +PS RP+ ++
Sbjct: 214 ILGPPLE-------------FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 48/294 (16%)
Query: 675 IGSGRFGHVYKGVL---QDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG VYKG L D + AVK L + + F RE +I++++ H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +C++ + +V+ M G L ++L + L L L+ +A G+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-- 122
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+H DL N L+ E+L ++DFG+++ + D + G L +
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY----------YKVKGGKL--PIR 169
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
++APE + ++ DV+SFGVLL EI T G P + + + E++K+ Y RL
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKKGY--RLPK 225
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
P + P EL +L L C +P RP+ ++ +
Sbjct: 226 ----------PPNCP-----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 88/300 (29%), Positives = 140/300 (46%), Gaps = 53/300 (17%)
Query: 675 IGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG VYKG L+ T +AVK L + E F +E +++K++ H N++R++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 731 TICSKPDFKALVLPLMSNGSLENHL------YPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+C++ + LVL M G L ++L +PS S L L L+ +A+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST-LSLKDLLSFAIQIAKGMEYL 121
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
K VH DL N L+ EDL ++DFG+++ V D T G L
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR---------KKTGGKL 169
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP-TDVLFHDGSSLHEWVKRHY 902
+ ++APE ++ DV+SFGVLL EI T G P + + + E++++
Sbjct: 170 --PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK-- 222
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+RL P++ P EL EL L C Q +P RP+ ++ +
Sbjct: 223 GYRLP----------KPEYCPD-----------ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 76/210 (36%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V++G+ + T +AVK L T F E QI+K++RH LI++ +C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ +V LM GSL +L G + L L QL+ + + VA G+AYL + I H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N+L+ E+ VADFG+A++ I E + A + F + + APE
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARV---IKEDIYEAREGAKF---------PIKWTAPE 174
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ R S DV+SFG+LL EIVT GR P
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 76/210 (36%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ G T++AVK L T +F +E QI+K++RH L+++ +CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ + +V MS GSL + L G L L QLV + + +AEG+AYL +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL NIL+ E+L +ADFG+A+L I++ A + F + + APE
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL---IEDDEYTAREGAKF---------PIKWTAPE 174
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
R + DV+SFG+LL EIVT GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 78/223 (34%), Positives = 116/223 (52%), Gaps = 25/223 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+GSG FG V++G+ ++ R+A+K+L + F++E Q LKR+RH++LI + +CS
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ-QDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ ++ LM GSL L G L + L+ + VAEG+AYL +H
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL NIL+ EDL VADFG+A+L+K E V ++D + APE
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIK---EDVYLSSDKKI----------PYKWTAPE 174
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE 896
ST DV+SFG+LL E+ T G+ P + G + HE
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVP-----YPGMNNHE 212
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 31/232 (13%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEIT-GSFKRECQILKRIRHRNLIRIIT 731
L+G G FG VY + +D +AVK ++L+ E + +RE +IL ++H N++R
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 732 ICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICS-DVAEGVAYLHHHS 788
+ L L +S GSL + L L +++ + + EG+AYLH +
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-----EPVIRKYTRQILEGLAYLHSN- 120
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+VH D+K +NIL+D D +ADFG AK + I+ G + G+
Sbjct: 121 --GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT-----------GSVRGTP 167
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-------TDVLFHDGSS 893
++APE G+ D++S G ++E+ TG+ P L+ GSS
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 55/296 (18%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG VYKGVL+ NT +AVK T ++ F +E +ILK+ H N++++I +C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +V+ L+ GSL L L + +L+++ D A G+ YL + I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKNCI--- 115
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N L+ E+ ++DFG+++ + +T +DGL + + AP
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----------EEEGGIYTVSDGLKQIPIKWTAP 164
Query: 854 E---YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP----HRL 906
E YG R ++ DV+S+G+LL E + G + YP +
Sbjct: 165 EALNYG---RYTSESDVWSYGILLWETFSL----------GDT-------PYPGMSNQQT 204
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+E APQ P E+ L L C Y+P RPS ++ +E+
Sbjct: 205 RERIESGYRMPAPQLCPE-----------EIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 88/296 (29%), Positives = 134/296 (45%), Gaps = 52/296 (17%)
Query: 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVL-DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+ IG G FG V G + ++AVK L D +T + +F E ++ +RH NL++++
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLL 66
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ + + +V M+ GSL ++L S G + + L Q + DV EG+ YL
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLR-SRGRAV-ITLAQQLGFALDVCEGMEYLEEK--- 121
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL N+L+ EDL A V+DFG+AK + S DS V +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQG--QDSGKL---------PVKW 165
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
APE K+ ST DV+SFG+LL EI + GR P + L + V
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-----YPRIPLKDVVPH--------- 211
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
VEK AP+ P KV D C + +P+ RP+ + ++ +
Sbjct: 212 VEKGYRMEAPEGCPPEVYKVMKD-----------CWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 73/289 (25%), Positives = 125/289 (43%), Gaps = 49/289 (16%)
Query: 669 FCPSSLIGSGRFGHVYKG-VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
F IG G FG VYK + +A+KV+ L + + E QILK+ +H N++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNIV 60
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ K D +V+ S GSL++ L + L Q+ +C ++ +G+ YLH +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
++H D+K +NILL D + DFG++ + S A ++M G+
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-----SDTKARNTM---------VGT 160
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
++APE GK D++S G+ +E+ G+ P+
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGK--------------------PPYSEL 200
Query: 908 PIVEKAIAKYAPQH--MPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P + KA+ + + + WSD + ++ C Q NP RP+
Sbjct: 201 PPM-KAL-FKIATNGPPGLRNPEKWSDEFKDFLK---KCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 51/307 (16%)
Query: 675 IGSGRFGHVYKG---VLQDNT--RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V L DNT ++AVK L+ + + F+RE +IL+ + H N+++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+C KP ++ L++ + +GSL ++L ++L +L+ S + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE--SVNCANDSMSFTSTDGLLC 845
+ +H DL NIL++ + ++DFG+AK++ + V +S F
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-------- 177
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
+ APE + S+ DV+SFGV L E+ T P+ S E+++ +
Sbjct: 178 ----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ------SPPAEFLRMIGIAQ 227
Query: 906 LDPIVEKAIAKY-------APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
IV + + P P D V +L++ LC + P RPS D+
Sbjct: 228 GQMIVTRLLELLKEGERLPRPPSCP--------DEVYDLMK---LCWEAEPQDRPSFADL 276
Query: 959 AHEMGRL 965
+ RL
Sbjct: 277 ILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 90/282 (31%), Positives = 139/282 (49%), Gaps = 48/282 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ G NT++AVK L T SF E QI+K++RH L+++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + +V MS GSL + L G L L LV + + VA G+AY+ + +
Sbjct: 72 EEPIY--IVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ + L +ADFG+A+L I+++ A F + + AP
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKF---------PIKWTAP 172
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
E + R + DV+SFG+LL E+VT GR P + G + E +++ VE+
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP-----YPGMNNREVLEQ---------VER 218
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
PQ PI L EL L C + +P RP+
Sbjct: 219 GYRMPCPQDCPI-----------SLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-27
Identities = 75/311 (24%), Positives = 123/311 (39%), Gaps = 34/311 (10%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRH-RNLIRI 729
+G G FG VY +D +A+KVL L + + F RE QIL + H N++++
Sbjct: 6 RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
LV+ + GSLE L G L + + I + + + YLH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQILSALEYLHSKG- 121
Query: 790 IKVVHCDLKPSNILLDEDLTALV-ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++H D+KP NILLD D + DFG+AKL+ + + + G+
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS-------VGTP 172
Query: 849 GYIAPEYGMGK---RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
GY+APE +G AS+ D++S G+ L E++TG P +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-------------FEGEKNSSA 219
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-LDVAHEMGR 964
++ + P + +L +P R S D++H++
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 965 LKQYLSSPSSL 975
+ S S
Sbjct: 280 HLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 83/289 (28%), Positives = 137/289 (47%), Gaps = 62/289 (21%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ G +T++A+K L + +F E ++K+++H L+R+ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + ++ M NGSL + L G L + +L+ + + +AEG+A++ + I
Sbjct: 72 QEPIY--IITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERKNYI--- 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ E L +ADFG+A+L I+++ A + F + + AP
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKF---------PIKWTAP 172
Query: 854 E---YGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
E YG + DV+SFG+LL EIVT GR P YP +P
Sbjct: 173 EAINYGT---FTIKSDVWSFGILLTEIVTYGRIP------------------YPGMTNPE 211
Query: 910 V----EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
V E+ P + P EL EL LC + P RP+
Sbjct: 212 VIQNLERGYRMPRPDNCP-----------EELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/211 (34%), Positives = 113/211 (53%), Gaps = 23/211 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V+ G TR+A+K L T +F +E Q++K++RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + +V MS GSL + L G L L QLV + + +A G+AY+ + V
Sbjct: 72 EEPIY--IVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ E+L VADFG+A+L I+++ A F + + AP
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKF---------PIKWTAP 172
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
E + R + DV+SFG+LL E+ T GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 23/211 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V+ G T++A+K L T + +F +E QI+K++RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + +V M GSL + L G L L QLV + + +A+G+AY+ + +
Sbjct: 72 EEPIY--IVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ ++L +ADFG+A+L I+++ A F + + AP
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKF---------PIKWTAP 172
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
E + R + DV+SFG+LL E+VT GR P
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V +D ++ A+KVL + E+ E IL RI H +++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE-HTLTERNILSRINHPFIVK-- 57
Query: 731 TICS--KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + LVL G L +HL S + + +++ + YLH
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS--EERARF--YAAEIVLALEYLHSL- 112
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+++ DLKP NILLD D + DFG+AK + S T+T CG+
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELS----------SEGSRTNTF---CGTP 157
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE +GK D +S GVLL E++TG+ P
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 82/294 (27%), Positives = 122/294 (41%), Gaps = 52/294 (17%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
L+G G FG V+KG L+D T +AVK E+ F E +ILK+ H N++++I +C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ +V+ L+ G + L L QLVK D A G+AYL + I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCI--- 115
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N L+ E+ ++DFG+++ + S+ GL + + AP
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSGLKQIPIKWTAP 163
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYP----HRLDP 908
E R S+ DV+S+G+LL E + G P YP +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCP------------------YPGMTNQQARE 205
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
VEK PQ P KV C Y P RP ++ E+
Sbjct: 206 QVEKGYRMSCPQKCPDDVYKVMQR-----------CWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IGSG+FG V+ G + ++A+K + E F E Q++ ++ H L+++ +C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ LV M +G L ++L G L+ +C DV EG+AYL + V+H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+ E+ V+DFG+ + V +D+ +TS+ G V + +PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV--LDD---------QYTSSTGTKF-PVKWSSPE 171
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885
+ S+ DV+SFGVL+ E+ + G+ P +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 78/291 (26%), Positives = 139/291 (47%), Gaps = 48/291 (16%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G++G VY+GV + + +AVK L T F +E ++K I+H NL++++ +C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 734 SK-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
++ P F ++ M+ G+L ++L + ++ + L+ + + ++ + YL + I
Sbjct: 72 TREPPF-YIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKKNFI-- 126
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
H DL N L+ E+ VADFG+++L+ G A+ F + + A
Sbjct: 127 -HRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKF---------PIKWTA 173
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
PE + S DV++FGVLL EI T G P + D S ++E +++ Y R++
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKGY--RME---- 225
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
P+ P ++ EL C Q+NPS RPS ++
Sbjct: 226 ------RPEGCPP-----------KVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG V +G L+ + +A+K L ++ + F E I+ + H N+IR+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +K ++ M NGSL+ L + G + QLV + +A G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL NIL++ +L V+DFG+++ E + + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSR----RLEDSEATYTTKGGKI-------PIRW 174
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
APE ++ ++ DV+SFG+++ E+++ G RP
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 47/283 (16%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIIT 731
LIG G FG VYKG+ + A+K + L E S +E +LK ++H N+++ I
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
D ++L NGSL + L + + + V +G+AYLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ----VLQGLAYLHEQ---G 119
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
V+H D+K +NIL +D +ADFG+A K D S D + G+ ++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVS-----------KDDASVVGTPYWM 166
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
APE AST D++S G ++E++TG P ++D + + + IV+
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP----YYDLNPMAALFR---------IVQ 213
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
H P+ + EL + + C Q +P+ RP+
Sbjct: 214 -------DDHPPLP-----EGISPELKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/222 (28%), Positives = 113/222 (50%), Gaps = 21/222 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V G + +A+K++ + E F E +++ ++ H L+++ +C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K +V MSNG L N+L HG QL+++C DV EG+AYL + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR-EHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+D+ V+DFG+++ V +D+ +TS+ G V + PE
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYV--LDD---------EYTSSVGSKF-PVRWSPPE 171
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLH 895
+ + S+ DV++FGVL+ E+ + G+ P + + +
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 3e-23
Identities = 70/296 (23%), Positives = 120/296 (40%), Gaps = 61/296 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY D +K +DL+ + + E +ILK++ H N+I+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 732 ICSKPDFKALVLPLMSNGSL---------ENHLYPSHGLSHGLDLIQLVKICSDVAEGVA 782
+ +V+ G L E +P Q++ + +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE---------QILDWFVQLCLALK 117
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
YLH K++H D+KP NI L + + DFGI+K++ + ++ T
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL----------SSTVDLAKT-- 162
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
+ G+ Y++PE K + D++S G +L E+ T + P F +G +L E +
Sbjct: 163 -VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----F-EGENLLELALK-- 214
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
I++ +Y P +P Y+ EL L Q +P RPS+ +
Sbjct: 215 ------ILKG---QYPP--IPSQYSS-------ELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 82/297 (27%), Positives = 144/297 (48%), Gaps = 52/297 (17%)
Query: 675 IGSGRFGHVY----KGVLQDN--TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY KGV++D TR+A+K ++ + F E ++K +++R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENH---LYPSHGLSHGL---DLIQLVKICSDVAEGVA 782
++ + S+ +++ LM+ G L+++ L P + L +++++ ++A+G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
YL+ + K VH DL N ++ ED T + DFG+ + + D G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK---------G 181
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901
LL V +++PE +T+ DV+SFGV+L EI T +P + G S +E V R
Sbjct: 182 LL--PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGMS-NEQVLRF 233
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
++E + P + P D++ EL+ +C QYNP RPS L++
Sbjct: 234 -------VMEGGLLD-KPDNCP--------DMLFELMR---MCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 82/300 (27%), Positives = 140/300 (46%), Gaps = 54/300 (18%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVL-DLTTTGEITGSFKRECQILKRIRHRNLI 727
+G G FG VY+G+ + TR+A+K + + + E F E ++K +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHL---YPSHGLSHGLD---LIQLVKICSDVAEGV 781
R++ + S +V+ LM+ G L+++L P + GL L + +++ +++A+G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
AYL K VH DL N ++ EDLT + DFG+ + + D
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD---------YYRKGGK 180
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900
GLL V ++APE +T DV+SFGV+L E+ T +P + G S +E V
Sbjct: 181 GLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP-----YQGLS-NEEV-- 230
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
L +++ P++ P L+EL +C QYNP RP+ L++
Sbjct: 231 -----LKFVIDGGHLDL-PENCPDK-----------LLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 29/211 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IG G FG V +G ++AVK + T + +F E ++ ++ H+NL+R++ +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQ---AFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+V+ LMS G+L N L + G + + +IQL++ DVAEG+ YL K+VH
Sbjct: 70 HNGLY-IVMELMSKGNLVNFLR-TRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 795 CDLKPSNILLDEDLTALVADFGIAKL-VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
DL NIL+ ED A V+DFG+A++ G+D S L V + AP
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS---------------KL--PVKWTAP 166
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
E K+ S+ DV+S+GVLL E+ + GR P
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 64/210 (30%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ G ++T++AVK L T +F E ++K ++H L+R+ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K + ++ M+ GSL + L G + L +L+ + +AEG+AY+ + I H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL+ +N+L+ E L +ADFG+A++ I+++ A + F + + APE
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV---IEDNEYTAREGAKF---------PIKWTAPE 174
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ DV+SFG+LL EIVT G+ P
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 78/297 (26%), Positives = 142/297 (47%), Gaps = 46/297 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG+G FG V++G+L+ R +A+K L T + F E I+ + H N+IR+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +K ++ M NG+L+ +L G QLV + +A G+ YL S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ VH DL NIL++ +L V+DFG++++++ E ++T++ G + +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--------TYTTSGGKI--PIR 175
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
+ APE ++ ++ DV+SFG+++ E+++ G RP + D S+ HE +K
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP----YWDMSN-HEVMKA-------- 222
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
+ AP P +L L C Q + + RP +D+ + + +L
Sbjct: 223 -INDGFRLPAPMDCPSAVY-----------QLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 55/291 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVL-----DLTTTGEITGSFKRECQILKRIRHRNLIR 728
IG G FG VY V L +AVK + D T EI E ++L+ ++H NL++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI----ADEMKVLELLKHPNLVK 63
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + + + S G+LE L HG +I++ + + EG+AYLH H
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTL--QLLEGLAYLHSH- 118
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+VH D+KP+NI LD + + DFG A +K N + L G+
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK--------NNTTTMGEEVQSLA-GTP 167
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
Y+APE G + HG D++S G ++LE+ TG+RP W
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-------------W------SE 208
Query: 906 LDPIVEKAIA-KYAPQHMPIYYNKV-WSDVVLELIELGLLCTQYNPSTRPS 954
LD E I H P + + S + ++ C + +P RP+
Sbjct: 209 LDN--EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 33/227 (14%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ G D +AVK L T + + F+RE ++L +H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHG----------LSHG-LDLIQLVKICSDV 777
+C++ D +V M +G L L SHG G L L QL++I +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL + VH DL N L+ DL + DFG+++ V D +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-----------Y 177
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
G + ++ PE M ++ +T DV+SFGV+L EI T G++P
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
++G G G VYK + A+K + + E RE + L+ +++
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
K ++VL M GSL + L + L I + +G+ YLH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPE----PVLAYIARQILKGLDYLHTKR--H 120
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
++H D+KPSN+L++ +ADFGI+K ++ +++ N +F G+V Y+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISK---VLENTLDQCN---TF-------VGTVTYM 167
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+PE G+ S D++S G+ LLE G+ P
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 7e-22
Identities = 73/225 (32%), Positives = 107/225 (47%), Gaps = 30/225 (13%)
Query: 674 LIGSGRFGHVYKGVL-QDNT---RIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLI 727
++G G FG V +G L QD+ ++AVK + L T EI F E +K H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPNVM 64
Query: 728 RIITIC------SKPDFKALVLPLMSNGSLENHLYPSH--GLSHGLDLIQLVKICSDVAE 779
++I +C K ++LP M +G L + L S GL L L L+K D+A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ YL S +H DL N +L ED+T VADFG++K + D M
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 177
Query: 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
V +IA E + ++ DV++FGV + EI T G+ P
Sbjct: 178 -------PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 671 PSSL-----IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN 725
PS L +GSG+FG V+ G + +A+K++ E F E +++ ++ H N
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPN 60
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
L+++ +C+K +V M+NG L N+L G L L+ +CSDV E + YL
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLE 117
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ +H DL N L+ ED V+DFG+A+ V +D+ +TS+ G
Sbjct: 118 SNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQ---------YTSSQGTKF 163
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885
V + PE R S+ DV+SFGVL+ E+ + G+ P +
Sbjct: 164 -PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-22
Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 30/226 (13%)
Query: 674 LIGSGRFGHVYKGVLQD-------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
+GSG FG VY+G D R+AVK L T + F +E ++ H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG---LDLIQLVKICSDVAEGVAY 783
++++ +C + + +++ LM G L ++L + G L L +L+ IC DVA+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 784 LHHHSPIKVVHCDLKPSNILLDE-----DLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
L + +H DL N L+ E D + DFG+A+ + +D
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--------KSDYYR-K 169
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+GLL V ++APE + + +T DV+SFGVL+ EI+T G++P
Sbjct: 170 EGEGLL--PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 82/292 (28%), Positives = 131/292 (44%), Gaps = 48/292 (16%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG V+ G L+ DNT +AVK T ++ F +E +ILK+ H N++R+I +C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ +V+ L+ G L + G L + +L+++ + A G+ YL I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR-TEGPR--LKVKELIQMVENAAAGMEYLESKHCI--- 116
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N L+ E ++DFG+++ + + ST G+ V + AP
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----------EEEDGVYASTGGMKQIPVKWTAP 165
Query: 854 E---YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
E YG R S+ DV+SFG+LL E F G+ + + +
Sbjct: 166 EALNYG---RYSSESDVWSFGILLWEA----------FSLGAVPYANLSNQQTREA---I 209
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
E+ + P+ P D V L+E C +Y+P RPS V E+
Sbjct: 210 EQGVRLPCPELCP--------DAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 39/270 (14%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLD---LTTTGEITGSFKRECQILKRI-RH 723
F +IG G F V + N A+K+LD L ++ K E ++L R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV-KYVKIEKEVLTRLNGH 61
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVAEGV 781
+I++ + VL NG L ++ Y S LD +++ +
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS------LDEKCTRFYAAEILLAL 115
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID-------ESVNCANDS 834
YLH ++H DLKP NILLD+D+ + DFG AK++ ++ N +
Sbjct: 116 EYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894
G+ Y++PE K A D+++ G ++ +++TG+ P F +
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRGSN-- 226
Query: 895 HEW------VKRHY--PHRLDPIVEKAIAK 916
E+ +K Y P P + I K
Sbjct: 227 -EYLTFQKILKLEYSFPPNFPPDAKDLIEK 255
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 75/317 (23%), Positives = 127/317 (40%), Gaps = 83/317 (26%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
IG G +G VYK + +A+K + + E IT RE ++L+++RH N++R+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT--AIREIKLLQKLRHPNIVRLK 64
Query: 731 TICSKPDFKA--LVLPLMS---NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
I + + +V M G L++ P + Q+ + EG+ YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDS---PEVKFTES----QIKCYMKQLLEGLQYLH 117
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS---TDG 842
+ ++H D+K SNIL++ D +ADFG+A+ N A+ +T+ T
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPY----TKRNSAD----YTNRVIT-- 164
Query: 843 LLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR-------------------- 881
+ Y PE +G R D++S G +L E+ G+
Sbjct: 165 -----LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG 219
Query: 882 RPTDVLFHDGSSLHEW----VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLEL 937
PTD + S L + K+ Y RL ++ + L+L
Sbjct: 220 SPTDENWPGVSKLPWFENLKPKKPYKRRLR----------------EFFKHLIDPSALDL 263
Query: 938 IELGLLCTQYNPSTRPS 954
++ LL +P R S
Sbjct: 264 LD-KLLT--LDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 85/290 (29%), Positives = 130/290 (44%), Gaps = 52/290 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII-TIC 733
IG G FG V G + ++AVK + T + +F E ++ ++RH NL++++ I
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +V M+ GSL ++L S G S L L+K DV E + YL ++ V
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLR-SRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N+L+ ED A V+DFG+ K ++ V + AP
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP----------------VKWTAP 168
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
E K+ ST DV+SFG+LL EI + GR P + L + V P VEK
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVV---------PRVEK 214
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
AP P VV ++++ C + +TRPS L + ++
Sbjct: 215 GYKMDAPDGCP--------PVVYDVMK---QCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 35/228 (15%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ QD +AVK L + F+RE ++L ++H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHG-----LSHG-------LDLIQLVKICSD 776
+C++ +V M +G L N SHG L+ G L L Q++ I S
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ YL + + VH DL N L+ + L + DFG+++ + D
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----------- 176
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ G + ++ PE + ++ +T D++SFGV+L EI T G++P
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 23/211 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ +T++AVK + + +F E ++K ++H L+++ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
K P + ++ M+ GSL + L G L +L+ + +AEG+A++ + I
Sbjct: 72 KEPIY--IITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ L +ADFG+A++ I+++ A + F + + AP
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKF---------PIKWTAP 172
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
E + DV+SFG+LL+EIVT GR P
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 21/215 (9%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG+G FG V G L+ + +A+K L T + F E I+ + H N+I +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +K +V M NGSL+ L G +IQLV + +A G+ YL S
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYL---SD 124
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ VH DL NIL++ +L V+DFG++++++ E+ +T+ G + +
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--------YTTRGGKI--PIR 174
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ APE ++ ++ DV+S+G+++ E+++ G RP
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-19
Identities = 40/89 (44%), Positives = 56/89 (62%)
Query: 336 LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI 395
L L + L G IP+++ + L+ + LS NS+ G IP + G I L +LDLS N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 396 PDSFANLSQLRRLLLYGNHLSGTIPSSLG 424
P+S L+ LR L L GN LSG +P++LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 71/213 (33%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 674 LIGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG VY G L D+ AVK L+ T E F +E I+K H N++ +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 730 ITICSKPDFKALV-LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ IC + LV LP M +G L N + +H + L+ VA+G+ YL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLV--KGIDESVNCANDSMSFTSTDGLLCG 846
K VH DL N +LDE T VADFG+A+ + K N +
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL----------- 164
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
V ++A E ++ +T DV+SFGVLL E++T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 53/300 (17%)
Query: 671 PSSL-----IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN 725
PS L +GSG+FG V+ G + ++A+K ++ E F E +++ ++ H
Sbjct: 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPK 60
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYL 784
L+++ +C++ +V M NG L N+L G LS + L+ +C DV EG+ YL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYL 116
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
+S I H DL N L+ V+DFG+ + V +D+ +TS+ G
Sbjct: 117 ERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDE---------YTSSSGAK 162
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYP 903
V + PE + S+ DV+SFGVL+ E+ T G+ P F S+
Sbjct: 163 F-PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVEMISRG 217
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
RL Y P+ + +V C P RP+ ++ +
Sbjct: 218 FRL----------YRPKLASMTVYEVM-----------YSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 82/300 (27%), Positives = 128/300 (42%), Gaps = 51/300 (17%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G VY + L +N ++A+K +DL ++E Q + + H N+++ T
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 734 SKPDFKALVLPLMSNGSLEN---HLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
D LV+P +S GSL + YP GL D + + +V +G+ YLH + I
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGL----DEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
H D+K NILL ED + +ADFG+ A L G D + G+
Sbjct: 125 ---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT----------FVGTPC 171
Query: 850 YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
++APE D++SFG+ +E+ TG P + YP P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP----YS-----------KYP----P 212
Query: 909 I-VEKAIAKYAPQHMPI-YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
+ V + P + K +S ++I LC Q +PS RP+ A E+ + K
Sbjct: 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS---LCLQKDPSKRPT----AEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 21/216 (9%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG+G FG V +G L+ + +A+K L T + F E I+ + H N+I +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +K ++ M NG+L++ L + G +IQLV + +A G+ YL S
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL---SE 124
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG-SV 848
+ VH DL NIL++ +L V+DFG+++ ++ +D+ T T L +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE---------DDTSDPTYTSSLGGKIPI 175
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ APE ++ ++ DV+S+G+++ E+++ G RP
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 83/315 (26%), Positives = 133/315 (42%), Gaps = 64/315 (20%)
Query: 675 IGSGRFGHVYK----GVL--QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
IG G FG V++ G+L + T +AVK+L + ++ F+RE ++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL-----YPSHGLSHG-------------LDLIQL 770
++ +C+ L+ M+ G L L LSH L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830
+ I VA G+AYL S K VH DL N L+ E++ +ADFG+++ + D
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889
ND++ + ++ PE R +T DV+++GV+L EI + G +P +
Sbjct: 190 ENDAI-----------PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-----Y 233
Query: 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
G + HE V + V P + P LEL L LC P
Sbjct: 234 YGMA-HEEVIYY--------VRDGNVLSCPDNCP-----------LELYNLMRLCWSKLP 273
Query: 950 STRPSMLDVAHEMGR 964
S RPS + + R
Sbjct: 274 SDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 675 IGSGRFGHVYKGVLQ--DNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V KGV + AVK L F RE ++ ++ H ++R+I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+C LV+ L G L +L DL +L VA G+AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLK-KRREIPVSDLKELA---HQVAMGMAYLESK--- 114
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS--V 848
VH DL N+LL A ++DFG+++ ++ +D T+ G +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSR-------ALGAGSDYYRATTA-----GRWPL 162
Query: 849 GYIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ APE YG + S+ DV+S+GV L E + G +P
Sbjct: 163 KWYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 671 PSSLIGSGRFGHVYKGVLQD--NTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
IG G+FG VY+GV N +I AVK T+ + F +E I+++ H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+++I + ++ +V+ L G L ++L + + LDL L+ ++ +AYL
Sbjct: 70 VKLIGVITENPV-WIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLE- 124
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ VH D+ N+L+ + DFG+++ ++ DES + ++ G L
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESY--------YKASKGKL-- 170
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ ++APE +R ++ DV+ FGV + EI+ G +P
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 675 IGSGRFGHVYKGV---LQDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+GSG FG VYKGV + +I A+KVL T+ + E ++ + H +++R+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ IC L+ LM G L +++ + L+ C +A+G++YL
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK-- 128
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++VH DL N+L+ + DFG+AKL+ ++ + + +
Sbjct: 129 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-----------PIK 176
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885
++A E + + + DV+S+GV + E++T G +P +
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 675 IGSGRFGHVYKGVLQDN-TRIAVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG V +D A+K + G + + E +IL+ + H L+ +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVLNERRILQELNHPFLVNLW 66
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ LV+ L+ G L HL S + + ++ + + YLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE--IVLALEYLHSK--- 119
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H D+KP NILLDE + DF IA V D+++ ++ G+ GY
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---------DTLTTST-----SGTPGY 165
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE + S D +S GV E + G+RP
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 63/293 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDL----TTTGEITGSFKRECQILKRIRHRNLIR 728
L+GSG FG VY+G+ L D AVK + L T E ++E +L +++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + D + L L+ GSL L +G + + G+ YLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYG---SFPEPVIRLYTRQILLGLEYLHDR- 121
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
VH D+K +NIL+D + +ADFG+AK V + + GS
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--------------GSP 165
Query: 849 GYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRP------TDVLFHDGSSLHEWVKRH 901
++APE + D++S G +LE+ TG+ P +F G S
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-------- 217
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
L PI P H+ SD + I L C Q +PS RP+
Sbjct: 218 --KELPPI---------PDHL--------SDEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-18
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 32/221 (14%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VYKG L T +A+K L ++ F++E +++ ++H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKICSD 776
++ +C+K ++ +++G L L + LD + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ YL H VH DL N L+ E LT ++DFG+++ + + D
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--------SADYYR 181
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 877
S L V ++ PE + + +T D++SFGV+L EI
Sbjct: 182 VQSKSLL---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 81/314 (25%), Positives = 127/314 (40%), Gaps = 63/314 (20%)
Query: 674 LIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNL 726
+G G FG V K + +AVK+L T + E +++K I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 727 IRIITICSKPDFKALVLPLMSNGSL------------ENHLYPSHGLSHGLDLIQLVKIC 774
I ++ +C++ +V+ ++G+L L LV
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
VA G+ +L K +H DL N+L+ ED +ADFG+A+ + ID
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT---- 191
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892
T+G L V ++APE + R TH DV+SFGVLL EI T G P + G
Sbjct: 192 -----TNGRL--PVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSP-----YPGI 238
Query: 893 SLHEWVKR-HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
+ E K +R++ PQ+ EL L C PS
Sbjct: 239 PVEELFKLLKEGYRMEK----------PQNCT-----------QELYHLMRDCWHEVPSQ 277
Query: 952 RPSMLDVAHEMGRL 965
RP+ + ++ R+
Sbjct: 278 RPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 3e-18
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 24/218 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
++GSG FG VYKG+ +A+K+L+ TT + F E I+ + H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
++ +C P + LV LM +G L ++++ H + G L L+ C +A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQL--LLNWCVQIAKGMMYLEER- 128
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++VH DL N+L+ + DFG+A+L++G ++ N M +
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-----------PI 175
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885
++A E ++ + DV+S+GV + E++T G +P D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 76/308 (24%), Positives = 131/308 (42%), Gaps = 74/308 (24%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+G +D TR+AVK ++ + + F E ++K +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLY---------PSHGLSHGLDLIQLVKICSDVAE 779
++ + SK +V+ LM++G L+++L P ++IQ+ +++A+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA---AEIAD 130
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+AYL+ K VH DL N ++ D T + DFG+ + + D
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK------- 180
Query: 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-------GRRPTDVL--FHD 890
GLL V ++APE +T D++SFGV+L EI + G VL D
Sbjct: 181 --GLL--PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
G L + + P R+ ++ +C Q+NP
Sbjct: 237 GGYLDQ--PDNCPERVTDLMR-------------------------------MCWQFNPK 263
Query: 951 TRPSMLDV 958
RP+ L++
Sbjct: 264 MRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 36/225 (16%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTG---------EITGSFKRECQILKRIRH 723
LIG G +G VY + +AVK ++L T ++ + + E + LK + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK-ICSDVAEGVA 782
N+++ + + ++ ++ L + GS+ + L ++G QLV+ V EG+A
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-----TYGRFEEQLVRFFTEQVLEGLA 122
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
YLH ++H DLK N+L+D D ++DFGI+K K D N N SM
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQ------ 171
Query: 843 LLCGSVGYIAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
GSV ++APE Y G A D++S G ++LE+ GRRP
Sbjct: 172 ---GSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IGSG G VYK + + R+ A+KV+ + RE +IL+ + H N+++ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++L M GSLE H D L + + G+AYLH +V
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIV 190
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+KPSN+L++ +ADFG++++ + ++++ N S+ G++ Y++P
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSSV----------GTIAYMSP 237
Query: 854 E-----YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E G GD++S GV +LE GR P
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 6e-17
Identities = 74/254 (29%), Positives = 109/254 (42%), Gaps = 53/254 (20%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---RECQILKRIRHRNLIR 728
IGSG +G V V + ++A+K + I K RE ++L+ +RH N+I
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA--KRILREIKLLRHLRHENIIG 63
Query: 729 IITIC---SKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQ--LVKICSDVAEGV 781
++ I S DF + V LM L + L+ D IQ L +I G+
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTD--DHIQYFLYQILR----GL 116
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
YLH V+H DLKPSNIL++ + + DFG+A +G+D
Sbjct: 117 KYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLA---RGVDPD----------EDEK 160
Query: 842 GLLCGSVG---YIAPE-YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897
G L V Y APE R + D++S G + E++T + LF G
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK----PLF-PG------ 209
Query: 898 VKRHYPHRLDPIVE 911
R Y +L+ IVE
Sbjct: 210 --RDYIDQLNLIVE 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 675 IGSGRFGHVYKGVL-QDNT--RIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V +G L QD++ ++AVK + + T E+ F E +K H N++R+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 730 ITIC----SKPDFKA--LVLPLMSNGSLENHLYPSH--GLSHGLDLIQLVKICSDVAEGV 781
I +C + + ++LP M +G L + L S L LVK +D+A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
YL S +H DL N +L+E++ VADFG++K + D M
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM------ 176
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
V +IA E + +T DV+SFGV + EI T G+ P
Sbjct: 177 -----PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-17
Identities = 73/216 (33%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 675 IGSGRFGHV----YKGVLQDNT--RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V Y D T +AVK L + T +K+E ILK + H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 729 IITICSKPDFKALVL-----PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
CS+ K L L PL GSL ++L P H L+ L QL+ + EG+AY
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPL---GSLRDYL-PKHKLN----LAQLLLFAQQICEGMAY 122
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH +H DL N+LLD D + DFG+AK V E D S
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------- 172
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
V + A E + S DV+SFGV L E++T
Sbjct: 173 ---PVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 45/281 (16%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEIT-GSFKRECQILKRIRHRNLIRIITI 732
IG G FG V+K V + + R+ A+K +DL+ E ++L ++ +IR
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+V+ NG L L G D + + + G+A+LH K+
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFIQILLGLAHLHSK---KI 122
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H D+K N+ LD + D G+AKL+ +D+ +F +T + G+ Y++
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLL----------SDNTNFANT---IVGTPYYLS 169
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE K + DV++ GV+L E TG+ P D + G+ + + ++ +P P+
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFP----PVS-- 222
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953
Y+ Q L +L C + RP
Sbjct: 223 --QMYSQQ----------------LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-17
Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 27/164 (16%)
Query: 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLL 516
L L + L G +P ++SK+ + +I+LS N++ G+IPP LGS +LE L+LS NS G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 517 PVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIA 576
P S+GQL L+ +++ N L G +P + + SFN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA---SFN------------------ 521
Query: 577 SFQGNDGLCGEIKGLQTCKKEHTHHLVILSILLSLFAMSLLFIF 620
F N GLCG I GL+ C HL + + + F +S+ F+F
Sbjct: 522 -FTDNAGLCG-IPGLRACGP----HLSVGAKIGIAFGVSVAFLF 559
|
Length = 623 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 32/226 (14%)
Query: 674 LIGSGRFGHVYKGVL--QDNT--RIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLI 727
++G G FG V + L +D + ++AVK+L D+ ++ +I F RE +K H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64
Query: 728 RIITICSKPDFKA------LVLPLMSNGSLENHLYPSHGLSHGLDLIQ--LVKICSDVAE 779
++I + + K ++LP M +G L L S L LV+ D+A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID-ESVNCANDSMSFT 838
G+ YL S +H DL N +L+E++T VADFG++K + D CA+
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL---- 177
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
V ++A E +TH DV++FGV + EI+T G+ P
Sbjct: 178 --------PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 60/307 (19%)
Query: 675 IGSGRFGHVY-------------KGVLQDNTRI----AVKVLDLTTTGEITGSFKRECQI 717
+G G+FG V+ DN AVKVL + F +E +I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 718 LKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLY----PSHGLSHGLDLIQ---L 770
L R+ N+ R++ +C+ +++ M NG L L + GL+ + L
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830
+ + + +A G+ YL + VH DL N L+ ++ T +ADFG+ S N
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGM---------SRNL 180
Query: 831 -ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLF 888
++D + G + ++A E + + +T DV++FGV L EI+T R
Sbjct: 181 YSSD---YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP---- 233
Query: 889 HDGSSLHEWVKRHYPHRLDP-IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947
Y H D ++E A + IY + + ++ EL L C +
Sbjct: 234 -------------YEHLTDQQVIENAGHFFRDDGRQIYLPRP-PNCPKDIYELMLECWRR 279
Query: 948 NPSTRPS 954
+ RP+
Sbjct: 280 DEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 33/232 (14%)
Query: 675 IGSGRFGHVYKGVLQ----DNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+G+ + D + V V L + + F E I+ + H+N++R
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL---YPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+I + + + ++L LM+ G L++ L P L + L+ DVA+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 786 HHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ +H D+ N LL A +ADFG+A+ + + G
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS-----------YYRKGG 179
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV-------TGRRPTDVL 887
+ ++ PE + ++ DV+SFGVLL EI GR +V+
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 83/317 (26%), Positives = 130/317 (41%), Gaps = 65/317 (20%)
Query: 673 SLIGSGRFGHVYK---GVLQDNTR--IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+G G FG V LQDNT +AVK L +T + F+RE +ILK ++H N++
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNIV 68
Query: 728 RIITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ +C + LV+ + GSL ++L LD +L+ S + +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL- 124
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE--SVNCANDSMSFTSTDGL 843
+ VH DL NIL++ + + DFG+ K++ E V +S F
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF------ 176
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT----GRRPTDVLFH------DGSS 893
+ APE + S DV+SFGV+L E+ T P G
Sbjct: 177 ------WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230
Query: 894 ----LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
L E +K + RL AP P E+ + C +P
Sbjct: 231 IVYHLIELLKNNG--RLP----------APPGCP-----------AEIYAIMKECWNNDP 267
Query: 950 STRPSMLDVAHEMGRLK 966
S RPS ++A ++ ++
Sbjct: 268 SQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V ++ ++ A K LD L + E +IL+++ R ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-EKKILEKVSSRFIVSLA 59
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
D LV+ LM+ G L+ H+Y + G G + + + + G+ +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY-NVG-EPGFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++V+ DLKP N+LLD+ ++D G+A +KG + A G+ GY
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--------------GTPGY 160
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE G+ D ++ G L E++ GR P
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 41/220 (18%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI---- 729
+G+G G V K + + +AVK + L I RE IL + ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 730 -----ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
I+IC + M GSL+ L G + L KI V +G+ YL
Sbjct: 69 YNNGDISIC---------MEYMDGGSLDKILKEVQG---RIPERILGKIAVAVLKGLTYL 116
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCANDSMSFTSTDGL 843
H K++H D+KPSNIL++ + DFG++ +LV +S++ T
Sbjct: 117 HEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV-----------NSLAKTFV--- 160
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ Y+APE G S D++S G+ L+E+ TGR P
Sbjct: 161 --GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 53/230 (23%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-------RECQILKRIRHR 724
+G G + VYK + +A+K + L GE + RE ++L+ ++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHP 62
Query: 725 NLIRIITICSKPDFKALVLPLMSNGSLEN-------HLYPSHGLSHGLDLIQLVKICSDV 777
N+I ++ + LV M LE L P+ S+ L ++
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR-------- 113
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
G+ YLH + ++H DLKP+N+L+ D +ADFG+A+ SF
Sbjct: 114 --GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR----------------SF 152
Query: 838 TSTDGLLCGSV---GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP 883
S + + V Y APE G R G D++S G + E++ R P
Sbjct: 153 GSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 74/300 (24%), Positives = 133/300 (44%), Gaps = 53/300 (17%)
Query: 674 LIGSGRFGHVYKGVL---QDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
L+GSG FG V+KG+ D+ +I A+K + + + + + H ++R
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
++ IC + LV L GSL +H+ LD +L+ C +A+G+ YL H
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH- 128
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV--NCANDSMSFTSTDGLLCG 846
++VH +L NILL D +ADFG+A L+ D+ + + + + + +L G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905
R + DV+S+GV + E+++ G P + + PH
Sbjct: 187 -------------RYTHQSDVWSYGVTVWEMMSYGAEPY-------AGMR-------PHE 219
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
+ ++EK PQ I DV + +++ C + + RP+ ++A+E R+
Sbjct: 220 VPDLLEKGERLAQPQICTI-------DVYMVMVK----CWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 675 IGSGRFGHVYK----GVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V G+ ++ T++AVK+L T + E +++K I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLY------------PSHGLSHGLDLIQLVKI 773
+I ++ C++ +++ S G+L +L P+ L LV
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA G+ YL + K +H DL N+L+ ED +ADFG+A+ + ID
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 198
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT 879
+T+G L V ++APE + R TH DV+SFGVLL EI T
Sbjct: 199 -----TTNGRL--PVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKV-----LDLTTTGEITGSFKRECQILKRIRHRNLI 727
L+G G FG VY D R +AVK T E+ + + E Q+LK ++H ++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN-ALECEIQLLKNLQHERIV 67
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ + ++ + M GS+++ L L+ + K + EGV YLH +
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR----KYTRQILEGVEYLHSN 123
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM-SFTSTDGLLCG 846
+VH D+K +NIL D + DFG +K ++ I + M S T G
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI----CSSGTGMKSVT-------G 169
Query: 847 SVGYIAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ +++PE G G++A DV+S G ++E++T + P
Sbjct: 170 TPYWMSPEVISGEGYGRKA----DVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G + VYKG + I A+K + L + RE ++K ++H N++R+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ LV M L+ ++ +HG+ LD + + +G+A+ H + +V+
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLKP N+L+++ +ADFG+A+ GI VN +F++ ++ Y AP
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAF-GI--PVN------TFSNE----VVTLWYRAP 169
Query: 854 EYGMGKRA-STHGDVYSFGVLLLEIVTGR 881
+ +G R ST D++S G ++ E++TGR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 675 IGSGRFGHVYKG------VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ +D +AVK L T F+RE ++L ++H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVK 71
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHG-----LSHG--------LDLIQLVKICS 775
+C D +V M +G L N +HG L G L L Q++ I S
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
+A G+ YL VH DL N L+ +L + DFG+++ V D
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---------- 177
Query: 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ G + ++ PE M ++ +T DV+SFGV+L EI T G++P
Sbjct: 178 -YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 86/317 (27%), Positives = 129/317 (40%), Gaps = 69/317 (21%)
Query: 671 PSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIR---HRN 725
+ IG G +G VYK L +A+K + + + E I S RE +LK++ H N
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 726 LIRIITICSKPDFK-----ALVLPLMS---NGSLENHLYPSHGLSHGL--DLI-QLVKIC 774
++R++ +C P LV + L P GL DL+ QL++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLR-- 118
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
GV +LH H ++VH DLKP NIL+ D +ADFG+A++
Sbjct: 119 -----GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS----------FE 160
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894
M+ TS L Y APE + +T D++S G + E+ RRP LF G+S
Sbjct: 161 MALTSVVVTLW----YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP---LF-RGTSE 211
Query: 895 HEWVKRHYPHRLDPIVEK----------AIAKYAPQHMPIYYNKVWSDVVLELIELGL-- 942
+ +LD I + P Y + + V E+ E GL
Sbjct: 212 AD--------QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDL 263
Query: 943 --LCTQYNPSTRPSMLD 957
+NP R S +
Sbjct: 264 LKKMLTFNPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ QD +AVK L + F RE ++L ++H ++++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVK 71
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHG-----LSHG-----LDLIQLVKICSDVA 778
+C + D +V M +G L N +HG ++ G L Q++ I +A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
G+ YL VH DL N L+ E+L + DFG+++ V D +
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-----------YY 176
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
G + ++ PE M ++ +T DV+S GV+L EI T G++P
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 51/222 (22%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G +G VYK + + +A+KV+ + + +E ILK+ +++
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGS 66
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK----------ICSDVAEGVA 782
K +V+ GS+ D++++ I +G+
Sbjct: 67 YFKNTDLWIVMEYCGAGSV-------------SDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCANDSMSFTSTD 841
YLH + K +H D+K NILL+E+ A +ADFG++ +L D+M+ +T
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-----------DTMAKRNT- 158
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ G+ ++APE + D++S G+ +E+ G+ P
Sbjct: 159 --VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGS-----FKRECQILKRIRHRNLIR 728
+G+G FG V + + + A+K+L +I E +IL+ IRH L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 729 IITICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLH 785
+ S D L V+ + G L +HL S + + + V + YLH
Sbjct: 66 LY--GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP-----EPVARFYAAQVVLALEYLH 118
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ +V+ DLKP N+LLD D + DFG AK VKG T T LC
Sbjct: 119 S---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------------TYT---LC 159
Query: 846 GSVGYIAPEY----GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ Y+APE G GK D ++ G+L+ E++ G P
Sbjct: 160 GTPEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 674 LIGSGRFGHVYKGVL---QDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
++GSG FG VYKG+ +N +I A+KVL T+ + E ++ + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
++ IC + LV LM G L +++ + DL+ C +A+G++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW---CVQIAKGMSYLEE-- 127
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+++VH DL N+L+ + DFG+A+L+ IDE+ + + G + +
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDET--------EYHADGGKV--PI 175
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
++A E + +R + DV+S+GV + E++T G +P D P R
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD---------------GIPAREI 220
Query: 908 P-IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
P ++EK P I DV + +++ C + RP ++ E R+
Sbjct: 221 PDLLEKGERLPQPPICTI-------DVYMIMVK----CWMIDSECRPRFRELVDEFSRMA 269
Query: 967 Q 967
+
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 67/307 (21%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIITI 732
IG G +G VYK +A+K + L E RE ++LK + H N+I+++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICS---DVAEGVAYLHHHSP 789
LV M + LY + + I S + +G+A+ H H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLY--KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++H DLKP N+L++ + +ADFG+A+ SF S V
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLAR----------------SFGSPVRPYTHYVV 160
Query: 850 ---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
Y APE +G + + D++S G + E+++ R LF S + + K
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFK------ 210
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKV---------WSDVVLELI-------ELGLL--CTQY 947
+ + + P+ P + + + + L + L LL Y
Sbjct: 211 ----IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHY 266
Query: 948 NPSTRPS 954
+P R +
Sbjct: 267 DPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 72/325 (22%), Positives = 123/325 (37%), Gaps = 72/325 (22%)
Query: 652 AKNPRVSYKQLIEATGGFCPSSL------IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT 704
+ + + K ++ P L IG G G VYK +A+K + L
Sbjct: 1 EEELKAALKDIVSEG---DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-- 55
Query: 705 GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG 764
+ E I+K +H N++ D +V+ M GSL + + +
Sbjct: 56 KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ-----NF 110
Query: 765 LDLI--QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI-AKLV 821
+ + Q+ +C +V +G+ YLH V+H D+K NILL +D + +ADFG A+L
Sbjct: 111 VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167
Query: 822 KGIDESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIV 878
K + S+ VG ++APE K D++S G++ +E+
Sbjct: 168 KEKSKRN-----SV------------VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 879 TGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMP-IYYNKVWSDVVLEL 937
G P L +A+ + +P + + WS +
Sbjct: 211 EG---------------------EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249
Query: 938 IELGLLCTQYNPSTRPSMLDVAHEM 962
+ C +P RPS A E+
Sbjct: 250 LN---KCLVKDPEKRPS----AEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 675 IGSGRFGHVYK-GVLQDNTRIAVKVLDL-TTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IG G G V+K + +A+K + L G I RE + L+ +H +++++ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
LV+ M L L L Q+ + +GVAY+H + +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DLKP+N+L+ D +ADFG+A+L + ++ + Y A
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSE--------EEPRLYSHQ----VATRWYRA 168
Query: 853 PEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
PE G R G D+++ G + E++ G
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 59/311 (18%)
Query: 674 LIGSGRFGHVYKGVLQ-DNTRI--AVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRI 729
+IG G FG V + +++ D ++ A+K+L + F E ++L ++ H N+I +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPS------------HGLSHGLDLIQLVKICSDV 777
+ C + + + G+L + L S HG + L QL++ SDV
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL S + +H DL N+L+ E+L + +ADFG+++ + +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR------------GEEVYV 173
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE 896
T G L V ++A E +T DV+SFGVLL EIV+ G P + G + E
Sbjct: 174 KKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP-----YCGMTCAE 226
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
+ EK PQ + + D V EL+ C + P RP
Sbjct: 227 ------------LYEK-----LPQGYRMEKPRNCDDEVYELMR---QCWRDRPYERPPFA 266
Query: 957 DVAHEMGRLKQ 967
++ ++ R+ +
Sbjct: 267 QISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IGSG +G VYK + +A+KV+ L + ++E +LK RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ D +V+ GSL++ +Y L +Q+ +C + +G+AYLH +
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IY--QVTRGPLSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 794 HCDLKPSNILLDEDLTALVADFGIA 818
H D+K +NILL ED +ADFG++
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (186), Expect = 1e-14
Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKV--LDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G G +G VYK + +A+K LD G I + RE +LK ++H N+++++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTALREISLLKELKHPNIVKLLD 65
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV L+ +L L + I + G+AY H H +
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYCHSH---R 118
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAK 819
++H DLKP NIL++ D +ADFG+A+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRN 725
S +G G G V K L++ I A+K + ++ RE +I K +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 726 LIRIITICSKPDFK--ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
+++ + + GSL++ + L KI V +G++Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH K++H D+KPSNILL + DFG V G E VN S G
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG----VSG--ELVN---------SLAGT 162
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ Y+APE GK S DV+S G+ LLE+ R P
Sbjct: 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 59/309 (19%)
Query: 674 LIGSGRFGHVYKGVLQDN---TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRI 729
+IG G FG V K ++ + A+K + + + F E ++L ++ H N+I +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPS------------HGLSHGLDLIQLVKICSDV 777
+ C + L + +G+L + L S + + L QL+ +DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL S + +H DL NIL+ E+ A +ADFG+++ +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYV 166
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE 896
T G L V ++A E +T+ DV+S+GVLL EIV+ G P + G + E
Sbjct: 167 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAE 219
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
++ PQ + D V +L+ C + P RPS
Sbjct: 220 LYEK-----------------LPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFA 259
Query: 957 DVAHEMGRL 965
+ + R+
Sbjct: 260 QILVSLNRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 31/176 (17%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E QIL+++ R ++ + D LVL LM+ G L+ H+Y H G + + V
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFY 107
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA------KLVKGIDES 827
+++ G+ LH ++V+ DLKP NILLD+ ++D G+A + +KG
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---- 160
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+VGY+APE +R + D ++ G LL E++ G+ P
Sbjct: 161 ----------------RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 29/215 (13%)
Query: 675 IGSGRFGHVY------KGVLQDNT--RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
+G G FG V +G DNT ++AVK L + G K+E +IL+ + H N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 727 IRIITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
++ IC++ L++ + +GSL+ +L P + + ++L Q +K + +G+ YL
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRN--KNKINLKQQLKYAVQICKGMDYL 125
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
+ VH DL N+L++ + + DFG+ K ++ E +D L
Sbjct: 126 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD----------L 172
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
V + APE + + DV+SFGV L E++T
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE--------ITGSFKRECQILKRIRH 723
+LIGSG FG VY G+ +AVK ++L + + + RE +LK ++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
N+++ + D + L + GS+ L L + + +G+ Y
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH+ ++H D+K +NIL+D ++DFGI+K ++ S++ + +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA--NSLSTKTNGARPS----- 171
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
L GSV ++APE + D++S G L++E++TG+ P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 675 IGSGRFGHVYK----GVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V G+ +D + +AVK+L T + E +++K I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSH--GLSHGLDLIQ----------LVKI 773
+I ++ C++ +++ S G+L +L G+ + D+ + LV
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA G+ YL K +H DL N+L+ E+ +ADFG+A+ V ID N
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT 879
+ V ++APE + R TH DV+SFGVL+ EI T
Sbjct: 200 RL-----------PVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 37/227 (16%)
Query: 675 IGSGRFGHVYK----GVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V + G+ + +AVK+L T + E +++K I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSH--GLSHGLDLIQ----------LVKI 773
+I ++ +C++ +++ + G+L L G + D+ + LV
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA G+ YL + +H DL N+L+ ED +ADFG+A+ V ID +N
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT 879
+ V ++APE + R TH DV+SFG+L+ EI T
Sbjct: 197 RL-----------PVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 70/294 (23%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI---- 729
+G G G VYK RI AVKV+ L T E+ E +IL + +I
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 730 -----ITICSKPDFKALVLPLMSNGSLENHLY---PSHGLSHGLDLIQLVKICSDVAEGV 781
I+IC++ M GSL+ +Y P H L +I V +G+
Sbjct: 69 FVENRISICTE---------FMDGGSLD--VYRKIPEHVLG---------RIAVAVVKGL 108
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCANDSMSFTST 840
YL +K++H D+KPSN+L++ + DFG++ +LV I ++
Sbjct: 109 TYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT------------- 152
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
G+ Y+APE G++ H DV+S G+ +E+ GR P + + SL
Sbjct: 153 ---YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL------ 203
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P +L + I P +P+ +S+ + I C + P RP+
Sbjct: 204 -MPLQL----LQCIVDEDPPVLPVG---QFSEKFVHFIT---QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-14
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 675 IGSGRFGHVYK----GVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V G+ +D +AVK+L T + E +++K I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSH--GLSHGLDLIQ----------LVKI 773
+I ++ C++ +++ S G+L +L G+ + D + LV
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA G+ YL K +H DL N+L+ ED +ADFG+A+ V ID
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK---- 192
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT 879
+T+G L V ++APE + R TH DV+SFGVLL EI T
Sbjct: 193 -----TTNGRL--PVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-14
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 674 LIGSGRFGHVYKGVLQD---NTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIR 728
LIG G G VY D + R+A+K + DL+ + F RE +I + H ++
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYP-------SHGLSHGLDLIQLVKICSDVAEGV 781
+ +ICS D +P + +L++ L S L+ + + I + +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG-----IDESVNCANDSMS 836
Y+H V+H DLKP NILL ++ D+G A K +D V+ N S
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ G + G+ Y+APE +G AS D+Y+ GV+L +++T P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 674 LIGSGRFGHVYKGVLQDN--TRIAVKVLDLTT---------TGEITGSFKRECQILK-RI 721
+GSG FG VYK ++N +A+K +++ + G E I+K ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 722 RHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
RH N++R + D +V+ L+ L H ++ I + +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
YLH ++VH DL P+NI+L ED + DFG+AK TS
Sbjct: 127 RYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ----------KQPESKLTS-- 172
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901
+ G++ Y PE + DV++FG +L ++ T + P F+ + L K
Sbjct: 173 --VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLATK-- 224
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
IVE A Y P ++S+ V ++I C + RP ++ V+
Sbjct: 225 -------IVE---AVYEPLP-----EGMYSEDVTDVIT---SCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 68/296 (22%), Positives = 129/296 (43%), Gaps = 52/296 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVL-----DLTTTGEITGSFKRECQILKRIRHRNLI 727
+G+G F Y+ ++ T +AVK + + E+ + ++E +++ R+ H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 728 RII-TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
R++ C F L + M+ GS+ + L + ++ + G++YLH
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLHE 121
Query: 787 HSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTD---G 842
+ +++H D+K +N+L+D L +ADFG A A + T G
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAA------------ARLAAKGTGAGEFQG 166
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
L G++ ++APE G++ DV+S G +++E+ T + P W +
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-------------WNAEKH 213
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ L I + A A AP +P + + DV L C + P RP ++
Sbjct: 214 SNHLALIFKIASATTAPS-IPEHLSPGLRDVTLR-------CLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 26/215 (12%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VYK ++ A K++ + + E+ F E IL +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +++ G+L++ + L GL Q+ +C + E + +LH H KV+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLK NILL D +ADFG++ K + + +F G+ ++AP
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD------TFI-------GTPYWMAP 172
Query: 854 EYGMGKRASTH-----GDVYSFGVLLLEIVTGRRP 883
E + + D++S G+ L+E+ P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 36/101 (35%), Positives = 57/101 (56%)
Query: 362 LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPS 421
L N L G IP+ + HL ++LS N + G+IP S +++ L L L N +G+IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 422 SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSN 462
SLG+ +L IL+L+ N +SG +P+ + G + N + N
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 40/231 (17%)
Query: 675 IGSGRFGHVYKGV------LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V K T +AVK+L + E +LK++ H ++I+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG--------------------LDLI 768
+ CS+ L++ GSL + L S + L +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
L+ ++ G+ YL + +K+VH DL N+L+ E ++DFG+++ V D V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
+ + V ++A E +T DV+SFGVLL EIVT
Sbjct: 185 KRSKGRIP-----------VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
+G G FG VYK R +A+K + + + IT RE +ILK+++H N++ +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHPNVVPLI 73
Query: 731 -TICSKPDFKA-------LVLPLMS---NGSLEN---HLYPSHGLSHGLDLIQLVKICSD 776
+PD +V P M +G LEN L S + L L+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL-------- 125
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
EG+ YLH + ++H D+K +NIL+D +ADFG+A+ G N
Sbjct: 126 --EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG-----PPPNPKGG 175
Query: 837 FTSTDGLLCGSV---GYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR 881
V Y PE +G +R +T D++ G + E+ T R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 672 SSLIGSGRFGHVYKGVLQDNTR-----IAVK-VLDLTTTGEITGSFKRECQILKRIRHRN 725
S L+ G FG ++ G+L D + VK V D + ++T +E +L + H+N
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYGLSHQN 69
Query: 726 LIRIITICSK-PDFKALVLPLMSNGSLENHL----YPSHGLSHGLDLIQLVKICSDVAEG 780
++ I+ +C + + ++ P M+ G+L+ L L QLV + +A G
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
++YLH V+H D+ N ++DE+L + D +++ + +D +C D+ +
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHCLGDNEN---- 180
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
V ++A E + K S+ DV+SFGVLL E++T
Sbjct: 181 -----RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 74/233 (31%), Positives = 113/233 (48%), Gaps = 35/233 (15%)
Query: 675 IGSGRFGHVYKGVLQD---NTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRII 730
IG G +G VYK +D N IA+K + L E + + RE +LK ++H N++R+
Sbjct: 10 IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQ--LVKICSDVAEGVAYLHHHS 788
+ LV + + L+ H+ S + LI+ L +I G+AY H H
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILR----GIAYCHSH- 121
Query: 789 PIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+V+H DLKP N+L+D AL +ADFG+A+ GI +FT +
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GI--------PVRTFTHE----VVT 166
Query: 848 VGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
+ Y APE +G R ST D++S G + E+V ++P LF S + E K
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKP---LFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 44/297 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKV-LDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
L+G G +G V K ++ +I A+K L+ + RE ++LK++RH NL+ +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 732 ICSKPDFKALVLPLMSNGSLEN-HLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ + LV + + L++ YP +GLD ++ K + G+ + H H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H D+KP NIL+ + + DFG A+ + E TD + Y
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-----------TD--YVATRWY 166
Query: 851 IAPEYGMGKRASTHG---DVYSFGVLLLEIVTGR------RPTDVLFHDGSSLHEWVKRH 901
APE +G + +G D+++ G L+ E++TG D L+H L + RH
Sbjct: 167 RAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 902 ----YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
+ L + K + + + K S +VL+L + C + +P RPS
Sbjct: 225 QEIFQKNPLFAGMRLPEVK-EIEPLEKRFPK-LSGLVLDLAK---QCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 62/217 (28%), Positives = 89/217 (41%), Gaps = 25/217 (11%)
Query: 674 LIGSGRFGHVYKG----VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V +G +AVK L +I F +E I+ + H NLIR+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +V L GSL + L L H + L +A G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLR-KDALGH-FLISTLCDYAVQIANGMRYLESK-- 116
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAK-LVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+ +H DL NILL D + DFG+ + L + D V + + F
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF----------- 164
Query: 849 GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVT-GRRP 883
+ APE + R +H DV+ FGV L E+ T G P
Sbjct: 165 AWCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 33/67 (49%), Positives = 45/67 (67%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141
++LS SI G I P+L +++SL VLDLS N F G IP LG L L+ L+L+ NSL G++
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 142 PSQLGSL 148
P+ LG
Sbjct: 507 PAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 38/104 (36%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 67 WSGVKC---NNSRNKVVE-LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELG 122
WSG C + ++ L L + + G I ++ L L ++LS N +G+IP LG
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 123 SLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIP 166
S+ L+ L LS+NS G IP LG L L L+L N L G +P
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 675 IGSGRFGHVYKGVLQDNTR---IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+GSG FG V KGV + + +A+KVL + RE +I+ ++ + ++R+I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+C LV+ + S G L L G + + +V++ V+ G+ YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
VH DL N+LL A ++DFG++K + A+DS + G + +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--------ADDSYYKARSAGKW--PLKWY 165
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
APE ++ S+ DV+S+G+ + E + G++P
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 675 IGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRII 730
+GSG FG V KG+ + +AVK+L + RE +++++ + ++R+I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
IC + LV+ L G L L + ++ ++ +LV V+ G+ YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEK-NITELVH---QVSMGMKYLEETN-- 115
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL N+LL A ++DFG++K + G DE+ A + V +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKW---------PVKW 164
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
APE + S+ DV+SFGVL+ E + G++P K + + +
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP--------------YKGMKGNEVTQM 210
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968
+E PQ P E+ +L LC Y RP E+ RL+ Y
Sbjct: 211 IESGERMECPQRCPP-----------EMYDLMKLCWTYGVDERPGF--AVVEL-RLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQIL-------KRIRHRN 725
++G G +G VY L RIA+K EI R Q L ++HRN
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIK--------EIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYL 784
+++ + S+ F + + + GSL L G L I + EG+ YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT--KQILEGLKYL 124
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
H + ++VH D+K N+L++ + ++DFG +K + GI+ +FT
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE------TFT----- 170
Query: 844 LCGSVGYIAPEY------GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G++ Y+APE G G A D++S G ++E+ TG+ P
Sbjct: 171 --GTLQYMAPEVIDKGPRGYGAPA----DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-13
Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 1/86 (1%)
Query: 384 LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443
L L L G IP+ + L L+ + L GN + G IP SLG +LE+LDLS+N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 444 PSDVAGLRSLKLYLNLSSNHLDGPLP 469
P + L SL++ LNL+ N L G +P
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 675 IGSGRFGHVYKGVLQDNT--RIAVKVLDLT----TTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V V NT A K LD +GE ++E IL+++ N
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKV---NSPF 54
Query: 729 IITICSKPDFKA---LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
I+ + + K LV+ LM+ G L+ H+Y + GL++ +++ + + G+ +LH
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIY--NVGERGLEMERVIHYSAQITCGILHLH 112
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ +V+ D+KP N+LLD+ ++D G+A +K A
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-------------- 155
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ GY+APE + S D ++ G + E+V GR P
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-13
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 32/240 (13%)
Query: 693 RIAVKVL-DLTTTGE-ITGSFKRECQILKRIRHRNLIRII-TICSKPDFKALVLPLMSNG 749
+A+K+L E F+RE + R+ H N++ ++ + + P V +
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DE 806
+L L L G + ++ V + +A H+ +VH DLKP NI++
Sbjct: 65 TLREVLAADGALPAG----ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117
Query: 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGD 866
A V DFGI L+ G+ ++ D + T T +L G+ Y APE G+ + + D
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDA-----DVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSD 171
Query: 867 VYSFGVLLLEIVTGRRP------TDVLFHDGS----SLHEWVKRHYPHRLDPIVEKAIAK 916
+Y++G++ LE +TG+R ++L+ S SL W+ H L ++ KA+ K
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIA---GHPLGQVLRKALNK 228
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 71/319 (22%), Positives = 123/319 (38%), Gaps = 69/319 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII-- 730
LIG G +G VY+G + +A+K+++L T + +RE +L ++R I
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 731 --------TICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
+ ++ V LM G + Y S I +V
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-EKYIS-------------VIIREVLVA 113
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ Y+H + V+H D+K +NIL+ + DFG+A L+ N + S ST
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL----------NQNSSKRST 160
Query: 841 DGLLCGSVGYIAPEYGM-GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
G+ ++APE GK T D++S G+ + E+ TG P
Sbjct: 161 ---FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP--------------YS 203
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
R I K P + + +S ++ E + C P R S ++
Sbjct: 204 DVDAFR----AMMLIPKSKPPRLE---DNGYSKLLREFVA---ACLDEEPKERLSAEELL 253
Query: 960 HEMGRLKQYLSSPSSLIEE 978
+ +K + +P S+++E
Sbjct: 254 -KSKWIKAHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITI 732
IG G +G VYKG + +A+K + L + E + + RE +LK ++H N++ + +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ L+ +S L+ +L S +D + + +G+ + H +V
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DLKP N+L+D +ADFG+A+ GI V +T L Y A
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRV--------YTHEVVTLW----YRA 169
Query: 853 PEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
PE +G R ST D++S G + E+ T ++P LFH S + +
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKP---LFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-13
Identities = 87/254 (34%), Positives = 132/254 (51%), Gaps = 10/254 (3%)
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387
S VN LNLSSN L +P L + L+ + S S S + ++ L LDL+
Sbjct: 44 SVAVNRLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLLPLPSLDLN 101
Query: 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV 447
N+L +I + L+ L L L N+++ P NL+ LDLS NKI +PS +
Sbjct: 102 LNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159
Query: 448 AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNL 507
L +LK L+LS N L LP LS + + +DLS N +S +PP++ ALE L+L
Sbjct: 160 RNLPNLK-NLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 508 SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK 567
S NS+ L S+ L L ++S+N+L ++P+S L+ L+ S N+ S +IS+
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSL 273
Query: 568 GAFSSLTIASFQGN 581
G+ ++L GN
Sbjct: 274 GSLTNLRELDLSGN 287
|
Length = 394 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 674 LIGSGRFGHVYKG-VLQDNTRI--AVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRI 729
+IG G FG V K + +D R+ A+K + + + F E ++L ++ H N+I +
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPS------------HGLSHGLDLIQLVKICSDV 777
+ C + L + +G+L + L S + + L QL+ +DV
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL S + +H DL NIL+ E+ A +ADFG+++ +
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYV 178
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
T G L V ++A E +T+ DV+S+GVLL EIV+
Sbjct: 179 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 34/218 (15%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRI-AVK-VLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
++G G +G V K + I A+K + ++ + RE ++L+++RH N++ +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 731 TICSKPDFKALVLPLMSNGSLEN-HLYPSHGLSHGLDLIQLVKICS-DVAEGVAYLHHHS 788
+ LV + LE P GL V+ + + +AY H H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPG-----GLP-PDAVRSYIWQLLQAIAYCHSH- 119
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST-----DGL 843
++H D+KP NIL+ E + DFG A+ ++ A+ + +T L
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRA-----RPASPLTDYVATRWYRAPEL 172
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
L G YG DV++ G ++ E++ G
Sbjct: 173 LVGD-----TNYGKPV------DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGS-----FKRECQILKRIRHRNLIR 728
++G G +G VY G+ IAVK ++L T+ + + E +LK ++H N+++
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ C + ++ + + GS+ + L L K + +GVAYLH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE----PVFCKYTKQILDGVAYLHNNC 122
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
VVH D+K +N++L + + DFG A+ + + +N S + G+
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS-------MHGTP 172
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
++APE S +G D++S G + E+ TG+ P
Sbjct: 173 YWMAPEV---INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 1/93 (1%)
Query: 287 LELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT 346
L L L G IP+ I L +L I+L N I G IPP + ++ +L +L+LS N NG+
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 347 IPHELCLMSKLERVYLSNNSLSGEIPSAFGDIP 379
IP L ++ L + L+ NSLSG +P+A G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 41/108 (37%), Positives = 61/108 (56%), Gaps = 15/108 (13%)
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+AE L H + +++ DLKP NILLDE+ + DFG++K ES++ + S
Sbjct: 104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYS 157
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRP 883
F CG+V Y+APE + +R T D +SFGVL+ E++TG P
Sbjct: 158 F-------CGTVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 68/255 (26%), Positives = 110/255 (43%), Gaps = 39/255 (15%)
Query: 672 SSLIGSGRFGHVYKGVLQDNTR---IAVKVLDLTTTGEI--TGSFKRECQILKRIRHRNL 726
+G+G FG V+ ++D A+KV+ + + E ++LK + H +
Sbjct: 6 IKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
IR+ F +++ + G L ++L S S+ L +I + YLH
Sbjct: 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC----ALEYLHS 119
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+V+ DLKP NILLD++ + DFG AK K D T T LCG
Sbjct: 120 KE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDR-----------TWT---LCG 160
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG--SSLHEWV---KRH 901
+ Y+APE K + D ++ G+L+ E++ G P F D ++E + K
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP----FFDDNPFGIYEKILAGKLE 216
Query: 902 YPHRLDPIVEKAIAK 916
+P LD + I K
Sbjct: 217 FPRHLDLYAKDLIKK 231
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 48/264 (18%)
Query: 675 IGSGRFGHVY----KGVLQDNTRIAVKVLDLTT------TGEITGSFKRECQILKRIRHR 724
+G+G +G V+ G A+KVL T T E T + E Q+L+ +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT---RTERQVLEAVRRC 64
Query: 725 NLIRIITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
+ + + D K L+L ++ G L HLY + +++ +AE V
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT--ESEVRVY-----IAEIVLA 117
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
L H + +++ D+K NILLD + ++ DFG++K + E A
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYS---------- 165
Query: 844 LCGSVGYIAPEYGMGKRASTHGDV---YSFGVLLLEIVTGRRPTDVLFHDG--SSLHEWV 898
CG++ Y+APE G + H +S GVL E++TG P V DG +S E
Sbjct: 166 FCGTIEYMAPEVIRGG-SGGHDKAVDWWSLGVLTFELLTGASPFTV---DGEQNSQSEIS 221
Query: 899 KR------HYPHRLDPIVEKAIAK 916
+R +P + I K
Sbjct: 222 RRILKSKPPFPKTMSAEARDFIQK 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVL--DLTTTGEITGSFKRECQIL-KRI-----RHR 724
++G G FG V+ L+ N A+K L D+ + EC ++ KR+ H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV-----ECTMVEKRVLSLAWEHP 56
Query: 725 NLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
L + + V+ ++ G L H+ H DL + +++ G+ +L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF----DLPRATFYAAEIICGLQFL 112
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H +V+ DLK NILLD D +ADFG+ K ++M +
Sbjct: 113 HSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK-------------ENMLGDAKTCTF 156
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889
CG+ YIAPE +G++ +T D +SFGVLL E++ G+ P FH
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP----FH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G RFG VYKG L + +A+K L G + FK E + R++H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLY------------PSHGLSHGLDLIQLVKICSD 776
++ + +K +++ S+ L L + L+ V I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ +L H VVH DL N+L+ + L ++D G+ + V D N +
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL- 188
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ +++PE M + S D++S+GV+L E+ + G +P
Sbjct: 189 ----------PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 675 IGSGRFGHVYK-GVLQDNTRIAVK------VLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+G G FG V V N A+K +++ I E +IL+ H ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI----FSEKEILEECNHPFIV 56
Query: 728 RIITICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
++ + D K + ++ G L L GL D + V YLH
Sbjct: 57 KLY--RTFKDKKYIYMLMEYCLGGELWTILR-DRGL---FDEYTARFYIACVVLAFEYLH 110
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ +++ DLKP N+LLD + + DFG AK +K + ++T C
Sbjct: 111 NRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---------SGQKTWT-----FC 153
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ Y+APE + K D +S G+LL E++TGR P
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 23/230 (10%)
Query: 662 LIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR 720
L + G F L+G+G +G VYKG ++ A+KV+D+T G+ K+E +LK+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKK 58
Query: 721 I-RHRNLIRIIT--ICSKP----DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
HRN+ I P D LV+ GS+ + + + G + L + I
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYI 116
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
C ++ G+++LH H KV+H D+K N+LL E+ + DFG++ +D +V N
Sbjct: 117 CREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRN- 169
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+F T + V IA + D++S G+ +E+ G P
Sbjct: 170 --TFIGTPYWMAPEV--IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 21/171 (12%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E QIL+++ + ++ + D LVL +M+ G L+ H+Y + G + G + + +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY-NMG-NPGFEEERALFY 107
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCAN 832
+++ G+ LH + V+ DLKP NILLD+ ++D G+A K+ +G ES+
Sbjct: 108 AAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGR- 161
Query: 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+VGY+APE +R + D + G L+ E++ G+ P
Sbjct: 162 ------------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G+GRFG + +G L+ ++ +A+ L + + F E L + H N++R+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ ++ + +V MSNG+L++ L G L QL+ + +A G+ YL S
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYL---SE 125
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ VH L +L++ DL ++ F + ++ +MS S V
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSP-------VL 173
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ APE S+ DV+SFG+++ E+++ G RP
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIIT 731
+IG G +G VYK + ++ A+K++D+ + K E IL++ H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 732 ICSKPDFKA------LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
K + LV+ L GS+ + + L + I + G+AYLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822
+ KV+H D+K NILL ++ + DFG++ +
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 31/176 (17%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E QIL+++ R ++ + D LVL LM+ G L+ H+Y + + G D + V
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFY 107
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA------KLVKGIDES 827
+++ G+ LH ++V+ DLKP NILLD+ ++D G+A + ++G
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG---- 160
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+VGY+APE +R + D + G L+ E++ G+ P
Sbjct: 161 ----------------RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVL----DLTTTGEITGSFKRECQILKRIRHRNLIR 728
L+G G FG VY D R +AVK + D T + + + E Q+LK +RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 729 IITICSKPDFKALVL--PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
P+ K L + M GS+++ L L+ + + + +GV+YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR----RYTRQILQGVSYLHS 124
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ +VH D+K +NIL D + DFG +K ++ I MS T + G
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI---------CMSGTGIKS-VTG 171
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ +++PE G+ DV+S ++E++T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 28/239 (11%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG +Y + D+ +K +DLT E S K+E +L +++H N++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ +V+ G L + G+ D Q++ ++ G+ ++H K
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLGLKHIHDR---K 121
Query: 792 VVHCDLKPSNILLDED-LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H D+K NI L ++ + A + DFGIA+ + NDSM T G+ Y
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----------NDSMELAYT---CVGTPYY 168
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
++PE + + D++S G +L E+ T + P +G++LH+ V + PI
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP-----FEGNNLHQLVLKICQGYFAPI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 38/231 (16%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIITI 732
IG G +G VYK +A+K + L T E S RE +LK + H N++R++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ LV + + L+ ++ S LI+ + +G+AY H H +V
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK--SYLYQLLQGIAYCHSH---RV 120
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGI------DESVNCANDSMSFTSTDGLLCG 846
+H DLKP N+L+D + +ADFG+A+ G+ E V
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV------------------ 161
Query: 847 SVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
++ Y APE +G R ST D++S G + E+V RRP LF S + +
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP---LFPGDSEIDQ 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 72/289 (24%), Positives = 112/289 (38%), Gaps = 50/289 (17%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
F IG G FG VYK + + N +A+KV+DL + ++E Q L + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 728 RIITICSKPDFK-ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+ K +++ GS + L P LD + I +V G+ YLH
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD-GLLC 845
+H D+K +NILL E+ +ADFG++ ++ T +
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSG--------------QLTSTMSKRNTFV 159
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
G+ ++APE D++S G+ +E+ G P S LH P R
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL-------SDLH-------PMR 205
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
V I K P P +S + + LC +P RPS
Sbjct: 206 ----VLFLIPKNNP---PSLEGNKFSKPFKDFVS---LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/228 (23%), Positives = 102/228 (44%), Gaps = 37/228 (16%)
Query: 675 IGSGRFGHVY----KGVLQ-----------DNTRIAVKVLDLTTTGEITGSFKRECQILK 719
+G G+FG V+ +G+ + +AVK+L T F +E +I+
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 720 RIRHRNLIRIITICSKPDFKALVLPLMSNGSL-----ENHLYPSHGLSHGLDLIQ---LV 771
R+++ N+IR++ +C D ++ M NG L + + + ++ + + L+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831
+ +A G+ YL + + VH DL N L+ T +ADFG+++ + D
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD------ 183
Query: 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
+ G + ++A E + + +T DV++FGV L E+ T
Sbjct: 184 -----YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 694 IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLEN 753
+AVK+L F +E +IL R++ N+IR++ +C D ++ M NG L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 754 HL------------YPSHGLSHGLDLIQ---LVKICSDVAEGVAYLHHHSPIKVVHCDLK 798
L + +H L I L+ + +A G+ YL S + VH DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 799 PSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG 858
N L+ E+LT +ADFG+++ + D + G + ++A E +
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGD-----------YYRIQGRAVLPIRWMAWECILM 214
Query: 859 KRASTHGDVYSFGVLLLEIV 878
+ +T DV++FGV L EI+
Sbjct: 215 GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 82/341 (24%), Positives = 139/341 (40%), Gaps = 71/341 (20%)
Query: 674 LIGSGRFGHVY---KGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNL 726
++G+G +G V+ K D ++ A+KVL L + + E +L+ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 727 IRIITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ + + + K L+L +S G + HLY S D ++ E + L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--DEVRFY-----SGEIILALE 119
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
H + +V+ D+K NILLD + ++ DFG++K ++ + SF C
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-----RTYSF-------C 167
Query: 846 GSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR-- 900
G++ Y+APE GK HG D +S G+L+ E++TG P L + ++ E +R
Sbjct: 168 GTIEYMAPEIIRGK--GGHGKAVDWWSLGILIFELLTGASPF-TLEGERNTQSEVSRRIL 224
Query: 901 ----HYPHRLDPIVEKAIAKY-----------APQ------HMPIYYNKVWSDVVLELIE 939
+P + P + + K PQ P + W + L +
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV- 283
Query: 940 LGLLCTQYNPSTRPSM---LDV---AHEMGRLKQYLSSPSS 974
NP RPS+ LDV A E L+ S +
Sbjct: 284 --------NPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGT 316
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITI 732
IG G +G VYK +A+K + L T E + + RE +LK + H N+++++ +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 733 CSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGL---DLIQLVKICSDVAEGVAYLHHH 787
+ LV + + L+ + P G+ L L QL+ +G+A+ H H
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL-------QGLAFCHSH 119
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+V+H DLKP N+L++ + +ADFG+A+ A T T ++ +
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRTYTHEVV--T 163
Query: 848 VGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR 881
+ Y APE +G K ST D++S G + E+VT R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 79/315 (25%), Positives = 131/315 (41%), Gaps = 75/315 (23%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVK----VLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
IGSG +G V + + ++A+K D+ T + T RE +IL+ +H N+I I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIAI 69
Query: 730 ITI--CSKPDFKA--LVLPLM---------SNGSLENH-----LYPSHGLSHGLDLIQLV 771
I DFK +V+ LM S+ L LY QL+
Sbjct: 70 RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLY------------QLL 117
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831
+ G+ Y+H V+H DLKPSN+L++ED + DFG+A+ +
Sbjct: 118 R-------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL--SSSPTEHK 165
Query: 832 NDSMSFTSTDGLLCGSVGYIAPE--YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889
+ +T Y APE + +T D++S G + E++ GRR LF
Sbjct: 166 YFMTEYVAT-------RWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML-GRRQ---LFP 213
Query: 890 DGSSLHE------WVKRHYPHRLDPI----VEKAIAKYAPQHMPIYYNKVWSDVVLELIE 939
+ +H+ + L+ I V K I P+ P+ ++K++ E ++
Sbjct: 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNL-PRKQPVPWSKIFPKASPEALD 272
Query: 940 LGLLCTQYNPSTRPS 954
L Q++P R +
Sbjct: 273 LLSQMLQFDPEERIT 287
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-11
Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
L L L+G IP+ + L L+ ++L N + G IP + S TSL+ +DLS NS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL---GSITSLEVLDLSYNSFN 479
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQAL 221
G IP ++ +L +LR L L N L G+VP AL
Sbjct: 480 GSIP-ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 47/281 (16%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG V+KG+ ++ A+K++DL + ++E +L + + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
K +++ + GS + L P LD Q+ I ++ +G+ YLH K +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKI 123
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K +N+LL E +ADFG+A + N G+ ++AP
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-------------TFVGTPFWMAP 170
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA 913
E + D++S G+ +E+ G P S LH P ++ ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPH-------SELH-------PMKVLFLI--- 213
Query: 914 IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P++ P +S + E +E C PS RP+
Sbjct: 214 -----PKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 23/230 (10%)
Query: 662 LIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR 720
L + G F ++G+G +G VYKG ++ A+KV+D+T E K E +LK+
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKK 68
Query: 721 I-RHRNLIRIITICSKP------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
HRN+ K D LV+ GS+ + + + G + D I I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--I 126
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
C ++ G+A+LH H KV+H D+K N+LL E+ + DFG++ +D +V N
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRN- 179
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+F T + V IA + D++S G+ +E+ G P
Sbjct: 180 --TFIGTPYWMAPEV--IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 49/301 (16%)
Query: 674 LIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+G G FG V+ + T + VK L T + F+RE + +++ H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-----LDLIQLVKICSDVAEGVA 782
R++ +C + + ++L G L+ L + L Q V +C+ +A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+L + + VH DL N L+ V+ ++K V E N +
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN-SEYYKLRNALI------- 180
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
+ ++APE ST DV+SFGVL+ E+ T L G S E + R
Sbjct: 181 ----PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----QGELPFYGLSDEEVLNR-- 230
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+ + P+ P L +L C NP RPS ++ +
Sbjct: 231 ------LQAGKLELPVPEGCP-----------SRLYKLMTRCWAVNPKDRPSFSELVSAL 273
Query: 963 G 963
G
Sbjct: 274 G 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
DL + +++ G+ +LH +++ DLK N++LD D +ADFG+ K
Sbjct: 93 FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK----- 144
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
E+V N + +F CG+ YIAPE G + + D +SFGVLL E++ G+ P
Sbjct: 145 -ENVFGDNRASTF-------CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP- 195
Query: 885 DVLFH--DGSSLHEWVKRHYPH 904
FH D L E ++ PH
Sbjct: 196 ---FHGDDEDELFESIRVDTPH 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 674 LIGSGRFGHVYKGVLQ---DNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
++GSG FG VYKG+ + +I A+K L T+ + E ++ + + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSH---GLSHGLDLIQLVKICSDVAEGVAYLH 785
++ IC + L+ LM G L +++ G + L+ C +A+G+ YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQY------LLNWCVQIAKGMNYLE 126
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
++VH DL N+L+ + DFG+AKL+ G DE + + G +
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GADEK--------EYHAEGGKV- 173
Query: 846 GSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVT-GRRPTD 885
+ ++A E + R TH DV+S+GV + E++T G +P D
Sbjct: 174 -PIKWMALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 675 IGSGRFGHVYKG---VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG+G FG V G R+ VK L + T + F +E Q + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGL-DLIQLVKICSDVAEGVAYLHHHSPI 790
C + LVL G L+N+L + G+ + L ++ +VA G+ +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---A 119
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+H DL N L DL+ + D+G+A D + T + +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED-----------YYITKDCHAVPLRW 168
Query: 851 IAPEYG-------MGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+APE + K + +++S GV + E+ T +P
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 70/227 (30%), Positives = 94/227 (41%), Gaps = 49/227 (21%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG VY+ +D RI A+KVL K+E K + H R I +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-----------KKEIVAKKEVAHTIGERNILVR 49
Query: 734 SKPD-----------FKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDV 777
+ D F+ LV MS G L HL S K +
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-----DRAKFY--I 102
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
AE V L H +V+ DLKP NILLD + DFG++K AN ++
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-----------AN--LTD 149
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRAST-HGDVYSFGVLLLEIVTGRRP 883
T CG+ Y+APE + ++ T H D +S GVL+ E+ G P
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 35/116 (30%), Positives = 56/116 (48%), Gaps = 12/116 (10%)
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
+++ + YLH + ++H DLKP NIL+D + + DFG++K+ V +
Sbjct: 100 AEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV-----GLVRRQINL 151
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890
D + G+ YIAPE +G+ S D +S G +L E + G P FH
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP----FHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-11
Identities = 75/286 (26%), Positives = 119/286 (41%), Gaps = 63/286 (22%)
Query: 644 DEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHV-YKGVLQDNTRIAVKVLDLT 702
DE KE+AK + S ++GSG G V + D AVKV+D+
Sbjct: 23 DEATAKEQAKK--------------YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME 68
Query: 703 --TTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK--------ALVLPLMSNGSLE 752
+ + + + E L ++++ +K D + ALVL + G L
Sbjct: 69 GMSEADKNRA-QAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLR 127
Query: 753 ---------NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNIL 803
N + H GL IQ++ +A H HS ++H D+K +NIL
Sbjct: 128 QEIKSRAKTNRTFREH--EAGLLFIQVL---------LAVHHVHSK-HMIHRDIKSANIL 175
Query: 804 LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAST 863
L + + DFG +K+ +D + T CG+ Y+APE K S
Sbjct: 176 LCSNGLVKLGDFGFSKMYA------ATVSDDVGRT-----FCGTPYYVAPEIWRRKPYSK 224
Query: 864 HGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
D++S GVLL E++T +RP DG ++ E + + R DP+
Sbjct: 225 KADMFSLGVLLYELLTLKRP-----FDGENMEEVMHKTLAGRYDPL 265
|
Length = 496 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 61/243 (25%)
Query: 675 IGSGRFGHVYKGVLQDNTR---IAVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIR 728
IG G +G VYK ++ A+K TG I+ S RE +L+ ++H N++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-ISQSACREIALLRELKHENVVS 66
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------------- 772
++ + + K++ L Y H DL Q++K
Sbjct: 67 LVEVFLEHADKSVYLLFD---------YAEH------DLWQIIKFHRQAKRVSIPPSMVK 111
Query: 773 -ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALVADFGIAKLVKGIDES 827
+ + GV YLH + V+H DLKP+NIL+ E + D G+A+L
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL------- 161
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDV 886
D ++ ++ Y APE +G R T D+++ G + E++T
Sbjct: 162 --FNAPLKPLADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE----P 214
Query: 887 LFH 889
+F
Sbjct: 215 IFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 68/245 (27%), Positives = 106/245 (43%), Gaps = 45/245 (18%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKREC-QILKRI-----RH 723
++G G FG V L+ + AVKVL + ++ EC KR+ +H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV------ECTMTEKRVLALAGKH 55
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
L ++ + D V+ ++ G L H+ S D + +++ G+ +
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF----DEPRARFYAAEIVLGLQF 111
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH +++ DLK N+LLD + +ADFG+ K +GI V TST
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVT--------TST--- 155
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSLHEWV 898
CG+ YIAPE + D ++ GVLL E++ G+ P D LF S L + V
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ--SILEDEV 213
Query: 899 KRHYP 903
YP
Sbjct: 214 --RYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVL----DLTTTGEITGSFKRECQILKRIRHRNLIR 728
L+G G FG VY D R +AVK + + T + + + E Q+LK + H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 729 IITICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
P + L + M GS+++ L L+ + K + EGV+YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR----KYTRQILEGVSYLHS 124
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ +VH D+K +NIL D + DFG +K ++ I C + + + T G
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI-----CLSGTGMKSVT-----G 171
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ +++PE G+ D++S G ++E++T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-11
Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 714 ECQILKRIRHRNLIRI-ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK 772
E +IL ++ R ++ + +K D LV+ +M+ G L H+Y + G +
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCA 831
+ + G+ +LH ++++ DLKP N+LLD D ++D G+A +L G ++ A
Sbjct: 102 YTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+ G++APE G+ D ++ GV L E++ R P
Sbjct: 159 --------------GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 43/243 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRIIT 731
IG G +G V+K ++ +I V + + + I RE ++LK+++H NL+ +I
Sbjct: 9 IGEGSYGVVFKCRNRETGQI-VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 732 ICSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ + LV + ++ N L P G+ + KI + V + H H
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKH-- 119
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST-----DGLL 844
+H D+KP NIL+ + + DFG A+++ G + D + +T LL
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD------DYTDYVATRWYRAPELL 172
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT------GRRPTDVLFHDGSSLHEWV 898
G Y P DV++ G + E++T G+ D L+ +L + +
Sbjct: 173 VGDTQYGPPV-----------DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI 221
Query: 899 KRH 901
RH
Sbjct: 222 PRH 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRI----AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG V + +D RI ++ + + E+T + E +L ++ ++ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
P+ LVL ++ G L +HL L + AE + L +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALENLHKF 112
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
V++ DLKP NILLD + DFG+ KL +M CG+ Y
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKL-------------NMKDDDKTNTFCGTPEY 159
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE +G + D ++ GVLL E++TG P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 96/315 (30%), Positives = 144/315 (45%), Gaps = 25/315 (7%)
Query: 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG--QV 217
+ + + + + ++LS+N L L L L L S +
Sbjct: 31 QSINLNFPDSNLESVAVNRLALNLSSN-----TLLLLPSSLSRLLSLDLLSPSGISSLDG 85
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+ L N L LDL N + + ++ L L L N+ T++ P
Sbjct: 86 SENLLNLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNI------TDIPPL--I 135
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
SN +EL+L+ N + +PS + +L NL + L N + +P +SNL NL L+
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNL-PNLKNLDLSFNDL-SDLPKLLSNLSNLNNLD 192
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397
LS N ++ +P E+ L+S LE + LSNNS+ E+ S+ ++ +L L+LS NKL +P+
Sbjct: 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
S NLS L L L N +S SSLG NL LDLS N +S +P L L+L L
Sbjct: 250 SIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
Query: 458 NLSSNHLDGPLPLEL 472
NL L L
Sbjct: 308 NLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 49/282 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTR--IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IG G FG VYKG+ + T+ +A+K++DL + ++E +L + + R
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
K +++ + GS + L P L+ + I ++ +G+ YLH I
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSERKI-- 123
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
H D+K +N+LL E +ADFG+A + N G+ ++A
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-------------FVGTPFWMA 169
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE D++S G+ +E+ G P S LH P R V
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPN-------SDLH-------PMR----VLF 211
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
I K +P + Y+K + + V C +P RP+
Sbjct: 212 LIPKNSPPTLEGQYSKPFKEFVEA-------CLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 44/129 (34%), Positives = 69/129 (53%), Gaps = 25/129 (19%)
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ +LH +++ DLK N+LLD+D +ADFG+ K E++N + +F
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK------ENMNGEGKASTF-- 156
Query: 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSL 894
CG+ YIAPE G++ + D +SFGVLL E++ G+ P D LF S L
Sbjct: 157 -----CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD--SIL 209
Query: 895 HEWVKRHYP 903
++ + H+P
Sbjct: 210 ND--RPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 40/121 (33%), Positives = 60/121 (49%), Gaps = 22/121 (18%)
Query: 770 LVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESV 828
L KI + + + YLH S + V+H D+KPSN+L++ + + DFGI+ LV
Sbjct: 105 LGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV------- 155
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEY----GMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
DS++ T G Y+APE K DV+S G+ ++E+ TGR P
Sbjct: 156 ----DSVAKTID----AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
Query: 885 D 885
D
Sbjct: 208 D 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 24/217 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVL----DLTTTGEITGSFKRECQILKRIRHRNLIR 728
L+G G FG VY D R +A K + + T + + + E Q+LK ++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 729 IITICSKPDFKALVLPL--MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
K L + + M GS+++ L L+ + K + EG++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR----KYTRQILEGMSYLHS 124
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ +VH D+K +NIL D + DFG +K ++ I MS T + G
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI---------CMSGTGIRS-VTG 171
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ +++PE G+ DV+S G ++E++T + P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 46/229 (20%)
Query: 673 SLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEI--TGSFKRECQILKRIRHRNLIRI 729
S +GSG +G V ++A+K L I ++ RE ++LK + H N+I +
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGL 79
Query: 730 ITICSKP----DFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
+ + + DF+ LV LM G+ N++ LS D IQ + + G+ Y
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSD--DHIQF--LVYQILRGLKY 133
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
+H ++H DLKPSNI ++ED + DFG+A+ TD
Sbjct: 134 IH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------------HTDDE 171
Query: 844 LCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLF 888
+ G V Y APE + D++S G ++ E++TG+ LF
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK----TLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 33/220 (15%)
Query: 673 SLIGSGRFGHV----YKGVLQDNTRIAVKVL---DLTTTGEI--TGSFKRECQILKRIRH 723
+++G G FG V YK A+K L D+ E+ KR + RH
Sbjct: 5 AVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
L+ + D V+ + G L H++ + + V + V G+ Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQY 116
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH + K+V+ DLK N+LLD + +ADFG+ K + M F
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-------------EGMGFGDRTST 160
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
CG+ ++APE + D + GVL+ E++ G P
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 69/298 (23%), Positives = 114/298 (38%), Gaps = 55/298 (18%)
Query: 668 GFCPSSLIGSGRFGHVYK-GVLQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHR 724
F +G G +G VYK L DN A+K +DL + E + E +IL + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59
Query: 725 NLIR----IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
N+I + +V+ G L + + ++ +I + G
Sbjct: 60 NIISYKEAFLDGNKL----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ LH K++H DLK +NILL + + D GI+K++K +M+ T
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK----------NMAKTQI 162
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
G+ Y+APE G+ S D++S G LL E+ T P + S+ + +
Sbjct: 163 -----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP-----FEARSMQDLRYK 212
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ PI P Y++ +L Q P RP+ +
Sbjct: 213 VQRGKYPPI-------------PPIYSQ-------DLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 61/239 (25%), Positives = 93/239 (38%), Gaps = 67/239 (28%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKR----ECQILKRIRHRNLI-- 727
IG G FG V K D + K +D G +T K+ E IL+ ++H N++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 728 --RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKIC----------- 774
RII SN +L ++ + G DL QL++ C
Sbjct: 65 YDRII--------------DRSNQTL--YIVMEY-CEGG-DLAQLIQKCKKERKYIEEEF 106
Query: 775 -----SDVAEGVAYLHHHSPIK--VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827
+ + + H+ S V+H DLKP+NI LD + + DFG+AK++
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL------ 160
Query: 828 VNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
SF T VG Y++PE D++S G L+ E+ P
Sbjct: 161 ----GHDSSFAKT------YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 37/165 (22%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
IG G FG V+K + +I A+K + + E IT RE +IL+ ++H N++ +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLKHENVVNLI 77
Query: 731 TICSKP-----DFKA---LVLP--------LMSNGSLENHLYPSHGLSHGLDLIQLVKIC 774
IC +K LV L+SN +++ L ++ K+
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK------------FTLSEIKKVM 125
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
+ G+ Y+H + K++H D+K +NIL+ +D +ADFG+A+
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 675 IGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G FG +YKG L +A+K L + G F++E ++ + H N++ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 730 ITICSKPDFKALVLPLMSNGSLENHL-----YPSHGLS--------HGLDLIQLVKICSD 776
+ + ++ ++ ++ G L L + G S LD + I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ YL H VH DL NIL+ E L ++D G+++ + D
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD---------YY 180
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
LL + ++ PE M + S+ D++SFGV+L EI + G +P
Sbjct: 181 RVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 63/256 (24%), Positives = 107/256 (41%), Gaps = 51/256 (19%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRIRHRN 725
F ++G G FG V + + A+K+L D+ + EC ++++
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV-----ECTMVEK----- 51
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI------------QLVKI 773
R++ + KP F + L S + LY +G DL+ Q V
Sbjct: 52 --RVLALQDKPPF---LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY 106
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
++++ G+ +LH +++ DLK N++LD + +ADFG+ K +
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------------E 150
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
M T CG+ YIAPE + D +++GVLL E++ G+ P D D
Sbjct: 151 HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD--GEDEDE 208
Query: 894 LHEWVKRH---YPHRL 906
L + + H YP L
Sbjct: 209 LFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 673 SLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIR 728
IG G +G VYK +D +A+K + L E IT RE +IL+++ HRN++
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAI--REIKILRQLNHRNIVN 70
Query: 729 IITICSKP----DFKA------LVLPLMSN---GSLENHLYPSHGLSHGLDLIQLVKICS 775
+ I + DFK LV M + G LE+ GL H +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES------GLVH-FSEDHIKSFMK 123
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
+ EG+ Y H + +H D+K SNILL+ +ADFG+A+L + +S
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYN--------SEESR 172
Query: 836 SFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRP 883
+T+ ++ Y PE +G +R DV+S G +L E+ T ++P
Sbjct: 173 PYTNK----VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII-TI 732
+G+G G V K + T +A KV+ + + RE QI+ R ++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--HHSPI 790
++ + + + M GSL+ +Y G + + L KI V EG+ YL+ H
Sbjct: 73 LNENNI-CMCMEFMDCGSLDR-IYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR--- 124
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H D+KPSNIL++ + DFG++ E +N D+ TST Y
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS------GELINSIADTFVGTST---------Y 168
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
++PE G + + DV+S G+ ++E+ G+ P
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 82/293 (27%), Positives = 121/293 (41%), Gaps = 68/293 (23%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY ++ N +A+K + + + E +E + L+++RH N I
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81
Query: 732 ICSKPDFKALVLPLMSNGS----LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
C + A ++ GS LE H P L +++ IC +G+AYLH H
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKKP-------LQEVEIAAICHGALQGLAYLHSH 134
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
I H D+K NILL E T +ADFG A L V+ AN SF G+
Sbjct: 135 ERI---HRDIKAGNILLTEPGTVKLADFGSASL-------VSPAN---SFV-------GT 174
Query: 848 VGYIAPEYGMGKRASTHG------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901
++APE + A G DV+S G+ +E+ R+P + S+L+
Sbjct: 175 PYWMAPEVIL---AMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYH----- 225
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
IA+ P + WSD ++ C Q P RPS
Sbjct: 226 ------------IAQNDS---PTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 675 IGSGRFGHVY----KGVLQ-------------DNTRIAVKVLDLTTTGEITGSFKRECQI 717
+G G+FG V+ +G+ + +AVK+L F +E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 718 LKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLEN----HLYPSHGLSHGLDLIQ---L 770
+ R++ N+IR++ +C D ++ M NG L H + I L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK-LVKGIDESVN 829
+ + + +A G+ YL S + VH DL N L+ ++ T +ADFG+++ L G
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG------ 183
Query: 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
+ G + +++ E + + +T DV++FGV L EI+T
Sbjct: 184 ------DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 671 PSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIR---HRN 725
P + IG G +G VYK +A+K + + T + + S RE +LKR+ H N
Sbjct: 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 726 LIRIITIC--SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
++R++ +C S+ D + V + + + Y GL + + G+ +
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH + +VH DLKP NIL+ +ADFG+A++ S A + T
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY-----SCQMALTPVVVT----- 170
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ Y APE + +T D++S G + E+ R+P
Sbjct: 171 ----LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 675 IGSGRFGHVYKGVLQDN---TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG V+KG+ DN +A+K++DL + ++E +L + + +
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
K +++ + GS + L + D Q+ + ++ +G+ YLH K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---K 121
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+H D+K +N+LL E +ADFG+A + D+ +T G+ ++
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQL----------TDTQIKRNT---FVGTPFWM 168
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD------VLFH 889
APE + D++S G+ +E+ G P VLF
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 671 PSSLIGSGRFGHVYKGV-LQDNTR-IAVKVLDLTTTGE-ITGSFKRECQILKRIR---HR 724
+ IG G +G V+K L++ R +A+K + + T E + S RE +L+ + H
Sbjct: 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 725 NLIRIITIC--SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVA 782
N++R+ +C S+ D + + + + + Y G+ + + + G+
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+LH H +VVH DLKP NIL+ +ADFG+A++ SF
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--------------YSFQMALT 167
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH- 901
+ ++ Y APE + +T D++S G + E+ R+P LF S + + K
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGSSDVDQLGKILD 223
Query: 902 ---YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELG----LLCTQYNPSTRPS 954
P D + A+ + A + V ++ ELG L C +NP+ R S
Sbjct: 224 VIGLPGEEDWPRDVALPRQAFHSKSA---QPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 23/196 (11%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E +L+ + H ++IR+ +VLP + L +L S L + Q + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR---SRPLPIDQALII 162
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
+ EG+ YLH +++H D+K NI +++ + D G A+ V
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF------PVVAPAF 213
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
L G+V APE + ++ D++S G++L E++ P+ + S+
Sbjct: 214 LG--------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPST 263
Query: 894 LHEWVKRHYPHRLDPI 909
E+VK + H L I
Sbjct: 264 PEEYVKSCHSHLLKII 279
|
Length = 357 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 67/300 (22%), Positives = 115/300 (38%), Gaps = 50/300 (16%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+G+G FG V + ++AVK+L T + E +I+ + H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHH 786
++ C+ ++ G L N L L L L+ VA+G+A+L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL---RRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ +H DL N+LL + DFG+A+ + NDS + L
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM---------NDSNYVVKGNARL-- 205
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905
V ++APE + DV+S+G+LL EI + G P + D S ++ +K Y
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGY--- 261
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
A ++AP + W +P RP+ + +G+
Sbjct: 262 -----RMAQPEHAPAEIYDIMKTCWD---------------ADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 59/303 (19%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITI 732
IG G +G V+K ++ I A+K + L E + S RE +LK ++H+N++R+ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 733 CSKPDFKALVLPLMS----------NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVA 782
LV NG ++ + S + QL+K G+A
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSF-------MFQLLK-------GLA 113
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ H H V+H DLKP N+L++++ +ADFG+A+ GI V C + +
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GI--PVRCYSAEVV------ 161
Query: 843 LLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901
++ Y P+ G K ST D++S G + E+ RP LF G+ + + +KR
Sbjct: 162 ----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LF-PGNDVDDQLKRI 213
Query: 902 YPHRLDPIVEK-----AIAKYAPQHMPIYY-NKVWSDVVLELIELGLLCTQ----YNPST 951
+ P E + Y P P+Y +VV +L G Q NP
Sbjct: 214 FRLLGTPTEESWPGVSKLPDYKP--YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQ 271
Query: 952 RPS 954
R S
Sbjct: 272 RIS 274
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAV-KVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VYK ++ +A KV+D + E+ + E IL H N+++++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 71
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +++ + G+++ + L L Q+ +C E + YLH + K++
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLK NIL D +ADFG++ A ++ + D + G+ ++AP
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS------------AKNTRTIQRRDSFI-GTPYWMAP 172
Query: 854 EYGMGKRASTH-----GDVYSFGVLLLEIVTGRRP 883
E M + + DV+S G+ L+E+ P
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 40/261 (15%)
Query: 674 LIGSGRFGHVY---KGVLQDNTRI-AVKVLDLTT---TGEITGSFKRECQILKRIRHRNL 726
++G+G +G V+ K D+ ++ A+KVL T + T + E Q+L+ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 727 IRIITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ + + D K L+L ++ G L HL Q V+I E V L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIY--SGEIVLALE 119
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
H + +++ D+K NILLD + ++ DFG++K + ++ V A C
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFHEDEVERAYS----------FC 167
Query: 846 GSVGYIAPEYGMGKRASTHG--DVYSFGVLLLEIVTGRRPTDVLFHDG--SSLHEWVKR- 900
G++ Y+AP+ G D +S GVL+ E++TG P V DG +S E +R
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV---DGEKNSQAEISRRI 224
Query: 901 -----HYPHRLDPIVEKAIAK 916
YP + + + I +
Sbjct: 225 LKSEPPYPQEMSALAKDIIQR 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 21/171 (12%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E +IL+++ R ++ + D LVL +M+ G L+ H+Y + G + G D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY-NMG-NPGFDEQRAIFY 107
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCAN 832
+++ G+ L ++V+ DLKP NILLD+ ++D G+A ++ +G E+V
Sbjct: 108 AAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGR- 161
Query: 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G+VGY+APE ++ + D + G L+ E++ G+ P
Sbjct: 162 ------------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 53/288 (18%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAV-KVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VYK ++ +A KV++ + E+ + E +IL H +++++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+++ G+++ + L GL Q+ IC + E + YLH +K++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH---SMKII 132
Query: 794 HCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
H DLK N+LL D +ADFG+ AK VK + DS G+ ++A
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-----RDS---------FIGTPYWMA 178
Query: 853 PEYGMGKRAST-----HGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
PE M + D++S G+ L+E+ P H L+
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-------------------HELN 219
Query: 908 PI-VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P+ V IAK P + WS + ++ L +P TRPS
Sbjct: 220 PMRVLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTAL---DKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
F S +G+G G V K V + + A K++ L I RE Q+L +
Sbjct: 7 FERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+ ++ + M GSL+ L + + + L K+ V G+AYL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE 121
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+++H D+KPSNIL++ + DFG++ + ID N SF G
Sbjct: 122 KH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMAN------SFV-------G 164
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ Y++PE G S D++S G+ L+E+ GR P
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G + VYKG+ + N + +A+KV+ + T + + RE +LK ++H N++ + I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHG----LDLIQLVKICSDVAEGVAYLHHHSP 789
+ V M L ++ G H L + QL++ G+AY+H
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ-- 122
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++H DLKP N+L+ +ADFG+A+ +S+ S ++
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLAR-----AKSIPSQTYSSEVV--------TLW 168
Query: 850 YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR 881
Y P+ +G S+ D++ G + +E++ G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-09
Identities = 83/277 (29%), Positives = 130/277 (46%), Gaps = 54/277 (19%)
Query: 638 NGADLEDEEK--EKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNT-RI 694
N + EDEEK + + ++P SYK ++IG+G FG VY+ + D + ++
Sbjct: 45 NAGEDEDEEKMIDNDINRSPNKSYKL----------GNIIGNGSFGVVYEAICIDTSEKV 94
Query: 695 AVK-VLDLTTTGEITGSFK-RECQILKRIRHRNLIRI----ITICSKPDFKALVLPL-MS 747
A+K VL +K RE I+K + H N+I + T C K + K + L + M
Sbjct: 95 AIKKVLQ-------DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 748 NGSLENHLYPSHGL--SHGLDLIQLVKICS-DVAEGVAYLHHHSPIKVVHCDLKPSNILL 804
H Y H +H L L LVK+ S + +AY+H + H DLKP N+L+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLF-LVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI 203
Query: 805 DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RAS 862
D + L + DFG AK + SV+ +C S Y APE +G +
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSVS-------------YIC-SRFYRAPELMLGATNYT 249
Query: 863 THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
TH D++S G ++ E++ G +F SS+ + V+
Sbjct: 250 THIDLWSLGCIIAEMILGYP----IFSGQSSVDQLVR 282
|
Length = 440 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-09
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 673 SLIGSGRFGHVY---KGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRN 725
++G G +G V+ K D +I A+KVL + + T K E IL+ ++H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
++ +I L+L +S G L HL G+ + C ++E L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLE-----REGIFMEDTA--CFYLSEISLALE 114
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
H +++ DLKP NILLD + DFG+ K ES++ +++ T C
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK------ESIH--EGTVTHT-----FC 161
Query: 846 GSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
G++ Y+APE M S HG D +S G L+ +++TG P
Sbjct: 162 GTIEYMAPEILM---RSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IGSG +G VYK + A+KV+ L GE ++E ++K +H N++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ D + + GSL++ + + LS Q+ + + +G+ YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSE----SQIAYVSRETLQGLYYLHSKGKM--- 128
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K +NILL ++ +ADFG++ A + + + G+ ++AP
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS------------AQITATIAKRKSFI-GTPYWMAP 175
Query: 854 EYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
E +R + D+++ G+ +E+ + P
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 69/311 (22%), Positives = 124/311 (39%), Gaps = 62/311 (19%)
Query: 675 IGSGRFGHVYKGVLQDNT---RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG+G FG V + +T R+ VK L + + F ++ + ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
C + LV G L+++L L+ L ++ ++A GV ++H H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+H DL N L DLT V D+GI + + T+ C + ++
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGP-----------SRYKEDYIETEDDKCVPLRWL 168
Query: 852 APEYGMGKR--------ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
APE +G+ + +V++ GV L E L E + Y
Sbjct: 169 APEL-VGEFHGGLITAEQTKPSNVWALGVTLWE-----------------LFENAAQPYS 210
Query: 904 HRLDP------IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957
H D I ++ + + P + + Y++ W + VL+ L +P R +
Sbjct: 211 HLSDREVLNHVIKDQQVKLFKP-QLELPYSERWYE-VLQFCWL-------SPEKRAT--- 258
Query: 958 VAHEMGRLKQY 968
A E+ RL Y
Sbjct: 259 -AEEVHRLLTY 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 46/228 (20%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G FG V + + A+K+L D+ + EC ++++ R+
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDV-----ECTMVEK-------RV 53
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDL---IQLVK---------ICSDV 777
+ + KP F + L S + LY +G DL IQ V +++
Sbjct: 54 LALPGKPPF---LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI 110
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ +LH +++ DLK N++LD + +ADFG+ K E++ + +F
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKTTRTF 161
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD 885
CG+ YIAPE + D ++FGVLL E++ G+ P D
Sbjct: 162 -------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 38/117 (32%), Positives = 58/117 (49%), Gaps = 23/117 (19%)
Query: 770 LVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESV 828
L KI V G+ YL K++H D+KPSNIL++ + DFG++ +L+
Sbjct: 101 LGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151
Query: 829 NCANDSM--SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
DSM SF G+ Y++PE G + D++S G+ L+E+ GR P
Sbjct: 152 ----DSMANSFV-------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 32/103 (31%)
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
V+H D+KPSNILLD + DFGI+ +LV DS + T + G C + Y
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV-----------DSKAKTRSAG--CAA--Y 180
Query: 851 IAPE----------YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE Y + RA DV+S G+ L+E+ TG+ P
Sbjct: 181 MAPERIDPPDPNPKYDI--RA----DVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 65/241 (26%), Positives = 97/241 (40%), Gaps = 56/241 (23%)
Query: 675 IGSGRFGHV----YKGVLQDNTRIAVKVLDLTTTGEI-----TGSFKRECQILKRIRHRN 725
+G+G FG V +KG A+K L EI +E IL + H
Sbjct: 26 LGTGSFGRVRIAKHKGT---GEYYAIKCL---KKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 726 LIRIITICSKPDFKAL--VLPLMSNGSLENHL-----YPSHGLSHGLDLIQLVKICSDVA 778
++ ++ CS D + +L + G L HL +P+ D+ + +++
Sbjct: 80 IVNMM--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN-------DVAKFY--HAELV 128
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
YLH +++ DLKP N+LLD V DFG AK V +FT
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----------DRTFT 174
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
LCG+ Y+APE K D ++ GVLL E + G P F D + +
Sbjct: 175 -----LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP----FFDDTPFRIYE 225
Query: 899 K 899
K
Sbjct: 226 K 226
|
Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 66/251 (26%), Positives = 96/251 (38%), Gaps = 56/251 (22%)
Query: 667 GGFCPSSLIGSGRFGHVYKGVLQDN-TRI--AVKVLDLTTTGEITGSFKRECQILKR--I 721
F +IG G FG V+ +++D T A+KVL R+ ++KR I
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVL-------------RKSDMIKRNQI 45
Query: 722 RHRNLIR-IITICSKP------------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLI 768
H R I+ P + LV+ M G L N L +
Sbjct: 46 AHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE--ETA 103
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
+ +AE V L + +H D+KP NIL+D D +ADFG+ K + +
Sbjct: 104 RFY-----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 829 NCANDSMSFTSTDGLLC----------------GSVGYIAPEYGMGKRASTHGDVYSFGV 872
NDS + D +L G+ YIAPE G D +S GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 873 LLLEIVTGRRP 883
+L E++ G P
Sbjct: 219 ILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDL-TTTGEITGSFKRECQILKRIRHRNLIRIIT 731
++G G FG V+ D + +K + + T + + + ECQ+LK + H N+I
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 732 ICSKPDFKALVLPLMSNGSLE-------NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+ +V+ G+L N L + H I L L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------------L 114
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
HH ++H DLK NILLD+ + + DFGI+K++ ++ S ++T
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------SSKSKAYT----- 160
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD 885
+ G+ YI+PE GK + D+++ G +L E+ + +R +
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 675 IGSGRFGHVYKGVLQDN---TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG+G FG V G + ++ VK L ++ + + F E Q + ++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGL-SHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
C++ LV+ G L+ +L D L ++ ++A G+ +LH ++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKL 820
+H DL N LL DLT + D+G++
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-08
Identities = 26/60 (43%), Positives = 37/60 (61%)
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
L+ + LSNN L+ AF +P+L +LDLS N L+ P++F+ L LR L L GN+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 72/294 (24%), Positives = 115/294 (39%), Gaps = 62/294 (21%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY N +AVK + + T E +E + L++++H N I
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 732 ICSKPDFKALVLPLMSNGS----LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
C + A ++ GS LE H P L +++ I +G+AYLH H
Sbjct: 89 -CYLKEHTAWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAITHGALQGLAYLHSH 140
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ ++H D+K NILL E +ADFG S S +S G+
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFG-----------------SASKSSPANSFVGT 180
Query: 848 VGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
++APE + + DV+S G+ +E+ R+P LF+ +
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPP--LFNMNAM----------- 226
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
A+ A P + W+D ++ C Q P RP+ ++
Sbjct: 227 -------SALYHIAQNDSPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 46/222 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIITI 732
+GSG +G V + + ++A+K L E+ RE ++LK ++H N+I ++ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 733 CSKPDFKA-------LVLPLMSN--GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
+ PD LV+P M G L H LS D IQ + + +G+ Y
Sbjct: 83 FT-PDLSLDRFHDFYLVMPFMGTDLGKLMKH----EKLSE--DRIQF--LVYQMLKGLKY 133
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
+H ++H DLKP N+ ++ED + DFG+A+ TD
Sbjct: 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QTDSE 171
Query: 844 LCGSV---GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
+ G V Y APE + T D++S G ++ E++TG+
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 80/308 (25%), Positives = 138/308 (44%), Gaps = 33/308 (10%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSL-IRLKQLS 131
+ + LDL+ + IS L L++L LDL N IP +G L LK+L
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNI-TDIPPLIGLLKSNLKELD 146
Query: 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
LS N ++ +PS L +L L+ LDL N L ++P ++ ++L +DLS N ++ +
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLP---KLLSNLSNLNNLDLSGNKIS-D 200
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ 251
+P + E L L L L +N ++ ++ +L+N L L+L +N E E I +
Sbjct: 201 LPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN--KLEDLPESIGNLSN 256
Query: 252 LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQ 311
L+ L LS N +++ SL + +N +EL+L+GN+L +P I L +
Sbjct: 257 LETLDLSNN------QISSIS----SLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306
Query: 312 IHL----------DCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVY 361
++L +++ + L++ +L N S L R
Sbjct: 307 LNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYI 366
Query: 362 LSNNSLSG 369
+ N + G
Sbjct: 367 VKNPNAIG 374
|
Length = 394 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT---TGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG V + D + AVKVL T E +LK ++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ VL ++ G L HL + ++VA + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP----RARFYAAEVASAIGYLH---S 114
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ +++ DLKP NILLD ++ DFG+ K +G++ TST CG+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPE--------ETTST---FCGTPE 161
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE + D + G +L E++ G P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDL----TTTGEITGSFKRECQILKRIRHRNLIR 728
+IG G FG VY D ++ A+K LD GE +R L I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 729 IITIC-SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
++ PD + +L LM+ G L HL HG+ ++ +++ G+ ++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYA---AEIILGLEHMHNR 116
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
VV+ DLKP+NILLDE ++D G+A D S + S+ G+
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASV----------GT 158
Query: 848 VGYIAPE-YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
GY+APE G + D +S G +L +++ G P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 44/233 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFK------------RECQILKR 720
+G G +G V K +A+K + + + ++T + RE +I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 721 IRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK-ICSDVAE 779
I+H N++ ++ + + DF LV+ +M+ L+ + L+ VK I +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLT-----ESQVKCILLQILN 130
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ LH +H DL P+NI ++ +ADFG+A+ S T
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR---------RYGYPPYSDTL 178
Query: 840 TDGLLCGS----------VGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
+ + Y APE MG D++S G + E++TG+
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 675 IGSGRFGHVYKG--VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G + VYKG L DN +A+K + L + RE +LK ++H N++ + I
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSH----GLDLIQLVKICSDVAEGVAYLHHHS 788
LV + + L+ +L + L L QL++ G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR- 123
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
KV+H DLKP N+L++E +ADFG+A+ K I + +L GS
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGST 180
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
Y ST D++ G + E+ TGR
Sbjct: 181 DY-----------STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 60/289 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY ++++ +A+K + + + E +E + L+++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 732 ICSKPDFKALVLPLMSNGS---LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ LV+ + LE H P L +++ + +G+AYLH H+
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAVTHGALQGLAYLHSHN 135
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++H D+K NILL E + DFG A ++ + V G+
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----------------GTP 175
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
++APE + + DV+S G+ +E+ + P LF+ +
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAM------------ 220
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
A+ A P + WS+ ++ C Q P RP+
Sbjct: 221 ------SALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 48/237 (20%)
Query: 713 RECQILKRIRHRNLIRIITIC----SKPDFKA--LVLPLM-SNGSLENHLYPSHGLSHGL 765
RE +LK + H+N+I ++ + S +F+ LV+ LM +N H+ H L
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128
Query: 766 DLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825
L Q+ +C G+ +LH ++H DLKPSNI++ D T + DFG+A+
Sbjct: 129 -LYQM--LC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 173
Query: 826 ESVNCANDSMS-FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
C N M+ + T Y APE +G + D++S G ++ E+V G
Sbjct: 174 ----CTNFMMTPYVVTR-------YYRAPEVILGMGYKENVDIWSVGCIMGELVKG---- 218
Query: 885 DVLFHDGSSLHEWVK---------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSD 932
V+F + +W K + +RL P V + PQ+ I + +++ D
Sbjct: 219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN-RPQYPGISFEELFPD 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 67/303 (22%), Positives = 124/303 (40%), Gaps = 59/303 (19%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRI-RHRNLIRII 730
+G G FG VY ++ + A+K + + E RE + L+++ H N++++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL--REVKSLRKLNEHPNIVKLK 64
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ + D V M G+L L + I + +G+A++H H
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHKHG-- 119
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS-FT---STDGLLCG 846
H DLKP N+L+ +ADFG+A+ ++ S +T ST
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAREIR-----------SRPPYTDYVSTR----- 162
Query: 847 SVGYIAPE-------YGMGKRASTHGDVYSFGVLLLEIVT------GRRPTDVLFHDGSS 893
Y APE Y S+ D+++ G ++ E+ T G D L+ S
Sbjct: 163 --WYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214
Query: 894 LHEWVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
L K+ +P ++L + ++AP + +++ + E I+L +++P
Sbjct: 215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSL----HQLIPNASPEAIDLIKDMLRWDPKK 270
Query: 952 RPS 954
RP+
Sbjct: 271 RPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
S +G+G G V+K + + I A K++ L I RE Q+L ++
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
++ + M GSL+ L + + + L K+ V +G+ YL K
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKH--K 124
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
++H D+KPSNIL++ + DFG++ + ID N SF G+ Y+
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMAN------SFV-------GTRSYM 169
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+PE G S D++S G+ L+E+ GR P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 67/238 (28%)
Query: 674 LIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT- 731
IG G FG V K + + T +AVK + T + + ++ R + I+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKF 68
Query: 732 -----------ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
IC + LM SL+ Y + + I ++
Sbjct: 69 YGALFREGDCWIC---------MELMDI-SLDK-FYK---YVYE---VLKSVIPEEILGK 111
Query: 781 VAY-----LHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIA-KLVKGIDESVNCAND 833
+A L++ +K++H D+KPSNILLD + + DFGI+ +LV I ++ +
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD---- 167
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG--------DVYSFGVLLLEIVTGRRP 883
G Y+APE R DV+S G+ L E+ TG+ P
Sbjct: 168 -----------AGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 53/228 (23%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 658 SYKQLIE-ATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQ 716
++ ++ E +TG C ++ +GR ++AVK +DL F E
Sbjct: 23 NFVKIGEGSTGIVCIATDKSTGR-------------QVAVKKMDLRKQQRRELLFN-EVV 68
Query: 717 ILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICS 775
I++ +H N++ + + D +V+ + G+L + + +H ++ Q+ +C
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCL 122
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
V + +++LH V+H D+K +ILL D ++DFG CA S
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF------------CAQVSK 167
Query: 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
L+ G+ ++APE T D++S G++++E+V G P
Sbjct: 168 EVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 24/218 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+IG G + V L+ N +I A+KV+ +L E + E + ++ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 731 TICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
C + + LV+ ++ G L H+ L +IC + +LH
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI----ALNFLHERG- 116
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+++ DLK N+LLD D + D+G+ K E + + + +F CG+
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCK------EGLGPGDTTSTF-------CGTPN 161
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887
YIAPE G+ D ++ GVL+ E++ GR P D++
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRIR-HRNLIRI 729
++G G FG V L+++ R+ AVKVL D+ + E +IL R H L ++
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
PD V+ ++ G L H+ S D + +++ + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF----DEARARFYAAEITSALMFLHDKG- 116
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+++ DLK N+LLD + +ADFG+ K +GI TST CG+
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKT--------TST---FCGTPD 161
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
YIAPE D ++ GVLL E++ G P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDL----TTTGEITGSFKRECQILKRIRHRNLIR 728
+IG G FG VY D ++ A+K LD GE +R L I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 729 IITIC-SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+T PD +L LM+ G L HL HG+ ++ +++ G+ ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEM---RFYATEIILGLEHMHNR 116
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
VV+ DLKP+NILLDE ++D G+A D S + S+ G+
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASV----------GT 158
Query: 848 VGYIAPE-YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
GY+APE G + D +S G +L +++ G P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 4e-08
Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 62/303 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY ++ N +A+K + + + E +E + L+RI+H N I
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 732 ICSKPDFKALVLPLMSNGS----LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
C + A ++ GS LE H P L +++ I +G+AYLH H
Sbjct: 93 -CYLREHTAWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAITHGALQGLAYLHSH 144
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ ++H D+K NILL E +ADFG S S S G+
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFG-----------------SASIASPANSFVGT 184
Query: 848 VGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
++APE + + DV+S G+ +E+ + P LF+ +
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAM----------- 230
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964
A+ A P + WSD ++ C Q P RP+ ++ M
Sbjct: 231 -------SALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPTSEELLKHMFV 280
Query: 965 LKQ 967
L++
Sbjct: 281 LRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 678 GRFGHVYKGVL---QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
G G V+ + ++ VK + T G+ G RE ILK I HR +I +I
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV---TGGKTPG---REIDILKTISHRAIINLIHAYR 156
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+V+P + L+ S L L Q + I + E +AYLH ++H
Sbjct: 157 WKSTVCMVMP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIH 208
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
D+K NI LDE A++ DFG A C D+ T G++ +PE
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAA-----------CKLDAHPDTPQCYGWSGTLETNSPE 257
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
D++S G++L E+
Sbjct: 258 LLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 41/220 (18%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIIT 731
+GSG +G V + + ++A+K L EI RE +LK ++H N+I ++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 732 I-CSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ S LV+P M + L G D +Q + + G+ Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQY--LVYQMLCGLKYIH 134
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
++H DLKP N+ ++ED + DFG+A+ D +
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 846 GSV---GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
G V Y APE + D++S G ++ E++TG+
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 50/226 (22%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRII 730
S +GSG +G V + R+AVK L I RE ++LK ++H N+I ++
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK-----------ICSDVAE 779
+ + A L ++ L HL G DL +VK + +
Sbjct: 83 DVFTP----ARSLEEFNDVYLVTHLM-------GADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ Y+H ++H DLKPSN+ ++ED + DFG+A+
Sbjct: 132 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------------------H 169
Query: 840 TDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR 881
TD + G V Y APE + + D++S G ++ E++TGR
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 6e-08
Identities = 23/61 (37%), Positives = 34/61 (55%), Gaps = 1/61 (1%)
Query: 404 QLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNH 463
L+ L L N L+ + NL++LDLS N ++ I P +GL SL+ L+LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLR-SLDLSGNN 59
Query: 464 L 464
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 653 KNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSF 711
+NP+ Y +LI+ +GSG +G VYK L AVK++ L G+
Sbjct: 5 RNPQHDY-ELIQR---------VGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLI 53
Query: 712 KRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLV 771
++E ++K +H N++ + + + GSL++ + + LS +Q+
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE----LQIA 109
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818
+C + +G+AYLH + H D+K +NILL ++ +ADFG+A
Sbjct: 110 YVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 34/216 (15%)
Query: 675 IGSGRFGHVY---KGVLQDNTRIAVKVL---DLTTTGEITGSFKRECQILKRIRHR-NLI 727
I G FG VY K D A+KVL D+ ++T K E I+ +
Sbjct: 4 ISKGAFGSVYLAKKRSTGD--YFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
++ D+ LV+ ++ G + L + G GL + ++V GV LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCAS-LIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
++H D+KP N+L+D+ + DFG+++ + G+
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSR---------------NGLENKK--FVGT 156
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE +G D +S G ++ E + G P
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-08
Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 25/134 (18%)
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
++V + +LH H V++ DLK NILLD + +ADFG+ K +GI V
Sbjct: 103 AEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGV------ 151
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFH 889
T+T CG+ YIAPE D ++ GVL+ E++ G+ P D LF
Sbjct: 152 --TTTT---FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
Query: 890 DGSSLHEWVKRHYP 903
S LH+ V YP
Sbjct: 207 --SILHDDVL--YP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG V + + + AVKVL + E +LK ++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
D VL ++ G L HL + +++A + YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLHS---L 115
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+++ DLKP NILLD ++ DFG+ K +GI+ S TST CG+ Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHS--------KTTST---FCGTPEY 162
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE + D + G +L E++ G P
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-08
Identities = 17/39 (43%), Positives = 24/39 (61%)
Query: 35 DRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCN 73
DR +L+ F SS+ P AL SWN + C+W+GV C+
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 73/257 (28%), Positives = 115/257 (44%), Gaps = 61/257 (23%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIR 728
S IG G +G V ++A+K + + T + T RE +IL+R +H N+I
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT---LREIKILRRFKHENIIG 67
Query: 729 IITICSKPDFKA-----LVLPLMSNGSLENHLYP---SHGLSHGLDLIQ--LVKICSDVA 778
I+ I P F++ +V LM E LY + LS+ D IQ L +I
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSN--DHIQYFLYQIL---- 116
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
G+ Y+H + V+H DLKPSN+LL+ + + DFG+A++ E +
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDH--------- 162
Query: 839 STDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894
G L V Y APE + K + D++S G +L E+++ R LF
Sbjct: 163 --TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR----PLFPG---- 212
Query: 895 HEWVKRHYPHRLDPIVE 911
+ Y H+L+ I+
Sbjct: 213 -----KDYLHQLNLILG 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-08
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 25/117 (21%)
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
QL+K + Y+H V+H DLKPSNILL+ D +ADFG+A+ + ++E+
Sbjct: 115 QLLK-------ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN- 163
Query: 829 NCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
+ +L V Y APE +G T G D++S G +L E++ G+
Sbjct: 164 ----------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 24/114 (21%)
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
C A+ V + + +V+ DLKP N+LLD+D + DFG AK+V D
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----------D 182
Query: 834 SMSFTSTDGLLCGSVGYIAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ ++T LCG+ YIAPE G GK A D ++ G+ + EI+ G P
Sbjct: 183 TRTYT-----LCGTPEYIAPEILLNVGHGKAA----DWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G V + + R +AVK++DL F E I++ +H+N++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +++ + G+L + + + L+ Q+ +C V + + YLH V+
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K +ILL D ++DFG CA S L+ G+ ++AP
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGF------------CAQISKDVPKRKSLV-GTPYWMAP 186
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E T D++S G++++E+V G P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG V + D AVKVL + E +LK ++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ VL ++ G L HL +++A + YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYA----AEIASALGYLH---S 114
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
I +V+ DLKP NILLD ++ DFG+ K E + ++ + +F CG+
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTF-------CGTPE 161
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE + D + G +L E++ G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 76/293 (25%)
Query: 673 SLIGSGRFGHV---YKGVLQDNTRIAVKVLDLTTTGEITGSFKR---ECQILKRIRHRNL 726
IGSG G V Y V +A+K L+ + KR E ++K + H+N+
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 727 IRIITIC----SKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
I ++ + S +F+ LV+ LM +L Q++++ D E
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDA-----------------NLCQVIQMDLD-HER 119
Query: 781 VAYL---------HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831
++YL H HS ++H DLKPSNI++ D T + DFG+A+
Sbjct: 120 MSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------- 168
Query: 832 NDSMSFTSTDGLLCGSVGYIAPE--YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889
SF T ++ + Y APE GMG + + D++S G ++ E++ G VLF
Sbjct: 169 --GTSFMMTPYVV--TRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIRGT----VLFP 218
Query: 890 DGSSLHEWVK---------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDV 933
+ +W K + RL P V + P++ + +++ DV
Sbjct: 219 GTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDV 270
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 19/119 (15%)
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
++++ + YLH +++ DLK N+LLD + + D+G+ K +
Sbjct: 103 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------------EG 146
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
+ T CG+ YIAPE G+ D ++ GVL+ E++ GR P D++ GSS
Sbjct: 147 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV---GSS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
L+G G FG V + + + A+K+L + E+ + E ++LK RH L +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSL 60
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
D V+ ++ G L HL S D + +++ + YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSE--DRTRFYG--AEIVSALDYLHSG-- 114
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K+V+ DLK N++LD+D + DFG+ K +GI ++ +T CG+
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDA-----------ATMKTFCGTPE 160
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE D + GV++ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 64/247 (25%), Positives = 107/247 (43%), Gaps = 33/247 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI-C 733
+G G +GHVYK +D L I+ S RE +L+ ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVK-----ICSDVAEGVAYLHHH 787
S D K +L + L H+ H S +QL + + + +G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLW-HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 788 SPIKVVHCDLKPSNILL----DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
V+H DLKP+NIL+ E +AD G A+L N + +
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----------NSPLKPLADLDP 174
Query: 844 LCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
+ + Y APE +G R T D+++ G + E++T ++ +FH E +K
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIFH---CRQEDIKTSN 227
Query: 903 PHRLDPI 909
P+ D +
Sbjct: 228 PYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G + VYKG + N + +A+KV+ L + RE +LK ++H N++ + I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 734 SKPDFKALVLPLMSNG---SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ LV + ++ H H + L L QL++ G++Y+H
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H DLKP N+L+ + +ADFG+A+ A S T ++ ++ ++ Y
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLAR-----------AKSVPSHTYSNEVV--TLWY 169
Query: 851 IAPEYGMGK-RASTHGDVYSFGVLLLEIVTG 880
P+ +G ST D++ G + +E++ G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI-C 733
+G G +GHVYK +D L I+ S RE +L+ ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHG------LDLIQLVKICSDVAEGVAYLHHH 787
S D K +L + L H+ H S L + + + +G+ YLH +
Sbjct: 69 SHSDRKVWLLFDYAEHDLW-HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 788 SPIKVVHCDLKPSNILL----DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
V+H DLKP+NIL+ E +AD G A+L N + +
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF----------NSPLKPLADLDP 174
Query: 844 LCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFH 889
+ + Y APE +G R T D+++ G + E++T ++ +FH
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 64/239 (26%), Positives = 94/239 (39%), Gaps = 68/239 (28%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+IG G FG V ++ RI A+K+L+ + ++LKR T
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILN-------------KWEMLKRAE--------TA 46
Query: 733 CSKPDFKALVLPLMSNGSL------------ENHLYPSHGLSHGLDLIQLVKICSD---- 776
C + + LV NG EN+LY G DL+ L+ D
Sbjct: 47 CFREERNVLV-----NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPE 101
Query: 777 ------VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830
+AE V +H + VH D+KP N+LLD + +ADFG +C
Sbjct: 102 DMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG------------SC 149
Query: 831 ANDSMSFTSTDGLLCGSVGYIAPEY------GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ T + G+ YI+PE GMGK D +S GV + E++ G P
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGP-ECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 65/304 (21%), Positives = 119/304 (39%), Gaps = 46/304 (15%)
Query: 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIA----VKVLDLTTTGEITGSFKRECQILKRI 721
G F IG G+F VYK + + R+ V++ ++ K E +LK++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 722 RHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
H N+I+ + + + +VL L G L + + + K + +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
++H +++H D+KP+N+ + + D G+ + S T+
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-------------SKTTAA 163
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901
L G+ Y++PE + D++S G LL E+ + P + D +L+ K+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK- 219
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---MLDV 958
+EK Y P Y S+ + +L+ C +P RP +L V
Sbjct: 220 --------IEK--CDYPPLPADHY-----SEELRDLVS---RCINPDPEKRPDISYVLQV 261
Query: 959 AHEM 962
A EM
Sbjct: 262 AKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 50/280 (17%)
Query: 675 IGSGRFGHV---YKGVLQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRII 730
IGSG G V Y +L+ N +A+K L + RE ++K + H+N+I ++
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 731 TIC----SKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+ S +F+ + V+ LM + + LD ++ + + G+ +L
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLCGIKHL 142
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H ++H DLKPSNI++ D T + DFG+A+ SF T ++
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTPYVV 187
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK----- 899
+ Y APE +G + D++S G ++ E++ G VLF + +W K
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKVIEQL 241
Query: 900 ----RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVL 935
+ +L P V + + P++ + K++ DV+
Sbjct: 242 GTPCPEFMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLF 280
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 675 IGSGRFGHVYKG--VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G + V+KG L +N +A+K + L + RE +LK ++H N++ + I
Sbjct: 13 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL--VKI-CSDVAEGVAYLHHHSP 789
LV L++ L L + +L+ + VKI + G++Y H
Sbjct: 72 IHTERCLTLVFEY-----LDSDL--KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K++H DLKP N+L++E +ADFG+A+ ++ + ++ + D LL GS
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-GSTE 180
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
Y ST D++ G +L E+ TGR
Sbjct: 181 Y-----------STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
L+G G FG V + + A+K+L ++ + E ++L+ RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
D V+ + G L HL S +I S + YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS----ALGYLHSC--- 114
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VV+ DLK N++LD+D + DFG+ K + +S +T CG+ Y
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK-------------EGISDGATMKTFCGTPEY 161
Query: 851 IAPE------YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE YG RA D + GV++ E++ GR P
Sbjct: 162 LAPEVLEDNDYG---RAV---DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVK-VLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG V Q +A+K ++ +T + RE ++LK +RH N+I + I
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 733 CSKP--DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK-ICSDVAEGVAYLHHHSP 789
P D V L+ G+ + L S L Q ++ + G+ Y+H
Sbjct: 78 FISPLEDI-YFVTELL--GTDLHRLLTSRPLEK-----QFIQYFLYQILRGLKYVHSAG- 128
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKL 820
VVH DLKPSNIL++E+ + DFG+A++
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 693 RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLE 752
++AVK +DL F E I++ H N++ + D +V+ + G+L
Sbjct: 49 QVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 753 NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV 812
+ + + ++ Q+ +C V ++YLH+ V+H D+K +ILL D +
Sbjct: 108 DIVTHTR-----MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGV 872
+DFG CA S L+ G+ ++APE T D++S G+
Sbjct: 160 SDFGF------------CAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 873 LLLEIVTGRRP 883
+++E++ G P
Sbjct: 207 MVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G VY + + +A+K ++L + E +++ ++ N++ +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSY 85
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
D +V+ ++ GSL + + + +D Q+ +C + + + +LH + +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K NILL D + + DFG CA + S + G+ ++AP
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF------------CAQITPE-QSKRSTMVGTPYWMAP 184
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E K D++S G++ +E+V G P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 54/265 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVK---VLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G+F VY+ L D +A+K + DL K E +LK++ H N+I+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHPNVIKYY 68
Query: 731 TICSKPDFKALVLPLMSNGSL---------ENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
+ + +VL L G L + L P + V++CS
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK-----YFVQLCS------ 117
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
A H HS +V+H D+KP+N+ + + D G+ + S T+
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------------SKTTAA 163
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR- 900
L G+ Y++PE + D++S G LL E+ + P + D +L+ K+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKI 220
Query: 901 -----------HYPHRLDPIVEKAI 914
HY L +V I
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 64/276 (23%)
Query: 674 LIGSGRFGHVYKGVL----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G FG + +L + + A+K + L + ++E +L +++H N++
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK------------ICSDV 777
K F+A + HLY G DL+Q +K + V
Sbjct: 64 -----KESFEA-----------DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
+ H H +V+H D+K NI L ++ + DFG A+L+ ++
Sbjct: 108 QMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----------TSPGAY 156
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897
T G+ Y+ PE + D++S G +L E+ T + P F S +
Sbjct: 157 ACT---YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP----FQANSWKNLI 209
Query: 898 VK----------RHYPHRLDPIVEKAIAKYAPQHMP 923
+K HY + L ++ K + K P+ P
Sbjct: 210 LKVCQGSYKPLPSHYSYELRSLI-KQMFKRNPRSRP 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 61/230 (26%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFK---------------RECQILK 719
IG G +G VY+ +D TT+GEI K RE +L
Sbjct: 15 IGEGTYGIVYRA--RD-----------TTSGEIVALKKVRMDNERDGIPISSLREITLLL 61
Query: 720 RIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL------VK- 772
+RH N++ + + ++ L +M Y L+ LD + VK
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFL-VME--------YCEQDLASLLDNMPTPFSESQVKC 112
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832
+ + G+ YLH + ++H DLK SN+LL + +ADFG+A+ +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK------ 163
Query: 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
M+ ++ Y APE +G T D+++ G +L E++ +
Sbjct: 164 -PMTPKVV------TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG V + + AVKVL + E +LK ++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
D VL ++ G L HL + +++A + YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLH---S 114
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ +V+ DLKP NILLD ++ DFG+ K +++ T CG+
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-------------ENIEHNGTTSTFCGTPE 161
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE + D + G +L E++ G P
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 41/238 (17%)
Query: 659 YKQLIEATGGFCPSSL-----IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK 712
Y+Q + T P +GSG +G V + ++AVK L I
Sbjct: 2 YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 713 -RECQILKRIRHRNLIRIITI----CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDL 767
RE ++LK ++H N+I ++ + S +F + L G+ N++ LS +
Sbjct: 62 YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSD--EH 119
Query: 768 IQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827
+Q + + G+ Y+H ++H DLKPSN+ ++ED + DFG+A+
Sbjct: 120 VQF--LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-------- 166
Query: 828 VNCANDSMSFTSTDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR 881
D + G V Y APE + + D++S G ++ E++ G+
Sbjct: 167 -----------QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 52/230 (22%)
Query: 674 LIGSGRFGHVY----KGVLQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLI 727
++G G FG V KG + A+K+L D+ + EC ++++
Sbjct: 7 VLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDV-----ECTMVEK------- 51
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI------------QLVKICS 775
R++ + KP F + L S + LY +G DL+ V +
Sbjct: 52 RVLALSGKPPF---LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAA 108
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
++A G+ +LH +++ DLK N++LD + +ADFG+ K ++M
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------------ENM 152
Query: 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD 885
T CG+ YIAPE + D ++FGVLL E++ G+ P +
Sbjct: 153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 22/60 (36%), Positives = 32/60 (53%)
Query: 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439
+L LDLS N+L+ +F L L+ L L GN+L+ P + +L LDLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 50/277 (18%)
Query: 675 IGSGRFGHV---YKGVLQDNTRIAVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRII 730
IGSG G V Y VL N +A+K L + RE ++K + H+N+I ++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 731 TICSK----PDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+ + +F+ LV+ LM + + LD ++ + + G+ +L
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCGIKHL 135
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H ++H DLKPSNI++ D T + DFG+A+ SF T ++
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTPYVV 180
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK----- 899
+ Y APE +G + D++S G ++ E+V + +LF + +W K
Sbjct: 181 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVIEQL 234
Query: 900 ----RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSD 932
+ +L P V + P++ + + K++ D
Sbjct: 235 GTPCPEFMKKLQPTVRNYVEN-RPKYAGLTFPKLFPD 270
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 16/105 (15%)
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+LH +++ DLK N+LLD + + D+G+ K +GI TST
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPG--------DTTST-- 155
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887
CG+ YIAPE G+ D ++ GVL+ E++ GR P D++
Sbjct: 156 -FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 61/294 (20%)
Query: 671 PSSLIGSGRFGH--VYKGVLQDNTRIAVKVLDLTTTGEITGSFKR----ECQILKRIRHR 724
P ++G G FG +Y+ +D++ + K ++LT ++ +R E IL ++H
Sbjct: 4 PIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLT---RLSEKERRDALNEIVILSLLQHP 59
Query: 725 NLIRIITICSKPDFKALVLPL--MSNGSLENHLYPSHGLSHGLDLI--QLVKICSDVAEG 780
N+I D L++ + + G+L + + G +++ L +I S
Sbjct: 60 NIIAYYN--HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS----A 113
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
V+Y+H ++H D+K NI L + + DFGI+K++ S T
Sbjct: 114 VSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL----------GSEYSMAET 160
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
+ G+ Y++PE G + + D+++ G +L E++T +R D ++ V +
Sbjct: 161 ---VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVK 212
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
IV+ Y P V S ELI L Q +P RP+
Sbjct: 213 --------IVQGN---YTP---------VVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 52/218 (23%)
Query: 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805
M GSL+ LY + G+ L +I V +G+ +L I +H D+KP+N+L++
Sbjct: 81 MDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IHRDVKPTNVLVN 137
Query: 806 EDLTALVADFGIA-KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEY----GMGKR 860
+ + DFG++ LV + + + C S Y+APE G +
Sbjct: 138 GNGQVKLCDFGVSGNLVASL--------------AKTNIGCQS--YMAPERIKSGGPNQN 181
Query: 861 A--STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK--AIAK 916
+ DV+S G+ +LE+ GR P + P I + AI
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP-----------------YPPETYANIFAQLSAIVD 224
Query: 917 YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P +P Y+ D V C P+ RP+
Sbjct: 225 GDPPTLPSGYSDDAQDFV-------AKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRI- 729
I G +G VY+ + +A+K L + E IT RE IL +++H N++ +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL--REINILLKLQHPNIVTVK 70
Query: 730 -ITICSKPDFKALVLPLMSN---GSLENHLYP-SHGLSHGLDLIQLVKICSDVAEGVAYL 784
+ + S D +V+ + + +E P L ++QL+ GVA+L
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQLL-------SGVAHL 122
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
H + ++H DLK SN+LL+ + DFG+A+
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 675 IGSGRFGHVYKGV--LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G + VYKG L +A+K + L + RE +LK ++H N++ + I
Sbjct: 13 LGEGSYATVYKGRSKLTGQ-LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 733 CSKPDFKALVLPLMSNG---SLENHLYPSHGLSHG---LDLIQLVKICSDVAEGVAYLHH 786
LV + +++ GLS L L QL++ G+AY H
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDC--GG-GLSMHNVRLFLFQLLR-------GLAYCHQ 121
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI------DESVNCANDSMSFTST 840
+V+H DLKP N+L+ E +ADFG+A+ K + +E V ++ +
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-----TLWYRPP 172
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
D LL GS Y ST D++ G + E+ TGR
Sbjct: 173 DVLL-GSTEY-----------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 675 IGSGRFGHVYKG--VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G + V+KG L +N +A+K + L + RE +LK ++H N++ + I
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHSPIK 791
LV + + L+ ++ + + VKI + G+AY H K
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMS----MHNVKIFLYQILRGLAYCHRR---K 124
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
V+H DLKP N+L++E +ADFG+A+ ++ + ++ + D LL S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS---- 180
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
EY ST D++ G + E+ +GR
Sbjct: 181 --EY------STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 38/222 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLI-RIIT 731
IG G +G VYK ++ + +A+K L E I + RE +L+ + I R++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 732 ICS------KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ KP LV + + + G L + + +GVA+ H
Sbjct: 69 VEHVEEKNGKPSL-YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAK-----LVKGIDESVNCANDSMSFTS 839
H V+H DLKP N+L+D+ L +AD G+ + + E V
Sbjct: 128 KHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----------- 173
Query: 840 TDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTG 880
++ Y APE +G ST D++S G + E+
Sbjct: 174 -------TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 24/155 (15%)
Query: 675 IGSGRFGHVYKG-VLQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIR-HRNLIRII 730
IG G F V K + A+K + + ++ RE Q L+R+ H N++R+I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRRLSPHPNILRLI 64
Query: 731 TIC--SKPDFKALVLPLMSNGSL----ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+ K ALV LM + +L + P + QL+K + ++
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLK-------SLDHM 116
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
H + + H D+KP NIL+ +D+ L ADFG +
Sbjct: 117 HRNG---IFHRDIKPENILIKDDILKL-ADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G VY + + +A+K ++L + E +++ +H N++ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSY 85
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
D +V+ ++ GSL + + + +D Q+ +C + + + +LH + +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K NILL D + + DFG CA + S + G+ ++AP
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF------------CAQITPE-QSKRSTMVGTPYWMAP 184
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E K D++S G++ +E+V G P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G V+ + + +A+K ++L + E ++K +++ N++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSF 85
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
D +V+ ++ GSL + + + +D Q+ +C + + + +LH + +V+
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K N+LL D + + DFG CA + S + G+ ++AP
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGF------------CAQITPE-QSKRSTMVGTPYWMAP 184
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E K D++S G++ +E+V G P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 56/204 (27%), Positives = 85/204 (41%), Gaps = 39/204 (19%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
L L L+ VA G+ +L + K +H DL NILL E+ + DFG+A+
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR----- 221
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ D D L + ++APE K +T DV+SFGVLL EI + G P
Sbjct: 222 ----DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
Query: 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLL 943
+ G + E + RL ++ AP++ E+ + L
Sbjct: 276 -----YPGVQIDE----EFCRRL----KEGTRMRAPEY-----------ATPEIYSIMLD 311
Query: 944 CTQYNPSTRPSMLDVAHEMGRLKQ 967
C NP RP+ ++ +G L Q
Sbjct: 312 CWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 675 IGSGRFGHVYKGVL--QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIIT 731
IG G +G V+K VL ++ ++ AVK+LD +I + E ILK + H N+++
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 732 ICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+ K D K LVL L + GS+ + + ++ + I + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ K +H D+K +NILL + + DFG+ S TST
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGV----------------SAQLTSTRLRRNT 183
Query: 847 SVG---YIAPEY-----GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
SVG ++APE + DV+S G+ +E+ G P
Sbjct: 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
K++H DLK +NI L + DFG +K +DS+S CG+ Y
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY----------SDSVSLDVASSF-CGTPYY 237
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE KR S D++S GV+L E++T RP
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDL--TTTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G+F VY+ L D +A+K + + + +E +LK++ H N+I+ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 732 ICSKPDFKALVLPLMSNGSL---------ENHLYPSHGLSHGLDLIQLVKICSDVAEGVA 782
+ + +VL L G L + L P + V++CS V
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK-----YFVQLCSAVE---- 120
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
H HS +V+H D+KP+N+ + + D G+ + S T+
Sbjct: 121 --HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------------SKTTAAH 164
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
L G+ Y++PE + D++S G LL E+ + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 46/210 (21%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G VY + + +A++ ++L + E +++ ++ N++ +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSY 86
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
D +V+ ++ GSL + + + +D Q+ +C + + + +LH + +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K NILL D + + DFG CA + S + G+ ++AP
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGF------------CAQITPE-QSKRSTMVGTPYWMAP 185
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E K D++S G++ +E++ G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G G V ++ + + +AVK +DL F E I++ +H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
D +V+ + G+L + + + ++ Q+ +C V + ++ LH V+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H D+K +ILL D ++DFG CA S L+ G+ ++AP
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGF------------CAQVSKEVPRRKSLV-GTPYWMAP 185
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
E D++S G++++E+V G P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 41/205 (20%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
L L L+ VA+G+ +L + K +H DL NILL E+ + DFG+A+ +
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
+ V + + ++APE + + DV+SFGVLL EI
Sbjct: 233 PDYVRKGDARLPLK-----------WMAPETIFDRVYTIQSDVWSFGVLLWEI------- 274
Query: 885 DVLFHDGSSLHEWVK--RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGL 942
F G+S + VK + RL ++ AP + E+ + L
Sbjct: 275 ---FSLGASPYPGVKIDEEFCRRL----KEGTRMRAPDY-----------TTPEMYQTML 316
Query: 943 LCTQYNPSTRPSMLDVAHEMGRLKQ 967
C PS RP+ ++ +G L Q
Sbjct: 317 DCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 52/300 (17%)
Query: 668 GFCPSSLIGSGRFGHV----YKGVLQDNTRIAVKVLDL-TTTGEITGSFKRECQILKRIR 722
+C ++G G +G V ++ D + +K L+L + + ++E Q+L +++
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 723 HRNLIRIITICSKPD-FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
H N++ D +V+ G L + L G L Q+V+ +A +
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMAL 115
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
YLH ++H DLK N+ L V D GIA++++ M+ T
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--------QCDMAST--- 161
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901
L G+ Y++PE K + DV++ G + E+ T + + D +SL V R
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA--KDMNSL---VYRI 214
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961
+L P+ + Y+P+ + ELI +L + P RPS+ + +
Sbjct: 215 IEGKLPPMPK----DYSPE-------------LGELIA-TMLSKR--PEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 202 NLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261
NL+ L L +NRL A L+ LDL N + + E S +P L+ L LS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 262 F 262
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
LDL L++ S VA+G+ +L + +H D+ N+LL + A + DFG+A+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----- 260
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ NDS + L V ++APE + DV+S+G+LL EI + G+ P
Sbjct: 261 ----DIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
Query: 884 TDVLFHDGSSLHEWVKRHY 902
+ + S ++ VKR Y
Sbjct: 315 YPGILVN-SKFYKMVKRGY 332
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 33/103 (32%), Positives = 50/103 (48%), Gaps = 14/103 (13%)
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
VA G+ +L + K +H DL NILL E+ + DFG+A+ + + V + +
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
++APE K +T DV+SFGVLL EI +
Sbjct: 240 LK-----------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 66/231 (28%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRI 729
SL+G G FG V A+KV+ + E F+ E IL + ++
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
D LV+ G L + L + D+ Q +AE V +H
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFY-----LAELVLAIHSVHQ 120
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFG-IAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+ VH D+KP N+L+D +ADFG A+L ++ VN L G+
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA--NKMVNSK-----------LPVGTP 167
Query: 849 GYIAPEY--GM-GKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
YIAPE M G T+G D +S GV+ E++ GR P FH+G+S
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 41/215 (19%)
Query: 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805
++ ++N L S S GL + L+ VA G+ +L + VH DL N+LL
Sbjct: 217 SNDSEVKNLL--SDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLA 271
Query: 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG 865
+ + DFG+A+ + +DS + L V ++APE +T
Sbjct: 272 QGKIVKICDFGLAR---------DIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLS 320
Query: 866 DVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPI 924
DV+S+G+LL EI + G P + D S+ + +K Y +AK P H
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIVD-STFYNKIKSGY----------RMAK--PDHAT- 366
Query: 925 YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
E+ ++ + C P RPS L ++
Sbjct: 367 ----------QEVYDIMVKCWNSEPEKRPSFLHLS 391
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 15/109 (13%)
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
+++ + YLH S VV+ DLK N++LD+D + DFG+ K +GI +
Sbjct: 102 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG------- 150
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+T CG+ Y+APE D + GV++ E++ GR P
Sbjct: 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 31/151 (20%), Positives = 59/151 (39%), Gaps = 19/151 (12%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI--RII 730
L+ G VY L VL + + E +RE IL+ + + L +++
Sbjct: 4 KLLKGGLTNRVYL--LGTKDE--DYVLKINPSREKGADREREVAILQLLARKGLPVPKVL 59
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ L++ + +L+ + + I +AE +A LH +
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDE-----------VSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 791 KVVHCDLKPSNILLDED-LTALVADFGIAKL 820
+ H DL P NIL+D+ + ++ D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGII-DWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 43/176 (24%), Positives = 61/176 (34%), Gaps = 37/176 (21%)
Query: 81 ELDLSARSIYGTISPALANL----SSLIVLDLSKNFFQG----HIPAELGSLIRLKQLSL 132
+L L + G ALA L L+L+ N + L + L+ L L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200
Query: 133 SWNSLQGKIPSQLG----SLHQLEYLDLGNNKLVGEIPIPIFCSNS---STSLQYIDLSN 185
+ N L + S L SL LE L+LG+N L + S + SL + LS
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNL-TDAGAAALASALLSPNISLLTLSLSC 259
Query: 186 NSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGEL 241
N +T + + + LA L LDL N F E
Sbjct: 260 NDITDDG---------------------AKDLAEVLAEKESLLELDLRGNKFGEEG 294
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 671 PSSLIGSGRFGHVYKGV-LQDNTRIAVKVL-----DLTTTGEITGSFKRECQILKRIRHR 724
P IG G FG V+ +D R+A+K + +L + + RE ++L +H
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF----RELKMLCFFKHD 59
Query: 725 NLIRIITICSKPD---FKAL-VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780
N++ + I P F+ + V+ + L + LS D +++ + G
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSS--DHVKV--FLYQILRG 115
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ YLH ++H D+KP N+L++ + + DFG+A+ V+ DES + + ++
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQY-- 169
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLF 888
Y APE MG R T D++S G + E++ R +LF
Sbjct: 170 ---------YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 35/120 (29%)
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTAL----VADFGIAK---------LVKGIDES 827
+ YLH++ +VH DLKP N+L +T++ + DFG++K L +G E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLL----ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEY----GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
D+ F D +CG+ YIAPE G GK D ++ G++L E + G P
Sbjct: 167 -----DTREF--LDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 16/109 (14%)
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
+++ + YLH VV+ D+K N++LD+D + DFG+ K +GI +
Sbjct: 102 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDG------- 149
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+T CG+ Y+APE D + GV++ E++ GR P
Sbjct: 150 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 675 IGSGRFGHVYKGVL----QDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIR 728
IG G FG K +L +D + +K ++++ + E S ++E +L ++H N+++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQ--LVKICSDVAEGVAYLHH 786
+ +V+ G L + G+ D I V+IC +A H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC------LALKHV 117
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC- 845
H K++H D+K NI L +D T + DFGIA+++ N ++ T C
Sbjct: 118 HDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----------NSTVELART----CI 162
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
G+ Y++PE + + D+++ G +L E+ T
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 33/104 (31%), Positives = 45/104 (43%), Gaps = 21/104 (20%)
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DLKP N L+D + DFG++K V AN + GS Y+A
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYANS----------VVGSPDYMA 166
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
PE GK D +S G +L E + G P GS+ +E
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP-----FSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 3e-05
Identities = 30/120 (25%), Positives = 52/120 (43%), Gaps = 21/120 (17%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKG 823
L ++ KI + E + LH H ++H D+K N+L D + + D+G+ K++
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG- 161
Query: 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
T G++ Y +PE G D ++ GVL E++TG+ P
Sbjct: 162 ----------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITI 732
IG G +G VYK +D + AVK+LD ++ + E IL+ + H N+++ +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD--PISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 733 CSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
K D LVL L + GS+ + LD + I G+ +LH++
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+++H D+K +NILL + + DFG+ S TST S
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGV----------------SAQLTSTRLRRNTS 188
Query: 848 VG---YIAPE---------YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
VG ++APE Y R DV+S G+ +E+ G P
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 63/295 (21%)
Query: 675 IGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
+G G F ++KG+ ++ T + +KVLD + + SF ++ ++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD-KSHRNYSESFFEAASMMSQLSHKHL 61
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY-LH 785
+ +C D +V + GSL+ +L + L + ++ VA+ +A+ LH
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE-------VAKQLAWALH 114
Query: 786 HHSPIKVVHCDLKPSNILL--DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
+ H ++ N+LL +ED G +K D + S++ + L
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREED-----RKTGNPPFIKLSDPGI-----SITVLPKEIL 164
Query: 844 LCGSVGYIAPE-YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
L + ++ PE + S D +SFG L EI +G
Sbjct: 165 L-ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---------------------- 201
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLL---CTQYNPSTRPS 954
+K ++ Q +Y + EL L C Y P RPS
Sbjct: 202 -------GDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+ +G G G V+ V D + R+AVK + LT + + RE +I++R+ H N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIV 65
Query: 728 RI--------------ITICSKPDFKALVLPLMSNG---SLENHLYPSHGLSHGLDLIQL 770
++ + ++ + +V M LE L + QL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR--LFMYQL 123
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAKLVKGIDESVN 829
++ G+ Y+H + V+H DLKP+N+ ++ EDL + DFG+A++V +
Sbjct: 124 LR-------GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSH 171
Query: 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
S + Y +P + T D+++ G + E++TG+
Sbjct: 172 KGYLSEGLVTK--------WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 53/231 (22%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIR 722
+IG G +G V + ++A+K +I F+ RE ++L+ +R
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIK--------KINDVFEHVSDATRILREIKLLRLLR 57
Query: 723 HRNLIRIITIC---SKPDFKAL--VLPLMSNG-----SLENHLYPSHGLSHGLDLIQLVK 772
H +++ I I S+ +FK + V LM + + L P H H L QL++
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH---HQFFLYQLLR 114
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832
+ Y+H + V H DLKP NIL + D + DFG+A++ + N
Sbjct: 115 -------ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV------AFNDTP 158
Query: 833 DSMSFTSTDGLLCGSVGYIAPEY--GMGKRASTHGDVYSFGVLLLEIVTGR 881
++ +T + Y APE + + D++S G + E++TG+
Sbjct: 159 TAIFWTD----YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-05
Identities = 63/246 (25%), Positives = 95/246 (38%), Gaps = 58/246 (23%)
Query: 674 LIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEIT--GSFKR---ECQILKRIRHRNLI 727
L+G G G V+ L+ A+KVLD E+ KR E +IL + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKK---EMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLY---PSHGLSHGLDLIQLVKI-CSDVAEGVAY 783
+ + LV+ G L L P LS ++ + ++V + Y
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLS-----EEVARFYAAEVLLALEY 118
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL---------------------VK 822
LH + +V+ DLKP NILL E +++DF ++K
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 823 GIDESVNCAND--SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEI 877
E+ + S SF T+ YIAPE HG D ++ G+LL E+
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEE-------YIAPEV---ISGDGHGSAVDWWTLGILLYEM 225
Query: 878 VTGRRP 883
+ G P
Sbjct: 226 LYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 72/306 (23%), Positives = 121/306 (39%), Gaps = 55/306 (17%)
Query: 676 GSGRFGHVYKGVLQDNTRIAVKV--LDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
H+ K NT +AVK LD + ++ + E ++++H N++ +T
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQ-EIITSRQLQHPNILPYVTSF 68
Query: 734 SKPDFKALVLPLMSNGS----LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+V PLM+ GS L+ H +P GL + + I DV + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTH-FPE-----GLPELAIAFILKDVLNALDYIHSKG- 121
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+H +K S+ILL D G L G+ SV+ SV
Sbjct: 122 --FIHRSVKASHILLSGD--------GKVVL-SGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 850 ---YIAPEYGMGKRASTHG-----DVYSFGVLLLEIVTGRRP-TDVLFHDGSSLHEWVKR 900
+++PE + + G D+YS G+ E+ G P D+ L E V+
Sbjct: 171 NLPWLSPEV---LQQNLQGYNEKSDIYSVGITACELANGHVPFKDM--PATQMLLEKVRG 225
Query: 901 HYPHRLD----PIVEKAIAKYAPQHM--------PIYYNKVWSDVVLELIELGLLCTQYN 948
P LD P+ E ++++ + Y + +S+ + +E LC Q +
Sbjct: 226 TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVE---LCLQRD 282
Query: 949 PSTRPS 954
P +RPS
Sbjct: 283 PESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 68/247 (27%)
Query: 664 EATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------R 713
E + P IG G +G V + N ++A+K +I +F R
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK--------KIANAFDNRIDAKRTLR 53
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLD-- 766
E ++L+ + H N+I I I P +A +V LM L + S LS D
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSD--DHC 110
Query: 767 ---LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823
L QL++ G+ Y+H + V+H DLKPSN+LL+ + + DFG+A+
Sbjct: 111 QYFLYQLLR-------GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR---- 156
Query: 824 IDESVNCANDSMS-------FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLE 876
+ + D M+ + + + LL S EY T DV+S G + E
Sbjct: 157 ---TTSEKGDFMTEYVVTRWYRAPELLLNCS------EYT------TAIDVWSVGCIFAE 201
Query: 877 IVTGRRP 883
++ GR+P
Sbjct: 202 LL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 20/108 (18%)
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ Y+H + V+H DLKP N+L++ D + DFG+A +G E +
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA---RGFSE---------NPGE 161
Query: 840 TDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP 883
G + V Y APE + ++ T DV+S G +L E++ GR+P
Sbjct: 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 28/80 (35%), Positives = 46/80 (57%), Gaps = 2/80 (2%)
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
+ L N L G IP + +LR+L+ + L N + G +P +L + + LE LDL N F+G
Sbjct: 423 LGLDNQGLRGFIP-NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 241 LPSEIISKMPQLQFLYLSYN 260
+P E + ++ L+ L L+ N
Sbjct: 482 IP-ESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
TIP + ++ + L NN L + G+I L + ++PD+ +
Sbjct: 192 TIPACI--PEQITTLILDNNELKSLPENLQGNIKTLYANSNQLTSIPATLPDTIQEMELS 249
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
+ L +PS+L + LDL HNKIS + + LR L +Y N S L
Sbjct: 250 INRIT---ELPERLPSAL------QSLDLFHNKISCLPENLPEELRYLSVYDN-SIRTLP 299
Query: 466 GPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPY 525
LP ++ ++ V + L+ L ++PP L++L N+L LP S+ P
Sbjct: 300 AHLPSGITHLN-VQSNSLTA--LPETLPP------GLKTLEAGENALTS-LPASLP--PE 347
Query: 526 LKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
L+ DVS N++ +P++ PT+ L+ S N
Sbjct: 348 LQVLDVSKNQI-TVLPETL--PPTITTLDVSRN 377
|
Length = 754 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-04
Identities = 66/271 (24%), Positives = 105/271 (38%), Gaps = 62/271 (22%)
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
L LR + L ++ + ++P L+ ++ LE L L ELPS I + +L+ L +S
Sbjct: 632 SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSI-QYLNKLEDLDMS 689
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP-SIIGDLSTNLVQIHLDCN 317
+ NLE L N + L NL G D+STN+ + LD
Sbjct: 690 RCE--------NLE----ILPTGINLKSLYRL--NLSGCSRLKSFPDISTNISWLDLDET 735
Query: 318 LIYGKIPP--HISNLVNLTLLNLSSNLLNGTIPHELCLMS----KLERVYLSNNSLSGEI 371
I + P + NL L L + S L + LM+ L R++LS+ E+
Sbjct: 736 AI-EEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVEL 794
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431
PS S NL +L L + C+NLE
Sbjct: 795 PS------------------------SIQNLHKLEHL-------------EIENCINLET 817
Query: 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSN 462
L N + + D++G L+ + ++S+N
Sbjct: 818 LPTGIN-LESLESLDLSGCSRLRTFPDISTN 847
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 675 IGSGRFGHVYKGVLQDNTRIA---VKVLDLTTTGEI----TGSFKRECQILKRIRHRNLI 727
+G G FG VY +++D +A +KVL GE+ T +E Q+L ++ H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ + D ++ L+ L L Q+ + + GV Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+++H DLK NI L +L + DFG+++L+ G S +T G+
Sbjct: 126 ---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMG----------SCDLATT---FTGT 168
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEI 877
Y++PE + + D++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 22/141 (15%)
Query: 769 QLVK-ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK--LVKG-- 823
+L+K I D+ + Y+H H + H D+KP NI++D + + D+GIA ++ G
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKH 182
Query: 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
I+ S + L G++ Y + G + GD+ S G +L+ + P
Sbjct: 183 IEYSKEQKD----------LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
Query: 884 TDVLFHDGSSLH----EWVKR 900
H+G+ +H +++KR
Sbjct: 233 WKGFGHNGNLIHAAKCDFIKR 253
|
Length = 294 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-04
Identities = 56/252 (22%), Positives = 107/252 (42%), Gaps = 47/252 (18%)
Query: 675 IGSGRFGHVYKGVLQDNTR--IAVKVLDLTTTGEITGS-FKRECQILKRIRHRNLIRIIT 731
IG+GRFG V+ V T+ K + E S E +++ ++H+N++R I
Sbjct: 21 IGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 732 -ICSKPDFKALVL-PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH--- 786
+K + K +L G L ++ + + ++ +V I + +AY H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 787 -HSPIKVVHCDLKPSNILLDEDL-----------------TALVADFGIAKLVKGIDESV 828
+ +V+H DLKP NI L + A + DFG++K
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--------- 190
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS--THGDVYSFGVLLLEIVTGRRPTDV 886
N +SM+ + G+ Y +PE + + S D+++ G ++ E+ +G+ P
Sbjct: 191 NIGIESMAHSCV-----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP--- 242
Query: 887 LFHDGSSLHEWV 898
FH ++ + +
Sbjct: 243 -FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 14/113 (12%)
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
LD L+ VA+G+++L + I H DL NILL + DFG+A+ ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIR-- 265
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 877
NDS + L V ++APE + DV+S+G+LL EI
Sbjct: 266 -------NDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 332 NLTLLNLSSNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNK 390
NL L+LS+N L IP + L+ + LS N+L+ P AF +P L LDLS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 391 L 391
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 24/179 (13%)
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
E IL+ I H ++I++ + F L+LP + LY + + ++ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILAI 187
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
V + YLH + ++H D+K NI ++ + DFG A I+ AN
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-----ANK 239
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH-DG 891
+ G++ APE D++S G++L E+ T D LF DG
Sbjct: 240 YYGWA-------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 46/223 (20%)
Query: 675 IGSGRFGHVYKGVLQDN-----------TRIAVKVLDLTTTGEITGSFKRECQILKRIRH 723
+G G F ++YKGVL+ + +KVL + + +F ++ ++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG--SDHRDSLAFFETASLMSQLSH 60
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
++L+++ +C + + +V + G L+ L H + + L + + +A + Y
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL---HREKNNVSLHWKLDVAKQLASALHY 116
Query: 784 LHHHSPIKVVHCDLKPSNILLDED-------LTALVADFGIAKLVKGIDESVNCANDSMS 836
L K+VH ++ NIL+ ++D GI V +E V
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------- 166
Query: 837 FTSTDGLLCGSVGYIAPEY--GMGKRASTHGDVYSFGVLLLEI 877
+ +IAPE + D +SFG LLEI
Sbjct: 167 ----------RIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-04
Identities = 42/148 (28%), Positives = 61/148 (41%), Gaps = 29/148 (19%)
Query: 752 ENHLYPSHGLSHGLDLIQLVKICSD----------VAEGVAYLHHHSPIKVVHCDLKPSN 801
EN+LY G DL+ L+ D +AE V + + VH D+KP N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132
Query: 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEY------ 855
+LLD++ +ADFG +C T + G+ YI+PE
Sbjct: 133 VLLDKNGHIRLADFG------------SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 856 GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G G R D +S GV + E++ G P
Sbjct: 181 GKG-RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 4/64 (6%)
Query: 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW 209
L+ LDL NN+L IP F +L+ +DLS N+LT I + L +LR L L
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAF--KGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLS 56
Query: 210 SNRL 213
N L
Sbjct: 57 GNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 25/61 (40%), Positives = 37/61 (60%), Gaps = 1/61 (1%)
Query: 428 NLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487
NL+ LDLS+N+++ I GL +LK L+LS N+L P S + + ++DLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLK-VLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 488 L 488
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 24/61 (39%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 102 SLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
+L LDLS N IP L LK L LS N+L P L L LDL N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 161 L 161
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 57/259 (22%), Positives = 92/259 (35%), Gaps = 50/259 (19%)
Query: 333 LTLLNLSSNLLNGTIPHELCLMS------KLERVYLSNNSLSGEIPSAFGDI---PHLGL 383
L L LS N L+ L+ + LS+N+L + + L
Sbjct: 53 LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQE 112
Query: 384 LDLSKNKLSGSIPDSFA-----NLSQLRRLLLYGNHLSGTIPSSLGKCV----NLEILDL 434
L L+ N L A L +L+L N L G +L K + +L+ L+L
Sbjct: 113 LKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNL 172
Query: 435 SHNKISGI-IPSDVAGLRSLKL--YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491
++N I I + GL++ L+L++N L S + LA
Sbjct: 173 ANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT---DEGASALAETLA----------- 218
Query: 492 IPPQLGSCIALESLNLSGNSLEG-----LLPVSVGQLPYLKQFDVSSNRL----FGEIPQ 542
S +LE LNL N+L L + L +S N + ++ +
Sbjct: 219 ------SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAE 272
Query: 543 SFQASPTLKQLNFSFNKFS 561
+L +L+ NKF
Sbjct: 273 VLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 57/298 (19%)
Query: 692 TRIAVKVLDL-TTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750
T + V++ DL T E + + E + RH N++ T+ + + ++ P M+ GS
Sbjct: 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS 85
Query: 751 LENHL---YPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED 807
N L Y G+S L + I G+ YLH + I H ++K S+IL+ D
Sbjct: 86 -ANSLLKTYFPEGMSEAL----IGNILFGALRGLNYLHQNGYI---HRNIKASHILISGD 137
Query: 808 LTALVADFGIAKLVKGID--ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG 865
LV+ G++ L + + D F+++ + +++PE R +G
Sbjct: 138 --GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS------VLPWLSPEL---LRQDLYG 186
Query: 866 -----DVYSFGVLLLEIVTGRRP------TDVLFH--DGSSLHEWVKRHYPHRLDP---- 908
D+YS G+ E+ TGR P T +L G +P
Sbjct: 187 YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNS 246
Query: 909 -------IVEKAIAKYAPQHMP-----IYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
I E +A Q M +K +S L+E LC Q +P RPS
Sbjct: 247 QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE---LCLQQDPEKRPS 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/118 (30%), Positives = 53/118 (44%), Gaps = 14/118 (11%)
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821
S L + LV VA G+ +L + VH DL N+L+ E + DFG+A+
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-- 287
Query: 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
+ DS + L + ++APE +T DV+SFG+LL EI T
Sbjct: 288 -------DIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 31/95 (32%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 230 LDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELEL 289
L L++ G +P++I SK+ LQ + LS N S GN SL + ++ + L+L
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGN---SIRGNIP-----PSLGSITSLEVLDL 473
Query: 290 AGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIP 324
+ N+ G IP +G L T+L ++L+ N + G++P
Sbjct: 474 SYNSFNGSIPESLGQL-TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 34/132 (25%)
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLV------KGIDESVNCANDSMSFTSTDG---- 842
+H D+KP NIL+D D + DFG+ K + + DSM +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 843 --------------------LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR 882
L G+ YIAPE + + D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 883 PTDVLFHDGSSL 894
P F +
Sbjct: 243 P----FLADTPA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 4/48 (8%)
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
++ V E VA LH +VH DL SN ++ +D L+ DFG+ K
Sbjct: 432 ELVRKVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGK 475
|
Length = 535 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 34/125 (27%)
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV------NCANDSMSFTSTDG---- 842
+H D+KP NIL+D D + DFG+ + +S + DSM F++ G
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 843 ------------------------LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878
L G+ YIAPE + + D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 879 TGRRP 883
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 79/344 (22%), Positives = 116/344 (33%), Gaps = 84/344 (24%)
Query: 128 KQLSLSWNSL-QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN--SSTSLQYIDLS 184
QLSL L + L L L+ L L N +GE S SL+ + LS
Sbjct: 1 LQLSLKGELLKTERATELLPKLLCLQVLRLEGN-TLGEEAAKALASALRPQPSLKELCLS 59
Query: 185 NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSE 244
N TG IP R + + Q L L+ LDL N +
Sbjct: 60 LNE-TGRIP------------------RGLQSLLQGLTKGCGLQELDLSDNALGPDGC-- 98
Query: 245 IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSII-- 302
SL SS+ QEL+L N LG ++
Sbjct: 99 ----------------------------GVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130
Query: 303 --GDLSTNLVQIHLDCNLIYG-------KIPPHISNLVNLTLLNLSSNLLNG----TIPH 349
DL L ++ L N + G K +L LNL++N + +
Sbjct: 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE---LNLANNGIGDAGIRALAE 187
Query: 350 ELCLMSKLERVYLSNNSLSGE----IPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN---- 401
L LE + L+NN L+ E + + L +L+L N L+ + + A+
Sbjct: 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLS 247
Query: 402 -LSQLRRLLLYGNHL----SGTIPSSLGKCVNLEILDLSHNKIS 440
L L L N + + + L + +L LDL NK
Sbjct: 248 PNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 41/148 (27%), Positives = 60/148 (40%), Gaps = 29/148 (19%)
Query: 752 ENHLYPSHGLSHGLDLIQLVKICSD----------VAEGVAYLHHHSPIKVVHCDLKPSN 801
EN+LY G DL+ L+ D +AE V + + VH D+KP N
Sbjct: 73 ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132
Query: 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEY------ 855
IL+D + +ADFG +C T + G+ YI+PE
Sbjct: 133 ILMDMNGHIRLADFG------------SCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 856 GMGKRASTHGDVYSFGVLLLEIVTGRRP 883
G G + D +S GV + E++ G P
Sbjct: 181 GKG-KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 4/48 (8%)
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
+ +V V LH +VH DL SNI+L + DFG+ +
Sbjct: 96 DLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGRIYFI-DFGLGE 139
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 983 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.82 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.55 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.38 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.36 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.35 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-110 Score=1063.67 Aligned_cols=878 Identities=32% Similarity=0.528 Sum_probs=586.4
Q ss_pred cHHhHHHHHHHHHhccCCCccccCCCCCCCCCCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCC
Q 042568 32 IIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKN 111 (983)
Q Consensus 32 ~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n 111 (983)
.+.|+.||++||+++. +|.+.+.+|+. ..+||.|.||+|++ .++|+.|||+++++.|.+++++..+++|++|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~-~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYLSNWNS-SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccCCCCCC-CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 3479999999999994 78888999975 46799999999986 468999999999999999999999999999999999
Q ss_pred cCCCCCccccC-CCCCCCEEeccCccCCCCch----------------------hhhcccccccEEeccCcccccccCCc
Q 042568 112 FFQGHIPAELG-SLIRLKQLSLSWNSLQGKIP----------------------SQLGSLHQLEYLDLGNNKLVGEIPIP 168 (983)
Q Consensus 112 ~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p----------------------~~~~~L~~L~~L~Ls~N~l~~~~p~~ 168 (983)
+++|.+|..+. .+++|++|+|++|++++.+| ..++++++|++|+|++|.+.+.+|..
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 99988887654 77777777777776665444 44444444444444444444444443
Q ss_pred ccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcC
Q 042568 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISK 248 (983)
Q Consensus 169 ~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 248 (983)
+. .+++|++|+|++|.+++.+|. .+..+++|++|+|++|++++.+|..++++++|++|+|++|++++.+|.. +..
T Consensus 184 ~~---~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~ 258 (968)
T PLN00113 184 LT---NLTSLEFLTLASNQLVGQIPR-ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGN 258 (968)
T ss_pred hh---hCcCCCeeeccCCCCcCcCCh-HHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh-HhC
Confidence 32 344444444444444444432 2334444555555555544444544555555555555555544444332 344
Q ss_pred CCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCC
Q 042568 249 MPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHIS 328 (983)
Q Consensus 249 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~ 328 (983)
+++|++|+|++|.+.. .++..+.++++|++|++++|++.+.+|..+..+ ++|+.|++++|.+.+.+|..+.
T Consensus 259 l~~L~~L~L~~n~l~~--------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l-~~L~~L~l~~n~~~~~~~~~~~ 329 (968)
T PLN00113 259 LKNLQYLFLYQNKLSG--------PIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL-QNLEILHLFSNNFTGKIPVALT 329 (968)
T ss_pred CCCCCEEECcCCeeec--------cCchhHhhccCcCEEECcCCeeccCCChhHcCC-CCCcEEECCCCccCCcCChhHh
Confidence 4555555555544432 122334444455555555555554444444444 2455555555555444444444
Q ss_pred CCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCC------------------------CCCCCCcEE
Q 042568 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF------------------------GDIPHLGLL 384 (983)
Q Consensus 329 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~------------------------~~l~~L~~L 384 (983)
.+++|+.|++++|.+++.+|..++.+++|+.|++++|.+.+.+|..+ +.+++|+.|
T Consensus 330 ~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L 409 (968)
T PLN00113 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409 (968)
T ss_pred cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEE
Confidence 44555555555555444444444444444444444444444444433 334444444
Q ss_pred EccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCC
Q 042568 385 DLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL 464 (983)
Q Consensus 385 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l 464 (983)
+|++|++++.+|..|.++++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+ ...+|+. |++++|++
T Consensus 410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~-L~ls~n~l 487 (968)
T PLN00113 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLEN-LDLSRNQF 487 (968)
T ss_pred ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceE-EECcCCcc
Confidence 444444444444444444444444444444444444444445555555555555555555433 2356664 88888888
Q ss_pred CCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccc
Q 042568 465 DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544 (983)
Q Consensus 465 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 544 (983)
++.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 88889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCcceEeccCCccccccCCCCCCcccccccccCCcCccCCCC--CcccccCCCCccchhhHHHHHHHHHHHHHHHH-
Q 042568 545 QASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIK--GLQTCKKEHTHHLVILSILLSLFAMSLLFIFG- 621 (983)
Q Consensus 545 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~~--~~~~c~~~~~~~~~~~~i~~~~~~~~~l~~~~- 621 (983)
.++++|++|++++|+++|.+|..+++..+...++.||+.+||.+. +.++|.........++++++++.+++++++++
T Consensus 568 ~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (968)
T PLN00113 568 GNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF 647 (968)
T ss_pred hcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999998652 34567543222211111111222222222222
Q ss_pred HhhhhhhccCCCccccCCCCchhHHHHHHhhcCCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEee
Q 042568 622 NFLVLRSKFGKDLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLD 700 (983)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~ 700 (983)
+++++|++++.........+...+...........++++++. ..|...++||+|+||.||+|+. .++..||||.++
T Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~ 724 (968)
T PLN00113 648 GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN 724 (968)
T ss_pred HHHHHHhhhcccccccccccccccccccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEcc
Confidence 222333322211111000000000000000111223444443 4577888999999999999996 578899999885
Q ss_pred cccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHH
Q 042568 701 LTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780 (983)
Q Consensus 701 ~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 780 (983)
.... ...+|++++++++|||||+++++|...+..++||||+++|+|.++++ .++|..+.+|+.|+|+|
T Consensus 725 ~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 725 DVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKA 792 (968)
T ss_pred CCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHH
Confidence 4322 22356889999999999999999999999999999999999999985 27899999999999999
Q ss_pred HHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCC
Q 042568 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR 860 (983)
Q Consensus 781 L~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 860 (983)
++|||..+..+|+||||||+||+++.++.+++. ||.+..... .....||+.|+|||++.+..
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~t~~y~aPE~~~~~~ 854 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----------------DTKCFISSAYVAPETRETKD 854 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----------------CCCccccccccCcccccCCC
Confidence 999997655579999999999999999988875 665543211 11136889999999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC-CcHHHHHHHhhcCCCCCccccccchHHHHHHHHH
Q 042568 861 ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR-LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIE 939 (983)
Q Consensus 861 ~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 939 (983)
++.|+|||||||++|||+||+.||+........+.+|....+... ....+++.+.. . .....+...++.+
T Consensus 855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-----~~~~~~~~~~~~~ 925 (968)
T PLN00113 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG----D-----VSVNQNEIVEVMN 925 (968)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC----C-----CCccHHHHHHHHH
Confidence 999999999999999999999999766555666777766544322 11111111111 0 0111346678899
Q ss_pred HHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 940 LGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 940 l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
++.+||+.+|++||+|+||+++|+++.+...
T Consensus 926 l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 926 LALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 9999999999999999999999998866443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-55 Score=555.87 Aligned_cols=467 Identities=38% Similarity=0.581 Sum_probs=373.6
Q ss_pred EEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccC
Q 042568 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158 (983)
Q Consensus 79 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~ 158 (983)
++.|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++
T Consensus 142 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 221 (968)
T PLN00113 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221 (968)
T ss_pred CCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcC
Confidence 45555555555555566666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccc
Q 042568 159 NKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 159 N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 238 (983)
|++++.+|..+. .+++|++|++++|.+++.+|. .+.++++|++|+|++|++++.+|..+.++++|++|+|++|.++
T Consensus 222 n~l~~~~p~~l~---~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~ 297 (968)
T PLN00113 222 NNLSGEIPYEIG---GLTSLNHLDLVYNNLTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297 (968)
T ss_pred CccCCcCChhHh---cCCCCCEEECcCceeccccCh-hHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec
Confidence 666666665543 556666666666666655553 3456666666666666666666666666666666666666666
Q ss_pred cccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCcc
Q 042568 239 GELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNL 318 (983)
Q Consensus 239 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~ 318 (983)
+.+|. .+..+++|++|++++|.+.. ..+..+..+++|++|++++|++.+.+|..++.+ .+|+.|++++|.
T Consensus 298 ~~~p~-~~~~l~~L~~L~l~~n~~~~--------~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~-~~L~~L~Ls~n~ 367 (968)
T PLN00113 298 GEIPE-LVIQLQNLEILHLFSNNFTG--------KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNN 367 (968)
T ss_pred cCCCh-hHcCCCCCcEEECCCCccCC--------cCChhHhcCCCCCEEECcCCCCcCcCChHHhCC-CCCcEEECCCCe
Confidence 55543 34566666666666666543 234557778889999999999988888888877 579999999999
Q ss_pred ccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCccc
Q 042568 319 IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398 (983)
Q Consensus 319 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 398 (983)
+++.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|.+++.+|..|..+++|+.|++++|++++.+|..
T Consensus 368 l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 447 (968)
T PLN00113 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447 (968)
T ss_pred eEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChh
Confidence 99889999988999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccc
Q 042568 399 FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478 (983)
Q Consensus 399 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L 478 (983)
+..+++|+.|++++|++.+.+|..+ ..++|+.|++++|++++.+|..+.++++|+. |+|++|++++.+|..+..+++|
T Consensus 448 ~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L 525 (968)
T PLN00113 448 KWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENKLSGEIPDELSSCKKL 525 (968)
T ss_pred hccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCE-EECcCCcceeeCChHHcCccCC
Confidence 9999999999999999999888866 4589999999999999999999999999996 9999999999999999999999
Q ss_pred ccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCC
Q 042568 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558 (983)
Q Consensus 479 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N 558 (983)
+.|+|++|.++|.+|..|..+++|+.|+|++|+++|.+|..+..++.|+.|++++|+++|.+|.. +.+..+....+.+|
T Consensus 526 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n 604 (968)
T PLN00113 526 VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGN 604 (968)
T ss_pred CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999964 44455566667788
Q ss_pred c-ccc
Q 042568 559 K-FSG 562 (983)
Q Consensus 559 ~-l~~ 562 (983)
+ ++|
T Consensus 605 ~~lc~ 609 (968)
T PLN00113 605 IDLCG 609 (968)
T ss_pred ccccC
Confidence 6 444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-50 Score=441.02 Aligned_cols=291 Identities=41% Similarity=0.630 Sum_probs=243.3
Q ss_pred cCCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeE
Q 042568 653 KNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 653 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
....|+++++..||++|...++||+|+||.||+|..++|+.||||+++...... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 456799999999999999999999999999999999999999999886655432 4669999999999999999999999
Q ss_pred EecCC-ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 733 CSKPD-FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 733 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
|.+.+ +.++|||||++|+|+++++..... .++|..|++||.++|+||+|||+.++++||||||||+|||+|+++.+|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999975432 899999999999999999999999888899999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCcc-ccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCccc-C
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLL-CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLF-H 889 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~-~ 889 (983)
|+|||+|+..+..... .... .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+... .
T Consensus 218 lsDFGLa~~~~~~~~~-------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~ 284 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS-------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR 284 (361)
T ss_pred ccCccCcccCCccccc-------------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc
Confidence 9999999654420111 1111 69999999999999999999999999999999999999987644 3
Q ss_pred CCCchHHHHHhhCCC-CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 890 DGSSLHEWVKRHYPH-RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+...+.+|+...... .+.+++|+.+.... +. ..+.+.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 285 ~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~-------~~--~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 285 GELSLVEWAKPLLEEGKLREIVDPRLKEGE-------YP--DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccccHHHHHHHHHHCcchhheeCCCccCCC-------CC--hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 344588887665544 34445554433200 00 015778899999999999999999999999999666543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=382.77 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=214.4
Q ss_pred CCCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe
Q 042568 656 RVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734 (983)
Q Consensus 656 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 734 (983)
.++..++.. .+.||+|..|+|||++++ +++.+|+|.+......+..+++.+|+++++..+||+||++||.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 355666654 688999999999999976 577799999977777778899999999999999999999999999
Q ss_pred cCC-ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 735 KPD-FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 735 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
.+. ...++||||++|||++.+... .++++....+|+.+|++||.|||+.. +||||||||+|||++..|++|||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEec
Confidence 988 499999999999999998753 45899999999999999999999632 59999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
|||.++.+... ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||-....+...
T Consensus 222 DFGVS~~lvnS---------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 222 DFGVSGILVNS---------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD 286 (364)
T ss_pred cccccHHhhhh---------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC
Confidence 99999877532 234578999999999999999999999999999999999999998643111111
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
. -+.++..+.. .+...|.. ..++++..++..|++.||.+||+++|+++|=
T Consensus 287 ~------------~~Ll~~Iv~~-ppP~lP~~------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 287 I------------FELLCAIVDE-PPPRLPEG------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred H------------HHHHHHHhcC-CCCCCCcc------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1 1222222221 22222211 3567899999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=377.83 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=208.5
Q ss_pred CCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcc------hhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE------ITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
+.|.+.+.+|+|+||.|-+|. .++|+.||||++++..... ......+|+++|++++|||||+++++|..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 457778999999999999999 5589999999997653221 123457999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC---CCEEEcccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED---LTALVADFG 816 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~---~~~kl~Dfg 816 (983)
||||||++||.|.+.+-.. ..+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 252 YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999988753 44667777899999999999999997 9999999999999765 789999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCC---CccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA---STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
+|+..+. ...+.+.+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.....+..
T Consensus 325 lAK~~g~--------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s- 389 (475)
T KOG0615|consen 325 LAKVSGE--------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS- 389 (475)
T ss_pred hhhcccc--------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-
Confidence 9998752 145667899999999999987543 4588999999999999999999975433221
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+.+.+ ..+... .....|.++..+..+++.+|+..||++|||+.|+++|=+
T Consensus 390 l~eQI---------------~~G~y~-----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 390 LKEQI---------------LKGRYA-----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred HHHHH---------------hcCccc-----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 22211 111111 122357789999999999999999999999999998754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=388.92 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=211.2
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCC-ceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPD-FKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g 749 (983)
.+.||+|+||+||+|.++....||||++...... +..++|.+|+.++.+++|||||+++|+|..+. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999984444999999665422 23679999999999999999999999999888 789999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccccCCcccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~~~~~~~~ 828 (983)
+|.++++.. ....+++..+.+|+.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--- 198 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--- 198 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc---
Confidence 999999864 25679999999999999999999999963 99999999999999997 99999999998765321
Q ss_pred cccCCCCccccccCccccccccccccccC--CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGM--GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.......||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ...
T Consensus 199 ----------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~------------- 254 (362)
T KOG0192|consen 199 ----------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV------------- 254 (362)
T ss_pred ----------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH-------------
Confidence 1112257999999999999 56999999999999999999999999975432 111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
.............| ..++..+..++.+||..||+.||++.+++..|+.+......
T Consensus 255 ---~~~v~~~~~Rp~~p-------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 255 ---ASAVVVGGLRPPIP-------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---HHHHHhcCCCCCCC-------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11111111111111 22667899999999999999999999999999999775554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.58 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=214.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.+|...+.||+|||+.||.++. .+|+.||+|++.+.. .....+...+|++|.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999997 889999999997643 2335788999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
|+|++++|..+++. ++++++.+++.+..||+.||.|||+++ |+|||||..|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999998873 567999999999999999999999996 99999999999999999999999999998874
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.++ ...+.+|||-|.|||++.....+..+||||+|||+|-|+.|++||+.. .
T Consensus 171 ~~E-------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~---------- 222 (592)
T KOG0575|consen 171 DGE-------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----T---------- 222 (592)
T ss_pred ccc-------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----h----------
Confidence 422 223479999999999999999999999999999999999999999731 1
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+.+...+...... ..| .....+..+||..+++.+|.+|||+++|+.+=-
T Consensus 223 --vkety~~Ik~~~Y--~~P-------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 223 --VKETYNKIKLNEY--SMP-------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred --HHHHHHHHHhcCc--ccc-------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 1222222222111 122 235678999999999999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=356.01 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=207.9
Q ss_pred CCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceee-EEecCCc-eeEEEe
Q 042568 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIIT-ICSKPDF-KALVLP 744 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e 744 (983)
|.+.++||+|.||+|||+. ..+|..||.|.+..... ...+.....|+.++++++|||||++++ .+.+... .+||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 5567899999999999999 56899999998864432 235677889999999999999999999 4444444 799999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI-KVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||.+|+|.+.++..+..++.+++..+|+++.|++.||.++|..-+. -|+||||||.||+++.+|.+|++|||+++++..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 9999999999987776678899999999999999999999984321 389999999999999999999999999998864
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. +.....+|||.||+||.+.+.+|+.|+||||+||++|||+.-+.||... .+.+.
T Consensus 181 ~~-------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L------ 236 (375)
T KOG0591|consen 181 KT-------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSL------ 236 (375)
T ss_pred hh-------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHH------
Confidence 32 3445679999999999999999999999999999999999999998632 22221
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccch-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVW-SDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..++.....++ .+ +..+.++.+++..|+..||+.||+...+++.+.
T Consensus 237 ----------~~KI~qgd~~~----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 237 ----------CKKIEQGDYPP----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----------HHHHHcCCCCC----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11112212221 12 346778889999999999999999655555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=362.19 Aligned_cols=200 Identities=32% Similarity=0.537 Sum_probs=180.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
-++|...+.||+|+||+||+|+++ ++..||||.+.+.. ..+..+.+..|+++++.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888888999999999999965 67889999997664 5556778899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC------CCEEEccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED------LTALVADFGI 817 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~------~~~kl~Dfgl 817 (983)
|||.||+|.++++.. ..+++..++.++.|+|.||++||+++ ||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999863 36999999999999999999999996 9999999999999764 4689999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
|+.+.+. ....+.+|++.|||||+++..+|+.|+|+||+|+|+|+|++|+.||+.
T Consensus 162 AR~L~~~--------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG--------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch--------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9988743 233457899999999999999999999999999999999999999974
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=380.12 Aligned_cols=475 Identities=27% Similarity=0.388 Sum_probs=335.0
Q ss_pred EEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccC
Q 042568 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158 (983)
Q Consensus 79 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~ 158 (983)
...++++.|.+. .+.+.+.+|..|++|++++|++. ..|++++.+..++.|+.|+|+++ .+|.+++++.+|..|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 567788888886 67788899999999999999998 88889999999999999999998 8999999999999999999
Q ss_pred cccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccc
Q 042568 159 NKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 159 N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 238 (983)
|.+. ++|.+++ .+..|..|+..+|+++ ..|.. +..+.+|..|++.+|+++...|+.+. ++.|++||+.+|-+.
T Consensus 124 n~~~-el~~~i~---~~~~l~dl~~~~N~i~-slp~~-~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 124 NELK-ELPDSIG---RLLDLEDLDATNNQIS-SLPED-MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE 196 (565)
T ss_pred ccee-ecCchHH---HHhhhhhhhccccccc-cCchH-HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh
Confidence 9998 7787776 5566667777777766 33332 23556666666666666644444333 666666666666664
Q ss_pred cccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCcc
Q 042568 239 GELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNL 318 (983)
Q Consensus 239 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~ 318 (983)
.+|.++ +.|.+|.-|+|..|++.. .+.|..++.|.+++++.|++. ++|...+.-..++..|||..|+
T Consensus 197 -tlP~~l-g~l~~L~~LyL~~Nki~~----------lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNk 263 (565)
T KOG0472|consen 197 -TLPPEL-GGLESLELLYLRRNKIRF----------LPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNK 263 (565)
T ss_pred -cCChhh-cchhhhHHHHhhhccccc----------CCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccc
Confidence 566553 556666666666666532 234555566666666666654 4444444222345555555555
Q ss_pred ccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCC--CcEEE-------ccCc
Q 042568 319 IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPH--LGLLD-------LSKN 389 (983)
Q Consensus 319 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~-------Ls~N 389 (983)
++ ..|+.+.-+++|.+||+|+|.|+ ..|.+++++ +|+.|-+.+|.+..+-.+.+.+-+. |++|. ++.-
T Consensus 264 lk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s 340 (565)
T KOG0472|consen 264 LK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS 340 (565)
T ss_pred cc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence 54 45555555555555555555555 344455555 5555555555554211111111000 11110 0000
Q ss_pred c---cc-Cc-Ccc---cccCcccchhhcccCccCCCCCcccccCCCC---CCEEEccCccccCcCCccccCCCccceecc
Q 042568 390 K---LS-GS-IPD---SFANLSQLRRLLLYGNHLSGTIPSSLGKCVN---LEILDLSHNKISGIIPSDVAGLRSLKLYLN 458 (983)
Q Consensus 390 ~---l~-~~-~~~---~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~ 458 (983)
. -+ +. .+. ....+...+.|+++.-+++ .+|+....... .+.++++.|++. .+|..+..++.+...+.
T Consensus 341 e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ 418 (565)
T KOG0472|consen 341 EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLV 418 (565)
T ss_pred cccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHH
Confidence 0 00 00 111 1234667888999999998 67776555444 788999999998 88988888887766577
Q ss_pred ccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccC
Q 042568 459 LSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG 538 (983)
Q Consensus 459 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 538 (983)
+++|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.|++|.|+|. .+|..+..+..|+.+-.++|++..
T Consensus 419 lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~ 495 (565)
T KOG0472|consen 419 LSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGS 495 (565)
T ss_pred hhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccc
Confidence 8888776 88999999999999999999998 89999999999999999999998 789888888888888888899985
Q ss_pred CcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCCcCc
Q 042568 539 EIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGL 584 (983)
Q Consensus 539 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~l 584 (983)
.-|..+.+|.+|..|||.+|.+...+|..+.+.++..+.+.|||+-
T Consensus 496 vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 496 VDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 5555599999999999999999999999999999999999999865
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=339.86 Aligned_cols=271 Identities=20% Similarity=0.309 Sum_probs=209.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+.|+...++|+|+||+|||++++ +|+.||||+|....+ +...+-..+|++++++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999965 689999999965554 4456678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
||+..-|.+ +... ...++...+.++++|+++|+.|+|++. +|||||||+|||+++++.+|+||||.|+.+...
T Consensus 82 ~~dhTvL~e-Le~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecchHHHHH-HHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 998744433 4332 456899999999999999999999995 999999999999999999999999999988743
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh--
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH-- 901 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~-- 901 (983)
.+. ...++.|.+|+|||.+.| .+|+..+||||.||++.||++|.+-| ++..++.+.....
T Consensus 155 gd~-------------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~----PG~SDiDQLy~I~kt 217 (396)
T KOG0593|consen 155 GDN-------------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW----PGRSDIDQLYLIRKT 217 (396)
T ss_pred cch-------------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC----CCcchHHHHHHHHHH
Confidence 221 234689999999999988 78999999999999999999999865 3444443332211
Q ss_pred ---CCCCCcHHHHHH--Hhh--cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 ---YPHRLDPIVEKA--IAK--YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ---~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..++-..++... ..+ .+...-+...+..++....-+++++..|++.||.+|++.+|++.+
T Consensus 218 LG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 218 LGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111110 000 011111222334455667789999999999999999999999853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=366.22 Aligned_cols=254 Identities=32% Similarity=0.480 Sum_probs=209.0
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
.+.||+|-||+||.|.++....||+|.++.... ..+.|.+|+++|++++|++||+++++|..++..+||||||+.|+|
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 577999999999999999888999999965432 357899999999999999999999999998899999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++.... ...+...+.+.++.|||+|++||+++. +|||||.+.|||++++..+||+|||+|+...+......
T Consensus 289 l~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-- 361 (468)
T KOG0197|consen 289 LDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-- 361 (468)
T ss_pred HHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec--
Confidence 99998733 567899999999999999999999995 99999999999999999999999999995443322111
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 910 (983)
....-...|.|||.+....++.|||||||||++|||+| |+.||..+ +..+ ++
T Consensus 362 ----------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~e------------v~ 414 (468)
T KOG0197|consen 362 ----------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEE------------VL 414 (468)
T ss_pred ----------CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHH------------HH
Confidence 11122457999999999999999999999999999999 88887543 2222 12
Q ss_pred HHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
+ .+........| +.|+.++.++|..||+.+|++|||++.+...++++....
T Consensus 415 ~-~le~GyRlp~P-------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 415 E-LLERGYRLPRP-------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred H-HHhccCcCCCC-------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 2 22222222112 348899999999999999999999999998888876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=347.16 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=204.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.+.|++.++||+|+||+||+++. ++++.+|+|++++..- ....+....|..++.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35788999999999999999995 4688899999966542 22467889999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+.||.|..+++.. ..+++..+.-++..|+.||.|||+.+ |||||+||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999853 45889999999999999999999997 9999999999999999999999999998543
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ..+.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||... +.
T Consensus 177 ~~~-------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~-------- 230 (357)
T KOG0598|consen 177 KDG-------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DV-------- 230 (357)
T ss_pred cCC-------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cH--------
Confidence 322 2334579999999999999999999999999999999999999998632 11
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC----CHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP----SMLDVA 959 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl 959 (983)
..++++..... ....+.+ ...+..+++.+.+..||++|. ++.++.
T Consensus 231 ----~~~~~~I~~~k-~~~~p~~-------ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 231 ----KKMYDKILKGK-LPLPPGY-------LSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred ----HHHHHHHhcCc-CCCCCcc-------CCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 22222222221 1111111 346788999999999999996 455544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=365.86 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=209.2
Q ss_pred CCCCccccCCcEeEEEEEECCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 670 CPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
...+.||+|.||+||+|.|. ..||||+++... ..+..+.|+.|+.++++-||.||+-+.|||..+.. .||+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 34788999999999999985 469999997654 33467899999999999999999999999999888 999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
-+|..+++.. ..+++..+.+.|++|||+|+.|||.+. |||||+|..||++.+++.|||+|||++..-......
T Consensus 472 sSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~- 544 (678)
T KOG0193|consen 472 SSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE- 544 (678)
T ss_pred chhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccc-
Confidence 9999999865 467999999999999999999999995 999999999999999999999999999865433111
Q ss_pred cccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......|...|||||+++. .+|++.+||||||+|+|||++|..||... ..
T Consensus 545 ----------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~-------------- 598 (678)
T KOG0193|consen 545 ----------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NR-------------- 598 (678)
T ss_pred ----------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--Ch--------------
Confidence 22233568899999999874 46899999999999999999999998621 11
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
|+.+......-...-..+...++++++.+|+..||.+++++||.+.+|+..|+.+..
T Consensus 599 -----dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 599 -----DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -----hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111111111111122335688899999999999999999999999998887765
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.34 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=214.3
Q ss_pred HHhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
....+|...+.||+|+|++||+|+ ..+++.||||++.+.- .+...+...+|-++|.+| .||.|++++..|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 344678889999999999999999 4578899999986542 122346678899999999 899999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
|+|+||+++|.|.+++.+. ..+++...+.++.+|+.||+|||++| ||||||||+|||+|++|+++|+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999864 45899999999999999999999997 9999999999999999999999999999
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
.+.+......-..+..........++||..|.+||++.....++.+|+|+||||+|+|+.|++||...-+
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---------- 292 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---------- 292 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----------
Confidence 9987654422111111111223558999999999999999999999999999999999999999964210
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.-++++.+.-... .| +..++.+.+|+.+.+..||.+|++++||.+|-
T Consensus 293 -------yliFqkI~~l~y~--fp-------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 293 -------YLIFQKIQALDYE--FP-------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------HHHHHHHHHhccc--CC-------CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1122222221111 11 11336788999999999999999999998763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.28 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=209.0
Q ss_pred CCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|..-.+||+|+.|.||.|. ..+++.||||+++..... ..+-+..|+.+|+..+|+|||.+++.|...++.++|||||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45556789999999999999 557888999999877655 3567889999999999999999999999889999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+||+|.+.+.. ..+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||.+..+.....
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999998873 45999999999999999999999997 99999999999999999999999999987764332
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
...+.+||+.|||||+.....|++|+||||||++++||+.|.+||-. +..+...
T Consensus 425 -------------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAl--------- 478 (550)
T KOG0578|consen 425 -------------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRAL--------- 478 (550)
T ss_pred -------------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHH---------
Confidence 33457899999999999999999999999999999999999999842 1111111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.....|.. +.++..+.++.+++.+|++.||++||+++|+++|
T Consensus 479 --------yLIa~ng~P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 479 --------YLIATNGTPKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --------HHHhhcCCCCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111111111 1235578899999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.13 Aligned_cols=267 Identities=22% Similarity=0.364 Sum_probs=209.6
Q ss_pred CCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.+|...+++|+|.||.||+|+ ..+|+.||||+++.....+ ......+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467778999999999999999 5589999999997765443 34578899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
||+. +|+..+... ...+...++..++.++++|++|+|.+. |+|||+||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9974 888888754 456889999999999999999999997 999999999999999999999999999988754
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH----
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK---- 899 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~---- 899 (983)
... ....+-|..|+|||.+.| +.|+..+|+||.|||+.||+-|.+-| +++.++.+...
T Consensus 155 ~~~-------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f----pG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 155 NRI-------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF----PGDSDIDQLSKIFRA 217 (318)
T ss_pred Ccc-------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC----CCCchHHHHHHHHHH
Confidence 322 111267899999999988 56899999999999999999887643 33444443322
Q ss_pred ------hhCCCCCcHHHHHH-HhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 900 ------RHYPHRLDPIVEKA-IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 900 ------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+.+|+. ...-|-. +..... +.....+..+..++.+++..|+.+||.+|++++|++++=
T Consensus 218 LGTP~~~~WP~~-~~lpdY~~~~~~P~----~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 218 LGTPTPDQWPEM-TSLPDYVKIQQFPK----PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cCCCCcccCccc-cccccHHHHhcCCC----CccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 112211 1111110 111111 111224556778889999999999999999999999763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=355.01 Aligned_cols=272 Identities=21% Similarity=0.266 Sum_probs=213.2
Q ss_pred hCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCC-ceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPD-FKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv 742 (983)
.++|...++||.|+||.||+|+ ..+++.||||+++.....-..-.-.||++.+++++ |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4577788999999999999999 55789999999876544322233468999999998 999999999999888 99999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||||+. +|.+.+... .+.+++..++.|+.||++||+|+|++| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999974 999988765 567999999999999999999999997 9999999999999999999999999999764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh-
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR- 900 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~- 900 (983)
.. ...+.++.|.+|+|||++.. ..|+.++|+||+|||++|+.+-++-| ++...+.+..+.
T Consensus 162 Sk--------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF----PG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 162 SK--------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF----PGASEIDQIYKIC 223 (538)
T ss_pred cC--------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC----CCCcHHHHHHHHH
Confidence 32 23345789999999998765 67899999999999999999988765 333333333221
Q ss_pred --hCCCC---Cc--HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 901 --HYPHR---LD--PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 901 --~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.-.+. .. ..+...+....++..+.........+..++.+++.+|+++||.+|||++|++++-
T Consensus 224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111 11 1122223333333333334444455788999999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.14 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=211.6
Q ss_pred CCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|+..++||.|..++||+|+ .+.++.||||+++.+......+.+.+|+..++.++||||++++..|......|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 467888999999999999999 5578999999999887777789999999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|.+||+.+.+.... ...+++..+..|.+++++||.|||.+| .||||||+.|||++.+|.+||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999998654 456999999999999999999999997 9999999999999999999999999987665433
Q ss_pred ccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... .....+.+||+.|||||++.. ..|+.|+||||||++..|+.+|..||....+-+. +-.-+....|
T Consensus 181 ~R~---------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll~tLqn~pp 250 (516)
T KOG0582|consen 181 DRQ---------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LLLTLQNDPP 250 (516)
T ss_pred cee---------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HHHHhcCCCC
Confidence 111 112256789999999999543 5799999999999999999999999975422111 1111111111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.......+ ..........+.+++..|++.||++|||+++++++
T Consensus 251 ~~~t~~~~---------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 251 TLLTSGLD---------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CcccccCC---------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000000 00011234567888888999999999999999964
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.08 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=214.7
Q ss_pred cCCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeE
Q 042568 653 KNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 653 ~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
....+.+++|.+ ++-+|+|+.|.||+|+++ ++.||||+++ +.-..+|+-|++++||||+.+.|+
T Consensus 117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHh--------hhhhhhHHHHHhccCcceeeEeee
Confidence 345667777765 678999999999999987 7889999762 233458889999999999999999
Q ss_pred EecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEE
Q 042568 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV 812 (983)
Q Consensus 733 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl 812 (983)
|....-++||||||..|-|...++. ...+.......|..+||.|+.|||.+. |||||+|.-|||+..+..+||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEe
Confidence 9999999999999999999999975 456888899999999999999999994 999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
+|||.++...+..+. + .++||..|||||++...++++|+||||||||+|||+||..||..... .
T Consensus 254 sDFGTS~e~~~~STk-------M-------SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--s 317 (904)
T KOG4721|consen 254 SDFGTSKELSDKSTK-------M-------SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--S 317 (904)
T ss_pred ccccchHhhhhhhhh-------h-------hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--h
Confidence 999999877643222 1 25799999999999999999999999999999999999999864210 0
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh-cCC
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY-LSS 971 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~-~~~ 971 (983)
..|+......+.. .....|+..+.-|+.+||+..|..||++.+++.||...... ...
T Consensus 318 -------------------AIIwGVGsNsL~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~ 375 (904)
T KOG4721|consen 318 -------------------AIIWGVGSNSLHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLST 375 (904)
T ss_pred -------------------eeEEeccCCcccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcc
Confidence 0122222221111 11245888899999999999999999999999999866433 344
Q ss_pred CchhHHH
Q 042568 972 PSSLIEE 978 (983)
Q Consensus 972 ~~~~~~~ 978 (983)
+++-+..
T Consensus 376 tee~yf~ 382 (904)
T KOG4721|consen 376 TEETYFK 382 (904)
T ss_pred cHHHHHH
Confidence 4444433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=365.60 Aligned_cols=451 Identities=28% Similarity=0.406 Sum_probs=372.5
Q ss_pred eEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEecc
Q 042568 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157 (983)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls 157 (983)
..+.++++.+.+. ++|++++.+..++.|+.++|+++ ++|+.++.+.+|++|+.++|.+. .+|+.++.+..|+.|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 4888999999997 89999999999999999999999 99999999999999999999999 899999999999999999
Q ss_pred CcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccccc
Q 042568 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMF 237 (983)
Q Consensus 158 ~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 237 (983)
+|+++ ..|..++ ++.+|..|++.+|.++ ..|.... +++.|++|+..+|-+. .+|..++.+.+|+.|+|.+|++
T Consensus 146 ~N~i~-slp~~~~---~~~~l~~l~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki 218 (565)
T KOG0472|consen 146 NNQIS-SLPEDMV---NLSKLSKLDLEGNKLK-ALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKI 218 (565)
T ss_pred ccccc-cCchHHH---HHHHHHHhhccccchh-hCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccc
Confidence 99998 7888876 7899999999999999 4554544 4999999999999988 7888999999999999999999
Q ss_pred ccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCc
Q 042568 238 SGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317 (983)
Q Consensus 238 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N 317 (983)
. .+| -|..+..|++|+++.|+|...+. .....++++..|||++|+++ ..|..+..+ .+|..||+++|
T Consensus 219 ~-~lP--ef~gcs~L~Elh~g~N~i~~lpa--------e~~~~L~~l~vLDLRdNklk-e~Pde~clL-rsL~rLDlSNN 285 (565)
T KOG0472|consen 219 R-FLP--EFPGCSLLKELHVGENQIEMLPA--------EHLKHLNSLLVLDLRDNKLK-EVPDEICLL-RSLERLDLSNN 285 (565)
T ss_pred c-cCC--CCCccHHHHHHHhcccHHHhhHH--------HHhcccccceeeeccccccc-cCchHHHHh-hhhhhhcccCC
Confidence 8 888 36889999999999999865432 23458999999999999998 688888877 57999999999
Q ss_pred cccccCCCCCCCCCcccEEeccccccCCCCCccc-ccCC--CCcEEE--eeCCccc---------CC-CCCC---CCCCC
Q 042568 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHEL-CLMS--KLERVY--LSNNSLS---------GE-IPSA---FGDIP 379 (983)
Q Consensus 318 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~--~L~~L~--L~~N~l~---------~~-~p~~---~~~l~ 379 (983)
.|+ .+|.+++++ +|+.|-+.+|.+.. +...+ ..-+ -|++|. +..-+++ +. .+.. ...+.
T Consensus 286 ~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i 362 (565)
T KOG0472|consen 286 DIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAII 362 (565)
T ss_pred ccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhh
Confidence 999 689999999 99999999999862 22111 1100 011110 0001111 01 1111 23456
Q ss_pred CCcEEEccCccccCcCcccccCccc---chhhcccCccCCCCCcccccCCCCCC-EEEccCccccCcCCccccCCCccce
Q 042568 380 HLGLLDLSKNKLSGSIPDSFANLSQ---LRRLLLYGNHLSGTIPSSLGKCVNLE-ILDLSHNKISGIIPSDVAGLRSLKL 455 (983)
Q Consensus 380 ~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~ 455 (983)
+.+.|+++.=+++ .+|+......+ .+..+++.|++. ++|..+..++.+. .+++++|.++ .+|..++.++++..
T Consensus 363 ~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~ 439 (565)
T KOG0472|consen 363 TTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTF 439 (565)
T ss_pred hhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhccee
Confidence 7888999998888 45554443333 788899999998 7888777777654 4556666665 88888899999985
Q ss_pred eccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcc
Q 042568 456 YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535 (983)
Q Consensus 456 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 535 (983)
|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+-.+..|+.+-.++|++..+.|..+.++.+|..|||.+|.
T Consensus 440 -L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNd 516 (565)
T KOG0472|consen 440 -LDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNND 516 (565)
T ss_pred -eecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCc
Confidence 999999887 78999999999999999999998 889988888888888888899997777779999999999999999
Q ss_pred ccCCcCccccCCCCcceEeccCCccc
Q 042568 536 LFGEIPQSFQASPTLKQLNFSFNKFS 561 (983)
Q Consensus 536 l~~~~p~~~~~l~~L~~l~l~~N~l~ 561 (983)
+. .||+.+++|++|++|++.+|+|.
T Consensus 517 lq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 517 LQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hh-hCChhhccccceeEEEecCCccC
Confidence 98 89999999999999999999998
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.76 Aligned_cols=272 Identities=23% Similarity=0.307 Sum_probs=204.4
Q ss_pred CCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 743 (983)
.|+..++||+|+||.||||+ ..+|+.||+|++.....+ +...-..+||.||+++.||||+++.+...+. ...|+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 45567889999999999999 568999999999776633 3456678999999999999999999998776 6889999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
|||++ +|.-++... .-.+++.++..++.|+++||+|+|.++ |+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus 198 eYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99987 776666532 346999999999999999999999997 99999999999999999999999999998875
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .....+-|.+|+|||++.| ..|+..+|+||.|||+.||++|++.|....+ -..+..+++-.-
T Consensus 271 ~~~~------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcG 337 (560)
T KOG0600|consen 271 SGSA------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCG 337 (560)
T ss_pred CCCc------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhC
Confidence 4422 1233578999999999998 4799999999999999999999998753211 111122221110
Q ss_pred CC--CCcHHHHHHHhhcCCC----CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PH--RLDPIVEKAIAKYAPQ----HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+ ...+. ..+...... ..+...+..+...+...++|+..++..||.+|.|+.++++.
T Consensus 338 SP~e~~W~~--~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 338 SPTEDYWPV--SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCChhcccc--ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 10 01110 000000000 00111112233456678999999999999999999999864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.53 Aligned_cols=363 Identities=25% Similarity=0.298 Sum_probs=240.3
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
.-+.|||++|.+...-+..|.++++|++++|.+|.++ .||...+...+|+.|+|.+|.|+..-...+ ..++.|++|
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L---~~l~alrsl 154 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEEL---SALPALRSL 154 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHH---HhHhhhhhh
Confidence 3456999999999888888999999999999999998 899877777789999999999983322223 478899999
Q ss_pred ecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccc
Q 042568 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261 (983)
Q Consensus 182 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 261 (983)
|||.|.|+ +||...|..-.++++|+|++|+|+......|.++.+|.+|.|++|+++ .+|...|+++++|+.|+|..|+
T Consensus 155 DLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ 232 (873)
T KOG4194|consen 155 DLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNR 232 (873)
T ss_pred hhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccccc
Confidence 99999998 888888888889999999999999988999999999999999999998 8999999999999999999999
Q ss_pred cccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEecccc
Q 042568 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341 (983)
Q Consensus 262 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 341 (983)
|.-..+ -.|..+++|+.|.|..|.+...-...|..+ .++++|+|+.|++...-..++.+++.|+.|+||+|
T Consensus 233 irive~--------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l-~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~N 303 (873)
T KOG4194|consen 233 IRIVEG--------LTFQGLPSLQNLKLQRNDISKLDDGAFYGL-EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYN 303 (873)
T ss_pred eeeehh--------hhhcCchhhhhhhhhhcCcccccCcceeee-cccceeecccchhhhhhcccccccchhhhhccchh
Confidence 865433 345666777777777776664444444444 34555555555555444445555555555555555
Q ss_pred ccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcc
Q 042568 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPS 421 (983)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 421 (983)
.|..+-++.+...++|+.|+|++|+|+...+..|..+..|++|+|+.|.++..-...|..+++|+.|+|++|.|+..+.+
T Consensus 304 aI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 304 AIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred hhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 55544445555555555555555555544444555555555555555555544444455555555555555554433221
Q ss_pred ---cccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccc
Q 042568 422 ---SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAI 481 (983)
Q Consensus 422 ---~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L 481 (983)
.|..+++|+.|+|.+|++..+.-..|.++..|+. |||.+|.|..+-|.+|..+ .|++|
T Consensus 384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~-LdL~~NaiaSIq~nAFe~m-~Lk~L 444 (873)
T KOG4194|consen 384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH-LDLGDNAIASIQPNAFEPM-ELKEL 444 (873)
T ss_pred chhhhccchhhhheeecCceeeecchhhhccCcccce-ecCCCCcceeecccccccc-hhhhh
Confidence 2344444444444444444333334444444443 4444444444444444444 34433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.42 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=204.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC--ceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD--FKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 743 (983)
.+|...+.||+|+||.||++... +|+..|||......... .+.+.+|++++.+++|||||+++|...... ..++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34666889999999999999965 48999999987663332 677899999999999999999999855444 589999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEcccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVK 822 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~ 822 (983)
||+++|+|.+++....+ ++++..+..+..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999986542 6999999999999999999999996 999999999999999 7999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... ........||+.|||||++..+ ...+++||||+||++.||+||+.||.... .. ..
T Consensus 170 ~~~~~----------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---~~-~~----- 230 (313)
T KOG0198|consen 170 SKGTK----------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---EE-AE----- 230 (313)
T ss_pred ccccc----------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---ch-HH-----
Confidence 31100 1222346799999999999953 34469999999999999999999986420 00 00
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
..+.- ......| ......+.+..+++.+|++.+|++|||+++++++.-...+.
T Consensus 231 ------~~~~i----g~~~~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 231 ------ALLLI----GREDSLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------HHHHH----hccCCCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 00100 0000111 11133667889999999999999999999999987654433
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=357.87 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=205.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC-
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD- 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 737 (983)
.++|.+.++||+|+||.||+|.+ .+++.||||++...........+.+|+++++++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999974 234679999987554444456799999999999 8999999999887654
Q ss_pred ceeEEEecccCcccccccccccC---------------------------------------------------------
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG--------------------------------------------------------- 760 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 760 (983)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999988764321
Q ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCcccc
Q 042568 761 -LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839 (983)
Q Consensus 761 -~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~ 839 (983)
....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........ .
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----------~ 231 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----------V 231 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch-----------h
Confidence 0234888999999999999999999986 999999999999999999999999999865432111 1
Q ss_pred ccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcC
Q 042568 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYA 918 (983)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 918 (983)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....+ +.+...+....
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----------------~~~~~~~~~~~ 294 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----------------EEFCQRLKDGT 294 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----------------HHHHHHHhcCC
Confidence 1122346788999999999999999999999999999997 99998642111 11111111111
Q ss_pred CCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 919 PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
....+ ..++.++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 295 ~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 RMRAP-------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 1245678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.78 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=207.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+++... ++..+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778899999999999999954 678899999976543 3356789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+.| +|..++.. ...++++.+..|+.+++.||.|||+.+ |+|||+||.|||+++.+.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99999976 346999999999999999999999995 999999999999999999999999999987642
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .....+.|||.|||||...+..|+..+|.||+||++||+++|++||... ++
T Consensus 154 t-------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si---------- 205 (808)
T KOG0597|consen 154 T-------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SI---------- 205 (808)
T ss_pred c-------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HH----------
Confidence 1 2223467999999999999999999999999999999999999998521 11
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.++....+.. ..| ......+..++...+..||..|.+-.+++.|
T Consensus 206 --~~Lv~~I~~d~v--~~p-------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 206 --TQLVKSILKDPV--KPP-------STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --HHHHHHHhcCCC--CCc-------ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122222221111 111 2466788999999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=333.94 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=209.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc--CCCCccceeeEEecC----Ccee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI--RHRNLIRIITICSKP----DFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~ 740 (983)
..-...+.||+|.||+||+|.|+ |+.||||+|... ..+.+.+|.+|++.+ ||+||+.+++.-... .+.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34556788999999999999998 999999999533 246788999999874 999999999987544 3679
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh-----ccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH-----HHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-----~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
+|++|.+.|||.|++. +..++...+++++..+|.||+||| .+|++.|.|||||++|||+.+++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999998 467999999999999999999999 467889999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCC------CCccchhHHHHHHHHHHHhCC--------
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR------ASTHGDVYSFGVLLLEIVTGR-------- 881 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~SlG~il~elltg~-------- 881 (983)
|+|.......... .......+||.+|||||++...- .-..+||||||.|+||++...
T Consensus 361 GLAv~h~~~t~~i---------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 361 GLAVRHDSDTDTI---------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred eeeEEecccCCcc---------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9998776543222 13334568999999999987532 124589999999999998743
Q ss_pred --CCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccch--HHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 882 --RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVW--SDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 882 --~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
.||.+..+.+.++.++ ..-...++.++.....| .+++..+.++|..||..+|..|.|+-.
T Consensus 432 y~~Pyyd~Vp~DPs~eeM----------------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEM----------------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred hcCCcccCCCCCCCHHHH----------------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence 3554443333333332 22222222222222333 457888999999999999999999999
Q ss_pred HHHHHHHhHh
Q 042568 958 VAHEMGRLKQ 967 (983)
Q Consensus 958 vl~~L~~~~~ 967 (983)
+.+.|.++.+
T Consensus 496 iKKtl~~l~~ 505 (513)
T KOG2052|consen 496 IKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHhc
Confidence 9999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=366.98 Aligned_cols=265 Identities=28% Similarity=0.441 Sum_probs=216.4
Q ss_pred CCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
...+.||+|+||+||+|+.. +...||||.++.........+|++|++.+..++|||||+++|+|...+-.++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 34678999999999999853 245599999988877778899999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCc----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 744 PLMSNGSLENHLYPSHGL----------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
|||..|+|.++|...... ..+++..+.+.||.|||.|++||-++. +|||||-..|+|+.++..|||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 999999999998643221 234889999999999999999999985 9999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~ 892 (983)
|||+++.....+.. ...+.-.=..+|||||.+..+++++++|||||||++||+++ |+.||.+..+
T Consensus 646 DfGLsRdiYssDYY-----------k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--- 711 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYY-----------KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--- 711 (774)
T ss_pred ccccchhhhhhhhh-----------cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---
Confidence 99999866533322 11111233578999999999999999999999999999999 9999865422
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 972 (983)
+++++....+.. + ...+.|+.++.+||.+||+.+|++||+++||-..|+...+....-
T Consensus 712 --------------~EVIe~i~~g~l---L-----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 712 --------------QEVIECIRAGQL---L-----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred --------------HHHHHHHHcCCc---c-----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 222322221111 1 112568899999999999999999999999999999887665543
Q ss_pred c
Q 042568 973 S 973 (983)
Q Consensus 973 ~ 973 (983)
+
T Consensus 770 ~ 770 (774)
T KOG1026|consen 770 S 770 (774)
T ss_pred c
Confidence 3
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=350.98 Aligned_cols=370 Identities=25% Similarity=0.270 Sum_probs=300.0
Q ss_pred CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccce
Q 042568 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRF 205 (983)
Q Consensus 126 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 205 (983)
.-+.||+|+|+|+...+..|.+|++|++++|..|.++ .||.... ...+|+.
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~----------------------------~sghl~~ 129 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGH----------------------------ESGHLEK 129 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccc----------------------------cccceeE
Confidence 4567999999999999999999999999999999998 7776432 4456888
Q ss_pred eecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCcc
Q 042568 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 206 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
|+|.+|.|+.+-.+.+..++.|+.||||.|.|+ .+|...|..-.++++|+|++|.|+.+.
T Consensus 130 L~L~~N~I~sv~se~L~~l~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~------------------- 189 (873)
T KOG4194|consen 130 LDLRHNLISSVTSEELSALPALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLE------------------- 189 (873)
T ss_pred EeeeccccccccHHHHHhHhhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccc-------------------
Confidence 888889888888888999999999999999998 788766666666777777777665543
Q ss_pred EEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCC
Q 042568 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 365 (983)
...|..+. +|.+|.|+.|+++...+..|.++++|+.|+|..|+|.-.---.|.++++|+.|.|..|
T Consensus 190 -------------~~~F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN 255 (873)
T KOG4194|consen 190 -------------TGHFDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRN 255 (873)
T ss_pred -------------cccccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhc
Confidence 23333332 5666666666666444556666888888888888877333456788888888888888
Q ss_pred cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCc
Q 042568 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445 (983)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 445 (983)
.|...-...|..+.+++.|+|+.|+++..-..++.+|++|+.|+|++|.|...-+++....++|+.|+|++|+|+...+.
T Consensus 256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~ 335 (873)
T KOG4194|consen 256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG 335 (873)
T ss_pred CcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChh
Confidence 88887778888888888888888888877778888889999999999988888888888888899999999999888888
Q ss_pred cccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCc---ccccccccceEEeCCCcccccccccccC
Q 042568 446 DVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPP---QLGSCIALESLNLSGNSLEGLLPVSVGQ 522 (983)
Q Consensus 446 ~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 522 (983)
.|..+..|+. |+|++|+++..--..|..+++|+.|||++|.|+..|.+ .|..+++|+.|.|.+|+|..+....|..
T Consensus 336 sf~~L~~Le~-LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsg 414 (873)
T KOG4194|consen 336 SFRVLSQLEE-LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSG 414 (873)
T ss_pred HHHHHHHhhh-hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhcc
Confidence 8888888886 99999999887778888999999999999999876644 4677889999999999999766678999
Q ss_pred CCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 523 LPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 523 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
+..|+.|||.+|.|-..-|..|..+ .|+.|-++.-.|
T Consensus 415 l~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 415 LEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred CcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 9999999999999988888999988 888887765544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.94 Aligned_cols=267 Identities=19% Similarity=0.246 Sum_probs=207.3
Q ss_pred HhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
..++|+.+.+||+|+||.||.|+ ..+|..+|+|++++... ....+..+.|-.+|....+|.||+++..|++.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45689999999999999999999 45789999999977642 2356788899999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||++||++..+|.. ...+++..+..++.+++-|++.+|+.| ||||||||+|+|+|+.|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999975 456999999999999999999999997 999999999999999999999999999654
Q ss_pred cCCccc------------ccc--cCCCCc----cc----------------cccCccccccccccccccCCCCCCccchh
Q 042568 822 KGIDES------------VNC--ANDSMS----FT----------------STDGLLCGSVGYIAPEYGMGKRASTHGDV 867 (983)
Q Consensus 822 ~~~~~~------------~~~--~~~~~~----~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv 867 (983)
...... ... ..+... .. ......+|||.|||||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 321110 000 000000 00 00112579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCC
Q 042568 868 YSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947 (983)
Q Consensus 868 ~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 947 (983)
||+|||+|||+.|.+||....+ .+...+.+.....-..| ...++..+..+||.+|+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp-----------------~~T~rkI~nwr~~l~fP-----~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETP-----------------QETYRKIVNWRETLKFP-----EEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHHHhhhccCC-----CcCcccHHHHHHHHHHhc-
Confidence 9999999999999999964211 12222222111111111 112355889999999999
Q ss_pred CCCCCCC---HHHHHHH
Q 042568 948 NPSTRPS---MLDVAHE 961 (983)
Q Consensus 948 dP~~RPs---~~evl~~ 961 (983)
||++|.- ++||.+|
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 9999964 7777653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=339.79 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=208.7
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|+..+.||+|.||.||||.+ .+++.||+|+++.+..++..+.+.+|+.++.+++++||.++|+.|......+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466778999999999999995 5788899999999888888899999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
.||++.+.+... ..+++..+.-|.+++..|+.|+|.++ .+|||||+.||++..+|.+|++|||.+..+....
T Consensus 94 ~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 94 GGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred cCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 999999999753 33477788889999999999999996 9999999999999999999999999998665321
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
....+.+||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+ + +
T Consensus 166 ------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--m------------r- 218 (467)
T KOG0201|consen 166 ------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--M------------R- 218 (467)
T ss_pred ------------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--c------------e-
Confidence 223567999999999999999999999999999999999999999875432 1 1
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+....+...|+.... ...+.+.+++..|++.||+.||++++++++
T Consensus 219 -------vlflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 219 -------VLFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -------EEEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 011112222222222 244567778888999999999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.73 Aligned_cols=253 Identities=32% Similarity=0.472 Sum_probs=206.7
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC----cchhHHHHHHHHHHHhcC-CCCccceeeEEecCCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT----GEITGSFKRECQILKRIR-HRNLIRIITICSKPDF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 738 (983)
..++|...+.||+|+||+|+.|.. .+++.||+|+++.... ....+.+.+|+.++++++ ||||+++++++..+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999985 4789999998765411 134567779999999999 9999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGI 817 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgl 817 (983)
.++||||+.+|.|.+++.. ..++.+..+.++++|++.|++|+|++| |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999986 346888999999999999999999997 9999999999999999 9999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCC-CC-ccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-AS-THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+......+ ....+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. ...
T Consensus 168 s~~~~~~~-------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~ 229 (370)
T KOG0583|consen 168 SAISPGED-------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVP 229 (370)
T ss_pred ccccCCCC-------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHH
Confidence 99773111 2234568999999999999977 75 8899999999999999999999741 111
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHH-HHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDV-VLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. ...+ +.. .....|.. . ..++..++.+|+..+|.+|+++.+++++=+
T Consensus 230 ~------------l~~k-i~~-~~~~~p~~-------~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 230 N------------LYRK-IRK-GEFKIPSY-------LLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred H------------HHHH-Hhc-CCccCCCC-------cCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 1 1111 111 11111211 2 678999999999999999999999995444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.84 Aligned_cols=277 Identities=27% Similarity=0.321 Sum_probs=209.7
Q ss_pred CCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHh--cCCCCccceeeEEecCC----ceeEEEe
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKR--IRHRNLIRIITICSKPD----FKALVLP 744 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e 744 (983)
..++||+|+||.||||.+. ++.||||++.. +..+.|..|-+|++. ++|+||++++++-...+ +.++|+|
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3578999999999999987 59999999953 346788889888876 58999999999876555 8899999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc------CCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH------SPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
|.+.|+|.+++. .+.++|....+|+..+++||+|||+. .+++|+|||||++|||+..|+++.|+|||+|
T Consensus 289 fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999998 56799999999999999999999963 3468999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR------ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
..+.+.... +.....+||.+|||||++.+.. .-.+.||||+|.|+|||++...-++....+..
T Consensus 364 l~~~p~~~~-----------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 364 LRLEPGKPQ-----------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred EEecCCCCC-----------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 988754322 1122268999999999987742 22468999999999999998765532111111
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
.+..-..-...+.++++.+-.+.+......|..+.+. ..+..+.+.+..||+.||+.|.|+.=|.+.+.++....+
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111111111223344444434333333333333322 356778999999999999999999999999998876654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=308.95 Aligned_cols=254 Identities=25% Similarity=0.370 Sum_probs=211.4
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+-++|++.+.||+|.||.||.|+.+ ++-.||+|++.++.- .....++.+|++|-..++||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3467889999999999999999954 667799999876542 2245789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
++||..+|.+...+.... ..++++.....++.|+|.|+.|+|... |+||||||+|+|++.++..||+|||.+...
T Consensus 100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999998544 456888899999999999999999985 999999999999999999999999998754
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
+. ....+.+||..|.+||+..+..++..+|+|++|+..||++.|.+||+... .+..
T Consensus 175 p~---------------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~et-------- 230 (281)
T KOG0580|consen 175 PS---------------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSET-------- 230 (281)
T ss_pred CC---------------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHH--------
Confidence 31 33445789999999999999999999999999999999999999997532 1111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
..+ +..... ..| +.+..+..+++.+|+..+|.+|.+..|++++-.-
T Consensus 231 --------Ykr-I~k~~~-~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 231 --------YKR-IRKVDL-KFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred --------HHH-HHHccc-cCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 111 111110 111 2356789999999999999999999999988653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=330.32 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=200.6
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----ceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD-----FKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 741 (983)
.|...+++|.|+||.||+|+.. +++.||||+.-.+.. --.+|+++|+.+.|||||++..+|.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4556789999999999999955 578899998743322 2357999999999999999999885432 3358
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEcccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIAKL 820 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgla~~ 820 (983)
|||||+. +|.+.+......+.+++...++-+.+|+.+||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999985 888888754444567888899999999999999999985 9999999999999966 9999999999998
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
+...+.+. .+.-|..|+|||.+.| ..|+.+.||||.|||+.||+-|++-|.+. .+...+..+++
T Consensus 176 L~~~epni--------------SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik 240 (364)
T KOG0658|consen 176 LVKGEPNI--------------SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIK 240 (364)
T ss_pred eccCCCce--------------eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHH
Confidence 87654432 3568899999999998 56999999999999999999999987531 11223333333
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccc----c-chHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYN----K-VWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..-.+. .+.+...-........|.... + .......++.+++.++++++|.+|.++.|++.+
T Consensus 241 ~lG~Pt-~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 241 VLGTPT-REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhCCCC-HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 322111 111111111111111111111 1 224467889999999999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.31 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=210.2
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+-|..++.||+|+.|.|..|++ .+|+.+|||++.+.. .......+.+|+-+|+-+.|||++++|+++....+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4566788999999999999995 589999999996652 2224567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|-|.+++-. +.++++.++.++++||+.|+.|+|..+ |+|||+||+|+|+|..+.+||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999875 456899999999999999999999985 99999999999999999999999999987543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
+. --.+.+|++.|.|||.+.|.+| +.++||||.|||+|.|+||+.||++ +++...
T Consensus 165 gk--------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~L----- 220 (786)
T KOG0588|consen 165 GK--------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVL----- 220 (786)
T ss_pred Cc--------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHH-----
Confidence 22 2244689999999999999887 5889999999999999999999972 222222
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+.+...+... +| ..++.++.+|+.+|+.+||+.|.|++||++|-.-
T Consensus 221 -------LlKV~~G~f~--MP-------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 221 -------LLKVQRGVFE--MP-------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred -------HHHHHcCccc--CC-------CcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 2222112111 12 3467899999999999999999999999998653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=316.95 Aligned_cols=275 Identities=23% Similarity=0.247 Sum_probs=203.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcch-hHHHHHHHHHHHhcCCCCccceeeEEec--CCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEI-TGSFKRECQILKRIRHRNLIRIITICSK--PDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 742 (983)
+.|+.++.|++|+||.||+|+++ +++.||+|+++.+..++. .-...+|+.++.+.+|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34677899999999999999954 678899999987765442 3456799999999999999999987743 4678999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||||+. +|...+... ..++...++..+..|+++|++|||..+ |+|||+||+|+|++..|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 777777654 467899999999999999999999997 9999999999999999999999999999887
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh-
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR- 900 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~- 900 (983)
.... .....+-|.+|+|||.+.+. .|++.+|+||+|||+.||+++++-|.+..+- ..+..++..
T Consensus 229 sp~k-------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~ll 294 (419)
T KOG0663|consen 229 SPLK-------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLL 294 (419)
T ss_pred CCcc-------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHh
Confidence 5422 12335789999999999884 6899999999999999999999876432110 111111111
Q ss_pred hCCCC-CcHHHH--HHHhhc-CCCCCccccccchHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 901 HYPHR-LDPIVE--KAIAKY-APQHMPIYYNKVWSD--VVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 901 ~~~~~-~~~~~~--~~~~~~-~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..|.. +.+-+. +..... .........++.+.. ....-.+++...+.+||.+|.|++|.+++=
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 11110 111000 000000 000001111222222 336778899999999999999999999763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=312.13 Aligned_cols=237 Identities=26% Similarity=0.342 Sum_probs=199.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|+..+.+|.|+||.|..++.+ +|..+|+|++++...- +..+....|..+++.+.||.++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35667899999999999999965 6788999999765432 24567788999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++||-|..+++. ..++++..++-++.||+.|++|||+.+ |++||+||+|||+|++|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999986 456899999999999999999999996 99999999999999999999999999998753
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.+-+.+|||.|+|||.+....+...+|.|||||++|||+.|..||....
T Consensus 197 ----------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--------------- 245 (355)
T KOG0616|consen 197 ----------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--------------- 245 (355)
T ss_pred ----------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC---------------
Confidence 2345799999999999999999999999999999999999999986321
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCC
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 952 (983)
...+.++.+.... ..|.++ ..++.+|+...++.|-.+|
T Consensus 246 --~~~iY~KI~~~~v--~fP~~f-------s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 246 --PIQIYEKILEGKV--KFPSYF-------SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --hHHHHHHHHhCcc--cCCccc-------CHHHHHHHHHHHhhhhHhh
Confidence 1233444333222 233333 3567788888888888888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.84 Aligned_cols=265 Identities=27% Similarity=0.373 Sum_probs=202.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-----------------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-----------------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 729 (983)
++|...++||+|+||.||+|.+++ +..||+|.+..........+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999998532 236999998765444456789999999999999999999
Q ss_pred eeEEecCCceeEEEecccCcccccccccccC---------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEe
Q 042568 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHG---------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794 (983)
Q Consensus 730 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH 794 (983)
++++...+..++||||+++|+|.+++..... ....+++..+++++.|+++||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999988754321 1234788999999999999999999996 999
Q ss_pred ecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHH
Q 042568 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874 (983)
Q Consensus 795 ~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il 874 (983)
|||||+||+++.++.+||+|||+++.+...... ...+...++..|+|||++.+..++.++||||||+++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 230 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-----------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee-----------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence 999999999999999999999999865432211 112234567899999999888899999999999999
Q ss_pred HHHHh--CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCC
Q 042568 875 LEIVT--GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952 (983)
Q Consensus 875 ~ellt--g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 952 (983)
|||++ +..||.... .......+.. ........ ........++..+.+++.+||+.+|++|
T Consensus 231 ~el~~~~~~~p~~~~~--~~~~~~~~~~------------~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 231 WEILMLCKEQPYGELT--DEQVIENAGE------------FFRDQGRQ----VYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred HHHHHccCCCCCCcCC--HHHHHHHHHH------------Hhhhcccc----ccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 99997 456665321 1111111110 00000000 0000012245678999999999999999
Q ss_pred CCHHHHHHHHH
Q 042568 953 PSMLDVAHEMG 963 (983)
Q Consensus 953 Ps~~evl~~L~ 963 (983)
||+.||.+.|+
T Consensus 293 Ps~~~i~~~l~ 303 (304)
T cd05096 293 PSFSDIHAFLT 303 (304)
T ss_pred cCHHHHHHHHh
Confidence 99999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=309.60 Aligned_cols=273 Identities=22% Similarity=0.261 Sum_probs=215.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec-----CCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-----PDF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 738 (983)
..++|++.+.+|+|||+-||.++ ..+++.+|+|++.... .+..+...+|++..++++|||+++++++... ..+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45689999999999999999999 6678889999997766 3467889999999999999999999998743 345
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.|++++|...|||.+.+.........+++.+.++|+.++++||.+||+..+ +++||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999999998766656679999999999999999999999875 6999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+...-.-........-. .......|..|+|||.+. +...++++|||||||++|+|+.|..||+..+..+.++.
T Consensus 177 ~~a~i~i~~~~~a~~lQ----e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQ----EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred cccceEeechHHHHHHH----HHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 86542211100000000 011124788999999875 45678999999999999999999999987666555443
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
-.+... ....|.. ...+..+.+++..|++.||.+||++.+++..+..+
T Consensus 253 LAv~n~-----------------q~s~P~~-----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 LAVQNA-----------------QISIPNS-----SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred Eeeecc-----------------ccccCCC-----CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222210 0000100 11557789999999999999999999999988765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=335.73 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=200.7
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEec----CCceeEEEec
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSK----PDFKALVLPL 745 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 745 (983)
...||+|++|.||+|.. +|+.||||.++..... +..+.|.+|++++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 4889999998654332 235778899999999999999999999866 3467899999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++... ..+++....+++.|++.|++|||+.. +++||||||+||++++++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999998753 45889999999999999999999852 37899999999999999999999999998654211
Q ss_pred ccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..
T Consensus 178 ----------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~-------- 228 (283)
T PHA02988 178 ----------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TK-------- 228 (283)
T ss_pred ----------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HH--------
Confidence 12358899999999876 678999999999999999999999986421 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+..+..+........+ ..++.++.+++.+||+.||++|||++|+++.|+.+..+
T Consensus 229 ----~~~~~i~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~ 282 (283)
T PHA02988 229 ----EIYDLIINKNNSLKLP-------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY 282 (283)
T ss_pred ----HHHHHHHhcCCCCCCC-------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence 1111111111111111 13567899999999999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.33 Aligned_cols=288 Identities=21% Similarity=0.280 Sum_probs=218.1
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec---
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK--- 735 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 735 (983)
+..+....|...+.||+|+||.|..|.. .+|+.||||++..... ....++..+|+++++.++|+||+.+.+.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3344556677788999999999999995 4789999999864432 3356788999999999999999999999865
Q ss_pred --CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 736 --PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 736 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
-...|+|+|+|+ .+|.+.++. ...++...+.-+.+|+++||.|+|+.+ |+|||+||+|++++.+..+||+
T Consensus 96 ~~f~DvYiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~ 167 (359)
T KOG0660|consen 96 DKFNDVYLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC 167 (359)
T ss_pred cccceeEEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence 346799999995 588888874 334899999999999999999999995 9999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
|||+|+..... . .....+.++.|..|+|||.+.. ..|+...||||+|||+.||++|+.-|- +..
T Consensus 168 DFGLAR~~~~~-~----------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp----G~d 232 (359)
T KOG0660|consen 168 DFGLARYLDKF-F----------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP----GKD 232 (359)
T ss_pred cccceeecccc-C----------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC----CCc
Confidence 99999987643 1 1234455789999999998764 689999999999999999999998763 222
Q ss_pred chHHH--HHhhCCCCCcHH--------HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH-
Q 042568 893 SLHEW--VKRHYPHRLDPI--------VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE- 961 (983)
Q Consensus 893 ~l~~~--~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~- 961 (983)
.+.+. +....+..-.+. ..+.+. ..+...+..+...++......++|+.+|+..||.+|+|++|+++|
T Consensus 233 ~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~-slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 233 YVHQLQLILELLGTPSEEDLQKIRSEKARPYIK-SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH-hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 22222 222222111111 112122 123333444555666778889999999999999999999999975
Q ss_pred -HHHhHhhcCCC
Q 042568 962 -MGRLKQYLSSP 972 (983)
Q Consensus 962 -L~~~~~~~~~~ 972 (983)
++...+...+|
T Consensus 312 Yl~~~hdp~dEP 323 (359)
T KOG0660|consen 312 YLAPYHDPEDEP 323 (359)
T ss_pred hhhhhcCCccCC
Confidence 44444433333
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.81 Aligned_cols=264 Identities=25% Similarity=0.322 Sum_probs=203.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc---------c----hhHHHHHHHHHHHhcCCCCcccee
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG---------E----ITGSFKRECQILKRIRHRNLIRII 730 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~---------~----~~~~~~~E~~~l~~l~h~niv~l~ 730 (983)
.-+.|+..+.||+|.||.|-+|+. .+++.||||++++.... . ..++..+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 346789999999999999999995 47889999999654211 1 235789999999999999999999
Q ss_pred eEEecC--CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 731 TICSKP--DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 731 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
.+..++ +..|||+|||..|.+...=.. ...++..++++++.+++.||+|||.++ ||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999765 578999999998887442221 233899999999999999999999996 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCC----CCccchhHHHHHHHHHHHhCCCCC
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR----ASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
++||+|||.+......... .........+|||.|+|||...++. .+.+.||||+||++|+|+.|+.||
T Consensus 248 ~VKIsDFGVs~~~~~~~~~--------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDE--------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred cEEeeccceeeecccCCcc--------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999876433111 0111222358999999999987732 357789999999999999999998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
...+ ..+..++.+.. .+. .+...++..++.+|+.+++..||+.|.+..+|..|.+.
T Consensus 320 ~~~~-----------------~~~l~~KIvn~----pL~---fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 320 FDDF-----------------ELELFDKIVND----PLE---FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ccch-----------------HHHHHHHHhcC----ccc---CCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 5321 11222222211 111 11123466789999999999999999999999998875
Q ss_pred hHh
Q 042568 965 LKQ 967 (983)
Q Consensus 965 ~~~ 967 (983)
-..
T Consensus 376 t~~ 378 (576)
T KOG0585|consen 376 TRD 378 (576)
T ss_pred ccC
Confidence 543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.48 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=208.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|+..+.||+|+||.||+++.. ++..||+|.+..........++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999965 6788999998765544556789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999998864 245889999999999999999999864 4999999999999999999999999998755321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC-
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP- 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~- 903 (983)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+.....
T Consensus 158 ~---------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~ 220 (331)
T cd06649 158 M---------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVD 220 (331)
T ss_pred c---------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccc
Confidence 1 122468999999999999999999999999999999999999985321 1111111110000
Q ss_pred --------------------------CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 904 --------------------------HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 904 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
...................+... ......++.+++.+||+.||++|||++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~~P~~Rpt~~e 297 (331)
T cd06649 221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP---NGVFTPDFQEFVNKCLIKNPAERADLKM 297 (331)
T ss_pred cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC---CccccHHHHHHHHHHccCCcccCCCHHH
Confidence 00000000111111110001000 0124567999999999999999999999
Q ss_pred HHHHHH
Q 042568 958 VAHEMG 963 (983)
Q Consensus 958 vl~~L~ 963 (983)
++++-.
T Consensus 298 ll~h~~ 303 (331)
T cd06649 298 LMNHTF 303 (331)
T ss_pred HhcChH
Confidence 998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.36 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=215.0
Q ss_pred CCCCccccCCcEeEEEEEECC-C---cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 670 CPSSLIGSGRFGHVYKGVLQD-N---TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+.++||.|.||.||+|+++- | ..||||.++....++.+..|..|+.||.++.||||+++.|+.....-..||+||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 356889999999999999752 3 459999999888888889999999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|++|+|+.+|.... .++.+.+...+.++||.|+.||-+.+ +|||||.+.|||++.+..+|++|||+++.+.++.
T Consensus 712 MENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 712 MENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999998764 45999999999999999999999996 9999999999999999999999999999876543
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
... +.+..+ .=..+|.|||.+..++++..+||||||+++||.++ |.+||..+.+
T Consensus 786 ~~~--------ytt~GG--KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------------- 840 (996)
T KOG0196|consen 786 EAA--------YTTLGG--KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------------- 840 (996)
T ss_pred Ccc--------ccccCC--ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------------
Confidence 111 011111 12368999999999999999999999999999887 9999865422
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
++ +-+.+.... ++|+. .+|+..|.+||+.||++|-.+||.+.|++.+|.++....
T Consensus 841 --Qd-VIkaIe~gy--RLPpP-----mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 841 --QD-VIKAIEQGY--RLPPP-----MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --HH-HHHHHHhcc--CCCCC-----CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 11 222222222 23332 358999999999999999999999999999999875433
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.01 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=208.8
Q ss_pred CCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+|++.+.+|+|+||.|-+|. +..|+.||||.+.+...+ ...-.+.+|++||..++||||+.+|.+|...+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 56677899999999999999 578999999999766433 345678999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|..+|.|.+++.. ...+++.+++++++||++|+.|+|.++ ++|||+|.+|||+|+++++||+|||++-.+.+.
T Consensus 134 YaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999986 456999999999999999999999995 999999999999999999999999999877542
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
...++++|++-|.+||.+.|.+| ++.+|-||+||++|.++.|..||+.. +...++.+...
T Consensus 207 --------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~ 267 (668)
T KOG0611|consen 207 --------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISR 267 (668)
T ss_pred --------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhc
Confidence 23356799999999999999988 58899999999999999999999743 22222322111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+.+.. ++.+....-||.+|+.++|++|.|+.+|..|.+
T Consensus 268 ------------GaYrE----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 268 ------------GAYRE----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------------ccccC----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11110 123345677889999999999999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=346.66 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=204.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|...+.||+|+||.||+|... ++..||||+++.....+....+.+|+++++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46778999999999999999842 23579999997655444567789999999999 899999999999999999
Q ss_pred eEEEecccCcccccccccccC-----------------------------------------------------------
Q 042568 740 ALVLPLMSNGSLENHLYPSHG----------------------------------------------------------- 760 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 760 (983)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999988753210
Q ss_pred -------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCC
Q 042568 761 -------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833 (983)
Q Consensus 761 -------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 833 (983)
...++++..+++++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~------ 268 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY------ 268 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce------
Confidence 1134788999999999999999999986 999999999999999999999999999765422110
Q ss_pred CCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHH
Q 042568 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912 (983)
Q Consensus 834 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 912 (983)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.....+. .....
T Consensus 269 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~--------------- 327 (374)
T cd05106 269 -----VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKM--------------- 327 (374)
T ss_pred -----eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHH---------------
Confidence 11122345678999999998899999999999999999997 999986432111 11111
Q ss_pred HHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 913 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
+........+ ...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 328 -~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 328 -VKRGYQMSRP-------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -HHcccCccCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1110110011 113467899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=346.02 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=203.8
Q ss_pred CCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|+..+.||+|+||.||+|.+ .++..||||+++........+.+.+|+++++.+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4677889999999999999974 235679999997554444457789999999999 899999999999999999
Q ss_pred eEEEecccCcccccccccccC-----------------------------------------------------------
Q 042568 740 ALVLPLMSNGSLENHLYPSHG----------------------------------------------------------- 760 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 760 (983)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999888754221
Q ss_pred ------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 761 ------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 761 ------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
....+++..+.+++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 0124789999999999999999999986 999999999999999999999999999865432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
...+...++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ .....++..
T Consensus 271 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~------- 332 (375)
T cd05104 271 ----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKE------- 332 (375)
T ss_pred ----------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHh-------
Confidence 11122345678999999999999999999999999999998 88888643211 111111111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
......+ ...+.++.+++.+|++.||++||++.|+++.|++.
T Consensus 333 ---------~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 333 ---------GYRMLSP-------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---------CccCCCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0000001 11346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.01 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=203.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 741 (983)
-++|...++||+|.||+|+++..+ +++.+|||++++.. ..+..+..+.|.+|+... +||.++.++..|...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 357888999999999999999965 67889999998764 344678889999998887 59999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+.||++..+.+ ...+++..+.-++..|+.||.|||+++ ||+||||.+|||+|.+|.+||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999655554 456999999999999999999999996 999999999999999999999999999843
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
. .....+.+++||+.|||||++.+..|+..+|.|||||++|||+.|+.||....+
T Consensus 519 m-------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------ 573 (694)
T KOG0694|consen 519 M-------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------ 573 (694)
T ss_pred C-------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------------
Confidence 2 223455678999999999999999999999999999999999999999863211
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 955 (983)
++++|..+..... .| -.++.+.+.++.+++..+|++|.-+
T Consensus 574 -----ee~FdsI~~d~~~--yP-------~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 -----EEVFDSIVNDEVR--YP-------RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----HHHHHHHhcCCCC--CC-------CcccHHHHHHHHHHhccCcccccCC
Confidence 2334443322221 11 1256889999999999999999866
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=332.42 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=200.7
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.|...+.||+|+||.||+|.. .+++.||||.+..... ......+.+|++++++++|++|+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366788999999999999995 5789999999865432 1234567889999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999988775432 346899999999999999999999996 999999999999999999999999999865321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. .....||..|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 156 ~~--------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~---------- 209 (285)
T cd05631 156 ET--------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--VK---------- 209 (285)
T ss_pred Ce--------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--hh----------
Confidence 11 11246899999999999999999999999999999999999998642111 00
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
...+...+..... . ...+...++.+++.+|++.||++||+ +++++++
T Consensus 210 --~~~~~~~~~~~~~-~-------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 210 --REEVDRRVKEDQE-E-------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --HHHHHHHhhcccc-c-------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111111111100 0 01224567889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=335.45 Aligned_cols=247 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||+|++..... .+..+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999965 688999999865432 123567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999998864 345889999999999999999999996 99999999999999999999999999876532
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...
T Consensus 154 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~------- 205 (291)
T cd05612 154 R----------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFG------- 205 (291)
T ss_pred C----------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHH-------
Confidence 1 112468999999999999889999999999999999999999986321 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHEM 962 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 962 (983)
..+....... ..+ ......+.+++.+|++.||.+||+ ++|++++-
T Consensus 206 -----~~~~i~~~~~--~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 206 -----IYEKILAGKL--EFP-------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred -----HHHHHHhCCc--CCC-------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1111111100 011 112457889999999999999995 89998774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.02 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=203.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|.+.+.||+|+||.||+|.+. .+..||+|.++..........+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778899999999999999853 35679999997665444557899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998753 246899999999999999999999986 9999999999999999999999999876432
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .+
T Consensus 159 ~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~----- 216 (266)
T cd05064 159 SEAI------------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QD----- 216 (266)
T ss_pred ccch------------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HH-----
Confidence 1100 01111245678999999999999999999999999999775 9999864211 01
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
..+. +...... + ....++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus 217 -------~~~~-~~~~~~~--~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 -------VIKA-VEDGFRL--P-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------HHHH-HHCCCCC--C-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 1111110 1 0123567789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.06 Aligned_cols=275 Identities=21% Similarity=0.314 Sum_probs=200.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999965 6889999998765444445677899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++ +++.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5776666543 345888999999999999999999996 999999999999999999999999998754321
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.........+.......-.
T Consensus 157 ~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (303)
T cd07869 157 S-------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223 (303)
T ss_pred C-------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence 1 11122468999999998875 457889999999999999999999996432111111111111000
Q ss_pred CC--CcHHHHHHHhhcCCCCC----ccccccchH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HR--LDPIVEKAIAKYAPQHM----PIYYNKVWS--DVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. ...... ......+... +......|. .....+.+++.+|++.||++|||++|+++|
T Consensus 224 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 224 PNEDTWPGVH-SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred CChhhccchh-hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00 000000 0000000000 000000111 123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.09 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=211.5
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-------chhHHHHHHHHHHHhc-CCCCccceeeEEe
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-------EITGSFKRECQILKRI-RHRNLIRIITICS 734 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 734 (983)
..-+.|...+.+|.|..++|.++.++ +|..+|+|++...... +..+.-.+|+.|++++ .||+|+++.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456788899999999999998854 6888999998544322 2345566799999998 6999999999999
Q ss_pred cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 735 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
.+.+.++|+|.|+.|-|.|++.. ...+++...++|++|+.+|+.|||... |||||+||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999975 456899999999999999999999994 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG------KRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
||.|+.+.+.+.. ...+|||+|+|||.+.. ..|+..+|.|+.|||+|.++.|.+||...
T Consensus 167 FGFa~~l~~GekL--------------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR- 231 (411)
T KOG0599|consen 167 FGFACQLEPGEKL--------------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR- 231 (411)
T ss_pred cceeeccCCchhH--------------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-
Confidence 9999988765432 23689999999998753 46788999999999999999999998421
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
. +-+.-+.+..... ....+.|.+...+..+|+.+|++.||++|.|++|+++|=.-
T Consensus 232 --k---------------QmlMLR~ImeGky----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 232 --K---------------QMLMLRMIMEGKY----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred --H---------------HHHHHHHHHhccc----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 0 1112222222221 12344688999999999999999999999999999986543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.48 Aligned_cols=273 Identities=21% Similarity=0.261 Sum_probs=200.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...++||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68889999987654444456788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++ +|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 888877543 335788999999999999999999996 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+.... .....
T Consensus 158 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-~~~~~~~~-~~~~~ 222 (288)
T cd07871 158 K-------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-KEELHLIF-RLLGT 222 (288)
T ss_pred c-------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH-HHhCC
Confidence 1 1122468999999998876 5688999999999999999999999864211 11111111 11111
Q ss_pred CCcHHHHH------HHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEK------AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+.... ......+...+............++.+++.+|++.||.+|||++|+++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 223 PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0000000000000000011234678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=315.83 Aligned_cols=278 Identities=25% Similarity=0.346 Sum_probs=203.8
Q ss_pred CCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCC-ccceeeEEecCC------ce
Q 042568 669 FCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRN-LIRIITICSKPD------FK 739 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~ 739 (983)
|...++||+|+||+||+|+. .+|+.||+|++......+ ......+|+.++++++|+| |+.+++++.... ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44567799999999999994 478899999997765532 4566789999999999999 999999998777 77
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||++. +|.+++.........++...+..+++|+++||+|||+++ |+||||||+|||+++.|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHH
Confidence 899999975 888888765432246777899999999999999999996 9999999999999999999999999999
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
...-... .....++|..|+|||++.+. .|+..+||||+|||++||++++.-|....+ -..+....
T Consensus 169 a~~ip~~-------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If 234 (323)
T KOG0594|consen 169 AFSIPMR-------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIF 234 (323)
T ss_pred HhcCCcc-------------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHH
Confidence 6552221 12335799999999999986 789999999999999999999887754322 11111111
Q ss_pred Hh-hCCC-CCcHHHHHHHhhcC---CCCC-ccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHh
Q 042568 899 KR-HYPH-RLDPIVEKAIAKYA---PQHM-PIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRL 965 (983)
Q Consensus 899 ~~-~~~~-~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 965 (983)
.. ..|. ...+-+.. ..... .... +.......+.......+++.+|++++|.+|.|++.+++| +..+
T Consensus 235 ~~lGtP~e~~Wp~v~~-~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSS-LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HHcCCCCccCCCCccc-cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11 0011 11111110 00000 0000 111111112223478999999999999999999999987 5444
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.65 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=212.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCCc-eeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPDF-KALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 743 (983)
++|...+++|+|+||.++.++++ ++..||+|.+......+ ......+|+.++++++|||||.+.+.|...+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999999865 56789999987665332 34578899999999999999999999988887 89999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
+|++||++.+.+...+ ..-++++.+.+|+.|++.|+.|||+. +|+|||||++||+++++..++|+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 45689999999999999999999987 499999999999999999999999999999875
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ....+++||+.||+||...+.+|..|+||||+||++|||++-+++|+.. +
T Consensus 159 ~~-------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~---------- 210 (426)
T KOG0589|consen 159 ED-------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----N---------- 210 (426)
T ss_pred ch-------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----c----------
Confidence 43 1234578999999999999999999999999999999999999998642 2
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.+.+....... ..| .....++..++..|++.+|+.||++.+++.+
T Consensus 211 --m~~Li~ki~~~~~~-Plp-------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 --MSELILKINRGLYS-PLP-------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --hHHHHHHHhhccCC-CCC-------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23333333333211 122 2356789999999999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.31 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=196.0
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.||+|+||.||+|+.. +|+.||||+++... ......++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999987543 2233467888999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---- 149 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---- 149 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----
Confidence 99888864 346899999999999999999999996 9999999999999999999999999987532111
Q ss_pred ccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ... .
T Consensus 150 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~------------~ 203 (323)
T cd05571 150 ---------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEK------------L 203 (323)
T ss_pred ---------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----HHH------------H
Confidence 11223579999999999999999999999999999999999999985311 111 1
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
....... ....+ .....++.+++.+|++.||++|| ++.+++++
T Consensus 204 ~~~~~~~--~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 204 FELILME--EIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHcC--CCCCC-------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1111111 00111 12456788999999999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.41 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=205.6
Q ss_pred CCCCCCccccCCcEeEEEEEECCC------cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDN------TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|...+.||+|+||.||+|..... ..||+|.+..........+|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 577789999999999999986432 46999998755554556789999999999999999999999998889999
Q ss_pred EEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC
Q 042568 742 VLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT 809 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~ 809 (983)
+|||+++++|.+++..... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999998865321 1146889999999999999999999996 999999999999999999
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~ 888 (983)
++|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 163 ~~L~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 163 VKISDFGLSRDIYSADYY-----------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred EEECCCcceeeccccccc-----------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999765322111 11122357889999999988889999999999999999998 999986421
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
. .+ ..+. +........ ...++.++.+++.+||+.+|.+||++.||+++|+.
T Consensus 232 ~-----~~------------~~~~-i~~~~~~~~-------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 232 N-----QE------------VIEM-IRSRQLLPC-------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-----HH------------HHHH-HHcCCcCCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11 1111 111010000 12356789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=336.23 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=204.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC-Cc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP-DF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 738 (983)
++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|+++++++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999632 24679999987554444456788899999999 899999999988654 46
Q ss_pred eeEEEecccCcccccccccccC---------------------------------------------------------c
Q 042568 739 KALVLPLMSNGSLENHLYPSHG---------------------------------------------------------L 761 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------~ 761 (983)
.++++||+++++|.+++..... .
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999988753211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCcccccc
Q 042568 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841 (983)
Q Consensus 762 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~ 841 (983)
...+++..+..++.||++||+|||+.+ |+||||||+||++++++.++|+|||+++.+...... ...
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-----------~~~ 232 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----------VRK 232 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----------hhc
Confidence 136899999999999999999999986 999999999999999999999999999876432211 112
Q ss_pred CccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCC
Q 042568 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQ 920 (983)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (983)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.....+ +.....+......
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~ 295 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----------------EEFCRRLKEGTRM 295 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----------------HHHHHHHhccCCC
Confidence 23456788999999999999999999999999999998 99998542111 1111111111110
Q ss_pred CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 921 HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 921 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
..+ .....++.+++.+|++.+|++||++.|++++|+++.+
T Consensus 296 ~~~-------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 RAP-------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011 1234678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.16 Aligned_cols=271 Identities=22% Similarity=0.283 Sum_probs=205.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|+..++||+|+||.||+|.+. ++..+|+|.+..........++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999976 6788999998765444456789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++.. ...+++..+..++.|+++|++|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999864 235788999999999999999999753 4999999999999999999999999998755321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 158 ~---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~ 220 (333)
T cd06650 158 M---------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEG 220 (333)
T ss_pred c---------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccC
Confidence 1 1224689999999999998899999999999999999999999864211 1111111000000
Q ss_pred C-------------------------CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 905 R-------------------------LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 905 ~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
. .................+.... .....++.+++.+||+.||++|||++|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 221 DPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS---GVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred CccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCC---CCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 0 0000000000000000000000 11346789999999999999999999998
Q ss_pred HHH
Q 042568 960 HEM 962 (983)
Q Consensus 960 ~~L 962 (983)
++-
T Consensus 298 ~h~ 300 (333)
T cd06650 298 VHA 300 (333)
T ss_pred hCH
Confidence 764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=341.76 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=206.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 738 (983)
.++|.+.++||+|+||.||+|... .+..||||+++........+.+.+|+++++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999853 134699999976554445678999999999996 9999999999999999
Q ss_pred eeEEEecccCcccccccccccC----------------------------------------------------------
Q 042568 739 KALVLPLMSNGSLENHLYPSHG---------------------------------------------------------- 760 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 760 (983)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999888754210
Q ss_pred ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 761 ----------------------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 761 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
....+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124788899999999999999999986 999999999999999
Q ss_pred CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 042568 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885 (983)
Q Consensus 807 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~ 885 (983)
++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 999999999999865432111 11122357788999999999899999999999999999997 999986
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
....+. .+...+........ ...++.++.+++.+||+.+|++||++.+|.++|+++
T Consensus 342 ~~~~~~-----------------~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 342 GMIVDS-----------------TFYNKIKSGYRMAK-------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ccchhH-----------------HHHHHHhcCCCCCC-------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 421110 01111111110000 123557889999999999999999999999999986
Q ss_pred Hh
Q 042568 966 KQ 967 (983)
Q Consensus 966 ~~ 967 (983)
.+
T Consensus 398 ~~ 399 (400)
T cd05105 398 LP 399 (400)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.28 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=207.8
Q ss_pred CCCccccCCcEeEEEEEECC--C--cE-EEEEEeec--ccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 671 PSSLIGSGRFGHVYKGVLQD--N--TR-IAVKVLDL--TTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~--~--~~-vAvK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
..++||+|+||.||+|.+.. + .. ||||..+. ....+...+|.+|+++|++++|||||++||++....-.++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 35899999999999999653 2 23 89999875 234556789999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
|+|+||+|++++.+.. ..++..++..++.++|.||+|||++. ++||||-+.|+|++.++.+||+|||+++.-..
T Consensus 241 El~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999998653 36999999999999999999999995 99999999999999999999999999875431
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. .......-...|+|||.+....+++++|||||||++||+++ |..||.....
T Consensus 315 ~~-------------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------------- 368 (474)
T KOG0194|consen 315 YV-------------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------------- 368 (474)
T ss_pred ee-------------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------------
Confidence 10 11101123468999999999999999999999999999999 8889864311
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
.++..+..........+ ...+.++..++.+||..+|++||+|.++.+.++.+.+....
T Consensus 369 ----~~v~~kI~~~~~r~~~~-------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 369 ----YEVKAKIVKNGYRMPIP-------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHHHHHHhcCccCCCC-------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11111111222222222 13567888889999999999999999999999999877664
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=340.00 Aligned_cols=246 Identities=25% Similarity=0.301 Sum_probs=199.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46788899999999999999965 68889999986542 1223567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999998874 345788999999999999999999996 99999999999999999999999999986532
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||... . ...
T Consensus 171 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~-~~~------- 222 (329)
T PTZ00263 171 RT----------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD----T-PFR------- 222 (329)
T ss_pred Cc----------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC----C-HHH-------
Confidence 11 1246999999999999999999999999999999999999998531 1 011
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
..+..... . ...+. ....++.+++.+|++.||++||+ ++|++.|
T Consensus 223 -----~~~~i~~~-~-~~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 223 -----IYEKILAG-R-LKFPN-------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----HHHHHhcC-C-cCCCC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111 0 01111 13356889999999999999997 7888866
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=340.08 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=194.0
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|...++||+|+||.||+|+.. +++.||||++...........+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 345688999999999999965 6889999998665544456789999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+.. ..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 2456778899999999999999996 99999999999999999999999999986542211
Q ss_pred ccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
......||..|+|||++.. ...+.++|||||||++|||++|+.||... ....+.....
T Consensus 224 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~--~~~~~~~~~~--- 286 (353)
T PLN00034 224 ------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG--RQGDWASLMC--- 286 (353)
T ss_pred ------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCccHHHHHH---
Confidence 1122469999999998743 33456899999999999999999998621 1111111110
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
. +........ ...+..++.+++.+||+.||++||+++|++++=
T Consensus 287 ---------~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 287 ---------A-ICMSQPPEA-------PATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---------H-HhccCCCCC-------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0 000000000 123456789999999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.14 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=207.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++.|+..+.||+|.|+.||++.. .+|+.+|+|+++... .....+.+.+|+.|-+.++||||+++.+...+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 34566678899999999999984 578889999885432 2235688999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~Dfgla~~ 820 (983)
|+|+|+.|..-+-. +..+++..+-+.++||++||+|+|.++ |||||+||.|+++- ..--+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999998655442 234678888999999999999999996 99999999999994 345689999999998
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
++... .....+|||+|||||+....+|+..+|||+-|||+|-++.|+.||... ++
T Consensus 163 l~~g~--------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--~~--------- 217 (355)
T KOG0033|consen 163 VNDGE--------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--DQ--------- 217 (355)
T ss_pred eCCcc--------------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc--cH---------
Confidence 77321 223368999999999999999999999999999999999999998631 11
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..++++.++...+... +.|+...++..+|+.+|+..||.+|.|+.|.++|=+
T Consensus 218 ------~rlye~I~~g~yd~~~-----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 218 ------HRLYEQIKAGAYDYPS-----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred ------HHHHHHHhccccCCCC-----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 2234444444333322 246678889999999999999999999999997644
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.70 Aligned_cols=254 Identities=21% Similarity=0.243 Sum_probs=202.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|+.. +++.||||+++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 588999999975432 223567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999864 345889999999999999999999996 99999999999999999999999999975432
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+..
T Consensus 154 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~----- 207 (333)
T cd05600 154 ----------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETW----- 207 (333)
T ss_pred ----------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHH-----
Confidence 1123469999999999999999999999999999999999999986421 11111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............+... ........++.+++.+|+..+|++||+++|++++
T Consensus 208 -------~~i~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 208 -------ENLKYWKETLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -------HHHHhccccccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1000000000000000 0001245678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.37 Aligned_cols=274 Identities=17% Similarity=0.224 Sum_probs=202.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|.+.+.||+|+||.||+|+.. +++.||||+++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 578899999865432 2345678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++++.+..+... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998877654332 345899999999999999999999986 999999999999999999999999999865422
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... ......
T Consensus 154 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~~-~~~~~~ 219 (287)
T cd07848 154 SN------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTI-QKVLGP 219 (287)
T ss_pred cc------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHhhCC
Confidence 11 1112346899999999999988999999999999999999999998642110 111111 111100
Q ss_pred CCcHHHHHHHhh--cCCCCCcc------ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAK--YAPQHMPI------YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+........ ......+. .........+.++.+++.+|++.||++|||++|+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 00000000 0001112345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=321.79 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=206.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||+||+|.+.. ...||||.++..........|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 3569999987665555567899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++.... ..+++..+++++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999987532 36899999999999999999999986 9999999999999999999999999998775
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... ......++..|+|||...+..++.++||||||+++|||++ |..||..... .
T Consensus 158 ~~~~~~-----------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~--------- 215 (266)
T cd05033 158 DSEATY-----------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--Q--------- 215 (266)
T ss_pred ccccce-----------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--H---------
Confidence 221110 0011235678999999998899999999999999999998 9999853210 0
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
...+. +...... +. ..+++..+.+++.+|++.+|++||+++|++++|.++
T Consensus 216 ------~~~~~-~~~~~~~--~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 216 ------DVIKA-VEDGYRL--PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HHHHH-HHcCCCC--CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 1111000 00 012456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=330.18 Aligned_cols=259 Identities=23% Similarity=0.401 Sum_probs=203.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
.+|+..+.||+|+||.||+|.+. +++ .||||.++.........++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999854 333 38999987554445567899999999999999999999999764 5689
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
++||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999988753 335889999999999999999999986 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
....... ......++..|+|||++.+..++.++||||||+++|||++ |+.||+... ..+
T Consensus 160 ~~~~~~~-----------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~---- 219 (316)
T cd05108 160 GADEKEY-----------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASE---- 219 (316)
T ss_pred cCCCcce-----------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHH----
Confidence 5332210 1111235678999999999999999999999999999998 999986321 111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+...+........+ ..+..++.+++.+||..+|++||++.++++++.++...
T Consensus 220 ---------~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 220 ---------ISSILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---------HHHHHhCCCCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111111100001 12346788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.34 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=205.9
Q ss_pred CCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.+.+.||+|+||.||+|...+ ++.||||.++.....+..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 46799999976655555688999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccC----------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 741 LVLPLMSNGSLENHLYPSHG----------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999865421 2345889999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
+|+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 162 kl~d~g~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EECCcccceecccCcce-----------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999765322110 11122346789999999999999999999999999999998 9999853211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. + ..+........ ..+ ...+.++.+++.+||+.+|++||++.||++.|+
T Consensus 231 --~---~------------~~~~~~~~~~~-~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 --E---E------------VIECITQGRLL-QRP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --H---H------------HHHHHHcCCcC-CCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1 11111111000 000 124567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=322.58 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=208.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|+.. +++.||||.++... ..+...++.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999954 78999999875432 2334567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.........+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999887643332455889999999999999999999986 99999999999999999999999999886643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......|+..|+|||...+..++.++||||+|+++|||++|+.||... ......+...
T Consensus 159 ~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~---~~~~~~~~~~--- 219 (267)
T cd08228 159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLFSLCQK--- 219 (267)
T ss_pred hhH-------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc---cccHHHHHHH---
Confidence 211 111235888999999999888999999999999999999999998532 1111111111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
+........ ........+.+++.+||+.+|++||++.+|++.++.++
T Consensus 220 ----------~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 ----------IEQCDYPPL------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ----------HhcCCCCCC------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111110000 01234567899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=333.50 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=195.4
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.||+|+||.||++... +|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999964 68899999986542 2234567788999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---- 149 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---- 149 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC----
Confidence 99888764 345899999999999999999999996 9999999999999999999999999987532111
Q ss_pred ccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ..
T Consensus 150 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~------------~~ 203 (323)
T cd05595 150 ---------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E------------RL 203 (323)
T ss_pred ---------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----H------------HH
Confidence 111234699999999999999999999999999999999999999853210 0 11
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.+....... ..+ .....++.+++.+|++.||++|| ++.+++++
T Consensus 204 ~~~~~~~~~--~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 204 FELILMEEI--RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHhcCCC--CCC-------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111111100 011 12456788999999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=353.62 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=210.7
Q ss_pred CCCCccccCCcEeEEEEEEC--CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ--DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~--~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+..+.||+|+||.||.|... ++. .||||.+..........+|.+|..+|++++|||||+++|+|-+....+|++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 34678999999999999954 343 389999987777777899999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCc---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGL---SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
|||++|+|..++...+.. ...+...+.+.++.|||+|+.||++++ +|||||.+.|+|++....+||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999876332 346899999999999999999999995 99999999999999999999999999995
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~ 899 (983)
....+.. ...+...-...|||||.+..+.++.|+|||||||++||++| |..||.... .
T Consensus 852 iy~~~yy-----------r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~----n------ 910 (1025)
T KOG1095|consen 852 IYDKDYY-----------RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS----N------ 910 (1025)
T ss_pred hhhchhe-----------eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc----h------
Confidence 5433221 11111123468999999999999999999999999999999 888874321 1
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.++........ +++.. ..|+..+.++|..||+.+|++||++..+++.+..+.+..
T Consensus 911 -------~~v~~~~~~gg---RL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 911 -------FEVLLDVLEGG---RLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred -------HHHHHHHHhCC---ccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11222122221 12211 347889999999999999999999999999888876543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=335.53 Aligned_cols=246 Identities=23% Similarity=0.277 Sum_probs=199.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECC--CcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD--NTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|.... +..||+|++.... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998543 3579999986542 223456788999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999988643 45889999999999999999999996 9999999999999999999999999998653
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... . .
T Consensus 183 ~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~-~------- 234 (340)
T PTZ00426 183 TR----------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE----P-L------- 234 (340)
T ss_pred CC----------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC----H-H-------
Confidence 21 112469999999999999889999999999999999999999986321 0 0
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
........... ..|. .....+.+++.+|++.||++|+ +++|++++
T Consensus 235 -----~~~~~i~~~~~--~~p~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 235 -----LIYQKILEGII--YFPK-------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----HHHHHHhcCCC--CCCC-------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111111110 0111 1335678999999999999995 89999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=332.86 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=193.4
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||.||+|... +++.||+|+++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 57889999986532 223456788999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------ 147 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------ 147 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC------
Confidence 998864 345899999999999999999999996 9999999999999999999999999987542211
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||... ...+. ..
T Consensus 148 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~------------~~ 203 (312)
T cd05585 148 -------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEM------------YR 203 (312)
T ss_pred -------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHH------------HH
Confidence 1112356999999999999999999999999999999999999998531 11111 11
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---MLDVAHE 961 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 961 (983)
..... ....+ .....++.+++.+|++.||++||+ +.|++.+
T Consensus 204 ~~~~~--~~~~~-------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 204 KILQE--PLRFP-------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcC--CCCCC-------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 11111 00011 124467889999999999999975 6677654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.51 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=199.7
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+|+..+.||+|+||.||+|.+.++..+|+|.+..... ..+++.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4777889999999999999988888999998754322 24678999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999886432 35899999999999999999999996 999999999999999999999999998865322111
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......++..|+|||+..+..++.++||||||+++|||++ |+.||.... ..+.
T Consensus 157 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~--------- 210 (256)
T cd05114 157 ------------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEV--------- 210 (256)
T ss_pred ------------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHH---------
Confidence 1111235678999999998889999999999999999999 899985321 1111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
++. +........+ ...+.++.+++.+||+.+|++||+++|+++.|
T Consensus 211 ---~~~-i~~~~~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 211 ---VEM-ISRGFRLYRP-------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---HHH-HHCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111 1110000011 11235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=345.80 Aligned_cols=273 Identities=22% Similarity=0.273 Sum_probs=211.6
Q ss_pred CCCCCCccccCCcEeEEEEEECCC-cEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeE-Eec------CCc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDN-TRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITI-CSK------PDF 738 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~ 738 (983)
+.++.++|.+|||+.||.|....+ ..||+|++-.. .+...+..++|+++|++|+ |+|||.+++. ... ..+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 456788999999999999997665 99999998666 5557888999999999996 9999999993 311 246
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.+|.||||.||+|-+++.... ...|++.++++|+.|+++|+++||... ++|||||||-+|||++.++..||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 689999999999999998654 345999999999999999999999986 47999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCcccccccccccccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG---MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
.-.....+.. .....-...-....|+-|+|||++ .+..+++|+|||++||+||-|+....||+.... .
T Consensus 194 tt~~~~~~~~----~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--l--- 264 (738)
T KOG1989|consen 194 TTKILSPTSA----QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--L--- 264 (738)
T ss_pred ccccCCCccH----HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--e---
Confidence 7543221100 000000011113579999999986 467889999999999999999999999974211 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCchh
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 975 (983)
.++... ...|. ++.+...+.+||..|++.||.+||++-||+.++.++........+.
T Consensus 265 aIlng~------------------Y~~P~-----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 265 AILNGN------------------YSFPP-----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred eEEecc------------------ccCCC-----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 000000 00111 1346788999999999999999999999999999998766554443
Q ss_pred H
Q 042568 976 I 976 (983)
Q Consensus 976 ~ 976 (983)
+
T Consensus 322 ~ 322 (738)
T KOG1989|consen 322 Y 322 (738)
T ss_pred c
Confidence 3
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=327.77 Aligned_cols=273 Identities=22% Similarity=0.282 Sum_probs=197.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhc---CCCCccceeeEEe-----c
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRI---RHRNLIRIITICS-----K 735 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 735 (983)
++|.+.+.||+|+||.||+|+.. +++.||||.++.....+ ....+.+|+++++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999986544322 345667788887776 6999999999885 2
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
....++||||++ ++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 346789999997 58888886433 345899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+.
T Consensus 155 g~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-~~~~~ 219 (290)
T cd07862 155 GLARIYSFQM--------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLG 219 (290)
T ss_pred cceEeccCCc--------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-HHHHH
Confidence 9998654221 11234689999999999988899999999999999999999999864211 11111
Q ss_pred HHHHhhCCCCCcHHHHHHH--h-hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAI--A-KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+....... ........ . .......+........+....+.+++.+|++.||++|||+.|++++
T Consensus 220 ~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 220 KILDVIGLPG-EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHhCCCC-hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 2211110000 00000000 0 0000000001111112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=338.60 Aligned_cols=271 Identities=19% Similarity=0.277 Sum_probs=200.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 357999999999999999999964 68889999642 2457889999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
++. ++|..++.. ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 164 ~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 996 577777654 345889999999999999999999996 999999999999999999999999999754321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccC-C-----CCchHHHH
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH-D-----GSSLHEWV 898 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~-~-----~~~l~~~~ 898 (983)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... + ...+...+
T Consensus 236 ~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~ 303 (391)
T PHA03212 236 NA------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303 (391)
T ss_pred cc------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHH
Confidence 11 111234799999999999999999999999999999999999988643211 1 11122222
Q ss_pred HhhC------CCCCcHHHHHHHhhc-CCCCCccccccch---HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 899 KRHY------PHRLDPIVEKAIAKY-APQHMPIYYNKVW---SDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 899 ~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.... +.......+...... .........+..| .+.+.++.+++.+|++.||++|||++|++++=.
T Consensus 304 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 2111 111111111111000 0000000111112 235678999999999999999999999997543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=333.12 Aligned_cols=243 Identities=22% Similarity=0.281 Sum_probs=195.8
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
++||+|+||.||++... +++.||||++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999964 68899999996542 2234567889999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---- 149 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---- 149 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc----
Confidence 99888764 345899999999999999999999996 9999999999999999999999999987532111
Q ss_pred ccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......
T Consensus 150 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~~~~~~--------- 206 (328)
T cd05593 150 ---------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKLFEL--------- 206 (328)
T ss_pred ---------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HHHHHHH---------
Confidence 11123469999999999999899999999999999999999999985321 1111111
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.... ....+ .....++.+++.+|++.||++|| ++.|++++
T Consensus 207 ---~~~~--~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 207 ---ILME--DIKFP-------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---hccC--CccCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1000 00111 12346788999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.65 Aligned_cols=439 Identities=28% Similarity=0.374 Sum_probs=367.6
Q ss_pred eEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEecc
Q 042568 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157 (983)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls 157 (983)
++.+||+++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|+|..|.+. .+|..+..+++|++||+|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4899999998875 88999999999999999999998 88999999999999999999999 999999999999999999
Q ss_pred CcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccccc
Q 042568 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMF 237 (983)
Q Consensus 158 ~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 237 (983)
.|++. .+|..+. .++.+..++.++|......+ . ...+.+++..|.+.+.++..+.+++. .|||..|.+
T Consensus 123 ~N~f~-~~Pl~i~---~lt~~~~~~~s~N~~~~~lg-----~-~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~ 190 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIE---VLTAEEELAASNNEKIQRLG-----Q-TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEM 190 (1081)
T ss_pred hhccC-CCchhHH---hhhHHHHHhhhcchhhhhhc-----c-ccchhhhhhhhhcccchhcchhhhhe--eeecccchh
Confidence 99997 8888765 78999999999994432332 2 23899999999999999999998877 799999998
Q ss_pred ccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCc
Q 042568 238 SGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317 (983)
Q Consensus 238 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N 317 (983)
. . ..+..+.+|+.|.+..|++.... -..++|+.|+.++|.++...+. ..+.+|+++++++|
T Consensus 191 ~-~---~dls~~~~l~~l~c~rn~ls~l~------------~~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n 251 (1081)
T KOG0618|consen 191 E-V---LDLSNLANLEVLHCERNQLSELE------------ISGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHN 251 (1081)
T ss_pred h-h---hhhhhccchhhhhhhhcccceEE------------ecCcchheeeeccCcceeeccc---cccccceeeecchh
Confidence 6 3 23577899999999999886543 2357899999999999843322 23468999999999
Q ss_pred cccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcc
Q 042568 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397 (983)
Q Consensus 318 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 397 (983)
+++ .+|++++.+.+|+.|+..+|+++ .+|..+..+++|+.|.+.+|.+. .+|.....++.|++|+|..|+|....+.
T Consensus 252 ~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~ 328 (1081)
T KOG0618|consen 252 NLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDN 328 (1081)
T ss_pred hhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchH
Confidence 998 56799999999999999999996 78888999999999999999999 6777888899999999999999844443
Q ss_pred cccCccc-chhhcccCccCCCCCcc-cccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccc
Q 042568 398 SFANLSQ-LRRLLLYGNHLSGTIPS-SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475 (983)
Q Consensus 398 ~~~~l~~-L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l 475 (983)
.|.-+.. |+.|+.+.|++. ..|. .=..++.|+.|++.+|.++...-..+.+.+.|++ |+|++|+|.......+.++
T Consensus 329 ~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKV-LhLsyNrL~~fpas~~~kl 406 (1081)
T KOG0618|consen 329 FLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKV-LHLSYNRLNSFPASKLRKL 406 (1081)
T ss_pred HHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceee-eeecccccccCCHHHHhch
Confidence 3444433 888888889888 4442 2234567899999999999877777888899997 9999999985555668899
Q ss_pred cccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCC-cCccccCCCCcceEe
Q 042568 476 DMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE-IPQSFQASPTLKQLN 554 (983)
Q Consensus 476 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~l~ 554 (983)
..|++|+||+|+|+ .+|..+..+..|++|...+|+|. ..| ++..++.|+.+|+|.|+|+-. +|... ..++|++||
T Consensus 407 e~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLd 482 (1081)
T KOG0618|consen 407 EELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLD 482 (1081)
T ss_pred HHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccceee
Confidence 99999999999998 88999999999999999999998 567 888999999999999998743 34433 338999999
Q ss_pred ccCCc
Q 042568 555 FSFNK 559 (983)
Q Consensus 555 l~~N~ 559 (983)
|++|.
T Consensus 483 lSGN~ 487 (1081)
T KOG0618|consen 483 LSGNT 487 (1081)
T ss_pred ccCCc
Confidence 99997
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=349.47 Aligned_cols=259 Identities=25% Similarity=0.335 Sum_probs=206.0
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC----
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD---- 737 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 737 (983)
...++|.+.+.||+|+||+||+|+. .+++.||||++..... ......+.+|+.++..++|+|++++.+.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 4789999999865532 334567889999999999999999988765432
Q ss_pred ----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 738 ----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 738 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 357999999999999988754444557899999999999999999999996 9999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... .
T Consensus 186 DFGls~~~~~~~~~-----------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-----~ 249 (496)
T PTZ00283 186 DFGFSKMYAATVSD-----------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-----N 249 (496)
T ss_pred ecccCeeccccccc-----------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-----C
Confidence 99999876432111 1122357999999999999999999999999999999999999998531 1
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+. ++......... .+ ...+.++.+++.+|++.+|++||++.+++++
T Consensus 250 ~~~~------------~~~~~~~~~~~-~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 MEEV------------MHKTLAGRYDP-LP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHH------------HHHHhcCCCCC-CC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 22222111110 11 1245678999999999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.83 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=205.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46778899999999999999988888999998754322 3578999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999987543 345888999999999999999999986 99999999999999999999999999986543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||+..+..++.++||||||+++|+|++ |+.||.... .....
T Consensus 159 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~---------- 214 (261)
T cd05072 159 T------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVM---------- 214 (261)
T ss_pred e------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHH----------
Confidence 0 1112346778999999998889999999999999999998 999985321 01111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
..+...... + .....+.++.+++.+|+..+|++||+++++.+.|+++
T Consensus 215 ------~~~~~~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 215 ------SALQRGYRM--P-----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ------HHHHcCCCC--C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111111100 0 0112456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=347.18 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=202.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC-C-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-D-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.|...+.||+|+||.||+|... + ++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3778899999999999999854 3 57788887644332 2346778899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++........++++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999887654333456899999999999999999999986 9999999999999999999999999998664321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.. .......||++|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 224 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~---------- 277 (478)
T PTZ00267 224 SL-----------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQR---------- 277 (478)
T ss_pred cc-----------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHH----------
Confidence 10 1122356999999999999999999999999999999999999998532 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+........... ..+ ..+..++.+++.+|+..+|++||++.+++++
T Consensus 278 --~~~~~~~~~~~~-~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 278 --EIMQQVLYGKYD-PFP-------CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --HHHHHHHhCCCC-CCC-------ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 112221111111 011 1244678999999999999999999999753
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.31 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=202.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
++++|+..+.||+|+||.||+|.+. ++..||||.+..........++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999999753 2467999998544333345678899999999999999999999999899
Q ss_pred eeEEEecccCcccccccccccCc------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEE
Q 042568 739 KALVLPLMSNGSLENHLYPSHGL------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV 812 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl 812 (983)
.++||||+++|+|.+++...... ...+++..+..++.|+++|++|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999988643211 234688899999999999999999986 999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDG 891 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~ 891 (983)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--- 226 (277)
T cd05062 161 GDFGMTRDIYETDYY-----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--- 226 (277)
T ss_pred CCCCCccccCCccee-----------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---
Confidence 999998765422111 01112346788999999998889999999999999999999 688875321
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
...... ... .......+ ..++..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 227 --~~~~~~------------~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 227 --NEQVLR------------FVM-EGGLLDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HHHHHH------------HHH-cCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 101 10000011 1245678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.82 Aligned_cols=269 Identities=26% Similarity=0.331 Sum_probs=202.9
Q ss_pred CCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEE
Q 042568 670 CPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALV 742 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 742 (983)
...+.||+|+||+||++.. .+++.||+|.++..........+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 357789999987654444567889999999999999999999988654 357899
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++.. ..+++..++.++.|+++|++|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999998863 35899999999999999999999996 9999999999999999999999999998665
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
...... .......++..|+|||...+..++.++||||||+++|||++|+.||..... ...+......
T Consensus 159 ~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~---~~~~~~~~~~ 225 (283)
T cd05080 159 EGHEYY----------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK---KFEEMIGPKQ 225 (283)
T ss_pred Ccchhh----------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc---hhhhhhcccc
Confidence 322110 001112356779999999988899999999999999999999999754221 1111111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.........+.+..... .+ ....++.++.+++.+|++.+|++|||++++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMR--LP-----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCC--CC-----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00101111111111110 00 01234578999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=310.65 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=207.2
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|.+++++|+|+||.||||.++ +|..||||.+..+. ...++.+|+.++++...|++|++||.|......++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 445788999999999999966 68899999985443 46889999999999999999999999988899999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
.|++.+.+.-. ++++.+.++..+.+..++||+|||... -+|||||+.|||++.+|.+|++|||.|..+.+.
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--- 182 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--- 182 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh---
Confidence 99999988754 578999999999999999999999984 799999999999999999999999999765421
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.....++.||+.|||||++..-.|+.++||||+|++..||..|++||....+-..
T Consensus 183 ----------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------- 237 (502)
T KOG0574|consen 183 ----------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------- 237 (502)
T ss_pred ----------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------
Confidence 2344567899999999999999999999999999999999999999875422100
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+ ...+...|+.++ ..++-+.++.+++..|+...|++|-|+.++++|
T Consensus 238 ------I-FMIPT~PPPTF~-KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 238 ------I-FMIPTKPPPTFK-KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ------e-EeccCCCCCCCC-ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0 111222233333 334556778899999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.41 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=212.8
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
...+.++||+|.||.|..+....+.+||||.++.......+..|.+|+++|.+++||||++++|+|..++-.++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 44567899999999999999987899999999888777778999999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++..+.. +........+|+.|||.|++||.+. ++||||+.+.|+|+|+++++||+|||+++-+...+.+
T Consensus 619 nGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred cCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999986642 2245566778999999999999987 5999999999999999999999999999865433222
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh--CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT--GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt--g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
...+..+-..+|||||.+.-++++.++|||+||+++||+++ ...||..+..
T Consensus 694 -----------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---------------- 746 (807)
T KOG1094|consen 694 -----------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---------------- 746 (807)
T ss_pred -----------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----------------
Confidence 22223455689999999999999999999999999999876 6778765422
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+++++....-...+.. ...-....-|+.++.+++.+||.++-++||+++++...|.+.
T Consensus 747 -e~vven~~~~~~~~~~-~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 747 -EQVVENAGEFFRDQGR-QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -HHHHHhhhhhcCCCCc-ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1222222222121111 111112234788999999999999999999999999988764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.58 Aligned_cols=250 Identities=31% Similarity=0.521 Sum_probs=193.3
Q ss_pred CCccccCCcEeEEEEEEC-----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.+.||.|.||.||+|.+. .+..|+||.++.....+..+.|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999976 256699999966555555789999999999999999999999999888899999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ...+++..++.|+.|+++||+|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998652 356899999999999999999999985 99999999999999999999999999987632111
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||... ..
T Consensus 159 ~-----------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~----------- 211 (259)
T PF07714_consen 159 Y-----------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DN----------- 211 (259)
T ss_dssp E-----------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CH-----------
T ss_pred c-----------cccccccccccccccccccccccccccccccccccccccccccccccccc-----cc-----------
Confidence 1 11222357789999999999889999999999999999999 67887532 11
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.+..+.. ........+ ..++..+.+++.+||+.+|++||+++++++.|
T Consensus 212 -~~~~~~~-~~~~~~~~~-------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 -EEIIEKL-KQGQRLPIP-------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HHHHHHH-HTTEETTSB-------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccccccc-cccccceec-------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111121 111111111 12456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.94 Aligned_cols=249 Identities=30% Similarity=0.449 Sum_probs=197.9
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
+.||+|+||.||+|... +++.||+|.+......+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 68889999886555555567899999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 149 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----- 149 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-----
Confidence 9988643 345889999999999999999999996 99999999999999999999999999875432110
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 910 (983)
........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 150 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------------------~~~ 205 (252)
T cd05084 150 ------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------------------QQT 205 (252)
T ss_pred ------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------------------HHH
Confidence 011111234567999999999889999999999999999998 8888753211 001
Q ss_pred HHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
...+........ ...++.++.+++.+|++.+|++|||+.|+.+.|+
T Consensus 206 ~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 206 REAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHcCCCCCC-------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111111111001 1124567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=334.74 Aligned_cols=273 Identities=19% Similarity=0.277 Sum_probs=197.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----cee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD-----FKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 740 (983)
+|+..++||+|+||.||+|+.. +++.||||++..... .....++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999964 688999999864322 223457889999999999999999999885432 469
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 588887754 345899999999999999999999996 99999999999999999999999999985
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+
T Consensus 153 ~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~--~~~~~~~~ 220 (338)
T cd07859 153 AFNDTPT----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLI 220 (338)
T ss_pred cccccCc----------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHH
Confidence 4321110 011123579999999999866 678999999999999999999999985321 11111111
Q ss_pred HhhCCCCCcHHH--------HHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIV--------EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ ........ ...+......+.....++.+++.+|++.||++|||++|++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 221 TDLLGTPSPETISRVRNEKARRYLSSMR-KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhhc-ccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 111111000000 00111111 001111111122345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.78 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=198.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.|...+.||+|+||+||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999954 67889999996543 22345678999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999988643 35889999999999999999999986 999999999999999999999999998654211
Q ss_pred cccccccC------C----------------------------CCccccccCccccccccccccccCCCCCCccchhHHH
Q 042568 825 DESVNCAN------D----------------------------SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSF 870 (983)
Q Consensus 825 ~~~~~~~~------~----------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~Sl 870 (983)
........ . ...........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 10000000 0 0000001123579999999999999889999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhh--hcCCC
Q 042568 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLL--CTQYN 948 (983)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~d 948 (983)
||++|||++|+.||...... +.....+........+. ......++.+++.+ |...+
T Consensus 235 G~il~elltG~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~-----~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT-----------------ETQLKVINWENTLHIPP-----QVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH-----------------HHHHHHHccccccCCCC-----CCCCCHHHHHHHHHHccCccc
Confidence 99999999999998642110 00111111000001111 11234567778877 55666
Q ss_pred CCCCCCHHHHHHH
Q 042568 949 PSTRPSMLDVAHE 961 (983)
Q Consensus 949 P~~RPs~~evl~~ 961 (983)
|..||+++|++++
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 7779999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.74 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=206.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
.+|.+.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46778899999999999999852 245589998865432 34567999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccC---------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 741 LVLPLMSNGSLENHLYPSHG---------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
+||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999988864321 1235899999999999999999999996 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHD 890 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~ 890 (983)
|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 161 l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~- 228 (288)
T cd05093 161 IGDFGMSRDVYSTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN- 228 (288)
T ss_pred eccCCccccccCCcee-----------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9999999865322111 11122346788999999998889999999999999999999 8888753211
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
....+........ ..+ ...+.++.+++.+|++.+|.+|||++|+.+.|+.+.+..
T Consensus 229 ----------------~~~~~~i~~~~~~-~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 229 ----------------NEVIECITQGRVL-QRP-------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred ----------------HHHHHHHHcCCcC-CCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0111111111110 001 113467899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=337.75 Aligned_cols=265 Identities=20% Similarity=0.229 Sum_probs=200.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|+.. +++.||||++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999965 68899999996542 2234567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999988642 35899999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccCCC--------------C-------c----cccccCccccccccccccccCCCCCCccchhHHHHHHHHHHH
Q 042568 824 IDESVNCANDS--------------M-------S----FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878 (983)
Q Consensus 824 ~~~~~~~~~~~--------------~-------~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ell 878 (983)
........... . . ........+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21110000000 0 0 000111246999999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC---H
Q 042568 879 TGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---M 955 (983)
Q Consensus 879 tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~ 955 (983)
+|+.||.... ... ..............+. . .....++.+++.+|+. +|.+|++ +
T Consensus 234 ~G~~Pf~~~~-----~~~------------~~~~i~~~~~~~~~~~--~---~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 234 VGYPPFCSDN-----PQE------------TYRKIINWKETLQFPD--E---VPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred cCCCCCCCCC-----HHH------------HHHHHHcCCCccCCCC--C---CCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999986321 111 1111111000000010 0 0134567888888986 9999998 9
Q ss_pred HHHHHH
Q 042568 956 LDVAHE 961 (983)
Q Consensus 956 ~evl~~ 961 (983)
+|++++
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=317.46 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=200.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|+||.||+|.+. +++ +||+|.+..........++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777899999999999999964 344 4778877544333345678888989999999999999998864 45688
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999998753 345899999999999999999999986 999999999999999999999999999866
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......++..|+|||+..+..++.++||||||+++||+++ |+.||..... ....+.
T Consensus 160 ~~~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~--- 223 (279)
T cd05111 160 YPDDKK-----------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDL--- 223 (279)
T ss_pred cCCCcc-----------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH---
Confidence 432211 11122457789999999998899999999999999999998 9999853211 111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
+........+ ..+...+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 224 -------------~~~~~~~~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 224 -------------LEKGERLAQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -------------HHCCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111100001 1134567889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.28 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=202.5
Q ss_pred CCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+|+..+.||+|+||.||+|.. .++..||+|.+...........+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 466788999999999999984 245789999987554444557889999999999999999999999999999999
Q ss_pred EecccCcccccccccccC-------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC
Q 042568 743 LPLMSNGSLENHLYPSHG-------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT 809 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~ 809 (983)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999998853211 1235889999999999999999999996 999999999999999999
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~ 888 (983)
+||+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++ |..||....
T Consensus 163 ~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 163 VKISDLGLSREIYSADYY-----------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred EEeccccccccccCCcce-----------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999865432211 11122346778999999988889999999999999999999 888875321
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.....+.+. ..... + ....++.++.+++.+|++.+|++||++.++.++|+.
T Consensus 232 --~~~~~~~~~----------------~~~~~--~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 --NQEVIEMVR----------------KRQLL--P-----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHH----------------cCCcC--C-----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011111111 10000 0 012245678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.22 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=194.1
Q ss_pred CccccCCcEeEEEEEE----CCCcEEEEEEeeccc---CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 673 SLIGSGRFGHVYKGVL----QDNTRIAVKVLDLTT---TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.||+|+||.||+++. .+++.||||+++... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357889999986532 222345678899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.. ...+.+..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998864 335788889999999999999999996 9999999999999999999999999987432211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...
T Consensus 155 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~--------- 207 (323)
T cd05584 155 -------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKK--------- 207 (323)
T ss_pred -------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHH---------
Confidence 11123469999999999999889999999999999999999999986321 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
..+....... ..+ .....++.+++.+|++.+|++|| ++++++++
T Consensus 208 ---~~~~~~~~~~--~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 208 ---TIDKILKGKL--NLP-------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred ---HHHHHHcCCC--CCC-------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111111100 111 12346788999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.72 Aligned_cols=255 Identities=31% Similarity=0.477 Sum_probs=204.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46788899999999999999987788899999865432 3567899999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..+..++.|+++|+.|||+.+ |+||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999987543 346899999999999999999999996 99999999999999999999999999987652111
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .
T Consensus 159 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~---------- 211 (261)
T cd05068 159 E------------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----A---------- 211 (261)
T ss_pred c------------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----H----------
Confidence 0 0011123468999999999899999999999999999999 9999853210 0
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.... .+........+ ..++..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 212 --~~~~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 212 --EVLQ-QVDQGYRMPCP-------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --HHHH-HHHcCCCCCCC-------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111 11111110001 12456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.16 Aligned_cols=246 Identities=25% Similarity=0.349 Sum_probs=194.1
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHH---HhcCCCCccceeeEEecCCceeEE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQIL---KRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
|.+.+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999965 68899999996542 222345677776665 456799999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988775 345899999999999999999999996 9999999999999999999999999987432
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+
T Consensus 153 ~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~------ 208 (324)
T cd05589 153 GFG-------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEE------ 208 (324)
T ss_pred CCC-------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHH------
Confidence 111 11223579999999999999999999999999999999999999986321 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
..+....... ..+ .....++.+++.+|++.||.+|| ++.+++++
T Consensus 209 ------~~~~i~~~~~--~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 209 ------VFDSIVNDEV--RYP-------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------HHHHHHhCCC--CCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111111111 011 12346788999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=316.07 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=202.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4667889999999999999965 57889999986432 23567899999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999886532 346899999999999999999999986 99999999999999999999999999986643211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||++.+..++.++||||||+++|||++ |..||... ...+.
T Consensus 160 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~-------- 214 (263)
T cd05052 160 T------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQV-------- 214 (263)
T ss_pred e------------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHH--------
Confidence 1 1111234678999999999899999999999999999998 88887531 11111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.+. +........+ ..++.++.+++.+|++.+|++||++.|+.+.|+.+
T Consensus 215 ----~~~-~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 215 ----YEL-LEKGYRMERP-------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----HHH-HHCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111 1110000011 12457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.52 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=209.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC-----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec-CCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-PDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 739 (983)
.++|...+.||+|+||.||+|.+.. +..||+|.+...........+.+|++++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999999765 678999998755555556788999999999999999999998765 5678
Q ss_pred eEEEecccCcccccccccccCc----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGL----SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
++++||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654321 146899999999999999999999986 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l 894 (983)
|+++.+.+.... .......++..|+|||++.+..++.++||||||+++||+++ |+.||... +...+
T Consensus 162 g~~~~~~~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--~~~~~ 228 (280)
T cd05043 162 ALSRDLFPMDYH-----------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--DPFEM 228 (280)
T ss_pred CCcccccCCceE-----------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--CHHHH
Confidence 999866432211 01112246778999999998889999999999999999999 99998642 11111
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
..++.. .... + ....++.++.+++.+||..+|++|||+.|+++.|+++.+.
T Consensus 229 ~~~~~~----------------~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 229 AAYLKD----------------GYRL--A-----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHHc----------------CCCC--C-----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111111 0000 0 0112456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.95 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=195.6
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||+||++... +++.||+|.+...... ...+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999965 6889999998654321 2345678899999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++.........+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 8877543333456899999999999999999999996 99999999999999999999999999976543221
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... ...
T Consensus 153 --------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~------------~~~ 211 (280)
T cd05608 153 --------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKE------------LKQ 211 (280)
T ss_pred --------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-hhHHH------------HHH
Confidence 112246899999999999999999999999999999999999998632110 00000 011
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
..... .... ....+.++.+++.+|++.||++|| ++++++++
T Consensus 212 ~~~~~--~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 212 RILND--SVTY-------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hhccc--CCCC-------cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 10000 0000 122456788999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=333.53 Aligned_cols=213 Identities=23% Similarity=0.297 Sum_probs=175.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|+..+.||+|+||+||+|... +++.||||++.... ..+....+.+|++++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 68899999996542 2223467888999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999874 346899999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccC-------C-------CC--------ccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCC
Q 042568 824 IDESVNCAN-------D-------SM--------SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 824 ~~~~~~~~~-------~-------~~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~ 881 (983)
......... + .. .........+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 211000000 0 00 0000112357999999999999999999999999999999999999
Q ss_pred CCCCc
Q 042568 882 RPTDV 886 (983)
Q Consensus 882 ~p~~~ 886 (983)
.||..
T Consensus 234 ~Pf~~ 238 (363)
T cd05628 234 PPFCS 238 (363)
T ss_pred CCCCC
Confidence 99863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=351.28 Aligned_cols=276 Identities=24% Similarity=0.349 Sum_probs=207.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.++||+|+||.||+|... +++.||||++..... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999965 588999999865432 234567999999999999999999999999999999999
Q ss_pred ecccCcccccccccccC-------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 744 PLMSNGSLENHLYPSHG-------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
||+++|+|.+++..... .....++..+++++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998764211 1234677888999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCccccc---cc--CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 817 IAKLVKGIDESVN---CA--NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 817 la~~~~~~~~~~~---~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
+++.......... .. .............+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 9987632111100 00 0000011122345799999999999999999999999999999999999999864211
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHhh
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-SMLDVAHEMGRLKQY 968 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~ 968 (983)
... .. ...+.. +... ..+.+.+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 237 ~ki---~~-----------~~~i~~--P~~~-----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 237 RKI---SY-----------RDVILS--PIEV-----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh---hh-----------hhhccC--hhhc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 00 000000 0000 00123556788999999999999995 677777888777543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=332.89 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=197.2
Q ss_pred CCCccccCCcEeEEEEEEC-CCcEEE---EEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc--eeEEEe
Q 042568 671 PSSLIGSGRFGHVYKGVLQ-DNTRIA---VKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF--KALVLP 744 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~-~~~~vA---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 744 (983)
...+||+|+|-+||||.+. +|-.|| ||.-+.....+..++|..|+.+|+.|+||||+++|.+|.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999965 466665 5554445555567899999999999999999999999987765 678899
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~~ 823 (983)
.+..|+|..|..+. +.++...+..|++||++||.|||++.| +|||||||.+||+++. .|.|||+|.|+|+.+..
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999864 357888999999999999999999875 7999999999999985 58999999999998764
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ...++|||.|||||+.. ..|++.+||||||++++||+|+.+||..-.+.
T Consensus 199 s~---------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------------- 249 (632)
T KOG0584|consen 199 SH---------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------------- 249 (632)
T ss_pred cc---------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------------
Confidence 22 23368999999999887 67999999999999999999999998643222
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+++.+.+.+..+..+... .-+++.++|.+|+.. .++|||+.|++++
T Consensus 250 ---AQIYKKV~SGiKP~sl~kV-------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 250 ---AQIYKKVTSGIKPAALSKV-------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ---HHHHHHHHcCCCHHHhhcc-------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1222222222222111111 125788999999999 9999999999863
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.13 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=208.4
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|.. .+++.||||.+.... ......++.+|+++++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677788999999999999995 578999999875432 2224567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.........+++..++.++.|+++|++|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988643333456899999999999999999999996 99999999999999999999999999876542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.... .....+..
T Consensus 159 ~~~-------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~---- 218 (267)
T cd08229 159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCK---- 218 (267)
T ss_pred CCc-------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc---chHHHHhh----
Confidence 211 1122468899999999998889999999999999999999999985321 11111111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.+........ .+.....++.+++.+|++.+|++|||+.+|++.++++.
T Consensus 219 ---------~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 ---------KIEQCDYPPL------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---------hhhcCCCCCC------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111110000 01235678999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.45 Aligned_cols=266 Identities=20% Similarity=0.218 Sum_probs=198.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||||++.... ..+..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999854 68899999986532 2234567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999998864 345889999999999999999999996 99999999999999999999999999975432
Q ss_pred Ccccccc---------cCC--CC--------c---------------cccccCccccccccccccccCCCCCCccchhHH
Q 042568 824 IDESVNC---------AND--SM--------S---------------FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYS 869 (983)
Q Consensus 824 ~~~~~~~---------~~~--~~--------~---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S 869 (983)
....... ... .. . ........+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1110000 000 00 0 000001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCC
Q 042568 870 FGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949 (983)
Q Consensus 870 lG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 949 (983)
+||++|||++|+.||..... .+. .............+. ......++.+++.+|+. +|
T Consensus 234 lGvil~elltG~~Pf~~~~~-----~~~------------~~~i~~~~~~~~~p~-----~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS-----HET------------YRKIINWRETLYFPD-----DIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH-----HHH------------HHHHHccCCccCCCC-----CCCCCHHHHHHHHHHhc-CH
Confidence 99999999999999853211 111 111110000000110 01234678899999997 67
Q ss_pred CCC---CCHHHHHHHH
Q 042568 950 STR---PSMLDVAHEM 962 (983)
Q Consensus 950 ~~R---Ps~~evl~~L 962 (983)
.+| +++.|++++-
T Consensus 291 ~~r~~r~~~~~~l~hp 306 (377)
T cd05629 291 ENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhcCCCCCHHHHhcCC
Confidence 665 6999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=322.15 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=204.3
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-----------------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-----------------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 729 (983)
++|++.+.||+|+||.||+|.... +..||+|.+.........+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578889999999999999998542 245899998766555556789999999999999999999
Q ss_pred eeEEecCCceeEEEecccCcccccccccccC-------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCe
Q 042568 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHG-------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNI 802 (983)
Q Consensus 730 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~Ni 802 (983)
++++...+..++|+||+++++|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 9999998999999999999999998865431 1236899999999999999999999986 99999999999
Q ss_pred EeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh--C
Q 042568 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT--G 880 (983)
Q Consensus 803 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt--g 880 (983)
+++.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY-----------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred eecCCCceEEccccceeecccCcce-----------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence 9999999999999998765432111 11223456789999999998889999999999999999998 6
Q ss_pred CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 881 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
..||..... .+ .++...........+... .....++.++.+++.+|++.||++|||+.|+++
T Consensus 231 ~~p~~~~~~-----~~------------~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 231 EQPYEHLTD-----QQ------------VIENAGHFFRDDGRQIYL-PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCcCh-----HH------------HHHHHHhccccccccccC-CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 677653210 01 111111000000000000 001124468999999999999999999999999
Q ss_pred HHH
Q 042568 961 EMG 963 (983)
Q Consensus 961 ~L~ 963 (983)
.|+
T Consensus 293 ~L~ 295 (296)
T cd05051 293 FLQ 295 (296)
T ss_pred Hhc
Confidence 885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=330.21 Aligned_cols=261 Identities=26% Similarity=0.379 Sum_probs=204.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCcee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 740 (983)
+|...+.||+|+||.||+|.+. .+..||||+++..........+.+|++++.++. ||||+++++++...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 4667889999999999999864 245799999976554444567899999999997 999999999999999999
Q ss_pred EEEecccCcccccccccccC------------------------------------------------------------
Q 042568 741 LVLPLMSNGSLENHLYPSHG------------------------------------------------------------ 760 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 760 (983)
+|+||+++|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999998864321
Q ss_pred ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 761 ----------------------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 761 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
....+++..++.++.|+++||+|||+.+ |+||||||+||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeC
Confidence 1124778889999999999999999985 999999999999999
Q ss_pred CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 042568 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885 (983)
Q Consensus 807 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~ 885 (983)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNY-----------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CCEEEEEecCcceeccccccc-----------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999865322111 01112357889999999998889999999999999999998 888975
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.... .+.....+........+ ..+..++.+++.+||..+|++||+++|+++.|+++
T Consensus 344 ~~~~-----------------~~~~~~~~~~~~~~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 344 ELPM-----------------NEQFYNAIKRGYRMAKP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCc-----------------hHHHHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3210 01111111111100011 12456889999999999999999999999999876
Q ss_pred H
Q 042568 966 K 966 (983)
Q Consensus 966 ~ 966 (983)
.
T Consensus 400 ~ 400 (401)
T cd05107 400 L 400 (401)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=319.83 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=204.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|...+.||+|+||.||+|... ....+|+|.+..........++.+|+++++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3677899999999999999853 2356899988655544445789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccC--------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCC
Q 042568 742 VLPLMSNGSLENHLYPSHG--------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSN 801 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~N 801 (983)
++||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999988754211 1235889999999999999999999986 9999999999
Q ss_pred eEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-C
Q 042568 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-G 880 (983)
Q Consensus 802 iLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g 880 (983)
|++++++.+||+|||+++........ .......++..|+|||...+..++.++||||||+++|||++ |
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 99999999999999999865432211 01112245678999999988889999999999999999999 9
Q ss_pred CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 881 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+.||.... ...+.++ +........+ ..+..++.+++.+|++.+|++||+++|+++
T Consensus 227 ~~p~~~~~--~~~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 227 GNPYPGIA--PERLFNL----------------LKTGYRMERP-------ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCCCC--HHHHHHH----------------HhCCCCCCCC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99975321 0011111 1110000001 124467889999999999999999999999
Q ss_pred HHHHhHh
Q 042568 961 EMGRLKQ 967 (983)
Q Consensus 961 ~L~~~~~ 967 (983)
.|+++..
T Consensus 282 ~l~~~~~ 288 (290)
T cd05045 282 ELEKMMV 288 (290)
T ss_pred HHHHHHh
Confidence 9998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.50 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred CCCCCCCccccCCcEeEEEEEECC---------------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD---------------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~---------------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 731 (983)
++|.+.+.||+|+||.||++.... ...||+|.+...........|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999987542 12489999875544445678999999999999999999999
Q ss_pred EEecCCceeEEEecccCcccccccccccC--------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeE
Q 042568 732 ICSKPDFKALVLPLMSNGSLENHLYPSHG--------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNIL 803 (983)
Q Consensus 732 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiL 803 (983)
++......++||||+++++|.+++..... ....+++..++.++.|+++|++|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854321 1124788999999999999999999996 999999999999
Q ss_pred eCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh--CC
Q 042568 804 LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT--GR 881 (983)
Q Consensus 804 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt--g~ 881 (983)
++.++.+||+|||++......... .......++..|+|||...+..++.++||||||+++|+|++ |.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY-----------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred EcCCCcEEecccccccccccCcce-----------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence 999999999999999765322110 11122346789999999998889999999999999999998 55
Q ss_pred CCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 882 RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 882 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.||..... .+.+... .+..+......... .....+..+.+++.+|++.+|++||++.+|++.
T Consensus 231 ~p~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~ 292 (295)
T cd05097 231 QPYSLLSD-----EQVIENT-----GEFFRNQGRQIYLS--------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292 (295)
T ss_pred CCCcccCh-----HHHHHHH-----HHhhhhccccccCC--------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 66653211 0111000 00000000000000 011245689999999999999999999999998
Q ss_pred HH
Q 042568 962 MG 963 (983)
Q Consensus 962 L~ 963 (983)
|+
T Consensus 293 l~ 294 (295)
T cd05097 293 LR 294 (295)
T ss_pred Hh
Confidence 86
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.42 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=207.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD 737 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 737 (983)
++|.+.+.||+|+||.||+|... +...||+|.++.........++.+|+++++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888999999999999999853 23469999997654444456788999999999 7999999999999999
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++||||+++|+|.+++..... ....+++..+++++.|+++||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999875421 1235899999999999999999999986 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.++|+|||.++........ .......++..|+|||...+..++.++|||||||++|||++ |+.||
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYY-----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred CCCcEEECCCcccccccccchh-----------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999998765421110 00111124568999999998889999999999999999998 88887
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
... ...+... .+........ ...+..++.+++.+|+..+|++||++.++++.|++
T Consensus 244 ~~~-----~~~~~~~-------------~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 244 PGV-----PVEELFK-------------LLKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred CcC-----CHHHHHH-------------HHHcCCCCCC-------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 421 1111111 1111111011 12245688899999999999999999999999999
Q ss_pred hHhhcC
Q 042568 965 LKQYLS 970 (983)
Q Consensus 965 ~~~~~~ 970 (983)
+.+...
T Consensus 299 ~~~~~~ 304 (307)
T cd05098 299 ILALTS 304 (307)
T ss_pred HHHHhh
Confidence 877644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.22 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=206.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|...+.||+|+||.||+|+.. ++..+|+|.++.... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4667889999999999999843 345589998854432 234678999999999999999999999999999999
Q ss_pred EEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC
Q 042568 742 VLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT 809 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~ 809 (983)
||||+++++|.+++..... ....+++..++.++.|+++|++|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 1235899999999999999999999996 999999999999999999
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~ 888 (983)
++|+|||+++........ .......|+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~l~dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCcee-----------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999765432110 11122457889999999999999999999999999999999 999985421
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
. .+ .++......... . ...++..+.+++.+|++.+|++||++++|+++|+++.+.
T Consensus 231 ~-----~~------------~~~~~~~~~~~~-~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 231 N-----TE------------VIECITQGRVLE-R-------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H-----HH------------HHHHHhCCCCCC-C-------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 11 111111110100 0 012456789999999999999999999999999999765
Q ss_pred c
Q 042568 969 L 969 (983)
Q Consensus 969 ~ 969 (983)
.
T Consensus 286 ~ 286 (291)
T cd05094 286 T 286 (291)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.48 Aligned_cols=253 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|...++||+|+||.||+|.. .+++.||+|.+......+...++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567789999999999999995 4688899999876544445577999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+++++..+. .+++..+..++.|++.|++|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999986542 3678889999999999999999996 999999999999999999999999999755321
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......||..|+|||++.+..++.++||||||+++|+|++|+.||........... .
T Consensus 149 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~----------~ 205 (279)
T cd06619 149 -------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----------P 205 (279)
T ss_pred -------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc----------h
Confidence 11224689999999999998999999999999999999999999865332211100 0
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..... .+........+ ......++.+++.+|++.+|++||+++|++++-.
T Consensus 206 ~~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 206 LQLLQ-CIVDEDPPVLP------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHH-HHhccCCCCCC------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 00011 11110111010 1123457889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=339.96 Aligned_cols=271 Identities=22% Similarity=0.299 Sum_probs=193.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-------- 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 736 (983)
.++|...++||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457999999999999999999964 68899999884322 2345799999999999999999886432
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADF 815 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Df 815 (983)
...++||||+++ ++.+++.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 245689999985 676666533323456899999999999999999999996 99999999999999665 7999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|+|+.+..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+
T Consensus 216 Gla~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~ 280 (440)
T PTZ00036 216 GSAKNLLAGQR--------------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQL 280 (440)
T ss_pred ccchhccCCCC--------------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Confidence 99986543211 1124689999999998764 689999999999999999999999864211 1112
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccch-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVW-----SDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+...-.+. .+.....-........+......+ ...+.++.+++.+|+++||++|||+.|++++
T Consensus 281 ~~i~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 281 VRIIQVLGTPT-EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhCCCC-HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 22221111111 010100000000000111000001 1234678999999999999999999999965
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.34 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=196.2
Q ss_pred ccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 674 LIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.||+|+||.||+|.+. ++..||+|++.........+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 3456999998765554456779999999999999999999998854 56799999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
|.+++... ...+++..+++++.|+++|++|||+++ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 152 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-- 152 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce--
Confidence 99988643 346899999999999999999999986 9999999999999999999999999998654322110
Q ss_pred cCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
.......++..|+|||...+..++.++||||||+++||+++ |+.||..... ...
T Consensus 153 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~--------------- 207 (257)
T cd05115 153 --------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEV--------------- 207 (257)
T ss_pred --------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--HHH---------------
Confidence 01111234678999999988889999999999999999996 9999864311 001
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
...+........+ ..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 208 -~~~~~~~~~~~~~-------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 208 -MSFIEQGKRLDCP-------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -HHHHHCCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111111111111 12457888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.45 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=201.3
Q ss_pred CCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
|...+.||+|+||.||+|...+ +..||+|+++........+.+.+|+++++.++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4456789999999999998642 4679999997655444567789999999999999999999999999999999
Q ss_pred EecccCccccccccccc------------CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSH------------GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
+||+++++|.+++.... .....+++..+..++.|+++||+|+|+.+ |+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999998875321 11235889999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 164 kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~- 231 (283)
T cd05091 164 KISDLGLFREVYAADYY-----------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS- 231 (283)
T ss_pred Eecccccccccccchhe-----------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 99999998865432211 11122346789999999988889999999999999999998 777875321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
..+ ..+....... ... ..+++..+.+++.+|++.+|++||+++++++.|+.
T Consensus 232 ----~~~------------~~~~i~~~~~-~~~-------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 232 ----NQD------------VIEMIRNRQV-LPC-------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHH------------HHHHHHcCCc-CCC-------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 1111111110 000 12355678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=313.40 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=202.3
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|++.++||+|+||.||+|.+.++..||+|.++.... ..+++.+|++++++++||||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 56888999999999999999987777899999865332 2467899999999999999999999875 45679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ...+++..+..++.|+++||+|+|+.+ ++||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999997532 345789999999999999999999986 99999999999999999999999999986643221
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ~------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---------------- 209 (262)
T cd05071 158 T------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------------- 209 (262)
T ss_pred c------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----------------
Confidence 1 1112346778999999998889999999999999999999 8888753211
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
....+..... ... + ...+.+..+.+++.+|++.+|++||+++++++.|+..
T Consensus 210 -~~~~~~~~~~-~~~--~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 210 -REVLDQVERG-YRM--P-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -HHHHHHHhcC-CCC--C-----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111111111 000 0 0123567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=331.42 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=194.2
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.||+|+||.||++... +++.||+|+++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999954 68899999997543 2223567788999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
+|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---
Confidence 99888764 3458999999999999999999997 54 9999999999999999999999999987532111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-----~~~~----------- 204 (325)
T cd05594 151 ----------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HEKL----------- 204 (325)
T ss_pred ----------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-----HHHH-----------
Confidence 11123469999999999999999999999999999999999999985321 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
....... ....+ .....++.+++.+|++.||++|+ ++++++++
T Consensus 205 -~~~i~~~--~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 205 -FELILME--EIRFP-------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -HHHHhcC--CCCCC-------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1111100 00111 11346788999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=335.68 Aligned_cols=265 Identities=24% Similarity=0.277 Sum_probs=205.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|... +++.||||+++... .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 68899999997543 2234567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998753 46899999999999999999999986 99999999999999999999999999987654
Q ss_pred CcccccccC----------------CCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 042568 824 IDESVNCAN----------------DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887 (983)
Q Consensus 824 ~~~~~~~~~----------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~ 887 (983)
......... .............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 320000000 0000011223457999999999999999999999999999999999999998642
Q ss_pred cCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 042568 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-MLDVAHE 961 (983)
Q Consensus 888 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 961 (983)
. . .. ..............+.. ...+.++.+++.+|+. +|++||+ ++|++++
T Consensus 234 ~----~-~~------------~~~~i~~~~~~~~~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 T----L-QE------------TYNKIINWKESLRFPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred C----H-HH------------HHHHHhccCCcccCCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 0 01 11111110000011110 1145678899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.97 Aligned_cols=365 Identities=30% Similarity=0.464 Sum_probs=202.7
Q ss_pred cCCCCcEEeCcCCcCC-CCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcc
Q 042568 99 NLSSLIVLDLSKNFFQ-GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTS 177 (983)
Q Consensus 99 ~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~ 177 (983)
-|+..+-.|+++|.|+ +..|.+...+++++.|.|.+.++. .+|..++.|.+|++|.+++|++. .+-..+ +.++.
T Consensus 5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGEL---s~Lp~ 79 (1255)
T KOG0444|consen 5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGEL---SDLPR 79 (1255)
T ss_pred ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhh---ccchh
Confidence 3566667788888888 468888888888888888888887 88888888888888888888887 333222 34555
Q ss_pred cceeecccccccCC-CCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEE
Q 042568 178 LQYIDLSNNSLTGE-IPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256 (983)
Q Consensus 178 L~~L~Ls~N~l~~~-ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 256 (983)
|+.+.+.+|++... ||...| .+..|..|+|++|+++ ..|..+...+++-.|+||+|+|. .||..++-+++.|-+||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLD 156 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLD 156 (1255)
T ss_pred hHHHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhc
Confidence 55555555555432 333322 4555555555555555 45555555555555555555554 55555444444333333
Q ss_pred ccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEE
Q 042568 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLL 336 (983)
Q Consensus 257 Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 336 (983)
||+| ++. .+|+.+..+.+|++|
T Consensus 157 LS~N---------------------------------------------------------rLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 157 LSNN---------------------------------------------------------RLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred cccc---------------------------------------------------------hhh-hcCHHHHHHhhhhhh
Confidence 3333 332 344445555555555
Q ss_pred eccccccCCCCCcccccCCCCcEEEeeCCccc-CCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccC
Q 042568 337 NLSSNLLNGTIPHELCLMSKLERVYLSNNSLS-GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415 (983)
Q Consensus 337 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 415 (983)
+|++|.+...-...+-.|++|+.|.+++.+=+ .-+|.++..+.+|..+|||.|.+. ..|+.+.++++|+.|+||+|.|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 55555544222222333444555555554322 234555555555555555555554 4555555555555555555555
Q ss_pred CCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCC-CCCccccccccccccccccccccccCCCc
Q 042568 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD-GPLPLELSKMDMVLAIDLSFNNLSGSIPP 494 (983)
Q Consensus 416 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 494 (983)
+ .+.-..+...+|++|+||+|+++ .+|..++.++.|+. |++.+|+++ .-+|..++.+.+|+.+..++|++. .+|+
T Consensus 258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k-Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPE 333 (1255)
T KOG0444|consen 258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK-LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPE 333 (1255)
T ss_pred e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH-HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCch
Confidence 5 33333444455555555555555 45555555555554 555555554 124455555555555555555554 4455
Q ss_pred ccccccccceEEeCCCcccccccccccCCCCccEEecCCcc
Q 042568 495 QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535 (983)
Q Consensus 495 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 535 (983)
.++.|..|+.|.|++|++- .+|+.+--|+.|+.||+..|.
T Consensus 334 glcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 334 GLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 5555555555555555554 344444444555555555443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.25 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=200.3
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+|...+.||+|+||.||+|.+.++..||||.+..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677889999999999999987777899998864332 24678999999999999999999999998888999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999886432 35899999999999999999999996 999999999999999999999999998765432110
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......++..|+|||+..+..++.++||||||+++|||++ |+.||.....
T Consensus 157 ------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----------------- 207 (256)
T cd05113 157 ------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----------------- 207 (256)
T ss_pred ------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----------------
Confidence 0111235678999999998889999999999999999999 9999853211
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
....+........ ..+ ...+.++.+++.+||+.+|++||++.++++.++
T Consensus 208 ~~~~~~~~~~~~~-~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 208 SETVEKVSQGLRL-YRP-------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHhcCCCC-CCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111111111111 001 113467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.50 Aligned_cols=264 Identities=26% Similarity=0.381 Sum_probs=207.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 736 (983)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+...........+.+|+++++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346778899999999999999742 24469999986554444567899999999999 899999999999999
Q ss_pred CceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
...++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999875321 1235889999999999999999999996 9999999999999
Q ss_pred CCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 042568 805 DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883 (983)
Q Consensus 805 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p 883 (983)
++++.+||+|||.++........ .......++..|+|||...+..++.++||||||+++|||++ |..|
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred cCCCcEEECCCccceeccccccc-----------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999866432211 11112246678999999998889999999999999999998 7777
Q ss_pred CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 884 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
|... ...++.. . +........ ...++.++.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~~~-----~~~~~~~------------~-~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 240 YPGI-----PVEELFK------------L-LKEGHRMDK-------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred cccC-----CHHHHHH------------H-HHcCCcCCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 6431 1111111 1 111110000 1235578899999999999999999999999999
Q ss_pred HhHhh
Q 042568 964 RLKQY 968 (983)
Q Consensus 964 ~~~~~ 968 (983)
++...
T Consensus 295 ~~~~~ 299 (304)
T cd05101 295 RILTL 299 (304)
T ss_pred HHHHh
Confidence 88654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=319.91 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=204.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|...+.||+|+||.||+|... ++..||||.++........+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999742 24579999987654444567899999999999 799999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++.... ...+++.++..++.|++.|++|||+.+ |+|+||||+||+++.++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999987432 234899999999999999999999986 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~ 898 (983)
........ .......++..|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 190 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------- 250 (302)
T cd05055 190 DIMNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------- 250 (302)
T ss_pred cccCCCce-----------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------
Confidence 65432111 01122346788999999999899999999999999999998 99998642110
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+...+.+........+ ...+.++.+++.+|+..+|++||++.|+++.|+++
T Consensus 251 ---------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 ---------SKFYKLIKEGYRMAQP-------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------HHHHHHHHcCCcCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0111111111110001 11346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=314.58 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=209.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|+..+.||+|+||.||+|... +++.||+|.++... .....+++.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 78999999886432 2233578999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.........+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888654333456899999999999999999999986 99999999999999999999999999876542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......|+..|+|||...+..++.++||||||+++|+|++|+.||... .....++..
T Consensus 159 ~~~-------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~---- 218 (267)
T cd08224 159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCK---- 218 (267)
T ss_pred CCc-------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHh----
Confidence 211 111235888999999999888999999999999999999999998532 111111111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
........ ..+ .......+.+++.+|+..+|++||++.++++.++.+.
T Consensus 219 --------~~~~~~~~-~~~------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 --------KIEKCDYP-PLP------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --------hhhcCCCC-CCC------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111000 001 1234567889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.03 Aligned_cols=274 Identities=22% Similarity=0.285 Sum_probs=201.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999987655444456788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++ ++.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 777776543 345789999999999999999999996 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ...+.. +......
T Consensus 159 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~-~~~~~~~ 223 (309)
T cd07872 159 K-------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-EDELHL-IFRLLGT 223 (309)
T ss_pred c-------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH-HHHHhCC
Confidence 1 1112357899999998865 4678999999999999999999999864211 111111 1111111
Q ss_pred CCcHHHHHH-----Hh-hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 905 RLDPIVEKA-----IA-KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 905 ~~~~~~~~~-----~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...+..... .. ...+...+............++.+++.+|++.||++|||++|++++-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 111110000 00 00000000000011123456789999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=326.05 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=202.7
Q ss_pred CCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC-Cc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP-DF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 738 (983)
++|...+.||+|+||.||+|.. .+++.||||+++..........+.+|++++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999973 346789999997654444456788999999999 689999999988654 45
Q ss_pred eeEEEecccCcccccccccccC----------------------------------------------------------
Q 042568 739 KALVLPLMSNGSLENHLYPSHG---------------------------------------------------------- 760 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 760 (983)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999988754211
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCC
Q 042568 761 -----LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835 (983)
Q Consensus 761 -----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~ 835 (983)
....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------- 235 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------- 235 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch--------
Confidence 0124788899999999999999999986 999999999999999999999999999865322111
Q ss_pred ccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHH
Q 042568 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAI 914 (983)
Q Consensus 836 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 914 (983)
.......++..|+|||...+..++.++||||||+++|||++ |..||...... ..+...+
T Consensus 236 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~ 295 (343)
T cd05103 236 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRL 295 (343)
T ss_pred ---hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----------------HHHHHHH
Confidence 11112346678999999988889999999999999999997 88887532111 0111111
Q ss_pred hhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 915 AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 915 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
........+. ....++.+++.+||+.+|++|||+.|++++|+.+.+.
T Consensus 296 ~~~~~~~~~~-------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 296 KEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred hccCCCCCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111111 1235688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.65 Aligned_cols=243 Identities=24% Similarity=0.337 Sum_probs=193.2
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|+.. +++.||||++.... .....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57889999986542 223456778899998877 699999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--- 150 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--- 150 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---
Confidence 999988864 345899999999999999999999996 9999999999999999999999999987532111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ....
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~----------- 204 (320)
T cd05590 151 ----------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDL----------- 204 (320)
T ss_pred ----------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHH-----------
Confidence 11123469999999999999999999999999999999999999986321 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM------LDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 961 (983)
.+....... ..+ .....++.+++.+|++.||++||++ ++++++
T Consensus 205 -~~~i~~~~~--~~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 205 -FEAILNDEV--VYP-------TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -HHHHhcCCC--CCC-------CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 111111100 011 1134678899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.12 Aligned_cols=243 Identities=26% Similarity=0.379 Sum_probs=200.7
Q ss_pred CCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 672 SSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
.+.||.|+||.||-|++ .+.+.||||.+.... ..+...++.+|+.++++++|||++.+-|+|-.....|+|||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl- 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL- 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-
Confidence 45699999999999994 578889999986543 23456789999999999999999999999999999999999996
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
||-.|.+.-. ++++.+-++..|+.+.++||+|||+.+ .||||||+.|||+++.|.||++|||.|.++.+.
T Consensus 110 GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---- 179 (948)
T KOG0577|consen 110 GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---- 179 (948)
T ss_pred ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch----
Confidence 5877877644 567889999999999999999999996 999999999999999999999999999887543
Q ss_pred cccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
..++|||.|||||++. .+.|+-|+||||+|++..|+...++|+-.+-
T Consensus 180 -------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----------------- 229 (948)
T KOG0577|consen 180 -------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------------- 229 (948)
T ss_pred -------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----------------
Confidence 3368999999999875 4789999999999999999999999964321
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.-..+-.+.....|......|.+.+.. ++..|++.-|.+|||.+++++|-
T Consensus 230 ----AMSALYHIAQNesPtLqs~eWS~~F~~---Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 230 ----AMSALYHIAQNESPTLQSNEWSDYFRN---FVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred ----HHHHHHHHHhcCCCCCCCchhHHHHHH---HHHHHHhhCcccCCcHHHHhhcc
Confidence 111222333444566666677766555 45559999999999999998764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=329.45 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=198.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeeccc---CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTT---TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
+|++.+.||+|+||.||+++.. +++.||+|++.... .....+.+.+|+++++++ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998853 57889999986532 222346788899999999 599999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998864 345889999999999999999999996 9999999999999999999999999997
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 154 ~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~---- 216 (332)
T cd05614 154 EFLSEEK------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQ---- 216 (332)
T ss_pred cccccCC------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCH----
Confidence 6532211 111234699999999998875 4788999999999999999999998632111 111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
..+...+..... ..+ ......+.+++.+|++.||++|| ++++++++
T Consensus 217 ---------~~~~~~~~~~~~-~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 217 ---------SEVSRRILKCDP-PFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---------HHHHHHHhcCCC-CCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111111111 111 12446788999999999999999 78888865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.89 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=199.5
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+|+..+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++|+||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4677889999999999999988778899999854332 24678899999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|.+++.... ..+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999886432 35899999999999999999999996 999999999999999999999999999865422110
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......++..|+|||+..+..++.++||||||+++|||++ |+.||+.... .
T Consensus 157 ------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~-------------- 208 (256)
T cd05059 157 ------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--S-------------- 208 (256)
T ss_pred ------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--H--------------
Confidence 0011124567999999999899999999999999999999 8888863211 0
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+..+. +........+ ..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 209 -~~~~~-~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 209 -EVVES-VSAGYRLYRP-------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -HHHHH-HHcCCcCCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01111 1111110011 12456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=333.75 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=199.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|+..+.||+|+||.||+|+.. +++.||+|+++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457888999999999999999965 68889999986532 122345678899999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998863 34788889999999999999999996 9999999999999999999999999998654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK----RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...
T Consensus 194 ~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~-- 254 (370)
T cd05596 194 ANGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LVG-- 254 (370)
T ss_pred CCCc------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HHH--
Confidence 2211 111234699999999998653 47899999999999999999999986321 111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 961 (983)
..............+. ....+.++.+++.+|++.+|.+ ||+++|++++
T Consensus 255 ----------~~~~i~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 ----------TYSKIMDHKNSLTFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----------HHHHHHcCCCcCCCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111101001110 1124578889999999999987 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=318.26 Aligned_cols=272 Identities=23% Similarity=0.349 Sum_probs=205.1
Q ss_pred CCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Ccee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 740 (983)
-|.+.+.||+|+||.||+++. .++..||+|.++..........+.+|++++++++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356788999999999999984 247789999987655555567899999999999999999999998765 5678
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998643 235899999999999999999999996 99999999999999999999999999986
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
........ .......|+..|+|||+..+..++.++||||||+++|||++++.|+..... .. ...
T Consensus 159 ~~~~~~~~----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~---~~~ 222 (284)
T cd05079 159 IETDKEYY----------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT---LF---LKM 222 (284)
T ss_pred cccCccce----------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc---hh---hhh
Confidence 64322210 111224577789999999888899999999999999999998877532111 00 000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
..+.................... ..+..++.++.+++.+|++.+|++||+++++++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 223 IGPTHGQMTVTRLVRVLEEGKRL----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccccHHHHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000011111111100000 01123567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=319.78 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=205.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
.++|...+.||+|+||.||+|.... ...+|+|.+......+...++.+|+++++++ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3467788999999999999998642 3579999987654444456789999999999 89999999999999999
Q ss_pred eeEEEecccCccccccccccc------------CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 739 KALVLPLMSNGSLENHLYPSH------------GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 999999999999999886421 12456899999999999999999999985 999999999999999
Q ss_pred CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 042568 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885 (983)
Q Consensus 807 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~ 885 (983)
++.+||+|||.++.+...... .......++..|+|||+..+..++.++|||||||++||+++ |..||.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYY-----------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred CCeEEeCccccccccccccce-----------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999876532211 01111235678999999988889999999999999999998 888875
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
... ..+ ..+ .+........ ...+..++.+++.+|++.+|++|||++|++++|+++
T Consensus 237 ~~~-----~~~------------~~~-~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 237 GIP-----VEE------------LFK-LLKEGYRMEK-------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CCC-----HHH------------HHH-HHHcCCcCCC-------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 311 111 111 1111110000 112456789999999999999999999999999887
Q ss_pred H
Q 042568 966 K 966 (983)
Q Consensus 966 ~ 966 (983)
.
T Consensus 292 ~ 292 (293)
T cd05053 292 L 292 (293)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.80 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=204.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
..+|...++||+|+||+||+|.+. +++ .||+|++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356788899999999999999853 444 48999987655555567889999999999999999999999754 568
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+++||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999988643 345899999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~ 899 (983)
+....... ......++..|+|||...+..++.++||||||+++|||++ |..||+... ...+..++.
T Consensus 159 ~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~ 225 (279)
T cd05109 159 LDIDETEY-----------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLE 225 (279)
T ss_pred ccccccee-----------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHH
Confidence 65322110 0111235678999999998899999999999999999998 889986321 111111111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.......+ ..++.++.+++.+||+.||++||++.|+++.++++...
T Consensus 226 ----------------~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 226 ----------------KGERLPQP-------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----------------CCCcCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11110001 12456788999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.93 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=198.8
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccc
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLE 752 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 752 (983)
++||+|+||.||+|...+++.||+|.++.....+....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988889999999876555545567899999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccC
Q 042568 753 NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832 (983)
Q Consensus 753 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 832 (983)
+++... ...+++..+..++.|+++||.|+|+.+ ++||||||+||+++.++.++++|||++........
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------ 148 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------ 148 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc------
Confidence 988643 235889999999999999999999986 99999999999999999999999999875432111
Q ss_pred CCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
.......++..|+|||+..+..++.++||||||+++|++++ |..||..... .. ..
T Consensus 149 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~------------~~- 204 (250)
T cd05085 149 ------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQ------------AR- 204 (250)
T ss_pred ------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HH------------HH-
Confidence 01111234678999999998889999999999999999998 9999853211 00 01
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..+........ ...++..+.+++.+|++.+|++||++.|++++|.
T Consensus 205 ~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 205 EQVEKGYRMSC-------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHcCCCCCC-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 11111111000 1124578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.43 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=189.8
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|... +++.||||+++... .....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57889999997543 122345566677777654 899999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--- 150 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--- 150 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---
Confidence 999988864 345899999999999999999999986 9999999999999999999999999997543211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~------------ 203 (316)
T cd05592 151 ----------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDE------------ 203 (316)
T ss_pred ----------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHH------------
Confidence 11223569999999999999999999999999999999999999986321 111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML-DVAH 960 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 960 (983)
...... ...+ ..+ .....++.+++.+|++.+|++||++. ++++
T Consensus 204 ~~~~i~-~~~~-~~~-------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 204 LFDSIL-NDRP-HFP-------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHH-cCCC-CCC-------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111111 1110 111 11345678999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.69 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=195.6
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|... +++.||||+++... ..+....+.+|..+++++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999965 67889999997543 223456688999999998 799999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--- 150 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--- 150 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC---
Confidence 999888754 346899999999999999999999996 9999999999999999999999999987422111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||+......... .....
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---------~~~~~ 211 (329)
T cd05588 151 ----------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD---------QNTED 211 (329)
T ss_pred ----------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc---------ccchH
Confidence 11123579999999999999999999999999999999999999996432111000 00001
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS------MLDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 961 (983)
.....+.... ...| .....++.+++.+|++.||++||+ ++|++++
T Consensus 212 ~~~~~~~~~~-~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 212 YLFQVILEKQ-IRIP-------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHHcCC-CCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111111111 1111 123467889999999999999997 6788764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=326.71 Aligned_cols=243 Identities=25% Similarity=0.322 Sum_probs=194.0
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|+.. +++.||||+++... ..+....+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 57889999986542 223456678899998876 799999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--- 150 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--- 150 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC---
Confidence 999888864 345889999999999999999999996 9999999999999999999999999987542211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~------------ 203 (321)
T cd05591 151 ----------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDD------------ 203 (321)
T ss_pred ----------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHH------------
Confidence 11123469999999999999899999999999999999999999986321 111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-------SMLDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~ 961 (983)
..+....... ..+. ....++.+++.+|++.||++|| ++++++++
T Consensus 204 ~~~~i~~~~~--~~p~-------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 204 LFESILHDDV--LYPV-------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHcCCC--CCCC-------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111111100 0111 1346788999999999999999 88888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.80 Aligned_cols=258 Identities=30% Similarity=0.450 Sum_probs=197.2
Q ss_pred CCCCCccccCCcEeEEEEEECCC-c--EEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecC------Cc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQDN-T--RIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKP------DF 738 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~~-~--~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 738 (983)
|.+.++||+|+||.||+|.+.+. . .||+|.++... .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678899999999999997543 3 58999886543 223457889999999999999999999987432 24
Q ss_pred eeEEEecccCcccccccccccC--cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHG--LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
.++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999888743221 1345899999999999999999999985 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~ 895 (983)
+++.+...... .......+++.|+|||+..+..++.++||||||+++|||++ |+.||.... ..
T Consensus 158 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~--- 221 (272)
T cd05075 158 LSKKIYNGDYY-----------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NS--- 221 (272)
T ss_pred cccccCcccce-----------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HH---
Confidence 99876432210 11122346778999999999999999999999999999999 788875321 11
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+ ..+. +........ ...++..+.+++.+||+.+|++|||+.+++++|+++
T Consensus 222 ~------------~~~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 E------------IYDY-LRQGNRLKQ-------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred H------------HHHH-HHcCCCCCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1111 111000000 012456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=324.52 Aligned_cols=252 Identities=21% Similarity=0.320 Sum_probs=194.7
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57889999997643 223455678899988877 899999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--- 150 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--- 150 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---
Confidence 999887754 346899999999999999999999996 9999999999999999999999999987532111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||+......... .....
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---------~~~~~ 211 (329)
T cd05618 151 ----------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QNTED 211 (329)
T ss_pred ----------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc---------cccHH
Confidence 11123579999999999999999999999999999999999999996432111100 00011
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS------MLDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 961 (983)
.+...+... ....| .....++.+++.+|++.||++||+ +.+++++
T Consensus 212 ~~~~~i~~~-~~~~p-------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 212 YLFQVILEK-QIRIP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHHhcC-CCCCC-------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111111111 11111 124467889999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=320.48 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=201.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-----------------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-----------------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 729 (983)
++|++.+.||+|+||.||++... +...||+|++..........++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998632 2345899998765444456789999999999999999999
Q ss_pred eeEEecCCceeEEEecccCcccccccccccCc-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCe
Q 042568 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGL-------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNI 802 (983)
Q Consensus 730 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~Ni 802 (983)
++++...+..++||||+++++|.+++...... ...+++..+..++.|++.|++|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999988654321 234788899999999999999999996 99999999999
Q ss_pred EeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh--C
Q 042568 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT--G 880 (983)
Q Consensus 803 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt--g 880 (983)
+++.++.++|+|||+++.+...... ...+...++..|+|||...+..++.++|||||||++|||++ |
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY-----------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce-----------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 9999999999999999865322110 11122345678999999888889999999999999999998 6
Q ss_pred CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhc-CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKY-APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 881 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
..||.... ..+.+.. ........ .....+. ...++..+.+++.+|++.||++||++.||+
T Consensus 231 ~~p~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 231 EQPYSQLS-----DEQVIEN---------TGEFFRDQGRQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred CCCccccC-----hHHHHHH---------HHHHHhhccccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 67875321 1111110 00000000 0000000 112456789999999999999999999999
Q ss_pred HHHH
Q 042568 960 HEMG 963 (983)
Q Consensus 960 ~~L~ 963 (983)
+.|+
T Consensus 292 ~~l~ 295 (296)
T cd05095 292 ATLL 295 (296)
T ss_pred HHHh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=314.47 Aligned_cols=255 Identities=32% Similarity=0.500 Sum_probs=206.7
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.+|...++||+|+||.||+|...+++.+|+|.+...... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 457778999999999999999888899999998655432 3567899999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|+++|++|||+.+ |+||||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997543 346899999999999999999999986 99999999999999999999999999976542211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. .....++..|+|||...+..++.++||||||+++|+|++ |+.||.... .
T Consensus 160 ~-------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~-------------- 210 (261)
T cd05148 160 L-------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--N-------------- 210 (261)
T ss_pred c-------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--H--------------
Confidence 0 012246778999999988889999999999999999998 899985321 0
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.+.++....... ... ...++..+.+++.+|++.+|++|||++++.+.|+.+
T Consensus 211 -~~~~~~~~~~~~-~~~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 211 -HEVYDQITAGYR-MPC-------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -HHHHHHHHhCCc-CCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111111111111 001 123456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=331.46 Aligned_cols=254 Identities=22% Similarity=0.231 Sum_probs=200.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||+|+++.... .+..+.+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999965 688999999975432 234567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998753 246899999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM------GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
.... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... . ...
T Consensus 155 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~-~~~ 217 (330)
T cd05601 155 NKMV------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT----S-AKT 217 (330)
T ss_pred CCce------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC----H-HHH
Confidence 2211 112246899999999986 4567899999999999999999999986321 1 111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.............+. ......++.+++..|++ +|++||++++++++
T Consensus 218 ------------~~~i~~~~~~~~~~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 218 ------------YNNIMNFQRFLKFPE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ------------HHHHHcCCCccCCCC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111111000000010 01245678889999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=319.41 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=203.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-Cc--EEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-NT--RIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|++.++||+|+||.||+|...+ +. .+|+|.++........+.+.+|+++++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998653 33 47888886544444457789999999999 799999999999999999999
Q ss_pred EecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
+||+++++|.+++..... ....+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865321 1235889999999999999999999986 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |+.||....
T Consensus 159 kl~dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~- 223 (297)
T cd05089 159 KIADFGLSRGEEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT- 223 (297)
T ss_pred EECCcCCCcccccee--------------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 999999986322110 0011123457999999998889999999999999999997 999985321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+ ..+....... ...+ ..++.++.+++.+|++.+|.+||++.++++.|+.+.+..
T Consensus 224 ----~~~------------~~~~~~~~~~-~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 224 ----CAE------------LYEKLPQGYR-MEKP-------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----HHH------------HHHHHhcCCC-CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 1111111100 0011 124567889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.24 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=195.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCC-CccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHR-NLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 743 (983)
+|+..+.||+|+||.||+|+.. +++.||||++.... .....+.+..|.++++.++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999965 56789999986542 223456788899999999765 5888999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988864 345889999999999999999999996 99999999999999999999999999874321
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+
T Consensus 154 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~~------- 208 (324)
T cd05587 154 GG-------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----EDE------- 208 (324)
T ss_pred CC-------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHH-------
Confidence 11 11123469999999999999999999999999999999999999986321 011
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-----LDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 961 (983)
.... +.... ...+ .....++.+++.+|+..||++|++. +++.++
T Consensus 209 -----~~~~-i~~~~-~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 209 -----LFQS-IMEHN-VSYP-------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -----HHHH-HHcCC-CCCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 11110 0011 1234678899999999999999986 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.13 Aligned_cols=272 Identities=21% Similarity=0.281 Sum_probs=206.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|.+.+.||+|+||.||+|... ++..||+|.++.....+...++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999965 57889999987654444567789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998643 45889999999999999999999742 49999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....|+..|+|||...+..++.++||||||+++|+|++|+.||.... ......+........
T Consensus 155 ---------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~ 217 (308)
T cd06615 155 ---------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEG 217 (308)
T ss_pred ---------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccc
Confidence 122468899999999988889999999999999999999999985321 111222111110000
Q ss_pred C-----------------cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 906 L-----------------DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 906 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
. .....+..........+... ......++.+++.+|+..+|++||+++|++++-.-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 0 00001111111111111100 11245678999999999999999999999988654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.61 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=198.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4567999999999999999999965 57889999986432 22234568899999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999998863 34788999999999999999999996 999999999999999999999999999865
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK----RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...
T Consensus 193 ~~~~~------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~~~- 254 (370)
T cd05621 193 DETGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----LVG- 254 (370)
T ss_pred ccCCc------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----HHH-
Confidence 42211 111235799999999998764 37889999999999999999999986321 111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHEM 962 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 962 (983)
..............+. .......+.+++.+|+..+|.+ ||+++|++++-
T Consensus 255 -----------~~~~i~~~~~~~~~p~-----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 255 -----------TYSKIMDHKNSLNFPE-----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred -----------HHHHHHhCCcccCCCC-----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 1111111111001110 1124566788888899755543 89999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=316.57 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=201.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
+++|...+.||+|+||.||+|.+.. +..||+|.+...........|.+|+.++++++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568889999999999999999753 5678999886554444456799999999999999999999999988899
Q ss_pred eEEEecccCcccccccccccC---cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEc
Q 042568 740 ALVLPLMSNGSLENHLYPSHG---LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVA 813 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~ 813 (983)
++||||+++++|.+++..... ....+++..+.+++.||++|++|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999998865431 1235899999999999999999999996 99999999999998654 69999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~ 892 (983)
|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 162 dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--~ 228 (277)
T cd05036 162 DFGMARDIYRASYY-----------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--Q 228 (277)
T ss_pred cCccccccCCccce-----------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H
Confidence 99999866321110 01111234578999999999899999999999999999997 9999863211 0
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+... +........+ ..++..+.+++.+|++.+|++||++.+|+++|.
T Consensus 229 ~~~~~----------------~~~~~~~~~~-------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 EVMEF----------------VTGGGRLDPP-------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHH----------------HHcCCcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 1110000011 124567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=317.56 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=203.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.+.+.||+|+||.||+|.... +..||+|.+...........+.+|+++++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467788999999999999998642 36799999865544444567889999999999999999999999999999
Q ss_pred EEEecccCcccccccccccCc------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 741 LVLPLMSNGSLENHLYPSHGL------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 999999999999988653321 234789999999999999999999986 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCc
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSS 893 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~ 893 (983)
||+++........ .......+|..|+|||...+..++.++||||||+++||+++ |+.||.... ..
T Consensus 163 fg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~- 228 (277)
T cd05032 163 FGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NE- 228 (277)
T ss_pred cccchhhccCccc-----------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HH-
Confidence 9999865432210 11122356789999999988889999999999999999998 888875311 11
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+ ..+ .+........+ ..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 229 --~------------~~~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 --E------------VLK-FVIDGGHLDLP-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --H------------HHH-HHhcCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 111 11111111111 113567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.00 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=200.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+|+..++||+|+||.||++... +++.||||.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999964 688999999864322 1224567889999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++.... ...+++..+..++.|+++|+.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998876432 346899999999999999999999996 999999999999999999999999998765321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. .....||..|+|||.+.+..++.++||||+||++|||++|+.||..... ...
T Consensus 156 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~~~---------- 209 (285)
T cd05605 156 ET--------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--KVK---------- 209 (285)
T ss_pred Cc--------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--hhH----------
Confidence 11 1123689999999999988899999999999999999999999864211 000
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.+.+...+...... . ....+..+.+++.+|++.||++|| ++++++++
T Consensus 210 --~~~~~~~~~~~~~~-~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 210 --REEVERRVKEDQEE-Y-------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --HHHHHHHhhhcccc-c-------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00111111111100 0 122456788999999999999999 88899775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.33 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=203.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc---EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT---RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~---~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|+..+.||+|+||.||+|... +++ .+|+|.++........+.+..|++++++++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999965 333 69999986654444567899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++++|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999988643 245899999999999999999999986 9999999999999999999999999987664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||..... .++..
T Consensus 159 ~~~~~~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~-- 221 (268)
T cd05063 159 DDPEGT----------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMK-- 221 (268)
T ss_pred cccccc----------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHH--
Confidence 322110 00011123567999999998889999999999999999998 9999853211 11111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.+.... ..+. ..+++.++.+++.+|++.+|++||++.+|++.|+++
T Consensus 222 -----------~i~~~~--~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 -----------AINDGF--RLPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----------HHhcCC--CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111110 0110 123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.07 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=203.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
+++|++.++||+|+||.||+|..+ .+..||+|.++..........+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 567889999999999999999753 24579999886554433455788999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccC------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 740 ALVLPLMSNGSLENHLYPSHG------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
++||||+++|+|.+++..... .....++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999864321 1234677889999999999999999986 9999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~ 892 (983)
|||+++........ .......++..|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 162 Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--- 227 (288)
T cd05061 162 DFGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--- 227 (288)
T ss_pred cCCccccccccccc-----------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 99998865432111 11112245778999999998889999999999999999999 7888753211
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.++ .+........ ..+ ..++..+.+++.+|++.+|++|||+.|+++.+++.
T Consensus 228 --~~~------------~~~~~~~~~~-~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 --EQV------------LKFVMDGGYL-DQP-------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --HHH------------HHHHHcCCCC-CCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111 1111110000 000 12356899999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.63 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=204.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-C---CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-D---NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~---~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|.+.+.||+|+||.||+|.+. + +..+|+|.++........+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999863 2 3369999987654444567899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||++..+.
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998653 235899999999999999999999986 9999999999999999999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... .......++..|+|||++.+..++.++||||||+++||+++ |+.||..... ...
T Consensus 158 ~~~~~~----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~------- 218 (267)
T cd05066 158 DDPEAA----------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDV------- 218 (267)
T ss_pred ccccee----------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHH-------
Confidence 322111 01111234568999999998889999999999999999887 9999853211 011
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.+. +..... .+. ...++..+.+++.+|++.+|++||++.++++.|.++
T Consensus 219 --------~~~-~~~~~~--~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 219 --------IKA-IEEGYR--LPA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------HHH-HhCCCc--CCC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 111000 010 112456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=333.73 Aligned_cols=264 Identities=23% Similarity=0.261 Sum_probs=196.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+|...++||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999964 678899999865421 2245678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999988642 35788999999999999999999996 999999999999999999999999998643211
Q ss_pred cccccc------cCCCC----------------------------ccccccCccccccccccccccCCCCCCccchhHHH
Q 042568 825 DESVNC------ANDSM----------------------------SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSF 870 (983)
Q Consensus 825 ~~~~~~------~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~Sl 870 (983)
...... ..+.. .........+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 100000 00000 00001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCC
Q 042568 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950 (983)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 950 (983)
||++|||++|+.||..... . +.....+........+. ......++.+++.+|+ .+|+
T Consensus 235 Gvil~elltG~~Pf~~~~~----~-------------~~~~~i~~~~~~~~~p~-----~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP----L-------------ETQMKVINWQTSLHIPP-----QAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH----H-------------HHHHHHHccCCCcCCCC-----cccCCHHHHHHHHHHc-cCHh
Confidence 9999999999999863210 0 00111111111111110 1123456777777765 4999
Q ss_pred CCCC---HHHHHHH
Q 042568 951 TRPS---MLDVAHE 961 (983)
Q Consensus 951 ~RPs---~~evl~~ 961 (983)
+|++ ++|+++|
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=323.86 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=190.7
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|... +++.||+|.++.... ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 688999999975431 22345677788888765 899999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--- 150 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC---
Confidence 999988864 345889999999999999999999996 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~------------ 203 (316)
T cd05620 151 ----------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDE------------ 203 (316)
T ss_pred ----------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHH------------
Confidence 11123569999999999999999999999999999999999999986321 111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML-DVAH 960 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 960 (983)
..+. +.... ...+. ....++.+++.+|++.||++||++. ++.+
T Consensus 204 ~~~~-~~~~~-~~~~~-------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 204 LFES-IRVDT-PHYPR-------WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHH-HHhCC-CCCCC-------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1111 11111 01111 1346788999999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.56 Aligned_cols=272 Identities=25% Similarity=0.338 Sum_probs=201.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 739 (983)
.+|.+.+.||+|+||.||+|..+ ++..||+|.+..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46788899999999999999743 577899999865432 3456789999999999999999999987543 467
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999998643 235899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
......... .......++..|+|||+..+..++.++||||||+++|||++|..|+.... ......+.
T Consensus 157 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~ 223 (284)
T cd05081 157 VLPQDKEYY----------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP---AEFMRMMG 223 (284)
T ss_pred cccCCCcce----------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc---hhhhhhcc
Confidence 765322110 00111234556999999998889999999999999999999987753211 00000000
Q ss_pred hhCC-CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 900 RHYP-HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 900 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.... ..........+..... .+ ....++.++.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 224 NDKQGQMIVYHLIELLKNNGR--LP-----APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccchHHHHHHHhcCCc--CC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000 0010111111111110 01 0123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.71 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=205.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD 737 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 737 (983)
++|.+.+.||+|+||.||+|... ....||+|.++..........+.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 24568999987554444567789999999999 6999999999999888
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++||||+++|+|.+++..... ....+++..+.+++.|++.||+|||+++ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999865321 1245899999999999999999999986 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.+||+|||.++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY-----------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred CCCcEEEccccccccccccccc-----------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 9999999999999866432111 00111234567999999998889999999999999999999 88887
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.... ..+ ..+ .+........+ ..++.++.+++.+|+..+|++||++.|+++.|++
T Consensus 238 ~~~~-----~~~------------~~~-~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 238 PGIP-----VEE------------LFK-LLREGHRMDKP-------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred CCCC-----HHH------------HHH-HHHcCCCCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 5321 111 111 11111100011 1245678899999999999999999999999998
Q ss_pred hHhhc
Q 042568 965 LKQYL 969 (983)
Q Consensus 965 ~~~~~ 969 (983)
+....
T Consensus 293 ~~~~~ 297 (314)
T cd05099 293 VLAAV 297 (314)
T ss_pred HHHHh
Confidence 86543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.02 Aligned_cols=253 Identities=32% Similarity=0.501 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|.+.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 35778899999999999999988888899999865433 2467999999999999999999999885 45679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||.+..+.....
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999887532 345899999999999999999999986 99999999999999999999999999986543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||.... ..
T Consensus 158 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~------------- 210 (260)
T cd05070 158 T------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NR------------- 210 (260)
T ss_pred c------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HH-------------
Confidence 1 0111235678999999988889999999999999999999 888885321 10
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+..+. +...... + ...+.+..+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 211 --~~~~~-~~~~~~~--~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 --EVLEQ-VERGYRM--P-----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --HHHHH-HHcCCCC--C-----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111 1110000 0 012345679999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.03 Aligned_cols=269 Identities=23% Similarity=0.345 Sum_probs=208.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|+..+.||+|+||+||+|... +++.||+|++......+..+++.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35667789999999999999965 68889999987655555567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ...+++..+..++.++++|+.|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999988764 235899999999999999999999743 4999999999999999999999999998654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......|+..|+|||++.+..++.++|||||||++|++++|+.||+.....+.. ...+..
T Consensus 158 --------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~~ 217 (284)
T cd06620 158 --------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPMG 217 (284)
T ss_pred --------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhhH
Confidence 112246899999999998888999999999999999999999999753321110 000000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
+.......+... ....+ ..+.+.++.+++.+|++.||++||+++|++++..-++...
T Consensus 218 ~~~~~~~~~~~~-~~~~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 218 ILDLLQQIVQEP-PPRLP------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred HHHHHHHHhhcc-CCCCC------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 111111111111 10000 1225567899999999999999999999999865554433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=321.35 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=212.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIR-HRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 741 (983)
...|...+.||+|.||.||+++.+ +|+.+|+|.+++.... .....+.+|+++|+++. |||||.++++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356778899999999999999966 5999999999766542 24578999999999998 9999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC----CCEEEccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED----LTALVADFGI 817 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~----~~~kl~Dfgl 817 (983)
|||+++||.|.+.+... .+++..+..++.|++.|+.|||+.| |+|||+||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998754 2899999999999999999999986 9999999999999633 5799999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
|...... ......+||+.|+|||.+....|+..+||||+||++|.|++|..||.......
T Consensus 186 a~~~~~~--------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------ 245 (382)
T KOG0032|consen 186 AKFIKPG--------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE------ 245 (382)
T ss_pred ceEccCC--------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH------
Confidence 9987651 22344789999999999999999999999999999999999999986421110
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.......... ......|+.....+.+++..|+..||.+|+|+.++++|-+
T Consensus 246 -----------~~~~i~~~~~-----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 246 -----------IFLAILRGDF-----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -----------HHHHHHcCCC-----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1111111111 2234457788899999999999999999999999999854
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=323.73 Aligned_cols=243 Identities=25% Similarity=0.317 Sum_probs=194.1
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|... +++.||||+++... .......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57889999997542 223456678899999888 799999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 150 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--- 150 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC---
Confidence 999888764 235899999999999999999999996 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....
T Consensus 151 ----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~---------- 205 (318)
T cd05570 151 ----------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELF---------- 205 (318)
T ss_pred ----------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHH----------
Confidence 11122468999999999999999999999999999999999999986321 11111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-----LDVAHE 961 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 961 (983)
...... . ...+ .....++.+++.+|++.||++||++ .+++++
T Consensus 206 --~~i~~~-~-~~~~-------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 206 --QSILED-E-VRYP-------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --HHHHcC-C-CCCC-------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111100 0 0011 1234678999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.50 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=200.0
Q ss_pred CCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCc-----
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDF----- 738 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 738 (983)
|...+.||+|+||.||+|.... +..||||.++.... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 36799999875432 2235678999999999999999999998865544
Q ss_pred -eeEEEecccCcccccccccccC--cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 739 -KALVLPLMSNGSLENHLYPSHG--LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 739 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 6899999999999988754321 1346899999999999999999999986 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l 894 (983)
|+++.+...... .......++..|+|||+..+..++.++||||||+++|||++ |..||..... .
T Consensus 158 g~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~-- 222 (273)
T cd05035 158 GLSKKIYSGDYY-----------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--H-- 222 (273)
T ss_pred cceeeccccccc-----------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--H--
Confidence 999866432211 01111235678999999988889999999999999999999 8888753211 0
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+..+... .......+ ..++.++.+++.+|++.||++||++.|++++|+++
T Consensus 223 -------------~~~~~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 -------------EIYDYLR-HGNRLKQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------------HHHHHHH-cCCCCCCC-------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 11111111 12456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=334.21 Aligned_cols=265 Identities=22% Similarity=0.238 Sum_probs=198.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999954 68889999985432 1223567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999998643 35788899999999999999999996 99999999999999999999999999864321
Q ss_pred CcccccccC-------------C-----------------CCccccccCccccccccccccccCCCCCCccchhHHHHHH
Q 042568 824 IDESVNCAN-------------D-----------------SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 873 (983)
Q Consensus 824 ~~~~~~~~~-------------~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~i 873 (983)
......... . ............||+.|+|||++.+..++.++||||+||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 100000000 0 0000011123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC
Q 042568 874 LLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953 (983)
Q Consensus 874 l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 953 (983)
+|||++|+.||..... .+... ...........+ .......++.+++.+|+ .+|++|+
T Consensus 234 lyell~G~~Pf~~~~~-----~~~~~------------~i~~~~~~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 234 LYEMLVGQPPFLADTP-----AETQL------------KVINWETTLHIP-----SQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeehhhCCCCCCCCCH-----HHHHH------------HHhccCccccCC-----CCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 9999999999864211 11110 000000000001 01124456777888876 4999999
Q ss_pred ---CHHHHHHH
Q 042568 954 ---SMLDVAHE 961 (983)
Q Consensus 954 ---s~~evl~~ 961 (983)
++.|++++
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 89999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=325.36 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=195.5
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+|.+.+.||+|+||.||+|+.. +++.||||++..... ......+..|.+++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 577899999875432 22345677788888877 5899999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999888864 245889999999999999999999996 99999999999999999999999999875321
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 154 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~------- 208 (323)
T cd05616 154 DG-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DE------- 208 (323)
T ss_pred CC-------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HH-------
Confidence 11 112235699999999999999999999999999999999999999863210 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-----LDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 961 (983)
.......... ..+ .....++.+++.+|++.+|++|++. .++.++
T Consensus 209 -----~~~~i~~~~~--~~p-------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 209 -----LFQSIMEHNV--AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----HHHHHHhCCC--CCC-------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111111100 011 1244678899999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.67 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=203.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcE--EEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTR--IAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~--vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|++.+.||+|+||.||+|.++ ++.. +|+|.++.........++.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999964 4543 5777775444444567889999999999 899999999999999999999
Q ss_pred EecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
+||+++++|.+++..... ....+++..++.++.|+++|++|||+.+ |+||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999998864321 1235889999999999999999999986 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 164 kl~dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 164 KIADFGLSRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred EeCccccCcccchhh--------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 999999986322100 0111234678999999988889999999999999999998 9999853211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.+. .+. +........+ ...+.++.+++.+|++.+|++||++++++++++++.+..
T Consensus 230 -----~~~------------~~~-~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 230 -----AEL------------YEK-LPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -----HHH------------HHH-HhcCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 111 1000000000 123457889999999999999999999999999886655
Q ss_pred C
Q 042568 970 S 970 (983)
Q Consensus 970 ~ 970 (983)
.
T Consensus 285 ~ 285 (303)
T cd05088 285 K 285 (303)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.06 Aligned_cols=249 Identities=26% Similarity=0.422 Sum_probs=195.1
Q ss_pred ccccCCcEeEEEEEEC---CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 674 LIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
.||+|+||.||+|.++ ++..||+|+++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 5678999998654332 245678999999999999999999998864 5668999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
+|.+++.. ...+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.+.......
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~- 152 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY- 152 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee-
Confidence 99998864 235889999999999999999999986 9999999999999999999999999998764322110
Q ss_pred ccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......++..|+|||......++.++||||||+++|||++ |+.||..... ......
T Consensus 153 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----------- 210 (257)
T cd05116 153 ---------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQM----------- 210 (257)
T ss_pred ---------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH-----------
Confidence 01111235678999999988888999999999999999998 9999864211 111111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+........+ ..++.++.+++.+||+.||++||++.+|++.|+..
T Consensus 211 -----i~~~~~~~~~-------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 211 -----IESGERMECP-------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -----HHCCCCCCCC-------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111100111 12457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.27 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=203.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|+..+.||+|+||.||+|... ++..||+|.+..........++.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888999999999999999864 46789999987655444567799999999999999999999999998999
Q ss_pred eEEEecccCcccccccccccC------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCC
Q 042568 740 ALVLPLMSNGSLENHLYPSHG------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSN 801 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~N 801 (983)
++|+||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999998864321 1235788999999999999999999986 9999999999
Q ss_pred eEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-C
Q 042568 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-G 880 (983)
Q Consensus 802 iLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g 880 (983)
|++++++.++|+|||.+..+...... .......++..|+|||.+.+..++.++|||||||++|||++ |
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY-----------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred eEecCCCceEECccccceecccCccc-----------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999998755322110 11111235678999999998899999999999999999998 8
Q ss_pred CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 881 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
..||.... ..+... .+........+ ...+.++.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~p~~~~~-----~~~~~~-------------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 230 MQPYYGMA-----HEEVIY-------------YVRDGNVLSCP-------DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCCC-----HHHHHH-------------HHhcCCCCCCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88875321 111111 11111000001 124567899999999999999999999999
Q ss_pred HHHH
Q 042568 961 EMGR 964 (983)
Q Consensus 961 ~L~~ 964 (983)
.|++
T Consensus 285 ~l~~ 288 (288)
T cd05050 285 ILQR 288 (288)
T ss_pred HhhC
Confidence 8863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=315.81 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=192.7
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||.||++... +|+.||+|.+...... .....+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999964 6899999998643221 1234566799999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----- 150 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----- 150 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-----
Confidence 88876432 345889999999999999999999986 99999999999999999999999999876542211
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
.....||..|+|||++.+..++.++||||+||++|||++|+.||...... ..... +..
T Consensus 151 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~------------~~~ 208 (277)
T cd05607 151 ---------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEE------------LKR 208 (277)
T ss_pred ---------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHH------------HHH
Confidence 11235899999999999988999999999999999999999998632111 01011 111
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
......... .......++.+++.+|++.||++||++.|+++++
T Consensus 209 ~~~~~~~~~--------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 209 RTLEDEVKF--------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred Hhhcccccc--------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 111110000 0012456789999999999999999997665443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.51 Aligned_cols=242 Identities=28% Similarity=0.395 Sum_probs=190.7
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|... +++.||||+++... .......+..|..+++.. +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57889999986542 122345667788888764 899999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 150 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--- 150 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---
Confidence 999988864 345889999999999999999999996 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~------------ 203 (316)
T cd05619 151 ----------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEE------------ 203 (316)
T ss_pred ----------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHH------------
Confidence 11122468999999999999899999999999999999999999986321 111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML-DVAH 960 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 960 (983)
..+. +..... ..+. ....++.+++.+|++.||++||++. ++.+
T Consensus 204 ~~~~-i~~~~~-~~~~-------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 204 LFQS-IRMDNP-CYPR-------WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHH-HHhCCC-CCCc-------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111 111110 1111 1345688999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.17 Aligned_cols=253 Identities=29% Similarity=0.479 Sum_probs=200.7
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|++|.||+|....+..||+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45778889999999999999988777899998754322 3467899999999999999999999885 45679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999987532 345899999999999999999999986 99999999999999999999999999976543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .
T Consensus 158 ~------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~------------- 210 (260)
T cd05069 158 T------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--R------------- 210 (260)
T ss_pred c------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--H-------------
Confidence 0 1111246778999999998889999999999999999999 8889853211 0
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+..+. +....... ...+.+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 211 --~~~~~-~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 --EVLEQ-VERGYRMP-------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHHHH-HHcCCCCC-------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111 11110000 012345778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.44 Aligned_cols=238 Identities=25% Similarity=0.328 Sum_probs=187.4
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHH-HHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQ-ILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||+||+|... +++.||+|++..... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 688999999865421 122344555555 46789999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--- 150 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---
Confidence 999988864 345889999999999999999999996 9999999999999999999999999987532211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~------------ 203 (323)
T cd05575 151 ----------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAE------------ 203 (323)
T ss_pred ----------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHH------------
Confidence 1122346999999999999999999999999999999999999998532 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
..+....... ..+ .....++.+++.+|++.||++||++.
T Consensus 204 ~~~~i~~~~~--~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 204 MYDNILNKPL--RLK-------PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHcCCC--CCC-------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111111111 011 12356788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.22 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=208.5
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+-|...+.||+|.|++|-.|++ -+|++||||++++..-.+ ....+.+|++.|+-++|||||++|.+...+...|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4567788899999999999984 589999999998765443 46788999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe-CCCCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL-DEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl-~~~~~~kl~Dfgla~~~~~ 823 (983)
.-++|+|.+++.++ ...+.+..+.+++.||+.|+.|+|+.+ +||||+||+||.+ .+-|-+|++|||.+-.+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999865 456999999999999999999999996 9999999999976 5678999999999987765
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS-THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.+.. .+.+|+..|-|||.+.|..|+ +++||||+|||+|-+++|+.||...- |...+.
T Consensus 172 G~kL--------------~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-DSETLT------- 229 (864)
T KOG4717|consen 172 GKKL--------------TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-DSETLT------- 229 (864)
T ss_pred cchh--------------hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-chhhhh-------
Confidence 5432 346899999999999998886 78899999999999999999997532 111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+.- .... ......++.+||..|+..||.+|.+.+||+.+-
T Consensus 230 ---------mImDC--KYtv-------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 230 ---------MIMDC--KYTV-------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ---------hhhcc--cccC-------chhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 11111 0111 245778999999999999999999999998643
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.22 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=202.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|.+.++||+|+||.||+|...+++.||+|.+..... ...++.+|++++++++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46778899999999999999988899999999864433 2468899999999999999999999874 45689999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999886543 346899999999999999999999986 99999999999999999999999999976542111
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+.
T Consensus 158 ~------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~-------- 212 (260)
T cd05067 158 T------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEV-------- 212 (260)
T ss_pred c------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHH--------
Confidence 0 1112245678999999998889999999999999999999 9999863210 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.+. +........ ....+.++.+++.+|++.+|++||+++++...|+.
T Consensus 213 ----~~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 213 ----IQN-LERGYRMPR-------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----HHH-HHcCCCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 111100000 11244679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=302.97 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=208.2
Q ss_pred CCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|...+.||+|.-|+||++..++ +..+|+|++++..- .+...+...|-+||+.+.||.+..+|+.++.++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4457889999999999999764 47799999977643 23456778899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|+||+|....+++. .+.+++..++-++..++-||+|||-.| ||.||+||+|||+.++|++-|+||.++.......
T Consensus 159 CpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999888765 567999999999999999999999997 9999999999999999999999999987653211
Q ss_pred cccc-------------------c------cCCC------------------CccccccCccccccccccccccCCCCCC
Q 042568 826 ESVN-------------------C------ANDS------------------MSFTSTDGLLCGSVGYIAPEYGMGKRAS 862 (983)
Q Consensus 826 ~~~~-------------------~------~~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 862 (983)
+.+. + .... .+.......++||-.|.|||++.|...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 1100 0 0000 0111233457899999999999999999
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHh
Q 042568 863 THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGL 942 (983)
Q Consensus 863 ~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 942 (983)
.++|.|+|||++|||+.|+.||.+.. ....+...+.+.. ..|. ..+.+..+.+||.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~~l------------------~Fp~-----~~~vs~~akDLIr 369 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQPL------------------KFPE-----EPEVSSAAKDLIR 369 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcCCC------------------cCCC-----CCcchhHHHHHHH
Confidence 99999999999999999999997532 1222222222210 0110 1245678999999
Q ss_pred hhcCCCCCCCCC----HHHHHHH
Q 042568 943 LCTQYNPSTRPS----MLDVAHE 961 (983)
Q Consensus 943 ~cl~~dP~~RPs----~~evl~~ 961 (983)
+.+..||++|.. +.||.+|
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHhccChhhhhccccchHHhhcC
Confidence 999999999998 8888764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.36 Aligned_cols=239 Identities=26% Similarity=0.315 Sum_probs=190.6
Q ss_pred CccccCCcEeEEEEEE----CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 673 SLIGSGRFGHVYKGVL----QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+.||+|+||.||+++. .+|+.||+|+++..... ....++.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 35788999999754322 234567889999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999988864 345899999999999999999999996 99999999999999999999999999875432211
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....
T Consensus 154 ------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~---------- 206 (318)
T cd05582 154 ------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKET---------- 206 (318)
T ss_pred ------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHH----------
Confidence 1122468999999999998889999999999999999999999986321 1111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
......... ..+ .....++.+++.+|++.||++||++.+
T Consensus 207 --~~~i~~~~~--~~p-------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 --MTMILKAKL--GMP-------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --HHHHHcCCC--CCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111111100 011 123467889999999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.34 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=190.8
Q ss_pred CccccCCcEeEEEEEECC---CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQD---NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 35689998866554444567899999999999999999999999989999999999999
Q ss_pred ccccccccccCc-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 750 SLENHLYPSHGL-SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 750 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
+|.+++...... ....++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++++|||.++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~- 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY- 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee-
Confidence 999998754321 235677888899999999999999986 999999999999999999999999998754321110
Q ss_pred cccCCCCccccccCccccccccccccccCCC-------CCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-------RASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
.......|+..|+|||++.+. .++.++||||||+++|||++ |+.||...... ......+.
T Consensus 157 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~~~~~- 224 (269)
T cd05087 157 ----------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-QVLTYTVR- 224 (269)
T ss_pred ----------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHhh-
Confidence 111224578899999987642 35789999999999999996 99998542111 00000000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
........ +... ......+.+++.+|+ .+|++|||++||++.|+
T Consensus 225 -----------~~~~~~~~---~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 -----------EQQLKLPK---PRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -----------cccCCCCC---CccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000 0000 113345778888898 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.37 Aligned_cols=254 Identities=21% Similarity=0.330 Sum_probs=198.7
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4688899999999999999996 4678899999865432 2346788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ...+++..+..++.|+++|+.|||+.+ |+|||+||+||+++.++.++|+|||+++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998864 345889999999999999999999986 9999999999999999999999999998654211
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.......|+..|+|||.+. ...++.++||||+||++|||++|+.||........ ...+...
T Consensus 161 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~-- 224 (267)
T cd06646 161 -------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKS-- 224 (267)
T ss_pred -------------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecC--
Confidence 1112246889999999874 34578899999999999999999999853211100 0000000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.......+ .....+.++.+++.+|+..+|++||+++++++++
T Consensus 225 -------------~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 -------------NFQPPKLK-----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -------------CCCCCCCc-----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000000 0012346788999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.63 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=203.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46778899999999999999876 88899999965543 4678999999999999999999999999889999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999987543 236899999999999999999999996 99999999999999999999999999986532111
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
...++..|+|||++.+..++.++||||||+++||+++ |+.||.... ..+
T Consensus 158 ----------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~--------- 207 (256)
T cd05039 158 ----------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKD--------- 207 (256)
T ss_pred ----------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHH---------
Confidence 1234568999999998889999999999999999998 999975321 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.. ..+........+ ...+.++.+++.+|+..+|++||+++|++++|+.+
T Consensus 208 ---~~-~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 208 ---VV-PHVEKGYRMEAP-------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---HH-HHHhcCCCCCCc-------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11 111111110001 12457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.84 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|++|.||+|... +++.||+|.+.... .......+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999965 68889999986543 233567889999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..++.++.|+++|+.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999987542 356899999999999999999999986 9999999999999999999999999988664321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++||||||+++++|++|+.||..... ..
T Consensus 156 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~--------- 208 (256)
T cd08529 156 N-------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GA--------- 208 (256)
T ss_pred c-------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HH---------
Confidence 1 11224688999999999998899999999999999999999999863210 00
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..........+. .+ ......+.+++.+|++.+|++||++.+++++
T Consensus 209 ---~~~~~~~~~~~~-~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 209 ---LILKIIRGVFPP-VS-------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---HHHHHHcCCCCC-Cc-------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111111111110 00 1345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.41 Aligned_cols=362 Identities=29% Similarity=0.419 Sum_probs=261.2
Q ss_pred eEEEEEcccCCcc-cccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 78 KVVELDLSARSIY-GTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 78 ~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
-|..+|+++|.++ +..|..+..+++++.|.|...++. .+|++++.|.+|++|.+++|++. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3788999999998 578999999999999999999998 89999999999999999999998 77888999999999999
Q ss_pred cCcccc-cccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccc
Q 042568 157 GNNKLV-GEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235 (983)
Q Consensus 157 s~N~l~-~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 235 (983)
.+|++. ..||..+| .+..|+.||||+|+++ +.|. .+..-.++-.|+|++|+|..+....|.+++.|-.||||+|
T Consensus 86 R~N~LKnsGiP~diF---~l~dLt~lDLShNqL~-EvP~-~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIF---RLKDLTILDLSHNQLR-EVPT-NLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNN 160 (1255)
T ss_pred hccccccCCCCchhc---ccccceeeecchhhhh-hcch-hhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccc
Confidence 999986 35788888 8899999999999998 6664 3446788999999999999666677889999999999999
Q ss_pred ccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCccc-ccCCccccccccCeeEEEc
Q 042568 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG-GMIPSIIGDLSTNLVQIHL 314 (983)
Q Consensus 236 ~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~~L~~L~L 314 (983)
++. .+|+.+ ..+..|++|.||+|.+.... ...+..+++|+.|++++.+-+ ..+|..+..+ .+|..+||
T Consensus 161 rLe-~LPPQ~-RRL~~LqtL~Ls~NPL~hfQ--------LrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l-~NL~dvDl 229 (1255)
T KOG0444|consen 161 RLE-MLPPQI-RRLSMLQTLKLSNNPLNHFQ--------LRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDL-HNLRDVDL 229 (1255)
T ss_pred hhh-hcCHHH-HHHhhhhhhhcCCChhhHHH--------HhcCccchhhhhhhcccccchhhcCCCchhhh-hhhhhccc
Confidence 997 788875 67889999999999764321 234556777778888776554 2345555555 35666666
Q ss_pred cCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccC-
Q 042568 315 DCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG- 393 (983)
Q Consensus 315 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~- 393 (983)
|+|.+. .+|+.+.++++|+.|+||+|+|+ .+.-......+|+.|+||.|+++ .+|++++.+++|+.|++.+|+++-
T Consensus 230 S~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~Fe 306 (1255)
T KOG0444|consen 230 SENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFE 306 (1255)
T ss_pred cccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccccc
Confidence 666665 55666666666666666666665 33333444555666666666665 555556666666666666665541
Q ss_pred cCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCC
Q 042568 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNH 463 (983)
Q Consensus 394 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 463 (983)
-+|..++.+.+|+.+..++|.+. .+|++++.+..|+.|.|++|++. .+|+.+.-++.|+. ||+..|.
T Consensus 307 GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~v-LDlreNp 373 (1255)
T KOG0444|consen 307 GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKV-LDLRENP 373 (1255)
T ss_pred CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcce-eeccCCc
Confidence 24555555555665555555555 55555555555555555555555 45555555555554 5555554
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=329.97 Aligned_cols=271 Identities=20% Similarity=0.317 Sum_probs=199.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
..+|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+||+++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457889999999999999999975 57889999632 2446789999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
++. ++|.+++... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 6887777542 236899999999999999999999996 999999999999999999999999999865432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCC--CC----chHHHH
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD--GS----SLHEWV 898 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~--~~----~l~~~~ 898 (983)
... .......||..|+|||++.+..++.++|||||||++|||++|..|+...... .. .+...+
T Consensus 314 ~~~-----------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i 382 (461)
T PHA03211 314 WST-----------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII 382 (461)
T ss_pred ccc-----------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence 111 1112346999999999999999999999999999999999998765322111 11 122222
Q ss_pred Hhh------CCCCCc-HHHHHHHhhcCCCCCccccccchH---HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRH------YPHRLD-PIVEKAIAKYAPQHMPIYYNKVWS---DVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... ++.... ...............+......|. ....++.+++.+|++.||++|||+.|++++
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 211 111100 011111000000011111111222 234478899999999999999999999986
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=327.88 Aligned_cols=272 Identities=21% Similarity=0.265 Sum_probs=198.5
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----cee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD-----FKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 740 (983)
+|+..+.||+|+||.||+|.. .+++.||||.+..... ....+++.+|+++++.++||||+++++++..++ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 4789999999864322 223567889999999999999999999998776 789
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+|+||+. ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 467666643 346899999999999999999999996 99999999999999999999999999986
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.
T Consensus 153 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~ 218 (372)
T cd07853 153 EEPDES------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP--IQQLDLIT 218 (372)
T ss_pred cccCcc------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH--HHHHHHHH
Confidence 542211 111224688999999998874 478999999999999999999999864211 11111111
Q ss_pred hhCCCCCcHHH-------HHHHhhcCCCCCccc--cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 900 RHYPHRLDPIV-------EKAIAKYAPQHMPIY--YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 900 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
........... ...+.... ...+.. ......+...++.+++.+|++.||++|||++|++++-
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGP-HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCC-CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 11111100000 01110000 000000 0001122356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.87 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=202.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|++.+.||+|+||.||++... +++.||+|.++........+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999965 688899999876554445678889999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+++++.+++.... ...+++..++.++.|+++|+.|||+.+ |+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999988876432 345789999999999999999999986 99999999999999999999999999876543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......|+..|+|||+..+..++.++||||||+++|+|++|+.||... ......
T Consensus 156 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~-------- 209 (255)
T cd08219 156 -------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLI-------- 209 (255)
T ss_pred -------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHH--------
Confidence 112246889999999999888999999999999999999999998632 111111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... .......+ ......+.+++.+||+.||++||++.+++..
T Consensus 210 ----~~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 ----LKVC-QGSYKPLP-------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----HHHh-cCCCCCCC-------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1110 10000011 1234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.70 Aligned_cols=251 Identities=26% Similarity=0.419 Sum_probs=197.8
Q ss_pred CccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|+... +..||+|.+.........+++.+|+++++++.|||++++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999998532 267999998766544456789999999999999999999998764 467999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998753 35899999999999999999999986 9999999999999999999999999998664322110
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......++..|+|||...+..++.++||||||+++|||++ |+.||+... ......++...
T Consensus 153 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~------ 214 (257)
T cd05060 153 ----------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESG------ 214 (257)
T ss_pred ----------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcC------
Confidence 01111234568999999999899999999999999999998 999986421 11111211111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.....+ ..++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 215 ----------~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 ----------ERLPRP-------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----------CcCCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 000001 124567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=315.21 Aligned_cols=250 Identities=19% Similarity=0.302 Sum_probs=201.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+++++.++|+|++++++++......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4788889999999999999995 46889999998765443 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998853 34789999999999999999999996 9999999999999999999999999987654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++|||||||++|+|++|+.||..... ...+...
T Consensus 171 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~~----- 228 (296)
T cd06654 171 S-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLI----- 228 (296)
T ss_pred c-------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHHH-----
Confidence 1 11123688999999999988889999999999999999999999863211 0000000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
....... .+ ........+.+++.+|+..+|++||++.|++++
T Consensus 229 -------~~~~~~~--~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 229 -------ATNGTPE--LQ-----NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -------hcCCCCC--CC-----CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000000 00 012345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.45 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=198.5
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC-----
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP----- 736 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 736 (983)
.+++.|+..+.||+|+||.||+|... +++.||+|.+..... ....+.+|+++++++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35677888899999999999999965 578899999865433 346788999999998 799999999998643
Q ss_pred -CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 737 -DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 737 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
...++||||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 45789999999999999887532 346899999999999999999999986 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
|++....... .......|+..|+|||++. +..++.++||||+||++|||++|+.||+....
T Consensus 156 g~~~~~~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~- 221 (272)
T cd06637 156 GVSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP- 221 (272)
T ss_pred CCceeccccc-------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-
Confidence 9987653211 1122356899999999986 34578899999999999999999999853211
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... ...... +... ....+.++.+++.+|+..+|.+|||+.|++++
T Consensus 222 ---~~~~~~--------------~~~~~~---~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 222 ---MRALFL--------------IPRNPA---PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---HHHHHH--------------HhcCCC---CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 000000 0000 11244678899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.70 Aligned_cols=466 Identities=30% Similarity=0.391 Sum_probs=374.5
Q ss_pred eEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEecc
Q 042568 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157 (983)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls 157 (983)
.++.|+++.|.+....-+.+...-.|+.|||++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 3777777777654322234444555999999999987 78888999999999999999998 888999999999999999
Q ss_pred CcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccccc
Q 042568 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMF 237 (983)
Q Consensus 158 ~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 237 (983)
+|++. .+|.++. .+.+|++|++|+|.+. .+|.- +..++.+..+..++|..... ++... ++.++|..|.+
T Consensus 100 ~n~l~-~lP~~~~---~lknl~~LdlS~N~f~-~~Pl~-i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l 168 (1081)
T KOG0618|consen 100 NNRLQ-SLPASIS---ELKNLQYLDLSFNHFG-PIPLV-IEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVL 168 (1081)
T ss_pred cchhh-cCchhHH---hhhcccccccchhccC-CCchh-HHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhc
Confidence 99987 7888775 6889999999999987 56643 34678888888998832222 33333 88888999988
Q ss_pred ccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCc
Q 042568 238 SGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317 (983)
Q Consensus 238 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N 317 (983)
.+.++.++ ..+.. .|+|++|.+.. ..+.++.+|+.|....|++.... ....+|+.|+.++|
T Consensus 169 ~~~~~~~i-~~l~~--~ldLr~N~~~~-----------~dls~~~~l~~l~c~rn~ls~l~-----~~g~~l~~L~a~~n 229 (1081)
T KOG0618|consen 169 GGSFLIDI-YNLTH--QLDLRYNEMEV-----------LDLSNLANLEVLHCERNQLSELE-----ISGPSLTALYADHN 229 (1081)
T ss_pred ccchhcch-hhhhe--eeecccchhhh-----------hhhhhccchhhhhhhhcccceEE-----ecCcchheeeeccC
Confidence 87776543 33333 49999998863 23677889999999999987432 11257999999999
Q ss_pred cccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcc
Q 042568 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397 (983)
Q Consensus 318 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 397 (983)
.++...+ -..-.+|+++++++|+++ .+|++++.+.+|+.|...+|.++ .+|..+...++|+.|++.+|.++ .+|+
T Consensus 230 ~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~ 304 (1081)
T KOG0618|consen 230 PLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPP 304 (1081)
T ss_pred cceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCC
Confidence 9983322 223468999999999999 56799999999999999999996 78889999999999999999999 6777
Q ss_pred cccCcccchhhcccCccCCCCCccc-ccCCCC-CCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccc
Q 042568 398 SFANLSQLRRLLLYGNHLSGTIPSS-LGKCVN-LEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475 (983)
Q Consensus 398 ~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l 475 (983)
....++.|+.|+|..|+|. .+|+. +..+.. |+.|+.+.|++....--.=.....|+. |++.+|+|+...-+.+.++
T Consensus 305 ~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~-LylanN~Ltd~c~p~l~~~ 382 (1081)
T KOG0618|consen 305 FLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQE-LYLANNHLTDSCFPVLVNF 382 (1081)
T ss_pred cccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHH-HHHhcCcccccchhhhccc
Confidence 8888999999999999998 55554 333433 888999999998433222234567776 9999999999888889999
Q ss_pred cccccccccccccccCCCc-ccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEe
Q 042568 476 DMVLAIDLSFNNLSGSIPP-QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554 (983)
Q Consensus 476 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ 554 (983)
.+|+.|+|++|+|. .+|. .+.++..|++|+||+|+|+ .+|.++..+..|++|...+|+|. ..| .+..++.|+.+|
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 99999999999998 5554 6789999999999999999 68899999999999999999998 788 899999999999
Q ss_pred ccCCccccc-cCCCCCCcccccccccCCcCccC
Q 042568 555 FSFNKFSGN-ISNKGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 555 l~~N~l~~~-~~~~~~~~~~~~~~~~~N~~lc~ 586 (983)
++.|+|+-. +|..-..+++..+++.||+++--
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~ 491 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVF 491 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceeeccCCccccc
Confidence 999999854 45544457888999999997554
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=319.94 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=206.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
+|.+.+.||+|+||.||+|... .+..||+|.++........+++.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 5788999999999999999742 12368999887655444567899999999999 89999999999999899
Q ss_pred eeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 739 KALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
.++++||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~ 169 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTE 169 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcC
Confidence 9999999999999998865321 1245889999999999999999999986 999999999999999
Q ss_pred CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 042568 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885 (983)
Q Consensus 807 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~ 885 (983)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred CCcEEECCcccceeccccccc-----------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 999999999999865432111 01111234568999999999999999999999999999998 888875
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.. ...++... +........+ ..++.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 239 ~~-----~~~~~~~~-------------~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 239 GI-----PVEELFKL-------------LKEGHRMDKP-------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred CC-----CHHHHHHH-------------HHcCCCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 32 11111111 1110000001 12456789999999999999999999999999998
Q ss_pred Hhhc
Q 042568 966 KQYL 969 (983)
Q Consensus 966 ~~~~ 969 (983)
....
T Consensus 294 ~~~~ 297 (334)
T cd05100 294 LTVT 297 (334)
T ss_pred hhhc
Confidence 7543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=328.30 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=200.3
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
++....++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++...+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999965 67889999986432 1223456788999999999999999999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999998863 34788889999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCC----CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK----RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||... .
T Consensus 189 a~~~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~ 251 (371)
T cd05622 189 CMKMNKEGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----S 251 (371)
T ss_pred eeEcCcCCc------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-----C
Confidence 986542211 111235799999999998754 3788999999999999999999998632 1
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHEM 962 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 962 (983)
.. ...............+ .......++.+++.+|+...+.+ ||+++|++++.
T Consensus 252 ~~------------~~~~~i~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 252 LV------------GTYSKIMNHKNSLTFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HH------------HHHHHHHcCCCcccCC-----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 1111111111100011 01234567888999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.11 Aligned_cols=273 Identities=21% Similarity=0.290 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999965 67889999987655444456788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888877643 345889999999999999999999996 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 159 ~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~ 223 (301)
T cd07873 159 K-------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGT 223 (301)
T ss_pred C-------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCC
Confidence 1 1112357889999998766 4578899999999999999999999864211 1111111111111
Q ss_pred CCcHHHHHHHhh--cCCCCCcccc----ccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAK--YAPQHMPIYY----NKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ ......+... ..........+.+++.+|++.||.+|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111111000 0000001000 00112245678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.05 Aligned_cols=249 Identities=29% Similarity=0.406 Sum_probs=198.7
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe-cCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS-KPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 745 (983)
.+|...+.||+|+||.||+|... +..||+|.++... ..+.+.+|+.++++++|+|++++++++. .....++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35778899999999999999876 7889999885432 3467899999999999999999999764 45678999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|++.||+|||+++ ++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999887533 345889999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
....++..|+|||+..+..++.++||||||+++|||++ |+.||... ...+..
T Consensus 157 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~------ 209 (256)
T cd05082 157 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVV------ 209 (256)
T ss_pred ----------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHH------
Confidence 11234578999999998889999999999999999998 99987521 111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+.+........ ...++..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 210 -------~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 210 -------PRVEKGYKMDA-------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------HHHhcCCCCCC-------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111111000 123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.60 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=198.9
Q ss_pred ccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccc
Q 042568 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLE 752 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 752 (983)
++|+|+||+||.|++. +..++|||-+...... ...-+..|+...++++|.|||+++|.+...++.-|.||-++||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999965 4566999988544333 4566889999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCCEEEccccccccccCCccccccc
Q 042568 753 NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 753 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
+.+....+. -+=++.++--+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||.++.+....
T Consensus 661 sLLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 661 SLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 999865431 12277888899999999999999995 99999999999996 57899999999998775321
Q ss_pred CCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
..+.++.||..|||||++..+ .|+..+|||||||++.||.||++||..+...+. .+.+
T Consensus 731 -------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFk---------- 790 (1226)
T KOG4279|consen 731 -------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFK---------- 790 (1226)
T ss_pred -------ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhh----------
Confidence 233456899999999999864 589999999999999999999999975533221 1111
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
-.+-+.. ....++...+...++.+|+..||.+||+++++++
T Consensus 791 --VGmyKvH--------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 791 --VGMYKVH--------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --hcceecC--------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 0010111 1123568889999999999999999999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.71 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=202.5
Q ss_pred CCCCCCccccCCcEeEEEEEECC-C---cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD-N---TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.|...+.||+|+||.||+|.... + ..||||.++.........+|..|++++++++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999999653 3 3599999876544445678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||.+.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999988653 345899999999999999999999986 99999999999999999999999999886643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
...... +... .....+..|+|||++.+..++.++||||||+++||+++ |+.||.... ......++
T Consensus 159 ~~~~~~-------~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i---- 224 (269)
T cd05065 159 DTSDPT-------YTSS-LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAI---- 224 (269)
T ss_pred Cccccc-------cccc-cCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHH----
Confidence 221100 0000 00112457999999999999999999999999999887 999985321 01111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
..... .+. ..+++..+.+++.+|++.+|.+||++.+++..|+++
T Consensus 225 ------------~~~~~--~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 ------------EQDYR--LPP-----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------------HcCCc--CCC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11000 110 123556788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=326.44 Aligned_cols=273 Identities=21% Similarity=0.185 Sum_probs=198.1
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD----- 737 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 737 (983)
..++|...+.||+|+||.||+|... +++.||||.+..... .....++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999964 688999999865432 234567889999999999999999999986443
Q ss_pred -ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 738 -FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 738 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
..++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 5555443 24788899999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++...... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||..... ...+..
T Consensus 169 ~a~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~-~~~~~~ 233 (359)
T cd07876 169 LARTACTNF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH-IDQWNK 233 (359)
T ss_pred CccccccCc--------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 997543211 11224689999999999999999999999999999999999999864311 111111
Q ss_pred HHHhhCCCCCcHH-------HHHHHhhcCCCCCcc-----------ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 042568 897 WVKRHYPHRLDPI-------VEKAIAKYAPQHMPI-----------YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958 (983)
Q Consensus 897 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 958 (983)
..... .....+. +.............. ...........++.+++.+|++.||++|||+.|+
T Consensus 234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 234 VIEQL-GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHhc-CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 11111 1100010 111000000000000 0000001134578999999999999999999999
Q ss_pred HHHHH
Q 042568 959 AHEMG 963 (983)
Q Consensus 959 l~~L~ 963 (983)
+++-.
T Consensus 313 l~hp~ 317 (359)
T cd07876 313 LRHPY 317 (359)
T ss_pred hcCch
Confidence 98753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.80 Aligned_cols=241 Identities=25% Similarity=0.301 Sum_probs=187.3
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHH-HHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQ-ILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 567899999865421 112234444444 56778999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+.+..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--- 150 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--- 150 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC---
Confidence 999988864 345788889999999999999999996 9999999999999999999999999987532211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~----------- 204 (325)
T cd05602 151 ----------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEM----------- 204 (325)
T ss_pred ----------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHH-----------
Confidence 11223569999999999999999999999999999999999999985321 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
.+........ . .......+.+++.+|++.+|.+||++.+.+
T Consensus 205 -~~~i~~~~~~--~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 205 -YDNILNKPLQ--L-------KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -HHHHHhCCcC--C-------CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1111111000 0 012456788999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.39 Aligned_cols=252 Identities=33% Similarity=0.478 Sum_probs=203.2
Q ss_pred CccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|.... +..||+|.++........+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 7789999997665544568899999999999999999999999999999999999999
Q ss_pred cccccccccccCc-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 749 GSLENHLYPSHGL-----SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 749 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
++|.+++...... ...+++..++.++.|+++|++|||+.+ ++||||||+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 356899999999999999999999986 99999999999999999999999999987654
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .......++..|+|||...+..++.++||||+|+++|||++ |+.||.... ..+
T Consensus 158 ~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~------ 215 (262)
T cd00192 158 DDYY-----------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEE------ 215 (262)
T ss_pred cccc-----------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-----HHH------
Confidence 3211 11122457889999999988889999999999999999999 699986431 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..+... .......+ ..++.++.+++.+|++.+|++|||+.|++++|+
T Consensus 216 ------~~~~~~-~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 216 ------VLEYLR-KGYRLPKP-------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------HHHHHH-cCCCCCCC-------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111111 11110111 224578999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=309.07 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=204.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|+||.||+|.+. +++ .||+|.............+.+|++++++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999864 333 5899988766554456789999999999999999999999987 78899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|+||+++|+|.+++... ...+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998754 235899999999999999999999985 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
....... ......++..|+|||.+....++.++||||||+++||+++ |+.||+... ..+
T Consensus 160 ~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~---- 219 (279)
T cd05057 160 DVDEKEY-----------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-----AVE---- 219 (279)
T ss_pred cCcccce-----------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-----HHH----
Confidence 5322110 0011224578999999988889999999999999999999 999986421 111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+...+........+ ..+..++.+++.+||..+|.+||++.++++.++++.+.
T Consensus 220 ---------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 220 ---------IPDLLEKGERLPQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---------HHHHHhCCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111111111111 11345788999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.62 Aligned_cols=271 Identities=21% Similarity=0.252 Sum_probs=197.3
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC-----
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP----- 736 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 736 (983)
+..++|...+.||+|+||.||+|.. .+++.||||.+...... .....+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999995 46788999998654322 2345678899999999999999999987533
Q ss_pred -CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 737 -DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 737 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
...++++|++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 678887765 345899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ...+
T Consensus 163 g~~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~ 225 (343)
T cd07878 163 GLARQADDE----------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQL 225 (343)
T ss_pred ccceecCCC----------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHH
Confidence 999865321 112468999999999877 5688999999999999999999999853210 0111
Q ss_pred HHHHHhhCCCCCcHH--------HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPI--------VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+...... ...+. ....+.... ..........+......+.+++.+|+..||++|||++|++++=
T Consensus 226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 226 KRIMEVVGT-PSPEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred HHHHHHhCC-CCHHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 111111000 00000 001111000 0000000001112334578999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.73 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=159.5
Q ss_pred CCccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec--CCceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 746 (983)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 468999999999999864 45789999985432 23567889999999999999999998854 34678999999
Q ss_pred cCcccccccccccC-----cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe----CCCCCEEEccccc
Q 042568 747 SNGSLENHLYPSHG-----LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALVADFGI 817 (983)
Q Consensus 747 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl----~~~~~~kl~Dfgl 817 (983)
.+ ++.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +..+.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 64 77666543211 1235899999999999999999999996 9999999999999 4667899999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVL 887 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~ 887 (983)
|+........ ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCcc----------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876432111 011223578999999999877 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=320.27 Aligned_cols=280 Identities=18% Similarity=0.246 Sum_probs=199.0
Q ss_pred CCCccccC--CcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 671 PSSLIGSG--RFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 671 ~~~~iG~G--~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
..++||+| +|++||++.. .+|+.||+|.++.... .+....+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 4788999999976543 234566788999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999886432 335899999999999999999999986 99999999999999999999999987654332111
Q ss_pred cccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
..... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........+.
T Consensus 157 ~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 229 (327)
T cd08227 157 RLRVV------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLNGTVPC 229 (327)
T ss_pred ccccc------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-HHHHHhcCCccc
Confidence 10000 011122357788999999876 458899999999999999999999996432111 111111111111
Q ss_pred CCcH--HHHHHHh-------------h------cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 905 RLDP--IVEKAIA-------------K------YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 905 ~~~~--~~~~~~~-------------~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+. ....... . ...................++.+++.+|+++||++|||++|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 0000 0000000 0 0000000000001123456789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.89 Aligned_cols=272 Identities=23% Similarity=0.299 Sum_probs=196.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhc---CCCCccceeeEEec-----CC
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRI---RHRNLIRIITICSK-----PD 737 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 737 (983)
+|++.+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999965 68889999986543222 234566788877766 69999999998854 24
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+++ ++.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999985 7877776432 345899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
++....... .....||..|+|||++.+..++.++||||+||++|||++|+.||..... ...+...
T Consensus 155 ~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~~~~ 219 (288)
T cd07863 155 ARIYSCQMA--------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKI 219 (288)
T ss_pred cccccCccc--------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHHHHH
Confidence 986542211 1124689999999999998999999999999999999999999853211 1111121
Q ss_pred HHhhCCCCCcHHHHHHHh---hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIA---KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ ......... .......+........+...++.+++.+|++.||++|||+.|++++
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 220 FDLIGLPP-EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred HHHhCCCC-hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11110000 000000000 0000000111111123355678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=308.33 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=195.9
Q ss_pred CccccCCcEeEEEEEECC-Cc--EEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQD-NT--RIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|...+ +. .+|+|.++.....+....+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 46888886544444567889999999999 799999999999999999999999999
Q ss_pred cccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 749 GSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 749 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
|+|.+++..... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999998865321 1235889999999999999999999986 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~ 895 (983)
++...... ........+..|+|||++.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 158 l~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~ 218 (270)
T cd05047 158 LSRGQEVY--------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA 218 (270)
T ss_pred Cccccchh--------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HH
Confidence 98532210 00011234567999999988889999999999999999997 999985321 11
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
+. .+... ....... ...+..++.+++.+|++.+|.+|||+.|+++.|+++.
T Consensus 219 ~~------------~~~~~-~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 EL------------YEKLP-QGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HH------------HHHHh-CCCCCCC-------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 11110 0000000 1124467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.21 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=191.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 743 (983)
+|...+.||+|+||.||+|... +++.||+|++.... .....+.+..|.++++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999965 68899999987542 2223466788999998885 577888999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999988864 245899999999999999999999996 99999999999999999999999999875321
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 154 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------------- 206 (323)
T cd05615 154 DG-------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------------- 206 (323)
T ss_pred CC-------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------------
Confidence 11 111234699999999999998999999999999999999999999864210
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 955 (983)
....+....... ..+ .....++.+++.+|++.+|.+|++.
T Consensus 207 ---~~~~~~i~~~~~--~~p-------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 207 ---DELFQSIMEHNV--SYP-------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHHHHHHhCCC--CCC-------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111111111 011 1234678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=308.04 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=201.4
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc----chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|++|.||+|.. .+++.||+|.+...... .....+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999995 46889999998654321 124578899999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|+||+++++|.+++... ..+++..+..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999988643 35788999999999999999999996 999999999999999999999999999765
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... ........|+..|+|||+..+..++.++||||+|+++|||++|+.||... .......
T Consensus 155 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~----~~~~~~~--- 217 (263)
T cd06625 155 QTICSS----------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIF--- 217 (263)
T ss_pred cccccc----------cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc----chHHHHH---
Confidence 432111 01112245788999999999988999999999999999999999998532 1111100
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...........+ ......+.+++.+|+..+|.+||++.|++++
T Consensus 218 ----------~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 ----------KIATQPTNPQLP-------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----------HHhccCCCCCCC-------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000000000011 2245678899999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.28 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=199.1
Q ss_pred CccccCCcEeEEEEEECC--Cc--EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQD--NT--RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|++|.||+|.+.+ ++ .||||.+......+..+++.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 32 5899998765543456789999999999999999999999988 888999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999875432 46899999999999999999999996 9999999999999999999999999998765322111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+...
T Consensus 155 ----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~-------- 211 (257)
T cd05040 155 ----------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----SQILK-------- 211 (257)
T ss_pred ----------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH--------
Confidence 11112457889999999998889999999999999999999 9999853211 11111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
........ .+ .....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 212 ----~~~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 212 ----KIDKEGER--LE-----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----HHHhcCCc--CC-----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11100000 00 00124567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.23 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=198.0
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++++++|+|++++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 6889999998654321 2345678899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886432 346999999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ...
T Consensus 157 --------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~----------- 210 (285)
T cd05632 157 --------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKR----------- 210 (285)
T ss_pred --------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHH-----------
Confidence 111246899999999999989999999999999999999999998632110 000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
..+...+...... .......++.+++..|++.||++||+ +.+++++
T Consensus 211 --~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 211 --EEVDRRVLETEEV--------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --HHHHHhhhccccc--------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0011111110000 01224467889999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.49 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=186.0
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHH-HHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQ-ILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||.||+|+.. +++.||+|++..... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 678899999865421 122344555554 57889999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 150 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--- 150 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---
Confidence 999887764 345788999999999999999999986 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||... +...
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~------------ 203 (321)
T cd05603 151 ----------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQ------------ 203 (321)
T ss_pred ----------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHH------------
Confidence 1112346999999999999989999999999999999999999998532 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
..+..... +...+ .....++.+++.+|++.+|.+||++.
T Consensus 204 ~~~~i~~~--~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 204 MYDNILHK--PLQLP-------GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHhcC--CCCCC-------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11111111 00111 11345788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.02 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=194.4
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|... +++.||+|+++.... .+..+.+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 578899999975432 23456688999999888 699999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 150 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--- 150 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC---
Confidence 999887764 345899999999999999999999996 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC-CchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG-SSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~-~~l~~~~~~~~~~~~~ 907 (983)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||+...... ....+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~----------- 209 (327)
T cd05617 151 ----------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED----------- 209 (327)
T ss_pred ----------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH-----------
Confidence 11123569999999999999999999999999999999999999996432211 11111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM------LDVAHE 961 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 961 (983)
.....+... +...| .....++.+++.+|++.||++||++ ++++++
T Consensus 210 -~~~~~~~~~-~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 210 -YLFQVILEK-PIRIP-------RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -HHHHHHHhC-CCCCC-------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111111111 11111 1234678899999999999999984 577654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.48 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=200.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|...++||+|+||.||+|... ++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 5667889999999999999742 35578999876443 2345689999999999999999999999999999999
Q ss_pred EEecccCcccccccccccC-----------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 742 VLPLMSNGSLENHLYPSHG-----------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
++||+++++|.+++..... ....+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998865321 1135899999999999999999999986 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
+|+|||++..+...... .......+++.|+|||+..+..++.++|||||||++|||++ |+.||.....
T Consensus 162 kL~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY-----------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred EECCCCceeEcCCCcee-----------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 99999999765422110 11122346788999999999999999999999999999998 8998753211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. ...+........ ..+ ..++..+.+++.+||+.||++||++.||.+.|+
T Consensus 231 --~---------------~~~~~~~~~~~~-~~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 --T---------------EAIECITQGREL-ERP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --H---------------HHHHHHHcCccC-CCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 011111111000 001 124567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.91 Aligned_cols=255 Identities=33% Similarity=0.515 Sum_probs=204.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.++|.+.++||+|+||.||+|...++..||||.+..... ..+++.+|++++++++|+|++++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357888999999999999999988788899999865433 357799999999999999999999999988899999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++++|||.++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999987543 346899999999999999999999996 9999999999999999999999999998664311
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... .
T Consensus 158 ~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~--------- 211 (261)
T cd05034 158 YT------------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----R--------- 211 (261)
T ss_pred hh------------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----H---------
Confidence 00 0011234568999999999889999999999999999999 9999853210 0
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
...+........ ..+ .+.+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 212 ---~~~~~~~~~~~~-~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 212 ---EVLEQVERGYRM-PRP-------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---HHHHHHHcCCCC-CCC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111111111000 000 1235678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=344.70 Aligned_cols=258 Identities=20% Similarity=0.321 Sum_probs=199.0
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec--CCcee
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKA 740 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 740 (983)
..++|.+.+.||+|+||+||+|... ++..||+|.+..... ......+..|+.++++++||||++++++|.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4468999999999999999999965 567799999865432 2345778999999999999999999998854 35679
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCC----CCeEeecCCCCCeEeCC----------
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP----IKVVHCDLKPSNILLDE---------- 806 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~ivH~Dikp~NiLl~~---------- 806 (983)
+||||+++|+|.+++.........+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999987543334569999999999999999999998541 24999999999999964
Q ss_pred -------CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHH
Q 042568 807 -------DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEI 877 (983)
Q Consensus 807 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~el 877 (983)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s--------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL 236 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES--------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc--------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence 3458999999998653211 1123469999999999864 4588999999999999999
Q ss_pred HhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 878 VTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 878 ltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
++|+.||... .....++.. +..... .+ ....+.++.+++..||..+|.+||++.|
T Consensus 237 LTGk~PF~~~----~~~~qli~~-------------lk~~p~--lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 237 CSGKTPFHKA----NNFSQLISE-------------LKRGPD--LP------IKGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred HHCCCCCCcC----CcHHHHHHH-------------HhcCCC--CC------cCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 9999998531 111111111 111110 01 0123467899999999999999999999
Q ss_pred HHHH
Q 042568 958 VAHE 961 (983)
Q Consensus 958 vl~~ 961 (983)
++++
T Consensus 292 lL~h 295 (1021)
T PTZ00266 292 CLGY 295 (1021)
T ss_pred Hhcc
Confidence 9854
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.79 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=201.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|+||.||+|.+. +++ .||+|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46777899999999999999854 444 47899886554444455788999999999999999999998754 4679
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999988643 235889999999999999999999986 999999999999999999999999999866
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .....+++.
T Consensus 160 ~~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~- 225 (303)
T cd05110 160 EGDEKE-----------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLE- 225 (303)
T ss_pred cCcccc-----------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH-
Confidence 432211 01112346778999999999999999999999999999998 899985321 111111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.......+ ..+...+.+++.+||..+|++||+++++++.++++.+.
T Consensus 226 ---------------~~~~~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 226 ---------------KGERLPQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------------CCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11100000 11345788999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.50 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=189.0
Q ss_pred CccccCCcEeEEEEEECC---CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGHVYKGVLQD---NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.||+|+||.||+|...+ ...+|+|.+...........+.+|+++++.++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 34688888765544444567889999999999999999999999999999999999999
Q ss_pred ccccccccccCc-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 750 SLENHLYPSHGL-SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 750 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
+|.+++...... ....++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY- 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe-
Confidence 999998764422 234567888999999999999999996 999999999999999999999999998754321110
Q ss_pred cccCCCCccccccCccccccccccccccC-------CCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGM-------GKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
.......++..|+|||+.. ...++.++|||||||++|||++ |..||..... .
T Consensus 157 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~--------- 216 (269)
T cd05042 157 ----------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-E--------- 216 (269)
T ss_pred ----------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-H---------
Confidence 0112234677899999864 3456889999999999999999 7778753210 0
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
......+..... ..+.. .........+.+++..|+ .||++||+++||++.|.
T Consensus 217 -------~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 -------QVLKQVVREQDI-KLPKP--QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -------HHHHHHhhccCc-cCCCC--cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 011111111110 00000 001123456677788888 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=321.87 Aligned_cols=193 Identities=27% Similarity=0.403 Sum_probs=168.9
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-C-----CCccceeeEEecCCcee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-H-----RNLIRIITICSKPDFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 740 (983)
+|.+.++||+|+||.|-||.+ .+++.||||+++... ....+...|+.+|..++ | -|+|+++++|....+.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 788999999999999999994 579999999996543 34567788999999996 4 48999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC--CCEEEcccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED--LTALVADFGIA 818 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~--~~~kl~Dfgla 818 (983)
||+|.++. +|.++++... -..++...++.++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|||.|
T Consensus 265 iVfELL~~-NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 99999964 9999998765 456999999999999999999999986 9999999999999754 47999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
......- -+++-+..|+|||++.|.+|+.+.|+||||||+.||++|.+-|
T Consensus 339 c~~~q~v----------------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 339 CFESQRV----------------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred cccCCcc----------------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 8765321 1357788999999999999999999999999999999997655
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.48 Aligned_cols=265 Identities=19% Similarity=0.225 Sum_probs=198.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|+..+.||+|+||.||+|... +++.||||++.... ..+....+.+|++++.+++||+|+++++++...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999965 68889999986432 2234567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999998864 345899999999999999999999996 99999999999999999999999999876532
Q ss_pred Cccccccc------CCC------------C----ccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCC
Q 042568 824 IDESVNCA------NDS------------M----SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 824 ~~~~~~~~------~~~------------~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~ 881 (983)
........ ... . .........+||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 21100000 000 0 0000112347999999999999999999999999999999999999
Q ss_pred CCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC---HHHH
Q 042568 882 RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---MLDV 958 (983)
Q Consensus 882 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev 958 (983)
.||..... . +..............+.. .....++.+++.+|+. +|++|++ +.|+
T Consensus 234 ~Pf~~~~~-----~------------~~~~~i~~~~~~~~~p~~-----~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei 290 (360)
T cd05627 234 PPFCSETP-----Q------------ETYRKVMNWKETLVFPPE-----VPISEKAKDLILRFCT-DSENRIGSNGVEEI 290 (360)
T ss_pred CCCCCCCH-----H------------HHHHHHHcCCCceecCCC-----CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH
Confidence 99863211 1 111111110000001100 0134567778888764 9999984 7788
Q ss_pred HHH
Q 042568 959 AHE 961 (983)
Q Consensus 959 l~~ 961 (983)
++|
T Consensus 291 ~~h 293 (360)
T cd05627 291 KSH 293 (360)
T ss_pred hcC
Confidence 766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.42 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=203.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||.|++|.||+|... +++.||+|.+...........+.+|+++++.++|+|++++++++......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999965 68889999987665444567789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999998874 26899999999999999999999986 9999999999999999999999999998765321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||...... ..
T Consensus 153 ~-------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~-------- 206 (274)
T cd06609 153 S-------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RV-------- 206 (274)
T ss_pred c-------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HH--------
Confidence 1 112246888999999999988999999999999999999999998642110 00
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
... +..... +.... ...+.++.+++.+|+..+|++||++++++++=
T Consensus 207 ----~~~-~~~~~~---~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 207 ----LFL-IPKNNP---PSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred ----HHH-hhhcCC---CCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 000 000000 00000 01346788999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.06 Aligned_cols=272 Identities=24% Similarity=0.339 Sum_probs=206.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec--CCcee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 740 (983)
.|...+.||+|+||.||+|.+. ++..||||.++..........|.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999854 3678999999765443346789999999999999999999999877 55789
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999998753 235899999999999999999999986 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
........ .......++..|+|||...+..++.++||||||+++|||++|+.|+........ .+...
T Consensus 159 ~~~~~~~~----------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~ 225 (284)
T cd05038 159 LPEDKDYY----------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL---RMIGI 225 (284)
T ss_pred cccCCcce----------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc---ccccc
Confidence 65322110 111112455679999999988899999999999999999999999754321110 00000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.............+........ ...++.++.+++.+|++.+|++||++.||+++|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 226 AQGQMIVTRLLELLKEGERLPR-------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccccHHHHHHHHHcCCcCCC-------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0011111111222211111100 123457799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=305.45 Aligned_cols=239 Identities=24% Similarity=0.382 Sum_probs=186.1
Q ss_pred CccccCCcEeEEEEEECC-------------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 673 SLIGSGRFGHVYKGVLQD-------------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
+.||+|+||.||+|...+ ...||+|.++.... .....+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998542 22488898755432 3456788899999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC-------EEE
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT-------ALV 812 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~-------~kl 812 (983)
++||||+++|+|..++... ...+++..++.++.|+++|++|||+.+ |+||||||+||+++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998887643 245899999999999999999999986 999999999999987664 899
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccC-CCCCCccchhHHHHHHHHHHH-hCCCCCCcccCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-GKRASTHGDVYSFGVLLLEIV-TGRRPTDVLFHD 890 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~SlG~il~ell-tg~~p~~~~~~~ 890 (983)
+|||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|+.||....
T Consensus 154 ~d~g~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-- 214 (262)
T cd05077 154 SDPGIPITVLSR-----------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-- 214 (262)
T ss_pred CCCCCCccccCc-----------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--
Confidence 999998654311 1235788999999886 467899999999999999998 5888764311
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+ ............ .....++.+++.+||+.||++||++.++++++
T Consensus 215 ---~~~-------------~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 215 ---LAE-------------KERFYEGQCMLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---hhH-------------HHHHHhcCccCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 011111101000 01235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.91 Aligned_cols=239 Identities=24% Similarity=0.327 Sum_probs=187.2
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHH-HHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQ-ILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|+.. +|+.||+|++..... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999964 688999999865421 223345556655 46778999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--- 150 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--- 150 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---
Confidence 999888764 346899999999999999999999996 9999999999999999999999999987432111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~------------ 203 (325)
T cd05604 151 ----------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAE------------ 203 (325)
T ss_pred ----------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHH------------
Confidence 1112356999999999999999999999999999999999999998532 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
..+........ .+ .....++.+++.+|++.+|++||++.+
T Consensus 204 ~~~~~~~~~~~--~~-------~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 204 MYDNILHKPLV--LR-------PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHcCCcc--CC-------CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 11111111100 00 113456889999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.16 Aligned_cols=256 Identities=23% Similarity=0.240 Sum_probs=195.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+++.. +++.||+|++.... .....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 68899999986432 1223466889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998642 345889999999999999999999996 99999999999999999999999999876543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||... ...+.
T Consensus 155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~~~- 216 (331)
T cd05597 155 DGT------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVET- 216 (331)
T ss_pred CCC------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHHHH-
Confidence 211 01122469999999999863 45788999999999999999999998531 11111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCC--CCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY--NPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~ 961 (983)
.............+. .....+.++.+++.+|+.. ++..||++++++++
T Consensus 217 -----------~~~i~~~~~~~~~~~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 -----------YGKIMNHKEHFQFPP----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----------HHHHHcCCCcccCCC----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111100000111 0112445677788877654 33448899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=305.97 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=202.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.++|...+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35788899999999999999998778889999886432 235678999999999999999999999887 778999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999987543 345889999999999999999999986 9999999999999999999999999997654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......++..|+|||++.+..++.++||||||+++|++++ |+.||.... .......+.
T Consensus 157 ~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~----- 217 (260)
T cd05073 157 YT------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALE----- 217 (260)
T ss_pred cc------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHh-----
Confidence 10 1111245678999999998889999999999999999999 899985321 111111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
..... + .....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 218 -----------~~~~~--~-----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 -----------RGYRM--P-----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----------CCCCC--C-----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11100 0 012245678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.83 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=205.0
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|...+.||+|+||.||+|.+. +++.||+|.++........+.+.+|++++++++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 444677999999999999864 5778999998765544456789999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++++|||++........
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988853 45889999999999999999999986 99999999999999999999999999876543211
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 157 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~---------- 212 (277)
T cd06642 157 ------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--RVLFL---------- 212 (277)
T ss_pred ------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--hHHhh----------
Confidence 111235888999999999988999999999999999999999998632111 00000
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCchh
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 975 (983)
+..... +. . ....+.++.+++.+|++.+|++||++.|++++-. +.+....++.+
T Consensus 213 ------~~~~~~---~~-~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~-~~~~~~~~~~~ 266 (277)
T cd06642 213 ------IPKNSP---PT-L---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF-ITRYTKKTSFL 266 (277)
T ss_pred ------hhcCCC---CC-C---CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH-HHHHhhhHHHH
Confidence 000000 00 0 0124567889999999999999999999998643 34444444444
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=323.14 Aligned_cols=272 Identities=21% Similarity=0.216 Sum_probs=197.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP------ 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 736 (983)
..++|...+.||+|+||.||+|... .++.||||.+..... .....++.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999854 688899999865432 23456788999999999999999999988543
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
...++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999975 5555553 24788999999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..
T Consensus 165 ~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~ 229 (355)
T cd07874 165 LARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNK 229 (355)
T ss_pred ccccCCCcc--------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 997543211 11224689999999999999999999999999999999999999863210 011111
Q ss_pred HHHhhCCC------CCcHHHHHHHhhcCCC---CCcc--------ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 897 WVKRHYPH------RLDPIVEKAIAKYAPQ---HMPI--------YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 897 ~~~~~~~~------~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
.+...... ...+............ ..+. ...........++.+++.+|++.||++|||+.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 11111000 0011111111100000 0000 00001112346789999999999999999999999
Q ss_pred HH
Q 042568 960 HE 961 (983)
Q Consensus 960 ~~ 961 (983)
++
T Consensus 310 ~h 311 (355)
T cd07874 310 QH 311 (355)
T ss_pred cC
Confidence 87
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.06 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=198.9
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccc
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLE 752 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 752 (983)
++||+|+||.||+|...+++.||+|.+......+....+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999977799999999876554445678999999999999999999999999999999999999999999
Q ss_pred cccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccC
Q 042568 753 NHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832 (983)
Q Consensus 753 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 832 (983)
+++... ...+++..+..++.+++.|++|||+++ ++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----- 149 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT----- 149 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce-----
Confidence 988643 235789999999999999999999996 999999999999999999999999999765421100
Q ss_pred CCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 150 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~--------------- 206 (251)
T cd05041 150 ------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRE--------------- 206 (251)
T ss_pred ------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHH---------------
Confidence 11111234667999999988889999999999999999999 8888753211 00111
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+........ ....+.++.+++.+|+..+|++||++.|+++.|.
T Consensus 207 -~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 207 -RIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -HHhcCCCCCC-------CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1111000000 1234568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=307.06 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=201.2
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-----cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-----GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+|...+.||+|+||.||+|...+++.+|||.++.... .+...++.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998865432 12345688999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+++++|.+++... ..+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999998642 35789999999999999999999986 9999999999999999999999999998653
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
....... .........|+..|+|||+..+..++.++||||+|+++|+|++|+.||.... .......
T Consensus 154 ~~~~~~~-------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~--- 219 (265)
T cd06631 154 WVGLHGT-------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD----RLAAMFY--- 219 (265)
T ss_pred hcccccc-------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC----hHHHHHH---
Confidence 2211100 0011123468999999999999889999999999999999999999986321 0000000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.. .....+.. ......++.+++.+|++.+|++||++.|++++
T Consensus 220 -----------~~~-~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 220 -----------IGA-HRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----------hhh-ccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00000000 11245678899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.13 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=187.1
Q ss_pred ccccCCcEeEEEEEECCCc---EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 674 LIGSGRFGHVYKGVLQDNT---RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.||+|+||.||+|...++. .+++|.+.........+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999854433 4567776554444456789999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
|.+++..........++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 99998764333345677888999999999999999985 99999999999999999999999999864321100
Q ss_pred cCCCCccccccCccccccccccccccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMG-------KRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
........|+..|+|||+... ..++.++||||||+++|||++ |..||.... ..+.
T Consensus 155 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~~~----- 217 (268)
T cd05086 155 -------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-----DREV----- 217 (268)
T ss_pred -------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-----HHHH-----
Confidence 011123468899999998753 245789999999999999997 466764311 1111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+...+............. ......+.+++..|| .+|++||+++||++.|.
T Consensus 218 -------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 -------LNHVIKDQQVKLFKPQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -------HHHHHhhcccccCCCccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111100000000000 113356777888899 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.37 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=203.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|...+ ...||||........+..+.+.+|++++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 357778999999999999998643 246899988665544556789999999999999999999999875 456899
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++++|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998653 235899999999999999999999986 9999999999999999999999999998654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... ......++..|+|||.+....++.++||||||+++||+++ |+.||..... .....
T Consensus 159 ~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~~~~~----- 219 (270)
T cd05056 159 DESYY------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--NDVIG----- 219 (270)
T ss_pred cccce------------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHH-----
Confidence 32111 0011234568999999988889999999999999999996 9999864211 00001
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
. +..... .+ ....++.++.+++.+|+..+|++|||+.++++.|+++.+.
T Consensus 220 ----------~-~~~~~~--~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 220 ----------R-IENGER--LP-----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----------H-HHcCCc--CC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000000 00 0123456899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.40 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=202.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... .+++.+|++++++++||||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578889999999999999999764 78899999865432 57899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ...+++..++.++.|+++|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 9999999988643 356899999999999999999999986 9999999999999999999999999988664321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....... ....
T Consensus 154 ~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~~~------ 210 (256)
T cd06612 154 A-------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AIFM------ 210 (256)
T ss_pred c-------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hhhh------
Confidence 1 1122458889999999999899999999999999999999999986421110 0000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+..... +.. ........++.+++.+|++.+|++|||++|++++
T Consensus 211 --------~~~~~~---~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 211 --------IPNKPP---PTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --------hccCCC---CCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 000000 000 0011244678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.20 Aligned_cols=254 Identities=30% Similarity=0.422 Sum_probs=192.5
Q ss_pred CccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe-cCCceeEEEeccc
Q 042568 673 SLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS-KPDFKALVLPLMS 747 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 747 (983)
+.||+|+||.||+|.+. ++..||+|.+.........+.+.+|+.+++.++|||++++++++. .....++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 235699998854433344678889999999999999999999775 4556789999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++... ....++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998643 234677888999999999999999985 999999999999999999999999999755421110
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCC-CCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR-PTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~-p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
. ........++..|+|||+..+..++.++||||||+++|||++|+. ||... ...+..
T Consensus 155 ~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~-------- 212 (262)
T cd05058 155 S---------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDIT-------- 212 (262)
T ss_pred e---------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH--------
Confidence 0 011112346778999999988889999999999999999999654 44321 111111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.. +........+ ...+..+.+++.+||+.+|++||++.|++++++++.
T Consensus 213 ----~~-~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 213 ----VY-LLQGRRLLQP-------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----HH-HhcCCCCCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11 1110000001 113467889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=305.88 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=202.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888899999999999999964 5788999999765433 467899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999988653 246899999999999999999999986 9999999999999999999999999987654211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK---RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
. ......++..|+|||...+. .++.++||||||+++|||++|+.||...... ...
T Consensus 156 ~-------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~----~~~----- 213 (262)
T cd06613 156 A-------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----RAL----- 213 (262)
T ss_pred h-------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHH-----
Confidence 1 11224688899999998876 7889999999999999999999998642110 000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ .......+.++.+++.+|+..+|.+||++++++.+
T Consensus 214 -------~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 214 -------FLISKSNFPPPK-----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -------HHHHhccCCCcc-----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=311.97 Aligned_cols=252 Identities=26% Similarity=0.346 Sum_probs=198.6
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|+..++||+|+||.||+|... +++.||||.+...... .....+.+|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 6889999998654322 2235677899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999998885432 345899999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. .....||..|+|||++.+..++.++||||+|+++|+|++|+.||....... . ..
T Consensus 157 ~--------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~-~~--------- 211 (285)
T cd05630 157 T--------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-K-RE--------- 211 (285)
T ss_pred c--------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-h-HH---------
Confidence 1 112368999999999999899999999999999999999999986421110 0 00
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
........... .. ......++.+++.+|++.||++||| ++|++++
T Consensus 212 ---~~~~~~~~~~~-~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 212 ---EVERLVKEVQE-EY-------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---HHHhhhhhhhh-hc-------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00000000000 00 0123456889999999999999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.67 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=194.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecc-cCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 744 (983)
..|++.++||+||.+.||++...+.+.||+|++... .+......|..|++.|.+++ |.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 347778999999999999999888888888876433 34446788999999999994 9999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|-+ .+|..++.... ....+| .++.++.|++.|+.++|++| |||.|+||.|+|+-+ |.+||+|||+|..+..+
T Consensus 441 ~Gd-~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ccc-ccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 975 48989887653 222334 78889999999999999997 999999999999874 68999999999987654
Q ss_pred cccccccCCCCccccccCccccccccccccccCCC-----------CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-----------RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
... ......+||+-||+||.+... ++++++||||+|||+|+|+.|+.||....
T Consensus 513 TTs-----------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----- 576 (677)
T KOG0596|consen 513 TTS-----------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----- 576 (677)
T ss_pred ccc-----------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----
Confidence 433 223445899999999987542 25789999999999999999999986321
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. +.+. ..+.+..-+..+.... ...++++++..|+++||.+||++.|++++
T Consensus 577 --n~------------~aKl-~aI~~P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 --NQ------------IAKL-HAITDPNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HH------------HHHH-HhhcCCCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 00 1111 0111110000000000 11238999999999999999999999964
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.70 Aligned_cols=274 Identities=21% Similarity=0.258 Sum_probs=198.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|++|.||+|... +++.||||.+...... .....+.+|++++++++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999965 6889999998654322 2346788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++ +++.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 588877754332 356899999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...... .............
T Consensus 156 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~ 221 (285)
T cd07861 156 R-------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTP 221 (285)
T ss_pred c-------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 0 11123578899999987654 5788999999999999999999998642110 0011111100000
Q ss_pred --CCc---HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 --RLD---PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 --~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... ..... .....+................++.+++.+|+..||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 222 TEDVWPGVTSLPD-YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred ChhhhhcchhhHH-HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00000 000000000000011112245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=324.42 Aligned_cols=273 Identities=23% Similarity=0.257 Sum_probs=201.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..+|.+.+.||+|+||.||++... .+..||||.+... ..+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 357999999999999999999753 3567999987432 3456899999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||++. +++.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++...
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99996 577777732 356899999999999999999999996 9999999999999999999999999997654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC--CchHHHHHh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG--SSLHEWVKR 900 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~--~~l~~~~~~ 900 (983)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+...+..
T Consensus 237 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 237 AHPDT-----------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred ccccc-----------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 32211 11123579999999999999999999999999999999999999986432211 112222221
Q ss_pred h------CCCCCcHHHHHHHhhcCCCCCcccc-ccc--hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 H------YPHRLDPIVEKAIAKYAPQHMPIYY-NKV--WSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. ++......+.+..........+... ... ......++.+++.+|+..||++||++.|++.+=.
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 1 1111111111111111111011000 000 0123457889999999999999999999998743
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.51 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=199.6
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
..|+..+.||+|+||.||+|.+.+++.+|+|.+..... ...++.+|++++++++|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 35677889999999999999987788999998864332 2467899999999999999999999999989999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++... ...+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988643 235789999999999999999999986 99999999999999999999999999876532211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......++.+|+|||+..+..++.++||||+|+++|||++ |+.||.... ...+
T Consensus 156 ------------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~-------- 210 (256)
T cd05112 156 ------------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEV-------- 210 (256)
T ss_pred ------------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHH--------
Confidence 00111235678999999998889999999999999999998 999985321 1111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.+.. ........+. ..+.++.+++.+|++.+|++||+++|++++|
T Consensus 211 ----~~~~-~~~~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 211 ----VETI-NAGFRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----HHHH-hCCCCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111 1100000010 1246789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=346.55 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred HhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.+-+|.....||.|.||.||-|. .++|+-.|||-++.... ....+...+|+.++..++|||+|+++|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 44577888999999999999999 56788899998865533 33567788999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||||++|+|++.+... ...++.....+..|++.|++|||++| ||||||||.||+++.+|.+|.+|||.|..+.
T Consensus 1313 MEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 9999999999998743 33667777889999999999999997 9999999999999999999999999998876
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK---RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...+.+ ....+..+||+.|||||.+.+. ....++||||+|||+.||+||+.||....+.-.-+.....
T Consensus 1386 ~~~~~~---------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTM---------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred CchhcC---------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence 542221 1333456899999999999874 3467899999999999999999999765333221111111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+ .|+ ..+....+-.+++.+|+..||++|+++.|++++
T Consensus 1457 gh--------------------~Pq----~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GH--------------------KPQ----IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cC--------------------CCC----CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11 111 112366788999999999999999999988765
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.48 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=201.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999976 788999999876544444578999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|..++..... ...+++..+..++.|+++|+.|||+.. +|+||||||+||+++.++.++|+|||.+..+....
T Consensus 82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999888764321 346899999999999999999999742 49999999999999999999999999987553211
Q ss_pred cccccCCCCccccccCccccccccccccccCCC------CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK------RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.....|+..|+|||.+.+. .++.++||||+||++|+|++|+.||..... .....
T Consensus 158 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~---- 217 (286)
T cd06622 158 --------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFA---- 217 (286)
T ss_pred --------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHH----
Confidence 1223588899999998654 347899999999999999999999853210 00000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+...... .... ...+...++.+++.+|++.+|++||++++++++-.
T Consensus 218 --------~~~~~~~~-~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 218 --------QLSAIVDG-DPPT-------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred --------HHHHHhhc-CCCC-------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 01111111 1111 11235677889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=321.93 Aligned_cols=273 Identities=21% Similarity=0.195 Sum_probs=197.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP------ 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 736 (983)
..++|...+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 678899999865432 23456788999999999999999999987543
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
...++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 346999999975 6666553 24788899999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..
T Consensus 172 ~a~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~ 236 (364)
T cd07875 172 LARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNK 236 (364)
T ss_pred CccccCCCC--------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 997653211 11224689999999999999999999999999999999999999864211 111111
Q ss_pred HHHhhCCCC------CcHHHHHHHhhcCCC-----------CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 897 WVKRHYPHR------LDPIVEKAIAKYAPQ-----------HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 897 ~~~~~~~~~------~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
.+...-... +...+.......... ...............++.+++.+|++.||++|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 237 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 111100000 000111111000000 000000001111245788999999999999999999999
Q ss_pred HHH
Q 042568 960 HEM 962 (983)
Q Consensus 960 ~~L 962 (983)
++=
T Consensus 317 ~hp 319 (364)
T cd07875 317 QHP 319 (364)
T ss_pred cCc
Confidence 873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=333.07 Aligned_cols=274 Identities=19% Similarity=0.226 Sum_probs=192.6
Q ss_pred HHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC------CccceeeEEe
Q 042568 662 LIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR------NLIRIITICS 734 (983)
Q Consensus 662 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~ 734 (983)
+...+++|.+.++||+|+||+||+|... +++.||||+++... .....+..|+++++.++|. +++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3345678999999999999999999964 57889999985432 2235567788888887654 5888888886
Q ss_pred cC-CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-----
Q 042568 735 KP-DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----- 808 (983)
Q Consensus 735 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----- 808 (983)
.. ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 54 4678999988 6688887764 245899999999999999999999741 399999999999998765
Q ss_pred -----------CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHH
Q 042568 809 -----------TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 877 (983)
Q Consensus 809 -----------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~el 877 (983)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 499999998753221 11235799999999999999999999999999999999
Q ss_pred HhCCCCCCcccCCCCchHHHHHhhC---CCCCc-----HHHHHHHhhcCCCCCccccc---------cchH--HHHHHHH
Q 042568 878 VTGRRPTDVLFHDGSSLHEWVKRHY---PHRLD-----PIVEKAIAKYAPQHMPIYYN---------KVWS--DVVLELI 938 (983)
Q Consensus 878 ltg~~p~~~~~~~~~~l~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~---------~~~~--~~~~~l~ 938 (983)
++|+.||+.... ......+.... +..+. +........... ..+.... ..+. .....+.
T Consensus 339 ltG~~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 339 YTGKLLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQ-LRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccc-ccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 999999964211 11111111110 10000 000000000000 0000000 0000 1134578
Q ss_pred HHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 939 ELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 939 ~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+|+.+|+++||++|||++|+++|=.
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhcCcc
Confidence 9999999999999999999998643
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.21 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=197.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... .......+.+|..++..++|++|+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 57889999986532 1223456888999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999998753 245889999999999999999999986 99999999999999999999999999976543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+
T Consensus 155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~~~-- 215 (331)
T cd05624 155 DGT------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVE-- 215 (331)
T ss_pred CCc------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----HHH--
Confidence 211 11122469999999998875 467889999999999999999999985321 111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 961 (983)
..............+ ....+.+.++.+++.+|+...+.+ |+++++++++
T Consensus 216 ----------~~~~i~~~~~~~~~p----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 216 ----------TYGKIMNHEERFQFP----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----------HHHHHHcCCCcccCC----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111111110000011 112234567888999988865544 5689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=307.64 Aligned_cols=239 Identities=24% Similarity=0.373 Sum_probs=184.8
Q ss_pred ccccCCcEeEEEEEECC-------------------------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccc
Q 042568 674 LIGSGRFGHVYKGVLQD-------------------------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 728 (983)
.||+|+||.||+|.+.. ...||+|+++.... +....+.+|++++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999997421 13488998854432 23567888999999999999999
Q ss_pred eeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 729 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
+++++......++||||+++|+|..++... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999888643 345889999999999999999999986 99999999999997643
Q ss_pred -------CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHH-h
Q 042568 809 -------TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIV-T 879 (983)
Q Consensus 809 -------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~ell-t 879 (983)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred cccCccceeeecCCccccccccc-----------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 3799999987643211 11257788999998875 56899999999999999995 6
Q ss_pred CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 880 GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 880 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
|+.||...... .... ...... ..+. ....++.+++.+||+.+|++||++++++
T Consensus 218 g~~p~~~~~~~--~~~~----------------~~~~~~--~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il 270 (274)
T cd05076 218 GEVPLKERTPS--EKER----------------FYEKKH--RLPE-------PSCKELATLISQCLTYEPTQRPSFRTIL 270 (274)
T ss_pred CCCCccccChH--HHHH----------------HHHhcc--CCCC-------CCChHHHHHHHHHcccChhhCcCHHHHH
Confidence 89887532110 0000 000000 0110 1224688999999999999999999999
Q ss_pred HHHH
Q 042568 960 HEMG 963 (983)
Q Consensus 960 ~~L~ 963 (983)
++|+
T Consensus 271 ~~L~ 274 (274)
T cd05076 271 RDLT 274 (274)
T ss_pred HhhC
Confidence 8873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.67 Aligned_cols=258 Identities=22% Similarity=0.353 Sum_probs=198.1
Q ss_pred HHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 663 IEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 663 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
..+++.+.....||+|+||.||+|... ++..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345666767789999999999999954 5778999988654332 45678999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEcccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKL 820 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~ 820 (983)
|+||+++++|.+++..... ....++..+..++.|+++|++|||+.+ |+||||||+||+++. ++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999874321 112278888999999999999999986 999999999999986 67999999999876
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
...... ......|+..|+|||+..+. .++.++||||||+++|+|++|+.||........ ..
T Consensus 159 ~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~-- 221 (268)
T cd06624 159 LAGINP-------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AM-- 221 (268)
T ss_pred cccCCC-------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hH--
Confidence 532111 11123578999999998664 378899999999999999999999864211100 00
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
......... ... ......++.+++.+|++.+|++|||+.|++++
T Consensus 222 -----------~~~~~~~~~-~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 -----------FKVGMFKIH-PEI-------PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----------hhhhhhccC-CCC-------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000000 001 12245678899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.73 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=202.5
Q ss_pred CCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEe
Q 042568 657 VSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICS 734 (983)
Q Consensus 657 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 734 (983)
+.++.+..+.++|++.+.||+|+||.||+|... +++.+|+|.++... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 344556667889999999999999999999964 57889999875432 2246788899999999 6999999999873
Q ss_pred -----cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC
Q 042568 735 -----KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT 809 (983)
Q Consensus 735 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~ 809 (983)
..+..++||||+++++|.+++.........+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 345679999999999999887643333456889999999999999999999986 999999999999999999
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
++|+|||+++....... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||
T Consensus 163 ~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred EEEccCCceeecccCCC-------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 99999999876542211 1122468999999998753 45788999999999999999999998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..... ...+.. ......... ... .....++.+++.+|++.+|++|||+.|++++.
T Consensus 230 ~~~~~----~~~~~~--------------~~~~~~~~~--~~~---~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 230 ADLHP----MRALFK--------------IPRNPPPTL--HQP---ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCch----hHHHhh--------------ccccCCCcc--cCC---CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 64211 011000 000000000 000 11235688999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=320.59 Aligned_cols=256 Identities=22% Similarity=0.231 Sum_probs=195.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...++||+|+||.||+++.+ +++.||+|++.... .......+.+|+.++..++|++|+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999965 56789999985432 1223455888999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999998743 245899999999999999999999986 99999999999999999999999999875432
Q ss_pred CcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
... .......||+.|+|||++. ...++.++|||||||++|||++|+.||... ...+..
T Consensus 155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~~~~ 217 (332)
T cd05623 155 DGT------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLVETY 217 (332)
T ss_pred CCc------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHHHHH
Confidence 111 1112346999999999986 346789999999999999999999998632 111111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCC--CCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS--TRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~evl~~ 961 (983)
............+ .....+..++.+++.+|+..++. .|++++|++++
T Consensus 218 ------------~~i~~~~~~~~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 218 ------------GKIMNHKERFQFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------------HHHhCCCccccCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111110000011 11123456788888888865444 47899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=310.76 Aligned_cols=277 Identities=22% Similarity=0.301 Sum_probs=198.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++++|...+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999854 688999999876544444457789999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+. +++.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 5776665432 235788889999999999999999996 99999999999999999999999999875432
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh-
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH- 901 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~- 901 (983)
... ......++..|+|||++.+. .++.++||||||+++|||++|+.||+........+.+.+...
T Consensus 156 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 222 (291)
T cd07870 156 PSQ-------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG 222 (291)
T ss_pred CCC-------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC
Confidence 111 11123578999999998764 578899999999999999999999864322111111111100
Q ss_pred CCCC-CcHHHH---HHHhhcCCCCCccccccchH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHR-LDPIVE---KAIAKYAPQHMPIYYNKVWS--DVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.. ...... ...........+......+. ....++.+++.+|++.||++|||++|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred CCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0100 000000 00000000000000000000 124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.54 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=200.9
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+|+..+.||.|+||.||+|.. .+++.||+|.+...... ..+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 3588889999999999999985 46889999998654433 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998853 35899999999999999999999996 9999999999999999999999999987654321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......
T Consensus 170 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~~~~~~------ 226 (296)
T cd06655 170 S-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYL------ 226 (296)
T ss_pred c-------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH------
Confidence 1 11123588999999999988899999999999999999999999864211 110000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+......... ........+.+++.+||..+|++||++.+++++
T Consensus 227 --------~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 227 --------IATNGTPELQ-----NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --------HHhcCCcccC-----CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000000 012245678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.76 Aligned_cols=263 Identities=24% Similarity=0.292 Sum_probs=202.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 743 (983)
++|...+.||.|++|.||+|... +++.+|+|.+..........++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46778899999999999999974 57889999987655444567899999999999999999999988543 4679999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.........+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998877543333456889999999999999999999986 99999999999999999999999999875432
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||+..........+....
T Consensus 158 ~~---------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 219 (287)
T cd06621 158 SL---------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--- 219 (287)
T ss_pred cc---------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH---
Confidence 11 112357889999999999899999999999999999999999987532111111111111
Q ss_pred CCCcHHHHHHHhhcCCCCCc--cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMP--IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+........+ .... ......+.+++.+|++.+|++|||+.|++++-.
T Consensus 220 ----------~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 220 ----------IVNMPNPELKDEPGNG---IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred ----------HhcCCchhhccCCCCC---CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0000000000 0000 113467899999999999999999999998554
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.95 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=203.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|+..+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999965 578899999876554445678999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.. .++++..+..++.|+++|++|+|+.+ ++|+||+|+||+++.++.++++|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998863 35788999999999999999999985 99999999999999999999999999976543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......++..|+|||+..+..++.++||||||+++|||++|+.||...... ..
T Consensus 157 -------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~--------- 209 (277)
T cd06640 157 -------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RV--------- 209 (277)
T ss_pred -------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hH---------
Confidence 111235788999999999888999999999999999999999998642110 00
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
... +.... .+ ......+..+.+++.+|++.+|++||++++++++-.
T Consensus 210 ---~~~-~~~~~---~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 210 ---LFL-IPKNN---PP----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ---hhh-hhcCC---CC----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 000 00000 01 112346678999999999999999999999988743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.79 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=203.3
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|+||.||.++. .+++.+|+|.+.... ......++.+|++++++++|+||+++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999999984 468889999986543 233456788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999887543 346899999999999999999999986 9999999999999999999999999998664322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++||||||+++|||++|+.||+.. ...+.
T Consensus 156 ~-------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~-------- 209 (256)
T cd08221 156 S-------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNL-------- 209 (256)
T ss_pred c-------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHH--------
Confidence 1 112246899999999999888899999999999999999999998531 11111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
......... +.. ....+.++.+++.+|+..+|++||+++|++++.
T Consensus 210 ----~~~~~~~~~----~~~----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 210 ----VVKIVQGNY----TPV----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----HHHHHcCCC----CCC----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111111100 000 022456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.19 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=206.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|+..+.||.|+||.||+|... ++..+|+|++...........+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67889999987655444567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865322 246899999999999999999999986 9999999999999999999999999998765432
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
... ........|+..|+|||++... .++.++||||||+++|+|++|+.||...... ...
T Consensus 157 ~~~---------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~---------- 216 (267)
T cd06610 157 DRT---------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVL---------- 216 (267)
T ss_pred ccc---------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhH----------
Confidence 210 0112334689999999998776 7899999999999999999999998643111 001
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+...... ...+ ....+...+.++.+++.+|++.||++||+++|++++
T Consensus 217 ------~~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 217 ------MLTLQNDP-PSLE--TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ------HHHhcCCC-CCcC--CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111100 0000 000122456788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=319.42 Aligned_cols=270 Identities=20% Similarity=0.265 Sum_probs=195.0
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
....+|.+.+.||+|+||.||+|... +++.||+|.... .....|+.++++++||||+++++++......++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34568999999999999999999965 567899997532 2335699999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+. ++|.+++... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99996 5787777543 346899999999999999999999996 9999999999999999999999999987532
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCC-CcccCCCC--------c
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT-DVLFHDGS--------S 893 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~-~~~~~~~~--------~ 893 (983)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+ +....... .
T Consensus 209 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~ 274 (357)
T PHA03209 209 VAP--------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274 (357)
T ss_pred cCc--------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHH
Confidence 111 111246999999999999999999999999999999999966654 32111100 0
Q ss_pred hHHHHHh------hCCCC-CcHHHHHHHhhcCCCCCccccc--cchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 894 LHEWVKR------HYPHR-LDPIVEKAIAKYAPQHMPIYYN--KVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 894 l~~~~~~------~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+...+.. .++.. ........+........+.... .........+.+++.+|++.||++|||+.|+++|
T Consensus 275 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 1111111 01100 0111111111111000000000 0001234566789999999999999999999876
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.40 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=197.1
Q ss_pred CccccCCcEeEEEEEECC-------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 673 SLIGSGRFGHVYKGVLQD-------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.||+|+||.||+|...+ +..||+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886554334567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccC---cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-----CEEEccccc
Q 042568 746 MSNGSLENHLYPSHG---LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-----TALVADFGI 817 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-----~~kl~Dfgl 817 (983)
+++++|.+++..... ....+++..++.++.|+++|++|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865322 1245889999999999999999999986 99999999999999877 899999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~ 896 (983)
++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 158 ~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~ 224 (269)
T cd05044 158 ARDIYKSDYY-----------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQ 224 (269)
T ss_pred cccccccccc-----------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHH
Confidence 9765432111 11112346788999999999999999999999999999998 999985321 001111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. +....... .....+..+.+++.+|++.+|++||+++++++.|.
T Consensus 225 ~----------------~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 225 H----------------VTAGGRLQ-------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred H----------------HhcCCccC-------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00000000 01234577899999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=312.26 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=201.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 5788899999999999999995 47899999998654433 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998853 35788999999999999999999986 9999999999999999999999999987654321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++||||||+++|++++|+.||.......... .
T Consensus 170 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~--------- 226 (297)
T cd06656 170 S-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L--------- 226 (297)
T ss_pred c-------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-e---------
Confidence 1 1122468899999999999889999999999999999999999986421110000 0
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... .+... ........+.+++.+|++.+|++||++++++++
T Consensus 227 --------~~~~~---~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 227 --------IATNG---TPELQ--NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --------eccCC---CCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 012244668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.48 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=202.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.....||+|+||.||+|+.+ +.+.||+|.+.....+.....+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999964 245699998865544445678999999999999999999999999989999
Q ss_pred EEEecccCcccccccccccCc-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGL-----SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
+||||+++|+|.+++...... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998754321 125899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l 894 (983)
|.+........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 162 ~~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----- 224 (275)
T cd05046 162 SLSKDVYNSEY------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----- 224 (275)
T ss_pred ccccccCcccc------------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----
Confidence 99864322110 11122356788999999988888999999999999999999 7788753211
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
...+.. ....... .+ . ...++..+.+++.+|++.+|++||++.|++++|+
T Consensus 225 ~~~~~~------------~~~~~~~--~~--~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 225 EEVLNR------------LQAGKLE--LP--V---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHH------------HHcCCcC--CC--C---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111 0000000 00 0 0124567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.51 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=196.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35666788999999999999954 6888999998655432 345688899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ...+++..++.++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998864 345899999999999999999999996 9999999999999999999999999987654211
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.......|+..|+|||++. ...++.++||||+||++|+|++|+.||....... ........
T Consensus 161 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~-- 224 (267)
T cd06645 161 -------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKS-- 224 (267)
T ss_pred -------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhcc--
Confidence 1112246899999999874 4567899999999999999999999975321100 00000000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... +.... ....+..+.+++.+|++.+|++||++++++++
T Consensus 225 -------------~~~~---~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 225 -------------NFQP---PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -------------CCCC---Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 00000 00123567899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=310.22 Aligned_cols=272 Identities=22% Similarity=0.280 Sum_probs=197.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999965 6889999998654322 2346678899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++ ++.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 777766532 245899999999999999999999996 9999999999999999999999999998654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......++..|+|||++.+. .++.++|||||||++|||++|+.|+.........+..........
T Consensus 154 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07839 154 R-------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220 (284)
T ss_pred C-------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 1 11123578899999988764 468999999999999999999999643211111111111111000
Q ss_pred CCcHHHHHHHhhcCCC-CCccc-c----ccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQ-HMPIY-Y----NKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~-~~~~~-~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ..... .+...... ..+.. . .........++.+++.+|++.||.+|||++|++++
T Consensus 221 ~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 221 T-EESWP-GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred C-hHHhH-HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0 00000 00000000 00000 0 00112245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.37 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=199.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC-CceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP-DFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 744 (983)
+|+..+.||+|++|.||++... +++.||+|.+..... ....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999965 578899999865432 23456788999999999999999999987644 45789999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++.... ...+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999887532 345899999999999999999999996 999999999999999999999999999866422
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......|++.|+|||+..+..++.++||||+|+++++|++|+.||+.. ....+.
T Consensus 156 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~------ 211 (257)
T cd08223 156 CD-------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLV------ 211 (257)
T ss_pred CC-------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHH------
Confidence 11 112346889999999999999999999999999999999999998632 111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........+ .. ......++.+++.+|++.+|++||++.+++++
T Consensus 212 ------~~~~~~~~~-~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 212 ------YRIIEGKLP-PM-------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ------HHHHhcCCC-CC-------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111110 00 12345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.97 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=196.3
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+++++.++|||++++++++......++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 445678999999999999965 467789998854432 345678899999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99998877542 346899999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.......||..|+|||++. +..++.++||||+||++|||++|+.||..... . ..
T Consensus 158 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~-~~----- 216 (282)
T cd06643 158 -----------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP----M-RV----- 216 (282)
T ss_pred -----------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH----H-HH-----
Confidence 1112246899999999874 34577899999999999999999999863210 0 00
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.......... ..+ . ....+.++.+++.+||+.+|++||++.+++++-.
T Consensus 217 -------~~~~~~~~~~-~~~--~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 217 -------LLKIAKSEPP-TLA--Q---PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred -------HHHHhhcCCC-CCC--C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0010000000 000 0 0123467889999999999999999999987654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.30 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=198.7
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcch-hHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEI-TGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|+..+.||+|+||+||+++.. +++.||+|.+........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456788999999999999976 456899999977654432 223456999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~- 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN- 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-
Confidence 99999999872 456899999999999999999999996 9999999999999999999999999997642111
Q ss_pred cccccCCCCccccccCccccccccccccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......+|..|+|||... +..++.++||||+|+++|+|++|+.||.... .....
T Consensus 153 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~---------- 208 (260)
T PF00069_consen 153 ------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQL---------- 208 (260)
T ss_dssp ------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHH----------
T ss_pred ------------ccccccccccccccccccccccccccccccccccccccccccccccccccc--chhhh----------
Confidence 1222356899999999998 8889999999999999999999999987430 00000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.+.......... ........++.+++.+|++.||++||++.+++++
T Consensus 209 --~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 209 --EIIEKILKRPLPSSS-----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --HHHHHHHHTHHHHHT-----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --hhhhhcccccccccc-----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111110000000 0001123789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=311.02 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=202.0
Q ss_pred CHHHHHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEec
Q 042568 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSK 735 (983)
Q Consensus 658 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 735 (983)
+++++..++++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3445556678999999999999999999996 468889999985432 2346778899999999 89999999999865
Q ss_pred C-----CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 736 P-----DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 736 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
. +..++|+||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999987643323456899999999999999999999986 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-----RASTHGDVYSFGVLLLEIVTGRRPTD 885 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~SlG~il~elltg~~p~~ 885 (983)
+|+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||.
T Consensus 168 kl~dfg~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~ 234 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234 (291)
T ss_pred EEeecccchhcccccc-------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence 9999999876542211 11123588999999987543 36889999999999999999999986
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ... +.+.. ........ . ..+....+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~----~~~-------------~~~~~-~~~~~~~~--~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 235 DMHP----VKT-------------LFKIP-RNPPPTLL--H---PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCcH----HHH-------------HHHHh-cCCCCCCC--c---ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 4211 000 00000 00000000 0 01234568999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.18 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=198.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc---------chhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG---------EITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
+|...+.||+|+||.||+|... +++.||+|.++..... ...+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999854 6889999988543211 12356888999999999999999999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999988653 45889999999999999999999986 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR--ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
++........ .......|+..|+|||...... ++.++||||+|+++||+++|+.||... ....
T Consensus 155 ~~~~~~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~~~~ 219 (272)
T cd06629 155 SKKSDDIYDN-----------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE----EAIA 219 (272)
T ss_pred cccccccccc-----------cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc----chHH
Confidence 9764321111 1112245889999999987654 789999999999999999999998531 1111
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+... .... .. +........+++.++.+++.+|+..+|++||+++|++++
T Consensus 220 ~~~~~------------~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 220 AMFKL------------GNKR-SA---PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHh------------hccc-cC---CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11100 0000 00 000011112356789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=306.25 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=204.6
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|+..+.||+|+||.||+|... +++.||+|.+......+...++.+|++++++++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677889999999999999976 688899999876655555678999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++++|.+++.... ..+++..+..++.|+++|++|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999887532 568899999999999999999999 75 9999999999999999999999999987553211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ....|+..|+|||+..+..++.++||||+|+++|+|++|+.||...........+
T Consensus 156 ~---------------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------- 211 (265)
T cd06605 156 A---------------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE--------- 211 (265)
T ss_pred h---------------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH---------
Confidence 1 1146888999999999999999999999999999999999998643221111111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+....... ...+ . .....++.+++.+|+..+|++|||+.|++++
T Consensus 212 ---~~~~~~~~~~-~~~~---~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 212 ---LLQYIVNEPP-PRLP---S---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---HHHHHhcCCC-CCCC---h---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111111111 0011 0 1145678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.27 Aligned_cols=198 Identities=25% Similarity=0.373 Sum_probs=158.6
Q ss_pred CCccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec--CCceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 746 (983)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 467999999999999965 34679999886432 23567899999999999999999998843 45678999998
Q ss_pred cCccccccccccc-----CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe----CCCCCEEEccccc
Q 042568 747 SNGSLENHLYPSH-----GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALVADFGI 817 (983)
Q Consensus 747 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl----~~~~~~kl~Dfgl 817 (983)
++ ++.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 6666553221 11235889999999999999999999996 9999999999999 5667999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
++......... .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 159 a~~~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPL----------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccc----------cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 98764322110 11223578999999999876 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.76 Aligned_cols=256 Identities=21% Similarity=0.309 Sum_probs=196.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHH-HHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQI-LKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|++.+.||+|+||.||+|+.. +|+.||+|.++.....+...++..|+.+ ++..+|||++++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999965 6899999998765444344566667775 556689999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++ |+|.+++.........+++..++.++.|++.|++|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5887777543333457899999999999999999999872 3999999999999999999999999998765321
Q ss_pred cccccccCCCCccccccCccccccccccccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
. ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ....
T Consensus 158 ~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~---- 216 (283)
T cd06617 158 V--------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---PFQQ---- 216 (283)
T ss_pred c--------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---CHHH----
Confidence 1 1112358889999998765 4568899999999999999999999853211 1110
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+...... .....+ . ...+.++.+++.+|+..+|++||++++++++-
T Consensus 217 ---------~~~~~~~-~~~~~~---~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 262 (283)
T cd06617 217 ---------LKQVVEE-PSPQLP---A---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHP 262 (283)
T ss_pred ---------HHHHHhc-CCCCCC---c---cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 1111111 000000 0 12456789999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.55 Aligned_cols=251 Identities=20% Similarity=0.327 Sum_probs=202.3
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|+||.||++... +++.||+|.+.... .....+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999954 68889999986543 223456789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999998886432 335789999999999999999999986 9999999999999999999999999998654321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++||||||+++++|++|+.||... ...
T Consensus 156 ~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~---------- 207 (256)
T cd08218 156 E-------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMK---------- 207 (256)
T ss_pred h-------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHH----------
Confidence 1 111245888999999999888999999999999999999999998531 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+..+..+...... . ......++.+++.+|++.+|++||++.||+++
T Consensus 208 --~~~~~~~~~~~~~-~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 208 --NLVLKIIRGSYPP-V-------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --HHHHHHhcCCCCC-C-------cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122222111110 0 11245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.12 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=193.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC----cchhHHHHHHHHHHHhcCCCCccceeeEEec--CCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT----GEITGSFKRECQILKRIRHRNLIRIITICSK--PDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 739 (983)
.+|...+.||+|+||.||+|... ++..||+|.+..... .+....+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 688999998864422 1234578899999999999999999998865 3567
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++++||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999988642 34788999999999999999999985 9999999999999999999999999987
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ ........|+..|+|||++.+..++.++||||+||++|||++|+.||.... ....
T Consensus 155 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~----~~~~--- 217 (266)
T cd06651 155 RLQTICMS----------GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE----AMAA--- 217 (266)
T ss_pred cccccccc----------CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc----hHHH---
Confidence 65321110 011112358899999999999889999999999999999999999986321 1110
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+............+ ......+.+++ +||..+|++||+++|++++
T Consensus 218 ----------~~~~~~~~~~~~~~-------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 218 ----------IFKIATQPTNPQLP-------SHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----------HHHHhcCCCCCCCc-------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11100000000011 12334556666 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.94 Aligned_cols=247 Identities=31% Similarity=0.445 Sum_probs=196.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|.+.+.||+|+||.||+|.. +++.||+|.++... ....+.+|++++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 3577889999999999999975 57889999985432 346789999999999999999999998654 579999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|+++|+.|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999987543 345899999999999999999999986 9999999999999999999999999987543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+.
T Consensus 155 ---------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~-------- 206 (254)
T cd05083 155 ---------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEV-------- 206 (254)
T ss_pred ---------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHH--------
Confidence 01234568999999998889999999999999999998 999975321 1111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.+ .+........ ...++.++.+++.+|++.+|++||+++++++.|++
T Consensus 207 ----~~-~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 207 ----KE-CVEKGYRMEP-------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----HH-HHhCCCCCCC-------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 1111110000 12245678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.21 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=197.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|++.+.||+|+||.||+|... +++.||+|.+.... .+....+.+|+++++.++|||++++++++......++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 45778899999999999999965 57889999986543 23467788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++++++..++... ...+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999998876543 345899999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.......++..|+|||++. ...++.++|||||||++|||++|+.||..... ...
T Consensus 165 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~--- 223 (292)
T cd06644 165 -------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRV--- 223 (292)
T ss_pred -------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHH---
Confidence 1112346889999999985 34567899999999999999999999853210 000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
....... .....+ . ......++.+++.+|+..+|++||+++|++++
T Consensus 224 ---------~~~~~~~-~~~~~~--~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 224 ---------LLKIAKS-EPPTLS--Q---PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---------HHHHhcC-CCccCC--C---CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0010000 000000 0 11244578899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=318.89 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=207.8
Q ss_pred CCCccccCCcEeEEEEEE-CCCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 671 PSSLIGSGRFGHVYKGVL-QDNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~-~~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
..++||+|+||+||||.+ +.|+ +||+|++......+...++.+|+-+|.+++|||+++++++|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 468899999999999995 4454 379999877666667789999999999999999999999998766 7889999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++.|+|.++++.+ +..+-....+.|..|||+|+.|||++ ++|||||-+.|||+.....+||+|||+|+...+..
T Consensus 779 mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999875 45688889999999999999999988 49999999999999999999999999999887655
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.....+ ...-.+.|||=|.+....++.++|||||||++||++| |..|++....
T Consensus 853 ~ey~~~-----------~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------------- 906 (1177)
T KOG1025|consen 853 KEYSAP-----------GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------------- 906 (1177)
T ss_pred cccccc-----------ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------------
Confidence 432211 1123467999999999999999999999999999999 9999864321
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
+.+.+.+..... ++. .+-+..++..++.+||..|+..||+++++..++.++..
T Consensus 907 ---~eI~dlle~geR--Lsq-----PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 907 ---EEIPDLLEKGER--LSQ-----PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---HHhhHHHhcccc--CCC-----CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 112222222111 111 12377889999999999999999999999999987753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.82 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=200.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--------chhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--------EITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
+|.....||+|++|.||+|... +++.||+|.+...... +..+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999864 5788999988654321 123568899999999999999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++|+||+++++|.+++... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999988642 45788999999999999999999986 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+.......... .........|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.... .....
T Consensus 154 ~~~~~~~~~~~-------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~- 221 (267)
T cd06628 154 KKLEANSLSTK-------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT----QLQAI- 221 (267)
T ss_pred cccccccccCC-------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc----HHHHH-
Confidence 87653211100 0011122458899999999998889999999999999999999999986421 11100
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... ........+ ...+.++.+++.+|++.+|.+||++.|++++
T Consensus 222 ------------~~~-~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 222 ------------FKI-GENASPEIP-------SNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------HHH-hccCCCcCC-------cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000 000010111 1245678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.58 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=207.5
Q ss_pred CCCCccccCCcEeEEEEEEC---CCcE--EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ---DNTR--IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~---~~~~--vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
...++||+|-||.||+|... .|+. ||||.-+.....+..+.|..|.-+|++++||||++++|.|.+. -.++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEe
Confidence 34678999999999999943 3443 8889888777777789999999999999999999999999865 4699999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
.++.|-|..+++.. +..++......++.||+.||+|||+. ++|||||...|||+.....+|++|||+++.+.+.
T Consensus 471 L~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 471 LAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred cccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999999865 45789999999999999999999998 5999999999999999999999999999987654
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.... . ....=...|||||-+.-++++.++|||.|||.+||++. |..||....+.+-
T Consensus 545 ~yYk----------a--S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------- 601 (974)
T KOG4257|consen 545 AYYK----------A--SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------- 601 (974)
T ss_pred chhh----------c--cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------
Confidence 3221 1 11123467999999999999999999999999999988 9999865322110
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
...++. ..++| ..+.|+..+..++.+||+++|.+||.+.|+...|+++.+
T Consensus 602 ---I~~iEn------GeRlP-----~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 ---IGHIEN------GERLP-----CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---EEEecC------CCCCC-----CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 000111 01111 124588999999999999999999999999999998865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=308.48 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|++.+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|++++++++|||++++++++......++||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46778889999999999999965 688899999865432 2456789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999988643 245899999999999999999999996 9999999999999999999999999987543211
Q ss_pred ccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||...... .
T Consensus 158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~---- 215 (280)
T cd06611 158 -------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----R---- 215 (280)
T ss_pred -------------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----H----
Confidence 1112346899999999874 345678999999999999999999998642110 0
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
........ .. +... .......++.+++.+|++.+|.+||++.+++++-
T Consensus 216 --------~~~~~~~~-~~---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 216 --------VLLKILKS-EP---PTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred --------HHHHHhcC-CC---CCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 01111000 00 0000 0112346788999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.13 Aligned_cols=273 Identities=21% Similarity=0.276 Sum_probs=201.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|+..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 588999999865432 2234568899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++++++..+... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888877643 235899999999999999999999986 999999999999999999999999999866432
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+. ....
T Consensus 154 ~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~-~~~~ 218 (286)
T cd07847 154 GD-------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIR-KTLG 218 (286)
T ss_pred cc-------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-HHhC
Confidence 21 1112357889999999876 45789999999999999999999998642211 1111111 1111
Q ss_pred CCCcHH---HHHH--Hhh--cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPI---VEKA--IAK--YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~---~~~~--~~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... .+.. ... .............+......+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 110000 0000 000 000000000001122345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.60 Aligned_cols=266 Identities=24% Similarity=0.272 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||+|.+...... ...+.+..|+++++.++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999965 5889999999765433 24567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999886432 356899999999999999999999986 99999999999999999999999999876543
Q ss_pred CcccccccCCC----------------CccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 042568 824 IDESVNCANDS----------------MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887 (983)
Q Consensus 824 ~~~~~~~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~ 887 (983)
........... ...........||..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110000000 00001122357899999999999988999999999999999999999998642
Q ss_pred cCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC----HHHHHHH
Q 042568 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS----MLDVAHE 961 (983)
Q Consensus 888 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~~ 961 (983)
... . .......... ..+. ....+.++.+++.+|++.+|++||+ ++|++++
T Consensus 236 ~~~-----~------------~~~~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRD-----E------------TFSNILKKEV--TFPG-----SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chH-----H------------HHHHHhcCCc--cCCC-----ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 111 0 0111110000 0010 1114678999999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.97 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=207.0
Q ss_pred CCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 670 CPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
...++||.|.||.||.|.|+. .-.||||.++.+..+ .++|..|..+|+.++|||+|+++|+|..+.-.|||+|||..
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 356899999999999999875 456999999765543 78999999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.... +..++.-..+.++.||+.|++||..+. +||||+.+.|.|+.++-.+||+|||+++++..+...
T Consensus 348 GNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 348 GNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred ccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 99999998754 455777788999999999999999984 999999999999999999999999999998643211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
......=...|.|||-+....++.|+|||+|||++||+.| |-.||-.. ++.
T Consensus 422 -----------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS------------ 473 (1157)
T KOG4278|consen 422 -----------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS------------ 473 (1157)
T ss_pred -----------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH------------
Confidence 1111122457999999999999999999999999999999 66776321 111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
++++ .+...+....| +.|+....+||+.||+++|.+||++.|+-+.++.+-..
T Consensus 474 qVY~-LLEkgyRM~~P-------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 474 QVYG-LLEKGYRMDGP-------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHH-HHhccccccCC-------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 1111 11222222111 35788999999999999999999999999999987544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.63 Aligned_cols=242 Identities=25% Similarity=0.291 Sum_probs=186.7
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc---CCCCccceeeEEecCCceeEEEecccC
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI---RHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
||+|+||+||+|+.. +++.||||++..... ......+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 688999999864321 12234556677777665 699999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--- 150 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--- 150 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---
Confidence 999888864 345899999999999999999999996 9999999999999999999999999987532211
Q ss_pred cccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......||+.|+|||.+.+. .++.++||||+||++|||++|+.||... ...+.
T Consensus 151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~---------- 205 (330)
T cd05586 151 ----------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQM---------- 205 (330)
T ss_pred ----------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHH----------
Confidence 112235699999999998764 4789999999999999999999998531 11111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP----SMLDVAHE 961 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~~ 961 (983)
....... ....+. .....++.+++.+|++.||.+|| ++.|++++
T Consensus 206 --~~~i~~~--~~~~~~------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 206 --YRNIAFG--KVRFPK------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --HHHHHcC--CCCCCC------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1111100 001110 11346778999999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.33 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=200.0
Q ss_pred CCCCCCccccCCcEeEEEEEECC--CcEEEEEEeeccc---------CcchhHHHHHHHHHHHh-cCCCCccceeeEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD--NTRIAVKVLDLTT---------TGEITGSFKRECQILKR-IRHRNLIRIITICSK 735 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 735 (983)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999764 6789999875332 12234567788888875 799999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.+..+++|||+++++|.+++.........+++..+++++.|++.|+.|||+.. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887543333456899999999999999999999632 4999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||... ...
T Consensus 159 g~~~~~~~~~--------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-----~~~ 219 (269)
T cd08528 159 GLAKQKQPES--------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST-----NML 219 (269)
T ss_pred cceeeccccc--------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc-----CHH
Confidence 9998654321 112246889999999999988999999999999999999999998531 111
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.. .......... +.. ......++.+++.+|++.||++||++.|+..+++
T Consensus 220 ~~------------~~~~~~~~~~---~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SL------------ATKIVEAVYE---PLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HH------------HHHHhhccCC---cCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 1111111000 000 0123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.26 Aligned_cols=274 Identities=23% Similarity=0.314 Sum_probs=197.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|+..+.||+|++|.||+|... +++.||||.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 67889999986554333345677899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 888877643 236889999999999999999999986 9999999999999999999999999987432111
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||.........+..........
T Consensus 158 ~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 224 (291)
T cd07844 158 K-------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224 (291)
T ss_pred c-------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence 0 0111246889999998876 4578999999999999999999999864321111111111110000
Q ss_pred CCcHHHHHHHh--hcCCCCC----ccccccchHHH--HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIA--KYAPQHM----PIYYNKVWSDV--VLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.......... ....... +.......... ..++.+++.+|++.+|++|||+.|++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 225 -TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred -ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 0000000 00000000011 2677899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=285.39 Aligned_cols=277 Identities=22% Similarity=0.329 Sum_probs=213.4
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecC
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKP 736 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 736 (983)
++++..-| .+.+|+|+|+.|--++ ..+|..||||++++. .+..+.+..+|++++.+.+ |+||++++++|.++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 55665555 4789999999999888 778999999999877 4557889999999999985 99999999999999
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVA 813 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~ 813 (983)
+..|+|||-|.||+|..++++. .-+++.++.++.++||.||.|||.+| |.|||+||+|||..... -+|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999864 45899999999999999999999997 99999999999997654 47999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
||.+..-......- .... .....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||...-
T Consensus 222 DfDLgSg~k~~~~~---spas---tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDC---SPAS---TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred ccccccccccCCCC---CCCC---CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 99998654322211 1111 12234468999999999753 2468899999999999999999999996543
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+-. |-....=...+..+-..|++... ..-.+.|..++.+..+++...+..|+..|.++.+++.+
T Consensus 296 g~dCG---WdrGe~Cr~CQ~~LFesIQEGkY----eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 296 GADCG---WDRGEVCRVCQNKLFESIQEGKY----EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCcCC---ccCCCccHHHHHHHHHHHhccCC----cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 32111 11110000111222222333222 12245788999999999999999999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.71 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=201.4
Q ss_pred CHHHHHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEec
Q 042568 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSK 735 (983)
Q Consensus 658 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 735 (983)
++.++....+.|++.+.||+|+||.||+|.. .+++.||+|.+..... ...++..|+.+++++ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4555556678899999999999999999996 4678899999865432 346788899999998 69999999999842
Q ss_pred ------CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC
Q 042568 736 ------PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT 809 (983)
Q Consensus 736 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~ 809 (983)
....+++|||+++|+|.+++.... ...+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 457799999999999999886533 345788889999999999999999986 999999999999999999
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
++|+|||++....... .......|+..|+|||.+. +..++.++|||||||++|||++|+.||
T Consensus 160 ~~l~dfg~~~~~~~~~-------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 160 VKLVDFGVSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred EEEeeCcchhhhhccc-------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 9999999987543211 1112346899999999875 346788999999999999999999998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... .... .. +..... +... ...++.++.+++.+||..||++||++.|++++
T Consensus 227 ~~~~~----~~~~-------------~~-~~~~~~---~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 227 CDMHP----MRAL-------------FL-IPRNPP---PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccCH----Hhhh-------------hh-HhhCCC---CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 53211 0000 00 000000 0000 12345679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.27 Aligned_cols=280 Identities=25% Similarity=0.334 Sum_probs=206.9
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC------Ccee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP------DFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 740 (983)
.|...+.||+|+||.||+|++ .+|+.||||.+.........++..+|++++++++|+|||++++.-.+. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355678899999999999994 579999999998776666788999999999999999999999876443 4678
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCC--CEEEcccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDL--TALVADFG 816 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~--~~kl~Dfg 816 (983)
+|||||.+|+|...+..-.. ...+++.+.+.+..+++.||.|||+++ ||||||||.||++- .+| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999976443 667999999999999999999999986 99999999999983 333 46999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
.|+.+++.. .....+||..|.+||+.. .+.|+..+|.|||||++|+++||..||....+......
T Consensus 170 ~Arel~d~s--------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~ 235 (732)
T KOG4250|consen 170 AARELDDNS--------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE 235 (732)
T ss_pred ccccCCCCC--------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch
Confidence 999876543 223468999999999998 48899999999999999999999999976443332211
Q ss_pred HHHHh--hCCCCCcHHHHHHHhh-c-CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC--CHHHHHHHHHHhH
Q 042568 896 EWVKR--HYPHRLDPIVEKAIAK-Y-APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP--SMLDVAHEMGRLK 966 (983)
Q Consensus 896 ~~~~~--~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~evl~~L~~~~ 966 (983)
-+... ..+..+.-...+...+ . ....+|.+ ..........+...+..++..+|++|. ...+....+..|.
T Consensus 236 ~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p-~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 236 IMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQP-NHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred hhhhhhccCCCceeEeeecccCCceeeeccCCCc-ccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 11111 1111111111111100 0 00111111 001122344566667778899999998 7777777666553
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=300.92 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=200.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEec--CCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 743 (983)
+|+..+.||+|+||.||+|... +++.||+|.++... .....+++..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777899999999999999854 67889999986543 23345678899999999999999999998754 34578999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC--CCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS--PIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||+++++|.+++........++++..++.++.|+++||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998764433567899999999999999999999332 225999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... ......|+..|+|||.+.+..++.++||||||+++++|++|+.||.... ...+.
T Consensus 161 ~~~~~-------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~--- 219 (265)
T cd08217 161 GHDSS-------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLA--- 219 (265)
T ss_pred cCCcc-------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHH---
Confidence 43221 0122468999999999999889999999999999999999999986421 11111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+........+ ...+.++.+++.+|++.+|++||++++|+++
T Consensus 220 ----------~~~~~~~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 ----------SKIKEGKFRRIP-------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----------HHHhcCCCCCCc-------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111111111111 1345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.78 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=199.9
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|...+.||+|+||.||+|... +++.||+|.+.........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556788999999999999864 6788999998655444456788999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999988863 35889999999999999999999986 99999999999999999999999999876542210
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
......|+..|+|||...+..++.++|||||||++|+|++|+.||..... ..+..
T Consensus 157 ------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-------- 211 (277)
T cd06641 157 ------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLF-------- 211 (277)
T ss_pred ------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHH--------
Confidence 11123578899999999888889999999999999999999999863211 00000
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. +..... +.. ....+.++.+++.+|++.+|++||++++++++
T Consensus 212 ----~-~~~~~~---~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 212 ----L-IPKNNP---PTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----H-HhcCCC---CCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 101000 000 01245678899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.36 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=195.2
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
...||+|+||.||++... ++..||||.++.... ...+.+.+|+.+++.++|+|++++++.+...+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 467999999999999964 688899999865433 245678899999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
|.+++.. ..+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 106 L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 106 LTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 9988752 35889999999999999999999996 9999999999999999999999999987543211
Q ss_pred cCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHH
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 910 (983)
.......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ... .+
T Consensus 173 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~~-------------~~ 227 (292)
T cd06658 173 --------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP----PLQ-------------AM 227 (292)
T ss_pred --------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHH-------------HH
Confidence 11122468999999999988889999999999999999999999985311 100 00
Q ss_pred HHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. +....+...+. .......+.+++.+|+..+|++|||++|++++
T Consensus 228 ~~-~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 RR-IRDNLPPRVKD-----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HH-HHhcCCCcccc-----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 10101100000 01234568889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.61 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=185.8
Q ss_pred CccccCCcEeEEEEEECC--------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 673 SLIGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++|||++++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998642 2348888875432 2345678899999999999999999999999899999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC--------EEEcccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT--------ALVADFG 816 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~--------~kl~Dfg 816 (983)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999987542 35889999999999999999999986 999999999999987765 5899999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCC-CCCCcccCCCCch
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGR-RPTDVLFHDGSSL 894 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~-~p~~~~~~~~~~l 894 (983)
.+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||.....
T Consensus 154 ~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----- 211 (258)
T cd05078 154 ISITVLPK-----------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----- 211 (258)
T ss_pred cccccCCc-----------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----
Confidence 88654321 12457889999999887 45789999999999999999995 45432100
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.. ....... ....+. ....++.+++.+|++.+|++|||+++++++|
T Consensus 212 ~~-------------~~~~~~~--~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 212 QK-------------KLQFYED--RHQLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HH-------------HHHHHHc--cccCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 0000000 001111 1235688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=302.30 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=200.0
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC---CCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR---HRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 743 (983)
.|+..+.||+|+||.||+|.+ .+++.||+|.++........+++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466788999999999999996 4688999999876555555678899999999997 999999999999989999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||+|+||+++.++.++|+|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999988753 36899999999999999999999996 99999999999999999999999999987653
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ......|+..|+|||+..+ ..++.++||||||+++|+|++|+.||..... ...+..
T Consensus 154 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~~-- 213 (277)
T cd06917 154 NSS-------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMML-- 213 (277)
T ss_pred Ccc-------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhhc--
Confidence 221 1122468899999998875 4568899999999999999999999864211 010000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+........+ ....+.++.+++.+|++.||++||++.|++++-
T Consensus 214 -----------~~~~~~~~~~------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 214 -----------IPKSKPPRLE------DNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred -----------cccCCCCCCC------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 0000000000 011456788999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=300.50 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=197.2
Q ss_pred CCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
|.+.+.||+|+||.||+|.+. +++.||||++..... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 367899999865432 234567889999999999999999999885432
Q ss_pred ceeEEEecccCcccccccccccC--cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG--LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
..++++||+++|+|.+++..... ....+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 23688999999999887653221 1235789999999999999999999986 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l 894 (983)
|.++........ .......+++.|++||...+..++.++||||||+++|||++ |+.||..... ...
T Consensus 158 g~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~ 224 (273)
T cd05074 158 GLSKKIYSGDYY-----------RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEI 224 (273)
T ss_pred cccccccCCcce-----------ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHH
Confidence 999865432111 11112345678999999998889999999999999999999 8888753211 111
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
..++. .......+ ...+.++.+++.+|++.+|++||++.|+++.|+++
T Consensus 225 ~~~~~----------------~~~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YNYLI----------------KGNRLKQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHH----------------cCCcCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 10000000 12446899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.73 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=197.3
Q ss_pred CCCCCccccCCcEeEEEEEECCCcE-EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~~~~-vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|.+...||.|+||.||+|+.++... .|-|++.... ++..+.|..|++|+....||+||++++.|...+..+|..|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 4455679999999999999774443 5778876554 3468899999999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
||-++..+-.- .+.+.+.++.-+++|++.||.|||++ +|||||+|+.|||++.+|.++++|||.+.....
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---- 182 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---- 182 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh----
Confidence 99999887643 56799999999999999999999999 499999999999999999999999998754321
Q ss_pred ccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.......++|||.|||||+.. ..+|+.++||||||+++.||..+.+|-.. -..+.-.+
T Consensus 183 ---------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe----lnpMRVll---- 245 (1187)
T KOG0579|consen 183 ---------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE----LNPMRVLL---- 245 (1187)
T ss_pred ---------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc----cchHHHHH----
Confidence 112345578999999999864 46899999999999999999999998432 11121111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccc-cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIY-YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
++.....|.. ....| ...+.+++.+|+..||..||++.++++|
T Consensus 246 -------------KiaKSePPTLlqPS~W---s~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 246 -------------KIAKSEPPTLLQPSHW---SRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------------HHhhcCCCcccCcchh---hhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111112222 12234 3567777888999999999999999975
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.76 Aligned_cols=237 Identities=25% Similarity=0.425 Sum_probs=187.0
Q ss_pred CccccCCcEeEEEEEECCCc-----------EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 673 SLIGSGRFGHVYKGVLQDNT-----------RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+.||+|+||.||+|.+.+.. .||+|.+...... ...+.+|++++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999976433 4788877544332 5788999999999999999999999987 77899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-------CEEEcc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-------TALVAD 814 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-------~~kl~D 814 (983)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .++|+|
T Consensus 78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999987542 26899999999999999999999985 99999999999999887 799999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHh-CCCCCCcccCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDG 891 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~ 891 (983)
||++...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||.....
T Consensus 152 fg~a~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-- 212 (259)
T cd05037 152 PGIPITVLSR-----------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-- 212 (259)
T ss_pred CCcccccccc-----------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--
Confidence 9999865321 113467789999998876 78999999999999999999 5667653211
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.....+ ... ....+.. ....+.+++.+|+..+|++||++.|+++.|
T Consensus 213 ~~~~~~----------------~~~--~~~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 213 SEKERF----------------YQD--QHRLPMP-------DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hhHHHH----------------Hhc--CCCCCCC-------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 000 0001100 116788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=299.81 Aligned_cols=257 Identities=22% Similarity=0.408 Sum_probs=201.2
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-----chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... +....+.+|++++++++|+|++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999995 57889999998654321 235678999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEcccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKL 820 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~ 820 (983)
|+||+++++|.+++.. ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999998864 245889999999999999999999996 99999999999998776 599999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
+....... ........||..|+|||...+..++.++||||+|+++|+|++|+.||..... ......+.
T Consensus 154 ~~~~~~~~---------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~- 221 (268)
T cd06630 154 LAAKGTGA---------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLALIF- 221 (268)
T ss_pred cccccccC---------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHHHH-
Confidence 65321110 0112234689999999999888899999999999999999999999853211 11111110
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........... ......++.+++.+|+..+|++||++.|++++
T Consensus 222 -----------~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 222 -----------KIASATTAPSI-------PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----------HHhccCCCCCC-------chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00000011001 12355778999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=302.98 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC-----
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD----- 737 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 737 (983)
.+++|+..+.||+|++|.||+|... +++.||+|++..... ..+++.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999975 578899999865443 346799999999999 6999999999996544
Q ss_pred -ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 738 -FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 738 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
..++||||+++++|.+++.........+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999988654323456899999999999999999999986 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
.+....... .......|+..|+|||++.. ..++.++||||||+++|+|++|+.||..... .
T Consensus 159 ~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~ 224 (275)
T cd06608 159 VSAQLDSTL-------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-M 224 (275)
T ss_pred cceecccch-------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-H
Confidence 987654221 11122468999999998753 3467899999999999999999999863211 0
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... +....... .. . ...+...++.+++.+|+..||++|||++|++++
T Consensus 225 ~~~~----------------~~~~~~~~-~~---~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 RALF----------------KIPRNPPP-TL---K--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHH----------------HhhccCCC-CC---C--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0010 10000000 00 0 011245678899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=297.07 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=200.1
Q ss_pred CCCCCccccCCcEeEEEEEECC-----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
|++.+.||+|+||.||++...+ +..||+|.+......+..+.+..|+++++.++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467889999999999999753 37799999976655445678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++++|||.++....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987532 122899999999999999999999996 99999999999999999999999999987653
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .. ....+++.|+|||...+..++.++||||+|+++++|++ |+.||... .....
T Consensus 156 ~~~~----------~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~----- 213 (258)
T smart00219 156 DDYY----------KK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEV----- 213 (258)
T ss_pred cccc----------cc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHH-----
Confidence 3111 00 01237789999999988889999999999999999998 78887531 11111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.+. +........+ ...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 214 -------~~~-~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 214 -------LEY-LKKGYRLPKP-------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------HHH-HhcCCCCCCC-------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 1111110011 12456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.08 Aligned_cols=274 Identities=24% Similarity=0.311 Sum_probs=198.8
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|++|.||+|+.. +++.||||.++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999965 6889999988654322 2346788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+. ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 58888776433 356899999999999999999999986 9999999999999999999999999987654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......++..|+|||...+.. ++.++||||||+++|||+||+.||..... .......+...-..
T Consensus 155 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~ 220 (284)
T cd07860 155 R-------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTP 220 (284)
T ss_pred c-------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence 1 111234688999999887644 58899999999999999999999853211 11111111111110
Q ss_pred C--CcHHHHHH--HhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 R--LDPIVEKA--IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ..+..... .........+............++.+++.+|++.||++||+++|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred ChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 00000000 000000000000000111234668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=312.97 Aligned_cols=280 Identities=21% Similarity=0.299 Sum_probs=201.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----ce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD-----FK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 739 (983)
+++|.+.+.||+|+||.||+|... +++.||||.++.........++.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 688999999865443445567889999999999999999999875443 46
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||+++ ++.+.+. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 899999975 7766664 345899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
......... .......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||... +.......+
T Consensus 155 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~--~~~~~~~~~ 222 (336)
T cd07849 155 IADPEHDHT----------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK--DYLHQLNLI 222 (336)
T ss_pred ecccccccc----------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHH
Confidence 654322110 11123468999999998755 56889999999999999999999998532 111111111
Q ss_pred HhhCCCCCcHHHHH----HHhh---cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhH
Q 042568 899 KRHYPHRLDPIVEK----AIAK---YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLK 966 (983)
Q Consensus 899 ~~~~~~~~~~~~~~----~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 966 (983)
.........+..+. .... ..+................++.+++.+|++.+|++||++.|++++ ++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 11111111111110 0000 000000000000112235678999999999999999999999987 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.32 Aligned_cols=256 Identities=24% Similarity=0.292 Sum_probs=193.8
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 445678999999999999965 578999999876554445678899999999996 999999999999889999999998
Q ss_pred cCcccccccccc-cCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 747 SNGSLENHLYPS-HGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 747 ~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
.. ++.++.... ......+++..+..++.|+++||+|||+.. +++||||||+||+++.++.++|+|||+++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 64 554432211 111356899999999999999999999752 49999999999999999999999999997654211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC---CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK---RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
. .....|+..|+|||.+.+. .++.++||||+||++|||++|+.||.... ...+.+..
T Consensus 163 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~-- 222 (288)
T cd06616 163 A--------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQ-- 222 (288)
T ss_pred c--------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhh--
Confidence 1 1123588899999998776 68899999999999999999999985321 11111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ..+......+...+.++.+++.+|++.+|++|||+++|+++
T Consensus 223 ----------~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 ----------VVKG----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----------hcCC----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00111111112356789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.49 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=200.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|+||.||+|... +++.+|||.+.... ..+....+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999964 67889999986543 223467889999999999999999999999988999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgla~~~~~~ 824 (983)
+++++|.+++.... ...+++..+..++.|+++|++|||+++ ++||||||+||+++++ +.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999987543 345899999999999999999999986 9999999999999865 46899999999866432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. .....|+..|+|||...+..++.++||||||+++|+|++|+.||+... ....+
T Consensus 156 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-----~~~~~------ 210 (256)
T cd08220 156 SK--------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-----LPALV------ 210 (256)
T ss_pred cc--------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-----hHHHH------
Confidence 11 112468899999999998888999999999999999999999985321 11111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
......... ..+ ...+.++.+++.+|++.+|++|||+.|++++
T Consensus 211 ------~~~~~~~~~-~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 211 ------LKIMSGTFA-PIS-------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ------HHHHhcCCC-CCC-------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111000 000 1245678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=297.99 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=195.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC----cchhHHHHHHHHHHHhcCCCCccceeeEEecC--Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT----GEITGSFKRECQILKRIRHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 739 (983)
.+|...+.||+|+||.||+|... ++..||||.+..... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 588999998854321 12346788999999999999999999988664 456
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 7999999999999988642 34788899999999999999999996 9999999999999999999999999988
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ ........|+..|+|||...+..++.++||||||+++|||++|+.||.... ....
T Consensus 155 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~~--- 217 (265)
T cd06652 155 RLQTICLS----------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE----AMAA--- 217 (265)
T ss_pred cccccccc----------ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc----hHHH---
Confidence 65421110 011122458899999999988889999999999999999999999985321 0010
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+............ .......+.+++.+|+. +|++||+++|++++
T Consensus 218 ----------~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 ----------IFKIATQPTNPVL-------PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----------HHHHhcCCCCCCC-------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1110000000001 12345677888889984 99999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=328.58 Aligned_cols=265 Identities=24% Similarity=0.370 Sum_probs=191.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-------- 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 736 (983)
..+|+..++||+||||.|||++.+ ||+.||||++.............+|++.+.+++|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 345777889999999999999966 89999999998776666678899999999999999999987553110
Q ss_pred --------------------------------------------------------------------------------
Q 042568 737 -------------------------------------------------------------------------------- 736 (983)
Q Consensus 737 -------------------------------------------------------------------------------- 736 (983)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh
Q 042568 737 -------------------------------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785 (983)
Q Consensus 737 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH 785 (983)
...||-||||+..++.+++....-. -.....++++++|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHH
Confidence 0125667777776666666543211 146778999999999999999
Q ss_pred ccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC----Ccccccc-cCCCCccccccCccccccccccccccCCC-
Q 042568 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG----IDESVNC-ANDSMSFTSTDGLLCGSVGYIAPEYGMGK- 859 (983)
Q Consensus 786 ~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~----~~~~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 859 (983)
++| ||||||||.||++|++..|||+|||+|+.... .+..... ....-......+..+||.-|+|||.+.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 997 99999999999999999999999999998321 1100000 00000001123446899999999998775
Q ss_pred --CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHH
Q 042568 860 --RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLEL 937 (983)
Q Consensus 860 --~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 937 (983)
.|+.|+|+||+|||++||+. ||....+. ...+........|.. ...+.+...+-
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------------------a~iL~~LR~g~iP~~-~~f~~~~~~~e 847 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--------------------ASILTNLRKGSIPEP-ADFFDPEHPEE 847 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH--------------------HHHHHhcccCCCCCC-cccccccchHH
Confidence 49999999999999999996 55432111 111112222222222 22234455667
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHH
Q 042568 938 IELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 938 ~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
..++.++++.||.+|||+.|+++
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 88999999999999999999985
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.87 Aligned_cols=256 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|+||.||+|... +++.||+|.++..... +..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5778899999999999999964 6889999998765432 3567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ..+++..+..++.|+++|++|||+.+ |+|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999988742 34788999999999999999999986 9999999999999999999999999998765432
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR---ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ........++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ...
T Consensus 154 ~~~---------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~-------- 215 (264)
T cd06626 154 TTM---------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQI-------- 215 (264)
T ss_pred Ccc---------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHH--------
Confidence 211 01012246788999999988766 889999999999999999999998642110 000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+........+ .+......+.+++.+|++.+|++||++.|++.+
T Consensus 216 --------~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 216 --------MFHVGAGHKPPIP-----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --------HHHHhcCCCCCCC-----cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000110111111 112245678899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=304.92 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=196.3
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
...||+|+||.||+|... +++.||+|.++..... ..+.+.+|+.+++.++|||++++++++...+..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 457999999999999964 6889999998654332 35678899999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
|.+++. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 105 L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---- 172 (297)
T cd06659 105 LTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---- 172 (297)
T ss_pred HHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc----
Confidence 988764 345889999999999999999999986 99999999999999999999999999875432111
Q ss_pred cCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHH
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 910 (983)
......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ... ...
T Consensus 173 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~----~~~-~~~----------- 227 (297)
T cd06659 173 ---------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS----PVQ-AMK----------- 227 (297)
T ss_pred ---------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHH-HHH-----------
Confidence 1122468999999999998889999999999999999999999985311 100 000
Q ss_pred HHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 911 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+....... ...+.....++.+++.+|++.+|++||++++++++--
T Consensus 228 --~~~~~~~~~-----~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~ 273 (297)
T cd06659 228 --RLRDSPPPK-----LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273 (297)
T ss_pred --HHhccCCCC-----ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence 010000000 0011123456889999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.12 Aligned_cols=272 Identities=24% Similarity=0.326 Sum_probs=201.8
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 688999999876543 33457899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+ +++|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999988643 256899999999999999999999986 9999999999999999999999999998664322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .......|+..|+|||++.+. .++.++||||+|+++|||++|+.||.... +...+. .+......
T Consensus 154 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~-~~~~~~~~ 219 (286)
T cd07832 154 P------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLA-IVFRTLGT 219 (286)
T ss_pred C------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHH-HHHHHcCC
Confidence 1 011123688999999998764 46899999999999999999987775321 111111 11111110
Q ss_pred CCcHHHHHHHh------h-cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIA------K-YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... .+... . ..+...+........+...++.+++.+|++.+|++||++++++++
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 220 PNEET-WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CChHH-HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000 0 000000000011112345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=303.68 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888999999999999999854 6788999998644332 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998863 35789999999999999999999996 9999999999999999999999999987554321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......|++.|+|||+..+..++.++||||||+++|++++|+.||........ ....
T Consensus 170 ~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~-------- 227 (293)
T cd06647 170 S-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI-------- 227 (293)
T ss_pred c-------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh--------
Confidence 1 11224688999999999888889999999999999999999999864211100 0000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.... .+. ..........+.+++.+||+.+|++||++.+++.+=
T Consensus 228 ---------~~~~---~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 228 ---------ATNG---TPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred ---------hcCC---CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0000 000 001123456788999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.11 Aligned_cols=274 Identities=23% Similarity=0.340 Sum_probs=199.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|+..+.||+|+||.||+|.++ +++.||+|++...... ...+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5888999998654322 235678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++++++.++... ...+++..++.++.|+++||+|||+.+ ++|||++|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888876643 234899999999999999999999986 999999999999999999999999998765432
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh--h
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR--H 901 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~--~ 901 (983)
.. ......++..|+|||+..+ ..++.++||||||+++|||++|+.||..... .......... .
T Consensus 154 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~ 219 (286)
T cd07846 154 GE-------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYHIIKCLGN 219 (286)
T ss_pred cc-------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHHHhCC
Confidence 11 1112458899999999875 4578899999999999999999998853210 0001111100 0
Q ss_pred CCCCCcHHHHH--HHhhcCCC--CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEK--AIAKYAPQ--HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.........+. ........ .........+...+..+.+++.+|++.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 00000000 00000001122356779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=297.87 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=199.5
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC----cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT----GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+|+..+.||+|+||.||+|... +++.||+|.+..... ++..+.+.+|+++++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 789999999865432 23456789999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+++++|.+++... ..+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999988642 35889999999999999999999986 9999999999999999999999999987654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
... ......|+..|+|||...... ++.++|+||||+++|+|++|+.||.... .....
T Consensus 154 ~~~--------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~----~~~~~---- 211 (258)
T cd06632 154 EFS--------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE----GVAAV---- 211 (258)
T ss_pred ccc--------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc----HHHHH----
Confidence 221 112245889999999987766 8899999999999999999999986421 10000
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. . ..... ..+. .......++.+++.+|+..+|.+||++++++++
T Consensus 212 --------~-~-~~~~~--~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 212 --------F-K-IGRSK--ELPP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --------H-H-HHhcc--cCCC----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 0 00000 0000 011245678899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=306.76 Aligned_cols=280 Identities=19% Similarity=0.248 Sum_probs=198.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC---CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Ccee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 740 (983)
+|...+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999965 47889999987633 122356788899999999999999999999888 7899
Q ss_pred EEEecccCcccccccccccCc-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC----CCCEEEccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGL-SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE----DLTALVADF 815 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~----~~~~kl~Df 815 (983)
+||||+++ ++.+++...... ...+++..++.++.|++.|++|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 565555432221 236899999999999999999999996 999999999999999 999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC--
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS-- 892 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~-- 892 (983)
|+++........ ........+|..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....+..
T Consensus 157 g~~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 157 GLARLFNAPLKP----------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred ccccccCCCccc----------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 999866432211 011223468899999998776 4578999999999999999999999975432210
Q ss_pred ------chHHHHHhhCCCCCc--H------HHHHHHhhcCCCCCc--ccccc--chHHHHHHHHHHHhhhcCCCCCCCCC
Q 042568 893 ------SLHEWVKRHYPHRLD--P------IVEKAIAKYAPQHMP--IYYNK--VWSDVVLELIELGLLCTQYNPSTRPS 954 (983)
Q Consensus 893 ------~l~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs 954 (983)
.+..++...-..... . ..............+ ..... .+.....++.+++.+|++.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 111111111000000 0 000000000000000 00000 00123457899999999999999999
Q ss_pred HHHHHHH
Q 042568 955 MLDVAHE 961 (983)
Q Consensus 955 ~~evl~~ 961 (983)
+.|++++
T Consensus 307 ~~eil~~ 313 (316)
T cd07842 307 AEEALEH 313 (316)
T ss_pred HHHHhcC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=304.98 Aligned_cols=274 Identities=22% Similarity=0.264 Sum_probs=196.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcC-CCCccceeeEEecCCc-----
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIR-HRNLIRIITICSKPDF----- 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 738 (983)
++|+..+.||+|+||.||+|... +++.||||.++..... .....+.+|+++++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 6889999988654332 23467888999999995 6999999999876665
Q ss_pred eeEEEecccCcccccccccccCc-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEcccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGL-SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFG 816 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfg 816 (983)
.++||||+++ ++.+++...... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 788877644322 346899999999999999999999996 999999999999998 8999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||... ....
T Consensus 157 ~~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~----~~~~ 219 (295)
T cd07837 157 LGRAFSIPVK-------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD----SELQ 219 (295)
T ss_pred cceecCCCcc-------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC----CHHH
Confidence 9875532111 0111256889999998765 45789999999999999999999998532 1111
Q ss_pred HHHH---hh-CCCC--CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVK---RH-YPHR--LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~---~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... .. .+.. .............+...+............++.+++.+|+.++|++||+++|++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1111 00 0000 00000000000000000000011112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.24 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=205.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|++|.||+|... +++.||||++...........+.+|++++++++|+|++++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 58999999987665434567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998743 568999999999999999999999 85 999999999999999999999999998866432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
... .....++..|+|||...+..++.++||||||+++|+|++|+.||..... ....+
T Consensus 154 ~~~-------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~-------- 210 (264)
T cd06623 154 LDQ-------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFE-------- 210 (264)
T ss_pred CCc-------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHH--------
Confidence 211 1134688999999999998999999999999999999999999864321 01111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSD-VVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... .......+ .. .+..+.+++.+|+..+|++||++.|++++
T Consensus 211 ----~~~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 211 ----LMQAIC-DGPPPSLP-------AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----HHHHHh-cCCCCCCC-------cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111 11110011 11 45689999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=302.73 Aligned_cols=246 Identities=28% Similarity=0.324 Sum_probs=199.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|+..+.||+|+||.||+|... +++.||+|++..... .+..+.+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999965 588999999865432 224567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999988653 45889999999999999999999986 99999999999999999999999999876542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ..
T Consensus 154 ~----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~-------- 204 (290)
T cd05580 154 R----------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PI-------- 204 (290)
T ss_pred C----------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HH--------
Confidence 1 112468899999999988888999999999999999999999985321 00
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
......... ....+ ......+.+++.+|+..+|.+|| +++|++++
T Consensus 205 ----~~~~~~~~~--~~~~~-------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 205 ----QIYEKILEG--KVRFP-------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----HHHHHHhcC--CccCC-------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011111100 00111 11246788999999999999999 77888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.16 Aligned_cols=272 Identities=20% Similarity=0.272 Sum_probs=199.5
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc----chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+|...+.||+|+||.||+|... +++.||||.+...... .....+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999965 6889999998655432 2345677899999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999886432 36899999999999999999999996 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||.... +...+..... .
T Consensus 154 ~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~-~ 218 (298)
T cd07841 154 SPNRK-------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFE-A 218 (298)
T ss_pred CCCcc-------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHH-H
Confidence 32111 111246788999998865 457899999999999999999977765321 1111111111 1
Q ss_pred CCCCCcHHHHH--HHhhcC--CCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEK--AIAKYA--PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........... ...... ....+......+.....++.+++.+|++.+|++|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 10000000000 000000 0000000111123346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.60 Aligned_cols=250 Identities=27% Similarity=0.347 Sum_probs=195.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.+|...+.||+|+||.||+|... +++.||+|.+..... .+...++.+|+++++.++|||++++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999965 688999999864322 233467889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++ |++.+.+... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 4666655432 245899999999999999999999986 99999999999999999999999999875432
Q ss_pred CcccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
. ....|+..|+|||.+. ...++.++||||||+++|||++|+.||..... .....
T Consensus 168 ~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~~~- 224 (307)
T cd06607 168 A-----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALY- 224 (307)
T ss_pred C-----------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHHHH-
Confidence 1 1235788999999874 35678999999999999999999999853210 00000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
. +.. ...+.... .....++.+++.+||..+|++||++.+++++..-
T Consensus 225 -----------~-~~~---~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 225 -----------H-IAQ---NDSPTLSS---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred -----------H-Hhc---CCCCCCCc---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 0 000 00011111 2245678999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.52 Aligned_cols=273 Identities=23% Similarity=0.324 Sum_probs=200.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
+|+..+.||+|++|.||+|+.. +|+.||||.++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 688899999876654444567888999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++ ++.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88877754332 346899999999999999999999986 99999999999999999999999999975532111
Q ss_pred cccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......+|..|+|||+..+. .++.++||||+|+++|+|++|+.||...... ..............
T Consensus 156 -------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (284)
T cd07836 156 -------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPT 221 (284)
T ss_pred -------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCC
Confidence 11123578899999987664 5688999999999999999999998643211 11111111110000
Q ss_pred CcHHHHHHHhhcC--CCCCccc----cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYA--PQHMPIY----YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... +.... ....+.. .....+....++.+++.+|++.||++||+++|++++
T Consensus 222 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 222 -ESTWPG-ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred -hhhHHH-HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 00000 0000000 000112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=297.85 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=199.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999965 578899999865432 22356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~~~~ 824 (983)
+++++|.+++.... ...+++..+..++.|+++|++|||+.+ ++|+||||+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999887533 345799999999999999999999986 99999999999999885 4699999999765432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
... .....|++.|+|||+..+..++.++||||||++++||++|+.||... ...+++.....
T Consensus 156 ~~~-------------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~- 216 (257)
T cd08225 156 MEL-------------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKICQ- 216 (257)
T ss_pred ccc-------------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHHhc-
Confidence 111 11235889999999998888999999999999999999999998532 11222221111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... . ......++.+++.+|+..+|++|||+.|++++
T Consensus 217 -----------~~~~~-~-------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 -----------GYFAP-I-------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----------ccCCC-C-------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00000 0 01234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.83 Aligned_cols=284 Identities=22% Similarity=0.274 Sum_probs=202.7
Q ss_pred CCCCCCCccccCCcEeEEEEEECC--C---cEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEec-CCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD--N---TRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSK-PDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~--~---~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 739 (983)
..|+....||+|+||.||||+-.+ + ..+|+|.++.+..+. ......+|+..++.++|||++.+..++-. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357788999999999999996432 2 258999997765443 34678899999999999999999998866 6788
Q ss_pred eEEEecccCcccccccccccC-cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC----CCEEEcc
Q 042568 740 ALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED----LTALVAD 814 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~----~~~kl~D 814 (983)
++++||.+. +|...++-++. ..+.++...+..|.+||+.|+.|||++. |+|||+||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999997 67666654332 2357899999999999999999999997 9999999999999877 9999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCC---
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHD--- 890 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~--- 890 (983)
||+|+.+...-... .....++-|..|+|||.+.|. .||++.|||+.|||+.||+|-++-|.....+
T Consensus 180 lGlaR~~~~plkpl----------~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 180 LGLARLFNNPLKPL----------ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred ccHHHHhhcccccc----------ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 99999886543221 223446789999999999984 6899999999999999999998887543211
Q ss_pred CCc-----hHHHHHh-hCCCC-Cc----------HHHHHHHhhcCCC-CCccccccchHHHHHHHHHHHhhhcCCCCCCC
Q 042568 891 GSS-----LHEWVKR-HYPHR-LD----------PIVEKAIAKYAPQ-HMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952 (983)
Q Consensus 891 ~~~-----l~~~~~~-~~~~~-~~----------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 952 (983)
... +..+.+- ..|.. .. ..+........+. .++.++.+ +..-.....+|+..++.+||.+|
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~-~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHK-HKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHH-hcCCCchHHHHHHHHhccCchhh
Confidence 100 1111110 00110 00 0011111111111 11111111 11112337899999999999999
Q ss_pred CCHHHHHHHHHHh
Q 042568 953 PSMLDVAHEMGRL 965 (983)
Q Consensus 953 Ps~~evl~~L~~~ 965 (983)
.|+++.+++.=.-
T Consensus 329 Ita~qAleh~yF~ 341 (438)
T KOG0666|consen 329 ITAEQALEHPYFT 341 (438)
T ss_pred ccHHHHhcccccc
Confidence 9999999876433
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.38 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=207.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..+.|.+...||+|.|+.|..|++ .++..||||.+++..-.. ....+.+|+++|+.++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346788899999999999999995 478999999998765332 345689999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+.+|.+.+++.... .+.+..+..++.|+.+|++|+|+++ |||||||++|||+++++.+||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999998653 3555888999999999999999996 9999999999999999999999999999876
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.. ...++.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+.- .+..
T Consensus 207 ~~--------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-----~lk~----- 262 (596)
T KOG0586|consen 207 YG--------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-----NLKE----- 262 (596)
T ss_pred cc--------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-----cccc-----
Confidence 32 23355789999999999999766 68999999999999999999999742 1111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.-++.+.... ..+.+ ...++.+++.+++..+|.+|++++++.++-+
T Consensus 263 -------Lr~rvl~gk~--rIp~~-------ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 263 -------LRPRVLRGKY--RIPFY-------MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred -------ccchheeeee--cccce-------eechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 1111111111 11211 3467889999999999999999999998655
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.47 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=196.9
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|...+.||+|++|.||+|... +++.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344578999999999999954 688899998864432 234668899999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|.+++.. .++++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++++|||.+.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999998864 35889999999999999999999996 9999999999999999999999999887543211
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......|++.|+|||...+..++.++||||||+++|||++|+.||.... . ...
T Consensus 170 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~-~~~---------- 223 (285)
T cd06648 170 -----------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----P-LQA---------- 223 (285)
T ss_pred -----------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----H-HHH----------
Confidence 01122458899999999998889999999999999999999999985311 0 011
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... +........+. .......+.+++.+|++.+|++||++++++++
T Consensus 224 --~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 224 --MKR-IRDNLPPKLKN-----LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --HHH-HHhcCCCCCcc-----cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111 11111100000 01244679999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.53 Aligned_cols=266 Identities=20% Similarity=0.217 Sum_probs=198.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999965 578899999865432 223467889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.++++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999998642 35899999999999999999999986 99999999999999999999999999874221
Q ss_pred CcccccccC--CCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 824 IDESVNCAN--DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 824 ~~~~~~~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
......... .............|+..|+|||++.+..++.++||||||+++|||++|+.||... ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-----~~~~----- 223 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEE----- 223 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHH-----
Confidence 110000000 0000001112245788999999998888999999999999999999999998531 1111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
............ +.. ....+.++.+++.+|++.+|++||++.++.+.+
T Consensus 224 -------~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 224 -------LFGQVISDDIEW--PEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred -------HHHHHHhcccCC--CCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 111111111000 000 012456789999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.94 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=203.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++.|...+.||+|++|.||+|..+ +++.||+|+++.... ..+.+.+|++++++++|+|++++++++...+..++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566778889999999999999976 688899999975543 4577889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999987532 36899999999999999999999986 99999999999999999999999999875542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ....
T Consensus 169 ~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~----~~~~------- 224 (286)
T cd06614 169 EKS-------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP----PLRA------- 224 (286)
T ss_pred chh-------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC----HHHH-------
Confidence 211 1112357889999999998889999999999999999999999985311 1000
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
... +........+ .....+.++.+++.+|++.+|.+||++.+++++-
T Consensus 225 ------~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 225 ------LFL-ITTKGIPPLK-----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred ------HHH-HHhcCCCCCc-----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 000 0000000000 0122456788999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=279.49 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=202.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...+++|+|.||.|-.++- .+++.+|+|+++++. ..+..+.-..|-++++..+||.+..+-..|+..+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35688899999999999999994 478889999997764 233456667799999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||..||.|.-++.. .+.+++...+-+-..|+.||.|||+++ ||.||+|.+|+|+|++|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988875 345788888889999999999999985 9999999999999999999999999998432
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.+...+.+.+|||.|+|||++....|+..+|.|.+||++|||++|+.||..-.+ ..+.+.+.
T Consensus 320 -------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl--- 381 (516)
T KOG0690|consen 320 -------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELIL--- 381 (516)
T ss_pred -------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHH---
Confidence 223456678999999999999999999999999999999999999999964322 11222111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
... -+.| .....+...|+...+..||.+|. .++||.++
T Consensus 382 ------------~ed--~kFP-------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 382 ------------MED--LKFP-------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------------hhh--ccCC-------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 110 0111 12456788888999999999995 45566543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.43 Aligned_cols=248 Identities=23% Similarity=0.301 Sum_probs=195.1
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
...||.|+.|.|++++.+ +|..+|||.+......+..+++...+.++..-+ .|.||+.+|||......++.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 567999999999999965 578899999988777777788888888877664 89999999999999999999999852
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
..+.++... ..++++..+-++...+.+||.||.+++ .|+|||+||+|||+|+.|.+|+||||++.++.+...+
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 455555433 456888888899999999999999877 6999999999999999999999999999887654433
Q ss_pred ccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
...+|-+.|||||.+.- ..|+-++||||||++++|+.||+.||..-..+-.
T Consensus 249 ------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------------- 302 (391)
T KOG0983|consen 249 ------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------------- 302 (391)
T ss_pred ------------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------------
Confidence 22468899999999875 4688999999999999999999999864211111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+..+.+.. .+..++... ..+..+.+++..|+..|+.+||...+++++
T Consensus 303 --~ltkvln~-ePP~L~~~~-----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 --VLTKVLNE-EPPLLPGHM-----GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --HHHHHHhc-CCCCCCccc-----CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111111 112222111 134678888888999999999999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=301.93 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=197.8
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|...+.||+|+||.||+|+.. ++..||+|.+.... ..+...++.+|++++++++|||++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 555778999999999999964 68889999986542 223456788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+.+ ++.+.+... ...+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 974 776666432 345899999999999999999999996 999999999999999999999999998754321
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
....|++.|+|||++. +..++.++|||||||++|||++|+.||.... ..
T Consensus 179 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~----~~-------- 230 (317)
T cd06635 179 ----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AM-------- 230 (317)
T ss_pred ----------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc----HH--------
Confidence 1235888999999874 4568899999999999999999999985321 00
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
............ ... .......+.+++.+|++.+|.+||++.+++++.........
T Consensus 231 -----~~~~~~~~~~~~----~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 231 -----SALYHIAQNESP----TLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred -----HHHHHHHhccCC----CCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 001111111000 000 11244678999999999999999999999998765544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.53 Aligned_cols=273 Identities=20% Similarity=0.309 Sum_probs=200.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|+..+.||+|+||.||+|... +++.||||.++.... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999965 578899999865432 3345789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++++.+..+... ...+++..+..++.|+++|++|||+.+ ++|||++|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777665532 345899999999999999999999996 999999999999999999999999999876532
Q ss_pred cccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..+.. ......
T Consensus 154 ~~------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~ 219 (288)
T cd07833 154 PA------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYL-IQKCLG 219 (288)
T ss_pred cc------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhC
Confidence 21 011224678899999999887 8899999999999999999999998632110 00000 000000
Q ss_pred CCCcHHHHHHH------hh--cCCCCCccccccch-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAI------AK--YAPQHMPIYYNKVW-SDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~------~~--~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+...... .. ......+......+ ..++.++.+++.+|+..+|++||++++++++
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 220 -PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred -CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000 00 00000000000000 1236789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.77 Aligned_cols=272 Identities=25% Similarity=0.316 Sum_probs=197.8
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|++++++++|||++++++++...+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 7899999998655422 23467889999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68988886533 246899999999999999999999985 99999999999999999999999999975532111
Q ss_pred cccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ...+...........
T Consensus 155 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~ 220 (283)
T cd07835 155 -------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPD 220 (283)
T ss_pred -------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Confidence 01112468899999987664 568899999999999999999999853211 111111111111000
Q ss_pred CcHHHH-----HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVE-----KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... .......+................++.+++.+|++.+|++||+++|++++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 221 -EDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred -hHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000000000000011112244678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=293.64 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=203.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|+||.||+++.. +++.+|+|.+.... .......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 67889999986543 223456788999999999999999999999988999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.........+++..++.++.|+++|++|||+.+ ++|+||+|+||+++.++.+|++|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999988764433467899999999999999999999996 9999999999999999999999999998765321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....|+..|+|||...+..++.++|+||+|+++|||++|+.||.... ...
T Consensus 158 ---------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~--------- 208 (256)
T cd08530 158 ---------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQD--------- 208 (256)
T ss_pred ---------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHH---------
Confidence 111357889999999999889999999999999999999999986421 000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
....+........ ......++.+++.+|+..+|++||++.|++++
T Consensus 209 ----~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 209 ----LRYKVQRGKYPPI-------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----HHHHHhcCCCCCC-------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111111110001 12355779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=323.46 Aligned_cols=279 Identities=18% Similarity=0.209 Sum_probs=189.4
Q ss_pred HhCCCCCCCccccCCcEeEEEEEECC--CcEEEEEEee--------------c--ccCcchhHHHHHHHHHHHhcCCCCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQD--NTRIAVKVLD--------------L--TTTGEITGSFKRECQILKRIRHRNL 726 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~~--~~~vAvK~~~--------------~--~~~~~~~~~~~~E~~~l~~l~h~ni 726 (983)
..++|.+.+.||+|+||+||++..+. +..+++|.+. + ........++.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987542 2222222110 0 0111234568899999999999999
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccC-cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
+++++++...+..++|+|++.+ ++.+++..... .........+..|+.|++.||+|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999864 66665543221 1222345677889999999999999986 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCC-
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT- 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~- 884 (983)
.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 9999999999999876432211 112247999999999999999999999999999999999988643
Q ss_pred CcccCC-CCchHHHHHhh------CCCCCcHHHHHHHhhc---CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC
Q 042568 885 DVLFHD-GSSLHEWVKRH------YPHRLDPIVEKAIAKY---APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954 (983)
Q Consensus 885 ~~~~~~-~~~l~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 954 (983)
...... ...+.+.+... ++.......+...... .....+..... ......+.+++.+|+++||++|||
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rps 447 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPG 447 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcC
Confidence 221111 11122222110 1111011111100000 00000100000 112345778899999999999999
Q ss_pred HHHHHHH
Q 042568 955 MLDVAHE 961 (983)
Q Consensus 955 ~~evl~~ 961 (983)
+.|++++
T Consensus 448 a~elL~h 454 (501)
T PHA03210 448 AAELLAL 454 (501)
T ss_pred HHHHhhC
Confidence 9999975
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.11 Aligned_cols=279 Identities=21% Similarity=0.275 Sum_probs=196.5
Q ss_pred CccccC--CcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSG--RFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G--~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
..||+| +||+||+|.+. +++.||||++..... .+..+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999964 789999999865432 23457889999999999999999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
+++.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999887543 345899999999999999999999986 9999999999999999999999998765433211110
Q ss_pred cccCCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh-hCCC-
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR-HYPH- 904 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~-~~~~- 904 (983)
.. .........++..|+|||++.+. .++.++||||+||++|||++|+.||........ ....... .+.+
T Consensus 159 ~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~ 231 (328)
T cd08226 159 KV------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPL 231 (328)
T ss_pred cc------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCc
Confidence 00 00111122456779999998763 478999999999999999999999864321110 1111000 0000
Q ss_pred -------CCcH-----------HHHHHHhhcCCCC--CccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 905 -------RLDP-----------IVEKAIAKYAPQH--MPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 905 -------~~~~-----------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.... +.+..+....... .+.............+.+++.+|++.||++|||++|++++-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000 0000000000000 000011112346678999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.51 Aligned_cols=243 Identities=25% Similarity=0.297 Sum_probs=186.1
Q ss_pred ccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHh---cCCCCccceeeEEecCCceeEEEeccc
Q 042568 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKR---IRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+||+|+||.||++... +++.||+|.+...... .....+.+|..+++. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 6889999988654322 112334455544443 379999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988764 345899999999999999999999996 9999999999999999999999999987543211
Q ss_pred ccccCCCCccccccCccccccccccccccC-CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGM-GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.....||..|+|||... +..++.++||||+||++|||++|+.||...... ...
T Consensus 152 -------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~----------- 205 (279)
T cd05633 152 -------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKH----------- 205 (279)
T ss_pred -------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc--CHH-----------
Confidence 11235899999999886 456789999999999999999999998643211 100
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.+...... ..... ......++.+++.+|++.||++|| +++|++++
T Consensus 206 --~~~~~~~~-~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 206 --EIDRMTLT-VNVEL-------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --HHHHHhhc-CCcCC-------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11111100 00001 122456788999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=296.50 Aligned_cols=268 Identities=20% Similarity=0.205 Sum_probs=194.6
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecC--CceeEEEe
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKP--DFKALVLP 744 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 744 (983)
|...+.||+|+||.||+|... +++.||+|.++............+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999954 688899999865433323344557899999885 99999999999877 88999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++ +++.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 4777776542 246899999999999999999999996 999999999999999 99999999999865422
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .....++..|+|||+..+ ..++.++||||+||++|||++|+.||.... .............
T Consensus 153 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~--~~~~~~~~~~~~~ 216 (282)
T cd07831 153 PP--------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN--ELDQIAKIHDVLG 216 (282)
T ss_pred CC--------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC--HHHHHHHHHHHcC
Confidence 11 112357889999997654 557889999999999999999999985421 1111122222111
Q ss_pred CCCcHHHHHHHhhcCCCC--Ccc----ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQH--MPI----YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... ........... .+. .........+.++.+++.+|++.+|++||++++++++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 217 TPDAEV-LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCHHH-HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 111111 11111100000 000 0000112356889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.00 Aligned_cols=273 Identities=21% Similarity=0.232 Sum_probs=197.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 742 (983)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778899999999999999975 5788999998755432 2344678899999999999999999998777 889999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 888877643 236899999999999999999999996 9999999999999999999999999998665
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ...+.... ..
T Consensus 158 ~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~-~~ 222 (293)
T cd07843 158 SPLK-------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-IDQLNKIF-KL 222 (293)
T ss_pred CCcc-------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH-HH
Confidence 3211 11123578899999988764 468899999999999999999999864211 11111111 11
Q ss_pred CCCCCcHHHHHH--HhhcC----CCCCccccccchHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKA--IAKYA----PQHMPIYYNKVWSD--VVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ +.... ...........+.. ....+.+++.+|++.+|++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 110000000000 00000 00000000001111 25678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=280.58 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=200.4
Q ss_pred CCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceee
Q 042568 654 NPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIIT 731 (983)
Q Consensus 654 ~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 731 (983)
...|+-++++. +..||.|+||+|+|-.++ .|+..|||++..........++..|.+...+- +.||||++||
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 34555556654 467999999999999965 68889999998877766778899999976655 7899999999
Q ss_pred EEecCCceeEEEecccCcccccccccccC-cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 732 ICSKPDFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 732 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
.+-.++..++.||.|+ .|++.+...... ....+++.-.-+|....+.||.||-+.. +|||||+||+|||+|..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 9999999999999996 477654332211 1456888888999999999999998775 79999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
|+||||++..+.+.- ....-+|-..|||||.+.. ..|+-++||||+|+++||+.||+.||....
T Consensus 208 KLCDFGIcGqLv~Si--------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI--------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred eeecccchHhHHHHH--------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 999999997664321 1122368889999999875 458999999999999999999999986421
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccc-cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIY-YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.++++...-. ....|.. .....-+....+.+++.-|+..|-..||...++.++
T Consensus 274 -------------------svfeql~~Vv-~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 274 -------------------SVFEQLCQVV-IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -------------------HHHHHHHHHH-cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1222221111 1111111 111112355678888889999999999999998753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=302.18 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=202.2
Q ss_pred CCccccCCcEeEEEEEEC--CCcE--EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 672 SSLIGSGRFGHVYKGVLQ--DNTR--IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~--~~~~--vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
.++||+|.||+|++|.|. .|+. ||||.+...........|.+|+.+|.+|+|||++++||+..+ .-..+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 578999999999999986 3444 799999766555567899999999999999999999999987 55689999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
.|||.+.+++. .+..+-......++.|||.|+.||..++ .||||+-..|+++-....+||+|||+.+-++..++.
T Consensus 194 lGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999873 2567888899999999999999999985 999999999999999999999999999988866544
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
+. ......-.+.|-|||.+....++.++|||+|||++|||+| |..||-...+
T Consensus 269 Yv----------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------- 321 (1039)
T KOG0199|consen 269 YV----------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------- 321 (1039)
T ss_pred eE----------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------
Confidence 32 1111233467999999999999999999999999999999 7778743210
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+++. +.. ...++. .+.|+..+++++.+||..+|++||++..+.+.+
T Consensus 322 ~qIL~~-iD~--~erLpR-----Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 322 IQILKN-IDA--GERLPR-----PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHh-ccc--cccCCC-----CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111111 111 111111 235889999999999999999999999997544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=299.66 Aligned_cols=264 Identities=18% Similarity=0.251 Sum_probs=183.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchh----------HHHHHHHHHHHhcCCCCccceeeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEIT----------GSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
++|.+.++||+|+||.||+|.+.+ +..+|+|+.......... .....+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999654 345677764333221101 112233344556689999999997
Q ss_pred EecCC----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 733 CSKPD----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 733 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 65443 34677777643 44444432 123567888999999999999999986 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
.++|+|||+|+.+.......... ........||+.|+|||+..+..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~------~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYS------KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cEEEEEcCCceeeccCCcccccc------cccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999998765332211100 111223469999999999999999999999999999999999999997532
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.... ....... +.+. ........ ...++.++.+++..|+..+|++||++.++++.+
T Consensus 238 ~~~~-~~~~~~~-------~~~~----~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGN-LIHAAKC-------DFIK----RLHEGKIK------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchH-HHHHhHH-------HHHH----Hhhhhhhc------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2111 1100000 0011 11100000 112457789999999999999999999999876
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=305.39 Aligned_cols=272 Identities=21% Similarity=0.231 Sum_probs=198.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKP------ 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 736 (983)
..++|...+.||+|+||.||+|... +++.||+|.+.... ......++.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 78899999986542 223346778899999999999999999988543
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
...++||||+.+ ++.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 346999999964 77776642 2788899999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++...... ......||..|+|||.+.+..++.++||||+||++|+|++|+.||..... ...+..
T Consensus 164 ~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-~~~~~~ 228 (353)
T cd07850 164 LARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-IDQWNK 228 (353)
T ss_pred cceeCCCCC--------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHH
Confidence 998654211 11223588999999999999999999999999999999999999853211 011111
Q ss_pred HHHhhCCCC---CcHHHHHHHhhcCCCC----------------CccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 897 WVKRHYPHR---LDPIVEKAIAKYAPQH----------------MPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 897 ~~~~~~~~~---~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
.+.. .... +....+.......... .+............++.+++.+|++.||++|||+.|
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 229 IIEQ-LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHh-cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 1111 1000 0011111111000000 000000001234567899999999999999999999
Q ss_pred HHHHH
Q 042568 958 VAHEM 962 (983)
Q Consensus 958 vl~~L 962 (983)
++++=
T Consensus 308 iL~~~ 312 (353)
T cd07850 308 ALQHP 312 (353)
T ss_pred HhcCh
Confidence 99764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=306.34 Aligned_cols=274 Identities=20% Similarity=0.289 Sum_probs=197.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|...+.||+|+||.||+|... +++.||||.+..... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378989999999999999999964 689999999865432 223466889999999999999999999986542
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++|+||+.. ++..+. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 555443 235889999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..
T Consensus 164 ~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-~~~~~~ 226 (342)
T cd07879 164 ARHADAE----------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQ 226 (342)
T ss_pred CcCCCCC----------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 8754311 112467889999999876 4688999999999999999999999863210 001111
Q ss_pred HHHhhCCCCCcHHHHHHHh--------hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhH
Q 042568 897 WVKRHYPHRLDPIVEKAIA--------KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLK 966 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 966 (983)
.+. ..+... +...+.+. ...+...+......+.....++.+++.+|++.||++||+++|++++ ++.++
T Consensus 227 ~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 227 ILK-VTGVPG-PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHH-hcCCCC-HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 111 000000 00000000 0000000000011112244678899999999999999999999976 66665
Q ss_pred hh
Q 042568 967 QY 968 (983)
Q Consensus 967 ~~ 968 (983)
+.
T Consensus 305 ~~ 306 (342)
T cd07879 305 DA 306 (342)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=299.94 Aligned_cols=277 Identities=21% Similarity=0.257 Sum_probs=194.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCc------
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDF------ 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 738 (983)
++|...+.||+|+||.||+|... +++.||||.+...... .....+.+|++++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47888999999999999999965 6889999988654322 234456789999999999999999999866543
Q ss_pred --eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 739 --KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 739 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
.++||||+.+ ++.+.+... ...+++.+++.++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 777766532 235899999999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
++.......... ........++..|+|||...+. .++.++||||||+++|||++|+.||.... .....
T Consensus 165 ~~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~--~~~~~ 233 (310)
T cd07865 165 LARAFSLSKNSK---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT--EQHQL 233 (310)
T ss_pred CcccccCCcccC---------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence 998664322110 0111224578899999987764 46889999999999999999999986421 11111
Q ss_pred HHHHhh---CCCCCcHHHHHH--Hhhc-CCCCCc-cccccc-hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRH---YPHRLDPIVEKA--IAKY-APQHMP-IYYNKV-WSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~---~~~~~~~~~~~~--~~~~-~~~~~~-~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+... .+....+..+.. .... .+.... ...... .......+.+++.+|+..||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 111111 111100000000 0000 000000 000000 00023457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=277.33 Aligned_cols=278 Identities=20% Similarity=0.297 Sum_probs=198.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecC--------C
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKP--------D 737 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 737 (983)
.|....+||+|.||.||+|+.. +|+.||+|+.-.+..++ ......+|+++++.++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445678999999999999955 57779998765544333 345678999999999999999999888432 2
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..|+|+++|+. +|.-.+... ..+++..++.+++.++..||.|+|.. +|+|||+||.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 46999999986 676666532 35689999999999999999999998 499999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
|+.+...+.... ......+-|..|++||.+.| +.|+++.|||+.|||+.||+||.+-+....+ .....
T Consensus 171 ar~fs~~~n~~k---------prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~ 239 (376)
T KOG0669|consen 171 ARAFSTSKNVVK---------PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLH 239 (376)
T ss_pred ccceecccccCC---------CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHH
Confidence 987765433211 11233467999999999988 5789999999999999999999987653211 11111
Q ss_pred HHHh---hCCCCCcHHHHHH--HhhcCCCCCccccccchHHHHH------HHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 897 WVKR---HYPHRLDPIVEKA--IAKYAPQHMPIYYNKVWSDVVL------ELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 897 ~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~------~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+.. .+.....+..+.. ...+.....+.-.....++..+ +..+++..++..||.+|+++++++.+--
T Consensus 240 ~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 240 LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 1111 1111111111111 0001000011111111222333 6789999999999999999999997654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=292.08 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=192.1
Q ss_pred HHHHHHhCCCCCCCcc--ccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEec
Q 042568 660 KQLIEATGGFCPSSLI--GSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSK 735 (983)
Q Consensus 660 ~~l~~~~~~f~~~~~i--G~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 735 (983)
.+.....++|.+.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|||++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3444455677777776 99999999999954 67889999986432221 122222223 69999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEcc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVAD 814 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~D 814 (983)
.+..++||||+++++|.+++... ..+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999998643 36899999999999999999999996 99999999999999998 999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
||+++..... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||..........
T Consensus 154 fg~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 154 YGLCKIIGTP-----------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred CccceecCCC-----------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9998755321 11358899999999999889999999999999999999999987432221111
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-MLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 961 (983)
..+... . ....+ ........+.+++.+|++.+|.+||+ ++|++++
T Consensus 217 ~~~~~~-------------~----~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 217 ESLLKR-------------Q----QKKLP-----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHh-------------h----cccCC-----cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 111111 0 00000 01235577899999999999999996 6988864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=299.67 Aligned_cols=276 Identities=20% Similarity=0.236 Sum_probs=198.1
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP--DFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 741 (983)
.++|.+.+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999965 6889999998654332 2234567899999999999999999998654 46799
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++ +|.+++... ...+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||.+...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 777777543 246899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.... .......+..
T Consensus 159 ~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~ 223 (309)
T cd07845 159 GLPAKP-------------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQ 223 (309)
T ss_pred CCccCC-------------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence 432111 111245788999999876 457899999999999999999999986321 1111111111
Q ss_pred hCCCCCcHHHHHH--HhhcCCCCCc----cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKA--IAKYAPQHMP----IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
............. .........+ ............++.+++.+|++.||++|||++|++++-.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 1111000000000 0000000000 0000011123567889999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=301.54 Aligned_cols=279 Identities=21% Similarity=0.264 Sum_probs=196.1
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecc-cCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.+.+|.|+++.||++.. +++.||||++... ...+..+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666555 6899999998765 334456789999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
+.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+..+.........
T Consensus 86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999887543 345889999999999999999999996 999999999999999999999999998765432211000
Q ss_pred cCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc-
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD- 907 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~- 907 (983)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.+....+..+.
T Consensus 161 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 161 ------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-QMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCcccccc
Confidence 0111233467889999999876 35789999999999999999999998643211 1111111111110000
Q ss_pred ---HHHHHHHhh----cCCCCCc-cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 908 ---PIVEKAIAK----YAPQHMP-IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 908 ---~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+........ ....... ............++.+++.+||..||++|||++|++++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000000 0000000 0000011234567889999999999999999999998644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.63 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=204.8
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|...+.||+|+||.||++... ++..||+|++..... .+....+.+|++++++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999965 688899999876543 24567789999999999999999999999988999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.........+++..+..++.++++|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999988765333467999999999999999999999996 9999999999999999999999999998654321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||+... ..+.
T Consensus 158 -------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~-------- 211 (258)
T cd08215 158 -------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLEL-------- 211 (258)
T ss_pred -------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHH--------
Confidence 11123468899999999988889999999999999999999999985321 1111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+....... ...+ .....++.+++.+|+..+|++||++.|++++
T Consensus 212 ----~~~~~~~~~-~~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 212 ----ALKILKGQY-PPIP-------SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----HHHHhcCCC-CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111 1111 1244678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=303.45 Aligned_cols=279 Identities=23% Similarity=0.320 Sum_probs=201.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec----CCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK----PDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 739 (983)
.++|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888999999999999999954 689999999865432 2345678889999999999999999998753 3467
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||+. ++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 588888764 334899999999999999999999986 9999999999999999999999999997
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
........ .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+
T Consensus 156 ~~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~~~~ 224 (334)
T cd07855 156 GLSSSPTE---------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQLKLI 224 (334)
T ss_pred eecccCcC---------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHHHHH
Confidence 65432211 0111223468999999998765 4688999999999999999999999864211 1111111
Q ss_pred HhhCC---CC-CcHHHHHHHhhc---CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 899 KRHYP---HR-LDPIVEKAIAKY---APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 899 ~~~~~---~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..... .. ........+... .....+........+.+.++.+++.+|++.+|++||++++++++-.
T Consensus 225 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 11100 00 000111111100 0100011111112234678999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=304.08 Aligned_cols=279 Identities=21% Similarity=0.259 Sum_probs=202.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKP-----DF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 738 (983)
.++|.+.+.||+|+||+||+|... +++.||||.++... ......++.+|+++++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999954 68899999986532 222345678899999999999999999988644 34
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++|+||+. ++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 678777753 345899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... .......
T Consensus 156 ~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~ 220 (337)
T cd07858 156 RTTSEKGD-------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD--YVHQLKL 220 (337)
T ss_pred cccCCCcc-------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC--hHHHHHH
Confidence 86542211 1122457889999998765 468899999999999999999999986421 1111111
Q ss_pred HHhhCCC----C----CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhHh
Q 042568 898 VKRHYPH----R----LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLKQ 967 (983)
Q Consensus 898 ~~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 967 (983)
+...... . ......+.+...... ........+.++..++.+++.+|++.+|++|||++|++++ ++.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYT-PRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHHHhCCCChHHhhhcCchhhhHHHHhcCcc-cccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 1111000 0 001111111111100 0011111123456788999999999999999999999988 665543
Q ss_pred h
Q 042568 968 Y 968 (983)
Q Consensus 968 ~ 968 (983)
.
T Consensus 300 ~ 300 (337)
T cd07858 300 P 300 (337)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=296.22 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=194.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|.+.+ ++.||||.++..........+.+|++++.+.. ||||+++++++......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 457778999999999999999764 88899999976544444566777888777775 9999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++ ++.+..... ...+++..+..++.|+++|++|||+.. +|+||||+|+||++++++.++|+|||++......
T Consensus 95 ~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 666655432 236899999999999999999999742 4999999999999999999999999998765321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR----ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.....+ .+
T Consensus 169 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~---- 226 (296)
T cd06618 169 KA--------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FE---- 226 (296)
T ss_pred Cc--------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HH----
Confidence 11 11134788999999987653 788999999999999999999998532110 00
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
........... ..+. ...+..++.+++.+|+..||++||++++++++-.
T Consensus 227 --------~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 227 --------VLTKILQEEPP-SLPP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred --------HHHHHhcCCCC-CCCC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 11111111100 0000 0124567899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=297.72 Aligned_cols=274 Identities=23% Similarity=0.287 Sum_probs=195.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|+..+.||+|++|.||+|... +++.||+|.+...... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 6889999998654322 234678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~~ 823 (983)
|++ +++.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 47777665332 234688889999999999999999986 999999999999985 56799999999975532
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ......|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||...... ..+...... .
T Consensus 156 ~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~-~ 220 (294)
T PLN00009 156 PVR-------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRI-L 220 (294)
T ss_pred Ccc-------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH-h
Confidence 110 1112357889999998876 45789999999999999999999998632110 111111100 0
Q ss_pred CCCCcHHHH-----HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVE-----KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
......... +......+...+............++.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000000000000000011234668899999999999999999999874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=293.24 Aligned_cols=249 Identities=25% Similarity=0.293 Sum_probs=200.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
+|...+.||.|+||.||+|... +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 688999999965432 2346789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999988642 36889999999999999999999986 999999999999999999999999998765432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......|+..|+|||...+..++.++||||+|+++|+|++|+.||...... ....++.
T Consensus 154 ~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----- 212 (258)
T cd05578 154 T--------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA----- 212 (258)
T ss_pred c--------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH-----
Confidence 1 111245888999999999888999999999999999999999998643211 0111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH--HHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM--LDVAH 960 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~ 960 (983)
.... .....+ ...+..+.+++.+|+..||.+||++ +|+++
T Consensus 213 --------~~~~-~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 213 --------KQET-ADVLYP-------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred --------Hhcc-ccccCc-------ccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1110 000011 1234788899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=304.11 Aligned_cols=277 Identities=22% Similarity=0.268 Sum_probs=200.6
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP 736 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 736 (983)
..++..++++|...+.||+|+||.||+|.. .+++.||+|+++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 356667889999999999999999999985 4788999999865432 22346788899999999999999999988533
Q ss_pred ------CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 737 ------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 737 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
...+++++++ +++|.+++.. ..+++..++.++.|+++|++|||+.+ |+||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3457888877 6788877752 35899999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
||+|||+++..... .....||..|+|||...+ ..++.++||||+|+++|||++|+.||.....
T Consensus 160 kl~dfg~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 160 KILDFGLARHTDDE----------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred EEeccccccccccc----------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998754311 112468899999998766 5678899999999999999999999853211
Q ss_pred CCCchHHHHHhhCC--CC----C-cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYP--HR----L-DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 890 ~~~~l~~~~~~~~~--~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...+......... .. + .......+... +...+......+.....++.+++.+|++.||.+||++.+++++=
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 224 -IDQLKLILRLVGTPGAELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred -HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHh-cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 1111111111000 00 0 00001111100 00000000111112356788999999999999999999999774
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=289.25 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=203.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 743 (983)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|++++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 688999999866543 23467899999999999999999999999888 8899999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ..+++..++.++.|+++|++|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998753 27899999999999999999999986 99999999999999999999999999987654
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.... .......++..|+|||...+...+.++||||||+++++|++|+.||.... .........
T Consensus 154 ~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~--- 216 (260)
T cd06606 154 IETG-----------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKI--- 216 (260)
T ss_pred cccc-----------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhc---
Confidence 3210 01123468899999999998889999999999999999999999986432 000000000
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ .......++.+++.+|++.+|++||++.|++++
T Consensus 217 ----------~~~~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 ----------GSSGEPPE-------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----------cccCCCcC-------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00000000 112235789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=302.54 Aligned_cols=282 Identities=20% Similarity=0.279 Sum_probs=201.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhc-CCCCccceeeEEecC--Cce
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRI-RHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 739 (983)
..++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+++++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999965 57889999885432 222345677899999999 999999999998654 357
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 588887753 25789999999999999999999986 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
......... .........||..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .......
T Consensus 156 ~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~ 226 (337)
T cd07852 156 SLSELEENP--------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKII 226 (337)
T ss_pred ccccccccc--------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 664322110 0011223468999999998765 45788999999999999999999998532111 1111111
Q ss_pred HhhCCCCCc--------HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhH
Q 042568 899 KRHYPHRLD--------PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLK 966 (983)
Q Consensus 899 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 966 (983)
.. ...... +..+............. ..........++.+++.+|++.+|++|||+.+++++ ++.+.
T Consensus 227 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 227 EV-IGPPSAEDIESIKSPFAATMLDSLPSRPRKP-LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HH-hCCCCHHHHHHHHhhhHHHhhhhcccccccc-hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 11 100000 00111111111111000 011112246788999999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.01 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=201.6
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+|++++++++|++++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677889999999999999975 688899999966544 34678999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++... ...+++..+..++.|+++|++|||..+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999988653 246899999999999999999999985 99999999999999999999999999886653211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.....|+..|+|||...+..++.++||||||+++|+|++|+.||..... .
T Consensus 154 --------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~----------- 203 (253)
T cd05122 154 --------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----M----------- 203 (253)
T ss_pred --------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----H-----------
Confidence 1234688999999999988899999999999999999999999863210 0
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ ..+ . ......++.+++.+|++.||++|||+.|++++
T Consensus 204 -~~~~~~~~~~~~-~~~---~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 204 -KALFKIATNGPP-GLR---N--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -HHHHHHHhcCCC-CcC---c--ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000010000000 000 0 01124678999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=292.33 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=192.4
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||+||+|... +|+.||+|.+.... .......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999986532 122345677899999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++.... ...+++..+..++.|+++|+.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------ 149 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------ 149 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC------
Confidence 99887543 246899999999999999999999996 9999999999999999999999999987654211
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
......++..|+|||+..+..++.++||||+|+++|+|++|+.||...... .... .+.
T Consensus 150 --------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~-------------~~~ 207 (277)
T cd05577 150 --------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKE-------------ELK 207 (277)
T ss_pred --------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHH-------------HHH
Confidence 111235788999999998888999999999999999999999998642210 0000 011
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
...... .... ......++.+++.+|++.+|++|| ++.+++.+
T Consensus 208 ~~~~~~-~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 208 RRTLEM-AVEY-------PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred hccccc-cccC-------CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 111000 0000 012356788999999999999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.48 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=196.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc----CcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT----TGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 739 (983)
.+|...+.||+|+||.||+|... ++..||+|.+.... ..+....+.+|++++++++|+||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999964 68899999875432 223456889999999999999999999998654 457
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||+++++|.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999888642 34788999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ ........|+..|+|||+..+..++.++|||||||++|++++|+.||... .....
T Consensus 155 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----~~~~~--- 217 (264)
T cd06653 155 RIQTICMS----------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY----EAMAA--- 217 (264)
T ss_pred cccccccc----------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc----CHHHH---
Confidence 65321100 01112246899999999999888899999999999999999999998532 11110
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+............ ......++.+++.+|+. +|..||++.+++.|
T Consensus 218 ----------~~~~~~~~~~~~~-------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 218 ----------IFKIATQPTKPML-------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----------HHHHHcCCCCCCC-------CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111110001111 12345778999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=294.06 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=193.9
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
.+||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999864 688999998854332 2456789999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++. ...+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.+.......
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------ 170 (292)
T cd06657 105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------ 170 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc------
Confidence 98774 235789999999999999999999996 9999999999999999999999999987543211
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
.......|++.|+|||+..+..++.++||||+|+++|+|++|+.||.... .......+...
T Consensus 171 -------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~---------- 231 (292)
T cd06657 171 -------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDN---------- 231 (292)
T ss_pred -------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhh----------
Confidence 11122468899999999988888999999999999999999999985311 00000111110
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+..... .......+.+++.+|++.+|.+||++.+++++
T Consensus 232 ------~~~~~~~-----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 232 ------LPPKLKN-----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ------CCcccCC-----cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0000000 11244578899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.36 Aligned_cols=244 Identities=25% Similarity=0.327 Sum_probs=194.6
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||.||+|... +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 588999999865432 23457899999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||.++......
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------ 147 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------ 147 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------
Confidence 9998753 34889999999999999999999986 9999999999999999999999999998664321
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
......|+..|+|||...+..++.++|+||+|+++|+|++|+.||.....+. .+ ...
T Consensus 148 --------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~------------~~~ 204 (262)
T cd05572 148 --------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---ME------------IYN 204 (262)
T ss_pred --------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HH------------HHH
Confidence 1112368889999999988889999999999999999999999986432110 11 111
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
...........+ .....++.+++.+|++.+|++||+ ++|++++
T Consensus 205 ~~~~~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 205 DILKGNGKLEFP-------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred HHhccCCCCCCC-------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 111000000011 112567999999999999999999 7777663
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=287.46 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=200.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+.|+.-++||+||||.||-++.+ +|+-+|.|.+.+...+ ....-...|-.++++++.+.||.+-.+|..++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56778899999999999999854 6888999988544322 12345678999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
..|.||+|.-+++... ...+++..+.-++.+|+.||++||... ||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998765 467999999999999999999999995 99999999999999999999999999998875
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.+.. ...+||.||||||++....|+...|.||+||++|||+.|+.||..-- .
T Consensus 340 g~~~--------------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K--------------e 391 (591)
T KOG0986|consen 340 GKPI--------------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK--------------E 391 (591)
T ss_pred CCcc--------------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh--------------h
Confidence 4422 12389999999999999999999999999999999999999985311 1
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 954 (983)
..-.+.+|+++..... .+. +.-++++.++....+..||++|.-
T Consensus 392 Kvk~eEvdrr~~~~~~-----ey~---~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDPE-----EYS---DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hhhHHHHHHHHhcchh-----hcc---cccCHHHHHHHHHHHccCHHHhcc
Confidence 1112345555433221 111 223456667777789999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=292.31 Aligned_cols=273 Identities=22% Similarity=0.286 Sum_probs=197.5
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEEEe
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALVLP 744 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 744 (983)
|.+.+.||+|+||.||+|... +++.||+|.+.... ..+....+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999966 57889999997654 223456788999999999999999999999887 88999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 887777543 246899999999999999999999986 999999999999999999999999999876543
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.... ...+.........
T Consensus 154 ~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~ 220 (287)
T cd07840 154 NSA------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGS 220 (287)
T ss_pred Ccc------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCC
Confidence 210 1112356788999998765 4578999999999999999999999864221 1111111110000
Q ss_pred CC--CcHHHHHH--Hhhc-CCCCCccccccchHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HR--LDPIVEKA--IAKY-APQHMPIYYNKVWSD-VVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~--~~~~~~~~--~~~~-~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. ..+..... .... .....+........+ ++.++.+++.+|+..+|++||++++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00000000 0000 000000000011111 26788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=293.69 Aligned_cols=272 Identities=24% Similarity=0.331 Sum_probs=197.2
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhc---CCCCccceeeEEecCCc-----
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRI---RHRNLIRIITICSKPDF----- 738 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 738 (983)
|.+.+.||+|+||.||+|+.+ +++.||+|+++.....+ ....+.+|+++++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556789999999999999976 48899999997543322 235567788887776 59999999999987776
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.+++|||+.+ ++.+++.... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 7888776433 235899999999999999999999986 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
..+..... .....++..|+|||...+..++.++||||||+++|||++|+.||.... ....+..+.
T Consensus 155 ~~~~~~~~--------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~ 219 (287)
T cd07838 155 RIYSFEMA--------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIF 219 (287)
T ss_pred eeccCCcc--------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHH
Confidence 87643211 112357889999999999889999999999999999999999886321 111122221
Q ss_pred HhhCCCCCcH-HHHHH-HhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDP-IVEKA-IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.......... ..... .........+........+....+.+++.+|++.||++||+++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 220 DVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred HHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 1111000000 00000 000000000001111223456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=300.19 Aligned_cols=273 Identities=22% Similarity=0.317 Sum_probs=199.2
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec-CC
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK-PD 737 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 737 (983)
++...+++|...+.||+|+||.||+|... +++.||||.+..... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34457789999999999999999999855 788999998854322 2245678899999999999999999998865 45
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++++||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 788999998 468887775 235788888999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .....
T Consensus 155 ~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~~ 216 (328)
T cd07856 155 ARIQDPQ----------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFS 216 (328)
T ss_pred ccccCCC----------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 8754311 112357889999998766 5689999999999999999999999853211 00000
Q ss_pred HHHhhCCCCCcHHHH--------HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVE--------KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.........+..+ +....... ..+............++.+++.+|++.+|++||++++++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 217 IITDLLGTPPDDVINTICSENTLRFVQSLPK-REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhCCCCHHHHHhccchhhHHHHhhccc-cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011110000011110 00111000 00000000111235688999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.79 Aligned_cols=271 Identities=20% Similarity=0.269 Sum_probs=196.0
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|.+.+.||+|++|.||+|... +++.||||++.............+|+..+++++ |||++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578899999865543323345567999999998 999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+|++.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789988876533 246899999999999999999999986 99999999999999999999999999986543211
Q ss_pred cccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....|+..|+|||++.+ ..++.++||||||++++||++|+.||...... ........ .....
T Consensus 155 --------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-~~~~~~~~-~~~~~ 218 (283)
T cd07830 155 --------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-DQLYKICS-VLGTP 218 (283)
T ss_pred --------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH-HHHHHHHH-hcCCC
Confidence 112458889999998754 55789999999999999999999998532110 01111111 00000
Q ss_pred CcHHHHH------HHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEK------AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
....... ......+...+............++.+++.+|++.+|++||+++|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 0000000000000000011124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=303.66 Aligned_cols=270 Identities=19% Similarity=0.261 Sum_probs=196.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCC-----
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPD----- 737 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 737 (983)
..++|...+.||+|+||.||+|.. .++..||||+++..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 47889999998654322 23457889999999999999999999886543
Q ss_pred -ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 738 -FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 738 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
..++||||+ +++|.+++. ...+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.++++|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 678887775 345899999999999999999999986 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
++...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||..... .....
T Consensus 164 ~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~~~~~ 226 (343)
T cd07880 164 LARQTDSE----------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH-LDQLM 226 (343)
T ss_pred cccccccC----------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence 98754321 112357889999998876 4578999999999999999999999863211 01111
Q ss_pred HHHHhhCCC--CCcHH-----HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPH--RLDPI-----VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
......... .+... .......... ..+......+.....++.+++.+|++.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPR-FRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhcCCCCHHHHHhhcchhHHHHHHhccc-cCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111110000 00000 0000100000 00000111122345678999999999999999999999953
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=295.04 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=194.1
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|...+.||+|+||.||+|+.. +++.||+|.+.... ..+...++.+|+++++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555678999999999999965 57889999886432 223346788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+. |++.+.+... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 97 5777766432 345889999999999999999999986 999999999999999999999999998765321
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
....|+..|+|||.+. ...++.++|||||||++|+|++|+.||...... ..
T Consensus 169 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~----- 222 (308)
T cd06634 169 ----------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA----- 222 (308)
T ss_pred ----------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HH-----
Confidence 1235888999999874 356788999999999999999999997532100 00
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
........ .+.... ......+.+++.+||+.+|++||++++++++-....
T Consensus 223 -------~~~~~~~~----~~~~~~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 223 -------LYHIAQNE----SPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -------HHHHhhcC----CCCcCc---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00000000 010001 124567889999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=289.37 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=195.4
Q ss_pred CCCCCCccccCCcEeEEEEEECC-CcEEEEEEeeccc----CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTT----TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+|.+.+.||+|+||.||++.... +..+++|..+... ......++.+|++++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57788999999999999998653 4446666654321 122344677899999999999999999999988999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+++++|.+++.........+++..++.++.|+++|+.|||+.+ ++|+||||+||+++. +.++|+|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888654333567999999999999999999999986 999999999999975 569999999987664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... ......|+..|+|||...+..++.++||||||+++|+|++|+.||... .......
T Consensus 157 ~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~--- 215 (260)
T cd08222 157 GSCD-------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVL--- 215 (260)
T ss_pred CCcc-------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHH---
Confidence 3211 111245788999999998888899999999999999999999998531 1111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... . .+. ....+..++.+++.+|+..+|++||++.|++++
T Consensus 216 ---------~~~~~-~---~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 ---------RIVEG-P---TPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---------HHHcC-C---CCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11110 0 000 012355788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=298.29 Aligned_cols=280 Identities=21% Similarity=0.263 Sum_probs=205.8
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----cee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD-----FKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 740 (983)
+|.+.+.||+|++|.||+|+.. +++.||||.+..... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5778899999999999999965 588999999865432 334578999999999999999999999987765 789
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||++ ++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 478887764 236899999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... ........+|..|+|||++.+. .++.++||||+|+++|+|++|+.||..... ......+.
T Consensus 153 ~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~ 220 (330)
T cd07834 153 VDPDEDE----------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIV 220 (330)
T ss_pred ecccccc----------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHH
Confidence 6543211 0111224688899999999887 789999999999999999999999864321 00011111
Q ss_pred hhCCCCC--------cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhHhh
Q 042568 900 RHYPHRL--------DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLKQY 968 (983)
Q Consensus 900 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~ 968 (983)
....... .......+...... .+........+.+.++.+++.+||+.+|++||++++++++ ++.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 221 EVLGTPSEEDLKFITSEKARNYLKSLPKK-PKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhcCCCChhHhhhccccchhhHHhhcccC-CcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 1110000 00001111110100 0000111112245778999999999999999999999986 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.91 Aligned_cols=271 Identities=21% Similarity=0.311 Sum_probs=201.1
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|...+.||+|++|.||+|... +++.+|+|.++..... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999964 6888999998655432 34567889999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++ ++.+++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 887777643 246899999999999999999999986 99999999999999999999999999986653220
Q ss_pred cccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC--
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP-- 903 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~-- 903 (983)
......++..|+|||...+. .++.++||||+|+++|+|++|+.||..... ...+.........
T Consensus 154 -------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~ 219 (283)
T cd05118 154 -------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-IDQLFKIFRTLGTPD 219 (283)
T ss_pred -------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCc
Confidence 01123578899999998876 789999999999999999999999853211 0001111111000
Q ss_pred -CC---CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 -HR---LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. .............. .........+++...++.+++.+|++.||.+||++++++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 220 PEVWPKFTSLARNYKFSFPK-KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hHhcccchhhhhhhhhhhcc-ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00000111000000 00111122234567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=289.12 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=185.7
Q ss_pred ccccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHH---HHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 674 LIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQI---LKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
+||+|+||.||+|... +++.||+|.+...... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 6889999998654321 112234444443 444579999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|+|.+++.. ...+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988753 345899999999999999999999986 9999999999999999999999999987543211
Q ss_pred ccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........
T Consensus 152 -------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-------------- 204 (278)
T cd05606 152 -------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-------------- 204 (278)
T ss_pred -------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--------------
Confidence 1123689999999998754 688999999999999999999999864211100
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
......... .....+ ...+.++.+++.+|+..+|++|| ++.+++++
T Consensus 205 -~~~~~~~~~-~~~~~~-------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 205 -HEIDRMTLT-MAVELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -HHHHHHhhc-cCCCCC-------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 001111110 000011 12356789999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=304.84 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=213.0
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEe--
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICS-- 734 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 734 (983)
++.+..-++-|++.+.||.|.+|.||+++ .++++.+|||+.+..... .++...|.++++.. .|||++.++|+|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34444456778899999999999999999 557889999998776554 46778899999988 6999999999984
Q ss_pred ---cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 735 ---KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 735 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
.++..++|||||.+||..|+++.-. ..++.|..+..|++.++.|+.+||... ++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 4578899999999999999998665 567999999999999999999999994 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
++|||.+..+.. ......+.+||+.|||||++.. ..|+.++|+||+|++..||..|.+|+..
T Consensus 164 LvDFGvSaQlds-------------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-------------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred Eeeeeeeeeeec-------------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 999999876542 2244566799999999999865 3477899999999999999999999765
Q ss_pred ccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 887 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+++- .+-+...+.|+..-+.++.-..++.+++..|+..|.+.||++.++++|
T Consensus 231 mHPm-----------------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 231 MHPM-----------------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cchh-----------------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 4321 111111223333444456667889999999999999999999999853
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=286.78 Aligned_cols=242 Identities=21% Similarity=0.305 Sum_probs=185.4
Q ss_pred CccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHH-hcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILK-RIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|... +++.||||.+..... ......+..|..++. ..+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999964 688999999864321 112234455555443 45899999999999999999999999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999988642 35889999999999999999999986 99999999999999999999999999875432
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.....|+..|+|||...+..++.++||||+|+++|||++|..||.... ....
T Consensus 150 ------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~----------- 201 (260)
T cd05611 150 ------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAV----------- 201 (260)
T ss_pred ------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHH-----------
Confidence 112358889999999988888999999999999999999999986321 1111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
.+........ .+ ......++.++.+++.+|++.+|++||++.++.+
T Consensus 202 -~~~~~~~~~~--~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 202 -FDNILSRRIN--WP---EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred -HHHHHhcccC--CC---CcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 1111111000 00 0011235578899999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=297.53 Aligned_cols=285 Identities=23% Similarity=0.279 Sum_probs=197.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|+..+.||+|+||.||+|... +++.||||.+......+ ....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999965 68889999986543322 2356788999999999999999999875433
Q ss_pred --ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 738 --FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 738 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
..++|+||+++ ++...+... ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 45899999975 565555432 346899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|+++............ ............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 160 g~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~ 236 (311)
T cd07866 160 GLARPYDGPPPNPKGG--GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQL 236 (311)
T ss_pred ccchhccCCCcccccC--CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHH
Confidence 9998665332211100 0001112233468899999998765 4578999999999999999999999863211 0111
Q ss_pred HHHHHhhCCC--CCcHHHHHHHhh----cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPH--RLDPIVEKAIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.......... ...+.. ..+.. ......+......+......+.+++.+|++.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGW-RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhh-hhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1111100000 000000 00000 000001111111122234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=283.64 Aligned_cols=249 Identities=28% Similarity=0.440 Sum_probs=200.9
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+|+..+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++|||++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 5788999998655432 3457899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988643 46899999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.. .....|+..|+|||...+..++.++||||+|+++|+|++|+.||.... ........
T Consensus 154 ~~-------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~----- 211 (254)
T cd06627 154 KD-------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRI----- 211 (254)
T ss_pred cc-------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-----
Confidence 11 122468899999999988888999999999999999999999986321 11111100
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... .. .......+.+++.+|+..+|++||++.|++.+
T Consensus 212 --------~~~~~~-~~-------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 212 --------VQDDHP-PL-------PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --------hccCCC-CC-------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 000000 00 11245678899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=294.38 Aligned_cols=277 Identities=22% Similarity=0.271 Sum_probs=197.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC-----
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD----- 737 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 737 (983)
..++|++.+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++++++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567889999999999999999975 588899999875532 223457788999999999999999999987654
Q ss_pred -----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEE
Q 042568 738 -----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV 812 (983)
Q Consensus 738 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl 812 (983)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 665655432 346899999999999999999999996 999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
+|||.+......... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... +.
T Consensus 158 ~dfg~~~~~~~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-~~ 224 (302)
T cd07864 158 ADFGLARLYNSEESR------------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-EL 224 (302)
T ss_pred CcccccccccCCccc------------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hH
Confidence 999999866432210 0111246788999998765 456889999999999999999999986321 11
Q ss_pred CchHHHHHhh---CCCCCcHHHHHHHhhcCCC--CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 892 SSLHEWVKRH---YPHRLDPIVEKAIAKYAPQ--HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 892 ~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+....... .+.....+.+.......+. .........+...+..+.+++.+|++.+|++||++++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111110 0000000000000000000 00000001112245778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=292.55 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=190.9
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
|...+.||+|+||.||+|+.. +++.||+|.+..... ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445678999999999999964 688899999865432 22345788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+. |++.+++... ...+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5776666532 345899999999999999999999996 99999999999999999999999998864321
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||.... ... ...
T Consensus 174 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~----~~~-~~~--- 230 (313)
T cd06633 174 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMS-ALY--- 230 (313)
T ss_pred ---------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHH-HHH---
Confidence 11246889999999974 4567889999999999999999999975321 000 000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... .+.... ......+.+++.+|++.+|++||++.+++++
T Consensus 231 ---------~~~~~~----~~~~~~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 231 ---------HIAQND----SPTLQS---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------HHHhcC----CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011111 1233568889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-33 Score=292.22 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=202.7
Q ss_pred CCccccCCcEeEEEEEE-CCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
.+++|+|.||+||-|++ ++|+.||||++++.. ..+...+++.|+.|+++++||.||.+...|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999995 479999999997654 3334578999999999999999999999999999999999999765
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC---CCEEEccccccccccCCcc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED---LTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~---~~~kl~Dfgla~~~~~~~~ 826 (983)
-|+-.+... ..++++....-+..||+.||.|||.++ |+|+|+||+|||+... -.+||||||.|++.++.
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 555555433 456888888899999999999999995 9999999999999643 47999999999988742
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.....++||+.|+|||++..+.|.+.-|+||+|||+|--++|..||.. ++++.+.+.
T Consensus 721 ------------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQ------- 777 (888)
T KOG4236|consen 721 ------------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQ------- 777 (888)
T ss_pred ------------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhh-------
Confidence 334457899999999999999999999999999999999999999863 222222221
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...- .+-...|.++..+.+++|...++..-++|.|+++.+.+
T Consensus 778 ---------NAaF----MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 778 ---------NAAF----MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ---------cccc----ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 1110 11123588899999999999999999999999887743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=295.20 Aligned_cols=287 Identities=21% Similarity=0.265 Sum_probs=197.7
Q ss_pred CCCCC-CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-------------hhHHHHHHHHHHHhcCCCCccceee
Q 042568 667 GGFCP-SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-------------ITGSFKRECQILKRIRHRNLIRIIT 731 (983)
Q Consensus 667 ~~f~~-~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~ 731 (983)
++|.. .+.||+|+||.||+|... +++.||||.+....... ....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999965 68899999986543221 1125778999999999999999999
Q ss_pred EEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 732 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
++...+..++||||++ |+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999997 588887753 345889999999999999999999986 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCC-ccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSM-SFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
|+|||.++.............+.. ..........++..|+|||++.+. .++.++||||+|+++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652111000000000 000111223578899999998764 468999999999999999999999863211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHH--Hhhc--CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKA--IAKY--APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
...+........... ....... +... .....+............++.+++.+|++.+|++||+++|++.+-.
T Consensus 240 -~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 240 -IDQLGRIFELLGTPN-EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred -HHHHHHHHHHhCCCc-hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 111111111100000 0000000 0000 0000000000111223567889999999999999999999997543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-33 Score=286.19 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=198.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--Cc----chhHHHHHHHHHHHhcCCCCccceeeEEe-cCC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TG----EITGSFKRECQILKRIRHRNLIRIITICS-KPD 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 737 (983)
.++|-.+++||+|||+.||||.+ ...+.||||+-.... .+ ...+...+|.+|.+.+.||.||++|+|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34677788999999999999994 456779999853322 11 13456778999999999999999999995 456
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEcc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVAD 814 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~D 814 (983)
..+-|.|||+|.+|+-++... +.+++.+++.|+.||+.||.||.+.. ++|||-|+||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 778899999999999998753 45889999999999999999999876 4799999999999994 457899999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
||+++++.+..... .+++ .-+...+||.+|++||.+-- .+.+.|+||||+|||+|+++.|+.||...
T Consensus 617 FGLSKIMdddSy~~---vdGm---eLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn--- 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNS---VDGM---ELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN--- 687 (775)
T ss_pred cchhhhccCCccCc---ccce---eeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc---
Confidence 99999997654321 1222 22344689999999998753 35688999999999999999999998531
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
....++... ..+........|. -+-...+...+|.+|+++--++|.++.++..
T Consensus 688 -qsQQdILqe-----------NTIlkAtEVqFP~-----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 688 -QSQQDILQE-----------NTILKATEVQFPP-----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -hhHHHHHhh-----------hchhcceeccCCC-----CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111110 0111111111110 0124567889999999999999999988864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=270.18 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=202.2
Q ss_pred hCCCCCC-CccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEec----CCc
Q 042568 666 TGGFCPS-SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSK----PDF 738 (983)
Q Consensus 666 ~~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 738 (983)
+++|.+. ++||-|-.|.|-.+..+ +++++|+|++. .....++|++..-.. .|||||.++++|.. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3444433 57999999999999854 78999999983 235567899986666 69999999998843 345
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADF 815 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Df 815 (983)
..+|||+|+||.|...++... ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+. +..+|++||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 679999999999999998765 56799999999999999999999998 4999999999999964 567999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|.|+.-... ....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....+ ..
T Consensus 209 GFAK~t~~~--------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~a-- 270 (400)
T KOG0604|consen 209 GFAKETQEP--------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LA-- 270 (400)
T ss_pred ccccccCCC--------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--cc--
Confidence 999865421 222345779999999999999999999999999999999999999975432 11
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+.+-..+.+...... .-...|+..++...++++.+++.+|++|.|+.|++.+=+
T Consensus 271 ----------ispgMk~rI~~gqy~----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 271 ----------ISPGMKRRIRTGQYE----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ----------CChhHHhHhhccCcc----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 111122222221111 113468889999999999999999999999999998755
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=287.40 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=194.2
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||.||++... +++.||+|.+..... ....+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865432 23457789999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++...........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-- 151 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL-- 151 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc--
Confidence 9988643 36899999999999999999999986 99999999999999999999999999876542211000
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
...........++..|+|||...+..++.++||||||+++|++++|+.||.... .. +..+
T Consensus 152 ---~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~------------~~~~ 211 (265)
T cd05579 152 ---NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PE------------EIFQ 211 (265)
T ss_pred ---ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HH------------HHHH
Confidence 000012233468889999999988888999999999999999999999986321 11 1111
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
....... ..+.. ...+..+.+++.+|++.+|++||++.++.+.+
T Consensus 212 ~~~~~~~--~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 212 NILNGKI--EWPED-----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHhcCCc--CCCcc-----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1111000 00100 01257789999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=289.03 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=195.3
Q ss_pred CCCCCCccccCCcEeEEEEEE----CCCcEEEEEEeecccC---cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL----QDNTRIAVKVLDLTTT---GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... ....+++.+|+++++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999986 3688899999865321 22346788999999999 599999999999988899
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++|+||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999998864 345788999999999999999999986 9999999999999999999999999997
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
....... .......|+..|+|||...+. .++.++||||||+++|+|++|+.||.... .......+
T Consensus 154 ~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~ 220 (290)
T cd05613 154 EFHEDEV------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG-EKNSQAEI 220 (290)
T ss_pred ecccccc------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC-ccccHHHH
Confidence 6542211 111124688999999998753 46789999999999999999999985321 11111111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.. .......+ .+ ......+.+++.+|++.+|++|| ++++++.+
T Consensus 221 ~~------------~~~~~~~~--~~-------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 SR------------RILKSEPP--YP-------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HH------------HhhccCCC--CC-------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11 11111000 01 12346788999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=295.40 Aligned_cols=274 Identities=18% Similarity=0.217 Sum_probs=194.3
Q ss_pred CCCCCCccccCCcEeEEEEEEC-C--CcEEEEEEeecccCc-chhHHHHHHHHHHHhc-CCCCccceeeEEec----CCc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-D--NTRIAVKVLDLTTTG-EITGSFKRECQILKRI-RHRNLIRIITICSK----PDF 738 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~--~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 738 (983)
+|...+.||+|+||.||+|... + +..||+|.+...... ...+.+.+|+++++++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999965 3 678999998643222 2356788999999999 59999999987532 245
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++++||++ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889986 588887753 346899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+......... ........||..|+|||+..+ ..++.++||||+|+++|+|++|+.||..... ...+...
T Consensus 153 ~~~~~~~~~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~ 222 (332)
T cd07857 153 RGFSENPGEN---------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQI 222 (332)
T ss_pred eecccccccc---------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHH
Confidence 8664322110 011223578999999998765 5688999999999999999999999864211 0011111
Q ss_pred HHhhCCCCCcHHHH--------HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 898 VKRHYPHRLDPIVE--------KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 898 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.. ......+... ........ .........+......+.+++.+|++.+|++|||++|++++
T Consensus 223 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 223 LQV-LGTPDEETLSRIGSPKAQNYIRSLPN-IPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHH-hCCCCHHHHHhhhhhhHHHHHHhccc-cCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111 0000000000 00000000 00001111112235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=298.44 Aligned_cols=272 Identities=20% Similarity=0.280 Sum_probs=194.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-------- 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 736 (983)
.++|...+.||+|+||.||+|... +++.||+|.+..... +..+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367889999999999999999964 688999999865543 3457788999999999999999999876543
Q ss_pred ------CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCC
Q 042568 737 ------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLT 809 (983)
Q Consensus 737 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~ 809 (983)
...++|+||++ ++|.+++. ...+++..++.++.|+++||.|||+.+ |+||||||+||+++. ++.
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~ 153 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCce
Confidence 34689999997 48877664 235889999999999999999999986 999999999999984 567
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
++++|||.++........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 154 ~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 154 LKIGDFGLARIVDPHYSH----------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred EEECCcccceecCCcccc----------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999865432111 011122357889999997654 567889999999999999999999986431
Q ss_pred CCCCchHHHHHhhCCCCCcHH-------HHHHHh-hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPI-------VEKAIA-KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~-------~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
.. ....... ...+...... ...... .......+ ..........++.+++.+|++.||++|||++|+++
T Consensus 224 ~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 224 EL-EQMQLIL-ESVPVVREEDRNELLNVIPSFVRNDGGEPRRP--LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HH-HHHHHHH-HhcCCCChHHhhhhhhhhhhhhhhcccccCCC--HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 10 0111111 1111110000 000010 00000000 00011224567889999999999999999999996
Q ss_pred H
Q 042568 961 E 961 (983)
Q Consensus 961 ~ 961 (983)
+
T Consensus 300 h 300 (342)
T cd07854 300 H 300 (342)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.01 Aligned_cols=271 Identities=25% Similarity=0.316 Sum_probs=198.9
Q ss_pred CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|+..+.||+|++|.||+|+.. +++.||+|.+.... .....+.+..|++++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 58999999987654 2234567889999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999887532 46899999999999999999999996 99999999999999999999999999876543211
Q ss_pred cccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||...... ..+.. +.......
T Consensus 154 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~-~~~~~~~~ 218 (282)
T cd07829 154 -------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFK-IFQILGTP 218 (282)
T ss_pred -------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHH-HHHHhCCC
Confidence 11123467789999998776 7899999999999999999999998532110 00111 11111000
Q ss_pred CcHHHHHH--H---hhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKA--I---AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ + ....+..........+......+.+++.+|++.+|++||++++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0 00000000000011112235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.84 Aligned_cols=270 Identities=22% Similarity=0.289 Sum_probs=197.9
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCc---
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDF--- 738 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 738 (983)
+..++|...+.||+|++|.||+|... +++.||||++..... .+....+.+|++++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 578899999865422 2234667889999999999999999998765554
Q ss_pred ---eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 739 ---KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 739 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.++|+||+ +++|.+++.. ..+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 79999999 5688888763 45899999999999999999999986 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|++...... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||..... ...+
T Consensus 163 g~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~ 225 (343)
T cd07851 163 GLARHTDDE----------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQL 225 (343)
T ss_pred ccccccccc----------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Confidence 999765321 112357889999998765 4678999999999999999999999853211 0011
Q ss_pred HHHHHhhCCCCCcHH--------HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPI--------VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ...+...... ....+...... ........+.....++.+++.+|+..+|++|||+.|++++
T Consensus 226 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 226 KRIM-NLVGTPDEELLQKISSESARNYIQSLPQM-PKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHH-HhcCCCCHHHHhhccchhHHHHHHhcccc-CCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1111 1111000000 01111110000 0000001111235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=289.04 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=196.8
Q ss_pred CCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccC---cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTT---GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
+|...+.||+|+||.||++... +++.||||.++.... ......+.+|+++++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667889999999999999843 567899999864321 22346788999999999 599999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999988864 235889999999999999999999986 9999999999999999999999999987
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR--ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
........ ......|+..|+|||...+.. .+.++||||||+++|||++|+.||..... ......
T Consensus 154 ~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~- 219 (288)
T cd05583 154 EFLAEEEE------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSE- 219 (288)
T ss_pred cccccccc------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHH-
Confidence 65432111 111245889999999987654 68899999999999999999999853110 011111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+.+.+..... ..+ ......+.+++.+|++.+|++|||++++.+.|+.
T Consensus 220 ------------~~~~~~~~~~-~~~-------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 220 ------------ISRRILKSKP-PFP-------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------------HHHHHHccCC-CCC-------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111111111 011 1234678899999999999999998877766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=278.55 Aligned_cols=270 Identities=21% Similarity=0.278 Sum_probs=202.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-C-C----CccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-H-R----NLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~ 738 (983)
+++|.+...+|+|+||.|-++.+. .+..||||+++.. +...+..+-|+++++++. + | -+|++.++|...++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678999999999999999999854 4678999998543 334567778999999993 2 2 37888889999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC------------
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE------------ 806 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~------------ 806 (983)
.++|+|.+ |-|+.+++.... -.+++...++.|++|++++++|||+.+ ++|-|+||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 458999998643 467899999999999999999999995 999999999999931
Q ss_pred --------CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHH
Q 042568 807 --------DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878 (983)
Q Consensus 807 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ell 878 (983)
+..++|+|||.|+...+.+ ..++.|..|+|||++.+-.++.++||||+|||++|+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----------------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----------------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----------------ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3468999999998765433 2367899999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHH-----Hhhc----------------CCCCCc-cccccchHHHHHH
Q 042568 879 TGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA-----IAKY----------------APQHMP-IYYNKVWSDVVLE 936 (983)
Q Consensus 879 tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----~~~~----------------~~~~~~-~~~~~~~~~~~~~ 936 (983)
+|..-|.. .++.+.+ .++.....+....++.+. .... .+...| ..+...-+....+
T Consensus 304 tG~~LFqt-Hen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 304 TGETLFQT-HENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred ccceeccc-CCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 99998753 1122222 222222221111122221 0000 000000 0111122456677
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 937 LIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 937 l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+|+.+|+.+||.+|+|+.|++.+
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=313.80 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=203.8
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
++.-..++|.+.++||+|+||.|..++.+ +++.||+|++++-.. ....+-|..|-.+|..-+.+-|+.+...|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33444567889999999999999999965 678899999865321 123577999999999999999999999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
+.|+|||||+||+|-..+.... .+++..++-++..|+-||+-+|+.| +|||||||+|||+|..|++|++|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999987542 5899999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccC----C-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM----G-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
+-.+...+. ......+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||...
T Consensus 222 Clkm~~dG~------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----- 284 (1317)
T KOG0612|consen 222 CLKMDADGT------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----- 284 (1317)
T ss_pred HHhcCCCCc------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----
Confidence 987764332 1223468999999999875 2 57899999999999999999999998531
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHHH
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---MLDVAHEM 962 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~L 962 (983)
++.+ .+.+.+.....-..| ...+++.++.+||.+.+. +|+.|.. ++|+..|-
T Consensus 285 slve------------TY~KIm~hk~~l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 285 SLVE------------TYGKIMNHKESLSFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHHH------------HHHHHhchhhhcCCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1111 111111111111111 012366778888887765 7888887 88888753
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=286.88 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999965 68999999986532 2223467889999999998 99999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999988753 36999999999999999999999986 9999999999999999999999999998765
Q ss_pred CCccccccc-------CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 823 GIDESVNCA-------NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 823 ~~~~~~~~~-------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
......... ..............|+..|+|||...+..++.++||||+|++++++++|+.||.... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~-- 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----E-- 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----H--
Confidence 432110000 000000112233468899999999988889999999999999999999999986421 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM----LDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~~ 961 (983)
.......... . ...+ ...+..+.+++.+|++.+|++||++ +|++++
T Consensus 228 -----------~~~~~~~~~~-~-~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 -----------YLTFQKILKL-E-YSFP-------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -----------HHHHHHHHhc-C-CCCC-------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0011111100 0 0011 1235678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.55 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=196.8
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.|...++||+|.||+||||+. .+++.||+|+.......+ ......+|+-+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355578899999999999994 568889999987765544 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|.. .|..+...- ...++...++.++.|+++||.|+|++. +.|||+||.|++++.+|+.|++|||+|+.++-.-
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 964 666655433 446899999999999999999999995 9999999999999999999999999999775322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCc---hHHHHHhh
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS---LHEWVKRH 901 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~---l~~~~~~~ 901 (983)
.. ....+-|..|++|.++.+.+ |++..|+||.|||+.|+.....|. +++... +..+.+..
T Consensus 156 rc-------------ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl---fpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 156 RC-------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPGNDVDDQLKRIFRLL 219 (292)
T ss_pred Ee-------------eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC---CCCCcHHHHHHHHHHHh
Confidence 11 11236789999999998854 788999999999999999966663 222221 22211110
Q ss_pred --CCCCCcHHHHHHHhhcCCCC-Cccc-cccchHHHHHH----HHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 --YPHRLDPIVEKAIAKYAPQH-MPIY-YNKVWSDVVLE----LIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 --~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~----l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.-.+ .+....+.. .|.+ ....|....+. -.+++...+.-+|..|.++++.+++
T Consensus 220 g~p~ed~wp----s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 220 GTPTEDQWP----SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCccccCC----ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0011011 011111111 1111 11134444444 4788888999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=314.20 Aligned_cols=147 Identities=27% Similarity=0.391 Sum_probs=131.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.++||+|+||.||+|... +++.||||+++... .......+.+|+++++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999966 68899999986543 2223577889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
||+++++|.+++... ..+++..++.|+.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999988642 35788999999999999999999986 99999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=276.16 Aligned_cols=240 Identities=29% Similarity=0.376 Sum_probs=192.3
Q ss_pred cccCCcEeEEEEEEC-CCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
||+|+||.||++... +++.||+|.+...... .....+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5889999998655332 2456889999999999999999999999999999999999999999
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccccc
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCA 831 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 831 (983)
.+++... ..+++..+..++.|+++|+.|+|+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----- 148 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----- 148 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-----
Confidence 9988643 35899999999999999999999985 99999999999999999999999999876543210
Q ss_pred CCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 832 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
......|+..|+|||...+...+.++|+||||+++|++++|+.||..... .. ..+
T Consensus 149 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~------------~~~ 203 (250)
T cd05123 149 --------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KE------------IYE 203 (250)
T ss_pred --------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HH------------HHH
Confidence 11224688899999999988889999999999999999999999863211 11 111
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH---HHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM---LDVAH 960 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~---~evl~ 960 (983)
..... ....+ ...+.++.+++.+|+..||++||++ +++.+
T Consensus 204 ~~~~~--~~~~~-------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 204 KILKD--PLRFP-------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHhcC--CCCCC-------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 11110 00111 1125678899999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=267.71 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=215.5
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeE
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
.+++.....+++...++-+|.||.||+|.|.+ .+.|-||.++....+.....+..|...+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555556678888899999999999998764 344678888777666677889999999999999999999998
Q ss_pred Eec-CCceeEEEecccCcccccccccccC----cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC
Q 042568 733 CSK-PDFKALVLPLMSNGSLENHLYPSHG----LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED 807 (983)
Q Consensus 733 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~ 807 (983)
+.+ .+..+++|.++.-|+|..++...++ ..+.++..+...++.|++.|++|||+++ |||.||.+.|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 854 4577889999999999999874332 2345788889999999999999999996 9999999999999999
Q ss_pred CCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 042568 808 LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDV 886 (983)
Q Consensus 808 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~ 886 (983)
.++||+|=.+++.+-+.+.+. .. ........||+||.+....|+..+|||||||++|||+| |+.||..
T Consensus 433 LqVkltDsaLSRDLFP~DYhc--LG---------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHC--LG---------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred eeEEeccchhccccCcccccc--cC---------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 999999999999887665442 21 12235678999999999999999999999999999999 9999864
Q ss_pred ccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 887 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.. ...+..+ +.+.+. ...+ -+|+.++..++..||+.+|++||+++|++..|+++.
T Consensus 502 ID--PfEm~~y----------------lkdGyR--laQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 502 ID--PFEMEHY----------------LKDGYR--LAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred cC--HHHHHHH----------------Hhccce--ecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 32 1111222 222111 1111 248899999999999999999999999999999875
Q ss_pred h
Q 042568 967 Q 967 (983)
Q Consensus 967 ~ 967 (983)
.
T Consensus 557 ~ 557 (563)
T KOG1024|consen 557 T 557 (563)
T ss_pred H
Confidence 4
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=303.48 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=205.2
Q ss_pred CCCCccccCCcEeEEEEEEC----C----CcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCcee
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ----D----NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~----~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 740 (983)
.+.+.+|+|.||.|++|... . ...||||.++........+.+..|+++|+.+ +|+||+.++|+|......+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34568999999999999843 1 3459999998777666788999999999999 6999999999999988999
Q ss_pred EEEecccCccccccccccc---Cc-------C--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 741 LVLPLMSNGSLENHLYPSH---GL-------S--HGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
+|+||++.|+|.+++...+ .. . ..++..+.+.+++|||.|++||++.. +||||+-+.|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCC
Confidence 9999999999999998665 10 1 23889999999999999999999984 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCcccc--ccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG--SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTD 885 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~ 885 (983)
.+||+|||+|+.....+... .. .-.| ...|||||.+....++.|+|||||||++||++| |..||.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~----------~~--~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYR----------TK--SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred EEEEccccceeccCCCCceE----------ec--CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 99999999999654332211 00 0112 245999999999999999999999999999999 778874
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.... . .++++ .+........| ..|..++.++|..||+.+|++||++.|+.+.++..
T Consensus 524 ~~~~-~---------------~~l~~-~l~~G~r~~~P-------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 524 GIPP-T---------------EELLE-FLKEGNRMEQP-------EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCc-H---------------HHHHH-HHhcCCCCCCC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 3110 0 11211 22222222222 34678899999999999999999999999999885
Q ss_pred H
Q 042568 966 K 966 (983)
Q Consensus 966 ~ 966 (983)
.
T Consensus 580 l 580 (609)
T KOG0200|consen 580 L 580 (609)
T ss_pred H
Confidence 3
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=248.66 Aligned_cols=201 Identities=25% Similarity=0.293 Sum_probs=169.3
Q ss_pred CCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
...||+|++|.|-+-++ .+|+..|||++.........++..+|+.+..+- .+|.+|.+||.+......++.||.|. .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 56799999999998885 578999999997766655677888899886654 79999999999999999999999996 4
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
||+.+..........+++..+-+|+..+.+||.|||++- .++|||+||+|||++.+|++|+||||++..+.+.-
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---- 203 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---- 203 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh----
Confidence 887776655444667899999999999999999999986 79999999999999999999999999998765321
Q ss_pred ccCCCCccccccCccccccccccccccCC----CCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMG----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
....-.|-..|||||.+.. ..|+-|+||||+|+++.||.+++.||+..+.
T Consensus 204 ----------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 ----------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ----------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 1112357788999998764 4789999999999999999999999986543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=249.41 Aligned_cols=265 Identities=21% Similarity=0.375 Sum_probs=199.5
Q ss_pred hCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCC--ceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPD--FKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l 741 (983)
.++|++.+++|+|.|++||.|. ..+.++++||+++.. ..+.+.+|+.|++.++ ||||+++++...++. ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 3567788899999999999999 557889999999533 3577899999999997 999999999997664 5579
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEcccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIAKL 820 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgla~~ 820 (983)
|+||+.+.+...... .++...+..++.++++||+|+|+.| |+|||+||.|+++|.. ..++++|||+|.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 999998866654432 4677788999999999999999997 9999999999999954 5789999999999
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
+.+..+. ...+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.|| |++.....+.++
T Consensus 183 YHp~~eY--------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF---FhG~dN~DQLVk 245 (338)
T KOG0668|consen 183 YHPGKEY--------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF---FHGHDNYDQLVK 245 (338)
T ss_pred cCCCcee--------------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc---cCCCCCHHHHHH
Confidence 9865432 23467778899998765 55788899999999999999999998 344444444443
Q ss_pred hh--------------CCCCCcHHHHHHHhhcCCCCCccccccch-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RH--------------YPHRLDPIVEKAIAKYAPQHMPIYYNKVW-SDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. +.-.+++.++..+................ .-..++.++++.+.+.+|-.+|||++|.+.|
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 21 11123333333222211111100000000 1134789999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=272.27 Aligned_cols=220 Identities=21% Similarity=0.209 Sum_probs=174.4
Q ss_pred CCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccccccc
Q 042568 678 GRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLY 756 (983)
Q Consensus 678 G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 756 (983)
|.+|.||++... +++.||+|.+.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999964 68889999986432 23345555556679999999999999999999999999999999886
Q ss_pred cccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCc
Q 042568 757 PSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836 (983)
Q Consensus 757 ~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~ 836 (983)
.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+.......
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----------- 139 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----------- 139 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------
Confidence 43 34899999999999999999999986 9999999999999999999999999886554211
Q ss_pred cccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhh
Q 042568 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAK 916 (983)
Q Consensus 837 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 916 (983)
....++..|+|||...+..++.++||||+|+++|||++|+.|++..... . ..
T Consensus 140 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~--------~~ 191 (237)
T cd05576 140 -----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------I--------NT 191 (237)
T ss_pred -----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------c--------cc
Confidence 1124567899999998888899999999999999999999886421100 0 00
Q ss_pred cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 917 YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 917 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
......+ .....++.+++.+|++.||++||++.
T Consensus 192 ~~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 192 HTTLNIP-------EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ccccCCc-------ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0000011 11346788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=284.32 Aligned_cols=243 Identities=23% Similarity=0.217 Sum_probs=193.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++.|.....+|.|+|+.|-.+.. .+++..|||++.... .+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 45666777899999999999885 467889999996552 3345677776665 7999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe-CCCCCEEEcccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL-DEDLTALVADFGIAKLVK 822 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl-~~~~~~kl~Dfgla~~~~ 822 (983)
|.+.++-+.+.+... +.....+..|+.+|+.|+.|||++| |||||+||+|||+ ++.+.++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999998887766532 2223678889999999999999997 9999999999999 589999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
+.. .+.+=|..|.|||+.....|++++|+||||+++|+|++|+.||..-..+ .
T Consensus 468 ~~~----------------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~------- 520 (612)
T KOG0603|consen 468 RSC----------------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----I------- 520 (612)
T ss_pred hhh----------------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----H-------
Confidence 431 1124578899999999999999999999999999999999998743221 1
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.+...+..... -...+.++.+|+.+|++.||.+||+|+++..+=..
T Consensus 521 ------ei~~~i~~~~~----------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 521 ------EIHTRIQMPKF----------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------HHHHhhcCCcc----------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11111111100 02366789999999999999999999999987666
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=269.25 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=188.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
.+|....+||+|+||.|..|..+ +.+.+|||++++.. +.+..+--+.|-+++.-. +-|.++++..+|+..+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999866 45669999997653 222334445566666655 578999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+.||+|-.+++... ++.+..+.-+|..||-||-|||++| |+.||+|.+|||+|.+|.+||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999998887654 4666778889999999999999997 9999999999999999999999999997422
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
- ...++.+.+||+.|+|||.+...+|+..+|.|||||++|||+.|+.||+.. +...+
T Consensus 502 ~-------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--DE~el-------- 558 (683)
T KOG0696|consen 502 F-------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--DEDEL-------- 558 (683)
T ss_pred c-------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--CHHHH--------
Confidence 1 123456689999999999999999999999999999999999999999753 21111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 953 (983)
+......... .| ...+.+.+.+....+...|.+|.
T Consensus 559 -------F~aI~ehnvs--yP-------KslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 -------FQAIMEHNVS--YP-------KSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------HHHHHHccCc--Cc-------ccccHHHHHHHHHHhhcCCcccc
Confidence 1111111110 01 23556777777778888888884
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=289.76 Aligned_cols=248 Identities=30% Similarity=0.401 Sum_probs=189.2
Q ss_pred CCCCCccccCCcEe-EEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecc
Q 042568 669 FCPSSLIGSGRFGH-VYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 669 f~~~~~iG~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
|...+++|.|+.|+ ||+|... |+.||||++- .+......+|+..++.- +|||||++++.-.+..+.||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44556789999874 7999986 8899999883 23345678999999987 6999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---C--CCEEEccccccccc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---D--LTALVADFGIAKLV 821 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~--~~~kl~Dfgla~~~ 821 (983)
. .+|+++++..............+.+..|+++||++||+.+ |||||+||.|||++. + .+++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 5999999864111111121456788999999999999975 999999999999975 3 57899999999998
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhC-CCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTG-RRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg-~~p~~~~~~~~~~l~~~~~~ 900 (983)
....... .......||.||+|||++....-+..+||||+||++|+.++| .+||......+.++ +..
T Consensus 662 ~~~~sS~----------~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI---l~~ 728 (903)
T KOG1027|consen 662 AGGKSSF----------SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI---LTG 728 (903)
T ss_pred CCCcchh----------hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh---hcC
Confidence 7655442 123456799999999999998888899999999999999996 89986432211110 000
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
... ... -....++ +..+||.+|+..+|..||++.+|+.
T Consensus 729 ----------------~~~--L~~--L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 ----------------NYT--LVH--LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----------------ccc--eee--eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 000 0001223 8899999999999999999999994
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=284.92 Aligned_cols=270 Identities=20% Similarity=0.222 Sum_probs=183.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-----------------CCCcEEEEEEeecccCcc-------------hhHHHHHH
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-----------------QDNTRIAVKVLDLTTTGE-------------ITGSFKRE 714 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~-------------~~~~~~~E 714 (983)
..++|.+.++||+|+||.||+|.. ..++.||||+++...... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 235679999986543221 11234457
Q ss_pred HHHHHhcCCCCc-----cceeeEEec--------CCceeEEEecccCcccccccccccC--------------------c
Q 042568 715 CQILKRIRHRNL-----IRIITICSK--------PDFKALVLPLMSNGSLENHLYPSHG--------------------L 761 (983)
Q Consensus 715 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 761 (983)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...+ .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 677777743 3567999999999999998864321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCcccccc
Q 042568 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841 (983)
Q Consensus 762 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~ 841 (983)
...+++..++.++.|+++||.|+|+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------------~~~ 367 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------------FNP 367 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc------------cCc
Confidence 123578889999999999999999986 99999999999999999999999999975532111 011
Q ss_pred CccccccccccccccCCCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCcccCCCCchHHHH
Q 042568 842 GLLCGSVGYIAPEYGMGKR--------------------A--STHGDVYSFGVLLLEIVTGRR-PTDVLFHDGSSLHEWV 898 (983)
Q Consensus 842 ~~~~gt~~y~aPE~~~~~~--------------------~--~~k~Dv~SlG~il~elltg~~-p~~~~~~~~~~l~~~~ 898 (983)
....+|+.|+|||.+.... + ..+.||||+||++|+|++|.. ||.....-...+..
T Consensus 368 ~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-- 445 (507)
T PLN03224 368 LYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-- 445 (507)
T ss_pred cccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh--
Confidence 1123578999999875422 1 235799999999999999885 65422100000000
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP---STRPSMLDVAHEM 962 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~L 962 (983)
+ ........ ...... +....+........+++.+++..+| .+|+|++|+++|-
T Consensus 446 ---~----~~~~~~~r-~~~~~~---~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 446 ---Y----DNDLNRWR-MYKGQK---YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred ---c----cchHHHHH-hhcccC---CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0 00000000 000000 0111234456788999999998766 6899999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=252.59 Aligned_cols=247 Identities=22% Similarity=0.335 Sum_probs=194.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|....+||+|+|++|-.+++. +.+.+|+|+++++- ..+...=...|-.+..+. +||.+|.+..+|..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57888999999999999999955 67779999997653 233344455676776666 799999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
.||++||+|--+++. .++++++.++-+...|.-||.|||++| |+.||+|.+|||+|..|.+|++|+|+++.--
T Consensus 330 ieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999877765 456999999999999999999999997 9999999999999999999999999997432
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccC--CCCchHHHHHh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH--DGSSLHEWVKR 900 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~--~~~~l~~~~~~ 900 (983)
.. ...+.+++||+.|.|||.+.+..|+..+|.|++||+++||+.|+.||+...- .+..-.++.-+
T Consensus 403 ~~-------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq 469 (593)
T KOG0695|consen 403 GP-------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ 469 (593)
T ss_pred CC-------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence 21 1334567999999999999999999999999999999999999999985432 22222233222
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 953 (983)
. ++++.+. .| ...+.+...++..-+..||.+|.
T Consensus 470 v-------ilekqir------ip-------rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 470 V-------ILEKQIR------IP-------RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred H-------Hhhhccc------cc-------ceeehhhHHHHHHhhcCCcHHhc
Confidence 1 1222111 11 11334556667778899999885
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=291.78 Aligned_cols=270 Identities=19% Similarity=0.157 Sum_probs=168.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-C----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeE------E
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-D----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI------C 733 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 733 (983)
..++|...+.||+|+||.||+|.+. + +..||||++...... +.+..| .++...+.+++.++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4568999999999999999999965 4 688999987532211 111111 1122222223222221 2
Q ss_pred ecCCceeEEEecccCcccccccccccCc----------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC
Q 042568 734 SKPDFKALVLPLMSNGSLENHLYPSHGL----------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL 797 (983)
Q Consensus 734 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di 797 (983)
......++||||+++++|.+++...... ........+..++.|+++||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 4556789999999999999887643210 001123446689999999999999986 999999
Q ss_pred CCCCeEeCC-CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-----------------
Q 042568 798 KPSNILLDE-DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK----------------- 859 (983)
Q Consensus 798 kp~NiLl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------- 859 (983)
||+|||++. ++.+||+|||+|+.+..... .......||+.|+|||.+...
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~------------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp 349 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP 349 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc------------cCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence 999999986 57999999999986542211 112235789999999964321
Q ss_pred -----CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc-HHHHHHHhhcCCCCCccccccchHHH
Q 042568 860 -----RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD-PIVEKAIAKYAPQHMPIYYNKVWSDV 933 (983)
Q Consensus 860 -----~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (983)
.++.++||||+||++|||+++..|++. ....+.........+ ......+...........+ ...+..
T Consensus 350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d~~ 422 (566)
T PLN03225 350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF-EVLDLD 422 (566)
T ss_pred hhccccCCCCcccHHHHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhh-hhcccc
Confidence 234567999999999999998776532 111111111000000 0000000000000000000 000111
Q ss_pred HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 934 VLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 934 ~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.....+|+.+|++.||++|||++|+++|
T Consensus 423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 423 GGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred chHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 2345689999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=269.14 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=200.8
Q ss_pred CCCccccCCcEeEEEEEECCCc-EEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNT-RIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~-~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
....||-||||.|=.++..... .+|+|++++.. ..+..+....|-.+|...+.|.||++|..|.+....|+.||-|=
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3567999999999999866443 38888875542 22345678889999999999999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
||.+...+.+ +..++..+..-++..+++|++|||.++ ||.||+||+|.++|.+|-+||.|||.|+.+...
T Consensus 504 GGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--- 573 (732)
T KOG0614|consen 504 GGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--- 573 (732)
T ss_pred Cchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC---
Confidence 9999999976 345888889999999999999999996 999999999999999999999999999987643
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
..+.+++||+.|.|||.+..+..+..+|.||+|+++||+++|.+||... +.......+.
T Consensus 574 -----------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--dpmktYn~IL-------- 632 (732)
T KOG0614|consen 574 -----------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--DPMKTYNLIL-------- 632 (732)
T ss_pred -----------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--chHHHHHHHH--------
Confidence 2334579999999999999999999999999999999999999999742 2221111111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHHH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHEMG 963 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 963 (983)
+.+... ..| ..+.+...+++.+.++.+|.+|.- +.|+.+|-+
T Consensus 633 ----kGid~i---~~P-------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 633 ----KGIDKI---EFP-------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ----hhhhhh---hcc-------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 111111 111 125567889999999999999975 788887765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=260.41 Aligned_cols=239 Identities=27% Similarity=0.348 Sum_probs=191.6
Q ss_pred CcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccccccccc
Q 042568 679 RFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYP 757 (983)
Q Consensus 679 ~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 757 (983)
+||.||+|... +++.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48899999997655443367899999999999999999999999988999999999999999998864
Q ss_pred ccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCcc
Q 042568 758 SHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837 (983)
Q Consensus 758 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~ 837 (983)
.. .+++..++.++.+++++++|||+.+ ++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------------ 141 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------------ 141 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------------
Confidence 32 2889999999999999999999985 9999999999999999999999999998765321
Q ss_pred ccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhc
Q 042568 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKY 917 (983)
Q Consensus 838 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 917 (983)
......++..|++||...+..++.++||||+|++++++++|..||+... +. . ...+......
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~---~------------~~~~~~~~~~ 203 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QL---L------------ELFKKIGKPK 203 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cH---H------------HHHHHHhccC
Confidence 1122457889999999988888999999999999999999999986421 10 1 1111111110
Q ss_pred CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 918 APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 918 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
... ...+.....++.+++.+|+..+|++||++.++++
T Consensus 204 ~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 204 PPF------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCC------ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 100 0000114467899999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=248.69 Aligned_cols=271 Identities=20% Similarity=0.274 Sum_probs=194.2
Q ss_pred CCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCC-----ceeEE
Q 042568 670 CPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPD-----FKALV 742 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 742 (983)
+..+.||-|+||+||.+.+ ++|++||.|++...... ...+++.+|++++...+|.|++..++....+. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3567899999999999985 47999999988543322 24678999999999999999999998875443 56788
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+|.|.. +|.+.+-. ...++...+.-+.+||++||.|||+.+ |.||||||.|+|++.+...||||||+|+...
T Consensus 136 TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 898864 67666643 445888899999999999999999995 9999999999999999999999999999765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..+. ..+...+-|..|+|||.++| +.|+..+||||+|||+.|++..+.-|....+ -..-+++.+.
T Consensus 208 ~d~~------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdL 273 (449)
T KOG0664|consen 208 QRDR------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDL 273 (449)
T ss_pred hhhh------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHH
Confidence 4332 22233467899999999998 5689999999999999999998887753211 0111222222
Q ss_pred CCCCCcHHHHHHHhhc---------CCCCCcccccc-chHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKY---------APQHMPIYYNK-VWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
....-.+.......+. .....+..+.- .-.+.-.+...+...++..||.+|.+..+.+.+.
T Consensus 274 LGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 274 LGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111111110 11111111110 1122345667788889999999999999988765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=265.90 Aligned_cols=215 Identities=24% Similarity=0.282 Sum_probs=174.0
Q ss_pred CCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
-|...+.||-|+||+|.+++ .++...||+|.+.+.. ........+.|-.||.....+-||++|..|.+.+..|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 47778889999999999998 5556678999885432 12245678889999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++||++-.+|... ..+.+..++-++..+..|+++.|..| +|||||||+|||||.+|.+||+|||+++-+.-.
T Consensus 710 YIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 99999998887643 34788888889999999999999997 999999999999999999999999998754221
Q ss_pred ccccc------ccCCCCcc-----------------------ccccCccccccccccccccCCCCCCccchhHHHHHHHH
Q 042568 825 DESVN------CANDSMSF-----------------------TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLL 875 (983)
Q Consensus 825 ~~~~~------~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ 875 (983)
+.... ...+++.. .......+||+.|+|||++....++..+|.||.|||+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 11100 00011111 11223358999999999999999999999999999999
Q ss_pred HHHhCCCCCCcccC
Q 042568 876 EIVTGRRPTDVLFH 889 (983)
Q Consensus 876 elltg~~p~~~~~~ 889 (983)
||+.|+.||.....
T Consensus 863 em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTP 876 (1034)
T ss_pred HHhhCCCCccCCCC
Confidence 99999999965443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=257.23 Aligned_cols=287 Identities=26% Similarity=0.353 Sum_probs=208.1
Q ss_pred HHHHhCCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 042568 662 LIEATGGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP 736 (983)
Q Consensus 662 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 736 (983)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...... .+...|++++..+ -+.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445567888999999999999999854 3567999999766544 6789999999999 589999999999999
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADF 815 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Df 815 (983)
+...+|+||++.....++.. .++...+..+++.+.+||+++|..| ||||||||+|++.+. .+.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 99999999999977777664 3667889999999999999999997 999999999999984 567889999
Q ss_pred cccccccCCcccccccC------------------------C-------CCccccccCccccccccccccccCCC-CCCc
Q 042568 816 GIAKLVKGIDESVNCAN------------------------D-------SMSFTSTDGLLCGSVGYIAPEYGMGK-RAST 863 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~------------------------~-------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ 863 (983)
|+|..+........... . ...........+||+||+|||++... ..++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 99984322110000000 0 00001122335799999999998764 5688
Q ss_pred cchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh----------CCCC--Cc------HHHH------HH-HhhcC
Q 042568 864 HGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH----------YPHR--LD------PIVE------KA-IAKYA 918 (983)
Q Consensus 864 k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~----------~~~~--~~------~~~~------~~-~~~~~ 918 (983)
++||||.|||++-+++++.||-....+-..+.+.+... .+.. +. ...+ .. +....
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999966555544444443210 0111 00 0001 00 11111
Q ss_pred CCCCccccccchHHHHH-HHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 919 PQHMPIYYNKVWSDVVL-ELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 919 ~~~~~~~~~~~~~~~~~-~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.+......|.++.. .+++++.+|+..||.+|.|++|.++|
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11111234445555554 89999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=241.25 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=196.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
..+|.....+|.|+- .|-.|.+ -.++.||+|....+.. ....++..+|...+..++|+||++++.++....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999998 4545543 3688999998755422 224577889999999999999999999996443
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..|+|||+|. .+|.+.+.. .++-.++..|..|++.|+.|||+.+ |+|||+||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 5689999996 488777652 3677889999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
|+..... -....++.|..|+|||++.+..+.+.+||||+||++.||++|+.-|. ++..+.+|
T Consensus 165 ar~e~~~--------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~ 226 (369)
T KOG0665|consen 165 ARTEDTD--------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQW 226 (369)
T ss_pred hcccCcc--------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHH
Confidence 9854321 12344789999999999999999999999999999999999998753 45556666
Q ss_pred HHhhCC-CCCcHHHHHHHhh--------------------cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 898 VKRHYP-HRLDPIVEKAIAK--------------------YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 898 ~~~~~~-~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
.+..-. +..++.+-..+.. ..+...+...+.. .-....+.+++.+|+..+|++|.|++
T Consensus 227 ~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 227 NKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHH
Confidence 543211 1111111111000 0000001000000 11344578999999999999999999
Q ss_pred HHHHH
Q 042568 957 DVAHE 961 (983)
Q Consensus 957 evl~~ 961 (983)
++++|
T Consensus 306 daL~H 310 (369)
T KOG0665|consen 306 DALRH 310 (369)
T ss_pred HHhcC
Confidence 99975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=258.10 Aligned_cols=197 Identities=24% Similarity=0.394 Sum_probs=168.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCc-------chhHHHHHHHHHHHhcC---CCCccceeeEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTG-------EITGSFKRECQILKRIR---HRNLIRIITICSK 735 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 735 (983)
.+|+..+.+|+|+||.|+.|.++. ...|+||.+.++..= ......-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999774 455899998665321 11233556999999997 9999999999999
Q ss_pred CCceeEEEecc-cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 736 PDFKALVLPLM-SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 736 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
.++.|++||-. ++-+|.+++.. ++.+++.++.-|++||+.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999976 45577788764 567999999999999999999999997 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTD 885 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~ 885 (983)
||.|..... .+..+++||.+|.|||++.|.+| +..-|||++|+++|.++....||.
T Consensus 714 fgsaa~~ks---------------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS---------------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC---------------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999876542 44556799999999999999887 466799999999999999998874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=241.82 Aligned_cols=132 Identities=26% Similarity=0.468 Sum_probs=112.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-----C---CCccceeeEEe--
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-----H---RNLIRIITICS-- 734 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~-- 734 (983)
.++|.+.++||=|.|++||++.+ .+.+.||+|+.+.. +...+....||+++++++ | .+||+++++|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 47899999999999999999984 46778999998643 335677889999999984 2 47999999994
Q ss_pred --cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 735 --KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 735 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
...+.+||+|++ |.+|..++.... -+.++...+.+|++||+.||.|||.++ +|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 345889999999 568888886543 467999999999999999999999998 79999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=233.33 Aligned_cols=212 Identities=31% Similarity=0.545 Sum_probs=182.4
Q ss_pred cccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCccccc
Q 042568 675 IGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLEN 753 (983)
Q Consensus 675 iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 753 (983)
||+|++|.||++.... ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999999765443245789999999999999999999999999899999999999999999
Q ss_pred ccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEccccccccccCCcccccccC
Q 042568 754 HLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVKGIDESVNCAN 832 (983)
Q Consensus 754 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 832 (983)
++.... ..+++..++.++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------ 148 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------
Confidence 886431 35899999999999999999999996 999999999999999 89999999999986653211
Q ss_pred CCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH
Q 042568 833 DSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911 (983)
Q Consensus 833 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 911 (983)
......+...|++||..... .++.+.|+|++|++++++
T Consensus 149 -------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 149 -------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred -------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 11123578899999998887 788999999999999999
Q ss_pred HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 912 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467788889999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=246.35 Aligned_cols=207 Identities=24% Similarity=0.288 Sum_probs=172.0
Q ss_pred CCCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC------CCCccc
Q 042568 656 RVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR------HRNLIR 728 (983)
Q Consensus 656 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 728 (983)
++.+.++ ..++|.+....|+|-|++|-+|... .|..||||++.... ...+.=.+|++||++|+ .-|+++
T Consensus 423 rv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3444444 3468988999999999999999965 57899999995432 23466678999999995 348999
Q ss_pred eeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-
Q 042568 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED- 807 (983)
Q Consensus 729 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~- 807 (983)
++..|....+.+||+|-+. -+|.+.+.+... ...+....+..++.|+.-||..|-..+ |+|.||||+|||+++.
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence 9999999999999999885 588888876543 567889999999999999999999886 9999999999999865
Q ss_pred CCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 808 LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 808 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
..+||||||.|......+ ...+.-+..|+|||.+.|-+|+...|+||+||++||+.||+.-|-+
T Consensus 574 ~iLKLCDfGSA~~~~ene---------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE---------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ceeeeccCcccccccccc---------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 567999999998776432 1224566789999999999999999999999999999999998743
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=255.98 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=197.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|.....+|+|+||.|||+++ .+++..|||+++..... ..+-..+|+-+++..+||||+.+++.|...+..+++|||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4566788999999999999995 47888999999877543 567788899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|.+|+|++.-+. ..++++.++..+++..++|++|||+.| -+|||||-.||++++.|.+|+.|||.+..+...
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 999999997764 457899999999999999999999997 789999999999999999999999998755421
Q ss_pred ccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
-.......||+.|||||+.. .+.|..++|||+.|++..|+-.-+.|.... ..+......
T Consensus 166 ------------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----hpmr~l~Lm-- 227 (829)
T KOG0576|consen 166 ------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----HPMRALFLM-- 227 (829)
T ss_pred ------------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----chHHHHHHh--
Confidence 12234468999999999864 467899999999999999999988884321 111111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
.+...+.........|.+.+.+ ++..|+..+|++||+++.+++
T Consensus 228 ------------TkS~~qpp~lkDk~kws~~fh~---fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 228 ------------TKSGFQPPTLKDKTKWSEFFHN---FVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------------hccCCCCCcccCCccchHHHHH---HHHHHhcCCCccCCChhhhee
Confidence 0001111111112245555444 555699999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=231.14 Aligned_cols=200 Identities=31% Similarity=0.440 Sum_probs=171.0
Q ss_pred CCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEeccc
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
|...+.||+|++|.||+|...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 888999999765443346789999999999999999999999999899999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+++|.+++.... ..+++..+..++.+++.++.|||+.+ ++|+|++|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 999999887532 11789999999999999999999995 99999999999999999999999999987653320
Q ss_pred ccccCCCCccccccCcccccccccccccc-CCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYG-MGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
.......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 154 -----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -----------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -----------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 011224578899999998 666778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-27 Score=245.34 Aligned_cols=405 Identities=22% Similarity=0.230 Sum_probs=254.8
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccC-cccccccCCcccccCCCcccce
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN-NKLVGEIPIPIFCSNSSTSLQY 180 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~-N~l~~~~p~~~~~~~~l~~L~~ 180 (983)
.-++++|..|.|+...|..|+.+++|+.||||+|+|+.+-|.+|..|.+|.+|-+-+ |+|+ .+|...|
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F---------- 136 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAF---------- 136 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHh----------
Confidence 456789999999966666899999999999999999999999999999888876665 8887 5665544
Q ss_pred eecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcccc
Q 042568 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260 (983)
Q Consensus 181 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 260 (983)
.+|..|+.|.+.-|++.-+..++|..+++|..|.+-+|.+. .++...+..+..++.+++..|
T Consensus 137 -----------------~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~n 198 (498)
T KOG4237|consen 137 -----------------GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQN 198 (498)
T ss_pred -----------------hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcC
Confidence 45666666666666666666666666666666666666665 566656666666666666666
Q ss_pred ccccCCCCCCCcc----cccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCC-CCCCCCcccE
Q 042568 261 DFVSHDGNTNLEP----FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP-HISNLVNLTL 335 (983)
Q Consensus 261 ~l~~~~~~~~~~~----~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~ 335 (983)
.+...-...++.. .+..++...-..-..+.++++...-+..+......+..=-.+.+...+..|. .|..+++|+.
T Consensus 199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~ 278 (498)
T KOG4237|consen 199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRK 278 (498)
T ss_pred ccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceE
Confidence 6443322111111 1112222223333334444444333333332211111111122222223332 4677888888
Q ss_pred EeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccC
Q 042568 336 LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415 (983)
Q Consensus 336 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 415 (983)
|+|++|+++++-+.+|.++..++.|+|..|+|..+-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+
T Consensus 279 lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 279 LNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence 88888888888888888888888888888888877777788888888888888888888888888888888888888876
Q ss_pred CCCC-----ccccc-----------CCCCCCEEEccCccccC---cCCccccCCCccceeccccCCCCCCCCcccccccc
Q 042568 416 SGTI-----PSSLG-----------KCVNLEILDLSHNKISG---IIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476 (983)
Q Consensus 416 ~~~~-----p~~l~-----------~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~ 476 (983)
.-.- .+++. .-..++.+.++++.+.. ..|++.+... ++.-|.. .+
T Consensus 359 ~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~-------------s~~cP~~---c~ 422 (498)
T KOG4237|consen 359 NCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLT-------------SSPCPPP---CT 422 (498)
T ss_pred cCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCC-------------CCCCCCC---cc
Confidence 5210 01111 01123344444433321 1111111100 0111111 11
Q ss_pred ccc-cccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEec
Q 042568 477 MVL-AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNF 555 (983)
Q Consensus 477 ~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l 555 (983)
-+. ..-.|++.+. .+|..+.. ...+|++.+|.++ .+|.+ .+..| .+|+|+|+++..-...|.++++|.+|-+
T Consensus 423 c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlil 495 (498)
T KOG4237|consen 423 CLDTVVRCSNKLLK-LLPRGIPV--DVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLIL 495 (498)
T ss_pred hhhhhHhhcccchh-hcCCCCCc--hhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEE
Confidence 122 2233444444 66665543 5678888999988 56766 56777 8899999988666678888998888888
Q ss_pred cCC
Q 042568 556 SFN 558 (983)
Q Consensus 556 ~~N 558 (983)
++|
T Consensus 496 syn 498 (498)
T KOG4237|consen 496 SYN 498 (498)
T ss_pred ecC
Confidence 876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-26 Score=221.26 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=185.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceee-EEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIIT-ICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~ 743 (983)
+.|.+.+.+|+|.||.+-.+.++ +.+.+|+|.++.+... .++|.+|..---.+ .|.||+.-|+ .|+..+..++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 45677899999999999999976 5677999998766543 57888887654444 5899998876 467778889999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCCCEEEccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDLTALVADFGIAKLV 821 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~~~kl~Dfgla~~~ 821 (983)
||++.|+|..-+.. ..+-+....+++.|+++|+.|||++ ++||||||.+|||+- +..++|+||||..+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999988764 4477788899999999999999999 599999999999983 3458999999998755
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-----RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+. ......-+..|-+||..... .+.+.+|||.||+++|.++||+.||....-.+..+.+
T Consensus 174 g~----------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~ 237 (378)
T KOG1345|consen 174 GT----------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE 237 (378)
T ss_pred Cc----------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence 42 11112345568899876542 3467899999999999999999999755444444444
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
|..-.. +. ....|. .+.-....++++..+-+..+|++|--+-++.++.
T Consensus 238 ~~~w~~--rk------------~~~~P~----~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 238 WEQWLK--RK------------NPALPK----KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHhc--cc------------CccCch----hhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 433211 10 001111 1222456778888889999999995555544433
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.9e-24 Score=268.91 Aligned_cols=363 Identities=25% Similarity=0.259 Sum_probs=215.2
Q ss_pred CeEEEEEcccCCccc--ccccccccCCCCcEEeCcCCc------CCCCCccccCCCC-CCCEEeccCccCCCCchhhhcc
Q 042568 77 NKVVELDLSARSIYG--TISPALANLSSLIVLDLSKNF------FQGHIPAELGSLI-RLKQLSLSWNSLQGKIPSQLGS 147 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~ 147 (983)
.+|..+.+.-..+.. .-+.++.++++|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..| .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 345554443333321 123468889999999987654 3345777777764 6999999999987 888887 5
Q ss_pred cccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCc
Q 042568 148 LHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL 227 (983)
Q Consensus 148 L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 227 (983)
..+|++|+|++|++. .+|..+. .+++|+.|+|++|.....+|. ++.+++|++|+|++|.....+|..++++++|
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~---~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L 683 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVH---SLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKL 683 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccc---cCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCC
Confidence 789999999999987 6776653 678888888888765556763 5678888888888877666788888888888
Q ss_pred ceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCcccccccc
Q 042568 228 EWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307 (983)
Q Consensus 228 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 307 (983)
+.|++++|...+.+|..+ .+++|+.|+|++|. ..+.+|.. +.
T Consensus 684 ~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~--------------------------------~L~~~p~~----~~ 725 (1153)
T PLN03210 684 EDLDMSRCENLEILPTGI--NLKSLYRLNLSGCS--------------------------------RLKSFPDI----ST 725 (1153)
T ss_pred CEEeCCCCCCcCccCCcC--CCCCCCEEeCCCCC--------------------------------Cccccccc----cC
Confidence 888888764434666543 45566666665553 22222221 23
Q ss_pred CeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
+|++|++++|.+. .+|..+ .+++|++|++.++... .++..+ ....|..+...++|+.|+|+
T Consensus 726 nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~~~~----------------~~l~~~~~~~~~sL~~L~Ls 786 (1153)
T PLN03210 726 NISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLWERV----------------QPLTPLMTMLSPSLTRLFLS 786 (1153)
T ss_pred CcCeeecCCCccc-cccccc-cccccccccccccchh-hccccc----------------cccchhhhhccccchheeCC
Confidence 4555666666554 344433 4556666666553321 111000 00011111222344555555
Q ss_pred CccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
+|...+.+|.+++++++|+.|++++|...+.+|..+ ++++|+.|++++|..-..+|.. ..+++. |+|++|.++ .
T Consensus 787 ~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~-L~Ls~n~i~-~ 860 (1153)
T PLN03210 787 DIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISD-LNLSRTGIE-E 860 (1153)
T ss_pred CCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCE-eECCCCCCc-c
Confidence 554444445555555555555555443223444433 4555556666555433334432 234443 666666665 4
Q ss_pred Ccccccccccccccccccc-ccccCCCcccccccccceEEeCCCc
Q 042568 468 LPLELSKMDMVLAIDLSFN-NLSGSIPPQLGSCIALESLNLSGNS 511 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~ 511 (983)
+|.++..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus 861 iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 861 VPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 5666666666666776663 344 566666677777777776663
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=266.34 Aligned_cols=341 Identities=20% Similarity=0.259 Sum_probs=250.7
Q ss_pred CCcccccccccceeecccCc------cccccchhhhccC-CcceecccccccccccchhhhcCCCCccEEEccccccccC
Q 042568 193 PLKNECELRNLRFLLLWSNR------LVGQVPQALANSS-KLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSH 265 (983)
Q Consensus 193 p~~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 265 (983)
....|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..+ ...+|++|+|++|++..
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~~- 625 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLEK- 625 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCccccc-
Confidence 34456678888888886553 3345677777764 5888888888886 777664 46788888888887654
Q ss_pred CCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCC
Q 042568 266 DGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345 (983)
Q Consensus 266 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 345 (983)
++..+..+++|+.|+|++|...+.+|. +..+ ++|+.|+|++|.....+|..+.++++|+.|++++|..-.
T Consensus 626 --------L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l-~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~ 695 (1153)
T PLN03210 626 --------LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMA-TNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE 695 (1153)
T ss_pred --------cccccccCCCCCEEECCCCCCcCcCCc-cccC-CcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC
Confidence 234456788888888888765556664 4444 578888888887667888888888899999998876555
Q ss_pred CCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCC-------CC
Q 042568 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS-------GT 418 (983)
Q Consensus 346 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-------~~ 418 (983)
.+|..+ ++++|+.|++++|...+.+|.. .++|+.|+|++|.+. .+|..+ .+++|+.|.+.++... ..
T Consensus 696 ~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l 769 (1153)
T PLN03210 696 ILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPL 769 (1153)
T ss_pred ccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcccccccc
Confidence 677655 6888888998888766566643 457888889888886 456544 5777888877764321 11
Q ss_pred CcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCccccc
Q 042568 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGS 498 (983)
Q Consensus 419 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (983)
.+..+...++|+.|+|++|...+.+|..++++++|+. |++++|..-+.+|..+ .+++|+.|+|++|.....+|..
T Consensus 770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~-L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--- 844 (1153)
T PLN03210 770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEH-LEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--- 844 (1153)
T ss_pred chhhhhccccchheeCCCCCCccccChhhhCCCCCCE-EECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---
Confidence 2222333467888999888877788888888888886 8888876555677666 6888888999887655566653
Q ss_pred ccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCc
Q 042568 499 CIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNK 559 (983)
Q Consensus 499 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~ 559 (983)
..+|+.|+|++|.++ .+|.++..+++|+.|+|++|+-...+|..+..+++|+.+++++|.
T Consensus 845 ~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 845 STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 357888899999888 578888888899999998854334688888888888888888874
|
syringae 6; Provisional |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=212.20 Aligned_cols=170 Identities=18% Similarity=0.166 Sum_probs=127.2
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++... ...+++..++.|+.|+++||+|||+++ ||+||+++.++.+++ ||.++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 5788888643 345999999999999999999999984 999999999999999 99988654211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
..||+.|||||++.+..++.++|||||||++|||++|+.||.........+..+...
T Consensus 64 ---------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 120 (176)
T smart00750 64 ---------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-------- 120 (176)
T ss_pred ---------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH--------
Confidence 258899999999999999999999999999999999999986432111111111111
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHH--HHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVL--ELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
...... ........... ++.+++.+|+..+|++||++.|+++++..+...
T Consensus 121 --------~~~~~~--~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 121 --------MPADDP--RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred --------hccCCc--cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 110000 00001122233 689999999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=246.91 Aligned_cols=264 Identities=27% Similarity=0.332 Sum_probs=156.7
Q ss_pred CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccce
Q 042568 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRF 205 (983)
Q Consensus 126 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 205 (983)
.-..|+|++|.|+ .+|..+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+ .+|. ..++|+.
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~------lp~~Lk~LdLs~N~Lt-sLP~----lp~sL~~ 266 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA------LPPELRTLEVSGNQLT-SLPV----LPPGLLE 266 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC------CCCCCcEEEecCCccC-cccC----cccccce
Confidence 4556777777777 6666665 36777777777776 4553 2366777777777776 3442 2356777
Q ss_pred eecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCcc
Q 042568 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 206 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
|+|++|.++ .+|..+ ++|+.|+|++|+++ .+|. ..++|++|+|++|++..++. + ..+|+
T Consensus 267 L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~Lp~------l------p~~L~ 325 (788)
T PRK15387 267 LSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLASLPA------L------PSELC 325 (788)
T ss_pred eeccCCchh-hhhhch---hhcCEEECcCCccc-cccc----cccccceeECCCCccccCCC------C------ccccc
Confidence 777777776 334322 45667777777776 4553 23567777777776654321 0 13456
Q ss_pred EEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCC
Q 042568 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 365 (983)
.|++++|++++ +|. ++.+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|
T Consensus 326 ~L~Ls~N~L~~-LP~----lp~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N 392 (788)
T PRK15387 326 KLWAYNNQLTS-LPT----LPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGN 392 (788)
T ss_pred ccccccCcccc-ccc----cccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCC
Confidence 66677776653 332 23456677777777663 4432 235666667777766 34432 245666777777
Q ss_pred cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCc
Q 042568 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445 (983)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 445 (983)
.|++ +|.. .++|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 393 ~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 393 RLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 6663 3332 2456666777766663 4432 234556666666666 5566666666666666666666655554
Q ss_pred cc
Q 042568 446 DV 447 (983)
Q Consensus 446 ~~ 447 (983)
.+
T Consensus 464 ~L 465 (788)
T PRK15387 464 AL 465 (788)
T ss_pred HH
Confidence 44
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-24 Score=265.49 Aligned_cols=209 Identities=18% Similarity=0.200 Sum_probs=138.8
Q ss_pred hcCC-CCccceeeEE-------ecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCC
Q 042568 720 RIRH-RNLIRIITIC-------SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791 (983)
Q Consensus 720 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 791 (983)
.++| +||++++++| ...+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5888888877 2223456778887 56999999642 345899999999999999999999986
Q ss_pred eEeecCCCCCeEeCCCCCE-------------------EEccccccccccCCccc-c--cccCCCCccccccCccccccc
Q 042568 792 VVHCDLKPSNILLDEDLTA-------------------LVADFGIAKLVKGIDES-V--NCANDSMSFTSTDGLLCGSVG 849 (983)
Q Consensus 792 ivH~Dikp~NiLl~~~~~~-------------------kl~Dfgla~~~~~~~~~-~--~~~~~~~~~~~~~~~~~gt~~ 849 (983)
|+||||||+|||++..+.+ |++|||+++........ . ........+........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999655444 55555555432110000 0 000000001111122468999
Q ss_pred cccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccc
Q 042568 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKV 929 (983)
Q Consensus 850 y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 929 (983)
|||||++.+..++.++|||||||++|||++|..|+... ...+..+. ....+ ...
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~----------------~~~~~----~~~--- 234 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLR----------------HRVLP----PQI--- 234 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHH----------------HhhcC----hhh---
Confidence 99999999999999999999999999999998886421 00000000 00000 000
Q ss_pred hHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 930 WSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 930 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.....+..+++.+|++.+|.+||++.|++++-
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 01123456788899999999999999998753
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=246.13 Aligned_cols=268 Identities=26% Similarity=0.386 Sum_probs=208.3
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccce
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQY 180 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~ 180 (983)
..-..|||++|.++ .+|+.+. .+|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l------p~sL~~ 266 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL------PPGLLE 266 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc------ccccce
Confidence 45667899999988 7888775 47899999999998 57753 578999999999998 56642 368889
Q ss_pred eecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcccc
Q 042568 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260 (983)
Q Consensus 181 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 260 (983)
|++++|.++ .+|. .+.+|+.|++++|+++. +|.. .++|+.|+|++|+|+ .+|. . ..+|+.|++++|
T Consensus 267 L~Ls~N~L~-~Lp~----lp~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~-~Lp~-l---p~~L~~L~Ls~N 332 (788)
T PRK15387 267 LSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLA-SLPA-L---PSELCKLWAYNN 332 (788)
T ss_pred eeccCCchh-hhhh----chhhcCEEECcCCcccc-cccc---ccccceeECCCCccc-cCCC-C---cccccccccccC
Confidence 999999887 4442 24678899999999884 4542 467999999999998 4654 2 246888899999
Q ss_pred ccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccc
Q 042568 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340 (983)
Q Consensus 261 ~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 340 (983)
++..++. + ..+|++|+|++|+|++ +|. .+.+|+.|++++|+|++ +|... .+|+.|+|++
T Consensus 333 ~L~~LP~----------l--p~~Lq~LdLS~N~Ls~-LP~----lp~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~ 391 (788)
T PRK15387 333 QLTSLPT----------L--PSGLQELSVSDNQLAS-LPT----LPSELYKLWAYNNRLTS-LPALP---SGLKELIVSG 391 (788)
T ss_pred ccccccc----------c--ccccceEecCCCccCC-CCC----CCcccceehhhcccccc-Ccccc---cccceEEecC
Confidence 8865331 1 1478999999999985 454 24578899999999984 66543 5799999999
Q ss_pred cccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCc
Q 042568 341 NLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420 (983)
Q Consensus 341 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 420 (983)
|+|++ +|.. .++|+.|++++|.|++ +|.. ..+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++..+
T Consensus 392 N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 392 NRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred CcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence 99984 5543 4689999999999985 5653 346889999999998 689999999999999999999998887
Q ss_pred ccccCC
Q 042568 421 SSLGKC 426 (983)
Q Consensus 421 ~~l~~l 426 (983)
..+..+
T Consensus 463 ~~L~~l 468 (788)
T PRK15387 463 QALREI 468 (788)
T ss_pred HHHHHH
Confidence 766443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=200.58 Aligned_cols=273 Identities=21% Similarity=0.305 Sum_probs=205.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC-CCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH-RNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 742 (983)
..+.|...++||+|+||.+|.|. ..+|+.||||+-..... -.++..|.++++.+++ ..|..+..|..+.+...+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 34678899999999999999999 66899999998654332 3678889999999976 6777888888888999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfgla~ 819 (983)
|+.+ |.||++...-. .+.++..+++-++-|++.-++|+|.++ ++||||||+|+|..- -..+.++|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 9999 67999887644 456899999999999999999999996 999999999999963 3468899999999
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
.+-+..+...++- .......||..|.+--...+...+.+.|.-|+|.++.+.--|..||........
T Consensus 163 ky~d~~t~~HIpy------re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk------- 229 (341)
T KOG1163|consen 163 KYRDIRTRQHIPY------REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK------- 229 (341)
T ss_pred hhccccccccCcc------ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-------
Confidence 9877655443331 223346799999999888888889999999999999999999999976532211
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
.+-.++........ ..+......+.|+.-.+.-|-..--++-|+..-+-+.++.+.....+
T Consensus 230 -------~QKyEkI~EkK~s~----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 230 -------KQKYEKISEKKMST----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred -------HHHHHHHHHhhcCC----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 01111111111110 00111122345666667778887888889888887777766544433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=202.98 Aligned_cols=269 Identities=17% Similarity=0.270 Sum_probs=201.7
Q ss_pred CCCCCCCccccCCcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 744 (983)
-.|.+.++||+|.||+.+.|+ +-+++.||||.-..... ..++..|.+.++.+. .++|..+|-|.....+..+|+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 468899999999999999999 56899999998654432 478889999999984 6899999988888888899999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-----CCEEEccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-----LTALVADFGIAK 819 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-----~~~kl~Dfgla~ 819 (983)
.+ |.||+|+..-. .++++..++..||.|+..-++|+|++. .|.|||||+|+||... ..+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99 67998887644 567999999999999999999999995 9999999999999643 358899999999
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
.+.+..+...++ ........||.+||+--...|.+.+++.|.-|+|-++++.+-|..||...-.+..
T Consensus 178 ~YrDp~TkqHIP------YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn------- 244 (449)
T KOG1165|consen 178 EYRDPKTKQHIP------YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN------- 244 (449)
T ss_pred hhcCccccccCc------cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-------
Confidence 998776654433 1334456799999999999999999999999999999999999999976533211
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.....++.+.+............+.++..-+.-.=..+-.+-|+.+-+...+.++.+..
T Consensus 245 -----------K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 245 -----------KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred -----------HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 11111111111111111111222334444444444556677788877776666655443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=240.85 Aligned_cols=318 Identities=23% Similarity=0.337 Sum_probs=157.0
Q ss_pred CCCCccccHHhHHHHHHHHHhccCCCccccCC----CCCCCCCCcceee----------------EEECCCCCeEEEEEc
Q 042568 25 DNADDDQIIRDRASLVTFMSSIISAPEHALES----WNSTDVHVCNWSG----------------VKCNNSRNKVVELDL 84 (983)
Q Consensus 25 ~~~~~~~~~~~~~~ll~~k~~~~~~~~~~l~s----w~~~~~~~c~w~g----------------v~c~~~~~~v~~l~l 84 (983)
|+.+.+..++|.+.++...+.+. -| +.+.+ |.+ +.++|.=.. |.|.. +.|+.+..
T Consensus 54 ~~~~~~~~~~~~~~~~~~~~~l~-~p-~~~~~~~~~~~~-~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~l~~ 128 (754)
T PRK15370 54 CHPPETASPEEIKSKFECLRMLA-FP-AYADNIQYSRGG-ADQYCILSENSQEILSIVFNTEGYTVEGGG--KSVTYTRV 128 (754)
T ss_pred hCCCCCCCHHHHHHHHHHHHHhc-CC-chhhccccccCC-CCcccccCCcchhhheeeecCCceEEecCC--Cccccccc
Confidence 44566778899999999999995 33 34555 987 467886443 56643 34666654
Q ss_pred ccCCcccccc--c--------------------------cc-----ccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEe
Q 042568 85 SARSIYGTIS--P--------------------------AL-----ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLS 131 (983)
Q Consensus 85 ~~~~l~g~~~--~--------------------------~l-----~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (983)
-+........ . ++ +-..+...|+|+++.++ .+|..+. ++|+.|+
T Consensus 129 ~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~ 205 (754)
T PRK15370 129 TESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLI 205 (754)
T ss_pred ccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEE
Confidence 4321111000 0 00 11123445555555555 3444432 3455555
Q ss_pred ccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccC
Q 042568 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211 (983)
Q Consensus 132 Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N 211 (983)
|++|+|+ .+|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|++|+++ .+
T Consensus 206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~-----~~L~~L~Ls~N~L~-~L------------------- 256 (754)
T PRK15370 206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP-----DTIQEMELSINRIT-EL------------------- 256 (754)
T ss_pred ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh-----ccccEEECcCCccC-cC-------------------
Confidence 5555555 4444333 35555555555554 3443322 24445555555444 33
Q ss_pred ccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccC
Q 042568 212 RLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291 (983)
Q Consensus 212 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 291 (983)
|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+++.++. .+. ++|+.|++++
T Consensus 257 ------P~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~LP~---------~lp--~sL~~L~Ls~ 313 (754)
T PRK15370 257 ------PERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRTLPA---------HLP--SGITHLNVQS 313 (754)
T ss_pred ------ChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccccCcc---------cch--hhHHHHHhcC
Confidence 33332 24455555555554 3443321 245555555554433211 111 2455555555
Q ss_pred CcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCC
Q 042568 292 NNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371 (983)
Q Consensus 292 n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 371 (983)
|+++. +|..+ +++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+ .++|+.|+|++|.|+. +
T Consensus 314 N~Lt~-LP~~l---~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-L 382 (754)
T PRK15370 314 NSLTA-LPETL---PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-L 382 (754)
T ss_pred Ccccc-CCccc---cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-C
Confidence 55553 33222 2345556666665553 444332 45666666666665 344433 2456666666666653 3
Q ss_pred CCCCCCCCCCcEEEccCccccCcCcccc----cCcccchhhcccCccCC
Q 042568 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSF----ANLSQLRRLLLYGNHLS 416 (983)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~l~~N~l~ 416 (983)
|..+. ..|+.|++++|+++ .+|..+ ..++++..|++.+|.++
T Consensus 383 P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 383 PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 33332 24666666666665 333332 23355566666666665
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-24 Score=221.92 Aligned_cols=420 Identities=22% Similarity=0.200 Sum_probs=260.2
Q ss_pred eEEECCC---------CCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccC-ccCC
Q 042568 69 GVKCNNS---------RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSW-NSLQ 138 (983)
Q Consensus 69 gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-n~l~ 138 (983)
-|.|+.. ....|+++|..|+|+...+.+|+.+++|+.||||+|+|+.+-|+.|..+.+|.+|-+.+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 3788764 23589999999999977778999999999999999999988899999999998888766 9999
Q ss_pred CCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccc
Q 042568 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP 218 (983)
Q Consensus 139 ~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p 218 (983)
..--..|++|..|+.|.+.-|++. -++...+ ..+++|..|.+-+|.+. .|+...|..+..++.+.+..|.+..
T Consensus 130 ~l~k~~F~gL~slqrLllNan~i~-Cir~~al--~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic--- 202 (498)
T KOG4237|consen 130 DLPKGAFGGLSSLQRLLLNANHIN-CIRQDAL--RDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC--- 202 (498)
T ss_pred hhhhhHhhhHHHHHHHhcChhhhc-chhHHHH--HHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc---
Confidence 666678999999999999999997 4444333 35666666666666665 4555555566666666666665220
Q ss_pred hhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccC
Q 042568 219 QALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMI 298 (983)
Q Consensus 219 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 298 (983)
..+++.|.. ++..|.+ .++...-..-..|.++++..++.... ...+.++..--.+.+...+..
T Consensus 203 --dCnL~wla~-~~a~~~i-------etsgarc~~p~rl~~~Ri~q~~a~kf-------~c~~esl~s~~~~~d~~d~~c 265 (498)
T KOG4237|consen 203 --DCNLPWLAD-DLAMNPI-------ETSGARCVSPYRLYYKRINQEDARKF-------LCSLESLPSRLSSEDFPDSIC 265 (498)
T ss_pred --ccccchhhh-HHhhchh-------hcccceecchHHHHHHHhcccchhhh-------hhhHHhHHHhhccccCcCCcC
Confidence 111111111 0111111 01222223333333333332221110 011112222222333333344
Q ss_pred CccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCC
Q 042568 299 PSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI 378 (983)
Q Consensus 299 p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 378 (983)
|..-+.-.++|++|+|++|+|++.-+.+|..+..+++|.|..|+|...-...|.+++.|+.|+|.+|+|+..-|.+|..+
T Consensus 266 P~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~ 345 (498)
T KOG4237|consen 266 PAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTL 345 (498)
T ss_pred hHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccccc
Confidence 44333323578888888888887778888888888888888888876656667888888888888888888888888888
Q ss_pred CCCcEEEccCccccC-----cCccc-----------ccCcccchhhcccCccCCC---CCcccccCCCCCCEEEccCccc
Q 042568 379 PHLGLLDLSKNKLSG-----SIPDS-----------FANLSQLRRLLLYGNHLSG---TIPSSLGKCVNLEILDLSHNKI 439 (983)
Q Consensus 379 ~~L~~L~Ls~N~l~~-----~~~~~-----------~~~l~~L~~L~l~~N~l~~---~~p~~l~~l~~L~~L~Ls~N~l 439 (983)
..|.+|+|-.|.+.= .+.++ -+.-..++.+.++.+.+.. ..|++.+..+
T Consensus 346 ~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------ 413 (498)
T KOG4237|consen 346 FSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLT------------ 413 (498)
T ss_pred ceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCC------------
Confidence 888888888887641 00011 1122345556665555431 1222221110
Q ss_pred cCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCccccccccc
Q 042568 440 SGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519 (983)
Q Consensus 440 ~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 519 (983)
++.-|.. .+-+..-..-|++.++ .+|..+. ....+|++.+|.++ .+|.+ .+++| .+++|+|+++..-...
T Consensus 414 s~~cP~~---c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~t 483 (498)
T KOG4237|consen 414 SSPCPPP---CTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYT 483 (498)
T ss_pred CCCCCCC---cchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhccc
Confidence 1111221 2222211344444444 3443332 13456778888887 77776 56677 8888888888766777
Q ss_pred ccCCCCccEEecCCc
Q 042568 520 VGQLPYLKQFDVSSN 534 (983)
Q Consensus 520 ~~~l~~L~~L~ls~N 534 (983)
|.++.+|.+|-||+|
T Consensus 484 f~n~tql~tlilsyn 498 (498)
T KOG4237|consen 484 FSNMTQLSTLILSYN 498 (498)
T ss_pred ccchhhhheeEEecC
Confidence 888888888888876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=220.13 Aligned_cols=176 Identities=20% Similarity=0.168 Sum_probs=132.4
Q ss_pred HHHHhCCCCCCCccccCCcEeEEEEEEC--CCcEEEEEEeeccc----CcchhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 662 LIEATGGFCPSSLIGSGRFGHVYKGVLQ--DNTRIAVKVLDLTT----TGEITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 662 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
.....++|...+.||+|+||+||+|.+. +++.||||++.... .......|.+|++++++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3445678999999999999999999864 57778999875321 122356799999999999999998533322
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC-CCCCeEeCCCCCEEEcc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL-KPSNILLDEDLTALVAD 814 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di-kp~NiLl~~~~~~kl~D 814 (983)
+..++||||++|++|... .. . . ...++.|+++||+|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~~----~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-RP----H---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-Cc----c---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 457999999999999632 11 0 1 1467889999999999996 999999 99999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK 859 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 859 (983)
||+|+.+.......... .........+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~-----~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIA-----AYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhh-----hhhhhhhhhccCccCCcccCChh
Confidence 99999876432211100 00111246789999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=213.59 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCCCCCccccCCcEeEEEEEECCC--cEEEEEEeecccCcchhHHHHHHHHHHHhcCC----CCccceeeEE-ecCCcee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDN--TRIAVKVLDLTTTGEITGSFKRECQILKRIRH----RNLIRIITIC-SKPDFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 740 (983)
+|.+.+.||+|+||.||+|..... ..+|+|........... .+..|+.++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997653 47899987655433222 78899999999973 6899999999 5778899
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-----CCEEEccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-----LTALVADF 815 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-----~~~kl~Df 815 (983)
+||+.+ |.+|.+...... ...++..++.+|+.|++.+|.++|+.| ++||||||+|+++... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999988 679998775443 467999999999999999999999997 9999999999999855 46899999
Q ss_pred ccccccc--CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 816 GIAKLVK--GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 816 gla~~~~--~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
|+|+... ......... .........||..|.++....+...+++.|+||++.++.|+..|..||........
T Consensus 172 Glar~~~~~~~~~~~~~~-----~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRP-----PRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred CCCccccccCCCCccccc-----CCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 9998332 221110000 00111335699999999999999999999999999999999999999854321111
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
...... ......... .....+.++.++...+-..+..++|....+...++......
T Consensus 246 ~~~~~~------------~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 KSKFEK------------DPRKLLTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHH------------Hhhhhcccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 001000 000000000 00113345666666677789999999999999988776553
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=229.54 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=167.8
Q ss_pred ccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcc
Q 042568 149 HQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228 (983)
Q Consensus 149 ~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 228 (983)
.+...|+++++.++ .+|..+. ++|+.|+|++|.++ .+|... .++|++|++++|+++ .+|..+. .+|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip-----~~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~ 244 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP-----EQITTLILDNNELK-SLPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQ 244 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc-----cCCcEEEecCCCCC-cCChhh---ccCCCEEECCCCccc-cCChhhh--cccc
Confidence 34667777777776 5665442 46777777777777 455443 257888999999888 4566554 4799
Q ss_pred eecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccC
Q 042568 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTN 308 (983)
Q Consensus 229 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~ 308 (983)
.|+|++|+++ .+|..+. ++|+.|+|++|++..++ ..+. .+|+.|++++|++++ +|..+ +.+
T Consensus 245 ~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~LP---------~~l~--~sL~~L~Ls~N~Lt~-LP~~l---p~s 305 (754)
T PRK15370 245 EMELSINRIT-ELPERLP---SALQSLDLFHNKISCLP---------ENLP--EELRYLSVYDNSIRT-LPAHL---PSG 305 (754)
T ss_pred EEECcCCccC-cCChhHh---CCCCEEECcCCccCccc---------cccC--CCCcEEECCCCcccc-Ccccc---hhh
Confidence 9999999998 8887654 47899999999886533 2222 478888888888874 45433 346
Q ss_pred eeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC
Q 042568 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 309 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (983)
|+.|++++|.++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++
T Consensus 306 L~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~ 376 (754)
T PRK15370 306 ITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSR 376 (754)
T ss_pred HHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCC
Confidence 7888888888873 554442 578888888888874 565543 57888888888777 4555442 5677788888
Q ss_pred ccccCcCcccccCcccchhhcccCccCCCCCccccc----CCCCCCEEEccCcccc
Q 042568 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLG----KCVNLEILDLSHNKIS 440 (983)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~----~l~~L~~L~Ls~N~l~ 440 (983)
|+|+ .+|..+. ..|+.|++++|+|+ .+|..+. .++++..|++.+|.++
T Consensus 377 N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 377 NALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 8777 3454443 35777777777776 4454332 3355666666666655
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-22 Score=195.24 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=184.8
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
..+|.+...|+.|+|+++ |..+++|+++.... ....+.|..|.-.++-+.||||..+++.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888999999999998 67777887754432 2345789999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEe-ecCCCCCeEeCCCCCEEEccccccccccCCccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH-CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVN 829 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH-~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~ 829 (983)
|...++... .--.+..++.+++.++|+|++|||+.- +++- --+.+..|++|++.+++|+ .+-+++.-+
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfq------ 342 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ------ 342 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeee------
Confidence 999998754 445778899999999999999999976 3443 4588999999999988874 222222111
Q ss_pred ccCCCCccccccCccccccccccccccCCCCC---CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 830 CANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA---STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 830 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
... ..-.+.||+||.++..+. -+.+|+|||++++||+.|...||....+-.-.+.-
T Consensus 343 ---------e~g--r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------- 401 (448)
T KOG0195|consen 343 ---------EVG--RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------- 401 (448)
T ss_pred ---------ccc--cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------
Confidence 110 123578999999887653 35689999999999999999999754321111000
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.+.+... ..| +.....+.+++.-|+..||.+||.+..++-.|+++.
T Consensus 402 ------aleglrv-~ip-------pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ------ALEGLRV-HIP-------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ------hhccccc-cCC-------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0111111 011 224455666666799999999999999999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=229.60 Aligned_cols=257 Identities=22% Similarity=0.266 Sum_probs=189.9
Q ss_pred CCCccccCCcEeEEEEEEC-CCcEEEEEEee-----cccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 671 PSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLD-----LTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~-----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
...++|.|++|.|+.+... .....+.|.+. ..........+..|+.+-..++|+|++..+..+.+.+...-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999988877743 34444444432 11111222336678888888999999888877766666666699
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++ +|...+... ..+...++..++.|+..|+.|+|..| |.|||+|++|++++.++.+||+|||.+....-.
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 998888743 25778889999999999999999997 999999999999999999999999999866432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCcc-chhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.+.. .......+|+..|+|||...+..|.++ .||||.|++++.|++|+.||......+....+
T Consensus 474 ~e~~---------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------- 537 (601)
T KOG0590|consen 474 WEKN---------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------- 537 (601)
T ss_pred cchh---------hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------
Confidence 2110 022334689999999999999998765 69999999999999999999754333222100
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..............+.+.+.+.+-..++.+|++.+|.+|.|+++|++.
T Consensus 538 ----------~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 538 ----------NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ----------hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 001111111222344567788889999999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=222.87 Aligned_cols=256 Identities=21% Similarity=0.192 Sum_probs=187.0
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHH--HhcCCCCccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQIL--KRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.|...+.+|++.|=+|.+|++++|. |+||++-+....-..+.|.++++-. .-++|||++++.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998777 9999996655444455555544443 445899999998887777788999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
..+ +|.|++.. ++-+...+.+-|+.|++.|+.-+|..+ |+|||||.+|||++.-..+.|+||..-+...-.+
T Consensus 103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 975 88888874 455777888899999999999999996 9999999999999999999999998876433222
Q ss_pred ccccccCCCCccccccCccccccccccccccCCC----------C-CCccchhHHHHHHHHHHHh-CCCCCCcccCCCCc
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK----------R-ASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSS 893 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~ 893 (983)
++ +.+|.....+...-.+|.|||.+... . .+++.||||+||++.|+++ |++||+-. .
T Consensus 175 DN------Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----Q 243 (1431)
T KOG1240|consen 175 DN------PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----Q 243 (1431)
T ss_pred CC------cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----H
Confidence 21 12233333344455689999976431 2 5788999999999999999 67777521 1
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
+..+.... ....+..+.++.+ ..+..++..|++.||++|.++++.++.-+
T Consensus 244 L~aYr~~~-----~~~~e~~Le~Ied---------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 LLAYRSGN-----ADDPEQLLEKIED---------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHhHhccC-----ccCHHHHHHhCcC---------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111110 1111222222222 25788899999999999999999998744
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-19 Score=200.47 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=197.2
Q ss_pred CCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcc--hhHHHHHHHHHHHhcCCC-CccceeeEEecCCceeEEEec
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE--ITGSFKRECQILKRIRHR-NLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 745 (983)
|...+.||.|+||.||++... ..+|+|.+....... ....+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999977 789999987665544 477899999999999988 799999999777778999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~~~~ 824 (983)
+.++++.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999665532211 36888999999999999999999996 99999999999999988 7999999999855433
Q ss_pred cccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCC--CCchHHHHH
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD--GSSLHEWVK 899 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~--~~~l~~~~~ 899 (983)
....... .......||..|+|||...+ ..+....|+||+|++++++++|..||...... .......+.
T Consensus 156 ~~~~~~~-------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 156 GSTSSIP-------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred Ccccccc-------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 2110000 12344689999999999988 57889999999999999999999996532211 011111111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... +.................+.+++..|+..+|..|.++.+....
T Consensus 229 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPT---------------PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCC---------------cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1000 0000000000001223568888999999999999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=183.53 Aligned_cols=141 Identities=17% Similarity=0.158 Sum_probs=109.4
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcc-h-------hH-----------------HHHHHHHHHHhcCCCCc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE-I-------TG-----------------SFKRECQILKRIRHRNL 726 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-~-------~~-----------------~~~~E~~~l~~l~h~ni 726 (983)
...||+|+||.||+|...+|+.||||+++...... . .. ...+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999986542110 0 11 22349999999988887
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEeecCCCCCeEeC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL-HHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dikp~NiLl~ 805 (983)
.....+.. ...++||||++++++...... ...+++..+..++.|++.+|.|+ |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 54444332 234899999998776544322 23588899999999999999999 6775 99999999999998
Q ss_pred CCCCEEEcccccccccc
Q 042568 806 EDLTALVADFGIAKLVK 822 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~ 822 (983)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=179.26 Aligned_cols=198 Identities=15% Similarity=0.047 Sum_probs=140.2
Q ss_pred CCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc---chhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEec
Q 042568 670 CPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG---EITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+...|++|+||+||.+.. .+.+++.+.++....- -....+.+|++++++++ |+++.+++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 5788888877554431 12236889999999995 5889999886 346999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC-CCCCeEeCCCCCEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL-KPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di-kp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
++|.+|.+.... ....++.|+++++.++|+.| |+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999888654321 11357889999999999997 999999 799999999999999999999865432
Q ss_pred cccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
..........+...........++.|++|+...- ..--.+.+.++-|.-+|.++|++.|...
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2100000000000000111235777888874332 2223567999999999999999998643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=183.04 Aligned_cols=173 Identities=11% Similarity=0.114 Sum_probs=133.3
Q ss_pred HhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcc--hhHH------HHHHHHHHHhcCCCCccceeeEEecC
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE--ITGS------FKRECQILKRIRHRNLIRIITICSKP 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 736 (983)
..++|...+++|.|+||.||.+.. ++..+|||.+....... .... +.+|++.+.+++||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999766 57789999996443221 2222 68999999999999999999886533
Q ss_pred --------CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 737 --------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 737 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
...++||||++|.+|.++.. ++. ....++++++..+|..+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 35789999999999977632 222 24569999999999996 99999999999999988
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
++++|||.......... ...+.....+..++|+||||+++.....
T Consensus 173 -i~liDfg~~~~~~e~~a-------------------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA-------------------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhh-------------------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99999998865431110 0113444456678999999999876653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-21 Score=175.77 Aligned_cols=163 Identities=31% Similarity=0.569 Sum_probs=98.2
Q ss_pred cCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEE
Q 042568 353 LMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEIL 432 (983)
Q Consensus 353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 432 (983)
.+++++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|++|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3445555555555555 44555666666666666666666 56666777777777777777776 677777777777777
Q ss_pred EccCccccC-cCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCc
Q 042568 433 DLSHNKISG-IIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNS 511 (983)
Q Consensus 433 ~Ls~N~l~~-~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 511 (983)
||++|++.. .+|..|..+..|+. |+|+.|.+. .+|+.++.+++|+.|.+..|.
T Consensus 108 dltynnl~e~~lpgnff~m~tlra-lyl~dndfe-------------------------~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRA-LYLGDNDFE-------------------------ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hccccccccccCCcchhHHHHHHH-HHhcCCCcc-------------------------cCChhhhhhcceeEEeeccCc
Confidence 777777752 34555555555553 555555544 455555555555555555555
Q ss_pred ccccccccccCCCCccEEecCCccccCCcCccccC
Q 042568 512 LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQA 546 (983)
Q Consensus 512 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 546 (983)
+- .+|.+++.+..|+.|++.+|+++ .+|.++++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 54 45555555555555555555555 45554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=176.05 Aligned_cols=141 Identities=22% Similarity=0.240 Sum_probs=111.7
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcc-------------------------hhHHHHHHHHHHHhcCCCCc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE-------------------------ITGSFKRECQILKRIRHRNL 726 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-------------------------~~~~~~~E~~~l~~l~h~ni 726 (983)
...||+|++|.||+|...+|+.||||++....... ....+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999986542110 01234678999999999988
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~ 805 (983)
.....+... ..++||||++++++...... ...++...+..++.|++.++.++|+ .| |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 655554433 24899999998865443221 2346788899999999999999999 75 99999999999999
Q ss_pred CCCCEEEcccccccccc
Q 042568 806 EDLTALVADFGIAKLVK 822 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~ 822 (983)
++.++|+|||+|+...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8999999999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-19 Score=184.35 Aligned_cols=232 Identities=22% Similarity=0.264 Sum_probs=147.2
Q ss_pred CCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcC----------CCCccceeeEEecC-
Q 042568 671 PSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIR----------HRNLIRIITICSKP- 736 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~~~- 736 (983)
..+.||.|+++.||.+.+. +++.+|||++..... ....+++++|.-....+. |-.++..++....+
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4578999999999999976 589999999855542 224567777776555532 22333333333211
Q ss_pred -----------C-----ceeEEEecccCccccccccc---ccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC
Q 042568 737 -----------D-----FKALVLPLMSNGSLENHLYP---SHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL 797 (983)
Q Consensus 737 -----------~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di 797 (983)
. ..+++|+-+. ++|.+.+.. .......+....+..+..|+.+.+++||..| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 1 2256777774 577666432 2111223445566788899999999999997 999999
Q ss_pred CCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC--------CCCCccchhHH
Q 042568 798 KPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--------KRASTHGDVYS 869 (983)
Q Consensus 798 kp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S 869 (983)
||+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----------------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----------------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----------------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----------------cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 999999999999999999988765421110 134577899997543 25788999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCC
Q 042568 870 FGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949 (983)
Q Consensus 870 lG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 949 (983)
+|+++|.|++|+.||+.......... .+..+. +.+..+.+|+..+++++|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~-----------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~ 285 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW-----------------------------DFSRCR-DMPEPVQFLIRGLLQRNP 285 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG-----------------------------GGTTSS----HHHHHHHHHHT-SSG
T ss_pred HHHHHHHHHHccCCCCCCCccccccc-----------------------------cchhcC-CcCHHHHHHHHHHccCCc
Confidence 99999999999999975422111100 111222 577889999999999999
Q ss_pred CCC
Q 042568 950 STR 952 (983)
Q Consensus 950 ~~R 952 (983)
++|
T Consensus 286 ~~R 288 (288)
T PF14531_consen 286 EDR 288 (288)
T ss_dssp GGS
T ss_pred ccC
Confidence 988
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-20 Score=169.72 Aligned_cols=180 Identities=28% Similarity=0.482 Sum_probs=134.6
Q ss_pred CcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccc
Q 042568 401 NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480 (983)
Q Consensus 401 ~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~ 480 (983)
++..++.|-|++|+++ .+|..+..+.+|+.|++++|+++ .+|..+++++.|+. |+++-|++. ..|..|+.++.|+.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~-lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRI-LNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhh-eecchhhhh-cCccccCCCchhhh
Confidence 3445555555555555 45555555555555555555555 45555555555554 666656555 56666777777777
Q ss_pred ccccccccc-cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCc
Q 042568 481 IDLSFNNLS-GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNK 559 (983)
Q Consensus 481 L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~ 559 (983)
|||++|+++ ..+|..|..+..|+.|+|++|.++ .+|..++++++|+.|.+.+|.+. ++|.+++.++.|+.|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 777777775 367889999999999999999999 89999999999999999999998 899999999999999999999
Q ss_pred cccccCCCCCCcc---cccccccCCcCccC
Q 042568 560 FSGNISNKGAFSS---LTIASFQGNDGLCG 586 (983)
Q Consensus 560 l~~~~~~~~~~~~---~~~~~~~~N~~lc~ 586 (983)
++-.+|+.+.+.- -.....+.|||.-.
T Consensus 185 l~vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 185 LTVLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred eeecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 9999998765533 33445788988653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-20 Score=204.21 Aligned_cols=212 Identities=27% Similarity=0.248 Sum_probs=127.4
Q ss_pred EEEcccCCcc-cccccccccCCCCcEEeCcCCcCCCC----CccccCCCCCCCEEeccCccCC------CCchhhhcccc
Q 042568 81 ELDLSARSIY-GTISPALANLSSLIVLDLSKNFFQGH----IPAELGSLIRLKQLSLSWNSLQ------GKIPSQLGSLH 149 (983)
Q Consensus 81 ~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~------~~~p~~~~~L~ 149 (983)
.|+|..+.+. +.....+..+++|++|++++|.+++. +++.+...++|++|+++++.+. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 33445566677788888888877542 5556667777888888887776 23445667777
Q ss_pred cccEEeccCcccccccCCcccccCCCcccceeecccccccCCCC---Ccccccc-cccceeecccCccccc----cchhh
Q 042568 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP---LKNECEL-RNLRFLLLWSNRLVGQ----VPQAL 221 (983)
Q Consensus 150 ~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip---~~~~~~l-~~L~~L~L~~N~l~~~----~p~~l 221 (983)
+|++|++++|.+.+..+..+..+...++|++|++++|.+++... ...+..+ ++|++|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 88888888887765444333211111447777777777663111 0122334 6777777777777632 33455
Q ss_pred hccCCcceecccccccccccchh---hhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccc
Q 042568 222 ANSSKLEWLDLESNMFSGELPSE---IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296 (983)
Q Consensus 222 ~~l~~L~~L~Ls~N~l~~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~ 296 (983)
..+.+|++|++++|.+++..... .+..+++|++|+|++|.+... ....+...+..+++|++|++++|.+++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~----~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE----GASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChH----HHHHHHHHhcccCCCCEEecCCCcCch
Confidence 56667777777777776421111 123445777777777766431 122333445556677777777776664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-18 Score=188.11 Aligned_cols=219 Identities=26% Similarity=0.382 Sum_probs=163.4
Q ss_pred HHhcCCCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC
Q 042568 718 LKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL 797 (983)
Q Consensus 718 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di 797 (983)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+... ...++|.....+.+++++||+|+|... + ..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeee
Confidence 35688999999999999999999999999999999999863 457999999999999999999999874 2 289999
Q ss_pred CCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCC-------CCccchhHHH
Q 042568 798 KPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-------ASTHGDVYSF 870 (983)
Q Consensus 798 kp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~Dv~Sl 870 (983)
++.|.++|..+.+|++|||+.......... .......-..-|.|||.+.+.. .+.+.|||||
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-----------~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEP-----------EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccc-----------cccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 999999999999999999998876431000 0111123446799999987631 4677999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhh-cCCCCCccccccchHHHHHHHHHHHhhhcCCCC
Q 042568 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAK-YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949 (983)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 949 (983)
|++++|+++.+.||+........ .+++.+ +.. ......|.... ..+...++..++.+||..+|
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~-------------~eii~~-~~~~~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDP-------------DEIILR-VKKGGSNPFRPSIEL--LNELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHHHHHHHhccCccccccccCCh-------------HHHHHH-HHhcCCCCcCcchhh--hhhcchHHHHHHHHhcccCh
Confidence 99999999999999753222111 112222 111 11111111111 01344579999999999999
Q ss_pred CCCCCHHHHHHHHHHhHhh
Q 042568 950 STRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 950 ~~RPs~~evl~~L~~~~~~ 968 (983)
++||+++++-..++.+...
T Consensus 209 ~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 209 EKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred hhCccHHHHHhhhhhhccc
Confidence 9999999999888776554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.8e-18 Score=201.54 Aligned_cols=197 Identities=21% Similarity=0.279 Sum_probs=158.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC---CCCccceeeEEecCCceeE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR---HRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 741 (983)
....|.+.+.||+|+||+||+|...+|+.||+|+-+.+..-+ |.-=.+++.+|+ -+.|..+..++...+.-++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 345688889999999999999998889999999876554332 222233444444 3455566666677788899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-------CCCCEEEcc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-------EDLTALVAD 814 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-------~~~~~kl~D 814 (983)
|+||.+.|+|.+++.. .+.++|..++.++.|+++.+++||..+ |||+||||+|+||. ....++|+|
T Consensus 772 v~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999983 566999999999999999999999996 99999999999994 234689999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
||.+-.+..-. ++ ......++|-++-.+|+..|+.++.++|-|.++-+++-|+.|++-
T Consensus 845 fG~siDm~lfp-------~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFP-------DG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcC-------CC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99997664322 11 223345789999999999999999999999999999999999863
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-20 Score=206.07 Aligned_cols=208 Identities=25% Similarity=0.330 Sum_probs=97.3
Q ss_pred ccCCCCcEEEeeCCcccCCCCCCCCCCCC---CcEEEccCccccC----cCcccccCc-ccchhhcccCccCCCC----C
Q 042568 352 CLMSKLERVYLSNNSLSGEIPSAFGDIPH---LGLLDLSKNKLSG----SIPDSFANL-SQLRRLLLYGNHLSGT----I 419 (983)
Q Consensus 352 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~ 419 (983)
..+++|+.|++++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. +
T Consensus 78 ~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~ 157 (319)
T cd00116 78 TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL 157 (319)
T ss_pred HhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence 33444444444444444333333322222 5555555554442 111222333 4445555555554421 1
Q ss_pred cccccCCCCCCEEEccCccccCc----CCccccCCCccceeccccCCCCCCC----CccccccccccccccccccccccC
Q 042568 420 PSSLGKCVNLEILDLSHNKISGI----IPSDVAGLRSLKLYLNLSSNHLDGP----LPLELSKMDMVLAIDLSFNNLSGS 491 (983)
Q Consensus 420 p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ 491 (983)
+..+..+++|+.|++++|.+++. ++..+...++|+. |++++|.+++. ++..+..+++|+.|++++|.+++.
T Consensus 158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~-L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~ 236 (319)
T cd00116 158 AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV-LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA 236 (319)
T ss_pred HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCE-EeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence 22334444555555555555421 1222233334543 55555555432 222334455566666666666542
Q ss_pred CCccccc-----ccccceEEeCCCcccc----cccccccCCCCccEEecCCccccCC----cCccccCC-CCcceEeccC
Q 042568 492 IPPQLGS-----CIALESLNLSGNSLEG----LLPVSVGQLPYLKQFDVSSNRLFGE----IPQSFQAS-PTLKQLNFSF 557 (983)
Q Consensus 492 ~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l-~~L~~l~l~~ 557 (983)
.+..+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. +...+... +.|+.+++.+
T Consensus 237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (319)
T cd00116 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD 316 (319)
T ss_pred HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence 2222221 2567777777776651 2233444556677777777776643 33334444 5666666666
Q ss_pred Ccc
Q 042568 558 NKF 560 (983)
Q Consensus 558 N~l 560 (983)
|++
T Consensus 317 ~~~ 319 (319)
T cd00116 317 DSF 319 (319)
T ss_pred CCC
Confidence 653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=190.62 Aligned_cols=226 Identities=25% Similarity=0.284 Sum_probs=176.1
Q ss_pred ccccCCcEeEEEEE----ECCCcEEEEEEeecccCcc-hhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEeccc
Q 042568 674 LIGSGRFGHVYKGV----LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLMS 747 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~----~~~~~~vAvK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 747 (983)
.+|+|.||.|+.+. .+.|..+|+|+.++..... .......|..++...+ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 2346678999886654321 2235667888899986 9999999999999999999999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCccc
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~ 827 (983)
+|.+...+... ..++......+...+|-|++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-- 151 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh--
Confidence 99998888753 34677778888899999999999997 9999999999999999999999999998654221
Q ss_pred ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
..+||..|||||.+. .....+|.||||++++||+||..||..
T Consensus 152 ---------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------- 193 (612)
T KOG0603|consen 152 ---------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------- 193 (612)
T ss_pred ---------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------------
Confidence 127899999999998 456789999999999999999999853
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 955 (983)
++.. .+...... . ..+....+.+++..+...+|..|.-.
T Consensus 194 ~~~~-~Il~~~~~-~-------p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 DTMK-RILKAELE-M-------PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHH-HHhhhccC-C-------chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1111 11111110 1 12355677788888888888888654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-17 Score=163.78 Aligned_cols=137 Identities=17% Similarity=0.244 Sum_probs=105.1
Q ss_pred CCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-----CCCCccceeeEEecCC---cee-
Q 042568 670 CPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-----RHRNLIRIITICSKPD---FKA- 740 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 740 (983)
...+.||+|+||.||. ++.....+||++...... ..+.+.+|+++++.+ .||||+++++++.+.. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3467899999999996 443333479988654332 357799999999999 5799999999998764 323
Q ss_pred EEEec--ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHH-HHHhccCCCCeEeecCCCCCeEeCC----CCCEEEc
Q 042568 741 LVLPL--MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGV-AYLHHHSPIKVVHCDLKPSNILLDE----DLTALVA 813 (983)
Q Consensus 741 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~Dikp~NiLl~~----~~~~kl~ 813 (983)
+|+|| +.+|+|.+++... .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999642 24444 35678888777 9999996 999999999999974 3479999
Q ss_pred cccccc
Q 042568 814 DFGIAK 819 (983)
Q Consensus 814 Dfgla~ 819 (983)
||+.+.
T Consensus 152 Dg~G~~ 157 (210)
T PRK10345 152 DNIGES 157 (210)
T ss_pred ECCCCc
Confidence 954443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=169.30 Aligned_cols=199 Identities=26% Similarity=0.278 Sum_probs=134.1
Q ss_pred CCCCccceeeEEec---------------------------CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHH
Q 042568 722 RHRNLIRIITICSK---------------------------PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKIC 774 (983)
Q Consensus 722 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 774 (983)
+|||||++.++|.+ +...|+||.-.+. +|.+++... ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 59999999987632 2245788877754 788877643 35566778899
Q ss_pred HHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCC--CEEEccccccccccCCcccccccCCCCccccccCcccccccc
Q 042568 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDL--TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850 (983)
Q Consensus 775 ~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 850 (983)
.|+++|+.|||++| |.|||+|++|||+. +|+ ..+|+|||.+---....-. .++.+..-..-|.-.-
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlq-------lpy~S~~Vd~GGNa~l 417 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQ-------LPYESDEVDLGGNAKL 417 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccc-------cccccccccCCCccee
Confidence 99999999999997 99999999999983 443 4679999987532221100 1111111223477788
Q ss_pred ccccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCcc
Q 042568 851 IAPEYGMGKR------ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPI 924 (983)
Q Consensus 851 ~aPE~~~~~~------~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (983)
||||.....+ .-.|+|.|+.|.+.||++....||....+---+...+-. ..+|.
T Consensus 418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe--------------------~qLPa 477 (598)
T KOG4158|consen 418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE--------------------SQLPA 477 (598)
T ss_pred cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh--------------------hhCCC
Confidence 9999876532 136899999999999999999998642110000111100 11111
Q ss_pred ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 925 YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 925 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
. .+.++..+.+++...++.||++|++..=...
T Consensus 478 l----p~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 478 L----PSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred C----cccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1 1236677899999999999999998764443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=165.02 Aligned_cols=144 Identities=19% Similarity=0.203 Sum_probs=111.8
Q ss_pred CCCCCCccccCCcEeEEEEE--ECCCcEEEEEEeecccCc-----------------------chhHHHHHHHHHHHhcC
Q 042568 668 GFCPSSLIGSGRFGHVYKGV--LQDNTRIAVKVLDLTTTG-----------------------EITGSFKRECQILKRIR 722 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~--~~~~~~vAvK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 722 (983)
.|.+.+.||+|+||.||+|. ..+|+.||||.++..... .....+.+|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999998 568999999998654211 01134678999999997
Q ss_pred CCC--ccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCC
Q 042568 723 HRN--LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPS 800 (983)
Q Consensus 723 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~ 800 (983)
+.. +.+++++ ...++||||++++++...... ........+..++.|++.++++||+.+ +|+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 533 3344443 235899999999888776532 223556667899999999999999985 4999999999
Q ss_pred CeEeCCCCCEEEcccccccccc
Q 042568 801 NILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 801 NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||+++ ++.++++|||.|....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-17 Score=180.79 Aligned_cols=128 Identities=25% Similarity=0.443 Sum_probs=108.0
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..|+.|++|+..+|.+|+..... ....++.....++.|++.|++| ++ .+|||+||.||++..+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 56899999999999999975432 4567888999999999999999 54 89999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
........+. ..........+||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 403 ~ts~~~~~~~-------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETV-------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcc-------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9876644311 111123344689999999999999999999999999999999998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-16 Score=187.71 Aligned_cols=153 Identities=31% Similarity=0.522 Sum_probs=129.4
Q ss_pred cccHHhHHHHHHHHHhccCCCccccCCCCCCCCCC----cceeeEEECC--CC--CeEEEEEcccCCcccccccccccCC
Q 042568 30 DQIIRDRASLVTFMSSIISAPEHALESWNSTDVHV----CNWSGVKCNN--SR--NKVVELDLSARSIYGTISPALANLS 101 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~----c~w~gv~c~~--~~--~~v~~l~l~~~~l~g~~~~~l~~l~ 101 (983)
.+.+.|.+||+++|+++. +|.. .+|.+ + .| |.|.||.|+. .. .+|+.|+|+++++.|.+|+.+++++
T Consensus 368 ~t~~~~~~aL~~~k~~~~-~~~~--~~W~g-~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLG-LPLR--FGWNG-D-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcC-Cccc--CCCCC-C-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 456679999999999995 4432 48975 2 23 2799999953 22 3699999999999999999999999
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
+|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..+++|++|++|+|++|+++|.+|..+.. ...++..+
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~--~~~~~~~l 520 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG--RLLHRASF 520 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh--ccccCceE
Confidence 9999999999999999999999999999999999999999999999999999999999999999987751 23455667
Q ss_pred eccccccc
Q 042568 182 DLSNNSLT 189 (983)
Q Consensus 182 ~Ls~N~l~ 189 (983)
++++|...
T Consensus 521 ~~~~N~~l 528 (623)
T PLN03150 521 NFTDNAGL 528 (623)
T ss_pred EecCCccc
Confidence 77776544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=160.10 Aligned_cols=135 Identities=21% Similarity=0.332 Sum_probs=113.4
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEEeecccCc--c-----hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG--E-----ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.||+|++|.||+|.. .+..|+||+....... + ...++.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5778999986432211 1 124678899999999999998888887777888999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887532 12 78899999999999999996 99999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-16 Score=157.43 Aligned_cols=138 Identities=20% Similarity=0.224 Sum_probs=109.5
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc---------------------chhHHHHHHHHHHHhcCCCC-
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG---------------------EITGSFKRECQILKRIRHRN- 725 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n- 725 (983)
-|...+.||+|+||.||+|...+|+.||||++...... .....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 37778999999999999999888999999987543210 01123677899999998874
Q ss_pred -ccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 726 -LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 726 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
+.+.++. ...++||||+++++|.+.... .....++.++++++.++|+.+ |+||||||+||++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 4444442 345899999999998765431 235678899999999999986 9999999999999
Q ss_pred CCCCCEEEcccccccccc
Q 042568 805 DEDLTALVADFGIAKLVK 822 (983)
Q Consensus 805 ~~~~~~kl~Dfgla~~~~ 822 (983)
++++.++|+|||.+....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-16 Score=158.92 Aligned_cols=132 Identities=23% Similarity=0.344 Sum_probs=107.8
Q ss_pred ccccCCcEeEEEEEECCCcEEEEEEeecccCc--c-----hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG--E-----ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~--~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.||+|+||.||+|.+ ++..|++|........ + ...++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 4788999986432211 1 2356788999999999988766666666677789999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
+|++|.+.+.... ..++.++++++.++|+.+ ++|||++|.||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988765321 078999999999999996 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=180.24 Aligned_cols=142 Identities=25% Similarity=0.303 Sum_probs=113.8
Q ss_pred HHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEe-eccc-Cc-----chhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 663 IEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVL-DLTT-TG-----EITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 663 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~-~~~~-~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
......|...+.||+|+||+||+|.+... .+++|+. .... .. ...+++.+|++++++++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33345566789999999999999987644 3444432 2111 11 123568899999999999999988888877
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
....++||||+++++|.+++. ....++.++++++.|||+.+ ++|||+||+||++ .++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999988764 35678999999999999996 9999999999999 6789999999
Q ss_pred cccccc
Q 042568 816 GIAKLV 821 (983)
Q Consensus 816 gla~~~ 821 (983)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.5e-16 Score=180.53 Aligned_cols=220 Identities=25% Similarity=0.298 Sum_probs=139.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
..+|..++.|-.|+||.||.++++ +.+++|+|+-+ .. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc------hhhhc--cccccCCccee-----------------
Confidence 357888999999999999999976 46778885321 11 00000 11111222222
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+=...+... ..++. +++.+++|+|+.+ |+|||+||+|.+++.-|.+|++|||+.+.-...
T Consensus 136 ----gDc~tllk~~----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKNI----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhcccC----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 2222223221 12222 2378899999997 999999999999999999999999998764221
Q ss_pred ccc--ccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 825 DES--VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 825 ~~~--~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ....-+.....-.....+||+.|+|||++....|+..+|.|++|+|+||.+.|+.||..... .+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----ee------ 265 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EE------ 265 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----HH------
Confidence 100 00000001111122446899999999999999999999999999999999999999864211 11
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 953 (983)
.+...+...... + ..-+....++.+++.+.++.+|..|-
T Consensus 266 ------lfg~visd~i~w--p----E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 266 ------LFGQVISDDIEW--P----EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------HHhhhhhhhccc--c----ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 111111111100 0 00112457888999999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=140.66 Aligned_cols=137 Identities=20% Similarity=0.260 Sum_probs=115.4
Q ss_pred CCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC--CCccceeeEEecCCceeEEEecccC
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH--RNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++...+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35679999999999999864 7899999854432 4678999999999976 5899999988888889999999998
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+.+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+....
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 777554 445677889999999999998643459999999999999999999999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-16 Score=170.38 Aligned_cols=179 Identities=32% Similarity=0.509 Sum_probs=122.1
Q ss_pred CCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceec
Q 042568 378 IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457 (983)
Q Consensus 378 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L 457 (983)
+.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ ..|..++.++ |+. |
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv-l 148 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV-L 148 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee-E
Confidence 333445666666666 56666666667777777777766 66666777777777777777776 5565665554 444 6
Q ss_pred cccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 458 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|.++..| .|..||+|.|+++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 66777776 56666776677777777777776 67777777777777777777777 466666644 3667777777777
Q ss_pred CCcCccccCCCCcceEeccCCccccccCC
Q 042568 538 GEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 538 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
.||..|.+|..|++|-|.+|+|...+..
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 7777777777777777777777655444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.8e-16 Score=180.83 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=194.5
Q ss_pred CCCCCCccccCCcEeEEEEEECC--CcEEEEEEeeccc-CcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD--NTRIAVKVLDLTT-TGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~--~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 743 (983)
.|...+.||+|+|+.|-...... ...+|+|.+.... ......+...|..+-+.+. |+|++.+++....++..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45566779999999998887543 3446777765553 3334455666888888886 999999999999999999999
Q ss_pred ecccCccccccc-ccccCcCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCCeEeecCCCCCeEeCCCC-CEEEcccccccc
Q 042568 744 PLMSNGSLENHL-YPSHGLSHGLDLIQLVKICSDVAEGVAYLH-HHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~ 820 (983)
+|.+++++.+.+ +.. ....+......++.|+..++.|+| ..+ +.|||+||+|.+++..+ ..++.|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999888 432 224566677889999999999999 775 99999999999999999 999999999997
Q ss_pred ccCCcccccccCCCCccccccCcccc-ccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCG-SVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+....... .......| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|.
T Consensus 175 ~~~~~g~~----------~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~ 244 (601)
T KOG0590|consen 175 YRNKNGAE----------RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK 244 (601)
T ss_pred ccccCCcc----------eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence 76521110 22233467 9999999998884 456789999999999999999999876543333222222
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ......|........++...++..+|..|.+.+++...
T Consensus 245 ~~~~---------------------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 245 SNKG---------------------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cccc---------------------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 2210 00112345566778888889999999999999988653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.2e-14 Score=144.53 Aligned_cols=138 Identities=22% Similarity=0.264 Sum_probs=99.5
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcc-hhHH----------------------HHHHHHHHHhcCCCC--c
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE-ITGS----------------------FKRECQILKRIRHRN--L 726 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~n--i 726 (983)
.+.||+|+||.||+|...+++.||||++....... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532211 1111 135666666665443 4
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~ 805 (983)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 23589999999865432211110 011 5678899999999999999 75 99999999999999
Q ss_pred CCCCEEEcccccccccc
Q 042568 806 EDLTALVADFGIAKLVK 822 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~ 822 (983)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 9999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=173.70 Aligned_cols=120 Identities=34% Similarity=0.579 Sum_probs=94.6
Q ss_pred ccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEecc
Q 042568 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556 (983)
Q Consensus 477 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~ 556 (983)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36678888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCccccccCCC--CCCcccccccccCCcCccCCCCCcccccCC
Q 042568 557 FNKFSGNISNK--GAFSSLTIASFQGNDGLCGEIKGLQTCKKE 597 (983)
Q Consensus 557 ~N~l~~~~~~~--~~~~~~~~~~~~~N~~lc~~~~~~~~c~~~ 597 (983)
+|+++|.+|.. ..+.......+.+|+.+|+.+ ....|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~~ 540 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGPH 540 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCccc
Confidence 88888887753 112344567889999999965 35678543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=144.78 Aligned_cols=136 Identities=20% Similarity=0.198 Sum_probs=105.2
Q ss_pred CCccc-cCCcEeEEEEEECCCcEEEEEEeeccc------------CcchhHHHHHHHHHHHhcCCCCc--cceeeEEecC
Q 042568 672 SSLIG-SGRFGHVYKGVLQDNTRIAVKVLDLTT------------TGEITGSFKRECQILKRIRHRNL--IRIITICSKP 736 (983)
Q Consensus 672 ~~~iG-~G~~g~Vy~~~~~~~~~vAvK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 736 (983)
...|| .||.|+||++... +..+|||++.... ......++.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999875 7889999885321 11234678899999999998875 6677764332
Q ss_pred C----ceeEEEecccC-cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 737 D----FKALVLPLMSN-GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 737 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
. ..++|+||+++ .+|.+++.. ..++.. .+.++++++.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 22599999997 688887753 224433 3678999999999997 99999999999999999999
Q ss_pred Ecccccccc
Q 042568 812 VADFGIAKL 820 (983)
Q Consensus 812 l~Dfgla~~ 820 (983)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.4e-15 Score=158.98 Aligned_cols=174 Identities=30% Similarity=0.505 Sum_probs=89.5
Q ss_pred CCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhc
Q 042568 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 330 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+.--...||+.|++. .+|..++.+..|+.+.|..|.+. .+| ..++++..|++|+
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip------------------------~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIP------------------------EAICNLEALTFLD 127 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecc------------------------hhhhhhhHHHHhh
Confidence 333445556666655 55555555555555555555555 444 4444455555555
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
|+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|.. |+.+.|.+. .+|..++++..|+.|.+..|++.
T Consensus 128 ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~-ld~s~nei~-slpsql~~l~slr~l~vrRn~l~ 202 (722)
T KOG0532|consen 128 LSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAH-LDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE 202 (722)
T ss_pred hccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHH-hhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence 5555544 4444444443 555555555554 44444444444443 555555554 44455555555555555555555
Q ss_pred cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
.+|++++. -.|..||+|.|+++ .+|..|.+|..|++|-|.+|.|+
T Consensus 203 -~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 203 -DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred -hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 44444442 23555555555555 45555555555555555555554
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.7e-13 Score=150.85 Aligned_cols=179 Identities=34% Similarity=0.494 Sum_probs=96.9
Q ss_pred CCCcEEEccCccccCcCcccccCcc-cchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceec
Q 042568 379 PHLGLLDLSKNKLSGSIPDSFANLS-QLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457 (983)
Q Consensus 379 ~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L 457 (983)
+.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|+++ .+|.....++.|+. |
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~-L 191 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN-L 191 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh-e
Confidence 44444444444444 3333333332 4555555555554 33344455555555555555554 33333334444443 5
Q ss_pred cccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 458 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
++++|+++ .+|........|++|++++|++. .++..+..+.++..|.+++|++. .++..++.+++++.|++++|+++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 55555555 34444444445666666666433 45555666666666666666665 33556666666777777777666
Q ss_pred CCcCccccCCCCcceEeccCCccccccCC
Q 042568 538 GEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 538 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
.++. +..+.+++.|++++|.++..+|.
T Consensus 269 -~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 -SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -cccc-ccccCccCEEeccCccccccchh
Confidence 4444 66666777777777766655554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-12 Score=146.36 Aligned_cols=143 Identities=19% Similarity=0.252 Sum_probs=101.3
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcch---------------------------------------hHHHH
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEI---------------------------------------TGSFK 712 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~---------------------------------------~~~~~ 712 (983)
.+.||+|++|.||+|++++|+.||||+.+....... .-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999753321100 01245
Q ss_pred HHHHHHHhcC-----CCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 042568 713 RECQILKRIR-----HRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE-GVAYLHH 786 (983)
Q Consensus 713 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~ 786 (983)
+|.+.+.+++ ++++.-..-|.......++||||++|+++.+...... ... .+.+++.++++ .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666666652 3333222222233456799999999999988764321 112 23456666666 4678898
Q ss_pred cCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 787 ~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
.| ++|+|+||.||+++.++.++++|||++..+.+
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 86 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.7e-13 Score=150.85 Aligned_cols=63 Identities=33% Similarity=0.583 Sum_probs=25.8
Q ss_pred cccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 472 LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 472 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
+..+.++..+.+++|++. .++..++.+..|+.|++++|+++. ++. ++.+.+++.|++++|.++
T Consensus 228 ~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 228 LSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred hhhcccccccccCCceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCcccc
Confidence 333333333444444433 223334444444444444444442 222 444444444444444444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-12 Score=130.15 Aligned_cols=208 Identities=18% Similarity=0.240 Sum_probs=142.7
Q ss_pred HHhcCCCCccceeeEEecCC-----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCe
Q 042568 718 LKRIRHRNLIRIITICSKPD-----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792 (983)
Q Consensus 718 l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 792 (983)
+-++-|.|+|++..|+.+.. ...+++|||+.|++.++++.-......+......+|+.||..||.|||+.. ++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 44557999999999986543 457899999999999999876655667888888999999999999999975 579
Q ss_pred EeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHH
Q 042568 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGV 872 (983)
Q Consensus 793 vH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~ 872 (983)
+|+++..+-|++..++-+|+.--.- ......-.. .. ........|-++|.|||+-.....+..+|||+||+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~------~~--~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNS------TR--EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred ccCCcchhheeecCCceEEecccCc-cccchhhhh------hh--HhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 9999999999999999998742111 111000000 00 01122234678999999988888888999999999
Q ss_pred HHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCC
Q 042568 873 LLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952 (983)
Q Consensus 873 il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 952 (983)
...||..+..--.. ..... ...+.+...+...... .-..++..|++..|..|
T Consensus 271 cAlemailEiq~tn---seS~~----------~~ee~ia~~i~~len~---------------lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 271 CALEMAILEIQSTN---SESKV----------EVEENIANVIIGLENG---------------LQRGSITKCLEGEPNGR 322 (458)
T ss_pred HHHHHHHheeccCC---Cccee----------ehhhhhhhheeeccCc---------------cccCcCcccccCCCCCC
Confidence 99999998764211 00000 0011111111111100 11244667999999999
Q ss_pred CCHHHHHHHHH
Q 042568 953 PSMLDVAHEMG 963 (983)
Q Consensus 953 Ps~~evl~~L~ 963 (983)
|+|.+++.|.-
T Consensus 323 p~ar~llfHpl 333 (458)
T KOG1266|consen 323 PDARLLLFHPL 333 (458)
T ss_pred cchhhhhcCce
Confidence 99999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-11 Score=120.36 Aligned_cols=131 Identities=19% Similarity=0.209 Sum_probs=98.5
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCcc-ceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.+.++.|.++.||++... ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356899999999999876 78899998754332 134568899999999765554 444443 234589999999988
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC--CCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS--PIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+.+.- .....++.+++++++.||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76531 011345679999999999985 22369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.8e-11 Score=140.77 Aligned_cols=146 Identities=18% Similarity=0.212 Sum_probs=94.3
Q ss_pred CCCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCc---------------------------------chhH----
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTG---------------------------------EITG---- 709 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~---------------------------------~~~~---- 709 (983)
.|+. +.||+|++|.||+|++++ |+.||||+......+ +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999887 999999998643110 1111
Q ss_pred --HHHHHHHHHHhcC----CCCccceeeEE-ecCCceeEEEecccCccccccc--ccccCcCCCCCHHHHHHHHHHHHHH
Q 042568 710 --SFKRECQILKRIR----HRNLIRIITIC-SKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVAEG 780 (983)
Q Consensus 710 --~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~a 780 (983)
+|.+|+..+.+++ +...+.+-.++ ......++||||++|+.+.+.- .........+....+..++.|+.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 2344554444442 33333333333 2345678999999999997742 21110011222333333444443
Q ss_pred HHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEccccccccccCC
Q 042568 781 VAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADFGIAKLVKGI 824 (983)
Q Consensus 781 L~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Dfgla~~~~~~ 824 (983)
..| ++|+|+||.||+++.++ .+++.|||++..+++.
T Consensus 278 -----~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 -----RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 454 99999999999999888 9999999999887653
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.1e-12 Score=128.42 Aligned_cols=133 Identities=26% Similarity=0.259 Sum_probs=86.2
Q ss_pred CCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceE
Q 042568 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL 505 (983)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 505 (983)
...|+.+|||+|.|+ .+.++..-++.++. |++|+|.|.. + ..+..+.+|+.||||+|.++ .+-.+=..+.+.+.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~-L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRR-LILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeE-Eeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 344555555555555 34444444455554 5555555542 1 22566677777777777776 555555667778888
Q ss_pred EeCCCcccccccccccCCCCccEEecCCccccCCc-CccccCCCCcceEeccCCccccccC
Q 042568 506 NLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI-PQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 506 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
.|++|.+.. -..++.+.+|..||+++|++...- -..++++|-|+.+.|.+|++.+.+.
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 888887763 234667777888888888876221 2468888889999999998887653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-11 Score=137.09 Aligned_cols=252 Identities=23% Similarity=0.213 Sum_probs=179.9
Q ss_pred CCCCCCcccc--CCcEeEEEEEE--C-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhc-CCCCccceeeEEecCCcee
Q 042568 668 GFCPSSLIGS--GRFGHVYKGVL--Q-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRI-RHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~--G~~g~Vy~~~~--~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 740 (983)
.|...+.+|+ |.+|.||.+.. . ++..+|+|.-+....+ ....+-.+|+...+++ .|++.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999987 3 5778999986554432 2334456777777777 4999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHH----HHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE----GVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADF 815 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Df 815 (983)
+-+|++. .++.++.+.. ..-++....+.+..+..+ |+.++|... ++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999996 6777776643 334677788888888888 999999985 9999999999999999 88999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+...+++..-..... ......|...|++||...+ .++..+||||+|.++.+-.++..+...-.. .
T Consensus 268 ~~v~~i~~~~~~~~~~--------~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~--- 333 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFK--------VSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--S--- 333 (524)
T ss_pred ceeEEccCCcccccee--------eeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--C---
Confidence 9998877544221100 0011247788999998776 457889999999999999998876432100 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
.|... +... +-++.+ .....++...+..|++.+|..|++.+.+..
T Consensus 334 ~W~~~--r~~~--ip~e~~----------------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQL--RQGY--IPLEFC----------------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Ccccc--cccc--Cchhhh----------------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11100 0000 000000 012234445788899999999999876653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.1e-12 Score=133.24 Aligned_cols=164 Identities=24% Similarity=0.263 Sum_probs=88.7
Q ss_pred CCCCCCCEEeccCccCCCCch--hhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCccccc
Q 042568 122 GSLIRLKQLSLSWNSLQGKIP--SQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199 (983)
Q Consensus 122 ~~l~~L~~L~Ls~n~l~~~~p--~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~ 199 (983)
+++.+|+...|.+..+. ..+ .....+++++.||||+|-+..-.|. ..-+..+++|+.|+||.|.+...+....-..
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v-~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~ 195 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPV-LKIAEQLPSLENLNLSSNRLSNFISSNTTLL 195 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHH-HHHHHhcccchhcccccccccCCccccchhh
Confidence 46677777777777775 333 3556677777777777776622221 1112466777777777776654333333334
Q ss_pred ccccceeecccCcccc-ccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 200 LRNLRFLLLWSNRLVG-QVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 200 l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
+++|+.|.|+.|.++. .+...+..+++|+.|+|+.|... .+...-...+..|++|+|++|++.+.+. +...
T Consensus 196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li~~~~-------~~~~ 267 (505)
T KOG3207|consen 196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLIDFDQ-------GYKV 267 (505)
T ss_pred hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCccccccc-------cccc
Confidence 6666777777766652 23334455666666666666321 1111112334556666666665544321 1233
Q ss_pred CCCCCccEEEccCCccc
Q 042568 279 ANSSNFQELELAGNNLG 295 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~ 295 (983)
..++.|+.|+++.|.+.
T Consensus 268 ~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 268 GTLPGLNQLNLSSTGIA 284 (505)
T ss_pred ccccchhhhhccccCcc
Confidence 34444444444444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-11 Score=130.33 Aligned_cols=163 Identities=23% Similarity=0.170 Sum_probs=80.9
Q ss_pred cccccceeecccCccccccc-hhhhccCCcceecccccccccccc-hhhhcCCCCccEEEccccccccCCCCCCCccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVP-QALANSSKLEWLDLESNMFSGELP-SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFA 276 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 276 (983)
++.+|+...|.+........ .....+++++.||||+|-|....+ ..+...+|+|+.|+|+.|++........
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~------ 192 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT------ 192 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc------
Confidence 45556666666555542111 355667777777777776653211 2345667777777777777654322110
Q ss_pred ccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCC-CcccccCC
Q 042568 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTI-PHELCLMS 355 (983)
Q Consensus 277 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~ 355 (983)
-..++.|+.|.|+.|+++..--.++....++|+.|+|..|...+.-......++.|++|||++|++-... -...+.++
T Consensus 193 -~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~ 271 (505)
T KOG3207|consen 193 -TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLP 271 (505)
T ss_pred -hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccccccc
Confidence 0134566666666666653211122222234555555555422222223334455566666665554211 02234445
Q ss_pred CCcEEEeeCCccc
Q 042568 356 KLERVYLSNNSLS 368 (983)
Q Consensus 356 ~L~~L~L~~N~l~ 368 (983)
.|+.|+++.+.+.
T Consensus 272 ~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 272 GLNQLNLSSTGIA 284 (505)
T ss_pred chhhhhccccCcc
Confidence 5555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.7e-11 Score=117.29 Aligned_cols=126 Identities=33% Similarity=0.369 Sum_probs=32.7
Q ss_pred cCCCCcEEeCcCCcCCCCCccccC-CCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcc
Q 042568 99 NLSSLIVLDLSKNFFQGHIPAELG-SLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTS 177 (983)
Q Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~ 177 (983)
+...+++|+|++|.|+ .|. .++ .+.+|+.|+||+|.|+ .++ .+..|++|++|++++|+|+ .++..+.
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~------- 84 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLD------- 84 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHH-------
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchH-------
Confidence 3344555666666555 222 343 3555666666666655 332 3555555666666666555 2222111
Q ss_pred cceeecccccccCCCCCcccccccccceeecccCccccc-cchhhhccCCcceecccccccccccc---hhhhcCCCCcc
Q 042568 178 LQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQ-VPQALANSSKLEWLDLESNMFSGELP---SEIISKMPQLQ 253 (983)
Q Consensus 178 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~~l~~L~ 253 (983)
..+++|++|+|++|+|... .-..++.+++|++|+|.+|.++. -+ ..++..+|+|+
T Consensus 85 --------------------~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk 143 (175)
T PF14580_consen 85 --------------------KNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLK 143 (175)
T ss_dssp --------------------HH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-S
T ss_pred --------------------HhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhh
Confidence 1234444444444444321 11334555566666666666552 12 23355667777
Q ss_pred EEEc
Q 042568 254 FLYL 257 (983)
Q Consensus 254 ~L~L 257 (983)
.||-
T Consensus 144 ~LD~ 147 (175)
T PF14580_consen 144 VLDG 147 (175)
T ss_dssp EETT
T ss_pred eeCC
Confidence 6654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.6e-10 Score=109.65 Aligned_cols=138 Identities=19% Similarity=0.222 Sum_probs=99.7
Q ss_pred CCccccCCcEeEEEEEECC-------CcEEEEEEeecccC-----------c----------chhHHHH----HHHHHHH
Q 042568 672 SSLIGSGRFGHVYKGVLQD-------NTRIAVKVLDLTTT-----------G----------EITGSFK----RECQILK 719 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~-------~~~vAvK~~~~~~~-----------~----------~~~~~~~----~E~~~l~ 719 (983)
...||.|.-+.||.|...+ +..+|||+++.... + ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998553 47899998753311 0 0122233 7999999
Q ss_pred hcCC--CCccceeeEEecCCceeEEEecccCccccc-ccccccCcCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEee
Q 042568 720 RIRH--RNLIRIITICSKPDFKALVLPLMSNGSLEN-HLYPSHGLSHGLDLIQLVKICSDVAEGVAYL-HHHSPIKVVHC 795 (983)
Q Consensus 720 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~ 795 (983)
++.. -++.+++++ ...++||||+.++.+.. .+. ...++......+..+++.++..+ |..+ +||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9854 456666664 45699999998654422 122 12244556678889999999999 7775 9999
Q ss_pred cCCCCCeEeCCCCCEEEcccccccccc
Q 042568 796 DLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 796 Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|+++.||+++ ++.+.++|||.|....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.7e-11 Score=123.19 Aligned_cols=208 Identities=26% Similarity=0.302 Sum_probs=141.6
Q ss_pred CCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc-CccccCcCcccccC
Q 042568 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS-KNKLSGSIPDSFAN 401 (983)
Q Consensus 323 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~ 401 (983)
+|-.+.-+++|..+.+|++.-. .+.+....-+.|+.+...+..++.. | .+-....+..+.-+ ..-..|..-.....
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~-~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDV-P-SLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccccc-c-cccchhhhcCccCCCCCccCCceEEecch
Confidence 3444555667777777776543 2222223345677777766655521 1 11111111111111 11223444444556
Q ss_pred cccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccc
Q 042568 402 LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAI 481 (983)
Q Consensus 402 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L 481 (983)
+..|+.++|++|.|+ .+.++..-+|.++.|++|+|.+.. +. .+..+.+|+. ||||+|.++ .+-.|-..+.+++.|
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~-LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQL-LDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-eh-hhhhcccceE-eecccchhH-hhhhhHhhhcCEeee
Confidence 778899999999988 677778888899999999999873 33 3778888886 999999988 566677788899999
Q ss_pred cccccccccCCCcccccccccceEEeCCCccccc-ccccccCCCCccEEecCCccccCCc
Q 042568 482 DLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGL-LPVSVGQLPYLKQFDVSSNRLFGEI 540 (983)
Q Consensus 482 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~ 540 (983)
.|++|.|.. + ..++.+.+|..||+++|+|... --..++++|-|+.+.|.+|.+.+..
T Consensus 358 ~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 358 KLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred ehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999998862 2 3577888999999999999853 2357899999999999999998543
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.9e-12 Score=132.30 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=129.6
Q ss_pred ccccceeecccCcccc----ccchhhhccCCcceeccccccccc----ccchh------hhcCCCCccEEEccccccccC
Q 042568 200 LRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSG----ELPSE------IISKMPQLQFLYLSYNDFVSH 265 (983)
Q Consensus 200 l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~----~~~~~------~~~~l~~L~~L~Ls~N~l~~~ 265 (983)
+..++.|+|++|.+.. .+...+.+.++|+..++|+- ++| .+|.. .+-..++|++|+||+|-|..
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~- 106 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP- 106 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc-
Confidence 3444555555554431 23334444555555555542 222 22221 23345567777777776532
Q ss_pred CCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCC
Q 042568 266 DGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345 (983)
Q Consensus 266 ~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 345 (983)
...+.+-.-+.++.+|++|.|.+|.+.-.--..++ ..|..|. .|. -...-+.|+.+..+.|++..
T Consensus 107 ---~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~---~al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 107 ---KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLG---RALFELA--VNK-------KAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred ---cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHH---HHHHHHH--HHh-------ccCCCcceEEEEeecccccc
Confidence 22334444455677777777777766522111111 1122222 111 11223456666666666542
Q ss_pred CC----CcccccCCCCcEEEeeCCcccCCC----CCCCCCCCCCcEEEccCccccCc----CcccccCcccchhhcccCc
Q 042568 346 TI----PHELCLMSKLERVYLSNNSLSGEI----PSAFGDIPHLGLLDLSKNKLSGS----IPDSFANLSQLRRLLLYGN 413 (983)
Q Consensus 346 ~~----p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N 413 (983)
.. ...+...+.|+.+.++.|.|.... ...|..+++|+.|||.+|-++.. +...+..++.|+.|+++.|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 21 123444566666666666665221 22355667777777777766532 2344556677777777777
Q ss_pred cCCCCCccccc-----CCCCCCEEEccCccccC----cCCccccCCCccceeccccCCCC
Q 042568 414 HLSGTIPSSLG-----KCVNLEILDLSHNKISG----IIPSDVAGLRSLKLYLNLSSNHL 464 (983)
Q Consensus 414 ~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~~L~l~~N~l 464 (983)
.+...-..+|. ..++|++|.|.+|.++. .+...+...+.|.. |+|++|.+
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~k-LnLngN~l 310 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEK-LNLNGNRL 310 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHH-hcCCcccc
Confidence 77643332221 35678888888887762 22334455677775 88888888
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.7e-10 Score=114.98 Aligned_cols=144 Identities=17% Similarity=0.257 Sum_probs=112.3
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC--CccceeeEEecCC---ceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR--NLIRIITICSKPD---FKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 746 (983)
.+.|+.|..+.||++...+|+.+++|.............+.+|+++++.+++. .+.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 35689999999999998767889999975543322356789999999999764 4567777776542 568999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC--------------------------------------
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS-------------------------------------- 788 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------- 788 (983)
+|.++.+.+.. ..++......++.++++++.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99988776531 24677778888889999999998421
Q ss_pred ---------------CCCeEeecCCCCCeEeCC--CCCEEEcccccccc
Q 042568 789 ---------------PIKVVHCDLKPSNILLDE--DLTALVADFGIAKL 820 (983)
Q Consensus 789 ---------------~~~ivH~Dikp~NiLl~~--~~~~kl~Dfgla~~ 820 (983)
+..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66788999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.9e-11 Score=139.86 Aligned_cols=219 Identities=31% Similarity=0.388 Sum_probs=147.3
Q ss_pred CCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchh
Q 042568 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRR 407 (983)
Q Consensus 328 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 407 (983)
..+..++.+++..|.+.. +-..+..+++|+.|++.+|.|..+ ...+..+++|+.|+|++|+|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 345566666677777763 334466777777777777777743 2236677788888888888875432 556666888
Q ss_pred hcccCccCCCCCcccccCCCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCcccccccccccccccccc
Q 042568 408 LLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486 (983)
Q Consensus 408 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 486 (983)
|++++|.|+. + ..+..++.|+.+++++|+++..-+ . ...+..++. +.+.+|.+. ....+..+..+..+++..|
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~-l~l~~n~i~--~i~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEE-LDLGGNSIR--EIEGLDLLKKLVLLSLLDN 218 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHH-HhccCCchh--cccchHHHHHHHHhhcccc
Confidence 8888888873 2 345567788888888888874433 1 456667775 888888876 3344555666666788888
Q ss_pred ccccCCCccccccc--ccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccc
Q 042568 487 NLSGSIPPQLGSCI--ALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561 (983)
Q Consensus 487 ~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 561 (983)
.++..-+ +..+. .|+.+++++|++. ..+..+..+.++..|++++|++... ..+...+.+..+....|.+.
T Consensus 219 ~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 219 KISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred cceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 8873322 22222 3888888888887 3445667788888888888888643 23445666777777888765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.4e-10 Score=124.67 Aligned_cols=167 Identities=19% Similarity=0.229 Sum_probs=127.8
Q ss_pred ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCH
Q 042568 688 LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDL 767 (983)
Q Consensus 688 ~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 767 (983)
..++..|.|..++.... +......+-++.++.+|||||+++++.+...+..|+|+|-+. -|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 44688898988876665 556778888999999999999999999999999999999885 45555543 224
Q ss_pred HHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccc
Q 042568 768 IQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847 (983)
Q Consensus 768 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 847 (983)
..+.-.++||+.||.|||+.+ +++|++|.-+.|+++..|+.||++|.++........ ......--
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------------~~~~~~~~ 168 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------------PAKSLYLI 168 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------------ccccchhh
Confidence 556677899999999999877 799999999999999999999999998865432211 00011112
Q ss_pred cccccccccCCCCCCccchhHHHHHHHHHHHhCC
Q 042568 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 848 ~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~ 881 (983)
-.|..|+.+.... -..|.|.||++++|++.|.
T Consensus 169 ~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 169 ESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 2456676544332 2469999999999999993
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-10 Score=114.25 Aligned_cols=132 Identities=27% Similarity=0.346 Sum_probs=50.8
Q ss_pred cCCCCCCCEEeccCccCCCCchhhhc-ccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCccccc
Q 042568 121 LGSLIRLKQLSLSWNSLQGKIPSQLG-SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199 (983)
Q Consensus 121 ~~~l~~L~~L~Ls~n~l~~~~p~~~~-~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~ 199 (983)
+.+..++++|+|++|.|+ .+ +.++ .+.+|+.|||++|.|+ .++ .+..
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-----------------------------~l~~ 62 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-----------------------------GLPG 62 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-----------------------------T---
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-----------------------------CccC
Confidence 444556777777777776 33 2354 4666777777777766 222 2336
Q ss_pred ccccceeecccCccccccchhh-hccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 200 LRNLRFLLLWSNRLVGQVPQAL-ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 200 l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
++.|+.|++++|+|+.. ...+ ..+++|++|+|++|+|...-.-..++.+++|++|+|.+|.+..... --..-+
T Consensus 63 L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~-----YR~~vi 136 (175)
T PF14580_consen 63 LPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN-----YRLFVI 136 (175)
T ss_dssp -TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT-----HHHHHH
T ss_pred hhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh-----HHHHHH
Confidence 78899999999999854 3344 4789999999999999843333557889999999999999875322 112335
Q ss_pred CCCCCccEEEcc
Q 042568 279 ANSSNFQELELA 290 (983)
Q Consensus 279 ~~l~~L~~L~L~ 290 (983)
..+++|+.||-.
T Consensus 137 ~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 137 YKLPSLKVLDGQ 148 (175)
T ss_dssp HH-TT-SEETTE
T ss_pred HHcChhheeCCE
Confidence 668899998753
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.9e-12 Score=129.08 Aligned_cols=145 Identities=23% Similarity=0.287 Sum_probs=69.1
Q ss_pred CCcceecccccccccccc----hhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCc
Q 042568 225 SKLEWLDLESNMFSGELP----SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300 (983)
Q Consensus 225 ~~L~~L~Ls~N~l~~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 300 (983)
++|+++...+|++. .-+ ...+...+.|+++.++.|.|..- ....+...+..+++|+.|||++|-++..-..
T Consensus 157 ~~Lrv~i~~rNrle-n~ga~~~A~~~~~~~~leevr~~qN~I~~e----G~~al~eal~~~~~LevLdl~DNtft~egs~ 231 (382)
T KOG1909|consen 157 PKLRVFICGRNRLE-NGGATALAEAFQSHPTLEEVRLSQNGIRPE----GVTALAEALEHCPHLEVLDLRDNTFTLEGSV 231 (382)
T ss_pred cceEEEEeeccccc-cccHHHHHHHHHhccccceEEEecccccCc----hhHHHHHHHHhCCcceeeecccchhhhHHHH
Confidence 34555555555553 222 22344555666666666655331 1223344455555555555555555422111
Q ss_pred cccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCC-CCCC
Q 042568 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF-GDIP 379 (983)
Q Consensus 301 ~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~ 379 (983)
.+...+..+++|+.|++++|.+.......+.. ++ ...+
T Consensus 232 ---------------------~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~--------------------al~~~~p 270 (382)
T KOG1909|consen 232 ---------------------ALAKALSSWPHLRELNLGDCLLENEGAIAFVD--------------------ALKESAP 270 (382)
T ss_pred ---------------------HHHHHhcccchheeecccccccccccHHHHHH--------------------HHhccCC
Confidence 11223334445555555555554332222110 11 1245
Q ss_pred CCcEEEccCccccCc----CcccccCcccchhhcccCccC
Q 042568 380 HLGLLDLSKNKLSGS----IPDSFANLSQLRRLLLYGNHL 415 (983)
Q Consensus 380 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 415 (983)
+|+.|.|.+|.|+.. +...+...+.|..|+|++|++
T Consensus 271 ~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 271 SLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred CCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 566666666666521 222344567777777777777
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=9.8e-11 Score=130.81 Aligned_cols=252 Identities=19% Similarity=0.170 Sum_probs=177.0
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC--CCcEEEEEEeecccCcchh-HHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ--DNTRIAVKVLDLTTTGEIT-GSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~~~~~~-~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
.-+.+|..+..||.|.|+.||+...+ ++..||+|........... ..-..|+-+...+ .|.++++.+..+...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999998744 5778999977544332211 1223466665555 589999988888888888
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEcccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIA 818 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgla 818 (983)
|+--||+++++...... ....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 89999999998877662 2345777889999999999999999885 9999999999999886 78889999998
Q ss_pred ccccCCcccccccCCCCccccccCccccccccc--cccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI--APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+.+.-.. ....+.-+++ +|+......+..+.|+||||..+.|.++|..--.. +.....
T Consensus 415 t~~~~~~----------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~ 474 (524)
T KOG0601|consen 415 TRLAFSS----------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLT 474 (524)
T ss_pred cccceec----------------ccccccccccccchhhccccccccccccccccccccccccCcccCcc----ccccee
Confidence 7432111 1112333444 55555667788999999999999999998764211 110000
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
. .....+.. ......+..+...+...++..||.+.++..+.+..+.
T Consensus 475 i--------------------~~~~~p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 475 I--------------------RSGDTPNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred e--------------------ecccccCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0 00000100 1122556666777899999999999998877666544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.7e-11 Score=136.64 Aligned_cols=245 Identities=30% Similarity=0.331 Sum_probs=114.1
Q ss_pred CCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEE
Q 042568 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360 (983)
Q Consensus 281 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 360 (983)
+..++.++++.|.+.. +-..+..+ .+|+.|++..|.|.+ +...+..+++|++|++++|+|+... .+..++.|+.|
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~-~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L 145 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKL-KSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL 145 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccc-cceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence 3455555566665553 11112222 345555555555542 2222444555555555555554331 23344445555
Q ss_pred EeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcccc
Q 042568 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 361 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
++++|.|... ..+..+++|+.+++++|++...-+ . . ...+.+++.+++.+|.+.
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~-~----------------------~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEN-D----------------------E-LSELISLEELDLGGNSIR 199 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhh-h----------------------h-hhhccchHHHhccCCchh
Confidence 5555555421 123334444444555544443222 0 1 244444555555555544
Q ss_pred CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccc
Q 042568 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520 (983)
Q Consensus 441 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 520 (983)
. ...+..+..+.. +++..|.++..-+........|+.+++++|.+. .++..+..+..+..|++++|++...- .+
T Consensus 200 ~--i~~~~~~~~l~~-~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~--~~ 273 (414)
T KOG0531|consen 200 E--IEGLDLLKKLVL-LSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLE--GL 273 (414)
T ss_pred c--ccchHHHHHHHH-hhcccccceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccc--cc
Confidence 1 122222333332 445555554222111111113666777777766 44455666677777777777776432 23
Q ss_pred cCCCCccEEecCCccccCC---cCcc-ccCCCCcceEeccCCcccc
Q 042568 521 GQLPYLKQFDVSSNRLFGE---IPQS-FQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 521 ~~l~~L~~L~ls~N~l~~~---~p~~-~~~l~~L~~l~l~~N~l~~ 562 (983)
.....+..+..+.|.+... .... ....+.+..+.+.+|+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (414)
T KOG0531|consen 274 ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRK 319 (414)
T ss_pred cccchHHHhccCcchhcchhhhhccccccccccccccccccCcccc
Confidence 3445566667777765421 1111 3344555555555555543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-09 Score=102.36 Aligned_cols=132 Identities=25% Similarity=0.316 Sum_probs=102.0
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEE-eecccCc-c-----hhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKV-LDLTTTG-E-----ITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~-~~~~~~~-~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
..+++|+-+.+|.+.+. |..+++|. +++.... + ...+-.+|+.++.+++--.|...+-+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999875 44466664 3322211 1 234567799999999877777777777888899999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
++|..|.+.+... ...++..+-+-+.-||..+ |+|+|+.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888877642 2456666777778899997 99999999999998776 99999999874
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.9e-10 Score=82.63 Aligned_cols=41 Identities=39% Similarity=0.873 Sum_probs=31.4
Q ss_pred HHhHHHHHHHHHhccCCCccccCCCCCCC-CCCcceeeEEEC
Q 042568 33 IRDRASLVTFMSSIISAPEHALESWNSTD-VHVCNWSGVKCN 73 (983)
Q Consensus 33 ~~~~~~ll~~k~~~~~~~~~~l~sw~~~~-~~~c~w~gv~c~ 73 (983)
.+|++||++||+++..+|.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57999999999999877888999999763 789999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-09 Score=99.61 Aligned_cols=144 Identities=19% Similarity=0.287 Sum_probs=105.9
Q ss_pred CCCccccCCcEeEEEEEECCCcEEEEEE-eecccC------cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNTRIAVKV-LDLTTT------GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~~vAvK~-~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
...++-+|+-+.|+++.+. |+...||. +.+... .-...+-++|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999987 77766664 322211 113467788999999987666665555666667778999
Q ss_pred ecccC-cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEccccccc
Q 042568 744 PLMSN-GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVADFGIAK 819 (983)
Q Consensus 744 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~Dfgla~ 819 (983)
||++| .++.+++.... ...........++..|-+.+.-||..+ |+|+|+..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99986 46777665432 222223333788889999999999996 99999999999996554 45899999976
Q ss_pred c
Q 042568 820 L 820 (983)
Q Consensus 820 ~ 820 (983)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.3e-08 Score=104.86 Aligned_cols=267 Identities=15% Similarity=0.165 Sum_probs=165.9
Q ss_pred CCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccc----eeeEE--e-cCCceeEE
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIR----IITIC--S-KPDFKALV 742 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~----l~~~~--~-~~~~~~lv 742 (983)
....+|+|+-+.+|-.--- ..-+-|++..+.... -.+.++.|... .||-+-. ..... . ......+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567999999999865311 123457776554321 11223333333 4554332 11111 1 11224667
Q ss_pred EecccCcc-cccccccc--cCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 743 LPLMSNGS-LENHLYPS--HGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gs-L~~~l~~~--~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
|+.+++.- +..+.... +..-...+|....++++.+|.+.+.||..| .+-+|+.++|+|+.+++.+.+.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776531 11122111 111234799999999999999999999997 8889999999999999999998866544
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhC-CCCCCcccCCC--
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTG-RRPTDVLFHDG-- 891 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg-~~p~~~~~~~~-- 891 (983)
..... . ...-.+|...|.+||... +..-+...|-|.+|+++++++.| ++||.......
T Consensus 166 i~~ng-~-------------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 166 INANG-T-------------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred eccCC-c-------------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 33211 1 111247899999999865 33456788999999999999986 99997654221
Q ss_pred -CchH-HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHHHhHh
Q 042568 892 -SSLH-EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYN--PSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 892 -~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~evl~~L~~~~~ 967 (983)
..+. .+....+-. .-+ ......+....-.|+-.+..+..+..+|+... +.-|||++-.+..|.++++
T Consensus 232 p~p~E~~Ia~g~f~y----a~~-----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 232 PNPLETDIAHGRFAY----ASD-----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred CCcchhhhhcceeee----chh-----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111 111111111 011 11122233334456677788888999999654 5689999999999988876
Q ss_pred hc
Q 042568 968 YL 969 (983)
Q Consensus 968 ~~ 969 (983)
+.
T Consensus 303 ~L 304 (637)
T COG4248 303 QL 304 (637)
T ss_pred hh
Confidence 54
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.9e-09 Score=128.73 Aligned_cols=105 Identities=31% Similarity=0.337 Sum_probs=50.9
Q ss_pred CCcEEeCcCCc--CCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccc
Q 042568 102 SLIVLDLSKNF--FQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179 (983)
Q Consensus 102 ~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~ 179 (983)
.|++|-+..|. +....++.|..++.|+.||||+|.=-+.+|..++.|-+|++|+|++..++ .+|.++. ++.+|.
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~---~Lk~L~ 621 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLG---NLKKLI 621 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHH---HHHhhh
Confidence 34455555443 33222223445555555555554443455555555555555555555554 4555443 444555
Q ss_pred eeecccccccCCCCCcccccccccceeecccC
Q 042568 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211 (983)
Q Consensus 180 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N 211 (983)
+||+..+.-...+ ....+.+.+|++|.+..-
T Consensus 622 ~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 622 YLNLEVTGRLESI-PGILLELQSLRVLRLPRS 652 (889)
T ss_pred eeccccccccccc-cchhhhcccccEEEeecc
Confidence 5555544433222 233344666666665544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.1e-09 Score=128.52 Aligned_cols=133 Identities=29% Similarity=0.356 Sum_probs=85.4
Q ss_pred cccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCcc--CCCCchhhhcccccccEEeccCcccccccCCcccccCC
Q 042568 97 LANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS--LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNS 174 (983)
Q Consensus 97 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~ 174 (983)
..+....+...+-+|.+. .++....+ ++|++|-+.+|. +....+..|..++.|+.|||++|.=-+++|..++
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~---- 592 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG---- 592 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh----
Confidence 445567777888888776 45544433 378888888886 5534444577888888888888776667887775
Q ss_pred CcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccE
Q 042568 175 STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQF 254 (983)
Q Consensus 175 l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 254 (983)
.|-+|++|+|++..++ .+|..++++.+|.+|++..+.-...+ +.+...|++|++
T Consensus 593 ------------------------~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~ 646 (889)
T KOG4658|consen 593 ------------------------ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRV 646 (889)
T ss_pred ------------------------hhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccE
Confidence 4555555555555555 56666666666666666665543222 444555666666
Q ss_pred EEccccc
Q 042568 255 LYLSYND 261 (983)
Q Consensus 255 L~Ls~N~ 261 (983)
|.+-.-.
T Consensus 647 L~l~~s~ 653 (889)
T KOG4658|consen 647 LRLPRSA 653 (889)
T ss_pred EEeeccc
Confidence 6665443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-08 Score=104.53 Aligned_cols=142 Identities=18% Similarity=0.103 Sum_probs=101.6
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEEeecccCcchh----------HHHHHHHHHHHhcCCCCc--cceeeEEec-----
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEIT----------GSFKRECQILKRIRHRNL--IRIITICSK----- 735 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 735 (983)
+.+-+.....|+++.+ +|+.|.||+.......+.. ..+.+|.+.+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 4788999987443322211 247899999999864444 344556532
Q ss_pred CCceeEEEecccCc-ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-------C
Q 042568 736 PDFKALVLPLMSNG-SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-------D 807 (983)
Q Consensus 736 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-------~ 807 (983)
....++|+|++++. +|.+++.... ....+...+..++.++++.+.-||..| |+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999976 7888764221 233456677899999999999999997 999999999999975 4
Q ss_pred CCEEEcccccccc
Q 042568 808 LTALVADFGIAKL 820 (983)
Q Consensus 808 ~~~kl~Dfgla~~ 820 (983)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6889999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=103.85 Aligned_cols=171 Identities=16% Similarity=0.152 Sum_probs=126.3
Q ss_pred CcEeEEEEE-ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec----CCceeEEEecccC-cccc
Q 042568 679 RFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK----PDFKALVLPLMSN-GSLE 752 (983)
Q Consensus 679 ~~g~Vy~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~ 752 (983)
...+.||+. ..||..|++|+++..... ....-..-+++++++.|+|+|++.+++.. .-..++||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 346789998 458999999999544322 12223445788999999999999998862 2356899999885 4555
Q ss_pred cccccccC-----------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 753 NHLYPSHG-----------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 753 ~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
+.-..... .....++..+|.++.|+..||.++|+.| ...+-+.|.+|+++++.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 44322111 1234788999999999999999999997 888999999999999999999988887665
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
..... |.+.+ -.+-|.-.||.+++.|.||..-
T Consensus 444 ~~d~~---------------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 43210 11111 2367999999999999999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.3e-08 Score=97.64 Aligned_cols=126 Identities=24% Similarity=0.290 Sum_probs=83.0
Q ss_pred eEEEEEECCCcEEEEEEeecccC------------c-------------chhHHHHHHHHHHHhcCCC--CccceeeEEe
Q 042568 682 HVYKGVLQDNTRIAVKVLDLTTT------------G-------------EITGSFKRECQILKRIRHR--NLIRIITICS 734 (983)
Q Consensus 682 ~Vy~~~~~~~~~vAvK~~~~~~~------------~-------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 734 (983)
.||.|...+|..+|||+...... . .......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998743210 0 0124567799999999766 456666553
Q ss_pred cCCceeEEEeccc--CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 735 KPDFKALVLPLMS--NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL-HHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 735 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
...+||||++ |..+..+.... ++......++.+++..+..+ |..| |+|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 3489999998 54454433211 11234566778888866664 6775 9999999999999988 999
Q ss_pred Eccccccccc
Q 042568 812 VADFGIAKLV 821 (983)
Q Consensus 812 l~Dfgla~~~ 821 (983)
++|||.|...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.3e-09 Score=125.70 Aligned_cols=261 Identities=21% Similarity=0.211 Sum_probs=164.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.+.|.+.+-+-+|.++.++.+.-. .|...+.|+...... ....+....+-.+.-..++|-++....-+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 345666777888999999887743 233334443311100 00112222222222223456555554444445667899
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
++|..++++...++... ..+..........+.++++|||... +.|||++|.|++...++..+++|||.....+
T Consensus 883 ~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999988887543 3455566677778899999999973 8999999999999999999999999554432
Q ss_pred CC---ccc-------------ccccCCC--CccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 823 GI---DES-------------VNCANDS--MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 823 ~~---~~~-------------~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
.. ... ....... ...........||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 11 000 0000000 00012234568999999999999999999999999999999999999998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
....+. .+++.......+. .....+...+..+++...+..+|.+|-.+.
T Consensus 1036 na~tpq-----------------~~f~ni~~~~~~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQ-----------------QIFENILNRDIPW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchh-----------------hhhhccccCCCCC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 753321 1111111111100 011123445667777778888888887665
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-08 Score=81.78 Aligned_cols=60 Identities=40% Similarity=0.597 Sum_probs=39.5
Q ss_pred ccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 501 ALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 501 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
+|+.|++++|+++...+..|..+++|+.|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 466666666666655555666666666666666666655556666777777777776654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.3e-09 Score=82.79 Aligned_cols=61 Identities=39% Similarity=0.525 Sum_probs=43.3
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCccc
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKL 161 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l 161 (983)
++|++|+|++|+++...+..|.++++|++|++++|.|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4567777777777744445677777777777777777766666777777777777777764
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.1e-07 Score=93.45 Aligned_cols=135 Identities=26% Similarity=0.272 Sum_probs=95.7
Q ss_pred CCCCccccCCcEeEEEEEECCCcEEEEEEeecccC---------------------cchhHHHHHHHHHHHhcCCC--Cc
Q 042568 670 CPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT---------------------GEITGSFKRECQILKRIRHR--NL 726 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--ni 726 (983)
.+...||-|.-+.||.|..+.|.++|||.-..... ........+|.++|+++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 35688999999999999999999999996321100 01234567899999999755 67
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
.+.+++ +...+||||++|--|...- ++......++..|++-+.-.-..| |||+|+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 777763 4558999999985554322 112223334444444444443454 999999999999999
Q ss_pred CCCEEEcccccccc
Q 042568 807 DLTALVADFGIAKL 820 (983)
Q Consensus 807 ~~~~kl~Dfgla~~ 820 (983)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.8e-09 Score=118.46 Aligned_cols=129 Identities=29% Similarity=0.330 Sum_probs=97.8
Q ss_pred CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccce
Q 042568 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRF 205 (983)
Q Consensus 126 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 205 (983)
.|..-+.+.|.+. ....++.-++.|+.|||++|+++.. . .+..++.|++|||++|.+. .+|.-..... .|..
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~----~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~ 236 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D----NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQL 236 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H----HHHhcccccccccccchhc-cccccchhhh-hhee
Confidence 4677778888887 7778888889999999999998732 2 2357888999999999888 4553322233 3888
Q ss_pred eecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcccccccc
Q 042568 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVS 264 (983)
Q Consensus 206 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 264 (983)
|.+++|.++.. ..+.+|.+|+.|||+.|-|++.-.-+.++.+..|+.|+|.+|.+..
T Consensus 237 L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 237 LNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred eeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99999988732 4578889999999999988865445557778888899999988754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.9e-09 Score=120.88 Aligned_cols=179 Identities=30% Similarity=0.365 Sum_probs=119.8
Q ss_pred CCCCCCCCcccEEeccccccCCCCCcccccC-CCCcEEEeeCCcccC---CCCCC---CCC---CCCCcEEEccCccccC
Q 042568 324 PPHISNLVNLTLLNLSSNLLNGTIPHELCLM-SKLERVYLSNNSLSG---EIPSA---FGD---IPHLGLLDLSKNKLSG 393 (983)
Q Consensus 324 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~---~~p~~---~~~---l~~L~~L~Ls~N~l~~ 393 (983)
|-.+..+.+|+.|.|.++.|.. ...+..+ ..|+.|- -.|.+.. ++... +.+ ...|.+.+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 5567777888888888887762 1111111 1233332 2222221 11111 111 235778888999887
Q ss_pred cCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCc-cccCCCccceeccccCCCCCCCCcccc
Q 042568 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS-DVAGLRSLKLYLNLSSNHLDGPLPLEL 472 (983)
Q Consensus 394 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~~L~l~~N~l~~~~p~~~ 472 (983)
....++.-++.|+.|+|++|+++.. +.+..++.|+.|||++|+++ .+|. ...++. |.. |++++|.++.. ..+
T Consensus 178 ~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~-L~lrnN~l~tL--~gi 250 (1096)
T KOG1859|consen 178 LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQL-LNLRNNALTTL--RGI 250 (1096)
T ss_pred hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-hee-eeecccHHHhh--hhH
Confidence 5666778888999999999999843 27888999999999999998 4443 223333 776 89999988742 346
Q ss_pred ccccccccccccccccccCCC-cccccccccceEEeCCCccc
Q 042568 473 SKMDMVLAIDLSFNNLSGSIP-PQLGSCIALESLNLSGNSLE 513 (983)
Q Consensus 473 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 513 (983)
.+|++|+.||+++|-|++.-- ..++.|..|..|+|.||.+-
T Consensus 251 e~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 251 ENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 788889999999998875432 23567788999999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.2e-07 Score=107.60 Aligned_cols=158 Identities=23% Similarity=0.328 Sum_probs=104.8
Q ss_pred HHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCcccccccccccc
Q 042568 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854 (983)
Q Consensus 775 ~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 854 (983)
.+++.|+.|+|..- ++||++|.|++|.+++.+..||+.|+.+....+... ..+..... ...-.......|.|||
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~---~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDP---PLPLLLQPHLNFLAPE 179 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCC---CCChhhccCcccccch
Confidence 34558999999876 799999999999999999999999998875544222 11111111 1111234566899999
Q ss_pred ccCCCCCCccchhHHHHHHHHHHHhCCCC-CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHH
Q 042568 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRP-TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDV 933 (983)
Q Consensus 855 ~~~~~~~~~k~Dv~SlG~il~elltg~~p-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 933 (983)
++.+...+.++|+||+|+.+|.+..|..+ ++. .+ ...... .+........ .....+.
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~-~~~~~~-------------~~~~~~~~~~-------~~~s~~~ 237 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NG-GLLSYS-------------FSRNLLNAGA-------FGYSNNL 237 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhc-cC-Ccchhh-------------hhhccccccc-------ccccccC
Confidence 99998889999999999999999955544 321 11 010000 0000000000 0011346
Q ss_pred HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 934 VLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 934 ~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+.++.+-+.+++..++..||++.++..
T Consensus 238 p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 238 PSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 678888888999999999998877763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.5e-06 Score=89.14 Aligned_cols=107 Identities=25% Similarity=0.300 Sum_probs=84.4
Q ss_pred hHHHHHHHHHHHhcCCCC--ccceeeEEecCC----ceeEEEecccCc-ccccccccccCcCCCCCHHHHHHHHHHHHHH
Q 042568 708 TGSFKRECQILKRIRHRN--LIRIITICSKPD----FKALVLPLMSNG-SLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780 (983)
Q Consensus 708 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 780 (983)
..+..+|...+.+++... ..+.+++..... ..++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 457888999988886443 456666665432 348999999874 7888876422 25566788999999999
Q ss_pred HHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEccccccccc
Q 042568 781 VAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVADFGIAKLV 821 (983)
Q Consensus 781 L~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~Dfgla~~~ 821 (983)
++-||..| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999997 99999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-08 Score=89.93 Aligned_cols=109 Identities=28% Similarity=0.353 Sum_probs=64.7
Q ss_pred ccEEeccccccCCCCCcc---cccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhc
Q 042568 333 LTLLNLSSNLLNGTIPHE---LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 333 L~~L~Ls~N~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+..++|++|++- .+++. +.....|+..+|++|.+....+..-..++.++.|+|++|+|+ .+|..+..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence 344455555443 23332 233344555566666666443333344556777777777776 5666677777777777
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 445 (983)
++.|.+. ..|..+..+.+|..|+..+|.+. .+|-
T Consensus 107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 7777776 55666666777777777777665 3443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.9e-08 Score=97.75 Aligned_cols=61 Identities=20% Similarity=0.175 Sum_probs=30.3
Q ss_pred CeeEEEccCcccccc-CCCCCCCCCcccEEeccccccCCCC-CcccccCCCCcEEEeeCCccc
Q 042568 308 NLVQIHLDCNLIYGK-IPPHISNLVNLTLLNLSSNLLNGTI-PHELCLMSKLERVYLSNNSLS 368 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 368 (983)
++..+.+..|.+... --.....++.+-.|+|+.|+|...- -+.+.+++.|..|.+++|.+.
T Consensus 200 nv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 200 NVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred cchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 344445555544321 1223344555556666666665221 123455556666666666555
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-08 Score=103.37 Aligned_cols=184 Identities=24% Similarity=0.261 Sum_probs=107.2
Q ss_pred cccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccc-ccccccchhhhcCCCCccE
Q 042568 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN-MFSGELPSEIISKMPQLQF 254 (983)
Q Consensus 176 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~ 254 (983)
+.|++||||+-.|+..--...+..+.+|+.|.|.++++.+.+...++.-.+|+.|+|+.+ .++..--.-++.+++.|.+
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 346666666666553222334456777888888888888777777888888888888775 3442222345667777777
Q ss_pred EEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCccc
Q 042568 255 LYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLT 334 (983)
Q Consensus 255 L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 334 (983)
|+|++|.+.... ++.....+ ..+|+.|+|+++.-. ....-+..-...+++|.
T Consensus 265 LNlsWc~l~~~~----Vtv~V~hi--se~l~~LNlsG~rrn----------------------l~~sh~~tL~~rcp~l~ 316 (419)
T KOG2120|consen 265 LNLSWCFLFTEK----VTVAVAHI--SETLTQLNLSGYRRN----------------------LQKSHLSTLVRRCPNLV 316 (419)
T ss_pred cCchHhhccchh----hhHHHhhh--chhhhhhhhhhhHhh----------------------hhhhHHHHHHHhCCcee
Confidence 777777654321 11111111 134444444443111 00000111123467788
Q ss_pred EEeccccc-cCCCCCcccccCCCCcEEEeeCCcccCCCCCC---CCCCCCCcEEEccCc
Q 042568 335 LLNLSSNL-LNGTIPHELCLMSKLERVYLSNNSLSGEIPSA---FGDIPHLGLLDLSKN 389 (983)
Q Consensus 335 ~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~Ls~N 389 (983)
+||||+|. ++......|.+++.|++|.++.|.. ++|.. +...|.|.+||+.+.
T Consensus 317 ~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 317 HLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred eeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 88888765 3333334566778888888888874 35553 566788888887764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 983 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 8e-50 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-50 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-31 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-24 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-24 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 6e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-07 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 7e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-06 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 6e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 3e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 5e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-05 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 6e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 3e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 5e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 8e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 8e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 8e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 455 bits (1173), Expect = e-147
Identities = 171/564 (30%), Positives = 256/564 (45%), Gaps = 54/564 (9%)
Query: 34 RDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTI 93
R+ L++F + ++ L W+S + + C + GV C + + V +DLS++ +
Sbjct: 12 REIHQLISFKDVLP--DKNLLPDWSS-NKNPCTFDGVTCRDDK--VTSIDLSSKPLNVGF 66
Query: 94 S--------------------------PALANLSSLIVLDLSKNFFQGHIPA--ELGSLI 125
S +SL LDLS+N G + LGS
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 126 RLKQLSLSWNSLQGKIP-SQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLS 184
LK L++S N+L S L+ LE LDL N + G + S+ L+++ +S
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 185 NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSE 244
N ++G++ + NL FL + SN +P L + S L+ LD+ N SG+
Sbjct: 187 GNKISGDVDVSR---CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRA 242
Query: 245 IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD 304
IS +L+ L +S N FV L + Q L LA N G IP +
Sbjct: 243 -ISTCTELKLLNISSNQFVGPIPPLPL----------KSLQYLSLAENKFTGEIPDFLSG 291
Query: 305 LSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLS 363
L + L N YG +PP + L L LSSN +G +P + L M L+ + LS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 364 NNSLSGEIPSAFGDI-PHLGLLDLSKNKLSGSIPDSFAN--LSQLRRLLLYGNHLSGTIP 420
N SGE+P + ++ L LDLS N SG I + + L+ L L N +G IP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480
+L C L L LS N +SG IPS + L L+ L L N L+G +P EL + +
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWLNMLEGEIPQELMYVKTLET 470
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540
+ L FN+L+G IP L +C L ++LS N L G +P +G+L L +S+N G I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 541 PQSFQASPTLKQLNFSFNKFSGNI 564
P +L L+ + N F+G I
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTI 554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-140
Identities = 161/511 (31%), Positives = 235/511 (45%), Gaps = 46/511 (9%)
Query: 81 ELDLSARSIYGTISPALA-NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
L L+ G I L+ +L LDLS N F G +P GS L+ L+LS N+ G
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 140 KIP-SQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK-NE 197
++P L + L+ LDL N+ GE+P + N S SL +DLS+N+ +G I +
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLT--NLSASLLTLDLSSNNFSGPILPNLCQ 390
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L+ L L +N G++P L+N S+L L L N SG +PS + + +L+ L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL-GSLSKLRDLKL 449
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317
N L G IP + + L + LD N
Sbjct: 450 W--------------------------------LNMLEGEIPQELMYVK-TLETLILDFN 476
Query: 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGD 377
+ G+IP +SN NL ++LS+N L G IP + + L + LSNNS SG IP+ GD
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 378 IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
L LDL+ N +G+IP + S + N ++G + + + N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 438 --KISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
+ GI + L + N++S G ++ +D+S+N LSG IP +
Sbjct: 593 LLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651
Query: 496 LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNF 555
+GS L LNL N + G +P VG L L D+SSN+L G IPQ+ A L +++
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711
Query: 556 SFNKFSGNISNKGAFSSLTIASFQGNDGLCG 586
S N SG I G F + A F N GLCG
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-138
Identities = 166/526 (31%), Positives = 253/526 (48%), Gaps = 27/526 (5%)
Query: 68 SGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRL 127
G ++ ++ L +S I G + ++ +L LD+S N F IP LG L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
+ L +S N L G + + +L+ L++ +N+ VG IP SLQY+ L+ N
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP-----PLPLKSLQYLSLAENK 280
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
TGEIP L L L N G VP + S LE L L SN FSGELP + +
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLAN-SSNFQELELAGNNLGGMIPSIIGDLS 306
KM L+ L LS+N+F SL N S++ L+L+ NN G I +
Sbjct: 341 KMRGLKVLDLSFNEFSG--------ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392
Query: 307 -TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
L +++L N GKIPP +SN L L+LS N L+GTIP L +SKL + L N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGK 425
L GEIP + L L L N L+G IP +N + L + L N L+G IP +G+
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF 485
NL IL LS+N SG IP+++ RSL +L+L++N +G +P + K + ++
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLI-WLDLNTNLFNGTIPAAMFK----QSGKIAA 567
Query: 486 NNLSGSIPPQLGSCIALESLNLSGN--SLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQS 543
N ++G + + + + +GN +G+ + +L +++S G +
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 544 FQASPTLKQLNFSFNKFSGNISNK-GAFSSLTIASFQGNDGLCGEI 588
F + ++ L+ S+N SG I + G+ L I + N + G I
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN-DISGSI 672
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-29
Identities = 47/116 (40%), Positives = 67/116 (57%), Gaps = 3/116 (2%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
++++R G SP N S++ LD+S N G+IP E+GS+ L L+L N +
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP 193
G IP ++G L L LDL +NKL G IP + ++ T L IDLSNN+L+G IP
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM---SALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-28
Identities = 49/200 (24%), Positives = 76/200 (38%), Gaps = 38/200 (19%)
Query: 72 CNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLS 131
N+ K + G S L LS+ +++ + GH + + L
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
+S+N L G IP ++GS+ L L+LG+N + G IP + L +DLS+N L G
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV---GDLRGLNILDLSSNKLDGR 695
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ 251
I PQA++ + L +DL +N SG +P
Sbjct: 696 I-------------------------PQAMSALTMLTEIDLSNNNLSGPIPEM------- 723
Query: 252 LQFLYLSYNDFVSHDGNTNL 271
QF F+ N L
Sbjct: 724 GQFETFPPAKFL---NNPGL 740
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = 5e-98
Identities = 118/528 (22%), Positives = 201/528 (38%), Gaps = 23/528 (4%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSL--IRLKQLSLSWNSLQ 138
LDLS + T L +L L LS N Q EL LK+L LS N ++
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP-LKNE 197
P ++ +L L L N +L + + ++TS++ + LSN+ L+
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
+ NL L L N L + A +LE+ LE N L S + + +++L L
Sbjct: 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNVRYLNL 303
Query: 258 SYNDFVSHDGNTNLEPF-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
+ +L S + L + N++ G+ ++ L NL + L
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL-INLKYLSLSN 362
Query: 317 NLIYGKIPPHIS----NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIP 372
+ + + + L +LNL+ N ++ + LE + L N + E+
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 373 -SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG--TIPSSLGKCVNL 429
+ + ++ + LS NK +SFA + L+RL+L L + PS NL
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL--------DGPLPLELSKMDMVLAI 481
ILDLS+N I+ I + GL L+ L+L N+L G L + + +
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLE-ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 482 DLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIP 541
+L N L+ ++L N+L L LK ++ N +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 542 QSFQASPT-LKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEI 588
+ F + L +L+ FN F + F + + L
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = 2e-92
Identities = 107/502 (21%), Positives = 182/502 (36%), Gaps = 30/502 (5%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
+ L+L+ + + S L LD+ N P L LK L+L N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
L L L +N + P +L +DLS+N L+ L +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPF---VKQKNLITLDLSHNGLSS-TKLGTQV 142
Query: 199 ELRNLRFLLLWSNRLVGQVPQALA--NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
+L NL+ LLL +N++ + L +S L+ L+L SN + +L L+
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLF 201
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS-TNLVQIHLD 315
L+ +L +++ + L L+ + L + L TNL + L
Sbjct: 202 LNNVQL-----GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 316 CNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN---------S 366
N + + L L L N + H L + + + L + S
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316
Query: 367 LSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLG-- 424
L +F + L L++ N + G + F L L+ L L + S ++
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376
Query: 425 --KCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLP-LELSKMDMVLAI 481
L IL+L+ NKIS I + L L+ L+L N + L E ++ + I
Sbjct: 377 SLAHSPLHILNLTKNKISKIESDAFSWLGHLE-VLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 482 DLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGL--LPVSVGQLPYLKQFDVSSNRLFGE 539
LS+N +L+ L L +L+ + P L L D+S+N +
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495
Query: 540 IPQSFQASPTLKQLNFSFNKFS 561
+ L+ L+ N +
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLA 517
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-65
Identities = 87/423 (20%), Positives = 154/423 (36%), Gaps = 40/423 (9%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANL--SSLIVLDLSKNFFQGHIPAELGSLIRLKQL 130
+ + L LS + T + L ++L +LDLS N L +L+
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 131 SLSWNSLQGKIPSQLGSL---------HQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181
L +N++Q L L + L L+++
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF---QWLKCLEHL 334
Query: 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALA----NSSKLEWLDLESNMF 237
++ +N + G I L NL++L L ++ + S L L+L N
Sbjct: 335 NMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 238 SGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGM 297
S + S+ S + L+ L L N+ L N E+ L+ N +
Sbjct: 394 SK-IESDAFSWLGHLEVLDLGLNEI-----GQELTG--QEWRGLENIFEIYLSYNKYLQL 445
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYG--KIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
+ + +L ++ L + P L NLT+L+LS+N + L +
Sbjct: 446 TRNSFALV-PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504
Query: 356 KLERVYLSNNSLS--------GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRR 407
KLE + L +N+L+ G + HL +L+L N + F +L +L+
Sbjct: 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564
Query: 408 LLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVA-GLRSLKLYLNLSSNHLDG 466
+ L N+L+ S V+L+ L+L N I+ + R+L L++ N D
Sbjct: 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT-ELDMRFNPFDC 623
Query: 467 PLP 469
Sbjct: 624 TCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-56
Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 12/300 (4%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340
+ + + + + L + DL TN+ ++L N + + + LT L++
Sbjct: 3 TVSHEVADCSHLKLT----QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 341 NLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA 400
N ++ P + L+ + L +N LS F +L L L N + + F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 401 NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL-YLNL 459
L L L N LS T + + NL+ L LS+NKI + ++ + L L L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA---LESLNLSGNSLEGLL 516
SSN + P + + + L+ L S+ +L +A + +L+LS + L
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 517 PVSVGQLPY--LKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
+ L + L D+S N L SF P L+ +N S+ + L
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH--SLHGLF 296
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-05
Identities = 18/113 (15%), Positives = 39/113 (34%), Gaps = 9/113 (7%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIR-LKQLSLSWNS 136
++ +DL ++ + N SL L+L KN G R L +L + +N
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP 620
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN----SSTSLQYIDLSN 185
S + +++ + + + C+ ++ D S+
Sbjct: 621 FDCTCESIAWF---VNWINETHTNIPE-LSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 3e-94
Identities = 88/303 (29%), Positives = 131/303 (43%), Gaps = 10/303 (3%)
Query: 298 IPSIIGD---LSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT--IPHELC 352
I +G+ LS+ L G + + + L+LS L IP L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 353 LMSKLERVYLSN-NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411
+ L +Y+ N+L G IP A + L L ++ +SG+IPD + + L L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 412 GNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE 471
N LSGT+P S+ NL + N+ISG IP L + +S N L G +P
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 472 LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDV 531
+ +++ +DLS N L G GS + ++L+ NSL L VG L D+
Sbjct: 194 FANLNLAF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 532 SSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGL 591
+NR++G +PQ L LN SFN G I G ++++ N LCG L
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPL 309
Query: 592 QTC 594
C
Sbjct: 310 PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 3e-72
Identities = 93/409 (22%), Positives = 140/409 (34%), Gaps = 118/409 (28%)
Query: 35 DRASLVTFMSSIISAPEHALESWN-STDVHVCNWSGVKCNNSRN--KVVELDLSARSIYG 91
D+ +L+ + + L SW +TD W GV C+ +V LDLS ++
Sbjct: 7 DKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 92 T--ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLH 149
I +LANL L L + N+L G IP + L
Sbjct: 65 PYPIPSSLANLPYLNFLYIG-----------------------GINNLVGPIPPAIAKLT 101
Query: 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW 209
QL YL + + + G I
Sbjct: 102 QLHYLYITHTNVSGAI-------------------------------------------- 117
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
P L+ L LD N SG LP I S +P L + N
Sbjct: 118 --------PDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGN--------- 159
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
+ G IP G S + + N + GKIPP +N
Sbjct: 160 -----------------------RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389
L NL ++LS N+L G ++++L+ NSL+ ++ G +L LDL N
Sbjct: 197 L-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNN 254
Query: 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
++ G++P L L L + N+L G IP G ++ ++NK
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 29/117 (24%), Positives = 43/117 (36%), Gaps = 5/117 (4%)
Query: 80 VELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
+DLS + G S + + + L+KN + ++G L L L N + G
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYG 258
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
+P L L L L++ N L GEIP +NN PL
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR----FDVSAYANNKCLCGSPLPA 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 7e-93
Identities = 108/325 (33%), Positives = 166/325 (51%), Gaps = 28/325 (8%)
Query: 641 DLEDEEKEKEEAKNPRV-SYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVL 699
D+ EE + + S ++L A+ F +++G G FG VYKG L D T +AVK L
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 700 DLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSH 759
T F+ E +++ HRNL+R+ C P + LV P M+NGS+ + L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 760 GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
LD + +I A G+AYLH H K++H D+K +NILLDE+ A+V DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879
L + + +T + G++G+IAPEY ++S DV+ +GV+LLE++T
Sbjct: 183 L----------MDYKDTHVTTA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
Query: 880 GRRPTDV---LFHDGSSLHEWVKRHYPH-RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVL 935
G+R D+ D L +WVK +L+ +V+ + + V
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-----------GNYKDEEVE 279
Query: 936 ELIELGLLCTQYNPSTRPSMLDVAH 960
+LI++ LLCTQ +P RP M +V
Sbjct: 280 QLIQVALLCTQSSPMERPKMSEVVR 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-89
Identities = 118/515 (22%), Positives = 184/515 (35%), Gaps = 36/515 (6%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
LDLS I A +LS L L L+ N Q L L++L +L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNEC 198
+G L L+ L++ +N + +P + SN T+L+++DLS+N + L+
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQS-FKLPEYFSNL-TNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 199 ELRNLRFLL-LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
++ L L L N + P A L L L +N S + I + L+ L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNL-GGMIPSIIGDLSTNLVQIHLDC 316
+F + + + +E LA + I + L TN+ L
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVS 291
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLN-------------------GTIPHELCLMSKL 357
I + S L L + G + L
Sbjct: 292 VTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
Query: 358 ERVYLSNNSLS--GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
E + LS N LS G + L LDLS N + + +F L QL L ++L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 416 SGTIPSS-LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE-LS 473
S NL LD+SH GL SL+ L ++ N + +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFT 467
Query: 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533
++ + +DLS L P S +L+ LN+S N+ L L L+ D S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 534 NRLFGEIPQSFQASPT-LKQLNFSFNKFSGNISNK 567
N + Q Q P+ L LN + N F+ ++
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 7e-89
Identities = 116/541 (21%), Positives = 188/541 (34%), Gaps = 47/541 (8%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
LDLS + S + + L VLDLS+ Q SL L L L+ N +Q
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
L L+ L L PI +L+ +++++N + +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPI---GHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 199 ELRNLRFLLLWSNRLVGQVPQALAN---------------------------SSKLEWLD 231
L NL L L SN++ L +L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291
L +N S + I + L+ L +F + + + +E LA
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 292 NNL-GGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE 350
+ I + L TN+ L I + S L L + +
Sbjct: 267 LDYYLDDIIDLFNCL-TNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLK 323
Query: 351 LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS--GSIPDSFANLSQLRRL 408
L + L+ S G + D+P L LDLS+N LS G S + L+ L
Sbjct: 324 LKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGP 467
L N + T+ S+ LE LD H+ + + V LR+L YL++S H
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI-YLDISHTHTRVA 436
Query: 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYL 526
+ + + + ++ N+ + P L L+LS LE L P + L L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 527 KQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN--KGAFSSLTIASFQGNDGL 584
+ ++S N F ++ +L+ L++S N + + SSL + ND
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
Query: 585 C 585
C
Sbjct: 557 C 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 9e-74
Identities = 97/494 (19%), Positives = 158/494 (31%), Gaps = 47/494 (9%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
S LDLS N + S L+ L LS +Q SL L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNECELRNLRFLLLWSNRLVG-QV 217
+ + +SLQ + +L + + L+ L+ L + N + ++
Sbjct: 88 IQSLALGAF---SGLSSLQKLVAVETNLASLENFPIGH---LKTLKELNVAHNLIQSFKL 141
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQF----LYLSYNDFVSHDGNTNLEP 273
P+ +N + LE LDL SN + + + Q+ L LS N
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA---- 196
Query: 274 FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL------DCNLIYGKIPPHI 327
F + +L L N + L L + + +
Sbjct: 197 -FKEI----RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 328 SNLVNLTLLNLSSNLLN---GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLL 384
L NLT+ L+ I ++ + L + ++ ++ L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHL 309
Query: 385 DLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS--GI 442
+L K +L +L G S +LE LDLS N +S G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGC 364
Query: 443 IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIA 501
G SLK YL+LS N + + ++ + +D +NL S
Sbjct: 365 CSQSDFGTTSLK-YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 502 LESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI-PQSFQASPTLKQLNFSFNKF 560
L L++S L L+ ++ N P F L L+ S +
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 561 SGNISNKGAFSSLT 574
AF+SL+
Sbjct: 483 EQLSPT--AFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-64
Identities = 83/449 (18%), Positives = 157/449 (34%), Gaps = 30/449 (6%)
Query: 71 KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQ 129
+ + LDLS + A + L L L NF ++ + L L+
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 130 LSLSWNSLQGK------IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDL 183
L + + S L L L + L + I N T++ L
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 184 SNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS 243
+ ++ + L L + + L + +L + + E
Sbjct: 290 VSVTIERVKDFSY---NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE--- 343
Query: 244 EIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIG 303
+P L+FL LS N G + S +++ + L+L+ N + M + +G
Sbjct: 344 ---VDLPSLEFLDLSRN------GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394
Query: 304 DLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362
L + + + + +L NL L++S +S LE + +
Sbjct: 395 --LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 363 SNNSLSGEI-PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPS 421
+ NS P F ++ +L LDLS+ +L P +F +LS L+ L + N+
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 422 SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE--LSKMDMVL 479
+L++LD S N I ++ S +LNL+ N + L +
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLS 508
+ + + + P + + SLN++
Sbjct: 573 QLLVEVERMECATPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-56
Identities = 87/494 (17%), Positives = 148/494 (29%), Gaps = 96/494 (19%)
Query: 95 PALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYL 154
P + + ++ + NF++ IP L K L LS+N L+ S +L+ L
Sbjct: 2 PCVEVVPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 155 DLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNECELRNLRFLLLWSNR 212
DL ++ + S + L + L+ N + L +L+ L+
Sbjct: 58 DLSRCEIQTIED-GAYQSL--SHLSTLILTGNPIQSLALGAFSG---LSSLQKLVAVETN 111
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
L + + L+ L++ N+ E S + L+ L LS N S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD--- 168
Query: 273 PFFASLANSSNFQ-ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPH-ISNL 330
L L+L+ N + + P ++ L ++ L N + I L
Sbjct: 169 --LRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI--RLHKLTLRNNFDSLNVMKTCIQGL 224
Query: 331 VNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNK 390
L + L + +L SA + +L + +
Sbjct: 225 AGLEVHRLVLGEFR------------------NEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 391 LSGS---IPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV 447
L I D F L+ + L + S + L+L + K +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKL 324
Query: 448 AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNL 507
L+ L +F + G +LE L+L
Sbjct: 325 KSLKRL------------------------------TFTSNKGGNAFSEVDLPSLEFLDL 354
Query: 508 SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK 567
S N L G QS + +LK L+ SFN SN
Sbjct: 355 SRNGLSFK----------------------GCCSQSDFGTTSLKYLDLSFNGVITMSSNF 392
Query: 568 GAFSSLTIASFQGN 581
L FQ +
Sbjct: 393 LGLEQLEHLDFQHS 406
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 9e-84
Identities = 94/504 (18%), Positives = 189/504 (37%), Gaps = 53/504 (10%)
Query: 88 SIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGS 147
S G + AN + LD+ L S R+ LSL G++P +G
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 148 LHQLEYLDLGNNKLVGEIPIPIFCS-NSSTSLQYIDLSNNSLTGEIPLK-NECELRNLRF 205
L +LE L LG++ + +++ S + + +L
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSH 265
+ S+ + ++ + K + SN + + + ++ +L+ Y+ + FV
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA-VMRLTKLRQFYMGNSPFV-- 219
Query: 266 DGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL-DCNLIYGKIP 324
+ ++ +L +L + + +C + K+P
Sbjct: 220 -----------AENICEAWENENSEYAQQYKTEDLKWDNL-KDLTDVEVYNCPNL-TKLP 266
Query: 325 PHISNLVNLTLLNLSSNLL--------NGTIPHELCLMSKLERVYLSNNSL-SGEIPSAF 375
+ L + L+N++ N + + + K++ +Y+ N+L + + ++
Sbjct: 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
Query: 376 GDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLS 435
+ LG+L+ N+L G +P +F + +L L L N ++ + G +E L +
Sbjct: 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFA 385
Query: 436 HNKISGIIPSDVAG-LRSLKLYLNLSSNHLDG-------PLPLELSKMDMVLAIDLSFNN 487
HNK+ I A + + ++ S N + PL K V +I+LS N
Sbjct: 386 HNKLKYIPNIFDAKSVSVMS-AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444
Query: 488 LSGSIPPQLGSCIALESLNLSGNSLEGL-------LPVSVGQLPYLKQFDVSSNRLFGEI 540
+S + L S+NL GN L + + L D+ N+L ++
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKL 503
Query: 541 PQSFQAS--PTLKQLNFSFNKFSG 562
F+A+ P L ++ S+N FS
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-76
Identities = 71/508 (13%), Positives = 156/508 (30%), Gaps = 91/508 (17%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
+ +++ +I + + N
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF------------------------- 197
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+ + L +L +GN+ V E + + + L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENI--------CEAWENENSEYAQQYKTEDL------ 243
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
N L +++ + +LP+ + +P++Q + ++ N
Sbjct: 244 -------------------KWDNLKDLTDVEVYNCPNLTKLPTF-LKALPEMQLINVACN 283
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNL-GGMIPSIIGDLSTNLVQIHLDCNLI 319
+S + + A Q + + NNL + + + + L + N +
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM-KKLGMLECLYNQL 342
Query: 320 YGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF--GD 377
G P + + L LNL+ N + + ++E + ++N L IP+ F
Sbjct: 343 EG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
Query: 378 IPHLGLLDLSKNKLSG-------SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLE 430
+ + +D S N++ + + + + L N +S L
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 431 ILDLSHNKISGI-------IPSDVAGLRSLKLYLNLSSNHLDG-PLPLELSKMDMVLAID 482
++L N ++ I + L ++L N L + + ++ ID
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLT-SIDLRFNKLTKLSDDFRATTLPYLVGID 519
Query: 483 LSFNNLSGSIPPQLGSCIALESL------NLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
LS+N+ S P Q + L+ + GN P + P L Q + SN +
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 537 FGEIPQSFQASPTLKQLNFSFNKFSGNI 564
++ + +P + L+ N
Sbjct: 579 -RKVNEKI--TPNISVLDIKDNPNISID 603
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-64
Identities = 58/358 (16%), Positives = 135/358 (37%), Gaps = 26/358 (7%)
Query: 221 LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLAN 280
L ++ ++ L LE SG +P I ++ +L+ L L + ++ ++
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAI-GQLTELEVLALGSHGEKVNE----RLFGPKGISA 131
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLS-TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLS 339
+ + ++ + + ++L++ ++ + I + T +
Sbjct: 132 NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSF 399
SN + + + ++KL + Y+ N+ E + + + + +
Sbjct: 192 SNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWE-----NENSEYAQQYKTEDLKW 245
Query: 400 ANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI--------IPSDVAGLR 451
NL L + +Y +P+ L +++++++ N+ +D
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305
Query: 452 SLKLYLNLSSNHL-DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGN 510
++ + + N+L P+ L KM + ++ +N L G P GS I L SLNL+ N
Sbjct: 306 KIQ-IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYN 363
Query: 511 SLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS--PTLKQLNFSFNKFSGNISN 566
+ + G ++ + N+L IP F A + ++FS+N+
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-50
Identities = 60/342 (17%), Positives = 122/342 (35%), Gaps = 32/342 (9%)
Query: 81 ELDLSARSI-YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
+ + ++ + +L + L +L+ N +G +P GS I+L L+L++N +
Sbjct: 309 IIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE 367
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE-- 197
+ G Q+E L +NKL IP + + + ID S N + +
Sbjct: 368 IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSV-SVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 198 ----CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG------ELPSEIIS 247
+ N+ + L +N++ + + S L ++L NM + + +E
Sbjct: 426 DPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFK 485
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307
L + L +N T L F ++L+ N+ P+ + ST
Sbjct: 486 NTYLLTSIDLRFNKL------TKLSDDF-RATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 308 -----NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362
Q N + P I+ +LT L + SN + + ++ + + +
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDI 594
Query: 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQ 404
+N S G+ L +K ++ +
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 6e-79
Identities = 100/632 (15%), Positives = 191/632 (30%), Gaps = 91/632 (14%)
Query: 27 ADDDQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWS------------GVKCNN 74
+ + I+D +L ++ + +H NW+ GV +N
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN 321
Query: 75 SRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSW 134
+ +V L L+ G + A+ L+ L VL + +
Sbjct: 322 N-GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 135 NSLQGKIPS-QLGSLHQLEYLDLGNNKL-----VGEIPIPIFCSNSS------------- 175
+ ++ L +L DL + + + I S
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 176 -------TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
T LQ I +N+ T + + + + +N L
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIA------VDWEDANSDYAKQYENEELSWSNLKDLT 494
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVS-HDGNTNLEPFFASLANSSNFQEL 287
++L + +LP + +P+LQ L ++ N +S + Q
Sbjct: 495 DVELYNCPNMTQLPDFL-YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 288 ELAGNNLGGMIPSI-IGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT 346
+ NNL S + + L + N + + V LT L L N +
Sbjct: 554 YMGYNNLEEFPASASLQKM-VKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-E 609
Query: 347 IPHELC-LMSKLERVYLSNNSLSGEIPSAF--GDIPHLGLLDLSKNKLSGSIPDSFA--- 400
IP + C ++E + S+N L IP+ F + +G +D S NK+ +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 401 --NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI-------IPSDVAGLR 451
+ L N + + + LS+N ++ I +
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 452 SLKLYLNLSSNHLDG-PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGN 510
L ++L N L + + + +D+S+N S S P Q + L++ +
Sbjct: 729 LLT-TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ 786
Query: 511 SLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAF 570
D NR+ + P P+L QL N +
Sbjct: 787 R------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE-KLT 826
Query: 571 SSLTIASFQGNDGLCGEIKGLQTCKKEHTHHL 602
L I N + ++ + + + L
Sbjct: 827 PQLYILDIADNPNISIDVTSVCPYIEAGMYVL 858
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 5e-68
Identities = 74/485 (15%), Positives = 150/485 (30%), Gaps = 76/485 (15%)
Query: 91 GTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQ 150
IS A+ L+ L ++ + + F A + + + + +L
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKD 492
Query: 151 LEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWS 210
L ++L N + ++P ++ LQ ++++ N LK +
Sbjct: 493 LTDVELYNCPNMTQLPDFLY---DLPELQSLNIACNRGISAAQLKADW------------ 537
Query: 211 NRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTN 270
++ K++ + N S + KM +L L +N +
Sbjct: 538 ----TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV------RH 587
Query: 271 LEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP--HIS 328
LE F + +L+L N + IP + + + N + IP +
Sbjct: 588 LEAF----GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAK 641
Query: 329 NLVNLTLLNLSSNLLNGTIPHELCLMS-----KLERVYLSNNSLSGEIPSAFGDIPHLGL 383
++ + ++ S N + + C M V LS N + F +
Sbjct: 642 SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIST 701
Query: 384 LDLSKNKLS-------GSIPDSFANLSQLRRLLLYGNHLSGTIPSSL--GKCVNLEILDL 434
+ LS N ++ ++ N L + L N L+ ++ L +D+
Sbjct: 702 IILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760
Query: 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPP 494
S+N S P+ LK + D N + P
Sbjct: 761 SYNCFSSF-PTQPLNSSQLK-AFGIRHQ------------------RDAEGNRILRQWPT 800
Query: 495 QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554
+ +C +L L + N + + + P L D++ N S
Sbjct: 801 GITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
Query: 555 FSFNK 559
++K
Sbjct: 858 LLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 9e-60
Identities = 71/521 (13%), Positives = 146/521 (28%), Gaps = 58/521 (11%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
+N K + + + I A + LD + + +
Sbjct: 248 DNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNK 306
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
+ + L + ++ L L G +P I T L+ + +S T
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG---QLTELKVLSFGTHSETVSG 363
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL 252
L + EL + L +L DL + + + + +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE---MKPIKKD 420
Query: 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQI 312
+ L + + ++ + Q + A + ++ +
Sbjct: 421 SRISLKDTQI--GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV------DWEDA 472
Query: 313 HLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG--- 369
+ D Y SNL +LT + L + +P L + +L+ + ++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 370 ------EIPSAFGDIPHLGLLDLSKNKLSG-SIPDSFANLSQLRRLLLYGNHLSGTIPSS 422
+ P + + + N L S + +L L N + +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEA 590
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG-PLPLELSKMDMVLAI 481
G V L L L +N+I I A ++ L S N L P + ++ ++
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVE-GLGFSHNKLKYIPNIFNAKSVYVMGSV 649
Query: 482 DLSFNNLSG-----SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
D S+N + S I ++ LS N ++
Sbjct: 650 DFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKF--------------------- 688
Query: 537 FGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIAS 577
+ F + + S N + N +
Sbjct: 689 ---PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-52
Identities = 57/383 (14%), Positives = 120/383 (31%), Gaps = 38/383 (9%)
Query: 75 SRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE--LGSLIRLKQLSL 132
+ N+ + ++ + + + N + PA L +++L L
Sbjct: 523 ACNRGISAAQLKADW-TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDC 580
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
N ++ + + G+ +L L L N++ EIP + ++ + S+N L
Sbjct: 581 VHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFC--AFTDQVEGLGFSHNKLKYIP 635
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALA-----NSSKLEWLDLESNMFSGELPSEIIS 247
+ N + + + N++ + + L N P+E+ +
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFA 694
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307
+ + LS N S N+ L+P + N+ ++L N L +
Sbjct: 695 TGSPISTIILSNNLMTSIPENS-LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSL 367
L + + N P N L + N +
Sbjct: 754 YLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRD------------------AEGNRI 794
Query: 368 SGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV 427
+ P+ P L L + N + + + QL L + N +S+ +
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYI 851
Query: 428 NLEILDLSHNKISGIIPSDVAGL 450
+ L ++K I D G+
Sbjct: 852 EAGMYVLLYDKTQDIRGCDALGI 874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-40
Identities = 55/343 (16%), Positives = 117/343 (34%), Gaps = 37/343 (10%)
Query: 81 ELDLSARSIYG-TISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
+ ++ S +L + L +LD N + H+ G+ ++L L L +N ++
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE 609
Query: 140 KIPSQLGS-LHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP----L 194
IP + Q+E L +NKL IP + + +D S N + E
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSV-YVMGSVDFSYNKIGSEGRNISCS 666
Query: 195 KNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI-------IS 247
++ + N + L N + + A S + + L +N+ + +P
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYK 725
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307
L + L +N T+L ++++ N P+ + +
Sbjct: 726 NTYLLTTIDLRFNKL------TSL-SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS-S 776
Query: 308 NLVQIHLDCNL------IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVY 361
L + I + P I+ +L L + SN + + +L +L +
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILD 833
Query: 362 LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQ 404
+++N ++ G+ L +K + +
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-77
Identities = 100/498 (20%), Positives = 182/498 (36%), Gaps = 27/498 (5%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L L+A + AL+ +L L + L + L+ L L N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+ +L+ LD NN + + S + ++L+ N + G P +
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEP--GAFDS 201
Query: 201 RNLRFLLLWSNRLVGQVPQALANSS--KLEWLDLESNMFSGELPSEIISKMP--QLQFLY 256
+ L + + + + L NS+ L E ++ + + ++ +
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESIN 260
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
L + F N+ + S QEL+L +L +PS + LS L ++ L
Sbjct: 261 LQKHYF------FNISS--NTFHCFSGLQELDLTATHLSE-LPSGLVGLS-TLKKLVLSA 310
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTI-PHELCLMSKLERVYLSNNSL--SGEIPS 373
N SN +LT L++ N + L + L + LS++ + S
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 374 AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP-SSLGKCVNLEIL 432
++ HL L+LS N+ ++F QL L L L S L++L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE---LSKMDMVLAIDLSFNNLS 489
+LSH+ + GL +L+ +LNL NH + L + + + LSF +LS
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQ-HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549
S + ++LS N L ++ L + +++SN + +P
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 550 LKQLNFSFNKFSGNISNK 567
+ +N N SN
Sbjct: 549 QRTINLRQNPLDCTCSNI 566
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 5e-75
Identities = 111/506 (21%), Positives = 181/506 (35%), Gaps = 33/506 (6%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
+ + I L +S L+ S N LI L L L+ +
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNEC 198
S H+L+ L L N L+ + + +L+++ ++ L N
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIF-MAETAL--SGPKALKHLFFIQTGISSIDFIPLHN-- 127
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
+ L L L SN + + KL+ LD ++N L E +S + Q L L+
Sbjct: 128 -QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLN 185
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS-TNLVQIHLDCN 317
N ++ +S+ FQ L G +I + + + +L +
Sbjct: 186 LN-------GNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 318 LIYGKIPPHISNLVNLTL--LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF 375
P L +++ +NL + + S L+ + L+ LS E+PS
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 376 GDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPS-SLGKCVNLEILDL 434
+ L L LS NK S +N L L + GN + + L NL LDL
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 435 SHNKISGIIPSDVA--GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI 492
SH+ I ++ L L+ LNLS N + + +DL+F L
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQ-SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 493 PP-QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ---SFQASP 548
+ L+ LNLS + L+ LP L+ ++ N Q S Q
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476
Query: 549 TLKQLNFSFNKFSGNISNKGAFSSLT 574
L+ L SF S ++ AF+SL
Sbjct: 477 RLEILVLSFCDLSS--IDQHAFTSLK 500
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-68
Identities = 104/445 (23%), Positives = 166/445 (37%), Gaps = 21/445 (4%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ L L + I P L VLD N ++ SL + LSL+ N
Sbjct: 130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
Query: 138 Q-GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK- 195
I + L+ G + + I +++ SL + P
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVI-FKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
++ + L + S L+ LDL + S ELPS + + L+ L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG-LVGLSTLKKL 306
Query: 256 YLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLD 315
LS N F NL S +N + L + GN + + + NL ++ L
Sbjct: 307 VLSANKF------ENLCQI--SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLS 358
Query: 316 CNLIY--GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG-EIP 372
+ I + NL +L LNLS N +LE + L+ L +
Sbjct: 359 HDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
Query: 373 SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI---PSSLGKCVNL 429
S F ++ L +L+LS + L S F L L+ L L GNH +SL L
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489
EIL LS +S I L+ + +++LS N L LS + + ++L+ N++S
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSHLKG-IYLNLASNHIS 536
Query: 490 GSIPPQLGSCIALESLNLSGNSLEG 514
+P L ++NL N L+
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-50
Identities = 72/347 (20%), Positives = 116/347 (33%), Gaps = 35/347 (10%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
V ++L + S S L LDL+ +P+ L L LK+L L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
S N + + L +L + N E+ + +L+ +DLS++ +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL--ENLENLRELDLSHDDIETSD 366
Query: 193 PLKNE-CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ 251
+ L +L+ L L N + +A +LE LDL + +
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426
Query: 252 LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQ 311
L+ L LS++ Q L L GN+ L
Sbjct: 427 LKVLNLSHSLL------DISSEQ--LFDGLPALQHLNLQGNHFPKGNIQKTNSL------ 472
Query: 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371
L L +L LS L+ H + + V LS+N L+
Sbjct: 473 ----------------QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
A + + L+L+ N +S +P LSQ R + L N L T
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-46
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 10/282 (3%)
Query: 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLN 344
+ L I G L + + N++ S L+NLT L+L+ +
Sbjct: 15 KTYNCENLGLN----EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 345 GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQ 404
+L+ + L+ N L +A L L + +S N
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 405 LRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK-LYLNLSSNH 463
L L L NH+S L++LD +N I + D++ L+ L LNL+ N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 464 LDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC--IALESLNLSGNSLEGLLPVSVG 521
+ G + + +++ I L + +L E + P
Sbjct: 191 IAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 522 QLP--YLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561
L ++ ++ + F +F L++L+ + S
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 9e-76
Identities = 104/331 (31%), Positives = 162/331 (48%), Gaps = 42/331 (12%)
Query: 656 RVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRE 714
RV L EAT F LIG G FG VYKGVL+D ++A+K ++ G F+ E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI--EEFETE 85
Query: 715 CQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKIC 774
+ L RH +L+ +I C + + L+ M NG+L+ HLY S + + Q ++IC
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES-VNCAND 833
A G+ YLH + ++H D+K NILLDE+ + DFGI+K +D++ +
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL----- 197
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV-LFHDGS 892
ST + G++GYI PEY + R + DVYSFGV+L E++ R L +
Sbjct: 198 -----STV--VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
Query: 893 SLHEWVKRHYPHR-LDPIVEKAIA-KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
+L EW + + L+ IV+ +A K P+ + K + + C +
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESL----RKF--------GDTAVKCLALSSE 298
Query: 951 TRPSMLDVAHEMGRLKQYLSSPSSLIEEAAL 981
RPSM DV + L+ L ++E+ +
Sbjct: 299 DRPSMGDVLWK---LEYALR-----LQESVI 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-75
Identities = 111/508 (21%), Positives = 169/508 (33%), Gaps = 36/508 (7%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
LDLS I A L L L L+ N Q P L L+ L L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+G L L+ L++ +N + +P + SN T+L ++DLS N + I + + L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNL-TNLVHVDLSYNYIQT-ITVNDLQFL 176
Query: 201 RNLRFLL----LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
R + + N + QA L L L N S + + + L
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
L +F EP E L N L+ N+ + L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLA-NVSAMSLAG 294
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLN-------------------GTIPHELCLMSKL 357
I K + L++ L G+I + + L
Sbjct: 295 VSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSL 352
Query: 358 ERVYLSNNSLSGEIPSAFGDI--PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
+ LS N+LS ++ D+ L LDLS N + +F L +L+ L + L
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTL 411
Query: 416 SGTIP-SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL-DGPLPLELS 473
S+ L LD+S+ GL SL L ++ N D L +
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFA 470
Query: 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533
+ +DLS L + L+ LN+S N+L L QL L D S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 534 NRLFGEIPQSFQASPTLKQLNFSFNKFS 561
NR+ +L N + N +
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 1e-73
Identities = 104/529 (19%), Positives = 171/529 (32%), Gaps = 46/529 (8%)
Query: 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
+ +DLS + S + +N S L LDLS+ + L L L L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
+Q P L LE L KL PI +L+ +++++N +
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPI---GQLITLKKLNVAHNFIHSCKLPAY 148
Query: 197 ECELRNLRFLLLWSNRLVGQVPQALANSS---------------------------KLEW 229
L NL + L N + L KL
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 230 LDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELEL 289
L L N S + + + L L +F EP E L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 290 AGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPH 349
N L+ N+ + L I K + L++ L
Sbjct: 269 TYTNDFSDDIVKFHCLA-NVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 350 ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANL--SQLRR 407
+L L+ + L+ N S I +P L LDLS+N LS S S+++L + LR
Sbjct: 326 DL---PFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 408 LLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDG 466
L L N + ++ L+ LD H+ + + L L YL++S +
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL-YLDISYTNTKI 438
Query: 467 PLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPY 525
+ + + ++ N+ + + L L+LS LE + L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 526 LKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
L+ ++S N L + +L L+ SFN+ +
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI--LQHFPK 545
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-52
Identities = 77/403 (19%), Positives = 138/403 (34%), Gaps = 33/403 (8%)
Query: 74 NSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSL 132
+ + LD+S I I L L L NF +I L +L L L
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 133 SWNSLQGKI------PSQLGSLHQL--EYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLS 184
+ + PS + L + + L + + C ++ + L+
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL---ANVSAMSLA 293
Query: 185 NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSE 244
S+ L++ + + L + +L L L+ L L N S
Sbjct: 294 GVSIKY---LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSISFK-- 345
Query: 245 IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD 304
+P L +L LS N + S +++ + L+L+ N + +
Sbjct: 346 -KVALPSLSYLDLSRNAL------SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMG 397
Query: 305 LSTNLVQIHLDCNLIYGKIPPH-ISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363
L L + + + +L L L++S ++ L + ++
Sbjct: 398 L-EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456
Query: 364 NNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS 422
NS S F + +L LDLSK +L F L +L+ L + N+L S
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
+ +L LD S N+I +SL + NL++N +
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLA-FFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-46
Identities = 77/495 (15%), Positives = 148/495 (29%), Gaps = 91/495 (18%)
Query: 91 GTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQ 150
G+++P + + ++ +P ++ S K + LS+N L+ + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSE 57
Query: 151 LEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWS 210
L++LDL ++ I + + L + L+ N + + L +L L+
Sbjct: 58 LQWLDLSRCEIET-IEDKAW--HGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVE 113
Query: 211 NRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTN 270
+L + L+ L++ N S + L + LSYN + N
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND- 172
Query: 271 LEPFFASLAN-SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPH-IS 328
L L+++ N + + + L ++ L N I +
Sbjct: 173 ----LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI--KLHELTLRGNFNSSNIMKTCLQ 226
Query: 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGL--LDL 386
NL L + L +L PS + + + L
Sbjct: 227 NLAGLHVHRLILGEF------------------KDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSD 446
+ F L+ + + L G + + K + L + ++
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPT-- 324
Query: 447 VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLN 506
L LK L L+ N SI + + +L L+
Sbjct: 325 -LDLPFLK-SLTLTMNKG--------------------------SISFKKVALPSLSYLD 356
Query: 507 LSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566
LS N+L G S + +L+ L+ SFN +N
Sbjct: 357 LSRNALSFS----------------------GCCSYSDLGTNSLRHLDLSFNGAIIMSAN 394
Query: 567 KGAFSSLTIASFQGN 581
L FQ +
Sbjct: 395 FMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-26
Identities = 38/187 (20%), Positives = 57/187 (30%), Gaps = 10/187 (5%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQG 139
LDLS +S L L LD + + SL +L L +S+ + +
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP--LKNE 197
L L L + N +F + T+L ++DLS L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT--TNLTFLDLSKCQLEQISWGVFDT- 495
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L L+ L + N L+ L LD N + L F L
Sbjct: 496 --LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNL 552
Query: 258 SYNDFVS 264
+ N
Sbjct: 553 TNNSVAC 559
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 8e-75
Identities = 86/340 (25%), Positives = 146/340 (42%), Gaps = 44/340 (12%)
Query: 643 EDEEKEKEEAKNPRVSYKQLIEATGGFCP------SSLIGSGRFGHVYKGVLQDNTRIAV 696
E++ E + + S+ +L T F + +G G FG VYKG + +NT +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 697 KVLDLTTTGEIT-GS--FKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLEN 753
K L F +E +++ + +H NL+ ++ S D LV M NGSL +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 754 HLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813
L G L KI A G+ +LH + +H D+K +NILLDE TA ++
Sbjct: 120 RLSCLDGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 873
DFG+A+ + ++V ++ + G+ Y+APE G+ + D+YSFGV+
Sbjct: 176 DFGLARASEKFAQTVM---------TSR--IVGTTAYMAPEALRGE-ITPKSDIYSFGVV 223
Query: 874 LLEIVTGRRPTDVLFHDGSSLHEWVKRHY--PHRLDPIVEKAIAKYAPQHMPIYYNKVWS 931
LLEI+TG D + L + + ++ ++K + +
Sbjct: 224 LLEIITGLPAVD-EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV--------- 273
Query: 932 DVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971
+ + C + RP + V L++ +S
Sbjct: 274 ---EAMYSVASQCLHEKKNKRPDIKKVQQL---LQEMTAS 307
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 8e-64
Identities = 111/499 (22%), Positives = 188/499 (37%), Gaps = 21/499 (4%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
LDLS I A +LS L L L+ N Q L L++L +L
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+G L L+ L++ +N + +P + SN T+L+++DLS+N + I + L
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN-LTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 201 RNLRFLLLW----SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
+ L L N + P A L L L +N S + I + L+
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
L +F + + + +E LA + + + TN+ L
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFG 376
I + S L L + +L L+R+ ++N +
Sbjct: 292 VTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGN--AFSEV 344
Query: 377 DIPHLGLLDLSKNKLS--GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434
D+P L LDLS+N LS G S + L+ L L N + T+ S+ LE LD
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 435 SHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIP 493
H+ + + V LR+L YL++S H + + + + ++ N+ +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLI-YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 494 PQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQ 552
P L L+LS LE L P + L L+ +++SN+L F +L++
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK 522
Query: 553 LNFSFNKFSGNISNKGAFS 571
+ N + + S
Sbjct: 523 IWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-54
Identities = 106/505 (20%), Positives = 182/505 (36%), Gaps = 45/505 (8%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
S LDLS N + S L+ L LS +Q SL L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL-VGQVPQ 219
+ + + F + +SLQ + +L + L+ L+ L + N + ++P+
Sbjct: 88 IQ-SLALGAF--SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 220 ALANSSKLEWLDLESNMFSGELPSEIISKMPQLQF----LYLSYNDFVSHDGNTNLEPFF 275
+N + LE LDL SN + + + Q+ L LS N E
Sbjct: 144 YFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 276 ASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTL 335
L +NF L + + G+ + L + + + L NLT+
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE---FRNEGNLEKFDKSALEGLCNLTI 259
Query: 336 LNLSSNLLNG---TIPHELCLMSKLERVYLSNNSLSGEIPSAFG--------------DI 378
L+ I ++ + L + ++ ++
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQF 319
Query: 379 PHLGL-----LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS--GTIPSSLGKCVNLEI 431
P L L L + NK + S +L L L L N LS G S +L+
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE-LSKMDMVLAIDLSFNNLSG 490
LDLS N + + S+ GL L+ +L+ ++L + ++ +D+S +
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 491 SIPPQLGSCIALESLNLSGNSLEGLLPVSV-GQLPYLKQFDVSSNRLFGEIPQSFQASPT 549
+ +LE L ++GNS + + +L L D+S +L P +F + +
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495
Query: 550 LKQLNFSFNKFSGNISNKGAFSSLT 574
L+ LN + N+ G F LT
Sbjct: 496 LQVLNMASNQLK--SVPDGIFDRLT 518
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-38
Identities = 72/378 (19%), Positives = 133/378 (35%), Gaps = 29/378 (7%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLS 131
+ + LDLS + A + L L L NF ++ + L L+
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 132 L------SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSN 185
L + +L+ S L L L + L + I N T++ L +
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291
Query: 186 NSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI 245
++ ++L + + + L+ L SN SE+
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLK------SLKRLTFTSNKGG-NAFSEV 344
Query: 246 ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL 305
+P L+FL LS N + S +++ + L+L+ N + + S L
Sbjct: 345 --DLPSLEFLDLSRNGL------SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395
Query: 306 STNLVQIHLDCNLIYGKIPPHI--SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363
L + + + ++ +L NL L++S +S LE + ++
Sbjct: 396 -EQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453
Query: 364 NNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS 422
NS F ++ +L LDLS+ +L P +F +LS L+ L + N L
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 423 LGKCVNLEILDLSHNKIS 440
+ +L+ + L N
Sbjct: 514 FDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 86/449 (19%), Positives = 141/449 (31%), Gaps = 72/449 (16%)
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
IP L + LDL N L + F S LQ +DLS + I L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLR-HLGSYSFFS--FPELQVLDLSRCEIQ-TIEDGAYQSL 75
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
+L L+L N + A + S L+ L + L + I + L+ L +++N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS---TNLVQIHLDCN 317
S L +F++L +N + L+L+ N + + + + L + + L N
Sbjct: 135 LIQS----FKLPEYFSNL---TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPSAFG 376
+ I P + L L L +N + + ++ LE L
Sbjct: 188 PM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF--------- 237
Query: 377 DIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG---TIPSSLGKCVNLEILD 433
++ L + L L +L I N+
Sbjct: 238 ---------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288
Query: 434 LSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI 492
L I + S G + L+L +N L + + + N +
Sbjct: 289 LVSVTIERVKDFSYNFGWQHLEL-VNCKFGQFPTLKLKSLKR------LTFTSNKGGNA- 340
Query: 493 PPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQ 552
+LE L+LS N L G QS + +LK
Sbjct: 341 -FSEVDLPSLEFLDLSRNGLSFK----------------------GCCSQSDFGTTSLKY 377
Query: 553 LNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L+ SFN SN L FQ +
Sbjct: 378 LDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-32
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 21/325 (6%)
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
I +L + + L N + + L +L+LS + +S L
Sbjct: 21 KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL-SGT 418
+ L+ N + AF + L L + L+ +L L+ L + N + S
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK---LYLNLSSNHLDGPLPLELSKM 475
+P NLE LDLS NKI I +D+ L + L L+LS N ++ P ++
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 476 DMVLAIDLSFNNLSGSIPPQLGSCIA-LESLNLSGNSLEG---LLPVSVGQLPYLKQFDV 531
+ + L N S ++ +A LE L L L L +
Sbjct: 201 RLHK-LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 532 SSNRL------FGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLC 585
RL +I F + + + +
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNC---- 314
Query: 586 GEIKGLQTCKKEHTHHLVILSILLS 610
+ T K + L S
Sbjct: 315 -KFGQFPTLKLKSLKRLTFTSNKGG 338
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-60
Identities = 110/487 (22%), Positives = 208/487 (42%), Gaps = 51/487 (10%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ ++ L ++ T+S +L + L + + L L Q++ S N L
Sbjct: 25 EKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQINFSNNQL 80
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
P L +L +L + + NN++ P+ + T+L + L NN +T PLKN
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIADITPL-----ANLTNLTGLTLFNNQITDIDPLKN- 132
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L NL L L SN + AL+ + L+ L N + P ++ + L+ L +
Sbjct: 133 --LTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP---LANLTTLERLDI 184
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317
S N +++ LA +N + L N + + P +G L TNL ++ L+ N
Sbjct: 185 SSNKV------SDISV----LAKLTNLESLIATNNQISDITP--LGIL-TNLDELSLNGN 231
Query: 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGD 377
+ K +++L NLT L+L++N ++ P L ++KL + L N +S P
Sbjct: 232 QL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 285
Query: 378 IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
+ L L+L++N+L P +NL L L LY N++S P + L+ L +N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 438 KISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLG 497
K+S + +A L ++ +L+ N + P L+ + + + L+ + + P
Sbjct: 342 KVSDVSS--LANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYK 395
Query: 498 SCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSF 557
+ +++ + + + P ++ + D++ N S+ S +
Sbjct: 396 ANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVSYTFS-QPVTIGKGT 453
Query: 558 NKFSGNI 564
FSG +
Sbjct: 454 TTFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 7e-59
Identities = 108/469 (23%), Positives = 177/469 (37%), Gaps = 50/469 (10%)
Query: 95 PALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYL 154
L+ + L K + L ++ L + K + L+ L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 155 DLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLV 214
+ NN+L P+ + T L I ++NN + PL N L NL L L++N++
Sbjct: 74 NFSNNQLTDITPL-----KNLTKLVDILMNNNQIADITPLAN---LTNLTGLTLFNNQIT 125
Query: 215 GQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPF 274
L N + L L+L SN S +S + LQ L T+L+P
Sbjct: 126 D--IDPLKNLTNLNRLELSSNTISD---ISALSGLTSLQQLSFGNQ-------VTDLKP- 172
Query: 275 FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLT 334
LAN + + L+++ N + S++ L TNL + N I I P + L NL
Sbjct: 173 ---LANLTTLERLDISSNKVSD--ISVLAKL-TNLESLIATNNQISD-ITP-LGILTNLD 224
Query: 335 LLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS 394
L+L+ N L L ++ L + L+NN +S P + L L L N++S
Sbjct: 225 ELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 280
Query: 395 IPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454
P A L+ L L L N L P + NL L L N IS I P V+ L L+
Sbjct: 281 SP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 334
Query: 455 LYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514
L +N + L+ + + + N +S P L + + L L+ +
Sbjct: 335 -RLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 515 LLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563
+ + L P + + + + ++N S
Sbjct: 390 APVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-52
Identities = 102/482 (21%), Positives = 178/482 (36%), Gaps = 73/482 (15%)
Query: 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
++V L I + L++L ++ S N P L +L +L + ++ N
Sbjct: 46 DQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 101
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
+ P L +L L L L NN++ P+ + T+L ++LS+N+++ L
Sbjct: 102 IADITP--LANLTNLTGLTLFNNQITDIDPL-----KNLTNLNRLELSSNTISDISALSG 154
Query: 197 ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
L +L+ L N++ + LAN + LE LD+ SN S +++K+ L+ L
Sbjct: 155 ---LTSLQQLSF-GNQVTD--LKPLANLTTLERLDISSNKVSDI---SVLAKLTNLESLI 205
Query: 257 LSYNDFVSHDG---NTNLEPF---------FASLANSSNFQELELAGNNLGGMIPSIIGD 304
+ N TNL+ +LA+ +N +L+LA N + + P +
Sbjct: 206 ATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSG 263
Query: 305 LSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364
L T L ++ L N I I P ++ L LT L L+ N L P + + L + L
Sbjct: 264 L-TKLTELKLGANQI-SNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318
Query: 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLG 424
N++S P + L L NK+S S ANL+ + L N +S P L
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LA 372
Query: 425 KCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLS 484
+ L L+ + + A + N
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN-------------------------- 406
Query: 485 FNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544
+ P + + +++ N VS + G + Q
Sbjct: 407 -VTGALIAPATISDGGSYTEPDITWNLPSYTNEVS-YTFSQPVTIGKGTTTFSGTVTQPL 464
Query: 545 QA 546
+A
Sbjct: 465 KA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 92/427 (21%), Positives = 175/427 (40%), Gaps = 45/427 (10%)
Query: 156 LGNNKLVGEIPIP-IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLV 214
LG+ + + PI IF + L ++T + + L + L +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTD---LDQVTTLQADRLGI- 58
Query: 215 GQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPF 274
+ + + L ++ +N + P + + +L + ++ N ++ P
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQI------ADITP- 107
Query: 275 FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLT 334
LAN +N L L N + + P + +L TNL ++ L N I +S L +L
Sbjct: 108 ---LANLTNLTGLTLFNNQITDIDP--LKNL-TNLNRLELSSNTI--SDISALSGLTSLQ 159
Query: 335 LLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS 394
L+ + + + L ++ LER+ +S+N +S S + +L L + N++S
Sbjct: 160 QLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI 214
Query: 395 IPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454
P L+ L L L GN L +L NL LDL++N+IS + P ++GL L
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 268
Query: 455 LYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514
L L +N + P L+ + + ++L+ N L P + + L L L N++
Sbjct: 269 -ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 515 LLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
+ PVS L L++ +N++ S + L+ N+ S +++ + +T
Sbjct: 324 ISPVS--SLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQIS-DLTPLANLTRIT 378
Query: 575 IASFQGN 581
Sbjct: 379 QLGLNDQ 385
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-59
Identities = 69/341 (20%), Positives = 126/341 (36%), Gaps = 44/341 (12%)
Query: 646 EKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG 705
+ + + L + + GRFG V+K L N +AVK+ +
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ 61
Query: 706 EITGSFKRECQILKRIRHRNLIRIITICSKPDFKA----LVLPLMSNGSLENHLYPSHGL 761
+ E L ++H N+++ I + L+ GSL + L
Sbjct: 62 SWQ--NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----- 114
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPI-------KVVHCDLKPSNILLDEDLTALVAD 814
++ + +L I +A G+AYLH P + H D+K N+LL +LTA +AD
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYS 869
FG+A + + + G+ Y+APE G + A D+Y+
Sbjct: 175 FGLALKFEAGKSAGDTHG-----------QVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 870 FGVLLLEIVTGRRPTDVLFHDGS-SLHEWVKRHYPHRLDPIVEKAIAKYAPQHM-PIYYN 927
G++L E+ + D + E + +H P +E + P+ +
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQH------PSLEDMQEVVVHKKKRPVLRD 277
Query: 928 KVWSDVVL-ELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
+ L E C ++ R S V + ++++
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-58
Identities = 93/384 (24%), Positives = 158/384 (41%), Gaps = 42/384 (10%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L I I P A+L+ I L K + L + +L ++ +
Sbjct: 4 TLATLPAPI-NQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
I + L LEYL+L N++ P+ ++ L + + N +T L+N L
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISPL-----SNLVKLTNLYIGTNKITDISALQN---L 109
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
NLR L L + + LAN +K+ L+L +N +L +S M L +L ++ +
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP--LSNMTGLNYLTVTES 165
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
++ P AN ++ L L N + + P + L T+L N I
Sbjct: 166 KV------KDVTPI----ANLTDLYSLSLNYNQIEDISP--LASL-TSLHYFTAYVNQIT 212
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPH 380
P ++N+ L L + +N + P L +S+L + + N +S +A D+
Sbjct: 213 DITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTK 266
Query: 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440
L +L++ N++S NLSQL L L N L +G NL L LS N I+
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHL 464
I P +A L + + ++ +
Sbjct: 325 DIRP--LASLSKMD-SADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 77/363 (21%), Positives = 152/363 (41%), Gaps = 39/363 (10%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ + L S+ T L S+ L ++ I + L L+ L+L+ N +
Sbjct: 23 EGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQI 78
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
P L +L +L L +G NK+ I + T+L+ + L+ ++++ PL N
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKITD---ISALQNL--TNLRELYLNEDNISDISPLAN- 130
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L + L L +N + L+N + L +L + + I+ + L L L
Sbjct: 131 --LTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD---VTPIANLTDLYSLSL 184
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317
+YN ++ P LA+ ++ N + + P + ++ T L + + N
Sbjct: 185 NYNQI------EDISP----LASLTSLHYFTAYVNQITDITP--VANM-TRLNSLKIGNN 231
Query: 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGD 377
I + P ++NL LT L + +N + + + + ++KL+ + + +N +S S +
Sbjct: 232 KI-TDLSP-LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 378 IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
+ L L L+ N+L + L+ L L L NH++ P L ++ D ++
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
Query: 438 KIS 440
I
Sbjct: 344 VIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-47
Identities = 72/362 (19%), Positives = 143/362 (39%), Gaps = 37/362 (10%)
Query: 221 LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLAN 280
A+ ++ L+ + + ++ + L ++ +++ +
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKV------ASIQG----IEY 64
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340
+N + L L GN + + P + +L L +++ N I + NL NL L L+
Sbjct: 65 LTNLEYLNLNGNQITDISP--LSNL-VKLTNLYIGTNKI--TDISALQNLTNLRELYLNE 119
Query: 341 NLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA 400
+ ++ P L ++K+ + L N S ++ L L ++++K+ P A
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IA 174
Query: 401 NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLS 460
NL+ L L L N + P L +L N+I+ I P VA + L L +
Sbjct: 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLN-SLKIG 229
Query: 461 SNHLDGPLPLE-LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519
+N + PL LS++ +++ N +S I + L+ LN+ N + + ++
Sbjct: 230 NNKITDLSPLANLSQLTW---LEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISDISVLN 284
Query: 520 VGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQ 579
L L +++N+L E + L L S N + +I + S + A F
Sbjct: 285 --NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLASLSKMDSADFA 341
Query: 580 GN 581
Sbjct: 342 NQ 343
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-57
Identities = 79/305 (25%), Positives = 130/305 (42%), Gaps = 47/305 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V K + +A+K ++ + +F E + L R+ H N++++ C
Sbjct: 16 VGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
P LV+ GSL N L+ + L + + C ++GVAYLH P ++H
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 795 CDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
DLKP N+LL T L + DFG A ++ T+ GS ++AP
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQ------------THMTNN----KGSAAWMAP 172
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA 913
E G S DV+S+G++L E++T R+P D + + V R P+
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--RP-PL---- 225
Query: 914 IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPS 973
+++P + L+ C +PS RPSM ++ M L +Y
Sbjct: 226 -----IKNLP--------KPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
Query: 974 SLIEE 978
++
Sbjct: 270 EPLQY 274
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-56
Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 44/297 (14%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITIC 733
IGSG FG VYKG + +AVK+L++T T + +FK E +L++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P A+V SL +HL H ++ +L+ I A G+ YLH ++
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAK---SII 142
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLK +NI L ED T + DFG+A S L GS+ ++AP
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-----------HQFEQLSGSILWMAP 191
Query: 854 E---YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
E S DVY+FG++L E++TG+ P Y + ++
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP------------------YSN-INN-R 231
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
++ I + +KV S+ + L C + RPS + E+ L +
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-56
Identities = 113/496 (22%), Positives = 186/496 (37%), Gaps = 32/496 (6%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQG 139
LDLS I L ++L VL L + I + SL L+ L LS N L
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSS 88
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199
S G L L+YL+L N + + N T+LQ + + N EI +
Sbjct: 89 LSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNL-TNLQTLRIGNVETFSEIRRIDFAG 146
Query: 200 LRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSY 259
L +L L + + L Q+L + + L L + + L + +++L L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRD 205
Query: 260 NDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLI 319
+ + +S F+ L + ++ + L + V+ DC L
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF-DDCTLN 264
Query: 320 Y-GKIPPHISN---------LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
G P S+ V + L++ L + L+ K++R+ + N+ +
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324
Query: 370 EIPSAFGDIPHLGLLDLSKNKLSGSIPDS---FANLSQLRRLLLYGNHLS--GTIPSSLG 424
S + L LDLS+N + + L+ L+L NHL L
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 425 KCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLS 484
NL LD+S N +P ++ +LNLSS + + + + VL D+S
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMR-FLNLSSTGIRV-VKTCIPQTLEVL--DVS 439
Query: 485 FNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544
NNL S L L+ L +S N L+ L S P L +S N+L F
Sbjct: 440 NNNLD-SFSLFLPR---LQELYISRNKLKTLPDAS--LFPVLLVMKISRNQLKSVPDGIF 493
Query: 545 QASPTLKQLNFSFNKF 560
+L+++ N +
Sbjct: 494 DRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-51
Identities = 93/499 (18%), Positives = 182/499 (36%), Gaps = 50/499 (10%)
Query: 100 LSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNN 159
+++ LDLS N +L + L+ L L + + SL LE+LDL +N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP- 218
L + F +SL+Y++L N L NL+ L + + ++
Sbjct: 85 HLS-SLSSSWF--GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 219 QALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278
A + L L++++ S+ + + + L L + + L
Sbjct: 142 IDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLS------ESAFLLEI--FA 192
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLI----------YGKIPPHIS 328
S+ + LEL NL + + K+ +I
Sbjct: 193 DILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 329 NLVNLTLLNLSSNLLNGTIPHELCLMSK--------LERVYLSNNSLSGEIPSAFGDIPH 380
L + + + N L P E ++S+ + R+++ L ++ + + +
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI---PSSLGKCVNLEILDLSHN 437
+ + + +K+ +L L L L N + + G +L+ L LS N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
Query: 438 KISGI--IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
+ + + L++L L++S N P+P + + ++LS + +
Sbjct: 372 HLRSMQKTGEILLTLKNLT-SLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428
Query: 496 LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNF 555
+ LE L++S N+L+ LP L++ +S N+L +P + P L +
Sbjct: 429 IPQ--TLEVLDVSNNNLDSFSL----FLPRLQELYISRNKL-KTLPDASL-FPVLLVMKI 480
Query: 556 SFNKFSGNISNKGAFSSLT 574
S N+ G F LT
Sbjct: 481 SRNQLK--SVPDGIFDRLT 497
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-44
Identities = 80/451 (17%), Positives = 158/451 (35%), Gaps = 42/451 (9%)
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
D + IP S + +++ +DLS N +T I + NL+ L+L S+R+
Sbjct: 10 CDGRSRSFT-SIP-----SGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRI 62
Query: 214 VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP 273
A + LE LDL N S L S + L++L L N + +
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQT-------LG 114
Query: 274 FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333
+ N +N Q L + I I T+L ++ + + + ++ ++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393
L L + + ++S + + L + +L+ S + + S
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLG------------------KCVNLEILDLS 435
+SF L +L R +L + + + G + V + L +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 436 HNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
+ + + + L +K + + ++ + + + +DLS N +
Sbjct: 295 QFYLFYDLSTVYSLLEKVK-RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 496 ---LGSCIALESLNLSGNSLEGL--LPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTL 550
G+ +L++L LS N L + + L L D+S N +P S Q +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKM 412
Query: 551 KQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
+ LN S + +L + N
Sbjct: 413 RFLNLSSTGIR--VVKTCIPQTLEVLDVSNN 441
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-40
Identities = 74/403 (18%), Positives = 147/403 (36%), Gaps = 37/403 (9%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
L + + I A L+SL L++ + + L S+ + L+L +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI------P 193
+ L + YL+L + L P+ S+ ++ + + LT E
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246
Query: 194 LKNECELRNLRFL---LLWSNRLVGQVPQALANSSKLEWLDLESNMFSG----ELPSEII 246
L+ EL + F L ++ K+E + + S +
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG--GMIPSIIGD 304
S + +++ + + + + F L + + L+L+ N + + S
Sbjct: 307 SLLEKVKRITVENSKVFLVPCS-----FSQHL---KSLEFLDLSENLMVEEYLKNSACKG 358
Query: 305 LSTNLVQIHLDCNLIY--GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362
+L + L N + K + L NLT L++S N + +P K+ + L
Sbjct: 359 AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS 422
S+ + + + L +LD+S N L S L +L+ L + N L T+P +
Sbjct: 418 SSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLK-TLPDA 469
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
L ++ +S N++ + L SL+ + L +N D
Sbjct: 470 -SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ-KIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 53/297 (17%), Positives = 103/297 (34%), Gaps = 16/297 (5%)
Query: 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS 392
+ + S +IP L + ++ + LS N ++ +L +L L ++++
Sbjct: 7 SGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 393 GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLR 451
D+F +L L L L NHLS S G +L+ L+L N + + + L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 452 SLKLYLNLSS-NHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGN 510
+L+ L + + ++ + + + +++ +L L S + L L +
Sbjct: 124 NLQ-TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 511 SLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAF 570
LL + L ++ ++ L FQ SP S K +
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-----ARFQFSPLPVDEVSSPMKKLAFRGS---- 233
Query: 571 SSLTIASFQGNDGLCGEIKGLQTCKKEHTHHLVILSILLSLFAMSLLFIFGNFLVLR 627
LT SF L I L + + + S + + +R
Sbjct: 234 -VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 55/254 (21%), Positives = 100/254 (39%), Gaps = 25/254 (9%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158
++ L + + + + L ++K++++ + + S L LE+LDL
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 159 NKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE--CELRNLRFLLLWSNRLVGQ 216
N +V E C + SLQ + LS N L + E L+NL L + N
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HP 401
Query: 217 VPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFA 276
+P + K+ +L+L S + + I L+ L +S N+ + F
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCI---PQTLEVLDVSNNNL------DSFSLFLP 451
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTL 335
L QEL ++ N L +P L L+ + + N + +P I L +L
Sbjct: 452 RL------QELYISRNKLK-TLPD--ASLFPVLLVMKISRNQL-KSVPDGIFDRLTSLQK 501
Query: 336 LNLSSNLLNGTIPH 349
+ L +N + + P
Sbjct: 502 IWLHTNPWDCSCPR 515
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-56
Identities = 86/310 (27%), Positives = 142/310 (45%), Gaps = 48/310 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVL-DLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG+G FG V++ + +AVK+L + E F RE I+KR+RH N++ +
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++P ++V +S GSL L+ G LD + + + DVA+G+ YLH+ +P +V
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H +LK N+L+D+ T V DFG+++L A+ +S S G+ ++AP
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLK---------ASTFLSSKSA----AGTPEWMAP 208
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP--IVE 911
E + ++ DVYSFGV+L E+ T ++P + + L+P +V
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQP------------------WGN-LNPAQVVA 249
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971
K +P N + +IE C P RPS + M L+ + S
Sbjct: 250 AVGFKCKRLEIPRNLNPQVAA----IIE---GCWTNEPWKRPSFATI---MDLLRPLIKS 299
Query: 972 PSSLIEEAAL 981
+ L
Sbjct: 300 AVPPPNRSDL 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-56
Identities = 57/306 (18%), Positives = 110/306 (35%), Gaps = 33/306 (10%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG K ++ + V + E +F +E ++++ + H N+++ I +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K + + G+L + + Q V D+A G+AYLH ++H
Sbjct: 78 KDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL-LCGSVGYIAP 853
DL N L+ E+ +VADFG+A+L+ + G+ ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA 913
E G+ DV+SFG++L EI+
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------------DPDYLPRTMDFGLN 235
Query: 914 IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPS 973
+ + ++ P + + + C +P RPS + + L+ +
Sbjct: 236 VRGFLDRYCP-------PNCPPSFFPITVRCCDLDPEKRPSFVKL---EHWLETLRMHLA 285
Query: 974 SLIEEA 979
+
Sbjct: 286 GHLPLG 291
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-54
Identities = 93/490 (18%), Positives = 173/490 (35%), Gaps = 45/490 (9%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLG 157
L++ L LS N+ + + L +L+ L L I + +L L LDLG
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE-LRNLRFLLLWSNRLVG- 215
++K+ + F L + L L+ + L+ L L L N++
Sbjct: 82 SSKIY-FLHPDAFQGL--FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138
Query: 216 QVPQALANSSKLEWLDLESNMFSGELPSEIIS--KMPQLQFLYLSYNDFVSHDGNTNLEP 273
+ + + L+ +D SN + + + L F L+ N S +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 274 FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333
+ + + L+++GN + N I + ++
Sbjct: 198 M--NPFRNMVLEILDVSGNGW-------------TVDITGNFSNAISKSQAFSLILAHHI 242
Query: 334 TLLNLSSNLLNGTIPHE----LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389
+ + L S + + LS+ + F + L +L+L+ N
Sbjct: 243 MGAGFGFHNIK-DPDQNTFAGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN 300
Query: 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAG 449
K++ ++F L L+ L L N L S+ + +DL N I+ I
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 450 LRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509
L L+ L+L N L + + + I LS N L ++P + ++LS
Sbjct: 361 LEKLQ-TLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSE 410
Query: 510 NSLEGLLPVSV-GQLPYLKQFDVSSNRL-FGEIPQSFQASPTLKQLNFSFNKFSGNIS-- 565
N LE L + ++P+L+ ++ NR Q+ +P+L+QL N
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470
Query: 566 -NKGAFSSLT 574
F L+
Sbjct: 471 LCWDVFEGLS 480
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-53
Identities = 107/521 (20%), Positives = 197/521 (37%), Gaps = 56/521 (10%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
L+L ++ TI A NL +L +LDL + P L L +L L + L
Sbjct: 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111
Query: 140 KI--PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK-- 195
+ +L L LDL N++ P F SL+ ID S+N + +
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL--NSLKSIDFSSNQIF-LVCEHEL 168
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSK------LEWLDLESNMFSGELPSEIISKM 249
+ + L F L +N L +V LE LD+ N ++ ++ + +
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL-STN 308
+ Q SL + + +N+ + L ++
Sbjct: 229 SKSQAF---------------------SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267
Query: 309 LVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSL 367
+ + L ++ + + L +L +LNL+ N +N + L+ + LS N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 368 SGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV 427
S F +P + +DL KN ++ +F L +L+ L L N L +++
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIP 381
Query: 428 NLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE-LSKMDMVLAIDLSFN 486
++ + LS NK+ + ++ ++LS N L+ L L ++ + + L+ N
Sbjct: 382 SIPDIFLSGNKLVTLPKINLTA-----NLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
Query: 487 NLSGSIPPQL-GSCIALESLNLSGNSLEGLLPVSV-----GQLPYLKQFDVSSNRLFGEI 540
S Q +LE L L N L+ + L +L+ ++ N L
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496
Query: 541 PQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
P F L+ L+ + N+ + +S+ ++L I N
Sbjct: 497 PGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-47
Identities = 122/600 (20%), Positives = 211/600 (35%), Gaps = 67/600 (11%)
Query: 81 ELDLSARSIYGTISP--ALANLSSLIVLDLSKNFFQG-HIPAELGSLIRLKQLSLSWNSL 137
EL L + + NL +L LDLSKN + ++ G L LK + S N +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 138 QGKIPSQLGSLHQ--LEYLDLGNNKLVGEIPIPIFCSNSS---TSLQYIDLSNNSLTGEI 192
+L L L + L N L + + + L+ +D+S N T +I
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 193 P-----------LKNECELRNLRFLLLWSNRLVGQVPQALAN--SSKLEWLDLESNMFSG 239
+ ++ + + A S + LDL
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF- 279
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP-FFASLANSSNFQELELAGNNLGGMI 298
L S + + L+ L L+YN + F L N Q L L+ N LG +
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKI------NKIADEAFYGL---DNLQVLNLSYNLLGELY 330
Query: 299 PSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
S L + I L N I L L L+L N L + + +
Sbjct: 331 SSNFYGL-PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIP 384
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG-SIPDSFANLSQLRRLLLYGNHLSG 417
++LS N L L+ LS+N+L I + L+ L+L N S
Sbjct: 385 DIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440
Query: 418 TIPSSL-GKCVNLEILDLSHNKISGIIPSDV-----AGLRSLKLYLNLSSNHLDGPLPLE 471
+ +LE L L N + +++ GL L+ L L+ N+L+ P
Sbjct: 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ-VLYLNHNYLNSLPPGV 499
Query: 472 LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDV 531
S + + + L+ N L+ + LE L++S N L + L D+
Sbjct: 500 FSHLTALRGLSLNSNRLT-VLSHNDLPA-NLEILDISRNQLLAP---NPDVFVSLSVLDI 554
Query: 532 SSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN-----KGAFSSLTIASFQGNDGLCG 586
+ N+ E + S + LN + +G ++ +FS +++ S C
Sbjct: 555 THNKFICEC----ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEG--CD 608
Query: 587 EIKGLQTCKKEHTHHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLNGADLEDEE 646
E + L++ K + +++ L L + + F F + K + L + + +
Sbjct: 609 EEEVLKSLKF-SLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPD 667
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-36
Identities = 71/357 (19%), Positives = 124/357 (34%), Gaps = 36/357 (10%)
Query: 243 SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSII 302
+++ + + L LS+N + +S Q LEL I
Sbjct: 17 TQVPQVLNTTERLLLSFNYI------RTVTA--SSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 303 GDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTI--PHELCLMSKLER 359
NL + L + IY + P L +L L L L+ + + L R
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 360 VYLSNNSLSG-EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQ--LRRLLLYGNHLS 416
+ LS N + + +FG + L +D S N++ L L L N L
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
Query: 417 GTIPSSLGKCVN------LEILDLSHNKISGIIPSD----VAGLRSLKL-------YLNL 459
+ GKC+N LEILD+S N + I + ++ ++ L
Sbjct: 188 SRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 460 SSNHLDGPLPLELSKMDM--VLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLP 517
+++ P + + V +DLS + + L+ LNL+ N + +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD 307
Query: 518 VSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
+ L L+ ++S N L +F P + ++ N + I F L
Sbjct: 308 EAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA--IIQDQTFKFLE 362
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-31
Identities = 79/348 (22%), Positives = 131/348 (37%), Gaps = 45/348 (12%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
+R+ V LDLS ++ S L L VL+L+ N L L+ L+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
S+N L S L ++ Y+DL N + I LQ +DL +N+LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAI---IQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL 252
+ ++ + L N+LV L + L N + ++P L
Sbjct: 376 ---TIHFIPSIPDIFLSGNKLVTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHL 428
Query: 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQI 312
Q L L+ N F S G+ + + + + ++L L N L + +
Sbjct: 429 QILILNQNRFSSCSGD-------QTPSENPSLEQLFLGENMLQLAWETELC--------- 472
Query: 313 HLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIP 372
L +L +L L+ N LN P ++ L + L++N L+
Sbjct: 473 -----------WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521
Query: 373 SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420
+ +L +LD+S+N+L PD F +LS L + N
Sbjct: 522 NDL--PANLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECE 564
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-26
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 19/241 (7%)
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
+ +L+ ++P + L LS N + SF L QL+ L L + TI
Sbjct: 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 420 -PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL--PLELSKMD 476
+ NL ILDL +KI + P GL L L L L + +
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF-ELRLYFCGLSDAVLKDGYFRNLK 123
Query: 477 MVLAIDLSFNNLSG-SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL--PYLKQFDVSS 533
+ +DLS N + + P G +L+S++ S N + + + L L F +++
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 534 NRLFGEIPQSFQASP------TLKQLNFSFNKFSGNISN--KGAFSSLTIASFQGNDGLC 585
N L+ + + L+ L+ S N ++ +I+ A S S +
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 586 G 586
G
Sbjct: 244 G 244
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 74/302 (24%), Positives = 119/302 (39%), Gaps = 62/302 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITG---SFKRECQILKRIRHRNLIRIIT 731
IG G FG VY+ +AVK +I+ + ++E ++ ++H N+I +
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+C K LV+ G L L G + LV +A G+ YLH + +
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL---SG--KRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 792 VVHCDLKPSNILLDEDLTAL--------VADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
++H DLK SNIL+ + + + DFG+A+ MS
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--------TTKMSA------ 174
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL---HEWVKR 900
G+ ++APE S DV+S+GVLL E++TG P F L +
Sbjct: 175 -AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRGIDGLAVAYGVAMN 229
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
L PI P P + +L+E C +P +RPS ++
Sbjct: 230 KL--AL-PI---------PSTCP--------EPFAKLME---DCWNPDPHSRPSFTNILD 266
Query: 961 EM 962
++
Sbjct: 267 QL 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-52
Identities = 63/311 (20%), Positives = 116/311 (37%), Gaps = 55/311 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG GRFG VY G + +A++++D+ + +FKRE ++ RH N++ + C
Sbjct: 41 IGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
P A++ L +L + + LD+ + +I ++ +G+ YLH ++
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GIL 152
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLK N+ D ++ DFG+ + + D + G + ++AP
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRR--EDKLRIQ------NGWLCHLAP 203
Query: 854 E---------YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
E S H DV++ G + E+ P +
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP------------------FKT 245
Query: 905 RLDP--IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
I+ + P I K SD++L C + RP+ + +
Sbjct: 246 -QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLF-------CWAFEQEERPTFTKLMDML 297
Query: 963 GRLKQYLSSPS 973
+L + S
Sbjct: 298 EKLPKRNRRLS 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 60/303 (19%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDL-TTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+ G ++KG Q N I VKVL + + + F EC L+ H N++ ++ C
Sbjct: 18 LNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 734 SKPDFK--ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
P L+ M GSL N L+ +D Q VK D+A G+A+LH P+
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+ L ++++DED+TA ++ + SF S + ++
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF----------------SFQSPGR--MYAPAWV 175
Query: 852 APEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
APE K T+ D++SF VLL E+VT P F D L
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FAD---------------LSN 216
Query: 909 IVEKAIAKYAPQHM----PIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964
+ + K A + + P + S L++ +C +P+ RP + + +
Sbjct: 217 M--EIGMKVALEGLRPTIPPGISPHVSK----LMK---ICMNEDPAKRPKFDMIVPILEK 267
Query: 965 LKQ 967
++
Sbjct: 268 MQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-50
Identities = 83/343 (24%), Positives = 126/343 (36%), Gaps = 45/343 (13%)
Query: 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI 717
+ + LIG GR+G VYKG L D +AVKV +F E I
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKNI 58
Query: 718 --LKRIRHRNLIRIITICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQL 770
+ + H N+ R I + LV+ NGSL +L H D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 771 VKICSDVAEGVAYLH------HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
++ V G+AYLH H + H DL N+L+ D T +++DFG++ + G
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-------KRASTHGDVYSFGVLLLEI 877
D+ + + G++ Y+APE G + A D+Y+ G++ EI
Sbjct: 174 RLVRPGEEDNAAIS-----EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 878 VTGRRPTDVLFHDGSS-----LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSD 932
R TD+ + V H P D V + K P+ + K S
Sbjct: 229 FM--RCTDLFPGESVPEYQMAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAW--KENSL 283
Query: 933 VVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975
V L E C + R + M L S+
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 58/302 (19%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVKVL------DLTTTGEITGSFKRECQILKRIRHRNLI 727
IG G FG V+KG L D + +A+K L T E F+RE I+ + H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
++ + P +V+ + G L + L +H + +++ D+A G+ Y+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 788 SPIKVVHCDLKPSNILLDE-----DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+P +VH DL+ NI L + A VADFG+++ + +
Sbjct: 142 NP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------------SVHSVSGL 186
Query: 843 LLCGSVGYIAPE--YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
G+ ++APE + + D YSF ++L I+TG P D + + R
Sbjct: 187 --LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-R 243
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960
R I P+ P + +IE LC +P RP +
Sbjct: 244 EEGLRP-TI---------PEDCP--------PRLRNVIE---LCWSGDPKKRPHFSYIVK 282
Query: 961 EM 962
E+
Sbjct: 283 EL 284
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-47
Identities = 97/515 (18%), Positives = 179/515 (34%), Gaps = 94/515 (18%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLI------- 125
N S + E + ++ + N+ S + + ++ + P G
Sbjct: 7 NVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 126 ------RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179
+ +L L+ L +P LE L N L E+P S SL
Sbjct: 66 RDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQ---SLKSLL 117
Query: 180 YIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239
+ + +L+ P L +L + +N+L ++P+ L NSS L+ +D+++N
Sbjct: 118 VDNNNLKALSDLPP--------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK- 166
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
+LP P L+F+ N L N + N+L +
Sbjct: 167 KLPDLP----PSLEFIAAGNNQLEE----------LPELQNLPFLTAIYADNNSLKKLPD 212
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
+L I N++ + P + NL LT + +NLL T+P LE
Sbjct: 213 LP-----LSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEA 261
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-------------DSFANLSQLR 406
+ + +N L+ ++P + L + + + LS P L
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 320
Query: 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466
L + N L +P+ LE L S N ++ + ++LK L++ N L
Sbjct: 321 ELNVSNNKLI-ELPALPP---RLERLIASFNHLAEVPEL----PQNLK-QLHVEYNPLRE 371
Query: 467 PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYL 526
P + DL N+ +P + L+ L++ N L P + L
Sbjct: 372 -FPDIPESV-----EDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDL 421
Query: 527 KQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561
++S R+ + + + L+ F +
Sbjct: 422 ---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-25
Identities = 56/272 (20%), Positives = 95/272 (34%), Gaps = 40/272 (14%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
I P + L S+ L +P E + Y + + P G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 383 L-------------LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429
+ L+L+ LS S+P+ L L+ N L+ +P +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSL 116
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489
+ + + +S + P L L +S+N L+ LP EL + ID+ N+L
Sbjct: 117 LVDNNNLKALSDLPPL----LEY----LGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK 166
Query: 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549
+P S LE + N LE L + LP+L +N L ++P +
Sbjct: 167 -KLPDLPPS---LEFIAAGNNQLEEL--PELQNLPFLTAIYADNNSL-KKLPDLPL---S 216
Query: 550 LKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L+ + N + LT N
Sbjct: 217 LESIVAGNNILE-ELPELQNLPFLTTIYADNN 247
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 65/311 (20%), Positives = 117/311 (37%), Gaps = 44/311 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI--LKRIRHRNLIRIIT 731
+G GR+G V++G Q +AVK+ S+ RE ++ +RH N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 732 ICSKPDFKA----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH-- 785
+ L+ GSL ++L LD + ++I +A G+A+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 786 ---HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ H DLK NIL+ ++ +AD G+A + ++ N+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR------- 177
Query: 843 LLCGSVGYIAPE------YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
G+ Y+APE + D+++FG++L E+ ++ ++
Sbjct: 178 --VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHM--PIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
V DP E I + L +L C NPS R +
Sbjct: 236 VV------PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 955 MLDVAHEMGRL 965
L + + ++
Sbjct: 290 ALRIKKTLTKI 300
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-46
Identities = 76/373 (20%), Positives = 150/373 (40%), Gaps = 33/373 (8%)
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176
I + L + + + + +L+ + + N+ + ++P + +S
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL--DSFR 75
Query: 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236
++ ++L++ + EI ++ L + N + P N L L LE N
Sbjct: 76 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134
Query: 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296
S LP I P+L L +S N+ + +T F + ++ Q L+L+ N L
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQAT---TSLQNLQLSSNRLT- 184
Query: 297 MIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK 356
+ L +L ++ NL+ ++ + + L+ S N +N + + +
Sbjct: 185 ---HVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--VE 233
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416
L + L +N+L+ + + P L +DLS N+L + F + +L RL + N L
Sbjct: 234 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 417 GTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476
+ L++LDLSHN + + + L+ L L N + L+LS
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV---TLKLSTHH 345
Query: 477 MVLAIDLSFNNLS 489
+ + LS N+
Sbjct: 346 TLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-43
Identities = 103/504 (20%), Positives = 189/504 (37%), Gaps = 51/504 (10%)
Query: 72 CNNSRNKVVELDLSARSIYGTISPALA--NLSSLIVLDLSKNFFQGHIPAE-LGSLIRLK 128
+N + V D+ + L++ ++ + + +PA L S +++
Sbjct: 20 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 78
Query: 129 QLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188
L+L+ ++ H ++ L +G N + +P +F + L + L N L
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF--QNVPLLTVLVLERNDL 135
Query: 189 TGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISK 248
+ +P L L + +N L ++ L+ L L SN + + +S
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD---LSL 190
Query: 249 MPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTN 308
+P L +SYN ++LA +EL+ + N+ I + G ++
Sbjct: 191 IPSLFHANVSYN-------------LLSTLAIPIAVEELDASHNS----INVVRGPVNVE 233
Query: 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLS 368
L + L N + + N L ++LS N L + H M +LER+Y+SNN L
Sbjct: 234 LTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
Query: 369 GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVN 428
+ IP L +LDLS N L + + +L L L N + T+ L
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHT 346
Query: 429 LEILDLSHNKISGIIPSDVAGLRSL-KLYLNLSSNHLDGPLPLE--------LSKMDMVL 479
L+ L LSHN S A R++ + ++ + H LE L
Sbjct: 347 LKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
++ ++ + G C A +++N + + L +Q + N L E
Sbjct: 405 LQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAE 464
Query: 540 IPQ----SFQASPTLKQLNFSFNK 559
+ Q Q L+ L+ +
Sbjct: 465 VQQLTNEQIQQEQLLQGLHAEIDT 488
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 77/379 (20%), Positives = 130/379 (34%), Gaps = 33/379 (8%)
Query: 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291
+ P + K Y V D T F +N + +
Sbjct: 1 VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60
Query: 292 NNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHE 350
+ + + +++ + ++L+ I +I + + + L + N + PH
Sbjct: 61 STMRKLPAALLDSF-RQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118
Query: 351 LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLL 410
+ L + L N LS F + P L L +S N L D+F + L+ L L
Sbjct: 119 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178
Query: 411 YGNHLSGTIP-----------------SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSL 453
N L+ + S+L + +E LD SHN I+ + L
Sbjct: 179 SSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI- 236
Query: 454 KLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSL 512
L L N+L L ++ +DLS+N L I LE L +S N L
Sbjct: 237 ---LKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290
Query: 513 EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSS 572
L + +P LK D+S N L + ++ L+ L N + +
Sbjct: 291 VA-LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKL-STHHT 346
Query: 573 LTIASFQGNDGLCGEIKGL 591
L + ND C ++ L
Sbjct: 347 LKNLTLSHNDWDCNSLRAL 365
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-15
Identities = 60/372 (16%), Positives = 118/372 (31%), Gaps = 27/372 (7%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQG 139
L L ++ T + L N L+ +DLS N + I + RL++L +S N L
Sbjct: 236 ILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV- 291
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199
+ + L+ LDL +N L+ + L+ + L +NS+ + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQP---QFDRLENLYLDHNSIV-TLKLST--- 343
Query: 200 LRNLRFLLLWSNRLVGQVPQAL-ANSSKLEWLDLESNMFSGELPSEII----SKMPQLQF 254
L+ L L N +AL N ++ D + + + S P L
Sbjct: 344 HHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDR 403
Query: 255 LYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL 314
L + + ++ ++ Q L GG+ L + ++
Sbjct: 404 LLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRA 463
Query: 315 DCNLIYGKIPP--------HISNLVNLTLLNLSSNLLNGTIPHELCLMSKL-ERVYLSNN 365
+ + + H NL L + L + + + + L ER
Sbjct: 464 EVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLR 523
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGK 425
A L+ L + + A ++LR+ + + +
Sbjct: 524 ETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNR 583
Query: 426 CVNLEILDLSHN 437
+ + H+
Sbjct: 584 NPDTRRVSHHHH 595
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-09
Identities = 57/336 (16%), Positives = 107/336 (31%), Gaps = 22/336 (6%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L +S + ++ + +L VLDLS N H+ RL+ L L NS+
Sbjct: 282 RLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+ L + H L+ L L +N +F ++ + + +I + E L
Sbjct: 339 LK--LSTHHTLKNLTLSHNDWDCNSLRALF-----RNVARPAVDDADQHCKIDYQLEHGL 391
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
+ +RL+ Q +A +S +E + S + Q Y++
Sbjct: 392 CCKESDKPYLDRLL----QYIALTSVVEKVQRAQGRCSATDTINSV----QSLSHYITQQ 443
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
V GN LE L Q+L ++ + ++ TNL + L + +
Sbjct: 444 GGVPLQGNEQLEAEVNELRA--EVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLA 501
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHEL-CLMSKLERVYLSNNSLSGEIPSAFGD-I 378
+L E + E + N +L ++ +
Sbjct: 502 RSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQA 561
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH 414
L + K+ N R + +H
Sbjct: 562 ELRQETSLKRQKVKQLEAKKNRNPDTRRVSHHHHHH 597
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-46
Identities = 85/445 (19%), Positives = 151/445 (33%), Gaps = 36/445 (8%)
Query: 122 GSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181
+ R K ++ +SL+ + S S ++ LDL N L +I T L+ +
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPF--TKLELL 63
Query: 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGEL 241
+LS+N L + L++ L LR L L +N + Q L +E L +N S +
Sbjct: 64 NLSSNVLYETLDLES---LSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RV 114
Query: 242 PSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSI 301
+ +YL+ N T L S Q L+L N + + +
Sbjct: 115 SCSR---GQGKKNIYLANNKI------TMLRD--LDEGCRSRVQYLDLKLNEIDTVNFAE 163
Query: 302 IGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVY 361
+ S L ++L N IY + + L L+LSSN L + E + + +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 362 LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS-GSIPDSFANLSQLRRLLLYGNHLSGTIP 420
L NN L I A +L DL N G++ D F+ +++ + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTG 277
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL----YLNLSSNHLDGPLPLELSKMD 476
+ +C + + L +LK L+ + + L E
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQA 336
Query: 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
ID I A +L +L+ + L +
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
Query: 537 FGEIPQSFQASPTLKQLNFSFNKFS 561
E+ + + L+ L ++
Sbjct: 397 -IELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-45
Identities = 76/515 (14%), Positives = 152/515 (29%), Gaps = 44/515 (8%)
Query: 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
N+ ++ S+ ++ + ++ LDLS N A+L +L+ L+LS N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
L L SL L LDL NN + E+ + S++ + +NN+++ +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-QELLVG-------PSIETLHAANNNIS-RVSCSR 118
Query: 197 ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
+ + + L +N++ S++++LDL+ N +E+ + L+ L
Sbjct: 119 ---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
L YN G + + L+L+ N L + + I L
Sbjct: 176 LQYNFIYDVKGQVVF----------AKLKTLDLSSNKL-AFMGPEFQSA-AGVTWISLRN 223
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFG 376
N + I + NL +L N + + ++ ++
Sbjct: 224 NKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 377 DIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG----TIPSSLGKCVNLEIL 432
+ L L L+R G + +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341
Query: 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI 492
D + + V + K+ L LD + +
Sbjct: 342 DALKEQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ---- 396
Query: 493 PPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQ 552
I L+ + L+ L + + N + L +
Sbjct: 397 -------IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAE 449
Query: 553 LNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGE 587
N K +G A ++ T+ +
Sbjct: 450 ENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-45
Identities = 60/425 (14%), Positives = 136/425 (32%), Gaps = 37/425 (8%)
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
I + ++ + + ++ L + + S+ +++ +DLS N L+ +I +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLK-QALASLR--QSAWNVKELDLSGNPLS-QISAADLAPF 57
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
L L L SN L L + S L LDL +N + P ++ L+ + N
Sbjct: 58 TKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQE------LLVGPSIETLHAANN 109
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
+ + + + LA N + + G + + + L N I
Sbjct: 110 NISRVSCSR-----GQGK------KNIYLANNKITMLRDLDEGCR-SRVQYLDLKLNEI- 156
Query: 321 GKIPPH--ISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI 378
+ ++ L LNL N + + ++ +KL+ + LS+N L+ + F
Sbjct: 157 DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSA 213
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
+ + L NKL I + L L GN N + ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQT 271
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS----IPP 494
+ + + L + + + ++ + + + + GS +
Sbjct: 272 VKKLTGQNEEECTVPTL-GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 495 QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554
+ + ++ ++ + + L ++ +A L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 555 FSFNK 559
Sbjct: 391 QQAVG 395
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 3e-36
Identities = 55/311 (17%), Positives = 113/311 (36%), Gaps = 17/311 (5%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKL 357
I I + + + + + + + N+ L+LS N L+ +L +KL
Sbjct: 2 IHEIKQNGN-RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 358 ERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG 417
E + LS+N L + L LDL+ N + + L N++S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG-PLPLELSKMD 476
+ S G+ + + L++NKI+ + D ++ YL+L N +D + D
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSD 169
Query: 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
+ ++L +N + + Q+ L++L+LS N L + + + +N+L
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
Query: 537 FGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKK 596
I ++ + S L+ + N F + + + + + C
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 597 EHTHHLVILSI 607
H
Sbjct: 286 PTLGHYGAYCC 296
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-46
Identities = 74/319 (23%), Positives = 122/319 (38%), Gaps = 47/319 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI--LKRIRHRNLIRIIT 731
IG GR+G V+ G + ++AVKV T E S+ RE +I +RH N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEA-SWFRETEIYQTVLMRHENILGFIA 98
Query: 732 ICSKPDFK----ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH-- 785
K L+ NGSL ++L S LD ++K+ G+ +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 786 ---HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ H DLK NIL+ ++ T +AD G+A V+ ++
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR------- 206
Query: 843 LLCGSVGYIAPEYGMGKRASTHG------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
G+ Y+ PE H D+YSFG++L E+ ++ H+
Sbjct: 207 --VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHM--PIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
V DP E + + + + ++ +L C +NP++R +
Sbjct: 265 LVP------SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 955 MLDVAHEMGRLKQYLSSPS 973
L V L + S
Sbjct: 319 ALRV---KKTLAKMSESQD 334
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-46
Identities = 83/381 (21%), Positives = 137/381 (35%), Gaps = 30/381 (7%)
Query: 90 YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLH 149
Y I L + + + E +L K ++ ++++ + L S
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW 209
Q+E L+L + ++ EI F ++Q + + N++ +P + L L+L
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYA--HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
N L N+ KL L + +N + + LQ L LS N D +
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSL 184
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
SL ++ N L S + + ++ N I + +
Sbjct: 185 -----IPSL------FHANVSYNLL-----STLAIP-IAVEELDASHNSI-NVVRGPV-- 224
Query: 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389
V LT+L L N L T L L V LS N L + F + L L +S N
Sbjct: 225 NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
Query: 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAG 449
+L ++ + L+ L L NHL + + + LE L L HN I + S
Sbjct: 283 RLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 340
Query: 450 LRSLKLYLN-LSSNHLDGPLP 469
L++L L N N L
Sbjct: 341 LKNLTLSHNDWDCNSLRALFR 361
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-45
Identities = 77/420 (18%), Positives = 149/420 (35%), Gaps = 81/420 (19%)
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176
I + L + + + + +L+ + + N+ + ++P + +S
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALL--DSFR 69
Query: 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236
++ ++L++ + EI ++ L + N + P N L L LE N
Sbjct: 70 QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296
S LP I P+L L +S N+ +E + +++ Q L+L+ N L
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNL------ERIED--DTFQATTSLQNLQLSSNRLTH 179
Query: 297 MIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK 356
+ S+I +L ++ NL+ ++ + + L+ S N +N + + +
Sbjct: 180 VDLSLI----PSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVN--VE 227
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416
L + L +N+L+ + + P L +DLS N+L + F + +L RL + N L
Sbjct: 228 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 417 GTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476
+ L++LDLSHN +
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL------------------------------------ 308
Query: 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
+ LE+L L NS+ L + LK +S N
Sbjct: 309 --------------HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-44
Identities = 89/404 (22%), Positives = 159/404 (39%), Gaps = 39/404 (9%)
Query: 72 CNNSRNKVVELDLSARSIYGTISPALA--NLSSLIVLDLSKNFFQGHIPAE-LGSLIRLK 128
+N + V D+ + L++ ++ + + +PA L S +++
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 129 QLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188
L+L+ ++ H ++ L +G N + +P +F + L + L N L
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF--QNVPLLTVLVLERNDL 129
Query: 189 TGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISK 248
+ +P L L + +N L ++ L+ L L SN + + +S
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD---LSL 184
Query: 249 MPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTN 308
+P L +SYN ++LA +EL+ + N+ I + G ++
Sbjct: 185 IPSLFHANVSYN-------------LLSTLAIPIAVEELDASHNS----INVVRGPVNVE 227
Query: 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLS 368
L + L N + + N L ++LS N L + H M +LER+Y+SNN L
Sbjct: 228 LTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
Query: 369 GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVN 428
+ IP L +LDLS N L + + +L L L N + T+ S
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHT 340
Query: 429 LEILDLSHNKISGIIPSDVAGLRSL-KLYLNLSSNHLDGPLPLE 471
L+ L LSHN S A R++ + ++ + H LE
Sbjct: 341 LKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-37
Identities = 84/401 (20%), Positives = 149/401 (37%), Gaps = 61/401 (15%)
Query: 194 LKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQ 253
L+ +C ++ + + G L N + + +++ +LP+ ++ Q++
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMR-KLPAALLDSFRQVE 72
Query: 254 FLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIH 313
L L+ ++ + A + Q+L + N +
Sbjct: 73 LLNLNDLQI------EEIDT--YAFAYAHTIQKLYMGFNAIR------------------ 106
Query: 314 LDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCL-MSKLERVYLSNNSLSGEI 371
+PPH+ N+ LT+L L N L+ ++P + KL + +SNN+L
Sbjct: 107 --------YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIE 157
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431
F L L LS N+L+ + + + L + N LS +L + +E
Sbjct: 158 DDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEE 209
Query: 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491
LD SHN I+ + L L L N+L L ++ +DLS+N L
Sbjct: 210 LDASHNSINVVRGPVNVELTIL----KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-K 262
Query: 492 IPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTL 550
I LE L +S N L L + +P LK D+S N L + ++ L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRL 320
Query: 551 KQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGL 591
+ L N + +L + ND C ++ L
Sbjct: 321 ENLYLDHNSIV-TLKL-STHHTLKNLTLSHNDWDCNSLRAL 359
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 59/300 (19%), Positives = 119/300 (39%), Gaps = 27/300 (9%)
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLS----TNLVQIHLDCNLIYGKIPPHI-SNLVNLT 334
+S+ + ++ + N + + + K+P + + +
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVE 72
Query: 335 LLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS 394
LLNL+ + + ++++Y+ N++ P F ++P L +L L +N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 395 IPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454
F N +L L + N+L + +L+ L LS N+++ + S + L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN 192
Query: 455 L---------------YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC 499
+ L+ S N ++ ++ + + L NNL+ L +
Sbjct: 193 VSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLTD--TAWLLNY 247
Query: 500 IALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNK 559
L ++LS N LE ++ ++ L++ +S+NRL + Q PTLK L+ S N
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNH 306
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-44
Identities = 69/313 (22%), Positives = 124/313 (39%), Gaps = 44/313 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI--LKRIRHRNLIRIIT 731
IG GRFG V++G + +AVK+ S+ RE +I +RH N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIA 103
Query: 732 ICSKPDFKA----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+K + LV +GSL ++L + + + ++K+ A G+A+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 788 SP-----IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ H DLK NIL+ ++ T +AD G+A ++++ A +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR------- 211
Query: 843 LLCGSVGYIAPEYGMGKRASTHG------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896
G+ Y+APE H D+Y+ G++ EI + ++
Sbjct: 212 --VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 897 WVKRHYPHRLDPIVEKAIAKYAPQHM--PIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
V DP VE+ Q + I + + + ++ C N + R +
Sbjct: 270 LVP------SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 955 MLDVAHEMGRLKQ 967
L + + +L Q
Sbjct: 324 ALRIKKTLSQLSQ 336
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-44
Identities = 61/326 (18%), Positives = 111/326 (34%), Gaps = 29/326 (8%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
+ L ++ L + D +S + Q +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-------NSNNPQIETRTGR 66
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
+L L + L L S L Q P S L+ + +++ ELP +
Sbjct: 67 ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM- 123
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS 306
+ L+ L L+ N L AS+A+ + +EL + +P +
Sbjct: 124 QQFAGLETLTLARN---------PLRALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 307 --------TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
NL + L+ I +P I+NL NL L + ++ L+ + + + KLE
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
+ L + P FG L L L ++P L+QL +L L G
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIP 444
+PS + + I+ + + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 65/339 (19%), Positives = 120/339 (35%), Gaps = 33/339 (9%)
Query: 223 NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSS 282
+SS E L + + + Q Q Y + + N ANS+
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVL----SQWQRHYNA---------DRNRWHSAWRQANSN 56
Query: 283 NFQELELAGNNLGGMIPSIIGDL-STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341
N Q G L ++ D V + L + + P L +L + + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAA 114
Query: 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN 401
L +P + + LE + L+ N L +P++ + L L + +P+ A+
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172
Query: 402 ---------LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRS 452
L L+ L L + ++P+S+ NL+ L + ++ +S + + L
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPK 230
Query: 453 LKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSL 512
L+ L+L P + + L + ++P + LE L+L G
Sbjct: 231 LE-ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289
Query: 513 EGLLPVSVGQLPYLKQFDVSSN---RLFGEIPQSFQASP 548
LP + QLP V + +L P + A P
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 60/320 (18%), Positives = 109/320 (34%), Gaps = 37/320 (11%)
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDL-------------------STNLVQIHLDCN 317
+SS + L G+ ++ S N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66
Query: 318 LIYGKIPPHISNL--VNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF 375
+ + + L L S L P + +S L+ + + L E+P
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 376 GDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKC--------- 426
L L L++N L ++P S A+L++LR L + +P L
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 427 VNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486
VNL+ L L I +P+ +A L++LK L + ++ L L + + + +DL
Sbjct: 183 VNLQSLRLEWTGIRS-LPASIANLQNLK-SLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQA 546
+ PP G L+ L L S LP+ + +L L++ D+ +P
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 547 SPTLKQLNFSFNKFSGNISN 566
P + + + +
Sbjct: 300 LPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 49/272 (18%), Positives = 91/272 (33%), Gaps = 36/272 (13%)
Query: 98 ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157
A + L+L P + L L+ +++ L ++P + LE L L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLA 135
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217
N L +P I S L+ + + E+P L +
Sbjct: 136 RNPLR-ALPASI---ASLNRLRELSIRACPELTELP----EPLAST------------DA 175
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
L+ L LE LP+ I+ + L+ L + + L +
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNS---------PLSALGPA 224
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL-DCNLIYGKIPPHISNLVNLTLL 336
+ + +EL+L G P I G L ++ L DC+ + +P I L L L
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGR-APLKRLILKDCSNL-LTLPLDIHRLTQLEKL 282
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSNNSLS 368
+L + +P + + + + + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 50/272 (18%), Positives = 91/272 (33%), Gaps = 57/272 (20%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
+ + A + + + + L L L++N + +PA + SL RL++LS+ +
Sbjct: 108 HMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+P L S +LQ + L + +P + L
Sbjct: 166 LPEPLASTDASGEH------------------QGLVNLQSLRLEWTGIR-SLP-ASIANL 205
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
+NL+ L + ++ L + A+ + KLE LDL P L+ L L
Sbjct: 206 QNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI-FGGRAPLKRLILK-- 261
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
+ SN L P I L T L ++ L +
Sbjct: 262 -------------------DCSNLLTL-----------PLDIHRL-TQLEKLDLRGCVNL 290
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHELC 352
++P I+ L ++ + +L H
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 38/242 (15%), Positives = 76/242 (31%), Gaps = 36/242 (14%)
Query: 345 GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGD-----------------IPHLGLLDLS 387
G+ H S E +Y ++ + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 388 KNKLSG--SIPDSFANLSQ--LRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443
+ D + +Q L L L P + +L+ + + + +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA-- 501
P + L+ L L+ N L LP ++ ++ + + + +P L S A
Sbjct: 120 PDTMQQFAGLE-TLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 502 -------LESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554
L+SL L + LP S+ L LK + ++ L + + P L++L+
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 555 FS 556
Sbjct: 236 LR 237
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 7/166 (4%)
Query: 393 GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRS 452
GS + S L G+ L + D + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57
Query: 453 LKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSL 512
++ LE + +A++L L P Q L+ + + L
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 513 EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
LP ++ Q L+ ++ N L +P S + L++L+
Sbjct: 117 ME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRAC 160
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-43
Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 61/311 (19%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ +T++AVK + + F E ++K ++H L+++ + +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAVVT 253
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K ++ M+ GSL + L G L +L+ + +AEG+A++ +H
Sbjct: 254 KEPI-YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL+ +NIL+ L +ADFG+A+++ D+ + + APE
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVI----------EDNEYTAREGAKFP--IKWTAPE 355
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRLD 907
+ DV+SFG+LL+EIVT GR P +V+ ++R Y R+
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI--------RALERGY--RMP 405
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
P++ P EL + + C + P RP+ + L
Sbjct: 406 R----------PENCPE-----------ELYNIMMRCWKNRPEERPTFEYIQS---VLDD 441
Query: 968 YLSSPSSLIEE 978
+ ++ S EE
Sbjct: 442 FYTATESQYEE 452
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-43
Identities = 78/301 (25%), Positives = 126/301 (41%), Gaps = 56/301 (18%)
Query: 675 IGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG V+ G L+ DNT +AVK T ++ F +E +ILK+ H N++R+I +C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ +V+ L+ G L + G L + L+++ D A G+ YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR-TEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N L+ E ++DFG+++ + ++ GL V + AP
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV-----------YAASGGLRQVPVKWTAP 284
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRL 906
E R S+ DV+SFG+LL E + G P E+V++ RL
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR--------EFVEKGG--RL 334
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
P+ P + L C Y P RPS + E+ ++
Sbjct: 335 PC----------PELCPD-----------AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
Query: 967 Q 967
+
Sbjct: 374 K 374
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 3e-43
Identities = 85/311 (27%), Positives = 133/311 (42%), Gaps = 59/311 (18%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V+ G TR+A+K L T F +E Q++K++RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + +V MS GSL + L G L L QLV + + +A G+AY+ V
Sbjct: 250 EEPIY--IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 302
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ E+L VADFG+A+L+ D+ + + AP
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI----------EDNEYTARQGAKF--PIKWTAP 350
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
E + R + DV+SFG+LL E+ T GR P YP ++ V
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVP------------------YPGMVNREVLD 392
Query: 913 AIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968
+ + P P L +L C + P RP+ + L+ Y
Sbjct: 393 QVERGYRMPCPPECPE-----------SLHDLMCQCWRKEPEERPTFEYLQA---FLEDY 438
Query: 969 LSSPSSLIEEA 979
+S +
Sbjct: 439 FTSTEPQYQPG 449
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 6e-43
Identities = 77/308 (25%), Positives = 142/308 (46%), Gaps = 63/308 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V+ G +T++AVK L + F E ++K+++H+ L+R+ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYAVVT 78
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + ++ M NGSL + L G+ L + +L+ + + +AEG+A++ +
Sbjct: 79 QEPIY--IITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ + L+ +ADFG+A+L++ D+ + + AP
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE----------DNEYTAREGAKF--PIKWTAP 179
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRL 906
E + DV+SFG+LL EIVT GR P +V+ + ++R Y R+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--------QNLERGY--RM 229
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
P + P EL +L LC + P RP+ + L+
Sbjct: 230 VR----------PDNCPE-----------ELYQLMRLCWKERPEDRPTFDYLRS---VLE 265
Query: 967 QYLSSPSS 974
+ ++
Sbjct: 266 DFFTATEG 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 6e-43
Identities = 76/306 (24%), Positives = 135/306 (44%), Gaps = 49/306 (16%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G++G VY+GV + + +AVK L T F +E ++K I+H NL++++ +C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 285
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ ++ M+ G+L ++L + + + L+ + + ++ + YL +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H +L N L+ E+ VADFG+++L+ G D +T+ G + + AP
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTG-DT----------YTAHAGAKF-PIKWTAP 388
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
E + S DV++FGVLL EI T G P + G L + + +EK
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-----YPGIDLSQVYEL---------LEK 434
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972
P+ P ++ EL C Q+NPS RPS ++ +
Sbjct: 435 DYRMERPEGCPE-----------KVYELMRACWQWNPSDRPSFAEIHQ---AFETMFQES 480
Query: 973 SSLIEE 978
S E
Sbjct: 481 SISDEV 486
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-42
Identities = 85/311 (27%), Positives = 133/311 (42%), Gaps = 59/311 (18%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V+ G TR+A+K L T F +E Q++K++RH L+++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 735 K-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ P + +V MS GSL + L G L L QLV + + +A G+AY+ V
Sbjct: 333 EEPIY--IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ E+L VADFG+A+L+ D+ + + AP
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI----------EDNEYTARQGAKF--PIKWTAP 433
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
E + R + DV+SFG+LL E+ T GR P YP ++ V
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVP------------------YPGMVNREVLD 475
Query: 913 AIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968
+ + P P L +L C + P RP+ + L+ Y
Sbjct: 476 QVERGYRMPCPPECPE-----------SLHDLMCQCWRKEPEERPTFEYLQA---FLEDY 521
Query: 969 LSSPSSLIEEA 979
+S +
Sbjct: 522 FTSTEPQYQPG 532
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 62/302 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+GSG+FG V G + +AVK++ + E F +E Q + ++ H L++ +CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED--EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K +V +SNG L N+L SHG GL+ QL+++C DV EG+A+L H + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLR-SHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+D DL V+DFG+ + V D +S V + APE
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL----------DDQYVSSVGTKF--PVKWSAPE 175
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRLD 907
+ S+ DV++FG+L+ E+ + G+ P ++V+ V + + RL
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV--------LKVSQGH--RLY 225
Query: 908 PIVEKAIAKYAPQHMP--IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
P IY ++ C P RP+ + + L
Sbjct: 226 R----------PHLASDTIY-------------QIMYSCWHELPEKRPTFQQLLSSIEPL 262
Query: 966 KQ 967
++
Sbjct: 263 RE 264
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 80/317 (25%), Positives = 143/317 (45%), Gaps = 62/317 (19%)
Query: 675 IGSGRFGHVYKGVLQDNT-----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
IG+G FG VYKG+L+ ++ +A+K L T + F E I+ + H N+IR+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ SK ++ M NG+L+ L G ++QLV + +A G+ YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM-- 166
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VH DL NIL++ +L V+DFG++++++ E+ +T++ G + +
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT--------YTTSGGKI--PIR 215
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
+ APE ++ ++ DV+SFG+++ E++T G RP +V+ + + +
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--------KAINDGF 267
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
RL P P + +L + C Q + RP D+
Sbjct: 268 --RLPT----------PMDCPS-----------AIYQLMMQCWQQERARRPKFADIVS-- 302
Query: 963 GRLKQYLSSPSSLIEEA 979
L + + +P SL A
Sbjct: 303 -ILDKLIRAPDSLKTLA 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 78/312 (25%), Positives = 125/312 (40%), Gaps = 61/312 (19%)
Query: 675 IGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG VY G D + A+K L T + +F RE +++ + H N++ +I
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 731 TICSKPD-FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
I P+ ++LP M +G L + + L+ VA G+ YL +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K VH DL N +LDE T VADFG+A+ + + L V
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS-------VQQHRHARL--PVK 193
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
+ A E R +T DV+SFGVLL E++T G P D+ ++ +
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT--------HFLAQGR 245
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
RL P++ P L ++ C + +P+ RP+ +
Sbjct: 246 --RLPQ----------PEYCPD-----------SLYQVMQQCWEADPAVRPTFRVLVG-- 280
Query: 963 GRLKQYLSSPSS 974
++Q +S+
Sbjct: 281 -EVEQIVSALLG 291
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 65/308 (21%), Positives = 121/308 (39%), Gaps = 65/308 (21%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V G + +A+K++ + E F E +++ + H L+++ +C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K ++ M+NG L N+L + H QL+++C DV E + YL + +H
Sbjct: 90 KQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+++ V+DFG+++ V D +S V + PE
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL----------DDEYTSSVGSKF--PVRWSPPE 191
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRLD 907
M + S+ D+++FGVL+ EI + G+ P ++ E + + RL
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--------EHIAQGL--RLY 241
Query: 908 PIVEKAIAKYAPQHMP--IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
P +Y + C RP+ + +
Sbjct: 242 R----------PHLASEKVY-------------TIMYSCWHEKADERPTFKILLS---NI 275
Query: 966 KQYLSSPS 973
+ S
Sbjct: 276 LDVMDEES 283
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 83/316 (26%), Positives = 131/316 (41%), Gaps = 61/316 (19%)
Query: 675 IGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IGSG G V G L+ + +A+K L T F E I+ + H N+IR+
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ ++ +V M NGSL+ L G ++QLV + V G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL N+L+D +L V+DFG++++++ ++ +T+T G + + +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA--------YTTTGGKI--PIRW 220
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYP 903
APE + S+ DV+SFGV++ E++ G RP DV+ V+ Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI--------SSVEEGY- 271
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
RL P P L +L L C + + RP +
Sbjct: 272 -RLPA----------PMGCPH-----------ALHQLMLDCWHKDRAQRPRFSQIVS--- 306
Query: 964 RLKQYLSSPSSLIEEA 979
L + SP SL A
Sbjct: 307 VLDALIRSPESLRATA 322
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 69/319 (21%), Positives = 126/319 (39%), Gaps = 72/319 (22%)
Query: 675 IGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG VY+GV ++ +AVK T + F E I+K + H +++++I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 731 TICSK-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
I + P + +++ L G L ++L + L ++ LV + + +AYL
Sbjct: 80 GIIEEEPTW--IIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VH D+ NIL+ + DFG+++ ++ D + ++ L +
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----------YKASVTRL--PIK 179
Query: 850 YIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVK 899
+++PE + R +T DV+ F V + EI++ G++P DV+ ++
Sbjct: 180 WMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--------GVLE 228
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
+ RL P P L L C Y+PS RP ++
Sbjct: 229 KGD--RLPK----------PDLCPP-----------VLYTLMTRCWDYDPSDRPRFTELV 265
Query: 960 HEMGRLKQYLSSPSSLIEE 978
L + E
Sbjct: 266 C---SLSDVYQMEKDIAME 281
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 61/305 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IGSG+FG V+ G + ++A+K + E F E +++ ++ H L+++ +C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ LV M +G L ++L GL L+ +C DV EG+AYL V+H
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+ E+ V+DFG+ + V D +ST V + +PE
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL----------DDQYTSSTGTKF--PVKWASPE 175
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRLD 907
R S+ DV+SFGVL+ E+ + G+ P ++V+ E + + RL
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--------EDISTGF--RLY 225
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
P+ + ++ C + P RP+ + +L +
Sbjct: 226 K----------PRLAST-----------HVYQIMNHCWRERPEDRPAFSRLLR---QLAE 261
Query: 968 YLSSP 972
S
Sbjct: 262 IAESG 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 61/315 (19%), Positives = 123/315 (39%), Gaps = 64/315 (20%)
Query: 675 IGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+GSG FG VYKG+ +A+K L T+ + E ++ + + ++ R+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ IC + L+ LM G L +++ + L+ C +A+G+ YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++VH DL N+L+ + DFG+AKL+ + + + G + +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---------AEEKEYHAEGGKV--PIK 184
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
++A E + + + DV+S+GV + E++T G +P +++ +++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS--------SILEKGE 236
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
RL P I ++ + C + +RP ++ E
Sbjct: 237 --RLPQ----------PPICTI-----------DVYMIMRKCWMIDADSRPKFRELIIE- 272
Query: 963 GRLKQYLSSPSSLIE 977
+ P +
Sbjct: 273 --FSKMARDPQRYLV 285
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 87/312 (27%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 675 IGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG VY G L DN AVK L+ T F E I+K H N++ ++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 731 TICSKPDFKAL-VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
IC + + L VLP M +G L N + +H + L+ VA+G+ YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K VH DL N +LDE T VADFG+A+ + + T L V
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS-------VHNKTGAKL--PVK 197
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
++A E ++ +T DV+SFGVLL E++T G P D+ ++ +
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--------VYLLQGR 249
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
RL P++ P L E+ L C RPS ++
Sbjct: 250 --RLLQ----------PEYCPD-----------PLYEVMLKCWHPKAEMRPSFSELVS-- 284
Query: 963 GRLKQYLSSPSS 974
R+ S+
Sbjct: 285 -RISAIFSTFIG 295
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 73/312 (23%), Positives = 131/312 (41%), Gaps = 61/312 (19%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G++G VY+GV + + +AVK L T F +E ++K I+H NL++++ +C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ ++ M+ G+L ++L + + + L+ + + ++ + YL +
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N L+ E+ VADFG+++L+ + + AP
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMT----------GDTYTAHAGAKF--PIKWTAP 181
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRL 906
E + S DV++FGVLL EI T G P + V E +++ Y R+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--------ELLEKDY--RM 231
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
+ P+ P ++ EL C Q+NPS RPS ++ +
Sbjct: 232 ER----------PEGCPE-----------KVYELMRACWQWNPSDRPSFAEIHQ---AFE 267
Query: 967 QYLSSPSSLIEE 978
S E
Sbjct: 268 TMFQESSISDEV 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 65/315 (20%), Positives = 129/315 (40%), Gaps = 72/315 (22%)
Query: 675 IGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G+FG V++G+ +A+K T+ + F +E +++ H +++++I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 731 TICSK-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ ++ P + +++ L + G L + L + LDL L+ ++ +AYL
Sbjct: 83 GVITENPVW--IIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ VH D+ N+L+ + + DFG+++ ++ + ++ G L +
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----------YKASKGKL--PIK 182
Query: 850 YIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVK 899
++APE + R ++ DV+ FGV + EI+ G +P DV+ ++
Sbjct: 183 WMAPESINFR---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--------GRIE 231
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
RL P + P L L C Y+PS RP ++
Sbjct: 232 NGE--RLPM----------PPNCPP-----------TLYSLMTKCWAYDPSRRPRFTELK 268
Query: 960 HEMGRLKQYLSSPSS 974
+L L +
Sbjct: 269 A---QLSTILEEEKA 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-41
Identities = 80/312 (25%), Positives = 136/312 (43%), Gaps = 61/312 (19%)
Query: 675 IGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G+G FG V G L+ +A+K L + T + F E I+ + H N+IR+
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +K +V M NGSL++ L +IQLV + +A G+ YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDM--- 166
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL NIL++ +L V+DFG+ ++++ E+ +T+ G + + +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--------YTTRGGKI--PIRW 216
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYP 903
+PE ++ ++ DV+S+G++L E+++ G RP DV+ + V Y
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------KAVDEGY- 267
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
RL P P P L +L L C Q + + RP +
Sbjct: 268 -RLPP----------PMDCPA-----------ALYQLMLDCWQKDRNNRPKFEQIVS--- 302
Query: 964 RLKQYLSSPSSL 975
L + + +P SL
Sbjct: 303 ILDKLIRNPGSL 314
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-40
Identities = 71/326 (21%), Positives = 128/326 (39%), Gaps = 18/326 (5%)
Query: 116 HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
+P + + L L N ++ + S LE L+L N + + F N+
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAF--NNL 79
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+L+ + L +N L IPL L NL L + N++V + + L+ L++ N
Sbjct: 80 FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDN 138
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
+ S + L+ L L + T++ +L++ L L N+
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNL------TSIPT--EALSHLHGLIVLRLRHLNIN 189
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCL-M 354
+ L L + + + P+ +NLT L+++ L +P+ +
Sbjct: 190 AIRDYSFKRL-YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHL 247
Query: 355 SKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH 414
L + LS N +S S ++ L + L +L+ P +F L+ LR L + GN
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 415 LSGTIPSSLGKCVNLEILDLSHNKIS 440
L+ S NLE L L N ++
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-40
Identities = 77/362 (21%), Positives = 131/362 (36%), Gaps = 48/362 (13%)
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
+ + V +P I T + +DL N + + +L L L N +
Sbjct: 16 VLCHRKRFV-AVPEGIP-----TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV 68
Query: 214 VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP 273
P A N L L L SN +P + + + L L +S N V
Sbjct: 69 SAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYM---- 123
Query: 274 FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVN 332
F L N + LE+ N+L I S L +
Sbjct: 124 -FQDL---YNLKSLEVGDNDLV--------------------------YISHRAFSGLNS 153
Query: 333 LTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
L L L L +IP E L + L + L + +++ +F + L +L++S
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLR 451
++ + L L + +L+ ++ V L L+LS+N IS I S + L
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272
Query: 452 SLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQL-GSCIALESLNLSGN 510
L+ + L L P ++ + +++S N L+ ++ + S LE+L L N
Sbjct: 273 RLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330
Query: 511 SL 512
L
Sbjct: 331 PL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-36
Identities = 67/299 (22%), Positives = 129/299 (43%), Gaps = 14/299 (4%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLS 339
+ + L+L N + + +L ++ L+ N++ + P +NL NL L L
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASF-PHLEELELNENIV-SAVEPGAFNNLFNLRTLGLR 88
Query: 340 SNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD- 397
SN L IP + +S L ++ +S N + + F D+ +L L++ N L I
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
+F+ L+ L +L L +L+ +L L +L L H I+ I L LK L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK-VL 205
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLL 516
+S + + ++ ++ NL+ ++P + + L LNLS N + +
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIE 264
Query: 517 PVSVGQLPYLKQFDVSSNRLFGEIPQ-SFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
+ +L L++ + +L + +F+ L+ LN S N+ + + + F S+
Sbjct: 265 GSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVG 320
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 5/223 (2%)
Query: 353 LMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYG 412
+ ++ + L N + F PHL L+L++N +S P +F NL LR L L
Sbjct: 30 IPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89
Query: 413 NHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLEL 472
N L NL LD+S NKI ++ L +LK L + N L
Sbjct: 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK-SLEVGDNDLVYISHRAF 148
Query: 473 SKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDV 531
S ++ + + L NL+ SIP + L L L L ++ + S +L LK ++
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEI 207
Query: 532 SSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
S + + L L+ + + + A L
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY-LAVRHLV 248
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-40
Identities = 89/472 (18%), Positives = 188/472 (39%), Gaps = 24/472 (5%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
+L++S+N+ +++ SL +L+ L +S N +Q S +LEYLDL +NK
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE-CELRNLRFLLLWSNRLVGQVPQ 219
L +I + + +L+++DLS N+ +P+ E + L+FL L + L
Sbjct: 81 L-VKIS-----CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 220 ALANSSKLE-WLDLESNMFSGELPSEI-ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+A+ + + L L E P + L ++ + +F +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
L+N E L + +NL +++ + + +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253
Query: 338 LSSNLLNGTIPHEL-----CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS 392
+S+ L G + + L + ++ + ++ + + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 393 GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI--IPSDVAGL 450
+ +S L N L+ T+ + G LE L L N++ + I +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 451 RSLKLYLNLSSNHLDGPLPLEL-SKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509
+SL+ L++S N + S +L++++S N L+ +I L ++ L+L
Sbjct: 374 KSLQ-QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHS 430
Query: 510 NSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ-SFQASPTLKQLNFSFNKF 560
N ++ +P V +L L++ +V+SN+L +P F +L+++ N +
Sbjct: 431 NKIKS-IPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 91/467 (19%), Positives = 170/467 (36%), Gaps = 26/467 (5%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L++S I + + +LS L +L +S N Q + L+ L LS N L K
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
I L++LDL N F + + L+++ LS L + + L
Sbjct: 84 ISCH--PTVNLKHLDLSFNAFDALPICKEF--GNMSQLKFLGLSTTHLE-KSSVLPIAHL 138
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLE--SNMFSGELPSEIISKMPQLQFLYLS 258
+ LL+ + E L + +N + + + L+ +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL--STNLVQIHLDC 316
+ + + A L + L L I L T + +
Sbjct: 199 CV--LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 317 NLIYGKIPPHISNLVN-----LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371
+ G++ + L++ + S++ + + S + + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLG---KCVN 428
I LD S N L+ ++ ++ +L++L L+L N L + + +
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375
Query: 429 LEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487
L+ LD+S N +S + +SL LN+SSN L + L VL DL N
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLL-SLNMSSNILTDTIFRCLPPRIKVL--DLHSNK 432
Query: 488 LSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
+ SIP Q+ AL+ LN++ N L+ + +L L++ + +N
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 64/428 (14%), Positives = 129/428 (30%), Gaps = 65/428 (15%)
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
+D N L+ +P + S +++S N ++ E+ + L LR L++ NR+
Sbjct: 5 VDRSKNGLI-HVP-----KDLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRI 57
Query: 214 VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP 273
+ +LE+LDL N ++ L+ L LS+N F + P
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDA-------LP 106
Query: 274 FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333
N S + L L+ +L I L+ + V + L L +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDF 163
Query: 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393
+L H + +S L +++ +L+ +K
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC-------------VLEDNKCSYFL 210
Query: 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV---NLEILDLSHNKISGIIPSDVAGL 450
SI +L L L + + + V + +S+ K+ G +
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 451 RSLKL----YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLN 506
L + S+ P + S + N
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQ-------------SYIYEIFS-----------NMNIKN 306
Query: 507 LSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566
+ + + + ++ D S+N L + ++ L+ L N+
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI 366
Query: 567 KGAFSSLT 574
+ +
Sbjct: 367 AEMTTQMK 374
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 46/222 (20%), Positives = 87/222 (39%), Gaps = 13/222 (5%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
S + + + S S++ + + + + + + L
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
S N L + G L +LE L L N+L E+ + SLQ +D+S NS++ +
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL 252
+ ++L L + SN L + + L +++ LDL SN +P +++ K+ L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV-KLEAL 446
Query: 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNL 294
Q L ++ N S F L ++ Q++ L N
Sbjct: 447 QELNVASNQLKSVPDGI-----FDRL---TSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 56/307 (18%), Positives = 106/307 (34%), Gaps = 23/307 (7%)
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
+ L++ S N L +P +L K + +S N +S S + L +L +S N++
Sbjct: 1 SEFLVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGL 450
F +L L L N L I VNL+ LDLS N + +
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 451 RSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNL--- 507
LK +L LS+ HL+ L ++ +++ + + P+ ESL++
Sbjct: 115 SQLK-FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 508 -----------SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556
S ++ L ++ + + + L ++ TL + +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 557 FNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHTHHLVILSILLSLFAMSL 616
+N F I +++ S L I ++ +F
Sbjct: 234 WNSFI-RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 617 LFIFGNF 623
+I+ F
Sbjct: 293 SYIYEIF 299
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 9e-16
Identities = 59/283 (20%), Positives = 97/283 (34%), Gaps = 35/283 (12%)
Query: 360 VYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
V S N L +P D+ +L++S+N +S +LS+LR L++ N +
Sbjct: 5 VDRSKNGLI-HVPK---DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478
S LE LDLSHNK+ I +LK +L+LS N D
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLK-HLDLSFNAFD------------A 104
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQF-DVSSNRLF 537
L I F N+S L+ L LS LE + + L K +
Sbjct: 105 LPICKEFGNMS-----------QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 538 GEIPQSFQASPTLK-QLNFSFNKFSGNISNKGAFSSLTIASFQGNDGL-CGEIKGLQTCK 595
E P+ Q T + F NK I + + + L + +
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 596 KEHTHHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLN 638
+ + + ++ L+ + ++ S+ N
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 8e-15
Identities = 45/298 (15%), Positives = 92/298 (30%), Gaps = 68/298 (22%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
+ + L + + + +L +L + + + F + +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
+ + + + + C + + ++D SNN LT +
Sbjct: 308 TVSGTRM---------------------------VHMLCPSKISPFLHLDFSNNLLT-DT 339
Query: 193 PLKNECELRNLRFLLLWSNRL--VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMP 250
+N L L L+L N+L + ++ + L+ LD+ N S + S
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 251 QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLV 310
L L +S N F + L+L N +
Sbjct: 400 SLLSLNMSSNILTD-------TIFRCLP---PRIKVLDLHSNKI---------------- 433
Query: 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSL 367
IP + L L LN++SN L ++P ++ L++++L N
Sbjct: 434 ----------KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 83/309 (26%), Positives = 129/309 (41%), Gaps = 67/309 (21%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IG G FG V G + ++AVK + T + +F E ++ ++RH NL++++ +
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 735 KPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +V M+ GSL ++L L L+K DV E + YL + V
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL N+L+ ED A V+DFG+ K + S T G L V + AP
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASS---------TQDTGKL--PVKWTAP 183
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHRL 906
E K+ ST DV+SFG+LL EI + GR P DV+ V++ Y ++
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------PRVEKGY--KM 233
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966
D P P + E+ C + + RPS L + +L+
Sbjct: 234 DA----------PDGCPP-----------AVYEVMKNCWHLDAAMRPSFLQLRE---QLE 269
Query: 967 QYLSSPSSL 975
+ L
Sbjct: 270 HIKTHELHL 278
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-40
Identities = 82/310 (26%), Positives = 129/310 (41%), Gaps = 69/310 (22%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IG G FG V G + ++AVK + T + +F E ++ ++RH NL++++ +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 735 K--PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ +V M+ GSL ++L L L+K DV E + YL +
Sbjct: 257 EEKGGL-YIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
VH DL N+L+ ED A V+DFG+ K S T G L V + A
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--------------EASSTQDTGKL--PVKWTA 354
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPHR 905
PE K+ ST DV+SFG+LL EI + GR P DV+ V++ Y +
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--------PRVEKGY--K 404
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
+D P P + ++ C + +TRP+ L + +L
Sbjct: 405 MDA----------PDGCPP-----------AVYDVMKNCWHLDAATRPTFLQLRE---QL 440
Query: 966 KQYLSSPSSL 975
+ + L
Sbjct: 441 EHIRTHELHL 450
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-40
Identities = 86/312 (27%), Positives = 127/312 (40%), Gaps = 61/312 (19%)
Query: 675 IGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G FG VY G L DN AVK L+ T F E I+K H N++ ++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 731 TICSKPDFKAL-VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
IC + + L VLP M +G L N + +H + L+ VA+G+ +L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K VH DL N +LDE T VADFG+A+ + + T L V
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS-------VHNKTGAKL--PVK 261
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
++A E ++ +T DV+SFGVLL E++T G P D+ ++ +
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--------VYLLQGR 313
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
RL P++ P L E+ L C RPS ++
Sbjct: 314 --RLLQ----------PEYCPD-----------PLYEVMLKCWHPKAEMRPSFSELVS-- 348
Query: 963 GRLKQYLSSPSS 974
R+ S+
Sbjct: 349 -RISAIFSTFIG 359
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-40
Identities = 82/419 (19%), Positives = 141/419 (33%), Gaps = 41/419 (9%)
Query: 71 KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQL 130
+C+ R + P L + + +DLS N L L+ L
Sbjct: 7 ECSVIGYNA---ICINRGL--HQVPEL--PAHVNYVDLSLNSIAELNETSFSRLQDLQFL 59
Query: 131 SLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
+ + I + L L L L N+ + ++ F N +L+ + L+ +L
Sbjct: 60 KVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAF--NGLANLEVLTLTQCNLD 116
Query: 190 GEIPLKNEC--ELRNLRFLLLWSNRLVGQVPQAL-ANSSKLEWLDLESNMFSGELPSEII 246
L L +L L+L N + P + N + LDL N + E +
Sbjct: 117 -GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDL 174
Query: 247 SKMP--QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD 304
L LS + + +++ L+L+GN + D
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFD 234
Query: 305 LSTNLVQIHLDCNLIYGKIPPHISNLV--------------NLTLLNLSSN---LLNGTI 347
L + Y + +LS + L ++
Sbjct: 235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSV 294
Query: 348 PHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLR 406
+ LE++ L+ N ++ +I AF + HL L+LS+N L F NL +L
Sbjct: 295 FSHF---TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLE 350
Query: 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
L L NH+ S NL+ L L N++ + L SL+ + L +N D
Sbjct: 351 VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ-KIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 70/355 (19%), Positives = 128/355 (36%), Gaps = 43/355 (12%)
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNL 309
+ ++ LS N L S + + Q L++ G +I + ++L
Sbjct: 30 AHVNYVDLSLNSI------AELNE--TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 310 VQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCL--MSKLERVYLSNNS 366
+ + LD N ++ + L NL +L L+ L+G + ++ LE + L +N+
Sbjct: 82 IILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 367 LSGEIP-SAFGDIPHLGLLDLSKNKLSGSIPDSFANL--SQLRRLLLYGNHL-------- 415
+ P S F ++ +LDL+ NK+ + N L L L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK----LYLNLSSNHLDGPLPLE 471
+ K ++ LDLS N + + L L+ S N
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 472 LSKMDM----------VLAIDLSFNNLSGSIPPQL-GSCIALESLNLSGNSLEGLLPVSV 520
D V DLS + + ++ + LE L L+ N + + +
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319
Query: 521 GQLPYLKQFDVSSNRLFGEIPQ-SFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
L +L + ++S N L G I F+ L+ L+ S+N + + +F L
Sbjct: 320 WGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGD-QSFLGLP 371
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-40
Identities = 67/312 (21%), Positives = 127/312 (40%), Gaps = 58/312 (18%)
Query: 675 IGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+GSG FG V+KGV + +KV++ + + + + + H +++R+
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +C + LV + GSL +H+ G L L+ +A+G+ YL H
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEH-- 134
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+VH +L N+LL VADFG+A L+ D+ + ++ +
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---------LYSEAKT--PIK 182
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE---WVKRHYPHR 905
++A E + + DV+S+GV + E++T G P + G L E +++ R
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP-----YAGLRLAEVPDLLEKGE--R 235
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
L PQ I ++ + + C + + RP+ ++A+E
Sbjct: 236 LAQ----------PQICTI-----------DVYMVMVKCWMIDENIRPTFKELANE---F 271
Query: 966 KQYLSSPSSLIE 977
+ P +
Sbjct: 272 TRMARDPPRYLV 283
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 65/305 (21%), Positives = 122/305 (40%), Gaps = 43/305 (14%)
Query: 675 IGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V ++AVK L + G K+E +IL+ + H N+++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
IC++ L++ + +GSL+ +L P + + ++L Q +K + +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNK--NKINLKQQLKYAVQICKGMDYLGSR 145
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ VH DL N+L++ + + DFG+ K ++ + D
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--------TDKEYYTVKDDRDS--P 192
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906
V + APE M + DV+SFGV L E++T + + + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT----HGQMT 248
Query: 907 DPIVEKAIAK-Y---APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+ + + P + P E+ +L C ++ PS R S ++
Sbjct: 249 VTRLVNTLKEGKRLPCPPNCPD-----------EVYQLMRKCWEFQPSNRTSFQNLIEGF 297
Query: 963 GRLKQ 967
L +
Sbjct: 298 EALLK 302
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 78/326 (23%), Positives = 125/326 (38%), Gaps = 70/326 (21%)
Query: 675 IGSGRFGHVYKGVLQDN----TRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V + L+ ++AVK+L D+ + +I F RE +K H ++ +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLREAACMKEFDHPHVAK 89
Query: 729 IITICSKPDFKA------LVLPLMSNGSLENHLYPS--HGLSHGLDLIQLVKICSDVAEG 780
++ + + K ++LP M +G L L S L L LV+ D+A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ YL S +H DL N +L ED+T VADFG+++ + D
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR---------QGC 197
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSS 893
L V ++A E + H DV++FGV + EI+T G+ P ++
Sbjct: 198 ASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY------ 249
Query: 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953
++ RL P E+ +L C +P RP
Sbjct: 250 --NYLIGGN--RLKQ----------PPECM-----------EEVYDLMYQCWSADPKQRP 284
Query: 954 SMLDVAHEMGRLKQYLSSPSSLIEEA 979
S + L+ L S L
Sbjct: 285 SFTCLRM---ELENILGHLSVLSTSQ 307
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 69/294 (23%), Positives = 108/294 (36%), Gaps = 62/294 (21%)
Query: 675 IGSGRFGHVYKGVLQ----DNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V +G +AVK L D+ + E F RE + + HRNLIR
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + P K +V L GSL + L L L + VAEG+ YL
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+ +H DL N+LL + DFG+ + + D+ + +
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---------YVMQEH------ 183
Query: 849 GYI-----APEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR-- 900
+ APE + S D + FGV L E+ T G+ P G + + + +
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKID 238
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
RL P+ P ++ + + C + P RP+
Sbjct: 239 KEGERLPR----------PEDCPQ-----------DIYNVMVQCWAHKPEDRPT 271
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 77/319 (24%), Positives = 130/319 (40%), Gaps = 72/319 (22%)
Query: 675 IGSGRFGHVYKGVLQD----NTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V +G L+ + ++AVK + D ++ EI F E +K H N+IR
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE-EFLSEAACMKDFSHPNVIR 100
Query: 729 IITICSKPDFKA-----LVLPLMSNGSLENHLYPS--HGLSHGLDLIQLVKICSDVAEGV 781
++ +C + + ++LP M G L +L S + L L+K D+A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
YL S +H DL N +L +D+T VADFG++K + D
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---------QGRI 208
Query: 842 GLLCGSVGYIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDG 891
+ V +IA E ++ DV++FGV + EI T G P ++
Sbjct: 209 AKM--PVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---- 259
Query: 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
+++ + RL P+ EL E+ C + +P
Sbjct: 260 ----DYLLHGH--RLKQ----------PEDCL-----------DELYEIMYSCWRTDPLD 292
Query: 952 RPSMLDVAHEMGRLKQYLS 970
RP+ + ++ +L + L
Sbjct: 293 RPTFSVLRLQLEKLLESLP 311
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 64/315 (20%), Positives = 126/315 (40%), Gaps = 58/315 (18%)
Query: 675 IGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+GSG FG VYKG+ +A+K L T+ + E ++ + + ++ R+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ IC + L+ LM G L +++ + L+ C +A+G+ YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR-- 136
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++VH DL N+L+ + DFG+AKL+ ++ + + G + +
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------EYHAEGGKV--PIK 184
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE---WVKRHYPHR 905
++A E + + + DV+S+GV + E++T G +P +DG E +++ R
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-----YDGIPASEISSILEKGE--R 237
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
L P I ++ + + C + +RP ++ E
Sbjct: 238 LPQ----------PPICTI-----------DVYMIMVKCWMIDADSRPKFRELIIE---F 273
Query: 966 KQYLSSPSSLIEEAA 980
+ P +
Sbjct: 274 SKMARDPQRYLVIQG 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 59/348 (16%), Positives = 120/348 (34%), Gaps = 33/348 (9%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLE 152
I N + + ++ + + + + S +K+L LS N L + L +LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L+L +N L S ++L+ +DL+NN + E+ ++ L +N
Sbjct: 62 LLNLSSNVLYE---TLDLESL--STLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNN 110
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
+ + + L +N + L ++Q+L L N+ +
Sbjct: 111 ISRVSCSRGQG---KKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDT-------V 159
Query: 273 PFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVN 332
F A+S + L L N + + + + L + L N + + P +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFI-YDVKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAG 215
Query: 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS 392
+T ++L +N L I L LE L N + + ++K +
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK 273
Query: 393 GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440
+ + L YG + +P+ ++ L H+
Sbjct: 274 -KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 59/302 (19%), Positives = 97/302 (32%), Gaps = 26/302 (8%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+ ++++SL + N++ L L N L LA +KLE L+L SN
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
+ E + + L+ L L+ N L + + L A NN+
Sbjct: 69 VLY-ETLD--LESLSTLRTLDLNNNYV-------------QELLVGPSIETLHAANNNIS 112
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG-TIPHELCLM 354
+ I+L N I + L+L N ++
Sbjct: 113 ----RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 355 SKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH 414
LE + L N + ++ L LDLS NKL+ + F + + + + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 415 LSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSK 474
L I +L NLE DL N D + + E
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 475 MD 476
+
Sbjct: 285 VP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 42/212 (19%), Positives = 87/212 (41%), Gaps = 13/212 (6%)
Query: 371 IPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLE 430
I + + ++ + L ++ + ++ L L GN LS + L LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 431 ILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG 490
+L+LS N + D+ L +L+ L+L++N++ EL + + + NN+S
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLR-TLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 491 SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG-EIPQSFQASPT 549
+ G +++ L+ N + L + G ++ D+ N + + +S T
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 550 LKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L+ LN +N ++ + F+ L N
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 54/260 (20%), Positives = 95/260 (36%), Gaps = 29/260 (11%)
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
++ + ++++SL + S ++ LDLS N LS A ++L L L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGI------------------IPSDVAGLRSLKL 455
L L L LDL++N + + + + K
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR--GQGKK- 123
Query: 456 YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG-SIPPQLGSCIALESLNLSGNSLEG 514
+ L++N + L+ V +DL N + + S LE LNL N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 515 LLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK-GAFSSL 573
+ LK D+SSN+L + FQ++ + ++ NK I +L
Sbjct: 184 VKGQV--VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 574 TIASFQGNDGLCGEIKGLQT 593
+GN CG ++ +
Sbjct: 240 EHFDLRGNGFHCGTLRDFFS 259
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 17/125 (13%), Positives = 36/125 (28%), Gaps = 9/125 (7%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ-G 139
LDLS+ + + P + + + + L N I L L+ L N G
Sbjct: 195 TLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199
+ +++ + K + ++ + ++P
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVKKLTGQN------EEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 200 LRNLR 204
L L
Sbjct: 307 LIALG 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 61/314 (19%)
Query: 675 IGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G G FG V +GV + +A+KVL T T RE QI+ ++ + ++R+I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+C LV+ + G L L + + + ++ V+ G+ YL
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEK---N 130
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
VH DL N+LL A ++DFG++K + A+DS + G + +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALG--------ADDSYYTARSAGKW--PLKWY 180
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYPH 904
APE ++ S+ DV+S+GV + E ++ G++P +V+ ++++
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--------AFIEQGK-- 230
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964
R++ P P EL L C Y RP L V R
Sbjct: 231 RMEC----------PPECPP-----------ELYALMSDCWIYKWEDRPDFLTVEQ---R 266
Query: 965 LKQYLSSPSSLIEE 978
++ S +S +E
Sbjct: 267 MRACYYSLASKVEG 280
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 64/310 (20%), Positives = 125/310 (40%), Gaps = 64/310 (20%)
Query: 675 IGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRII 730
IG G+FG V++G+ +A+K T+ + F +E +++ H +++++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ ++ +++ L + G L + L LDL L+ ++ +AYL
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+ VH D+ N+L+ + + DFG+++ ++ + ++ G L + +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY----------YKASKGKL--PIKW 558
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHYP 903
+APE +R ++ DV+ FGV + EI+ G +P DV+ ++
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--------GRIENGE- 609
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
RL P + P L L C Y+PS RP ++
Sbjct: 610 -RLPM----------PPNCPP-----------TLYSLMTKCWAYDPSRRPRFTELKA--- 644
Query: 964 RLKQYLSSPS 973
+L L
Sbjct: 645 QLSTILEEEK 654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 73/320 (22%), Positives = 125/320 (39%), Gaps = 67/320 (20%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+G + ++AVK L + + F E I+ + H+N++R
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL---YPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
I + + + +++ LM+ G L++ L P L ++ L+ + D+A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 786 HHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+H D+ N LL A + DFG+A+ +
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---------KGGCA 205
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLH 895
+L V ++ PE M ++ D +SFGVLL EI + G P +VL
Sbjct: 206 ML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------- 255
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
E+V R+DP P++ P + + C Q+ P RP+
Sbjct: 256 EFVTSGG--RMDP----------PKNCP-----------GPVYRIMTQCWQHQPEDRPNF 292
Query: 956 LDVAHEMGRLKQYLSSPSSL 975
+ R++ P +
Sbjct: 293 AIILE---RIEYCTQDPDVI 309
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 79/317 (24%), Positives = 139/317 (43%), Gaps = 67/317 (21%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+GV + TR+A+K ++ + F E ++K +++R
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL------YPSHGLSHGLDLIQLVKICSDVAEGVA 782
++ + S+ +++ LM+ G L+++L ++ + L +++++ ++A+G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
YL+ + K VH DL N ++ ED T + DFG+ + + D G
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---------KGGKG 200
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLH 895
LL V +++PE +T+ DV+SFGV+L EI T +P VL
Sbjct: 201 LL--PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-------- 250
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+V LD P + P L EL +C QYNP RPS
Sbjct: 251 RFVMEGG--LLDK----------PDNCP-----------DMLFELMRMCWQYNPKMRPSF 287
Query: 956 LDVAHEMGRLKQYLSSP 972
L++ +K+ +
Sbjct: 288 LEIIS---SIKEEMEPG 301
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-37
Identities = 72/413 (17%), Positives = 133/413 (32%), Gaps = 88/413 (21%)
Query: 98 ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157
+ VL++ ++ +P L + + L + N+L +P+ +L L++
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVS 89
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217
N+L +P+ L L L L ++ N+L +
Sbjct: 90 GNQLT-SLPVLP---PGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQL-TSL 136
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
P L+ L + N + LP+ +L L+ N S
Sbjct: 137 PVLPPG---LQELSVSDNQLA-SLPALP----SELCKLWAYNNQLTS------------- 175
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
+P + L ++ + N + +P S L L N
Sbjct: 176 --------------------LPMLPS----GLQELSVSDNQL-ASLPTLPSELYKLWAYN 210
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397
N L ++P S L+ + +S N L+ +P L L +S N+L+ S+P
Sbjct: 211 ---NRLT-SLPALP---SGLKELIVSGNRLT-SLPV---LPSELKELMVSGNRLT-SLPM 258
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
S L L +Y N L+ +P SL + ++L N +S + + S Y
Sbjct: 259 L---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGN 510
+ LA +P + G + ++ G
Sbjct: 315 GPIIRFDMAGASAPRETRALHLAAADWL------VPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 69/359 (19%), Positives = 134/359 (37%), Gaps = 55/359 (15%)
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
C L + + L +P L + L + N + LP+ P+L+ L
Sbjct: 35 RACLNNGNAVLNVGESGL-TTLPDCLPAH--ITTLVIPDNNLT-SLPALP----PELRTL 86
Query: 256 YLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLD 315
+S N L +L P++ + L ++ +
Sbjct: 87 EVSGN---------QLTSLPVLPPGLLELSIFSNPLTHL----PALP----SGLCKLWIF 129
Query: 316 CNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAF 375
N + +P L L++S N L ++P +L +++ NN L+ +P
Sbjct: 130 GNQL-TSLPVLPPGLQE---LSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPM-- 178
Query: 376 GDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLS 435
L L +S N+L+ S+P S+L +L Y N L+ ++P+ L+ L +S
Sbjct: 179 -LPSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLT-SLPALPS---GLKELIVS 229
Query: 436 HNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
N+++ +P + L+ L +S N L LP+ S + + + N L+ +P
Sbjct: 230 GNRLTS-LPVLPSELKE----LMVSGNRLTS-LPMLPSGLLS---LSVYRNQLT-RLPES 279
Query: 496 LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554
L + ++NL GN L ++ ++ + R + + + L
Sbjct: 280 LIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 77/371 (20%), Positives = 138/371 (37%), Gaps = 58/371 (15%)
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNL-EPFFASLANSSNFQELELAGNNLGGMIP 299
+ L + + T L + A + L + NNL +P
Sbjct: 31 VQKMRACLNNGNAVLNVGESGL------TTLPDCLPAHI------TTLVIPDNNLTS-LP 77
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
++ L + + N + +P L+ L++ + L L S L +
Sbjct: 78 ALPP----ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCK 125
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
+++ N L+ +P P L L +S N+L+ S+P S+L +L Y N L+ ++
Sbjct: 126 LWIFGNQLT-SLPV---LPPGLQELSVSDNQLA-SLPAL---PSELCKLWAYNNQLT-SL 176
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
P L+ L +S N+++ +P+ + L L +N L LP S +
Sbjct: 177 PMLPS---GLQELSVSDNQLA-SLPTLPSELYKL----WAYNNRLT-SLPALPSGL---K 224
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
+ +S N L+ S+P L+ L +SGN L L P+ L L V N+L
Sbjct: 225 ELIVSGNRLT-SLPVLPSE---LKELMVSGNRLTSL-PMLPSGLLSL---SVYRNQL-TR 275
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHT 599
+P+S + +N N S +T A + ++ G ++
Sbjct: 276 LPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPIIRFDMAGASAPRETRA 333
Query: 600 HHLVILSILLS 610
HL L+
Sbjct: 334 LHLAAADWLVP 344
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 69/350 (19%), Positives = 115/350 (32%), Gaps = 58/350 (16%)
Query: 98 ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157
A L L++S N +P L+ L S L L L +
Sbjct: 78 ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIF 129
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217
N+L +P LQ + +S+N L +P L L ++N+L +
Sbjct: 130 GNQL-TSLP------VLPPGLQELSVSDNQLA-SLP----ALPSELCKLWAYNNQLT-SL 176
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
P + L+ L + N + LP+ +L L+ N T+L +
Sbjct: 177 PMLPSG---LQELSVSDNQLA-SLPTLP----SELYKLWAYNNRL------TSLPALPSG 222
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
L +EL ++GN L + + L ++ + N + +P S L L+
Sbjct: 223 L------KELIVSGNRLTSLPVLP-----SELKELMVSGNRL-TSLPMLPS---GLLSLS 267
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLD---LSKNKLSGS 394
+ N L +P L +S V L N LS A +I + + S
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
Query: 395 IPDSFANLSQLRRLLLYGNHLSGTIP----SSLGKCVNLEILDLSHNKIS 440
P L L P G+ N + L +++S
Sbjct: 327 APRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 25/147 (17%), Positives = 57/147 (38%), Gaps = 22/147 (14%)
Query: 417 GTIPSSLGKCV--NLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSK 474
+ + C+ +L++ + ++ + A + + L + N+L LP +
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLTTLPDCLPAHITT----LVIPDNNLTS-LPALPPE 82
Query: 475 MDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
+ +++S N L+ S+P + L + L L L + + N
Sbjct: 83 L---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGN 131
Query: 535 RLFGEIPQSFQASPTLKQLNFSFNKFS 561
+L +P P L++L+ S N+ +
Sbjct: 132 QL-TSLPVLP---PGLQELSVSDNQLA 154
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 72/319 (22%), Positives = 124/319 (38%), Gaps = 73/319 (22%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G RFG VYKG L + +A+K L G + F+ E + R++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKICSD 776
++ + +K +++ S+G L L + L+ V + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ YL S VVH DL N+L+ + L ++D G+ + V D
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK-------- 185
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFH 889
+ LL + ++APE M + S D++S+GV+L E+ + G +P DV+
Sbjct: 186 -LLGNSLL--PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV-- 240
Query: 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
E ++ L P P + L + C P
Sbjct: 241 ------EMIRNRQ--VLPC----------PDDCP-----------AWVYALMIECWNEFP 271
Query: 950 STRPSMLDVAHEMGRLKQY 968
S RP D+ RL+ +
Sbjct: 272 SRRPRFKDIHS---RLRAW 287
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 70/316 (22%), Positives = 123/316 (38%), Gaps = 73/316 (23%)
Query: 675 IGSGRFGHVYKGVLQDN---TRIAVKVL-DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+GSG FG V KG Q +AVK+L + + E +++++ + ++R+I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
IC + LV+ + G L +L + + ++++ V+ G+ YL
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRHVK----DKNIIELVHQVSMGMKYLEES--- 136
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL N+LL A ++DFG++K ++ D + + G
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALR---------ADENYYKAQTH------GK 181
Query: 851 I-----APEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWV 898
APE + S+ DV+SFGVL+ E + G++P ++V +
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--------AML 233
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
++ R+ P P E+ +L LC Y+ RP V
Sbjct: 234 EKGE--RMGC----------PAGCPR-----------EMYDLMNLCWTYDVENRPGFAAV 270
Query: 959 AHEMGRLKQYLSSPSS 974
RL+ Y +
Sbjct: 271 EL---RLRNYYYDVVN 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 74/320 (23%), Positives = 125/320 (39%), Gaps = 67/320 (20%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+G + ++AVK L + + F E I+ + H+N++R
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL---YPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
I + + + ++L LM+ G L++ L P L ++ L+ + D+A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 786 HHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+H D+ N LL A + DFG+A+ +
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---------KGGCA 246
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLH 895
+L V ++ PE M ++ D +SFGVLL EI + G P +VL
Sbjct: 247 ML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------- 296
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
E+V R+DP P++ P + + C Q+ P RP+
Sbjct: 297 EFVTSGG--RMDP----------PKNCP-----------GPVYRIMTQCWQHQPEDRPNF 333
Query: 956 LDVAHEMGRLKQYLSSPSSL 975
+ R++ P +
Sbjct: 334 AIILE---RIEYCTQDPDVI 350
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 73/317 (23%), Positives = 118/317 (37%), Gaps = 47/317 (14%)
Query: 675 IGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V +AVK L + + F+RE QILK + +++
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHSDFIVKY 89
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ P ++ LV+ + +G L + L H LD +L+ S + +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHR--ARLDASRLLLYSSQICKGMEYLGSR 146
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ VH DL NIL++ + +ADFG+AKL+ + G
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLP--------LDKDYYVVREPGQS--P 193
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906
+ + APE S DV+SFGV+L E+ T + + +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPA 249
Query: 907 DPIVEKAIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+ + + + AP P E+ EL LC +P RPS +
Sbjct: 250 LSRLLELLEEGQRLPAPPACPA-----------EVHELMKLCWAPSPQDRPSFSALGP-- 296
Query: 963 GRLKQYLSSPSSLIEEA 979
+L S A
Sbjct: 297 -QLDMLWSGSRGCETHA 312
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-37
Identities = 83/440 (18%), Positives = 156/440 (35%), Gaps = 56/440 (12%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
+ +Q L L LD N+ + I T L + ++N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKL-----TGLTKLICTSN 74
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
++T + L NL +L SN+L + + +KL +L+ ++N + +L +
Sbjct: 75 NIT-TLDLSQ---NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD---V 123
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS 306
S+ P L +L + N D +++++ EL+ N I +
Sbjct: 124 SQNPLLTYLNCARNTLTEID-----------VSHNTQLTELDCHLNKK---ITKLDVTPQ 169
Query: 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNS 366
T L + N I ++ +S L LN +N + + L +L + S+N
Sbjct: 170 TQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNK 223
Query: 367 LSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKC 426
L+ EI + L D S N L+ + S LS+L L L I L
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHN 274
Query: 427 VNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486
L + I DV L L+ + + L+LS+ ++ + L+
Sbjct: 275 TQLIYFQAEGCRK--IKELDVTHNTQLY-LLDCQAAGIT---ELDLSQNPKLVYLYLNNT 328
Query: 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQA 546
L+ + + L+SL+ ++ VG++P L + + ++
Sbjct: 329 ELT-ELD--VSHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTN 383
Query: 547 SPTLKQLNFSFNKFSGNISN 566
+ ++ GN N
Sbjct: 384 NSLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 77/439 (17%), Positives = 161/439 (36%), Gaps = 63/439 (14%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
+A + T + + L++L LD + + + L L +L + N++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-T 78
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+ L L YL +NKL + + T L Y++ N LT ++ +
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT-NLDV-----TPLTKLTYLNCDTNKLT-KLDVSQ---N 126
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
L +L N L ++ ++++++L LD N +L ++ QL L S+N
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFN 180
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
T L+ ++ + L NN I + + + L + N +
Sbjct: 181 KI------TELD-----VSQNKLLNRLNCDTNN----ITKLDLNQNIQLTFLDCSSNKLT 225
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPH 380
+I ++ L LT + S N L + + +SKL ++ L EI
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQ 276
Query: 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440
L + + + +QL L ++ + L + L L L++ +++
Sbjct: 277 LIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGS-- 498
+ DV+ LK L+ + H+ + K+ + + ++P + +
Sbjct: 332 EL---DVSHNTKLK-SLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTNN 384
Query: 499 ----CIALESLNLSGNSLE 513
++ + L+ GN +
Sbjct: 385 SLTIAVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-31
Identities = 61/390 (15%), Positives = 126/390 (32%), Gaps = 47/390 (12%)
Query: 202 NLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261
N + + + + + L LD ++ + ++ I K+ L L + N+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNN 75
Query: 262 FVSHD--GNTNLEPFFAS--------LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQ 311
+ D NTNL + + L N L + + L
Sbjct: 76 ITTLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT----KLDVSQNPLLTY 131
Query: 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371
++ N + +I +S+ LT L+ N ++ ++L + S N ++ E+
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKIT-EL 185
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431
L L+ N ++ + QL L N L+ I + L
Sbjct: 186 D--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTY 237
Query: 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491
D S N ++ + S ++ L + L+ L ++L+ ++
Sbjct: 238 FDCSVNPLTELDVSTLSKLTT----LHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKE 290
Query: 492 IPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLK 551
+ + L L+ + L + Q P L +++ L E+ + LK
Sbjct: 291 LD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL-TELD--VSHNTKLK 342
Query: 552 QLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L+ + S+ G +L
Sbjct: 343 SLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 41/234 (17%), Positives = 86/234 (36%), Gaps = 26/234 (11%)
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387
N + + +L + L + N+S++ + + L L +
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQL---ATLTSLDCHNSSITD--MTGIEKLTGLTKLICT 72
Query: 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV 447
N ++ ++ + + L L N L+ + + L L+ NK++ + DV
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DV 123
Query: 448 AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNL 507
+ L YLN + N L +++S + +D N + + L +L+
Sbjct: 124 SQNPLLT-YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 508 SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561
S N + L V Q L + + +N + ++ + L L+ S NK +
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 58/321 (18%), Positives = 114/321 (35%), Gaps = 84/321 (26%)
Query: 675 IGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL 726
+G G F ++KGV ++ T + +KVLD + SF ++ ++ H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHL 74
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+ +C D LV + GSL+ +L + ++++ +++ +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 787 HSPIKVVHCDLKPSNILLDEDLTAL--------VADFGIAKLVKGIDESVNCANDSMSFT 838
+ ++H ++ NILL + ++D GI+ V D +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--------KDILQE- 179
Query: 839 STDGLLCGSVGYIAPE-YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHD 890
+ ++ PE K + D +SFG L EI + G +P L
Sbjct: 180 --------RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--- 228
Query: 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
++ + + +L P+ + L C Y P
Sbjct: 229 -----QFYEDRH--QLPA----------PKAAELA-------------NLINNCMDYEPD 258
Query: 951 TRPSMLDVAHEMGRLKQYLSS 971
RPS + L +
Sbjct: 259 HRPSFRAIIR---DLNSLFTP 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 7e-37
Identities = 73/317 (23%), Positives = 130/317 (41%), Gaps = 65/317 (20%)
Query: 675 IGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G G FG V +GV + +A+KVL T T RE QI+ ++ + ++R+I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG--LDLIQLVKICSDVAEGVAYLHHHSP 789
+C LV+ + G L L + + + + ++ V+ G+ YL
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKYLEEK-- 455
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VH +L N+LL A ++DFG++K + G D+S A + + +
Sbjct: 456 -NFVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWP---------LK 504
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHDGSSLHEWVKRHY 902
+ APE ++ S+ DV+S+GV + E ++ G++P +V+ ++++
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--------AFIEQGK 556
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
R++ P P EL L C Y RP L V
Sbjct: 557 --RMEC----------PPECPP-----------ELYALMSDCWIYKWEDRPDFLTVEQ-- 591
Query: 963 GRLKQYLSSPSSLIEEA 979
R++ S +S +E
Sbjct: 592 -RMRACYYSLASKVEGG 607
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 64/324 (19%), Positives = 117/324 (36%), Gaps = 67/324 (20%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+G+G FG V + +AVK+L + + E ++L + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHL--------------YPSHGLSHGLDLIQLVKI 773
++ C+ ++ G L N L LDL L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA+G+A+L + +H DL NILL + DFG+A+ +K V
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV---- 203
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892
+ L V ++APE + DV+S+G+ L E+ + G P + G
Sbjct: 204 -----KGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGM 251
Query: 893 SLHEWVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
+ + R+ P+H P E+ ++ C +P
Sbjct: 252 PVDSKFYKMIKEGFRMLS----------PEHAP-----------AEMYDIMKTCWDADPL 290
Query: 951 TRPSMLDVAHEMGRLKQYLSSPSS 974
RP+ + +++ +S ++
Sbjct: 291 KRPTFKQIVQ---LIEKQISESTN 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 74/310 (23%), Positives = 128/310 (41%), Gaps = 44/310 (14%)
Query: 675 IGSGRFGHVYKGV---LQDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V LQDNT AVK L +T + F+RE +ILK ++H N+++
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 76
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+C + L++ + GSL ++L H +D I+L++ S + +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHK--ERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ +H DL NIL++ + + DFG+ K++ + G
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLP--------QDKEFFKVKEPGES--P 180
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
+ + APE + S DV+SFGV+L E+ T + + + K +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK--QGQMIV 238
Query: 908 PIVEKAIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
+ + + P P E+ + C N + RPS D+A
Sbjct: 239 FHLIELLKNNGRLPRPDGCPD-----------EIYMIMTECWNNNVNQRPSFRDLAL--- 284
Query: 964 RLKQYLSSPS 973
R+ Q + +
Sbjct: 285 RVDQIRDNMA 294
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 76/323 (23%), Positives = 120/323 (37%), Gaps = 66/323 (20%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+G G FG V + +AVK+L T + E +IL I H N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 728 RIITICSKPDFKALV-LPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKIC 774
++ C+KP +V + G+L +L P L L L+
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
VA+G+ +L + K +H DL NILL E + DFG+A+ + + V
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR----- 206
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSS 893
D L + ++APE + + DV+SFGVLL EI + G P + G
Sbjct: 207 ----KGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVK 255
Query: 894 LHEWVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
+ E R R+ P + E+ + L C PS
Sbjct: 256 IDEEFCRRLKEGTRMRA----------PDYTT-----------PEMYQTMLDCWHGEPSQ 294
Query: 952 RPSMLDVAHEMGRLKQYLSSPSS 974
RP+ ++ L L + +
Sbjct: 295 RPTFSELVE---HLGNLLQANAQ 314
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 70/366 (19%), Positives = 123/366 (33%), Gaps = 73/366 (19%)
Query: 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW 209
L + + L ++P + +DL NN +T EI
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP-----PDTALLDLQNNKIT-EIK---------------- 68
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
N L L L +N S ++ + + +L+ LYLS N
Sbjct: 69 --------DGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLKELPEKM 119
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY-GKIPPHI- 327
+L QEL + N + + S+ L ++ + L N + I
Sbjct: 120 -----PKTL------QELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAF 167
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDL 386
+ L+ + ++ + TIP L L ++L N ++ ++ + + + +L L L
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGL 223
Query: 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSD 446
S N +S S AN LR L L N L +P L ++++ L +N IS I +D
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 447 VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS-GSIPPQLGSCI-ALES 504
+ S + L N + I P C+ +
Sbjct: 283 FCPPGYNTKKASYSG-------------------VSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 505 LNLSGN 510
+ L
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 74/322 (22%), Positives = 132/322 (40%), Gaps = 34/322 (10%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
L+ + S L+ K+P L LDL NNK+ EI F + +L + L NN
Sbjct: 33 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKIT-EIKDGDF--KNLKNLHTLILINN 86
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
++ +I L L L L N+L ++P+ + + L+ L + N + ++ +
Sbjct: 87 KIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEIT-KVRKSVF 141
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS 306
+ + Q+ + L N S + +E + + +A N+ IP L
Sbjct: 142 NGLNQMIVVELGTNPLKS----SGIEN--GAFQGMKKLSYIRIADTNIT-TIPQ---GLP 191
Query: 307 TNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
+L ++HLD N I K+ L NL L LS N ++ L L ++L+NN
Sbjct: 192 PSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS-------FANLSQLRRLLLYGNHLSGT 418
L ++P D ++ ++ L N +S +I + + + L+ N +
Sbjct: 251 KLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308
Query: 419 -IPSSLGKCV-NLEILDLSHNK 438
I S +CV + L + K
Sbjct: 309 EIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 21/290 (7%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLS 339
+ L+L N + + +L NL + L N I KI P + LV L L LS
Sbjct: 51 PPDTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKI-SKISPGAFAPLVKLERLYLS 108
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI--PD 397
N L +P ++ L+ + + N ++ S F + + +++L N L S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
+F + +L + + +++ TIP L +L L L NKI+ + + + GL +L L
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA-KL 221
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGL-- 515
LS N + L+ + + L+ N L +P L ++ + L N++ +
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 280
Query: 516 ----LPVSVGQLPYLKQFDVSSNRL-FGEIPQS-FQASPTLKQLNFSFNK 559
P + + SN + + EI S F+ + K
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 24/262 (9%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P + + LL+L +N + + + L + L NN +S P AF + L
Sbjct: 46 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103
Query: 383 LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI-SG 441
L LSKN+L L +LR ++ N ++ S + +++L N + S
Sbjct: 104 RLYLSKNQLKELPEKMPKTLQELR---VHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160
Query: 442 IIPSDV-AGLRSLKLYLNLSSNHL---DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-L 496
I + G++ L Y+ ++ ++ LP L++ + L N ++ + L
Sbjct: 161 GIENGAFQGMKKLS-YIRIADTNITTIPQGLPPSLTE------LHLDGNKIT-KVDAASL 212
Query: 497 GSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556
L L LS NS+ + S+ P+L++ +++N+L ++P ++ +
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLH 271
Query: 557 FNKFS----GNISNKGAFSSLT 574
N S + G +
Sbjct: 272 NNNISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/270 (23%), Positives = 103/270 (38%), Gaps = 29/270 (10%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
L L I ISP A A L L L LSKN + +P ++ L++L + N +
Sbjct: 80 TLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK 135
Query: 140 KIPSQLGSLHQLEYLDLGNNKL-VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
S L+Q+ ++LG N L I F L YI +++ ++T IP
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAF--QGMKKLSYIRIADTNIT-TIPQGL-- 190
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
+L L L N++ +L + L L L N S + + ++ P L+ L+L+
Sbjct: 191 -PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLN 248
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNL-----GGMIPSIIGDLSTNLVQIH 313
N V G LA+ Q + L NN+ P + +
Sbjct: 249 NNKLVKVPGG---------LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 299
Query: 314 LDCNLI-YGKIPPHI-SNLVNLTLLNLSSN 341
L N + Y +I P + + L +
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 357 LERVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
L V S+ L ++P D+P LLDL NK++ F NL L L+L N +
Sbjct: 33 LRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475
S P + V LE L LS N++ +P + ++L+ L + N + + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQ-ELRVHENEITKVRKSVFNGL 144
Query: 476 DMVLAIDLSFNNL-SGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533
+ ++ ++L N L S I L + ++ ++ + G P L + +
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDG 201
Query: 534 NRLFGEIP-QSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
N++ ++ S + L +L SFN S + N G+ ++
Sbjct: 202 NKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDN-GSLANTP 240
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 11/89 (12%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-------LGSLIRLKQLSLS 133
EL L+ + + LA+ + V+ L N I + +SL
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLF 301
Query: 134 WNSLQ-GKIPSQL-GSLHQLEYLDLGNNK 160
N +Q +I ++ + LGN K
Sbjct: 302 SNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 74/324 (22%), Positives = 123/324 (37%), Gaps = 78/324 (24%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V K T +AVK+L + E +LK++ H ++I+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL--------------------YPSHGLSHGLDLI 768
+ CS+ L++ GSL L H L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
L+ +++G+ YL + +K+VH DL NIL+ E ++DFG+++ V D V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP---- 883
+ G + V ++A E +T DV+SFGVLL EIVT G P
Sbjct: 208 K---------RSQGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 884 --TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELG 941
+ +K + R++ P + E+ L
Sbjct: 257 PPERLF--------NLLKTGH--RMER----------PDNCS-----------EEMYRLM 285
Query: 942 LLCTQYNPSTRPSMLDVAHEMGRL 965
L C + P RP D++ ++ ++
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 76/330 (23%), Positives = 130/330 (39%), Gaps = 79/330 (23%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ QD +AVK L + F+RE ++L ++H++++R
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 107
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL-----------YPSHGLSHGLDLIQLVKICSDV 777
+C++ +V M +G L L L L QL+ + S V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL + + VH DL N L+ + L + DFG+++ + D
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR--------- 215
Query: 838 TSTDGLLCGSVGYIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVL 887
+L + ++ PE Y + +T DV+SFGV+L EI T G++P T+ +
Sbjct: 216 VGGRTML--PIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947
+ + + L+ P+ P E+ + C Q
Sbjct: 271 --------DCITQGR--ELER----------PRACP-----------PEVYAIMRGCWQR 299
Query: 948 NPSTRPSMLDVAHEMGRLKQYLSSPSSLIE 977
P R S+ DV RL+ +P ++
Sbjct: 300 EPQQRHSIKDVHA---RLQALAQAPPVYLD 326
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 74/312 (23%), Positives = 112/312 (35%), Gaps = 48/312 (15%)
Query: 675 IGSGRFGHVYKGVL---QDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V D T AVK L + +K+E IL+ + H ++I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
C + LV+ + GSL ++L H + L QL+ + EG+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+H DL N+LLD D + DFG+AK V DG
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP--------EGHEYYRVREDGDS--P 200
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRL 906
V + APE + DV+SFGV L E++T + E +
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS----PPTKFLELIGIAQGQMT 256
Query: 907 DPIVEKAIAK-Y---APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+ + + + P P E+ L C + S RP+ ++
Sbjct: 257 VLRLTELLERGERLPRPDKCPA-----------EVYHLMKNCWETEASFRPTFENLIP-- 303
Query: 963 GRLKQYLSSPSS 974
LK
Sbjct: 304 -ILKTVHEKYQG 314
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 75/329 (22%), Positives = 130/329 (39%), Gaps = 74/329 (22%)
Query: 674 LIGSGRFGHVYKGVLQDN---TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRI 729
+IG G FG V K ++ + A+K + + + F E ++L ++ H N+I +
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 730 ITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKICSDV 777
+ C + L + +G+L + L ++ + L QL+ +DV
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A G+ YL S + +H DL NIL+ E+ A +ADFG+++ +
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------GQEVYV 196
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDVLFHD 890
T G L V ++A E +T+ DV+S+GVLL EIV+ G P ++
Sbjct: 197 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--- 251
Query: 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
E + + Y RL+ P + E+ +L C + P
Sbjct: 252 -----EKLPQGY--RLEK----------PLNCD-----------DEVYDLMRQCWREKPY 283
Query: 951 TRPSMLDVAHEMGRLKQYLSSPSSLIEEA 979
RPS + L + L + +
Sbjct: 284 ERPSFAQILV---SLNRMLEERKTYVNTT 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 73/329 (22%), Positives = 128/329 (38%), Gaps = 73/329 (22%)
Query: 675 IGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V +AVK+L T + E +++K I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKI 773
+I ++ C++ +++ S G+L +L + + LV
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
+A G+ YL + K +H DL N+L+ E+ +ADFG+A+ + ID
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 215
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDV 886
+T+G L V ++APE + + DV+SFGVL+ EI T G P ++
Sbjct: 216 -----TTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
+ +K + R+D P + EL + C
Sbjct: 269 F--------KLLKEGH--RMDK----------PANCT-----------NELYMMMRDCWH 297
Query: 947 YNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975
PS RP+ + ++ R+ ++ L
Sbjct: 298 AVPSQRPTFKQLVEDLDRILTLTTNEEYL 326
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-36
Identities = 81/328 (24%), Positives = 131/328 (39%), Gaps = 76/328 (23%)
Query: 675 IGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V T++AVK+L T + E +++K I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKI 773
+I ++ C++ +++ S G+L +L PSH L LV
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA G+ YL + K +H DL N+L+ ED +ADFG+A+ + ID
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK---- 249
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDV 886
+T+G L V ++APE + + DV+SFGVLL EI T G P ++
Sbjct: 250 -----TTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
+ +K + R+D P + EL + C
Sbjct: 303 F--------KLLKEGH--RMDK----------PSNCT-----------NELYMMMRDCWH 331
Query: 947 YNPSTRPSMLDVAHEMGRLKQYLSSPSS 974
PS RP+ + L + ++ S+
Sbjct: 332 AVPSQRPTFKQLVE---DLDRIVALTSN 356
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 73/321 (22%)
Query: 675 IGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRN 725
+G G FG V +AVK+L T + E +++K I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKI 773
+I ++ C++ +++ S G+L +L + + LV
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
+A G+ YL + K +H DL N+L+ E+ +ADFG+A+ + ID
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK---- 261
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDV 886
+T+G L V ++APE + + DV+SFGVL+ EI T G P ++
Sbjct: 262 -----TTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
+ +K + R+D P + EL + C
Sbjct: 315 F--------KLLKEGH--RMDK----------PANCT-----------NELYMMMRDCWH 343
Query: 947 YNPSTRPSMLDVAHEMGRLKQ 967
PS RP+ + ++ R+
Sbjct: 344 AVPSQRPTFKQLVEDLDRILT 364
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 74/326 (22%), Positives = 125/326 (38%), Gaps = 80/326 (24%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V+ +D +AVK L T F+RE ++L ++H ++++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEHIVK 81
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL------------YPSHGLSHGLDLIQLVKICSD 776
+C D +V M +G L L L L Q++ I S
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A G+ YL + VH DL N L+ +L + DFG+++ V D
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-------- 190
Query: 837 FTSTDGLLCGSVGYIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP------TDV 886
+L + ++ PE Y + +T DV+SFGV+L EI T G++P T+V
Sbjct: 191 -VGGHTML--PIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
+ E + + L+ P+ P E+ ++ L C Q
Sbjct: 245 I--------ECITQGR--VLER----------PRVCP-----------KEVYDVMLGCWQ 273
Query: 947 YNPSTRPSMLDVAHEMGRLKQYLSSP 972
P R ++ ++ L +
Sbjct: 274 REPQQRLNIKEIYK---ILHALGKAT 296
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 74/339 (21%), Positives = 128/339 (37%), Gaps = 87/339 (25%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
IG G FG V++ T +AVK+L + ++ F+RE ++ + N+++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 729 IITICSKPDFKALVLPLMSNGSLENHL--------------------YPSHGLSHGLDLI 768
++ +C+ L+ M+ G L L S L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
+ + I VA G+AYL S K VH DL N L+ E++ +ADFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPE---YGMGKRASTHGDVYSFGVLLLEIVT-GRRP- 883
+ + + ++ PE Y R +T DV+++GV+L EI + G +P
Sbjct: 232 ---------ADGNDAI--PIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 884 -----TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELI 938
+V+ +V+ L P++ P LEL
Sbjct: 278 YGMAHEEVI--------YYVRDGN--ILAC----------PENCP-----------LELY 306
Query: 939 ELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSLIE 977
L LC P+ RPS + L++ +
Sbjct: 307 NLMRLCWSKLPADRPSFCSIHR---ILQRMCERAEGTVG 342
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 41/304 (13%)
Query: 675 IGSGRFGHVYKGV---LQDNTRI--AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G FG V LQDNT AVK L +T + F+RE +ILK ++H N+++
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKY 107
Query: 730 ITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+C + L++ + GSL ++L H +D I+L++ S + +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHK--ERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+ +H DL NIL++ + + DFG+ K++ + G
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLP--------QDKEYYKVKEPGES--P 211
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
+ + APE + S DV+SFGV+L E+ T + + + K +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK--QGQMIV 269
Query: 908 PIVEKAIAK----YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
+ + + P P E+ + C N + RPS D+A +
Sbjct: 270 FHLIELLKNNGRLPRPDGCPD-----------EIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 964 RLKQ 967
+++
Sbjct: 319 QIRD 322
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 61/318 (19%), Positives = 112/318 (35%), Gaps = 70/318 (22%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+G+G FG V + ++AVK+L T + + E +I+ + +H N++
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHL----------YPSHGLSHGLDLIQLVKICSDV 777
++ C+ ++ G L N L + L+ S V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
A+G+A+L + +H D+ N+LL A + DFG+A+ + +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV-------- 222
Query: 838 TSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP-------TDVLFH 889
+ L V ++APE + DV+S+G+LL EI + G P +
Sbjct: 223 -KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-- 277
Query: 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
+ VK Y ++ P P + + C P
Sbjct: 278 ------KLVKDGY--QMAQ----------PAFAP-----------KNIYSIMQACWALEP 308
Query: 950 STRPSMLDVAHEMGRLKQ 967
+ RP+ + + Q
Sbjct: 309 THRPTFQQICSFLQEQAQ 326
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 65/263 (24%), Positives = 116/263 (44%), Gaps = 44/263 (16%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G G VY N ++A+K + E F+RE ++ H+N++ +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHS 788
I + + D LV+ + +L ++ SHG L + + + + +G+ + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++VH D+KP NIL+D + T + DFGIAK A S T T+ +L G+V
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAK-----------ALSETSLTQTNHVL-GTV 176
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS--------LHE---- 896
Y +PE G+ D+YS G++L E++ G P +G + + +
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP-----FNGETAVSIAIKHIQDSVPN 231
Query: 897 ---WVKRHYPHRLDPIVEKAIAK 916
V++ P L ++ +A K
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEK 254
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 62/274 (22%), Positives = 105/274 (38%), Gaps = 68/274 (24%)
Query: 673 SLIGSGRFGHVYKGVLQDNT---RIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLI 727
L+G G G VY+ +D +A+K++ L++ +RE + R++ +++
Sbjct: 40 RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL------------VKICS 775
I DF G ++ LY L +G+DL + V I
Sbjct: 98 PIH------DF----------GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVR 141
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
+ + H H D+KP NIL+ D A + DFGIA A
Sbjct: 142 QIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-----------ATTDE 187
Query: 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS-- 893
T G G++ Y+APE A+ D+Y+ +L E +TG P + G
Sbjct: 188 KLTQL-GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP-----YQGDQLS 241
Query: 894 -----LHE------WVKRHYPHRLDPIVEKAIAK 916
+++ V+ P D ++ + +AK
Sbjct: 242 VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 53/301 (17%), Positives = 109/301 (36%), Gaps = 38/301 (12%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
++G G +V++G + A+KV + + RE ++LK++ H+N++++ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 733 --CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ K L++ GSL L ++GL + + + DV G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 791 KVVHCDLKPSNILL----DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+VH ++KP NI+ D + DFG A+ ++ +D + L G
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---------DDEQFVS-----LYG 177
Query: 847 SVGYIAPE--------YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
+ Y+ P+ K+ D++S GV TG P F E +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP-FEGPRRNKEVM 236
Query: 899 KR----HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
+ + + + + + + L + + +
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 955 M 955
Sbjct: 297 F 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 57/296 (19%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIRHRNL--IRII 730
IGSG V++ + + A+K ++L + S++ E L +++ + IR+
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +V+ N L + L +D + ++ E V +H H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLK-KKK---SIDPWERKSYWKNMLEAVHTIHQH--- 146
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+VH DLKP+N L+ + + DFGIA ++ ++ + DS G+V Y
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ--PDTTSVVKDSQ---------VGTVNY 194
Query: 851 IAPEYGMGKRASTHG-----------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
+ PE +S DV+S G +L + G+ P F
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ--------- 241
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + K A P H + + + +++ C + +P R S+
Sbjct: 242 ------IINQISKLHAIIDPNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRISI 287
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-34
Identities = 61/329 (18%), Positives = 111/329 (33%), Gaps = 72/329 (21%)
Query: 675 IGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+GSG FG V + ++AVK+L + E +++ ++ H N++
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHL-------------------YPSHGLSHGLDLI 768
++ C+ L+ G L N+L + L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
L+ VA+G+ +L VH DL N+L+ + DFG+A+ + V
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVL 887
+ L V ++APE + DV+S+G+LL EI + G P
Sbjct: 230 V---------RGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---- 274
Query: 888 FHDGSSLHEWVKRHYP--HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCT 945
+ G + + ++D P + E+ + C
Sbjct: 275 -YPGIPVDANFYKLIQNGFKMDQ----------PFYAT-----------EEIYIIMQSCW 312
Query: 946 QYNPSTRPSMLDVAHEMGRLKQYLSSPSS 974
++ RPS ++ L L+
Sbjct: 313 AFDSRKRPSFPNLTS---FLGCQLADAEE 338
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-34
Identities = 71/320 (22%), Positives = 123/320 (38%), Gaps = 34/320 (10%)
Query: 202 NLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261
+LR + L VP+ + S LDL++N S EL + + L L L N
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYG 321
+ + + + Q+L ++ N+L I +L ++LV++ + N I
Sbjct: 90 I------SKIHE--KAFSPLRKLQKLYISKNHL----VEIPPNLPSSLVELRIHDNRIR- 136
Query: 322 KIPPHI-SNLVNLTLLNLSSNLL-NGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIP 379
K+P + S L N+ + + N L N KL + +S L+G
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLP---E 193
Query: 380 HLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
L L L NK+ +I S+L RL L N + SL L L L +NK
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSNHL-----DGPLPLELSKMDMVL-AIDLSFNNLS-GS 491
+S +P+ + L+ L+ + L +N++ + P+ I L N +
Sbjct: 253 LS-RVPAGLPDLKLLQ-VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 492 IPPQLGSCI-ALESLNLSGN 510
+ P C+ ++
Sbjct: 311 VQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 72/348 (20%), Positives = 121/348 (34%), Gaps = 61/348 (17%)
Query: 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKL 161
L V+ S + +P E+ L L N + L L L L NNK+
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 162 VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQAL 221
+I F + LQ + +S N L EIP P
Sbjct: 91 S-KIHEKAF--SPLRKLQKLYISKNHLV-EIP------------------------PNLP 122
Query: 222 ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP-FFASLAN 280
++ L L + N ++P + S + + + + N N+ EP F L
Sbjct: 123 SS---LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL----ENSGFEPGAFDGL-- 172
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP-HISNLVNLTLLNLS 339
L ++ L IP DL L ++HLD N I I + L L L
Sbjct: 173 --KLNYLRISEAKL-TGIPK---DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLG 225
Query: 340 SNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398
N + I + + L ++L NN LS +P+ D+ L ++ L N ++ +
Sbjct: 226 HNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283
Query: 399 FA------NLSQLRRLLLYGNHLS-GTIPSSLGKCV-NLEILDLSHNK 438
F + + L+ N + + + +CV + + + K
Sbjct: 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 60/301 (19%), Positives = 109/301 (36%), Gaps = 34/301 (11%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNN 159
+LDL N + L L L L N + KI + L +L+ L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKN 112
Query: 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL-VGQVP 218
LV EIP + +SL + + +N + ++P LRN+ + + N L
Sbjct: 113 HLV-EIPPNLP-----SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 219 QALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278
+ KL +L + + +P ++ L L+L +N +E L
Sbjct: 166 PGAFDGLKLNYLRISEAKLT-GIPKDLPET---LNELHLDHNKI------QAIEL--EDL 213
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338
S L L N + + + L L ++HLD N + ++P + +L L ++ L
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFL-PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271
Query: 339 SSNLLNGTIP-------HELCLMSKLERVYLSNNSLSGEI--PSAFGDIPHLGLLDLSKN 389
+N + + + + L NN + P+ F + +
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
Query: 390 K 390
K
Sbjct: 331 K 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 21/257 (8%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P IS + TLL+L +N ++ + + L + L NN +S AF + L
Sbjct: 48 VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105
Query: 383 LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442
L +SKN L P+ ++L +LR ++ N + N+ +++ N +
Sbjct: 106 KLYISKNHLVEIPPNLPSSLVELR---IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
Query: 443 IPSDVAGLRSLKL-YLNLSSNHL---DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LG 497
A LKL YL +S L LP L+++ L N + +I + L
Sbjct: 163 GFEPGA-FDGLKLNYLRISEAKLTGIPKDLPETLNELH------LDHNKIQ-AIELEDLL 214
Query: 498 SCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSF 557
L L L N + + S+ LP L++ + +N+L +P L+ +
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHT 273
Query: 558 NKFSGNISNKGAFSSLT 574
N + + F +
Sbjct: 274 NNIT-KVGV-NDFCPVG 288
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 17/221 (7%)
Query: 357 LERVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
L V S+ L +P +I LLDL N +S D F L L L+L N +
Sbjct: 35 LRVVQCSDLGLK-AVPK---EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475
S + L+ L +S N + IP ++ SL L + N + S +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV-ELRIHDNRIRKVPKGVFSGL 146
Query: 476 DMVLAIDLSFNNL-SGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
+ I++ N L + P + L L +S L G+ L + + N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPK---DLPETLNELHLDHN 203
Query: 535 RLFGEIPQ-SFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
++ I L +L N+ I N G+ S L
Sbjct: 204 KI-QAIELEDLLRYSKLYRLGLGHNQIR-MIEN-GSLSFLP 241
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 37/188 (19%), Positives = 68/188 (36%), Gaps = 18/188 (9%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKN-FFQGHIPAELGSLIRLKQLSLSWNSLQ 138
EL + I + + L ++ +++ N ++L L +S L
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
IP L L L L +NK+ I + + L + L +N + I +
Sbjct: 186 -GIPKDL--PETLNELHLDHNKIQ-AIELEDL--LRYSKLYRLGLGHNQIR-MIENGSLS 238
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM------PQL 252
L LR L L +N+L +VP L + L+ + L +N + ++ +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 253 QFLYLSYN 260
+ L N
Sbjct: 297 NGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 26/115 (22%), Positives = 38/115 (33%), Gaps = 14/115 (12%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG 139
L L I I +L+ L +L L L N +PA L L L+ + L N++
Sbjct: 221 RLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 140 KIPSQ-------LGSLHQLEYLDLGNNKL-VGEIPIPIFCSNSSTSLQYIDLSNN 186
K+ + L NN + E+ F T I N
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF--RCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 16/89 (17%), Positives = 26/89 (29%), Gaps = 11/89 (12%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-------LGSLIRLKQLSLS 133
EL L + + L +L L V+ L N + +SL
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLF 302
Query: 134 WNSLQGKI--PSQLGSLHQLEYLDLGNNK 160
N + P+ + + GN K
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 57/296 (19%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIRHRNL--IRII 730
IGSG V++ + + A+K ++L + S++ E L +++ + IR+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +V+ N L + L +D + ++ E V +H H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLK-KKK---SIDPWERKSYWKNMLEAVHTIHQH--- 127
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+VH DLKP+N L+ + + DFGIA ++ ++ + DS G+V Y
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQ--PDTTSVVKDSQ---------VGTVNY 175
Query: 851 IAPEYGMGKRASTHG-----------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
+ PE +S DV+S G +L + G+ P F
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ--------- 222
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + K A P H + + + +++ C + +P R S+
Sbjct: 223 ------IINQISKLHAIIDPNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRISI 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 61/296 (20%), Positives = 112/296 (37%), Gaps = 57/296 (19%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEIT-GSFKRECQILKRIRHRNL--IRII 730
IGSG V++ + + A+K ++L T S++ E L +++ + IR+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +V+ N L + L +D + ++ E V +H H
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLK-KKK---SIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+VH DLKP+N L+ + + L DFGIA ++ ++ + DS G+V Y
Sbjct: 175 GIVHSDLKPANFLIVDGMLKL-IDFGIANQMQ--PDTTSVVKDSQ---------VGAVNY 222
Query: 851 IAPEYGMGKRASTHG-----------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
+ PE +S DV+S G +L + G+ P F
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ--------- 269
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + K A P H + + + +++ C + +P R S+
Sbjct: 270 ------IINQISKLHAIIDPNHEIEFPDIP-EKDLQDVL---KCCLKRDPKQRISI 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 53/316 (16%), Positives = 112/316 (35%), Gaps = 44/316 (13%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
++G G +V++G + A+KV + + RE ++LK++ H+N++++ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 733 --CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ K L++ GSL L ++GL + + + DV G+ +L +
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 791 KVVHCDLKPSNILL----DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+VH ++KP NI+ D + DFG A+ ++ +D + L G
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---------DDEQFVS-----LYG 177
Query: 847 SVGYIAPE--------YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS----- 893
+ Y+ P+ K+ D++S GV TG P F
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNK 233
Query: 894 --LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
+++ + + + + + + + L + + +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 952 RPSMLDVAHEMGRLKQ 967
E +
Sbjct: 294 CWGFDQFFAETSDILH 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 75/329 (22%), Positives = 128/329 (38%), Gaps = 57/329 (17%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
FCP ++G G G + + DN +AVK + RE Q+L+ H N+I
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA----DREVQLLRESDEHPNVI 81
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
R F+ + + L + +L+ ++ GL+ I L++ G+A+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSL 137
Query: 788 SPIKVVHCDLKPSNILLDE-----DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+VH DLKP NIL+ + A+++DFG+ K + SF+ G
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA---------VGRHSFSRRSG 185
Query: 843 LLCGSVGYIAPEY---GMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
+ G+ G+IAPE + + D++S G + +++ F
Sbjct: 186 -VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGK--------- 232
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV- 958
L + + ++ K + ELIE +P RPS V
Sbjct: 233 -----SLQRQANILLGACSLD--CLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHVL 282
Query: 959 AH----EMGRLKQYLSSPSSLIEEAALKG 983
H + + Q+ S IE+ +L G
Sbjct: 283 KHPFFWSLEKQLQFFQDVSDRIEKESLDG 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-33
Identities = 46/256 (17%), Positives = 85/256 (33%), Gaps = 46/256 (17%)
Query: 673 SLIGSGRFGHVYKG---VLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
I G G +Y + + +K L + E E Q L + H ++++I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 730 ITICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
D +V+ + SL+ L + + + ++ ++YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYL 198
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H +V+ DLKP NI+L E+ + D G + S G L
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----------------NSF-GYL 237
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH--- 901
G+ G+ APE + D+Y+ G L + +G + +
Sbjct: 238 YGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT-----RNGRYVDGLPEDDPVL 291
Query: 902 -YPHRLDPIVEKAIAK 916
++ +AI
Sbjct: 292 KTYDSYGRLLRRAIDP 307
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 70/324 (21%), Positives = 121/324 (37%), Gaps = 60/324 (18%)
Query: 638 NGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAV 696
D +E + K + + + IG G F VYKG+ + +A
Sbjct: 6 QQQDDIEELETKAVGMSNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTVEVAW 56
Query: 697 KVLDLT-TTGEITGSFKRECQILKRIRHRNLIRII----TICSKPDFKALVLPLMSNGSL 751
L T FK E ++LK ++H N++R + LV LM++G+L
Sbjct: 57 CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTA 810
+ + + L C + +G+ +LH +P ++H DLK NI + +
Sbjct: 117 -KTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSV 171
Query: 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSF 870
+ D G+A L + + + + G+ ++APE K DVY+F
Sbjct: 172 KIGDLGLATLKRA--------SFAKAVI-------GTPEFMAPEMYEEK-YDESVDVYAF 215
Query: 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVW 930
G+ +LE+ T P + + ++ V P ++KV
Sbjct: 216 GMCMLEMATSEYP-------------YSECQNAAQIYRRV-------TSGVKPASFDKVA 255
Query: 931 SDVVLELIELGLLCTQYNPSTRPS 954
V E+IE C + N R S
Sbjct: 256 IPEVKEIIE---GCIRQNKDERYS 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-33
Identities = 63/310 (20%), Positives = 119/310 (38%), Gaps = 40/310 (12%)
Query: 664 EATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR 722
+ G + +G+G FG+V + + ++A+K + + + E QI+K++
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 723 HRNLIRIITI------CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSD 776
H N++ + + D L + G L +L GL + + SD
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSD 129
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL---VADFGIAKLVKGIDESVNCAND 833
++ + YLH + +++H DLKP NI+L L + D G AK +
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---------QG 177
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
+ G++ Y+APE K+ + D +SFG L E +TG RP F
Sbjct: 178 ELCTE-----FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP----FLPNWQ 228
Query: 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHM-----PIYYNKVWSDVVLELIELGLLCTQYN 948
+W + + IV A + P + + + + + ++ L ++
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWH 285
Query: 949 PSTRPSMLDV 958
R +
Sbjct: 286 QRQRGTDPQN 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 1e-32
Identities = 44/338 (13%), Positives = 92/338 (27%), Gaps = 73/338 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIR-- 728
+ G V+ ++ A+KV + + R+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 729 ----------IITICSKPDFKA--------------LVLPLM--SNGSLENHLYPSHGLS 762
+ + S+P F L++P L + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 763 HGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822
++ L + + + A L +VH P N+ + D ++ D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVT 879
+ V Y E+ + +T + + G+ + +
Sbjct: 243 -------------KVGTRGPASSVPVTYAPREF-LNASTATFTHALNAWQLGLSIYRVWC 288
Query: 880 GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIE 939
P F + + + L ++A + +P D V LI
Sbjct: 289 LFLP----FGLVTPGIKGSWKR--PSLRVPGTDSLAFGSCTPLP--------DFVKTLIG 334
Query: 940 LGLLCTQYNPSTRPSMLDV-AH-EMGRLKQYLSSPSSL 975
L ++ R L+ E +L+ +SS S
Sbjct: 335 -RFL--NFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 45/266 (16%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G V+ L+D+ +AVKVL DL F+RE Q + H ++ +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 730 ITICSKPDFKA----LVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYL 784
+V+ + +L + + + G + + +++ +D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFS 132
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H + ++H D+KP+NI++ V DFGIA+ + A+ S T T ++
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI---------ADSGNSVTQTAAVI 180
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS--------LHE 896
G+ Y++PE G DVYS G +L E++TG P G S + E
Sbjct: 181 -GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVRE 234
Query: 897 WVKR------HYPHRLDPIVEKAIAK 916
LD +V KA+AK
Sbjct: 235 DPIPPSARHEGLSADLDAVVLKALAK 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 61/268 (22%), Positives = 107/268 (39%), Gaps = 18/268 (6%)
Query: 202 NLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261
+ + S L VP + S L+LESN LP + K+ QL L LS N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNG 63
Query: 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYG 321
+ S +++ + L+L+ N + + S L L + + +
Sbjct: 64 L------SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL-EQLEHLDFQHSNL-K 114
Query: 322 KIPPH--ISNLVNLTLLNLSSNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPS-AFGD 377
++ +L NL L++S + + +S LE + ++ NS F +
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 378 IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
+ +L LDLS+ +L P +F +LS L+ L + N+ +L++LD S N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 438 KISGIIPSDVAGLRSLKLYLNLSSNHLD 465
I ++ S +LNL+ N
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 11/246 (4%)
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
+ T + +S L ++P + S R+ L +N L F + L L LS N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 392 S--GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-A 448
S G S + L+ L L N + T+ S+ LE LD H+ + + V
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 449 GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNL 507
LR+L YL++S H + + + + ++ N+ + P L L+L
Sbjct: 124 SLRNLI-YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 508 SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK 567
S LE L P + L L+ ++S N F ++ +L+ L++S N S K
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM--TSKK 240
Query: 568 GAFSSL 573
Sbjct: 241 QELQHF 246
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 55/262 (20%), Positives = 104/262 (39%), Gaps = 17/262 (6%)
Query: 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSN 341
+ E+ L S+ + ++ ++ L+ N + +P + L LT L+LSSN
Sbjct: 8 SGTEIRCNSKGL----TSVPTGIPSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSN 62
Query: 342 LLN--GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS- 398
L+ G + L+ + LS N + + S F + L LD + L + +
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 120
Query: 399 -FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLY 456
F +L L L + H +LE+L ++ N D+ LR+L +
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-F 179
Query: 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGL 515
L+LS L+ P + + + +++S NN S+ +L+ L+ S N +
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 516 LPVSVGQLPY-LKQFDVSSNRL 536
+ P L +++ N
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 58/312 (18%), Positives = 96/312 (30%), Gaps = 63/312 (20%)
Query: 106 LDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEI 165
+ + +P + +L L N LQ L QL L L +N L
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL-SFK 67
Query: 166 PIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSS 225
+TSL+Y+DLS N + +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI--------------------------TMSSNFLGLE 101
Query: 226 KLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285
+LE LD + + + + L +L +S+ S+ +
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT------RVAFN--GIFNGLSSLE 153
Query: 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345
L++AGN+ P + L NLT L+LS L
Sbjct: 154 VLKMAGNSFQENFL------------------------PDIFTELRNLTFLDLSQCQLEQ 189
Query: 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANL-SQ 404
P +S L+ + +S+N+ + + L +LD S N + S + S
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249
Query: 405 LRRLLLYGNHLS 416
L L L N +
Sbjct: 250 LAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 32/276 (11%)
Query: 64 VCNWSGVKCNNSRNKVV---------ELDLSARSIYGTISPALANLSSLIVLDLSKNF-- 112
C+ + ++CN+ V L+L + + L+ L L LS N
Sbjct: 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 113 FQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCS 172
F+G LK L LS+N + + S L QLE+LD ++ L +F
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF-- 122
Query: 173 NSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV-PQALANSSKLEWLD 231
S +L Y+D+S+ L +L L + N P L +LD
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291
L +L + + LQ L +S+N+F +L+ F ++ Q L+ +
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF------FSLDTFP--YKCLNSLQVLDYSL 232
Query: 292 NNLGGMIPSIIGDLSTNLVQIHL-------DCNLIY 320
N++ + ++L ++L C
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 66/315 (20%), Positives = 116/315 (36%), Gaps = 63/315 (20%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
++G G G V +AVK + + + E ++L H N+I
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVI 72
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHL---YPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
R + F + L L N +L++ + S + + +A GVA+L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 785 HHHSPIKVVHCDLKPSNILLD-------------EDLTALVADFGIAKLVKGIDESVNCA 831
H K++H DLKP NIL+ E+L L++DFG+ K +
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD--------- 179
Query: 832 NDSMSFTSTDGLLCGSVGYIAPE-------YGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883
+ SF + G+ G+ APE +R + D++S G + I++ G+ P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLL 943
F D S + R ++ M +++ +LI
Sbjct: 240 ----FGDKYSRESNIIR--------------GIFSLDEMKCLHDRSLIAEATDLIS---Q 278
Query: 944 CTQYNPSTRPSMLDV 958
++P RP+ + V
Sbjct: 279 MIDHDPLKRPTAMKV 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 67/330 (20%), Positives = 127/330 (38%), Gaps = 47/330 (14%)
Query: 646 EKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLT-- 702
+ + ++A P + Y L F IG G+F VY+ L D +A+K + +
Sbjct: 15 QFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL 70
Query: 703 TTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLS 762
+ +E +LK++ H N+I+ + + +VL L G L +
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK 130
Query: 763 HGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822
+ + K + + ++H +V+H D+KP+N+ + + D G+ +
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF- 186
Query: 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR 882
+ + + L G+ Y++PE + D++S G LL E+ +
Sbjct: 187 ---------SSKTTAAHS---LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
Query: 883 PTDVLFH-DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELG 941
P F+ D +L+ K+ I + Y P Y S+ EL +L
Sbjct: 235 P----FYGDKMNLYSLCKK--------IEQC---DYPPLPSDHY-----SE---ELRQLV 271
Query: 942 LLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971
+C +P RP + V R+ +S
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTAS 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-31
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 19/264 (7%)
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
++ L +VPQ + S +L+L N + ++ + L+ L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
+E + ++ LEL N L + L + L ++ L N I
Sbjct: 110 SI------RQIEV--GAFNGLASLNTLELFDNWLTVIPSGAFEYL-SKLRELWLRNNPI- 159
Query: 321 GKIPPHI-SNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSLSGEIPSAFGDI 378
IP + + + +L L+L I + L+ + L ++ ++P +
Sbjct: 160 ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPL 217
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
L L++S N P SF LS L++L + + +S ++ +L L+L+HN
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSN 462
+S + LR L L+L N
Sbjct: 278 LSSLPHDLFTPLRYLV-ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 14/258 (5%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLS 339
S+ F ++ L +P + +N ++L N I I +L +L +L L
Sbjct: 53 SNQFSKVVCTRRGLSE-VPQ---GIPSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLG 107
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDS 398
N + ++ L + L +N L+ IPS AF + L L L N + +
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYA 166
Query: 399 FANLSQLRRLLLYG-NHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
F + L RL L L + NL+ L+L I + ++ L L+ L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLE-EL 223
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLL 516
+S NH P + + + + + +S I +L LNL+ N+L L
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLP 282
Query: 517 PVSVGQLPYLKQFDVSSN 534
L YL + + N
Sbjct: 283 HDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 68/315 (21%), Positives = 113/315 (35%), Gaps = 70/315 (22%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
+ + ++ +P + + L+L N++Q LH LE L LG N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQA 220
+ +I + F N SL ++L +N LT IP A
Sbjct: 111 I-RQIEVGAF--NGLASLNTLELFDNWLT-VIP------------------------SGA 142
Query: 221 LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGN--TNLEPFFASL 278
SKL L L +N +PS +++P L L L + + +
Sbjct: 143 FEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG-------ELKKLEYISE--GAF 192
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338
N + L L N+ ++ P+++ LV L L +
Sbjct: 193 EGLFNLKYLNLGMCNI------------KDM---------------PNLTPLVGLEELEM 225
Query: 339 SSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398
S N P +S L+++++ N+ +S +AF + L L+L+ N LS D
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285
Query: 399 FANLSQLRRLLLYGN 413
F L L L L+ N
Sbjct: 286 FTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 65/254 (25%), Positives = 98/254 (38%), Gaps = 34/254 (13%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P I N LNL N + + LE + L NS+ AF + L
Sbjct: 69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126
Query: 383 LLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSH-NKIS 440
L+L N L+ IP +F LS+LR L L N + + + +L LDL K+
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCI 500
I GL +LK YLNL ++ P L +
Sbjct: 186 YISEGAFEGLFNLK-YLNLGMCNI--------------------------KDMPNLTPLV 218
Query: 501 ALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560
LE L +SGN + P S L LK+ V ++++ +F +L +LN + N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 561 SGNISNKGAFSSLT 574
S ++ F+ L
Sbjct: 279 S-SLP-HDLFTPLR 290
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 68/279 (24%), Positives = 103/279 (36%), Gaps = 41/279 (14%)
Query: 64 VCNWSG--VKCNNSR---------NKVVELDLSARSIYGTISP-ALANLSSLIVLDLSKN 111
C+ V C + L+L +I I +L L VL L +N
Sbjct: 51 SCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNI-QMIQADTFRHLHHLEVLQLGRN 109
Query: 112 FFQGHIPAE-LGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPI 169
+ I L L L L N L IPS L +L L L NN + IP
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 170 FCSNSSTSLQYIDLS-NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
F N SL +DL L I L NL++L L + + L LE
Sbjct: 167 F--NRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGLE 221
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELE 288
L++ N F E+ + L+ L++ + + +E + ++ EL
Sbjct: 222 ELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV------SLIER--NAFDGLASLVELN 272
Query: 289 LAGNNLGGMIPSIIGDLSTNLVQIHL-------DCNLIY 320
LA NNL +P + LV++HL DC++++
Sbjct: 273 LAHNNL-SSLPHDLFTPLRYLVELHLHHNPWNCDCDILW 310
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 13/139 (9%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQG 139
L+L +I P L L L L++S N F I L LK+L + + +
Sbjct: 200 YLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199
+ L L L+L +N L +P +F L + L +N P +C+
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLF--TPLRYLVELHLHHN------PWNCDCD 307
Query: 200 LRNLRFLLLWSNRLVGQVP 218
+ L + L
Sbjct: 308 ILWLAWWLREYIPTNSTCC 326
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
++G G +G VY G L + RIA+K + + E + K ++H+N+++ +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
S+ F + + + GSL L G L I + EG+ YLH + +
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG--FYTKQILEGLKYLHDN---Q 142
Query: 792 VVHCDLKPSNILLD-EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+VH D+K N+L++ ++DFG +K + GI+ +FT G++ Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE------TFT-------GTLQY 189
Query: 851 IAPE--YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+APE + D++S G ++E+ TG+ P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-30
Identities = 47/343 (13%), Positives = 91/343 (26%), Gaps = 84/343 (24%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIR-------- 722
++G + + V V T K E L+ +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 723 --HRNLIRIITICSKPDFKALV-------------------LPLMSNGSLENHLYPSHGL 761
H I + P K ++ + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821
L +++ V +A LHH+ +VH L+P +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG-----DVYSFGVLLLE 876
+ + + + G A + D ++ G+ +
Sbjct: 260 ---------RDGASAVSPI-GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 877 IVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLE 936
I P + + + + +++P V
Sbjct: 310 IWCADLP-----NTDDAALGGSEWIFRS--------------CKNIP--------QPVRA 342
Query: 937 LIELGLLCTQYNPSTRPSMLDV--AHEMGRLKQYLSSPSSLIE 977
L+E G L +Y R L E +L+ LS+ L +
Sbjct: 343 LLE-GFL--RYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQ 382
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 84/496 (16%), Positives = 162/496 (32%), Gaps = 74/496 (14%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
L LS+N ++ L L+ L LS N ++ LEYLD+ +N+
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR 111
Query: 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE-CELRNLRFLLLWSNRLVGQVPQ 219
L I SL+++DLS N +P+ E L L FL L + + Q+
Sbjct: 112 LQ-NISCCPM-----ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF-RQLDL 163
Query: 220 ALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN----------DFVSHDGNT 269
L + L+ + + ++P L+L ++ V+ G+
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL 223
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHIS- 328
L + N ++ + + T + + +++
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283
Query: 329 -------------------NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
L +L + ++ + + + + +++ LS +
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343
Query: 370 EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429
L+ ++N + S+ + L +L+ L+L N L N+
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402
Query: 430 EILDLSHNKI----SGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF 485
L+ + S A S+ LNLSSN L F
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESIL-VLNLSSNMLT----------------GSVF 445
Query: 486 NNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ-SF 544
L ++ L+L N + +P V L L++ +V+SN+L +P F
Sbjct: 446 RCLPPK----------VKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL-KSVPDGVF 493
Query: 545 QASPTLKQLNFSFNKF 560
+L+ + N +
Sbjct: 494 DRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 69/418 (16%), Positives = 123/418 (29%), Gaps = 68/418 (16%)
Query: 165 IPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANS 224
+ + S+ +D SN +LT VP+ L
Sbjct: 20 LIVGSMTPFSNELESMVDYSNRNLT--------------------------HVPKDL--P 51
Query: 225 SKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN-----DFVSHDGNTNLEPFFASLA 279
+ + L L N S EL IS + +L+ L LS+N DF N +LE
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE------- 103
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPH--ISNLVNLTLLN 337
L+++ N L +I +L + L N + +P NL LT L
Sbjct: 104 ------YLDVSHNRLQ----NISCCPMASLRHLDLSFND-FDVLPVCKEFGNLTKLTFLG 152
Query: 338 LSSN-LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPH--LGLLDLSKNKLSGS 394
LS+ + L + L + + G + L L+ + S
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 395 IPDSFANLS--QLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRS 452
+ S L QL + L + + +L+++ I V +
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 453 LKL----YLNLSSNHLDGPLPLEL-----SKMDMVLAIDLSFNNLSGSIPPQLGSCIALE 503
YLN+ + + + E + + ++ + S +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 504 SLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561
LS + + V + + N + Q L+ L N
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 66/283 (23%), Positives = 104/283 (36%), Gaps = 37/283 (13%)
Query: 360 VYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
V SN +L+ +P D+P L LS+N +S + LS+LR L L N + +
Sbjct: 36 VDYSNRNLT-HVPK---DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90
Query: 419 IPSSL-GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDM 477
+ + +LE LD+SHN++ I + SL+ +L+LS N D
Sbjct: 91 LDFHVFLFNQDLEYLDVSHNRLQN-ISCCP--MASLR-HLDLSFNDFD------------ 134
Query: 478 VLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLP-YLKQFDVSSNRL 536
VL + F NL+ L L LS L + V L D+ S +
Sbjct: 135 VLPVCKEFGNLT-----------KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183
Query: 537 FGEIPQSFQASPTLK-QLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCK 595
G +S Q T L F N N + ++L + L T
Sbjct: 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVN-MSVNALGHLQLSNIKLNDENCQRLMTFL 242
Query: 596 KEHTHHLVILSILLSLFAMSLLFIFGNFLVLRSKFGKDLSVLN 638
E T +L++ L + F + + L++ N
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 47/250 (18%), Positives = 86/250 (34%), Gaps = 15/250 (6%)
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
++++ S+ L +P +L + + + LS NS+S + L +L LS N++
Sbjct: 32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88
Query: 392 SGSIPDS-FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AG 449
S+ F L L + N L I +L LDLS N +
Sbjct: 89 R-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGN 144
Query: 450 LRSLKLYLNLSSNHL-DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLS 508
L L +L LS+ L + +DL ++ G L L+L
Sbjct: 145 LTKLT-FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLV 202
Query: 509 GNS---LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565
+ + +SV L +L+ ++ N + +F + T + +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 566 NKGAFSSLTI 575
K +
Sbjct: 263 WKCSVKLFQF 272
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 9/184 (4%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
LS + SS L+ ++N F + +L RL+ L L N L+
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-N 391
Query: 141 IPSQLGSLHQLEYLDLGNNKLVG--EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
+ L+ + L C+ + S+ ++LS+N LTG + C
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA-WAESILVLNLSSNMLTGSVF---RC 447
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
++ L L +NR+ +P+ + + L+ L++ SN +P + ++ LQ+++L
Sbjct: 448 LPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 259 YNDF 262
N +
Sbjct: 506 DNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 35/169 (20%), Positives = 70/169 (41%), Gaps = 10/169 (5%)
Query: 72 CNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQ--GHIPAELGSLIRLKQ 129
C S + L+ + ++ + L L L L +N + + ++ L+
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407
Query: 130 LSLSWNSLQGKIPSQLGSLHQ-LEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188
L +S NSL + + + + L+L +N L G + + ++ +DL NN +
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL-----PPKVKVLDLHNNRI 462
Query: 189 TGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMF 237
IP K+ L+ L+ L + SN+L + L+++ L N +
Sbjct: 463 M-SIP-KDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 59/262 (22%), Positives = 111/262 (42%), Gaps = 34/262 (12%)
Query: 304 DLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363
LS N + + Y L + N + CL+++ + L+
Sbjct: 12 SLSQNSFYNTI--SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLN 67
Query: 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSL 423
+LS +P P + +L++++N L S+P+ A+L L N LS T+P
Sbjct: 68 RLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELP 119
Query: 424 GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDL 483
+L+ LD+ +N+++ ++P A L Y+N +N L LP + +++ + +
Sbjct: 120 A---SLKHLDVDNNQLT-MLPELPALLE----YINADNNQLTM-LPELPTSLEV---LSV 167
Query: 484 SFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQ----FDVSSNRLFGE 539
N L+ +P S LE+L++S N LE L P + + ++ F NR+
Sbjct: 168 RNNQLT-FLPELPES---LEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRI-TH 221
Query: 540 IPQSFQASPTLKQLNFSFNKFS 561
IP++ + + N S
Sbjct: 222 IPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 63/399 (15%), Positives = 117/399 (29%), Gaps = 50/399 (12%)
Query: 167 IPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWS---NRLVGQVPQALAN 223
+ I ++ + N+++ L N V + + L N
Sbjct: 1 MSIMLPINNNFSLSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59
Query: 224 SSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSN 283
L L S LP + PQ+ L ++ N +L ASL
Sbjct: 60 Q--FSELQLNRLNLS-SLPDNLP---PQITVLEITQNAL------ISLPELPASL----- 102
Query: 284 FQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLL 343
+ L+ N L +P + +L + +D N + +P + L +N +N L
Sbjct: 103 -EYLDACDNRLS-TLPELPA----SLKHLDVDNNQL-TMLPELPALL---EYINADNNQL 152
Query: 344 NGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLS 403
+P + LE + + NN L+ +P L LD+S N L S+P
Sbjct: 153 T-MLPELP---TSLEVLSVRNNQLT-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNH 203
Query: 404 QLRRLL----LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459
N ++ IP ++ + L N +S I ++ + Y
Sbjct: 204 HSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
Query: 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519
D + + N+ L
Sbjct: 263 RIYFSMSDGQQNT---LHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL-DR 318
Query: 520 VGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
+ + ++ + AS L+Q +F+
Sbjct: 319 LSDTVSARNTSGFREQVA-AWLEKLSASAELRQQSFAVA 356
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-22
Identities = 63/375 (16%), Positives = 116/375 (30%), Gaps = 80/375 (21%)
Query: 73 NNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132
+RN+ V L ++ L L++ +P L ++ L +
Sbjct: 43 GENRNEAVSL------------LKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEI 87
Query: 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI 192
+ N+L +P LEYLD +N+L +P SL+++D+ NN LT +
Sbjct: 88 TQNALI-SLPELPA---SLEYLDACDNRLS-TLP------ELPASLKHLDVDNNQLT-ML 135
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL 252
P L ++ +N+L +P+ + LE L + +N + LP L
Sbjct: 136 PE----LPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLT-FLPEL----PESL 182
Query: 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD---LSTNL 309
+ L +S N S +P++
Sbjct: 183 EALDVSTNLLES---------------------------------LPAVPVRNHHSEETE 209
Query: 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
+ N I IP +I +L + L N L+ I L + + S
Sbjct: 210 IFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 370 EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429
+ H L D + + + + N S L V+
Sbjct: 269 SDG--QQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSA 325
Query: 430 EILDLSHNKISGIIP 444
+++ +
Sbjct: 326 RNTSGFREQVAAWLE 340
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 26/202 (12%), Positives = 43/202 (21%), Gaps = 20/202 (9%)
Query: 81 ELDLSARSIYGTISPALANLSSL----IVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
LD+S + ++ I +N HIP + SL + L N
Sbjct: 184 ALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP 241
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS--------- 187
L +I L N
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH 301
Query: 188 ----LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS 243
+ + ++ QV L S L +S + + +
Sbjct: 302 AFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAAD-AT 360
Query: 244 EIISKMPQLQFLYLSYNDFVSH 265
E L + L V
Sbjct: 361 ESCEDRVALTWNNLRKTLLVHQ 382
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 39/293 (13%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G F +V L D A+K + + + +RE + + H N++R++
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA-QREADMHRLFNHPNILRLVAY 94
Query: 733 CSKPDFKA----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
C + L+LP G+L N + + L Q++ + + G+ +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK- 153
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
H DLKP+NILL ++ ++ D G E A + + ++
Sbjct: 154 --GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ----RCTI 207
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905
Y APE + DV+S G +L ++ G P D++F G S+ V+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL--- 264
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
PQ P + S + +L+ ++ +P RP + +
Sbjct: 265 -----------SIPQS-PRH-----SSALWQLLN-SMM--TVDPHQRPHIPLL 297
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 63/291 (21%), Positives = 112/291 (38%), Gaps = 46/291 (15%)
Query: 149 HQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLL 208
+Q + L E+P I T+ + ++L N + I + + LR+L L L
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS-----TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQL 95
Query: 209 WSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGN 268
N + A + L L+L N + +P+ + +L+ L+L N
Sbjct: 96 SRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI------ 148
Query: 269 TNLEPF-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI 327
++ + F + + + L+L ++ I
Sbjct: 149 ESIPSYAFNRI---PSLRRLDLGELK-----------------RLS--------YISEGA 180
Query: 328 -SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDL 386
L NL LNL+ L IP+ L + KL+ + LS N LS P +F + HL L +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
++++ ++F NL L + L N+L+ +LE + L HN
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-30
Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 10/239 (4%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P IS N LLNL N + + + LE + LS N + AF + +L
Sbjct: 58 VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 383 LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSH-NKIS 440
L+L N+L+ +F LS+L+ L L N + +IPS + +L LDL ++S
Sbjct: 116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSC 499
I GL +L+ YLNL+ +L +P L+ + + +DLS N+LS +I P
Sbjct: 175 YISEGAFEGLSNLR-YLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGL 230
Query: 500 IALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
+ L+ L + + ++ + + L L + +++ N L F L++++ N
Sbjct: 231 MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-29
Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 12/257 (4%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLS 339
S+ F ++ NL +P +STN ++L N I I + +L +L +L LS
Sbjct: 42 SNQFSKVICVRKNLRE-VPD---GISTNTRLLNLHENQI-QIIKVNSFKHLRHLEILQLS 96
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSF 399
N + ++ L + L +N L+ AF + L L L N + +F
Sbjct: 97 RNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF 156
Query: 400 ANLSQLRRLLLYG-NHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLN 458
+ LRRL L LS + NL L+L+ + I ++ L L L+
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLD-ELD 213
Query: 459 LSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCI-ALESLNLSGNSLEGLLP 517
LS NHL P + + + + + + I + +L +NL+ N+L L
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPH 272
Query: 518 VSVGQLPYLKQFDVSSN 534
L +L++ + N
Sbjct: 273 DLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 63/288 (21%), Positives = 108/288 (37%), Gaps = 63/288 (21%)
Query: 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSN 185
+ L+L N +Q + L LE L L N + I I F N +L ++L +
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAF--NGLANLNTLELFD 121
Query: 186 NSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI 245
N LT IP A SKL+ L L +N +PS
Sbjct: 122 NRLT-TIP------------------------NGAFVYLSKLKELWLRNNPIE-SIPSYA 155
Query: 246 ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL 305
+++P L+ L L L + L
Sbjct: 156 FNRIPSLRRLDLGEL-------------------------------KRLSYISEGAFEGL 184
Query: 306 STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
+NL ++L + +IP +++ L+ L L+LS N L+ P + L+++++ +
Sbjct: 185 -SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
+ +AF ++ L ++L+ N L+ D F L L R+ L+ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 41/265 (15%)
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
++ L +VP + S+ L+L N + + L+ L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
+E + +N LEL N L + L + L ++ L N I
Sbjct: 99 HI------RTIEI--GAFNGLANLNTLELFDNRLTTIPNGAFVYL-SKLKELWLRNNPI- 148
Query: 321 GKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIP 379
IP + + + +L L+L LS AF +
Sbjct: 149 ESIPSYAFNRIPSLRRLDLGEL-----------------------KRLSYISEGAFEGLS 185
Query: 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439
+L L+L+ L IP+ L +L L L GNHLS P S ++L+ L + ++I
Sbjct: 186 NLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
Query: 440 SGIIPSDVAGLRSLKLYLNLSSNHL 464
I + L+SL +NL+ N+L
Sbjct: 244 QVIERNAFDNLQSLV-EINLAHNNL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-25
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 11/222 (4%)
Query: 355 SKLERVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
++ +V +L E+P I + LL+L +N++ +SF +L L L L N
Sbjct: 43 NQFSKVICVRKNLR-EVPD---GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELS 473
H+ + NL L+L N+++ I L LK L L +N ++ +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLK-ELWLRNNPIESIPSYAFN 157
Query: 474 KMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVS 532
++ + +DL I L LNL+ +L + ++ L L + D+S
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT--PLIKLDELDLS 215
Query: 533 SNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
N L P SFQ L++L ++ I + AF +L
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFDNLQ 255
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 8e-22
Identities = 69/252 (27%), Positives = 105/252 (41%), Gaps = 30/252 (11%)
Query: 80 VELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSL 137
L+L I I + +L L +L LS+N + I L L L L N L
Sbjct: 67 RLLNLHENQI-QIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124
Query: 138 QGKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLS-NNSLTGEIPLK 195
IP+ L +L+ L L NN + IP F N SL+ +DL L+ I
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF--NRIPSLRRLDLGELKRLS-YISEG 179
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
L NLR+L L L ++P L KL+ LDL N S + + LQ L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKL 236
Query: 256 YLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL- 314
++ + + N F +L + E+ LA NNL ++P + +L +IHL
Sbjct: 237 WMIQSQIQVIERNA-----FDNL---QSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLH 287
Query: 315 ------DCNLIY 320
+C++++
Sbjct: 288 HNPWNCNCDILW 299
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 33/291 (11%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
+K L LS N + S L L+ L L +N + I F +S SL+++DLS N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSF--SSLGSLEHLDLSYN 110
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQAL-ANSSKLEWLDLESNMFSGELPSEI 245
L+ + L +L FL L N +L ++ +KL+ L + + ++ +
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 246 ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL 305
+ + L+ L + +D + EP SL + N L L ++ I D+
Sbjct: 170 FAGLTFLEELEIDASDL------QSYEPK--SLKSIQNVSHLILHMKQHI-LLLEIFVDV 220
Query: 306 STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
++++ + L + +S +L+ + V +++
Sbjct: 221 TSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT----------------FRNVKITDE 264
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS-FANLSQLRRLLLYGNHL 415
SL ++ I L L+ S+N+L S+PD F L+ L+++ L+ N
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 54/329 (16%), Positives = 118/329 (35%), Gaps = 60/329 (18%)
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
S+ + +P L + ++ LDL +N + + + + + LQ L L+ N + + ++
Sbjct: 39 SSGSLNSIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDS 95
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-S 328
F+SL + + L+L+ N L +
Sbjct: 96 -----FSSL---GSLEHLDLSYNYLS--------------------------NLSSSWFK 121
Query: 329 NLVNLTLLNLSSNLLNGTIPHELCL--MSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLD 385
L +LT LNL N T+ ++KL+ + + N +I F + L L+
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 386 LSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445
+ + L P S ++ + L+L+ + + ++E L+L + S
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 446 DVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL 505
+++ + L + ++ ++ +L + L L L
Sbjct: 241 ELSTGETNSLIKKFTFRNV-----------------KITDESLF-QVMKLLNQISGLLEL 282
Query: 506 NLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
S N L+ + +L L++ + +N
Sbjct: 283 EFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 6e-22
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 13/238 (5%)
Query: 355 SKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH 414
++ + LSNN ++ S +L L L+ N ++ DSF++L L L L N+
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 415 LSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGPLPLE-L 472
LS S +L L+L N + + + + L L+ L + + + +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ-ILRVGNMDTFTKIQRKDF 170
Query: 473 SKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDV 531
+ + + +++ ++L S P+ L S + L L LL + V ++ ++
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 532 SSNRL----FGEIP----QSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L F E+ S T + + + + S L F N
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 29/149 (19%), Positives = 52/149 (34%), Gaps = 22/149 (14%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAELGS--------LIRLKQLS 131
L L + + + SS+ L+L +EL + + +
Sbjct: 202 HLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
++ SL ++ L + L L+ N+L +P IF + TSLQ I L N
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIF--DRLTSLQKIWLHTNPWD-- 314
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQA 220
C + +L W N+ + +
Sbjct: 315 ------CSCPRIDYLSRWLNKNSQKEQGS 337
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 58/308 (18%), Positives = 111/308 (36%), Gaps = 50/308 (16%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLD----------------LTTTGEITGSFKRECQIL 718
+ G+F + +DN A+K + + FK E QI+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 719 KRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGL----SHGLDLIQLVKIC 774
I++ + I + D ++ M N S+ L + + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 775 SDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDS 834
V +Y+H+ + H D+KPSNIL+D++ ++DFG ++ + D
Sbjct: 158 KSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----------DK 205
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDG 891
S G+ ++ PE+ + S +G D++S G+ L + P F
Sbjct: 206 KIKGS-----RGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVP----FSLK 255
Query: 892 SSLHEWVKRHYPHRLD-PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
SL E ++ P+ N S+ ++ ++ L + NP+
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK-LFL--RKNPA 312
Query: 951 TRPSMLDV 958
R + D
Sbjct: 313 ERITSEDA 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 60/314 (19%), Positives = 106/314 (33%), Gaps = 49/314 (15%)
Query: 643 EDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDL 701
+ E+ K Y++ + +G G FG V++ Q + AVK + L
Sbjct: 37 NEGVLLTEKLKPVDYEYREEVHWMTHQ---PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 702 TTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGL 761
E + ++ + + + + + L+ GSL L G
Sbjct: 94 EV------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC 146
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIAKL 820
L + + EG+ YLH +++H D+K N+LL D A + DFG A
Sbjct: 147 ---LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTG 880
++ G+ ++APE MGK D++S ++L ++ G
Sbjct: 201 LQPDGLG-KSLLTGDYIP-------GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252
Query: 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIEL 940
P + P+ K IA P I + + + I+
Sbjct: 253 CHP----WTQ---YFRG----------PLCLK-IASEPPPIREI--PPSCAPLTAQAIQ- 291
Query: 941 GLLCTQYNPSTRPS 954
+ P R S
Sbjct: 292 --EGLRKEPVHRAS 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 69/290 (23%), Positives = 113/290 (38%), Gaps = 53/290 (18%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G F ++ A K++ + E I + + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSP 789
DF +VL L SL L + + G YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRN-- 134
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+V+H DLK N+ L+EDL + DFG+A V+ E LCG+
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------RKKV---LCGTPN 180
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
YIAPE K S DV+S G ++ ++ G+ P F S L E R I
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FET-SCLKETYLR--------I 227
Query: 910 VEKAIAKYA-PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ +Y+ P+H+ + V LI+ +L Q +P+ RP++ ++
Sbjct: 228 KK---NEYSIPKHI--------NPVAASLIQ-KML--QTDPTARPTINEL 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G +G V V +AVK++D+ + + K+E I K + H N+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---QLVKICSDVAEGVAYLHHHSP 789
+ + + L L S G L + + P G+ QL+ GV YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM-------AGVVYLHGI-- 124
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL---CG 846
+ H D+KP N+LLDE ++DFG+A + + + + LL CG
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATV--------------FRYNNRERLLNKMCG 169
Query: 847 SVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS----LHEWVKRH 901
++ Y+APE + + DV+S G++L ++ G P + S +W ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYSDWKEKK 225
Query: 902 Y 902
Sbjct: 226 T 226
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 46/292 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIIT 731
IG+G +G K D + K LD + T E +L+ ++H N++R
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 732 ICSKPDFKALVLPLM---SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--H 786
L + +M G L + + LD ++++ + + + H
Sbjct: 73 RIIDRTNTTLYI-VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
V+H DLKP+N+ LD + DFG+A+++ N SF T G
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----------NHDTSFAKT---FVG 178
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
+ Y++PE + D++S G LL E+ P F S E +
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----F-TAFSQKELAGK------ 227
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
I E K+ +P Y+ EL E+ RPS+ ++
Sbjct: 228 --IRE---GKFRR--IPYRYSD-------ELNEIITRMLNLKDYHRPSVEEI 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 48/288 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLD--LTTTGEITGSFKRECQILKRIRHRNLIRII 730
L+G G F VY+ + +A+K++D + + E +I +++H +++ +
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
++ LVL + NG + +L + + G+ YLH H
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSH--- 131
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H DL SN+LL ++ +ADFG+A +K +T LCG+ Y
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLK--------MPHEKHYT-----LCGTPNY 178
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
I+PE DV+S G + ++ GR P F ++ + + V
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDT-DTVKNTLNK---------V 224
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
A + P + S +LI LL + NP+ R S+ V
Sbjct: 225 VLADYEM-PSFL--------SIEAKDLIH-QLL--RRNPADRLSLSSV 260
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 59/293 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G F ++ A K++ + E I + + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSP 789
DF +VL L SL L + + G YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVLGCQYLHRN-- 160
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+V+H DLK N+ L+EDL + DFG+A V+ E LCG+
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----------RKKV---LCGTPN 206
Query: 850 YIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
YIAPE K H DV+S G ++ ++ G+ P F S L E R
Sbjct: 207 YIAPEVLSKK---GHSFEVDVWSIGCIMYTLLVGKPP----FET-SCLKETYLR------ 252
Query: 907 DPIVEKAIAKYA-PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
I + +Y+ P+H+ + V LI+ +L Q +P+ RP++ ++
Sbjct: 253 --IKK---NEYSIPKHI--------NPVAASLIQ-KML--QTDPTARPTINEL 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 62/311 (19%), Positives = 124/311 (39%), Gaps = 48/311 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG +D + +K ++++ + + +RE +L ++H N+++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ +V+ G L + G+ Q++ + + ++H K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVHDR---K 145
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
++H D+K NI L +D T + DFGIA+++ N ++ G+ Y+
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVL----------NSTVELARA---CIGTPYYL 192
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
+PE K + D+++ G +L E+ T + F GS + +V
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAGS-------------MKNLVL 235
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS---MLDVAHEMGRLKQY 968
K I + + ++Y+ +L L + NP RPS +L+ R++++
Sbjct: 236 K-IISGSFPPVSLHYSY-------DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKF 287
Query: 969 LSSPSSLIEEA 979
LS E
Sbjct: 288 LSPQLIAEEFC 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 68/288 (23%), Positives = 117/288 (40%), Gaps = 51/288 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G+FG+VY Q +A+KVL + +RE +I +RH N++R+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
L+L G++ L + +++A ++Y H
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANALSYCHSK--- 128
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+V+H D+KP N+LL +ADFG + S + LCG++ Y
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------------SRRTD---LCGTLDY 173
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
+ PE G+ D++S GVL E + G+ P F ++ E KR +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEA-NTYQETYKR---------I 219
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ + P + ++ +LI LL ++NPS RP + +V
Sbjct: 220 SRVEFTF-PDFV--------TEGARDLIS-RLL--KHNPSQRPMLREV 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 40/241 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G +G V V +AVK++D+ + + K+E I K + H N+++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---QLVKICSDVAEGVAYLHHHSP 789
+ + + L L S G L + + P G+ QL+ GV YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM-------AGVVYLHGI-- 124
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL---CG 846
+ H D+KP N+LLDE ++DFG+A + + + + LL CG
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATV--------------FRYNNRERLLNKMCG 169
Query: 847 SVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS----LHEWVKRH 901
++ Y+APE + + DV+S G++L ++ G P + S +W ++
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP----WDQPSDSCQEYSDWKEKK 225
Query: 902 Y 902
Sbjct: 226 T 226
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 56/284 (19%), Positives = 92/284 (32%), Gaps = 52/284 (18%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEI-TGSFKRECQILKRI-RHRNLIRII 730
+G G +G V+K +D AVK G E +++ +H +R+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ L L SL+ H L Q+ D +A+LH
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHCEAWGAS---LPEAQVWGYLRDTLLALAHLHSQ--- 176
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+VH D+KP+NI L + DFG+ + + G Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-----------GTAGAGEV---QEGDPRY 222
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
+APE G T DV+S G+ +LE+ H G + + + P
Sbjct: 223 MAPELLQGS-YGTAADVFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEF---- 273
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
S EL + ++ + +P R +
Sbjct: 274 --------TAG--------LSS---ELRSVLVMMLEPDPKLRAT 298
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 52/299 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI--- 729
++G G FG V K D+ A+K + T E + E +L + H+ ++R
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 730 ----------ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE 779
+T K + + NG+L + + S L+ + ++ + E
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLN--QQRDEYWRLFRQILE 127
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
++Y+H ++H DLKP NI +DE + DFG+AK V DS +
Sbjct: 128 ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH--RSLDILKLDSQNLPG 182
Query: 840 TDGLL---CGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895
+ L G+ Y+A E G D+YS G++ E++ F G
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-------FSTGMERV 235
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
+ K + + P ++ V ++I L ++P+ RP
Sbjct: 236 N-------------ILKKL-RSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG 277
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 65/321 (20%), Positives = 113/321 (35%), Gaps = 51/321 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIIT 731
++ G F VY+ + A+K L + + +E +K++ H N+++ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCS 93
Query: 732 ICSKP-------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
S + L+L + G L L L ++KI V ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H P ++H DLK N+LL T + DFG A + + + + +
Sbjct: 153 HRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTIS-HYPDYSWSAQRRALVEEEITR 210
Query: 845 CGSVGYIAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
+ Y PE Y D+++ G +L + + P F DG+ L
Sbjct: 211 NTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL------ 259
Query: 901 HYPHRLDPIVEKAI--AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
I KY+ V LI +L Q NP R S+ +V
Sbjct: 260 ------------RIVNGKYSIPPHDTQ-----YTVFHSLIR-AML--QVNPEERLSIAEV 299
Query: 959 AHEMGRLKQYLS-SPSSLIEE 978
H++ + + +P S I E
Sbjct: 300 VHQLQEIAAARNVNPKSPITE 320
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 58/271 (21%), Positives = 99/271 (36%), Gaps = 43/271 (15%)
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
C L VP + + + + L N S +P+ L L+L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317
N ++ A+ + ++L+L+ N Q+
Sbjct: 64 HSNVL------ARIDA--AAFTGLALLEQLDLSDNA-----------------QLR---- 94
Query: 318 LIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSLSGEIPS-A 374
+ P L L L+L L + ++ L+ +YL +N+L +P
Sbjct: 95 ----SVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 375 FGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434
F D+ +L L L N++S +F L L RLLL+ N ++ P + L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
N +S + +A LR+L+ YL L+ N
Sbjct: 209 FANNLSALPTEALAPLRALQ-YLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/241 (23%), Positives = 90/241 (37%), Gaps = 35/241 (14%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSK 356
+P + +I L N I +P NLT+L L SN+L ++
Sbjct: 26 VPV---GIPAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 357 LERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNH 414
LE++ LS+N+ + F + L L L + L + F L+ L+ L L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 415 LSGTIPS-SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELS 473
L +P + NL L L N+IS + GL SL L L N + +
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-RLLLHQNRVAH-VH---- 193
Query: 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533
+F +L L +L L N+L L ++ L L+ ++
Sbjct: 194 --------PHAFRDLG-----------RLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 534 N 534
N
Sbjct: 235 N 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 49/228 (21%), Positives = 70/228 (30%), Gaps = 22/228 (9%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNN 159
++ + L N A + L L L N L +I + L LE LDL +N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ 219
+ + F + L + L L E+ L L++L L N L
Sbjct: 91 AQLRSVDPATF--HGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 220 ALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLA 279
+ L L L N S +P + L L L N + F L
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHA-----FRDL- 200
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL-------DCNLIY 320
L L NNL +P+ L + L DC
Sbjct: 201 --GRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPWVCDCRARP 245
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 47/231 (20%), Positives = 81/231 (35%), Gaps = 32/231 (13%)
Query: 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
+P + + +R++L N +S ++F +L +L L N L+ +F L+ L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 406 RRLLLYGNHLSGTIPSS-LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL 464
+L L N ++ + L L L + + P GL +L+ YL L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ-YLYLQDNAL 141
Query: 465 DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQL 523
++P L L L GN + + + L
Sbjct: 142 Q-------------------------ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 524 PYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
L + + NR+ P +F+ L L N S + A + L
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALP-TEALAPLR 225
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 50/243 (20%), Positives = 85/243 (34%), Gaps = 41/243 (16%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
+++ L N + + + L L L +N L I F L+ +DLS+N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAF--TGLALLEQLDLSDN 90
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
+ + P +L L L+ EL +
Sbjct: 91 AQLRSVD------------------------PATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS 306
+ LQ+LYL N L + + N L L GN + + L
Sbjct: 126 RGLAALQYLYLQDNAL------QALPD--DTFRDLGNLTHLFLHGNRISSVPERAFRGL- 176
Query: 307 TNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSN 364
+L ++ L N + + PH +L L L L +N L+ +P E L + L+ + L++
Sbjct: 177 HSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
Query: 365 NSL 367
N
Sbjct: 235 NPW 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 61/261 (23%), Positives = 100/261 (38%), Gaps = 44/261 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIR- 728
L+G G +G V + + + R AVK+L L + K+E Q+L+R+RH+N+I+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 729 --IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
++ K +V+ G E + Q + +G+ YLH
Sbjct: 72 VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEK---RFPVCQAHGYFCQLIDGLEYLHS 127
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL-- 844
+VH D+KP N+LL T ++ G+A+ + + D
Sbjct: 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEA--------------LHPFAADDTCRT 170
Query: 845 -CGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGS--SLHEWV 898
GS + PE G G D++S GV L I TG P F + L E +
Sbjct: 171 SQGSPAFQPPEIANGLDT-FSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFENI 225
Query: 899 KR---HYPHRLDPIVEKAIAK 916
+ P P + +
Sbjct: 226 GKGSYAIPGDCGPPLSDLLKG 246
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 46/330 (13%), Positives = 84/330 (25%), Gaps = 97/330 (29%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIR-------- 722
++G + + V V T K E L+ +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 723 -----------------HRNLIRIITICSKPDFKALVLPLM----SNGSLENHLYPSHGL 761
+ +IR+ + + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821
L +++ V +A LHH+ +VH L+P +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEY--------GMGKRASTHG---DVYSF 870
+ S G+ PE R + D ++
Sbjct: 257 -----------------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 871 GVLLLEIVTGRRPTDVLFHDGS--SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNK 928
G+++ I P + EW+ R +++P
Sbjct: 300 GLVIYWIWCADLP----ITKDAALGGSEWIFRS-----------------CKNIP----- 333
Query: 929 VWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
V L+E G L +Y R L
Sbjct: 334 ---QPVRALLE-GFL--RYPKEDRLLPLQA 357
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 54/300 (18%), Positives = 103/300 (34%), Gaps = 67/300 (22%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
LIGSG FG V+K D +K + +RE + L ++ H N++
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNIVHYNGC 72
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK--------------ICSDVA 778
D+ S+ S L+ L Q ++ + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
+GV Y+H K+++ DLKPSNI L + + DFG+ + + T
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL----------KNDGKRT 179
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898
+ G++ Y++PE + D+Y+ G++L E++ + S
Sbjct: 180 RS----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKF---- 227
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ ++K ++ +L+ P RP+ ++
Sbjct: 228 ---------------FTDLRDGIISDIFDKKEKTLLQKLL-------SKKPEDRPNTSEI 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 72/291 (24%), Positives = 112/291 (38%), Gaps = 57/291 (19%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G+FG+VY + N I A+KVL + + +RE +I +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
L+L G L L + ++A+ + Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEELADALHYCHER--- 133
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
KV+H D+KP N+L+ +ADFG + T +CG++ Y
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS------------LRRRT---MCGTLDY 178
Query: 851 IAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
+ PE GK TH D++ GVL E + G P F S E +R
Sbjct: 179 LPPEMIEGK---THDEKVDLWCAGVLCYEFLVGMPP----FDS-PSHTETHRR------- 223
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ K+ P + SD +LI LL +Y+P R + V
Sbjct: 224 --IVNVDLKF-PPFL--------SDGSKDLIS-KLL--RYHPPQRLPLKGV 260
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 63/302 (20%), Positives = 95/302 (31%), Gaps = 38/302 (12%)
Query: 221 LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLAN 280
LE+L + + I K L+ L + + + +
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARI-----PSRILFGALRVLG 93
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340
S QEL L + G P + + + +L L L N+S
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATG--------------------PDLNILNLRNVSW 133
Query: 341 NLLNGTIPH-ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSF 399
+ + + L L+ + ++ P L LDLS N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 400 A----NLSQLRRLLLYGNH---LSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRS 452
A L+ L L SG + V L+ LDLSHN + + S
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 453 LKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSL 512
LNLS L +P L VL DLS+N L + P + +L+L GN
Sbjct: 254 QLNSLNLSFTGLKQ-VPKGLPAKLSVL--DLSYNRLDRN--PSPDELPQVGNLSLKGNPF 308
Query: 513 EG 514
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 52/288 (18%), Positives = 92/288 (31%), Gaps = 16/288 (5%)
Query: 189 TGEIPLKNECELRNLRFLLLWSNRLVGQVPQA-LANSSKLEWLDLESNMFSGELPSEIIS 247
G ++ R+L +LL + + S L+ L + + + +
Sbjct: 31 LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307
+ L+ + + G A+ + + ++ + + L
Sbjct: 91 VLGISGLQELTLEN-LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149
Query: 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG--TIPHELCL--MSKLERVYLS 363
L + + + L+ L+LS N G + LC L+ + L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 364 NN---SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSGTI 419
N + SG + L LDLS N L + S SQL L L L +
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467
P L L +LDLS+N++ L + L+L N
Sbjct: 269 PKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVG-NLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 55/280 (19%), Positives = 97/280 (34%), Gaps = 20/280 (7%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQ---LGSLHQLEYLD 155
S +L ++ + LK+L++ + +I + + L+ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 156 LGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE---CELRNLRFLLLWSNR 212
L N ++ G P P+ + L ++L N S E L+ L +
Sbjct: 102 LENLEVTGTAPPPLL-EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELP---SEIISKMPQLQFLYLSYNDFVSHDGNT 269
+ + + L LDL N GE + K P LQ L L T
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-----ET 215
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
A A Q L+L+ N+L + D + L ++L + ++P +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA 274
Query: 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
L++L+LS N L+ P L ++ + L N
Sbjct: 275 --KLSVLDLSYNRLD-RNPSPDEL-PQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 9e-23
Identities = 60/304 (19%), Positives = 89/304 (29%), Gaps = 39/304 (12%)
Query: 121 LGSLIRLKQLSLSWN-SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179
G L+ L + + + L+ L + ++ I + LQ
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 180 YIDLSNNSLTGEIPLKN-ECELRNLRFLLLWSNRLVGQVPQALANSSK----LEWLDLES 234
+ L N +TG P E +L L L + + L+ L +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 235 NMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNL 294
E + P L L LS N + G + Q L L +
Sbjct: 159 AHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLIS----ALCPLKFPTLQVLALRNAGM 213
Query: 295 GGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCL- 353
G + V L L+LS N L C
Sbjct: 214 ----------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
S+L + LS L ++P L +LDLS N+L P S L Q+ L L GN
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGN 306
Query: 414 HLSG 417
Sbjct: 307 PFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 58/330 (17%), Positives = 103/330 (31%), Gaps = 58/330 (17%)
Query: 269 TNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHIS 328
++ +P ++S N ++EL G D +L Q I
Sbjct: 18 SDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQF------------TDII 65
Query: 329 NLVNLTLLNLSSNLLNGTIPH---ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLD 385
++L L + + + I + +S L+ + L N ++G P + L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 386 LSKNKLSGSIPDSFAN------LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439
L+ +S + D++ L+ L + H + L LDLS N
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185
Query: 440 SGIIPSDVA----GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
G A +L+ L L + + SG
Sbjct: 186 LGERGLISALCPLKFPTLQ-VLALRNAGM---------------------ETPSGVCSAL 223
Query: 496 LGSCIALESLNLSGNSLEGLLPVSVGQLPY-LKQFDVSSNRL---FGEIPQSFQASPTLK 551
+ + L+ L+LS NSL P L ++S L +P L
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK------LS 277
Query: 552 QLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
L+ S+N+ + + S +GN
Sbjct: 278 VLDLSYNRLDR-NPSPDELPQVGNLSLKGN 306
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 50/281 (17%), Positives = 79/281 (28%), Gaps = 55/281 (19%)
Query: 75 SRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLI--RLKQLSL 132
R V + +R ++G + + +S L L L G P L L L+L
Sbjct: 71 KRLTVRAARIPSRILFGAL--RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 133 SWNSLQGKIPS----QLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188
S + Q L+ L + + +L +DLS+N
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN---FSCEQVRVFPALSTLDLSDNPE 185
Query: 189 TGEIPLKN---ECELRNLRFLLLWSNR---LVGQVPQALANSSKLEWLDLESNMFSGELP 242
GE L + + L+ L L + G A +L+ LDL N
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 243 SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSII 302
+ QL L LS+ + +
Sbjct: 246 APSCDWPSQLNSLNLSFT------------------------------------GLKQVP 269
Query: 303 GDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLL 343
L L + L N + P L + L+L N
Sbjct: 270 KGLPAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 32/191 (16%), Positives = 58/191 (30%), Gaps = 11/191 (5%)
Query: 428 NLEILDLSHNKISGIIPSDVAGLRSLKL-YLNLSSNHLDGPLPLELSK---MDMVLAIDL 483
+LE L + + + ++SL L L + + + + + + + + L
Sbjct: 44 SLEYLLKRVDTEADLGQF-TDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 484 SFNNLSGSIPPQLGSCI--ALESLNLSGNSLEGLLP----VSVGQLPYLKQFDVSSNRLF 537
++G+ PP L L LNL S + P LK ++
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 538 GEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKE 597
+ + P L L+ S N G A L + Q ++
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 598 HTHHLVILSIL 608
V L L
Sbjct: 223 LAAARVQLQGL 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 70/273 (25%), Positives = 108/273 (39%), Gaps = 67/273 (24%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLD-------------------------LTTTGEI 707
IG G +G V DNT A+KVL
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 708 TGSFKRECQILKRIRHRNLIRIITICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGL 765
+E ILK++ H N+++++ + P+ L V L++ G + P+ L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLK---PL 134
Query: 766 DLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825
Q D+ +G+ YLH+ K++H D+KPSN+L+ ED +ADFG++
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE----- 186
Query: 826 ESVNCANDSMSFTSTDGLL---CGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVT 879
F +D LL G+ ++APE R G DV++ GV L V
Sbjct: 187 -----------FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
Query: 880 GRRPTDVLFHDGS--SLHEWVKR---HYPHRLD 907
G+ P F D LH +K +P + D
Sbjct: 236 GQCP----FMDERIMCLHSKIKSQALEFPDQPD 264
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 45/303 (14%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
F P +G G FG V++ D+ A+K + L RE + L ++ H ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 728 RIIT----------ICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICS 775
R + L + L +L++ + + + + I
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHIFL 125
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
+AE V +LH ++H DLKPSNI D V DFG+ + DE M
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ-DEEEQTVLTPM 181
Query: 836 SFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895
+ G+ Y++PE G S D++S G++L E++ P F
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P----FSTQMERV 234
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + + +++ +P RP
Sbjct: 235 RTLTD-------------VRNLKFPPLFTQK----YPCEYVMVQ---DMLSPSPMERPEA 274
Query: 956 LDV 958
+++
Sbjct: 275 INI 277
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 55/225 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG--------SFKRECQILKRI-RHR 724
+G G V + + AVK++D+T G + + +E IL+++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 725 NLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICS 775
N+I++ F LV LM G L D + I
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSEKETRKIMR 131
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
+ E + LH +VH DLKP NILLD+D+ + DFG + +
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------G 177
Query: 836 SFTSTDGLLCGSVGYIAPE---YGMGKRASTHG---DVYSFGVLL 874
+CG+ Y+APE M +G D++S GV++
Sbjct: 178 EKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 51/314 (16%), Positives = 99/314 (31%), Gaps = 53/314 (16%)
Query: 675 IGSGR--FGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRII 730
IG G V + V+ ++L + E+ + E + K H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ +V M+ GS ++ + G++ + + I V + + Y+HH
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKALDYIHHM--- 147
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VH +K S+IL+ D ++ ++ + L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV---LP---- 200
Query: 850 YIAPE------YGMGKRASTHGDVYSFGVLLLEIVTGR------RPTDVLFH-------- 889
+++PE G ++ D+YS G+ E+ G T +L
Sbjct: 201 WLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 890 ---------DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIEL 940
+ ++ D + Y++ +S +E
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE- 315
Query: 941 GLLCTQYNPSTRPS 954
C Q NP RPS
Sbjct: 316 --QCLQRNPDARPS 327
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 71/310 (22%), Positives = 120/310 (38%), Gaps = 61/310 (19%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIIT 731
++G G V + L + AVK+++ G I RE ++L + + HRN++ +I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSDVAEGVA 782
+ D LV M GS+ L I + + DVA +
Sbjct: 79 FFEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALD 125
Query: 783 YLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
+LH+ + H DLKP NIL ++ + DF + +K + + +
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP- 181
Query: 840 TDGLLCGSVGYIAPE--YGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGS-S 893
CGS Y+APE + AS + D++S GV+L +++G P F S
Sbjct: 182 -----CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGS 232
Query: 894 LHEWVKRHYPHRLDPIVEKAI--AKYAPQHMPIYYNKVWSDVVLE---LIELGLLCTQYN 948
W + ++ ++I KY + +K W+ + LI LL +
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYE------FPDKDWAHISCAAKDLIS-KLLV--RD 283
Query: 949 PSTRPSMLDV 958
R S V
Sbjct: 284 AKQRLSAAQV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 46/219 (21%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD-------LTTTGEITGSFKRECQILKRIRHRNL 726
+GSG G V + ++A+K++ + + + E +ILK++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 727 IRIITICSKPDFKALVLPLMSNGSL-----ENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
I+I D+ +VL LM G L N + V
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127
Query: 782 AYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
YLH + ++H DLKP N+LL +ED + DFG +K++ S
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----------GETSLM 173
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLL 874
T LCG+ Y+APE + + + D +S GV+L
Sbjct: 174 RT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 77/331 (23%), Positives = 124/331 (37%), Gaps = 71/331 (21%)
Query: 644 DEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLT 702
E+ R Y+ IGSG V ++A+K ++L
Sbjct: 2 SEDSSALPWSINRDDYELQEV----------IGSGATAVVQAAYCAPKKEKVAIKRINLE 51
Query: 703 TTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLEN---HLYPSH 759
+E Q + + H N++ T D LV+ L+S GS+ + H+
Sbjct: 52 KCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG 111
Query: 760 GLSHG-LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI- 817
G LD + I +V EG+ YLH + +H D+K NILL ED + +ADFG+
Sbjct: 112 EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168
Query: 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG---DVYSFG 871
A L G D + N + VG ++APE + ++ + D++SFG
Sbjct: 169 AFLATGGDITRNKVRKTF------------VGTPCWMAPE--VMEQVRGYDFKADIWSFG 214
Query: 872 VLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA---IAKYAP-----QHMP 923
+ +E+ TG P +H P+ K + P
Sbjct: 215 ITAIELATGAAP----YHK---------------YPPM--KVLMLTLQNDPPSLETGVQD 253
Query: 924 IYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
K + ++I LC Q +P RP+
Sbjct: 254 KEMLKKYGKSFRKMIS---LCLQKDPEKRPT 281
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 72/299 (24%), Positives = 109/299 (36%), Gaps = 73/299 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD-------LTTTGEITGSFKRECQILKRIRHRNL 726
+GSG FG V+ V + N + VK + G E IL R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 727 IRIITICSKPDFKALVLPLMSNGS-LENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYL 784
I+++ I F LV+ +G L + H LD I + V YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-----DRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
++H D+K NI++ ED T + DFG A ++ L
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-----------------RGKLF 186
Query: 845 ---CGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
CG++ Y APE MG +++S GV L +V P F +
Sbjct: 187 YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP----FCE---------- 232
Query: 901 HYPHRLDPIVEKAIAKYA-PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
L+ VE A P + S ++ L+ GLL Q P R ++ +
Sbjct: 233 -----LEETVE---AAIHPPYLV--------SKELMSLVS-GLL--QPVPERRTTLEKL 272
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 75/307 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD-------LTTTGEITGSFKRECQILKRIRHRNL 726
+GSG G V + ++A++++ + + + E +ILK++ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSDV 777
I+I D+ +VL LM G L D + K +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQM 248
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDS 834
V YLH + ++H DLKP N+LL +ED + DFG +K++
Sbjct: 249 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----------GE 294
Query: 835 MSFTSTDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDG 891
S T LCG+ Y+APE + + + D +S GV+L ++G P F +
Sbjct: 295 TSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP----FSEH 347
Query: 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST 951
+ L + + P+ + +V S+ L+L++ LL +P
Sbjct: 348 RT---------QVSLKDQITSGKYNFIPE----VWAEV-SEKALDLVK-KLL--VVDPKA 390
Query: 952 RPSMLDV 958
R + +
Sbjct: 391 RFTTEEA 397
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 75/348 (21%), Positives = 126/348 (36%), Gaps = 72/348 (20%)
Query: 645 EEKEKEEAKNPRVSYKQLIEATGGFCPS------SLIGSGRFGHVYKGVL-QDNTRIAVK 697
EE E +E + R+ + G S +G+G G V+K +A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 698 VLDLTTTGEITGSFKRECQILKRIRHRNLIR---------IITICSKPDFKALVLPLMSN 748
++ L I RE Q+L ++ I+IC + M
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC---------MEHMDG 115
Query: 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808
GSL+ + G + L K+ V +G+ YL K++H D+KPSNIL++
Sbjct: 116 GSLDQ-VLKKAG---RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169
Query: 809 TALVADFGIA-KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDV 867
+ DFG++ +L+ DSM+ + G+ Y++PE G S D+
Sbjct: 170 EIKLCDFGVSGQLI-----------DSMANSFV-----GTRSYMSPERLQGTHYSVQSDI 213
Query: 868 YSFGVLLLEIVTGRRP--------TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAP 919
+S G+ L+E+ GR P +++F P + K P
Sbjct: 214 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRP 273
Query: 920 -------------QHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
+ P + V+S + + C NP+ R
Sbjct: 274 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 318
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/304 (18%), Positives = 97/304 (31%), Gaps = 71/304 (23%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEIT-GSFKRECQILKRI-RHRNLIRII 730
IGSG FG V+K V D A+K G + + RE + +H +++R
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ ++ D + + GSL + + ++ + +L + V G+ Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--- 134
Query: 791 KVVHCDLKPSNILLDED-------------------LTALVADFGIAKLVKGIDESVNCA 831
+VH D+KPSNI + + + D G
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------------ 182
Query: 832 NDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRPTDVLFHD 890
+S G ++A E D+++ + ++ +
Sbjct: 183 --RISSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRN 233
Query: 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950
G HE + P I PQ S E EL + +P
Sbjct: 234 GDQWHEIRQGRLP----RI---------PQV--------LSQ---EFTELLKVMIHPDPE 269
Query: 951 TRPS 954
RPS
Sbjct: 270 RRPS 273
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 45/214 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
++GSG F V+ A+K + + + S + E +LK+I+H N++ + I
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHENIVTLEDI 74
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
LV+ L+S G L D I + V V Y
Sbjct: 75 YESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
LH + +VH DLKP N+L +E+ ++ DFG++K+ + ST
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN------------GIMST 166
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
CG+ GY+APE K S D +S GV+
Sbjct: 167 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 42/256 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V G ++AVK+L+ + ++ G KRE Q LK RH ++I++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSP 789
+ S P +V+ +S G L +++ HG ++ ++ ++ + V Y H H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI-----CKHGRVEEMEARRLFQQILSAVDYCHRH-- 130
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL---CG 846
VVH DLKP N+LLD + A +ADFG++ ++ L CG
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-----------------GEFLRTSCG 172
Query: 847 SVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS--SLHEWVKR--- 900
S Y APE G+ A D++S GV+L ++ G P F D +L + ++
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP----FDDEHVPTLFKKIRGGVF 228
Query: 901 HYPHRLDPIVEKAIAK 916
+ P L+ V +
Sbjct: 229 YIPEYLNRSVATLLMH 244
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 54/224 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-------TGEITGSFKRECQILKRIR-HRN 725
IG G V + V AVK++++T E+ + +RE IL+++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSD 776
+I +I F LV LM G L D + I
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRS 208
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+ E V++LH + +VH DLKP NILLD+++ ++DFG + ++
Sbjct: 209 LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-----------GE 254
Query: 837 FTSTDGLLCGSVGYIAPE---YGMGKRASTHG---DVYSFGVLL 874
LCG+ GY+APE M + +G D+++ GV+L
Sbjct: 255 KLRE---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLD---LTTTGEITGSFK--RECQILKRIRHR--N 725
L+GSG FG VY G+ + DN +A+K ++ ++ GE+ + E +LK++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 726 LIRIITICSKPDFKALVLPLMSN-GSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAY 783
+IR++ +PD L+L L + + G L V E V +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEAVRH 164
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
H+ V+H D+K NIL+D + L + DFG L+K D
Sbjct: 165 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK------------------DT 203
Query: 843 LL---CGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHD 890
+ G+ Y PE+ R HG V+S G+LL ++V G P F
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIP----FEH 251
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 46/254 (18%), Positives = 84/254 (33%), Gaps = 57/254 (22%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD----LTTTGEITGSFKRECQILKRIRHRNLIRI 729
IG G +G V + Q A+K+++ + K E +++K++ H N+ R+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 730 ITICSKPDFKALVLPLMSNGSL------ENHLYPSHGLSHGLDLIQLV------------ 771
+ + LV+ L G L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 772 ------------------KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL--DEDLTAL 811
I + + YLH+ + H D+KP N L ++
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE--YGMGKRASTHGDVYS 869
+ DFG++K ++ +T G+ ++APE + D +S
Sbjct: 211 LVDFGLSKEFYKLNN------GEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 870 FGVLLLEIVTGRRP 883
GVLL ++ G P
Sbjct: 262 AGVLLHLLLMGAVP 275
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-25
Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 35/251 (13%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEIT-GSFKRECQILKRIRHRNLIRIITI 732
IG G F V + +A+K++D T + RE +I+K + H N++++ +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSPIK 791
L++ S G + ++L ++HG + + + V Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL-----VAHGRMKEKEARSKFRQIVSAVQYCHQK---R 134
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+VH DLK N+LLD D+ +ADFG + CG+ Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFT---------VGGKLDAF-----CGAPPYA 180
Query: 852 APEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS--SLHEWVKR---HYPHR 905
APE GK+ DV+S GV+L +V+G P F + L E V R P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP----FDGQNLKELRERVLRGKYRIPFY 236
Query: 906 LDPIVEKAIAK 916
+ E + +
Sbjct: 237 MSTDCENLLKR 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 32/225 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+GSG FG V+ +K ++ + + E ++LK + H N+I+I +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+V+ G L + + L + ++ + +AY H VV
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 794 HCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
H DLKP NIL + DFG+A+L K T+ G+ Y
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFK----------SDEHSTN----AAGTALY 192
Query: 851 IAPE---YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
+APE + + D++S GV++ ++TG P F S
Sbjct: 193 MAPEVFKRDVTFKC----DIWSAGVVMYFLLTGCLP----FTGTS 229
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 77/303 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG V K AVKV++ + + T + RE ++LK++ H N++++ I
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
+V L + G L D I +I V G+ Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+H H +VH DLKP NILL ++D + DFG++ + +
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----------QNTKMKD- 182
Query: 841 DGLLCGSVGYIAPE-----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895
G+ YIAPE Y ++ DV+S GV+L +++G P F+ +
Sbjct: 183 ---RIGTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGKN--- 226
Query: 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + K + + W + + +L ++PS R +
Sbjct: 227 -----------EYDILKRVETGKYA----FDLPQWRTISDDAKDLIRKMLTFHPSLRITA 271
Query: 956 LDV 958
Sbjct: 272 TQC 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 69/299 (23%), Positives = 107/299 (35%), Gaps = 68/299 (22%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G G FG V AVKV+ S RE Q+LK++ H N++++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVA 782
+ LV + + G L D I +I V G+
Sbjct: 94 FFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 783 YLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
Y+H + K+VH DLKP N+LL +D + DFG++ + + M
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--------SKKMK--- 186
Query: 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
G+ YIAPE + DV+S GV+L +++G P F+ +
Sbjct: 187 ---DKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNGAN------- 231
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ + K + K + W V +L Y PS R S D
Sbjct: 232 -------EYDILKKVEKGKYT----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 64/298 (21%), Positives = 106/298 (35%), Gaps = 67/298 (22%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
+GSG +G V + A+K++ T+ + E +LK + H N++++
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
LV+ G L D I I V GV Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
LH H +VH DLKP N+LL ++D + DFG++ + + +
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE----------NQKKMKE- 197
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
G+ YIAPE + K+ DV+S GV+L ++ G P F +
Sbjct: 198 ---RLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP----FGGQT-------- 241
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
D + + + K + + W +V +L Q++ R S
Sbjct: 242 ------DQEILRKVEKGKYT----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 74/253 (29%), Positives = 119/253 (47%), Gaps = 36/253 (14%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V G ++AVK+L+ + ++ G +RE Q LK RH ++I++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSP 789
+ S P +V+ +S G L +++ +G LD + ++ + GV Y H H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI-----CKNGRLDEKESRRLFQQILSGVDYCHRH-- 135
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
VVH DLKP N+LLD + A +ADFG++ ++ + TS CGS
Sbjct: 136 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---------DGEFLRTS-----CGSPN 180
Query: 850 YIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS--SLHEWVKR---HYP 903
Y APE G+ A D++S GV+L ++ G P F D +L + + + P
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP----FDDDHVPTLFKKICDGIFYTP 236
Query: 904 HRLDPIVEKAIAK 916
L+P V +
Sbjct: 237 QYLNPSVISLLKH 249
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 54/236 (22%), Positives = 86/236 (36%), Gaps = 51/236 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLD---LTTTGEITGSFK--RECQILKRIR----H 723
L+G G FG V+ G L D ++A+KV+ + ++ S E +L ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGS-LENHLYPSHGLSHG-LDLIQLVKICSDVAEGV 781
+IR++ + LVL L +++ G L V +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-----TEKGPLGEGPSRCFFGQVVAAI 152
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTST 840
+ H VVH D+K NIL+D + DFG L+
Sbjct: 153 QHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH------------------ 191
Query: 841 DGLL---CGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHD 890
D G+ Y PE+ + H V+S G+LL ++V G P F
Sbjct: 192 DEPYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIP----FER 241
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 86/455 (18%), Positives = 153/455 (33%), Gaps = 88/455 (19%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIR-LKQLSLSWNSLQGK----IPSQLGSLHQLEYLD 155
+ LD+ AEL L++ + + L L I S L L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 156 LGNNKLVGEIPIPIFCS---NSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L +N+L G++ + S +Q + L N LTG
Sbjct: 63 LRSNEL-GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG-------------------- 101
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGN 268
G + L L+ L L N+ L ++ +L+ L L Y
Sbjct: 102 -CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL----SA 156
Query: 269 TNLEPFFASLANSSNFQELELAGNNLGG----MIPSIIGDLSTNLVQIHLDCNLI----Y 320
+ EP + L +F+EL ++ N++ ++ + D L + L+ +
Sbjct: 157 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLM-----SKLERVYLSNNSLSGE----I 371
+ +++ +L L L SN L ELC S+L +++ ++ + +
Sbjct: 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 276
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANL-----SQLRRLLLYGNHLSGT----IPSS 422
L L L+ N+L QL L + + S
Sbjct: 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAID 482
L + L L +S+N++ AG+R L L + L +
Sbjct: 337 LAQNRFLLELQISNNRLED------AGVRELCQGLGQPGSVLR--------------VLW 376
Query: 483 LSFNNLS----GSIPPQLGSCIALESLNLSGNSLE 513
L+ ++S S+ L + +L L+LS N L
Sbjct: 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 74/443 (16%), Positives = 147/443 (33%), Gaps = 77/443 (17%)
Query: 175 STSLQYIDLSNNSLTGEIPLKNECE-LRNLRFLLLWSNRL----VGQVPQALANSSKLEW 229
S +Q +D+ L + L+ + + L L + AL + L
Sbjct: 2 SLDIQSLDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 230 LDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285
L+L SN + + + ++Q L L ++L Q
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL----TGAGCGVLSSTLRTLPTLQ 116
Query: 286 ELELAGNNLGG----MIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLV----NLTLLN 337
EL L+ N LG ++ + D L ++ L+ + +++++ + L
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 338 LSSNLLNGTIPHELCLM-----SKLERVYLSNNSLSGE----IPSAFGDIPHLGLLDLSK 388
+S+N +N LC +LE + L + ++ + + L L L
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 389 NKLSGS-----IPDSFANLSQLRRLLLYGNHLS----GTIPSSLGKCVNLEILDLSHNKI 439
NKL P S+LR L ++ ++ G + L +L+ L L+ N++
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296
Query: 440 SGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG----SIPPQ 495
G R L L L ++ + + +
Sbjct: 297 GD------EGARLLCETLLEPGCQL--------------ESLWVKSCSFTAACCSHFSSV 336
Query: 496 LGSCIALESLNLSGNSL--EGLLPVSVG---QLPYLKQFDVSSNRL----FGEIPQSFQA 546
L L L +S N L G+ + G L+ ++ + + + A
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 396
Query: 547 SPTLKQLNFSFNKFSGNISNKGA 569
+ +L++L+ S N + + G
Sbjct: 397 NHSLRELDLSNN----CLGDAGI 415
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 81/413 (19%), Positives = 140/413 (33%), Gaps = 61/413 (14%)
Query: 81 ELDLSARSI-YGTISPALANLSSLIVLDLSKNFFQ----GHIPAELGSLIRLKQLSLSWN 135
LD+ + + L L V+ L I + L L +L+L N
Sbjct: 7 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 66
Query: 136 SLQGK----IPSQLGSLH-QLEYLDLGNNKLVGEIPIPIFCS--NSSTSLQYIDLSNNSL 188
L + L + +++ L L N L + S + +LQ + LS+N L
Sbjct: 67 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL-TGAGCGVLSSTLRTLPTLQELHLSDNLL 125
Query: 189 T-------GEIPLKNECELRNLRFLLLWSNRL----VGQVPQALANSSKLEWLDLESNMF 237
E L +C L L+ L L + L + L + +N
Sbjct: 126 GDAGLQLLCEGLLDPQCRLEKLQ---LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 238 SGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN 293
+ L + QL+ L L + N +A+ ++ +EL L N
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGV----TSDNCRDLCGIVASKASLRELALGSNK 238
Query: 294 LGG----MIPSIIGDLSTNLVQIHLDCNLI----YGKIPPHISNLVNLTLLNLSSNLLNG 345
LG + + S+ L + + I G + + +L L+L+ N L
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 346 TIPHELCLM-----SKLERVYLSNNSLSGE----IPSAFGDIPHLGLLDLSKNKLSGSIP 396
LC +LE +++ + S + S L L +S N+L +
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358
Query: 397 DSFA-----NLSQLRRLLLYGNHLS----GTIPSSLGKCVNLEILDLSHNKIS 440
S LR L L +S ++ ++L +L LDLS+N +
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/321 (20%), Positives = 116/321 (36%), Gaps = 56/321 (17%)
Query: 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
IF + + I +++T + + L + L + +
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQAD---LDGITTLSAFGTGVT-------------- 54
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELE 288
+E + + L L L N T+L P L N + ELE
Sbjct: 55 --TIEG-----------VQYLNNLIGLELKDNQI------TDLAP----LKNLTKITELE 91
Query: 289 LAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIP 348
L+GN L + I L ++ + L I + P ++ L NL +L L N + P
Sbjct: 92 LSGNPLKNVSA--IAGL-QSIKTLDLTSTQI-TDVTP-LAGLSNLQVLYLDLNQITNISP 146
Query: 349 HELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408
L ++ L+ + + N +S ++ + ++ L L NK+S I A+L L +
Sbjct: 147 --LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEV 200
Query: 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL 468
L N +S S L NL I+ L++ I+ L + S +
Sbjct: 201 HLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA--- 255
Query: 469 PLELSKMDMVLAIDLSFNNLS 489
P +S + +L++N S
Sbjct: 256 PATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/305 (19%), Positives = 115/305 (37%), Gaps = 31/305 (10%)
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
+N ++ +N+ + DL + + + I + L NL L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADL-DGITTLSAFGTGV-TTIEG-VQYLNNLIGLE 69
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397
L N + P L ++K+ + LS N L SA + + LDL+ +++ P
Sbjct: 70 LKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
A LS L+ L L N ++ S L NL+ L + + ++S + P +A L L L
Sbjct: 125 -LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLT-TL 178
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLP 517
N + PL + + ++ + L N +S + P L + L + L+ ++
Sbjct: 179 KADDNKISDISPL--ASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPV 234
Query: 518 VSVGQLPYL-----------KQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566
L +S N + ++ + + ++++FN+ +
Sbjct: 235 FYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNT 294
Query: 567 KGAFS 571
FS
Sbjct: 295 TVPFS 299
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 57/275 (20%), Positives = 110/275 (40%), Gaps = 33/275 (12%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLE 152
I P L++ I + K+ L + LS + I + L+ L
Sbjct: 12 IFP-DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L+L +N++ P+ + T + ++LS N L + L++++ L L S +
Sbjct: 67 GLELKDNQITDLAPL-----KNLTKITELELSGNPLKNVSAIAG---LQSIKTLDLTSTQ 118
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
+ P LA S L+ L L+ N + + ++ + LQ+L + ++L
Sbjct: 119 ITDVTP--LAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQV------SDLT 167
Query: 273 PFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVN 332
P LAN S L+ N + + P + L NL+++HL N I + P ++N N
Sbjct: 168 P----LANLSKLTTLKADDNKISDISP--LASL-PNLIEVHLKNNQI-SDVSP-LANTSN 218
Query: 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSL 367
L ++ L++ + + V + +
Sbjct: 219 LFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 19/180 (10%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L+L I ++P L NL+ + L+LS N + + L +K L L+ +
Sbjct: 67 GLELKDNQI-TDLAP-LKNLTKITELELSGN--PLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
P L L L+ L L N++ P+ T+LQY+ + N ++ PL N L
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISPL-----AGLTNLQYLSIGNAQVSDLTPLAN---L 172
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
L L N++ LA+ L + L++N S P ++ L + L+
Sbjct: 173 SKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP---LANTSNLFIVTLTNQ 227
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 42/272 (15%), Positives = 81/272 (29%), Gaps = 34/272 (12%)
Query: 650 EEAKNPRVSYKQLIEATGG-FCPSSLIGSGRFGHVYKGVLQDNT------RIAVKVLDLT 702
+ K P + K + L+G G F VY+ D + +KV
Sbjct: 47 WQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA 106
Query: 703 TTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHL-YPSHGL 761
E + + LK ++ + + LV L S G+L N + +
Sbjct: 107 NPWEFY-IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP 165
Query: 762 SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL-----------DEDLTA 810
+ ++ + + +H +++H D+KP N +L D
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222
Query: 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSF 870
+ D G + +K FT+ C + G+ E K + D +
Sbjct: 223 ALIDLGQSIDMKLFP-------KGTIFTA----KCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
+ ++ G +R
Sbjct: 272 AATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 57/229 (24%), Positives = 86/229 (37%), Gaps = 47/229 (20%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IGSG FG +AVK ++ I + +RE + +RH N++R +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEV 84
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVA--------EGVAYL 784
P A+++ S G L + + G + D A GV+Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----CNAG-------RFSEDEARFFFQQLLSGVSYC 132
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTAL--VADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
H ++ H DLK N LLD + DFG +K S ++
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---------LHSQPKST--- 177
Query: 843 LLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890
G+ YIAPE + + DV+S GV L ++ G P F D
Sbjct: 178 --VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP----FED 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 50/290 (17%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR-IRHRNLIRIITI 732
IG G +G V K V +AVK + T + + ++ R +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ + + LM + S + + + + L KI + + +L + K
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--K 146
Query: 792 VVHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H D+KPSNILLD + DFGI +LV DS++ T G Y
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-----------DSIAKTRD----AGCRPY 191
Query: 851 IAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
+APE + DV+S G+ L E+ TGR P YP
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP------------------YPK-W 232
Query: 907 DPIVE--KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
+ + + + K P + + +S + + LC + S RP
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVN---LCLTKDESKRPK 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 44/229 (19%), Positives = 86/229 (37%), Gaps = 38/229 (16%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD----LTTTGEITGSFKRECQILKRIRHRNLIRI 729
IG G F V + + + + AVK++D ++ G T KRE I ++H +++ +
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL-----VKICSDVAEGVAYL 784
+ S +V M L + + + E + Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 785 HHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
H + ++H D+KP +LL + + FG+A + + ++
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--------SGLVAGG--- 192
Query: 842 GLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890
G+ ++APE + DV+ GV+L +++G P F+
Sbjct: 193 --RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYG 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 44/214 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G F V + V A K+++ + +RE +I ++++H N++R+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL---------VKICSDVAEGVAY 783
+ F LV L++ G L + I + E +AY
Sbjct: 74 IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
H + +VH +LKP N+LL + +ADFG+A V DS ++
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN----------DSEAWHG- 166
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ GY++PE S D+++ GV+L
Sbjct: 167 ---FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 63/314 (20%), Positives = 104/314 (33%), Gaps = 88/314 (28%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLD---LTTTGEITGS---------FKRECQILKRI 721
+GSG +G V ++ A+KV+ + E +LK +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 722 RHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVK 772
H N+I++ + + LV G L + I
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDAAN 150
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVN 829
I + G+ YLH H +VH D+KP NILL + L + DFG++
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS------- 200
Query: 830 CANDSMSFTSTDGLLCGSVGYIAPE-----YGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
G+ YIAPE Y ++ DV+S GV++ ++ G P
Sbjct: 201 ---KDYKLRD----RLGTAYYIAPEVLKKKY--NEKC----DVWSCGVIMYILLCGYPP- 246
Query: 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLC 944
F + D + K + K + W ++ E EL L
Sbjct: 247 ---FGGQN--------------DQDIIKKVEKGKYY----FDFNDWKNISDEAKELIKLM 285
Query: 945 TQYNPSTRPSMLDV 958
Y+ + R + +
Sbjct: 286 LTYDYNKRCTAEEA 299
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 8e-24
Identities = 61/287 (21%), Positives = 107/287 (37%), Gaps = 20/287 (6%)
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
+ + L ++ + +L ++ QI + + I + I L N+T L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDI-KSVQG-IQYLPNVTKLF 71
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397
L+ N L P L + L ++L N + ++ S+ D+ L L L N +S I +
Sbjct: 72 LNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-N 125
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
+L QL L L N + T + L + L+ L L N+IS I +AGL L+ L
Sbjct: 126 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQ-NL 180
Query: 458 NLSSNHLDGPLPLE-LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLL 516
LS NH+ L L +D+ ++L + + ++ + SL
Sbjct: 181 YLSKNHISDLRALAGLKNLDV---LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 237
Query: 517 PVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563
+S E+ F T+ + F+
Sbjct: 238 IISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQ 284
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 37/275 (13%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLE 152
I P + I +L K + L + Q+ + + ++ + + L +
Sbjct: 14 IFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVT 68
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L L NKL P+ + +L ++ L N + LK+ L+ L+ L L N
Sbjct: 69 KLFLNGNKLTDIKPL-----TNLKNLGWLFLDENKIKDLSSLKD---LKKLKSLSLEHNG 120
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
+ L + +LE L L +N + ++ +S++ +L L L N +++
Sbjct: 121 I--SDINGLVHLPQLESLYLGNNKIT-DITV--LSRLTKLDTLSLEDNQI------SDIV 169
Query: 273 PFFASLANSSNFQELELAGNNLGGMIPSIIGDLS--TNLVQIHLDCNLIYGKIPPHISNL 330
P LA + Q L L+ N++ S + L+ NL + L K H SNL
Sbjct: 170 P----LAGLTKLQNLYLSKNHI-----SDLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 331 VNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
V + + L P + E+ + +
Sbjct: 221 VVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-21
Identities = 57/267 (21%), Positives = 108/267 (40%), Gaps = 32/267 (11%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ ++ +L +S+ T + L+S+ + + + + + + L + +L L+ N L
Sbjct: 22 ETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 77
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
I L +L L +L L NK+ + L+ + L +N ++ L +
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDENKIKDLSSL-----KDLKKLKSLSLEHNGISDINGLVH- 129
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L L L L +N++ L+ +KL+ L LE N S ++ ++ + +LQ LYL
Sbjct: 130 --LPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYL 182
Query: 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317
S N ++L LA N LEL + +L + D +
Sbjct: 183 SKNHI------SDLRA----LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232
Query: 318 LIYGKIPPHISNLVNLTLLNLSSNLLN 344
L+ P IS+ + N+ +L
Sbjct: 233 LVT---PEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 3e-20
Identities = 49/289 (16%), Positives = 95/289 (32%), Gaps = 52/289 (17%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+L S+T + L ++ ++ ++ + + Q + + L L N
Sbjct: 21 AETIKDNLKKKSVTDAVTQNE---LNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGN 75
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
+ P ++ + L +L+L N +L L + + L L N
Sbjct: 76 KLTDIKP---LTNLKNLGWLFLDEN------KIKDLSS----LKDLKKLKSLSLEHNG-- 120
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
I D++ + +L L L L +N + T L ++
Sbjct: 121 ------ISDIN-------------------GLVHLPQLESLYLGNNKI--TDITVLSRLT 153
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
KL+ + L +N +S +I + L L LSKN +S + + A L L L L+
Sbjct: 154 KLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQEC 209
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNH 463
+ V + + + SD + +L
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 37/253 (14%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRII 730
+G G FG V + ++A+K + ++ +RE LK +RH ++I++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVKICSDVAEGVAYLHHHSP 789
+ + P +V+ + G L +++ + + + + + + Y H H
Sbjct: 76 DVITTPTDIVMVIEY-AGGELFDYI-----VEKKRMTEDEGRRFFQQIICAIEYCHRH-- 127
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
K+VH DLKP N+LLD++L +ADFG++ ++ + + TS CGS
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---------DGNFLKTS-----CGSPN 172
Query: 850 YIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS--SLHEWVKR---HYP 903
Y APE GK A DV+S G++L ++ GR P F D +L + V P
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP----FDDEFIPNLFKKVNSCVYVMP 228
Query: 904 HRLDPIVEKAIAK 916
L P + I +
Sbjct: 229 DFLSPGAQSLIRR 241
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTL 335
++ ++ E+ NL +P DL + +HL NL+ LT
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP---DLPKDTTILHLSENLL-YTFSLATLMPYTRLTQ 59
Query: 336 LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI 395
LNL L + + L L + LS+N L +P +P L +LD+S N+L+ S+
Sbjct: 60 LNLDRAELT-KLQVDGTL-PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 396 P-DSFANLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSHNKISGIIPSDV-AGLRS 452
P + L +L+ L L GN L T+P L LE L L++N ++ +P+ + GL +
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLEN 173
Query: 453 LKLYLNLSSNHL 464
L L L N L
Sbjct: 174 LD-TLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 55/248 (22%), Positives = 91/248 (36%), Gaps = 54/248 (21%)
Query: 172 SNSSTSLQYIDLSNNSLT---GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
+ S ++ +LT ++P ++ L L N L L ++L
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLP-------KDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELE 288
L+L+ + +L + +P L L LS+N S
Sbjct: 59 QLNLDRAELT-KLQ--VDGTLPVLGTLDLSHNQLQS------------------------ 91
Query: 289 LAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTI 347
+P + L L + + N + +P L L L L N L T+
Sbjct: 92 ---------LPLLGQTL-PALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TL 139
Query: 348 PHELC-LMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
P L KLE++ L+NN+L+ E+P+ + +L L L +N L +IP F L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 406 RRLLLYGN 413
L+GN
Sbjct: 198 PFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 10/183 (5%)
Query: 282 SNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341
+ L L+ N L T L Q++LD + L L L+LS N
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHN 87
Query: 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS-FA 400
L ++P + L + +S N L+ A + L L L N+L ++P
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 401 NLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459
+L +L L N+L+ +P+ L NL+ L L N + IP G L + L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLP-FAFL 202
Query: 460 SSN 462
N
Sbjct: 203 HGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 55/269 (20%), Positives = 85/269 (31%), Gaps = 73/269 (27%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158
++S + ++ K +P +L L LS N L + L +L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 159 NKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP 218
+L + + + L +DLS+N L +P
Sbjct: 65 AELTK---LQVD--GTLPVLGTLDLSHNQLQ--------------------------SLP 93
Query: 219 QALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP-FFAS 277
L LD+ N + LP + + +LQ LYL N+ L P
Sbjct: 94 LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL------KTLPPGLLTP 146
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLL 336
++L LA NNL ++P + + L NL L
Sbjct: 147 T---PKLEKLSLANNNL--------------------------TELPAGLLNGLENLDTL 177
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSNN 365
L N L TIP L +L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 61/234 (26%), Positives = 89/234 (38%), Gaps = 40/234 (17%)
Query: 352 CLMSKLERVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLL 410
+ S LE V +L+ +P D+P +L LS+N L + ++L +L L
Sbjct: 8 KVASHLE-VNCDKRNLT-ALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 411 YGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPL 470
L+ + G L LDLSHN++ + P L +L L++S N L LPL
Sbjct: 63 DRAELT-KLQVD-GTLPVLGTLDLSHNQLQSL-PLLGQTLPALT-VLDVSFNRLTS-LPL 117
Query: 471 ELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFD 530
L L+ L L GN L+ L P + P L++
Sbjct: 118 GA------------LRGLG-----------ELQELYLKGNELKTLPPGLLTPTPKLEKLS 154
Query: 531 VSSNRLFGEIPQS-FQASPTLKQLNFSFNKFSGNISNKGAF--SSLTIASFQGN 581
+++N L E+P L L N I KG F L A GN
Sbjct: 155 LANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIP-KGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 46/180 (25%), Positives = 69/180 (38%), Gaps = 32/180 (17%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L LS +Y L + L L+L + + + G+L L L LS N LQ
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-S 91
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+P +L L LD+ N+L +P+ LQ + L N L +P
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGAL--RGLGELQELYLKGNELK-TLP------- 140
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
P L + KLE L L +N + ELP+ +++ + L L L N
Sbjct: 141 -----------------PGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 42/132 (31%), Positives = 56/132 (42%), Gaps = 8/132 (6%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAEL-GSLIRLKQLSLSWNSLQG 139
LDLS + ++ L +L VLD+S N +P L L++L L N L+
Sbjct: 81 TLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT 138
Query: 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199
P L +LE L L NN L E+P + N +L + L NSL IP K
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLT-ELPAGLL--NGLENLDTLLLQENSLYT-IP-KGFFG 193
Query: 200 LRNLRFLLLWSN 211
L F L N
Sbjct: 194 SHLLPFAFLHGN 205
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 54/220 (24%), Positives = 105/220 (47%), Gaps = 15/220 (6%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
IP ++ + L+LS N L + +L+ + LS + A+ + HL
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 383 LLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSHNKIS 440
L L+ N + S+ +F+ LS L++L+ +L+ ++ + G L+ L+++HN I
Sbjct: 80 TLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 441 GIIPSDV-AGLRSLKLYLNLSSNHLDGPLPLE----LSKMDMV-LAIDLSFNNLSGSIPP 494
+ + L +L+ +L+LSSN + + L +M ++ L++DLS N ++ I P
Sbjct: 138 SFKLPEYFSNLTNLE-HLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 495 QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
I L+ L L N L+ + +L L++ + +N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 57/248 (22%), Positives = 87/248 (35%), Gaps = 43/248 (17%)
Query: 172 SNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLD 231
N S + +DLS N L + + L+ L L + A + S L L
Sbjct: 24 DNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82
Query: 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291
L N L S + LQ L + S + L +EL +A
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFP-----IGHL---KTLKELNVAH 133
Query: 292 NNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHEL 351
N + + K+P + SNL NL L+LSSN + +I
Sbjct: 134 NLI------------QSF------------KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD 168
Query: 352 -----CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQL 405
+ + LS N ++ I L L L N+L S+PD F L+ L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSL 226
Query: 406 RRLLLYGN 413
+++ L+ N
Sbjct: 227 QKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 45/246 (18%), Positives = 91/246 (36%), Gaps = 48/246 (19%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
K L LS+N L+ S +L+ LDL ++ I + S + L + L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAY--QSLSHLSTLILTGN 86
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
+ + A + S L+ L + L + I
Sbjct: 87 PIQ-SLA------------------------LGAFSGLSSLQKLVAVETNLA-SLENFPI 120
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEP--FFASLANSSNFQELELAGNNLGGMIPSIIGD 304
+ L+ L +++N + + +F++L +N + L+L+ N + I
Sbjct: 121 GHLKTLKELNVAHNLI------QSFKLPEYFSNL---TNLEHLDLSSNKI-QSIYCTDLR 170
Query: 305 LSTNL----VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLER 359
+ + + + L N + I P + L L L +N L ++P ++ L++
Sbjct: 171 VLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK 228
Query: 360 VYLSNN 365
++L N
Sbjct: 229 IWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 48/189 (25%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAEL-GSLIRLKQLSLSWNSLQ 138
LDLS I TI A +LS L L L+ N Q + L L++L +L
Sbjct: 56 VLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 139 GKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
+ + G L L+ L++ +N + +P + SN T+L+++DLS+N + I +
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL-TNLEHLDLSSNKIQ-SIYCTDL 169
Query: 198 CELRNLRF----LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQ 253
L + L L N + + +L+ L L++N +P I ++ LQ
Sbjct: 170 RVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQ 227
Query: 254 FLYLSYNDF 262
++L N +
Sbjct: 228 KIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 54/244 (22%), Positives = 84/244 (34%), Gaps = 48/244 (19%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAEL-GSLIRLKQLSLSWNSLQ 138
LDLS + + + + L VLDLS+ Q I SL L L L+ N +Q
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 139 GKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
+ L L+ L L + +L+ +++++N + L
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLA-SLENFPI--GHLKTLKELNVAHNLIQ-SFKL--- 141
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQF--- 254
P+ +N + LE LDL SN + + + Q+
Sbjct: 142 --------------------PEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180
Query: 255 -LYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIH 313
L LS N F + +EL L N L +P I D T+L +I
Sbjct: 181 SLDLSLNPMNFIQPGA-----FKEI----RLKELALDTNQL-KSVPDGIFDRLTSLQKIW 230
Query: 314 LDCN 317
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 43/219 (19%), Positives = 69/219 (31%), Gaps = 59/219 (26%)
Query: 359 RVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG 417
+ +IP ++P LDLS N L SF + +L+ L L +
Sbjct: 11 TYQCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 418 TIPSSL-GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476
TI +L L L+ N I +
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSL-ALGA----------------------------- 95
Query: 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
F+ LS +L+ L +L L +G L LK+ +V+ N +
Sbjct: 96 --------FSGLS-----------SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 537 -FGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
++P+ F L+ L+ S NK +I L
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC-TDLRVLH 173
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/237 (25%), Positives = 97/237 (40%), Gaps = 59/237 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG V K AVKV++ + + T + RE ++LK++ H N++++ I
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
+V L + G L D I +I V G+ Y
Sbjct: 90 LEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+H H +VH DLKP NILL ++D + DFG++ + +
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----------QNTKMKD- 182
Query: 841 DGLLCGSVGYIAPE-----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
G+ YIAPE Y ++ DV+S GV+L +++G P F+ +
Sbjct: 183 ---RIGTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FYGKN 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 44/214 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G F V + V A K+++ + +RE +I ++++H N++R+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSDVAEGVAY 783
+ F LV L++ G L + I + + E +AY
Sbjct: 97 IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
H + +VH +LKP N+LL + +ADFG+A V DS ++
Sbjct: 144 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN----------DSEAWHG- 189
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ GY++PE S D+++ GV+L
Sbjct: 190 ---FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/236 (23%), Positives = 84/236 (35%), Gaps = 59/236 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G +G V V R A K + ++ FK+E +I+K + H N+IR+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLYETF 75
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAYL 784
LV+ L + G L + + +I DV VAY
Sbjct: 76 EDNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 785 HHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
H V H DLKP N L D + DFG+A K +
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----------PGKMMRTK- 168
Query: 842 GLLCGSVGYIAPE-----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
G+ Y++P+ Y G D +S GV++ ++ G P F +
Sbjct: 169 ---VGTPYYVSPQVLEGLY--GPEC----DEWSAGVMMYVLLCGYPP----FSAPT 211
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 46/214 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G VY+ A+KVL T + + E +L R+ H N+I++ I
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLSHPNIIKLKEI 116
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
P +LVL L++ G L D I + E VAY
Sbjct: 117 FETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
LH + +VH DLKP N+L D +ADFG++K+V+ + +
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----------HQVLMKT- 209
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+CG+ GY APE G D++S G++
Sbjct: 210 ---VCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 46/214 (21%), Positives = 84/214 (39%), Gaps = 43/214 (20%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G F V + V + A +++ + +RE +I + ++H N++R+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLI---------QLVKICSDVAEGVAY 783
S+ L+ L++ G L + I + E V +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
H VVH +LKP N+LL + +ADFG+A V+G + ++
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG---------EQQAWFG- 172
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ GY++PE D+++ GV+L
Sbjct: 173 ---FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 44/210 (20%), Positives = 85/210 (40%), Gaps = 38/210 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+GSG FG V++ V K ++ + + K E I+ ++ H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAF 117
Query: 734 SKPDFKALVLPLMSNGSL------ENHLYPSHGLSHGLDLIQLVK-ICSDVAEGVAYLHH 786
L+L +S G L E++ ++I ++ C EG+ ++H
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEA------EVINYMRQAC----EGLKHMHE 167
Query: 787 HSPIKVVHCDLKPSNILL--DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H +VH D+KP NI+ + + + DFG+A + ++ + +
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--------DEIVK------VT 210
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+ + APE + + D+++ GVL
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+ ++G GRFG V+K ++A K++ + K E ++ ++ H NLI
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149
Query: 728 RIITICSKPDFKALVLPLMSNGSL------ENHLYPSHGLSHGLDLIQLVK-ICSDVAEG 780
++ + LV+ + G L E++ D I +K IC EG
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL------DTILFMKQIC----EG 199
Query: 781 VAYLHHHSPIKVVHCDLKPSNILL-DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFT 838
+ ++H ++H DLKP NIL + D + + DFG+A+ K + +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--------REKLK-- 246
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+ G+ ++APE S D++S GV+
Sbjct: 247 ----VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 44/210 (20%), Positives = 78/210 (37%), Gaps = 39/210 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG V++ V K + G K+E IL RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 734 SKPDFKALVLPLMSNGSL------ENHLYPSHGLSHGLDLIQLVK-ICSDVAEGVAYLHH 786
+ ++ +S + +++ V +C E + +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNER------EIVSYVHQVC----EALQFLHS 120
Query: 787 HSPIKVVHCDLKPSNILL--DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H+ + H D++P NI+ T + +FG A+ +K ++ L
Sbjct: 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRL-------------L 163
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+ Y APE ST D++S G L+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 61/221 (27%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR-IRHRNLIRIITI 732
IG G + + + N AVK++D + E +IL R +H N+I + +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDV 84
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSDVAEGVAY 783
+ +V LM G L LD I K + + + V Y
Sbjct: 85 YDDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTS 839
LH VVH DLKPSNIL + ++ + DFG AK ++ + + T
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--------ENGLLMT- 179
Query: 840 TDGLLCGSVGYIAPE------YGMGKRASTHGDVYSFGVLL 874
C + ++APE Y D++S GVLL
Sbjct: 180 ----PCYTANFVAPEVLERQGY--DAAC----DIWSLGVLL 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-22
Identities = 63/342 (18%), Positives = 107/342 (31%), Gaps = 88/342 (25%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG V++ D+ A+K + L RE + L ++ H ++R
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 733 CSKPDF--------------KALVLPLMSNGSLENHLYPSHGLS---------------- 762
+ ++ PL S ++ +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 763 -----------HGLDLIQLVK---------------ICSDVAEGVAYLHHHSPIKVVHCD 796
+L + I +AE V +LH ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRD 189
Query: 797 LKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG 856
LKPSNI D V DFG+ + DE M +T G+ Y++PE
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQ-DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 857 MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAK 916
G S D++S G++L E L + S+ E V+ I+
Sbjct: 249 HGNNYSHKVDIFSLGLILFE----------LLYSFSTQMERVR---------IITDVRNL 289
Query: 917 YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
P Y + +++ +P+ RP D+
Sbjct: 290 KFPLLFTQKYPQEH-----MMVQ---DMLSPSPTERPEATDI 323
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 72/316 (22%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG V+KG+ + +A+K++DL + ++E +L + + +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
K +++ + GS L L Q+ I ++ +G+ YLH K +
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLLEPGPLDET----QIATILREILKGLDYLHSE---KKI 141
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG---Y 850
H D+K +N+LL E +ADFG+A D+ +T VG +
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAG----------QLTDTQIKRNT------FVGTPFW 185
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGR------RPTDVLFHDGSSLHEWVKRHYPH 904
+APE + D++S G+ +E+ G P VLF
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL--------------- 230
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964
I K P P +S + E +E C PS RP+ A E+ +
Sbjct: 231 ---------IPKNNP---PTLEGN-YSKPLKEFVE---ACLNKEPSFRPT----AKELLK 270
Query: 965 ---LKQYLSSPSSLIE 977
+ + S L E
Sbjct: 271 HKFILRNAKKTSYLTE 286
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 55/218 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITI 732
+G G F K V + N AVK++ ++E LK H N++++ +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT----QKEITALKLCEGHPNIVKLHEV 74
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK---------ICSDVAEGVAY 783
LV+ L++ G L + I+ K I + V++
Sbjct: 75 FHDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 784 LHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+H VVH DLKP N+L +++L + DFG A+L ++ +
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---------PLKTP 169
Query: 841 DGLLCGSVGYIAPE----YGMGKRASTHGDVYSFGVLL 874
C ++ Y APE G + D++S GV+L
Sbjct: 170 ----CFTLHYAAPELLNQNGYDESC----DLWSLGVIL 199
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 30/298 (10%), Positives = 71/298 (23%), Gaps = 76/298 (25%)
Query: 673 SLIGSGRFGHVYKGVLQDNT---RIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLI 727
G ++ + D ++A+ + ++ L RI +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
R++ + +V + GSL+ + ++ +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
V PS + + D G L
Sbjct: 149 G---VALSIDHPSRVRVSID--------GDVVL-------------------------AY 172
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
+ A+ D+ G L ++ R P + + +
Sbjct: 173 PATMPD-------ANPQDDIRGIGASLYALLVNRWP-----LPEAGVRSGLAPAERDTAG 220
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965
+ P + D+ ++ + Q + R + + + M +
Sbjct: 221 QPI-------EPAD-------IDRDIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQA 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 58/290 (20%), Positives = 101/290 (34%), Gaps = 55/290 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR-IRHRNLIRIITI 732
+GSG G V+K + IAVK + + E + ++ + +++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ + LM + + + + L K+ + + + YL V
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKH--GV 146
Query: 793 VHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+H D+KPSNILLDE + DFGI +LV D + + G Y+
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLV-----------DDKAKDRS----AGCAAYM 191
Query: 852 APE-----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
APE DV+S G+ L+E+ TG+ P Y +
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP------------------YKN-C 232
Query: 907 DPIVE--KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
E + + P +P + +S ++ C + RP
Sbjct: 233 KTDFEVLTKVLQEEPPLLP--GHMGFSGDFQSFVK---DCLTKDHRKRPK 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 57/288 (19%), Positives = 99/288 (34%), Gaps = 50/288 (17%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKR-IRHRNLIRIITI 732
+G G +G V K + +AVK + T + + I R + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ + + LM + SL+ + L KI + + + +LH V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 793 VHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+H D+KPSN+L++ + DFGI LV D ++ G Y+
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLV-----------DDVAKDID----AGCKPYM 176
Query: 852 APE----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
APE K S D++S G+ ++E+ R P Y
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP------------------YDSWGT 218
Query: 908 PI-VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
P K + + +P +S ++ C + N RP+
Sbjct: 219 PFQQLKQVVEEPSPQLP---ADKFSAEFVDFTS---QCLKKNSKERPT 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G+G FG V++ A K + + + ++E Q + +RH L+ +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVK-ICSDVAEGVAYLHHHSPIKV 792
+ ++ MS G L + H + ++ ++ +C +G+ ++H +
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC----KGLCHMHEN---NY 276
Query: 793 VHCDLKPSNILL-DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DLKP NI+ + L + DFG+ + S+ + G+ +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--------KQSVK------VTTGTAEF 322
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
APE GK + D++S GVL +++G P
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKV-----LDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+GSG+F V K A K L + G +RE IL+ IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ I L+L L+S G L + L L+ + Q +K + +GV YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLK---QILDGVHYLHSK- 127
Query: 789 PIKVVHCDLKPSNILL---DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
++ H DLKP NI+L + + + DFGIA ++ + +
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--------GNEFK------NI 171
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ ++APE + D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGS-----FKRECQILKRIRHRNLIR 728
+GSG+F V K A K + + +RE IL+++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + L+L L+S G L + L LS + +K + +GV YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIK---QILDGVNYLHTK- 134
Query: 789 PIKVVHCDLKPSNILL---DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
K+ H DLKP NI+L + + + + DFG+A ++ +
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK------NI 178
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ ++APE + D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-----SFKRECQILKRIRHRNLIR 728
+GSG+F V K A K + + +RE IL+++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + L+L L+S G L + L LS + +K + +GV YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSE-EEATSFIK---QILDGVNYLHTK- 134
Query: 789 PIKVVHCDLKPSNILL---DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
K+ H DLKP NI+L + + + + DFG+A ++ +
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK------NI 178
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
G+ ++APE + D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 64/292 (21%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
IG G FG V D ++ A+K ++ E+ + +E QI++ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR-NVFKELQIMQGLEHPFLVNL 80
Query: 730 ITICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAY 783
F+ +V+ L+ G L HL + + VK+ ++ + Y
Sbjct: 81 -----WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-----EETVKLFICELVMALDY 130
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
L + ++H D+KP NILLDE + DF IA ++ + +T
Sbjct: 131 LQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-----------ITT--- 173
Query: 844 LCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900
+ G+ Y+APE ++ + + D +S GV E++ GRRP +H SS
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP----YHIRSS------- 222
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
IV + + Y WS ++ L++ LL + NP R
Sbjct: 223 ---TSSKEIVHTF------ETTVVTYPSAWSQEMVSLLK-KLL--EPNPDQR 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 29/208 (13%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT-TTGEITGSFKRECQILKRIRHR-NLIRIIT 731
+G G+F V + + A K L + E +L+ + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG-LDLIQLVK-ICSDVAEGVAYLHHHSP 789
+ L+L + G + + P D+I+L+K I EGV YLH +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL----EGVYYLHQN-- 150
Query: 790 IKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+VH DLKP NILL + DFG+++ + + + G
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELRE------IMG 195
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+ Y+APE +T D+++ G++
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 50/216 (23%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGS-----FKRECQILKRIRHRNLIR 728
+GSG+F V K + A K + T +RE ILK I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 729 IITICSKPDFKALVLPLMSNGSL------ENHLYPSHGLSHGLDLIQLVKICSDVAEGVA 782
+ + L+L L++ G L + L + + +K + GV
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-------EATEFLK---QILNGVY 128
Query: 783 YLHHHSPIKVVHCDLKPSNILL---DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFT 838
YLH ++ H DLKP NI+L + + + DFG+A + +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--------GNEFK-- 175
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL 874
+ G+ ++APE + D++S GV+
Sbjct: 176 ----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 52/269 (19%), Positives = 110/269 (40%), Gaps = 18/269 (6%)
Query: 298 IPSIIGDLS-TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK 356
I I D + ++ +L + + + L ++ + +++ + ++ + +
Sbjct: 14 IKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPN 69
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416
+ +++L+ N L+ +I ++ +LG L L +NK+ + S +L +L+ L L N +S
Sbjct: 70 VTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS 125
Query: 417 GTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476
I + L LE L L +NKI+ I + ++ L L L+L N + +P L+ +
Sbjct: 126 -DI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD-TLSLEDNQISDIVP--LAGLT 178
Query: 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
+ + LS N++S + L L+ L L L + L
Sbjct: 179 KLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
Query: 537 FGEIPQSFQASPTLKQLNFSFNKFSGNIS 565
S + + +F+ +S
Sbjct: 237 VTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 55/266 (20%), Positives = 97/266 (36%), Gaps = 33/266 (12%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLE 152
I + I +L K + L + Q+ + + ++ + + L +
Sbjct: 17 IFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVT 71
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L L NKL P+ + +L ++ L N + LK+ L+ L+ L L N
Sbjct: 72 KLFLNGNKLTDIKPL-----ANLKNLGWLFLDENKVKDLSSLKD---LKKLKSLSLEHNG 123
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN---DFVSHDGNT 269
+ L + +LE L L +N + ++S++ +L L L N D V G T
Sbjct: 124 I--SDINGLVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQISDIVPLAGLT 178
Query: 270 NLEPFFAS---------LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
L+ + S LA N LEL + +L + D +L+
Sbjct: 179 KLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGT 346
P IS+ + N+ +L T
Sbjct: 239 ---PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 35/285 (12%)
Query: 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
IF ++ +L S+T + L ++ ++ ++ + + Q + +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQNE---LNSIDQIIANNSDI--KSVQGIQYLPNVT 71
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELE 288
L L N + P ++ + L +L+L N +L L + + L
Sbjct: 72 KLFLNGNKLTDIKP---LANLKNLGWLFLDENKV------KDLSS----LKDLKKLKSLS 118
Query: 289 LAGNNLGGMIPSIIGDLS--TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT 346
L N + S I L L ++L N I I +S L L L+L N + +
Sbjct: 119 LEHNGI-----SDINGLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI--S 169
Query: 347 IPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLR 406
L ++KL+ +YLS N +S ++ A + +L +L+L + + +NL
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 407 RL-LLYGNHLSGTIPSSLGKCVNLEI---LDLSHNKISGIIPSDV 447
+ G+ ++ I S G + L N++S I V
Sbjct: 228 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 272
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 21/196 (10%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIP--AELGSLIRLKQLSLSWN 135
V +L L+ + I P LANL +L L L +N + + L L +LK LSL N
Sbjct: 69 NVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDEN----KVKDLSSLKDLKKLKSLSLEHN 122
Query: 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK 195
+ I L L QLE L LGNNK+ + + T L + L +N ++ +PL
Sbjct: 123 GIS-DING-LVHLPQLESLYLGNNKITDITVL-----SRLTKLDTLSLEDNQISDIVPLA 175
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
L L+ L L N + +ALA L+ L+L S P S + +
Sbjct: 176 G---LTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTV 229
Query: 256 YLSYNDFVSHDGNTNL 271
+ V+ + ++
Sbjct: 230 KNTDGSLVTPEIISDD 245
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 59/314 (18%), Positives = 113/314 (35%), Gaps = 93/314 (29%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRII- 730
++G G G V + + + A+K+L + ++E + +++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILD 89
Query: 731 ---TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL-----------VKICSD 776
+ +++ M G L IQ +I D
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGEL-------------FSRIQERGDQAFTEREAAEIMRD 136
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCAND 833
+ + +LH H + H D+KP N+L ++D + DFG AK +
Sbjct: 137 IGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---------QN 184
Query: 834 SMSFTSTDGLLCGSVGYIAPE----YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889
++ T C + Y+APE K D++S GV++ ++ G P F+
Sbjct: 185 AL-QT-----PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIMYILLCGFPP----FY 230
Query: 890 DGSSLHEWVKRHYPHRLDPIVEKAI--AKYAPQHMPIYYNKVWSDV---VLELIELGLLC 944
+ + P +++ I +Y + N WS+V +LI LL
Sbjct: 231 SNT----------GQAISPGMKRRIRLGQYG------FPNPEWSEVSEDAKQLIR-LLLK 273
Query: 945 TQYNPSTRPSMLDV 958
T +P+ R ++
Sbjct: 274 T--DPTERLTITQF 285
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 48/224 (21%), Positives = 92/224 (41%), Gaps = 29/224 (12%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G F V +R A+K+L+ + ++ RE ++ R+ H +++
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKL 95
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHS 788
+ L NG L ++ + +++ + YLH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETCTRFYTAEIVSALEYLHGK- 149
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++H DLKP NILL+ED+ + DFG AK++ + ++ G+
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--------ANS---FVGTA 196
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
Y++PE K A D+++ G ++ ++V G P F G+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGN 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 5e-20
Identities = 44/257 (17%), Positives = 78/257 (30%), Gaps = 21/257 (8%)
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
V ++P L L + S L+ + +S ND +
Sbjct: 17 QESKVTEIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV---- 69
Query: 270 NLEPF-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI- 327
+E F++L E+ + N I NL + + I +P
Sbjct: 70 -IEADVFSNL---PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHK 124
Query: 328 SNLVNLTLLNLSSNLLNGTIPHEL--CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLD 385
+ + LL++ N+ TI L + ++L+ N + SAF L
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184
Query: 386 LSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445
N L D F S L + + L L + K +P+
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 241
Query: 446 DVAGLRSLKLYLNLSSN 462
+ L +L +L+
Sbjct: 242 -LEKLVALM-EASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 60/335 (17%), Positives = 102/335 (30%), Gaps = 95/335 (28%)
Query: 106 LDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEI 165
++ IP++L +L L+ LE +++ N ++ I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 166 PIPIFCSNSSTSLQYIDLSN-NSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANS 224
+F ++ L I + N+L I P+A N
Sbjct: 71 EADVF--SNLPKLHEIRIEKANNLL-YIN------------------------PEAFQNL 103
Query: 225 SKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNF 284
L++L + + LP Q L + N
Sbjct: 104 PNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN------------------------ 138
Query: 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLN 344
N+ + + LS V + L+ N I +I N L LNL
Sbjct: 139 -------INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL------ 184
Query: 345 GTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPD-SFANL 402
NN+L E+P+ F +LD+S+ ++ S+P NL
Sbjct: 185 -----------------SDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENL 225
Query: 403 SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
+LR Y +P +L K V L L++
Sbjct: 226 KKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 42/243 (17%), Positives = 80/243 (32%), Gaps = 22/243 (9%)
Query: 79 VVELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLS-WN 135
+EL + I A + L +++S+N I A+ +L +L ++ + N
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK 195
+L P +L L+YL + N + +P S +D+ +N I
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKI--HSLQKVLLDIQDNINIHTIERN 147
Query: 196 NECELR-NLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQF 254
+ L L L N + A + E ++N ELP+++
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVI 206
Query: 255 LYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL 314
L +S S +L L +P++ + L++ L
Sbjct: 207 LDISRTRIHSLPSYG-----LENLKK------LRARSTYNLKKLPTL--EKLVALMEASL 253
Query: 315 DCN 317
Sbjct: 254 TYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 36/172 (20%), Positives = 60/172 (34%), Gaps = 10/172 (5%)
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
R L + ++ IPS L N L K+ I +G L+ + +S N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLE-KIEISQNDVL 67
Query: 466 GPLPLE-LSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQL 523
+ + S + + I + N I P+ + L+ L +S ++ L V
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 524 PYLKQFDVSSNRLFGEIPQ-SFQA-SPTLKQLNFSFNKFSGNISNKGAFSSL 573
D+ N I + SF S L + N I N AF+
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHN-SAFNGT 177
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 9/113 (7%)
Query: 76 RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSW 134
+ V L L+ I I + N + L L+LS N +P + L +S
Sbjct: 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211
Query: 135 NSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
+ L +L +L N K +P +L L+ S
Sbjct: 212 TRIHSLPSYGLENLKKLRARSTYNLKK-----LPTL--EKLVALMEASLTYPS 257
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 31/171 (18%), Positives = 60/171 (35%), Gaps = 18/171 (10%)
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLS-----TNLVQIHLDCNLIYGKIPPHISNLV 331
+ A ++ + LA N + DL+ N+ + ++ P IS L
Sbjct: 39 TEAQMNSLTYITLANIN--------VTDLTGIEYAHNIKDLTINNIHA-TNYNP-ISGLS 88
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
NL L + + L ++ L + +S+++ I + +P + +DLS N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442
I L +L+ L + + + + L L I G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 34/181 (18%), Positives = 71/181 (39%), Gaps = 11/181 (6%)
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
L +S + + L + L+ ++ + ++ L + H
Sbjct: 24 AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHA 78
Query: 416 SGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475
+ + + NLE L + ++ +++GL SL L++S + D + +++ +
Sbjct: 79 TNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTL 135
Query: 476 DMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535
V +IDLS+N I P L + L+SLN+ + + + P L Q S
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQT 192
Query: 536 L 536
+
Sbjct: 193 I 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 24/166 (14%), Positives = 65/166 (39%), Gaps = 12/166 (7%)
Query: 327 ISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDL 386
+ + +LT + L++ + + ++ + ++N + + + +L L +
Sbjct: 40 EAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRI 95
Query: 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN-KISGIIPS 445
++ + + L+ L L + + +I + + + +DLS+N I+ I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI--M 153
Query: 446 DVAGLRSLKLYLNLSSNHLDGPLPLE-LSKMDMVLAIDLSFNNLSG 490
+ L LK LN+ + + +E K++ + + G
Sbjct: 154 PLKTLPELK-SLNIQFDGVHDYRGIEDFPKLNQ---LYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 35/223 (15%), Positives = 72/223 (32%), Gaps = 48/223 (21%)
Query: 123 SLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYID 182
+ L +S +Q+ + L Y+ L N + I +++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTGIEYA-----HNIKDLT 72
Query: 183 LSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELP 242
++N T P+ L NL L + + L+ + L LD+ + +
Sbjct: 73 INNIHATNYNPISG---LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 243 SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSII 302
++ I+ +P++ + LSYN + T++ P L + L + + +
Sbjct: 130 TK-INTLPKVNSIDLSYNGAI-----TDIMP----LKTLPELKSLNIQFDG--------V 171
Query: 303 GDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345
D I + L L S + G
Sbjct: 172 HDYR-------------------GIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 26/199 (13%), Positives = 73/199 (36%), Gaps = 23/199 (11%)
Query: 98 ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157
+ + + L ++ A++ S L ++L+ ++ + + + H ++ L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVT-DL-TGIEYAHNIKDLTIN 74
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217
N PI + ++L+ + + +T + N L +L L + + +
Sbjct: 75 NIHATNYNPI-----SGLSNLERLRIMGKDVTS-DKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+ K+ +DL N ++ + +P+L+ L + ++ +
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGV------HDYRG---- 176
Query: 278 LANSSNFQELELAGNNLGG 296
+ + +L +GG
Sbjct: 177 IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 31/165 (18%), Positives = 61/165 (36%), Gaps = 13/165 (7%)
Query: 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
N + + L+ ++ ++ + ++ L ++ + L L++L +
Sbjct: 44 NSLTYITLANINV-TDLTG-IEYAHNIKDLTINNI--HATNYNPISGLSNLERLRIMGKD 99
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEI-PLK 195
+ L L L LD+ ++ I I N+ + IDLS N +I PLK
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI---NTLPKVNSIDLSYNGAITDIMPLK 156
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
L L+ L + + + + + KL L S G+
Sbjct: 157 T---LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 30/183 (16%), Positives = 66/183 (36%), Gaps = 15/183 (8%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ L S I+ A ++SL + L+ + + +K L+++
Sbjct: 24 AYLNGLLGQSST-ANITEA--QMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA 78
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
+ + L LE L + + + + + TSL +D+S+++ + L
Sbjct: 79 TN--YNPISGLSNLERLRIMGKDVTSDKIPNL---SGLTSLTLLDISHSAHD-DSILTKI 132
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
L + + L N + + L +L+ L+++ + I P+L LY
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD---YRGIEDFPKLNQLYA 188
Query: 258 SYN 260
Sbjct: 189 FSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 26/188 (13%), Positives = 60/188 (31%), Gaps = 34/188 (18%)
Query: 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSL 453
+IPD + LL + + + + +L + L++ ++ D+ G+
Sbjct: 16 NIPD--STFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-----DLTGIEYA 65
Query: 454 KLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLE 513
N+ + ++ + + P + LE L + G +
Sbjct: 66 H---NIKD-------------------LTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 514 GLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSL 573
++ L L D+S + I P + ++ S+N +I L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPEL 161
Query: 574 TIASFQGN 581
+ Q +
Sbjct: 162 KSLNIQFD 169
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G FG V+ ++ ++ A K L+ L E +IL ++ R ++ +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRFIVSL 250
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
LV+ +M+ G + H+Y + G + + + + G+ +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+++ DLKP N+LLD+D ++D G+A +K T G+ G
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK----------TKG---YAGTPG 354
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
++APE +G+ D ++ GV L E++ R P
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 45/224 (20%), Positives = 82/224 (36%), Gaps = 64/224 (28%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRII-- 730
+G G G V + + + A+K+L +RE ++ R + +++RI+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDV 123
Query: 731 --TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL-----------VKICSDV 777
+ + +V+ + G L IQ +I +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSI 170
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVKGIDESVNCANDS 834
E + YLH + H D+KP N+L + + DFG AK ++S
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--------HNS 219
Query: 835 MSFTSTDGLLCGSVGYIAPE----YGMGKRASTHGDVYSFGVLL 874
++ T C + Y+APE K D++S GV++
Sbjct: 220 LT-T-----PCYTPYYVAPEVLGPEKYDKSC----DMWSLGVIM 253
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 46/265 (17%), Positives = 83/265 (31%), Gaps = 46/265 (17%)
Query: 198 CELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257
CE + + ++P + + L L +PS S +P + +Y+
Sbjct: 8 CECHQEEDFRVTCKDIQ-RIPSLPPS---TQTLKLIETHLR-TIPSHAFSNLPNISRIYV 62
Query: 258 SYNDFVSHDGNTNLEPF-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
S + + LE F +L S +E+ NL I D
Sbjct: 63 SIDVTL-----QQLESHSFYNL---SKVTHIEIRNTR--------------NLTYIDPDA 100
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE--LCLMSKLERVYLSNNSLSGEIPS- 373
+ L L L + + L P + + +++N IP
Sbjct: 101 ----------LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 374 AFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSL--GKCVNLE 430
AF + L L N + S+ N ++L + L N I G
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 431 ILDLSHNKISGIIPSDVAGLRSLKL 455
+LD+S ++ + + L+ L
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 37/217 (17%), Positives = 76/217 (35%), Gaps = 15/217 (6%)
Query: 175 STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP-QALANSSKLEWLDLE 233
S Q + L L IP L N+ + + + + Q+ + N SK+ +++
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 234 SNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN 293
+ + + + ++P L+FL + P + ++ F LE+ N
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGL------KMF-PDLTKVYSTDIFFILEITDNP 141
Query: 294 LGGMIPS-IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC 352
IP L + + L N + + N L + L+ N I +
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200
Query: 353 --LMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDL 386
+ S + +S S++ +PS + L +
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 13/209 (6%)
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDL 386
S + L L L H + + R+Y+S + ++ S +F ++ + +++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 387 SKNKLSGSIP-DSFANLSQLRRLLLYGNHLSGTIP--SSLGKCVNLEILDLSHNKISGII 443
+ I D+ L L+ L ++ L P + + IL+++ N I
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 444 PSDV-AGLRSLKLYLNLSSNHLD--GPLPLELSKMDMVLAIDLSFNNLSGSIPPQL--GS 498
P + GL + L L L +N +K+D A+ L+ N I G
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLD---AVYLNKNKYLTVIDKDAFGGV 203
Query: 499 CIALESLNLSGNSLEGLLPVSVGQLPYLK 527
L++S S+ L + L L
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 36/219 (16%), Positives = 79/219 (36%), Gaps = 22/219 (10%)
Query: 127 LKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSN 185
+ L L L+ IPS +L + + + + + ++ F + + + +I++ N
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSF--YNLSKVTHIEIRN 89
Query: 186 NSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ--ALANSSKLEWLDLESNMFSGELPS 243
I EL L+FL +++ L P + ++ L++ N + +P
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 244 EIISKMP-QLQFLYLSYNDFVSHDGNTNLEPF-FASLANSSNFQELELAGNNLGGMIPS- 300
+ + L L N F T+++ + F N + + L N +I
Sbjct: 149 NAFQGLCNETLTLKLYNNGF------TSVQGYAF----NGTKLDAVYLNKNKYLTVIDKD 198
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNL 338
G + + + + + +P +L L N
Sbjct: 199 AFGGVYSGPSLLDVSQTSV-TALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 39/233 (16%), Positives = 79/233 (33%), Gaps = 19/233 (8%)
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNK 390
++ + IP L + + L L IPS AF ++P++ + +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDV 66
Query: 391 LSGSIP-DSFANLSQLRRLLLYGNHLSGTIPSS-LGKCVNLEILDLSHNKISGIIPSDVA 448
+ SF NLS++ + + I L + L+ L + + +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126
Query: 449 GLRSLKLYLNLSSNHLDGPLP----LELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALES 504
+ L ++ N +P L + L L N + S+ + L++
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL--KLYNNGFT-SVQGYAFNGTKLDA 183
Query: 505 LNLSGNSLEGLLPVSV--GQLPYLKQFDVSSNRLFGEIP-QSFQASPTLKQLN 554
+ L+ N ++ G DVS + +P + + L N
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 34/189 (17%), Positives = 69/189 (36%), Gaps = 9/189 (4%)
Query: 81 ELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPAEL-GSLIRLKQLSLSWNSLQ 138
L L + TI A +NL ++ + +S + + + +L ++ + +
Sbjct: 35 TLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93
Query: 139 GKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNE 197
I L L L++L + N L P S+ +++++N IP+
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY-STDIFFILEITDNPYMTSIPVNAF 151
Query: 198 CELRN-LRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ-LQFL 255
L N L L++N V N +KL+ + L N + + + + L
Sbjct: 152 QGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 256 YLSYNDFVS 264
+S +
Sbjct: 211 DVSQTSVTA 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 69/296 (23%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VYK + A KV++ + E+ + E +IL H +++++
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+++ G+++ + L GL Q+ +C + E + +LH +++
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RII 139
Query: 794 HCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVG--- 849
H DLK N+L+ + +ADFG+ AK ++ + +G
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKN-----------LKTLQKRDS------FIGTPY 182
Query: 850 YIAPEYGMGKRASTHG-----DVYSFGVLLLEIVTGR------RPTDVLFHDGSSLHEWV 898
++APE M + D++S G+ L+E+ P VL
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK--------- 233
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954
IAK P + WS + ++ + NP TRPS
Sbjct: 234 ---------------IAKSDPPTLLTPSK--WSVEFRDFLK---IALDKNPETRPS 269
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 93/327 (28%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVK--VLDLTTTGEITGSFKRECQILKRIRHRNLIR---- 728
IG+G FG V++ L ++ +A+K + D RE QI++ ++H N++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-------RELQIMRIVKHPNVVDLKAF 100
Query: 729 IITICSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLI-------QLVKICSDVAE 779
+ K D LVL + ++ L + ++ QL++
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR------- 152
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAK-LVKGIDESVNCANDSMSF 837
+AY+H + H D+KP N+LLD L + DFG AK L+ G
Sbjct: 153 SLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP------------ 197
Query: 838 TSTDGLLCGSVGYI------APEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890
+V YI APE G +T+ D++S G ++ E++ G +P LF
Sbjct: 198 ---------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP---LFPG 244
Query: 891 GSSLHEWVKRHYPHRLDPIVE----------KAI-AKYAPQHMPIYYNKVWSDVVL---- 935
S + + L I++ K + Y P +S V
Sbjct: 245 ESGIDQ---------LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTP 295
Query: 936 -ELIELGLLCTQYNPSTRPSMLDV-AH 960
+ I+L +Y PS R + ++ H
Sbjct: 296 PDAIDLISRLLEYTPSARLTAIEALCH 322
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 70/305 (22%), Positives = 118/305 (38%), Gaps = 75/305 (24%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITI 732
+G+G +G VYKG ++ A+KV+D+T G+ K+E +LK+ HRN+
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 733 CSKPDFKA------LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
K + LV+ GS+ + + + G + L + IC ++ G+++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ 147
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
H KV+H D+K N+LL E+ + DFG++ + ++ +T
Sbjct: 148 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------RTVGRRNT------ 188
Query: 847 SVG---YIAPEYGMGKRASTHG-----DVYSFGVLLLEIVTGR------RPTDVLFHDGS 892
+G ++APE D++S G+ +E+ G P LF
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--- 245
Query: 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
I + P +K WS IE C N S R
Sbjct: 246 ---------------------IPRNPA---PRLKSKKWSKKFQSFIE---SCLVKNHSQR 278
Query: 953 PSMLD 957
P+
Sbjct: 279 PATEQ 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 69/337 (20%), Positives = 129/337 (38%), Gaps = 65/337 (19%)
Query: 638 NGADLEDEEKEKEEAKNPRVSYKQLIEATGGFC----PSSL------IGSGRFGHVYKGV 687
+G DL E ++ V+++Q A P L IG G G V
Sbjct: 9 SGVDLGTENLYF---QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65
Query: 688 -LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746
++AVK++DL E I++ +H N++ + + +++ +
Sbjct: 66 EKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806
G+L + + L+ Q+ +C V + +AYLH V+H D+K +ILL
Sbjct: 125 QGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176
Query: 807 DLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHG 865
D ++DFG A++ + + + L G+ ++APE +T
Sbjct: 177 DGRVKLSDFGFCAQI-----------SKDVPKRKS---LVGTPYWMAPEVISRSLYATEV 222
Query: 866 DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIY 925
D++S G++++E+V G P S P + K + P +
Sbjct: 223 DIWSLGIMVIEMVDGEPPY-------FSDS-------PVQ----AMKRLRDSPPPKLK-- 262
Query: 926 YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
+ S V+ + +E +P R + A E+
Sbjct: 263 NSHKVSPVLRDFLE---RMLVRDPQERAT----AQEL 292
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G FG V ++ ++ A K L+ + E QIL+++ R ++ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA-MALNEKQILEKVNSRFVVSL 249
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
D LVL LM+ G L+ H+Y H G + V +++ G+ LH
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLEDLHRE-- 305
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
++V+ DLKP NILLD+ ++D G+A + T G+VG
Sbjct: 306 -RIVYRDLKPENILLDDHGHIRISDLGLAV--------------HVPEGQTIKGRVGTVG 350
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
Y+APE +R + D ++ G LL E++ G+ P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 43/229 (18%), Positives = 88/229 (38%), Gaps = 22/229 (9%)
Query: 351 LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLL 410
++ + L S++ + ++ + + + + S+ + L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 411 YGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL-YLNLSSNHLDGPLP 469
N +S + S L LE L ++ N++ ++ G+ S L L L +N L
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDS 123
Query: 470 LELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQF 529
L + + + + N L SI LG LE L+L GN + ++ +L +
Sbjct: 124 --LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWI 177
Query: 530 DVSSNRLFGEIP---QSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTI 575
D++ + E + T+K + + ISN G++ +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY-YISNGGSYVDGCV 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 42/255 (16%), Positives = 85/255 (33%), Gaps = 34/255 (13%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLE 152
+ P L++ + +L K L ++ + +++Q + + L+
Sbjct: 12 VFP-DPGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLK 66
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L L +N++ P+ T L+ + ++ N L + + L L L +N
Sbjct: 67 ELHLSHNQISDLSPL-----KDLTKLEELSVNRNRLKNLNGIPS----ACLSRLFLDNNE 117
Query: 213 LVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
L + +L + LE L + +N + + + +L+ L L N TN
Sbjct: 118 L--RDTDSLIHLKNLEILSIRNNKLK-SIVM--LGFLSKLEVLDLHGN------EITNTG 166
Query: 273 PFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP-HISNLV 331
L ++L G + L + + I P +ISN
Sbjct: 167 G----LTRLKKVNWIDLTGQK----CVNEPVKYQPELYITNTVKDPDGRWISPYYISNGG 218
Query: 332 NLTLLNLSSNLLNGT 346
+ + L T
Sbjct: 219 SYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 46/257 (17%), Positives = 92/257 (35%), Gaps = 51/257 (19%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+ +L S+T + K L ++ ++ + L
Sbjct: 19 ANAVKQNLGKQSVTDLVSQKE---LSGVQNFNGDNSNIQ----------------SLAG- 58
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
+ L+ L+LS+N ++L P L + + +EL + N
Sbjct: 59 ----------MQFFTNLKELHLSHNQI------SDLSP----LKDLTKLEELSVNRNR-- 96
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
+ ++ G S L ++ LD N + + + +L NL +L++ +N L +I L +S
Sbjct: 97 --LKNLNGIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLS 150
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL-LLYGNH 414
KLE + L N ++ + + +DL+ K L + G
Sbjct: 151 KLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
Query: 415 LSGTIPSSLGKCVNLEI 431
+S S+ G V+ +
Sbjct: 209 ISPYYISNGGSYVDGCV 225
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 30/161 (18%), Positives = 59/161 (36%), Gaps = 13/161 (8%)
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480
N +L ++ ++ L ++ N ++++ ++ +
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQ-NFNGDNSNIQSLAGMQ--FFTNLKE 67
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540
+ LS N +S + P L LE L+++ N L+ L + L + + +N L
Sbjct: 68 LHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLDNNEL--RD 120
Query: 541 PQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581
S L+ L+ NK +I G S L + GN
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 57/251 (22%)
Query: 171 CSNSSTSLQYIDLSNNSLT---GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL 227
C+N+ S +D S+ LT IP + + L L SN+L +A +KL
Sbjct: 14 CNNNKNS---VDCSSKKLTAIPSNIPA-------DTKKLDLQSNKLSSLPSKAFHRLTKL 63
Query: 228 EWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQEL 287
L L N LP+ I ++ L+ L+++ N +
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA----------------------- 99
Query: 288 ELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGT 346
+P + D NL ++ LD N + +PP + +L LT L+L N L +
Sbjct: 100 ----------LPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-S 147
Query: 347 IPH----ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANL 402
+P +L + L+ + L NN L AF + L L L N+L +F +L
Sbjct: 148 LPKGVFDKL---TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 403 SQLRRLLLYGN 413
+L+ L L N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 20/201 (9%)
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176
IPA+ K+L L N L L +L L L +NKL +P IF
Sbjct: 35 IPADT------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF--KELK 85
Query: 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236
+L+ + +++N L +P+ +L NL L L N+L P+ + +KL +L L N
Sbjct: 86 NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144
Query: 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296
LP + K+ L+ L L N F L + + L+L N L
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGA-----FDKL---TELKTLKLDNNQL-K 194
Query: 297 MIPSIIGDLSTNLVQIHLDCN 317
+P D L + L N
Sbjct: 195 RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 52/186 (27%), Positives = 79/186 (42%), Gaps = 17/186 (9%)
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNHL 415
+++ L +N LS AF + L LL L+ NKL ++P F L L L + N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 416 SGTIPSSL-GKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHLDGPLPL--- 470
+P + + VNL L L N++ +P V L L YL+L N L LP
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLT-YLSLGYNELQS-LPKGVF 153
Query: 471 -ELSKMDMVLAIDLSFNNLSGSIPPQL-GSCIALESLNLSGNSLEGLLPVSVGQLPYLKQ 528
+L+ + + L N L +P L++L L N L+ + + L LK
Sbjct: 154 DKLTSLK---ELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
Query: 529 FDVSSN 534
+ N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 15/189 (7%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVG 163
LDL N L +L+ L L+ N LQ +P+ + L LE L + +NKL
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 164 EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALAN 223
+PI +F + +L + L N L +P + L L +L L N L
Sbjct: 99 ALPIGVF--DQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDK 155
Query: 224 SSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSN 283
+ L+ L L +N +P K+ +L+ L L N F SL
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA-----FDSL---EK 206
Query: 284 FQELELAGN 292
+ L+L N
Sbjct: 207 LKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 427 VNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPL----ELSKMDMVLAID 482
+ + LDL NK+S + L L+ L L+ N L LP EL ++ +
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLR-LLYLNDNKLQT-LPAGIFKELKNLETL---W 91
Query: 483 LSFNNLSGSIPPQLGSC-IALESLNLSGNSLEGLLPVSV-GQLPYLKQFDVSSNRLFGEI 540
++ N L ++P + + L L L N L+ LP V L L + N L +
Sbjct: 92 VTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNEL-QSL 148
Query: 541 PQ-SFQASPTLKQLNFSFNKFSGNISNKGAFSSLT 574
P+ F +LK+L N+ + GAF LT
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLK-RVPE-GAFDKLT 181
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 78/304 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY ++++ +A+K + + + E +E + L+++RH N I+
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV+ GS + L L +++ + +G+AYLH H
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 792 VVHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNCANDSMSFTSTDGLLCGSVG- 849
++H D+K NILL E + DFG + + +S VG
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---------ANSF------------VGT 213
Query: 850 --YIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGR------RPTDVLFHDGSSLHEWV 898
++APE + + DV+S G+ +E+ + L+H
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------- 264
Query: 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
IA+ P + WS+ ++ C Q P RP+
Sbjct: 265 ---------------IAQNES---PALQSGHWSEYFRNFVD---SCLQKIPQDRPT---- 299
Query: 959 AHEM 962
+ +
Sbjct: 300 SEVL 303
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 49/233 (21%), Positives = 102/233 (43%), Gaps = 35/233 (15%)
Query: 653 KNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSF 711
+P+ Y + + IG G G VY + + +A++ ++L +
Sbjct: 16 GDPKKKYTRFEK----------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LI 64
Query: 712 KRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLV 771
E +++ ++ N++ + D +V+ ++ GSL + + + +D Q+
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIA 119
Query: 772 KICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI-AKLVKGIDESVNC 830
+C + + + +LH + +V+H D+K NILL D + + DFG A++
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---------- 166
Query: 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
S ST + G+ ++APE K D++S G++ +E++ G P
Sbjct: 167 -TPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 9e-18
Identities = 54/218 (24%), Positives = 81/218 (37%), Gaps = 41/218 (18%)
Query: 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811
E P L L L+ VA+G+ +L + K +H DL NILL E
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 233
Query: 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFG 871
+ DFG+A+ + + V D L + ++APE + + DV+SFG
Sbjct: 234 ICDFGLARDIYKDPDYVR---------KGDARL--PLKWMAPETIFDRVYTIQSDVWSFG 282
Query: 872 VLLLEIVT-GRRP-TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKV 929
VLL EI + G P V +K R+ P +
Sbjct: 283 VLLWEIFSLGASPYPGV--KIDEEFCRRLKEGT--RMRA----------PDYTT------ 322
Query: 930 WSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
E+ + L C PS RP+ ++ +G L Q
Sbjct: 323 -----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 25/213 (11%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLI 727
+G G FG V + +AVK+L T + E +IL I H N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 728 RIITICSKPDFKALV-LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
++ C+KP +V + G+L +L S + + + +G Y+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
DLK + ++ + F K + ++E + F + + L+C
Sbjct: 145 I------PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 847 SVGYIAPEYGMGKRAS---THGDVYSFGVLLLE 876
S +A GM AS H D+ + +LL E
Sbjct: 199 SFQ-VA--KGMEFLASRKCIHRDLAARNILLSE 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 62/333 (18%), Positives = 126/333 (37%), Gaps = 76/333 (22%)
Query: 647 KEKEEAKNPRVSYKQLIEATGGFCPSSL------IGSGRFGHVYKGV-LQDNTRIAVKVL 699
+ + PR K+L E + P + +G G +G VYK + + +A+K +
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 700 DLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSH 759
+ + + +E I+++ ++++ K +V+ GS+ + + +
Sbjct: 63 PVESDLQ---EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 760 GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI-A 818
L ++ I +G+ YLH + +H D+K NILL+ + A +ADFG+
Sbjct: 120 K---TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLL 875
+L D+M+ +T +G ++APE + D++S G+ +
Sbjct: 174 QL-----------TDTMAKRNT------VIGTPFWMAPEVIQEIGYNCVADIWSLGITAI 216
Query: 876 EIVTGR------RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKV 929
E+ G+ P +F I P ++
Sbjct: 217 EMAEGKPPYADIHPMRAIFM------------------------IPTNPPP--TFRKPEL 250
Query: 930 WSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
WSD + ++ C +P R + A ++
Sbjct: 251 WSDNFTDFVK---QCLVKSPEQRAT----ATQL 276
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 58/319 (18%), Positives = 123/319 (38%), Gaps = 88/319 (27%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITI 732
+G G++ V++ + + +N ++ VK+L +I KRE +IL+ +R N+I + I
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGGPNIITLADI 99
Query: 733 CSKPDFKALVL---PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSD---------VAEG 780
P + L + D QL + +D + +
Sbjct: 100 VKDPVSRTPALVFEHVN-----------------NTDFKQLYQTLTDYDIRFYMYEILKA 142
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTS 839
+ Y H ++H D+KP N+++D + L + D+G+A+ F
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE-----------------FYH 182
Query: 840 TDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSS-- 893
V + PE + + + D++S G +L ++ + P FH G
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFH-GHDNY 238
Query: 894 --------------LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYN----KVWSDVVL 935
L++++ + Y LDP + +++ + + + + S L
Sbjct: 239 DQLVRIAKVLGTEDLYDYIDK-YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 297
Query: 936 ELIELGLLCTQYNPSTRPS 954
+ ++ LL +Y+ +R +
Sbjct: 298 DFLD-KLL--RYDHQSRLT 313
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-17
Identities = 81/328 (24%), Positives = 125/328 (38%), Gaps = 94/328 (28%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVK--VLDLTTTGEITGSFKRECQILKRIRHRNLIR--- 728
IG+G FG VY+ L D +A+K + D RE QI++++ H N++R
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 729 -IITICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLI-------QLVKICSDVA 778
+ K D L VL + ++ L +I QL +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR------ 167
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAK-LVKGIDESVNCANDSMS 836
+AY+H + H D+KP N+LLD D L + DFG AK LV+G
Sbjct: 168 -SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----------- 212
Query: 837 FTSTDGLLCGSVGYI------APEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889
+V YI APE G ++ DV+S G +L E++ G +P +F
Sbjct: 213 ----------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFP 258
Query: 890 DGSSLHEWVKRHYPHRLDPIVE----------KAI-AKYAPQHMPIYYNKVWSDVVL--- 935
S + + L I++ + + Y P W+ V
Sbjct: 259 GDSGVDQ---------LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 309
Query: 936 --ELIELGLLCTQYNPSTRPSMLDV-AH 960
E I L +Y P+ R + L+ AH
Sbjct: 310 PPEAIALCSRLLEYTPTARLTPLEACAH 337
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 357 LERVYLSNNSLSGEIPS--AFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGN 413
+ LS+N+LS + + + +L L LS N L+ I ++F + LR L L N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 414 HLSGTIPS-SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE- 471
HL T+ LE+L L +N I + + + L+ L LS N + P+E
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ-KLYLSQNQISR-FPVEL 155
Query: 472 ---LSKMDMVLAIDLSFNNLSGSIPP---QLGSCIALESLNLSGNSL 512
+K+ ++ +DLS N L +P Q L L N L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 17/173 (9%)
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNL 309
L LS+N+ + L + +N L L+ N+L + + NL
Sbjct: 39 SYTALLDLSHNNL------SRLRAEWT-PTRLTNLHSLLLSHNHLNFISSEAFVPV-PNL 90
Query: 310 VQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSL 367
+ L N + + + S+L L +L L +N + + M++L+++YLS N +
Sbjct: 91 RYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148
Query: 368 SGEIPSAFGDI---PHLGLLDLSKNKLSGSIPDSFANLSQLRR--LLLYGNHL 415
S D P L LLDLS NKL L + L L+ N L
Sbjct: 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 25/190 (13%)
Query: 64 VCNWSGVKCNNSR---------NKVVELDLSARSIYGTISP--ALANLSSLIVLDLSKNF 112
+C + + C+ + + LDLS ++ + L++L L LS N
Sbjct: 17 LCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNH 75
Query: 113 FQGHIPAE-LGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPIF 170
I +E + L+ L LS N L + L LE L L NN +V + F
Sbjct: 76 LN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAF 132
Query: 171 CSNSSTSLQYIDLSNNSLTGEIP---LKNECELRNLRFLLLWSNRLVGQVPQALANSSKL 227
LQ + LS N ++ P +K+ +L L L L SN+L L
Sbjct: 133 --EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189
Query: 228 --EWLDLESN 235
L L +N
Sbjct: 190 VKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 51/217 (23%), Positives = 77/217 (35%), Gaps = 41/217 (18%)
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
L +L +P + + +DLS+N+L+ L NL LLL N L
Sbjct: 23 LSCSKQQLP-NVPQSL-----PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76
Query: 214 VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP 273
+A L +LDL SN L + S + L+ L L N ++
Sbjct: 77 NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI------VVVDR 129
Query: 274 F-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVN 332
F + + Q+L L+ N + +I D + L
Sbjct: 130 NAFEDM---AQLQKLYLSQNQISRFPVELIKDG----------------------NKLPK 164
Query: 333 LTLLNLSSNLLNGTIPHELCLMSKL--ERVYLSNNSL 367
L LL+LSSN L +L + +YL NN L
Sbjct: 165 LMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 26/243 (10%)
Query: 116 HIPAELGSLIRLKQLSLSWNSLQGKIPSQ--LGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173
+P+ L LS N+L ++ ++ L L L L +N L I F
Sbjct: 36 SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAF--V 85
Query: 174 SSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLE 233
+L+Y+DLS+N L + +L+ L LLL++N +V A + ++L+ L L
Sbjct: 86 PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144
Query: 234 SNMFSGELPSEII---SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELA 290
N S P E+I +K+P+L L LS N L L L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD-----LQKLPAWVK-NGLYLH 197
Query: 291 GNNLG---GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTI 347
N L + L + +Y + N+ +L N S +
Sbjct: 198 NNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWE 257
Query: 348 PHE 350
H
Sbjct: 258 AHL 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 47/222 (21%), Positives = 74/222 (33%), Gaps = 64/222 (28%)
Query: 360 VYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIP--DSFANLSQLRRLLLYGNHLS 416
+ S L +P +P + LLDLS N LS + + L+ L LLL NHL+
Sbjct: 23 LSCSKQQLP-NVPQ---SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 417 GTIPS-SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM 475
I S + NL LDLS N + + +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFL---------------------------- 107
Query: 476 DMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535
F++L ALE L L N + + + + L++ +S N+
Sbjct: 108 ---------FSDLQ-----------ALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 536 LFGEIPQSFQAS---PTLKQLNFSFNKFSGNISNKGAFSSLT 574
+ + + P L L+ S NK + L
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLP 187
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 1e-16
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 37/221 (16%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVLD---LTTTGEITGSFKRECQILKRI---RHRNL 726
+IG G FG VY D ++ A+K LD + T + E +L + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFI 254
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLH 785
+ + PD + +L LM+ G L HL HG+ ++ +++ G+ ++H
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEIILGLEHMH 309
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ VV+ DLKP+NILLDE ++D G+A
Sbjct: 310 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------------PHA---SV 351
Query: 846 GSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
G+ GY+APE + ++ + D +S G +L +++ G P
Sbjct: 352 GTHGYMAPE--VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 40/225 (17%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G+G FG V +++ A+K+L + +I E +IL+ + L+++
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFPFLVKL 106
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHS 788
+V+ ++ G + +HL S + + + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-----PHARFYAAQIVLTFEYLHSLD 161
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+++ DLKP N+L+D+ V DFG AK VKG T T LCG+
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-------------TWT---LCGTP 202
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHD 890
+APE + K + D ++ GVL+ E+ G P F
Sbjct: 203 EALAPEIILSKG---YNKAVDWWALGVLIYEMAAGYPP----FFA 240
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 69/325 (21%), Positives = 109/325 (33%), Gaps = 89/325 (27%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVK-VLDLTTTGEITGSFK---------RECQILKRIRHR 724
I SG +G V GV + +A+K V + + G RE ++L H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 725 NLIRIITI---CSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE 779
N++ + I +P LV LM DL Q++ V
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----------------RTDLAQVIHDQRIVIS 132
Query: 780 -------------GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826
G+ LH VVH DL P NILL ++ + DF +A+
Sbjct: 133 PQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARE------ 183
Query: 827 SVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRR 882
+ D V Y APE M K + D++S G ++ E+ +
Sbjct: 184 -----------DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK- 231
Query: 883 PTDVLFHDGSSLHEWVK------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVV-- 934
LF + ++ K + + Y + + W+ VV
Sbjct: 232 ---ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT 288
Query: 935 -----LELIELGLLCTQYNPSTRPS 954
L+LI +L ++NP R S
Sbjct: 289 ADPVALDLIA-KML--EFNPQRRIS 310
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 35/176 (19%), Positives = 64/176 (36%), Gaps = 44/176 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRII-- 730
+G G G V + + + A+K+L +RE ++ R + +++RI+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVDV 79
Query: 731 --TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL-----------VKICSDV 777
+ + +V+ + G L IQ +I +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSI 126
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLV--KGIDESV 828
E + YLH + H D+KP N+L + + DFG AK + D+S
Sbjct: 127 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC 179
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 61/304 (20%), Positives = 112/304 (36%), Gaps = 77/304 (25%)
Query: 638 NGADLEDEEKEKEEAKNPRVSY---KQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTR 693
+G+ E +++++ + P S + + LIG+G +GHV + +
Sbjct: 21 SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80
Query: 694 IAVKVLDLTTTGEITGSFK---------RECQILKRIRHRNLIRIITICSKPDFKA---- 740
+A+K +I F+ RE IL R+ H ++++++ I D +
Sbjct: 81 VAIK--------KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 741 -LVLPLM---------SNGSLEN-H----LYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+VL + + L H LY L+ GV Y+H
Sbjct: 133 YVVLEIADSDFKKLFRTPVYLTELHIKTLLY------------NLLV-------GVKYVH 173
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
++H DLKP+N L+++D + V DFG+A+ V + + S + +
Sbjct: 174 SAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 846 GSVG--------------YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHD 890
Y APE + + T DV+S G + E++ + D
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 891 GSSL 894
L
Sbjct: 291 RGPL 294
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCL--MSKLERVYLSNNSLSGEIPSAFGDIPH 380
IP HI L L++N + + +L ++ SNN ++ AF
Sbjct: 26 IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 381 LGLLDLSKNKLSGSIPDS-FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439
+ + L+ N+L ++ F L L+ L+L N ++ S ++ +L L N+I
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 440 SGIIPSDVAGLRSLKLYLNLSSNHLD 465
+ + P L SL LNL +N +
Sbjct: 142 TTVAPGAFDTLHSLS-TLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 29/157 (18%), Positives = 57/157 (36%), Gaps = 14/157 (8%)
Query: 65 CNWSGVKCNNSRNKVV---------ELDLSARSIYGTISPAL-ANLSSLIVLDLSKNFFQ 114
C + V C+N + + EL L+ + + L L ++ S N
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 115 GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNS 174
+ ++ L+ N L+ L L+ L L +N++ + F
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF--IG 127
Query: 175 STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211
+S++ + L +N +T + L +L L L +N
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 28/153 (18%), Positives = 53/153 (34%), Gaps = 19/153 (12%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+ L+NN T +L LR + +N++ A +S + + L SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPF-FASLANSSNFQELELAGNNL 294
+ ++ + L+ L L N + F L S+ + L L N +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITC------VGNDSFIGL---SSVRLLSLYDNQI 141
Query: 295 GGMIPSIIGDLSTNLVQIHL-------DCNLIY 320
+ D +L ++L +C L +
Sbjct: 142 TT-VAPGAFDTLHSLSTLNLLANPFNCNCYLAW 173
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 28/179 (15%), Positives = 55/179 (30%), Gaps = 55/179 (30%)
Query: 360 VYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSG 417
V SN L+ +IP IP + L L+ N+ + F L QLR++ N ++
Sbjct: 16 VDCSNQKLN-KIPE---HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD 71
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDM 477
+ + + L+ N++ + +
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLENV-QHKM------------------------------ 100
Query: 478 VLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536
F L L++L L N + + S L ++ + N++
Sbjct: 101 -------FKGLES-----------LKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 65/322 (20%), Positives = 115/322 (35%), Gaps = 84/322 (26%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHR 724
IGSG G V +A+K +++ F+ RE ++K + H+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIK--------KLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 725 NLIRIITI----CSKPDFKA--LVLPLMS---NGSLENHLYPSHGLSHGLDLIQLVKICS 775
N+I ++ + S +F+ +V+ LM ++ L L Q++
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER---MSYLLYQMLC--- 138
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
G+ +LH ++H DLKPSNI++ D T + DFG+A+
Sbjct: 139 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--------------- 176
Query: 836 SFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
T ++ V Y APE +G + D++S G ++ E++ G VLF
Sbjct: 177 --AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTD 230
Query: 893 SLHEWVK--------------------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSD 932
+ +W K R Y + K P + ++
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 933 VVLELIELGLLCTQYNPSTRPS 954
+ +L + S R S
Sbjct: 291 KASQARDLLSKMLVIDASKRIS 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 7e-16
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
IG G +G V+K + + +A+K + L E + RE +LK ++H+N++R+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHKNIVRLH 67
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ LV L+ + + LD + + +G+ + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR--- 120
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV-- 848
V+H DLKP N+L++ + +A+FG+A+ +F V
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLAR----------------AFGIPVRCYSAEVVT 164
Query: 849 -GYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
Y P+ G + ST D++S G + E+ RP LF G+
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFP-GND 207
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 9e-16
Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+G+G FG V+ + N R A+KVL + ++ E +L + H +IR+
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIVTHPFIIRM 71
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHS 788
+++ + G L + L S + K ++V + YLH
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALEYLHSKD 126
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+++ DLKP NILLD++ + DFG AK V + T T LCG+
Sbjct: 127 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------------TYT---LCGTP 167
Query: 849 GYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHD 890
YIAPE K + D +SFG+L+ E++ G P F+D
Sbjct: 168 DYIAPEVVSTKP---YNKSIDWWSFGILIYEMLAGYTP----FYD 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 60/250 (24%), Positives = 98/250 (39%), Gaps = 35/250 (14%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHR 724
F L+G G FG V + R A+K+L + E+ E ++L+ RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQNSRHP 208
Query: 725 NLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAY 783
L + D V+ + G L HL S + +++ + Y
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSALDY 263
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH + V+ DLK N++LD+D + DFG+ K + + +T
Sbjct: 264 LHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK-------------EGIKDGATMKT 308
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSLHEWV 898
CG+ Y+APE D + GV++ E++ GR P + LF L E +
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LILMEEI 366
Query: 899 KRHYPHRLDP 908
+ +P L P
Sbjct: 367 R--FPRTLGP 374
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 70/372 (18%), Positives = 126/372 (33%), Gaps = 87/372 (23%)
Query: 628 SKFGKDLSVLNGADLEDEEKEKEEAKNPRVSY---KQLIEATGGFCPSSLIGSGRFGHVY 684
G D V + K + N S + IGSG G V
Sbjct: 20 FCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVC 79
Query: 685 KGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHRNLIRIITI-- 732
+ +A+K +++ F+ RE ++K + H+N+I ++ +
Sbjct: 80 AAYDAVLDRNVAIK--------KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 733 --CSKPDFKA--LVLPLMS---NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ +F+ LV+ LM ++ L L Q++ G+ +LH
Sbjct: 132 PQKTLEEFQDVYLVMELMDANLCQVIQMELDHER---MSYLLYQMLC-------GIKHLH 181
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
++H DLKPSNI++ D T + DFG+A+ T ++
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----------------AGTSFMMT 221
Query: 846 GSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK--- 899
V Y APE +G + D++S G ++ E+V + +LF + +W K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKVIE 277
Query: 900 -----------------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGL 942
R+Y K P + ++ + +L
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337
Query: 943 LCTQYNPSTRPS 954
+P+ R S
Sbjct: 338 KMLVIDPAKRIS 349
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 60/289 (20%), Positives = 109/289 (37%), Gaps = 48/289 (16%)
Query: 642 LEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVL- 699
LE + + K R+ + F +IG G FG V L++ ++ A+K+L
Sbjct: 56 LEWAKPFTSKVKQMRLHRED-------FEILKVIGRGAFGEVAVVKLKNADKVFAMKILN 108
Query: 700 --DLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYP 757
++ E F+ E +L + + + + LV+ G L L
Sbjct: 109 KWEMLKRAETA-CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167
Query: 758 SHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816
L ++ + +++ + +H VH D+KP NIL+D + +ADFG
Sbjct: 168 FEDR---LPE-EMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220
Query: 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE--YGMGKRASTHG---DVYSFG 871
+ D +S G+ YI+PE M +G D +S G
Sbjct: 221 SCLKLM---------EDGTVQSSV---AVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 872 VLLLEIVTGRRPTDVLFHDGSS-------LHEWVKRHYPHRLDPIVEKA 913
V + E++ G P F+ S ++ + +P ++ + E A
Sbjct: 269 VCMYEMLYGETP----FYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 68/307 (22%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRIIT 731
+G G +G VYK +A+K + L E T RE +LK + H N++ +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI--REISLLKELHHPNIVSLID 86
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV M L+ L GL Q+ + GVA+ H H +
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQH---R 139
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG-- 849
++H DLKP N+L++ D +ADFG+A+ +F V
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLAR----------------AFGIPVRSYTHEVVTL 183
Query: 850 -YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR--------------------RPTDVL 887
Y AP+ MG + ST D++S G + E++TG+ P
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243
Query: 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947
+ L W +R + + + ++L+ +L +
Sbjct: 244 WPQVQELPLWKQRTFQ------------VFEKKPWSSIIPGF-CQEGIDLLS-NML--CF 287
Query: 948 NPSTRPS 954
+P+ R S
Sbjct: 288 DPNKRIS 294
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 55/233 (23%)
Query: 674 LIGSGRFGHVY---KGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHR-- 724
++G+G +G V+ K D ++ A+KVL + + T + E Q+L+ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 725 --NLIRIITICSKPDFKA-----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSD 776
L + F+ L+L ++ G L HL + V+I +
Sbjct: 121 LVTLH-----YA---FQTETKLHLILDYINGGELFTHLSQRERFT-----EHEVQIYVGE 167
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+ + +LH +++ D+K NILLD + ++ DFG++K E V +
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETER-- 216
Query: 837 FTSTDGLLCGSVGYIAPE------YGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
CG++ Y+AP+ G K D +S GVL+ E++TG P
Sbjct: 217 -AYD---FCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.1 bits (189), Expect = 1e-14
Identities = 55/355 (15%), Positives = 99/355 (27%), Gaps = 41/355 (11%)
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
+ +S + + + LL + + +
Sbjct: 248 VHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAA 307
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
++ + + S + E + A EL+ ++ S
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQS 366
Query: 301 IIGDLS--TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
+ L + C L + + L+ + L P + L
Sbjct: 367 ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
+L NS+ + + +L L+ L+ + L + L L N L
Sbjct: 427 SKFLLENSVLKM------EYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-A 477
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMV 478
+P +L LE+L S N + + VA L L+ L L +N L ++
Sbjct: 478 LPPALAALRCLEVLQASDNALENV--DGVANLPRLQ-ELLLCNNRLQQSAAIQ------- 527
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGN---SLEGLLPVSVGQLPYLKQFD 530
L SC L LNL GN EG+ LP +
Sbjct: 528 ----------------PLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 61/365 (16%), Positives = 105/365 (28%), Gaps = 63/365 (17%)
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
++ + L + L S++ L L + + + ++L
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNL 318
S + F S + +E L + L + L
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS--ATDEQLFRCELSVEK 360
Query: 319 IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI 378
+ + + L L + TI + LM L+ + +L D
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDP 416
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
LD ++K + +R L L L T+ L + + + LDLSHN+
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNR 474
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGS 498
+ ++PP L +
Sbjct: 475 LR--------------------------------------------------ALPPALAA 484
Query: 499 CIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL--FGEIPQSFQASPTLKQLNFS 556
LE L S N+LE + V LP L++ + +NRL I Q + P L LN
Sbjct: 485 LRCLEVLQASDNALENVDGV--ANLPRLQELLLCNNRLQQSAAI-QPLVSCPRLVLLNLQ 541
Query: 557 FNKFS 561
N
Sbjct: 542 GNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 9e-11
Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 11/160 (6%)
Query: 50 PEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLS 109
P A + + S +K + + L L+ + + T+ L L + LDLS
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVR--VLHLAHKDL--TVLCHLEQLLLVTHLDLS 471
Query: 110 KNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPI 169
N + +P L +L L+ L S N+L+ + + +L +L+ L L NN+L I
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQP 528
Query: 170 FCSNSSTSLQYIDLSNNSLTGEIPLKNECE--LRNLRFLL 207
S L ++L NSL E ++ L ++ +L
Sbjct: 529 LVSC--PRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 36/154 (23%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGE 164
VL L+ + L L+ + L LS N L+ +P L +L LE L +N L
Sbjct: 445 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--- 498
Query: 165 IPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG-QVPQALAN 223
++ + L L+ LLL +NRL Q L +
Sbjct: 499 -----------ENVDGVA----------------NLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 224 SSKLEWLDLESNMFSG--ELPSEIISKMPQLQFL 255
+L L+L+ N + + +P + +
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 61/323 (18%), Positives = 118/323 (36%), Gaps = 64/323 (19%)
Query: 174 SSTSLQYIDLSNNSLTGE------IPLKNECELRNLRFLLLWSNRL----VGQVPQALAN 223
+ S++ L +++T E L +++ ++L N + + + +A+
Sbjct: 2 ARFSIEGKSLKLDAITTEDEKSVFAVLLE---DDSVKEIVLSGNTIGTEAARWLSENIAS 58
Query: 224 SSKLEWLDLESNMFSGELPSEI----------ISKMPQLQFLYLSYNDFVSHDGNTNLEP 273
LE + S++F+G + EI + K P+L + LS N F G T EP
Sbjct: 59 KKDLEIAEF-SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF----GPTAQEP 113
Query: 274 FFASLANSSNFQELELAGNNLG------------GMIPSIIGDLSTNLVQIHLDCNLIYG 321
L+ + + L L N LG + + + L I N +
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 322 KIPPHISNLV----NLTLLNLSSNLLN-----GTIPHELCLMSKLERVYLSNNSLSGE-- 370
+ L + + N + + L +L+ + L +N+ +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 371 --IPSAFGDIPHLGLLDLSKNKLSG----SIPDSFANLS--QLRRLLLYGNHLSGTIPSS 422
+ A P+L L L+ LS ++ D+F+ L L+ L L N + +
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293
Query: 423 LGKCV-----NLEILDLSHNKIS 440
L + +L L+L+ N+ S
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 55/291 (18%)
Query: 77 NKVVELDLSARSIYG-----TISPALANLSSLIVLDLSKNF---FQGHIPAELGSLIR-- 126
+ V E+ LS +I G +S +A+ L + + S F + IP L L++
Sbjct: 32 DSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 90
Query: 127 -----LKQLSLSWNSLQGKIPSQLGSL----HQLEYLDLGNNKL-------VGEI---PI 167
L + LS N+ L LE+L L NN L +
Sbjct: 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELA 150
Query: 168 PIFCSNSSTSLQYIDLSNNSLTGE------IPLKNECELRNLRFLLLWSNRL-----VGQ 216
+ ++ L+ I N L ++ L ++ + N +
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVK---MVQNGIRPEGIEHL 207
Query: 217 VPQALANSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLE 272
+ + LA +L+ LDL+ N F+ L + + P L+ L L+ +S G +
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSAL-AIALKSWPNLRELGLNDCL-LSARGAAAVV 265
Query: 273 PFFASLANSSNFQELELAGNNLGG----MIPSIIGDLSTNLVQIHLDCNLI 319
F+ L N Q L L N + + ++I + +L+ + L+ N
Sbjct: 266 DAFSKLENIGL-QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 55/336 (16%), Positives = 106/336 (31%), Gaps = 65/336 (19%)
Query: 221 LANSSKLEWLDLESNMFSGELPSEI---ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+A S +E L+ + + E + + + ++ + LS N G +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI----GTEAARWLSEN 55
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
+A+ + + E + G + I L + + L +
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRL---------------LLQALLKCPKLHTVR 100
Query: 338 LSSNLLNGT----IPHELCLMSKLERVYLSNNSLSGE-------------IPSAFGDIPH 380
LS N T + L + LE +YL NN L + + + P
Sbjct: 101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP 160
Query: 381 LGLLDLSKNKLSG----SIPDSFANLSQLRRLLLYGNHL-----SGTIPSSLGKCVNLEI 431
L + +N+L +F + L + + N + + L C L++
Sbjct: 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220
Query: 432 LDLSHNKISGI----IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA------I 481
LDL N + + + + +L+ L L+ L + L +
Sbjct: 221 LDLQDNTFTHLGSSALAIALKSWPNLR-ELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279
Query: 482 DLSFNNLSGSIPPQLGSCIA-----LESLNLSGNSL 512
L +N + L + I L L L+GN
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 52/297 (17%), Positives = 95/297 (31%), Gaps = 51/297 (17%)
Query: 93 ISPALANLSSLIVLDLSKNFF--QG--HIPAELGSLIRLKQLSLSWNS---LQGKIPSQL 145
+ L S+ + LS N + + + S L+ S ++ +IP L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 146 GSL-------HQLEYLDLGNNKLVGEIPIPIFCS--NSSTSLQYIDLSNNSLTGE----- 191
L +L + L +N G + T L+++ L NN L +
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142
Query: 192 -------IPLKNECELRNLRFLLLWSNRL----VGQVPQALANSSKLEWLDLESNMFSGE 240
K LR ++ NRL + + + + L + + N E
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202
Query: 241 ----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG- 295
L E ++ +L+ L L N F + +L + N +EL L L
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTF----THLGSSALAIALKSWPNLRELGLNDCLLSA 258
Query: 296 ----GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-----SNLVNLTLLNLSSNLL 343
++ + + L + L N I + + +L L L+ N
Sbjct: 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 40/277 (14%), Positives = 81/277 (29%), Gaps = 53/277 (19%)
Query: 330 LVNLTL--LNLSSNLLNG----TIPHELCLMSKLERVYLSNNSLSGE----IPSAFGDIP 379
+ ++ +L + + ++ L ++ + LS N++ E +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 380 HLGLLDLSKNKLS----------GSIPDSFANLSQLRRLLLYGNHLSGT----IPSSLGK 425
L + + S + + +L + L N T + L K
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120
Query: 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF 485
LE L L +N + + L + + L I
Sbjct: 121 HTPLEHLYLHNNGLG------PQAGAKIARALQELAVNKKAKNAPPLRS------IICGR 168
Query: 486 NNLSG----SIPPQLGSCIALESLNLSGNSL-----EGLLPVSVGQLPYLKQFDVSSNRL 536
N L S L ++ + N + E LL + LK D+ N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 537 FGE----IPQSFQASPTLKQLNFSFNKFSGNISNKGA 569
+ + ++ P L++L + +S +GA
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCL----LSARGA 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 68/333 (20%), Positives = 117/333 (35%), Gaps = 95/333 (28%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVK-VLDLTTTGEITGSFKRECQILK---RIRHRNLIR- 728
G G FG V G + +A+K V+ RE QI++ + H N+++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQL 84
Query: 729 --IITICSKPDFK----ALVLPLMSNGSLENHLYPSHGLSHGLDLI-------QLVKICS 775
+ D + +V+ + + +L + I QL++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR--- 140
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDS 834
+ LH S + V H D+KP N+L++E L + DFG AK + +
Sbjct: 141 ----SIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-------- 187
Query: 835 MSFTSTDGLLCGSVGYI------APEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVL 887
+V YI APE G + +T D++S G + E++ G P +
Sbjct: 188 ------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EP---I 231
Query: 888 FHDGSSLHEWVKRHYPHRLDPIVE----------KAI-----AKYAPQHMPIYYNKVWSD 932
F G + +L IV + + I ++ V+SD
Sbjct: 232 FR-GDN--------SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 933 VVLELIELGL-LCT---QYNPSTRPSMLDV-AH 960
L+ + L + QY P R + H
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 72/366 (19%), Positives = 122/366 (33%), Gaps = 100/366 (27%)
Query: 645 EEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTR---IAVKVLDL 701
+ K K ++ RV E +G G +GHVYK +D A+K ++
Sbjct: 6 DFKVKLSSERERVEDLFEYE-------GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG 58
Query: 702 TTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL----------PLMSNGSL 751
T I+ S RE +L+ ++H N+I + + + + L ++
Sbjct: 59 T---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRA 115
Query: 752 ENHLYPSHGLSHGLD---LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808
L G+ L Q++ G+ YLH + V+H DLKP+NIL+ +
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILD-------GIHYLHAN---WVLHRDLKPANILVMGEG 165
Query: 809 TAL----VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG------YIAPEYGMG 858
+AD G A+L F S L Y APE +G
Sbjct: 166 PERGRVKIADMGFARL----------------FNSPLKPLADLDPVVVTFWYRAPELLLG 209
Query: 859 KRA-STHGDVYSFGVLLLEIVTGR-----------------------------RPTDVLF 888
R + D+++ G + E++T P D +
Sbjct: 210 ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDW 269
Query: 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYN 948
D + E R + ++ KY +H L++ L +
Sbjct: 270 EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----DSKAFHLLQKLL---TMD 321
Query: 949 PSTRPS 954
P R +
Sbjct: 322 PIKRIT 327
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 49/229 (21%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
IG G FG V+K + + A+K + + E IT RE +IL+ ++H N++ +I
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL--REIKILQLLKHENVVNLI 82
Query: 731 TICSKPDFKA--------LVLPLMSN---GSLENHLYPSHGLSHGLD---LIQLVKICSD 776
IC LV + G L N + + L+
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLL----- 134
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
G+ Y+H + K++H D+K +N+L+ D +ADFG+A+ S+ +
Sbjct: 135 --NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF-----SLAKNSQPNR 184
Query: 837 FTSTDGLLCGSVG---YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR 881
+T+ V Y PE +G+R D++ G ++ E+ T
Sbjct: 185 YTNR-------VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK----RECQILKRIRHRNLIRI 729
+G G+F VYK N +A+K + L E RE ++L+ + H N+I +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +LV M LE + S L + +G+ YLH H
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 131
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAK 819
++H DLKP+N+LLDE+ +ADFG+AK
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
L+G G FG V + R A+K+L + E+ E ++L+ RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQNTRHPFLTAL 70
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHS 788
D V+ + G L HL + + + +++ + YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLHSR- 124
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
VV+ D+K N++LD+D + DFG+ K GI + + T CG+
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDG--------ATMKT---FCGTP 169
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSLHEWVKRHYP 903
Y+APE D + GV++ E++ GR P + LF L E ++ +P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILMEEIR--FP 225
Query: 904 HRLDP 908
L P
Sbjct: 226 RTLSP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 38/147 (25%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G+G + VYKG+ + A+K + L + + RE ++K ++H N++R+ +
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 734 SKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV M N L+ ++ GL+L + + +G+A+ H + K
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIA 818
++H DLKP N+L+++ + DFG+A
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 43/225 (19%)
Query: 674 LIGSGRFGHVY---KGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNL 726
++G G +G V+ K + +I A+KVL + + T K E IL+ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 727 IRII----TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGV 781
+ +I T L+L +S G L L ++++ +
Sbjct: 84 VDLIYAFQT----GGKLYLILEYLSGGELFMQLEREGIFM-----EDTACFYLAEISMAL 134
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTD 841
+LH +++ DLKP NI+L+ + DFG+ K I + + T T
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDG--------TVTHT- 180
Query: 842 GLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
CG++ Y+APE M H D +S G L+ +++TG P
Sbjct: 181 --FCGTIEYMAPEILMRSG---HNRAVDWWSLGALMYDMLTGAPP 220
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-14
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 22/154 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
IG G +G VYK +A+K + L T E T RE +LK + H N+++++
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNHPNIVKLL 68
Query: 731 TICSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLD---LIQLVKICSDVAEGVAYLH 785
+ + LV + L+ + G+ L L QL++ G+A+ H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ-------GLAFCH 120
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
H +V+H DLKP N+L++ + +ADFG+A+
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/317 (17%), Positives = 100/317 (31%), Gaps = 47/317 (14%)
Query: 68 SGVKCNNSRNKVVELDLSARSIYGTISPALA-----NLSSLIVLDLSKNFFQGHIPAELG 122
+ L+LS S+ S L +++ L+LS NF EL
Sbjct: 44 QAFANTPASVT--SLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101
Query: 123 SLIR-----LKQLSLSWNSLQGK----IPSQLGSLHQ-LEYLDLGNNKLVGEIPIPIFCS 172
+ + L L WN K +L + L+L N L G
Sbjct: 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQ 160
Query: 173 ---NSSTSLQYIDLSNNSLTGE------IPLKNECELRNLRFLLLWSNRLVGQVPQALA- 222
++ ++L N+L + L + ++ L L +N L + LA
Sbjct: 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA--SVTSLDLSANLLGLKSYAELAY 218
Query: 223 ----NSSKLEWLDLESNMFSGE---LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFF 275
+ + L+L N G + + LQ +YL Y+ + +
Sbjct: 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALG 277
Query: 276 ASLANSSNFQELELAGNNLGG----MIPSIIGDLSTNLVQIHL-DCNLIYGKIPPHISNL 330
A+ N ++ G + I ++I +LS L + LI+ +
Sbjct: 278 AAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIED 337
Query: 331 VN----LTLLNLSSNLL 343
+N L + L
Sbjct: 338 LNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 59/348 (16%), Positives = 104/348 (29%), Gaps = 56/348 (16%)
Query: 93 ISPALANLSSLIVLDLSKNFFQGHIPAELGSLIR-----LKQLSLSWNSLQGKIPSQLGS 147
+ + + LDLS N EL + L+LS NSL K +L
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73
Query: 148 L-----HQLEYLDLGNNKLVGEIPIPIFCS---NSSTSLQYIDLSNNSLT-------GEI 192
+ + L+L N L ++ +DL N + +
Sbjct: 74 ILAAIPANVTSLNLSGNFL-SYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA 132
Query: 193 PLKNECELRNLRFLLLWSNRLVGQVPQALA-----NSSKLEWLDLESNMFSGE----LPS 243
+ +L L N L + L + + L+L N + + L
Sbjct: 133 FSNLPASITSLN---LRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAK 189
Query: 244 EIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIG 303
+ S + L LS N L F+S ++ L L N L G +
Sbjct: 190 FLASIPASVTSLDLSANLL-GLKSYAELAYIFSS--IPNHVVSLNLCLNCLHGPSLENLK 246
Query: 304 DL---STNLVQIHLDCNLIYGKIPPHISNLV-------NLTLLNLSSNLLNGTIPHELC- 352
L +L ++LD +++ L + L++ + ++ + +
Sbjct: 247 LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISN 306
Query: 353 ----LMSKLERVYLSNNSLSGE----IPSAFGDIP-HLGLLDLSKNKL 391
L K + L N L +IP L + L
Sbjct: 307 LIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 61/377 (16%), Positives = 120/377 (31%), Gaps = 78/377 (20%)
Query: 174 SSTSLQYIDLSNNSLT-------GEIPLKNECELRNLRFLLLWSNRLVGQVPQALA---- 222
+ +DLS N+L + + +L L N L + L
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLN---LSGNSLGFKNSDELVQILA 76
Query: 223 -NSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+ + L+L N S + L + + + L L +NDF + + F +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF----SSKSSSEFKQA 132
Query: 278 LAN-SSNFQELELAGNNLGGM----IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLV- 331
+N ++ L L GN+LG + I+ + N+ ++L N + K ++ +
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 332 ----NLTLLNLSSNLLNGTIPHELCLM-----SKLERVYLSNNSLSGE----IPSAFGDI 378
++T L+LS+NLL EL + + + + L N L G + +
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
HL + L + + + L ++ + ++D + +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALG-----------------AAFPNIQKIILVDKNGKE 295
Query: 439 ISGIIPSDVAGLRSL--KLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQL 496
I PS + +L +L L + K + L
Sbjct: 296 IH---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIE--------------DL 338
Query: 497 GSCIALESLNLSGNSLE 513
L + L
Sbjct: 339 NIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 57/361 (15%), Positives = 106/361 (29%), Gaps = 65/361 (18%)
Query: 219 QALANSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPF 274
+ + + LDL N L + + L LS N G N +
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL----GFKNSDEL 71
Query: 275 FASLA-NSSNFQELELAGNNLGG----MIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
LA +N L L+GN L + + + + + L N K
Sbjct: 72 VQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131
Query: 330 LV-----NLTLLNLSSNLLNGTIPHELCLM-----SKLERVYLSNNSLSGE----IPSAF 375
++T LNL N L EL + + + + L N+L+ + +
Sbjct: 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFL 191
Query: 376 GDIP-HLGLLDLSKNKLSGSIPDSFA-----NLSQLRRLLLYGNHLSGT----IPSSLGK 425
IP + LDLS N L A + + L L N L G +
Sbjct: 192 ASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDS 251
Query: 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF 485
+L+ + L ++ + + L + + ++ +D +
Sbjct: 252 LKHLQTVYLDYDIVKNMSKEQCKALGAA------------------FPNIQKIILVDKNG 293
Query: 486 NNLSGSIPPQLGSCIA-----LESLNLSGNSL-----EGLLPVSVGQLPYLKQFDVSSNR 535
+ S + + I + +L L + L++ +
Sbjct: 294 KEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
Query: 536 L 536
L
Sbjct: 354 L 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 55/325 (16%), Positives = 103/325 (31%), Gaps = 64/325 (19%)
Query: 327 ISNLVNLTLLNLSSNLLNGTIPHELCLM-----SKLERVYLSNNSLSGE----IPSAFGD 377
S +T L+LS N L EL + + + LS NSL + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 378 IP-HLGLLDLSKNKLSGSIPDSFANL-----SQLRRLLLYGNHLSGT----IPSSLGKC- 426
IP ++ L+LS N LS D + L L N S +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 427 VNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486
++ L+L N + + L L ++ +++L N
Sbjct: 138 ASITSLNLRGNDLG------IKSSDELIQILAAIPANV--------------NSLNLRGN 177
Query: 487 NLSGSIPPQLGSCIA-----LESLNLSGNSL-----EGLLPVSVGQLPYLKQFDVSSNRL 536
NL+ +L +A + SL+LS N L L + ++ ++ N L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 537 FGE----IPQSFQASPTLKQLNFSFNKFSGNISNKGAF---------SSLTIASFQGNDG 583
G + + L+ + ++ N+S + + + G +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 584 LCGEIKGLQTCKKEHTHHLVILSIL 608
+ +E + + S+L
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLL 321
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 54/297 (18%), Positives = 100/297 (33%), Gaps = 84/297 (28%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQIL 718
+ LIG G +G+VY +A+K ++ F+ RE IL
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--------KVNRMFEDLIDCKRILREITIL 79
Query: 719 KRIRHRNLIRIITICSKPDFKA-----LVLPLM---------SNGSLEN-H----LYPSH 759
R++ +IR+ + D +VL + + L H LY
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY--- 136
Query: 760 GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
L+ G ++H ++H DLKP+N LL++D + V DFG+A+
Sbjct: 137 ---------NLLL-------GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVG---------YIAPEYGMGKRASTHG-DVYS 869
+ ++ + + Y APE + + T D++S
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 870 FGVLLLEIVTG----------RRP-----TDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
G + E++ R P + + + ++ +L+ I
Sbjct: 238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 33/227 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG V + ++ A+K+L ++ + F E I+ ++++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FFWEERDIMAFANSPWVVQL 134
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ +V+ M G L N + ++ + ++V + +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM-- 187
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+H D+KP N+LLD+ +ADFG + + M T G+
Sbjct: 188 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK---------EGMVRCDT---AVGTPD 234
Query: 850 YIAPEYGMGK-RASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGS 892
YI+PE + +G D +S GV L E++ G P F+ S
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP----FYADS 277
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 5e-14
Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRIIT 731
IG G +G VYK A+K + L E T RE ILK ++H N++++
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI--REISILKELKHSNIVKLYD 67
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV + L+ L GL+ + + G+AY H +
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG-- 849
V+H DLKP N+L++ + +ADFG+A+ +F +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR----------------AFGIPVRKYTHEIVTL 164
Query: 850 -YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR 881
Y AP+ MG + ST D++S G + E+V G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 67/316 (21%), Positives = 119/316 (37%), Gaps = 81/316 (25%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIRHRNLIRII 730
+G G +G VYK + N +A+K + L E T RE +LK ++HRN+I +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI--REVSLLKELQHRNIIELK 99
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLD---LIQLVKICSDVAEGVAYLHHH 787
++ L+ N L+ ++ + +S + L QL+ GV + H
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN-------GVNFCHSR 151
Query: 788 SPIKVVHCDLKPSNILLDEDLTAL-----VADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
+ +H DLKP N+LL + + DFG+A+ +F
Sbjct: 152 ---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR----------------AFGIPIR 192
Query: 843 LLCGSVG---YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR----------------- 881
+ Y PE +G R ST D++S + E++
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252
Query: 882 ---RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELI 938
P D + ++L +W K+ +P K+ + + + D L+L+
Sbjct: 253 VLGLPDDTTWPGVTALPDW-KQSFP------------KFRGKTLKRVLGALLDDEGLDLL 299
Query: 939 ELGLLCTQYNPSTRPS 954
+L + +P R S
Sbjct: 300 T-AML--EMDPVKRIS 312
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 51/228 (22%)
Query: 674 LIGSGRFGHVY---KGVLQDNTRI-AVKVL--------DLTTTGEITGSFKRECQILKRI 721
++G G FG V+ K D ++ A+KVL D T K E IL +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-------KMERDILVEV 83
Query: 722 RHRNLIRIITICS--KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVA 778
H ++++ + L+L + G L L + + VK +++A
Sbjct: 84 NHPFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELA 136
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFT 838
+ +LH +++ DLKP NILLDE+ + DFG++K ID
Sbjct: 137 LALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHE--------KKA 183
Query: 839 STDGLLCGSVGYIAPEYGMGKRASTHG---DVYSFGVLLLEIVTGRRP 883
+ CG+V Y+APE + H D +SFGVL+ E++TG P
Sbjct: 184 YS---FCGTVEYMAPEVVNRRG---HTQSADWWSFGVLMFEMLTGTLP 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 66/324 (20%), Positives = 117/324 (36%), Gaps = 63/324 (19%)
Query: 642 LEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRI-AVKVL- 699
L+ E K R+ F +IG G F V ++ ++ A+K++
Sbjct: 43 LQWAEPIVVRLKEVRLQRDD-------FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN 95
Query: 700 --DLTTTGEITGSFKRECQILKRIRHRNLIRIITICS--KPDFKALVLPLMSNGSLENHL 755
D+ GE++ F+ E +L R + ++ + ++ LV+ G L L
Sbjct: 96 KWDMLKRGEVS-CFREERDVLVNGDRRWITQLH--FAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 756 YPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815
G ++ + +++ + +H VH D+KP NILLD +ADF
Sbjct: 153 S-KFGERIPAEMARFY--LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206
Query: 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE----YGMGKRASTHG---DVY 868
G ++ D + G+ Y++PE G G ++G D +
Sbjct: 207 GSCLKLRA---------DGTVRSLV---AVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 869 SFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNK 928
+ GV E+ G+ P F+ S K + +P+
Sbjct: 255 ALGVFAYEMFYGQTP----FYADS-------------TAETYGKIVHYKEHLSLPLVDEG 297
Query: 929 VWSDVVLELIELGLLCTQYNPSTR 952
V + + I+ LLC P TR
Sbjct: 298 V-PEEARDFIQ-RLLC---PPETR 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 59/255 (23%), Positives = 93/255 (36%), Gaps = 73/255 (28%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHR 724
+G G +G V +A+K ++ F RE +ILK +H
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIE---------PFDKPLFALRTLREIKILKHFKHE 69
Query: 725 NLIRIITICSKPDFKA-----LVLPLM--------SNGSLEN-H----LYPSHGLSHGLD 766
N+I I I F+ ++ LM S L + H +Y
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY---------- 119
Query: 767 LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826
Q ++ V LH V+H DLKPSN+L++ + V DFG+A+++
Sbjct: 120 --QTLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID---- 163
Query: 827 SVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRR 882
A D+ T + V Y APE + + DV+S G +L E+ R
Sbjct: 164 --ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR- 220
Query: 883 PTDVLFHDGSSLHEW 897
+F H+
Sbjct: 221 ---PIFPGRDYRHQL 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK----RECQILKRIR---HRNL 726
IG G +G VYK +A+K + + G G RE +L+R+ H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 727 IRIITICSKPDFKA-----LVLPLMSN---GSLENHLYPSHGLSHGLD---LIQLVKICS 775
+R++ +C+ LV + L+ P GL + Q ++
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLR--- 131
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
G+ +LH + +VH DLKP NIL+ T +ADFG+A+ + M
Sbjct: 132 ----GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQ---------M 174
Query: 836 SFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
+ T V Y APE + +T D++S G + E+ +
Sbjct: 175 ALTPV-------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 62/306 (20%), Positives = 111/306 (36%), Gaps = 64/306 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIITI 732
+G G +G V K +D RI A+K + ++ RE ++LK++RH NL+ ++ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
C K LV + + ++ + L +GLD + K + G+ + H H +
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSH---NI 145
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG--- 849
+H D+KP NIL+ + + DFG A+ + + + V
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFAR----------------TLAAPGEVYDDEVATRW 189
Query: 850 YIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR--------------------RPTDVLF 888
Y APE +G DV++ G L+ E+ G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYN 948
+ + P + + S+VV++L + L +
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKL------------SEVVIDLAK-KCL--HID 294
Query: 949 PSTRPS 954
P RP
Sbjct: 295 PDKRPF 300
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 69/249 (27%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIR-H 723
+G G +G V+K + + +AVK +I +F+ RE IL + H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK--------KIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 724 RNLIRIITICSKPDFKA--LVLPLM---------SNGSLENH----LYPSHGLSHGLDLI 768
N++ ++ + + + LV M +N H +Y
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY------------ 116
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
QL+K + YLH S ++H D+KPSNILL+ + VADFG+++ I
Sbjct: 117 QLIK-------VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 829 N-----CANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVT 879
N ++ +F +L V Y APE +G T G D++S G +L EI+
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 880 GRRPTDVLF 888
G+ +F
Sbjct: 227 GK----PIF 231
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCL-MS 355
IP+ +L + +I L+ N I IPP S L ++LS+N ++ + + +
Sbjct: 26 IPT---NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNH 414
L + L N ++ S F + L LL L+ NK++ + D+F +L L L LY N
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 415 LSGTIPSSLGKCVNLEILDLSHN 437
L + ++ + L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/133 (24%), Positives = 57/133 (42%), Gaps = 5/133 (3%)
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
++ L N+++ P +L +DL NN++ E+ F SL + L N
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAF--QGLRSLNSLVLYGNK 91
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
+T E+P L +L+ LLL +N++ A + L L L N + S
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS 149
Query: 248 KMPQLQFLYLSYN 260
+ +Q ++L+ N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 36/158 (22%), Positives = 56/158 (35%), Gaps = 17/158 (10%)
Query: 65 CNWSGVKCNNSR---------NKVVELDLSARSIYGTISP-ALANLSSLIVLDLSKNFFQ 114
C+ + V C + E+ L +I I P A + L +DLS N
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS 69
Query: 115 GHIPAEL-GSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173
+ + L L L L N + S L L+ L L NK+ + + F
Sbjct: 70 -ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAF--Q 125
Query: 174 SSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211
+L + L +N L I LR ++ + L N
Sbjct: 126 DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 13/141 (9%)
Query: 152 EYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211
+ L N + IP F + L+ IDLSNN ++ E+ LR+L L+L+ N
Sbjct: 35 TEIRLEQNTIK-VIPPGAF--SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 212 RLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNL 271
++ L+ L L +N + L + + L L L N + T
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT-- 147
Query: 272 EPFFASLANSSNFQELELAGN 292
F+ L Q + LA N
Sbjct: 148 ---FSPL---RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 29/171 (16%), Positives = 54/171 (31%), Gaps = 51/171 (29%)
Query: 384 LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPS-SLGKCVNLEILDLSHNKISGI 442
+ L +N + P +F+ +LRR+ L N +S + + +L L L NKI+ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITEL 95
Query: 443 IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIAL 502
P + F L +L
Sbjct: 96 -PKSL-------------------------------------FEGLF-----------SL 106
Query: 503 ESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQL 553
+ L L+ N + L + L L + N+L +F ++ +
Sbjct: 107 QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 31/132 (23%), Positives = 54/132 (40%), Gaps = 7/132 (5%)
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYLNLSSNHL 464
+ L N + P + L +DLS+N+IS + D GLRSL L L N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLN-SLVLYGNKI 92
Query: 465 DGPLPLEL-SKMDMVLAIDLSFNNLSGSIPPQL-GSCIALESLNLSGNSLEGLLPVSVGQ 522
LP L + + + L+ N ++ + L L+L N L+ + +
Sbjct: 93 TE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 523 LPYLKQFDVSSN 534
L ++ ++ N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 3e-13
Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 35/246 (14%)
Query: 673 SLIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIR 728
++G G FG V + + AVK+L + ++ E ++L +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-CTMVEKRVLALPGKPPFLT 405
Query: 729 IITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ C + + V+ ++ G L H+ V +++A G+ +L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAAEIAIGLFFLQSK 461
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+++ DLK N++LD + +ADFG+ K I + T T CG+
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDG--------VTTKT---FCGT 505
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSLHEWVKRHY 902
YIAPE + D ++FGVLL E++ G+ P D LF S + V Y
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ--SIMEHNVA--Y 561
Query: 903 PHRLDP 908
P +
Sbjct: 562 PKSMSK 567
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 58/241 (24%)
Query: 675 IGSGRFGHVYKG--VLQDNTRIAVKVLDLTTTGE---ITGSFKRECQILKRIR---HRNL 726
IG G +G V+K + +A+K + + T E ++ RE +L+ + H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI--REVAVLRHLETFEHPNV 76
Query: 727 IRIITICSKPDFKA-----LVLPLMSN---GSLENHLYPSHGLSHGLD---LIQLVKICS 775
+R+ +C+ LV + L+ P G+ + QL++
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLR--- 131
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
G+ +LH H +VVH DLKP NIL+ +ADFG+A++ + M
Sbjct: 132 ----GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY----------SFQM 174
Query: 836 SFTSTDGLLCGSVG---YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
+ TS V Y APE + +T D++S G + E+ R+P LF GS
Sbjct: 175 ALTSV-------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFR-GS 222
Query: 893 S 893
S
Sbjct: 223 S 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 64/305 (20%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G + VYKG + + A+K + L + RE +LK ++H N++ + I
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
LV + L+ +L + +++ + + G+AY H KV+
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVL 122
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG---Y 850
H DLKP N+L++E +ADFG+A+ + + V Y
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR----------------AKSIPTKTYDNEVVTLWY 166
Query: 851 IAPEYGMGKRA-STHGDVYSFGVLLLEIVTGR--------------------RPTDVLFH 889
P+ +G ST D++ G + E+ TGR PT+ +
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
S E+ +YP KY + + + ++ +L+ LL Q+
Sbjct: 227 GILSNEEFKTYNYP------------KYRAEALLSHAPRL-DSDGADLLT-KLL--QFEG 270
Query: 950 STRPS 954
R S
Sbjct: 271 RNRIS 275
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 67/246 (27%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHR 724
+GSG +G V + + ++A+K +++ F+ RE +LK ++H
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIK--------KLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 725 NLIRIITI----CSKPDFKA--LVLPLMS---NGSLENHLYPSHGLSHGLDLIQLVKICS 775
N+I ++ + S +F LV+P M + + Q++K
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK---IQYLVYQMLK--- 137
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
G+ Y+H VVH DLKP N+ ++ED + DFG+A+
Sbjct: 138 ----GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---------------- 174
Query: 836 SFTSTDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891
D + G V Y APE + + D++S G ++ E++TG+ LF
Sbjct: 175 ---HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGK 227
Query: 892 SSLHEW 897
L +
Sbjct: 228 DYLDQL 233
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFK-RECQILKRIRHRNLIRIITI 732
IG G +G V+K +D +I A+K + + RE ++LK+++H NL+ ++ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ LV + ++ + L G+ + I + V + H H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NC 123
Query: 793 VHCDLKPSNILLDEDLTALVADFGIA 818
+H D+KP NIL+ + + DFG A
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFA 149
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 64/351 (18%), Positives = 113/351 (32%), Gaps = 108/351 (30%)
Query: 675 IGSGRFGHVYKGVLQD-NTRIAVK--VLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G+G FG V + + R A+K + D RE I+K + H N+I+++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHVNIIKLVD 67
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGL---------------------DLIQL 770
+ P + + + +H L ++
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 771 VKICSDVAE----------------GVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL-VA 813
+K V ++H + H D+KP N+L++ L +
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLC 184
Query: 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI------APEYGMG-KRASTHGD 866
DFG AK + + SV YI APE +G + D
Sbjct: 185 DFGSAKKLIPSEP--------------------SVAYICSRFYRAPELMLGATEYTPSID 224
Query: 867 VYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE----------KAI-A 915
++S G + E++ G +P LF G + +L I++ +
Sbjct: 225 LWSIGCVFGELILG-KP---LF-SGET--------SIDQLVRIIQIMGTPTKEQMIRMNP 271
Query: 916 KYAPQHMPIYYNKVWSDVV-----LELIELGLLCTQYNPSTRPSMLDV-AH 960
Y P K W ++ I+L +Y P R + + AH
Sbjct: 272 HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 50/256 (19%), Positives = 96/256 (37%), Gaps = 64/256 (25%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIR----- 722
+G G F V+ + +NT +A+K++ T E E ++L+R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED------EIKLLQRVNDADNT 78
Query: 723 ---HRNLIRIITICSKPDFKA-------LVLPLMSNGSLENHL--YPSHGLSHGLDLIQL 770
I+ + + K +V ++ +L + Y G+ L ++
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIP--LIYVK- 134
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL------VADFGIAKLVKGI 824
+I + G+ Y+H ++H D+KP N+L++ + +AD G A
Sbjct: 135 -QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----C 186
Query: 825 DESVNCANDSMS-FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
+ N + Y +PE +G D++S L+ E++TG
Sbjct: 187 WYDEHYTNSIQTRE------------YRSPEVLLGAPWGCGADIWSTACLIFELITG--- 231
Query: 884 TDVLFHDGSSLHEWVK 899
D LF + H + K
Sbjct: 232 -DFLF-EPDEGHSYTK 245
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 28/237 (11%)
Query: 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
I +S P E L + + ++ + ++
Sbjct: 3 ITVSTPIKQI-FPDDAFAETIKAN---LKKKSVT-DAV-TQNELNSIDQIIANNSDIK-S 55
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
+ I +P +++L L N ++ L +N L L GN L +P+
Sbjct: 56 VQG--IQYLPNVRYLALGGNKL------HDI-SALKEL---TNLTYLILTGNQLQS-LPN 102
Query: 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISN-LVNLTLLNLSSNLLNGTIPHELC-LMSKLE 358
+ D TNL ++ L N + +P + + L NLT LNL+ N L ++P + ++ L
Sbjct: 103 GVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLT 160
Query: 359 RVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGN 413
+ LS N L +P F + L L L +N+L S+PD F L+ L+ + L+ N
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 49/187 (26%), Positives = 73/187 (39%), Gaps = 14/187 (7%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340
+ + L ++ + + ++ QI + + I K I L N+ L L
Sbjct: 18 FAETIKANLKKKSVTDAVT---QNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGG 72
Query: 341 NLLNGTIP--HELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398
N L+ I EL + L + L+ N L F + +L L L +N+L
Sbjct: 73 NKLH-DISALKEL---TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV 128
Query: 399 FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV-AGLRSLKLYL 457
F L+ L L L N L K NL LDLS+N++ +P V L LK L
Sbjct: 129 FDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLK-DL 186
Query: 458 NLSSNHL 464
L N L
Sbjct: 187 RLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 44/190 (23%), Positives = 69/190 (36%), Gaps = 39/190 (20%)
Query: 74 NSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELG---SLIRLKQL 130
N N + ++ + I + L ++ L L N ++ L L L
Sbjct: 38 NELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYL 90
Query: 131 SLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG 190
L+ N LQ L L+ L L N+L +P +F + T+L Y++L++N L
Sbjct: 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF--DKLTNLTYLNLAHNQLQ- 146
Query: 191 EIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMP 250
L F ++L L LDL N LP + K+
Sbjct: 147 --------SLPKGVF-----DKLT-----------NLTELDLSYNQLQ-SLPEGVFDKLT 181
Query: 251 QLQFLYLSYN 260
QL+ L L N
Sbjct: 182 QLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L L+ + + L++L L L +N Q L L L+L+ N LQ
Sbjct: 89 YLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 141 IPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188
+P + L L LDL N+L +P +F + T L+ + L N L
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQL-QSLPEGVF--DKLTQLKDLRLYQNQL 193
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 16/174 (9%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIP----HELCL 353
+PS I + L L + L LT LNL N L T+ +L
Sbjct: 29 VPSGIPADTEKL---DLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDL-- 82
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS-FANLSQLRRLLLYG 412
++L + L+NN L+ F + L L L N+L S+P F L++L+ L L
Sbjct: 83 -TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140
Query: 413 NHLSGTIPSSL-GKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
N L +IP+ K NL+ L LS N++ + L L+ + L N D
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQ-TITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 25/169 (14%)
Query: 253 QFLYLSYNDFVSHDGNTNLEPF-FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQ 311
+ L L L F L + L L N L + + + D T L
Sbjct: 38 EKLDLQSTGL------ATLSDATFRGL---TKLTWLNLDYNQLQT-LSAGVFDDLTELGT 87
Query: 312 IHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPH----ELCLMSKLERVYLSNNS 366
+ L N + +P + +L L L L N L ++P L +KL+ + L+ N
Sbjct: 88 LGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL---TKLKELRLNTNQ 142
Query: 367 LSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGN 413
L IP+ AF + +L L LS N+L S+P +F L +L+ + L+GN
Sbjct: 143 LQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 19/184 (10%)
Query: 65 CNWSG--VKCNNSRNKVV---------ELDLSARSIYGTISPALANLSSLIVLDLSKNFF 113
CN V C V +LDL + + L+ L L+L N
Sbjct: 12 CNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71
Query: 114 QGHIPAEL-GSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFC 171
Q + A + L L L L+ N L +P + L QL+ L LG N+L +P +F
Sbjct: 72 QT-LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVF- 127
Query: 172 SNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLD 231
+ T L+ + L+ N L IP +L NL+ L L +N+L A KL+ +
Sbjct: 128 -DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTIT 185
Query: 232 LESN 235
L N
Sbjct: 186 LFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 15/160 (9%)
Query: 106 LDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEI 165
LDL A L +L L+L +N LQ L +L L L NN+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 166 PIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANS- 224
P+ +F + T L + L N L +P L L+ L L +N+L Q++
Sbjct: 99 PLGVF--DHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-----QSIPAGA 150
Query: 225 ----SKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
+ L+ L L +N +P ++ +LQ + L N
Sbjct: 151 FDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 38/137 (27%), Positives = 58/137 (42%), Gaps = 5/137 (3%)
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
++L L L + L +L +L+L N+L + +F + T L + L+NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVF--DDLTELGTLGLANNQ 94
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
L +PL L L L L N+L +KL+ L L +N +P+
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 248 KMPQLQFLYLSYNDFVS 264
K+ LQ L LS N S
Sbjct: 153 KLTNLQTLSLSTNQLQS 169
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 67/279 (24%), Positives = 107/279 (38%), Gaps = 64/279 (22%)
Query: 643 EDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDL 701
A P + Q+ + + S IG G +G V + R+A+K +
Sbjct: 3 HHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS- 61
Query: 702 TTTGEITGSFK---------RECQILKRIRHRNLIRIITICSKPDFKA-----LVLPLMS 747
F+ RE +IL R RH N+I I I P + +V LM
Sbjct: 62 --------PFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM- 112
Query: 748 NGSLENHLYPSHGLSHGLD-----LIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNI 802
+ L + LS+ D L Q+++ G+ Y+H V+H DLKPSN+
Sbjct: 113 -ETDLYKLLKTQHLSN--DHICYFLYQILR-------GLKYIH---SANVLHRDLKPSNL 159
Query: 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGK 859
LL+ + DFG+A++ + G L V Y APE +
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHD-------------HTGFLTEYVATRWYRAPEIMLNS 206
Query: 860 RASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897
+ T D++S G +L E+++ R +F L +
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLDQL 241
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 59/256 (23%), Positives = 101/256 (39%), Gaps = 86/256 (33%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHR 724
+GSG +G V V + ++A+K ++ F+ RE ++LK +RH
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIK--------KLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 725 NLIRIITI----CSKPDFKA--LVLPLM--------SNGSLENH-----LYPSHGLSHGL 765
N+I ++ + + DF LV+P M + L +Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY--------- 135
Query: 766 DLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825
Q++K G+ Y+H ++H DLKP N+ ++ED + DFG+A+
Sbjct: 136 ---QMLK-------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------ 176
Query: 826 ESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGR 881
D + G V Y APE + T D++S G ++ E++TG+
Sbjct: 177 -------------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
Query: 882 RPTDVLFHDGSSLHEW 897
LF L +
Sbjct: 224 ----TLFKGSDHLDQL 235
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 26/94 (27%), Positives = 39/94 (41%), Gaps = 2/94 (2%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNSLSGEIPSAFGDIPHL 381
H+ NLT L + + + L + +L + + + L P AF P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 382 GLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHL 415
L+LS N L + LS L+ L+L GN L
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 23/99 (23%), Positives = 38/99 (38%), Gaps = 2/99 (2%)
Query: 340 SNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPDS 398
+ H L L +Y+ N + + L L + K+ L PD+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 399 FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHN 437
F +L RL L N L ++ + ++L+ L LS N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 23/103 (22%), Positives = 37/103 (35%), Gaps = 3/103 (2%)
Query: 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSGTIPSS 422
+ + +L L + + + L +LR L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
L L+LS N + + V GL SL+ L LS N L
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQ-ELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 29/136 (21%), Positives = 43/136 (31%), Gaps = 11/136 (8%)
Query: 95 PALANLSSLIVLDLSKNFFQGHIPAE-LGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEY 153
L +L L + H+ L L L+ L++ + L+ P +L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
L+L N L + SLQ + LS N PL C LR L+
Sbjct: 85 LNLSFNALE-SLSWKTV---QGLSLQELVLSGN------PLHCSCALRWLQRWEEEGLGG 134
Query: 214 VGQVPQALANSSKLEW 229
V + L
Sbjct: 135 VPEQKLQCHGQGPLAH 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 16/114 (14%), Positives = 32/114 (28%), Gaps = 13/114 (11%)
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
+ L + L L +E+ L + + +L+ L + + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIH-----LDCNL 318
F L L+ N L + + LS + + C L
Sbjct: 76 -----FHFT---PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 16/95 (16%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
L L L + N + + + + L+ + + + L +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDL--RGLGELRNLTIVKSGLR-FVAPDAFHFT 79
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
L L L N L + + S L+ L L N
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 2/88 (2%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+L + + N + L++ L LR L + + L P A + +L L+L N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFV 263
L + + + LQ L LS N
Sbjct: 91 ALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 3e-05
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 6/99 (6%)
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQ-LGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
L L +L + + + L L +L L + + L + F
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT-- 79
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLV 214
L ++LS N+L + + +L+ L+L N L
Sbjct: 80 PRLSRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 14/81 (17%), Positives = 30/81 (37%), Gaps = 2/81 (2%)
Query: 481 IDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
+ + + + L L +L + + L + P + P L + ++S N L
Sbjct: 36 LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL-ES 94
Query: 540 IPQSFQASPTLKQLNFSFNKF 560
+ +L++L S N
Sbjct: 95 LSWKTVQGLSLQELVLSGNPL 115
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 65/234 (27%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIRHR--- 724
+IG G FG V K + + +A+K++ E +IL+ +R +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE------EIRILEHLRKQDKD 156
Query: 725 NLIRIITICSKPDFKA---LVLPLMSNGSLENHLY------PSHGLSHGLDLIQLVKICS 775
N + +I + F+ + L+S N LY G S L L++ K
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLS----MN-LYELIKKNKFQGFS--LPLVR--KFAH 207
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILL-DEDLTAL-VADFGIAKLVKGIDESVNCAND 833
+ + + LH + +++HCDLKP NILL + + + V DFG + C
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS-----------CYEH 253
Query: 834 SMSFTSTDGLLCGSVGYI------APEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
+T YI APE +G R D++S G +L E++TG
Sbjct: 254 QRVYT-----------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 35/245 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKR-IRHRNLIR 728
++G G FG V+ + + A+K L + ++ E ++L H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLSLAWEHPFLTH 82
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + V+ ++ G L H+ H L + +++ G+ +LH
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQFLHSK- 137
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+V+ DLK NILLD+D +ADFG+ K + + T+T CG+
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGD--------AKTNT---FCGTP 182
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP-----TDVLFHDGSSLHEWVKRHYP 903
YIAPE +G++ + D +SFGVLL E++ G+ P + LFH S + YP
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPF--YP 238
Query: 904 HRLDP 908
L+
Sbjct: 239 RWLEK 243
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 59/246 (23%), Positives = 103/246 (41%), Gaps = 66/246 (26%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFK---------RECQILKRIRHR 724
+GSG +G V + R+AVK +++ F+ RE ++LK ++H
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVK--------KLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 725 NLIRIITI----CSKPDFKA--LVLPLMSNGSLENHLYPSHGLSHG---LDLIQLVKICS 775
N+I ++ + S +F LV LM L N + L+ + Q+++
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILR--- 143
Query: 776 DVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSM 835
G+ Y+H ++H DLKPSN+ ++ED + DFG+A+
Sbjct: 144 ----GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------------- 180
Query: 836 SFTSTDGLLCGSVG---YIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891
T + G V Y APE + + D++S G ++ E++TGR LF
Sbjct: 181 ---HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGT 233
Query: 892 SSLHEW 897
+ +
Sbjct: 234 DHIDQL 239
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 16/107 (14%)
Query: 777 VAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMS 836
+A + YLH +V+ DLKP NILLD ++ DFG+ K I+ + S
Sbjct: 148 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHN--------S 194
Query: 837 FTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
TST CG+ Y+APE + D + G +L E++ G P
Sbjct: 195 TTST---FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 60/302 (19%), Positives = 120/302 (39%), Gaps = 39/302 (12%)
Query: 633 DLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPS-----SLIGSGRFGHVYKGV 687
D+ + E + ++ ++ +A+ +IG G + V
Sbjct: 13 DIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVR 72
Query: 688 LQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA-LV 742
L+ RI A++V+ + +I + E + ++ + + + C + + + V
Sbjct: 73 LKKTDRIYAMRVVKKELVNDDEDID-WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131
Query: 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHHSPIKVVHCDLKPSN 801
+ ++ G L H+ L + + ++++ + YLH +++ DLK N
Sbjct: 132 IEYVNGGDLMFHMQRQRKLP-----EEHARFYSAEISLALNYLHER---GIIYRDLKLDN 183
Query: 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA 861
+LLD + + D+G+ K G+ TST CG+ YIAPE G+
Sbjct: 184 VLLDSEGHIKLTDYGMCKE--GLRPG--------DTTST---FCGTPNYIAPEILRGEDY 230
Query: 862 STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQH 921
D ++ GVL+ E++ GR P F S + + I+EK I + P+
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNTEDYLFQVILEKQI-RI-PRS 284
Query: 922 MP 923
+
Sbjct: 285 LS 286
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRI-RHRNLIR 728
++G G FG V +++ + AVKVL + ++ E +IL H L +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-CTMTEKRILSLARNHPFLTQ 88
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ PD V+ ++ G L H+ S + +++ + +LH
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEIISALMFLHDK- 143
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+++ DLK N+LLD + +ADFG+ K GI T+T CG+
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNG--------VTTAT---FCGTP 188
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
YIAPE D ++ GVLL E++ G P
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 45/285 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G + V L+ RI A+KV+ + +I + E + ++ + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID-WVQTEKHVFEQASNHPFLVG 74
Query: 730 ITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHH 787
+ C + + + V+ ++ G L H+ L + + ++++ + YLH
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-----EEHARFYSAEISLALNYLHER 129
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+++ DLK N+LLD + + D+G+ K G+ TST CG+
Sbjct: 130 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPG--------DTTST---FCGT 173
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
YIAPE G+ D ++ GVL+ E++ GR P F S + +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNTEDYLFQ 229
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
I+EK I + S +++ L +P R
Sbjct: 230 VILEK----------QIRIPRSLSVKAASVLK-SFL--NKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 674 LIGSGRFGHVYKGVLQDNTRI-AVKVL---DLTTTGEITGSFKRECQILKRIRHRNLIRI 729
++G G FG V + + AVK+L + ++ E ++L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-CTMVEKRVLALPGKPPFLTQ 85
Query: 730 ITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI-CSDVAEGVAYLHHH 787
+ C + + V+ ++ G L H+ +++A G+ +L
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-----EPHAVFYAAEIAIGLFFLQSK 140
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
+++ DLK N++LD + +ADFG+ K I + T T CG+
Sbjct: 141 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDG--------VTTKT---FCGT 184
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883
YIAPE + D ++FGVLL E++ G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 62/510 (12%), Positives = 153/510 (30%), Gaps = 54/510 (10%)
Query: 52 HALESWNSTDVHVCNWSGVKCNNSRNK---VVELDLSARSIYGTISPALANLSSLIVLDL 108
+ +E W V + N V + V ++L + + + +V D
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFN---------LVPDG 88
Query: 109 SKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLG-SLHQLEYLDLGNNKLVGEIPI 167
+ I A S L+++ L + + S + L L + + +
Sbjct: 89 WGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGL 148
Query: 168 PIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFL----LLWSNRLVGQ--VPQAL 221
+ +L+ +DL + + L + V + + +
Sbjct: 149 AAIAATCR-NLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207
Query: 222 ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANS 281
L+ L L + E + ++ + PQL+ L +L+
Sbjct: 208 TRCPNLKSLKL-NRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDV--YSGLSVALSGC 264
Query: 282 SNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL-DCNLIYGKIPPHISNLVNLTLLNLSS 340
+ L + + +P++ + + L ++L + + + L L +
Sbjct: 265 KELRCLSGFWDAVPAYLPAV-YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD 323
Query: 341 NLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA 400
+ + + L + + + + GL+ +S
Sbjct: 324 YIEDAGLEVLASTCKDLRELRVFP--SEPFVMEPNVALTEQGLVSVSMG----------- 370
Query: 401 NLSQLRRLLLYGNHLSGTIPSSLGK-CVNLEILDLSHNKISGIIPSDV----AGLRSL-- 453
+L +L + ++ ++ + N+ L + + G ++
Sbjct: 371 -CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVE 429
Query: 454 ---KL-YLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG-SIPPQLGSCIALESLNLS 508
L L+LS D + + + ++F S + L C +L L +
Sbjct: 430 HCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489
Query: 509 GNSL--EGLLPVSVGQLPYLKQFDVSSNRL 536
+ LL + +L ++ +SS +
Sbjct: 490 DCPFGDKALL-ANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 69/442 (15%), Positives = 136/442 (30%), Gaps = 50/442 (11%)
Query: 74 NSRNKVVELDLSARSIY-GTISPALANLSSLIVLDLSK--NFFQGHIPAELGSLIRLKQL 130
+S + E+ L + + + + VL LS F + A + LK+L
Sbjct: 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKEL 161
Query: 131 SLSWNSLQGKIPSQLGSL----HQLEYLDLGN-NKLVGEIPIPIFCSNSSTSLQYIDLSN 185
L + + L L L++ V + + +L+ + L+
Sbjct: 162 DLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC-PNLKSLKLNR 220
Query: 186 N-SLTGEIPLKNEC----ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240
L L EL + + + AL+ +L L +
Sbjct: 221 AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280
Query: 241 LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300
LP+ + S +L L LSY S+D L Q L + + +
Sbjct: 281 LPA-VYSVCSRLTTLNLSYATVQSYDL-------VKLLCQCPKLQRLWVL-DYIEDAGLE 331
Query: 301 IIGDLSTNLVQIHL-DCNLIYGKIPPHIS---------NLVNLTLLNLS-SNLLNGTIPH 349
++ +L ++ + + ++ L + + N +
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391
Query: 350 ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409
+ R L I D L LD+ + + LRRL
Sbjct: 392 IARNRPNMTRFRLCI------IEPKAPDYLTLEPLDIGFGAIV-------EHCKDLRRLS 438
Query: 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI-IPSDVAGLRSLKLYLNLSS-NHLDGP 467
L G +E+L ++ S + + ++G SL+ L + D
Sbjct: 439 LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR-KLEIRDCPFGDKA 497
Query: 468 LPLELSKMDMVLAIDLSFNNLS 489
L SK++ + ++ +S ++S
Sbjct: 498 LLANASKLETMRSLWMSSCSVS 519
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 61/430 (14%), Positives = 136/430 (31%), Gaps = 54/430 (12%)
Query: 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE-LRNLRF 205
+L QL+ + + + + + L+ + L S L + R ++
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARAD-DLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168
Query: 206 LLLWSNRLVGQVPQALA----NSSKLEWLDL---ESNMFSGELPSEIISKMPQLQFLYLS 258
LL+ + + + L +++ LE L+ E S + I L + +
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228
Query: 259 YNDFVSHDG----------------NTNLEPFFASLANSSNFQELELAGNNLGGMIPSII 302
+ + G N ++ + + L + +G I+
Sbjct: 229 DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPIL 288
Query: 303 GDLSTNLVQIHL-DCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVY 361
+ + ++ L L I NL +L + + + + +L+R+
Sbjct: 289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348
Query: 362 LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS----G 417
+ + + G + GL+ L++ +L + +Y + ++
Sbjct: 349 IERGADEQGMEDEEGLVSQRGLIALAQ------------GCQELEYMAVYVSDITNESLE 396
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSD------VAGLRSLK-LYLNLSSNHL-DGPLP 469
+I + L + ++ L + +P D + G + L+ L L D L
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456
Query: 470 LELSKMDMVLAIDLSFNNLS-GSIPPQLGSCIALESLNLSGNSL--EGLLPVSVGQLPYL 526
V + L + S + C L+ L + G + V +LP L
Sbjct: 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA-VTKLPSL 515
Query: 527 KQFDVSSNRL 536
+ V R
Sbjct: 516 RYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 57/387 (14%), Positives = 112/387 (28%), Gaps = 41/387 (10%)
Query: 97 LANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156
N SL+ + + +F + + L++ + +P + +L L
Sbjct: 216 ARNCRSLVSVKVG-DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274
Query: 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQ 216
+G +PI ++ ++ +DL L E + NL L +
Sbjct: 275 LGLSYMGPNEMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG 333
Query: 217 VPQALANSSKLEWLDLESNMFSGELPSE-----------IISKMPQLQFLYLSYNDFVSH 265
+ +L+ L +E + E + +L+++ + +D
Sbjct: 334 LEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI--- 390
Query: 266 DGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP 325
N +LE L N +F+ + L I DL + L
Sbjct: 391 -TNESLESIGTYLKNLCDFRLVLLDR-------EERITDLPLDNGVRSLLIGC------- 435
Query: 326 HISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGE-IPSAFGDIPHLGLL 384
L L + + + + + L S E + P+L L
Sbjct: 436 --KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKL 493
Query: 385 DLSKNKLS-GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGK---CVNLEILDLSHNKIS 440
++ S +I + L LR L + G S T + N+E++
Sbjct: 494 EMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEV 553
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHLDGP 467
+ S L G
Sbjct: 554 NQQGEIREMEHPAHILAYYS---LAGQ 577
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 55/230 (23%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIRHR--- 724
SLIG G FG V K + +A+K++ +I E ++L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI------EVRLLELMNKHDTE 113
Query: 725 NLIRIITICSKPDFKA---LVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVAE 779
I+ + F+ LV ++S +L + L G+S L+L + K +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVS--LNLTR--KFAQQMCT 168
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILL-DEDLTAL-VADFGIAKLVKGIDESVNCANDSMSF 837
+ +L + ++HCDLKP NILL + +A+ + DFG + C +
Sbjct: 169 ALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----------CQLGQRIY 216
Query: 838 TSTDGLLCGSVGYI------APEYGMGKRASTHGDVYSFGVLLLEIVTGR 881
YI +PE +G D++S G +L+E+ TG
Sbjct: 217 Q-----------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 73/262 (27%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+ +G G G V+ V + R+A+K + LT + + RE +I++R+ H N++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIV 71
Query: 728 RIITI------------CSKPDFKA--LVLPLM---------SNGSLENH----LYPSHG 760
++ I S + + +V M LE H +Y
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY---- 127
Query: 761 LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAK 819
QL++ G+ Y+H V+H DLKP+N+ ++ EDL + DFG+A+
Sbjct: 128 --------QLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVG---YIAPEYGMGKRASTHG-DVYSFGVLLL 875
++ S G L + Y +P + T D+++ G +
Sbjct: 170 IMD-------------PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 876 EIVTGRRPTDVLFHDGSSLHEW 897
E++TG+ LF L +
Sbjct: 217 EMLTGK----TLFAGAHELEQM 234
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 26/129 (20%), Positives = 50/129 (38%), Gaps = 9/129 (6%)
Query: 336 LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI 395
+ L++ L+ + + L + I + + +D S N++ +
Sbjct: 2 VKLTAELIE-QAAQYTNA-VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 396 PDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL 455
D F L +L+ LL+ N + +L L L++N + + D+ L SLK
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKS 114
Query: 456 --YLNLSSN 462
YL + N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 27/131 (20%), Positives = 49/131 (37%), Gaps = 9/131 (6%)
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
+ L+ ++ + Q + + LDL K IP+ + ID S+N +
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYK----IPVIENLGATLDQFDAIDFSDNEIR 55
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
L LR L+ LL+ +NR+ L L L +N + ++ +
Sbjct: 56 ---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112
Query: 250 PQLQFLYLSYN 260
L +L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 6/118 (5%)
Query: 94 SPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEY 153
+ N LDL I +L + + S N ++ K+ L +L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211
L + NN++ I + L + L+NNSL L L++L +L + N
Sbjct: 69 LLVNNNRICR---IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 28/118 (23%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 276 ASLANSSNFQELELAGNNLGGMIPSI--IGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333
A N+ +EL+L G IP I +G I N I K+ L L
Sbjct: 13 AQYTNAVRDRELDLRGYK----IPVIENLGATLDQFDAIDFSDNEI-RKL-DGFPLLRRL 66
Query: 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLS--GEIPSAFGDIPHLGLLDLSKN 389
L +++N + + L + L+NNSL G++ + L L + +N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 24/140 (17%), Positives = 42/140 (30%), Gaps = 31/140 (22%)
Query: 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLA 480
+ V LDL KI I L ++ S N +
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGAT-LDQFD-AIDFSDNEI---------------- 54
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL--FG 538
L G L++L ++ N + + LP L + +++N L G
Sbjct: 55 -----RKLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 539 EIPQSFQASPTLKQLNFSFN 558
++ + +L L N
Sbjct: 105 DL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 32/114 (28%), Positives = 42/114 (36%), Gaps = 9/114 (7%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIP--AELGSLIRLKQLSLSWN 135
+ ELDL I I A L +D S N I L RLK L ++ N
Sbjct: 20 RDRELDLRGYKI-PVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNN 74
Query: 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
+ +L L L L NN LV + S SL Y+ + N +T
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL--KSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLL 516
+ L++ ++ + + +DL + I + ++++ S N + L
Sbjct: 2 VKLTAELIE--QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 517 PVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS--GNISNKGAFSSLT 574
L LK V++NR+ QA P L +L + N G++ + SLT
Sbjct: 59 GFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 575 IASFQGN 581
N
Sbjct: 117 YLCILRN 123
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 34/181 (18%), Positives = 76/181 (41%), Gaps = 18/181 (9%)
Query: 386 LSKNKLSGSIPDSFANLSQLRRLLLYGNHLS-GTIPSSLGKCVNLEILDLSHNKISGIIP 444
K+ + ++ ++ L+G + ++L + L LS N I I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-- 63
Query: 445 SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALES 504
S ++G+ +L+ L+L N + L+ + D + + +S+N ++ S+ + + L
Sbjct: 64 SSLSGMENLR-ILSLGRNLIKKIENLD-AVADTLEELWISYNQIA-SLSG-IEKLVNLRV 119
Query: 505 LNLSGNSLEGLLPVS-VGQLPYLKQFDVSSNRLFGEIPQSFQAS----------PTLKQL 553
L +S N + + + L L+ ++ N L+ + ++ S P LK+L
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
Query: 554 N 554
+
Sbjct: 180 D 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 42/206 (20%)
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSN--NSLSGEIPSAFGDIPHLGLLDLSKNKLSGS 394
+ + + + ++ E+V L + ++ + + L LS N +
Sbjct: 5 TTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-K 62
Query: 395 IPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454
I S + + LR L L N + I + LE L +S+N+I+ + S + L +L+
Sbjct: 63 I-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118
Query: 455 LYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514
L +S+N + ++ +L + LE L L+GN L
Sbjct: 119 -VLYMSNNKITNWGEID-----------------------KLAALDKLEDLLLAGNPLYN 154
Query: 515 LLPVS----------VGQLPYLKQFD 530
+ V +LP LK+ D
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 34/156 (21%)
Query: 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLS 368
V++H I K+ +S L L LS+N + K+ SLS
Sbjct: 27 KVELHGMIPPI-EKMDATLSTLKACKHLALSTNNI-----------EKIS-------SLS 67
Query: 369 GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVN 428
G + +L +L L +N + I + A L L + N ++ ++ S + K VN
Sbjct: 68 G--------MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVN 116
Query: 429 LEILDLSHNKISGIIPSDVAGLRSLKL--YLNLSSN 462
L +L +S+NKI+ ++ L +L L L+ N
Sbjct: 117 LRVLYMSNNKITNW--GEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 30/161 (18%)
Query: 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345
EL + M ++ + L N I KI +S + NL +L+L NL+
Sbjct: 29 ELHGMIPPIEKMDATL--STLKACKHLALSTNNI-EKIS-SLSGMENLRILSLGRNLIK- 83
Query: 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
I + + LE +++S N ++ + S + +L +L +S NK++ ++ + +L
Sbjct: 84 KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT-----NWGEIDKL 136
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSD 446
L LE L L+ N + +
Sbjct: 137 AAL------------------DKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 42/185 (22%), Positives = 69/185 (37%), Gaps = 24/185 (12%)
Query: 71 KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQL 130
+ + VEL I + L+ L + L LS N + I + L + L+ L
Sbjct: 19 SVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75
Query: 131 SLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG 190
SL N ++ KI + LE L + N++ I +L+ + +SNN +T
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGI-----EKLVNLRVLYMSNNKITN 129
Query: 191 EIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMP 250
+ L L LLL N L + A S E++ ++P
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI---------------EVVKRLP 174
Query: 251 QLQFL 255
L+ L
Sbjct: 175 NLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 25/147 (17%), Positives = 56/147 (38%), Gaps = 14/147 (9%)
Query: 129 QLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS--TSLQYIDLSNN 186
+L ++ K+ + L +L ++L L N + +I S+ S +L+ + L N
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI------SSLSGMENLRILSLGRN 80
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEII 246
+ L + L L + N++ + L L + +N + + +
Sbjct: 81 LIKKIENLDAVAD--TLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 247 SKMPQLQFLYLSYNDFVSHDGNTNLEP 273
+ + +L+ L L+ N + N
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 2/108 (1%)
Query: 358 ERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG 417
+YL N + +P + HL L+DLS N++S SF+N++QL L+L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
P + +L +L L N IS + L +L +L + +N L
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALS-HLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 6/99 (6%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P I ++T L L N +P EL L + LSNN +S +F ++ L
Sbjct: 25 LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 383 LLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSGTIP 420
L LS N+L IP +F L LR L L+GN +S +P
Sbjct: 82 TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 37/149 (24%), Positives = 60/149 (40%), Gaps = 19/149 (12%)
Query: 65 CNWSGVKCNNSRNKVV---------ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQG 115
C + V+C+N KV+ EL L + L+N L ++DLS N
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIST 68
Query: 116 HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
++ +L L LS+N L+ P L L L L N + +P F N
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAF--NDL 125
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLR 204
++L ++ + N PL +C ++ L
Sbjct: 126 SALSHLAIGAN------PLYCDCNMQWLS 148
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 7/109 (6%)
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
+L L N +P +L + L +DL NN++ + F ++ T L + LS N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSF--SNMTQLLTLILSYNR 89
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ-ALANSSKLEWLDLESN 235
L IP + L++LR L L N + VP+ A + S L L + +N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 42/165 (25%), Positives = 65/165 (39%), Gaps = 41/165 (24%)
Query: 171 CSNSSTSLQYIDLSNNSLT---GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL 227
C+ T + SN L IP R++ L L N+ VP+ L+N L
Sbjct: 8 CTCLDTV---VRCSNKGLKVLPKGIP-------RDVTELYLDGNQFT-LVPKELSNYKHL 56
Query: 228 EWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVS-----HDGNTNLEPFFASLANSS 282
+DL +N S L ++ S M QL L LSYN DG +L
Sbjct: 57 TLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSL----------- 104
Query: 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHL-------DCNLIY 320
+ L L GN++ ++P + + L + + DCN+ +
Sbjct: 105 --RLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPLYCDCNMQW 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 7/111 (6%)
Query: 355 SKLERVYLSNNSLS-GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
S ++ + L N+ + G++ + L L L+ SI + L++L++L L N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDN 74
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL--YLNLSSN 462
+SG + KC NL L+LS NKI + S + L+ L+ L+L +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 5/114 (4%)
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387
S++ L L N SN G + +LE + N L+ I + + L L+LS
Sbjct: 17 SDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSG-TIPSSLGKCVNLEILDLSHNKIS 440
N++SG + L L L GN + + L K NL+ LDL + +++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 24/114 (21%), Positives = 43/114 (37%), Gaps = 5/114 (4%)
Query: 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFL 206
+ ++ L L N++ ++ L+++ N LT + N +L L+ L
Sbjct: 15 TPSDVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKL 69
Query: 207 LLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
L NR+ G + L L+L N E + K+ L+ L L
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 29/135 (21%), Positives = 46/135 (34%), Gaps = 10/135 (7%)
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLST--NLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
S+ +EL L +N + G L + + I ++ L L L
Sbjct: 15 TPSDVKELVL--DNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLE 70
Query: 338 LSSNLLNGTIPHELCLMSKLERVYLSNNSLSG-EIPSAFGDIPHLGLLDLSKN---KLSG 393
LS N ++G + L + LS N + + +L LDL L+
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 394 SIPDSFANLSQLRRL 408
+ F L QL L
Sbjct: 131 YRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 26/161 (16%), Positives = 47/161 (29%), Gaps = 55/161 (34%)
Query: 401 NLSQLRRLLLYGNHLS-GTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459
S ++ L+L + + G + + LE L + ++ +A L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLN----- 64
Query: 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519
L+ L LS N + G L V
Sbjct: 65 -----------------------------------------KLKKLELSDNRVSGGLEVL 83
Query: 520 VGQLPYLKQFDVSSNRL--FGEIPQSFQASPTLKQLNFSFN 558
+ P L ++S N++ I + + LK L+
Sbjct: 84 AEKCPNLTHLNLSGNKIKDLSTI-EPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 29/114 (25%), Positives = 42/114 (36%), Gaps = 5/114 (4%)
Query: 77 NKVVELDLSARSI-YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWN 135
+ V EL L G + L L I A L L +LK+L LS N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDN 74
Query: 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
+ G + L +L+L NK+ I +L+ +DL N +T
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL--ENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 26/108 (24%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGN---SLEGLLPVSVGQLPYLKQFDVSSNR 535
L +D S +N G + LE L+ S+ L +L LK+ ++S NR
Sbjct: 22 LVLDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIANL-----PKLNKLKKLELSDNR 75
Query: 536 LFGEIPQSFQASPTLKQLNFSFNKFS--GNISNKGAFSSLTIASFQGN 581
+ G + + P L LN S NK I +L
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 12/120 (10%)
Query: 223 NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSS 282
S ++ L L+++ + + + +L+FL S L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN----------LPKLN 64
Query: 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYG-KIPPHISNLVNLTLLNLSSN 341
++LEL+ N + G ++ + NL ++L N I + L NL L+L +
Sbjct: 65 KLKKLELSDNRVSG-GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 7/111 (6%)
Query: 355 SKLERVYLSNNSLS-GEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
+ + + L N + G+I + +L L L L S+ + L +L++L L N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSEN 81
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL--YLNLSSN 462
+ G + K NL L+LS NK+ I S + L+ L+ L+L +
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 308 NLVQIHLD-CNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNS 366
+ ++ LD C GKI + VNL L+L + L ++ + L + KL+++ LS N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 367 LSGEIPSAFGDIPHLGLLDLSKNKLSG-SIPDSFANLSQLRRLLLYGN---HLSGTIPSS 422
+ G + +P+L L+LS NKL S + L L+ L L+ +L+ S
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESV 142
Query: 423 LGKCVNLEILD 433
L LD
Sbjct: 143 FKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 136 SLQGKIPSQLG--SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP 193
++ +I +L + + L L N K + +L+++ L N L
Sbjct: 9 DMKRRIHLELRNRTPAAVRELVLDNCKS--NDGKIEGLTAEFVNLEFLSLINVGLIS--- 63
Query: 194 LKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQ 253
+ N +L L+ L L NR+ G + L L+L N E + K+ L+
Sbjct: 64 VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123
Query: 254 FLYLSYN 260
L L
Sbjct: 124 SLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 31/136 (22%), Positives = 49/136 (36%), Gaps = 29/136 (21%)
Query: 401 NLSQLRRLLLYGNHLS-GTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459
+ +R L+L + G I + VNLE L L + + V+ L L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLP---KL 73
Query: 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519
++LS N + G + L LNLSGN L+ + +
Sbjct: 74 KK-------------------LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLE 114
Query: 520 V-GQLPYLKQFDVSSN 534
+L LK D+ +
Sbjct: 115 PLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 32/114 (28%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 77 NKVVELDLS-ARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWN 135
V EL L +S G I A +L L L + + L L +LK+L LS N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSEN 81
Query: 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
+ G + L L +L+L NKL + L+ +DL N +T
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKL--ECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 27/105 (25%), Positives = 41/105 (39%), Gaps = 5/105 (4%)
Query: 479 LAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG 538
L +D +N G I + LE L+L L + + +LP LK+ ++S NR+FG
Sbjct: 29 LVLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLELSENRIFG 85
Query: 539 EIPQSFQASPTLKQLNFSFNKFS--GNISNKGAFSSLTIASFQGN 581
+ + P L LN S NK + L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 12/120 (10%)
Query: 223 NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSS 282
+ + L L++ + + ++ L+FL L +S L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN----------LPKLP 71
Query: 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYG-KIPPHISNLVNLTLLNLSSN 341
++LEL+ N + G ++ + NL ++L N + + L L L+L +
Sbjct: 72 KLKKLELSENRIFG-GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 54/274 (19%), Positives = 96/274 (35%), Gaps = 63/274 (22%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-----HRNL 726
+G G F V+ +Q +A+KV+ + T + E ++LK +R N
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 727 IRIITICSKPDFK---------ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDV 777
++ + DFK +V ++ + L + S+ GL L + KI V
Sbjct: 101 EMVVQLLD--DFKISGVNGTHICMVFEVLGH-HLLKWIIKSNY--QGLPLPCVKKIIQQV 155
Query: 778 AEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSF 837
+G+ YLH + +++H D+KP NILL + + A + + +
Sbjct: 156 LQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 838 TSTDGLLCG---------------------------------SVGYIAPEYGMGKRASTH 864
+T G + Y + E +G +T
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 865 GDVYSFGVLLLEIVTGRRPTDVLF--HDGSSLHE 896
D++S + E+ TG LF H G
Sbjct: 274 ADIWSTACMAFELATGDY----LFEPHSGEEYTR 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 39/244 (15%), Positives = 80/244 (32%), Gaps = 57/244 (23%)
Query: 673 SLIGSGRFGHVYKGV--LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIRHR-- 724
+G G FG V + + + +++A+K++ + E +LK+I+ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL------EINVLKKIKEKDK 78
Query: 725 -NLIRIITICSKPDFKA---LVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVA 778
N + + +F + L+ + L L ++ + +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYP--LPHVR--HMAYQLC 133
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV--------NC 830
+ +LH + ++ H DLKP NIL + + + K + +
Sbjct: 134 HALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 831 ANDSMSFTSTDGLLCGSVGYI------APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
+ T + PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTT-----------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG---- 235
Query: 885 DVLF 888
LF
Sbjct: 236 FTLF 239
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 57.3 bits (137), Expect = 1e-08
Identities = 27/174 (15%), Positives = 60/174 (34%), Gaps = 17/174 (9%)
Query: 91 GTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGS--L 148
+SP L + L L + ++ LK L + L + + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 149 HQLEYLDL--GNNKLVGEIPI----PIFCSNSSTSLQYIDLSNNSLTGEIP--LKNECEL 200
LE L L G + + P+F + +L+++ + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 201 RNLRFLLLWSNRL----VGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMP 250
L + + + L + + L++++++ N S E+ E+ +P
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 37/268 (13%), Positives = 87/268 (32%), Gaps = 54/268 (20%)
Query: 220 ALANSSKLEWLDLESNMFSGELPSEII-------SKMPQLQFLYLSYNDF----VSHDGN 268
L+ + + + GE S+I K + L+ DF +S
Sbjct: 102 KDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQ 161
Query: 269 TNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI- 327
+L P ++ +N + ++G NL + + + + I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKK-------PRPNLKSLEIISGGLPDSVVEDIL 214
Query: 328 -SNLVNLTLLNL---SSNLLNGTIPHELC------LMSKLERVYLSNNSLSGEIPSAFGD 377
S+L NL L L + + L+ + + + + F +
Sbjct: 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274
Query: 378 ---IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434
+P L +D+S L+ + + K +L+ +++
Sbjct: 275 SDILPQLETMDISAGVLTDEGARLLLD--------------------HVDKIKHLKFINM 314
Query: 435 SHNKISGIIPSDVAGLRSLKLYLNLSSN 462
+N +S + ++ +SL + +++S +
Sbjct: 315 KYNYLSDEMKKELQ--KSLPMKIDVSDS 340
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 6e-06
Identities = 21/147 (14%), Positives = 54/147 (36%), Gaps = 14/147 (9%)
Query: 96 ALANLSSLIVLDLSKNFFQGHIPAELGS--LIRLKQLSLSWNSLQGKIPSQLGSLH---- 149
+L L++ + ++ L L++L L +
Sbjct: 188 GKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247
Query: 150 -----QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT---GEIPLKNECELR 201
L++L + + + + S+ L+ +D+S LT + L + +++
Sbjct: 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307
Query: 202 NLRFLLLWSNRLVGQVPQALANSSKLE 228
+L+F+ + N L ++ + L S ++
Sbjct: 308 HLKFINMKYNYLSDEMKKELQKSLPMK 334
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 9e-06
Identities = 28/189 (14%), Positives = 59/189 (31%), Gaps = 23/189 (12%)
Query: 347 IPHELCLMSKLERVYLSNNSLSGEIPSAF--GDIPHL--GLLDLSKNKLSGSIPDSFANL 402
I + E ++ + + S D+ + + L+ K+ G+ S
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190
Query: 403 S--QLRRLLLYGNHLSGTIPSSLG--KCVNLEILDLSHNKISGIIPSDVAGLRSLKL--- 455
L+ L + L ++ + NLE L L D+ R L
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250
Query: 456 -----YLNLSSNHLDGPLPLELSKMDMV---LAIDLSFNNLSGS----IPPQLGSCIALE 503
+L + + + D++ +D+S L+ + + L+
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310
Query: 504 SLNLSGNSL 512
+N+ N L
Sbjct: 311 FINMKYNYL 319
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 54/251 (21%), Positives = 88/251 (35%), Gaps = 67/251 (26%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIRHR--- 724
+G G FG V + + AVKV+ T + +I E ILK+I++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI------EADILKKIQNDDIN 94
Query: 725 --NLIRIIT-------ICSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKI 773
N+++ +C L+ + SL + +G ++ I+
Sbjct: 95 NNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFH--IEDIK--LY 142
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
C ++ + + YL + H DLKP NIL L + L+ +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENIL-------LDDPYFEKSLITVRRVTDGKKIQ 192
Query: 834 SMSFTSTDGLLC--GS--------VGYI------APEYGMGKRASTHGDVYSFGVLLLEI 877
ST L G I APE + D++SFG +L E+
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 878 VTGRRPTDVLF 888
TG +LF
Sbjct: 253 YTG----SLLF 259
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 27/157 (17%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIITI 732
IG G FG + G L N +A+K+ + + E + K++ + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP---QLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHG---LSHGLDL-IQLVKICSDVAEGVAYLHHHS 788
+ A+VL L+ SLE+ L L + IQL+ + Y+H +
Sbjct: 74 GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISR-------MEYVHSKN 125
Query: 789 PIKVVHCDLKPSNILL------DEDLTALVADFGIAK 819
+++ D+KP N L+ + + ++ DF +AK
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHII-DFALAK 158
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 43/132 (32%), Positives = 58/132 (43%), Gaps = 7/132 (5%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVG 163
+L L N P SLI LK+L L N L +P + SL QL LDLG N+L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 164 EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALAN 223
+P +F + L+ + + N LT E+P + L +L L L N+L A
Sbjct: 102 VLPSAVF--DRLVHLKELFMCCNKLT-ELP-RGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 224 SSKLEWLDLESN 235
S L L N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 6/141 (4%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P I N +L L N + P + L+ +YL +N L F + L
Sbjct: 34 VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 383 LLDLSKNKLSGSIPDS-FANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441
+LDL N+L+ +P + F L L+ L + N L+ +P + + +L L L N++
Sbjct: 92 VLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149
Query: 442 IIPSDVAGLRSLKLYLNLSSN 462
I L SL + L N
Sbjct: 150 IPHGAFDRLSSLT-HAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 41/135 (30%), Positives = 66/135 (48%), Gaps = 14/135 (10%)
Query: 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLL 343
Q L L N + + + D NL +++L N + G +P + +L LT+L+L +N L
Sbjct: 43 QILYLHDNQITK-LEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQL 100
Query: 344 NGTIPH----ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-S 398
+P L L+ +++ N L+ E+P + HL L L +N+L SIP +
Sbjct: 101 T-VLPSAVFDRL---VHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGA 154
Query: 399 FANLSQLRRLLLYGN 413
F LS L L+GN
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 2/107 (1%)
Query: 358 ERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG 417
+ +YL +N ++ P F + +L L L N+L F +L+QL L L N L+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL 464
+ + V+L+ L + NK++ +P + L L +L L N L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLT-HLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/122 (28%), Positives = 52/122 (42%), Gaps = 12/122 (9%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLL----NGTIPHELCL 353
+P+ I + L +L N I P +L+NL L L SN L G + L
Sbjct: 34 VPAGIPTNAQIL---YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFDSL-- 87
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
++L + L N L+ + F + HL L + NKL+ +P L+ L L L N
Sbjct: 88 -TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
Query: 414 HL 415
L
Sbjct: 146 QL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 6/133 (4%)
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
+ L L N + P SL L+ L LG+N+L +P+ +F +S T L +DL N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVF--DSLTQLTVLDLGTNQ 99
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
LT +P L +L+ L + N+L ++P+ + + L L L+ N +P
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKS-IPHGAFD 156
Query: 248 KMPQLQFLYLSYN 260
++ L YL N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 23/154 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIITI 732
IGSG FG +Y G + +A+K+ + T E +I K ++ I I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWC 73
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHG---LSHGLDL-IQLVKICSDVAEGVAYLHHHS 788
++ D+ +V+ L+ SLE+ L L L Q++ + Y+H +
Sbjct: 74 GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISR-------IEYIHSKN 125
Query: 789 PIKVVHCDLKPSNILLDEDLTA---LVADFGIAK 819
+H D+KP N L+ + DFG+AK
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 25/156 (16%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIITI 732
IG G FG +++G L +N ++A+K + + E + K + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHG---LSHGLDL-IQLVKICSDVAEGVAYLHHHS 788
+ LV+ L+ SLE+ L + Q++ V +H S
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLAR-------VQSIHEKS 126
Query: 789 PIKVVHCDLKPSNILLDEDLTA-----LVADFGIAK 819
+V+ D+KP N L+ + V DFG+ K
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 30/171 (17%), Positives = 61/171 (35%), Gaps = 38/171 (22%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IGSG FG +Y + A V+ + G E + +R+ ++ I+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE--NGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 733 CSKP-------------------DFKALVLPLMSNGSLENHLYPSHGLSHGLDL---IQL 770
+ ++ +V+ + L+ + L I++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRM 160
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV--ADFGIAK 819
+ + + Y+H + VH D+K +N+LL V AD+G++
Sbjct: 161 LDV-------LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 33/189 (17%), Positives = 58/189 (30%), Gaps = 44/189 (23%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGS-------FKRECQILKRI------ 721
IG G FG V++ + D+T +A+K++ + + GS E I K +
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 722 ---RHRNLIRI--ITICSKPDFKALVLPLM----SNGSLENHL--YPSHGLS-------H 763
R I + + L+ + GS + + L
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 764 GLDLI----------QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813
G+DL I + +A ++ H DL N+LL + +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 814 DFGIAKLVK 822
K
Sbjct: 205 YTLNGKSST 213
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 23/154 (14%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIITI 732
IGSG FG +Y G +Q N +A+K+ ++ T E +I + ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWF 71
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHG---LSHGLDL-IQLVKICSDVAEGVAYLHHHS 788
+ D+ LV+ L+ SLE+ L L L Q++ V ++H S
Sbjct: 72 GVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINR-------VEFVHSKS 123
Query: 789 PIKVVHCDLKPSNILLDEDLTA---LVADFGIAK 819
+H D+KP N L+ A + DFG+AK
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 46/244 (18%), Positives = 82/244 (33%), Gaps = 57/244 (23%)
Query: 673 SLIGSGRFGHVYKGV--LQDNTRIAVKVL----DLTTTGEITGSFKRECQILKRIRHR-- 724
+G G FG V + + +AVK++ E Q+L+ +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS------EIQVLEHLNTTDP 73
Query: 725 -NLIRIITICSKPDFKA---LVLPLMSNGSLENHL--YPSHGLSHGLDLIQLVKICSDVA 778
+ R + + + +V L+ S + + LD I+ K+ +
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFR--LDHIR--KMAYQIC 128
Query: 779 EGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV--------NC 830
+ V +LH + K+ H DLKP NIL + + I + + +
Sbjct: 129 KSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 831 ANDSMSFTSTDGLLCGSVGYI------APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
+D T + APE + S DV+S G +L+E G
Sbjct: 186 YDDEHHST-----------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG---- 230
Query: 885 DVLF 888
+F
Sbjct: 231 FTVF 234
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 38/132 (28%), Positives = 56/132 (42%), Gaps = 6/132 (4%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGE 164
LDL N + L L QL L N LQ L L YL+L N+L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 165 IPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ-ALAN 223
+P +F + T L+ + L+ N L +P +L L+ L L+ N+L VP
Sbjct: 91 LPNGVF--DKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR 146
Query: 224 SSKLEWLDLESN 235
+ L+++ L N
Sbjct: 147 LTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 7/142 (4%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
+P I T L+L +N L ++ L ++YL N L F + L
Sbjct: 22 VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 383 LLDLSKNKLSGSIPDS-FANLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSHNKIS 440
L+LS N+L S+P+ F L+QL+ L L N L ++P + K L+ L L N++
Sbjct: 80 YLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 441 GIIPSDVAGLRSLKLYLNLSSN 462
+ L SL+ Y+ L N
Sbjct: 138 SVPDGVFDRLTSLQ-YIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 43/177 (24%), Positives = 64/177 (36%), Gaps = 29/177 (16%)
Query: 171 CSNSSTSLQYIDLSNNSLT---GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL 227
CS S T+ ++ + T IP +L L +N L + L
Sbjct: 5 CSCSGTT---VECYSQGRTSVPTGIPA-------QTTYLDLETNSLKSLPNGVFDELTSL 54
Query: 228 EWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP-FFASLANSSNFQE 286
L L N LP+ + +K+ L +L LS N +L F L + +E
Sbjct: 55 TQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL------QSLPNGVFDKL---TQLKE 104
Query: 287 LELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPH--ISNLVNLTLLNLSSN 341
L L N L +P + D T L + L N + K P L +L + L N
Sbjct: 105 LALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL--KSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 37/120 (30%), Positives = 56/120 (46%), Gaps = 7/120 (5%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC-LMSK 356
+P+ I +T L L+ N + L +LT L L N L ++P+ + ++
Sbjct: 22 VPTGIPAQTTYL---DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHL 415
L + LS N L F + L L L+ N+L S+PD F L+QL+ L LY N L
Sbjct: 78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 40/133 (30%), Positives = 53/133 (39%), Gaps = 29/133 (21%)
Query: 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNS 187
L L NSL+ L L L LG NKL +P +F N TSL Y++LS N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVF--NKLTSLTYLNLSTNQ 87
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
L L N F ++L +L+ L L +N LP +
Sbjct: 88 LQ---------SLPNGVF-----DKLT-----------QLKELALNTNQLQ-SLPDGVFD 121
Query: 248 KMPQLQFLYLSYN 260
K+ QL+ L L N
Sbjct: 122 KLTQLKDLRLYQN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 29/131 (22%), Positives = 47/131 (35%), Gaps = 28/131 (21%)
Query: 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLL 343
EL L N LG + + +LV++ L N + I P+ ++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI 90
Query: 344 NGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD-SFANL 402
I + F + L L+L N++S + SF +L
Sbjct: 91 K-EISN-----------------------KMFLGLHQLKTLNLYDNQIS-CVMPGSFEHL 125
Query: 403 SQLRRLLLYGN 413
+ L L L N
Sbjct: 126 NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 322 KIPPHISNLVNLTLLNLSSNLLNGTIPHEL-CLMSKLERVYLSNNSLSGEIPSAFGDIPH 380
+IP I ++ T L L+ N L L + L ++ L N L+G P+AF H
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 381 LGLLDLSKNKLSGSIPD-SFANLSQLRRLLLYGNHLSGTIP 420
+ L L +NK+ I + F L QL+ L LY N +S +
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 33/134 (24%), Positives = 59/134 (44%), Gaps = 17/134 (12%)
Query: 65 CNWSGVKCNNSRNKVV---------ELDLSARSIYGTISPA--LANLSSLIVLDLSKNFF 113
C + V C K + EL L+ + G IS L L+ L+L +N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQL 66
Query: 114 QGHIPAELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCS 172
G P +++L L N ++ +I +++ LHQL+ L+L +N++ + F
Sbjct: 67 TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSF-- 122
Query: 173 NSSTSLQYIDLSNN 186
SL ++L++N
Sbjct: 123 EHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 105 VLDLSKNFFQGHIP-AELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLV 162
L L+ N G L L +L L N L I ++ L LG NK+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI- 90
Query: 163 GEIPIPIFCSNSSTSLQYIDLSNNSLT 189
EI +F L+ ++L +N ++
Sbjct: 91 KEISNKMF--LGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 1/85 (1%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+ L++N L L +L L L N+L G P A +S ++ L L N
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88
Query: 236 MFSGELPSEIISKMPQLQFLYLSYN 260
E+ +++ + QL+ L L N
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDN 112
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 32/114 (28%), Positives = 47/114 (41%), Gaps = 13/114 (11%)
Query: 230 LDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEP-FFASLANSSNFQELE 288
L L N + ++P L L L N T +EP F S+ QEL+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQL------TGIEPNAFEGA---SHIQELQ 84
Query: 289 LAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSN 341
L N + I + + L ++L N I + P +L +LT LNL+SN
Sbjct: 85 LGENKIKE-ISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 66/459 (14%), Positives = 144/459 (31%), Gaps = 120/459 (26%)
Query: 598 HTHHLVILSILLSLFAMSLL-FIFGNFL-VLRSKFGKDLSVLNGADLEDEEKE---KEE- 651
H HH+ F + + + L V F + D++D K KEE
Sbjct: 3 HHHHMD--------FETGEHQYQYKDILSVFEDAFVDNFDC---KDVQDMPKSILSKEEI 51
Query: 652 -----AKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDN-----TRIAVKVLDL 701
+K+ +L +F + VL+ N + I +
Sbjct: 52 DHIIMSKDAVSGTLRLFWT---LLSKQEEMVQKF---VEEVLRINYKFLMSPIKTEQRQP 105
Query: 702 TTTGEITGSFK----RECQILK-----RIRHRNLIR----------IITI-----CSKPD 737
+ + + + Q+ R++ +R + I K
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-- 163
Query: 738 FKALVLPLMSNGSLENHL-YPSHGLSHG------LDLIQLVKICSDVA-EGVAYLHHHSP 789
+ L + + ++ + + L+ L L K+ + + H S
Sbjct: 164 -TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 790 IKVVHCDLKP--SNILLDEDL-TAL-----VADFGIAKLVKGIDESVNCANDSMSFTS-- 839
IK+ ++ +L + L V + AK + ++C + T+
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN---AKAWNAFN--LSC---KILLTTRF 274
Query: 840 ---TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLL--LEIVTGRRPTDVLFHD---- 890
TD L + +I+ + + T +LL L+ P +VL +
Sbjct: 275 KQVTDFLSAATTTHIS----LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 891 ---GSSLHEWVKR--HYPH----RLDPIVEKAIAKYAPQHMPIYYNK--VWSDVVLELIE 939
S+ + + ++ H +L I+E ++ P +++ V+ I
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA--HIP 388
Query: 940 LGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSLIEE 978
LL + + ++ V +++ + SL+E+
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHK--------YSLVEK 419
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 7e-07
Identities = 68/442 (15%), Positives = 129/442 (29%), Gaps = 142/442 (32%)
Query: 17 IFFVVSGEDNADDDQIIRDRASLVTFMSSIISAPEHA------LESW------------- 57
IF++ N+ + + + L + S +H+ + S
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 58 -NSTDV--HVCNWS-----GVKCN---NSRNKVVELDLSARSIY--------GTISPA-- 96
N V +V N + C +R K V LSA + T++P
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 97 ---LANLSSLIVLDLSKNFFQGHIPAELGSLI--RLKQLSLSWNSLQGKIPSQLG----- 146
L DL + + P L S+I ++ +W++ + +L
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTN-PRRL-SIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 147 SLHQLE-------YLDLG----NNKLVGEIPIPIFC---SNSST-------------SLQ 179
SL+ LE + L + IP + + SL
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAH----IPTILLSLIWFDVIKSDVMVVVNKLHKYSL- 416
Query: 180 YIDLSNNSLTGEIP---LKNECELRNLRFLLLWSNRLVGQ--VPQALANSSKL-EWLDLE 233
++ T IP L+ + +L N L +V +P+ + + +LD
Sbjct: 417 -VEKQPKESTISIPSIYLELKVKLENEYAL---HRSIVDHYNIPKTFDSDDLIPPYLD-- 470
Query: 234 SNMFSGELPSEIISKMPQLQFLYLSYNDFVSH---DGNTNLEPFFASLANSSNF--QELE 288
F + ++ + H + F + F Q++
Sbjct: 471 -QYF----------------YSHIGH-----HLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 289 LAGNNLG--GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLT---LLNLSSNLL 343
G I + + L I + P LVN L + NL+
Sbjct: 509 HDSTAWNASGSILNTLQQLKFYKPYICDND--------PKYERLVNAILDFLPKIEENLI 560
Query: 344 NGTIPH----ELCLMSKLERVY 361
+ + LM++ E ++
Sbjct: 561 CS--KYTDLLRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 3e-06
Identities = 81/560 (14%), Positives = 158/560 (28%), Gaps = 129/560 (23%)
Query: 230 LDLESNMFSGELPSEIISKMPQLQFLYL-----------SYNDFVSHDGNTNLEPFFASL 278
D+ ++ S E II + FV N + + +
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 279 AN-----SSNFQELELAGNNLGGMIPSI----------IGDLSTNLVQIHLDCNLI---- 319
S + + L L L+++ N++
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 320 --YGKIPPHISNLVNLTLLNLSS-----------NLLNGTIPHELC-----LMSKLERVY 361
GK + + L+ NL N P + L+ +++ +
Sbjct: 159 LGSGK-----TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 362 LSNNSLSGEIPSAFGDI-----------PHL-GLLDLSKNKLSGSIPDSFAN-------- 401
S + S I I P+ LL L N + ++F
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-NVQNAKAWNAFNLSCKILLTT 272
Query: 402 --------LSQLRRLLLYGNHLSGTIPSS-----LGKCVNLEILDLSHNKISGIIPSDVA 448
LS + +H S T+ L K ++ DL ++ P ++
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR-EVLTTNPRRLS 331
Query: 449 GL-RSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC-----IAL 502
+ S++ L N + K+ + I+ S N L P + +
Sbjct: 332 IIAESIRDGLATWDNWKH----VNCDKLTTI--IESSLNVLE---PAEYRKMFDRLSVFP 382
Query: 503 ESLNLSGNSLEGLLPVSVGQLP--YLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560
S ++ L + + + + S L + P+ S + +
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS--LVEKQPKESTIS--IPSIYLELKV- 437
Query: 561 SGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKK---EHT-HHLVILSI--LLSLFAM 614
+ N+ A + + + + H HHL + ++LF M
Sbjct: 438 --KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495
Query: 615 SLLFIFGNFLVLRSKFGKDLSVLNGA-----DLEDEEKEKEEAKNPRVSYKQLIEATGGF 669
+F +F L K D + N + L+ + K + Y++L+ A F
Sbjct: 496 ----VFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 670 CPSSLIGSGRFGHVYKGVLQ 689
P I Y +L+
Sbjct: 552 LPK--IEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 6e-06
Identities = 66/449 (14%), Positives = 141/449 (31%), Gaps = 112/449 (24%)
Query: 64 VCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQG-HIPAELG 122
VC V+C K+ L+L + T+ L L I + + +I +
Sbjct: 170 VCLSYKVQCKMD-FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 123 SLI-RLKQLSLSW---NSL-------QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFC 171
S+ L++L S N L K +L L+
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKA---------WNAFNLSCKILL--------- 270
Query: 172 SNSSTSLQYIDLSNNSLTGEIPLKN------ECELRNLRFLLLWSNRLVGQVPQALANSS 225
++ Q D + + T I L + E+++L L
Sbjct: 271 --TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL-----------------LLK-- 309
Query: 226 KLEWLDLESNMFSGELPSEIISKMPQL----------------QFLYLSYNDFVSHDGNT 269
+LD +LP E+++ P+ + +++ + T
Sbjct: 310 ---YLDCRP----QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL-----TT 357
Query: 270 NLEPFFASLANSSNFQEL--ELAGNNLGGMIPSII-----GDLSTNLVQIHLD--CN--L 318
+E L + ++++ L+ IP+I+ D+ + V + ++ L
Sbjct: 358 IIESSLNVL-EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 319 IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS-KLERVYLSNNSLSGEIPSAFGD 377
+ + ++ ++ L L L N H + + + + S++ + P
Sbjct: 417 VEKQPKESTISIPSI-YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI---PPYLDQY 472
Query: 378 I-PHLG--LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434
H+G L ++ + F + L + + + T ++ G +N + L
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRH----DSTAWNASGSILNT-LQQL 527
Query: 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNH 463
K I +D R + L+
Sbjct: 528 KFYK-PYICDNDPKYERLVNAILDFLPKI 555
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 8e-06
Identities = 108/708 (15%), Positives = 206/708 (29%), Gaps = 195/708 (27%)
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLST 307
+ + Q+ Y D +S + F + + ++++ M SI LS
Sbjct: 10 ETGEHQY---QYKDILSV----FEDAFVDNF----DCKDVQ-------DMPKSI---LSK 48
Query: 308 NLVQIHLDCNLIYGKIPPHISNLVNL--TLLNLSSNLLNGTIPHELC-----LMSKLERV 360
+ + I +S + L TLL+ ++ + L LMS ++
Sbjct: 49 E------EIDHII-MSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 361 Y----LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416
+ + + D ++S+ + + + L + +L+ G +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG--VL 159
Query: 417 GTIPSSLGK-------CVNLEILDLSHNKI----SGIIPSDVAGLRSL-KLYLNLSSNHL 464
G+ GK C++ ++ KI S L L KL + N
Sbjct: 160 GS-----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 465 DGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLP 524
D I L + SI +L + + N L LL V +
Sbjct: 215 SRS--------DHSSNIKLRIH----SIQAELRRLLKSKPYE---NCLLVLLNVQNAKA- 258
Query: 525 YLKQFDVSSNRLF----GEIPQSFQAS----PTLKQLNFSFNKFSGNISNKGAFSSLTI- 575
F++S L ++ A+ +L + + ++
Sbjct: 259 -WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE----------VKSLL 307
Query: 576 ASFQGNDGLCGEIKGL--QTCKKEHTHHLVILSILLSLFAMSL---LFIFGNFL-VLRSK 629
+ + L + T+ + S+ A S+ L + N+ V K
Sbjct: 308 LKYLDCR-----PQDLPREVLT---TNPRRL-----SIIAESIRDGLATWDNWKHVNCDK 354
Query: 630 FGK--DLSVLNGADLEDEEKEKEEAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV 687
+ S+ LE E R + +L V
Sbjct: 355 LTTIIESSL---NVLEPAEY--------RKMFDRL-----------------------SV 380
Query: 688 LQDNTRIAVKVLDL-------TTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD-FK 739
+ I +L L + + + + K+ + I I P +
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-PKESTISI------PSIYL 433
Query: 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--HHSPIKVVHCDL 797
L + L + +L + + + D L+ D Y H HH L
Sbjct: 434 ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIGHH---------L 481
Query: 798 KPSNILLDED---LTALVADFGI--AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
K NI E + DF K+ D + A+ S+ T L YI
Sbjct: 482 K--NIEHPERMTLFRMVFLDFRFLEQKIRH--DSTAWNASGSILNTLQQ--LKFYKPYIC 535
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV----LFHDGSSLHE 896
+R + F + E + + TD+ L + ++ E
Sbjct: 536 DNDPKYERLV--NAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFE 581
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 47/317 (14%), Positives = 96/317 (30%), Gaps = 67/317 (21%)
Query: 81 ELDLSARSIYGTISPALA-----NLSSLIVLDLSKNFFQGHIPAE-----LGSLIRLKQL 130
+L+L+ + +A +L ++L+ + L +R ++L
Sbjct: 76 QLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASC----QLDPAGLRTLLPVFLRARKL 131
Query: 131 SLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG 190
L NSL + L L L +++ + + LSNN LT
Sbjct: 132 GLQLNSLGPEACKDLRDL-------LLHDQ---------------CQITTLRLSNNPLTA 169
Query: 191 E------IPLKNECELRNLRFLLLWSNRL----VGQVPQALANSSKLEWLDLESNMFSGE 240
L + +L L L + + L + +L+ L++ N
Sbjct: 170 AGVAVLMEGLAGNTSVTHLS---LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
Query: 241 ---LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGM 297
+ + P L+ L+L +N+ S +G L + + G +
Sbjct: 227 AALALARAAREHPSLELLHLYFNEL-SSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEY 285
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT----IPHELCL 353
I+ ++ NL D + + L L +L + L +
Sbjct: 286 WSVILSEVQRNL--NSWD--------RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRV 335
Query: 354 MSKLERVYLSNNSLSGE 370
++ + S
Sbjct: 336 EGEVRALLEQLGSSGSP 352
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 48/303 (15%), Positives = 94/303 (31%), Gaps = 70/303 (23%)
Query: 200 LRNLRFLLLWSNRLVGQVPQALA-----NSSKLEWLDLESNMFSGELPSEIISKMPQLQF 254
L +LR L L R+ +A L+ ++L S ++ + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 255 LYLSYNDFVSHDGNTNLEPFFASLA-NSSNFQELELAGNNLGGMIPSIIGD-LSTNLVQI 312
L L N G + L + L L+ N L +++ + L+ N
Sbjct: 131 LGLQLNSL----GPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN---- 182
Query: 313 HLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLM----SKLERVYLSNNSLS 368
++T L+L L L +L+ + ++ N
Sbjct: 183 ------------------TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
Query: 369 GE----IPSAFGDIPHLGLLDLSKNKLS-------GSIPDSFANLSQLRRLLLYGNHLSG 417
+ A + P L LL L N+LS + + +++ L G +S
Sbjct: 225 DTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSE 284
Query: 418 T---------------IPSSLGKCVNLEILDLSHNKISGIIPSDVA-------GLRSLKL 455
+ + + + L + DL ++ + + P A +R+L
Sbjct: 285 YWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLE 344
Query: 456 YLN 458
L
Sbjct: 345 QLG 347
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 31/173 (17%), Positives = 60/173 (34%), Gaps = 39/173 (22%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVL-DLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IG G FG +Y + + + + G E + +R I+
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 733 CSKP-------------------DFKALVLPLMSNGSLENHLYPSHG----LSHGLDL-I 768
K ++ +++ + L+ +Y ++ L L +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV--ADFGIAK 819
+++ I + Y+H H VH D+K SN+LL+ V D+G+A
Sbjct: 160 RILDI-------LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 32/171 (18%), Positives = 60/171 (35%), Gaps = 37/171 (21%)
Query: 675 IGSGRFGHVYKGV---------LQDNTRIAVKV------LDLTTTGEITGSFKRECQILK 719
G +Y+ + ++K+ L + + K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 720 RIRHRNLIRIITI----CSKPDFKALVLPLMSNGSLENHL--YPSHGLSHGLDL---IQL 770
++ L+ I T + ++ LVLP + SL++ L P H LS L +L
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 771 VKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV--ADFGIAK 819
+ + +LH + VH ++ NI +D + + V A +G A
Sbjct: 169 LDA-------LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 32/108 (29%), Positives = 49/108 (45%), Gaps = 6/108 (5%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVG 163
L+L N Q L +L +LSLS N +Q +P + L +L L L NKL
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-Q 89
Query: 164 EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211
+P +F + T L+ + L N L +P L +L+ + L +N
Sbjct: 90 SLPNGVF--DKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 10/119 (8%)
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176
IP+ +L L N LQ L QL L L N++ +P +F + T
Sbjct: 26 IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVF--DKLT 76
Query: 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
L + L N L +P +L L+ L L +N+L + L+ + L +N
Sbjct: 77 KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 17/123 (13%)
Query: 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPH----ELC 352
+P+ I +T L L+ N + +P + L LT L+LS N + ++P +L
Sbjct: 22 VPTGIPSSATRL---ELESNKL-QSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL- 75
Query: 353 LMSKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSIPD-SFANLSQLRRLLL 410
+KL +YL N L +P+ F + L L L N+L S+PD F L+ L+++ L
Sbjct: 76 --TKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 131
Query: 411 YGN 413
+ N
Sbjct: 132 HTN 134
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 49/268 (18%), Positives = 85/268 (31%), Gaps = 38/268 (14%)
Query: 75 SRNKVVELDLSARSI-YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLS 133
S +V +DLS I T+ L+ S L L L I L L +L+LS
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 134 W-NSLQGKIPSQLGS-LHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
+ L S +L+ L+L E + + ++ S ++ ++LS
Sbjct: 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG------ 204
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQALANS-SKLEWLDLESNMFSGELPSEIISKMP 250
+ L L L LDL ++ + ++
Sbjct: 205 -----------------YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247
Query: 251 QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLV 310
LQ L LS + + L + L++ G G + L L
Sbjct: 248 YLQHLSLSRCYDIIPET-------LLELGEIPTLKTLQVFGIVPDGTLQL----LKEALP 296
Query: 311 QIHLDCNLIYGKIPPHISNLVNLTLLNL 338
+ ++C+ P I N N + +
Sbjct: 297 HLQINCSHFTTIARPTIGNKKNQEIWGI 324
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 33/221 (14%)
Query: 316 CNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN-NSLSGEIPSA 374
+ + +S L L+L L+ I + L S L R+ LS + S
Sbjct: 103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 162
Query: 375 FGD-IPHLGLLDLSKNKL--SGSIPDSFA-NLSQLRRLLLYG--NHLSGTIPSSLGK-CV 427
L L+LS + + A + +L L G +L + S+L + C
Sbjct: 163 LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCP 222
Query: 428 NLEILDLSH-NKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486
NL LDLS + + L L+ +L+LS +
Sbjct: 223 NLVHLDLSDSVMLKNDCFQEFFQLNYLQ-HLSLSRCY----------------------- 258
Query: 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLK 527
++ +LG L++L + G +G L + LP+L+
Sbjct: 259 DIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 50/281 (17%), Positives = 81/281 (28%), Gaps = 51/281 (18%)
Query: 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFL-LLWSNRLVGQVPQALANSSKLEWLDLESN 235
S I + PL ++ + L S V + L+ SKL+ L LE
Sbjct: 69 SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 128
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
S + ++K L L LS S L L++ S EL L+
Sbjct: 129 RLSDPI-VNTLAKNSNLVRLNLSGCSGFSEFALQTL------LSSCSRLDELNLSWCF-- 179
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
D + VQ+ + + L L NL + +
Sbjct: 180 --------DFTEKHVQVAVAHVS---------ETITQLNLSGYRKNLQKSDLSTLVRRCP 222
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYG-NH 414
L + LS++ L F L+ L+ L L
Sbjct: 223 NLVHLDLSDSV-----------------------MLKNDCFQEFFQLNYLQHLSLSRCYD 259
Query: 415 LSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL 455
+ LG+ L+ L + G + L L++
Sbjct: 260 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 30/85 (35%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 105 VLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLG---SLHQLEYLDLGNNKL 161
L L+ N P L+ L+QL + N L IP+ G L QL LDL +N L
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLNDNHL 93
Query: 162 VGEIPIPIFCSNSSTSLQYIDLSNN 186
IP F ++ SL +I L NN
Sbjct: 94 KS-IPRGAF--DNLKSLTHIYLYNN 115
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 983 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.44 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.42 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.4 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.16 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.93 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.89 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.76 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.74 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.79 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.7 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.21 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.49 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.39 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.13 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.86 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.43 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.86 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-76 Score=733.72 Aligned_cols=550 Identities=37% Similarity=0.543 Sum_probs=410.1
Q ss_pred cccHHhHHHHHHHHHhccCCCccccCCCCCCCCCCcceeeEEECCCCCeEEEEEcccCCcccc---cc------------
Q 042568 30 DQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGT---IS------------ 94 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~------------ 94 (983)
.+.++|++||++||+++. ||. .+++|+. +.+||.|.||+|+ +++|+.|||+++++.|. +|
T Consensus 8 ~~~~~~~~all~~k~~~~-~~~-~l~~W~~-~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLP-DKN-LLPDWSS-NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCS-CTT-SSTTCCT-TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCC-Ccc-cccCCCC-CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 346789999999999996 887 9999984 5689999999998 68999999999999887 54
Q ss_pred -----------cccccCCCCcEEeCcCCcCCCCCcc--ccCCCCCCCEEeccCccCCCCchhhh-cccccccEEeccCcc
Q 042568 95 -----------PALANLSSLIVLDLSKNFFQGHIPA--ELGSLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNK 160 (983)
Q Consensus 95 -----------~~l~~l~~L~~L~Ls~n~l~~~~p~--~~~~l~~L~~L~Ls~n~l~~~~p~~~-~~L~~L~~L~Ls~N~ 160 (983)
+.++++++|++|||++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|||++|+
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 162 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS 162 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence 3567778888888888888877777 77777777777777776665555433 333333333333333
Q ss_pred cc-------------------------------------------------cccCCcccccCCCcccceeecccccccC-
Q 042568 161 LV-------------------------------------------------GEIPIPIFCSNSSTSLQYIDLSNNSLTG- 190 (983)
Q Consensus 161 l~-------------------------------------------------~~~p~~~~~~~~l~~L~~L~Ls~N~l~~- 190 (983)
++ +.+|. + ..+++|++|+|++|.+++
T Consensus 163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l---~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-L---GDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-C---TTCCSCCEEECCSSCCCSC
T ss_pred cCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-c---ccCCCCCEEECcCCcCCCc
Confidence 32 22221 1 123333333333333332
Q ss_pred ---------------------------------------------CCCCcccccccccceeecccCccccccchhhhccC
Q 042568 191 ---------------------------------------------EIPLKNECELRNLRFLLLWSNRLVGQVPQALANSS 225 (983)
Q Consensus 191 ---------------------------------------------~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 225 (983)
.+|...+..+++|++|+|++|++++.+|..|++++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 22222111124444444444444444555555555
Q ss_pred CcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCC-CccEEEccCCcccccCCccccc
Q 042568 226 KLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSS-NFQELELAGNNLGGMIPSIIGD 304 (983)
Q Consensus 226 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~ 304 (983)
+|++|+|++|+++|.+|...+..+++|++|+|++|++.. .++..+.+++ +|++|++++|++++.+|..+..
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~--------~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~ 390 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG--------ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQ 390 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEE--------CCCTTHHHHTTTCSEEECCSSEEEEECCTTTTC
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCc--------cccHHHHhhhcCCcEEEccCCCcCCCcChhhhh
Confidence 555555555555555555445555555555555555432 1223333444 5666666666666655555544
Q ss_pred c-ccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcE
Q 042568 305 L-STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGL 383 (983)
Q Consensus 305 l-~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 383 (983)
. .++|++|++++|.+++.+|..+.++++|++|+|++|++++.+|..++.+++|++|++++|.+.+.+|..+..+++|+.
T Consensus 391 ~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 470 (768)
T 3rgz_A 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470 (768)
T ss_dssp STTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred cccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceE
Confidence 1 246777777777777778888888888888888888888888888888888888888888888888888888888888
Q ss_pred EEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCC
Q 042568 384 LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNH 463 (983)
Q Consensus 384 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 463 (983)
|+|++|++++.+|..+.++++|+.|++++|++++.+|.+++.+++|++|+|++|+++|.+|..+..+++|+. |++++|+
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~-L~Ls~N~ 549 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW-LDLNTNL 549 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCE-EECCSSE
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCE-EECCCCc
Confidence 888888888888888888888888888888888888888888888888888888888888888888888885 8888888
Q ss_pred CCCCCcccc----------------------------------------------------------------------c
Q 042568 464 LDGPLPLEL----------------------------------------------------------------------S 473 (983)
Q Consensus 464 l~~~~p~~~----------------------------------------------------------------------~ 473 (983)
++|.+|.++ .
T Consensus 550 l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~ 629 (768)
T 3rgz_A 550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629 (768)
T ss_dssp EESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCS
T ss_pred cCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhh
Confidence 887777544 3
Q ss_pred cccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceE
Q 042568 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQL 553 (983)
Q Consensus 474 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l 553 (983)
.+++|+.|||++|+++|.+|..|+.+++|+.|+|++|+++|.+|.+++.+++|+.|||++|+++|.+|..+.++++|++|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCccccccCCCCCCcccccccccCCcCccCCCCCcccccCCCC
Q 042568 554 NFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIKGLQTCKKEHT 599 (983)
Q Consensus 554 ~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~~~~~~c~~~~~ 599 (983)
++++|+++|.+|..++|.+++..+|.|||++||.|. .+|.....
T Consensus 710 ~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C~~~~~ 753 (768)
T 3rgz_A 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--PRCDPSNA 753 (768)
T ss_dssp ECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS--CCCCSCC-
T ss_pred ECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC--cCCCCCcc
Confidence 999999999999999999999999999999999884 47865543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=581.34 Aligned_cols=468 Identities=36% Similarity=0.551 Sum_probs=409.4
Q ss_pred eEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEecc
Q 042568 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157 (983)
Q Consensus 78 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls 157 (983)
+++.|+|++|.+.+.+|. ++++++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|.. .+++|++|+|+
T Consensus 201 ~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~ 277 (768)
T 3rgz_A 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLA 277 (768)
T ss_dssp TCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECC
T ss_pred cCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECc
Confidence 577777777777776666 777888888888888887777777888888888888888877777664 77788888888
Q ss_pred CcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchh-hhccCCcceecccccc
Q 042568 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQA-LANSSKLEWLDLESNM 236 (983)
Q Consensus 158 ~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~ 236 (983)
+|+++|.+|..++ ..+++|++|+|++|.+++.+|. .+..+++|++|+|++|+++|.+|.. ++++++|++|+|++|+
T Consensus 278 ~n~l~~~ip~~~~--~~~~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~ 354 (768)
T 3rgz_A 278 ENKFTGEIPDFLS--GACDTLTGLDLSGNHFYGAVPP-FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354 (768)
T ss_dssp SSEEEESCCCCSC--TTCTTCSEEECCSSEEEECCCG-GGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSE
T ss_pred CCccCCccCHHHH--hhcCcCCEEECcCCcCCCccch-HHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCc
Confidence 8888888888775 2359999999999999987774 5678999999999999999888876 9999999999999999
Q ss_pred cccccchhhhcCCC-CccEEEccccccccCCCCCCCcccccccCC--CCCccEEEccCCcccccCCccccccccCeeEEE
Q 042568 237 FSGELPSEIISKMP-QLQFLYLSYNDFVSHDGNTNLEPFFASLAN--SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIH 313 (983)
Q Consensus 237 l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~ 313 (983)
++|.+|..+ ..++ +|++|+|++|++... .+..+.. +++|++|++++|++++.+|..+..+ ++|++|+
T Consensus 355 l~~~~p~~l-~~l~~~L~~L~Ls~N~l~~~--------~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~ 424 (768)
T 3rgz_A 355 FSGELPESL-TNLSASLLTLDLSSNNFSGP--------ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC-SELVSLH 424 (768)
T ss_dssp EEECCCTTH-HHHTTTCSEEECCSSEEEEE--------CCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGC-TTCCEEE
T ss_pred cCccccHHH-HhhhcCCcEEEccCCCcCCC--------cChhhhhcccCCccEEECCCCccccccCHHHhcC-CCCCEEE
Confidence 998888775 4455 999999999998642 2233444 7889999999999999999999888 5799999
Q ss_pred ccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccC
Q 042568 314 LDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393 (983)
Q Consensus 314 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 393 (983)
|++|.+++.+|..+..+++|++|++++|++++.+|..+..+++|++|+|++|.+++.+|..++++++|+.|+|++|++++
T Consensus 425 Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 504 (768)
T 3rgz_A 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG 504 (768)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred CcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCcccc-------------------------
Q 042568 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVA------------------------- 448 (983)
Q Consensus 394 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~------------------------- 448 (983)
.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|++++|+++|.+|..+.
T Consensus 505 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (768)
T 3rgz_A 505 EIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCC
T ss_pred cCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccc
Confidence 9999999999999999999999999999999999999999999999988886543
Q ss_pred ---------------------------------------------CCCccceeccccCCCCCCCCccccccccccccccc
Q 042568 449 ---------------------------------------------GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDL 483 (983)
Q Consensus 449 ---------------------------------------------~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 483 (983)
.+++|+. |+|++|+++|.+|.+++.++.|+.|+|
T Consensus 585 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~-LdLs~N~l~g~ip~~l~~l~~L~~L~L 663 (768)
T 3rgz_A 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF-LDMSYNMLSGYIPKEIGSMPYLFILNL 663 (768)
T ss_dssp TTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE-EECCSSCCBSCCCGGGGGCTTCCEEEC
T ss_pred ccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE-EECcCCcccccCCHHHhccccCCEEeC
Confidence 2456775 999999999999999999999999999
Q ss_pred cccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCc-ccc
Q 042568 484 SFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNK-FSG 562 (983)
Q Consensus 484 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~ 562 (983)
++|+++|.+|..|+.+++|+.|+|++|+++|.+|..++.+++|+.||+++|+++|.||.. ..+.++....+.+|+ ++|
T Consensus 664 s~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred cCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence 999999999999999999999999999999999999999999999999999999999964 345556666778885 666
Q ss_pred c
Q 042568 563 N 563 (983)
Q Consensus 563 ~ 563 (983)
.
T Consensus 743 ~ 743 (768)
T 3rgz_A 743 Y 743 (768)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-58 Score=555.87 Aligned_cols=487 Identities=20% Similarity=0.296 Sum_probs=353.7
Q ss_pred cccHHhHHHHHHHHHhccCCCcc-------ccCCCCCCCCCCcce---eeEEECCCCCeEEEEEcccCCccccccccccc
Q 042568 30 DQIIRDRASLVTFMSSIISAPEH-------ALESWNSTDVHVCNW---SGVKCNNSRNKVVELDLSARSIYGTISPALAN 99 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~-------~l~sw~~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~ 99 (983)
.....|++||.+|+.++..+... ...+|+. +.+||.| .||+|+.. +||+.|+|+++++.|.+|+++++
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhc
Confidence 44567999999999998644322 2348986 5789999 99999865 89999999999999999999999
Q ss_pred CCCCcEEeCcCCcC------CC------CCccccCCCCCCCEEeccCccCCCCchhhhcc-cccccEEecc---------
Q 042568 100 LSSLIVLDLSKNFF------QG------HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGS-LHQLEYLDLG--------- 157 (983)
Q Consensus 100 l~~L~~L~Ls~n~l------~~------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~-L~~L~~L~Ls--------- 157 (983)
|++|++|||++|.+ .| .+|... +.+|+ ++++.|.+.+.+|..++. +..+..+++.
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 99999999999976 33 455544 56788 999999999988888774 3344444444
Q ss_pred -----------CcccccccCCcccccCCCcccceeecccccccCC-----------------CCCcccc--cccccceee
Q 042568 158 -----------NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE-----------------IPLKNEC--ELRNLRFLL 207 (983)
Q Consensus 158 -----------~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------ip~~~~~--~l~~L~~L~ 207 (983)
.|+++| +|..++ ++++|++|+|++|.+++. +|.. +. ++++|++|+
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~---~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~ 255 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVM---RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVE 255 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGG---GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEE
T ss_pred cchhhhhhccccCCCcc-CCHHHh---cccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEE
Confidence 455554 555443 455555555555555543 4422 22 455555555
Q ss_pred cccCccccccchhhhccCCcceecccccc-ccc-ccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCcc
Q 042568 208 LWSNRLVGQVPQALANSSKLEWLDLESNM-FSG-ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 208 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+. .+ ..+..+++|+
T Consensus 256 L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L--------------------------~~~~~l~~L~ 308 (636)
T 4eco_A 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-AL--------------------------ADAPVGEKIQ 308 (636)
T ss_dssp EECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HH--------------------------HHSGGGGTCC
T ss_pred ecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hh--------------------------hccccCCCCC
Confidence 55555555555555555555555555554 554 4444321 11 0112236666
Q ss_pred EEEccCCcccccCCc--cccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCC-CcEEEe
Q 042568 286 ELELAGNNLGGMIPS--IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK-LERVYL 362 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~--~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~L 362 (983)
+|++++|+++ .+|. .++.+ ++|++|++++|.++|.+| .++.+++|++|++++|+++ .+|..+..+++ |++|++
T Consensus 309 ~L~L~~n~l~-~ip~~~~l~~l-~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~L 384 (636)
T 4eco_A 309 IIYIGYNNLK-TFPVETSLQKM-KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSF 384 (636)
T ss_dssp EEECCSSCCS-SCCCHHHHTTC-TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEEC
T ss_pred EEECCCCcCC-ccCchhhhccC-CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEc
Confidence 7777777776 5666 66666 467777777777777777 7777788888888888887 67777777877 888888
Q ss_pred eCCcccCCCCCCCCCCC--CCcEEEccCccccCcCccccc-------CcccchhhcccCccCCCCCcccccCCCCCCEEE
Q 042568 363 SNNSLSGEIPSAFGDIP--HLGLLDLSKNKLSGSIPDSFA-------NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILD 433 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 433 (983)
++|.++ .+|..+..++ +|+.|+|++|++++.+|..|. .+++|+.|+|++|.+++..+..+..+++|+.|+
T Consensus 385 s~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~ 463 (636)
T 4eco_A 385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN 463 (636)
T ss_dssp CSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEE
T ss_pred cCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEE
Confidence 888887 6677776654 788888888888888887777 777888888888888843334455688888888
Q ss_pred ccCccccCcCCccc-cCCC-------ccceeccccCCCCCCCCccccc--cccccccccccccccccCCCcccccccccc
Q 042568 434 LSHNKISGIIPSDV-AGLR-------SLKLYLNLSSNHLDGPLPLELS--KMDMVLAIDLSFNNLSGSIPPQLGSCIALE 503 (983)
Q Consensus 434 Ls~N~l~~~~p~~~-~~l~-------~L~~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 503 (983)
|++|+++ .+|..+ .... +|+. |+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+
T Consensus 464 Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~-L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~ 539 (636)
T 4eco_A 464 LMGNMLT-EIPKNSLKDENENFKNTYLLTS-IDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK 539 (636)
T ss_dssp CCSSCCS-BCCSSSSEETTEECTTGGGCCE-EECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCC
T ss_pred CCCCCCC-CcCHHHhccccccccccCCccE-EECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCC
Confidence 8888888 455433 3222 7775 888888888 6777776 88888888888888886 888888888899
Q ss_pred eEEe------CCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccC
Q 042568 504 SLNL------SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 504 ~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
.|+| ++|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|++++|++.....
T Consensus 540 ~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDL 604 (636)
T ss_dssp EEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEEC
T ss_pred EEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccccH
Confidence 9988 56888889999999999999999999999 68888766 799999999998876543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-56 Score=537.05 Aligned_cols=509 Identities=20% Similarity=0.206 Sum_probs=444.6
Q ss_pred eeeEEECCC---------CCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccC
Q 042568 67 WSGVKCNNS---------RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137 (983)
Q Consensus 67 w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 137 (983)
+..|.|... ...++.|+|++|.+++..|.+++++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 456888653 24799999999999988889999999999999999999988899999999999999999999
Q ss_pred CCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccccc
Q 042568 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217 (983)
Q Consensus 138 ~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 217 (983)
++..|..|+++++|++|+|++|++++..|..+ ..+++|++|++++|.+++.. ...+..+++|++|++++|++++..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~---~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPL---HNQKTLESLYLGSNHISSIK-LPKGFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCC---TTCTTCCEEECCSSCCCCCC-CCTTCCCTTCCEEECCSSCCCEEC
T ss_pred cccChhhhcccccccEeeccccCcccCCcchh---ccCCcccEEECCCCcccccC-cccccCCcccCEEEcccCcccccC
Confidence 98889999999999999999999996545555 48999999999999999632 223345999999999999999999
Q ss_pred chhhhccCCcc--eecccccccccccchhhhcCCCCccEEEccccccc---------------------cCCCCCCCccc
Q 042568 218 PQALANSSKLE--WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFV---------------------SHDGNTNLEPF 274 (983)
Q Consensus 218 p~~l~~l~~L~--~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~---------------------~~~~~~~~~~~ 274 (983)
|..|+.+++|+ +|++++|++++. +...+. ..+|++|++++|... .......-...
T Consensus 170 ~~~~~~l~~L~~l~L~l~~n~l~~~-~~~~~~-~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~ 247 (606)
T 3t6q_A 170 KEDMSSLQQATNLSLNLNGNDIAGI-EPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247 (606)
T ss_dssp HHHHHTTTTCCSEEEECTTCCCCEE-CTTTTT-TCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGG
T ss_pred hhhhhhhcccceeEEecCCCccCcc-ChhHhh-hccccccccCCchhHHHHhhhccccchhheechhhccccccccChhH
Confidence 99999999999 899999999954 444444 468999999987510 00000000111
Q ss_pred ccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccC
Q 042568 275 FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLM 354 (983)
Q Consensus 275 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 354 (983)
+..+... +|++|++++|++++..+..+..+ ++|++|++++|.++ .+|..+..+++|++|++++|++++..|..+..+
T Consensus 248 ~~~l~~~-~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l 324 (606)
T 3t6q_A 248 FEGLCEM-SVESINLQKHYFFNISSNTFHCF-SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324 (606)
T ss_dssp GGGGGGS-EEEEEECTTCCCSSCCTTTTTTC-TTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGC
T ss_pred hchhhcC-ceeEEEeecCccCccCHHHhccc-cCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhcc
Confidence 2222222 79999999999998888778887 58999999999998 789999999999999999999998888899999
Q ss_pred CCCcEEEeeCCcccCCCCC-CCCCCCCCcEEEccCccccCcC--cccccCcccchhhcccCccCCCCCcccccCCCCCCE
Q 042568 355 SKLERVYLSNNSLSGEIPS-AFGDIPHLGLLDLSKNKLSGSI--PDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431 (983)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 431 (983)
++|++|++++|.+.+.+|. .+..+++|+.|++++|++++.. +..+..+++|+.|++++|.+++..|..|..+++|+.
T Consensus 325 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 404 (606)
T 3t6q_A 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL 404 (606)
T ss_dssp TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence 9999999999999976665 4999999999999999999776 788999999999999999999888999999999999
Q ss_pred EEccCccccCcCCcc-ccCCCccceeccccCCCCCCCCccccccccccccccccccccccC---CCcccccccccceEEe
Q 042568 432 LDLSHNKISGIIPSD-VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS---IPPQLGSCIALESLNL 507 (983)
Q Consensus 432 L~Ls~N~l~~~~p~~-~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L 507 (983)
|++++|++++..|.. +..+++|+. |++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+.|++
T Consensus 405 L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~L 483 (606)
T 3t6q_A 405 LDLAFTRLKVKDAQSPFQNLHLLKV-LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483 (606)
T ss_dssp EECTTCCEECCTTCCTTTTCTTCCE-EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEEC
T ss_pred EECCCCcCCCcccchhhhCcccCCE-EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEEC
Confidence 999999999877654 889999996 99999999999999999999999999999999873 3467899999999999
Q ss_pred CCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC-CCCCcccccccccCCcCccC
Q 042568 508 SGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 508 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~N~~lc~ 586 (983)
++|++++..|..+..+++|+.|+|++|++++..|..|.+++.| +|++++|++++.+|. ...+..+..+.+.+||+.|.
T Consensus 484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred CCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 9999999999999999999999999999999999999999999 999999999998876 35677888999999999985
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=550.37 Aligned_cols=492 Identities=21% Similarity=0.282 Sum_probs=308.1
Q ss_pred ccccHHhHHHHHHHHHhccCCCccccCCCCCCC----CCC--cce------------eeEEECCCCCeEEEEEcccCCcc
Q 042568 29 DDQIIRDRASLVTFMSSIISAPEHALESWNSTD----VHV--CNW------------SGVKCNNSRNKVVELDLSARSIY 90 (983)
Q Consensus 29 ~~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~----~~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~ 90 (983)
+.+..+|++||++||+++. +| +|+.++ .+| |.| .||+|+. .+||+.|+|+++++.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK 336 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred cccchHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence 3456789999999999994 55 787543 344 999 9999987 689999999999999
Q ss_pred cccccccccCCCCcEEeC-cCCcCCCCCcccc------------------------------------------------
Q 042568 91 GTISPALANLSSLIVLDL-SKNFFQGHIPAEL------------------------------------------------ 121 (983)
Q Consensus 91 g~~~~~l~~l~~L~~L~L-s~n~l~~~~p~~~------------------------------------------------ 121 (983)
|.+|+++++|++|++||| ++|.++|..|-..
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 8898877644221
Q ss_pred ---CCCCCCCEEeccC--ccCCCCchhhhcccccccEEeccCcccccc-cCCcccccCCCcccceeecccccccCCCCCc
Q 042568 122 ---GSLIRLKQLSLSW--NSLQGKIPSQLGSLHQLEYLDLGNNKLVGE-IPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK 195 (983)
Q Consensus 122 ---~~l~~L~~L~Ls~--n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~-~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~ 195 (983)
.....++.+.++. |++++ +|..|++|++|++|+|++|+++|. +|.... .++.|.++|.+|..
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~-----------~~s~n~~~g~iP~~ 484 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE-----------DANSDYAKQYENEE 484 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS-----------CTTSHHHHHHTTSC
T ss_pred cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc-----------ccccccccccCChh
Confidence 1122334444433 67775 777777777777777777777762 111110 01112222234433
Q ss_pred c-cccccccceeecccCccccccchhhhccCCcceecccccc-ccc-ccchhh------hcCCCCccEEEccccccccCC
Q 042568 196 N-ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM-FSG-ELPSEI------ISKMPQLQFLYLSYNDFVSHD 266 (983)
Q Consensus 196 ~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~~------~~~l~~L~~L~Ls~N~l~~~~ 266 (983)
. |.++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+ +..+++|++|+|++|++..
T Consensus 485 l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~-- 562 (876)
T 4ecn_A 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-- 562 (876)
T ss_dssp CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB--
T ss_pred hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc--
Confidence 2 2355555555555555555555555556666666666655 554 455432 1223356666666665532
Q ss_pred CCCCCccccc--ccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCc-ccEEecccccc
Q 042568 267 GNTNLEPFFA--SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVN-LTLLNLSSNLL 343 (983)
Q Consensus 267 ~~~~~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l 343 (983)
++. .+.++++|++|+|++|+++ .+| .++.+ ++|+.|+|++|.++ .+|..+..+++ |++|+|++|++
T Consensus 563 -------ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L-~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 563 -------FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTN-VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -------CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTT-SEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred -------cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCC-CcceEEECcCCccc-cchHHHhhccccCCEEECcCCCC
Confidence 223 4555666666666666666 555 55554 35666666666666 66666666666 77777777776
Q ss_pred CCCCCcccccCCC--CcEEEeeCCcccCCCCCCC---C--CCCCCcEEEccCccccCcCcccccCcccchhhcccCccCC
Q 042568 344 NGTIPHELCLMSK--LERVYLSNNSLSGEIPSAF---G--DIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416 (983)
Q Consensus 344 ~~~~p~~l~~l~~--L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 416 (983)
+ .+|..+..++. |+.|+|++|.+.+.+|... . .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++
T Consensus 632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~ 710 (876)
T 4ecn_A 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710 (876)
T ss_dssp C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence 6 55666655543 7777777777766554322 2 2346777777777777332333346777777777777777
Q ss_pred CCCcccccCC--------CCCCEEEccCccccCcCCcccc--CCCccceeccccCCCCCCCCccccccccccccccccc-
Q 042568 417 GTIPSSLGKC--------VNLEILDLSHNKISGIIPSDVA--GLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF- 485 (983)
Q Consensus 417 ~~~p~~l~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~- 485 (983)
.+|..+... ++|+.|+|++|+++ .+|..+. .+++|+. |+|++|++++ +|..+..+++|+.|+|++
T Consensus 711 -~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~-L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N 786 (876)
T 4ecn_A 711 -SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSN-MDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786 (876)
T ss_dssp -CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCE-EECCSSCCSS-CCCGGGGCTTCCEEECCCC
T ss_pred -ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCE-EEeCCCCCCc-cchhhhcCCCCCEEECCCC
Confidence 455443332 27777777777777 5666665 7777775 7777777776 677777777777777766
Q ss_pred -----cccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 486 -----NNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 486 -----N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
|++.+.+|..|..+++|+.|+|++|++ +.+|..+. ++|+.|||++|++...-+..+.....+..+.|.+|++
T Consensus 787 ~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863 (876)
T ss_dssp BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTT
T ss_pred CCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCc
Confidence 556666666666666666666666666 45555544 4566666666666544444444444444445554443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=529.98 Aligned_cols=508 Identities=24% Similarity=0.240 Sum_probs=359.6
Q ss_pred cceeeEEECCC---------CCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCc
Q 042568 65 CNWSGVKCNNS---------RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWN 135 (983)
Q Consensus 65 c~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n 135 (983)
|.+.-|.|+.. ..+++.|+|+++.+.+..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 55566677542 247999999999999877788999999999999999999888999999999999999999
Q ss_pred cCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccc
Q 042568 136 SLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG 215 (983)
Q Consensus 136 ~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~ 215 (983)
++++..+..|+++++|++|+|++|++++..|..+ ..+++|++|+|++|.+++..| ..+..+++|++|++++|++++
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~ 159 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF---VKQKNLITLDLSHNGLSSTKL-GTQVQLENLQELLLSNNKIQA 159 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTT---TTCTTCCEEECCSSCCSCCCC-CSSSCCTTCCEEECCSSCCCC
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHc---cccCCCCEEECCCCcccccCc-hhhcccccCCEEEccCCcccc
Confidence 9996555679999999999999999985444544 478999999999999986544 556789999999999999998
Q ss_pred ccchhhh--ccCCcceecccccccccccchhhhcCCC---------------------------CccEEEccccccccCC
Q 042568 216 QVPQALA--NSSKLEWLDLESNMFSGELPSEIISKMP---------------------------QLQFLYLSYNDFVSHD 266 (983)
Q Consensus 216 ~~p~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~---------------------------~L~~L~Ls~N~l~~~~ 266 (983)
..+..+. .+++|++|++++|++++.. ...+..++ +|++|++++|.+....
T Consensus 160 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~ 238 (680)
T 1ziw_A 160 LKSEELDIFANSSLKKLELSSNQIKEFS-PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238 (680)
T ss_dssp BCHHHHGGGTTCEESEEECTTCCCCCBC-TTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEEC
T ss_pred cCHHHhhccccccccEEECCCCcccccC-hhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccC
Confidence 8887765 4588999999999988543 33344443 3444445544443321
Q ss_pred CCCCCcccccccCCC--CCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCC------------------
Q 042568 267 GNTNLEPFFASLANS--SNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPH------------------ 326 (983)
Q Consensus 267 ~~~~~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~------------------ 326 (983)
. ..+..+ ++|++|++++|++++..|..+..+ ++|++|++++|.+.+..|..
T Consensus 239 ~--------~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~ 309 (680)
T 1ziw_A 239 N--------TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWL-PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309 (680)
T ss_dssp T--------TTTGGGGGSCCCEEECTTSCCCEECTTTTTTC-TTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCC
T ss_pred h--------hHhhccCcCCCCEEECCCCCcCccCcccccCc-ccccEeeCCCCccCccChhhhcCCCCccEEeccchhhh
Confidence 1 112222 224555555555544444444444 24455555555444443333
Q ss_pred ---------------CCCCCcccEEeccccccCCCCCcccccCCCCcEEEe----------------------------e
Q 042568 327 ---------------ISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL----------------------------S 363 (983)
Q Consensus 327 ---------------l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L----------------------------~ 363 (983)
+..+++|++|++++|++++..+..+..+++|++|++ +
T Consensus 310 ~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~ 389 (680)
T 1ziw_A 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389 (680)
T ss_dssp C------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECT
T ss_pred cccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECC
Confidence 333444444444445554444444444444433333 3
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCc-ccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcccc--
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS-- 440 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-- 440 (983)
+|.+++..|..|..+++|+.|+|++|++++.+| ..|.++++|+.|++++|++++..+..|..+++|+.|++++|.++
T Consensus 390 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~ 469 (680)
T 1ziw_A 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469 (680)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCT
T ss_pred CCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccc
Confidence 444444555556666666666666666655443 45666666666666666666555666666666666666666665
Q ss_pred CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCC--------CcccccccccceEEeCCCcc
Q 042568 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSI--------PPQLGSCIALESLNLSGNSL 512 (983)
Q Consensus 441 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------p~~~~~l~~L~~L~Ls~N~l 512 (983)
+.+|..+..+++|+. |++++|++++..|..|.++++|++|+|++|++++.. +..|..+++|+.|+|++|++
T Consensus 470 ~~~p~~~~~l~~L~~-L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l 548 (680)
T 1ziw_A 470 DSSPSPFQPLRNLTI-LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548 (680)
T ss_dssp TCSSCTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCC
T ss_pred ccCCcccccCCCCCE-EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCC
Confidence 467778888888886 999999998877888888999999999999888542 12377888999999999999
Q ss_pred cccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCC-C-CCcccccccccCCcCccCC
Q 042568 513 EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK-G-AFSSLTIASFQGNDGLCGE 587 (983)
Q Consensus 513 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~-~~~~~~~~~~~~N~~lc~~ 587 (983)
+...+..|..+++|+.|+|++|++++..+..|.++++|+.|++++|++++.++.. . .+..+..+.+.+|||.|.-
T Consensus 549 ~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred CCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence 8655567899999999999999999666677889999999999999999877652 2 4677888899999999963
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=524.74 Aligned_cols=502 Identities=22% Similarity=0.201 Sum_probs=434.3
Q ss_pred CCccee----eEEECCC---------CCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCE
Q 042568 63 HVCNWS----GVKCNNS---------RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQ 129 (983)
Q Consensus 63 ~~c~w~----gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (983)
++|.|. .|.|+.. ..+++.|+|+++.+.+..+..+.++++|++|+|++|.+++..|..|+++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 456653 5778652 357999999999999888889999999999999999999888889999999999
Q ss_pred EeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccC-CCCCcccccccccceeec
Q 042568 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG-EIPLKNECELRNLRFLLL 208 (983)
Q Consensus 130 L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~-~ip~~~~~~l~~L~~L~L 208 (983)
|+|++|.+++..|..|+++++|++|+|++|++++..|..+ ..+++|++|++++|.+++ .+| ..+.++++|++|++
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~~~~lp-~~~~~l~~L~~L~L 160 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI---GQLITLKKLNVAHNFIHSCKLP-AYFSNLTNLVHVDL 160 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCC---TTCTTCCEEECCSSCCCCCCCC-GGGGTCTTCCEEEC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCcccccccccc---CCCCCCCEEeCCCCcccceech-HhHhhcCCCCEEEc
Confidence 9999999998889999999999999999999985554555 489999999999999986 455 46779999999999
Q ss_pred ccCccccccchhhhccCCcc----eecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCC-
Q 042568 209 WSNRLVGQVPQALANSSKLE----WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSN- 283 (983)
Q Consensus 209 ~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~- 283 (983)
++|++++..|..|+.+++|+ +|++++|+++ .++...+... +|++|++++|.+.. ...+..+.++++
T Consensus 161 s~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~-~~~~~~~~~~-~L~~L~L~~n~~~~-------~~~~~~~~~l~~L 231 (606)
T 3vq2_A 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI-KLHELTLRGNFNSS-------NIMKTCLQNLAGL 231 (606)
T ss_dssp CSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCC-EECTTTTTTC-EEEEEEEESCCSCH-------HHHHHHHHTTTTC
T ss_pred cCCcceecChhhhhhhhccccccceeeccCCCcc-eeCcccccCc-eeeeeeccCCccch-------hHHHHHhcccccc
Confidence 99999999999898887776 8999999998 6777776655 89999999997642 011222333333
Q ss_pred -------------------------------ccEEEc-cCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCC
Q 042568 284 -------------------------------FQELEL-AGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLV 331 (983)
Q Consensus 284 -------------------------------L~~L~L-~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~ 331 (983)
++.+++ ..|.+.+.+|. +..+ ++|+.|++++|.+. .+| .+..++
T Consensus 232 ~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l-~~L~~L~l~~~~~~-~l~-~l~~~~ 307 (606)
T 3vq2_A 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCL-ANVSAMSLAGVSIK-YLE-DVPKHF 307 (606)
T ss_dssp EEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGG-TTCSEEEEESCCCC-CCC-CCCTTC
T ss_pred ccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccc-cccC-CCCCEEEecCccch-hhh-hccccc
Confidence 444555 67778877777 5555 58999999999996 566 899999
Q ss_pred cccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCc--CcccccCcccchhhc
Q 042568 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS--IPDSFANLSQLRRLL 409 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~ 409 (983)
+|++|++++|++ +.+| .+ .+++|++|++++|...+.. .+..+++|+.|++++|++++. .|..+..+++|+.|+
T Consensus 308 ~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~ 382 (606)
T 3vq2_A 308 KWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382 (606)
T ss_dssp CCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEE
T ss_pred cCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeE
Confidence 999999999999 5788 45 9999999999999665444 678999999999999999876 388899999999999
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCcccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (983)
+++|.+++ +|..+..+++|+.|++++|++++..| ..+..+++|+. |++++|.+++..|..+..+++|+.|+|++|++
T Consensus 383 L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 460 (606)
T 3vq2_A 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY-LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460 (606)
T ss_dssp CCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE-EECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred CCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE-EECcCCCCCccchhhhcCCCCCCEEECCCCcC
Confidence 99999984 67889999999999999999998888 68899999996 99999999999999999999999999999999
Q ss_pred cc-CCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCC
Q 042568 489 SG-SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK 567 (983)
Q Consensus 489 ~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~ 567 (983)
++ .+|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|..|.++++|++|++++|+++..++..
T Consensus 461 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~ 540 (606)
T 3vq2_A 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540 (606)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCG
T ss_pred CCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhH
Confidence 98 47889999999999999999999999999999999999999999999999999999999999999999999777666
Q ss_pred CCCc-ccccccccCCcCccCCC
Q 042568 568 GAFS-SLTIASFQGNDGLCGEI 588 (983)
Q Consensus 568 ~~~~-~~~~~~~~~N~~lc~~~ 588 (983)
..+. .+..+.+.+||+.|.-+
T Consensus 541 ~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 541 QHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp GGSCTTCCEEECCSCCCCCSST
T ss_pred hhhcccCcEEEccCCCcccCCc
Confidence 6665 48888999999999644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=535.38 Aligned_cols=502 Identities=22% Similarity=0.218 Sum_probs=387.1
Q ss_pred cceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCC-ccccCCCCCCCEEeccCccCCCCchh
Q 042568 65 CNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHI-PAELGSLIRLKQLSLSWNSLQGKIPS 143 (983)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~n~l~~~~p~ 143 (983)
|.|..|-+ ...+++.|||++|.+++..+..+.++++|++|||++|.+.+.+ |..|+++++|++|+|++|.|++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777776 3467999999999999988999999999999999999777676 78899999999999999999988899
Q ss_pred hhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhc
Q 042568 144 QLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALAN 223 (983)
Q Consensus 144 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 223 (983)
.|+++++|++|+|++|.+++.+|... .+..+++|++|+|++|.+++..+...+.++++|++|+|++|.+++..|..+..
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDG-YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTC-CCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCc-cccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 99999999999999999998776541 12589999999999999998777778899999999999999999999999998
Q ss_pred c--CCcceecccccccccccchhhhcCCC------CccEEEccccccccCCCCCCC--------c---------------
Q 042568 224 S--SKLEWLDLESNMFSGELPSEIISKMP------QLQFLYLSYNDFVSHDGNTNL--------E--------------- 272 (983)
Q Consensus 224 l--~~L~~L~Ls~N~l~~~~~~~~~~~l~------~L~~L~Ls~N~l~~~~~~~~~--------~--------------- 272 (983)
+ ++|+.|+|++|.+++..|..+ ..++ .|++|+|++|.+......... .
T Consensus 171 l~~~~L~~L~L~~n~l~~~~~~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~ 249 (844)
T 3j0a_A 171 LQGKTLSFFSLAANSLYSRVSVDW-GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249 (844)
T ss_dssp HHHCSSCCCEECCSBSCCCCCCCC-CSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSC
T ss_pred ccCCccceEECCCCccccccccch-hhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccc
Confidence 8 899999999999997776543 3344 499999999976532110000 0
Q ss_pred -----ccccccCC--CCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCC
Q 042568 273 -----PFFASLAN--SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345 (983)
Q Consensus 273 -----~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 345 (983)
.....+.. .++|++|++++|.+.+..|..+..+ ++|+.|+|++|.+++..|..|..+++|++|+|++|++++
T Consensus 250 ~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 328 (844)
T 3j0a_A 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328 (844)
T ss_dssp SSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSC-CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSC
T ss_pred cccCCCChhhhhccccCCccEEECCCCcccccChhhhhcC-CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCc
Confidence 00011222 2678888888888888777777776 478888888888888888888888888888888888887
Q ss_pred CCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccC
Q 042568 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGK 425 (983)
Q Consensus 346 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~ 425 (983)
..|..+..+++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++. ..+++|+.|++++|+++ .+|..
T Consensus 329 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~--- 399 (844)
T 3j0a_A 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI--- 399 (844)
T ss_dssp CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---
T ss_pred cCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---
Confidence 7788888888888888888888887777888888888888888888742 23677788888888877 45543
Q ss_pred CCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCcc-ccccccccccccccccccc-----cCCCccccc
Q 042568 426 CVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPL-ELSKMDMVLAIDLSFNNLS-----GSIPPQLGS 498 (983)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~ 498 (983)
..+++.|++++|++++... ..+..+++|+. |+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|..
T Consensus 400 ~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~ 478 (844)
T 3j0a_A 400 NLTANLIHLSENRLENLDILYFLLRVPHLQI-LILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEG 478 (844)
T ss_dssp CTTCCEEECCSCCCCSSTTHHHHTTCTTCCE-EEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSC
T ss_pred ccccceeecccCccccCchhhhhhcCCccce-eeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcC
Confidence 3456677777777764321 22446677775 77777777754433 3455677777777777776 334455667
Q ss_pred ccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccc
Q 042568 499 CIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASF 578 (983)
Q Consensus 499 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~ 578 (983)
+++|+.|+|++|+|++.+|..+..+++|+.|+|++|+|++..|..+. ++|+.|++++|++++.+|. .+..+..+++
T Consensus 479 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l 554 (844)
T 3j0a_A 479 LSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDI 554 (844)
T ss_dssp BCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEE
T ss_pred cccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEe
Confidence 77777777777777777777777777777777777777765555554 6777777777777777764 3556667777
Q ss_pred cCCcCcc
Q 042568 579 QGNDGLC 585 (983)
Q Consensus 579 ~~N~~lc 585 (983)
.+||+.|
T Consensus 555 ~~Np~~C 561 (844)
T 3j0a_A 555 THNKFIC 561 (844)
T ss_dssp EEECCCC
T ss_pred cCCCccc
Confidence 7777777
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=504.55 Aligned_cols=473 Identities=22% Similarity=0.220 Sum_probs=420.3
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+++.|+|++|.+.+..|.+++++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L 136 (606)
T 3t6q_A 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136 (606)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEEC
T ss_pred ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEEC
Confidence 46999999999999888999999999999999999999888999999999999999999999777899999999999999
Q ss_pred cCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccc--eeecccCccccccchhhhccCCcceecccc
Q 042568 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLR--FLLLWSNRLVGQVPQALANSSKLEWLDLES 234 (983)
Q Consensus 157 s~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 234 (983)
++|++++..+..+. .+++|++|++++|.+++ ++...+..+++|+ .|++++|++++..|..+.. .+|++|++++
T Consensus 137 ~~n~l~~~~~~~~~---~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~ 211 (606)
T 3t6q_A 137 GSNHISSIKLPKGF---PTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGG 211 (606)
T ss_dssp CSSCCCCCCCCTTC---CCTTCCEEECCSSCCCE-ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCcccccCccccc---CCcccCEEEcccCcccc-cChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCC
Confidence 99999853222232 48999999999999984 4446677899999 8999999999888887665 6899999988
Q ss_pred cccc-------------------------cccchhhhcCCC--CccEEEccccccccCCCCCCCcccccccCCCCCccEE
Q 042568 235 NMFS-------------------------GELPSEIISKMP--QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQEL 287 (983)
Q Consensus 235 N~l~-------------------------~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L 287 (983)
|... ..++...+..+. +|++|++++|.+..+.. ..+..+++|++|
T Consensus 212 ~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~L 283 (606)
T 3t6q_A 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS--------NTFHCFSGLQEL 283 (606)
T ss_dssp CSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT--------TTTTTCTTCSEE
T ss_pred chhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH--------HHhccccCCCEE
Confidence 7511 022233333333 79999999999876442 347889999999
Q ss_pred EccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcc-cccCCCCcEEEeeCCc
Q 042568 288 ELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE-LCLMSKLERVYLSNNS 366 (983)
Q Consensus 288 ~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~ 366 (983)
++++|+++ .+|..+..+ ++|++|++++|.+.+..|..+..+++|++|++++|.+.+.+|.. +..+++|++|++++|.
T Consensus 284 ~l~~n~l~-~lp~~l~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 361 (606)
T 3t6q_A 284 DLTATHLS-ELPSGLVGL-STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361 (606)
T ss_dssp ECTTSCCS-CCCSSCCSC-TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSC
T ss_pred eccCCccC-CCChhhccc-ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCc
Confidence 99999998 678888887 58999999999999888999999999999999999998776654 8999999999999999
Q ss_pred ccCCC--CCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCccc-ccCCCCCCEEEccCccccCcC
Q 042568 367 LSGEI--PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS-LGKCVNLEILDLSHNKISGII 443 (983)
Q Consensus 367 l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~ 443 (983)
+.+.. |..+..+++|+.|++++|++.+..|..|..+++|+.|++++|++++..|.. +..+++|+.|++++|++++..
T Consensus 362 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 441 (606)
T 3t6q_A 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441 (606)
T ss_dssp CCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTC
T ss_pred cccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcC
Confidence 99876 888999999999999999999999999999999999999999999776654 899999999999999999999
Q ss_pred CccccCCCccceeccccCCCCCC---CCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccc
Q 042568 444 PSDVAGLRSLKLYLNLSSNHLDG---PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520 (983)
Q Consensus 444 p~~~~~l~~L~~~L~l~~N~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 520 (983)
|..+..+++|+. |++++|++++ ..+..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+
T Consensus 442 ~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 520 (606)
T 3t6q_A 442 EQLFDGLPALQH-LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520 (606)
T ss_dssp TTTTTTCTTCCE-EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGG
T ss_pred HHHHhCCCCCCE-EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHh
Confidence 999999999996 9999999987 334679999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC
Q 042568 521 GQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 521 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
..+++| .|++++|++++..|..+..+++|+.|++++|++++..+.
T Consensus 521 ~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp TTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred Cccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 999999 999999999998899999999999999999999987653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=500.82 Aligned_cols=489 Identities=22% Similarity=0.229 Sum_probs=330.1
Q ss_pred EEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCc
Q 042568 80 VELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNN 159 (983)
Q Consensus 80 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N 159 (983)
..+|.++++++ .+|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 35889999887 6777664 79999999999999877788999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccccccc
Q 042568 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG 239 (983)
Q Consensus 160 ~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 239 (983)
+++ .+|...+ ..+++|++|+|++|.++ .++...+..+++|++|+|++|.+++..|..++++++|++|++++|++++
T Consensus 84 ~l~-~l~~~~~--~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 159 (680)
T 1ziw_A 84 ELS-QLSDKTF--AFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159 (680)
T ss_dssp CCC-CCCTTTT--TTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred ccC-ccChhhh--ccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence 998 5665432 48999999999999998 5666678899999999999999999999999999999999999999985
Q ss_pred ccchhh-hcCCCCccEEEccccccccCCCCCCCcccccccC------------------------CCCCccEEEccCCcc
Q 042568 240 ELPSEI-ISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLA------------------------NSSNFQELELAGNNL 294 (983)
Q Consensus 240 ~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~------------------------~l~~L~~L~L~~n~l 294 (983)
..+..+ ...+++|++|++++|++....... +..+. ..++|++|++++|++
T Consensus 160 ~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-----~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l 234 (680)
T 1ziw_A 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGC-----FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234 (680)
T ss_dssp BCHHHHGGGTTCEESEEECTTCCCCCBCTTG-----GGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCC
T ss_pred cCHHHhhccccccccEEECCCCcccccChhh-----hhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcc
Confidence 444332 235689999999999887643210 11111 237899999999999
Q ss_pred cccCCccccccc-cCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccC----
Q 042568 295 GGMIPSIIGDLS-TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG---- 369 (983)
Q Consensus 295 ~~~~p~~~~~l~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~---- 369 (983)
++..|..+..+. ++|++|+|++|.+++..|..+..+++|++|++++|++++..|..+..+++|++|++++|...+
T Consensus 235 ~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~ 314 (680)
T 1ziw_A 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314 (680)
T ss_dssp CEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC----
T ss_pred cccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc
Confidence 999999888775 359999999999999999999999999999999999988777666555555555554443221
Q ss_pred -CCC----CCCCCCCCCcEEEccCccccCcCcccccCcccc----------------------------hhhcccCccCC
Q 042568 370 -EIP----SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL----------------------------RRLLLYGNHLS 416 (983)
Q Consensus 370 -~~p----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L----------------------------~~L~l~~N~l~ 416 (983)
.+| ..|..+++|+.|++++|++++..+..|.++++| +.|++++|+++
T Consensus 315 ~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~ 394 (680)
T 1ziw_A 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS 394 (680)
T ss_dssp --CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCC
T ss_pred ccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCC
Confidence 111 133344444444444444444333333333333 33333344444
Q ss_pred CCCcccccCCCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCcc-------------------------
Q 042568 417 GTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPL------------------------- 470 (983)
Q Consensus 417 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~------------------------- 470 (983)
+..|..|..+++|+.|++++|++++.+| ..+.++++|+. |++++|++++..+.
T Consensus 395 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p 473 (680)
T 1ziw_A 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE-IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCE-EECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSS
T ss_pred eEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccE-EecCCCCcceeChhhhhcCcccccchhccccccccccCC
Confidence 4445556666666666666666655444 45555666664 66666665544444
Q ss_pred -ccccccccccccccccccccCCCcccccccccceEEeCCCccccccc--------ccccCCCCccEEecCCccccCCcC
Q 042568 471 -ELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLP--------VSVGQLPYLKQFDVSSNRLFGEIP 541 (983)
Q Consensus 471 -~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~ls~N~l~~~~p 541 (983)
.|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+ ..+..+++|+.|+|++|+++...+
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 553 (680)
T 1ziw_A 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCT
T ss_pred cccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCH
Confidence 44445555555555555554444444555555555555555543211 124444555555555555542222
Q ss_pred ccccCCCCcceEeccCCccccccCCC-CCCcccccccccCC
Q 042568 542 QSFQASPTLKQLNFSFNKFSGNISNK-GAFSSLTIASFQGN 581 (983)
Q Consensus 542 ~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~N 581 (983)
..|.++++|+.|++++|++++.++.. ..+..+..+.+.+|
T Consensus 554 ~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred HHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 33555555555555555555444332 33344444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=494.97 Aligned_cols=474 Identities=23% Similarity=0.181 Sum_probs=416.4
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+++.|+|++|.+.+..|.+++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 46999999999999888889999999999999999999888999999999999999999999877789999999999999
Q ss_pred cCccccc-ccCCcccccCCCcccceeecccccccCCCCCcccccccccc----eeecccCccccccchhhhccCCcceec
Q 042568 157 GNNKLVG-EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLR----FLLLWSNRLVGQVPQALANSSKLEWLD 231 (983)
Q Consensus 157 s~N~l~~-~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~ 231 (983)
++|++++ .+|..+. .+++|++|++++|.+++ ++...+..+++|+ +|++++|++++..+..+... +|++|+
T Consensus 136 ~~n~l~~~~lp~~~~---~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~ 210 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFS---NLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELT 210 (606)
T ss_dssp CSSCCCCCCCCGGGG---TCTTCCEEECCSSCCCE-ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEE
T ss_pred CCCcccceechHhHh---hcCCCCEEEccCCccee-cChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeee
Confidence 9999985 5787765 89999999999999996 4445566676665 89999999997777766655 999999
Q ss_pred ccccccccccchhhhcCCCCccEEEccccccccCC------------------------CCCCCcccccccCCCCCccEE
Q 042568 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHD------------------------GNTNLEPFFASLANSSNFQEL 287 (983)
Q Consensus 232 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~------------------------~~~~~~~~~~~l~~l~~L~~L 287 (983)
+++|.+++......+..++.|+.+++..+.+.... ....+......+..+++|++|
T Consensus 211 L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L 290 (606)
T 3vq2_A 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM 290 (606)
T ss_dssp EESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEE
T ss_pred ccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEE
Confidence 99999986666677889999999888665543211 111122223337788999999
Q ss_pred EccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcc
Q 042568 288 ELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSL 367 (983)
Q Consensus 288 ~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 367 (983)
++++|.+.. +| .+..+ ++|++|++++|.+ +.+| .+ .+++|++|++++|...+.+ .+..+++|++|++++|.+
T Consensus 291 ~l~~~~~~~-l~-~l~~~-~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l 362 (606)
T 3vq2_A 291 SLAGVSIKY-LE-DVPKH-FKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNAL 362 (606)
T ss_dssp EEESCCCCC-CC-CCCTT-CCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCE
T ss_pred EecCccchh-hh-hcccc-ccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCcc
Confidence 999999974 55 66665 5899999999999 6888 55 9999999999999765444 677899999999999999
Q ss_pred cCC--CCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCc-ccccCCCCCCEEEccCccccCcCC
Q 042568 368 SGE--IPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP-SSLGKCVNLEILDLSHNKISGIIP 444 (983)
Q Consensus 368 ~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p 444 (983)
++. .|..+..+++|+.|+|++|++++ +|..|..+++|+.|++++|++++..| ..+..+++|+.|++++|++++..|
T Consensus 363 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 441 (606)
T 3vq2_A 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441 (606)
T ss_dssp EEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCT
T ss_pred CCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccch
Confidence 976 47889999999999999999985 66889999999999999999998877 689999999999999999999999
Q ss_pred ccccCCCccceeccccCCCCCC-CCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCC
Q 042568 445 SDVAGLRSLKLYLNLSSNHLDG-PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL 523 (983)
Q Consensus 445 ~~~~~l~~L~~~L~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 523 (983)
..+..+++|+. |++++|++++ .+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.+|..+..+
T Consensus 442 ~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 520 (606)
T 3vq2_A 442 GIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520 (606)
T ss_dssp TTTTTCTTCCE-EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTC
T ss_pred hhhcCCCCCCE-EECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCC
Confidence 99999999996 9999999998 489999999999999999999999999999999999999999999999999999999
Q ss_pred CCccEEecCCccccCCcCccccCCC-CcceEeccCCccccccCC
Q 042568 524 PYLKQFDVSSNRLFGEIPQSFQASP-TLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 524 ~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~ 566 (983)
++|+.|++++|+++ .+|..+..++ +|++|++++|++.+..+.
T Consensus 521 ~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 521 YSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999 7888899997 599999999999987654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=490.04 Aligned_cols=481 Identities=23% Similarity=0.237 Sum_probs=406.4
Q ss_pred CcceeeEEECCCC-----------CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEec
Q 042568 64 VCNWSGVKCNNSR-----------NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL 132 (983)
Q Consensus 64 ~c~w~gv~c~~~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 132 (983)
.|.|.|+ |+... .+++.|+|++|.+.+..|.++.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4999998 87531 36999999999999888899999999999999999999888899999999999999
Q ss_pred cCccCCCCchhhhcccccccEEeccCccccc-ccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccC
Q 042568 133 SWNSLQGKIPSQLGSLHQLEYLDLGNNKLVG-EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211 (983)
Q Consensus 133 s~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N 211 (983)
++|++++..|..|+++++|++|+|++|++++ .+|..+ ..+++|++|++++|.+.+.+|...+..+++|++|++++|
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n 158 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF---PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSC---TTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhh---hccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence 9999998888889999999999999999985 344444 489999999999999777888888899999999999999
Q ss_pred ccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccC
Q 042568 212 RLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291 (983)
Q Consensus 212 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 291 (983)
++++.+|..++++++|++|++++|.+. .+|...+..+++|++|+|++|++....... ......+++|++|++++
T Consensus 159 ~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-----~~~~~~~~~L~~L~l~~ 232 (549)
T 2z81_A 159 SLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSP-----LPVDEVSSPMKKLAFRG 232 (549)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCC-----CSSCCCCCCCCEEEEES
T ss_pred cccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccc-----cchhhhhhcccceeccc
Confidence 999999999999999999999999986 788877788999999999999987643110 11234578999999999
Q ss_pred CcccccCCccccc---cccCeeEEEccCccccccC------CCCCCCCCcccEEeccccccCCC-----CCcccccCCCC
Q 042568 292 NNLGGMIPSIIGD---LSTNLVQIHLDCNLIYGKI------PPHISNLVNLTLLNLSSNLLNGT-----IPHELCLMSKL 357 (983)
Q Consensus 292 n~l~~~~p~~~~~---l~~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L 357 (983)
|.+++..+..+.. ...+|+.+++++|.+.+.. ...+..+.+|+.|+++++.+... ++..+....+|
T Consensus 233 n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L 312 (549)
T 2z81_A 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312 (549)
T ss_dssp CEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTC
T ss_pred cccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccc
Confidence 9998765544432 1257999999999987632 23456788999999999987632 22223456789
Q ss_pred cEEEeeCCcccCCCCCCC-CCCCCCcEEEccCccccCcCc---ccccCcccchhhcccCccCCCCCc--ccccCCCCCCE
Q 042568 358 ERVYLSNNSLSGEIPSAF-GDIPHLGLLDLSKNKLSGSIP---DSFANLSQLRRLLLYGNHLSGTIP--SSLGKCVNLEI 431 (983)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~L~~ 431 (983)
+.|++++|.+. .+|..+ ..+++|+.|+|++|++++.+| ..++.+++|+.|++++|++++..+ ..+..+++|++
T Consensus 313 ~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~ 391 (549)
T 2z81_A 313 KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391 (549)
T ss_dssp CEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCE
T ss_pred eEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCE
Confidence 99999999998 566655 579999999999999998764 347889999999999999985432 46889999999
Q ss_pred EEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCc
Q 042568 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNS 511 (983)
Q Consensus 432 L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 511 (983)
|++++|+++ .+|..+..+++|+. |++++|++++ +|..+. ++|+.|||++|+|++.+ ..+++|+.|+|++|+
T Consensus 392 L~Ls~N~l~-~lp~~~~~~~~L~~-L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~ 462 (549)
T 2z81_A 392 LDISRNTFH-PMPDSCQWPEKMRF-LNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNK 462 (549)
T ss_dssp EECTTCCCC-CCCSCCCCCTTCCE-EECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSC
T ss_pred EECCCCCCc-cCChhhcccccccE-EECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCc
Confidence 999999999 68888999999996 9999999984 444332 58999999999999643 578899999999999
Q ss_pred ccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC
Q 042568 512 LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 512 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
|+ .+|. ...+++|+.|+|++|++++.+|..|..+++|+.|++++|+++|.+|.
T Consensus 463 l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred cC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99 5675 46799999999999999998888899999999999999999887764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=495.35 Aligned_cols=463 Identities=24% Similarity=0.264 Sum_probs=400.1
Q ss_pred CeEEEEEcccCCccccc-ccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhh--hcccccccE
Q 042568 77 NKVVELDLSARSIYGTI-SPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQ--LGSLHQLEY 153 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~--~~~L~~L~~ 153 (983)
.+++.|+|++|...+.+ |.+++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++.+|.. |+++++|++
T Consensus 48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~ 127 (844)
T 3j0a_A 48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127 (844)
T ss_dssp CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence 46899999999887788 678999999999999999999888999999999999999999999877776 999999999
Q ss_pred EeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccc--cccceeecccCccccccchhhhccCC-----
Q 042568 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL--RNLRFLLLWSNRLVGQVPQALANSSK----- 226 (983)
Q Consensus 154 L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~----- 226 (983)
|+|++|.+++..|...+ .++++|++|+|++|.+++..+ ..+..+ ++|+.|++++|.+.+..|..++.+.+
T Consensus 128 L~Ls~N~l~~~~~~~~~--~~L~~L~~L~Ls~N~i~~~~~-~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~ 204 (844)
T 3j0a_A 128 LDLSKNQIRSLYLHPSF--GKLNSLKSIDFSSNQIFLVCE-HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204 (844)
T ss_dssp EEEESCCCCCCCCCGGG--GTCSSCCEEEEESSCCCCCCS-GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTC
T ss_pred EECCCCcccccccchhH--hhCCCCCEEECCCCcCCeeCH-HHcccccCCccceEECCCCccccccccchhhcCCccccC
Confidence 99999999866554332 489999999999999987655 445556 89999999999999988888777766
Q ss_pred -cceecccccccccccchhhhcC-------------------------------------CCCccEEEccccccccCCCC
Q 042568 227 -LEWLDLESNMFSGELPSEIISK-------------------------------------MPQLQFLYLSYNDFVSHDGN 268 (983)
Q Consensus 227 -L~~L~Ls~N~l~~~~~~~~~~~-------------------------------------l~~L~~L~Ls~N~l~~~~~~ 268 (983)
|++|+|++|.+++.++..+... .++|++|+|++|.+....
T Consensus 205 ~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~-- 282 (844)
T 3j0a_A 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN-- 282 (844)
T ss_dssp CBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC--
T ss_pred ceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccC--
Confidence 9999999998876665443321 267999999999886532
Q ss_pred CCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCC
Q 042568 269 TNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIP 348 (983)
Q Consensus 269 ~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 348 (983)
+..+..+++|++|+|++|++++..|..+..+ ++|++|+|++|.+++..|..+..+++|++|++++|++++..+
T Consensus 283 ------~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 355 (844)
T 3j0a_A 283 ------SRVFETLKDLKVLNLAYNKINKIADEAFYGL-DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355 (844)
T ss_dssp ------SCCSSSCCCCCEEEEESCCCCEECTTTTTTC-SSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCS
T ss_pred ------hhhhhcCCCCCEEECCCCcCCCCChHHhcCC-CCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccCh
Confidence 3557889999999999999999888888887 589999999999998889999999999999999999998888
Q ss_pred cccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCC-cccccCCC
Q 042568 349 HELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI-PSSLGKCV 427 (983)
Q Consensus 349 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~l~ 427 (983)
..+..+++|++|+|++|.+++. ..+++|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+..++
T Consensus 356 ~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~ 426 (844)
T 3j0a_A 356 QTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVP 426 (844)
T ss_dssp SCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCT
T ss_pred hhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCC
Confidence 8899999999999999999843 33889999999999998 45543 467899999999999642 23466899
Q ss_pred CCCEEEccCccccCcCCc-cccCCCccceeccccCCCCC-----CCCccccccccccccccccccccccCCCcccccccc
Q 042568 428 NLEILDLSHNKISGIIPS-DVAGLRSLKLYLNLSSNHLD-----GPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA 501 (983)
Q Consensus 428 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 501 (983)
+|+.|+|++|++++..+. .+..+++|+. |++++|.++ +..|..|.++++|+.|+|++|+|++..|..|..+++
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~-L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCB-CEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred ccceeeCCCCcccccccccccccCCcccc-ccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 999999999999976544 4566889996 999999997 455677999999999999999999988889999999
Q ss_pred cceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC
Q 042568 502 LESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 502 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..| ++|+.|++++|++.+..+.
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSC
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCccccccc
Confidence 99999999999987777766 899999999999999999876 4789999999999987653
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=478.74 Aligned_cols=475 Identities=23% Similarity=0.233 Sum_probs=402.0
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+++.|+|++|.+.+..+.++.++++|++|||++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46899999999999888889999999999999999999877888999999999999999999877899999999999999
Q ss_pred cCcccccccCCcccccCCCcccceeecccccccC-CCCCcccccccccceeecccCccccccchhhhccCCc----ceec
Q 042568 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG-EIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL----EWLD 231 (983)
Q Consensus 157 s~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L----~~L~ 231 (983)
++|++++..+..+ ..+++|++|++++|.+++ .+| ..+.++++|++|++++|++++..|..++.+++| +.|+
T Consensus 108 ~~n~l~~l~~~~~---~~l~~L~~L~L~~n~l~~~~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~ 183 (570)
T 2z63_A 108 VETNLASLENFPI---GHLKTLKELNVAHNLIQSFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183 (570)
T ss_dssp TTSCCCCSTTCSC---TTCTTCCEEECCSSCCCCCCCC-GGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEE
T ss_pred cccccccCCCccc---cccccccEEecCCCccceecCh-hhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcc
Confidence 9999984333344 489999999999999986 345 457789999999999999999889999999999 8999
Q ss_pred ccccccccccchhhhcCCCCccEEEccccccccC----------------------CCCCCCc----ccccccCCCCCcc
Q 042568 232 LESNMFSGELPSEIISKMPQLQFLYLSYNDFVSH----------------------DGNTNLE----PFFASLANSSNFQ 285 (983)
Q Consensus 232 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----------------------~~~~~~~----~~~~~l~~l~~L~ 285 (983)
+++|.++ .++...+..+ +|++|++++|..... .....+. ..+..+.++ .++
T Consensus 184 l~~n~l~-~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l-~l~ 260 (570)
T 2z63_A 184 LSLNPMN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL-TIE 260 (570)
T ss_dssp CTTCCCC-EECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS-EEE
T ss_pred cCCCCce-ecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc-chh
Confidence 9999998 4555666655 899999998832110 0000000 001111111 356
Q ss_pred EEEccCC-cccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeC
Q 042568 286 ELELAGN-NLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364 (983)
Q Consensus 286 ~L~L~~n-~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 364 (983)
.+++++| .+.+.+|..+..+ ++|+.|++++|.+. .+|..+..+ +|++|++++|.++ .+|. ..+++|+.|++++
T Consensus 261 ~l~l~~~~~~~~~~~~~~~~l-~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~ 334 (570)
T 2z63_A 261 EFRLAYLDYYLDDIIDLFNCL-TNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTS 334 (570)
T ss_dssp EEEEEETTEEESCSTTTTGGG-TTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEES
T ss_pred hhhhhcchhhhhhchhhhcCc-CcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcC
Confidence 7777777 7777788888777 57999999999998 688888888 9999999999998 5565 4788999999999
Q ss_pred CcccCCCCCCCCCCCCCcEEEccCccccCcC--cccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc
Q 042568 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI--PDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
|.+.+..+. ..+++|+.|++++|++++.. |..+.++++|+.|++++|.+++. |..+..+++|+.|++++|++++.
T Consensus 335 n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~ 411 (570)
T 2z63_A 335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQM 411 (570)
T ss_dssp CBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESC
T ss_pred Ccccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccc
Confidence 998877665 78899999999999998654 77888999999999999999854 44599999999999999999987
Q ss_pred CC-ccccCCCccceeccccCCCCCCCCccccccccccccccccccccc-cCCCcccccccccceEEeCCCcccccccccc
Q 042568 443 IP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS-GSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520 (983)
Q Consensus 443 ~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 520 (983)
.| ..+..+++|+. |++++|.+++..|..+.++++|+.|+|++|+++ +.+|..+..+++|+.|+|++|++++..|..+
T Consensus 412 ~~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 412 SEFSVFLSLRNLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp TTSCTTTTCTTCCE-EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred cchhhhhcCCCCCE-EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 66 56888999996 999999999999999999999999999999998 6789999999999999999999998889999
Q ss_pred cCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCC
Q 042568 521 GQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKG 568 (983)
Q Consensus 521 ~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~ 568 (983)
..+++|+.|++++|++++..|..|.++++|+.|++++|+++|.+|...
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 999999999999999998888889999999999999999999888643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=438.43 Aligned_cols=263 Identities=29% Similarity=0.438 Sum_probs=205.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+++...++||+|+||+||+|+++ ..||||+++... ..+..++|.+|++++++++|||||++++++.. +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 45667889999999999999875 359999986543 33456789999999999999999999999865 568999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|++|+|.++++.. ..+++|..+..|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999753 346999999999999999999999985 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. ......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... .
T Consensus 187 ~~-----------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~-------- 243 (307)
T 3omv_A 187 GS-----------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----R-------- 243 (307)
T ss_dssp ------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----H--------
T ss_pred cc-----------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----H--------
Confidence 11 12234579999999999864 4689999999999999999999999864211 0
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+...+...... +.....+.+++.++.+++.+||+.||++|||+.||+++|+.++...
T Consensus 244 -----~~~~~~~~~~~~~---p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 244 -----DQIIFMVGRGYAS---PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp -----HHHHHHHHTTCCC---CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred -----HHHHHHHhcCCCC---CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111111111100 0011123446788999999999999999999999999999886554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=442.23 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=210.0
Q ss_pred CCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
+...+.||+|+||+||+|.+. +++.||||+++........++|.+|++++++++|||||+++|+|..++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 345688999999999999863 46789999997666555678999999999999999999999999999999999
Q ss_pred EecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
||||++|+|.+++..... ....++|..+.+|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 999999999999964321 1346999999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+|+.....+.. .......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 185 Ki~DFGlar~~~~~~~~-----------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~- 252 (308)
T 4gt4_A 185 KISDLGLFREVYAADYY-----------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS- 252 (308)
T ss_dssp EECCSCCBCGGGGGGCB-----------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-
T ss_pred EECCcccceeccCCCce-----------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-
Confidence 99999999876533211 22234579999999999999999999999999999999999 899986421
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.. ++++. +........ .++++.++.+++.+||+.||++|||++||+++|+.+
T Consensus 253 ----~~------------~~~~~-i~~~~~~~~-------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 ----NQ------------DVVEM-IRNRQVLPC-------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----HH------------HHHHH-HHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----HH------------HHHHH-HHcCCCCCC-------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 11111 111111111 134667899999999999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=440.03 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=213.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++++|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 35667889999999999999864 46789999997543 335678999999999999999999999999999999
Q ss_pred EEEecccCccccccccccc---------CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 741 LVLPLMSNGSLENHLYPSH---------GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
+|||||++|+|.++++... .....++|..+++|+.|||+||+|||+++ ||||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 12357999999999999999999999985 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHD 890 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~ 890 (983)
|+|||+|+........ .......||+.|||||++.+..|+.++|||||||++|||+| |+.||....
T Consensus 169 i~DFGla~~~~~~~~~-----------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-- 235 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-- 235 (299)
T ss_dssp ECCCSCHHHHTGGGCE-----------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred ECCcccceecCCCCce-----------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--
Confidence 9999999876532211 22233579999999999999999999999999999999999 899986421
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
. .+++........ ...| ..++.++.+++.+||+.||++|||++||.+.|+++.+...
T Consensus 236 ---~------------~~~~~~i~~~~~-~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 236 ---N------------NEVIECITQGRV-LQRP-------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp ---H------------HHHHHHHHHTCC-CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---H------------HHHHHHHHcCCC-CCCC-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 1 111222111111 1111 2356789999999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=441.82 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=206.2
Q ss_pred CCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+|...++||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++|||||+++++|.+.+..++
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4556788999999999999864 46789999996543 3356789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccC-----------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 742 VLPLMSNGSLENHLYPSHG-----------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
|||||++|+|.++++.... ...+++|.++++|+.|||+||+|||+.+ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999875432 1246999999999999999999999985 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 198 Ki~DFGla~~~~~~~~~-----------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~- 265 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYY-----------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS- 265 (329)
T ss_dssp EECCCC---------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-
T ss_pred EEcccccceeccCCCcc-----------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-
Confidence 99999999876432211 12233579999999999999999999999999999999999 899986421
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
. .++++..... .....| ..++.++.+++.+||+.||++|||++||+++|+.+.+..
T Consensus 266 ----~------------~~~~~~i~~g-~~~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 266 ----N------------TEAIDCITQG-RELERP-------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp ----H------------HHHHHHHHHT-CCCCCC-------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred ----H------------HHHHHHHHcC-CCCCCc-------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1 1112221111 111111 235678999999999999999999999999999997753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=467.92 Aligned_cols=481 Identities=22% Similarity=0.202 Sum_probs=408.6
Q ss_pred EEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCccc
Q 042568 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKL 161 (983)
Q Consensus 82 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l 161 (983)
++.++.+++ .+|..+. +++++|||++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 88 (570)
T 2z63_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (570)
T ss_dssp EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence 333444554 4565443 5799999999999988888999999999999999999987788999999999999999999
Q ss_pred ccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccc-ccchhhhccCCcceecccccccccc
Q 042568 162 VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG-QVPQALANSSKLEWLDLESNMFSGE 240 (983)
Q Consensus 162 ~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~ 240 (983)
++..|..+ ..+++|++|++++|.+++ ++...+..+++|++|++++|.+++ .+|..|+++++|++|++++|+++ .
T Consensus 89 ~~~~~~~~---~~l~~L~~L~L~~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~-~ 163 (570)
T 2z63_A 89 QSLALGAF---SGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-S 163 (570)
T ss_dssp CEECTTTT---TTCTTCCEEECTTSCCCC-STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC-E
T ss_pred CccCHhhh---cCcccccccccccccccc-CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc-e
Confidence 85555555 489999999999999984 555557899999999999999987 47999999999999999999998 4
Q ss_pred cchhhhcCCCCc----cEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCccccc-------------------
Q 042568 241 LPSEIISKMPQL----QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGM------------------- 297 (983)
Q Consensus 241 ~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~------------------- 297 (983)
++...+..+++| ++|++++|.+..... ..+. ..+|++|++++|.....
T Consensus 164 ~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~--------~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~ 234 (570)
T 2z63_A 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP--------GAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234 (570)
T ss_dssp ECGGGGHHHHTCTTCCCEEECTTCCCCEECT--------TTTT-TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEE
T ss_pred ecHHHccchhccchhhhhcccCCCCceecCH--------HHhc-cCcceeEecccccccccchhhhhcCccccceeeecc
Confidence 555666778888 899999999876432 2233 33799999988743210
Q ss_pred ------------CCccccccc-cCeeEEEccCc-cccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee
Q 042568 298 ------------IPSIIGDLS-TNLVQIHLDCN-LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363 (983)
Q Consensus 298 ------------~p~~~~~l~-~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 363 (983)
....+..+. -.++.++++.| .+.+.+|..+..+++|++|++++|.++ .+|..+..+ +|++|+++
T Consensus 235 ~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~ 312 (570)
T 2z63_A 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELV 312 (570)
T ss_dssp EECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEE
T ss_pred ccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeec
Confidence 011111111 14677888888 788889999999999999999999999 688888888 99999999
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCC--cccccCCCCCCEEEccCccccC
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI--PSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
+|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|+.|++++|.+++.. |..+..+++|++|++++|++++
T Consensus 313 ~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 387 (570)
T 2z63_A 313 NCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387 (570)
T ss_dssp SCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE
T ss_pred cCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc
Confidence 99999 5554 5789999999999999877665 78999999999999998554 6789999999999999999996
Q ss_pred cCCccccCCCccceeccccCCCCCCCCc-cccccccccccccccccccccCCCcccccccccceEEeCCCccc-cccccc
Q 042568 442 IIPSDVAGLRSLKLYLNLSSNHLDGPLP-LELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLE-GLLPVS 519 (983)
Q Consensus 442 ~~p~~~~~l~~L~~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~ 519 (983)
..+. +..+++|+. |++++|.+++..| ..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|+++ +.+|..
T Consensus 388 ~~~~-~~~l~~L~~-L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~ 465 (570)
T 2z63_A 388 MSSN-FLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465 (570)
T ss_dssp EEEE-EETCTTCCE-EECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSC
T ss_pred cccc-ccccCCCCE-EEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhh
Confidence 5554 999999996 9999999998776 57899999999999999999999999999999999999999998 679999
Q ss_pred ccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC-CCCCcccccccccCCcCccCCC
Q 042568 520 VGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGNDGLCGEI 588 (983)
Q Consensus 520 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~N~~lc~~~ 588 (983)
+..+++|+.|++++|++++..|..|..+++|++|++++|++++.+|. ...+..+..+.+.+|++.|.-+
T Consensus 466 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999999999999988899999999999999999999998875 4678889999999999988644
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=437.04 Aligned_cols=252 Identities=21% Similarity=0.322 Sum_probs=204.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+++.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999999999999964 689999999976542 3346789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
||+||+|.+++.... ...+++..++.|+.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997543 345789999999999999999999996 999999999999999999999999999876432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+
T Consensus 179 ~-------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~-------- 232 (350)
T 4b9d_A 179 V-------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----SMKN-------- 232 (350)
T ss_dssp H-------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH--------
T ss_pred c-------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHHH--------
Confidence 1 1123467999999999999999999999999999999999999998632 1111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+........+. .+...+.++.+++.+||+.||++|||++|++++
T Consensus 233 ----~~~~i~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 233 ----LVLKIISGSFPP--------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----HHHHHHHTCCCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHcCCCCC--------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222221110 112345788999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=431.71 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=208.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|+..+.||+|+||+||+|++. +|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45888899999999999999975 6899999999765433 456789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|++|+|.+++.. ..+++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999998863 45999999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...
T Consensus 225 -------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~---------- 276 (346)
T 4fih_A 225 -------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPL---------- 276 (346)
T ss_dssp -------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH----------
T ss_pred -------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH----------
Confidence 1123468999999999999999999999999999999999999998631 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+.. +........ ..+..++.++.+++.+|++.||++|||++|+++|
T Consensus 277 --~~~~~-i~~~~~~~~-----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 277 --KAMKM-IRDNLPPRL-----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --HHHHH-HHHSSCCCC-----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --HHHHH-HHcCCCCCC-----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 111111111 1234466789999999999999999999999986
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=478.15 Aligned_cols=456 Identities=21% Similarity=0.277 Sum_probs=389.1
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccC------CC------CchhhhcccccccEEeccCcccccccCCc
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL------QG------KIPSQLGSLHQLEYLDLGNNKLVGEIPIP 168 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l------~~------~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~ 168 (983)
.+++.|+|++|+++|.+|++|++|++|++|+|++|.+ .| .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4788999999999999999999999999999999987 33 556655 67788 999999999888776
Q ss_pred ccccCCCcccceeecccccccCCCCCcccccccccceeecc--cCccccccchhhhccCCcceecccccccccc------
Q 042568 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW--SNRLVGQVPQALANSSKLEWLDLESNMFSGE------ 240 (983)
Q Consensus 169 ~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~------ 240 (983)
+.. .+..+..+++....+.. .....++.+.+. +|++++ +|..|+++++|++|+|++|+++|.
T Consensus 158 ~~~--~~~~l~~~~l~~~~~~~-------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 227 (636)
T 4eco_A 158 FSD--LIKDCINSDPQQKSIKK-------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAW 227 (636)
T ss_dssp SCH--HHHHHHHHCTTSCCCCC-------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC
T ss_pred HHH--HHHHHhhcCcccccccc-------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccc
Confidence 642 24455556665544331 123344444444 588998 899999999999999999999975
Q ss_pred -----------cchhhhc--CCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCc-ccc-cCCcccccc
Q 042568 241 -----------LPSEIIS--KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN-LGG-MIPSIIGDL 305 (983)
Q Consensus 241 -----------~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~-l~~-~~p~~~~~l 305 (983)
+|..+ . ++++|++|+|++|++.. .++..+.++++|++|++++|+ +++ .+|..++.+
T Consensus 228 ~~~~~~~~~~~ip~~l-~~~~l~~L~~L~L~~n~l~~--------~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L 298 (636)
T 4eco_A 228 ENENSEYAQQYKTEDL-KWDNLKDLTDVEVYNCPNLT--------KLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298 (636)
T ss_dssp SCTTSHHHHHHTTSCC-CGGGCTTCCEEEEECCTTCS--------SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHH
T ss_pred cccccchhcccCchhh-hhcccCCCCEEEecCCcCCc--------cChHHHhcCCCCCEEECcCCCCCccccchHHHHhh
Confidence 77664 5 89999999999998754 345678899999999999998 998 899988876
Q ss_pred c-----cCeeEEEccCccccccCCC--CCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCC
Q 042568 306 S-----TNLVQIHLDCNLIYGKIPP--HISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI 378 (983)
Q Consensus 306 ~-----~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 378 (983)
. ++|++|++++|.++ .+|. .++++++|++|++++|+++|.+| .++.+++|++|+|++|.++ .+|..+..+
T Consensus 299 ~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 375 (636)
T 4eco_A 299 ADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGF 375 (636)
T ss_dssp HHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEE
T ss_pred hccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhh
Confidence 2 58999999999999 8999 89999999999999999999999 9999999999999999999 889999999
Q ss_pred CC-CcEEEccCccccCcCcccccCcc--cchhhcccCccCCCCCccccc-------CCCCCCEEEccCccccCcCCcccc
Q 042568 379 PH-LGLLDLSKNKLSGSIPDSFANLS--QLRRLLLYGNHLSGTIPSSLG-------KCVNLEILDLSHNKISGIIPSDVA 448 (983)
Q Consensus 379 ~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~~ 448 (983)
++ |+.|+|++|+++ .+|..+..++ +|+.|++++|.+++.+|..+. .+++|+.|+|++|+++...+..+.
T Consensus 376 ~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 454 (636)
T 4eco_A 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454 (636)
T ss_dssp CTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHH
T ss_pred cccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHc
Confidence 99 999999999999 7888888765 999999999999999999888 888999999999999954444566
Q ss_pred CCCccceeccccCCCCCCCCccc-cccc-------cccccccccccccccCCCcccc--cccccceEEeCCCcccccccc
Q 042568 449 GLRSLKLYLNLSSNHLDGPLPLE-LSKM-------DMVLAIDLSFNNLSGSIPPQLG--SCIALESLNLSGNSLEGLLPV 518 (983)
Q Consensus 449 ~l~~L~~~L~l~~N~l~~~~p~~-~~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~ 518 (983)
.+++|+. |+|++|+++ .+|.. +... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|.
T Consensus 455 ~l~~L~~-L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~ 530 (636)
T 4eco_A 455 TGSPLSS-INLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530 (636)
T ss_dssp TTCCCSE-EECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCC
T ss_pred cCCCCCE-EECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cCh
Confidence 7899996 999999999 55554 4333 39999999999999 7999887 99999999999999998 899
Q ss_pred cccCCCCccEEec------CCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCCcCccCCC
Q 042568 519 SVGQLPYLKQFDV------SSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEI 588 (983)
Q Consensus 519 ~~~~l~~L~~L~l------s~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~ 588 (983)
.+..+++|+.|+| ++|++.+.+|..+.++++|+.|++++|++ +.+|.. .++.+..+.+.+|+..|-..
T Consensus 531 ~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp GGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEEC
T ss_pred hhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccH
Confidence 9999999999999 56889999999999999999999999999 556553 33788999999999988654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=427.38 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=207.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|...++||+|+||+||+|++. +|+.||||+++.... ..+|++++++++|||||++++++.+.+..|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677788999999999999965 689999999975432 24799999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~~~~ 824 (983)
++||+|.+++... ..+++..+..|+.||++||+|||+++ ||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999753 46999999999999999999999996 99999999999999987 6999999999977543
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.... ........+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .+..
T Consensus 205 ~~~~--------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~-------- 266 (336)
T 4g3f_A 205 GLGK--------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCL-------- 266 (336)
T ss_dssp -----------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHH--------
T ss_pred Cccc--------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHH--------
Confidence 2110 011223467999999999999999999999999999999999999999643211 1111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.......+ ....+.+++.++.+++.+||+.||++|||+.|+++++.+..+..
T Consensus 267 -------~i~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 267 -------KIASEPPP------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp -------HHHHSCCG------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------HHHcCCCC------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 11111000 01112345678999999999999999999999999998876654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=428.51 Aligned_cols=278 Identities=22% Similarity=0.281 Sum_probs=203.9
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC----ceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD----FKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 743 (983)
+|...+.||+|+||+||+|++. |+.||||+++.... ....+..|+..+.+++|||||+++++|..++ ..++||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4566789999999999999985 89999999964422 1223345666667889999999999997654 569999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS-----PIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
||+++|+|.++++. .+++|..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.+||+|||+|
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999973 45899999999999999999999861 235999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC------CCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK------RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
+......... .......+||+.|||||++.+. .++.++|||||||++|||+||+.||........
T Consensus 156 ~~~~~~~~~~---------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 156 VRHDSATDTI---------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEEETTTTEE---------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred ccccCCCCce---------eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 8775433211 1122345799999999998764 467899999999999999999988754322221
Q ss_pred chHHHHHhhCCCC-CcHHHHHHH-hhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 893 SLHEWVKRHYPHR-LDPIVEKAI-AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 893 ~l~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.+..+ .+.. ..+.+...+ ........|. .....+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 227 p~~~~----~~~~~~~~~~~~~~~~~~~rp~~p~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 227 PYYDL----VPSDPSVEEMRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTT----SCSSCCHHHHHHHHTTSCCCCCCCG--GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchhc----ccccchHHHHHHHHhcccCCCCCCc--cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11110 0110 111112211 1111111121 111235778899999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=433.32 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=214.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCC-CCccceeeEEecC-C
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRH-RNLIRIITICSKP-D 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~ 737 (983)
.++|...+.||+|+||+||+|.+.. ++.||||+++........+.|.+|++++++++| ||||+++++|..+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 3578888999999999999998642 357999999776655566789999999999965 8999999999765 4
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++|||||++|+|.++++.... ....+++..+..|+.|||+||+|||+++ ||||||||+|||++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeC
Confidence 67999999999999999975432 1345899999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
+++.+||+|||+|+.+...... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~-----------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDY-----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTS-----------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCCEEECcchhhhhcccCCCc-----------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 9999999999999876533221 22234579999999999999999999999999999999998 99998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
..... .+.+...+........| +.++.++.+++.+||+.||++|||++||+++|++
T Consensus 289 ~~~~~-----------------~~~~~~~i~~g~~~~~p-------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 289 PGVKI-----------------DEEFCRRLKEGTRMRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TTCCC-----------------SHHHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCH-----------------HHHHHHHHHcCCCCCCC-------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 64211 11122222222211112 2245789999999999999999999999999999
Q ss_pred hHhhc
Q 042568 965 LKQYL 969 (983)
Q Consensus 965 ~~~~~ 969 (983)
+.+..
T Consensus 345 llq~~ 349 (353)
T 4ase_A 345 LLQAN 349 (353)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 87653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=423.97 Aligned_cols=250 Identities=21% Similarity=0.326 Sum_probs=207.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||+||+|+.. +++.||||++++.. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999964 68999999997542 2234678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++||+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999753 46999999999999999999999996 99999999999999999999999999998754
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..
T Consensus 185 ~~~~-----------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~-------- 240 (311)
T 4aw0_A 185 ESKQ-----------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEG-------- 240 (311)
T ss_dssp TTTC-----------CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH--------
T ss_pred CCCc-----------ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHH--------
Confidence 3221 2234468999999999999999999999999999999999999999631 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+++........ ..| +..+.++.+++.+|++.||++|||++|++.
T Consensus 241 ----~~~~~i~~~~~--~~p-------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 241 ----LIFAKIIKLEY--DFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----HHHHHHHHTCC--CCC-------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----HHHHHHHcCCC--CCC-------cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 12222222111 111 123467899999999999999999998753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=464.57 Aligned_cols=485 Identities=21% Similarity=0.233 Sum_probs=401.3
Q ss_pred EECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhccccc
Q 042568 71 KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQ 150 (983)
Q Consensus 71 ~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~ 150 (983)
.|... .| .|.++++++ .+|+.+. ++|++|+|++|.+++..|..|+++++|++|+|++|+|++..|..|+++++
T Consensus 3 ~C~~~--~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 3 SCDAS--GV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp EECTT--SE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCC--ce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 57542 24 688998887 6777664 79999999999999888999999999999999999999888899999999
Q ss_pred ccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccccc-chhhhccCCcce
Q 042568 151 LEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV-PQALANSSKLEW 229 (983)
Q Consensus 151 L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~ 229 (983)
|++|+|++|++++..|..+ ..+++|++|+|++|.+++......+..+++|++|++++|++.+.+ +..|+++++|++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~ 152 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWF---GPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152 (549)
T ss_dssp CCEEECTTSCCCSCCHHHH---TTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred CCEEECCCCccCccCHHHh---ccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCe
Confidence 9999999999996554445 488999999999999986333346779999999999999954445 478999999999
Q ss_pred ecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccC--Ccccccccc
Q 042568 230 LDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMI--PSIIGDLST 307 (983)
Q Consensus 230 L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~--p~~~~~l~~ 307 (983)
|++++|++++.+|. .+..+++|++|+++.|.+.... . ..+..+++|++|++++|++++.. |..+....+
T Consensus 153 L~L~~n~l~~~~~~-~l~~l~~L~~L~l~~n~~~~~~------~--~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~ 223 (549)
T 2z81_A 153 LEIKALSLRNYQSQ-SLKSIRDIHHLTLHLSESAFLL------E--IFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223 (549)
T ss_dssp EEEEETTCCEECTT-TTTTCSEEEEEEEECSBSTTHH------H--HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCC
T ss_pred eeccCCcccccChh-hhhccccCceEecccCcccccc------h--hhHhhcccccEEEccCCccccccccccchhhhhh
Confidence 99999999976664 4688999999999999864321 1 11345899999999999999753 334444457
Q ss_pred CeeEEEccCccccccCC----CCCCCCCcccEEeccccccCCCC------CcccccCCCCcEEEeeCCcccCCC-----C
Q 042568 308 NLVQIHLDCNLIYGKIP----PHISNLVNLTLLNLSSNLLNGTI------PHELCLMSKLERVYLSNNSLSGEI-----P 372 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~~-----p 372 (983)
+|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.. ...+..+.+|+.|++.++.+.... +
T Consensus 224 ~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~ 303 (549)
T 2z81_A 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303 (549)
T ss_dssp CCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCC
T ss_pred cccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccch
Confidence 89999999999987543 44567889999999999987642 234567889999999999876421 1
Q ss_pred CCCCCCCCCcEEEccCccccCcCcccc-cCcccchhhcccCccCCCCCcc---cccCCCCCCEEEccCccccCcCC--cc
Q 042568 373 SAFGDIPHLGLLDLSKNKLSGSIPDSF-ANLSQLRRLLLYGNHLSGTIPS---SLGKCVNLEILDLSHNKISGIIP--SD 446 (983)
Q Consensus 373 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~p--~~ 446 (983)
..+...++|+.|++++|++. .+|..+ ..+++|+.|++++|++++.+|. .++.+++|++|++++|++++..+ ..
T Consensus 304 ~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 382 (549)
T 2z81_A 304 TVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382 (549)
T ss_dssp HHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHH
T ss_pred hhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhh
Confidence 11233568999999999998 566665 5799999999999999976643 47889999999999999986543 45
Q ss_pred ccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCc
Q 042568 447 VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYL 526 (983)
Q Consensus 447 ~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 526 (983)
+..+++|+. |++++|+++ .+|..+..+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.+ ..+++|
T Consensus 383 ~~~l~~L~~-L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L 453 (549)
T 2z81_A 383 LLTLKNLTS-LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRL 453 (549)
T ss_dssp GGGCTTCCE-EECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTC
T ss_pred hhcCCCCCE-EECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChh
Confidence 888999996 999999999 68999999999999999999998 5665543 58999999999999753 578999
Q ss_pred cEEecCCccccCCcCccccCCCCcceEeccCCccccccCC-CCCCcccccccccCCcCccC
Q 042568 527 KQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 527 ~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~N~~lc~ 586 (983)
+.|+|++|+++ .+|. ...+++|++|++++|++++.+|. ...+..+..+++.+|++.|.
T Consensus 454 ~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 454 QELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred cEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 99999999998 7887 56899999999999999998886 57788899999999999886
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=415.75 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=196.9
Q ss_pred CCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEec----CCceeEEE
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSK----PDFKALVL 743 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 743 (983)
...++||+|+||+||+|.+. ++..||||.+.... .....++|.+|++++++++|||||+++++|.. ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45667999999999999965 68889999996543 33346789999999999999999999999864 34579999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEcccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVK 822 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~ 822 (983)
|||++|+|.+++.. ...+++..+..|+.||++||+|||++++ +||||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999975 3468999999999999999999999853 4999999999999984 7999999999998543
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||... ........
T Consensus 184 ~---------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~----~~~~~~~~--- 240 (290)
T 3fpq_A 184 A---------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIYR--- 240 (290)
T ss_dssp T---------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHHH---
T ss_pred C---------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC----CcHHHHHH---
Confidence 2 11223589999999998875 6999999999999999999999998532 11111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.... .+.... ...+.++.+++.+||+.||++|||++|+++|
T Consensus 241 ----------~i~~~~---~~~~~~---~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 241 ----------RVTSGV---KPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----------HHTTTC---CCGGGG---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----------HHHcCC---CCCCCC---ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110 111111 1234578999999999999999999999875
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=455.60 Aligned_cols=454 Identities=20% Similarity=0.247 Sum_probs=278.9
Q ss_pred EEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcc
Q 042568 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160 (983)
Q Consensus 81 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~ 160 (983)
.||+++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..|..|+++++|++|||++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 4666666666 4555544 666666666666665555666666666666666666665556666666666666666666
Q ss_pred cccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccc
Q 042568 161 LVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGE 240 (983)
Q Consensus 161 l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 240 (983)
++ .+|.. .+++|++|+|++|.+++. .+|..|+++++|++|+|++|++++
T Consensus 81 l~-~lp~~-----~l~~L~~L~L~~N~l~~~------------------------~~p~~~~~l~~L~~L~L~~n~l~~- 129 (520)
T 2z7x_B 81 LV-KISCH-----PTVNLKHLDLSFNAFDAL------------------------PICKEFGNMSQLKFLGLSTTHLEK- 129 (520)
T ss_dssp CC-EEECC-----CCCCCSEEECCSSCCSSC------------------------CCCGGGGGCTTCCEEEEEESSCCG-
T ss_pred ee-ecCcc-----ccCCccEEeccCCccccc------------------------cchhhhccCCcceEEEecCcccch-
Confidence 65 44432 344455555555554431 234455555555555555555442
Q ss_pred cchhhhcCCCCc--cEEEccccccccCCCCCCCcccccccCCCC-CccEEEccCCcccccCCccccccccCeeEEEccCc
Q 042568 241 LPSEIISKMPQL--QFLYLSYNDFVSHDGNTNLEPFFASLANSS-NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317 (983)
Q Consensus 241 ~~~~~~~~l~~L--~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N 317 (983)
..+..+++| ++|+|++|.+.... ..+..+..+. +...+++++|++.+.++.....-.++|+.|++++|
T Consensus 130 ---~~~~~l~~L~L~~L~l~~n~l~~~~------~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 200 (520)
T 2z7x_B 130 ---SSVLPIAHLNISKVLLVLGETYGEK------EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200 (520)
T ss_dssp ---GGGGGGTTSCEEEEEEEECTTTTSS------CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEEC
T ss_pred ---hhccccccceeeEEEeecccccccc------cccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccc
Confidence 123334444 55555555441100 0111222222 22345566666665555443333356777777776
Q ss_pred c-------ccccCCCCCCCCCcccEEeccccccCCCCCcccc---cCCCCcEEEeeCCcccCCCCCCC-----CCCCCCc
Q 042568 318 L-------IYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC---LMSKLERVYLSNNSLSGEIPSAF-----GDIPHLG 382 (983)
Q Consensus 318 ~-------l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~ 382 (983)
. +.+.+| .++.+++|+.|++++|.+++..+..+. ..++|++|++++|.+.+.+|..+ +.+++|+
T Consensus 201 ~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~ 279 (520)
T 2z7x_B 201 LEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279 (520)
T ss_dssp CSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEE
T ss_pred ccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeE
Confidence 5 555555 666777777777777776643222211 23567777777777777777776 7777777
Q ss_pred EEEccCccccCcCc-ccccCc---ccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceecc
Q 042568 383 LLDLSKNKLSGSIP-DSFANL---SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLN 458 (983)
Q Consensus 383 ~L~Ls~N~l~~~~~-~~~~~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~ 458 (983)
.+++++|.+ .+| ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|..+..+++|+. |+
T Consensus 280 ~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~-L~ 354 (520)
T 2z7x_B 280 IHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELET-LI 354 (520)
T ss_dssp EEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCE-EE
T ss_pred eccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCE-EE
Confidence 777777777 344 444444 55777777777765322 1256677777777777777777777777777775 77
Q ss_pred ccCCCCCC--CCccccccccccccccccccccccCCCcc-cccccccceEEeCCCcccccccccccCCCCccEEecCCcc
Q 042568 459 LSSNHLDG--PLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535 (983)
Q Consensus 459 l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 535 (983)
+++|++++ .+|..+..+++|+.|||++|++++.+|.. +..+++|+.|++++|++++.+|..+. ++|+.|++++|+
T Consensus 355 L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNK 432 (520)
T ss_dssp CCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSC
T ss_pred ccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCc
Confidence 77777775 45566777777777777777777656553 66677777777777777776666554 677777777777
Q ss_pred ccCCcCccccCCCCcceEeccCCccccccCC-CCCCcccccccccCCcCccC
Q 042568 536 LFGEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 536 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~N~~lc~ 586 (983)
++ .+|..+..+++|++|++++|+++..++. ...+..+..+.+.+|++.|.
T Consensus 433 l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 433 IK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence 77 6777666777777777777777755544 45566677777777777664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=432.87 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=208.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|+..+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+++|++++|||||+++++|.+.+..|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46888999999999999999965 6899999999765433 457799999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
|+||+|.+++.. ..+++..+..|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999998863 45999999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...
T Consensus 302 -------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~---------- 353 (423)
T 4fie_A 302 -------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPL---------- 353 (423)
T ss_dssp -------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH----------
T ss_pred -------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH----------
Confidence 1223468999999999999999999999999999999999999998531 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+.. +........ ..+..++.++.+++.+||+.||++|||++|+++|
T Consensus 354 --~~~~~-i~~~~~~~~-----~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 354 --KAMKM-IRDNLPPRL-----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --HHHHH-HHHSCCCCC-----SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --HHHHH-HHcCCCCCC-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 111111111 1123356789999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=409.72 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=192.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||+||+|+.. +++.||||+++... ..+..+++.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 78999999997553 2234678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+ +|+|.+++.. ..++++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799888864 346999999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... .....
T Consensus 165 ~~--------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~~~~~----- 220 (275)
T 3hyh_A 165 GN--------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----SIPVL----- 220 (275)
T ss_dssp ------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH-----
T ss_pred CC--------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----CHHHH-----
Confidence 21 1223579999999999998876 58999999999999999999998631 11111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+....... ..| ...+.++.+++.+|++.||++|||++|+++|=.
T Consensus 221 -------~~~i~~~~~--~~p-------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 221 -------FKNISNGVY--TLP-------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp -------HHHHHHTCC--CCC-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred -------HHHHHcCCC--CCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence 111111111 111 124567899999999999999999999998643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=465.98 Aligned_cols=445 Identities=22% Similarity=0.281 Sum_probs=353.3
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEec-cCccCCCCchhhhccc----c-----cccEE------ec-cCccccc
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSL-SWNSLQGKIPSQLGSL----H-----QLEYL------DL-GNNKLVG 163 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L-s~n~l~~~~p~~~~~L----~-----~L~~L------~L-s~N~l~~ 163 (983)
..++.|+|++|++.|.+|+.|++|++|++|+| ++|.++|..|.....+ + .++.. +. ....+.+
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 56889999999999999999999999999999 8888877644321111 0 00000 00 0000000
Q ss_pred cc-------CC--cccccCCCcccceeeccc--ccccCCCCCcccccccccceeecccCcccc-----------------
Q 042568 164 EI-------PI--PIFCSNSSTSLQYIDLSN--NSLTGEIPLKNECELRNLRFLLLWSNRLVG----------------- 215 (983)
Q Consensus 164 ~~-------p~--~~~~~~~l~~L~~L~Ls~--N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~----------------- 215 (983)
.+ |. .+. ......++.+.++. |.+++ +|. .+.++++|++|+|++|++++
T Consensus 403 l~~~~l~~~~~~~~i~-~~~~l~l~~l~l~~~~N~L~~-IP~-~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g 479 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIK-KDSRISLKDTQIGNLTNRITF-ISK-AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQ 479 (876)
T ss_dssp HHHHHHHTCTTSCCCC-CCCCCCCCTTTTTCCSCEEEE-ECG-GGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHHhhhCccccccc-cccccchhhceeccccCcccc-hhH-HHhcCCCCCEEECcCCcCCCCcccccccccccccccc
Confidence 00 00 000 01233455555554 77776 664 46678888888888888887
Q ss_pred ccchhhh--ccCCcceecccccccccccchhhhcCCCCccEEEccccc-ccc--CCCCCCCcccccccCCCCCccEEEcc
Q 042568 216 QVPQALA--NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND-FVS--HDGNTNLEPFFASLANSSNFQELELA 290 (983)
Q Consensus 216 ~~p~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~-l~~--~~~~~~~~~~~~~l~~l~~L~~L~L~ 290 (983)
.+|..++ ++++|++|+|++|++.+.+|. .+..+++|++|+|++|+ ++. ++. .+..+...+..+++|++|+|+
T Consensus 480 ~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~-~l~~L~~L~~L~Ls~N~~lsg~~iP~--~i~~L~~~~~~l~~L~~L~Ls 556 (876)
T 4ecn_A 480 YENEELSWSNLKDLTDVELYNCPNMTQLPD-FLYDLPELQSLNIACNRGISAAQLKA--DWTRLADDEDTGPKIQIFYMG 556 (876)
T ss_dssp HTTSCCCGGGCTTCCEEEEESCTTCCSCCG-GGGGCSSCCEEECTTCTTSCHHHHHH--HHHHHHHCTTTTTTCCEEECC
T ss_pred cCChhhhhccCCCCCEEECcCCCCCccChH-HHhCCCCCCEEECcCCCCcccccchH--HHHhhhhcccccCCccEEEee
Confidence 4899987 999999999999999999985 46899999999999998 642 110 000111134456799999999
Q ss_pred CCcccccCCc--cccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCC-CcEEEeeCCcc
Q 042568 291 GNNLGGMIPS--IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK-LERVYLSNNSL 367 (983)
Q Consensus 291 ~n~l~~~~p~--~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~L~~N~l 367 (983)
+|+++ .+|. .++.+ ++|+.|+|++|.++ .+| .++.+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.+
T Consensus 557 ~N~L~-~ip~~~~l~~L-~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 557 YNNLE-EFPASASLQKM-VKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp SSCCC-BCCCHHHHTTC-TTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred CCcCC-ccCChhhhhcC-CCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCC
Confidence 99999 8888 88888 48999999999999 888 9999999999999999999 88999999999 99999999999
Q ss_pred cCCCCCCCCCCCC--CcEEEccCccccCcCcccc---c--CcccchhhcccCccCCCCCcccc-cCCCCCCEEEccCccc
Q 042568 368 SGEIPSAFGDIPH--LGLLDLSKNKLSGSIPDSF---A--NLSQLRRLLLYGNHLSGTIPSSL-GKCVNLEILDLSHNKI 439 (983)
Q Consensus 368 ~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l 439 (983)
+ .+|..+..++. |+.|+|++|++.+.+|... . .+++|+.|+|++|.++ .+|..+ ..+++|+.|+|++|++
T Consensus 632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L 709 (876)
T 4ecn_A 632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLM 709 (876)
T ss_dssp C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCC
T ss_pred C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcC
Confidence 9 78888887765 9999999999998776432 2 3458999999999999 566654 5899999999999999
Q ss_pred cCcCCccccCC--------CccceeccccCCCCCCCCccccc--cccccccccccccccccCCCcccccccccceEEeCC
Q 042568 440 SGIIPSDVAGL--------RSLKLYLNLSSNHLDGPLPLELS--KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509 (983)
Q Consensus 440 ~~~~p~~~~~l--------~~L~~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 509 (983)
+ .+|..+... ++|+. |+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++
T Consensus 710 ~-~ip~~~~~~~~~~l~nl~~L~~-L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~ 785 (876)
T 4ecn_A 710 T-SIPENSLKPKDGNYKNTYLLTT-IDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785 (876)
T ss_dssp S-CCCTTSSSCTTSCCTTGGGCCE-EECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCC
T ss_pred C-ccChHHhccccccccccCCccE-EECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCC
Confidence 9 666654433 28986 999999999 7888887 99999999999999997 899999999999999976
Q ss_pred ------CcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccC
Q 042568 510 ------NSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 510 ------N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
|++.+.+|..+..+++|+.|+|++|++ +.+|..+. ++|+.|+|++|++....+
T Consensus 786 N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred CCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 889999999999999999999999999 79999876 699999999999976554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=457.32 Aligned_cols=443 Identities=21% Similarity=0.217 Sum_probs=331.6
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+++.|+|++|.+.+..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57999999999999888889999999999999999999888999999999999999999999 78877 8999999999
Q ss_pred cCccccc-ccCCcccccCCCcccceeecccccccCCCCCccccccccc--ceeecccCcc--ccccchhhhccC-Cccee
Q 042568 157 GNNKLVG-EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNL--RFLLLWSNRL--VGQVPQALANSS-KLEWL 230 (983)
Q Consensus 157 s~N~l~~-~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L--~~L~L~~N~l--~~~~p~~l~~l~-~L~~L 230 (983)
++|++++ .+|..+. .+++|++|++++|.+++ ..+..+++| ++|++++|++ .+..|..+..+. +...+
T Consensus 98 ~~N~l~~~~~p~~~~---~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l 170 (520)
T 2z7x_B 98 SFNAFDALPICKEFG---NMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHI 170 (520)
T ss_dssp CSSCCSSCCCCGGGG---GCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEE
T ss_pred cCCccccccchhhhc---cCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccccccceEEE
Confidence 9999986 4676665 78999999999999985 345678888 9999999999 888999888876 45577
Q ss_pred cccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCcccccc--ccC
Q 042568 231 DLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL--STN 308 (983)
Q Consensus 231 ~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l--~~~ 308 (983)
++++|++.+.++...+..+++|+.|++++|.-.. .........+.+..+++|++|++++|.+++..+..+... .++
T Consensus 171 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~--~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~ 248 (520)
T 2z7x_B 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN--KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248 (520)
T ss_dssp ECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTT--TTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSS
T ss_pred EeccCcchhhhhhhhhhcccceeecccccccccc--ccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCc
Confidence 8999999988998889999999999999986100 000111223467888999999999998886433322210 137
Q ss_pred eeEEEccCccccccCCCCC-----CCCCcccEEeccccccCCCCC-cccccC---CCCcEEEeeCCcccCCCCCCCCCCC
Q 042568 309 LVQIHLDCNLIYGKIPPHI-----SNLVNLTLLNLSSNLLNGTIP-HELCLM---SKLERVYLSNNSLSGEIPSAFGDIP 379 (983)
Q Consensus 309 L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~l~~l---~~L~~L~L~~N~l~~~~p~~~~~l~ 379 (983)
|++|++++|.++|.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..++
T Consensus 249 L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~ 324 (520)
T 2z7x_B 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKIS 324 (520)
T ss_dssp CSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCC
T ss_pred ccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCC
Confidence 8999999999988888888 8889999999999988 455 444444 67888888888876432 126777
Q ss_pred CCcEEEccCccccCcCcccccCcccchhhcccCccCCC--CCcccccCCCCCCEEEccCccccCcCCcc-ccCCCcccee
Q 042568 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG--TIPSSLGKCVNLEILDLSHNKISGIIPSD-VAGLRSLKLY 456 (983)
Q Consensus 380 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~~ 456 (983)
+|+.|++++|++++..|..++++++|+.|++++|++++ .+|..+..+++|++|++++|++++.+|.. +..+++|+.
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~- 403 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS- 403 (520)
T ss_dssp CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE-
T ss_pred cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE-
Confidence 88888888888887777777777788888888887775 44566777777777777777777644432 455555553
Q ss_pred ccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccc
Q 042568 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536 (983)
Q Consensus 457 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 536 (983)
|++++|++++. +|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++
T Consensus 404 L~Ls~N~l~~~------------------------~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l 456 (520)
T 2z7x_B 404 LNMSSNILTDT------------------------IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456 (520)
T ss_dssp EECCSSCCCGG------------------------GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred EECcCCCCCcc------------------------hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcC
Confidence 55555555544 443332 45555555555555 4555555566666666666666
Q ss_pred cCCcCcc-ccCCCCcceEeccCCcccccc
Q 042568 537 FGEIPQS-FQASPTLKQLNFSFNKFSGNI 564 (983)
Q Consensus 537 ~~~~p~~-~~~l~~L~~l~l~~N~l~~~~ 564 (983)
+ .+|.. |..+++|++|++++|++++..
T Consensus 457 ~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 457 K-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp C-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred C-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 5 34443 556666666666666665544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=415.13 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=197.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|++.+.||+|+||+||+|+.. +++.||||+++.... .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 467899999965432 2234578899999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||++||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999975 346999999999999999999999996 999999999999999999999999999865
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||... +..+
T Consensus 177 ~~~~-------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~~~----- 233 (304)
T 3ubd_A 177 IDHE-------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DRKE----- 233 (304)
T ss_dssp -----------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH-----
T ss_pred cCCC-------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CHHH-----
Confidence 4322 1223468999999999999999999999999999999999999998632 1111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
.......... ..| ..++.++.+++.+||+.||++||| ++|+++|
T Consensus 234 -------~~~~i~~~~~--~~p-------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 234 -------TMTMILKAKL--GMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -------HHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -------HHHHHHcCCC--CCC-------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1122111111 111 124567899999999999999998 4677764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=410.94 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=193.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC---------
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD--------- 737 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 737 (983)
+|++.+.||+|+||+||+|++. +|+.||||+++....+...+++.+|++++++++|||||++++++...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5788999999999999999965 689999999987665556678999999999999999999999986544
Q ss_pred ---ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 738 ---FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 738 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
..|+||||+++|+|.+++..... ....++..++.|+.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999975432 234577788999999999999999996 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
||+|+............. ...........+||+.|||||++.+..|+.++||||+||++|||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~-~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLT-PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER 233 (299)
T ss_dssp CCCC---------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred CccceecCCCcccccccc-ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence 999998765432211100 0011122334679999999999999999999999999999999996 764210 00
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ..+........| ..+.+....+.+++.+|++.||++|||+.|++++
T Consensus 234 ~----------------~~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 V----------------RTLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H----------------HHHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H----------------HHHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 001111111111 1234455667889999999999999999999885
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=435.48 Aligned_cols=521 Identities=23% Similarity=0.199 Sum_probs=378.9
Q ss_pred ccccCCCCCCC---CCCccee----eEEECCC---------CCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCC
Q 042568 51 EHALESWNSTD---VHVCNWS----GVKCNNS---------RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQ 114 (983)
Q Consensus 51 ~~~l~sw~~~~---~~~c~w~----gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~ 114 (983)
...+++|+.+- .++|.|. .|.|... ...++.|||++|.|++..+.+|.++++|++|||++|+|+
T Consensus 10 ~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~ 89 (635)
T 4g8a_A 10 DDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 89 (635)
T ss_dssp ---------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred cchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC
Confidence 34555665321 1235543 4678642 236899999999999777778999999999999999999
Q ss_pred CCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCC
Q 042568 115 GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPL 194 (983)
Q Consensus 115 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~ 194 (983)
+..|..|+++++|++|+|++|+|++..+..|++|++|++|+|++|++++ +|...+ ..+++|++|+|++|.+++....
T Consensus 90 ~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 90 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPI--GHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC-STTCCC--TTCTTCCEEECCSSCCCCCCCC
T ss_pred CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC-CChhhh--hcCcccCeeccccCccccCCCc
Confidence 7777789999999999999999997677789999999999999999984 444322 4889999999999999865444
Q ss_pred cccccccccceeecccCccccccchhhhccCCcc----eecccccccccccchhhhcCCCCccEEEccccccccC-----
Q 042568 195 KNECELRNLRFLLLWSNRLVGQVPQALANSSKLE----WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSH----- 265 (983)
Q Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----- 265 (983)
..+..+++|++|+|++|++++..|..|..+.+++ .++++.|.++ .++...+. ...++.|++++|.....
T Consensus 167 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~ 244 (635)
T 4g8a_A 167 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTC 244 (635)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHH
T ss_pred hhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc-ccCccccc-chhhhhhhhhcccccccccchh
Confidence 5677899999999999999998898888876654 5778888887 45555443 34566777776632110
Q ss_pred ----C-------------CCCCCc-ccccccCCCCCccEEEccCCccccc---CCccccccccCeeEEEccCccccccCC
Q 042568 266 ----D-------------GNTNLE-PFFASLANSSNFQELELAGNNLGGM---IPSIIGDLSTNLVQIHLDCNLIYGKIP 324 (983)
Q Consensus 266 ----~-------------~~~~~~-~~~~~l~~l~~L~~L~L~~n~l~~~---~p~~~~~l~~~L~~L~L~~N~l~~~~p 324 (983)
. ....+. .....+.....+...++..+..... ++..+.. ..+++.+++..|.+...
T Consensus 245 ~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~-~~~l~~l~~~~~~~~~~-- 321 (635)
T 4g8a_A 245 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNC-LTNVSSFSLVSVTIERV-- 321 (635)
T ss_dssp HHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGG-GTTCSEEEEESCEEEEC--
T ss_pred hcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhh-hcccccccccccccccc--
Confidence 0 000000 0001112222333333332222111 1111222 24567777777766543
Q ss_pred CCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccC--cCcccccCc
Q 042568 325 PHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG--SIPDSFANL 402 (983)
Q Consensus 325 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l 402 (983)
..+....+|+.|++++|.+.+..+ ..+..|+.+++++|.+.... .+..+++|+.|++++|.+.. ..+..+..+
T Consensus 322 ~~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~ 396 (635)
T 4g8a_A 322 KDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 396 (635)
T ss_dssp GGGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSC
T ss_pred cccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCCc--ccccccccccchhhccccccccccccchhhh
Confidence 235556678888888888775433 24567888888888776433 35578889999999998853 355667778
Q ss_pred ccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCccccccccccccc
Q 042568 403 SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAI 481 (983)
Q Consensus 403 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L 481 (983)
.+|+.|++..|.+. ..+..+..+++|+.+++++|+.....+ ..+..+..++. ++++.|.+++..|..+..++.|+.|
T Consensus 397 ~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~-l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 397 ISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE-EECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccccc-ccccccccccccccccccchhhhhh
Confidence 88999999888877 455667888999999999888776554 45677888885 9999999998888899999999999
Q ss_pred cccccccc-cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 482 DLSFNNLS-GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 482 ~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
+|++|++. +.+|..|..+++|+.|+|++|+|++.+|..|.++++|+.|+|++|+|++..|..|.++++|++|++++|++
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l 554 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 554 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcC
Confidence 99999754 45678889999999999999999988899999999999999999999988888899999999999999999
Q ss_pred ccccCCC-CCC-cccccccccCCcCccC
Q 042568 561 SGNISNK-GAF-SSLTIASFQGNDGLCG 586 (983)
Q Consensus 561 ~~~~~~~-~~~-~~~~~~~~~~N~~lc~ 586 (983)
++.+|.. ..+ .++..+.+.+||+.|.
T Consensus 555 ~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 555 MTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred CCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 9988763 334 5678888999999884
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=431.96 Aligned_cols=455 Identities=21% Similarity=0.206 Sum_probs=330.5
Q ss_pred EEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCc
Q 042568 80 VELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNN 159 (983)
Q Consensus 80 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N 159 (983)
..+|++++++++ +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|+|++..|..|+++++|++|||++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 678889998884 776654 78999999999999777788999999999999999999877888999999999999999
Q ss_pred ccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCc--ceeccccccc
Q 042568 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL--EWLDLESNMF 237 (983)
Q Consensus 160 ~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~l 237 (983)
+++ .+|.. .+++|++|+|++|++++.-....+.++++|++|++++|++++. .+..+++| ++|+|++|++
T Consensus 111 ~l~-~lp~~-----~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 111 RLQ-NISCC-----PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CCC-EECSC-----CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred cCC-ccCcc-----ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 998 67765 5789999999999988532235678899999999999998864 34555555 9999999988
Q ss_pred --ccccchhhhcCCC-CccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCc-----ccccCCccccccccCe
Q 042568 238 --SGELPSEIISKMP-QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN-----LGGMIPSIIGDLSTNL 309 (983)
Q Consensus 238 --~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~-----l~~~~p~~~~~l~~~L 309 (983)
++..|.. +..+. ..-.++++.|.+...- ....+.++++|+.|++++|+ +.+.+ ..+..+ ++|
T Consensus 182 ~~~~~~~~~-l~~l~~~~l~l~l~~n~~~~~~-------~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l-~~L 251 (562)
T 3a79_B 182 HIKGGETES-LQIPNTTVLHLVFHPNSLFSVQ-------VNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRG-PTL 251 (562)
T ss_dssp CCCSSSCCE-EEECCEEEEEEEECSSSCCCCC-------CEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSC-SSC
T ss_pred cccccCccc-ccccCcceEEEEecCccchhhh-------hhhcccccceEEEecccccccccchHHHHH-HHHhcc-Ccc
Confidence 6555543 33333 1224566766654311 11345566778888888774 22111 223333 356
Q ss_pred eEEEccCcccccc----CCCCCCCCCcccEEeccccccCCCCCccc-----ccCCCCcEEEeeCCcccCCCC-CCCCC--
Q 042568 310 VQIHLDCNLIYGK----IPPHISNLVNLTLLNLSSNLLNGTIPHEL-----CLMSKLERVYLSNNSLSGEIP-SAFGD-- 377 (983)
Q Consensus 310 ~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~p-~~~~~-- 377 (983)
+.|+++++.+.+. +++.+ ..++|++|++++|+++|.+|..+ ..++.|+.++++.|.+ .+| ..+..
T Consensus 252 ~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~ 328 (562)
T 3a79_B 252 LNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVF 328 (562)
T ss_dssp EEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHH
T ss_pred eEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhh
Confidence 6666666655432 11111 22477888888888877777766 5566666666666665 233 22221
Q ss_pred -CCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc--CCccccCCCccc
Q 042568 378 -IPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI--IPSDVAGLRSLK 454 (983)
Q Consensus 378 -l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~ 454 (983)
..+|+.|++++|++.... ....+++|+.|++++|.+++.+|..+..+++|+.|++++|++++. +|..+..+++|+
T Consensus 329 ~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~ 406 (562)
T 3a79_B 329 AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406 (562)
T ss_dssp HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC
T ss_pred ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC
Confidence 146788888888775322 125777888888888888877788888888888888888888763 345677888888
Q ss_pred eeccccCCCCCCCCcc-ccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCC
Q 042568 455 LYLNLSSNHLDGPLPL-ELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533 (983)
Q Consensus 455 ~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 533 (983)
. |++++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++
T Consensus 407 ~-L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~ 482 (562)
T 3a79_B 407 T-LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482 (562)
T ss_dssp E-EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCS
T ss_pred E-EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCC
Confidence 5 88888888874554 477888888888998888877776655 68999999999998 6777777899999999999
Q ss_pred ccccCCcCcc-ccCCCCcceEeccCCccccccCC
Q 042568 534 NRLFGEIPQS-FQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 534 N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
|+++ .+|.. |..+++|++|++++|+++|..+.
T Consensus 483 N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 483 NQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 9998 56665 88999999999999999887653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=426.75 Aligned_cols=453 Identities=20% Similarity=0.222 Sum_probs=372.8
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
..+++|+++|+++ .+|..+. ++|++|+|++|.|++..|..|+++++|++|+|++|++++..|..+. .+++|++|
T Consensus 32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L 105 (562)
T 3a79_B 32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL---FNQDLEYL 105 (562)
T ss_dssp -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTT---TCTTCCEE
T ss_pred CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhC---CCCCCCEE
Confidence 3489999999999 5887765 8999999999999988889999999999999999999966666554 89999999
Q ss_pred ecccccccCCCCCcccccccccceeecccCcccc-ccchhhhccCCcceecccccccccccchhhhcCCCCc--cEEEcc
Q 042568 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG-QVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL--QFLYLS 258 (983)
Q Consensus 182 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L--~~L~Ls 258 (983)
+|++|.++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++ . .+..+++| ++|+|+
T Consensus 106 ~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-~---~~~~l~~L~L~~L~L~ 177 (562)
T 3a79_B 106 DVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-L---DLLPVAHLHLSCILLD 177 (562)
T ss_dssp ECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-T---TTGGGTTSCEEEEEEE
T ss_pred ECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc-C---chhhhhhceeeEEEee
Confidence 99999998 67765 79999999999999997 457899999999999999999984 2 24455555 999999
Q ss_pred cccc--ccCCCCCCCcccccccCCCC-CccEEEccCCcccccCCccccccccCeeEEEccCcc-----ccccCCCCCCCC
Q 042568 259 YNDF--VSHDGNTNLEPFFASLANSS-NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNL-----IYGKIPPHISNL 330 (983)
Q Consensus 259 ~N~l--~~~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~-----l~~~~p~~l~~l 330 (983)
+|.+ .... +..+..+. ..-.+++++|.+.+.++.....-.++|+.+++++|. +.+. +..+..+
T Consensus 178 ~n~l~~~~~~--------~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l 248 (562)
T 3a79_B 178 LVSYHIKGGE--------TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRG 248 (562)
T ss_dssp ESSCCCCSSS--------CCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSC
T ss_pred cccccccccC--------cccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhcc
Confidence 9988 4321 12233322 222668899999987777655555789999999985 2222 2356778
Q ss_pred CcccEEeccccccCCCC----CcccccCCCCcEEEeeCCcccCCCCCCC-----CCCCCCcEEEccCccccCcCc-cccc
Q 042568 331 VNLTLLNLSSNLLNGTI----PHELCLMSKLERVYLSNNSLSGEIPSAF-----GDIPHLGLLDLSKNKLSGSIP-DSFA 400 (983)
Q Consensus 331 ~~L~~L~Ls~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~~-~~~~ 400 (983)
++|+.|+++++.+++.. +..+ ..++|++|++++|.+++.+|..+ ..++.|+.++++.|.+ .+| ..+.
T Consensus 249 ~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~ 325 (562)
T 3a79_B 249 PTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALY 325 (562)
T ss_dssp SSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHH
T ss_pred CcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhh
Confidence 88999999888876432 2222 34589999999999999999887 7788888888888887 344 3333
Q ss_pred Cc---ccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC--Cccccccc
Q 042568 401 NL---SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP--LPLELSKM 475 (983)
Q Consensus 401 ~l---~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~--~p~~~~~l 475 (983)
.+ .+|+.|++++|.+.... ....+++|++|++++|++++.+|..+..+++|+. |++++|++++. +|..+..+
T Consensus 326 ~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~~~l 402 (562)
T 3a79_B 326 SVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLKNFFKVALMTKNM 402 (562)
T ss_dssp HHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCE-EECCSSCCCBTTHHHHTTTTC
T ss_pred hhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCE-EECCCCCcCCcccchhhhcCC
Confidence 32 57999999999987432 1268899999999999999999999999999996 99999999973 45779999
Q ss_pred cccccccccccccccCCCc-ccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEe
Q 042568 476 DMVLAIDLSFNNLSGSIPP-QLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLN 554 (983)
Q Consensus 476 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~ 554 (983)
++|+.|+|++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|++|+
T Consensus 403 ~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 9999999999999986765 478899999999999999988887665 79999999999998 7888888999999999
Q ss_pred ccCCccccccCC-CCCCcccccccccCCcCccC
Q 042568 555 FSFNKFSGNISN-KGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 555 l~~N~l~~~~~~-~~~~~~~~~~~~~~N~~lc~ 586 (983)
+++|++++.++. ...+..+..+.+.+|++.|.
T Consensus 480 L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 480 VASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp CCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred CCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 999999976665 67788889999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=407.12 Aligned_cols=276 Identities=22% Similarity=0.262 Sum_probs=205.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEec------CCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSK------PDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 738 (983)
++|.+.+.||+|+||+||+|++. +|+.||||+++..... ...+++.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57889999999999999999965 7899999999655432 345678899999999999999999998754 356
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 799999996 678888864 356999999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+.+...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.... ....+..+
T Consensus 206 ~~~~~~~~~---------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I 275 (398)
T 4b99_A 206 RGLCTSPAE---------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLI 275 (398)
T ss_dssp BCC----------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHH
T ss_pred eecccCccc---------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHH
Confidence 876432111 01223446899999999998875 56999999999999999999999986321 01111122
Q ss_pred HHhhCCCC--C-c----HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 898 VKRHYPHR--L-D----PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 898 ~~~~~~~~--~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ . . ......+.. .+...+......+.....++.+|+.+|++.||++|||++|+++|
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQS-LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHS-SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhc-CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 22111111 0 0 001111111 11111211222223346788999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=398.42 Aligned_cols=284 Identities=22% Similarity=0.281 Sum_probs=203.1
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
...++|.+.++||+|+||+||+|+.+ +++.||||.+.... ...++.+|+++++.+ +||||+++++++.+.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34578999999999999999999853 46789999986543 246788999999998 69999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGI 817 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgl 817 (983)
.++||||+++|+|.+++. .+++.+++.++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999874 3889999999999999999999996 9999999999999876 7999999999
Q ss_pred cccccCCcccccccCC---------------CCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCC
Q 042568 818 AKLVKGIDESVNCAND---------------SMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~ 881 (983)
|+...+.......... ...........+||+.|||||++.+. .|+.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9876543211100000 00001122345799999999999875 5899999999999999999999
Q ss_pred CCCCcccCCCCchHHHHHh---------------------hCCCC-CcHHHHHHHhhcCCC--------CCccccccchH
Q 042568 882 RPTDVLFHDGSSLHEWVKR---------------------HYPHR-LDPIVEKAIAKYAPQ--------HMPIYYNKVWS 931 (983)
Q Consensus 882 ~p~~~~~~~~~~l~~~~~~---------------------~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 931 (983)
.||.....+...+..+... ..+.. .....+. +...... .........|.
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCER-LRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHH-HC----------------------CT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHh-hccccccccccccccccccccccccc
Confidence 9985322111111111110 00100 1111111 1000000 00000112234
Q ss_pred HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 932 DVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 932 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.++.+|+.+|++.||++|||++|+++|
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 456788999999999999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=403.37 Aligned_cols=394 Identities=26% Similarity=0.317 Sum_probs=158.8
Q ss_pred cccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccc-------------cEEeccCccccc
Q 042568 97 LANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQL-------------EYLDLGNNKLVG 163 (983)
Q Consensus 97 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L-------------~~L~Ls~N~l~~ 163 (983)
-...++|++|++++|.+ |.+|++|+++++|++|++++|.++|.+|..++++++| ++|++++|.++
T Consensus 7 ~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~- 84 (454)
T 1jl5_A 7 NVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84 (454)
T ss_dssp ----------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-
T ss_pred ccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-
Confidence 33457788888888888 6888888888888888888888888888888887776 56666666655
Q ss_pred ccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccch
Q 042568 164 EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS 243 (983)
Q Consensus 164 ~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 243 (983)
.+|. ..++|++|++++|.+++ +|. .+++|++|++++|++++. |.. .++|++|++++|++++ +|
T Consensus 85 ~lp~------~~~~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp- 147 (454)
T 1jl5_A 85 SLPE------LPPHLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP- 147 (454)
T ss_dssp CCCS------CCTTCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-
T ss_pred cCCC------CcCCCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-
Confidence 2333 12455556666665554 442 135555555555555531 111 1455555555555552 44
Q ss_pred hhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccC
Q 042568 244 EIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKI 323 (983)
Q Consensus 244 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~ 323 (983)
+ +..+++|++|++++|++..++. ...+|++|++++|++++ +
T Consensus 148 ~-~~~l~~L~~L~l~~N~l~~lp~------------~~~~L~~L~L~~n~l~~--------------------------l 188 (454)
T 1jl5_A 148 E-LQNSSFLKIIDVDNNSLKKLPD------------LPPSLEFIAAGNNQLEE--------------------------L 188 (454)
T ss_dssp C-CTTCTTCCEEECCSSCCSCCCC------------CCTTCCEEECCSSCCSS--------------------------C
T ss_pred c-cCCCCCCCEEECCCCcCcccCC------------CcccccEEECcCCcCCc--------------------------C
Confidence 1 4555555555555555433211 01244555555555443 2
Q ss_pred CCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcc
Q 042568 324 PPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLS 403 (983)
Q Consensus 324 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 403 (983)
| .++++++|++|++++|++++ +|.. .++|++|++++|.++ .+| .++.+++|+.|++++|++++ +|.. ++
T Consensus 189 ~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~ 257 (454)
T 1jl5_A 189 P-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PP 257 (454)
T ss_dssp C-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CT
T ss_pred c-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---cc
Confidence 3 34444444444444444443 2221 124444455554444 333 24444445555555554443 2221 23
Q ss_pred cchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccc-ccccccc
Q 042568 404 QLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKM-DMVLAID 482 (983)
Q Consensus 404 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l-~~L~~L~ 482 (983)
+|+.|++++|++++ +|.. +++|+.|++++|++++. |.. .++|+. |++++|++++ ++ .+ ++|+.|+
T Consensus 258 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~-L~l~~N~l~~-i~----~~~~~L~~L~ 323 (454)
T 1jl5_A 258 SLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYY-LNASSNEIRS-LC----DLPPSLEELN 323 (454)
T ss_dssp TCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCE-EECCSSCCSE-EC----CCCTTCCEEE
T ss_pred ccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCE-EECcCCcCCc-cc----CCcCcCCEEE
Confidence 44444455554442 3322 23445555555544431 110 123332 4455554443 11 11 2444455
Q ss_pred ccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccC--CcCccccCC-------------
Q 042568 483 LSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG--EIPQSFQAS------------- 547 (983)
Q Consensus 483 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l------------- 547 (983)
+++|++++ +|.. +++|+.|++++|++++ +|. .+++|+.|++++|++++ .+|.++.++
T Consensus 324 Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~ 395 (454)
T 1jl5_A 324 VSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELP 395 (454)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------
T ss_pred CCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccccccccccc
Confidence 55555543 3332 2445555555555542 333 23445555555555554 444444444
Q ss_pred CCcceEeccCCcccc--ccCCCCCCcccccccccCCcCccC
Q 042568 548 PTLKQLNFSFNKFSG--NISNKGAFSSLTIASFQGNDGLCG 586 (983)
Q Consensus 548 ~~L~~l~l~~N~l~~--~~~~~~~~~~~~~~~~~~N~~lc~ 586 (983)
++|++|++++|++++ .+|. .+..+.+.+|...|.
T Consensus 396 ~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~~ 431 (454)
T 1jl5_A 396 QNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVDP 431 (454)
T ss_dssp -----------------------------------------
T ss_pred CcCCEEECCCCcCCccccchh-----hHhheeCcCcccCCc
Confidence 789999999999997 4443 233445555554443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=381.20 Aligned_cols=293 Identities=28% Similarity=0.448 Sum_probs=215.4
Q ss_pred cccHHhHHHHHHHHHhccCCCccccCCCCCCCCCCcc--eeeEEECCCC--CeEEEEEcccCCccc--ccccccccCCCC
Q 042568 30 DQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCN--WSGVKCNNSR--NKVVELDLSARSIYG--TISPALANLSSL 103 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L 103 (983)
.|.++|++||++||+++. ||. .+++|.. +.+||. |.||+|+..+ ++|+.|+|+++++.| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 478899999999999994 775 7999976 467898 9999998765 899999999999999 899999999999
Q ss_pred cEEeCcC-CcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceee
Q 042568 104 IVLDLSK-NFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYID 182 (983)
Q Consensus 104 ~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~ 182 (983)
++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..+.
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~------------ 146 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS------------ 146 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG------------
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHh------------
Confidence 9999995 899989999999999999999999999988999999999999999999998877765543
Q ss_pred cccccccCCCCCcccccccccceeecccCccccccchhhhccC-CcceecccccccccccchhhhcCCCCccEEEccccc
Q 042568 183 LSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSS-KLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261 (983)
Q Consensus 183 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 261 (983)
.+++|++|+|++|++++.+|..++.++ +|++|+|++|++++.+|..+
T Consensus 147 ----------------~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~---------------- 194 (313)
T 1ogq_A 147 ----------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF---------------- 194 (313)
T ss_dssp ----------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGG----------------
T ss_pred ----------------cCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHH----------------
Confidence 456666666666666666666676666 66777777776665544322
Q ss_pred cccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEecccc
Q 042568 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341 (983)
Q Consensus 262 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 341 (983)
..+ .|++|++++|.+++..|..+..+++|++|+|++|
T Consensus 195 -----------------------------------------~~l--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 231 (313)
T 1ogq_A 195 -----------------------------------------ANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp -----------------------------------------GGC--CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred -----------------------------------------hCC--cccEEECcCCcccCcCCHHHhcCCCCCEEECCCC
Confidence 111 1333344444444444445555566666666666
Q ss_pred ccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCcc
Q 042568 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH 414 (983)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 414 (983)
++++.+|. +..+++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 232 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp EECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 66644443 555666666666666666666666666666666666666666666654 666667777776665
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=385.28 Aligned_cols=295 Identities=35% Similarity=0.534 Sum_probs=236.7
Q ss_pred hcCCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceee
Q 042568 652 AKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731 (983)
Q Consensus 652 ~~~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 731 (983)
.....++++++...+++|...+.||+|+||.||+|...+++.||||++..........++.+|++++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 44567899999999999999999999999999999988899999999976654444557999999999999999999999
Q ss_pred EEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 732 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
++...+..++||||+++|+|.+++.........+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987655556799999999999999999999998333399999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc---c
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL---F 888 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~---~ 888 (983)
|+|||+++........ ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||+.. .
T Consensus 175 l~Dfg~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH------------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp ECCCSSCEECCSSSSC------------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred eccCccccccCccccc------------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 9999999876532211 122346999999999998888999999999999999999999999632 1
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
........|+.......... ..... ........+.+.++.+++.+|++.||++|||++||+++|+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLE-------ALVDV---DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCST-------TSSCT---TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred ccchhHHHHHHHHhhchhhh-------hhcCh---hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 23344555554433322100 00000 011122356788999999999999999999999999999875433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=376.84 Aligned_cols=288 Identities=32% Similarity=0.533 Sum_probs=228.8
Q ss_pred CCCHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 656 RVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 656 ~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
++.+.++..++++|...+.||+|+||.||+|.+.+++.||||++..... ...+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3444455667889999999999999999999988899999999865433 346789999999999999999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.+..++||||+++|+|.+++.........+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999999765444456999999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCC-CCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD-GSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~-~~~l 894 (983)
|+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 184 g~~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~ 252 (321)
T 2qkw_B 184 GISKKGTELDQT-----------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252 (321)
T ss_dssp TTCEECSSSSCC-----------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred cccccccccccc-----------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence 999865432211 1122346999999999998889999999999999999999999999754322 2222
Q ss_pred HHHHHhhCC-CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 895 HEWVKRHYP-HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 895 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..|...... ..+. ... .+........+++.++.+++.+|++.||++|||++|++++|+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 253 AEWAVESHNNGQLE--------QIV---DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHHTHHHHTTTCCC--------SSS---SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhhhccccccHH--------Hhc---ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 333221111 0000 000 011112233568889999999999999999999999999999887643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=396.63 Aligned_cols=374 Identities=19% Similarity=0.168 Sum_probs=231.1
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCc-hhhhcccccccEEeccCcccccccCCcccccCCCcccc
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI-PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQ 179 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~ 179 (983)
++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++..|..+. .+++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~---~l~~L~ 106 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFN---GLANLE 106 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTT---TCTTCC
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhcc---CcccCC
Confidence 67888888888888777778888888888888888887555 45678888888888888888766566554 677888
Q ss_pred eeecccccccCCCC-CcccccccccceeecccCccccccchh-hhccCCcceecccccccccccchhhhcCC--CCccEE
Q 042568 180 YIDLSNNSLTGEIP-LKNECELRNLRFLLLWSNRLVGQVPQA-LANSSKLEWLDLESNMFSGELPSEIISKM--PQLQFL 255 (983)
Q Consensus 180 ~L~Ls~N~l~~~ip-~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l--~~L~~L 255 (983)
+|+|++|.+++.+| ...+..+++|++|+|++|++++..|.. +.++++|++|+|++|++++..+. .+..+ .+|+.|
T Consensus 107 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~l~~l~~~~L~~L 185 (455)
T 3v47_A 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE-DLLNFQGKHFTLL 185 (455)
T ss_dssp EEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTT-TSGGGTTCEEEEE
T ss_pred EEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChh-hhhcccccccccc
Confidence 88888888776433 234667888888888888888777765 77888888888888888754443 33433 577788
Q ss_pred EccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccc--cCeeEEEccCccccccCCCCCCCCCcc
Q 042568 256 YLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS--TNLVQIHLDCNLIYGKIPPHISNLVNL 333 (983)
Q Consensus 256 ~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~~L~~L~L~~N~l~~~~p~~l~~l~~L 333 (983)
++++|.+...............+..+++|++|++++|++++..|..+.... ++|+.|++++|.+.+..
T Consensus 186 ~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~---------- 255 (455)
T 3v47_A 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS---------- 255 (455)
T ss_dssp ECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC----------
T ss_pred ccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc----------
Confidence 888887765433221112223344567778888888877776666655431 45666777666654321
Q ss_pred cEEeccccccCCCCCccccc--CCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 334 TLLNLSSNLLNGTIPHELCL--MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
+..+.+.+..+..+.. .++|++|++++|.+.+.+|..|+.+++|+.|+|++|++++..|..|.++++|+.|+|+
T Consensus 256 ----~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 331 (455)
T 3v47_A 256 ----FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS 331 (455)
T ss_dssp ----TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred ----cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECC
Confidence 1111222122222222 2455666666666655555555555556666665555555545555555555555555
Q ss_pred CccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccC
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 491 (983)
+|.+++..|..|..+++|++|+|++|+++ +..|..|..+++|++|+|++|+|++.
T Consensus 332 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 332 QNFLGSIDSRMFENLDKLEVLDLSYNHIR-------------------------ALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp SSCCCEECGGGGTTCTTCCEEECCSSCCC-------------------------EECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCccCCcChhHhcCcccCCEEECCCCccc-------------------------ccChhhccccccccEEECCCCccccC
Confidence 55554444444444555555555555444 44444455555555555555555544
Q ss_pred CCcccccccccceEEeCCCccccccc
Q 042568 492 IPPQLGSCIALESLNLSGNSLEGLLP 517 (983)
Q Consensus 492 ~p~~~~~l~~L~~L~Ls~N~l~~~~p 517 (983)
.+..+..+++|+.|+|++|++++..|
T Consensus 387 ~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 387 PDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CHhHhccCCcccEEEccCCCcccCCC
Confidence 44445666666666666666665554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=403.40 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=199.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHH---HHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKR---ECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.+.++||+|+||+||+|+.. +|+.||||++++... ......+.+ ++++++.++|||||+++++|.+++..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 46889999999999999999965 689999999965421 112233333 456667779999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||++||+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999753 46999999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
+.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||...... ....
T Consensus 342 ~~~~~---------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~--~~~~--- 401 (689)
T 3v5w_A 342 FSKKK---------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE--- 401 (689)
T ss_dssp CSSCC---------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC--CHHH---
T ss_pred cCCCC---------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHH---
Confidence 64321 223589999999999974 57999999999999999999999999642111 1111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
+....... . ...| ...+.++.+++.+|++.||++|++ ++||++|
T Consensus 402 ---------i~~~i~~~-~-~~~p-------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 402 ---------IDRMTLTM-A-VELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------HHHHHHHC-C-CCCC-------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------HHHhhcCC-C-CCCC-------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11111111 1 1111 224578899999999999999998 6888865
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=394.69 Aligned_cols=390 Identities=19% Similarity=0.176 Sum_probs=265.9
Q ss_pred cEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeec
Q 042568 104 IVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDL 183 (983)
Q Consensus 104 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L 183 (983)
+.++.++++++ .+|. + .++|++|+|++|.|++..|..|+++++|++|+|++|.+.+.+|..
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~--------------- 73 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN--------------- 73 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTT---------------
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcc---------------
Confidence 35777777777 6676 3 267888888888888777888888888888888888876555432
Q ss_pred ccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccch-hhhcCCCCccEEEcccccc
Q 042568 184 SNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS-EIISKMPQLQFLYLSYNDF 262 (983)
Q Consensus 184 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~Ls~N~l 262 (983)
.+..+++|++|+|++|++++..|..|+++++|++|+|++|++++.++. ..+..+++|++|+|++|++
T Consensus 74 ------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l 141 (455)
T 3v47_A 74 ------------TFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141 (455)
T ss_dssp ------------TTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBC
T ss_pred ------------cccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCcc
Confidence 334667777777777777777777777778888888888877754332 3355666666666666665
Q ss_pred ccCCCCCCCcccccc-cCCCCCccEEEccCCcccccCCccccccc-cCeeEEEccCccccccCCCCC--------CCCCc
Q 042568 263 VSHDGNTNLEPFFAS-LANSSNFQELELAGNNLGGMIPSIIGDLS-TNLVQIHLDCNLIYGKIPPHI--------SNLVN 332 (983)
Q Consensus 263 ~~~~~~~~~~~~~~~-l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~~L~~L~L~~N~l~~~~p~~l--------~~l~~ 332 (983)
.... +.. +.++++|++|++++|++++..|..+..+. .+|+.|++++|.+.+..+..+ ..+++
T Consensus 142 ~~~~--------~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~ 213 (455)
T 3v47_A 142 KKIQ--------PASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213 (455)
T ss_dssp CSCC--------CCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCE
T ss_pred CccC--------cccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccce
Confidence 4321 111 45566677777777777666666555542 356666666666654333222 23445
Q ss_pred ccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccC
Q 042568 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYG 412 (983)
Q Consensus 333 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 412 (983)
|++|++++|++++..|..+... ...++|+.|++++|.+.+... ..
T Consensus 214 L~~L~Ls~n~l~~~~~~~~~~~---------------------~~~~~L~~L~l~~~~~~~~~~--------------~~ 258 (455)
T 3v47_A 214 ITTLDLSGNGFKESMAKRFFDA---------------------IAGTKIQSLILSNSYNMGSSF--------------GH 258 (455)
T ss_dssp EEEEECTTSCCCHHHHHHHHHH---------------------TTTCCEEEEECTTCTTTSCCT--------------TC
T ss_pred eeeEecCCCcccccchhhhhcc---------------------ccccceeeEeecccccccccc--------------ch
Confidence 5555555555554444433322 011344444444444332110 11
Q ss_pred ccCCCCCcccccC--CCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccccccc
Q 042568 413 NHLSGTIPSSLGK--CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG 490 (983)
Q Consensus 413 N~l~~~~p~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (983)
+.+.+..+..+.. .++|+.|++++|++++.+|..+..+++|+. |++++|++++..|..|..+++|+.|+|++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 337 (455)
T 3v47_A 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ-LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337 (455)
T ss_dssp CSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred hhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCE-EECCCCcccccChhHhcCcccCCEEECCCCccCC
Confidence 1122112222222 357888888888888888888888888885 8888888888788888888888889999999887
Q ss_pred CCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCC
Q 042568 491 SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKG 568 (983)
Q Consensus 491 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~ 568 (983)
..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..|..+++|++|++++|++++.+|...
T Consensus 338 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 778888889999999999999998888899999999999999999987666778899999999999999998888643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=391.49 Aligned_cols=406 Identities=25% Similarity=0.312 Sum_probs=277.9
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCC-------------CEEeccCccCCCCchh
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRL-------------KQLSLSWNSLQGKIPS 143 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~Ls~n~l~~~~p~ 143 (983)
.++.+|+++++.+ |.+|++++++++|++|++++|.++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4688999999999 8999999999999999999999999999999999875 999999999994 555
Q ss_pred hhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhc
Q 042568 144 QLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALAN 223 (983)
Q Consensus 144 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 223 (983)
. .++|++|++++|++++ +|.. .++|++|++++|++++ +|. ..++|++|++++|++++ +| .|++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~------~~~L~~L~l~~n~l~~-l~~----~~~~L~~L~L~~n~l~~-lp-~~~~ 151 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL------PQSLKSLLVDNNNLKA-LSD----LPPLLEYLGVSNNQLEK-LP-ELQN 151 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC------CTTCCEEECCSSCCSC-CCS----CCTTCCEEECCSSCCSS-CC-CCTT
T ss_pred C---cCCCCEEEccCCcCCc-cccc------cCCCcEEECCCCccCc-ccC----CCCCCCEEECcCCCCCC-Cc-ccCC
Confidence 2 3789999999999995 7752 4799999999999985 432 12799999999999997 67 5999
Q ss_pred cCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCcccc
Q 042568 224 SSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIG 303 (983)
Q Consensus 224 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 303 (983)
+++|++|++++|++++ +|.. .++|++|++++|++... +.+.++++|++|++++|++++ +|..
T Consensus 152 l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~l----------~~~~~l~~L~~L~l~~N~l~~-l~~~-- 213 (454)
T 1jl5_A 152 SSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEEL----------PELQNLPFLTAIYADNNSLKK-LPDL-- 213 (454)
T ss_dssp CTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSSC----------CCCTTCTTCCEEECCSSCCSS-CCCC--
T ss_pred CCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCcC----------ccccCCCCCCEEECCCCcCCc-CCCC--
Confidence 9999999999999984 6643 46999999999998653 247889999999999999986 4443
Q ss_pred ccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcE
Q 042568 304 DLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGL 383 (983)
Q Consensus 304 ~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 383 (983)
+.+|++|++++|.++ .+| .++.+++|++|++++|++++ +|.. +++|+.|++++|.+++ +|.. .++|+.
T Consensus 214 --~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~ 281 (454)
T 1jl5_A 214 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTF 281 (454)
T ss_dssp --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCE
T ss_pred --cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCE
Confidence 358999999999998 677 49999999999999999995 5543 4789999999999996 5543 378999
Q ss_pred EEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCC-CCCCEEEccCccccCcCCccccCCCccceeccccCC
Q 042568 384 LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKC-VNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSN 462 (983)
Q Consensus 384 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N 462 (983)
|++++|++++. |.. .++|+.|++++|.+++ ++ .+ ++|+.|++++|++++ +|.. +++|+. |++++|
T Consensus 282 L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~-L~L~~N 347 (454)
T 1jl5_A 282 LDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLER-LIASFN 347 (454)
T ss_dssp EECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCE-EECCSS
T ss_pred EECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCE-EECCCC
Confidence 99999999862 221 2688999999999984 22 33 589999999999996 6654 467875 999999
Q ss_pred CCCCCCcccccccccccccccccccccc--CCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccC--
Q 042568 463 HLDGPLPLELSKMDMVLAIDLSFNNLSG--SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG-- 538 (983)
Q Consensus 463 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-- 538 (983)
++++ +|. .+++|++|+|++|++++ .+|.+++. |+.|.+.|.+|.. +++|+.|++++|++++
T Consensus 348 ~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~ 412 (454)
T 1jl5_A 348 HLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFP 412 (454)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-----------------------------
T ss_pred cccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccc
Confidence 9984 665 47889999999999998 67776654 3457777778764 5789999999999997
Q ss_pred CcCccccCCCCcceEeccCCccccccCC
Q 042568 539 EIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 539 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
.+|.+ ++.|.+.+|.+.+.++.
T Consensus 413 ~iP~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 413 DIPES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp ----------------------------
T ss_pred cchhh------HhheeCcCcccCCcccc
Confidence 67754 56677889988887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=404.99 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=207.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|.+.+.||+|+||.||+|..+ +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57999999999999999999965 789999999866543 2457789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC--CCEEEccccccccccC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED--LTALVADFGIAKLVKG 823 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~--~~~kl~Dfgla~~~~~ 823 (983)
|+||+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999988643 346899999999999999999999996 9999999999999854 8999999999997753
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||... ...
T Consensus 310 ~~--------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~-----~~~-------- 362 (573)
T 3uto_A 310 KQ--------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDD-------- 362 (573)
T ss_dssp TS--------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHH--------
T ss_pred CC--------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH--------
Confidence 22 112357999999999999999999999999999999999999998632 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+......... . ....+...+.++.+|+.+|++.||++|||+.|+++|
T Consensus 363 ----~~~~~i~~~~~~--~---~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 363 ----ETLRNVKSCDWN--M---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----HHHHHHHTTCCC--C---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHhCCCC--C---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111111 0 112233456788999999999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=397.46 Aligned_cols=490 Identities=23% Similarity=0.214 Sum_probs=380.5
Q ss_pred eeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhc
Q 042568 67 WSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLG 146 (983)
Q Consensus 67 w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 146 (983)
|....|..... ..+-++.+++ .+|+.+- +++++|||++|+|++..|.+|+++++|++|+|++|+|++..|.+|+
T Consensus 24 ~~~c~~~~~~~---~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~ 97 (635)
T 4g8a_A 24 WEPCVEVVPNI---TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 97 (635)
T ss_dssp -CCSEEEETTT---EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred CCCccccCCCC---EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhc
Confidence 76666654332 2355666776 6676442 4799999999999977778999999999999999999977788999
Q ss_pred ccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccc-ccchhhhccC
Q 042568 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG-QVPQALANSS 225 (983)
Q Consensus 147 ~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~ 225 (983)
+|++|++|+|++|+|+ .+|...+ ..+++|++|+|++|+++ .+|...|.++++|++|+|++|++++ ..|..++.++
T Consensus 98 ~L~~L~~L~Ls~N~l~-~l~~~~f--~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~ 173 (635)
T 4g8a_A 98 SLSHLSTLILTGNPIQ-SLALGAF--SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 173 (635)
T ss_dssp TCTTCCEEECTTCCCC-EECGGGG--TTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred CCCCCCEEEccCCcCC-CCCHHHh--cCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence 9999999999999998 5665544 58999999999999998 5666778899999999999999976 4688999999
Q ss_pred CcceecccccccccccchhhhcCCCC----ccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCC--
Q 042568 226 KLEWLDLESNMFSGELPSEIISKMPQ----LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP-- 299 (983)
Q Consensus 226 ~L~~L~Ls~N~l~~~~~~~~~~~l~~----L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-- 299 (983)
+|++|+|++|++++ ++...+..+.+ +..++++.|.+..+.. .......++.+++++|.....++
T Consensus 174 ~L~~L~L~~N~l~~-~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~---------~~~~~~~~~~l~l~~n~~~~~~~~~ 243 (635)
T 4g8a_A 174 NLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP---------GAFKEIRLHKLTLRNNFDSLNVMKT 243 (635)
T ss_dssp TCCEEECCSSCCCE-ECGGGGHHHHTCTTCCCEEECTTCCCCEECT---------TTTTTCEEEEEEEESCCSSHHHHHH
T ss_pred hhhhhcccCccccc-cccccccchhhhhhhhhhhhcccCcccccCc---------ccccchhhhhhhhhcccccccccch
Confidence 99999999999985 44444444444 3478899998765432 22233344555555554332111
Q ss_pred -----------------------------ccccccccCeeEEEccCccc---cccCCCCCCCCCcccEEeccccccCCCC
Q 042568 300 -----------------------------SIIGDLSTNLVQIHLDCNLI---YGKIPPHISNLVNLTLLNLSSNLLNGTI 347 (983)
Q Consensus 300 -----------------------------~~~~~l~~~L~~L~L~~N~l---~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 347 (983)
..+... ..+...++..+.. ...++..+..+.+++.+++.+|.+....
T Consensus 244 ~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~-~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~ 322 (635)
T 4g8a_A 244 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL-CNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK 322 (635)
T ss_dssp HHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGG-GGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG
T ss_pred hhcCCcccccccccccccccccccccccccccccc-cchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc
Confidence 111111 1233333332221 1233455666778888888888876432
Q ss_pred CcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCC--CCCcccccC
Q 042568 348 PHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS--GTIPSSLGK 425 (983)
Q Consensus 348 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~ 425 (983)
.+.....|+.|++.+|.+.+..+ ..++.|+.++++.|.+... ..+..+++|+.|++++|.+. +..+..+..
T Consensus 323 --~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 323 --DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp --GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred --ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhh
Confidence 35667889999999999986544 3467788999999988643 34567899999999999886 345667788
Q ss_pred CCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCc-cccccccccccccccccccccCCCcccccccccce
Q 042568 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLP-LELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALES 504 (983)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 504 (983)
+.+|+.++++.|.+.. .+..+..+++|+. ++++.|......+ ..+..+.+++.++++.|.+.+..|..+..++.|+.
T Consensus 396 ~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~-l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 396 TISLKYLDLSFNGVIT-MSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp CSCCCEEECCSCSEEE-ECSCCTTCTTCCE-EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hhhhhhhhcccccccc-ccccccccccccc-hhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 8999999999999884 5667888999996 9999888876554 56889999999999999999999999999999999
Q ss_pred EEeCCCcc-cccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC-CCCCcccccccccCCc
Q 042568 505 LNLSGNSL-EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGND 582 (983)
Q Consensus 505 L~Ls~N~l-~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~~~~~~~~~N~ 582 (983)
|+|++|++ .+.+|..+..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++.+|. ...+..+..+++.+|.
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~ 553 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 553 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSC
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCc
Confidence 99999985 456888999999999999999999999999999999999999999999998875 4667888889999996
Q ss_pred CccC
Q 042568 583 GLCG 586 (983)
Q Consensus 583 ~lc~ 586 (983)
..--
T Consensus 554 l~~~ 557 (635)
T 4g8a_A 554 IMTS 557 (635)
T ss_dssp CCBC
T ss_pred CCCC
Confidence 5433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=371.06 Aligned_cols=278 Identities=24% Similarity=0.317 Sum_probs=211.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc----eeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF----KAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~l 741 (983)
.++|...++||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++..... .++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 357888999999999999999986 78999999965432 34566779999999999999999999976543 599
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc----------CCCCeEeecCCCCCeEeCCCCCEE
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH----------SPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
||||+++|+|.+++.. ..+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999964 3589999999999999999999997 6 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 172 L~DFg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 172 IADFGLALKFEAGKSA-----------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp ECCCTTCEEECTTSCC-----------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred EccCCcccccccccCc-----------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 9999999876543221 11223579999999999887 3556788999999999999999999975
Q ss_pred ccCCCCc-hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 887 LFHDGSS-LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 887 ~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
....... ...... .........+...........+... .....+.++.+++.+||+.||++|||++|+++.|+++
T Consensus 241 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 241 PVDEYMLPFEEEIG--QHPSLEDMQEVVVHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCCCCCCTTHHHHC--SSCCHHHHHHHHTTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchhccchhhhhc--cCCchhhhhhhhhcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 4332211 111111 1111122222222121111111111 1134677899999999999999999999999999999
Q ss_pred Hhhc
Q 042568 966 KQYL 969 (983)
Q Consensus 966 ~~~~ 969 (983)
.+..
T Consensus 317 ~~~~ 320 (322)
T 3soc_A 317 QRLT 320 (322)
T ss_dssp HHHC
T ss_pred HHHh
Confidence 7653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=374.39 Aligned_cols=266 Identities=24% Similarity=0.379 Sum_probs=214.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD 737 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 737 (983)
++|...+.||+|+||.||+|.+. ++..||||+++........+++.+|+++++++ +||||+++++++...+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56888899999999999999852 34579999997665555667899999999999 8999999999999999
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEEC
Confidence 99999999999999999875431 1245899999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTT-----------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCEEEccccCCcccCcccce-----------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999866532211 11122357889999999999999999999999999999999 99998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.... .. +.... +........+ ..++.++.+++.+||+.||++||++.|++++|++
T Consensus 307 ~~~~--~~---------------~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 307 PGIP--VE---------------ELFKL-LKEGHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp TTCC--GG---------------GHHHH-HHTTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC--HH---------------HHHHH-HhcCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 6421 11 11111 1111111111 1245678999999999999999999999999999
Q ss_pred hHhhcCC
Q 042568 965 LKQYLSS 971 (983)
Q Consensus 965 ~~~~~~~ 971 (983)
+.+....
T Consensus 362 il~~~~~ 368 (370)
T 2psq_A 362 ILTLTTN 368 (370)
T ss_dssp HHHHHC-
T ss_pred HHHHhcc
Confidence 9765543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.61 Aligned_cols=287 Identities=31% Similarity=0.480 Sum_probs=226.3
Q ss_pred cCCCCCHHHHHHHhCCCCCC------CccccCCcEeEEEEEECCCcEEEEEEeeccc---CcchhHHHHHHHHHHHhcCC
Q 042568 653 KNPRVSYKQLIEATGGFCPS------SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTT---TGEITGSFKRECQILKRIRH 723 (983)
Q Consensus 653 ~~~~~~~~~l~~~~~~f~~~------~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h 723 (983)
....+++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ..+..+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999887 8899999999999987 58899999986532 23346789999999999999
Q ss_pred CCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeE
Q 042568 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNIL 803 (983)
Q Consensus 724 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiL 803 (983)
|||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 9999999999999999999999999999998865432 456999999999999999999999996 999999999999
Q ss_pred eCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 804 LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 804 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
++.++.+||+|||+++........ .......||+.|+|||.+.+ .++.++||||||+++|+|++|+.|
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQT-----------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSC-----------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred EcCCCcEEEeeccccccccccccc-----------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 999999999999999866532211 11223469999999998876 478999999999999999999999
Q ss_pred CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 884 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
|+..... ..+..+........ ..+...+.. .. .......+..+.+++.+|++.||++|||++|++++|+
T Consensus 234 ~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~----~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 234 VDEHREP-QLLLDIKEEIEDEE--KTIEDYIDK----KM----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp BCTTBSS-SBTTHHHHHHHTTS--CCHHHHSCS----SC----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccCcch-HHHHHHHHHhhhhh--hhhhhhccc----cc----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 8753322 11222211111000 001111111 11 1123457788999999999999999999999999999
Q ss_pred HhHh
Q 042568 964 RLKQ 967 (983)
Q Consensus 964 ~~~~ 967 (983)
++..
T Consensus 303 ~l~~ 306 (307)
T 2nru_A 303 EMTA 306 (307)
T ss_dssp HHC-
T ss_pred HHhc
Confidence 8854
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.53 Aligned_cols=270 Identities=29% Similarity=0.416 Sum_probs=204.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|+. +++.||||++..... .+..+++.+|++++++++||||+++++++...+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788899999999999999987 488999999865542 3345689999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++..... ...+++..++.++.|+++||+|||+.++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 115 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred cCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999875321 2348999999999999999999999842 3999999999999999999999999999754322
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..
T Consensus 193 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-----~~--------- 245 (309)
T 3p86_A 193 F-------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PA--------- 245 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-----HH---------
T ss_pred c-------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH---------
Confidence 1 11223579999999999999999999999999999999999999986421 11
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCchh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 975 (983)
...............+ ..++.++.+++.+||+.||++|||++|+++.|+.+.+....+...
T Consensus 246 ---~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 246 ---QVVAAVGFKCKRLEIP-------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp ---HHHHHHHHSCCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred ---HHHHHHHhcCCCCCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 1111111111111111 124567899999999999999999999999999998876665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=359.59 Aligned_cols=252 Identities=19% Similarity=0.312 Sum_probs=206.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35799999999999999999995 57889999998765433 35778999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|+|.+++.. ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999863 35899999999999999999999996 999999999999999999999999999876532
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ...
T Consensus 170 ~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~--------- 223 (297)
T 3fxz_A 170 QS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLR--------- 223 (297)
T ss_dssp TC-------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHH---------
T ss_pred cc-------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHH---------
Confidence 21 1223579999999999999999999999999999999999999985321 100
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
........... ..+ .....+..+.+++.+|++.||++|||++|++++-
T Consensus 224 ----~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 224 ----ALYLIATNGTP-ELQ-----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp ----HHHHHHHHCSC-CCS-----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ----HHHHHHhCCCC-CCC-----CccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 01111111110 000 0123456789999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=364.95 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=211.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|.+.+.||+|+||.||+|.+. .+..||||+++........+.+.+|++++++++||||+++++++...+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46778899999999999999974 34459999997665555677899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999998643 346899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 203 ~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------ 260 (325)
T 3kul_A 203 DDPDAA----------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------------ 260 (325)
T ss_dssp ----CC----------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------
T ss_pred cCccce----------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------------
Confidence 432111 11122356889999999998899999999999999999999 9999853211
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
...... +........+ ..++.++.+++.+||+.||++|||+.|+++.|+++.+...+
T Consensus 261 -----~~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 261 -----RDVISS-VEEGYRLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -----HHHHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -----HHHHHH-HHcCCCCCCC-------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111111 1111111111 22457889999999999999999999999999999876554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.31 Aligned_cols=256 Identities=24% Similarity=0.400 Sum_probs=205.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|.+.+.||+|+||.||+|... +++.||||++......+..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57889999999999999999976 78899999997665544557789999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999874 345899999999999999999999996 9999999999999999999999999998664322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+...
T Consensus 160 ~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---- 224 (323)
T 3tki_A 160 RE-----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---- 224 (323)
T ss_dssp EE-----------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT----
T ss_pred cc-----------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc----
Confidence 11 11223579999999999988765 778999999999999999999997432221111111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
... ...+.....++.+++.+|++.||++|||++|++++-.
T Consensus 225 ------------~~~-------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 225 ------------KTY-------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ------------CTT-------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ------------ccc-------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 000 0112335577889999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=359.89 Aligned_cols=265 Identities=21% Similarity=0.280 Sum_probs=213.1
Q ss_pred CCCCCHHHHHHHhCC----------CCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC
Q 042568 654 NPRVSYKQLIEATGG----------FCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR 722 (983)
Q Consensus 654 ~~~~~~~~l~~~~~~----------f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~ 722 (983)
.+.++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCC
Confidence 356778888777754 556678999999999999976 789999999975543 34677899999999999
Q ss_pred CCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCe
Q 042568 723 HRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNI 802 (983)
Q Consensus 723 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~Ni 802 (983)
||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 172 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSI 172 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 99999999999999999999999999999998863 45899999999999999999999996 99999999999
Q ss_pred EeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCC
Q 042568 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR 882 (983)
Q Consensus 803 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~ 882 (983)
+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCcEEEeeeeeeeecccCcc-------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999986643211 1123479999999999999999999999999999999999999
Q ss_pred CCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 883 PTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 883 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
||.... ... .... +......... .....+.++.+++.+|++.||++|||++|++++-
T Consensus 240 pf~~~~-----~~~------------~~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 240 PYFSDS-----PVQ------------AMKR-LRDSPPPKLK-----NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp TTTTSC-----HHH------------HHHH-HHHSSCCCCT-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCCCC-----HHH------------HHHH-HhcCCCCCcC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 985321 011 1111 1111111110 1123456789999999999999999999999874
Q ss_pred H
Q 042568 963 G 963 (983)
Q Consensus 963 ~ 963 (983)
.
T Consensus 297 ~ 297 (321)
T 2c30_A 297 F 297 (321)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=363.94 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=206.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|...+.||+|+||.||+|.+ .+|+.||||++..... ....+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788999999999999999997 5789999999976543 334677899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998653 45899999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS-THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. ......||+.|+|||.+.+..+. .++||||+||++|||++|+.||+.. ...
T Consensus 167 ~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~------- 220 (328)
T 3fe3_A 167 GG--------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-----NLK------- 220 (328)
T ss_dssp SC--------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH-------
T ss_pred CC--------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----CHH-------
Confidence 21 12235799999999999888765 7999999999999999999998632 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...+....... ..|. ..+.++.+++.+|++.||++|||++|++++-
T Consensus 221 -----~~~~~i~~~~~--~~p~-------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 221 -----ELRERVLRGKY--RIPF-------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp -----HHHHHHHHCCC--CCCT-------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred -----HHHHHHHhCCC--CCCC-------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 11122111111 1111 1346788999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=375.03 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=212.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|.+. +++.||||.++.....+..++|.+|++++++++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 46778899999999999999976 78899999987655444567889999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 194 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 194 VQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999998753 345899999999999999999999996 9999999999999999999999999998643221
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 268 ~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------------- 321 (377)
T 3cbl_A 268 Y-----------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------------- 321 (377)
T ss_dssp E-----------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------------
T ss_pred e-----------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------------
Confidence 1 111122346788999999998889999999999999999998 9999864211
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
......+........+ ..++.++.+++.+||+.||++|||++++++.|+++.+..
T Consensus 322 ---~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 322 ---QQTREFVEKGGRLPCP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ---HHHHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0111111111111111 124567899999999999999999999999999997653
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=372.53 Aligned_cols=363 Identities=21% Similarity=0.247 Sum_probs=246.2
Q ss_pred cccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCc
Q 042568 89 IYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIP 168 (983)
Q Consensus 89 l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~ 168 (983)
..+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|++++ +|
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--
T ss_pred cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--
Confidence 334455567788888888888888885 35 67888888888888888885 34 7788888888888888874 33
Q ss_pred ccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcC
Q 042568 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISK 248 (983)
Q Consensus 169 ~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 248 (983)
+ ..+++|++|++++|.+++ +| +..+++|++|++++|++++. + ++++++|++|++++|+..+.++ +..
T Consensus 102 ~---~~l~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~---~~~ 168 (457)
T 3bz5_A 102 V---TPLTKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD---VTP 168 (457)
T ss_dssp C---TTCTTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC---CTT
T ss_pred c---CCCCcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc---ccc
Confidence 2 356677777777776664 33 44666666666666666653 2 5566666666666664433432 334
Q ss_pred CCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCC
Q 042568 249 MPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHIS 328 (983)
Q Consensus 249 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~ 328 (983)
+++|++|++++| ++++ +| +..+ ++|+.|++++|.+++. .++
T Consensus 169 l~~L~~L~ls~n--------------------------------~l~~-l~--l~~l-~~L~~L~l~~N~l~~~---~l~ 209 (457)
T 3bz5_A 169 QTQLTTLDCSFN--------------------------------KITE-LD--VSQN-KLLNRLNCDTNNITKL---DLN 209 (457)
T ss_dssp CTTCCEEECCSS--------------------------------CCCC-CC--CTTC-TTCCEEECCSSCCSCC---CCT
T ss_pred CCcCCEEECCCC--------------------------------ccce-ec--cccC-CCCCEEECcCCcCCee---ccc
Confidence 444555555544 4443 22 2333 3456666666666543 366
Q ss_pred CCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 329 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
.+++|++|++++|++++ +| ++.+++|+.|++++|.+++.. ++.+++|+.|++++|+ |+.|
T Consensus 210 ~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L 269 (457)
T 3bz5_A 210 QNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEI 269 (457)
T ss_dssp TCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCC
T ss_pred cCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEE
Confidence 67777777777777775 44 667777777777777777643 4556677777777653 4567
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (983)
++++|.+.+.+| ++.+++|+.|++++|++.+.+|.. ...++. +++++| ++|+.|+|++|+|
T Consensus 270 ~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~-L~l~~~-------------~~L~~L~L~~N~l 330 (457)
T 3bz5_A 270 DLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITE-LDLSQN-------------PKLVYLYLNNTEL 330 (457)
T ss_dssp CCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSC-CCCTTC-------------TTCCEEECTTCCC
T ss_pred ECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceE-echhhc-------------ccCCEEECCCCcc
Confidence 777887776666 467788888888888877777643 344553 555554 5678888888888
Q ss_pred ccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCC
Q 042568 489 SGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 489 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
++ +| ++.+++|+.|++++|+|++ ++.|..|++++|+++|. ..+..|+.+++++|+++|.+|.
T Consensus 331 ~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 331 TE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp SC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred cc-cc--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence 86 33 8888888888888888885 24567778888888875 3456677888899999888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.79 Aligned_cols=274 Identities=23% Similarity=0.388 Sum_probs=212.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...++||+|+||.||+|.+. +++.||+|.+... ..+..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 56778899999999999999975 6889999988543 334567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999753 346899999999999999999999996 9999999999999999999999999998765432
Q ss_pred ccccccCC-CCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCAND-SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
........ ............||+.|+|||.+.+..++.++||||||+++|||++|..||..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------- 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------- 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------
Confidence 21100000 0000011124579999999999999999999999999999999999999986432211110
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
............+ ..++.++.+++.+|++.||++|||++|+++.|+.++....
T Consensus 233 --~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 --GLNVRGFLDRYCP-----------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp --SBCHHHHHHHTCC-----------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --hhhhhccccccCC-----------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011111111111 1233568899999999999999999999999999987644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=351.83 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=211.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|.+.+++.||||++...... .+++.+|++++++++||||+++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467788999999999999999988999999999755433 477999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999998653 345899999999999999999999996 99999999999999999999999999986643221
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......||+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ..
T Consensus 162 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~---------- 214 (269)
T 4hcu_A 162 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NS---------- 214 (269)
T ss_dssp ------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH----------
T ss_pred ------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HH----------
Confidence 11122357889999999998899999999999999999999 999986321 11
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
...+..... .....+ ...+.++.+++.+|++.||++|||++|++++|+++.+.
T Consensus 215 --~~~~~~~~~-~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 --EVVEDISTG-FRLYKP-------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --HHHHHHHTT-CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --HHHHHHhcC-ccCCCC-------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111111111 111111 11346789999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=370.97 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|.+.+.||+|+||.||+|+.. ++..||||.++........++|.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 56779999997665555667899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999753 346899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 199 ~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-----~~------ 257 (373)
T 2qol_A 199 DDPEAA----------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQ------ 257 (373)
T ss_dssp -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-----HH------
T ss_pred cCCccc----------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HH------
Confidence 432110 11112246788999999999999999999999999999998 999985321 11
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
...+........ .. ..+++.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 258 ------~~~~~i~~~~~~-~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 258 ------DVIKAVDEGYRL-PP-------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ------HHHHHHHTTEEC-CC-------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ------HHHHHHHcCCCC-CC-------CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111111111110 00 1234577899999999999999999999999999986543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=369.51 Aligned_cols=273 Identities=25% Similarity=0.346 Sum_probs=215.8
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceee
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIIT 731 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 731 (983)
..+.....++|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 334444567899999999999999999984 245789999997665555567899999999999 7999999999
Q ss_pred EEecCCc-eeEEEecccCcccccccccccCc-------------------------------------------------
Q 042568 732 ICSKPDF-KALVLPLMSNGSLENHLYPSHGL------------------------------------------------- 761 (983)
Q Consensus 732 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 761 (983)
++...+. .++||||+++|+|.+++......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9977654 89999999999999998754321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 762 -------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 762 -------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 249 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY- 249 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc-
Confidence 122899999999999999999999996 999999999999999999999999999866432211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 250 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------- 302 (359)
T 3vhe_A 250 ----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------- 302 (359)
T ss_dssp ----------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----------------
T ss_pred ----------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----------------
Confidence 12233568999999999999999999999999999999998 99998642111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+...+........+ ..+..++.+++.+|++.||++|||++|++++|+++.+..
T Consensus 303 ~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 303 EEFCRRLKEGTRMRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1111122221111111 123467899999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.24 Aligned_cols=271 Identities=22% Similarity=0.363 Sum_probs=212.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... .+..+++.+|++++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999965 688999999865432 23457899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999998753 45899999999999999999999996 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... . .....
T Consensus 163 ~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~----~-~~~~~--- 222 (294)
T 4eqm_A 163 ETSL------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET----A-VSIAI--- 222 (294)
T ss_dssp ------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC----H-HHHHH---
T ss_pred cccc------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC----h-HHHHH---
Confidence 3211 11223569999999999999999999999999999999999999986421 1 11110
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHhhcCCCchhH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-SMLDVAHEMGRLKQYLSSPSSLI 976 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~~~~~~ 976 (983)
..+... .+........+.+..+.+++.+|++.||++|| +++++.+.|+.+.......++..
T Consensus 223 ---------~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 284 (294)
T 4eqm_A 223 ---------KHIQDS----VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284 (294)
T ss_dssp ---------HHHSSC----CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCC
T ss_pred ---------HHhhcc----CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchh
Confidence 111110 01000111123557899999999999999998 99999999998876655554443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.97 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=210.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.++|...+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++++++||||+++++++......++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356888899999999999999998888999999965443 347799999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999998753 345899999999999999999999996 9999999999999999999999999998765332
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......||+.|+|||.+.+..++.++||||+|+++|||++ |+.||+.... .
T Consensus 159 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~--------- 212 (268)
T 3sxs_A 159 YV------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----S--------- 212 (268)
T ss_dssp EE------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---------
T ss_pred hh------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----H---------
Confidence 11 1112356788999999998889999999999999999999 9999863211 1
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..... +........+ ...+.++.+++.+|++.||++|||++|++++|+.+++..
T Consensus 213 ---~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 213 ---EVVLK-VSQGHRLYRP-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ---HHHHH-HHTTCCCCCC-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ---HHHHH-HHcCCCCCCC-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11111 1111111111 113457889999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=354.50 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=203.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHh--cCCCCccceeeEEec----CCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKR--IRHRNLIRIITICSK----PDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 739 (983)
.++|...+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999998 5899999998543 34566778887777 799999999998644 3457
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh--------ccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--------HHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
++||||+++|+|.+++. ...+++..+++++.|+++||+||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 89999999999999995 346899999999999999999999 664 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCC------CCCccchhHHHHHHHHHHHhC-----
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK------RASTHGDVYSFGVLLLEIVTG----- 880 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~SlG~il~elltg----- 880 (983)
|+|||+|+.......... .......||+.|+|||.+.+. .+++++||||||+++|||++|
T Consensus 154 l~Dfg~a~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~ 224 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLD---------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224 (301)
T ss_dssp ECCCTTCEEEETTTTEEE---------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EeeCCCeeeccccccccc---------ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence 999999987654322211 112234799999999998876 455799999999999999999
Q ss_pred -----CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhh-cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC
Q 042568 881 -----RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAK-YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954 (983)
Q Consensus 881 -----~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 954 (983)
+.||............+. ..... ......+ .......++.++.+++.+||+.||++|||
T Consensus 225 ~~~~~~~pf~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDPSFEDMR-------------KVVCVDQQRPNIP--NRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHH-------------HHHTTSCCCCCCC--GGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred ccccccccccccCCCCcchhhhh-------------HHHhccCCCCCCC--hhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 777654333222222211 11111 1111111 11112457788999999999999999999
Q ss_pred HHHHHHHHHHh
Q 042568 955 MLDVAHEMGRL 965 (983)
Q Consensus 955 ~~evl~~L~~~ 965 (983)
++|+++.|+++
T Consensus 290 ~~~i~~~L~~i 300 (301)
T 3q4u_A 290 ALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHhcc
Confidence 99999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=365.68 Aligned_cols=268 Identities=27% Similarity=0.395 Sum_probs=216.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD 737 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 737 (983)
++|.+.+.||+|+||.||+|... .+..||||+++.........++.+|+++++++ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 57788899999999999999852 23579999997766655668899999999999 9999999999999999
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEc
Confidence 99999999999999999875431 1245999999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~ 294 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYY-----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTT-----------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCcEEEcccCccccccccccc-----------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999876532211 11222457899999999999999999999999999999999 99998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.... ..+ ..+ .+........+ ..++.++.+++.+||+.||++|||++|++++|++
T Consensus 295 ~~~~-----~~~------------~~~-~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 295 PGVP-----VEE------------LFK-LLKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp TTCC-----HHH------------HHH-HHHTTCCCCCC-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-----HHH------------HHH-HHHcCCCCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 5321 111 111 11111111111 1245678999999999999999999999999999
Q ss_pred hHhhcCCCc
Q 042568 965 LKQYLSSPS 973 (983)
Q Consensus 965 ~~~~~~~~~ 973 (983)
+.......+
T Consensus 350 ~~~~~~~~~ 358 (382)
T 3tt0_A 350 IVALTSNQE 358 (382)
T ss_dssp HHHHSCSCC
T ss_pred HHHHHhcCC
Confidence 986655443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=355.19 Aligned_cols=281 Identities=19% Similarity=0.267 Sum_probs=212.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC--ceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD--FKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 743 (983)
++|.+.++||+|+||.||+|... +++.||||+++........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999976 588999999976554445678899999999999999999999997665 679999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe----CCCCCEEEccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALVADFGIAK 819 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl----~~~~~~kl~Dfgla~ 819 (983)
||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976432 334999999999999999999999996 9999999999999 888889999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccC--------CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM--------GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 165 ELEDDEQ--------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp ECCTTCC--------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred ecCCCCc--------------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 7653221 12246999999999876 5778999999999999999999999996432211
Q ss_pred Cc---hHHHHHhhCCCCCcHHHHHHHhhc-CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 892 SS---LHEWVKRHYPHRLDPIVEKAIAKY-APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 892 ~~---l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.. +........+..........-... .....+ ............+.+++.+|++.||++|||++|++++..+..
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hhHHHHHHHhcCCCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11 111111110000000000000000 000000 001123567788999999999999999999999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=368.87 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=210.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||.||+|.+. +++.||||+++.........++.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46778899999999999999953 456799999976555555678999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccC---cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEcc
Q 042568 741 LVLPLMSNGSLENHLYPSHG---LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVAD 814 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~D 814 (983)
+||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999876432 1245999999999999999999999996 99999999999999554 599999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCc
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSS 893 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~ 893 (983)
||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 228 FG~a~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~----- 291 (367)
T 3l9p_A 228 FGMARDIYRAGYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS----- 291 (367)
T ss_dssp CHHHHHHHHHSSC-----------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred Ccccccccccccc-----------ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence 9999865432111 12223468999999999999999999999999999999998 999985321
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.. ...+. +........+ ..++.++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 292 ~~------------~~~~~-i~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 292 NQ------------EVLEF-VTSGGRMDPP-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HH------------HHHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HH------------HHHHH-HHcCCCCCCC-------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 11111 1111111111 12456789999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=362.90 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=206.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-----chhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-----EITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... ...+.+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457888999999999999999975 6889999999765432 1357899999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADF 815 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Df 815 (983)
++||||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999864 346899999999999999999999996 99999999999998877 7999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||... ...
T Consensus 164 G~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~-----~~~ 224 (361)
T 2yab_A 164 GLAHEIEDGV--------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQ 224 (361)
T ss_dssp SSCEECCTTC--------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHH
T ss_pred CCceEcCCCC--------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-----CHH
Confidence 9998765321 112346999999999999999999999999999999999999998532 111
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+ ........... . ....|...+.++.+++.+|+..||++|||+.|++++
T Consensus 225 ~------------~~~~i~~~~~~--~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 225 E------------TLANITAVSYD--F---DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp H------------HHHHHHTTCCC--C---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H------------HHHHHHhcCCC--C---CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 11111111110 0 011233456778999999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=349.25 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=208.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.++|...+.||+|+||.||+|.+.++..||||+++..... .+++.+|++++++++||||+++++++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3567788999999999999999998889999999755433 47799999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999998753 345999999999999999999999996 9999999999999999999999999998764322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .......||+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 175 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------------- 227 (283)
T 3gen_A 175 Y------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------------- 227 (283)
T ss_dssp H------------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------------
T ss_pred c------------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---------------
Confidence 1 11122357889999999998899999999999999999998 9999864211
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
....+. +........+ ...+..+.+++.+|++.||++|||++|++++|+++.+.
T Consensus 228 --~~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 228 --SETAEH-IAQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --HHHHHH-HHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --hHHHHH-HhcccCCCCC-------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 011111 1111111111 11346788999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=357.89 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|+.. +++.||||+++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999965 68899999996542 2234577899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999998864 346899999999999999999999996 99999999999999999999999999985432
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...
T Consensus 158 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~-------- 211 (337)
T 1o6l_A 158 DG-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHE-------- 211 (337)
T ss_dssp TT-------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SHH--------
T ss_pred CC-------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-----CHH--------
Confidence 11 1123357999999999999999999999999999999999999998532 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
...+....... ..| ...+.++.+++.+|++.||++|| +++|+++|
T Consensus 212 ----~~~~~i~~~~~--~~p-------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 212 ----RLFELILMEEI--RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----HHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----HHHHHHHcCCC--CCC-------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11111111111 111 12346789999999999999999 89999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.55 Aligned_cols=275 Identities=24% Similarity=0.312 Sum_probs=204.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||+||+|+..+++.||||++...... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3678899999999999999999988999999998654332 245778999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++ ++.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 777776543 345899999999999999999999996 999999999999999999999999999876432
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..+......
T Consensus 173 ~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~ 238 (311)
T 3niz_A 173 VR-------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQLPKIFSILGT 238 (311)
T ss_dssp CC----------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST-TTHHHHHHHHHCC
T ss_pred cc-------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHHCC
Confidence 11 1122468999999999876 5689999999999999999999999975322 2222222221111
Q ss_pred ---CCCcHHHH--HHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 ---HRLDPIVE--KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ---~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.......+ ........................++.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100000 00000000000000011112245678999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=362.24 Aligned_cols=268 Identities=26% Similarity=0.416 Sum_probs=213.4
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
..++|...+.||+|+||.||+|... +++.||||+++.....+..+.+.+|++++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3468889999999999999999974 3478999999766555567889999999999999999999999999999
Q ss_pred eeEEEecccCcccccccccccCc--------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCC
Q 042568 739 KALVLPLMSNGSLENHLYPSHGL--------------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLK 798 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dik 798 (983)
.++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999998753211 156999999999999999999999996 9999999
Q ss_pred CCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHH
Q 042568 799 PSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878 (983)
Q Consensus 799 p~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ell 878 (983)
|+||+++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYY-----------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCB-----------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred cceEEECCCCeEEEeecCCCcccccCccc-----------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 99999999999999999999876432211 1122346899999999999889999999999999999999
Q ss_pred h-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 879 T-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 879 t-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
+ |+.||.... ..+ .... +........+ ..++.++.+++.+||+.||++|||+.|
T Consensus 271 t~g~~p~~~~~-----~~~------------~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 271 SYGLQPYYGMA-----HEE------------VIYY-VRDGNILACP-------ENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTCCTTTTSC-----HHH------------HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hcCCCcCCCCC-----hHH------------HHHH-HhCCCcCCCC-------CCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9 999986321 111 1111 1111111111 124567899999999999999999999
Q ss_pred HHHHHHHhHhhcCC
Q 042568 958 VAHEMGRLKQYLSS 971 (983)
Q Consensus 958 vl~~L~~~~~~~~~ 971 (983)
++++|+++.+....
T Consensus 326 ~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 326 IHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHTTC----
T ss_pred HHHHHHHHHhhhhh
Confidence 99999998765543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.44 Aligned_cols=273 Identities=24% Similarity=0.340 Sum_probs=207.4
Q ss_pred CCCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 739 (983)
++|.+.+.||+|+||.||+|++ .+++.||||++.... .+..+++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5678899999999999999984 257889999986543 33467899999999999999999999998543 457
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999754 235899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
......... .......||..|+|||.+.+..++.++||||||+++|||++|..|+.... ..+..
T Consensus 163 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~------~~~~~ 226 (295)
T 3ugc_A 163 VLPQDKEFF----------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMR 226 (295)
T ss_dssp -----------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH------HHHHH
T ss_pred cccCCccee----------eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh------HHHHh
Confidence 765432210 11222457888999999999999999999999999999999999975421 11111
Q ss_pred hhCCCCCcHH----HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 900 RHYPHRLDPI----VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 900 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.......... ....+........ ...++.++.+++.+||+.||++|||++|+++.|+++++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 227 MIGNDKQGQMIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhcCccccchhHHHHHHHHhccCcCCC-------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111111111 1111111111111 1235678999999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=361.82 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=206.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc----CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT----TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+.+|+++++.++||||+++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999965 68999999986432 12245789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC---EEEcccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT---ALVADFGIA 818 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~---~kl~Dfgla 818 (983)
||||+++|+|.+++.........+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998887654333456899999999999999999999996 999999999999986654 999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+....... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||....
T Consensus 181 ~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------- 237 (351)
T 3c0i_A 181 IQLGESGL-------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------- 237 (351)
T ss_dssp EECCTTSC-------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----------
T ss_pred eEecCCCe-------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----------
Confidence 87653221 1223479999999999999999999999999999999999999986421
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
....+......... ....|...+.++.+++.+|++.||++|||+.|++++-
T Consensus 238 --------~~~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 238 --------ERLFEGIIKGKYKM-----NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp --------HHHHHHHHHTCCCC-----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HHHHHHHHcCCCCC-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 01111111111110 0112233567899999999999999999999999753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=365.40 Aligned_cols=346 Identities=27% Similarity=0.359 Sum_probs=172.8
Q ss_pred cCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccc
Q 042568 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSL 178 (983)
Q Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 178 (983)
.+++|+.|++++|.++ .+| .+..+++|++|+|++|.+++. |. ++++++|++|++++|++++..| + ..+++|
T Consensus 44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~---~~l~~L 114 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--L---ANLTNL 114 (466)
T ss_dssp HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--G---TTCTTC
T ss_pred HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--h---cCCCCC
Confidence 3455666666666665 344 356666666666666666633 33 6666666666666666653222 2 244555
Q ss_pred ceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcc
Q 042568 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258 (983)
Q Consensus 179 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 258 (983)
++|++++|.+++..+ +..+++|++|++++|.+++. + .++.+++|++|+++ |.+.+ ++. +..+++|++|+++
T Consensus 115 ~~L~L~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~-~~~--~~~l~~L~~L~l~ 185 (466)
T 1o6v_A 115 TGLTLFNNQITDIDP---LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD-LKP--LANLTTLERLDIS 185 (466)
T ss_dssp CEEECCSSCCCCCGG---GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC-CGG--GTTCTTCCEEECC
T ss_pred CEEECCCCCCCCChH---HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccC-chh--hccCCCCCEEECc
Confidence 555555555443221 34556666666666666542 2 36666666666664 34432 221 4555556666655
Q ss_pred ccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEec
Q 042568 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338 (983)
Q Consensus 259 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 338 (983)
+|.+... ..+..+++|++|++++|++++.. | ++.+++|++|++
T Consensus 186 ~n~l~~~----------~~l~~l~~L~~L~l~~n~l~~~~-------------------------~--~~~l~~L~~L~l 228 (466)
T 1o6v_A 186 SNKVSDI----------SVLAKLTNLESLIATNNQISDIT-------------------------P--LGILTNLDELSL 228 (466)
T ss_dssp SSCCCCC----------GGGGGCTTCSEEECCSSCCCCCG-------------------------G--GGGCTTCCEEEC
T ss_pred CCcCCCC----------hhhccCCCCCEEEecCCcccccc-------------------------c--ccccCCCCEEEC
Confidence 5554321 12334444444444444444332 2 334444555555
Q ss_pred cccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCC
Q 042568 339 SSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418 (983)
Q Consensus 339 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 418 (983)
++|++++. ..+..+++|+.|++++|.+.+..| +..+++|+.|++++|++++..+ +..+++|+.|++++|++++.
T Consensus 229 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~ 302 (466)
T 1o6v_A 229 NGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC
T ss_pred CCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc
Confidence 55544432 234444555555555555544333 4445555555555555543322 44445555555555555432
Q ss_pred CcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCccccc
Q 042568 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGS 498 (983)
Q Consensus 419 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 498 (983)
.+ +..+++|+.|++++|++++..| +..+++|+. |++++|++++. ..+..+++|+.|++++|++++..| +..
T Consensus 303 ~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~-L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 373 (466)
T 1o6v_A 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LAN 373 (466)
T ss_dssp GG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCE-EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTT
T ss_pred hh--hcCCCCCCEEECcCCcCCCchh--hccCccCCE-eECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhc
Confidence 22 4445555555555555554333 344444443 55555544432 234444455555555555544433 444
Q ss_pred ccccceEEeCCCcccc
Q 042568 499 CIALESLNLSGNSLEG 514 (983)
Q Consensus 499 l~~L~~L~Ls~N~l~~ 514 (983)
+++|+.|++++|++++
T Consensus 374 l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 374 LTRITQLGLNDQAWTN 389 (466)
T ss_dssp CTTCCEEECCCEEEEC
T ss_pred CCCCCEEeccCCcccC
Confidence 5555555555555543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.77 Aligned_cols=254 Identities=21% Similarity=0.293 Sum_probs=207.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 367888999999999999999975 57889999986443 235678999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC--CCCEEEcccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE--DLTALVADFGIAKLVK 822 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~--~~~~kl~Dfgla~~~~ 822 (983)
|+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998643 346899999999999999999999996 999999999999987 7899999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ..
T Consensus 156 ~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~------- 209 (321)
T 1tki_A 156 PGDN--------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQ------- 209 (321)
T ss_dssp TTCE--------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HH-------
T ss_pred CCCc--------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----HH-------
Confidence 3221 123579999999999999889999999999999999999999986321 11
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
...+......... ....+.+.+.++.+++.+|+..||++|||+.|++++-.
T Consensus 210 -----~~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 210 -----QIIENIMNAEYTF-----DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp -----HHHHHHHHTCCCC-----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred -----HHHHHHHcCCCCC-----ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 1111111111110 11123345678999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.24 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=213.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|...+.||+|+||.||+|.. .+++.||||+++........+++.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 35688889999999999999986 235789999997665555668899999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccC--------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCC
Q 042568 740 ALVLPLMSNGSLENHLYPSHG--------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKP 799 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp 799 (983)
++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999875432 1234899999999999999999999996 99999999
Q ss_pred CCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 800 SNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 800 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||+|+++|||++
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSY-----------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCE-----------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred heEEEcCCCCEEEccccccccccccccc-----------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999876533221 11223457889999999998889999999999999999999
Q ss_pred -CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 042568 880 -GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958 (983)
Q Consensus 880 -g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 958 (983)
|+.||..... ..+...+. .......+ ..++.++.+++.+|++.||++||++.|+
T Consensus 248 ~g~~p~~~~~~--~~~~~~~~----------------~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 248 LGGNPYPGIPP--ERLFNLLK----------------TGHRMERP-------DNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp TSCCSSTTCCG--GGHHHHHH----------------TTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCCCCH--HHHHHHhh----------------cCCcCCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999864211 11111111 11111111 2245678999999999999999999999
Q ss_pred HHHHHHhHhh
Q 042568 959 AHEMGRLKQY 968 (983)
Q Consensus 959 l~~L~~~~~~ 968 (983)
+++|+++.+.
T Consensus 303 ~~~l~~~~~~ 312 (314)
T 2ivs_A 303 SKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhh
Confidence 9999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=358.37 Aligned_cols=267 Identities=23% Similarity=0.325 Sum_probs=208.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
.++|...+.||+|+||.||+|.. .++..||||+++........+.+.+|+++++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 35788899999999999999996 235679999997655555568899999999999 89999999999999999
Q ss_pred eeEEEecccCcccccccccccCc-------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCC
Q 042568 739 KALVLPLMSNGSLENHLYPSHGL-------------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKP 799 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp 799 (983)
.++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999998754321 134899999999999999999999996 99999999
Q ss_pred CCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 800 SNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 800 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
+||+++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNY-----------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS-----------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccc-----------eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 9999999999999999999866532211 12233568899999999998899999999999999999998
Q ss_pred -CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 042568 880 -GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958 (983)
Q Consensus 880 -g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 958 (983)
|+.||...... ..+...+........+ ..++.++.+++.+||+.||++|||+.|+
T Consensus 270 ~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 270 LGVNPYPGIPVD-----------------ANFYKLIQNGFKMDQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp TSCCSSTTCCCS-----------------HHHHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCcccCCcH-----------------HHHHHHHhcCCCCCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 99998643211 1111112111111111 1235678999999999999999999999
Q ss_pred HHHHHHhHhhcC
Q 042568 959 AHEMGRLKQYLS 970 (983)
Q Consensus 959 l~~L~~~~~~~~ 970 (983)
+++|+.+.....
T Consensus 326 ~~~l~~~~~~~~ 337 (344)
T 1rjb_A 326 TSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHC----
T ss_pred HHHHHHHHHHHH
Confidence 999998866544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.10 Aligned_cols=258 Identities=23% Similarity=0.414 Sum_probs=200.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcE----EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...++||+|+||.||+|.+. +++. ||+|.+.........+++.+|++++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46888899999999999999964 4443 58888765555556688999999999999999999999998754 789
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|+||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999998754 346899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||+... ...+..
T Consensus 168 ~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~---- 230 (327)
T 3poz_A 168 GAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISS---- 230 (327)
T ss_dssp TTTCC------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHH----
T ss_pred cCCccc-----------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--HHHHHH----
Confidence 543221 11122357889999999999999999999999999999999 999986421 111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.+........+ ..+..++.+++.+||+.||++||++.|++++|+++..
T Consensus 231 ------------~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 231 ------------ILEKGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------HHHTTCCCCCC-------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ------------HHHcCCCCCCC-------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111111111 1244678899999999999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.70 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=195.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-------------------------chhHHHHHHHHHHHh
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-------------------------EITGSFKRECQILKR 720 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-------------------------~~~~~~~~E~~~l~~ 720 (983)
++|...+.||+|+||.||+|... +++.||||++...... ...+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888999999999999999965 6788999998654311 123578999999999
Q ss_pred cCCCCccceeeEEec--CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCC
Q 042568 721 IRHRNLIRIITICSK--PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLK 798 (983)
Q Consensus 721 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dik 798 (983)
++||||+++++++.. .+..++||||+++++|.++.. ...+++..++.++.|+++||+|||+++ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 999999999999976 567899999999999988764 346999999999999999999999996 9999999
Q ss_pred CCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCC---CCccchhHHHHHHHH
Q 042568 799 PSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR---ASTHGDVYSFGVLLL 875 (983)
Q Consensus 799 p~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~SlG~il~ 875 (983)
|+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence 9999999999999999999987653221 112246999999999988765 478899999999999
Q ss_pred HHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH
Q 042568 876 EIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955 (983)
Q Consensus 876 elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 955 (983)
||++|+.||... ....+ .......... .+. ....+.++.+++.+|++.||++|||+
T Consensus 232 ~l~~g~~pf~~~-----~~~~~------------~~~~~~~~~~--~~~-----~~~~~~~l~~li~~~l~~dp~~R~s~ 287 (298)
T 2zv2_A 232 CFVFGQCPFMDE-----RIMCL------------HSKIKSQALE--FPD-----QPDIAEDLKDLITRMLDKNPESRIVV 287 (298)
T ss_dssp HHHHSSCSSCCS-----SHHHH------------HHHHHHCCCC--CCS-----SSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHCCCCCCCc-----cHHHH------------HHHHhcccCC--CCC-----ccccCHHHHHHHHHHhhcChhhCCCH
Confidence 999999998532 11111 1111111110 010 01244678999999999999999999
Q ss_pred HHHHHH
Q 042568 956 LDVAHE 961 (983)
Q Consensus 956 ~evl~~ 961 (983)
+|++++
T Consensus 288 ~e~l~h 293 (298)
T 2zv2_A 288 PEIKLH 293 (298)
T ss_dssp HHHTTC
T ss_pred HHHhcC
Confidence 999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.13 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=213.9
Q ss_pred CCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|...+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+++++++ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5688889999999999999985 246789999997665545568899999999999 999999999999999999
Q ss_pred eEEEecccCcccccccccccCc--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 740 ALVLPLMSNGSLENHLYPSHGL--------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEc
Confidence 9999999999999998754321 225899999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS-----------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCEEEccccccccccccccc-----------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999876543211 11223468899999999998899999999999999999999 99998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
...... ......+........+ ...+.++.+++.+|++.||++|||+.|++++|++
T Consensus 249 ~~~~~~-----------------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 249 PGMPVD-----------------SKFYKMIKEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp TTCCSS-----------------HHHHHHHHHTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ccccch-----------------hHHHHHhccCCCCCCc-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 642111 1111111111111111 1245678999999999999999999999999998
Q ss_pred hHhhc
Q 042568 965 LKQYL 969 (983)
Q Consensus 965 ~~~~~ 969 (983)
+.+..
T Consensus 305 ~~~~~ 309 (313)
T 1t46_A 305 QISES 309 (313)
T ss_dssp HHHHT
T ss_pred HHHHh
Confidence 87653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=345.66 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=195.9
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc---chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG---EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888899999999999999986 889999998654322 23578899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC--------CCCEEEccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE--------DLTALVADF 815 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~--------~~~~kl~Df 815 (983)
||+++++|.+++. ...+++..++.++.|+++||+|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999885 346899999999999999999999986445999999999999986 778999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+++...... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..... .
T Consensus 161 g~~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~ 220 (271)
T 3dtc_A 161 GLAREWHRTT---------------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----L 220 (271)
T ss_dssp CC----------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----H
T ss_pred Cccccccccc---------------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 9998654321 1124689999999999998999999999999999999999999864210 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
...............+ ..++.++.+++.+|++.||++|||+.|++++|+++
T Consensus 221 ------------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ------------AVAYGVAMNKLALPIP-------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------------HHHHHHHTSCCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------------HHHHhhhcCCCCCCCC-------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0011111111111111 22456789999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=357.10 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=203.1
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC-------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD------- 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 737 (983)
.++|.+.+.||+|+||.||+|+.. +++.||||+++........+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999976 789999999987665556788999999999999999999999985443
Q ss_pred --------------------------------------------------ceeEEEecccCcccccccccccCcCCCCCH
Q 042568 738 --------------------------------------------------FKALVLPLMSNGSLENHLYPSHGLSHGLDL 767 (983)
Q Consensus 738 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 767 (983)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27899999999999999976543 344677
Q ss_pred HHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccc
Q 042568 768 IQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847 (983)
Q Consensus 768 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 847 (983)
..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.............. ...........||
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~-~~~~~~~~~~~gt 239 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP-MPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------------CCCSCC-C
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc-ccccccccccCCC
Confidence 889999999999999999996 999999999999999999999999999987654322110000 0001122335799
Q ss_pred cccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccc
Q 042568 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYN 927 (983)
Q Consensus 848 ~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 927 (983)
+.|+|||.+.+..++.++||||+|+++|||++|..|+... . ..... .. ....+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~------------~~~~~-~~---~~~~~---- 292 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------V------------RIITD-VR---NLKFP---- 292 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------H------------HHHHH-HH---TTCCC----
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------H------------HHHHH-hh---ccCCC----
Confidence 9999999999999999999999999999999987774210 0 00111 11 11111
Q ss_pred cchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 928 KVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 928 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+.....++.+++.+|++.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 1223455678999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.61 Aligned_cols=280 Identities=25% Similarity=0.339 Sum_probs=208.9
Q ss_pred CCHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc--CCCCccceeeEEe
Q 042568 657 VSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI--RHRNLIRIITICS 734 (983)
Q Consensus 657 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~ 734 (983)
.....-....++|.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 333333445678999999999999999999986 899999998543 234556666766655 8999999999997
Q ss_pred cC----CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCCeEeecCCCCCeEeC
Q 042568 735 KP----DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS-----PIKVVHCDLKPSNILLD 805 (983)
Q Consensus 735 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NiLl~ 805 (983)
.. ...++||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+ ..+|+||||||+||+++
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 76 678999999999999999963 35899999999999999999999871 11399999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCcc------chhHHHHHHHHHHHh
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTH------GDVYSFGVLLLEIVT 879 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~SlG~il~ellt 879 (983)
.++.+||+|||+++......... ........||+.|+|||.+.+...+.+ +|||||||++|||++
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEV---------DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp TTSCEEECCCTTCEECC------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEeCCCceeeccccccc---------cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh
Confidence 99999999999998665332211 111223579999999999988766655 999999999999999
Q ss_pred CC----------CCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhh-cCCCCCccccccchHHHHHHHHHHHhhhcCCC
Q 042568 880 GR----------RPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAK-YAPQHMPIYYNKVWSDVVLELIELGLLCTQYN 948 (983)
Q Consensus 880 g~----------~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 948 (983)
|+ .||............ ....+.. ......+. .....+++.++.+++.+||+.|
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDPSYED-------------MREIVCIKKLRPSFPN--RWSSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHH-------------HHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHSCSS
T ss_pred ccCcccccccccccHhhhcCCCCchhh-------------hHHHHhhhccCccccc--cchhhHHHHHHHHHHHHhhhhC
Confidence 94 444332222211111 1111111 11111111 1112468889999999999999
Q ss_pred CCCCCCHHHHHHHHHHhHhhcC
Q 042568 949 PSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 949 P~~RPs~~evl~~L~~~~~~~~ 970 (983)
|++|||++|++++|+++.+...
T Consensus 313 P~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 313 PASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp GGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhCCCHHHHHHHHHHHHhhcc
Confidence 9999999999999999987653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=366.87 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=205.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..++|...+.||+|+||.||+|... +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467889999999999999999964 6888999998765432 3456789999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~Dfgla~ 819 (983)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999998875 345899999999999999999999996 99999999999998 56889999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||... ..
T Consensus 162 ~~~~~~~-------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~----- 218 (444)
T 3soa_A 162 EVEGEQQ-------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQ----- 218 (444)
T ss_dssp CCCTTCC-------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SH-----
T ss_pred EecCCCc-------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cH-----
Confidence 6653221 112357999999999999999999999999999999999999998531 11
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............... ...|...+.++.+++.+|++.||++|||+.|++++
T Consensus 219 -------~~~~~~i~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 219 -------HRLYQQIKAGAYDFP-----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------HHHHHHHHHTCCCCC-----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------HHHHHHHHhCCCCCC-----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111222111111111 11234456789999999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=357.37 Aligned_cols=269 Identities=19% Similarity=0.267 Sum_probs=211.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|...+.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788899999999999999996 5788999999865433 35688999999999 9999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC-----EEEcccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT-----ALVADFGIA 818 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~-----~kl~Dfgla 818 (983)
||+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 89999998753 346999999999999999999999996 999999999999998887 999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+.+.......... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+
T Consensus 158 ~~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~--~~~~~~~~ 229 (330)
T 2izr_A 158 KEYIDPETKKHIP------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK--ADTLKERY 229 (330)
T ss_dssp EESBCTTTCCBCC------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CSSHHHHH
T ss_pred eeeecCCCCcccc------ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc--cccHHHHH
Confidence 8765432211100 011234679999999999999999999999999999999999999997532 11111111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
. ......... + ........+ ++.+++.+|++.||.+||+++++.+.|+++.+..
T Consensus 230 ~------------~i~~~~~~~--~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 230 Q------------KIGDTKRAT--P--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp H------------HHHHHHHHS--C--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H------------HHHhhhccC--C--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 1 110000000 0 000001133 8999999999999999999999999999887654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=362.59 Aligned_cols=279 Identities=15% Similarity=0.212 Sum_probs=209.3
Q ss_pred HhCCCCCCCccccCCcEeEEEEEECC------CcEEEEEEeecccCcc----------hhHHHHHHHHHHHhcCCCCccc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQD------NTRIAVKVLDLTTTGE----------ITGSFKRECQILKRIRHRNLIR 728 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~~------~~~vAvK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 728 (983)
..++|.+.+.||+|+||.||+|.+.. ++.||||++....... ....+.+|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578999999999999999999764 3679999986543210 1123344556667778999999
Q ss_pred eeeEEecC----CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 729 IITICSKP----DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 729 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
+++++... ...++||||+ +++|.+++... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998664 4579999999 99999998753 356999999999999999999999996 9999999999999
Q ss_pred C--CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCC
Q 042568 805 D--EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR 882 (983)
Q Consensus 805 ~--~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~ 882 (983)
+ .++.+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAY------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCS------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred ecCCCCeEEEEECCcceecccCCccccc------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9 8899999999999877643322110 0112233569999999999999999999999999999999999999
Q ss_pred CCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 883 PTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 883 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
||.....+ ..........+...+....++.... ..++.++.+++..||+.+|++||+++++++.|
T Consensus 260 Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 260 PWEDNLKD-PKYVRDSKIRYRENIASLMDKCFPA--------------ANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp TTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSCT--------------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CccccccC-HHHHHHHHHHhhhhHHHHHHHhccc--------------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 99753222 1122222222222222222221100 12356789999999999999999999999999
Q ss_pred HHhHhhcCC
Q 042568 963 GRLKQYLSS 971 (983)
Q Consensus 963 ~~~~~~~~~ 971 (983)
+++.+....
T Consensus 325 ~~~~~~~~~ 333 (364)
T 3op5_A 325 LQGLKAIGS 333 (364)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHcCC
Confidence 998776544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.88 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-----chhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||.||+|... +++.||||+++..... ...+.+.+|++++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999975 6889999998765322 13578999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEcccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADFG 816 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Dfg 816 (983)
+||||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999864 346899999999999999999999996 99999999999999887 89999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ..+
T Consensus 164 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~ 224 (326)
T 2y0a_A 164 LAHKIDFGNE--------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----KQE 224 (326)
T ss_dssp TCEECCTTSC--------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----HHH
T ss_pred CCeECCCCCc--------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----HHH
Confidence 9987643211 122469999999999999999999999999999999999999985321 111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. .......... .+ ...+...+..+.+++.+|++.||++|||++|++++
T Consensus 225 ~------------~~~~~~~~~~--~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 225 T------------LANVSAVNYE--FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp H------------HHHHHHTCCC--CC---HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred H------------HHHHHhcCCC--cC---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 1111111000 00 11122345678999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=358.63 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=207.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..++|...+.||+|+||.||+|... +++.||||+++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467889999999999999999965 688999999976543 23457789999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC---CCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED---LTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~---~~~kl~Dfgla~ 819 (983)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.+ +.+||+|||+++
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999988864 345899999999999999999999996 9999999999999865 459999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ..
T Consensus 180 ~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~---- 236 (362)
T 2bdw_A 180 EVNDSE--------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QH---- 236 (362)
T ss_dssp CCTTCC--------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH----
T ss_pred EecCCc--------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HH----
Confidence 664321 1123579999999999999999999999999999999999999985321 11
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
............. + ...|..++.++.+++.+|++.||++||++.|++++-
T Consensus 237 --------~~~~~i~~~~~~~--~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 237 --------RLYAQIKAGAYDY--P---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp --------HHHHHHHHTCCCC--C---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred --------HHHHHHHhCCCCC--C---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 1111111111111 1 122345667899999999999999999999999763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=352.39 Aligned_cols=272 Identities=24% Similarity=0.355 Sum_probs=210.0
Q ss_pred CCCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 739 (983)
.+|...+.||+|+||.||+|++ .+++.||||++.........+++.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577789999999999999984 367889999997665555678899999999999999999999999876 667
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999998643 345899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ ........||..|+|||.+.+..++.++||||+|+++|||++|+.|+... ...+..
T Consensus 175 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~ 238 (302)
T 4e5w_A 175 AIETDKEY----------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP------MALFLK 238 (302)
T ss_dssp ECCTTCCE----------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH------HHHHHH
T ss_pred cccCCCcc----------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch------hhHHhh
Confidence 76543221 11223346889999999999988999999999999999999999986432 111111
Q ss_pred hhCCCCCcHH---HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 900 RHYPHRLDPI---VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 900 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
...+...... +...+........+ ..++.++.+++.+|++.||++|||++|+++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 239 MIGPTHGQMTVTRLVNTLKEGKRLPCP-------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHCSCCGGGHHHHHHHHHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ccCCcccccCHHHHHHHHhccCCCCCC-------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 1111111111 11112211111111 2345789999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.38 Aligned_cols=272 Identities=17% Similarity=0.249 Sum_probs=213.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++++ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35788899999999999999996 5788999999865432 35688999999999 7999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC-----EEEcccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT-----ALVADFGIA 818 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~-----~kl~Dfgla 818 (983)
||+ +++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999753 345899999999999999999999996 999999999999987776 999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+............ ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 159 ~~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~- 229 (298)
T 1csn_A 159 KFYRDPVTKQHIP------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQK- 229 (298)
T ss_dssp EESBCTTTCCBCC------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHH-
T ss_pred ccccccccccccc------ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc--cHHH-
Confidence 8776432211100 012234579999999999999999999999999999999999999997532111 1111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
............. ......++.++.+++.+|++.||++||++++|++.|+++.+....
T Consensus 230 -----------~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 230 -----------YERIGEKKQSTPL----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp -----------HHHHHHHHHHSCH----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----------HHHHHhhccCccH----HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1111100000000 001113457899999999999999999999999999999877554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.34 Aligned_cols=269 Identities=25% Similarity=0.393 Sum_probs=213.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 736 (983)
.++|...+.||+|+||.||+|.+. ++..||||+++........+++.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357888999999999999999863 46789999997665555677899999999999 899999999999999
Q ss_pred CceeEEEecccCcccccccccccCc------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGL------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999998754321 234899999999999999999999996 9999999999999
Q ss_pred CCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCC
Q 042568 805 DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRP 883 (983)
Q Consensus 805 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p 883 (983)
+.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSE-----------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCEEEccccccccccccccc-----------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999876532211 11122357889999999988889999999999999999999 9999
Q ss_pred CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 884 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
|... ...+ .... +........+ ..++.++.+++.+|++.||++|||+.|++++|+
T Consensus 260 ~~~~-----~~~~------------~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 260 YPGI-----PVEE------------LFKL-LKEGHRMDKP-------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp STTC-----CHHH------------HHHH-HHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCcC-----CHHH------------HHHH-HhcCCCCCCC-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 8532 1111 1111 1111111111 124567899999999999999999999999999
Q ss_pred HhHhhcCCCc
Q 042568 964 RLKQYLSSPS 973 (983)
Q Consensus 964 ~~~~~~~~~~ 973 (983)
++.+.....+
T Consensus 315 ~l~~~~~~~~ 324 (334)
T 2pvf_A 315 RILTLTTNEE 324 (334)
T ss_dssp HHHHHHC---
T ss_pred HHHhccccCc
Confidence 9987655443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.79 Aligned_cols=274 Identities=24% Similarity=0.302 Sum_probs=212.3
Q ss_pred CCCCCccccCCcEeEEEEEEC-----CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQ-----DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKAL 741 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 741 (983)
|...+.||+|+||.||++.+. +++.||||+++........+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999988753 57889999998765555677899999999999999999999999774 56789
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999964 34899999999999999999999996 999999999999999999999999999877
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... ........||..|+|||.+.+..++.++||||+|+++|||++|+.||...... .... ..
T Consensus 185 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~--~~ 249 (318)
T 3lxp_A 185 PEGHEY----------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLEL--IG 249 (318)
T ss_dssp CTTCSE----------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHH--HC
T ss_pred cccccc----------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhhh--hc
Confidence 543221 11222346888999999999988999999999999999999999998532110 0000 00
Q ss_pred CCCCC--cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 042568 902 YPHRL--DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972 (983)
Q Consensus 902 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 972 (983)
..... .......+........ ...++.++.+++.+||+.||++|||++|+++.|+++.+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccccchhHHHHHHHHhcccCCCC-------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 00000 0011111111111111 1235578999999999999999999999999999998776543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=355.47 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=203.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcE----EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|+||.||+|.+. +++. ||+|.+..........++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999964 4444 78888765544445577889999999999999999999986 456889
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999998753 245888999999999999999999996 999999999999999999999999999877
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......||..|+|||.+.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 166 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~---- 228 (325)
T 3kex_A 166 PPDDKQ-----------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--LAEVPD---- 228 (325)
T ss_dssp CCCTTC-----------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--TTHHHH----
T ss_pred Cccccc-----------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--HHHHHH----
Confidence 543221 11223468889999999998899999999999999999999 999986421 111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.+........+ ..++.++.+++.+||+.||++|||++|++++|+++..
T Consensus 229 ------------~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 229 ------------LLEKGERLAQP-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ------------HHHTTCBCCCC-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ------------HHHcCCCCCCC-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 1133467889999999999999999999999998854
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=376.85 Aligned_cols=265 Identities=27% Similarity=0.432 Sum_probs=213.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|.+.. +..||||.++.... ..++|.+|++++++++||||++++++|...+..++||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456778899999999999999764 78899999965433 367899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999997543 356899999999999999999999996 9999999999999999999999999998764321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...
T Consensus 373 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--~~~----------- 427 (495)
T 1opk_A 373 Y------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQ----------- 427 (495)
T ss_dssp E------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGG-----------
T ss_pred e------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--HHH-----------
Confidence 1 11122356789999999998899999999999999999999 999986421 111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCchh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~ 975 (983)
+.+. +........+ ..++.++.+++.+||+.||++|||+.|+++.|+.+.+......+.
T Consensus 428 ----~~~~-~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~~~ 486 (495)
T 1opk_A 428 ----VYEL-LEKDYRMERP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486 (495)
T ss_dssp ----HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHHHH
T ss_pred ----HHHH-HHcCCCCCCC-------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccchHH
Confidence 1111 1111111111 235578899999999999999999999999999886544333333
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=360.18 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=200.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 741 (983)
.++|...++||+|+||.||+|+.. +++.||||+++... .......+.+|.++++.+ +||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999965 68899999997542 223456788999999998 79999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999988753 45899999999999999999999996 999999999999999999999999999853
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .
T Consensus 175 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~------- 229 (353)
T 3txo_A 175 ICNG-------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----E------- 229 (353)
T ss_dssp CC----------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----H-------
T ss_pred ccCC-------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----H-------
Confidence 3211 12233579999999999999899999999999999999999999986321 1
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM------LDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 961 (983)
.+..+....... ..|. ....++.+++.+|++.||++||++ +|+++|
T Consensus 230 -----~~~~~~i~~~~~--~~p~-------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 230 -----DDLFEAILNDEV--VYPT-------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----HHHHHHHHHCCC--CCCT-------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----HHHHHHHHcCCC--CCCC-------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111222221111 1111 134678899999999999999998 778764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=361.44 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=213.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC--ceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD--FKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 743 (983)
++|.+.++||+|+||.||+|.+. +++.||||++.........+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999976 588999999976554445678899999999999999999999997765 679999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe----CCCCCEEEccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALVADFGIAK 819 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl----~~~~~~kl~Dfgla~ 819 (983)
||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999976432 334999999999999999999999996 9999999999999 788889999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC--------CCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 165 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 165 ELEDDEQ--------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp ECCCGGG--------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred EccCCCc--------------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 7653221 122469999999998765 567889999999999999999999996533222
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCC-----------------CCccccccchHHHHHHHHHHHhhhcCCCCCCCCC
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQ-----------------HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS 954 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 954 (983)
.... .+...+...... ..+ ............+.+++.+|++.||++||+
T Consensus 231 ~~~~-------------~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 231 RNKE-------------VMYKIITGKPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp TCHH-------------HHHHHHHSCCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred chHH-------------HHHHHhcCCCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhcc
Confidence 2111 111111111100 000 011123567888999999999999999999
Q ss_pred HHHHHHHHHHhHhh
Q 042568 955 MLDVAHEMGRLKQY 968 (983)
Q Consensus 955 ~~evl~~L~~~~~~ 968 (983)
+.|++++++++.+.
T Consensus 297 ~~e~l~~l~~il~~ 310 (396)
T 4eut_A 297 FDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=354.87 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=202.4
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ..+...++.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999996 578899999986542 1223568999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+ +|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 6788888764 345899999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. ......||+.|+|||.+.+..+ ++++||||+||++|+|++|+.||+....... .
T Consensus 161 ~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------~ 217 (336)
T 3h4j_B 161 GN--------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------F 217 (336)
T ss_dssp SB--------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------B
T ss_pred Cc--------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------H
Confidence 21 1123479999999999998776 7899999999999999999999964321100 0
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. .+ .. .....+ ...+.++.+++.+|++.||.+|||++|++++-.
T Consensus 218 ~-~i--------~~-~~~~~p-------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 218 K-KV--------NS-CVYVMP-------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp C-CC--------CS-SCCCCC-------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred H-HH--------Hc-CCCCCc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0 00 00 000011 123467889999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=372.36 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=210.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.++|...+.||+|+||.||+|.+.++..||||.++... ...+.|.+|++++++++||||+++++++. .+..++||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 34677789999999999999999888999999997543 24678999999999999999999999986 5678999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999997542 235889999999999999999999996 9999999999999999999999999998764321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 339 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-----~~--------- 392 (454)
T 1qcf_A 339 Y------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NP--------- 392 (454)
T ss_dssp H------------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH---------
T ss_pred e------------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-----HH---------
Confidence 1 11122346889999999998899999999999999999999 999986321 11
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
++.+. +........+ ..++.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 393 ---~~~~~-i~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 393 ---EVIRA-LERGYRMPRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---HHHHH-HHHTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---HHHHH-HHcCCCCCCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11111 1111111111 235578999999999999999999999999999886543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.76 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=201.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|++. ++.||||.+... ...+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46778899999999999999986 788999998533 24578999999999999999999999886 3579999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC-EEEccccccccccCCc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT-ALVADFGIAKLVKGID 825 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~-~kl~Dfgla~~~~~~~ 825 (983)
++|+|.+++..... ...+++..++.++.|+++||+|||+.++.+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 99999999875432 235789999999999999999999943225999999999999998886 799999999755321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||+...... ...
T Consensus 160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~-------- 213 (307)
T 2eva_A 160 ---------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRI-------- 213 (307)
T ss_dssp --------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---HHH--------
T ss_pred ---------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---HHH--------
Confidence 112358999999999999999999999999999999999999986432110 000
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
... ......... ...++..+.+++.+|++.||++|||++|++++|+.+.+....
T Consensus 214 ----~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 214 ----MWA-VHNGTRPPL-------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----HHH-HHTTCCCCC-------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----HHH-HhcCCCCCc-------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 000 111010000 122456788999999999999999999999999999876644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=367.74 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=206.6
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC-ceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD-FKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46777899999999999999986 7899999997543 3578999999999999999999999987665 78999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999997542 334799999999999999999999996 9999999999999999999999999998543211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 344 ----------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~----------- 394 (450)
T 1k9a_A 344 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KD----------- 394 (450)
T ss_dssp -------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TT-----------
T ss_pred ----------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HH-----------
Confidence 11257889999999999999999999999999999998 9999864321 11
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.... +........+ ..++.++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 395 ----~~~~-i~~~~~~~~p-------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 395 ----VVPR-VEKGYKMDAP-------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp ----HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ----HHHH-HHcCCCCCCC-------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 1111 1111111111 235678999999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.79 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=211.7
Q ss_pred CCCCCC-ccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSS-LIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~-~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+|.+.+ .||+|+||.||+|... ++..||||+++........+++.+|++++++++||||+++++++. .+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEE
Confidence 444555 8999999999999854 577899999977655556788999999999999999999999994 45689999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp ECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998643 346899999999999999999999996 99999999999999999999999999987654
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
..... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ....
T Consensus 163 ~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~-------- 222 (287)
T 1u59_A 163 DDSYY----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEV-------- 222 (287)
T ss_dssp CSCEE----------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHH--------
T ss_pred Cccee----------eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHH--------
Confidence 32211 11222357899999999988889999999999999999998 999986421 1111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCc
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPS 973 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 973 (983)
. ..+........+ ..++.++.+++.+|++.||++||++.|++++|+.+..+...+.
T Consensus 223 -------~-~~i~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 223 -------M-AFIEQGKRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp -------H-HHHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred -------H-HHHhcCCcCCCC-------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 1 111111111111 2345789999999999999999999999999999987765544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.34 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=210.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|...+++.||+|.+...... .+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467788999999999999999988889999999765433 478999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999998753 345899999999999999999999996 99999999999999999999999999986643211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......||..|+|||...+..++.++||||+|+++|||++ |+.||.... ..+
T Consensus 160 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~--------- 213 (267)
T 3t9t_A 160 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NSE--------- 213 (267)
T ss_dssp ------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHH---------
T ss_pred ------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HHH---------
Confidence 11122357889999999998889999999999999999999 899986321 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
..+. +........+ ...+.++.+++.+|++.||++|||++|++++|+++.+.
T Consensus 214 ---~~~~-i~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 214 ---VVED-ISTGFRLYKP-------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---HHHH-HHTTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHHH-HhcCCcCCCC-------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 1111111111 11346788999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.13 Aligned_cols=246 Identities=26% Similarity=0.303 Sum_probs=203.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|+.. +|+.||+|+++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999975 688999999965431 224567889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999875 345899999999999999999999996 99999999999999999999999999986542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.... .
T Consensus 159 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~--------- 208 (318)
T 1fot_A 159 V----------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----T--------- 208 (318)
T ss_dssp C----------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----H---------
T ss_pred c----------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----H---------
Confidence 1 123479999999999999999999999999999999999999985321 1
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.......+.... ..+ .....++.+++.+|++.||++|| +++|+++|
T Consensus 209 ---~~~~~~i~~~~~--~~p-------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 209 ---MKTYEKILNAEL--RFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---HHHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHHHHhCCC--CCC-------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111122221111 111 11346788999999999999999 89999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=366.35 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=207.1
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
++....++|...++||+|+||.||+|+.. +++.||+|+++... .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44445678999999999999999999976 58889999986532 1123456889999999999999999999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999998863 35899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCC----CCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR----ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
|+....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||... .
T Consensus 215 a~~~~~~~~------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~ 277 (410)
T 3v8s_A 215 CMKMNKEGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-----S 277 (410)
T ss_dssp CEECCTTSE------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-----S
T ss_pred eEeeccCCc------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-----C
Confidence 987643221 1123457999999999988755 789999999999999999999998632 1
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHEM 962 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 962 (983)
.. ......+........|. +...+.++.+++.+|+..+|++ ||+++|+++|-
T Consensus 278 ~~------------~~~~~i~~~~~~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 278 LV------------GTYSKIMNHKNSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HH------------HHHHHHHTHHHHCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred hh------------hHHHHHHhccccccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 11 11111111110000110 1124577899999999999988 99999999874
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=362.56 Aligned_cols=358 Identities=25% Similarity=0.383 Sum_probs=197.8
Q ss_pred CCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeeccccccc
Q 042568 110 KNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189 (983)
Q Consensus 110 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~ 189 (983)
.+.+.+.++. ..+++|+.|++++|.++ .+|. +..+++|++|+|++|.+++. |. + ..+++|++|++++|.++
T Consensus 33 ~~~~~~~i~~--~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~---~~l~~L~~L~l~~n~l~ 103 (466)
T 1o6v_A 33 KTNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-L---KNLTKLVDILMNNNQIA 103 (466)
T ss_dssp CSSTTSEECH--HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-G---TTCTTCCEEECCSSCCC
T ss_pred ccccccccCh--hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-h---hccccCCEEECCCCccc
Confidence 3344444332 34678888899888887 5664 78888888888888888743 32 3 36677777777777766
Q ss_pred CCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCC
Q 042568 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269 (983)
Q Consensus 190 ~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 269 (983)
+..+ +..+++|++|++++|++++..+ +.++++|++|++++|.++ .++. +..+++|++|+++ |.+..
T Consensus 104 ~~~~---~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~-~~~~~----- 169 (466)
T 1o6v_A 104 DITP---LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLSFG-NQVTD----- 169 (466)
T ss_dssp CCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC-CCGG--GTTCTTCSEEEEE-ESCCC-----
T ss_pred cChh---hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccC-CChh--hccCCcccEeecC-CcccC-----
Confidence 4433 4566666666666666665433 666666666666666665 2332 4555555555554 22111
Q ss_pred CCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCc
Q 042568 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPH 349 (983)
Q Consensus 270 ~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 349 (983)
...+.++++ |++|++++|.+++. +.+..+++|++|++++|.+++..|
T Consensus 170 -----~~~~~~l~~-------------------------L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~- 216 (466)
T 1o6v_A 170 -----LKPLANLTT-------------------------LERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP- 216 (466)
T ss_dssp -----CGGGTTCTT-------------------------CCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred -----chhhccCCC-------------------------CCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-
Confidence 011233333 33333333333321 124555666666666666665443
Q ss_pred ccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCC
Q 042568 350 ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNL 429 (983)
Q Consensus 350 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 429 (983)
++.+++|+.|++++|.+.+. ..+..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+ +..+++|
T Consensus 217 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L 289 (466)
T 1o6v_A 217 -LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL 289 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred -ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc
Confidence 55566666666666666542 245555666666666666654433 5555555555555555553222 4555555
Q ss_pred CEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCC
Q 042568 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509 (983)
Q Consensus 430 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 509 (983)
+.|++++|++++..+ +. .+++|+.|+|++|++++..| +..+++|+.|++++
T Consensus 290 ~~L~L~~n~l~~~~~--~~-------------------------~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~ 340 (466)
T 1o6v_A 290 TNLELNENQLEDISP--IS-------------------------NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340 (466)
T ss_dssp SEEECCSSCCSCCGG--GG-------------------------GCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred CeEEcCCCcccCchh--hc-------------------------CCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence 555555555554322 34 44444555555555543333 44455555555555
Q ss_pred CcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccc
Q 042568 510 NSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 510 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 563 (983)
|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp SCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred CccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 555543 244555555555555555554444 45555555555555555553
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.32 Aligned_cols=275 Identities=25% Similarity=0.347 Sum_probs=216.6
Q ss_pred CHHHHHHHhCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCcccee
Q 042568 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRII 730 (983)
Q Consensus 658 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 730 (983)
.........++|...+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3334444567899999999999999999984 246789999997665555567899999999999 799999999
Q ss_pred eEEecCC-ceeEEEecccCcccccccccccCc------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecC
Q 042568 731 TICSKPD-FKALVLPLMSNGSLENHLYPSHGL------------SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDL 797 (983)
Q Consensus 731 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Di 797 (983)
+++...+ ..++||||+++|+|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987655 489999999999999998754321 123889999999999999999999996 999999
Q ss_pred CCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHH
Q 042568 798 KPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 877 (983)
Q Consensus 798 kp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~el 877 (983)
||+||+++.++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDY-----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTS-----------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccceEEECCCCCEEECCCccccccccCccc-----------eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHH
Confidence 999999999999999999999866432211 122335688999999999999999999999999999999
Q ss_pred Hh-CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 878 VT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 878 lt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
++ |+.||...... ..+...+........+ .....++.+++.+|++.||++|||+.
T Consensus 244 ~t~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ 299 (316)
T 2xir_A 244 FSLGASPYPGVKID-----------------EEFCRRLKEGTRMRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFS 299 (316)
T ss_dssp HTTSCCSSTTCCCS-----------------HHHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhCCCCCCcccchh-----------------HHHHHHhccCccCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 98 99998642111 1111111111111111 11346789999999999999999999
Q ss_pred HHHHHHHHhHhhcC
Q 042568 957 DVAHEMGRLKQYLS 970 (983)
Q Consensus 957 evl~~L~~~~~~~~ 970 (983)
|++++|+.+.+...
T Consensus 300 ell~~L~~~~~~~~ 313 (316)
T 2xir_A 300 ELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhhhc
Confidence 99999999976543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=357.52 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=202.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...++||+|+||.||+|+.. +++.||||+++.... .+..+.+.+|..+++++ +||||+++++++...+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57888999999999999999976 577899999976532 22346688999999887 899999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988753 45899999999999999999999996 9999999999999999999999999998532
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 205 ~~~-------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------- 262 (396)
T 4dc2_A 205 RPG-------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------- 262 (396)
T ss_dssp CTT-------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------
T ss_pred cCC-------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc---------
Confidence 211 1223457999999999999999999999999999999999999999643211100
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM------LDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 961 (983)
.......+.+.+.... ...| .....++.+++.+|++.||++||++ +|+++|
T Consensus 263 ~~~~~~~~~~~i~~~~-~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 263 DQNTEDYLFQVILEKQ-IRIP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CCHHHHHHHHHHCC-CCCC-------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred chhhHHHHHHHHhccc-cCCC-------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0001111112221111 1111 1245678999999999999999995 677654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=348.21 Aligned_cols=277 Identities=25% Similarity=0.334 Sum_probs=192.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|... +++.||||+++..........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457889999999999999999964 6889999999766555556789999999999999999999999999999999999
Q ss_pred cccCcccccccccccC--cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 745 LMSNGSLENHLYPSHG--LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|++ |+|.+++..... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 589888764321 1245899999999999999999999996 9999999999999999999999999998764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+.......
T Consensus 160 ~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~ 225 (317)
T 2pmi_A 160 IPVN-------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIM 225 (317)
T ss_dssp SCCC-------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHH
T ss_pred CCcc-------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHh
Confidence 3211 1122468999999999876 4689999999999999999999999864211 11111111110
Q ss_pred C--CCCCcHHHHHHHhhcC---CCCCccc-----cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 Y--PHRLDPIVEKAIAKYA---PQHMPIY-----YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~--~~~~~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. +....+.... ..... ....+.. ..........++.+++.+|++.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTK-LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGG-CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhh-hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000000 00000 0000000 000001234678999999999999999999999976
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.60 Aligned_cols=271 Identities=27% Similarity=0.421 Sum_probs=218.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|.+. ++..||||.+..... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 456888899999999999999976 478899999865432 46789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 90 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999997543 456899999999999999999999996 999999999999999999999999999876532
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... ....
T Consensus 165 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~--------- 221 (288)
T 3kfa_A 165 TY------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQV--------- 221 (288)
T ss_dssp SS------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGH---------
T ss_pred cc------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHH---------
Confidence 21 11222457889999999998899999999999999999999 999986421 1111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCchhHHHhh
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPSSLIEEAA 980 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~~~~ 980 (983)
.+. +........+ ..++.++.+++.+|++.||++|||++|+++.|+.+.+....+.+...+-.
T Consensus 222 ------~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~ 284 (288)
T 3kfa_A 222 ------YEL-LEKDYRMERP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 284 (288)
T ss_dssp ------HHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ------HHH-HhccCCCCCC-------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccccchhhcccc
Confidence 111 1111111111 22456789999999999999999999999999999877665555544443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.90 Aligned_cols=261 Identities=31% Similarity=0.473 Sum_probs=196.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|+.. ..||||+++.... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467889999999999999999864 3599999865543 33457899999999999999999999976 4556799999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999988643 356899999999999999999999996 999999999999999999999999999865432
Q ss_pred cccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
... .......||+.|+|||.+. +..++.++||||+|+++|||++|+.||...... .
T Consensus 174 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~--------- 232 (289)
T 3og7_A 174 SGS-----------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-D--------- 232 (289)
T ss_dssp ---------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-H---------
T ss_pred ccc-----------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-H---------
Confidence 211 1122356999999999986 567888999999999999999999998642111 0
Q ss_pred CCCCCcHHHHHHHhh-cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 902 YPHRLDPIVEKAIAK-YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.+...+.. ..... .......++.++.+++.+|++.||++|||+.|+++.|+++.+
T Consensus 233 -------~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 233 -------QIIEMVGRGSLSPD----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------HHHHHHHHTSCCCC----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HHHHHhcccccCcc----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111 11111 111123456789999999999999999999999999998864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.03 Aligned_cols=273 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|...+++.||||++...... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999988999999998655432 2357788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++ +|.+++... ...+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 888877643 346899999999999999999999996 9999999999999999999999999998664221
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..........
T Consensus 155 ~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~ 220 (288)
T 1ob3_A 155 R-------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTP 220 (288)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCC
T ss_pred c-------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCC
Confidence 1 1122468999999999876 4589999999999999999999999864211 11111111110000
Q ss_pred C--CcHHHHHHHhhc---CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 R--LDPIVEKAIAKY---APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ..+.... .... .....+............++.+++.+|++.||++|||++|++++
T Consensus 221 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 221 NSKNWPNVTE-LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTTSTTGGG-STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Chhhchhhhc-ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000000 0000 00000011111122356778999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=371.71 Aligned_cols=264 Identities=22% Similarity=0.225 Sum_probs=208.5
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
+.++....++|...++||+|+||+||+|+.. +++.||||+++.... ......+.+|.+++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 3445556788999999999999999999976 478899999965321 1234458899999999999999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999753 346999999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
|+|+....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 220 Gla~~~~~~~~------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--- 284 (437)
T 4aw2_A 220 GSCLKLMEDGT------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--- 284 (437)
T ss_dssp TTCEECCTTSC------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---
T ss_pred hhhhhcccCCC------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---
Confidence 99986643221 1122357999999999987 567899999999999999999999998632
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPST--RPSMLDVAHE 961 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~ 961 (983)
... +.....+........|.. +...+.++.+++.+|+..+|++ ||+++|+++|
T Consensus 285 --~~~------------~~~~~i~~~~~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 285 --SLV------------ETYGKIMNHKERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --SHH------------HHHHHHHTHHHHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --Chh------------HHHHhhhhccccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111 111111111000011110 1124567899999999988888 9999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=347.52 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=198.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|.... +..||+|.++........+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 578888999999999999999643 45699999876555556778999999999999999999999985 4567999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999998743 346899999999999999999999996 9999999999999999999999999998764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 168 ~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~------- 226 (281)
T 1mp8_A 168 DSTYY------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV------- 226 (281)
T ss_dssp -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGH-------
T ss_pred ccccc------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHH-------
Confidence 32211 1122357889999999998899999999999999999997 9999864211 111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
....... .....+ ..++.++.+++.+|++.||++|||+.|++++|+++.+.
T Consensus 227 --------~~~i~~~-~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 227 --------IGRIENG-ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------HHHHHTT-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHcC-CCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 100011 22456789999999999999999999999999998654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=356.52 Aligned_cols=286 Identities=25% Similarity=0.302 Sum_probs=202.3
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHH--HHhcCCCCccceeeEEec-----CCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQI--LKRIRHRNLIRIITICSK-----PDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 739 (983)
++|...+.||+|+||.||+|+. +++.||||+++... ...+..|.++ +..++||||+++++++.. ....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 5788899999999999999987 58999999986432 3444555555 445899999999986532 2356
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc---------CCCCeEeecCCCCCeEeCCCCCE
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH---------SPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~---------~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
++||||+++|+|.+++.. ...++..+..++.|+++||+|||+. + |+||||||+|||++.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 899999999999999964 3458999999999999999999998 6 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-------CCCCccchhHHHHHHHHHHHhCCCC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-------KRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
||+|||+++.+......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 160 kL~DFG~a~~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPG-----EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp EECCCTTCEECSSSSCC--------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred EEeeccceeecccccccCcc-----ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 99999999876543211000 00112223579999999999887 4567889999999999999999887
Q ss_pred CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcC-CCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYA-PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 884 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
|............+..................... ....+.. ......++.++.+++.+||+.||++|||++|+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 64322111110011111111111111111111111 1111111 112344778899999999999999999999999999
Q ss_pred HHhHhhcCC
Q 042568 963 GRLKQYLSS 971 (983)
Q Consensus 963 ~~~~~~~~~ 971 (983)
+++......
T Consensus 314 ~~ll~~~~~ 322 (336)
T 3g2f_A 314 AELMMIWER 322 (336)
T ss_dssp HHHHHCCCC
T ss_pred HHHHHHHHh
Confidence 999755443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=349.31 Aligned_cols=274 Identities=21% Similarity=0.274 Sum_probs=202.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||+||+|... +++.||||++...... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 6889999999765433 345788899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++ ++.+.+... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 454444332 346999999999999999999999996 999999999999999999999999999876432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.........+.........
T Consensus 155 ~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 155 VR-------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CS-------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred cc-------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 11 112346899999999998765 7999999999999999999999864221111111111111111
Q ss_pred CC--CcHHHHHHHhhcCCC---CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HR--LDPIVEKAIAKYAPQ---HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. ..+.... .....+. ...............++.+++.+|++.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 222 PTEEQWPSMTK-LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGG-STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CChhhhhhhcc-cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000000 0000000 00000111122355778999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.43 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=202.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999965 57889999986543 2234578899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999874 345899999999999999999999996 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.. ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......
T Consensus 168 ~~--------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~--- 228 (384)
T 4fr4_A 168 ET--------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEI--- 228 (384)
T ss_dssp TC--------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT--SCHHHH---
T ss_pred CC--------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC--ccHHHH---
Confidence 21 1223579999999999874 4589999999999999999999999864211 111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-MLDVAH 960 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~ 960 (983)
......... ..+ ...+.++.+++.+|++.||++||+ ++++.+
T Consensus 229 ---------~~~~~~~~~--~~p-------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 229 ---------VHTFETTVV--TYP-------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---------HHHHHHCCC--CCC-------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---------HHHHhhccc--CCC-------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111111111 111 123467899999999999999998 777765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.27 Aligned_cols=255 Identities=24% Similarity=0.417 Sum_probs=207.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|... +++.||||+++........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356888999999999999999975 6889999999766555566889999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999864 345899999999999999999999996 999999999999999999999999999866432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+...........+...
T Consensus 159 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--- 224 (276)
T 2yex_A 159 NRE-----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--- 224 (276)
T ss_dssp TEE-----------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---
T ss_pred cch-----------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---
Confidence 211 11223568999999999988765 788999999999999999999997532221111111110
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... . ..+...+.++.+++.+|++.||++|||++|++++
T Consensus 225 -------------~~~--~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 225 -------------KTY--L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -------------CTT--S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------------ccc--c-----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000 0 0122345678899999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=358.19 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=190.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888999999999999999976 57889999997543 24678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfgla~~~ 821 (983)
|+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999998864 345899999999999999999999996 999999999999975 889999999999865
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 202 ~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~------ 257 (349)
T 2w4o_A 202 EHQV--------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----Q------ 257 (349)
T ss_dssp -------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----H------
T ss_pred Cccc--------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----H------
Confidence 4221 112356999999999999999999999999999999999999998532111 0
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............. ....+.+.+.++.+++.+|++.||++|||+.|++++
T Consensus 258 ------~~~~~i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 258 ------FMFRRILNCEYYF-----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ------HHHHHHHTTCCCC-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHHhCCCcc-----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111110 011223456789999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.02 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=196.1
Q ss_pred HhCCCCCCCccccCCcEeEEEEEECCC-c---EEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQDN-T---RIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~~~-~---~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
..++|...+.||+|+||.||+|.+... + .||||+++... .....+++.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 346799999999999999999996533 2 79999986543 233467899999999999999999999999877655
Q ss_pred ------eEEEecccCcccccccccccC--cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 740 ------ALVLPLMSNGSLENHLYPSHG--LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 740 ------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999864332 1235899999999999999999999996 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHD 890 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~ 890 (983)
|+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 l~Dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~- 245 (323)
T 3qup_A 178 VADFGLSRKIYSGDYY-----------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN- 245 (323)
T ss_dssp ECCCCC----------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-
T ss_pred Eeeccccccccccccc-----------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-
Confidence 9999999876432211 11122357889999999999999999999999999999999 8999864211
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.+............ .+ ..++.++.+++.+|++.||++|||+.|+++.|+++.+.
T Consensus 246 ----------------~~~~~~~~~~~~~~-~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 246 ----------------AEIYNYLIGGNRLK-QP-------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ----------------GGHHHHHHTTCCCC-CC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----------------HHHHHHHhcCCCCC-CC-------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111111 11 12446789999999999999999999999999988654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=359.18 Aligned_cols=399 Identities=20% Similarity=0.221 Sum_probs=302.6
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+++.|+++++.+.+. | .++.+++|++|+|++|.+++ +| ++.+++|++|+|++|.|++. | ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 3589999999999974 4 79999999999999999996 44 99999999999999999964 4 999999999999
Q ss_pred cCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccc
Q 042568 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236 (983)
Q Consensus 157 s~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 236 (983)
++|++++ +| + ..+++|++|++++|.+++ ++ +..+++|++|++++|+..+.+ .++.+++|++|++++|+
T Consensus 114 ~~N~l~~-l~--~---~~l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 114 DTNKLTK-LD--V---SQNPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181 (457)
T ss_dssp CSSCCSC-CC--C---TTCTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred CCCcCCe-ec--C---CCCCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence 9999985 55 3 488999999999999997 44 568999999999999766666 48899999999999999
Q ss_pred cccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccC
Q 042568 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316 (983)
Q Consensus 237 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~ 316 (983)
+++ +| +..+++|++|++++|++... .+..+++|++|++++|++++ +| +..+ ++|+.|++++
T Consensus 182 l~~-l~---l~~l~~L~~L~l~~N~l~~~-----------~l~~l~~L~~L~Ls~N~l~~-ip--~~~l-~~L~~L~l~~ 242 (457)
T 3bz5_A 182 ITE-LD---VSQNKLLNRLNCDTNNITKL-----------DLNQNIQLTFLDCSSNKLTE-ID--VTPL-TQLTYFDCSV 242 (457)
T ss_dssp CCC-CC---CTTCTTCCEEECCSSCCSCC-----------CCTTCTTCSEEECCSSCCSC-CC--CTTC-TTCSEEECCS
T ss_pred cce-ec---cccCCCCCEEECcCCcCCee-----------ccccCCCCCEEECcCCcccc-cC--cccc-CCCCEEEeeC
Confidence 985 66 67899999999999998753 26778999999999999997 55 5565 5799999999
Q ss_pred ccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCc
Q 042568 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP 396 (983)
Q Consensus 317 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 396 (983)
|.+++.. ++.+++|+.|++++|+ |+.|++++|.+.+.+| ++.+++|+.|+|++|++.+.+|
T Consensus 243 N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 243 NPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp SCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred CcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence 9998753 4567788888887663 5567788888777776 5678889999999998877777
Q ss_pred ccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccc
Q 042568 397 DSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476 (983)
Q Consensus 397 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~ 476 (983)
. ...+|+.|++++| ++|+.|++++|++++. + +..+++|+. |++++|++++ ++
T Consensus 304 ~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~-L~l~~N~l~~--------l~ 355 (457)
T 3bz5_A 304 C---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKS-LSCVNAHIQD--------FS 355 (457)
T ss_dssp C---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSE-EECCSSCCCB--------CT
T ss_pred c---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcE-EECCCCCCCC--------cc
Confidence 4 3345555555444 5678888888888763 2 777777875 8888888775 24
Q ss_pred ccccccccccccccCCCcccccccccceEEeCCCcccccccccccC-CCCccEEecCCccccCCcCc--cccCCC-----
Q 042568 477 MVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQ-LPYLKQFDVSSNRLFGEIPQ--SFQASP----- 548 (983)
Q Consensus 477 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~--~~~~l~----- 548 (983)
.|..|++++|+++|. +.+..|+.+++++|+++|.+|..+.. ..++....-+.+........ .+.+++
T Consensus 356 ~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~~~~~~~~~~~~~~~~y~~~~~~i~~k~~~~~~~~ 430 (457)
T 3bz5_A 356 SVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430 (457)
T ss_dssp TGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBCTTSCCCEEEESSSEEEETTTTEEEESSCCTTSCE
T ss_pred ccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhcccCceeeccCCCCccccCCCCeeEEEeccCCCce
Confidence 566777888888765 35566777888888888877765433 23333333333322211110 111111
Q ss_pred CcceEeccCCccccccCC
Q 042568 549 TLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 549 ~L~~l~l~~N~l~~~~~~ 566 (983)
-+.....++|.++|.++.
T Consensus 431 ~~y~~~~~~~~fsG~i~~ 448 (457)
T 3bz5_A 431 VTYTFTSENGAIVGTVTT 448 (457)
T ss_dssp ECEEEECTTSSEEEEEEE
T ss_pred EEEEEecCCcEEeeEecc
Confidence 123333457888888764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.04 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=212.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC-C-----cEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD-N-----TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
.++|...+.||+|+||.||+|.... + ..||||.+......+..+.+.+|+++++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999999652 2 479999997665555677899999999999 89999999999999999
Q ss_pred eeEEEecccCcccccccccccC----------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 739 KALVLPLMSNGSLENHLYPSHG----------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
.++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999865321 1345899999999999999999999996 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVL 887 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~ 887 (983)
.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNY-----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTS-----------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred eEEECccccccccccccce-----------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999866432211 11223468899999999998899999999999999999999 99998642
Q ss_pred cCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 888 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
... ......+........+ ..++.++.+++.+|++.||++|||+.|++++|+++.+
T Consensus 271 ~~~-----------------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 271 LVN-----------------SKFYKLVKDGYQMAQP-------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp CSS-----------------HHHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chh-----------------HHHHHHHhcCCCCCCC-------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111 1111111111111111 1134678899999999999999999999999998865
Q ss_pred h
Q 042568 968 Y 968 (983)
Q Consensus 968 ~ 968 (983)
.
T Consensus 327 ~ 327 (333)
T 2i1m_A 327 E 327 (333)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=359.91 Aligned_cols=284 Identities=18% Similarity=0.253 Sum_probs=207.6
Q ss_pred hCCCCCCCccccC--CcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSG--RFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G--~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
.++|.+.++||+| +||.||+|+.. +++.||||+++.... .+..+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999976 689999999976543 2345778899999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999987542 345899999999999999999999996 999999999999999999999999998765
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
......... .........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+...+.
T Consensus 179 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~ 251 (389)
T 3gni_B 179 ISHGQRQRV------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKLN 251 (389)
T ss_dssp EETTEECSC------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT-HHHHC--
T ss_pred ccccccccc------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhc
Confidence 432211110 0112233479999999999987 678999999999999999999999996532211 1111111
Q ss_pred hhCCCCCcHH-------------------HHHHHhhcC--CCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 042568 900 RHYPHRLDPI-------------------VEKAIAKYA--PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958 (983)
Q Consensus 900 ~~~~~~~~~~-------------------~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 958 (983)
...+...... ......... ...........+.....++.+++.+|++.||++|||++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 1111000000 000000000 0000000011123356779999999999999999999999
Q ss_pred HHH
Q 042568 959 AHE 961 (983)
Q Consensus 959 l~~ 961 (983)
+++
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 976
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=353.92 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=204.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999975 68999999996543 2234577889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999998753 45899999999999999999999996 99999999999999999999999999986542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ..
T Consensus 194 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~--------- 243 (350)
T 1rdq_E 194 R----------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QP--------- 243 (350)
T ss_dssp C----------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---------
T ss_pred C----------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----CH---------
Confidence 1 12357999999999999999999999999999999999999998632 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHEM 962 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 962 (983)
.+..+....... ..+ ...+.++.+++.+|++.||++||+ ++|+++|-
T Consensus 244 ---~~~~~~i~~~~~--~~p-------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 244 ---IQIYEKIVSGKV--RFP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp ---HHHHHHHHHCCC--CCC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ---HHHHHHHHcCCC--CCC-------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 111122111111 111 123467899999999999999998 89988753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.70 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=201.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc------hhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE------ITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
++|...+.||+|+||.||+|.+. +++.||||++....... ..+++.+|++++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888999999999999999974 78899999986543321 1267899999999999999999999996654
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC-----EEEcc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT-----ALVAD 814 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~-----~kl~D 814 (983)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++. +|+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~-~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCC-CeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888643 3469999999999999999999999842 3999999999999988776 99999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccC--CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM--GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
||+++..... .....||+.|+|||.+. ...++.++||||+|+++|||++|+.||........
T Consensus 173 fg~~~~~~~~----------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 173 FGLSQQSVHS----------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CTTCBCCSSC----------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCcccccccc----------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 9999744321 12246999999999984 45678999999999999999999999864321111
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.. .............+ ..++.++.+++.+|++.||++|||++|+++.|+++
T Consensus 237 ~~---------------~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 KF---------------INMIREEGLRPTIP-------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH---------------HHHHHHSCCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HH---------------HHHHhccCCCCCCC-------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 11111111111111 23457889999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.90 Aligned_cols=255 Identities=25% Similarity=0.369 Sum_probs=205.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC--CceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP--DFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 743 (983)
++|...+.||+|+||.||+|+++ ++.||||+++.... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888999999999999999986 88999999976542 33457799999999999999999999999877 7789999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+. +|+||||||+||+++.++.++|+|||.+.....
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999997543 3368999999999999999999999742 399999999999999999999999988754221
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCc---cchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAST---HGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.....
T Consensus 166 ------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------- 216 (271)
T 3kmu_A 166 ------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----------- 216 (271)
T ss_dssp ------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------
T ss_pred ------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------
Confidence 1236899999999998765544 79999999999999999999863211
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
................+ ..++.++.+++.+|++.||++|||++|+++.|+++.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 217 ------MEIGMKVALEGLRPTIP-------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------HHHHHHHHHSCCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------HHHHHHHHhcCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111111111111111 2245678999999999999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.31 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=201.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... ++..||+|++.........+.+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999965 68899999997766555678899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEcccccccccc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLVK 822 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~~~~ 822 (983)
+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988654333467999999999999999999999996 9999999999999 456889999999998654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .....||+.|+|||.+. ..++.++||||+|+++|||++|+.||.... ...
T Consensus 179 ~~~~--------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-----~~~------ 232 (285)
T 3is5_A 179 SDEH--------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-----LEE------ 232 (285)
T ss_dssp ----------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH------
T ss_pred Cccc--------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-----HHH------
Confidence 3211 12346899999999876 468899999999999999999999986321 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ +.. ......++.+++.+|++.||++|||+.|++++
T Consensus 233 ------~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 233 ------VQQKATYKEPNY--AVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ------HHHHHHHCCCCC--CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ------HHhhhccCCccc--ccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111100 000 01134678899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.76 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=203.7
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
...++|...+.||+|+||.||+|+.. +++.||||+++... .......+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 68889999997542 123456788899999987 999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999998753 45899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...... ......+||+.|+|||.+.+..++.++||||+||++|||++|+.||... ...
T Consensus 167 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~---- 224 (345)
T 1xjd_A 167 ENMLGD-------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEE---- 224 (345)
T ss_dssp CCCCTT-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH----
T ss_pred hcccCC-------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC-----CHH----
Confidence 543211 1123357999999999999999999999999999999999999998632 111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML-DVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 961 (983)
+..+....... ..+ .....++.+++.+|++.||++||++. |+++|
T Consensus 225 --------~~~~~i~~~~~--~~p-------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 225 --------ELFHSIRMDNP--FYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --------HHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --------HHHHHHHhCCC--CCC-------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11111111111 111 11346789999999999999999997 77643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=348.88 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=204.8
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+.||+|+||.||+|.... +..||||.++..........+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999998642 235999999766555556789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999998753 346899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 198 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~----- 257 (333)
T 1mqb_A 198 EDDPEAT----------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NH----- 257 (333)
T ss_dssp -----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH-----
T ss_pred ccccccc----------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-----HH-----
Confidence 5322110 11112346889999999999999999999999999999999 999985321 01
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
+..+. +........+ ..++.++.+++.+||+.||++||++.|++++|+++.+....
T Consensus 258 -------~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 258 -------EVMKA-INDGFRLPTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp -------HHHHH-HHTTCCCCCC-------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -------HHHHH-HHCCCcCCCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 11111 1111110011 12456789999999999999999999999999988765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.48 Aligned_cols=267 Identities=19% Similarity=0.266 Sum_probs=204.8
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc----CcchhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT----TGEITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
++....++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999964 67889999986542 23456789999999999999999999999999
Q ss_pred CCceeEEEecccCcccccccccccCc------------------------------------CCCCCHHHHHHHHHHHHH
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGL------------------------------------SHGLDLIQLVKICSDVAE 779 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~ 779 (983)
.+..++||||+++|+|.+++...... ...+++..++.++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988521100 112467788899999999
Q ss_pred HHHHHhccCCCCeEeecCCCCCeEeCCCC--CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccC
Q 042568 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDL--TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM 857 (983)
Q Consensus 780 aL~~LH~~~~~~ivH~Dikp~NiLl~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 857 (983)
||+|||+.+ |+||||||+||+++.++ .+||+|||+++.+....... ........||+.|+|||.+.
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---------YYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------------CCCGGGCCHHHHT
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc---------cccccccCCCccccCchhhc
Confidence 999999996 99999999999998776 89999999998764322110 01122356999999999987
Q ss_pred C--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHH
Q 042568 858 G--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVL 935 (983)
Q Consensus 858 ~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 935 (983)
+ ..++.++||||||+++|||++|+.||..... .+............. ...+.....
T Consensus 248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~-----~~~~~~~~~ 305 (345)
T 3hko_A 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-----------------ADTISQVLNKKLCFE-----NPNYNVLSP 305 (345)
T ss_dssp CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCCCCTT-----SGGGGGSCH
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-----------------HHHHHHHHhcccccC-----CcccccCCH
Confidence 5 6789999999999999999999999863211 111112221111111 111233567
Q ss_pred HHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 936 ELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 936 ~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
++.+++.+|++.||++||++.|++++
T Consensus 306 ~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 306 LARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 89999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=349.03 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=203.5
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688899999999999999996 478999999986532 2334678899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998754333556899999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......
T Consensus 189 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~----- 247 (310)
T 2wqm_A 189 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLC----- 247 (310)
T ss_dssp -----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC------CCHHHHH-----
T ss_pred CCc-------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc---hhHHHHH-----
Confidence 211 1122468999999999999999999999999999999999999985321 1111111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCc
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPS 973 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 973 (983)
.. +..... +... ....+.++.+++.+|++.||++|||+.++++.|+++.....+|.
T Consensus 248 -------~~-~~~~~~---~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 248 -------KK-IEQCDY---PPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp -------HH-HHTTCS---CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred -------HH-hhcccC---CCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 11 111110 0000 12245678999999999999999999999999999987765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.75 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=203.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|+.. +++.||||+++.... .+..+.+.+|.++++++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999975 578899999976532 23456788999999998 899999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999988743 45899999999999999999999996 9999999999999999999999999998543
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 162 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------- 220 (345)
T 3a8x_A 162 RPG-------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------- 220 (345)
T ss_dssp CTT-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------
T ss_pred CCC-------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc--------
Confidence 211 11233579999999999999999999999999999999999999996432111000
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM------LDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~ 961 (983)
......+...+.... ...| ...+.++.+++.+|++.||++||++ +|+++|
T Consensus 221 -~~~~~~~~~~i~~~~-~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 221 -QNTEDYLFQVILEKQ-IRIP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CHHHHHHHHHHCC-CCCC-------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -cccHHHHHHHHHcCC-CCCC-------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 000111111111111 1111 1244678999999999999999995 677764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=349.50 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=194.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE----CCCcEEEEEEeeccc---CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL----QDNTRIAVKVLDLTT---TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
++|...+.||+|+||.||+|+. .+++.||||+++... .......+.+|++++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788899999999999999997 478899999997543 122356788999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999988743 45889999999999999999999996 9999999999999999999999999997
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..
T Consensus 170 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~---- 227 (327)
T 3a62_A 170 ESIHDG-------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----RK---- 227 (327)
T ss_dssp ----------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HH----
T ss_pred ccccCC-------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----HH----
Confidence 543221 11223579999999999999999999999999999999999999986321 11
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
...+....... ..+ .....++.+++.+|++.||++|| ++.|+++|
T Consensus 228 --------~~~~~i~~~~~--~~p-------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 228 --------KTIDKILKCKL--NLP-------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------HHHHHHHHTCC--CCC-------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------HHHHHHHhCCC--CCC-------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11122111111 111 12346789999999999999999 78888875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=355.33 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=205.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++......++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 357889999999999999999975 688899999865432 235678999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC--CCCEEEcccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE--DLTALVADFGIAKLVK 822 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~--~~~~kl~Dfgla~~~~ 822 (983)
|+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988643 346899999999999999999999996 999999999999974 5789999999998764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+
T Consensus 203 ~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~~~------ 257 (387)
T 1kob_A 203 PDEI--------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLE------ 257 (387)
T ss_dssp TTSC--------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHH------
T ss_pred CCcc--------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----HHH------
Confidence 3211 122469999999999999999999999999999999999999986321 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ ....+...+.++.+++.+|++.||++|||+.|++++
T Consensus 258 ------~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 258 ------TLQNVKRCDWEF-----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ------HHHHHHHCCCCC-----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ------HHHHHHhCCCCC-----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111111100 011223456789999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=350.45 Aligned_cols=276 Identities=24% Similarity=0.339 Sum_probs=212.9
Q ss_pred CHHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHh--cCCCCccceeeEEec
Q 042568 658 SYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKR--IRHRNLIRIITICSK 735 (983)
Q Consensus 658 ~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 735 (983)
....-....++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|+++++. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33333445678999999999999999999985 899999998533 34678889999988 789999999999987
Q ss_pred CC----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh--------ccCCCCeEeecCCCCCeE
Q 042568 736 PD----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--------HHSPIKVVHCDLKPSNIL 803 (983)
Q Consensus 736 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dikp~NiL 803 (983)
.. ..++||||+++|+|.+++.. ..+++..++.++.|+++||+||| +.+ |+||||||+||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 76 78999999999999999963 35899999999999999999999 664 999999999999
Q ss_pred eCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC------CCCccchhHHHHHHHHHH
Q 042568 804 LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK------RASTHGDVYSFGVLLLEI 877 (983)
Q Consensus 804 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~SlG~il~el 877 (983)
++.++.+||+|||+++......... ........||+.|+|||.+.+. .++.++||||||+++|||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 250 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTI---------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEE---------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCEEEEECCCceecccccccc---------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence 9999999999999998765432211 0122335799999999998875 234789999999999999
Q ss_pred HhC----------CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCC
Q 042568 878 VTG----------RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947 (983)
Q Consensus 878 ltg----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 947 (983)
++| +.||............+.... .........+... ...+++..+.+++.+||+.
T Consensus 251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------------CEQKLRPNIPNRW--QSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH------------TTSCCCCCCCGGG--GTSHHHHHHHHHHHHHCCS
T ss_pred HhccCcCCcccccccCccccCcCcccHHHHHHHH------------HHHHhCCCCcccc--cchhHHHHHHHHHHHHhcc
Confidence 999 667654332222222222111 1111111111100 1135778899999999999
Q ss_pred CCCCCCCHHHHHHHHHHhHhhc
Q 042568 948 NPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 948 dP~~RPs~~evl~~L~~~~~~~ 969 (983)
||++|||++|++++|+++.+..
T Consensus 317 dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 317 NGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTT
T ss_pred ChhhCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999997754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.78 Aligned_cols=258 Identities=23% Similarity=0.409 Sum_probs=201.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcE----EEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~----vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...++||+|+||.||+|.+. +++. ||+|.+.........+++.+|++++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999964 4444 57777765555556788999999999999999999999998754 789
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|+||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999998754 346899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+..
T Consensus 168 ~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~---- 230 (327)
T 3lzb_A 168 GAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISS---- 230 (327)
T ss_dssp -----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHH----
T ss_pred cCcccc-----------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHH----
Confidence 543221 11122357889999999999999999999999999999999 999986421 111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.+........+ ..++.++.+++.+||+.||++||++.|+++.|+++.+
T Consensus 231 ------------~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 231 ------------ILEKGERLPQP-------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ------------HHHTTCCCCCC-------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ------------HHHcCCCCCCC-------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111111111 1244678899999999999999999999999998863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=367.74 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=205.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|.+.++..||||.++.... ..+.|.+|++++++++||||+++++++.. +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 45777889999999999999998888899999975443 35789999999999999999999999876 6789999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999997532 345899999999999999999999996 99999999999999999999999999987643211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 336 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-----~~---------- 388 (452)
T 1fmk_A 336 ------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NR---------- 388 (452)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH----------
T ss_pred ------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-----HH----------
Confidence 11122357889999999998899999999999999999999 999985321 11
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
+..+. +........+ ..++.++.+++.+||+.||++|||++++++.|+.+.....
T Consensus 389 --~~~~~-i~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 389 --EVLDQ-VERGYRMPCP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp --HHHHH-HHTTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred --HHHHH-HHcCCCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11111 1111111111 2355788999999999999999999999999998865543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=352.47 Aligned_cols=256 Identities=23% Similarity=0.271 Sum_probs=196.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999976 788999999965433 34678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC--EEEcccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT--ALVADFGIAKLVK 822 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~--~kl~Dfgla~~~~ 822 (983)
|+++|+|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999998864 345899999999999999999999996 999999999999987765 9999999997433
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCcc-chhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
... ......||+.|+|||.+.+..++.+ +||||+||++|+|++|+.||..... .......
T Consensus 170 ~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~---- 230 (361)
T 3uc3_A 170 LHS--------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKT---- 230 (361)
T ss_dssp -------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHH----
T ss_pred ccC--------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHH----
Confidence 211 1123469999999999988877655 8999999999999999999964321 1111111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+......... .+. ....+.++.+++.+|++.||++|||+.|+++|-.-
T Consensus 231 --------~~~~~~~~~~--~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 231 --------IQRILSVKYS--IPD-----DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp --------HHHHHTTCCC--CCT-----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred --------HHHHhcCCCC--CCC-----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1111111111 110 01134678899999999999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=361.03 Aligned_cols=282 Identities=23% Similarity=0.273 Sum_probs=211.3
Q ss_pred CCCCCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-----CCCcc
Q 042568 654 NPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-----HRNLI 727 (983)
Q Consensus 654 ~~~~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 727 (983)
...+++++.....++|.+.++||+|+||.||+|+.. +++.||||+++.. ......+..|+++++.++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345555555566789999999999999999999974 6889999998642 234567888999999996 99999
Q ss_pred ceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-
Q 042568 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE- 806 (983)
Q Consensus 728 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~- 806 (983)
++++++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 9999999999999999999 899999987543 345899999999999999999999996 999999999999975
Q ss_pred ------------------------CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCC
Q 042568 807 ------------------------DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS 862 (983)
Q Consensus 807 ------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 862 (983)
++.+||+|||+|+..... .....||+.|+|||++.+..++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------------HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------------CCSCCSCGGGCCHHHHTTCCCC
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----------------CcCccCcccccCcHHHcCCCCC
Confidence 789999999999864421 1234689999999999999999
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCC-----CC----Ccccccc-----
Q 042568 863 THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAP-----QH----MPIYYNK----- 928 (983)
Q Consensus 863 ~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~----- 928 (983)
.++||||+||++|||++|+.||.... .......+..................... .. .+.....
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 315 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTHE--HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK 315 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred CccchHHHHHHHHHHHHCCCCCCCCc--HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence 99999999999999999999996421 11111122222221111111111110000 00 0000000
Q ss_pred --------chHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 929 --------VWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 929 --------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........+.+++.+|++.||++|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000012567899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=344.11 Aligned_cols=265 Identities=29% Similarity=0.392 Sum_probs=205.8
Q ss_pred CCCCCCCccccCCcEeEEEEEECCC----cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEE-ecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC-SKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 741 (983)
.+|...++||+|+||.||+|...+. ..||||.+.........+++.+|++++++++||||+++++++ ...+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4577789999999999999986422 258999987655555668899999999999999999999986 45567899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999643 346899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCC-CCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR-PTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~-p~~~~~~~~~~l~~~~~~ 900 (983)
....... ........||+.|+|||.+.+..++.++||||+|+++|||++|.. ||... . .......+
T Consensus 179 ~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~-~~~~~~~~-- 245 (298)
T 3f66_A 179 YDKEYYS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-N-TFDITVYL-- 245 (298)
T ss_dssp SCGGGCB---------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-C-TTTHHHHH--
T ss_pred cccchhc---------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-C-HHHHHHHH--
Confidence 5432110 011223468899999999999999999999999999999999554 54321 1 11111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
... .....+ ..++.++.+++.+|++.||++|||++|+++.|+++......
T Consensus 246 -------------~~~-~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 246 -------------LQG-RRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -------------HTT-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -------------hcC-CCCCCC-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111 111111 11346789999999999999999999999999999876543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=362.39 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|++. +|+.||||+++.... .+....+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999975 789999999965432 224568999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999874 345899999999999999999999996 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+... .
T Consensus 169 ~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~-------- 221 (476)
T 2y94_A 169 GE--------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----V-------- 221 (476)
T ss_dssp TC--------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----S--------
T ss_pred cc--------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----H--------
Confidence 21 1123479999999999998765 689999999999999999999986321 1
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
............. .+ .....++.+++.+|++.||++|||++|++++-
T Consensus 222 ----~~~~~~i~~~~~~--~p-------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 222 ----PTLFKKICDGIFY--TP-------QYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp ----HHHHHHHHTTCCC--CC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ----HHHHHHHhcCCcC--CC-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 1112221111111 11 11346788999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=354.55 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=196.6
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 567999999999999964 688999999976433 345789999999999999999999999999999999999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe--CCCCCEEEccccccccccCCcccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL--DEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl--~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99888643 345899999999999999999999996 9999999999999 6778999999999987653221
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcH
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 908 (983)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. +
T Consensus 245 ------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~------------~ 295 (373)
T 2x4f_A 245 ------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-----DA------------E 295 (373)
T ss_dssp ------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-----HH------------H
T ss_pred ------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----HH------------H
Confidence 122469999999999999999999999999999999999999986321 11 1
Q ss_pred HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.+.......... ....+.....++.+++.+|++.||++|||++|++++-
T Consensus 296 ~~~~i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 296 TLNNILACRWDL-----EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp HHHHHHHTCCCS-----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHhccCCC-----ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 111111111110 0112234567899999999999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=351.80 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=197.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCC--CCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRH--RNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 742 (983)
.++|.+.+.||+|+||.||+|...+++.||||++..... ....+.+.+|++++++++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356888999999999999999988899999999976543 2345788999999999986 9999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||+ .+++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 994 57899999875 346899999999999999999999996 99999999999997 6789999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~- 226 (343)
T 3dbq_A 159 PDTTS-----------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ- 226 (343)
T ss_dssp ----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-
T ss_pred ccccc-----------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-
Confidence 32211 11223579999999999864 67899999999999999999999998642110
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.. .....+........+. ....++.+++.+|++.||++|||+.|++++-.
T Consensus 227 --~~-------------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 227 --IS-------------KLHAIIDPNHEIEFPD-------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp --HH-------------HHHHHHCTTSCCCCCC-------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --HH-------------HHHHHhcCCcccCCcc-------cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 00 1111111111111111 12357889999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.78 Aligned_cols=265 Identities=27% Similarity=0.375 Sum_probs=208.4
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCc---EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce-eEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNT---RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK-ALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~---~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 742 (983)
.|...++||+|+||.||+|.+. +++ .||+|.+.........+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455688999999999999853 232 69999997655555678899999999999999999999999766655 999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
+||+.+|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999998753 356899999999999999999999996 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
...... ........||+.|+|||...+..++.++||||||+++|+|++|+.|+.... +.......+.
T Consensus 176 ~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~--- 242 (298)
T 3pls_A 176 DREYYS---------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-DPFDLTHFLA--- 242 (298)
T ss_dssp TGGGGC---------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CGGGHHHHHH---
T ss_pred CCcccc---------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-CHHHHHHHhh---
Confidence 322110 112233468999999999999999999999999999999999766643211 1111111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
.......+ ..++.++.+++.+|++.||++|||++|+++.|+++.+....
T Consensus 243 -------------~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 243 -------------QGRRLPQP-------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -------------TTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -------------cCCCCCCC-------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111111 12346789999999999999999999999999999877654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.31 Aligned_cols=281 Identities=21% Similarity=0.308 Sum_probs=211.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEE-ecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC-SKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 742 (983)
..++|...+.||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++|++++..+.++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 457899999999999999999996 5788899998754433 35688999999999988877777665 667778999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~ 819 (983)
|||+ +++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 89999988643 346999999999999999999999996 9999999999999 789999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC-chHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS-SLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~-~l~~~~ 898 (983)
............ ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-- 228 (296)
T 4hgt_A 157 KYRDARTHQHIP------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-- 228 (296)
T ss_dssp ECBCTTTCCBCC------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH--
T ss_pred eccCcccCccCC------CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh--
Confidence 776433221100 0122345799999999999999999999999999999999999999975322111 1000
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCCc-hhHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSPS-SLIE 977 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~-~~~~ 977 (983)
......... . . .......+.++.+++.+|++.||++|||++++++.|+++.+....+. +..+
T Consensus 229 ---------~~~~~~~~~-~---~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~d 291 (296)
T 4hgt_A 229 ---------RISEKKMST-P---I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 291 (296)
T ss_dssp ---------HHHHHHHHS-C---H----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCG
T ss_pred ---------hhhcccccc-h---h----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccc
Confidence 011111100 0 0 00011235689999999999999999999999999999988765533 3445
Q ss_pred Hhh
Q 042568 978 EAA 980 (983)
Q Consensus 978 ~~~ 980 (983)
|.+
T Consensus 292 w~~ 294 (296)
T 4hgt_A 292 WNM 294 (296)
T ss_dssp GGG
T ss_pred hhh
Confidence 544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.64 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=208.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|...+++.||||.+..... ..+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 46778899999999999999998888999999865433 35789999999999999999999999864 5679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||.++.......
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999987532 236899999999999999999999996 99999999999999999999999999987653221
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+
T Consensus 165 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~--------- 218 (279)
T 1qpc_A 165 ------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPE--------- 218 (279)
T ss_dssp ------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH---------
T ss_pred ------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-----HHH---------
Confidence 11122357889999999988889999999999999999999 899985321 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.... +........+ ..++.++.+++.+|++.||++|||++++++.|+++....
T Consensus 219 ---~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 219 ---VIQN-LERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ---HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHH-HhcccCCCCc-------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 1111111111 124567899999999999999999999999999987654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.97 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=206.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999965 588999999976542 334577889999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC---EEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT---ALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~---~kl~Dfgla~~ 820 (983)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||.+..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999888764 345899999999999999999999996 999999999999986655 99999999976
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ..
T Consensus 158 ~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~----- 213 (284)
T 3kk8_A 158 VNDSEA--------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QH----- 213 (284)
T ss_dssp CCSSCB--------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH-----
T ss_pred cccCcc--------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-----hh-----
Confidence 653221 122469999999999999999999999999999999999999985321 11
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
............... ..+...+.++.+++.+|++.||++|||++|++++-.
T Consensus 214 -------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 214 -------RLYAQIKAGAYDYPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp -------HHHHHHHHTCCCCCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred -------HHHHHHHhccccCCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 111111111111111 112235577899999999999999999999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=351.05 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=203.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 741 (983)
.++|...+.||+|+||.||+|+.. +++.||||+++... .....+.+.+|.++++.+ +||+|+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467889999999999999999976 47889999997543 223456788999999988 89999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999998753 45899999999999999999999996 999999999999999999999999999854
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ..
T Consensus 172 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~------- 226 (353)
T 2i0e_A 172 IWDG-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DE------- 226 (353)
T ss_dssp CCTT-------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SH-------
T ss_pred ccCC-------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-----CH-------
Confidence 3211 1123357999999999999999999999999999999999999998632 11
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
.+..+....... ..| ...+.++.+++.+|++.||++||+ ++|+++|
T Consensus 227 -----~~~~~~i~~~~~--~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 227 -----DELFQSIMEHNV--AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----HHHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----HHHHHHHHhCCC--CCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111222221111 111 124567899999999999999995 5788765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=345.11 Aligned_cols=246 Identities=23% Similarity=0.258 Sum_probs=193.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...++||+|+||+||+|... +++.||||++...... ....++..|+..+.++ +||||+++++++...+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999976 7899999998654322 2344566677666665 8999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+ +++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 66888887653 346999999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||++|+|||++.+ .++.++|||||||++|||++|..|+... .....+..
T Consensus 210 ~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~---- 266 (311)
T 3p1a_A 210 AG--------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQ---- 266 (311)
T ss_dssp -------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTT----
T ss_pred CC--------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhc----
Confidence 21 1123469999999999876 6899999999999999999997775321 11111100
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... +. ......+.++.+++.+|++.||++|||++|++++
T Consensus 267 ~~~----------------~~---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 GYL----------------PP---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TCC----------------CH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCC----------------Cc---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000 00 0012245679999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=339.63 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=205.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
.++|...+.||+|+||.||+|.+.. +..||||.+......+..+++.+|++++++++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 3578888999999999999998542 235999999766555567889999999999999999999999865 45689
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999998753 345899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.
T Consensus 164 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~- 228 (281)
T 3cc6_A 164 EDEDYY------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLE- 228 (281)
T ss_dssp ---------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHH-
T ss_pred cccccc------------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHh-
Confidence 532211 1122357889999999998899999999999999999998 9999863211 11111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.......+ ..++..+.+++.+|++.||++|||+.|++++|+++.+.
T Consensus 229 ---------------~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 ---------------KGDRLPKP-------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---------------HTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------cCCCCCCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11111111 12346789999999999999999999999999988653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.24 Aligned_cols=275 Identities=24% Similarity=0.304 Sum_probs=201.5
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC----cchhHHHHHHHHHHHhcC---CCCccceeeEEecC
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT----GEITGSFKRECQILKRIR---HRNLIRIITICSKP 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 736 (983)
.+++|.+.+.||+|+||+||+|+. .+++.||||++..... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999996 4688999999865432 123456778888888775 99999999999765
Q ss_pred C-----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 737 D-----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 737 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
. ..++||||++ ++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 4789999997 59999887543 344899999999999999999999996 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
|+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .
T Consensus 161 l~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~ 225 (308)
T 3g33_A 161 LADFGLARIYSYQM--------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-A 225 (308)
T ss_dssp ECSCSCTTTSTTCC--------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-H
T ss_pred EeeCccccccCCCc--------------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-H
Confidence 99999998654321 11235799999999999999999999999999999999999999864211 1
Q ss_pred CchHHHHHhhCC-C-C-CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 892 SSLHEWVKRHYP-H-R-LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 892 ~~l~~~~~~~~~-~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+......... . . ..... ...........+........+...++.+++.+|++.||++|||+.|++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 DQLGKIFDLIGLPPEDDWPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHCCCCTTTSCSSC-SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCChhhccchh-hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111111000 0 0 00000 00000000000111111122355778999999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=348.88 Aligned_cols=263 Identities=27% Similarity=0.438 Sum_probs=211.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
..++|...+.||+|+||.||+|.+. +++.||||.+..........++.+|++++++++||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4567888999999999999999864 3678999999766555556779999999999999999999999999999
Q ss_pred eeEEEecccCcccccccccccC------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEE
Q 042568 739 KALVLPLMSNGSLENHLYPSHG------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALV 812 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl 812 (983)
.++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 9999999999999999875321 1245799999999999999999999996 999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDG 891 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~ 891 (983)
+|||+++........ .......||+.|+|||.+.+..++.++||||+|+++|||++ |+.||....
T Consensus 180 ~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--- 245 (322)
T 1p4o_A 180 GDFGMTRDIYETDYY-----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 245 (322)
T ss_dssp CCTTCCCGGGGGGCE-----------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---
T ss_pred CcCcccccccccccc-----------ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---
Confidence 999999865432211 11223467899999999998899999999999999999999 888885321
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
..+ .......... ...+ ..++.++.+++.+|++.||++|||+.|++++|+++.
T Consensus 246 --~~~------------~~~~~~~~~~-~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 246 --NEQ------------VLRFVMEGGL-LDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --HHH------------HHHHHHTTCC-CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --HHH------------HHHHHHcCCc-CCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 111 1111111111 0011 124567899999999999999999999999998763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.79 Aligned_cols=272 Identities=19% Similarity=0.293 Sum_probs=201.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999975 5889999998655433 245678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999887754 345899999999999999999999996 999999999999999999999999999876532
Q ss_pred cccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ......+.....
T Consensus 156 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~ 220 (311)
T 4agu_A 156 SD-------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLG 220 (311)
T ss_dssp -----------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHC
T ss_pred cc-------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhc
Confidence 21 1123468999999999876 6689999999999999999999999864211 111111111111
Q ss_pred CCCcHHHHHHHhh---cCCCCCcc-----ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAK---YAPQHMPI-----YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... ...... ......+. .....+...+.++.+++.+|++.||++|||++|++++
T Consensus 221 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 221 DLIPRH-QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SCCHHH-HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccc-ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111100 000000 00000000 0011123356678999999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=349.25 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=183.9
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
.+.||+|+||.||+|... +++.||||++... ....+.+|+++++.++ ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999975 6889999998543 3467889999999997 999999999999999999999999999
Q ss_pred ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---CEEEccccccccccCCcc
Q 042568 750 SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---TALVADFGIAKLVKGIDE 826 (983)
Q Consensus 750 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~~kl~Dfgla~~~~~~~~ 826 (983)
+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+++.......
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999875 346899999999999999999999996 99999999999997665 899999999986543221
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ....
T Consensus 165 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------~~~~ 221 (325)
T 3kn6_A 165 -------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT----------CTSA 221 (325)
T ss_dssp --------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----------------CCCH
T ss_pred -------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc----------cccH
Confidence 11234689999999999999999999999999999999999999964321100 0001
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+..+....... ......|...+.++.+++.+|++.||++|||++|++++-.
T Consensus 222 ~~~~~~i~~~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 222 VEIMKKIKKGDF-----SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHHHHTTTCC-----CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHHHHHcCCC-----CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 111111111111 1112234456778999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=339.01 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=203.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 357888999999999999999965 567899999865432 22356789999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999988653 45899999999999999999999986 9999999999999999999999999986543
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||... ....
T Consensus 161 ~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~------ 214 (279)
T 3fdn_A 161 SSR---------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQE------ 214 (279)
T ss_dssp ----------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHH------
T ss_pred ccc---------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----cHHH------
Confidence 211 12246899999999999999999999999999999999999998632 1111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
.... +..... ..+ ...+.++.+++.+|++.||++|||++|++++-.--.
T Consensus 215 ------~~~~-~~~~~~-~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 215 ------TYKR-ISRVEF-TFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp ------HHHH-HHHTCC-CCC-------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------HHHH-HHhCCC-CCC-------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 1111 111111 111 113467889999999999999999999999865443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=348.48 Aligned_cols=269 Identities=27% Similarity=0.425 Sum_probs=201.3
Q ss_pred HHHhCCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 663 IEATGGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 663 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
....++|...+.||+|+||.||+|... ++..||||.++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334567888999999999999999854 344799999875533 334577999999999999999999999997655
Q ss_pred c-----eeEEEecccCccccccccccc--CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 738 F-----KALVLPLMSNGSLENHLYPSH--GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 738 ~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
. .++||||+++|+|.+++.... .....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 3 499999999999999884322 12456999999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 187 kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYY-----------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp EECSCSCC---------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEeecCcceeccccccc-----------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999866432211 11223457889999999999999999999999999999999 8888853211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
. ...+........ ..+ ..++.++.+++.+|++.||++|||+.+++++|+++.+..
T Consensus 256 --~---------------~~~~~~~~~~~~-~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 256 --H---------------EMYDYLLHGHRL-KQP-------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --G---------------GHHHHHHTTCCC-CCB-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --H---------------HHHHHHHcCCCC-CCC-------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 111111111111 111 224567899999999999999999999999999998765
Q ss_pred C
Q 042568 970 S 970 (983)
Q Consensus 970 ~ 970 (983)
.
T Consensus 311 p 311 (313)
T 3brb_A 311 P 311 (313)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=363.47 Aligned_cols=263 Identities=20% Similarity=0.210 Sum_probs=206.4
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEec
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSK 735 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 735 (983)
+++.....++|...++||+|+||.||+|+.. +++.||||+++... .....+.+.+|.+++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3344445678999999999999999999975 68999999996532 12234568899999999999999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999753 246899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccC-------CCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-------GKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
|+++....... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 207 Gla~~~~~~~~------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGT------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSC------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCc------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 99987653221 1122357999999999987 4568999999999999999999999986321
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCC---CCHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR---PSMLDVAHE 961 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~ 961 (983)
..+ .....+........|.. ....+.++.+++.+|+. +|++| |+++|+++|
T Consensus 275 -----~~~------------~~~~i~~~~~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 275 -----TAE------------TYGKIVHYKEHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -----HHH------------HHHHHHTHHHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -----HHH------------HHHHHHhcccCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111 11111110000001100 11245789999999999 99998 699999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.51 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=197.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCce---
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFK--- 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 739 (983)
.++|.+.+.||+|+||.||+|.+ .+++.||||++..... .+...++.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999996 5788899999976532 23456789999999999999999999998765543
Q ss_pred -eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 740 -ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 740 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
++||||+++++|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999998753 45899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ....
T Consensus 164 ~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-----~~~~- 227 (311)
T 3ork_A 164 RAIADSGNSV----------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSV- 227 (311)
T ss_dssp ----------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHH-
T ss_pred cccccccccc----------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-----hHHH-
Confidence 8765432110 12223569999999999999999999999999999999999999986321 1111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH-HHHHHhH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA-HEMGRLK 966 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~L~~~~ 966 (983)
.......... .+ ...+...+.++.+++.+|++.||++||++.+++ +.+.++.
T Consensus 228 -----------~~~~~~~~~~--~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 228 -----------AYQHVREDPI--PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----------HHHHHHCCCC--CH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------HHHHhcCCCC--Cc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111111000 00 001122456789999999999999999777665 4555443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=358.92 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=194.9
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-------cchhHHHHHHHHHHHhcCCCCccceeeEEecC
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-------GEITGSFKRECQILKRIRHRNLIRIITICSKP 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 736 (983)
..++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4578999999999999999999965 678999999865421 1123468899999999999999999999865
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC---CCEEEc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED---LTALVA 813 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~---~~~kl~ 813 (983)
+..++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.+ +.+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 457999999999999998864 346899999999999999999999996 9999999999999754 459999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
|||+|+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 285 DFG~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~- 349 (419)
T 3i6u_A 285 DFGHSKILGETS--------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT- 349 (419)
T ss_dssp CSSTTTSCC-------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS-
T ss_pred ecccceecCCCc--------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc-
Confidence 999998764321 1223579999999999864 5678899999999999999999999964221
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...+...+..... .. ....+...+.++.+++.+|++.||++|||++|++++-
T Consensus 350 ~~~~~~~i~~~~~----------------~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 350 QVSLKDQITSGKY----------------NF----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp SCCHHHHHHTTCC----------------CC----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hHHHHHHHhcCCC----------------CC----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 1122222211110 00 0112233567899999999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=375.79 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=204.0
Q ss_pred ccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccCcc
Q 042568 674 LIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.||+|+||.||+|.+. ++..||||+++........++|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999864 4567999999776555567889999999999999999999999976 56899999999999
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccc
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNC 830 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~ 830 (983)
|.+++... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 493 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-- 493 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee--
Confidence 99998643 356899999999999999999999996 9999999999999999999999999998765322110
Q ss_pred cCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCcHH
Q 042568 831 ANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909 (983)
Q Consensus 831 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 909 (983)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... . ++
T Consensus 494 --------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~---------------~~ 548 (613)
T 2ozo_A 494 --------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--P---------------EV 548 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--H---------------HH
T ss_pred --------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--H---------------HH
Confidence 11122346789999999998999999999999999999998 9999864211 1 11
Q ss_pred HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 042568 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972 (983)
Q Consensus 910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 972 (983)
.+ .+........+ ..++.++.+++.+||+.||++||++.++++.|+.+.......
T Consensus 549 ~~-~i~~~~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 549 MA-FIEQGKRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HH-HHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HH-HHHcCCCCCCC-------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 11 11111111111 235578999999999999999999999999999987665543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=354.54 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=197.7
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcC--CCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIR--HRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 743 (983)
.+|.+.+.||+|+||.||+|...+++.||||++..... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888999999999999999988899999999976543 334678999999999996 599999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
| +.+++|.+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5678999998753 36889999999999999999999996 99999999999996 58999999999987653
Q ss_pred CcccccccCCCCccccccCccccccccccccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
.... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 207 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-- 273 (390)
T 2zmd_A 207 DTTS-----------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-- 273 (390)
T ss_dssp ------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--
T ss_pred CCcc-----------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--
Confidence 2211 11223579999999999865 46889999999999999999999998642110
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. ..+...+........+. ....++.+++.+||+.||++|||+.|++++-.
T Consensus 274 --~------------~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 274 --I------------SKLHAIIDPNHEIEFPD-------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp --H------------HHHHHHHCTTSCCCCCC-------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --H------------HHHHHHhCccccCCCCc-------cchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 0 01111111111111111 12357889999999999999999999998643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.00 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=206.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcE--EEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTR--IAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~--vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|+.. ++.. ||||.++........+++.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999964 5554 4999987655555567899999999999 899999999999999999999
Q ss_pred EecccCccccccccccc------------CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSH------------GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
|||+++|+|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999987543 22346999999999999999999999996 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~ 889 (983)
||+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 182 kL~Dfg~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~- 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT- 246 (327)
T ss_dssp EECCTTCEESSCEE--------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred EEcccCcCcccccc--------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999998743211 11122357889999999988889999999999999999998 999985321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+. .+ .+........+ ..++.++.+++.+|++.||++|||++|++++|+++.+..
T Consensus 247 ----~~~~------------~~-~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 247 ----CAEL------------YE-KLPQGYRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ----HHHH------------HH-HGGGTCCCCCC-------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----HHHH------------HH-HhhcCCCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 11 11111111111 124467899999999999999999999999999987765
Q ss_pred CC
Q 042568 970 SS 971 (983)
Q Consensus 970 ~~ 971 (983)
..
T Consensus 303 ~~ 304 (327)
T 1fvr_A 303 KT 304 (327)
T ss_dssp SC
T ss_pred cC
Confidence 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=354.64 Aligned_cols=264 Identities=28% Similarity=0.394 Sum_probs=198.0
Q ss_pred CCCCCCccccCCcEeEEEEEEC--CC--cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec-CCceeEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ--DN--TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-PDFKALV 742 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~--~~--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 742 (983)
.|...++||+|+||.||+|.+. ++ ..||||.++........++|.+|++++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556788999999999999853 22 35899998765555567889999999999999999999998754 4577999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999643 345889999999999999999999996 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... .......+..
T Consensus 244 ~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~- 311 (373)
T 3c1x_A 244 DKEFDS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQ- 311 (373)
T ss_dssp -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHT-
T ss_pred cccccc---------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHc-
Confidence 322110 011122457889999999999999999999999999999999 666765321 1111111111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
. .....+ ..++.++.+++.+||+.||++|||++|++++|+++......
T Consensus 312 --------------~-~~~~~p-------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 312 --------------G-RRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --------------T-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --------------C-CCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 1 110011 12456789999999999999999999999999999766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.92 Aligned_cols=264 Identities=25% Similarity=0.369 Sum_probs=206.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEE------CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|...+.||+|+||.||+|++ .+++.||||.+..........++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35788899999999999999984 246789999997655555567899999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCc---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGL---SHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVA 813 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~ 813 (983)
++||||+++++|.+++...... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999998764321 245899999999999999999999996 999999999999984 4569999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCC
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGS 892 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~ 892 (983)
|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 186 Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---- 250 (327)
T 2yfx_A 186 DFGMARDIYRASYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---- 250 (327)
T ss_dssp CCHHHHHHHC-----------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred cccccccccccccc-----------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC----
Confidence 99999865432211 11223468999999999988899999999999999999998 999985321
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
... ..+. +........+ ..++..+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 251 -~~~------------~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 251 -NQE------------VLEF-VTSGGRMDPP-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -HHH------------HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HHH------------HHHH-HhcCCCCCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111 1111 1111111111 12456789999999999999999999999999988643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.32 Aligned_cols=279 Identities=21% Similarity=0.313 Sum_probs=213.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEE-ecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC-SKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 743 (983)
.++|...+.||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++|++++..+.++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999996 5788999999865443 35689999999999998877766665 5667779999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~~ 820 (983)
||+ +++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||++ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 89999998643 346999999999999999999999996 9999999999999 4889999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC-CchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG-SSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~-~~l~~~~~ 899 (983)
........... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....
T Consensus 158 ~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--- 228 (296)
T 3uzp_A 158 YRDARTHQHIP------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE--- 228 (296)
T ss_dssp CBCTTTCCBCC------CCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH---
T ss_pred ccccccccccc------cccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh---
Confidence 76443221100 011234579999999999999999999999999999999999999997532211 11111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCC-chhHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP-SSLIEE 978 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~-~~~~~~ 978 (983)
.+....... . . ......++.++.+++.+|++.||++|||++++++.|+++.+....+ .+..+|
T Consensus 229 --------~~~~~~~~~-~---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 229 --------RISEKKMST-P---I----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp --------HHHHHHHHS-C---H----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred --------hhcccccCC-c---h----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 011111100 0 0 0001124567999999999999999999999999999998776553 333444
Q ss_pred h
Q 042568 979 A 979 (983)
Q Consensus 979 ~ 979 (983)
.
T Consensus 293 ~ 293 (296)
T 3uzp_A 293 N 293 (296)
T ss_dssp G
T ss_pred c
Confidence 4
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=346.49 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=205.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-----hhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-----ITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|.+.+.||+|+||.||+|... +++.||||.++...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999975 68899999987654321 357899999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADF 815 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Df 815 (983)
++||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999864 345899999999999999999999996 99999999999999888 7999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||... ...
T Consensus 164 g~~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~ 224 (321)
T 2a2a_A 164 GLAHEIEDGVE--------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQ 224 (321)
T ss_dssp TTCEECCTTCC--------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-----SHH
T ss_pred ccceecCcccc--------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-----CHH
Confidence 99986653211 12246999999999999999999999999999999999999998532 111
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.. ......... .+ ...+...+..+.+++.+|++.||++|||+.|++++
T Consensus 225 ~~~------------~~i~~~~~~--~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 225 ETL------------ANITSVSYD--FD---EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHH------------HHHHTTCCC--CC---HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHH------------HHHHhcccc--cC---hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 111110000 00 01112345678999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=352.38 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=199.1
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|...+.||+|+||.||+|... +|+.||||++...... ...+++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999964 6899999998654332 34577899999999999999999999997653
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899998863 45899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..
T Consensus 175 a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~ 237 (367)
T 1cm8_A 175 ARQADSE----------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKE 237 (367)
T ss_dssp CEECCSS----------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH
T ss_pred ccccccc----------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 9865421 122478999999999887 6789999999999999999999999864211 011111
Q ss_pred HHHhhCCCC-------CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHR-------LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+....... ........+.... ...+......+.....++.+++.+|++.||++|||++|+++|
T Consensus 238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhCC-CCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 111111100 0011111111111 111111222234456789999999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=338.79 Aligned_cols=254 Identities=25% Similarity=0.295 Sum_probs=204.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... ++..||+|++...... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456888999999999999999976 4678999998765433 46789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~~~ 821 (983)
|+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999988865 345899999999999999999999996 9999999999999 78899999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... .....||+.|+|||.+.+. ++.++||||+|+++|||++|+.||..... .
T Consensus 160 ~~~~~--------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~------ 213 (277)
T 3f3z_A 160 KPGKM--------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----S------ 213 (277)
T ss_dssp CTTSC--------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----H------
T ss_pred cCccc--------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----H------
Confidence 53221 1224699999999998765 89999999999999999999999864210 0
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+........... .+ ...+...+.++.+++.+|++.||++|||+.|++++-.-
T Consensus 214 ------~~~~~~~~~~~~--~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 214 ------EVMLKIREGTFT--FP---EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp ------HHHHHHHHCCCC--CC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ------HHHHHHHhCCCC--CC---chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 111111111110 01 11122345788999999999999999999999986543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.11 Aligned_cols=272 Identities=25% Similarity=0.288 Sum_probs=209.2
Q ss_pred CCCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe--cCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS--KPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 739 (983)
++|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5688899999999999999984 357889999986543 234577999999999999999999999886 44568
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999998753 235899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....
T Consensus 176 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~------~~~~ 239 (327)
T 3lxl_A 176 LLPLDKDY----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA------EFLR 239 (327)
T ss_dssp ECCTTCSE----------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHH
T ss_pred ecccCCcc----------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc------hhhh
Confidence 76543221 1122334688999999999988899999999999999999999999753211 1111
Q ss_pred hhCCCC-C--cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 900 RHYPHR-L--DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 900 ~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
...... . .......+........ ...++.++.+++.+|++.||++|||++|++++|+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 240 MMGCERDVPALSRLLELLEEGQRLPA-------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HCC----CCHHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hcccccccccHHHHHHHhhcccCCCC-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111011 0 0111111111111111 123557889999999999999999999999999988543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.27 Aligned_cols=275 Identities=21% Similarity=0.258 Sum_probs=197.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999976 78899999997654443344566899999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
++ |+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 5888887653 346899999999999999999999996 9999999999999999999999999998654221
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC--
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY-- 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~-- 902 (983)
.......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..+....-
T Consensus 155 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~ 220 (324)
T 3mtl_A 155 -------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTP 220 (324)
T ss_dssp ---------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCC
T ss_pred -------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence 11123468999999999877 5689999999999999999999999864211 011111111100
Q ss_pred -CCCCcHHHH-HHHh-hcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 -PHRLDPIVE-KAIA-KYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 -~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+........ .... ...+................++.+++.+|++.||++|||++|++++=
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 000000000 0000 00000000000111123456789999999999999999999999853
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.76 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=200.8
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-C-------cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-N-------TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
++|...+.||+|+||.||+|.... + ..||+|++..... ...+++.+|++++++++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467788999999999999998653 3 4699999865433 346789999999999999999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC--------E
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT--------A 810 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~--------~ 810 (983)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999753 234899999999999999999999996 999999999999998887 9
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
||+|||.+...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+....
T Consensus 161 kl~Dfg~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~- 222 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL- 222 (289)
T ss_dssp EECCCCSCTTTSCH-----------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred eeccCcccccccCc-----------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-
Confidence 99999998754321 12458899999999987 778999999999999999999665543211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.... ......... ..+. ..+.++.+++.+|++.||++|||++|++++|+++....
T Consensus 223 ---~~~~-------------~~~~~~~~~--~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 223 ---DSQR-------------KLQFYEDRH--QLPA-------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ---CHHH-------------HHHHHHTTC--CCCC-------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ---chHH-------------HHHHhhccC--CCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0000 011111111 1111 12345789999999999999999999999999886654
Q ss_pred CC
Q 042568 970 SS 971 (983)
Q Consensus 970 ~~ 971 (983)
..
T Consensus 278 ~~ 279 (289)
T 4fvq_A 278 LV 279 (289)
T ss_dssp --
T ss_pred CC
Confidence 44
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=353.66 Aligned_cols=273 Identities=16% Similarity=0.211 Sum_probs=210.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECC---------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccc---------
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD---------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR--------- 728 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 728 (983)
++|...+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 678899999999999999999763 788999998643 46889999999999999988
Q ss_pred ------eeeEEec-CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCC
Q 042568 729 ------IITICSK-PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSN 801 (983)
Q Consensus 729 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~N 801 (983)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6677765 67889999999 999999997542 356999999999999999999999996 9999999999
Q ss_pred eEeCCCC--CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 802 ILLDEDL--TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 802 iLl~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
|+++.++ .+||+|||+++.+......... .........||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 263 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY 263 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCC------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccc------cccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999998 9999999999877543322110 0112233579999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 880 GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 880 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
|+.||.........+.... ... ...... ... ....+...+.++.+++.+|++.||++|||++|++
T Consensus 264 g~~pf~~~~~~~~~~~~~~------------~~~-~~~~~~-~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 264 GFLPWTNCLPNTEDIMKQK------------QKF-VDKPGP-FVG-PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp SCCTTGGGTTCHHHHHHHH------------HHH-HHSCCC-EEC-TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred CCCCcccCCcCHHHHHHHH------------Hhc-cCChhh-hhh-hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 9999975322211111111 110 110000 000 0001123457899999999999999999999999
Q ss_pred HHHHHhHhhcCCC
Q 042568 960 HEMGRLKQYLSSP 972 (983)
Q Consensus 960 ~~L~~~~~~~~~~ 972 (983)
+.|+++.+.....
T Consensus 329 ~~L~~~~~~~~~~ 341 (352)
T 2jii_A 329 NNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHhcCCC
Confidence 9999998776543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.76 Aligned_cols=275 Identities=22% Similarity=0.302 Sum_probs=199.8
Q ss_pred CCCCC-CCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCP-SSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~-~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+ .++||+|+||.||+|.. .+++.||||++..... ....++.+|++++.++ +||||+++++++...+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45666 47899999999999995 4789999999976533 3467899999999995 7999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC---EEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT---ALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~---~kl~Dfgla~~ 820 (983)
||+++|+|.+++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++.
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999998753 45899999999999999999999996 999999999999998776 99999999986
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
.......... .........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........
T Consensus 164 ~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 164 IKLNGDCSPI------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp ------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred cccCCccccc------cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 5432211000 0011223469999999999875 5578999999999999999999999975432221110
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
. ..........+...+..... ..+ ...+...+.++.+++.+|++.||++|||++|++++-
T Consensus 238 ~---~~~~~~~~~~~~~~i~~~~~-~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 238 R---GEACPACQNMLFESIQEGKY-EFP---DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp ------CCHHHHHHHHHHHHHCCC-CCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred c---cccchhHHHHHHHHHhccCc-ccC---chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0 00000000111111111111 111 111223567899999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.17 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=208.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|...+.||+|+||.||+|... +++.||||+++........+.+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46888899999999999999964 68899999998766555678899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999998863 46899999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..
T Consensus 174 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~--------- 226 (303)
T 3a7i_A 174 I-------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MK--------- 226 (303)
T ss_dssp C-------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HH---------
T ss_pred c-------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HH---------
Confidence 1 11234689999999999999999999999999999999999999863210 00
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
.. ..+........+ ...+..+.+++.+|++.||++|||+.|++++..-.
T Consensus 227 ---~~-~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 227 ---VL-FLIPKNNPPTLE-------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp ---HH-HHHHHSCCCCCC-------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred ---HH-HHhhcCCCCCCc-------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 00 111111111111 12346789999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.72 Aligned_cols=250 Identities=23% Similarity=0.310 Sum_probs=200.2
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+.|...+.||+|+||.||+|.. .+++.||||++..... .+..+++.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3577889999999999999996 5788999999975432 223567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++ |++.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 5777776533 356899999999999999999999996 99999999999999999999999999976542
Q ss_pred CcccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.... . .
T Consensus 207 ~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~----~-~----- 259 (348)
T 1u5q_A 207 A-----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A-M----- 259 (348)
T ss_dssp B-----------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H-H-----
T ss_pred C-----------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----h-H-----
Confidence 1 1246999999999884 5678999999999999999999999985321 0 0
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
...........+. ... ...+..+.+++.+||+.||++|||++|++++-.-
T Consensus 260 -------~~~~~~~~~~~~~----~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 260 -------SALYHIAQNESPA----LQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp -------HHHHHHHHSCCCC----CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -------HHHHHHHhcCCCC----CCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 0111111111111 111 1234568899999999999999999999987553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=361.99 Aligned_cols=348 Identities=22% Similarity=0.267 Sum_probs=262.5
Q ss_pred ceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCC
Q 042568 204 RFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSN 283 (983)
Q Consensus 204 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~ 283 (983)
+.++.++++++ .+|..+. ++|++|+|++|+++ .++...+..+++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L------------------------------- 58 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHL------------------------------- 58 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCC-EECTTTTTTCTTC-------------------------------
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccc-eECHhHccCCCCC-------------------------------
Confidence 45666666666 4454442 46667777777766 3433444445444
Q ss_pred ccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee
Q 042568 284 FQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363 (983)
Q Consensus 284 L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 363 (983)
++|+|++|++++..|..+..+ ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 59 -~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~ 136 (477)
T 2id5_A 59 -EELELNENIVSAVEPGAFNNL-FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136 (477)
T ss_dssp -CEEECTTSCCCEECTTTTTTC-TTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEEC
T ss_pred -CEEECCCCccCEeChhhhhCC-ccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECC
Confidence 455555555555555555555 356677777776665555567777888888888888877777777888888888888
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcC
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 443 (983)
+|.+.+..|..|..+++|+.|+|++|++++..+..|.++++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.+
T Consensus 137 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~ 216 (477)
T 2id5_A 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216 (477)
T ss_dssp CTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEE
T ss_pred CCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccccc
Confidence 88888777778888888888888888888776677888888888888888888777777888888888888888887777
Q ss_pred CccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCC
Q 042568 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL 523 (983)
Q Consensus 444 p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 523 (983)
|..+....+|+. |++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+
T Consensus 217 ~~~~~~~~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 295 (477)
T 2id5_A 217 TPNCLYGLNLTS-LSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL 295 (477)
T ss_dssp CTTTTTTCCCSE-EEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC
T ss_pred CcccccCccccE-EECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc
Confidence 777766678885 8888888886655778888999999999999987778888999999999999999998889999999
Q ss_pred CCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCCcCccCCCC
Q 042568 524 PYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEIK 589 (983)
Q Consensus 524 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~~ 589 (983)
++|+.|+|++|++++..+..|..+++|+.|++++|++.+..+....+.......+.++...|+.|.
T Consensus 296 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 296 NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred ccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 999999999999997777788899999999999999987654322222233456778888887763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=365.06 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=207.1
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...++||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999975 78999999996542 122356788999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999887543 345899999999999999999999996 9999999999999999999999999998764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... .
T Consensus 338 ~~~~--------------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~--------- 393 (576)
T 2acx_A 338 EGQT--------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-K--------- 393 (576)
T ss_dssp TTCC--------------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-C---------
T ss_pred cCcc--------------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-h---------
Confidence 3211 112479999999999999999999999999999999999999997432111 1
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
...+...+..... ..+ ...+.++.+++.+|++.||++|| +++|+++|
T Consensus 394 ----~~~i~~~i~~~~~-~~p-------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 394 ----REEVERLVKEVPE-EYS-------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----HHHHHHHHHHCCC-CCC-------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----HHHHHHHhhcccc-cCC-------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112222222111 111 12456789999999999999999 78999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=350.40 Aligned_cols=272 Identities=16% Similarity=0.177 Sum_probs=201.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeecccCcc----------hhHHHHHHHHHHHhcCCCCccceeeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTTTGE----------ITGSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
++|...+.||+|+||.||+|... ++..||||++....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999975 56789999986553210 12346788899999999999999999
Q ss_pred Eec----CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 733 CSK----PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 733 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
+.. ....++||||+ +++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 977 67889999999 99999998753 26899999999999999999999996 99999999999998877
Q ss_pred --CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 809 --TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 809 --~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
.+||+|||+|+.+........ ..........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQ------YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCC------CCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceeccccccccc------chhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987754322110 001112335799999999999999999999999999999999999999964
Q ss_pred ccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 887 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
...+.......... ....+....... .+ ...++.++.+++.+||+.||++||+++++++.|+.+.
T Consensus 263 ~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 263 NLKDPVAVQTAKTN-LLDELPQSVLKW----AP----------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp GTTCHHHHHHHHHH-HHHTTTHHHHHH----SC----------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccccHHHHHHHHh-hcccccHHHHhh----cc----------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 22221111111111 000001111100 00 0024568999999999999999999999999998875
Q ss_pred h
Q 042568 967 Q 967 (983)
Q Consensus 967 ~ 967 (983)
.
T Consensus 328 ~ 328 (345)
T 2v62_A 328 I 328 (345)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=348.84 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=202.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 457888999999999999999975 688899999965432 345788999888 7999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC----CCEEEccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED----LTALVADFGIAK 819 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~----~~~kl~Dfgla~ 819 (983)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++..+ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999998864 345899999999999999999999996 9999999999998533 359999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.... .....+
T Consensus 169 ~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~--- 230 (342)
T 2qr7_A 169 QLRAENG-------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP--DDTPEE--- 230 (342)
T ss_dssp ECBCTTC-------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST--TSCHHH---
T ss_pred cCcCCCC-------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC--cCCHHH---
Confidence 7643221 1123478999999999988888999999999999999999999996421 111111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
+........... ....|...+.++.+++.+|++.||++||++.|++++-.-
T Consensus 231 ---------~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 231 ---------ILARIGSGKFSL-----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---------HHHHHHHCCCCC-----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---------HHHHHccCCccc-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 111111111110 111233456789999999999999999999999987554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=363.47 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=206.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...++||+|+||.||+|+.. +|+.||||++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999975 689999999965432 223567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998765433456999999999999999999999996 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....
T Consensus 342 ~~~-------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~-------- 399 (543)
T 3c4z_A 342 GQT-------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENK-------- 399 (543)
T ss_dssp TCC-------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHH--------
T ss_pred CCc-------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHH--------
Confidence 221 112347999999999999999999999999999999999999999643211 1111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-----LDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 961 (983)
.+......... ..+ ...+.++.+++.+|++.||++||++ +|+++|
T Consensus 400 ----~~~~~i~~~~~--~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 400 ----ELKQRVLEQAV--TYP-------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp ----HHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ----HHHHHHhhccc--CCC-------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 11111111111 111 1245678899999999999999965 677753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=347.71 Aligned_cols=273 Identities=21% Similarity=0.257 Sum_probs=208.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe----cCCcee
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS----KPDFKA 740 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~ 740 (983)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 45788999999999999999996 578999999986543 335678999999999999999999999986 334778
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++|+|.+++.........+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999998764433567999999999999999999999996 99999999999999999999999999876
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCC---CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR---ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
.......... ...........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||+............
T Consensus 184 ~~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 184 ACIHVEGSRQ----ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEEEESHHH----HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cccccccccc----cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 5421110000 00000112245799999999987654 6889999999999999999999986432222222111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
+.. ... .+. ....+.++.+++.+|++.||.+|||++|++++|+.+....
T Consensus 260 ~~~----------------~~~--~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 260 VQN----------------QLS--IPQ-----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHC----------------C----CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hhc----------------cCC--CCc-----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 111 000 000 0123467899999999999999999999999999886443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=365.04 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=194.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...++||+|+||.||+|... +++.||||+++... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999964 68899999997542 233456788999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998865 3468999999999999999999998 75 999999999999999999999999999854
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 300 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~------ 355 (446)
T 4ejn_A 300 IKDG-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE------ 355 (446)
T ss_dssp CC------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH------
T ss_pred cCCC-------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HH------
Confidence 3221 11233579999999999999999999999999999999999999985321 11
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
...+....... ..+ .....++.+++.+|++.||++|| +++|+++|
T Consensus 356 ------~~~~~i~~~~~--~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 356 ------KLFELILMEEI--RFP-------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------HHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------HHHHHHHhCCC--CCC-------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11111111111 111 12346789999999999999999 99999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.85 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=183.8
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|.. .+++.||||++..... .+..+++.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 4789999999865432 223578999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+.....
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998743 356899999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .......
T Consensus 165 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~- 225 (278)
T 3cok_A 165 PHE-------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-----NTLNKVV- 225 (278)
T ss_dssp ----------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC-
T ss_pred CCC-------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-----HHHHHHh-
Confidence 211 111246899999999999988999999999999999999999998642111 0000000
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. .....+ ...+.++.+++.+|++.||++|||++|++++
T Consensus 226 -----------~--~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 -----------L--ADYEMP-------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----------S--SCCCCC-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----------h--cccCCc-------cccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 000011 1234678899999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=353.40 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=208.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... +++.||+|++.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999976 68899999998765555678899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
+++++|.+++... ..+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999998753 3589999999999999999999985 5 999999999999999999999999999765321
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh----
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR---- 900 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~---- 900 (983)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+...+..
T Consensus 186 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~ 248 (360)
T 3eqc_A 186 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA--KELELMFGCQVEG 248 (360)
T ss_dssp ---------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH--HHHHHHHC-----
T ss_pred ---------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHhcccccc
Confidence 11224799999999999999999999999999999999999999864211 111111000
Q ss_pred ----------------------hCC-CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 901 ----------------------HYP-HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 901 ----------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
..+ ....+..+......... .+ ....+.++.+++.+|++.||++|||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e 321 (360)
T 3eqc_A 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK-LP------SGVFSLEFQDFVNKCLIKNPAERADLKQ 321 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSCCCC-CC------TTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCC-CC------cccccHHHHHHHHHHhhcChhhCCCHHH
Confidence 000 01112222222221111 11 1123567899999999999999999999
Q ss_pred HHHHHH
Q 042568 958 VAHEMG 963 (983)
Q Consensus 958 vl~~L~ 963 (983)
+++|-.
T Consensus 322 ll~hp~ 327 (360)
T 3eqc_A 322 LMVHAF 327 (360)
T ss_dssp HHTSHH
T ss_pred HhhChH
Confidence 998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.44 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=202.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-------chhHHHHHHHHHHHhcCCCCccceeeEEecC
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-------EITGSFKRECQILKRIRHRNLIRIITICSKP 736 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 736 (983)
..++|...+.||+|+||.||+|... +++.||||+++..... .....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3567999999999999999999954 6888999999765321 1345678899999999999999999999999
Q ss_pred CceeEEEecccCc-ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 737 DFKALVLPLMSNG-SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 737 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
+..++||||+.+| +|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99888864 345899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 175 GSAAYLERGKL--------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp TTCEECCTTCC--------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred ccceECCCCCc--------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 99987653221 123569999999999988776 78999999999999999999998642110
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.. ... ..+ ...+.++.+++.+|++.||++|||++|++++-
T Consensus 237 -------~~------------~~~--~~~-------~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -------VE------------AAI--HPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -------TT------------TCC--CCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -------Hh------------hcc--CCC-------cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00 000 001 01346789999999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=352.78 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=193.8
Q ss_pred CCCCCC-CccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHh-cCCCCccceeeEEec----CCce
Q 042568 667 GGFCPS-SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKR-IRHRNLIRIITICSK----PDFK 739 (983)
Q Consensus 667 ~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 739 (983)
++|... ++||+|+||+||+|... +++.||||++.. ...+.+|++++.+ .+||||+++++++.. ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 345554 68999999999999965 688999999852 2567789998755 489999999998865 5578
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEcccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFG 816 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfg 816 (983)
++||||+++|+|.+++.... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999997532 346999999999999999999999986 999999999999997 7899999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 210 ~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--- 272 (400)
T 1nxk_A 210 FAKETTSHN--------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--- 272 (400)
T ss_dssp TCEECC-------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---
T ss_pred cccccCCCC--------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---
Confidence 998654221 112357899999999999999999999999999999999999999643221100
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
............. .+ ...|..++.++.+++.+|++.||++|||+.|++++-.-
T Consensus 273 ----------~~~~~~i~~~~~~--~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 273 ----------PGMKTRIRMGQYE--FP---NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp ----------CSHHHHHHHTCCC--CC---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ----------HHHHHHHHcCccc--CC---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 0011111111111 01 11233456789999999999999999999999987553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=358.50 Aligned_cols=272 Identities=21% Similarity=0.214 Sum_probs=197.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|...+.||+|+||.||+|... +++.||||++.... .....+++.+|+++++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468889999999999999999965 68889999997543 2334678899999999999999999999996553
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||++++ +.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 469999999864 544443 24899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
|+...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+...
T Consensus 211 a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i 275 (464)
T 3ttj_A 211 ARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKV 275 (464)
T ss_dssp C-----CC--------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred eeecCCCc--------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 98654321 12235799999999999999999999999999999999999999863210 0111111
Q ss_pred HHhhCCC------CCcHHHHHHHhhcCCCC---Ccc--------ccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 898 VKRHYPH------RLDPIVEKAIAKYAPQH---MPI--------YYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 898 ~~~~~~~------~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+...-.+ .........+....... .+. ...........++.+++.+|++.||++|||++|+++
T Consensus 276 ~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 276 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111100 11111222111111000 000 001111223678999999999999999999999998
Q ss_pred HH
Q 042568 961 EM 962 (983)
Q Consensus 961 ~L 962 (983)
|=
T Consensus 356 Hp 357 (464)
T 3ttj_A 356 HP 357 (464)
T ss_dssp ST
T ss_pred Ch
Confidence 63
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.70 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec---------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK--------- 735 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 735 (983)
.++|...+.||+|+||.||+|... +++.||||.++... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 356888999999999999999976 78999999986542 457789999999999999999998854
Q ss_pred -------CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 736 -------PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 736 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
....++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 345789999999999999997543 356899999999999999999999996 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 224 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET- 224 (284)
T ss_dssp EEEECCCTTCEESSCCSC--------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-
T ss_pred CEEECcchhheecccccc--------------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-
Confidence 999999999987653221 12246899999999999999999999999999999999999886321
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
. ........... + ...+.++.+++.+|++.||++|||+.|++++|+.+.+.
T Consensus 225 ------~------------~~~~~~~~~~~----~-------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 ------S------------KFFTDLRDGII----S-------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ------H------------HHHHHHHTTCC----C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ------H------------HHHHHhhcccc----c-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 01111111111 1 11335688999999999999999999999999998765
Q ss_pred cCC
Q 042568 969 LSS 971 (983)
Q Consensus 969 ~~~ 971 (983)
...
T Consensus 276 ~~~ 278 (284)
T 2a19_B 276 PEK 278 (284)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.26 Aligned_cols=267 Identities=19% Similarity=0.255 Sum_probs=209.1
Q ss_pred CCCCHHHHHHHhCCCCCC-CccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcC-CCCcccee
Q 042568 655 PRVSYKQLIEATGGFCPS-SLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIR-HRNLIRII 730 (983)
Q Consensus 655 ~~~~~~~l~~~~~~f~~~-~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~ 730 (983)
+.+.+.......++|... +.||+|+||.||+|... +++.||||+++.... ......+.+|++++++++ ||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344455555556677776 88999999999999965 689999999876543 234678999999999994 69999999
Q ss_pred eEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---C
Q 042568 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---D 807 (983)
Q Consensus 731 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~ 807 (983)
+++...+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. +
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~ 170 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL 170 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTB
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCC
Confidence 99999999999999999999999986432 456999999999999999999999996 999999999999998 7
Q ss_pred CCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 042568 808 LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887 (983)
Q Consensus 808 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~ 887 (983)
+.+||+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...
T Consensus 171 ~~~kL~Dfg~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (327)
T 3lm5_A 171 GDIKIVDFGMSRKIGHACE--------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236 (327)
T ss_dssp CCEEECCGGGCEEC-----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcEEEeeCccccccCCccc--------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 8999999999987643211 12246999999999999999999999999999999999999998532
Q ss_pred cCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 888 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.. . +............ ....+..+...+.+++.+|++.||++|||++|++++-
T Consensus 237 ~~-----~------------~~~~~i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 237 DN-----Q------------ETYLNISQVNVDY-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp SH-----H------------HHHHHHHHTCCCC-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred Cc-----h------------HHHHHHHhccccc-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 10 0 1111111111110 0111233557789999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.94 Aligned_cols=273 Identities=24% Similarity=0.340 Sum_probs=210.7
Q ss_pred CCCCCCCccccCCcEeEEEEEE-----CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC--ce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-----QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD--FK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 739 (983)
++|...+.||+|+||.||+|+. .+++.||||++.... .+..+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4677889999999999999984 368889999986543 335678999999999999999999999986554 67
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999998754 345899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
......... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+..
T Consensus 194 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~ 257 (326)
T 2w1i_A 194 VLPQDKEYY----------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMR 257 (326)
T ss_dssp ECCSSCSEE----------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHH
T ss_pred hcccccccc----------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHH
Confidence 765432211 11122457888999999998889999999999999999999999975321 11111
Q ss_pred hhCCCCCcHH----HHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 900 RHYPHRLDPI----VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 900 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.......... +...+........ ...++.++.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 258 MIGNDKQGQMIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHCTTCCTHHHHHHHHHHHHTTCCCCC-------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhccccchhhhHHHHHHHhhcCCCCCC-------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111 1111111111111 1235578999999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=337.28 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=203.1
Q ss_pred CCCCCCC-ccccCCcEeEEEEEE---CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSS-LIGSGRFGHVYKGVL---QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~-~iG~G~~g~Vy~~~~---~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
++|...+ .||+|+||.||+|.+ .+++.||||+++.... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566677 899999999999964 2467899999976543 23467899999999999999999999999 5567899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999875 345899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 168 ~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~------- 228 (291)
T 1xbb_A 168 RADENYY----------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SE------- 228 (291)
T ss_dssp CTTCSEE----------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH-------
T ss_pred ccCCCcc----------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HH-------
Confidence 5432211 11122347789999999988889999999999999999999 9999864211 11
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+...+........+ ..++.++.+++.+|++.||++||++.|+++.|+++-..
T Consensus 229 ---------~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 229 ---------VTAMLEKGERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ---------HHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111111 12456799999999999999999999999999988543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=370.50 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=209.1
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.. +..++||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45777889999999999999998888899999975443 35789999999999999999999999876 6789999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ...+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999997532 345899999999999999999999996 99999999999999999999999999987643211
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..
T Consensus 419 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-----~~---------- 471 (535)
T 2h8h_A 419 ------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NR---------- 471 (535)
T ss_dssp ------------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-----HH----------
T ss_pred ------------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HH----------
Confidence 11122357889999999998899999999999999999999 999986321 11
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
++.+. +........+ ..++.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 472 --~~~~~-i~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 472 --EVLDQ-VERGYRMPCP-------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --HHHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --HHHHH-HHcCCCCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111 1111111111 234567899999999999999999999999999886543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=336.89 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=200.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...+.||+|+||.||+|... +++.||||+++.... .....++.+|+..+.++ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999976 789999999976533 23457788999999999 999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC----------------
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---------------- 806 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---------------- 806 (983)
|||+++++|.+++.........+++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999765433366899999999999999999999996 999999999999984
Q ss_pred ---CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCC
Q 042568 807 ---DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRR 882 (983)
Q Consensus 807 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~ 882 (983)
...+||+|||.+....... ...||+.|+|||.+.+. .+++++||||||+++|+|++|+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cCCceEEEEcccccccccCCcc-----------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4479999999998654321 13589999999998876 56689999999999999999988
Q ss_pred CCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 883 PTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 883 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
|+.. ...... ...... ...+ ...+.++.+++.+|++.||++|||+.|++++
T Consensus 230 ~~~~----~~~~~~----------------~~~~~~-~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 230 LPRN----GDQWHE----------------IRQGRL-PRIP-------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCSS----SHHHHH----------------HHTTCC-CCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCcc----hhHHHH----------------HHcCCC-CCCC-------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 7532 111111 111111 1111 1234678999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.09 Aligned_cols=257 Identities=15% Similarity=0.141 Sum_probs=205.0
Q ss_pred hCCCCCCCccccCCcEeEEEEE------ECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC---CCCccceeeEEecC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGV------LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR---HRNLIRIITICSKP 736 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 736 (983)
.++|.+.++||+|+||.||+|. ..+++.||||+++.. ...++.+|++++++++ |+||+++++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4678889999999999999994 446888999998543 3467888999988886 99999999999999
Q ss_pred CceeEEEecccCcccccccccccC-cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---------
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHG-LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE--------- 806 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~--------- 806 (983)
+..++||||+++|+|.+++..... ....+++..++.|+.|+++||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999975332 1456999999999999999999999986 999999999999998
Q ss_pred --CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 807 --DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 807 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
++.+||+|||+|+.+...... .......||++|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKG-----------TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTT-----------EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCCEEEeeCchhhhhhccCCC-----------ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 899999999999765422111 1223357999999999999999999999999999999999999998
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCC-CCHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR-PSMLDVAHEMG 963 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~ 963 (983)
.....+... .. ...+.. + ....+.+++..|++.+|.+| |+++++.+.|+
T Consensus 286 ~~~~~~~~~-----------------------~~-~~~~~~----~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 286 VKNEGGECK-----------------------PE-GLFRRL----P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp EEEETTEEE-----------------------EC-SCCTTC----S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred ccCCCCcee-----------------------ec-hhcccc----C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 543211100 00 000000 0 23456678888999999998 78888899998
Q ss_pred HhHhhcC
Q 042568 964 RLKQYLS 970 (983)
Q Consensus 964 ~~~~~~~ 970 (983)
++.+...
T Consensus 336 ~~l~~~~ 342 (365)
T 3e7e_A 336 KVFQQHY 342 (365)
T ss_dssp HHHHHHT
T ss_pred HHHHHhh
Confidence 8876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=352.14 Aligned_cols=285 Identities=21% Similarity=0.260 Sum_probs=194.7
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcC-CCCccceeeEEecCC--ce
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIR-HRNLIRIITICSKPD--FK 739 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 739 (983)
..++|...+.||+|+||.||+|.+. +++.||||++.... ......++.+|+.++++++ ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 68899999985443 2334567889999999997 999999999997554 67
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 588888763 45899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccC--------CCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 820 LVKGIDESVNCAN--------DSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 820 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
.+........... ............+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~- 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST- 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 7643211100000 00000112334689999999999887 6789999999999999999999999864211
Q ss_pred CCchHHHHHhhC-----------CCCCcHHHHHHHhhcCCCCCccccccch-------------HHHHHHHHHHHhhhcC
Q 042568 891 GSSLHEWVKRHY-----------PHRLDPIVEKAIAKYAPQHMPIYYNKVW-------------SDVVLELIELGLLCTQ 946 (983)
Q Consensus 891 ~~~l~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~l~~~cl~ 946 (983)
...+...+...- .......++. +....... .......+ ..+..++.+++.+|++
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIES-LKEKVEIR-QSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHH-HHHHCC------CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh-Cccccccc-CCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 011111111100 0000111111 11100000 00000001 1235678999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 042568 947 YNPSTRPSMLDVAHE 961 (983)
Q Consensus 947 ~dP~~RPs~~evl~~ 961 (983)
.||++|||++|+++|
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.24 Aligned_cols=253 Identities=29% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC-CceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-DFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 745 (983)
++|...+.||+|+||.||+|... ++.||||+++... ..+++.+|++++++++||||+++++++... +..++||||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 56888999999999999999885 8899999986443 357899999999999999999999987544 478999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999987532 234789999999999999999999996 9999999999999999999999999987554211
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 172 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~------------ 221 (278)
T 1byg_A 172 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LK------------ 221 (278)
T ss_dssp --------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GG------------
T ss_pred ----------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--HH------------
Confidence 12357889999999998899999999999999999998 999986321 11
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..... +........+ ..++.++.+++.+|++.||++|||+.|+++.|++++...
T Consensus 222 ---~~~~~-~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 222 ---DVVPR-VEKGYKMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ---GHHHH-HTTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---HHHHH-HhcCCCCCCc-------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 11111 1111111111 224567899999999999999999999999999997653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=351.52 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=190.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHH-HHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQI-LKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|+.. +++.||||+++.... ......+.+|..+ ++.++||||+++++++...+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56888999999999999999976 578899999976542 2234556677776 5678999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999988753 45889999999999999999999996 9999999999999999999999999998543
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||... ..
T Consensus 191 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-----~~-------- 244 (373)
T 2r5t_A 191 EHN-------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----NT-------- 244 (373)
T ss_dssp CCC-------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-----BH--------
T ss_pred cCC-------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CH--------
Confidence 211 1223457999999999999999999999999999999999999998632 11
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 957 (983)
.+..+..+.... ..+ .....++.+++.+|++.||++||++.+
T Consensus 245 ----~~~~~~i~~~~~--~~~-------~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 245 ----AEMYDNILNKPL--QLK-------PNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ----HHHHHHHHHSCC--CCC-------SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ----HHHHHHHHhccc--CCC-------CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 112222222111 111 123467899999999999999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=340.14 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=200.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
-++|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 688899999865432 22357899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999998753 45899999999999999999999996 9999999999999999999999999998654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .
T Consensus 186 ~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~------- 241 (309)
T 2h34_A 186 DEKL------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----S------- 241 (309)
T ss_dssp -----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----H-------
T ss_pred cccc------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----H-------
Confidence 3211 111234699999999999999999999999999999999999999863210 0
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhHhhcC
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-SMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 970 (983)
.....+...... + .......+.++.+++.+|++.||++|| +++++++.|+.......
T Consensus 242 ------~~~~~~~~~~~~--~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 242 ------VMGAHINQAIPR--P---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ------HHHHHHHSCCCC--G---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ------HHHHHhccCCCC--c---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 111111111110 0 011123456788999999999999999 99999999998765543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=348.90 Aligned_cols=277 Identities=23% Similarity=0.297 Sum_probs=206.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cc
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-----DF 738 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 738 (983)
..++|...+.||+|+||.||+|... +++.||||++..........++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999965 67889999997655555567899999999999999999999999655 36
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 799999998 588888863 45899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+........ ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...
T Consensus 176 ~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i 244 (364)
T 3qyz_A 176 RVADPDHDH----------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-LDQLNHI 244 (364)
T ss_dssp EECCGGGCB----------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-GGHHHHH
T ss_pred EecCCCCCc----------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-HHHHHHH
Confidence 876543221 011233579999999998654 4589999999999999999999999864211 1112222
Q ss_pred HHhhCCCC-------CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 898 VKRHYPHR-------LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 898 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+....... ............ +..........+.....++.+++.+|++.||++|||++|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 245 LGILGSPSQEDLNCIINLKARNYLLSL-PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTS-CCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHhCCCCHHHHHHhhhhhHHHHHHhc-CCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 21111111 000011111111 11111111111223457789999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.97 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-----chhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||.||+|... +++.||||.++..... ...+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999976 6899999998654322 23678999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEcccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADFG 816 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Dfg 816 (983)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999864 346899999999999999999999996 99999999999998877 89999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
.+........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+
T Consensus 158 ~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~ 218 (283)
T 3bhy_A 158 IAHKIEAGNE--------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----KQE 218 (283)
T ss_dssp TCEECC----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHH
T ss_pred cceeccCCCc--------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----hHH
Confidence 9986643211 122468999999999999999999999999999999999999986321 111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhHh
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLKQ 967 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~ 967 (983)
.. .. +...... .+ ...+...+..+.+++.+|++.||++|||+.|++++ ++.++.
T Consensus 219 ~~------------~~-~~~~~~~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 219 TL------------TN-ISAVNYD-FD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HH------------HH-HHTTCCC-CC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HH------------HH-hHhcccC-Cc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 11 11 1110000 00 01112345678999999999999999999999985 445443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=352.05 Aligned_cols=273 Identities=19% Similarity=0.269 Sum_probs=199.4
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP------ 736 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 736 (983)
...++|...+.||+|+||.||+|.. .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3467899999999999999999996 5789999999864422 234799999999999999999998432
Q ss_pred --------------------------------CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHH
Q 042568 737 --------------------------------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784 (983)
Q Consensus 737 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L 784 (983)
...++||||++ |+|.+.+.........+++..++.++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 587777664333356799999999999999999999
Q ss_pred hccCCCCeEeecCCCCCeEeC-CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCC
Q 042568 785 HHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RAS 862 (983)
Q Consensus 785 H~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 862 (983)
|+.+ |+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||.+.+. .++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--------------SVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------CCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------CcCcccCCCccCHHHhcCCCCCC
Confidence 9996 99999999999998 689999999999987643221 1224689999999998875 489
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchH-----HHHHHH
Q 042568 863 THGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWS-----DVVLEL 937 (983)
Q Consensus 863 ~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l 937 (983)
.++||||+||++|||++|+.||.... ....+...+...-.+.. +.+...-........+......|. ..+.++
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGET-SIDQLVRIIQIMGTPTK-EQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCH-HHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCH-HHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 99999999999999999999986421 11112222222211111 111111111111111111122222 245679
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 938 IELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 938 ~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+++.+|++.||++|||+.|+++|
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=339.06 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=205.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEe--cCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICS--KPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 741 (983)
.++|...+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999975 688999999976542 334678999999999999999999999874 4567899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCC--CCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP--IKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~--~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
||||+++++|.+++.........+++..++.++.|+++||+|||+.+. .+|+||||||+||+++.++.+||+|||.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997654434569999999999999999999999841 139999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..
T Consensus 165 ~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---- 222 (279)
T 2w5a_A 165 ILNHDTS-------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QK---- 222 (279)
T ss_dssp HC---CH-------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HH----
T ss_pred eeccccc-------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HH----
Confidence 7643211 1122468999999999999899999999999999999999999986421 01
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
...+. +........+ ...+.++.+++.+|++.||++|||++|+++++...
T Consensus 223 --------~~~~~-i~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 223 --------ELAGK-IREGKFRRIP-------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp --------HHHHH-HHHTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred --------HHHHH-HhhcccccCC-------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11111 1111111111 12446789999999999999999999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=356.97 Aligned_cols=287 Identities=19% Similarity=0.230 Sum_probs=190.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP-----DF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 738 (983)
.++|.+.++||+|+||.||+|.+. +++.||||++..... ....+++.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999965 688999999865432 23457899999999999999999999999433 56
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||+. ++|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 688888764 346999999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccC--------------CCCccccccCcccccccccccccc-CCCCCCccchhHHHHHHHHHHHhC---
Q 042568 819 KLVKGIDESVNCAN--------------DSMSFTSTDGLLCGSVGYIAPEYG-MGKRASTHGDVYSFGVLLLEIVTG--- 880 (983)
Q Consensus 819 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~SlG~il~elltg--- 880 (983)
+............. ............+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 87753321100000 000001123446799999999976 456799999999999999999995
Q ss_pred --------CCCCCcccCCC-------------------CchHHHHHhhCCCC-------CcHHHHHHHhhcCCCCCcccc
Q 042568 881 --------RRPTDVLFHDG-------------------SSLHEWVKRHYPHR-------LDPIVEKAIAKYAPQHMPIYY 926 (983)
Q Consensus 881 --------~~p~~~~~~~~-------------------~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 926 (983)
+.+|.....-. ..+..+....-... ........+. ..+.......
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 362 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR-IFPKREGTDL 362 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHT-TSCCCCCCCG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHH-hcCCCCCCCH
Confidence 44442210000 00000000000000 0001111111 1111111122
Q ss_pred ccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 927 NKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 927 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+.....++.+|+.+|++.||++|||++|+++|
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 22334457789999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=348.19 Aligned_cols=269 Identities=22% Similarity=0.255 Sum_probs=188.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP------D 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 737 (983)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ....+++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46888999999999999999995 4688999999865432 23457888999999999999999999998654 5
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6899988863 45899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..
T Consensus 179 a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~ 241 (367)
T 2fst_X 179 ARHTADE----------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKL 241 (367)
T ss_dssp ----------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH
T ss_pred ccccccc----------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 9865321 122479999999999887 6789999999999999999999999864211 011111
Q ss_pred HHHhhCCC-------CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPH-------RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+....-.+ .........+...... .+......+.....++.+++.+|++.||++|||++|++++
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCC-CCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhccCCC-CCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111110 0111112222211111 1111111222345778999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=344.61 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=206.1
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-------chhHHHHHHHHHHHhc-CCCCccceee
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-------EITGSFKRECQILKRI-RHRNLIRIIT 731 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~ 731 (983)
......++|.+.+.||+|+||.||+|... +|+.||||++...... +..+.+.+|+++++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999975 7899999998654321 2246788999999999 7999999999
Q ss_pred EEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 732 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
++......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999874 345899999999999999999999996 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCCCccccccCccccccccccccccCC------CCCCccchhHHHHHHHHHHHhCCCCCC
Q 042568 812 VADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG------KRASTHGDVYSFGVLLLEIVTGRRPTD 885 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~SlG~il~elltg~~p~~ 885 (983)
|+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 241 l~DfG~~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 306 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306 (365)
T ss_dssp ECCCTTCEECCTTCC--------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCcccccCCCcc--------------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence 999999987653221 123579999999998753 357899999999999999999999985
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
... ... ............ ....|...+.++.+++.+|++.||++|||++|++++
T Consensus 307 ~~~-----~~~------------~~~~i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 307 HRR-----QIL------------MLRMIMEGQYQF-----SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CSS-----HHH------------HHHHHHHTCCCC-----CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCC-----HHH------------HHHHHHhCCCCC-----CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 321 011 111111111110 011122345678999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=356.28 Aligned_cols=271 Identities=22% Similarity=0.328 Sum_probs=209.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC-CCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH-RNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|.+.++||+|+||.||+|.+ .+++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36799999999999999999996 5689999998865443 3568899999999987 55666666677788889999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~~ 820 (983)
||+ +++|.+++... ...+++..++.|+.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999998743 346999999999999999999999996 9999999999999 6889999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
+.......... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 156 ~~~~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~ 227 (483)
T 3sv0_A 156 YRDTSTHQHIP------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEK 227 (483)
T ss_dssp CBCTTTCCBCC------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SHHHHHHH
T ss_pred ccCCccccccc------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch--hHHHHHHH
Confidence 76433221100 11223467999999999999999999999999999999999999999753221 11111110
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
+.+...... .......++.++.+++.+||+.+|++||++++|++.|+++.+...
T Consensus 228 --------i~~~~~~~~--------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 228 --------ISEKKVATS--------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp --------HHHHHHHSC--------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --------Hhhcccccc--------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 011111000 000011245689999999999999999999999999999866543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=369.74 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=200.5
Q ss_pred CccccCCcEeEEEEEEC---CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
+.||+|+||.||+|.+. .++.||||+++.... ....+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 457799999976533 3346789999999999999999999999975 457899999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..++.|+.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999964 346899999999999999999999996 9999999999999999999999999998765432211
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 527 ----------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------------ 578 (635)
T 4fl3_A 527 ----------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------------ 578 (635)
T ss_dssp ------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------
T ss_pred ----------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------
Confidence 11222357889999999999999999999999999999998 9999864211
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+...+........+ ..++.++.+++.+||+.||++||++++|++.|+++....
T Consensus 579 ~~~~~~i~~~~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 579 SEVTAMLEKGERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCC-------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1111112111111111 235578999999999999999999999999999886554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=347.31 Aligned_cols=350 Identities=22% Similarity=0.238 Sum_probs=225.3
Q ss_pred ccCCCCCCCCCCc-ceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEe
Q 042568 53 ALESWNSTDVHVC-NWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLS 131 (983)
Q Consensus 53 ~l~sw~~~~~~~c-~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (983)
.+++|... .+|| .|.+..|.....+ +............-..+++|++|++++|.++...+..+..+++|++|+
T Consensus 2 ~~~~~~~~-~~C~~~~~~~~c~~~~~~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~ 75 (390)
T 3o6n_A 2 NVKPRQPE-YKCIDSNLQYDCVFYDVH-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLN 75 (390)
T ss_dssp -----CCE-ECBCC------EEEESCE-----ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEE
T ss_pred CcCCCCCc-cceehhhhhhccceeeee-----eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEE
Confidence 36789874 4555 4555555422111 122222222223334678999999999999844334578999999999
Q ss_pred ccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccC
Q 042568 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN 211 (983)
Q Consensus 132 Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N 211 (983)
|++|.+++..|..|+.+++|++|+|++|++++..|..+ ..+++|++|+|++|.++ .+|...+..+++|++|++++|
T Consensus 76 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n 151 (390)
T 3o6n_A 76 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF---QNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151 (390)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT---TTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHh---cCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCC
Confidence 99999997777799999999999999999986555544 37889999999999988 677777788999999999999
Q ss_pred ccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccC
Q 042568 212 RLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAG 291 (983)
Q Consensus 212 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~ 291 (983)
++++..|..|+++++|++|++++|++++ ++ +..+++|++|++++|.+.. +...++|++|++++
T Consensus 152 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~---~~~l~~L~~L~l~~n~l~~-------------~~~~~~L~~L~l~~ 214 (390)
T 3o6n_A 152 NLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLST-------------LAIPIAVEELDASH 214 (390)
T ss_dssp CCCBCCTTTTSSCTTCCEEECCSSCCSB-CC---GGGCTTCSEEECCSSCCSE-------------EECCSSCSEEECCS
T ss_pred ccCccChhhccCCCCCCEEECCCCcCCc-cc---cccccccceeecccccccc-------------cCCCCcceEEECCC
Confidence 9998888889999999999999999873 43 4567888888888887643 22335677777777
Q ss_pred CcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCC
Q 042568 292 NNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371 (983)
Q Consensus 292 n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 371 (983)
|++... |... ..+|+.|++++|.+++. +.+..+++|++|++++|.+++..|..+..+++|++|+|++|.+++ +
T Consensus 215 n~l~~~-~~~~---~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~ 287 (390)
T 3o6n_A 215 NSINVV-RGPV---NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-L 287 (390)
T ss_dssp SCCCEE-ECCC---CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-E
T ss_pred Ceeeec-cccc---cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-c
Confidence 776643 2211 23566666666666542 345555666666666666655555555556666666666665553 3
Q ss_pred CCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcccc
Q 042568 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|.+++. + +..+++|+.|++++|+++
T Consensus 288 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 444455555555555555555 3344455555555555555555532 2 444555555555555554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=348.05 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred CCCCCCCccccCCcEeEEEEEE----CCCcEEEEEEeeccc---CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL----QDNTRIAVKVLDLTT---TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~----~~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 738 (983)
++|...+.||+|+||.||+|+. .+++.||||+++... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999997 368999999986543 122456778899999999 69999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999998753 45899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 207 ~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~ 273 (355)
T 1vzo_A 207 KEFVADET------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAE 273 (355)
T ss_dssp EECCGGGG------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHH
T ss_pred eecccCCC------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHH
Confidence 86543221 11223579999999999986 34789999999999999999999998643211 11111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHEMG 963 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 963 (983)
+....... ... .+ .+....+.+++.+|++.||++|| +++|++++..
T Consensus 274 ------------~~~~~~~~-~~~-~~-------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 274 ------------ISRRILKS-EPP-YP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ------------HHHHHHHC-CCC-CC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ------------HHHHHhcc-CCC-CC-------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 11111111 110 11 12446788999999999999999 9999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=337.39 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=202.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|+.. +++.||||.++..... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 356888999999999999999975 6889999999754322 34678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~~~ 821 (983)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999988642 45899999999999999999999996 9999999999999 78899999999998754
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ..
T Consensus 160 ~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~------ 213 (304)
T 2jam_A 160 QNG---------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----ES------ 213 (304)
T ss_dssp CCB---------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----HH------
T ss_pred CCC---------------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HH------
Confidence 321 1122468999999999999999999999999999999999999985321 01
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
...+......... + ...+...+.++.+++.+|++.||++|||++|++++-.
T Consensus 214 ------~~~~~i~~~~~~~--~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 214 ------KLFEKIKEGYYEF--E---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ------HHHHHHHHCCCCC--C---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ------HHHHHHHcCCCCC--C---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 1111111111110 0 1112335578999999999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.05 Aligned_cols=281 Identities=20% Similarity=0.222 Sum_probs=202.4
Q ss_pred HHHHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcc----------hhHHHHHHHHHHHhcCCCCccc
Q 042568 659 YKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE----------ITGSFKRECQILKRIRHRNLIR 728 (983)
Q Consensus 659 ~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~ 728 (983)
.+++....++|...+.||+|+||.||+|...+++.||||++....... ..+++.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 456777889999999999999999999998889999999985543221 2378999999999999999999
Q ss_pred eeeEEec-----CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeE
Q 042568 729 IITICSK-----PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNIL 803 (983)
Q Consensus 729 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiL 803 (983)
+++++.. ....++||||++ |+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999843 335799999998 5787777643 346899999999999999999999996 999999999999
Q ss_pred eCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCC
Q 042568 804 LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRR 882 (983)
Q Consensus 804 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~ 882 (983)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp ECTTCCEEECCTTC-----------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EcCCCCEEEEecCccccccccc--------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999999999997543221 1123468999999999887 678999999999999999999999
Q ss_pred CCCcccCCCCchHHHHHhhCCCCCcH-------HHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH
Q 042568 883 PTDVLFHDGSSLHEWVKRHYPHRLDP-------IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955 (983)
Q Consensus 883 p~~~~~~~~~~l~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 955 (983)
||..... ...+...+.......... .....+......................+.+++.+|++.||++|||+
T Consensus 233 pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 233 LFRGSTF-YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp SCCCSSH-HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCH-HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 9864211 111112211111111110 11111111111111111111112345678999999999999999999
Q ss_pred HHHHHH
Q 042568 956 LDVAHE 961 (983)
Q Consensus 956 ~evl~~ 961 (983)
+|++++
T Consensus 312 ~ell~h 317 (362)
T 3pg1_A 312 EQALRH 317 (362)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=358.85 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=205.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|.+.++||+|+||+||+|... +++.||||++.... .......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357889999999999999999975 78899999986543 2234678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEcccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKL 820 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~Dfgla~~ 820 (983)
||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999888653 45899999999999999999999996 99999999999995 566899999999986
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .
T Consensus 174 ~~~~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~------ 227 (486)
T 3mwu_A 174 FQQNT--------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----E------ 227 (486)
T ss_dssp BCCC------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H------
T ss_pred CCCCC--------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H------
Confidence 64321 1123479999999999876 58999999999999999999999985321 1
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+.+........... ...|...+.++.+++.+|++.||++|||+.|++++-.
T Consensus 228 ------~~~~~~i~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 228 ------YDILKRVETGKYAFD-----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp ------HHHHHHHHHTCCCSC-----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred ------HHHHHHHHhCCCCCC-----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 111222221211111 1224456678999999999999999999999998744
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.70 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=205.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888999999999999999976 57889999986553 2234678899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++....
T Consensus 95 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998764 346899999999999999999999996 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ..+.
T Consensus 168 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~------ 223 (294)
T 2rku_A 168 DGE-------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKET------ 223 (294)
T ss_dssp TTC-------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHH------
T ss_pred Ccc-------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHH------
Confidence 211 1123468999999999999889999999999999999999999986421 1111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
......... ..+ .....++.+++.+|++.||++|||++|++++-.-
T Consensus 224 ------~~~~~~~~~--~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 224 ------YLRIKKNEY--SIP-------KHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp ------HHHHHTTCC--CCC-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ------HHHHhhccC--CCc-------cccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence 111111100 111 1234578899999999999999999999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=343.95 Aligned_cols=277 Identities=23% Similarity=0.293 Sum_probs=198.1
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc----chhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG----EITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
...++|...+.||+|+||.||+|... +++.||||+++..... .....+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999965 6899999998654322 123578899999999999999999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 787777643 345888999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+....... ......||+.|+|||.+.+. .++.++||||+||++|||++|..||..... ...+...
T Consensus 160 ~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i 225 (346)
T 1ua2_A 160 KSFGSPNR-------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRI 225 (346)
T ss_dssp STTTSCCC-------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred eeccCCcc-------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHH
Confidence 87643211 11234689999999998764 588999999999999999999999753210 1111111
Q ss_pred HHhhCCCC---CcHHHHHHHhhc-CCCCCc-cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 898 VKRHYPHR---LDPIVEKAIAKY-APQHMP-IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 898 ~~~~~~~~---~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
........ .... .. .... .....+ ......+.....++.+++.+|++.||++|||++|++++-.
T Consensus 226 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 226 FETLGTPTEEQWPDM-CS-LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp HHHHCCCCTTTSSST-TS-STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHHcCCCChhhhhhh-cc-CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 11110000 0000 00 0000 000000 0001112334578999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=331.27 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=203.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|...+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999976 577899999865421 223567899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999988753 35899999999999999999999996 99999999999999999999999999875542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ...
T Consensus 167 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~------- 219 (284)
T 2vgo_A 167 LR---------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----HTE------- 219 (284)
T ss_dssp SC---------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HHH-------
T ss_pred cc---------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----HhH-------
Confidence 11 122468999999999999999999999999999999999999986321 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.... +.... ...+ ...+.++.+++.+|++.||++||+++|++++-.
T Consensus 220 -----~~~~-~~~~~-~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 220 -----THRR-IVNVD-LKFP-------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp -----HHHH-HHTTC-CCCC-------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred -----HHHH-Hhccc-cCCC-------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 1111 11111 0111 123467889999999999999999999998543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=353.19 Aligned_cols=287 Identities=20% Similarity=0.254 Sum_probs=202.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKP-----DF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 738 (983)
.++|.+.+.||+|+||.||+|... +++.||||++..... ....+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468889999999999999999965 578899999965432 23457899999999999999999999999766 56
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||++ |+|.+++.. ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999997 599888864 345899999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCccccccc---------CCCCccccccCcccccccccccccc-CCCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 819 KLVKGIDESVNCA---------NDSMSFTSTDGLLCGSVGYIAPEYG-MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 819 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
+............ .............+||+.|+|||++ .+..++.++||||+||++|||++|..||....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 9765432110000 0000001123456899999999986 55679999999999999999999776664321
Q ss_pred CCCCc---------------------------hHHHHHhhCCC-------CCcHHHHHHHhhcCCCCCccccccchHHHH
Q 042568 889 HDGSS---------------------------LHEWVKRHYPH-------RLDPIVEKAIAKYAPQHMPIYYNKVWSDVV 934 (983)
Q Consensus 889 ~~~~~---------------------------l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 934 (983)
.++.. +..++...-.+ ...+...+.+.... ...+......+....
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP-HRKPINLKQKYPSIS 335 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC-CCCCCCHHHHSTTSC
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCC-CCCCCCHHHHCCCCC
Confidence 11100 00000000000 00111112221111 111111122223456
Q ss_pred HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 935 LELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 935 ~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.++.+++.+|++.||++|||++|++++
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 789999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.52 Aligned_cols=273 Identities=23% Similarity=0.349 Sum_probs=201.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888999999999999999975 5889999998655433 245668899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|++++++.++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999887653 345899999999999999999999996 999999999999999999999999999865432
Q ss_pred cccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||+.|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ...+...+.....
T Consensus 178 ~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 178 GE-------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGN 243 (331)
T ss_dssp -------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCS
T ss_pred cc-------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCC
Confidence 21 11224689999999998875 789999999999999999999999864211 1111111111110
Q ss_pred CCCcHHHHHHHhh---cCCCCCc-----cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 904 HRLDPIVEKAIAK---YAPQHMP-----IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 904 ~~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
. .+........ ......+ ......+..++.++.+++.+|++.||++|||++|++++=
T Consensus 244 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 244 -L-IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp -C-CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -C-ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0 0000100000 0000001 011111223567899999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.61 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=188.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhH-HHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITG-SFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|+..+.||+|+||.||+|.. .+++.||||++.......... .+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 35788899999999999999996 478889999997654333333 3444555578889999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
||++ |+|.+++.........+++..++.++.|+++||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 488777764333356799999999999999999999997 6 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCcccccccccccccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG----MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
.... .....||+.|+|||.+ .+..++.++||||+|+++|||++|+.||+......
T Consensus 162 ~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------- 220 (290)
T 3fme_A 162 DDVA--------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------- 220 (290)
T ss_dssp ----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-------
T ss_pred cccc--------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-------
Confidence 3211 1223699999999996 56678999999999999999999999986321110
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+...+........ ....+.++.+++.+|++.||++|||+.|++++-
T Consensus 221 ---------~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp 268 (290)
T 3fme_A 221 ---------QQLKQVVEEPSPQLP-------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP 268 (290)
T ss_dssp ---------HHHHHHHHSCCCCCC-------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred ---------HHHHHHhccCCCCcc-------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence 111111111111110 112456789999999999999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=359.00 Aligned_cols=250 Identities=16% Similarity=0.161 Sum_probs=191.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHH---HHHhcCCCCcccee-------eE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQ---ILKRIRHRNLIRII-------TI 732 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 732 (983)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+.+|++ ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688889999999999999995 568999999997542 2234678999995 45555899999998 66
Q ss_pred EecCC-----------------ceeEEEecccCcccccccccccCc---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCe
Q 042568 733 CSKPD-----------------FKALVLPLMSNGSLENHLYPSHGL---SHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792 (983)
Q Consensus 733 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 792 (983)
+..++ ..++||||+ +|+|.+++...... ...+++..++.|+.|+++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65553 278999999 58999998754221 123446888999999999999999996 9
Q ss_pred EeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-----------CC
Q 042568 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-----------RA 861 (983)
Q Consensus 793 vH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~ 861 (983)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~ 290 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLM 290 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----------------cccCCCC-cCccChhhhcccccccccccccccC
Confidence 9999999999999999999999999985432 1122467 999999999887 89
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHH
Q 042568 862 STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELG 941 (983)
Q Consensus 862 ~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 941 (983)
+.++|||||||++|||++|+.||........ ... ... .+..++.++.+++
T Consensus 291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~--------~~~---------~~~~~~~~~~~li 340 (377)
T 3byv_A 291 TFSFDAWALGLVIYWIWCADLPITKDAALGG-------------SEW--------IFR---------SCKNIPQPVRALL 340 (377)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCC------CC-------------SGG--------GGS---------SCCCCCHHHHHHH
T ss_pred ChhhhHHHHHHHHHHHHHCCCCCcccccccc-------------hhh--------hhh---------hccCCCHHHHHHH
Confidence 9999999999999999999999864211100 000 000 0012346789999
Q ss_pred hhhcCCCCCCCCCHHHHHHH--HHHhH
Q 042568 942 LLCTQYNPSTRPSMLDVAHE--MGRLK 966 (983)
Q Consensus 942 ~~cl~~dP~~RPs~~evl~~--L~~~~ 966 (983)
.+||+.||++|||+.|++++ ++.+.
T Consensus 341 ~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 341 EGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999999999999999974 44443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=361.19 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=207.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...++||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++......++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999975 789999999865532 23467899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe---CCCCCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL---DEDLTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl---~~~~~~kl~Dfgla~ 819 (983)
|||+++|+|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+||++ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999988864 346899999999999999999999996 9999999999999 567899999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... .....||+.|+|||.+.+ .++.++||||+||++|+|++|+.||.... .
T Consensus 178 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~----- 232 (484)
T 3nyv_A 178 HFEASKK--------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----E----- 232 (484)
T ss_dssp HBCCCCS--------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H-----
T ss_pred Ecccccc--------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----H-----
Confidence 7653221 122469999999999876 68999999999999999999999986321 1
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+............. ...|...+.++.+++.+|++.||++|||+.|+++|-.
T Consensus 233 -------~~~~~~i~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 233 -------YDILKKVEKGKYTFE-----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp -------HHHHHHHHHCCCCCC-----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred -------HHHHHHHHcCCCCCC-----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 111111111111111 1224456778999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=342.66 Aligned_cols=278 Identities=19% Similarity=0.250 Sum_probs=201.2
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP-------- 736 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 736 (983)
++|...+.||+|+||.||+|+. .+++.||||++...... .....+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999997 47899999998655432 2356788999999999999999999998763
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
+..++||||+++ ++.+.+... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999985 666666533 345899999999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+|+.+....... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ....
T Consensus 170 ~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~ 238 (351)
T 3mi9_A 170 LARAFSLAKNSQ---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQL 238 (351)
T ss_dssp TCEECCCCSSSS---------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH
T ss_pred hccccccccccc---------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh--HHHH
Confidence 998765332211 112233578999999999876 4579999999999999999999999864211 1111
Q ss_pred HHHHh---hCCCCCcHHHHHHHhhcCCCCCccccccchHH------HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 896 EWVKR---HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSD------VVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 896 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..+.. ..+....+..+..- ................+ ...++.+++.+|++.||++|||++|++++-.
T Consensus 239 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 239 ALISQLCGSITPEVWPNVDNYE-LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCG-GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHhCCCChhhccccccch-hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 11111 01111000000000 00000000000000111 1356889999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=342.22 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=205.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999975 57889999986553 223467889999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++++|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998764 346899999999999999999999996 9999999999999999999999999998764
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.
T Consensus 193 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~----- 249 (335)
T 2owb_A 193 YDGE-------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----LKET----- 249 (335)
T ss_dssp STTC-------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHH-----
T ss_pred cCcc-------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----HHHH-----
Confidence 3211 1123469999999999999899999999999999999999999986321 1111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
......... ..+ .....++.+++.+|++.||++|||++|++++-.
T Consensus 250 -------~~~~~~~~~--~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 250 -------YLRIKKNEY--SIP-------KHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp -------HHHHHHTCC--CCC-------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -------HHHHhcCCC--CCC-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 111111111 111 113457889999999999999999999998644
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.09 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=196.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|... +++.||||++.... ..+..+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999976 78999999986543 2234578899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999998653 35899999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... .....||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+.. ....
T Consensus 164 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~------ 218 (276)
T 2h6d_A 164 GEF--------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE-----HVPT------ 218 (276)
T ss_dssp ---------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH------
T ss_pred Ccc--------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-----cHHH------
Confidence 211 122468999999999988765 68999999999999999999998632 1111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..+....... ..+ .....++.+++.+|++.||++|||++|++++-
T Consensus 219 ------~~~~~~~~~~--~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 219 ------LFKKIRGGVF--YIP-------EYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp ------HHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ------HHHHhhcCcc--cCc-------hhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 1111111111 011 11346788999999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=335.76 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=197.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--CCc--EEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--DNT--RIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~--~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||.||+|.+. +++ .||||+++... ..+..+++.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 56888999999999999999853 333 58999986543 2345678999999999999999999999998765 78
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+|+||+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999998753 245899999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~ 899 (983)
........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+
T Consensus 171 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~--- 232 (291)
T 1u46_A 171 LPQNDDHY----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GSQ--- 232 (291)
T ss_dssp CCC-CCEE----------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHH---
T ss_pred ccccccch----------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HHH---
Confidence 65432211 11223467889999999988889999999999999999999 999986421 111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.............. ...++.++.+++.+|++.||++|||+.+++++|+++...
T Consensus 233 ---------~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ---------ILHKIDKEGERLPR-------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------HHHHHHTSCCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------HHHHHHccCCCCCC-------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11111111111000 123457799999999999999999999999999988654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=349.03 Aligned_cols=270 Identities=22% Similarity=0.307 Sum_probs=197.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC------cee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD------FKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 740 (983)
.+|...++||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888999999999999999988777799998854322 2247999999999999999999985433 378
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCCEEEccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAK 819 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Dfgla~ 819 (983)
+||||++++.+..... .......+++..++.++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccHHHHHHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999998754433322 2222457999999999999999999999996 99999999999999 79999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... ...+..++
T Consensus 191 ~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~ 255 (394)
T 4e7w_A 191 ILIAGEP--------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEII 255 (394)
T ss_dssp ECCTTCC--------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHH
T ss_pred cccCCCC--------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 7643221 1224689999999998765 589999999999999999999999864211 11122222
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWS-----DVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...-... .+.+............+......+. ..+.++.+++.+|++.||++|||+.|+++|
T Consensus 256 ~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 256 KVLGTPS-REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCCCC-HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCC-HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 2211111 1111111111111111111111121 245689999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.04 Aligned_cols=273 Identities=22% Similarity=0.287 Sum_probs=193.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..++|...+.||+|+||.||+|... +++.||||+++..... .....+.+|++++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999955 6888999999655432 2356778999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe-----CCCCCEEEccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL-----DEDLTALVADFGI 817 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl-----~~~~~~kl~Dfgl 817 (983)
|||+++ +|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999984 998888653 45899999999999999999999996 9999999999999 4556699999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+..
T Consensus 184 a~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~ 249 (329)
T 3gbz_A 184 ARAFGIPIR-------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFK 249 (329)
T ss_dssp HHHHC------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHH
T ss_pred ccccCCccc-------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-HHHHHH
Confidence 987643211 11224689999999999874 489999999999999999999999864211 011111
Q ss_pred HHHhhC-CCC-CcHHHHHHHhhcCCCCCccccccch-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHY-PHR-LDPIVEKAIAKYAPQHMPIYYNKVW-----SDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.... +.. ..+.... ... .....+....... .....++.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTA-LPD-WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHHHCCCCTTTSTTGGG-STT-CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhCCCchhhhhhhhh-hhh-hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 111100 000 0000000 000 0000000000001 1134678999999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=357.85 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=199.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|+.. ++..||||++..... ......+.+|+++++.++||||+++++++......++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888999999999999999975 688899999875532 2346788999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfgla~~~ 821 (983)
|+++|+|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999888864 345899999999999999999999996 999999999999976 455999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||.... .
T Consensus 190 ~~~~~--------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~------- 242 (494)
T 3lij_A 190 ENQKK--------------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-----D------- 242 (494)
T ss_dssp BTTBC--------------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H-------
T ss_pred CCCcc--------------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----H-------
Confidence 53221 12346999999999876 468999999999999999999999986321 1
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+............ ....|...+.++.+++.+|++.||++|||+.|++++
T Consensus 243 -----~~~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 243 -----QEILRKVEKGKYTF-----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----HHHHHHHHHTCCCC-----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----HHHHHHHHhCCCCC-----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11122211111111 112234566789999999999999999999999976
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.82 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=199.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
..++|...+.||+|+||.||+|... +++.||||.+.... ....+.+|++++++++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3467889999999999999999975 58899999997543 3477899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++... ...+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999988632 356899999999999999999999996 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ....
T Consensus 178 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~------- 233 (314)
T 3com_A 178 TMA-------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH----PMRA------- 233 (314)
T ss_dssp TBS-------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHH-------
T ss_pred hcc-------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----hHHH-------
Confidence 211 1123468999999999999999999999999999999999999986321 0000
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.. .+......... .....+.++.+++.+|++.||++|||+.|++++-
T Consensus 234 ------~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 234 ------IF-MIPTNPPPTFR-----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp ------HH-HHHHSCCCCCS-----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred ------HH-HHhcCCCcccC-----CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00 01111110000 0122346788999999999999999999999743
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=358.98 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=202.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc------------chhHHHHHHHHHHHhcCCCCccceeeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG------------EITGSFKRECQILKRIRHRNLIRIITI 732 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 732 (983)
.++|.+.++||+|+||+||+|... +++.||||++...... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467889999999999999999975 5788999998654321 345778999999999999999999999
Q ss_pred EecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC---C
Q 042568 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---T 809 (983)
Q Consensus 733 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---~ 809 (983)
+......++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999988864 345899999999999999999999996 99999999999998775 6
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
+||+|||+++...... ......||+.|+|||.+.+ .++.++||||+||++|+|++|+.||....
T Consensus 188 ~kl~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~- 251 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--------------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN- 251 (504)
T ss_dssp EEECCCTTCEECCTTS--------------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred EEEEECCCCEEcCCCC--------------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 9999999998765321 1123469999999999874 68999999999999999999999986321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
..+ .+.......... ....|...+.++.+++.+|++.||++|||++|++++-.
T Consensus 252 ----~~~------------~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 252 ----DQD------------IIKKVEKGKYYF-----DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp ----HHH------------HHHHHHHCCCCC-----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ----HHH------------HHHHHHcCCCCC-----CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 111 111111111110 11123345678999999999999999999999998644
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.86 Aligned_cols=267 Identities=19% Similarity=0.285 Sum_probs=201.5
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEec--CCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSK--PDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 742 (983)
++|...+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5788899999999999999996 57889999998532 3577999999999997 9999999999987 5677999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLV 821 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~ 821 (983)
|||+++++|.+++. .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+|+..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999988874 2788999999999999999999996 99999999999999776 8999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||.........+......
T Consensus 182 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 182 HPGQE--------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp CTTCC--------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred CCCCc--------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 53221 122468999999999887 678999999999999999999999985322211111111111
Q ss_pred hC-----------CCCCcHHHHHHHhhcCCCCCccc-cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HY-----------PHRLDPIVEKAIAKYAPQHMPIY-YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.- .....+................. ..........++.+++.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 10 11111111111111111100000 001112246789999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.66 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=196.6
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEec----CCceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSK----PDFKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 741 (983)
.|...+.||+|+||.||+|... ++..||+|.+.... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666778999999999999965 67789999986543 23346789999999999999999999998864 355799
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCCEEEcccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAKL 820 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Dfgla~~ 820 (983)
||||+++|+|.+++... ..+++..++.++.|+++||+|||+.++ +|+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999742 458999999999999999999999842 399999999999998 789999999999975
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... .....||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||.... .......
T Consensus 182 ~~~~~---------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~- 240 (290)
T 1t4h_A 182 KRASF---------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NAAQIYR- 240 (290)
T ss_dssp CCTTS---------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SHHHHHH-
T ss_pred ccccc---------------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC----cHHHHHH-
Confidence 43211 122468999999998775 58999999999999999999999986321 1111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
....... +.... ...+.++.+++.+|++.||++|||++|++++
T Consensus 241 -----------~~~~~~~----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 -----------RVTSGVK----PASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -----------HHTTTCC----CGGGG---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----------HHhccCC----ccccC---CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111101 11111 1133578999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=351.49 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=196.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC------Cce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP------DFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 739 (983)
.+|...+.||+|+||.||+|++. +++.||||++.... ..+.+|++++++++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999975 68999999985432 2234799999999999999999988432 235
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-CCEEEcccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIA 818 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-~~~kl~Dfgla 818 (983)
++||||+++ ++.+.+.........+++..++.++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+|||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 555554432222467999999999999999999999996 9999999999999965 56899999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+..+
T Consensus 205 ~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i 269 (420)
T 1j1b_A 205 KQLVRGEP--------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEI 269 (420)
T ss_dssp EECCTTCC--------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHH
T ss_pred hhcccCCC--------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence 87643221 1224689999999998765 78999999999999999999999986421 11122222
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWS-----DVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
+...-... .+.+............+......|. ....++.+|+.+|++.||++||++.|+++|-
T Consensus 270 ~~~lg~p~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 270 IKVLGTPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHCSCC-HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHhCCCC-HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 22211111 1111111111111112222222232 2357899999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=343.28 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=186.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|.. .+++.||||++.........+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 46889999999999999999995 46889999998765544456788999999999999999999999999999999999
Q ss_pred cccCccccccccccc----CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 745 LMSNGSLENHLYPSH----GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
|+++++|.+++.... .....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999999999886421 11345899999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
........ .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~ 240 (303)
T 2vwi_A 171 LATGGDIT--------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLMLTL 240 (303)
T ss_dssp CC-----------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHH
T ss_pred eccCCCcc--------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHHHh
Confidence 65322110 0011223579999999999876 56899999999999999999999998643211 1100000
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...+....... .........+.++.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 241 QNDPPSLETGV--------------QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TSSCCCTTC-------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccCCCcccccc--------------ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 10010000000 0000111234678899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=343.06 Aligned_cols=269 Identities=19% Similarity=0.211 Sum_probs=203.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcc----------------hhHHHHHHHHHHHhcCCCCccce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE----------------ITGSFKRECQILKRIRHRNLIRI 729 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l 729 (983)
.++|.+.+.||+|+||.||+|.. +++.||||++....... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788999999999999999999 89999999986543221 11789999999999999999999
Q ss_pred eeEEecCCceeEEEecccCcccccc------cccccCcCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCe
Q 042568 730 ITICSKPDFKALVLPLMSNGSLENH------LYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNI 802 (983)
Q Consensus 730 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~Ni 802 (983)
++++...+..++||||+++|+|.++ +... ....+++..++.++.|+++||+|||+ .+ |+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 9999999999999999999999998 4432 14569999999999999999999998 75 99999999999
Q ss_pred EeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCc-cchhHHHHHHHHHHHhC
Q 042568 803 LLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RAST-HGDVYSFGVLLLEIVTG 880 (983)
Q Consensus 803 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~SlG~il~elltg 880 (983)
+++.++.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EEcCCCcEEEeccccccccccc---------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 9999999999999999875432 11224689999999999887 6666 99999999999999999
Q ss_pred CCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 881 RRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 881 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+.||...... ......+.......... .. .......+..........+.++.+++.+|++.||++|||++|+++
T Consensus 249 ~~pf~~~~~~-~~~~~~i~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 249 VVPFSLKISL-VELFNNIRTKNIEYPLD-RN----HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSSCCSSCS-HHHHHHHTSCCCCCCCS-SS----SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcH-HHHHHHHhccCcCCccc-hh----hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9998643211 11111111100000000 00 000000000000001234578899999999999999999999997
Q ss_pred H
Q 042568 961 E 961 (983)
Q Consensus 961 ~ 961 (983)
+
T Consensus 323 h 323 (348)
T 2pml_X 323 H 323 (348)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.19 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=197.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|....+||+|+||.||+|... +++.||||.++.... ...+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3444568999999999999964 678899999875533 34678999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEccccccccccCCc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFGIAKLVKGID 825 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfgla~~~~~~~ 825 (983)
++++|.+++..... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||.++......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999875432 345678999999999999999999996 999999999999987 8999999999998664321
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR--ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ..
T Consensus 178 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~------- 234 (295)
T 2clq_A 178 P-------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ---AA------- 234 (295)
T ss_dssp ----------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH---HH-------
T ss_pred C-------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh---HH-------
Confidence 1 112346899999999987643 7899999999999999999999986421100 00
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ .....+ ...+.++.+++.+|++.||++||+++|++++
T Consensus 235 -----~~~~~~~~-~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 235 -----MFKVGMFK-VHPEIP-------ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -----HHHHHHHC-CCCCCC-------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -----HHhhcccc-cccccc-------ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111111 111111 2245678899999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.08 Aligned_cols=197 Identities=25% Similarity=0.344 Sum_probs=170.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc------CCCCccceeeEEecCCc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI------RHRNLIRIITICSKPDF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 738 (983)
..+|.+.++||+|+||.||+|... +++.||||++... .....++.+|+++++.+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 357889999999999999999865 5788999999643 23356788899999887 46799999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC--EEEcccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT--ALVADFG 816 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~--~kl~Dfg 816 (983)
.++||||+. ++|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 58888887543 345899999999999999999999996 999999999999999887 9999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 248 ~a~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 248 SSCYEHQR----------------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TCEETTCC----------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cceecCCc----------------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 99754321 1224799999999999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=345.39 Aligned_cols=269 Identities=20% Similarity=0.271 Sum_probs=200.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCce----
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFK---- 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 739 (983)
.++|...+.||+|+||.||+|... +++.||||++...... ...+++.+|+++++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888999999999999999965 6889999999765433 3457889999999999999999999999877655
Q ss_pred --eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 740 --ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 740 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
++||||++ ++|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 57777663 34899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++..... .....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ...+..
T Consensus 191 a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~ 253 (371)
T 4exu_A 191 ARHADAE----------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQ 253 (371)
T ss_dssp C------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHH
T ss_pred ccccccC----------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHH
Confidence 9865421 122468999999999887 7789999999999999999999999864211 111111
Q ss_pred HHHhhCCC-------CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 897 WVKRHYPH-------RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 897 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
.+...... ................ ........+.....++.+++.+|++.||++|||++|++++-
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCC-cchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 11111100 0111111222221111 11111111223467899999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=343.71 Aligned_cols=283 Identities=23% Similarity=0.243 Sum_probs=204.1
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP-----DFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 739 (983)
.++|...+.||+|+||.||+|... +++.||||++..........++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 68889999997555545567888999999999999999999988654 677
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 588888763 45899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
............ ...........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+....
T Consensus 161 ~~~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEP---TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-RHQLLLIF 236 (353)
T ss_dssp ECC-------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHH
T ss_pred ccccccccccCc---cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHH
Confidence 765432111000 000011223579999999998754 6789999999999999999999999864211 00011111
Q ss_pred HhhC-CC-------CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 899 KRHY-PH-------RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 899 ~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...- +. .........+...... ........+...+.++.+++.+|++.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMY-PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHhCCCchhccccccccchhhHHhhcccCC-CCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 1000 00 0011111112111110 00011111234567889999999999999999999999853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=338.44 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=196.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-------cchhHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-------GEITGSFKRECQILKRIRHRNLIRIITICSKPD 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 737 (983)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357889999999999999999965 578899999864321 123456889999999999999999999997655
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC---EEEcc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT---ALVAD 814 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~---~kl~D 814 (983)
.++||||+++++|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 7999999999999998864 346899999999999999999999996 999999999999987654 99999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
||+++...... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||..... .
T Consensus 161 fg~~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~ 225 (322)
T 2ycf_A 161 FGHSKILGETS--------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-Q 225 (322)
T ss_dssp CTTCEECCCCH--------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC-S
T ss_pred Cccceeccccc--------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-H
Confidence 99998764321 112346899999999863 56788999999999999999999999864321 1
Q ss_pred CchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 892 SSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 892 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..+...+..... ... ...+.+.+.++.+++.+|++.||++||++.|++++
T Consensus 226 ~~~~~~~~~~~~----------------~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 226 VSLKDQITSGKY----------------NFI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp SCHHHHHHHTCC----------------CCC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCcc----------------ccC----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 122222211100 000 11122345788999999999999999999999853
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=351.11 Aligned_cols=284 Identities=22% Similarity=0.194 Sum_probs=194.1
Q ss_pred ccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccc
Q 042568 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFF 275 (983)
Q Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 275 (983)
.|..+++|++|+|++|.+++..|.+|.++++|++|+|++|+++ .+|...+..+++|++|+|+
T Consensus 51 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls----------------- 112 (477)
T 2id5_A 51 EFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDIS----------------- 112 (477)
T ss_dssp TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECT-----------------
T ss_pred HccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECC-----------------
Confidence 3445666666666666666666666666666666666666665 4554444444444444444
Q ss_pred cccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCC
Q 042568 276 ASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355 (983)
Q Consensus 276 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 355 (983)
+|++++..|..+..+ ++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..+..++
T Consensus 113 ---------------~n~i~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~ 176 (477)
T 2id5_A 113 ---------------ENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLH 176 (477)
T ss_dssp ---------------TSCCCEECTTTTTTC-TTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCT
T ss_pred ---------------CCccccCChhHcccc-ccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccC
Confidence 444444444455544 3566777777777666777788888888888888888876666788888
Q ss_pred CCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEcc
Q 042568 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLS 435 (983)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 435 (983)
+|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|++++|.+++..+..+..+++|+.|+|+
T Consensus 177 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 256 (477)
T 2id5_A 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS 256 (477)
T ss_dssp TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECC
T ss_pred CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECC
Confidence 88888888888888777788888888888888887777777666666677777777777775444567777777777777
Q ss_pred CccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccc
Q 042568 436 HNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514 (983)
Q Consensus 436 ~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 514 (983)
+|++++..+..+..+++|+. |+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++.
T Consensus 257 ~n~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 257 YNPISTIEGSMLHELLRLQE-IQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp SSCCCEECTTSCTTCTTCCE-EECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCcCCccChhhccccccCCE-EECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 77777666666666777764 6777776666666666666666666666666665444455666666666666666653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=340.09 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=199.5
Q ss_pred CCHHHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEe
Q 042568 657 VSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICS 734 (983)
Q Consensus 657 ~~~~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 734 (983)
+++.++....++|...+.||+|+||.||+|.+. +++.||||++..... ....+.+|+++++++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334444556788999999999999999999974 688999999865433 357899999999999 8999999999997
Q ss_pred c------CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC
Q 042568 735 K------PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL 808 (983)
Q Consensus 735 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~ 808 (983)
. .+..++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 6 467899999999999999987543 356899999999999999999999996 99999999999999999
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
.+||+|||++....... .......||+.|+|||.+. +..++.++||||||+++|+|++|+.|
T Consensus 167 ~~kl~Dfg~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CEEECCCTTTC--------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CEEEeeCcCceecCcCc-------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999998654321 1112346999999999987 56788999999999999999999999
Q ss_pred CCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 884 TDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 884 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
|..... . . ..........+. ... ...+.++.+++.+|+..||++||++.|++++
T Consensus 234 ~~~~~~----~-~------------~~~~~~~~~~~~----~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 234 LCDMHP----M-R------------ALFLIPRNPAPR----LKS---KKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TTTSCH----H-H------------HHHHHHHSCCCC----CSC---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCcH----H-H------------HHHHhhcCcccc----CCc---cccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 853210 0 0 000001110100 001 1234678899999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.03 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=198.4
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC---cchhHHHHHHHHHHHhcCCCCccceeeEEe--cCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT---GEITGSFKRECQILKRIRHRNLIRIITICS--KPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 739 (983)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 688999999965431 234578999999999999999999999984 45578
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||++++ +.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 666665432 456899999999999999999999996 9999999999999999999999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCC--CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR--ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
........ .......||+.|+|||...+.. ++.++||||+|+++|||++|+.||... .....
T Consensus 158 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~ 221 (305)
T 2wtk_C 158 ALHPFAAD-----------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD-----NIYKL 221 (305)
T ss_dssp ECCTTCSS-----------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHH
T ss_pred ccCccccc-----------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hHHHH
Confidence 76432211 1112346999999999987644 378999999999999999999998632 11111
Q ss_pred HHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 898 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
.+....... ..+ .++..++.+++.+|++.||++|||++|++++-.
T Consensus 222 ------------~~~i~~~~~--~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 222 ------------FENIGKGSY--AIP-------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp ------------HHHHHHCCC--CCC-------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred ------------HHHHhcCCC--CCC-------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 111111111 011 124467889999999999999999999998744
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.17 Aligned_cols=281 Identities=21% Similarity=0.209 Sum_probs=192.9
Q ss_pred HHHHHHhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc
Q 042568 660 KQLIEATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF 738 (983)
Q Consensus 660 ~~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 738 (983)
.......++|.+.+.||+|+||.||+|... +++.||||++..... ...++.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345566789999999999999999999975 688999998855432 34567788889999999999999999865433
Q ss_pred -------eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh--ccCCCCeEeecCCCCCeEeCC-CC
Q 042568 739 -------KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH--HHSPIKVVHCDLKPSNILLDE-DL 808 (983)
Q Consensus 739 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~ivH~Dikp~NiLl~~-~~ 808 (983)
.++||||+++ ++.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999986 444433322222556899999999999999999999 775 999999999999996 89
Q ss_pred CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcc
Q 042568 809 TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVL 887 (983)
Q Consensus 809 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~ 887 (983)
.+||+|||+++....... .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cEEEeeCCCceecCCCCC--------------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999987653221 12246899999999987654 899999999999999999999998642
Q ss_pred cCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchH--------HHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWS--------DVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 888 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
.. ...+..++.... ....+.....................|. ....++.+++.+|++.||++|||+.|++
T Consensus 236 ~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 236 NS-AGQLHEIVRVLG-CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp SH-HHHHHHHHHHHC-CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred Ch-HHHHHHHHHHcC-CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 11 111222222111 1111111111110000000000001111 2467899999999999999999999999
Q ss_pred HHH
Q 042568 960 HEM 962 (983)
Q Consensus 960 ~~L 962 (983)
++-
T Consensus 314 ~hp 316 (360)
T 3e3p_A 314 CHP 316 (360)
T ss_dssp TSG
T ss_pred cCc
Confidence 863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=367.75 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=204.6
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCcee
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 740 (983)
..++|...++||+|+||.||+|+.. +++.||||+++... .....+.+..|.+++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467889999999999999999965 57889999997542 223457788999999988 7999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999998753 45899999999999999999999996 99999999999999999999999999985
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ..
T Consensus 492 ~~~~~-------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-----~~------ 547 (674)
T 3pfq_A 492 NIWDG-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-----DE------ 547 (674)
T ss_dssp CCCTT-------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-----SH------
T ss_pred cccCC-------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-----CH------
Confidence 43211 1123457999999999999999999999999999999999999998632 11
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM-----LDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 961 (983)
.+..+....... ..| .....++.+++.+|++.||++||++ +||++|
T Consensus 548 ------~~~~~~i~~~~~--~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 548 ------DELFQSIMEHNV--AYP-------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------HHHHHHHHSSCC--CCC-------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------HHHHHHHHhCCC--CCC-------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 112222221111 111 1245678999999999999999998 777754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=350.79 Aligned_cols=254 Identities=11% Similarity=0.020 Sum_probs=182.1
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhc--CCCCcccee-------eEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRI--RHRNLIRII-------TICSK 735 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~ 735 (983)
.|...+.||+|+||.||+|.+. +++.||||++..... ....+.+.+|+++++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4778899999999999999965 788999999977543 23456788886665555 599988755 44433
Q ss_pred C-----------------CceeEEEecccCcccccccccccCcCCCCCHHHH------HHHHHHHHHHHHHHhccCCCCe
Q 042568 736 P-----------------DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQL------VKICSDVAEGVAYLHHHSPIKV 792 (983)
Q Consensus 736 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~i 792 (983)
+ ...++||||++ |+|.+++.... ..+++..+ ..++.|+++||+|||+++ |
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 2 23799999999 89999997542 22345555 778899999999999996 9
Q ss_pred EeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHH
Q 042568 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSF 870 (983)
Q Consensus 793 vH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~Sl 870 (983)
+||||||+|||++.++.+||+|||+|+...... ....||+.|+|||++.+ ..++.++|||||
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----------------PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE----------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc----------------cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 999999999999999999999999998654211 12357799999999987 779999999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCC
Q 042568 871 GVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPS 950 (983)
Q Consensus 871 G~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 950 (983)
||++|||++|+.||.......... +.... ....... ......+..++.++.+++.+|++.||+
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~-------~~~~~-------~~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~ 342 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGS-------WKRPS-------LRVPGTD---SLAFGSCTPLPDFVKTLIGRFLNFDRR 342 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTC-------CCBCC-------TTSCCCC---SCCCTTSSCCCHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHhCCCCCCCcCcccccc-------hhhhh-------hhhcccc---ccchhhccCCCHHHHHHHHHHcCCChh
Confidence 999999999999997543221100 00000 0000000 000011123567899999999999999
Q ss_pred CCCCHHHHHHH
Q 042568 951 TRPSMLDVAHE 961 (983)
Q Consensus 951 ~RPs~~evl~~ 961 (983)
+|||+.|++++
T Consensus 343 ~Rpt~~e~l~h 353 (371)
T 3q60_A 343 RRLLPLEAMET 353 (371)
T ss_dssp TCCCHHHHTTS
T ss_pred hCCCHHHHhcC
Confidence 99999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=361.05 Aligned_cols=351 Identities=22% Similarity=0.226 Sum_probs=228.6
Q ss_pred CccccCCCCCCCCCCcc----eeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCC
Q 042568 50 PEHALESWNSTDVHVCN----WSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLI 125 (983)
Q Consensus 50 ~~~~l~sw~~~~~~~c~----w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 125 (983)
....+++|... .+||. |.++.|+. .++...... .....-..+++++.|++++|.++...+..+++++
T Consensus 5 ~~~~l~~~~~~-~~C~~~~~~~~c~~~~~------~i~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~ 75 (597)
T 3oja_B 5 QRYNVKPRQPE-YKCIDSNLQYDCVFYDV------HIDMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75 (597)
T ss_dssp ------CCCSE-ECCCCC--CCSEEECSC------EECSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCC
T ss_pred ccccccCCCCC-CcCcccCcCceeEecCc------eeccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCC
Confidence 34467889863 45663 66666642 111111111 1112233578899999999999855555678899
Q ss_pred CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccce
Q 042568 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRF 205 (983)
Q Consensus 126 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 205 (983)
+|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..+ ..+++|++|+|++|.++ .+|...|..+++|++
T Consensus 76 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~ 151 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF---QNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT 151 (597)
T ss_dssp CCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTT---TTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred CCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHH---cCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCE
Confidence 99999999999998888899999999999999999986555444 37888999999999888 567677778899999
Q ss_pred eecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCcc
Q 042568 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 206 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
|+|++|.+++..|..|+++++|++|+|++|.+++ ++ +..+++|+.|++++|.+.. +...++|+
T Consensus 152 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~---~~~l~~L~~L~l~~n~l~~-------------l~~~~~L~ 214 (597)
T 3oja_B 152 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLST-------------LAIPIAVE 214 (597)
T ss_dssp EECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CC---GGGCTTCSEEECCSSCCSE-------------EECCTTCS
T ss_pred EEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cC---hhhhhhhhhhhcccCcccc-------------ccCCchhh
Confidence 9999999998888889999999999999998874 44 3557778888888776643 22334566
Q ss_pred EEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCC
Q 042568 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 365 (983)
+|++++|.++...+. + .++|+.|+|++|.+++ +..+..+++|+.|+|++|
T Consensus 215 ~L~ls~n~l~~~~~~--------------------------~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N 264 (597)
T 3oja_B 215 ELDASHNSINVVRGP--------------------------V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYN 264 (597)
T ss_dssp EEECCSSCCCEEECS--------------------------C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSS
T ss_pred eeeccCCcccccccc--------------------------c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCC
Confidence 666666655432211 1 1345555555555553 234555555555555555
Q ss_pred cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCc
Q 042568 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS 445 (983)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 445 (983)
.+.+.+|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++..
T Consensus 265 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~-- 340 (597)
T 3oja_B 265 ELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK-- 340 (597)
T ss_dssp CCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--
T ss_pred ccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--
Confidence 5555555555555666666666666553 3444555566666666666665 45555566666666666666665432
Q ss_pred cccCCCccceeccccCCCCCC
Q 042568 446 DVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 446 ~~~~l~~L~~~L~l~~N~l~~ 466 (983)
+..+++|+. |++++|.+++
T Consensus 341 -~~~~~~L~~-L~l~~N~~~~ 359 (597)
T 3oja_B 341 -LSTHHTLKN-LTLSHNDWDC 359 (597)
T ss_dssp -CCTTCCCSE-EECCSSCEEH
T ss_pred -hhhcCCCCE-EEeeCCCCCC
Confidence 344555554 6666666653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.08 Aligned_cols=272 Identities=19% Similarity=0.217 Sum_probs=189.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEe--------c
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICS--------K 735 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 735 (983)
..+|.+.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 347888999999999999999964 68899999985443 334677899999999996 999999999984 3
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
....++||||++ |+|.+++..... ...+++..++.++.|+++||+|||+.++ +|+||||||+||+++.++.+||+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecC
Confidence 345789999996 688888764322 3469999999999999999999999842 3999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCcccccccccccccc---CCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCC
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG---MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~ 892 (983)
|+++............ .............||+.|+|||.+ .+..++.++||||||+++|||++|+.||.....
T Consensus 183 g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 258 (337)
T 3ll6_A 183 GSATTISHYPDYSWSA-QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--- 258 (337)
T ss_dssp TTCBCCSSCC--------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccc-cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---
Confidence 9998775432211000 000000111234699999999998 566789999999999999999999999853210
Q ss_pred chHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 893 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
... .... .....+ ......+.+++.+|++.||++|||++|++++|+++.+...
T Consensus 259 --~~~------------~~~~----~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 259 --LRI------------VNGK----YSIPPH-------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------------------CCCCTT-------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --HHh------------hcCc----ccCCcc-------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 000 0000 000000 1122457889999999999999999999999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.02 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=198.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 457888999999999999999976 588999999865433 346789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999988643 345899999999999999999999996 999999999999999999999999997643211
Q ss_pred cccccccCCCCccccccCcccccccccccccc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYG-----MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
. .......||+.|+|||.+ .+..++.++||||||+++|+|++|+.||..... .
T Consensus 171 ~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---- 228 (302)
T 2j7t_A 171 L-------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----M---- 228 (302)
T ss_dssp H-------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H----
T ss_pred c-------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----H----
Confidence 1 111224699999999987 466789999999999999999999999864211 0
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...........+. .. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 229 --------~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 229 --------RVLLKIAKSDPPT-LL-----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --------HHHHHHHHSCCCC-CS-----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --------HHHHHHhccCCcc-cC-----CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111111111110 00 012245678899999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=340.39 Aligned_cols=273 Identities=21% Similarity=0.199 Sum_probs=195.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|...+.||+|+||.||+|... +++.||||++..... ....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999965 688899999975432 234567889999999999999999999997655
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 6777664 24889999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~ 897 (983)
++...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...+...
T Consensus 174 a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i 238 (371)
T 2xrw_A 174 ARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKV 238 (371)
T ss_dssp ------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH
T ss_pred cccccccc--------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 98654211 11234799999999999999999999999999999999999999864211 0011111
Q ss_pred HHhhCC------CCCcHHHHHHHhhcCCCC-----------CccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 042568 898 VKRHYP------HRLDPIVEKAIAKYAPQH-----------MPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAH 960 (983)
Q Consensus 898 ~~~~~~------~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 960 (983)
+..... ..+.+.+........... ..+...........++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 111000 001111111111110000 000001112334678999999999999999999999998
Q ss_pred HHH
Q 042568 961 EMG 963 (983)
Q Consensus 961 ~L~ 963 (983)
+=.
T Consensus 319 hp~ 321 (371)
T 2xrw_A 319 HPY 321 (371)
T ss_dssp SHH
T ss_pred Ccc
Confidence 653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=337.32 Aligned_cols=266 Identities=22% Similarity=0.395 Sum_probs=199.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|...+.||+|+||.||+|.... .||+|+++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678899999999999999999753 499999865432 2345678899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++++|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999753 346899999999999999999999996 99999999999998 679999999998765432
Q ss_pred cccccccCCCCccccccCccccccccccccccCC---------CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
.... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ..
T Consensus 183 ~~~~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~ 249 (319)
T 2y4i_B 183 QAGR--------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AE 249 (319)
T ss_dssp -------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HH
T ss_pred cccc--------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH
Confidence 1110 0111223469999999999874 457889999999999999999999986421 11
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 972 (983)
. ..........+. .. . ..++.++.+++.+|++.||++|||+.|+++.|+++.+.....
T Consensus 250 ~------------~~~~~~~~~~~~-~~---~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 250 A------------IIWQMGTGMKPN-LS---Q---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp H------------HHHHHHTTCCCC-CC---C---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred H------------HHHHhccCCCCC-CC---c---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1 111111111110 00 0 113356889999999999999999999999999987765443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=336.77 Aligned_cols=268 Identities=20% Similarity=0.287 Sum_probs=200.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCc-----
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDF----- 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 738 (983)
.++|...+.||+|+||.||+|... +|+.||||++...... ...+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999965 6889999999665433 345788999999999999999999999977654
Q ss_pred -eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 739 -KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 739 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
.++||||++ ++|.+++. ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 58887764 24899999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++..... .....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ...+..
T Consensus 173 ~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~ 235 (353)
T 3coi_A 173 ARHADAE----------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQ 235 (353)
T ss_dssp TTC------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHH
T ss_pred ccCCCCC----------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH
Confidence 9764321 112468999999999887 6789999999999999999999999864211 011111
Q ss_pred HHHhhC-C------CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHY-P------HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~-~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.....- + ..........+...... ........+.....++.+++.+|++.||++|||++|++++
T Consensus 236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBC-SSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCC-CCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111100 0 00111111112111111 1111112233456789999999999999999999999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.68 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=203.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--------cchhHHHHHHHHHHHhcC-CCCccceeeEEec
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--------GEITGSFKRECQILKRIR-HRNLIRIITICSK 735 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 735 (983)
.++|...+.||+|+||.||+|... +++.||||+++.... ....+.+.+|++++++++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468889999999999999999975 688899999965431 123467889999999995 9999999999999
Q ss_pred CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccc
Q 042568 736 PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADF 815 (983)
Q Consensus 736 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Df 815 (983)
....++||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999874 345899999999999999999999996 999999999999999999999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccC------CCCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM------GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
|.+........ .....||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 169 g~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~- 233 (298)
T 1phk_A 169 GFSCQLDPGEK--------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK- 233 (298)
T ss_dssp TTCEECCTTCC--------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred cchhhcCCCcc--------------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-
Confidence 99987643221 12246899999999875 4567899999999999999999999985321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. .............. ...+...+.++.+++.+|++.||++|||+.|++++
T Consensus 234 ----~~------------~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 234 ----QM------------LMLRMIMSGNYQFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ----HH------------HHHHHHHHTCCCCC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----HH------------HHHHHHhcCCcccC-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 01 11111111111110 11223456789999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.47 Aligned_cols=271 Identities=19% Similarity=0.246 Sum_probs=199.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC--------CCCccceeeEEe--
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR--------HRNLIRIITICS-- 734 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 734 (983)
.++|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 368999999999999999999964 6788999998643 234578899999999996 788999999987
Q ss_pred --cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCC---
Q 042568 735 --KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDL--- 808 (983)
Q Consensus 735 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~--- 808 (983)
.....++||||+. +++.+++.... ...+++..++.++.|+++||+|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 114 GVNGTHICMVFEVLG-HHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp ETTEEEEEEEECCCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred CCCCceEEEEEeccC-ccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 5567899999995 55555554322 34699999999999999999999998 6 99999999999999775
Q ss_pred ----------------------------------------------CEEEccccccccccCCcccccccCCCCccccccC
Q 042568 809 ----------------------------------------------TALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842 (983)
Q Consensus 809 ----------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~ 842 (983)
.+||+|||+|+..... ..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------------~~ 251 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------------FT 251 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------------SC
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------------Cc
Confidence 8999999999865421 12
Q ss_pred ccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc-----hHHHHHhhCCCCCcHHHHHHH-h-
Q 042568 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS-----LHEWVKRHYPHRLDPIVEKAI-A- 915 (983)
Q Consensus 843 ~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~-----l~~~~~~~~~~~~~~~~~~~~-~- 915 (983)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... +...... ........+.... .
T Consensus 252 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL-LGKVPRKLIVAGKYSK 330 (397)
T ss_dssp SCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHH-HCSCCHHHHHHCTTGG
T ss_pred cCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHh-cCCCChHHhhcccccc
Confidence 246899999999999999999999999999999999999999753322111 1111110 0000000000000 0
Q ss_pred hcCC--CCCccc--------------cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 916 KYAP--QHMPIY--------------YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 916 ~~~~--~~~~~~--------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ...... ......+...++.+++.+|++.||++|||++|++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 000000 001124567889999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.37 Aligned_cols=267 Identities=19% Similarity=0.271 Sum_probs=202.3
Q ss_pred CCCCCCCccccCCcEeEEEEEE-C-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC------ccceeeEEecCCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-Q-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN------LIRIITICSKPDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 738 (983)
++|.+.+.||+|+||.||+|.. . +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 5788899999999999999986 3 5788999998643 234577889999999987654 9999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC------------
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE------------ 806 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~------------ 806 (983)
.++||||+ +++|.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 789999887543 346899999999999999999999996 999999999999987
Q ss_pred -------CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 807 -------DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 807 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----------------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccCCCceEeeCcccccCccc----------------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 678999999999864321 122468999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCCchHHHHHhhCCCCCcHHHH----------------------HHHhhcCCCCCccccccchHHHHHHH
Q 042568 880 GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE----------------------KAIAKYAPQHMPIYYNKVWSDVVLEL 937 (983)
Q Consensus 880 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l 937 (983)
|+.||.... .......+............. ......... .. ...........++
T Consensus 230 g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~l 305 (339)
T 1z57_A 230 GFTVFPTHD--SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LK-EFMLSQDVEHERL 305 (339)
T ss_dssp SSCSCCCSC--HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GG-GGCSCCSHHHHHH
T ss_pred CCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hh-hhcccchhhHHHH
Confidence 999986421 111111111111111011100 000000000 00 0001123467889
Q ss_pred HHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 938 IELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 938 ~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+++.+|++.||++|||++|++++
T Consensus 306 ~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 306 FDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHhCcCcccccCHHHHhcC
Confidence 999999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=364.31 Aligned_cols=259 Identities=22% Similarity=0.382 Sum_probs=205.5
Q ss_pred hCCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
.++|...+.||+|+||.||+|.+.. +..||||.++........+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3567778899999999999999742 45699999876555556688999999999999999999999985 456899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999998743 345899999999999999999999996 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+
T Consensus 542 ~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-----~~~---- 600 (656)
T 2j0j_A 542 EDSTY------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NND---- 600 (656)
T ss_dssp CC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHH----
T ss_pred CCCcc------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-----HHH----
Confidence 43221 11122357889999999998899999999999999999997 999986421 111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
........ .....+ ..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 601 --------~~~~i~~~-~~~~~~-------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 601 --------VIGRIENG-ERLPMP-------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------HHHHHHHT-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHHcC-CCCCCC-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11111111 111111 22456889999999999999999999999999998643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.48 Aligned_cols=274 Identities=19% Similarity=0.259 Sum_probs=195.7
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe----------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS---------- 734 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 734 (983)
.++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 357888999999999999999976 48899999986543 335678899999999999999999999873
Q ss_pred ----cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCC
Q 042568 735 ----KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLT 809 (983)
Q Consensus 735 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~ 809 (983)
.....++||||++ |+|.+++. ...+++..++.++.|+++||+|||+++ |+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3457799999998 69998886 345899999999999999999999996 99999999999997 5679
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
+||+|||+++........ ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSH----------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EEECCCTTCBCC------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEccCccccccCCCccc----------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999876432111 011223468999999998765 678999999999999999999999986421
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhh-------cCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAK-------YAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ......+....+....+........ ..... .......+...+.++.+++.+|++.||++|||++|++++
T Consensus 230 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 230 E--LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp H--HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSC-CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCC-CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1 1111111122221111111111100 00000 000011112356789999999999999999999999986
Q ss_pred H
Q 042568 962 M 962 (983)
Q Consensus 962 L 962 (983)
-
T Consensus 307 p 307 (320)
T 2i6l_A 307 P 307 (320)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.83 Aligned_cols=259 Identities=22% Similarity=0.243 Sum_probs=181.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHH-HHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQ-ILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|... +++.||||+++.........++.+|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999975 688999999976654444556667776 6777899999999999999999999999
Q ss_pred cccCccccccccccc-CcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 745 LMSNGSLENHLYPSH-GLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|+++ +|.+++.... .....+++..+..++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 7776664311 1145689999999999999999999998 6 9999999999999999999999999998664
Q ss_pred CCcccccccCCCCccccccCcccccccccccccc----CCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG----MGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... +.+
T Consensus 178 ~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~ 239 (327)
T 3aln_A 178 DSIA--------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQL 239 (327)
T ss_dssp ------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred cccc--------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HHH
Confidence 3211 1123699999999998 45678999999999999999999999986421110 000
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. .......+......+.....++.+++.+|++.||++|||+.|++++-.
T Consensus 240 ~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 240 T----------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp C----------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred H----------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 0 000000111111111234567899999999999999999999997543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=330.30 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=198.0
Q ss_pred HHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcC--CCCccceeeEEecCCcee
Q 042568 664 EATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIR--HRNLIRIITICSKPDFKA 740 (983)
Q Consensus 664 ~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 740 (983)
...++|.+.+.||+|+||.||+|...+++.||||++..... ....+.+.+|++++++++ ||||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34567889999999999999999988899999999976543 334678999999999997 599999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||| +.+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++ +.+||+|||+++.
T Consensus 105 lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence 9999 5678999998753 46899999999999999999999996 999999999999964 8999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-----------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 176 MQPDTTS-----------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp -------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccCcccc-----------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 6532211 11123469999999999875 4688899999999999999999999864211
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
. .. .....+........+. ....++.+++.+|++.||++||+++|++++-.
T Consensus 245 ~---~~-------------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 245 Q---IS-------------KLHAIIDPNHEIEFPD-------IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp H---HH-------------HHHHHHCTTSCCCCCC-------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred H---HH-------------HHHHHHhcccccCCcc-------cchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1 00 1111111111111111 12457889999999999999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=343.27 Aligned_cols=279 Identities=21% Similarity=0.252 Sum_probs=184.2
Q ss_pred CCCC-CCccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEe--cCCceeE
Q 042568 668 GFCP-SSLIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS--KPDFKAL 741 (983)
Q Consensus 668 ~f~~-~~~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 741 (983)
.|.+ .++||+|+||.||+|++. +++.||||++..... ...+.+|++++++++||||+++++++. .....++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3444 568999999999999965 577899999964432 357889999999999999999999994 4678899
Q ss_pred EEecccCcccccccccccC-----cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe----CCCCCEEE
Q 042568 742 VLPLMSNGSLENHLYPSHG-----LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL----DEDLTALV 812 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl----~~~~~~kl 812 (983)
||||+++ +|.+++..... ....+++..++.|+.|++.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 77766643221 1235899999999999999999999996 9999999999999 77899999
Q ss_pred ccccccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCC
Q 042568 813 ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDG 891 (983)
Q Consensus 813 ~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~ 891 (983)
+|||+|+........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.....+.
T Consensus 174 ~Dfg~a~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 243 (405)
T 3rgf_A 174 ADMGFARLFNSPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243 (405)
T ss_dssp CCTTCCC--------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred EECCCceecCCCCcc----------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence 999999876532111 0122335799999999998874 58999999999999999999999996432210
Q ss_pred --------CchHHHHHhhC-CCC--CcHH-----HHHHHhhcCCCCCcc-----ccccchHHHHHHHHHHHhhhcCCCCC
Q 042568 892 --------SSLHEWVKRHY-PHR--LDPI-----VEKAIAKYAPQHMPI-----YYNKVWSDVVLELIELGLLCTQYNPS 950 (983)
Q Consensus 892 --------~~l~~~~~~~~-~~~--~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~ 950 (983)
..+..++...- +.. .... ............... ...........++.+|+.+|++.||+
T Consensus 244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 01111111100 000 0000 000000000000000 00000000145688999999999999
Q ss_pred CCCCHHHHHHHHH
Q 042568 951 TRPSMLDVAHEMG 963 (983)
Q Consensus 951 ~RPs~~evl~~L~ 963 (983)
+|||++|+++|=.
T Consensus 324 ~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 324 KRITSEQAMQDPY 336 (405)
T ss_dssp GSCCHHHHHTSGG
T ss_pred cCCCHHHHhcChh
Confidence 9999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=325.43 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=203.2
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
..++|.+.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3467899999999999999999975 688999999865432 33467899999999999999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC---CCEEEccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED---LTALVADFGIAK 819 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~---~~~kl~Dfgla~ 819 (983)
+||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.+ +.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999998887643 35899999999999999999999996 9999999999999754 479999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
...... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||.... ..+
T Consensus 173 ~~~~~~--------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~--- 229 (287)
T 2wei_A 173 CFQQNT--------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-----EYD--- 229 (287)
T ss_dssp TBCCCS--------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH---
T ss_pred eecCCC--------------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC-----HHH---
Confidence 654321 11224689999999988764 8899999999999999999999986421 111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..............+ .+...+.++.+++.+|++.||++|||+.|++++
T Consensus 230 ---------~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 230 ---------ILKRVETGKYAFDLP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---------HHHHHHHCCCCCCSG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------HHHHHHcCCCCCCch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 111111111111111 123355788999999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=332.99 Aligned_cols=275 Identities=22% Similarity=0.280 Sum_probs=202.8
Q ss_pred HhCCCCCCCccccCCcEeEEEEEE--CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhc---CCCCccceeeEEe----
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVL--QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRI---RHRNLIRIITICS---- 734 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~--~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 734 (983)
+.++|.+.+.||+|+||.||+|.. .+++.||||+++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 36788999998654322 2345677888888777 8999999999986
Q ss_pred -cCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 735 -KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 735 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
.....++||||++ |+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 59999887543 345899999999999999999999996 9999999999999999999999
Q ss_pred cccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCc
Q 042568 814 DFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893 (983)
Q Consensus 814 Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~ 893 (983)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 163 Dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~ 227 (326)
T 1blx_A 163 DFGLARIYSFQM--------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQ 227 (326)
T ss_dssp SCCSCCCCCGGG--------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHH
T ss_pred cCcccccccCCC--------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-HHH
Confidence 999998654221 11234689999999999999999999999999999999999999864211 011
Q ss_pred hHHHHHhhCCCCCcHHHHHHH---hhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 894 LHEWVKRHYPHRLDPIVEKAI---AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+...+.......... ..... ...............+.+.+.++.+++.+|++.||++|||+.|++++
T Consensus 228 ~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 228 LGKILDVIGLPGEED-WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHHHHHCCCCGGG-SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCCCccc-CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111100000000 00000 00000000001111223456788999999999999999999999975
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=329.81 Aligned_cols=258 Identities=31% Similarity=0.511 Sum_probs=202.5
Q ss_pred cccEEeccccccCC--CCCcccccCCCCcEEEeeC-CcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 332 NLTLLNLSSNLLNG--TIPHELCLMSKLERVYLSN-NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
+++.|+|++|.+++ .+|..+..+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45555666666655 5555666666666666663 66666666666666666666666666666666666666666666
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCC-ccceeccccCCCCCCCCccccccccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLR-SLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 487 (983)
++++|.+++.+|..+..+++|++|++++|++++.+|..+..++ .|+. |++++|++++.+|..+..+. |+.|+|++|+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~-L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS-MTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCE-EECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcE-EECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 6666666666777777777777777777777777777777776 6774 77777777777777787776 8889999999
Q ss_pred cccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCC
Q 042568 488 LSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNK 567 (983)
Q Consensus 488 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~ 567 (983)
+++.+|..|..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|..|..+++|++|++++|+++|.+|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 9888888999999999999999999977766 788999999999999999999999999999999999999999999998
Q ss_pred CCCcccccccccCCcCccCCCCCcccc
Q 042568 568 GAFSSLTIASFQGNDGLCGEIKGLQTC 594 (983)
Q Consensus 568 ~~~~~~~~~~~~~N~~lc~~~~~~~~c 594 (983)
+.++.+..+.+.+|+++||.|. +.|
T Consensus 288 ~~l~~L~~l~l~~N~~lc~~p~--~~C 312 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCGSPL--PAC 312 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred ccccccChHHhcCCCCccCCCC--CCC
Confidence 8999999999999999999874 356
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=345.06 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=187.5
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEecc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456789999999998777778999999998543 245678999999987 8999999999999999999999999
Q ss_pred cCcccccccccccCcCCC---CCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCC-------------CCE
Q 042568 747 SNGSLENHLYPSHGLSHG---LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDED-------------LTA 810 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~-------------~~~ 810 (983)
+ |+|.+++......... .++..++.++.||++||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999998754322111 133456789999999999999996 9999999999999654 489
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCC-------CCCCccchhHHHHHHHHHHHh-CCC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-------KRASTHGDVYSFGVLLLEIVT-GRR 882 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~SlG~il~ellt-g~~ 882 (983)
||+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.
T Consensus 168 kL~DFG~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSF---------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp EECCCTTCEECCC-----------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred EEcccccceecCCCCccc---------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 999999998775432110 111233579999999999876 678999999999999999999 999
Q ss_pred CCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 883 PTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 883 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
||..... ....++. ..... +..........+.++.+++.+|++.||++|||+.|++++
T Consensus 239 Pf~~~~~---~~~~i~~----------------~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 239 PFGDKYS---RESNIIR----------------GIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTCSTTT---HHHHHHH----------------TCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCchh---hHHHHhc----------------CCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 9853211 0111111 11110 000111124567889999999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=333.25 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=175.3
Q ss_pred hCCCCCCC-ccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHH-HHHhcCCCCccceeeEEec----CCc
Q 042568 666 TGGFCPSS-LIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQ-ILKRIRHRNLIRIITICSK----PDF 738 (983)
Q Consensus 666 ~~~f~~~~-~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~----~~~ 738 (983)
.++|.+.+ +||+|+||.||+|... +++.||||++... ....+|+. .++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46787744 6999999999999976 6899999998542 22233333 4566799999999999865 445
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADF 815 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Df 815 (983)
.++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 799999999999999997543 346999999999999999999999996 999999999999986 455999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
|+++...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||........ .
T Consensus 176 g~~~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 238 (336)
T 3fhr_A 176 GFAKETTQNA---------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--S 238 (336)
T ss_dssp TTCEEC-------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ccceeccccc---------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--h
Confidence 9998654211 1234689999999999888899999999999999999999999864321110 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
......+.... ...+ ...+..++.++.+++.+|++.||++|||++|++++-.-
T Consensus 239 ------------~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 239 ------------PGMKRRIRLGQ-YGFP---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp -------------------------CCC---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ------------hhHHHhhhccc-cccC---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 00000000000 0000 11123456789999999999999999999999986553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=332.32 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=197.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcc-----hhHHHHHHHHHHHhcC--CCCccceeeEEecCC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGE-----ITGSFKRECQILKRIR--HRNLIRIITICSKPD 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 737 (983)
.++|...+.||+|+||.||+|... +++.||||++....... ...++.+|++++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 467889999999999999999964 68889999997654321 2356788999999996 599999999999999
Q ss_pred ceeEEEecccC-cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCCEEEccc
Q 042568 738 FKALVLPLMSN-GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADF 815 (983)
Q Consensus 738 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Df 815 (983)
..++|+||+.+ ++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999986 899998875 345899999999999999999999996 99999999999999 7899999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 195 g~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------ 253 (320)
T 3a99_A 195 GSGALLKDTV---------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------ 253 (320)
T ss_dssp TTCEECCSSC---------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred cccccccccc---------------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------
Confidence 9998764321 112469999999999887665 688999999999999999999986310
Q ss_pred HHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... .... .+ ...+.++.+++.+|++.||++|||++|++++
T Consensus 254 -~~~~----------------~~~~--~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 -EIIR----------------GQVF--FR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHH----------------CCCC--CS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhhc----------------cccc--cc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 0000 00 1134678899999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.90 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=169.1
Q ss_pred HhCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CC-----CccceeeEEecCC
Q 042568 665 ATGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HR-----NLIRIITICSKPD 737 (983)
Q Consensus 665 ~~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 737 (983)
..++|.+.+.||+|+||.||+|... +++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3578999999999999999999965 6788999999643 234567888999999885 55 4999999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCCCEEEccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDLTALVADF 815 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~~~kl~Df 815 (983)
..++||||++ |+|.+++.... ...+++..++.++.|++.||+|||.+. .+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 59999887543 345899999999999999999999521 1499999999999994 5788999999
Q ss_pred cccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 816 GIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 816 gla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
|+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 G~a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR----------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC----------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc----------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999866421 1224789999999999999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=327.24 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=192.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec---------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK--------- 735 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 735 (983)
.++|...+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|++++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457888999999999999999964 7889999998643 2345788999999999999999999998854
Q ss_pred ----CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEE
Q 042568 736 ----PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTAL 811 (983)
Q Consensus 736 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~k 811 (983)
....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 34678999999999999999753 345788999999999999999999996 99999999999999999999
Q ss_pred EccccccccccCCcccccccCCC-CccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccC
Q 042568 812 VADFGIAKLVKGIDESVNCANDS-MSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFH 889 (983)
Q Consensus 812 l~Dfgla~~~~~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~ 889 (983)
|+|||.++............... ...........||+.|+|||.+.+. .++.++||||+|+++|||++ ||....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~- 232 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM- 232 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence 99999998765322110000000 0001122335799999999998864 68999999999999999998 543210
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... ... +..... ..+.. .....+..+.+++.+|++.||++|||+.|++++
T Consensus 233 ---~~~~~------------~~~-~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---ERVNI------------LKK-LRSVSI-EFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHH------------HHH-HHSTTC-CCCTT---CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hHHHH------------HHh-cccccc-ccCcc---ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00011 111 111110 11111 112345678899999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=337.52 Aligned_cols=271 Identities=17% Similarity=0.272 Sum_probs=198.7
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-----------CCCccceeeEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-----------HRNLIRIITICS 734 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 734 (983)
++|...+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 5788899999999999999996 468889999986432 23567889999999886 899999999987
Q ss_pred cCC----ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeC----
Q 042568 735 KPD----FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLD---- 805 (983)
Q Consensus 735 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~---- 805 (983)
..+ ..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 544 779999999 889999887543 34589999999999999999999997 6 99999999999994
Q ss_pred --CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 806 --EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 806 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred CcCcceEEEcccccccccCCC----------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 4458999999999866421 1124689999999999999999999999999999999999999
Q ss_pred CCcccCCC-----CchHHHHHhhCCCCCcHHHHHHH--hhc-CCC----C---Cc--------cccccchHHHHHHHHHH
Q 042568 884 TDVLFHDG-----SSLHEWVKRHYPHRLDPIVEKAI--AKY-APQ----H---MP--------IYYNKVWSDVVLELIEL 940 (983)
Q Consensus 884 ~~~~~~~~-----~~l~~~~~~~~~~~~~~~~~~~~--~~~-~~~----~---~~--------~~~~~~~~~~~~~l~~l 940 (983)
|....... ..+...+... ............ ... ... . .. ............++.++
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELL-GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313 (373)
T ss_dssp C---------CHHHHHHHHHHHH-CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhc-CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence 97432211 0111111110 000000000000 000 000 0 00 00001124577889999
Q ss_pred HhhhcCCCCCCCCCHHHHHHHH
Q 042568 941 GLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 941 ~~~cl~~dP~~RPs~~evl~~L 962 (983)
+.+|++.||++|||++|++++-
T Consensus 314 i~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCG
T ss_pred HHHHhccCccccCCHHHHhhCh
Confidence 9999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.40 Aligned_cols=268 Identities=18% Similarity=0.256 Sum_probs=199.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CC-cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC------ccceeeEEecCC
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DN-TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN------LIRIITICSKPD 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~-~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 737 (983)
.++|.+.+.||+|+||.||+|... ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 367889999999999999999965 34 68999998643 234577889999999997765 899999999999
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe-------------
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL------------- 804 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl------------- 804 (983)
..++||||+ ++++.+++.... ...+++..++.++.|+++||+|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 556666665432 346899999999999999999999996 9999999999999
Q ss_pred ------CCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHH
Q 042568 805 ------DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878 (983)
Q Consensus 805 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ell 878 (983)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 233 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----------------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccCCCcEEEeecCcccccccc----------------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence 56789999999999864321 12246999999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCCchHHHHHhhCCCCCcHHHH----------------------HHHhhcCCCCCccccccchHHHHHH
Q 042568 879 TGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE----------------------KAIAKYAPQHMPIYYNKVWSDVVLE 936 (983)
Q Consensus 879 tg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (983)
+|+.||..... ......+............. +......... +. ..........+
T Consensus 234 ~g~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~ 309 (355)
T 2eu9_A 234 RGFTLFQTHEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KS-YMLQDSLEHVQ 309 (355)
T ss_dssp HSSCSCCCSSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GG-GCSCCSHHHHH
T ss_pred hCCCCCCCCCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cc-cccccchhHHH
Confidence 99999864211 11111111111111011100 0000000000 00 00011335678
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 937 LIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 937 l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+++.+|++.||++|||+.|++++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.23 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=191.5
Q ss_pred HHHHhCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-----chhHHHHHHHHHHHhc----CCCCccceee
Q 042568 662 LIEATGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-----EITGSFKRECQILKRI----RHRNLIRIIT 731 (983)
Q Consensus 662 l~~~~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~~ 731 (983)
.....++|...+.||+|+||.||+|.. .+++.||||+++..... .....+.+|+++++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 334567899999999999999999986 46889999999654322 1234567799999999 8999999999
Q ss_pred EEecCCceeEEEec-ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCC
Q 042568 732 ICSKPDFKALVLPL-MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLT 809 (983)
Q Consensus 732 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~ 809 (983)
++...+..++|+|| +.+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 99999999999999 7899999998753 35899999999999999999999996 99999999999999 8899
Q ss_pred EEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCccc
Q 042568 810 ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRAS-THGDVYSFGVLLLEIVTGRRPTDVLF 888 (983)
Q Consensus 810 ~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~SlG~il~elltg~~p~~~~~ 888 (983)
+||+|||+++...... .....||..|+|||++.+..+. .++||||+|+++|||++|+.||...
T Consensus 179 ~kl~dfg~~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~- 242 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---------------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD- 242 (312)
T ss_dssp EEECCCSSCEECCSSC---------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred EEEEEcchhhhcccCc---------------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-
Confidence 9999999998765321 1224689999999998776654 5899999999999999999998631
Q ss_pred CCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 889 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
..... ... ..+ .....++.+++.+|++.||++|||++|++++-
T Consensus 243 ------~~~~~----------------~~~--~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 243 ------QEILE----------------AEL--HFP-------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp ------HHHHH----------------TCC--CCC-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred ------HHHhh----------------hcc--CCc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 01000 000 011 12346788999999999999999999999854
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.06 Aligned_cols=336 Identities=22% Similarity=0.234 Sum_probs=212.5
Q ss_pred cccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
.++++++|++++|.++...+..|..+++|++|+|++|.++ .++...+..+++|++|+|++|.+
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l---------------- 105 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAI---------------- 105 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCC----------------
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCC----------------
Confidence 4566666666666666555555666666666666666665 44444455555555555555554
Q ss_pred CCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCc
Q 042568 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 358 (983)
++..|..+..+ ++|++|+|++|.++...+..+.++++|++|++++|++++..|..+..+++|+
T Consensus 106 ----------------~~~~~~~~~~l-~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 168 (390)
T 3o6n_A 106 ----------------RYLPPHVFQNV-PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168 (390)
T ss_dssp ----------------CCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCC
T ss_pred ----------------CcCCHHHhcCC-CCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCC
Confidence 44444444444 2455555555555532223345556666666666666555555555566666
Q ss_pred EEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcc
Q 042568 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438 (983)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 438 (983)
+|++++|.+++. .+..+++|+.|++++|.+++ +...++|+.|++++|.++. +|.. ..++|+.|++++|+
T Consensus 169 ~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~-~~~~--~~~~L~~L~l~~n~ 237 (390)
T 3o6n_A 169 NLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNN 237 (390)
T ss_dssp EEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCE-EECC--CCSSCCEEECCSSC
T ss_pred EEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeee-cccc--ccccccEEECCCCC
Confidence 666666665543 24445566666666666553 2233456666666666653 2322 23567777777777
Q ss_pred ccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccc
Q 042568 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPV 518 (983)
Q Consensus 439 l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 518 (983)
+++. ..+..+++|+. |++++|.+++..|..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.
T Consensus 238 l~~~--~~l~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~ 312 (390)
T 3o6n_A 238 LTDT--AWLLNYPGLVE-VDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312 (390)
T ss_dssp CCCC--GGGGGCTTCSE-EECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGG
T ss_pred Cccc--HHHcCCCCccE-EECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCc
Confidence 7643 45666777775 777777777777777777777778888888777 35666677888888888888888 4666
Q ss_pred cccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCCcCccCCC
Q 042568 519 SVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEI 588 (983)
Q Consensus 519 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~ 588 (983)
.+..+++|+.|++++|++++ +| +..+++|+.|++++|++++.... ..+..+....+.+++..|..+
T Consensus 313 ~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 313 NQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp GHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred cccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence 77788888888888888874 44 67788899999999998875322 233445556677888888765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=323.27 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=179.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHH-HHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGS-FKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~-~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|...+.||+|+||.||+|... +++.||||++......+...+ +.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 46778899999999999999975 689999999976654433333 4445556788899999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
|+ ++.+....... ...+++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 44554444321 35689999999999999999999985 5 99999999999999999999999999976543
Q ss_pred CcccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||.....+
T Consensus 178 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------- 235 (318)
T 2dyl_A 178 DKA--------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------- 235 (318)
T ss_dssp -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--------
T ss_pred Ccc--------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------
Confidence 211 12246899999999984 456889999999999999999999998642111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............. ..+. ....+.++.+++.+|++.||++||+++|++++
T Consensus 236 --------~~~~~~~~~~~~~-~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 236 --------FEVLTKVLQEEPP-LLPG-----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --------HHHHHHHHHSCCC-CCCS-----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --------HHHHHHHhccCCC-CCCc-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111211111 1110 11244678899999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=337.94 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=186.0
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
.+|...++||+|+||+||.....+++.||||++.... ...+.+|+++++++ +||||+++++++......++||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4578889999999999766556679999999985432 23467899999999 899999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-----CCCEEEcccccccc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-----DLTALVADFGIAKL 820 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-----~~~~kl~Dfgla~~ 820 (983)
++ |+|.+++.... ....+..++.++.|+++||+|||+.+ |+||||||+||+++. ...+||+|||+|+.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 97 59999887543 23444566789999999999999996 999999999999943 34688999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccC---CCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM---GKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~ 896 (983)
....... ........||+.|+|||++. ...++.++||||+||++|||++ |+.||..... ..
T Consensus 173 ~~~~~~~----------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~-- 237 (432)
T 3p23_A 173 LAVGRHS----------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQ-- 237 (432)
T ss_dssp C----------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HH--
T ss_pred ccCCCcc----------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HH--
Confidence 6533211 01123357999999999987 4567889999999999999999 8999853210 00
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............. .........+.+++.+|++.||++|||++|+++|
T Consensus 238 -------------~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 238 -------------ANILLGACSLDCL-----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -------------HHHHTTCCCCTTS-----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------------HHHHhccCCcccc-----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0000100000000 0112345668899999999999999999999953
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=349.89 Aligned_cols=278 Identities=22% Similarity=0.306 Sum_probs=203.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec------CCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK------PDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 739 (983)
++|.+.+.||+|+||.||+|.+. +|+.||||++.........+++.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999964 6889999998766555567789999999999999999999998755 6677
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCC---EEEcccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLT---ALVADFG 816 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~---~kl~Dfg 816 (983)
++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999875432 345889999999999999999999996 999999999999997665 9999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
.++....... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.... ....
T Consensus 170 ~a~~~~~~~~--------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----~~~~ 231 (676)
T 3qa8_A 170 YAKELDQGEL--------------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----QPVQ 231 (676)
T ss_dssp CCCBTTSCCC--------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----HHHH
T ss_pred cccccccccc--------------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----chhh
Confidence 9987643221 123479999999999999999999999999999999999999986421 1111
Q ss_pred HHHhhCCCCCcH-HHHHHHhhc--CCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHH-----HHHHHHHhHh
Q 042568 897 WVKRHYPHRLDP-IVEKAIAKY--APQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD-----VAHEMGRLKQ 967 (983)
Q Consensus 897 ~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----vl~~L~~~~~ 967 (983)
|........... ......... .....+ .........+..+.+++.+|++.||++|||+.| ..+.++.+.+
T Consensus 232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp-~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLP-TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SSTTCC------CCSCCCCSSSCCCCSSSC-CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhcccchhhhhhhhhccccccccccC-CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 111100000000 000000000 000000 111123446788999999999999999999988 4456665543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=347.15 Aligned_cols=336 Identities=22% Similarity=0.231 Sum_probs=222.9
Q ss_pred cccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
.+.+++.|++++|.+....+..|.++++|++|+|++|.++ .++...+..+++|++|+|++|.
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~----------------- 110 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA----------------- 110 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSC-----------------
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-CCChHHhcCCCCCCEEECCCCc-----------------
Confidence 4566777777777776665666667777777777777776 3444444555555555555554
Q ss_pred CCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCc
Q 042568 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 358 (983)
+++..|..++.+ ++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|..++.+++|+
T Consensus 111 ---------------l~~~~~~~~~~l-~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 174 (597)
T 3oja_B 111 ---------------IRYLPPHVFQNV-PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 174 (597)
T ss_dssp ---------------CCCCCTTTTTTC-TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCC
T ss_pred ---------------CCCCCHHHHcCC-CCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCc
Confidence 444444444444 3455555555555533333445666666666666666655555566666666
Q ss_pred EEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcc
Q 042568 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438 (983)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 438 (983)
+|+|++|.+++.. ++.+++|+.|++++|.+++ +...++|+.|++++|.++. +|..+ .++|+.|+|++|.
T Consensus 175 ~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~ 243 (597)
T 3oja_B 175 NLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNN 243 (597)
T ss_dssp EEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSC
T ss_pred EEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCC
Confidence 6666666665432 4445566666666666653 2333456666666666653 22222 2567777777777
Q ss_pred ccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccc
Q 042568 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPV 518 (983)
Q Consensus 439 l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 518 (983)
+++ +..+..+++|+. |+|++|.+++.+|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|.
T Consensus 244 l~~--~~~l~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~ 318 (597)
T 3oja_B 244 LTD--TAWLLNYPGLVE-VDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVER 318 (597)
T ss_dssp CCC--CGGGGGCTTCSE-EECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGG
T ss_pred CCC--ChhhccCCCCCE-EECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCc
Confidence 775 356677777775 7777777777777778888888888888888874 5777777888999999999888 5777
Q ss_pred cccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCCcCccCCC
Q 042568 519 SVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCGEI 588 (983)
Q Consensus 519 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~~lc~~~ 588 (983)
.+..+++|+.|+|++|++++. | +..+++|+.|++++|++++.... ..+..+....+.+++..|+.+
T Consensus 319 ~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 319 NQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp GHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred ccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 788888999999999998744 3 66788999999999999876432 234556666788999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=321.31 Aligned_cols=280 Identities=19% Similarity=0.256 Sum_probs=181.1
Q ss_pred cccHHhHHHHHHHHHhccCCCccccCCCC---CCCCCCcceeeEEECC--------CCCeEEEEEcccCCcccccccccc
Q 042568 30 DQIIRDRASLVTFMSSIISAPEHALESWN---STDVHVCNWSGVKCNN--------SRNKVVELDLSARSIYGTISPALA 98 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~---~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~~~~~l~ 98 (983)
.+..+|++||++||+++..||.+.+++|. ....++|.|.|+.|+. ...+|+.|+|+++++. .+|+.++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 45678999999999999878888889994 3356799999999953 3457888888888887 7788888
Q ss_pred cCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccc
Q 042568 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSL 178 (983)
Q Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 178 (983)
++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..|+++++|++|+|++|++.+.+|..+..
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~------- 172 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS------- 172 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE-------
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh-------
Confidence 8888888888888888 78888888888888888888888 77888888888888888888777777765531
Q ss_pred ceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcc
Q 042568 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258 (983)
Q Consensus 179 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 258 (983)
+.+. ..+..+++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|.. +.
T Consensus 173 -------~~~~-----~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~-l~----------- 226 (328)
T 4fcg_A 173 -------TDAS-----GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA-IH----------- 226 (328)
T ss_dssp -------EC-C-----CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGG-GG-----------
T ss_pred -------ccch-----hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchh-hc-----------
Confidence 0000 12234555555555555555 45555555555555555555554 23322 12
Q ss_pred ccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEec
Q 042568 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338 (983)
Q Consensus 259 ~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 338 (983)
.+++ |++|+|++|.+.+.+|..++.+++|++|+|
T Consensus 227 ---------------------~l~~-------------------------L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 227 ---------------------HLPK-------------------------LEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp ---------------------GCTT-------------------------CCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred ---------------------cCCC-------------------------CCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 2223 333333333333344444555555555555
Q ss_pred cccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccc
Q 042568 339 SSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391 (983)
Q Consensus 339 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (983)
++|++.+.+|..+..+++|++|+|++|.+.+.+|..++++++|+.+++..|.+
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 55555555555555555555555555555555555555555555555554444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=352.06 Aligned_cols=239 Identities=21% Similarity=0.313 Sum_probs=193.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCc-----e
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDF-----K 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 739 (983)
++|.+.+.||+|+||.||+|.+. +++.||||++......+....+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999975 5889999998765555556789999999999999999999999987665 6
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
++||||+++++|.+++.. .+++..++.|+.||++||+|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887642 5899999999999999999999996 9999999999999986 99999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
..... ....||++|+|||++.+.. +.++|||||||++|+|++|..||.....+..
T Consensus 230 ~~~~~-----------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------- 284 (681)
T 2pzi_A 230 RINSF-----------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------- 284 (681)
T ss_dssp ETTCC-----------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------
T ss_pred hcccC-----------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------
Confidence 65421 2246999999999987654 8899999999999999999988754221110
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHHHHHh
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-MLDVAHEMGRL 965 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~~~ 965 (983)
+. ..........+.+++.+|++.||++||+ ++++.+.+..+
T Consensus 285 ---~~----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ---PE----------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---CT----------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---cc----------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0001123467889999999999999995 55666666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=310.54 Aligned_cols=305 Identities=23% Similarity=0.383 Sum_probs=164.2
Q ss_pred cccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
.+++|++|++++|.+.. +| .+..+++|++|++++|+++ .++. +..+++|++|+|++|.+... ..+
T Consensus 42 ~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~~----------~~~ 106 (347)
T 4fmz_A 42 ELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITDI----------SAL 106 (347)
T ss_dssp HHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC----------GGG
T ss_pred hcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccCc----------hHH
Confidence 44555555555555542 22 2555555666666666555 3333 45555555555555554321 124
Q ss_pred CCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCc
Q 042568 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 358 (983)
..+++|++|++++|++++..+ +..+++|++|++++|.....++ .+..+++|+
T Consensus 107 ~~l~~L~~L~l~~n~i~~~~~---------------------------~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~ 158 (347)
T 4fmz_A 107 QNLTNLRELYLNEDNISDISP---------------------------LANLTKMYSLNLGANHNLSDLS-PLSNMTGLN 158 (347)
T ss_dssp TTCTTCSEEECTTSCCCCCGG---------------------------GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCC
T ss_pred cCCCcCCEEECcCCcccCchh---------------------------hccCCceeEEECCCCCCccccc-chhhCCCCc
Confidence 444555555555555443211 3333344444444443222221 244444444
Q ss_pred EEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcc
Q 042568 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438 (983)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 438 (983)
+|++++|.+.+..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|+
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence 44444444443222 4444445555555554443222 4445555555555555543222 4555555555555555
Q ss_pred ccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccc
Q 042568 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPV 518 (983)
Q Consensus 439 l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 518 (983)
+++..+ +..+++|+. |++++|.+++. ..+..+++|+.|++++|++++. +.+..+++|+.|++++|++++..|.
T Consensus 233 l~~~~~--~~~l~~L~~-L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 233 ITDLSP--LANLSQLTW-LEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCCCGG--GTTCTTCCE-EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred cCCCcc--hhcCCCCCE-EECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence 553322 455555553 55555555542 3456666677777777777643 3467777788888888888777777
Q ss_pred cccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccc
Q 042568 519 SVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561 (983)
Q Consensus 519 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 561 (983)
.+..+++|+.|++++|++++..| +..+++|++|++++|+++
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77778888888888888876555 777888888888888765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=307.07 Aligned_cols=235 Identities=14% Similarity=0.128 Sum_probs=184.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|... +++.||||++..... .+..+++.+|++++++++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999975 588999999976543 234578999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++++|.+++.. .....++.+|+.|+++||+|||+++ |+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 99999999999853 1355678899999999999999996 9999999999999999999997443
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
|++| ++.++|||||||++|||++|+.||........ +.... ....
T Consensus 175 --------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~~~-~~~~ 219 (286)
T 3uqc_A 175 --------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAPAE-RDTA 219 (286)
T ss_dssp --------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEECC-BCTT
T ss_pred --------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHHHH-HHhc
Confidence 3332 67899999999999999999999975322110 00000 0000
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcC
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 970 (983)
... ........+++.++.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 220 ~~~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 220 GQP-----------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCB-----------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCC-----------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000 00001112345678999999999999999 99999999999875443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.76 Aligned_cols=305 Identities=22% Similarity=0.332 Sum_probs=247.2
Q ss_pred hhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCc
Q 042568 221 LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPS 300 (983)
Q Consensus 221 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 300 (983)
+..+++|++|++++|.++ .++. +..+++|++|++++|++ ++..+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i--------------------------------~~~~~- 83 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQI--------------------------------TDISP- 83 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCC--------------------------------CCCGG-
T ss_pred chhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCcc--------------------------------ccchh-
Confidence 455666777777776665 3432 44555555555555544 32211
Q ss_pred cccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCC
Q 042568 301 IIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPH 380 (983)
Q Consensus 301 ~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 380 (983)
+..+ ++|++|++++|.+++ + +.+..+++|++|++++|.+++. +. +..+++|++|++++|.....++ .+..+++
T Consensus 84 -~~~l-~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~ 156 (347)
T 4fmz_A 84 -LSNL-VKLTNLYIGTNKITD-I-SALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTG 156 (347)
T ss_dssp -GTTC-TTCCEEECCSSCCCC-C-GGGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTT
T ss_pred -hhcC-CcCCEEEccCCcccC-c-hHHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCC
Confidence 3333 356666666666653 2 3578899999999999999855 33 8899999999999997665544 4999999
Q ss_pred CcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceecccc
Q 042568 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLS 460 (983)
Q Consensus 381 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~ 460 (983)
|+.|++++|++.+..+ +..+++|+.|++++|.+++ ++. +..+++|+.|++++|++++..+ +..+++|+. |+++
T Consensus 157 L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~-L~l~ 229 (347)
T 4fmz_A 157 LNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNS-LKIG 229 (347)
T ss_dssp CCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCE-EECC
T ss_pred CcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCE-EEcc
Confidence 9999999999986554 8899999999999999985 444 8899999999999999996655 888999996 9999
Q ss_pred CCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCc
Q 042568 461 SNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540 (983)
Q Consensus 461 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 540 (983)
+|++++..+ +..+++|+.|++++|.+++ + +.+..+++|+.|++++|++++. ..+..+++|+.|++++|++++..
T Consensus 230 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 230 NNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcC
Confidence 999996554 8999999999999999985 3 5689999999999999999974 45889999999999999999999
Q ss_pred CccccCCCCcceEeccCCccccccCCCCCCcccccccccCCc
Q 042568 541 PQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGND 582 (983)
Q Consensus 541 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N~ 582 (983)
|..|..+++|++|++++|++++.+| ...+..+..+++.+|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQV 344 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC-
T ss_pred hhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhc
Confidence 9999999999999999999999888 6778888899999886
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=319.74 Aligned_cols=244 Identities=16% Similarity=0.214 Sum_probs=187.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-------cchhHHHHHHHHHHHhcC---------CCCcccee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-------GEITGSFKRECQILKRIR---------HRNLIRII 730 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l~ 730 (983)
++|...+.||+|+||.||+|+. +|+.||||+++.... ....+.+.+|++++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4677899999999999999998 589999999976532 223478999999999986 66666666
Q ss_pred eEE-----------------ec-------------CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHH
Q 042568 731 TIC-----------------SK-------------PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEG 780 (983)
Q Consensus 731 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 780 (983)
+.+ .. .+..++||||+++|++.+.+. ...+++..++.++.|+++|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHH
Confidence 553 22 678899999999998777664 2458999999999999999
Q ss_pred HHHHh-ccCCCCeEeecCCCCCeEeCCCC--------------------CEEEccccccccccCCcccccccCCCCcccc
Q 042568 781 VAYLH-HHSPIKVVHCDLKPSNILLDEDL--------------------TALVADFGIAKLVKGIDESVNCANDSMSFTS 839 (983)
Q Consensus 781 L~~LH-~~~~~~ivH~Dikp~NiLl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~ 839 (983)
|+||| +.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------------- 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------------- 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----------------
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----------------
Confidence 99999 886 99999999999999887 899999999986542
Q ss_pred ccCccccccccccccccCCCCCCccchhHHHHHH-HHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcC
Q 042568 840 TDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL-LLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYA 918 (983)
Q Consensus 840 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~i-l~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 918 (983)
...+||+.|+|||++.+.. +.++||||+|++ .+++++|..||... .|.. ...+.......
T Consensus 235 --~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~--------~~~~~~~~~~~ 295 (336)
T 2vuw_A 235 --GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLH--------YLTDKMLKQMT 295 (336)
T ss_dssp --TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHH--------HHHHHHHHTCC
T ss_pred --CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhh--------HHHHhhhhhhc
Confidence 1247999999999998876 899999998777 78899999997421 0100 11112221111
Q ss_pred CCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH-HH
Q 042568 919 PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA-HE 961 (983)
Q Consensus 919 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl-~~ 961 (983)
.. .......+...+.++.+++.+|++.| |++|++ +|
T Consensus 296 ~~--~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 296 FK--TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CS--SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cC--cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 11 11112235678889999999999976 899988 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.05 Aligned_cols=233 Identities=20% Similarity=0.309 Sum_probs=179.3
Q ss_pred CCCCCC-CccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHH-HhcCCCCccceeeEEec----CCce
Q 042568 667 GGFCPS-SLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQIL-KRIRHRNLIRIITICSK----PDFK 739 (983)
Q Consensus 667 ~~f~~~-~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 739 (983)
++|... ++||+|+||.||+|.. .+++.||||++.. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 7799999999999996 4688999999852 35678899988 55699999999999876 6678
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEcccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFG 816 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfg 816 (983)
++||||+++|+|.+++.... ...+++..++.++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999997543 346999999999999999999999996 999999999999998 7899999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
++.... +..++.++||||+||++|||++|+.||........
T Consensus 166 ~a~~~~-----------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---- 206 (299)
T 3m2w_A 166 FAKETT-----------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---- 206 (299)
T ss_dssp TCEECT-----------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------
T ss_pred cccccc-----------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----
Confidence 986432 12356789999999999999999999864221100
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 963 (983)
... .... .... ........+..++.++.+++.+|++.||++|||++|++++-.
T Consensus 207 -~~~-~~~~-----------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 207 -SPG-MKTR-----------IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp --CC-SCCS-----------SCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -hHH-HHHH-----------Hhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 000 0000 0000 000001112235678999999999999999999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=329.82 Aligned_cols=243 Identities=16% Similarity=0.121 Sum_probs=178.8
Q ss_pred CCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc--chhHHHHHHHHHHHhcCC-CCccce---------eeE--
Q 042568 668 GFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG--EITGSFKRECQILKRIRH-RNLIRI---------ITI-- 732 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~niv~l---------~~~-- 732 (983)
.|...++||+|+||.||+|.+ .+|+.||||++...... ...+.+.+|+.+++.++| +|.... .+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 466678999999999999995 47899999998743322 236789999999999987 322111 111
Q ss_pred ----------Eec-----CCceeEEEecccCcccccccccc---cCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEe
Q 042568 733 ----------CSK-----PDFKALVLPLMSNGSLENHLYPS---HGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794 (983)
Q Consensus 733 ----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH 794 (983)
+.. ....+++|+++ +++|.+++... ......+++..++.++.|+++||+|||+++ |+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 111 12346666665 57898887421 112345788899999999999999999996 999
Q ss_pred ecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCcccccccccccccc----------CCCCCCcc
Q 042568 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYG----------MGKRASTH 864 (983)
Q Consensus 795 ~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k 864 (983)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----------------cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 999999999999999999999998865421 122467 999999998 56678899
Q ss_pred chhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhh
Q 042568 865 GDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLC 944 (983)
Q Consensus 865 ~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 944 (983)
+|||||||++|||++|+.||........ ... .... +...+.++.+++.+|
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~-------------~~~--------~~~~---------~~~~~~~~~~li~~~ 347 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGG-------------SEW--------IFRS---------CKNIPQPVRALLEGF 347 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSC-------------SGG--------GGSS---------CCCCCHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhh-------------HHH--------HHhh---------cccCCHHHHHHHHHH
Confidence 9999999999999999999864321100 000 0000 012346789999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 042568 945 TQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 945 l~~dP~~RPs~~evl~~ 961 (983)
|+.||++||++.|++++
T Consensus 348 l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 348 LRYPKEDRLLPLQAMET 364 (413)
T ss_dssp TCSSGGGSCCHHHHTTS
T ss_pred ccCChhhCcCHHHHHhC
Confidence 99999999999888754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-32 Score=298.87 Aligned_cols=268 Identities=24% Similarity=0.294 Sum_probs=200.8
Q ss_pred CCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEE
Q 042568 282 SNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVY 361 (983)
Q Consensus 282 ~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 361 (983)
+++++|++++|++++..|..+..+ ++|++|+|++|.+++..|..+.++++|++|++++|+++ .+|..+. ++|++|+
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~ 129 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGL-QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELR 129 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEE
T ss_pred CCCeEEECCCCcCCccCHhHhhCC-CCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEE
Confidence 355666666666665555566665 36777777777777666777777788888888888877 4555443 6788888
Q ss_pred eeCCcccCCCCCCCCCCCCCcEEEccCcccc--CcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccc
Q 042568 362 LSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS--GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439 (983)
Q Consensus 362 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 439 (983)
+++|.+.+..+..|..+++|+.|++++|+++ +..|..+..+ +|+.|++++|.+++ +|..+. ++|+.|++++|++
T Consensus 130 l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp CCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCC
T ss_pred CCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcC
Confidence 8888888666667788888888888888885 3667777777 88888888888874 555443 6788888888888
Q ss_pred cCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCccccccccc
Q 042568 440 SGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVS 519 (983)
Q Consensus 440 ~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 519 (983)
++..+..+..+++|+. |++++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..
T Consensus 206 ~~~~~~~l~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~ 283 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYR-LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVND 283 (332)
T ss_dssp CCCCTTSSTTCTTCSC-CBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTS
T ss_pred CccCHHHhcCCCCCCE-EECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhH
Confidence 8777778888888885 888888888777778888888888888888888 77888888888888888888888776666
Q ss_pred ccCC------CCccEEecCCcccc--CCcCccccCCCCcceEeccCCc
Q 042568 520 VGQL------PYLKQFDVSSNRLF--GEIPQSFQASPTLKQLNFSFNK 559 (983)
Q Consensus 520 ~~~l------~~L~~L~ls~N~l~--~~~p~~~~~l~~L~~l~l~~N~ 559 (983)
|... ..|+.|++++|++. +..|..|..+++|+.+++++|+
T Consensus 284 ~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 284 FCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp SSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 6543 56888888888876 5667788888888888888874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-36 Score=350.48 Aligned_cols=357 Identities=19% Similarity=0.189 Sum_probs=221.3
Q ss_pred ccceeecccccccCCCCCcccccccccceeecccCcccc----ccchhhhccCCcceecccccccccccchhhhcCCC--
Q 042568 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSGELPSEIISKMP-- 250 (983)
Q Consensus 177 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-- 250 (983)
+|++|+|++|+++.......+..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+...++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 344444444444322222224466777777777777764 34666777788888888888876544445555555
Q ss_pred --CccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCcccccc----ccCeeEEEccCcccccc--
Q 042568 251 --QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL----STNLVQIHLDCNLIYGK-- 322 (983)
Q Consensus 251 --~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l----~~~L~~L~L~~N~l~~~-- 322 (983)
+|++|+|++|++.... ...++..+..+++|++|++++|.+++..+..+... .++|++|++++|.+++.
T Consensus 84 ~~~L~~L~L~~n~i~~~~----~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 159 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAG----CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159 (461)
T ss_dssp TCCCCEEECTTSCCBGGG----HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred CCceeEEEccCCCCCHHH----HHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHH
Confidence 6888888888765321 22345667777888888888888775444433321 23577788888777753
Q ss_pred --CCCCCCCCCcccEEeccccccCCCCCccccc-----CCCCcEEEeeCCcccCC----CCCCCCCCCCCcEEEccCccc
Q 042568 323 --IPPHISNLVNLTLLNLSSNLLNGTIPHELCL-----MSKLERVYLSNNSLSGE----IPSAFGDIPHLGLLDLSKNKL 391 (983)
Q Consensus 323 --~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l 391 (983)
++..+..+++|++|++++|.+++..+..+.. .++|++|++++|.+++. ++..+..+++|+.|+|++|++
T Consensus 160 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l 239 (461)
T 1z7x_W 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred HHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcC
Confidence 2445556677888888888776544443332 55788888888877753 355566677788888888877
Q ss_pred cCcC-----cccccCcccchhhcccCccCCCC----CcccccCCCCCCEEEccCccccCcCCccccC-----CCccceec
Q 042568 392 SGSI-----PDSFANLSQLRRLLLYGNHLSGT----IPSSLGKCVNLEILDLSHNKISGIIPSDVAG-----LRSLKLYL 457 (983)
Q Consensus 392 ~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~~L 457 (983)
++.. +..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|++++..+..+.. .++|+. |
T Consensus 240 ~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~-L 318 (461)
T 1z7x_W 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES-L 318 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCE-E
T ss_pred ChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCcccee-e
Confidence 6432 22233567777777777777643 4566666777778888777776443333322 245664 6
Q ss_pred cccCCCCCCC----CccccccccccccccccccccccCCCccccc-----ccccceEEeCCCcccc----cccccccCCC
Q 042568 458 NLSSNHLDGP----LPLELSKMDMVLAIDLSFNNLSGSIPPQLGS-----CIALESLNLSGNSLEG----LLPVSVGQLP 524 (983)
Q Consensus 458 ~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~ 524 (983)
++++|.+++. ++..+..+++|+.|||++|++++..+..+.. .++|+.|+|++|++++ .+|..+..++
T Consensus 319 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~ 398 (461)
T 1z7x_W 319 WVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398 (461)
T ss_dssp ECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCC
T ss_pred EcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCC
Confidence 7777766654 3445555566666666666666544444432 4466666666666664 4555666666
Q ss_pred CccEEecCCccccC
Q 042568 525 YLKQFDVSSNRLFG 538 (983)
Q Consensus 525 ~L~~L~ls~N~l~~ 538 (983)
+|+.|++++|++++
T Consensus 399 ~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 399 SLRELDLSNNCLGD 412 (461)
T ss_dssp CCCEEECCSSSCCH
T ss_pred CccEEECCCCCCCH
Confidence 66666666666653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-32 Score=299.88 Aligned_cols=285 Identities=22% Similarity=0.313 Sum_probs=173.9
Q ss_pred EEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCc
Q 042568 80 VELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNN 159 (983)
Q Consensus 80 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N 159 (983)
+.++++++++. .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34455555665 5665553 67888888888888666777888888888888888888777888888888888888888
Q ss_pred ccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccc--cccchhhhccCCcceeccccccc
Q 042568 160 KLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLV--GQVPQALANSSKLEWLDLESNMF 237 (983)
Q Consensus 160 ~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l 237 (983)
+++ .+|..++ ++|++|++++|.++ .+|...+..+++|++|++++|.++ +..|..+..+ +|++|++++|++
T Consensus 113 ~l~-~l~~~~~-----~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l 184 (332)
T 2ft3_A 113 HLV-EIPPNLP-----SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184 (332)
T ss_dssp CCC-SCCSSCC-----TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred cCC-ccCcccc-----ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence 887 5665442 44555555555544 233333344444444444444442 1333333333 344444444333
Q ss_pred ccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCc
Q 042568 238 SGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCN 317 (983)
Q Consensus 238 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N 317 (983)
+ + +|..+. ++|++|++++|
T Consensus 185 ~---------------------------------------------------------~-l~~~~~---~~L~~L~l~~n 203 (332)
T 2ft3_A 185 T---------------------------------------------------------G-IPKDLP---ETLNELHLDHN 203 (332)
T ss_dssp S---------------------------------------------------------S-CCSSSC---SSCSCCBCCSS
T ss_pred C---------------------------------------------------------c-cCcccc---CCCCEEECCCC
Confidence 3 2 222211 34556666666
Q ss_pred cccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcc
Q 042568 318 LIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD 397 (983)
Q Consensus 318 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 397 (983)
.+++..|..+..+++|++|+|++|++++..+..+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|+|++..+.
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChh
Confidence 666555666777777777777777777666667777777777777777777 5666677777777777777777766555
Q ss_pred cccCc------ccchhhcccCccCC--CCCcccccCCCCCCEEEccCc
Q 042568 398 SFANL------SQLRRLLLYGNHLS--GTIPSSLGKCVNLEILDLSHN 437 (983)
Q Consensus 398 ~~~~l------~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~Ls~N 437 (983)
.|... .+|+.|++++|.+. +..|..|..+++|+.|++++|
T Consensus 283 ~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp SSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred HccccccccccccccceEeecCcccccccCcccccccchhhhhhcccc
Confidence 55442 34555555555554 344455555555555555555
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-31 Score=295.64 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=154.4
Q ss_pred cccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCccccc
Q 042568 84 LSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVG 163 (983)
Q Consensus 84 l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~ 163 (983)
++++++. .+|..+. +.|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus 38 ~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~- 113 (330)
T 1xku_A 38 CSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK- 113 (330)
T ss_dssp CTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-
T ss_pred ecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-
Confidence 3344444 4554443 57889999999998776778899999999999999998777888999999999999999887
Q ss_pred ccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccccccc-ccc
Q 042568 164 EIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSG-ELP 242 (983)
Q Consensus 164 ~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~ 242 (983)
.+|..++ ++|++|++++|++++..+..|.++++|++|++++|.++. .+.
T Consensus 114 ~l~~~~~------------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 163 (330)
T 1xku_A 114 ELPEKMP------------------------------KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 163 (330)
T ss_dssp BCCSSCC------------------------------TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC
T ss_pred ccChhhc------------------------------ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcC
Confidence 5665432 455666666666665666666666777777777766642 122
Q ss_pred hhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCcccccc
Q 042568 243 SEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGK 322 (983)
Q Consensus 243 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~ 322 (983)
...+..+++|++|++++|.+.. +|..+. ++|++|++++|.+++.
T Consensus 164 ~~~~~~l~~L~~L~l~~n~l~~---------------------------------l~~~~~---~~L~~L~l~~n~l~~~ 207 (330)
T 1xku_A 164 NGAFQGMKKLSYIRIADTNITT---------------------------------IPQGLP---PSLTELHLDGNKITKV 207 (330)
T ss_dssp TTGGGGCTTCCEEECCSSCCCS---------------------------------CCSSCC---TTCSEEECTTSCCCEE
T ss_pred hhhccCCCCcCEEECCCCcccc---------------------------------CCcccc---ccCCEEECCCCcCCcc
Confidence 2334455555555555554432 111111 2455555555555544
Q ss_pred CCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCccccc
Q 042568 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA 400 (983)
Q Consensus 323 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 400 (983)
.|..+..+++|++|+|++|++++..+..+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|+|++..+..|+
T Consensus 208 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 4555555566666666666666555555566666666666666665 4555566666666666666666655444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=292.92 Aligned_cols=268 Identities=22% Similarity=0.272 Sum_probs=175.4
Q ss_pred CccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEe
Q 042568 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362 (983)
Q Consensus 283 ~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 362 (983)
++++|++++|++++..+..+..+ ++|++|+|++|.+++..|..+..+++|++|++++|+++ .+|..+. ++|++|++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNL-KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTC-TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCeEEECCCCcCCEeChhhhccC-CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 34445555555554444445444 35666666666666555666666666777777666666 3444433 56677777
Q ss_pred eCCcccCCCCCCCCCCCCCcEEEccCccccC--cCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcccc
Q 042568 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG--SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
++|.+.+..+..|..+++|+.|++++|++.. ..+..|.++++|+.|++++|.++ .+|..+. ++|+.|++++|+++
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCC
Confidence 7777766666666667777777777776642 55666667777777777777776 3454433 66777777777777
Q ss_pred CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccc
Q 042568 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520 (983)
Q Consensus 441 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 520 (983)
+..|..+..+++|+. |++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..|
T Consensus 206 ~~~~~~~~~l~~L~~-L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f 283 (330)
T 1xku_A 206 KVDAASLKGLNNLAK-LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283 (330)
T ss_dssp EECTGGGTTCTTCCE-EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSS
T ss_pred ccCHHHhcCCCCCCE-EECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhc
Confidence 666777777777775 777777777666667777777777777777777 677777777777777777777776666555
Q ss_pred cCC------CCccEEecCCccccC--CcCccccCCCCcceEeccCCc
Q 042568 521 GQL------PYLKQFDVSSNRLFG--EIPQSFQASPTLKQLNFSFNK 559 (983)
Q Consensus 521 ~~l------~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~l~l~~N~ 559 (983)
... ..|+.|++++|++.. ..|..|..+++++.+++++|+
T Consensus 284 ~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 432 567777788877752 445677777777778777774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-36 Score=347.44 Aligned_cols=395 Identities=21% Similarity=0.180 Sum_probs=196.0
Q ss_pred CCCcEEeCcCCcCCCCCcc-ccCCCCCCCEEeccCccCCC----CchhhhcccccccEEeccCcccccccCCcccccCCC
Q 042568 101 SSLIVLDLSKNFFQGHIPA-ELGSLIRLKQLSLSWNSLQG----KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l 175 (983)
++|++|||++|+++..... .+..+++|++|+|++|.+++ .++..+..+++|++|+|++|++++..+..++ ..+
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~--~~l 80 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL--QGL 80 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH--HTT
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHH--HHH
Confidence 4566777777776643322 25667777777777777763 3456666777777777777777643332222 011
Q ss_pred cccceeecccccccCCCCCcccccccccceeecccCcccc----ccchhhhccCCcceecccccccccccchhh----hc
Q 042568 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSGELPSEI----IS 247 (983)
Q Consensus 176 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~ 247 (983)
+. ..++|++|+|++|+++. .+|..+..+++|++|+|++|.+++..+..+ ..
T Consensus 81 ~~---------------------~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~ 139 (461)
T 1z7x_W 81 QT---------------------PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLD 139 (461)
T ss_dssp CS---------------------TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred hh---------------------CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhc
Confidence 10 00135555555555542 335555666666666666666543222211 22
Q ss_pred CCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccc----cccCeeEEEccCcccccc-
Q 042568 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD----LSTNLVQIHLDCNLIYGK- 322 (983)
Q Consensus 248 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~----l~~~L~~L~L~~N~l~~~- 322 (983)
..++|++|+|++|++.... ...++..+..+++|++|++++|.+++..+..+.. ..++|++|++++|.+++.
T Consensus 140 ~~~~L~~L~L~~n~l~~~~----~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 140 PQCRLEKLQLEYCSLSAAS----CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp TTCCCCEEECTTSCCBGGG----HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred CCCcceEEECCCCCCCHHH----HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 2345555665555543311 1122333444556666666666655433222221 012444444444444431
Q ss_pred ---CCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCc----C
Q 042568 323 ---IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS----I 395 (983)
Q Consensus 323 ---~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~ 395 (983)
++..+..+++|++|++++|.+++.....+. +..+..+++|+.|+|++|++++. +
T Consensus 216 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l 276 (461)
T 1z7x_W 216 CRDLCGIVASKASLRELALGSNKLGDVGMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDL 276 (461)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred HHHHHHHHHhCCCccEEeccCCcCChHHHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHH
Confidence 233333444455555555544322110000 11122334444444444444322 2
Q ss_pred cccccCcccchhhcccCccCCCCCccccc-----CCCCCCEEEccCccccCc----CCccccCCCccceeccccCCCCCC
Q 042568 396 PDSFANLSQLRRLLLYGNHLSGTIPSSLG-----KCVNLEILDLSHNKISGI----IPSDVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 396 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~ 466 (983)
+..+..+++|+.|++++|.+++..+..+. ..++|+.|++++|.+++. ++..+..+++|+. |++++|.+++
T Consensus 277 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~-L~Ls~n~i~~ 355 (461)
T 1z7x_W 277 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE-LQISNNRLED 355 (461)
T ss_dssp HHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCE-EECCSSBCHH
T ss_pred HHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccE-EEccCCcccc
Confidence 33333344444444444444322222221 123555555555555543 2344444555554 6666665554
Q ss_pred CCcccccc-----cccccccccccccccc----CCCcccccccccceEEeCCCccccccccccc-----CCCCccEEecC
Q 042568 467 PLPLELSK-----MDMVLAIDLSFNNLSG----SIPPQLGSCIALESLNLSGNSLEGLLPVSVG-----QLPYLKQFDVS 532 (983)
Q Consensus 467 ~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ls 532 (983)
..+..+.. .++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.-...+. ...+|+.|++.
T Consensus 356 ~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~ 435 (461)
T 1z7x_W 356 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred ccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeec
Confidence 43333332 4577777888887775 6677777788888888888888754221111 23457777777
Q ss_pred CccccCCcCc
Q 042568 533 SNRLFGEIPQ 542 (983)
Q Consensus 533 ~N~l~~~~p~ 542 (983)
+|.+....+.
T Consensus 436 ~~~~~~~~~~ 445 (461)
T 1z7x_W 436 DIYWSEEMED 445 (461)
T ss_dssp TCCCCHHHHH
T ss_pred ccccCHHHHH
Confidence 7666544443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-33 Score=333.21 Aligned_cols=437 Identities=14% Similarity=0.114 Sum_probs=251.0
Q ss_pred CcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcC---CCCCccccC------------CCCCCC
Q 042568 64 VCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFF---QGHIPAELG------------SLIRLK 128 (983)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~l~~L~ 128 (983)
|++|.++.+.. . ..+.+.. .....++..+..+++|++|+|+++.. .+.+|..++ .+++|+
T Consensus 41 ck~W~~~~~~~-~---~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSET-R---EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHH-C---CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhcc-c---cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 45799985432 1 1222222 22334455678899999999988532 135555444 789999
Q ss_pred EEeccCccCCCCchhhhccc--ccccEEeccCcccccccCCccc-ccCCCcccceeecccccccCCCCC---cccccccc
Q 042568 129 QLSLSWNSLQGKIPSQLGSL--HQLEYLDLGNNKLVGEIPIPIF-CSNSSTSLQYIDLSNNSLTGEIPL---KNECELRN 202 (983)
Q Consensus 129 ~L~Ls~n~l~~~~p~~~~~L--~~L~~L~Ls~N~l~~~~p~~~~-~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~ 202 (983)
+|+|++|.+++..+..++.+ ++|++|+|++|.-. .+..+. ....+++|++|+|++|.+++.-.. .....+++
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~--~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~ 193 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGF--TTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEE--EHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCc--CHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCC
Confidence 99999999998888888775 55999999998721 111111 113578999999999988754211 13346789
Q ss_pred cceeecccCccc----cccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 203 LRFLLLWSNRLV----GQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 203 L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
|++|++++|.++ +.++..+.++++|++|+|++|.+.+ +| ..+..+++|++|+++.+... ......+..+
T Consensus 194 L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~-~~~~~~~~L~~L~l~~~~~~-----~~~~~~~~~l 266 (592)
T 3ogk_B 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LV-GFFKAAANLEEFCGGSLNED-----IGMPEKYMNL 266 (592)
T ss_dssp CCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GH-HHHHHCTTCCEEEECBCCCC-----TTCTTSSSCC
T ss_pred ccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HH-HHHhhhhHHHhhcccccccc-----cchHHHHHHh
Confidence 999999999987 3455667788999999999999884 55 56788899999999863221 1112334556
Q ss_pred CCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCC-CCCCCCCcccEEeccccccCCCCCcccccCCCC
Q 042568 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIP-PHISNLVNLTLLNLSSNLLNGTIPHELCLMSKL 357 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 357 (983)
..+++|+.|+++++.. +.+|..+..+ ++|++|+|++|.+++... ..+..+++|++|+++++...+.++.....+++|
T Consensus 267 ~~~~~L~~L~l~~~~~-~~l~~~~~~~-~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L 344 (592)
T 3ogk_B 267 VFPRKLCRLGLSYMGP-NEMPILFPFA-AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344 (592)
T ss_dssp CCCTTCCEEEETTCCT-TTGGGGGGGG-GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTC
T ss_pred hccccccccCccccch-hHHHHHHhhc-CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCC
Confidence 6777888888777533 2444444444 357777777666554322 224556666666666322222223333455666
Q ss_pred cEEEeeC-----------CcccCCC-CCCCCCCCCCcEEEccCccccCcCcccccC-cccchhhccc----CccCCCC--
Q 042568 358 ERVYLSN-----------NSLSGEI-PSAFGDIPHLGLLDLSKNKLSGSIPDSFAN-LSQLRRLLLY----GNHLSGT-- 418 (983)
Q Consensus 358 ~~L~L~~-----------N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-- 418 (983)
++|+|++ |.+++.. +..+..+++|+.|+++.|++++..+..++. +++|+.|+++ .|.+++.
T Consensus 345 ~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~ 424 (592)
T 3ogk_B 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPL 424 (592)
T ss_dssp CEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCC
T ss_pred CEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchH
Confidence 6666662 3443221 111223555666666555555544444443 4555555553 4444432
Q ss_pred ---CcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccc-ccccccccccccccccc-CCC
Q 042568 419 ---IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELS-KMDMVLAIDLSFNNLSG-SIP 493 (983)
Q Consensus 419 ---~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p 493 (983)
++..+..+++|+.|++++|. +.+++..+..+. .+++|+.|+|++|++++ .++
T Consensus 425 ~~~~~~~~~~~~~L~~L~L~~~~-----------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 425 DNGVRSLLIGCKKLRRFAFYLRQ-----------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp HHHHHHHHHHCTTCCEEEEECCG-----------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred HHHHHHHHHhCCCCCEEEEecCC-----------------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 12223445555555554321 112222222222 13445555555555543 223
Q ss_pred cccccccccceEEeCCCccccc-ccccccCCCCccEEecCCccccCC
Q 042568 494 PQLGSCIALESLNLSGNSLEGL-LPVSVGQLPYLKQFDVSSNRLFGE 539 (983)
Q Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~ 539 (983)
..+..+++|+.|+|++|++++. ++..+..+++|+.|+|++|++++.
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 3334555566666666655433 222334455666666666665543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=277.91 Aligned_cols=287 Identities=21% Similarity=0.266 Sum_probs=189.6
Q ss_pred CCCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCC--
Q 042568 62 VHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQG-- 139 (983)
Q Consensus 62 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~-- 139 (983)
.+.|.|.+|.|+.. +++ .+|..+. ++|++|+|++|.++...+..|+++++|++|+|++|.++.
T Consensus 4 ~C~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 4 RCSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TCEEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCeeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 34588999999753 233 4454332 689999999999994444457999999999999999983
Q ss_pred CchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccch
Q 042568 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ 219 (983)
Q Consensus 140 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~ 219 (983)
..|..+..+++|++|+|++|.++ .+|..+. .+++|++|++++|.+++..+...+..+++|++|++++|++.+..|.
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~---~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 144 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL---GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 144 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEE-EEEEEEE---TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT
T ss_pred CcccccccccccCEEECCCCccc-cChhhcC---CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh
Confidence 34778888999999999999998 5665543 5667777777777666443334455566666666666666655555
Q ss_pred hhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCC
Q 042568 220 ALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299 (983)
Q Consensus 220 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 299 (983)
.+.++++|++|+|++|.+++...... +..++
T Consensus 145 ~~~~l~~L~~L~l~~n~l~~~~~~~~--------------------------------~~~l~----------------- 175 (306)
T 2z66_A 145 IFNGLSSLEVLKMAGNSFQENFLPDI--------------------------------FTELR----------------- 175 (306)
T ss_dssp TTTTCTTCCEEECTTCEEGGGEECSC--------------------------------CTTCT-----------------
T ss_pred hcccCcCCCEEECCCCccccccchhH--------------------------------HhhCc-----------------
Confidence 56556666666666665543111111 22222
Q ss_pred ccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCC
Q 042568 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIP 379 (983)
Q Consensus 300 ~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 379 (983)
+|++|++++|.+++..|..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+..|..+..++
T Consensus 176 --------~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 247 (306)
T 2z66_A 176 --------NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247 (306)
T ss_dssp --------TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCC
T ss_pred --------CCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhh
Confidence 344455555555555566677777888888888888876666777888888888888888888888888874
Q ss_pred -CCcEEEccCccccCcCc--ccccCcccchhhcccCccCCCCCccccc
Q 042568 380 -HLGLLDLSKNKLSGSIP--DSFANLSQLRRLLLYGNHLSGTIPSSLG 424 (983)
Q Consensus 380 -~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 424 (983)
+|+.|+|++|++++..+ .....+...+.+.+..+.+....|..+.
T Consensus 248 ~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 248 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 295 (306)
T ss_dssp TTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGT
T ss_pred ccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhC
Confidence 78888888888875422 1112233444444555555544444443
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=313.13 Aligned_cols=218 Identities=23% Similarity=0.257 Sum_probs=133.7
Q ss_pred CCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 329 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
.+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..| |+.+++|+.|+|++|+|++..+ .++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 34466666666666666555666666666666666666665544 6666666666666666654322 2566666
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccc-cccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELS-KMDMVLAIDLSFNN 487 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~ 487 (983)
++++|.+++..+. .+++|+.|+|++|++++..|..+..+++|+. |+|++|.+++.+|..+. .+++|+.|+|++|.
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEE-EECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCE-EECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 6666666644332 2455666666666666666666666666664 66666666666665554 56666666666666
Q ss_pred cccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccc
Q 042568 488 LSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFS 561 (983)
Q Consensus 488 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 561 (983)
|++. |. +..+++|+.|+|++|+|++.+| .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++.
T Consensus 181 l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 181 IYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBC
T ss_pred cccc-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCc
Confidence 6644 22 2346666666666666665333 3666666666777766666 35666666666666666666665
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=285.70 Aligned_cols=280 Identities=19% Similarity=0.195 Sum_probs=210.8
Q ss_pred CCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEE
Q 042568 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERV 360 (983)
Q Consensus 281 l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 360 (983)
++.....++++|+++ .+|..+. ++|++|++++|.+++..+..+.++++|++|++++|++++..|..+..+++|++|
T Consensus 30 C~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 30 CDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp ECTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 344445677777776 3455433 467888888888876666677888888888888888887777778888888888
Q ss_pred EeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCc-ccccCcccchhhcccCc-cCCCCCcccccCCCCCCEEEccCcc
Q 042568 361 YLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRLLLYGN-HLSGTIPSSLGKCVNLEILDLSHNK 438 (983)
Q Consensus 361 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~ 438 (983)
+|++|.+++..+..|+.+++|++|+|++|++++..+ ..|.++++|+.|++++| .+++..+..|..+++|+.|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 888888886555557788888888888888875444 46778888888888887 4665556677888888888888888
Q ss_pred ccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccc---cccccceEEeCCCcccc-
Q 042568 439 ISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLG---SCIALESLNLSGNSLEG- 514 (983)
Q Consensus 439 l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~- 514 (983)
+++..|..+..+++|+. |++++|+++...+..+..+++|+.|+|++|++++..+..+. ....++.++|++|.+++
T Consensus 186 l~~~~~~~l~~l~~L~~-L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSH-LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp CCEECTTTTTTCSEEEE-EEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred cCccCHHHHhccccCCe-ecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 88777888888888885 88888888644333455678888888888888866555443 35667888888888876
Q ss_pred ---cccccccCCCCccEEecCCccccCCcCcc-ccCCCCcceEeccCCccccccCC
Q 042568 515 ---LLPVSVGQLPYLKQFDVSSNRLFGEIPQS-FQASPTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 515 ---~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~ 566 (983)
.+|..+..+++|+.|++++|+++ .+|.. |.++++|++|++++|++++.+|.
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 46778889999999999999998 66665 58999999999999999987764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=278.77 Aligned_cols=251 Identities=26% Similarity=0.278 Sum_probs=147.9
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCC--CCcccccCCCCcEEEe
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT--IPHELCLMSKLERVYL 362 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L 362 (983)
+.+++++++++ .+|..+ +++|++|+|++|.++...+..|.++++|++|+|++|+++.. .|..+..+++|++|+|
T Consensus 10 ~~l~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCS-SCCSCC---CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcc-cCCCCC---CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 46777777776 344432 24566777777776643333456666677777776666522 2444555566666666
Q ss_pred eCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc
Q 042568 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
++|.+. .+|..+..+++|+.|++++|++++..+ +..+..+++|++|++++|++++.
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~-----------------------~~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE-----------------------FSVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTT-----------------------TTTTTTCTTCCEEECTTSCCEEC
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCccccccc-----------------------chhhhhccCCCEEECCCCcCCcc
Confidence 666655 234445555555555555555554332 02344444555555555555544
Q ss_pred CCccccCCCccceeccccCCCCCC-CCccccccccccccccccccccccCCCcccccccccceEEeCCCccccccccccc
Q 042568 443 IPSDVAGLRSLKLYLNLSSNHLDG-PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVG 521 (983)
Q Consensus 443 ~p~~~~~l~~L~~~L~l~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 521 (983)
.+..+..+++|+. |++++|.+++ .+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+.
T Consensus 142 ~~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 220 (306)
T 2z66_A 142 FNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220 (306)
T ss_dssp STTTTTTCTTCCE-EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred chhhcccCcCCCE-EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence 4444555555553 5555555544 3455555666666666666666655566666666677777777777665555666
Q ss_pred CCCCccEEecCCccccCCcCccccCCC-CcceEeccCCcccccc
Q 042568 522 QLPYLKQFDVSSNRLFGEIPQSFQASP-TLKQLNFSFNKFSGNI 564 (983)
Q Consensus 522 ~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~ 564 (983)
.+++|+.|++++|++++..|..+..++ +|++|++++|++++..
T Consensus 221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 677777777777777766666666664 6777777777776543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=299.52 Aligned_cols=293 Identities=25% Similarity=0.308 Sum_probs=175.2
Q ss_pred cccCCCCCCCCCCcceeeEEEC------CCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCC
Q 042568 52 HALESWNSTDVHVCNWSGVKCN------NSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLI 125 (983)
Q Consensus 52 ~~l~sw~~~~~~~c~w~gv~c~------~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~ 125 (983)
...++|.. +.+||.|+|..|. .....++.|++++++++ .+|..+. ++|++|+|++|.|+ .+|. .++
T Consensus 10 ~~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 10 AVWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp CHHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 44567765 3568999764331 11224677777777776 6666554 67777777777777 4555 467
Q ss_pred CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccce
Q 042568 126 RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRF 205 (983)
Q Consensus 126 ~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~ 205 (983)
+|++|+|++|+|+ .+|. .+++|++|+|++|+++ .+|. .+++|+.|++++|++++ +|. .+++|++
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~------~l~~L~~L~L~~N~l~~-lp~----~l~~L~~ 145 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA------LPSGLCKLWIFGNQLTS-LPV----LPPGLQE 145 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC------CCTTCCEEECCSSCCSC-CCC----CCTTCCE
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC------CCCCcCEEECCCCCCCc-CCC----CCCCCCE
Confidence 7777777777777 4555 5677777777777776 3443 24566667777666663 442 2356666
Q ss_pred eecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCcc
Q 042568 206 LLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 206 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
|+|++|++++ +|. .+.+|+.|++++|+++ .+| ..+++|+.|+|++|.
T Consensus 146 L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~-~l~----~~~~~L~~L~Ls~N~------------------------ 192 (622)
T 3g06_A 146 LSVSDNQLAS-LPA---LPSELCKLWAYNNQLT-SLP----MLPSGLQELSVSDNQ------------------------ 192 (622)
T ss_dssp EECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSC------------------------
T ss_pred EECcCCcCCC-cCC---ccCCCCEEECCCCCCC-CCc----ccCCCCcEEECCCCC------------------------
Confidence 6666666653 232 2345566666666665 344 234455555555554
Q ss_pred EEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCC
Q 042568 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 365 (983)
+++ +|.. .++|+.|++++|.++ .+|.. +++|++|+|++|++++ +| ..+++|+.|+|++|
T Consensus 193 --------l~~-l~~~----~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N 251 (622)
T 3g06_A 193 --------LAS-LPTL----PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGN 251 (622)
T ss_dssp --------CSC-CCCC----CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSS
T ss_pred --------CCC-CCCc----cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCC
Confidence 442 2221 134555555555555 23332 3556666666666664 34 34466667777777
Q ss_pred cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCC
Q 042568 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV 427 (983)
Q Consensus 366 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 427 (983)
.|+. +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++..|..+..++
T Consensus 252 ~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 252 RLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 6663 343 4566777777777776 5566677777777777777777766666555443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=273.16 Aligned_cols=235 Identities=20% Similarity=0.282 Sum_probs=176.9
Q ss_pred cCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEc
Q 042568 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDL 386 (983)
Q Consensus 307 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 386 (983)
..++.|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++.+++|+.|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 35677777777776 66666777777777777777777 66666777777777777777776 55666777777777777
Q ss_pred cCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCC
Q 042568 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 387 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 466 (983)
++|++.+.+|..+... ..+..|..+++|++|+|++|+++ .+|..+..+++|+. |++++|++++
T Consensus 158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~-L~L~~N~l~~ 220 (328)
T 4fcg_A 158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS-LKIRNSPLSA 220 (328)
T ss_dssp EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE-EEEESSCCCC
T ss_pred CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE-EEccCCCCCc
Confidence 7766666666654431 11123455777888888888777 67777777777775 8888888874
Q ss_pred CCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccC
Q 042568 467 PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQA 546 (983)
Q Consensus 467 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 546 (983)
+|..+..+++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.+
T Consensus 221 -l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp -CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred -CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 5556888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCcceEeccCCcccc
Q 042568 547 SPTLKQLNFSFNKFSG 562 (983)
Q Consensus 547 l~~L~~l~l~~N~l~~ 562 (983)
+++|+.+++..|.+..
T Consensus 300 L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 300 LPANCIILVPPHLQAQ 315 (328)
T ss_dssp SCTTCEEECCGGGSCC
T ss_pred ccCceEEeCCHHHHHH
Confidence 8888888888776643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=281.89 Aligned_cols=250 Identities=21% Similarity=0.208 Sum_probs=146.6
Q ss_pred ccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee
Q 042568 284 FQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363 (983)
Q Consensus 284 L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 363 (983)
...++.++++++ .+|..+ ++++++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 56 ~~~v~c~~~~l~-~iP~~~---~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcC-ccCCCC---CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 455666666665 344332 2455666666666665555556666666666666666655555555555555555555
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcC
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 443 (983)
+|.+++..+..|..+++|+.|+|++|+++...+..|.++++|+.|++++| |.+....
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~i~ 188 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL-----------------------KKLEYIS 188 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCEEC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC-----------------------CCccccC
Confidence 55555555555555555555555555555444444555555555555542 2222222
Q ss_pred CccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCC
Q 042568 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL 523 (983)
Q Consensus 444 p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 523 (983)
+..+.++++|+. |+|++|++++. | .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+
T Consensus 189 ~~~~~~l~~L~~-L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 265 (452)
T 3zyi_A 189 EGAFEGLFNLKY-LNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265 (452)
T ss_dssp TTTTTTCTTCCE-EECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhccCCCCCCE-EECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence 223444444443 44444444432 2 24555666666677777766666677777777777777777777667777777
Q ss_pred CCccEEecCCccccCCcCccccCCCCcceEeccCCccccc
Q 042568 524 PYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 524 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 563 (983)
++|+.|+|++|+|++..+..|..+++|+.|++++|++.+.
T Consensus 266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 7777777777777765556667777777777777776543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.62 Aligned_cols=224 Identities=27% Similarity=0.277 Sum_probs=124.4
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeC
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 364 (983)
+++++++++++. +|..+ +++|++|++++|.+++..+..|..+++|++|++++|.+++..|..+..+++|++|++++
T Consensus 14 ~~~~c~~~~l~~-ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCSS-CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCccc-CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 455666666652 33322 24566666666666655555666666666666666666655566666666666666666
Q ss_pred Cc-ccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcC
Q 042568 365 NS-LSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443 (983)
Q Consensus 365 N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 443 (983)
|. +....|..|..+++|++|+|++|++++..|..|.++++|+.|++++|.+++..+..|..+++|+.|+|++|++++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 65 55555566666666666666666666555555666666666666666665444444555556666666666555444
Q ss_pred CccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCccc
Q 042568 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLE 513 (983)
Q Consensus 444 p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 513 (983)
+..+..+++|+. |++++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 170 ~~~~~~l~~L~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 170 ERAFRGLHSLDR-LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp TTTTTTCTTCCE-EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred HHHhcCccccCE-EECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 444555555553 555555554444444444444444444444444333333444444444444444443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=280.18 Aligned_cols=248 Identities=23% Similarity=0.231 Sum_probs=158.1
Q ss_pred ccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee
Q 042568 284 FQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363 (983)
Q Consensus 284 L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 363 (983)
...++.++++++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 456777777666 3454332 456667777777766666666666777777777776665555666666666666666
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCcc-CCCCCcccccCCCCCCEEEccCccccCc
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH-LSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
+|.+++..+..|..+++|+.|+|++|+++...+..|.++++|+.|++++|+ +....+..|..+++|++|+|++|+++
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-- 198 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-- 198 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS--
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc--
Confidence 666665555566666666666666666665555555555555555555532 22222224445555555555555544
Q ss_pred CCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccC
Q 042568 443 IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQ 522 (983)
Q Consensus 443 ~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 522 (983)
.+| .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..
T Consensus 199 ------------------------~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 253 (440)
T 3zyj_A 199 ------------------------EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253 (440)
T ss_dssp ------------------------SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred ------------------------ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence 122 2455556666777777777666777777777777777777777777777777
Q ss_pred CCCccEEecCCccccCCcCccccCCCCcceEeccCCcccc
Q 042568 523 LPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 523 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+
T Consensus 254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 7777777777777776666667777777777777777654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=265.37 Aligned_cols=227 Identities=21% Similarity=0.206 Sum_probs=131.4
Q ss_pred eEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCc
Q 042568 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389 (983)
Q Consensus 310 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (983)
+.++++++.++ .+|..+ .++|++|++++|++++..+..+..+++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45677777766 445433 356777777777776655556666666777777776666666666666666666666666
Q ss_pred c-ccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCC
Q 042568 390 K-LSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL 468 (983)
Q Consensus 390 ~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 468 (983)
+ +....|..|..+++|+.|++++|.+++..|..+..+++|++|++++|++++..+..+..+++|+. |++++|++++..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH-LFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccE-EECCCCcccccC
Confidence 5 55555556666666666666666666555555566666666666666665444444555555553 555555554333
Q ss_pred ccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCC
Q 042568 469 PLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASP 548 (983)
Q Consensus 469 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 548 (983)
+. .|..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+..++
T Consensus 170 ~~------------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 170 ER------------------------AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TT------------------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred HH------------------------HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence 33 444455555555555555554455555555555555555555544444455555
Q ss_pred CcceEeccCCcccccc
Q 042568 549 TLKQLNFSFNKFSGNI 564 (983)
Q Consensus 549 ~L~~l~l~~N~l~~~~ 564 (983)
+|++|++++|++.+..
T Consensus 226 ~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDC 241 (285)
T ss_dssp TCCEEECCSSCEECSG
T ss_pred ccCEEeccCCCccCCC
Confidence 5555555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=276.02 Aligned_cols=273 Identities=21% Similarity=0.234 Sum_probs=237.9
Q ss_pred eEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCc
Q 042568 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389 (983)
Q Consensus 310 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (983)
...++++|.++ .+|..+. ++|++|++++|++++..+..+..+++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (353)
T 2z80_A 34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110 (353)
T ss_dssp SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCC
Confidence 45889999998 6777665 58999999999999777778999999999999999999988999999999999999999
Q ss_pred cccCcCcccccCcccchhhcccCccCCCCCc-ccccCCCCCCEEEccCc-cccCcCCccccCCCccceeccccCCCCCCC
Q 042568 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIP-SSLGKCVNLEILDLSHN-KISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 390 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
++++..+..|+++++|++|++++|++++..+ ..+..+++|++|++++| .+.+..+..+..+++|+. |++++|++++.
T Consensus 111 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~-L~l~~n~l~~~ 189 (353)
T 2z80_A 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE-LEIDASDLQSY 189 (353)
T ss_dssp CCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE-EEEEETTCCEE
T ss_pred cCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE-EECCCCCcCcc
Confidence 9997767779999999999999999995444 47899999999999999 577777888999999996 99999999999
Q ss_pred CccccccccccccccccccccccCCCcc-cccccccceEEeCCCccccccccccc---CCCCccEEecCCccccC----C
Q 042568 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSLEGLLPVSVG---QLPYLKQFDVSSNRLFG----E 539 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~ls~N~l~~----~ 539 (983)
.|..+..+++|+.|++++|++. .+|.. +..+++|+.|++++|++++..+..+. ....++.+++++|.+++ .
T Consensus 190 ~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~ 268 (353)
T 2z80_A 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268 (353)
T ss_dssp CTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHH
T ss_pred CHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhh
Confidence 9999999999999999999997 45554 45689999999999999987665543 35678888999888876 4
Q ss_pred cCccccCCCCcceEeccCCccccccCCC-CCCcccccccccCCcCccCC
Q 042568 540 IPQSFQASPTLKQLNFSFNKFSGNISNK-GAFSSLTIASFQGNDGLCGE 587 (983)
Q Consensus 540 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~N~~lc~~ 587 (983)
+|..+..+++|++|++++|+++..++.. ..+..+..+.+.+|++.|..
T Consensus 269 l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred hHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 7889999999999999999999766553 67889999999999998863
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-31 Score=318.70 Aligned_cols=413 Identities=14% Similarity=0.090 Sum_probs=254.2
Q ss_pred CccccCCCCCCCEEeccCccC---CCCchhhhc------------ccccccEEeccCcccccccCCcccccCCCc-ccce
Q 042568 117 IPAELGSLIRLKQLSLSWNSL---QGKIPSQLG------------SLHQLEYLDLGNNKLVGEIPIPIFCSNSST-SLQY 180 (983)
Q Consensus 117 ~p~~~~~l~~L~~L~Ls~n~l---~~~~p~~~~------------~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~-~L~~ 180 (983)
.+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+.. ..+ +|++
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~--~~~~~L~~ 142 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAK--ARADDLET 142 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHH--HHGGGCCE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHH--hccccCcE
Confidence 344456667777777766432 123332222 5566666666666665433333220 012 2555
Q ss_pred eecccccccCCCCCcccccccccceeecccCcccc-ccchhhhccCCcceeccccccccccc---chhhhcCCCCccEEE
Q 042568 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVG-QVPQALANSSKLEWLDLESNMFSGEL---PSEIISKMPQLQFLY 256 (983)
Q Consensus 181 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~L~~L~ 256 (983)
|+|++|.- ++. .++....++++|++|+|++|.+++.- -..++..+++|++|+
T Consensus 143 L~L~~~~~------------------------~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~ 198 (592)
T 3ogk_B 143 LKLDKCSG------------------------FTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198 (592)
T ss_dssp EEEESCEE------------------------EEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEE
T ss_pred EECcCCCC------------------------cCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEE
Confidence 55544431 110 11222234455555555555544321 112334455555555
Q ss_pred ccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCcccc---ccCCCCCCCCCcc
Q 042568 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY---GKIPPHISNLVNL 333 (983)
Q Consensus 257 Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~---~~~p~~l~~l~~L 333 (983)
|++|.+.... ...+...+.++++|++|++++|.+.+ +|..+..+ ++|++|+++.+... +..+..+..+++|
T Consensus 199 L~~n~~~~~~----~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~-~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L 272 (592)
T 3ogk_B 199 FYMTEFAKIS----PKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA-ANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272 (592)
T ss_dssp CTTCCCSSCC----HHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC-TTCCEEEECBCCCCTTCTTSSSCCCCCTTC
T ss_pred eeccCCCccC----HHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh-hHHHhhcccccccccchHHHHHHhhccccc
Confidence 5555543111 11222333445666666666666654 44445444 45666666643222 2344566777888
Q ss_pred cEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCC-CCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccC
Q 042568 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIP-SAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYG 412 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 412 (983)
+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+|+++...+.++..+..+++|+.|++++
T Consensus 273 ~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~ 351 (592)
T 3ogk_B 273 CRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351 (592)
T ss_dssp CEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEEC
T ss_pred cccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeec
Confidence 8888887543 3567777778888888888888664333 2357788888888883332223344445678888888883
Q ss_pred -----------ccCCCC-CcccccCCCCCCEEEccCccccCcCCccccC-CCccceecccc----CCCCCCC-----Ccc
Q 042568 413 -----------NHLSGT-IPSSLGKCVNLEILDLSHNKISGIIPSDVAG-LRSLKLYLNLS----SNHLDGP-----LPL 470 (983)
Q Consensus 413 -----------N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~~L~l~----~N~l~~~-----~p~ 470 (983)
|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+. |+++ .|.+++. ++.
T Consensus 352 g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~-L~l~~~~~~n~l~~~p~~~~~~~ 430 (592)
T 3ogk_B 352 GADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD-FRLVLLDREERITDLPLDNGVRS 430 (592)
T ss_dssp CCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCE-EEEEECSCCSCCSSCCCHHHHHH
T ss_pred CccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcE-EEEeecCCCccccCchHHHHHHH
Confidence 555532 2223455889999999888888776666655 778885 8885 7778764 444
Q ss_pred cccccccccccccccc--ccccCCCccccc-ccccceEEeCCCcccc-cccccccCCCCccEEecCCccccCC-cCcccc
Q 042568 471 ELSKMDMVLAIDLSFN--NLSGSIPPQLGS-CIALESLNLSGNSLEG-LLPVSVGQLPYLKQFDVSSNRLFGE-IPQSFQ 545 (983)
Q Consensus 471 ~~~~l~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~ 545 (983)
.+.++++|+.|+|++| .+++..+..++. +++|+.|+|++|++++ .++..+..+++|+.|++++|++++. ++..+.
T Consensus 431 ~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 510 (592)
T 3ogk_B 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVT 510 (592)
T ss_dssp HHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHH
T ss_pred HHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHH
Confidence 5778999999999854 477666666654 8899999999999987 3556668899999999999998755 455566
Q ss_pred CCCCcceEeccCCccccc
Q 042568 546 ASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 546 ~l~~L~~l~l~~N~l~~~ 563 (983)
.+++|++|++++|+++..
T Consensus 511 ~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 511 KLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HCSSCCEEEEESCBCCTT
T ss_pred hcCccCeeECcCCcCCHH
Confidence 899999999999998754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-29 Score=275.64 Aligned_cols=255 Identities=23% Similarity=0.253 Sum_probs=161.9
Q ss_pred cccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccC-CCCchhhhc-------ccccccEEeccCcccccccCCc
Q 042568 97 LANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL-QGKIPSQLG-------SLHQLEYLDLGNNKLVGEIPIP 168 (983)
Q Consensus 97 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l-~~~~p~~~~-------~L~~L~~L~Ls~N~l~~~~p~~ 168 (983)
++..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 34455666666666666 555555443 66666666666 334555554 5666666666666666666655
Q ss_pred ccccCCCcccceeecccccccCCCCCcccccc-----cccceeecccCccccccchhhhccCCcceeccccccccccc--
Q 042568 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL-----RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGEL-- 241 (983)
Q Consensus 169 ~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l-----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-- 241 (983)
++ ...+++|++|+|++|++++. | ..+..+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+.+
T Consensus 115 ~~-~~~l~~L~~L~Ls~N~l~~~-~-~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 191 (312)
T 1wwl_A 115 LL-EATGPDLNILNLRNVSWATR-D-AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191 (312)
T ss_dssp SS-SCCSCCCSEEEEESCBCSSS-S-SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred HH-HhcCCCccEEEccCCCCcch-h-HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence 42 23566666666666666654 3 333344 67777777777777666677777777777777777765442
Q ss_pred chh-hhcCCCCccEEEccccccccCCCCCCCcccc-cccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccc
Q 042568 242 PSE-IISKMPQLQFLYLSYNDFVSHDGNTNLEPFF-ASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLI 319 (983)
Q Consensus 242 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~-~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l 319 (983)
+.. .+..+++|++|+|++|++... ...+ ..+..+++|++|++++|++++..|.......++|++|+|++|.+
T Consensus 192 ~~~~~~~~l~~L~~L~L~~N~l~~~------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 265 (312)
T 1wwl_A 192 ISALCPLKFPTLQVLALRNAGMETP------SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265 (312)
T ss_dssp HHHSCTTSCTTCCEEECTTSCCCCH------HHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC
T ss_pred HHHHHhccCCCCCEEECCCCcCcch------HHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc
Confidence 222 236677777777777766421 1111 12345677777777777777766433333235788888888888
Q ss_pred cccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccC
Q 042568 320 YGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369 (983)
Q Consensus 320 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 369 (983)
+ .+|..+. ++|++|+|++|++++. |. +..+++|++|+|++|.+++
T Consensus 266 ~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 266 K-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp S-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred C-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 7 6677666 7788888888888755 55 7778888888888888774
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=275.92 Aligned_cols=248 Identities=25% Similarity=0.270 Sum_probs=186.0
Q ss_pred CccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCC
Q 042568 251 QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNL 330 (983)
Q Consensus 251 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l 330 (983)
..+.++.+++.++.++ ..+. +++++|+|++|++++..|..+..+ ++|++|+|++|.+++..|..|..+
T Consensus 55 ~~~~v~c~~~~l~~iP---------~~~~--~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l 122 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVP---------QGIP--SNTRYLNLMENNIQMIQADTFRHL-HHLEVLQLGRNSIRQIEVGAFNGL 122 (452)
T ss_dssp SSCEEECCSSCCSSCC---------SCCC--TTCSEEECCSSCCCEECTTTTTTC-TTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCcEEEECCCCcCccC---------CCCC--CCccEEECcCCcCceECHHHcCCC-CCCCEEECCCCccCCcChhhccCc
Confidence 4578888888776543 2222 689999999999999889989888 589999999999999989999999
Q ss_pred CcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCc-cccCcCcccccCcccchhhc
Q 042568 331 VNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN-KLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 331 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~ 409 (983)
++|++|+|++|++++..+..+..+++|++|+|++|.+....+..|..+++|+.|+|++| .+....+..|.++++|+.|+
T Consensus 123 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 202 (452)
T 3zyi_A 123 ASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202 (452)
T ss_dssp TTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEE
Confidence 99999999999999877788999999999999999999888889999999999999994 55544445677788888888
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
|++|++++ +| .+..+++|+.|+|++|++++..|..|.++++|+. |++++|++++..|..|..+++|+.|+|++|+|+
T Consensus 203 L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 203 LGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKK-LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp CTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCE-EECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCE-EEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence 88888774 34 3666777777777777777666666666666664 666666665555555555555555555555555
Q ss_pred cCCCcccccccccceEEeCCCccc
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLE 513 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~ 513 (983)
+..+..|..+++|+.|+|++|++.
T Consensus 280 ~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 280 SLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ccChHHhccccCCCEEEccCCCcC
Confidence 433444444455555555555443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=277.67 Aligned_cols=223 Identities=25% Similarity=0.285 Sum_probs=148.9
Q ss_pred ccEEeccccccC-CCCCcccc-------cCCCCcEEEeeCCcccCCCCCCC--CCCCCCcEEEccCccccCcCcccccCc
Q 042568 333 LTLLNLSSNLLN-GTIPHELC-------LMSKLERVYLSNNSLSGEIPSAF--GDIPHLGLLDLSKNKLSGSIPDSFANL 402 (983)
Q Consensus 333 L~~L~Ls~N~l~-~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l 402 (983)
|+.|+|++|+++ +.+|..+. .+++|++|+|++|.+++.+|..+ +.+++|+.|+|++|++++. |..++.+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 455555555552 23343333 45666666666666666566554 6666666666666666655 5555555
Q ss_pred -----ccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc--CCccc--cCCCccceeccccCCCCCC--CCc-c
Q 042568 403 -----SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI--IPSDV--AGLRSLKLYLNLSSNHLDG--PLP-L 470 (983)
Q Consensus 403 -----~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~~L~l~~N~l~~--~~p-~ 470 (983)
++|++|++++|++++..|..|+.+++|++|+|++|++.+. .|..+ ..+++|+. |++++|++++ .++ .
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~ 222 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV-LALRNAGMETPSGVCSA 222 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCE-EECTTSCCCCHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCE-EECCCCcCcchHHHHHH
Confidence 6666666666666666656666677777777777766544 22233 56666764 7777777763 122 2
Q ss_pred ccccccccccccccccccccCCC-cccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCC
Q 042568 471 ELSKMDMVLAIDLSFNNLSGSIP-PQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549 (983)
Q Consensus 471 ~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 549 (983)
.+..+++|+.|||++|++++.+| ..+..+++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++
T Consensus 223 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~ 297 (312)
T 1wwl_A 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQ 297 (312)
T ss_dssp HHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCE
T ss_pred HHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCC
Confidence 34566788888888888887665 45566788888888888888 6777666 7888888888888855 66 888888
Q ss_pred cceEeccCCcccc
Q 042568 550 LKQLNFSFNKFSG 562 (983)
Q Consensus 550 L~~l~l~~N~l~~ 562 (983)
|++|++++|++++
T Consensus 298 L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 298 VGNLSLKGNPFLD 310 (312)
T ss_dssp EEEEECTTCTTTC
T ss_pred CCEEeccCCCCCC
Confidence 9999999988875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=274.18 Aligned_cols=248 Identities=27% Similarity=0.300 Sum_probs=202.7
Q ss_pred CccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCC
Q 042568 251 QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNL 330 (983)
Q Consensus 251 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l 330 (983)
..+.++.+++.+..++ ..+. ++++.|+|++|++++..+..+..+ ++|++|+|++|.+++..+..|.++
T Consensus 44 ~~~~v~c~~~~l~~iP---------~~~~--~~l~~L~L~~n~i~~~~~~~~~~l-~~L~~L~Ls~n~i~~i~~~~~~~l 111 (440)
T 3zyj_A 44 QFSKVICVRKNLREVP---------DGIS--TNTRLLNLHENQIQIIKVNSFKHL-RHLEILQLSRNHIRTIEIGAFNGL 111 (440)
T ss_dssp TSCEEECCSCCCSSCC---------SCCC--TTCSEEECCSCCCCEECTTTTSSC-SSCCEEECCSSCCCEECGGGGTTC
T ss_pred CCCEEEeCCCCcCcCC---------CCCC--CCCcEEEccCCcCCeeCHHHhhCC-CCCCEEECCCCcCCccChhhccCC
Confidence 4678888888776543 2332 689999999999998888888888 589999999999998888899999
Q ss_pred CcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCc-cccCcCcccccCcccchhhc
Q 042568 331 VNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN-KLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 331 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~ 409 (983)
++|++|+|++|+++...+..+..+++|++|+|++|.+....+..|..+++|+.|+|++| .+....+..|.++++|+.|+
T Consensus 112 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~ 191 (440)
T 3zyj_A 112 ANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191 (440)
T ss_dssp SSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEE
T ss_pred ccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeec
Confidence 99999999999999777778999999999999999999888889999999999999995 55545556899999999999
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
|++|.++ .+| .+..+++|+.|+|++|++++..|..|.++++|+. |+|++|++++..|..|.++++|+.|||++|+|+
T Consensus 192 L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK-LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp CTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCE-EECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred CCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCE-EECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 9999998 566 4788889999999999998877888888887775 777777777666666666666666666666666
Q ss_pred cCCCcccccccccceEEeCCCccc
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLE 513 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~ 513 (983)
+..+..|..+++|+.|+|++|++.
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ccChhHhccccCCCEEEcCCCCcc
Confidence 554555556666666666666654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=269.36 Aligned_cols=270 Identities=24% Similarity=0.250 Sum_probs=180.8
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEec
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~L 156 (983)
.+....+++.+.+...+...+..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..| ++.+++|++|+|
T Consensus 10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~L 87 (317)
T 3o53_A 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDL 87 (317)
T ss_dssp TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEEC
T ss_pred CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEEC
Confidence 345666666666655555555666778888888888877666778888888888888888875444 777888888888
Q ss_pred cCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccc
Q 042568 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236 (983)
Q Consensus 157 s~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 236 (983)
++|++++ +| ..++|++|++++|.+++..+. .+++|++|++++|++++..|..++.+++|++|+|++|+
T Consensus 88 s~n~l~~-l~-------~~~~L~~L~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 155 (317)
T 3o53_A 88 NNNYVQE-LL-------VGPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155 (317)
T ss_dssp CSSEEEE-EE-------ECTTCCEEECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred cCCcccc-cc-------CCCCcCEEECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence 8887763 22 236677777777777643321 35666777777777766666666666666666666666
Q ss_pred cccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccC
Q 042568 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316 (983)
Q Consensus 237 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~ 316 (983)
+++..+..+...+++|++|+|++|.+
T Consensus 156 l~~~~~~~~~~~l~~L~~L~L~~N~l------------------------------------------------------ 181 (317)
T 3o53_A 156 IDTVNFAELAASSDTLEHLNLQYNFI------------------------------------------------------ 181 (317)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCC------------------------------------------------------
T ss_pred CCcccHHHHhhccCcCCEEECCCCcC------------------------------------------------------
Confidence 66433333333344444444444332
Q ss_pred ccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCcccc-CcC
Q 042568 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS-GSI 395 (983)
Q Consensus 317 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~ 395 (983)
++. | ....+++|++|+|++|++++ +|..+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|++. +.+
T Consensus 182 ---~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 182 ---YDV-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp ---CEE-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHH
T ss_pred ---ccc-c-cccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCH
Confidence 211 1 11235667777777777774 3445777788888888888887 46777888899999999999998 778
Q ss_pred cccccCcccchhhcccC-ccCCCCCcc
Q 042568 396 PDSFANLSQLRRLLLYG-NHLSGTIPS 421 (983)
Q Consensus 396 ~~~~~~l~~L~~L~l~~-N~l~~~~p~ 421 (983)
|..+..+++|+.|++++ +.++|..|.
T Consensus 255 ~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 255 RDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHHhccccceEEECCCchhccCCchh
Confidence 88888999999999984 456555443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=274.57 Aligned_cols=269 Identities=25% Similarity=0.326 Sum_probs=148.1
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccce
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQY 180 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~ 180 (983)
..+++|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+++ .+|. .+++|++
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~------~l~~L~~ 105 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV------LPPGLLE 105 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC------CCTTCCE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC------CCCCCCE
Confidence 46889999999998 7887776 78999999999988 6666 5788888888888887 4554 3456666
Q ss_pred eecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEcccc
Q 042568 181 IDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260 (983)
Q Consensus 181 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 260 (983)
|+|++|.+++ +|. .+++| ++|++++|+++ .+|.. +++|++|+|++|
T Consensus 106 L~Ls~N~l~~-l~~----~l~~L------------------------~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N 151 (622)
T 3g06_A 106 LSIFSNPLTH-LPA----LPSGL------------------------CKLWIFGNQLT-SLPVL----PPGLQELSVSDN 151 (622)
T ss_dssp EEECSCCCCC-CCC----CCTTC------------------------CEEECCSSCCS-CCCCC----CTTCCEEECCSS
T ss_pred EECcCCcCCC-CCC----CCCCc------------------------CEEECCCCCCC-cCCCC----CCCCCEEECcCC
Confidence 6666666553 222 23444 44444444444 23321 234444444444
Q ss_pred ccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccc
Q 042568 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS 340 (983)
Q Consensus 261 ~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 340 (983)
++..++. ..++|+.|++++|++++ +| ...++|+.|++++|.+++ +|.. +++|+.|++++
T Consensus 152 ~l~~l~~------------~~~~L~~L~L~~N~l~~-l~----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~ 210 (622)
T 3g06_A 152 QLASLPA------------LPSELCKLWAYNNQLTS-LP----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYN 210 (622)
T ss_dssp CCSCCCC------------CCTTCCEEECCSSCCSC-CC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred cCCCcCC------------ccCCCCEEECCCCCCCC-Cc----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcC
Confidence 4332110 11334444444444442 22 112345555555555542 2322 23444555555
Q ss_pred cccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCc
Q 042568 341 NLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIP 420 (983)
Q Consensus 341 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 420 (983)
|.++ .+| . .+++|+.|+|++|+|++ +| ..+++|+.|++++|.|+ .+|
T Consensus 211 N~l~-~l~------------------------~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp 257 (622)
T 3g06_A 211 NRLT-SLP------------------------A---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257 (622)
T ss_dssp SCCS-SCC------------------------C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC
T ss_pred Cccc-ccC------------------------C---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC
Confidence 5444 222 2 12445555555555553 33 23345555555555555 344
Q ss_pred ccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccc
Q 042568 421 SSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMD 476 (983)
Q Consensus 421 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~ 476 (983)
. .+++|+.|+|++|+|+ .+|..+..+++|+. |+|++|.+++.+|..+..++
T Consensus 258 ~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~-L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 258 M---LPSGLLSLSVYRNQLT-RLPESLIHLSSETT-VNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp C---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCE-EECCSCCCCHHHHHHHHHHH
T ss_pred c---ccccCcEEeCCCCCCC-cCCHHHhhccccCE-EEecCCCCCCcCHHHHHhcc
Confidence 3 3455666666666666 45666666666664 66666666666665555443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=268.46 Aligned_cols=249 Identities=24% Similarity=0.192 Sum_probs=147.0
Q ss_pred cccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccc
Q 042568 197 ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFA 276 (983)
Q Consensus 197 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 276 (983)
+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+ +..+++|++|+|++|++...
T Consensus 30 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l----------- 95 (317)
T 3o53_A 30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQEL----------- 95 (317)
T ss_dssp HTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEE-----------
T ss_pred hccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCccccc-----------
Confidence 3456678888888888887777788888888888888888875433 67777777877777776432
Q ss_pred ccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccc-cCC
Q 042568 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC-LMS 355 (983)
Q Consensus 277 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~ 355 (983)
...++|++|++++|++++..+..+ ++|++|++++|.+++..|..+..+++|++|++++|.+++..+..+. .++
T Consensus 96 --~~~~~L~~L~l~~n~l~~~~~~~~----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 169 (317)
T 3o53_A 96 --LVGPSIETLHAANNNISRVSCSRG----QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169 (317)
T ss_dssp --EECTTCCEEECCSSCCSEEEECCC----SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTT
T ss_pred --cCCCCcCEEECCCCccCCcCcccc----CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccC
Confidence 223566777777776665443321 3466666666666655555666666666666666666655444442 455
Q ss_pred CCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEcc
Q 042568 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLS 435 (983)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 435 (983)
+|++|+|++|.+++..+ ...+++|+.|+|++|++++ +|..+..+++|+.|+|+
T Consensus 170 ~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-------------------------l~~~~~~l~~L~~L~L~ 222 (317)
T 3o53_A 170 TLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-------------------------MGPEFQSAAGVTWISLR 222 (317)
T ss_dssp TCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-------------------------ECGGGGGGTTCSEEECT
T ss_pred cCCEEECCCCcCccccc--ccccccCCEEECCCCcCCc-------------------------chhhhcccCcccEEECc
Confidence 56666666665554311 2224555555555555543 22234444555555555
Q ss_pred CccccCcCCccccCCCccceeccccCCCCC-CCCcccccccccccccccc-ccccccCCCc
Q 042568 436 HNKISGIIPSDVAGLRSLKLYLNLSSNHLD-GPLPLELSKMDMVLAIDLS-FNNLSGSIPP 494 (983)
Q Consensus 436 ~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~ 494 (983)
+|+++ .+|..+..+++|+. |++++|.++ +.+|.++..++.|+.|+++ .+.+.|..|.
T Consensus 223 ~N~l~-~l~~~~~~l~~L~~-L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 223 NNKLV-LIEKALRFSQNLEH-FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp TSCCC-EECTTCCCCTTCCE-EECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred CCccc-chhhHhhcCCCCCE-EEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 55554 23444455555553 555555555 4455566666666667766 3345555444
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=282.94 Aligned_cols=185 Identities=16% Similarity=0.052 Sum_probs=130.5
Q ss_pred cccCCcEeEEEEE-ECCCcEEEEEEeecccC---------cchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEEE
Q 042568 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT---------GEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 675 iG~G~~g~Vy~~~-~~~~~~vAvK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 743 (983)
.+.|+.|.+..++ .-.|+.||||++..... +...++|.+|+++|+++ .|+||+++++++.+....||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666655 33588999999965421 12346799999999999 7999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++|++|.+++... .+++.. +|+.||++||+|+|++| ||||||||+|||+++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999753 345543 58999999999999997 99999999999999999999999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
.. ......+||++|||||++.+. +..++|+||+|++.+++.++..|
T Consensus 392 ~~-------------~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC-------------SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC-------------ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 21 122346899999999998764 56789999999998888766554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-30 Score=313.51 Aligned_cols=465 Identities=12% Similarity=0.089 Sum_probs=249.9
Q ss_pred CcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCC---CCcc------------ccCCCCCCC
Q 042568 64 VCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQG---HIPA------------ELGSLIRLK 128 (983)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~---~~p~------------~~~~l~~L~ 128 (983)
|++|.++.. .....+++..+... .....+..+++|++|+|++|.... ..|. ....+++|+
T Consensus 34 ck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 557988821 12345555544321 222356788999999999975321 2222 234678999
Q ss_pred EEeccCccCCCCchhhhc-ccccccEEeccCc-ccccc-cCCcccccCCCcccceeecccccccCCCCC---cccccccc
Q 042568 129 QLSLSWNSLQGKIPSQLG-SLHQLEYLDLGNN-KLVGE-IPIPIFCSNSSTSLQYIDLSNNSLTGEIPL---KNECELRN 202 (983)
Q Consensus 129 ~L~Ls~n~l~~~~p~~~~-~L~~L~~L~Ls~N-~l~~~-~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~---~~~~~l~~ 202 (983)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++. +. ..+++|++|+|++|.+++..+. .....+++
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~--~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA-IA--ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHH-HH--HHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHH-HH--HhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 999999999987787776 6899999999999 55432 222 21 3578999999999987754321 12235678
Q ss_pred cceeecccCc--ccc-ccchhhhccCCcceeccccc-ccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 203 LRFLLLWSNR--LVG-QVPQALANSSKLEWLDLESN-MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 203 L~~L~L~~N~--l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
|++|++++|. +.. .++..+.++++|++|+|++| .+. .++ ..+..+++|++|+++.+...- ....+..+...+
T Consensus 186 L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~-~~~~~~~~L~~L~l~~~~~~~--~~~~~~~l~~~l 261 (594)
T 2p1m_B 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLA-TLLQRAPQLEELGTGGYTAEV--RPDVYSGLSVAL 261 (594)
T ss_dssp CCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHH-HHHHHCTTCSEEECSBCCCCC--CHHHHHHHHHHH
T ss_pred CcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHH-HHHhcCCcceEcccccccCcc--chhhHHHHHHHH
Confidence 9999999886 321 12223355689999999988 454 344 456778899999876553100 001122233456
Q ss_pred CCCCCccEE-EccCCcccccCCccccccccCeeEEEccCccccccCC-CCCCCCCcccEEeccccccCCC-CCcccccCC
Q 042568 279 ANSSNFQEL-ELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIP-PHISNLVNLTLLNLSSNLLNGT-IPHELCLMS 355 (983)
Q Consensus 279 ~~l~~L~~L-~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~ 355 (983)
.++++|+.| .+.+... +.++..+..+ ++|++|+|++|.+++... ..+..+++|++|++++| ++.. ++.....++
T Consensus 262 ~~~~~L~~Ls~~~~~~~-~~l~~~~~~~-~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 262 SGCKELRCLSGFWDAVP-AYLPAVYSVC-SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp HTCTTCCEEECCBTCCG-GGGGGGHHHH-TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred hcCCCcccccCCcccch-hhHHHHHHhh-CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 677777777 3333222 1233322222 356666666666543221 12345556666666655 3211 111122355
Q ss_pred CCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCccccc-CcccchhhcccCccCCCCCccccc-CCCCCCEEE
Q 042568 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA-NLSQLRRLLLYGNHLSGTIPSSLG-KCVNLEILD 433 (983)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~ 433 (983)
+|++|+++++.-.| ..+.|.+++.....+. .+++|+.|.++.|.+++..+..+. .+++|+.|+
T Consensus 339 ~L~~L~L~~~~~~g---------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~ 403 (594)
T 2p1m_B 339 DLRELRVFPSEPFV---------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFR 403 (594)
T ss_dssp TCCEEEEECSCTTC---------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCEEEEecCcccc---------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeE
Confidence 55666553321000 0012222222111121 244444444444444433333332 345555555
Q ss_pred cc--C----ccccCcC-----CccccCCCccceeccccCCCCCCCCcccccc-ccccccccccccccccCCCccc-cccc
Q 042568 434 LS--H----NKISGII-----PSDVAGLRSLKLYLNLSSNHLDGPLPLELSK-MDMVLAIDLSFNNLSGSIPPQL-GSCI 500 (983)
Q Consensus 434 Ls--~----N~l~~~~-----p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~ 500 (983)
++ + |.+++.. +..+..+++|+. |++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..++
T Consensus 404 L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~-L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 481 (594)
T 2p1m_B 404 LCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRR-LSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCD 481 (594)
T ss_dssp EEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCE-EECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCT
T ss_pred eecccCCCcccccCCchhhHHHHHHhhCCCccE-EeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCC
Confidence 55 2 3333111 111334445553 55544 444333333333 5566666666666654444444 4566
Q ss_pred ccceEEeCCCcccccccc-cccCCCCccEEecCCccccCCcCccc-cCCCCcceEeccCCcc
Q 042568 501 ALESLNLSGNSLEGLLPV-SVGQLPYLKQFDVSSNRLFGEIPQSF-QASPTLKQLNFSFNKF 560 (983)
Q Consensus 501 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~l~l~~N~l 560 (983)
+|+.|+|++|++++.... .+..+++|+.|++++|+++......+ ..+++|+...+..+..
T Consensus 482 ~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 482 SLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp TCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred CcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 777777777777543333 23446677777777776643323333 3456666555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-27 Score=276.81 Aligned_cols=233 Identities=22% Similarity=0.262 Sum_probs=137.5
Q ss_pred eeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC
Q 042568 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 309 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (983)
|++|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .++|+.|+|++
T Consensus 36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~ 108 (487)
T 3oja_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAAN 108 (487)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCS
T ss_pred ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcC
Confidence 4444444444444333444444444444444444443332 4444444444444444443221 14455555555
Q ss_pred ccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCcccc-CCCccceeccccCCCCCCC
Q 042568 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVA-GLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~~L~l~~N~l~~~ 467 (983)
|.+++..+.. +++|+.|+|++|.+++..|..++.+++|+.|+|++|++++.+|..+. .+++|+. |+|++|.|++.
T Consensus 109 N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~-L~Ls~N~l~~~ 184 (487)
T 3oja_A 109 NNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH-LNLQYNFIYDV 184 (487)
T ss_dssp SCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE-EECTTSCCCEE
T ss_pred CcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccE-EecCCCccccc
Confidence 5555433322 34455555555555554455555555555555555555555555543 4555553 55666655543
Q ss_pred CccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc-CCcCccccC
Q 042568 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF-GEIPQSFQA 546 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~ 546 (983)
.+ +..+++|+.|+|++|+|++ +|+.+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++. +.+|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 22 2246677788888888875 44558888888888888888885 6777888888999999999887 677788888
Q ss_pred CCCcceEecc
Q 042568 547 SPTLKQLNFS 556 (983)
Q Consensus 547 l~~L~~l~l~ 556 (983)
++.|+.++++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 8888877775
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=241.00 Aligned_cols=228 Identities=22% Similarity=0.254 Sum_probs=138.6
Q ss_pred EEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccc
Q 042568 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391 (983)
Q Consensus 312 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (983)
++..+..+. .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++|++
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 444444444 4454442 3566666666666655555566666666666666666655555566666666666666666
Q ss_pred cCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccc
Q 042568 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE 471 (983)
Q Consensus 392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~ 471 (983)
++..+..|.++++|+.|++++|.+++..+..+..+++|++|++++|++++. .+|..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~~ 144 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPEY 144 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCchh
Confidence 555555555555555555555555544443445555555555555554432 23555
Q ss_pred cccccccccccccccccccCCCcccccccccc----eEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCC
Q 042568 472 LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALE----SLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS 547 (983)
Q Consensus 472 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 547 (983)
+..+++|+.|+|++|++++..+..+..+.+|+ .|++++|++++..+..+. ..+|+.|++++|++++..+..|..+
T Consensus 145 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l 223 (276)
T 2z62_A 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRL 223 (276)
T ss_dssp GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTC
T ss_pred hccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhccc
Confidence 55555666666666666655555565555555 778888888765554444 3478888888888886656667888
Q ss_pred CCcceEeccCCccccccCCC
Q 042568 548 PTLKQLNFSFNKFSGNISNK 567 (983)
Q Consensus 548 ~~L~~l~l~~N~l~~~~~~~ 567 (983)
++|++|++++|++++..+..
T Consensus 224 ~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 224 TSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CSCCEEECCSSCBCCCTTTT
T ss_pred ccccEEEccCCcccccCCch
Confidence 88888888888888776643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=237.71 Aligned_cols=231 Identities=24% Similarity=0.256 Sum_probs=187.8
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeC
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 364 (983)
..++.++.+++ .+|..+ +.+|++|++++|.+++..+..+.++++|++|++++|++++..+..+..+++|++|+|++
T Consensus 10 ~~~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 85 (276)
T 2z62_A 10 ITYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (276)
T ss_dssp TEEECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ceEEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence 35677777776 455543 46799999999999988888999999999999999999988788899999999999999
Q ss_pred CcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCC-CcccccCCCCCCEEEccCccccCcC
Q 042568 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT-IPSSLGKCVNLEILDLSHNKISGII 443 (983)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~ 443 (983)
|.+++..+..|..+++|+.|++++|++.+..+..+..+++|+.|++++|.+++. +|..+..+++|+.|++++|++++..
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~ 165 (276)
T 2z62_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165 (276)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence 999999889999999999999999999988887899999999999999999864 6899999999999999999998776
Q ss_pred CccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCC
Q 042568 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL 523 (983)
Q Consensus 444 p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 523 (983)
+..+..+..++. +++ .|++++|++++..+..+. ..+|+.|+|++|++++..+..+..+
T Consensus 166 ~~~~~~l~~L~~-l~l--------------------~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l 223 (276)
T 2z62_A 166 CTDLRVLHQMPL-LNL--------------------SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRL 223 (276)
T ss_dssp GGGGHHHHTCTT-CCE--------------------EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTC
T ss_pred HHHhhhhhhccc-cce--------------------eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhccc
Confidence 666655554442 110 466666666644343333 3478888888888886666667778
Q ss_pred CCccEEecCCccccCCcC
Q 042568 524 PYLKQFDVSSNRLFGEIP 541 (983)
Q Consensus 524 ~~L~~L~ls~N~l~~~~p 541 (983)
++|+.|++++|++++..|
T Consensus 224 ~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 224 TSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CSCCEEECCSSCBCCCTT
T ss_pred ccccEEEccCCcccccCC
Confidence 888888888888876543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-28 Score=294.70 Aligned_cols=422 Identities=15% Similarity=0.104 Sum_probs=269.4
Q ss_pred eEEEEEcccCCccccc---------------ccccccCCCCcEEeCcCCcCCCCCccccC-CCCCCCEEeccCc-cCCCC
Q 042568 78 KVVELDLSARSIYGTI---------------SPALANLSSLIVLDLSKNFFQGHIPAELG-SLIRLKQLSLSWN-SLQGK 140 (983)
Q Consensus 78 ~v~~l~l~~~~l~g~~---------------~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~n-~l~~~ 140 (983)
++..|+++++.....+ +.....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++..
T Consensus 67 ~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~ 146 (594)
T 2p1m_B 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD 146 (594)
T ss_dssp TCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHH
T ss_pred CceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHH
Confidence 4788888876432111 12245788999999999999987777775 6899999999999 66532
Q ss_pred -chhhhcccccccEEeccCcccccccCCccccc-CCCcccceeecccccccCCCCCccc----ccccccceeecccC-cc
Q 042568 141 -IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCS-NSSTSLQYIDLSNNSLTGEIPLKNE----CELRNLRFLLLWSN-RL 213 (983)
Q Consensus 141 -~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~-~~l~~L~~L~Ls~N~l~~~ip~~~~----~~l~~L~~L~L~~N-~l 213 (983)
++..+.++++|++|+|++|.+++..+..+..+ ..+++|++|++++|. +.++...+ ..+++|++|++++| .+
T Consensus 147 ~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~~~~ 224 (594)
T 2p1m_B 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRAVPL 224 (594)
T ss_dssp HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTTSCH
T ss_pred HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCCCcH
Confidence 55666689999999999999886554444322 367899999999997 23332222 34699999999999 44
Q ss_pred ccccchhhhccCCcceecc-------cccccccccchhhhcCCCCccEE-EccccccccCCCCCCCcccccccCCCCCcc
Q 042568 214 VGQVPQALANSSKLEWLDL-------ESNMFSGELPSEIISKMPQLQFL-YLSYNDFVSHDGNTNLEPFFASLANSSNFQ 285 (983)
Q Consensus 214 ~~~~p~~l~~l~~L~~L~L-------s~N~l~~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~ 285 (983)
.+ +|..+..+++|++|++ +.|.+. .++. .+..+++|+.| .+..... ..+...+..+++|+
T Consensus 225 ~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~-~l~~~~~L~~Ls~~~~~~~---------~~l~~~~~~~~~L~ 292 (594)
T 2p1m_B 225 EK-LATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSV-ALSGCKELRCLSGFWDAVP---------AYLPAVYSVCSRLT 292 (594)
T ss_dssp HH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHH-HHHTCTTCCEEECCBTCCG---------GGGGGGHHHHTTCC
T ss_pred HH-HHHHHhcCCcceEcccccccCccchhhHH-HHHH-HHhcCCCcccccCCcccch---------hhHHHHHHhhCCCC
Confidence 54 8899999999999994 455565 3444 46889999999 3433221 12233344678999
Q ss_pred EEEccCCcccccCCcc-ccccccCeeEEEccCcccccc-CCCCCCCCCcccEEeccc---------cccCCCCCcccc-c
Q 042568 286 ELELAGNNLGGMIPSI-IGDLSTNLVQIHLDCNLIYGK-IPPHISNLVNLTLLNLSS---------NLLNGTIPHELC-L 353 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~-~~~l~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~---------N~l~~~~p~~l~-~ 353 (983)
+|++++|.+++..... +..+ ++|++|++++| +.+. ++.....+++|++|++++ +.+++.....+. .
T Consensus 293 ~L~L~~~~l~~~~l~~~~~~~-~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~ 370 (594)
T 2p1m_B 293 TLNLSYATVQSYDLVKLLCQC-PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG 370 (594)
T ss_dssp EEECTTCCCCHHHHHHHHTTC-TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHH
T ss_pred EEEccCCCCCHHHHHHHHhcC-CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHh
Confidence 9999999987543333 3344 68999999998 4432 222233578999999954 444433222232 3
Q ss_pred CCCCcEEEeeCCcccCCCCCCCC-CCCCCcEEEcc--C----ccccCcCcccccCcccchhhcccCccCCCCCcccccCC
Q 042568 354 MSKLERVYLSNNSLSGEIPSAFG-DIPHLGLLDLS--K----NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKC 426 (983)
Q Consensus 354 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 426 (983)
+++|+.|.++.|.+++..+..+. .+++|+.|+|+ + |.+++...+ ..++..+..+
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~-------------------~~~~~l~~~~ 431 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD-------------------IGFGAIVEHC 431 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH-------------------HHHHHHHHHC
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh-------------------hHHHHHHhhC
Confidence 67777777777777654443343 36667777776 2 333311100 0011123445
Q ss_pred CCCCEEEccCccccCcCCccccC-CCccceeccccCCCCCCCCcccc-ccccccccccccccccccCCCc-ccccccccc
Q 042568 427 VNLEILDLSHNKISGIIPSDVAG-LRSLKLYLNLSSNHLDGPLPLEL-SKMDMVLAIDLSFNNLSGSIPP-QLGSCIALE 503 (983)
Q Consensus 427 ~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~~L~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~ 503 (983)
++|+.|+|++ .+++..+..+.. +++|+. |++++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|+
T Consensus 432 ~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~-L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~ 509 (594)
T 2p1m_B 432 KDLRRLSLSG-LLTDKVFEYIGTYAKKMEM-LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR 509 (594)
T ss_dssp TTCCEEECCS-SCCHHHHHHHHHHCTTCCE-EEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred CCccEEeecC-cccHHHHHHHHHhchhccE-eeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence 5566666655 444333333333 555554 6666666654434333 4567777777777777544333 334577888
Q ss_pred eEEeCCCcccccccccc-cCCCCccEEecCCccc
Q 042568 504 SLNLSGNSLEGLLPVSV-GQLPYLKQFDVSSNRL 536 (983)
Q Consensus 504 ~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l 536 (983)
.|++++|+++......+ ..+++|+...+..+.-
T Consensus 510 ~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 510 SLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp EEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred EEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 88888888754433334 4567777766666543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.9e-24 Score=227.37 Aligned_cols=205 Identities=25% Similarity=0.305 Sum_probs=124.8
Q ss_pred cccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
+.+.+++++|+++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|+++...+..|.++++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 4566777777776 3454332 456666666666665555566666666666666666654444444555555555555
Q ss_pred CccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccC
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 491 (983)
+|.+++..+..|..+++|++|++++| ++++..|..|..+++|++|+|++|+|++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n-------------------------~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 148 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRN-------------------------QLKSLPPRVFDSLTKLTYLSLGYNELQSL 148 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSS-------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCC-------------------------ccCeeCHHHhCcCcCCCEEECCCCcCCcc
Confidence 55555433344444444555555444 44444444455555666666666666644
Q ss_pred CCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcccccc
Q 042568 492 IPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNI 564 (983)
Q Consensus 492 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 564 (983)
.+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|++++|++.+..
T Consensus 149 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 4445666777777777777777666666777777777777777777555556777777777777777766543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-23 Score=224.92 Aligned_cols=203 Identities=25% Similarity=0.288 Sum_probs=158.9
Q ss_pred cCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEc
Q 042568 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDL 386 (983)
Q Consensus 307 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 386 (983)
...+.+++++|.++ .+|..+. ++|++|+|++|++++..+..+..+++|++|+|++|.++...+..|..+++|++|+|
T Consensus 16 ~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l 92 (270)
T 2o6q_A 16 NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92 (270)
T ss_dssp TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence 35778999999998 5777664 68999999999999877778999999999999999999877778899999999999
Q ss_pred cCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCC
Q 042568 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 387 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 466 (983)
++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+. |++++|++++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~-L~L~~n~l~~ 171 (270)
T 2o6q_A 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE-LRLYNNQLKR 171 (270)
T ss_dssp CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCSC
T ss_pred CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccce-eEecCCcCcE
Confidence 999999888888999999999999999999888888999999999999999998766666777777775 7777766665
Q ss_pred CCccccccccccccccccccccccCCCcccccccccceEEeCCCccc
Q 042568 467 PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLE 513 (983)
Q Consensus 467 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 513 (983)
..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred eChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 44444555555555555555555333333444444444444444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-25 Score=259.16 Aligned_cols=193 Identities=17% Similarity=0.157 Sum_probs=147.7
Q ss_pred CCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-------chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 669 FCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-------EITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+...++||+|+||.||+|.. .++.+|+|........ ...+++.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567899999999999954 4788999986432211 124568999999999999999977777777788899
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+|+..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999874 4689999999999999996 999999999999999 9999999999987
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG--KRASTHGDVYSFGVLLLEIVTGRRPTD 885 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~SlG~il~elltg~~p~~ 885 (983)
........ ..........||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~------~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAV------DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHH------HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCcccccc------chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 54321100 00001234689999999999987 567888999999999999998888763
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=230.22 Aligned_cols=163 Identities=23% Similarity=0.269 Sum_probs=65.8
Q ss_pred CCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccc
Q 042568 375 FGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454 (983)
Q Consensus 375 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 454 (983)
+..+++|++|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+
T Consensus 81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160 (272)
T ss_dssp GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence 33344444444444444433333333334444444444444333333344444444444444444433333333333333
Q ss_pred eeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCc
Q 042568 455 LYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534 (983)
Q Consensus 455 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 534 (983)
. |++++|++++..+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++.+. +++|+.|+++.|
T Consensus 161 ~-L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n 232 (272)
T 3rfs_A 161 E-LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWIN 232 (272)
T ss_dssp E-EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHH
T ss_pred E-EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHH
Confidence 2 33333333333333333333444444444444433333344444444444444444321 223444444444
Q ss_pred cccCCcCcccc
Q 042568 535 RLFGEIPQSFQ 545 (983)
Q Consensus 535 ~l~~~~p~~~~ 545 (983)
+++|.+|.+++
T Consensus 233 ~~~g~ip~~~~ 243 (272)
T 3rfs_A 233 KHSGVVRNSAG 243 (272)
T ss_dssp HTGGGBBCTTS
T ss_pred hCCCcccCccc
Confidence 44444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.8e-24 Score=228.61 Aligned_cols=178 Identities=26% Similarity=0.254 Sum_probs=108.3
Q ss_pred CCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccc
Q 042568 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459 (983)
Q Consensus 380 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l 459 (983)
+++.|+|++|++++..+..|.++++|+.|+|++|.+++. +.. ..+++|++|++++|+++ .+|..+..+++|+. |++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~-L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTV-LDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCE-EEC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCE-EEC
Confidence 444444444444444444444455555555555554422 221 45555666666666665 44555555666654 666
Q ss_pred cCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCC
Q 042568 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539 (983)
Q Consensus 460 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 539 (983)
++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ 186 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-c
Confidence 666666555556666666666677777666555555666777777777777777655555667777777777777776 6
Q ss_pred cCccccCCCCcceEeccCCcccc
Q 042568 540 IPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 540 ~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
+|..+..+++|+.+++++|++.+
T Consensus 187 ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 187 IPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhhcccccCCeEEeCCCCccC
Confidence 67666667777777777776654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-25 Score=247.63 Aligned_cols=264 Identities=19% Similarity=0.182 Sum_probs=123.6
Q ss_pred EeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCch----hhhcccc-cccEEeccCcccccccCCcccc-cCC-Cccc
Q 042568 106 LDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIP----SQLGSLH-QLEYLDLGNNKLVGEIPIPIFC-SNS-STSL 178 (983)
Q Consensus 106 L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~-~~~-l~~L 178 (983)
++|+.|+++|.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|++++..+..+.. +.. .++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4455555555555555555555555555555554444 4455555 5555555555555333322220 000 0333
Q ss_pred ceeecccccccCCCCCc---ccccc-cccceeecccCccccccchhhhc-----cCCcceecccccccccccchhhhcCC
Q 042568 179 QYIDLSNNSLTGEIPLK---NECEL-RNLRFLLLWSNRLVGQVPQALAN-----SSKLEWLDLESNMFSGELPSEIISKM 249 (983)
Q Consensus 179 ~~L~Ls~N~l~~~ip~~---~~~~l-~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~~~~~~~~~~~l 249 (983)
++|+|++|.+++..+.. .+..+ ++|++|+|++|++++..+..+.. .++|++|+|++|++++..+.
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~------ 156 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD------ 156 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH------
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH------
Confidence 33333333333211110 11122 55666666666665555544433 14555666665555532111
Q ss_pred CCccEEEccccccccCCCCCCCcccccccCCCC-CccEEEccCCcccccCCccccc----cccCeeEEEccCcccccc--
Q 042568 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSS-NFQELELAGNNLGGMIPSIIGD----LSTNLVQIHLDCNLIYGK-- 322 (983)
Q Consensus 250 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~----l~~~L~~L~L~~N~l~~~-- 322 (983)
.+...+...+ +|++|+|++|++++..+..+.. .+++|++|+|++|.+++.
T Consensus 157 -----------------------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~ 213 (362)
T 3goz_A 157 -----------------------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY 213 (362)
T ss_dssp -----------------------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred -----------------------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH
Confidence 1122222222 4444444444444333322221 112455555555554431
Q ss_pred --CCCCCCC-CCcccEEeccccccCCCCC----cccccCCCCcEEEeeCCcccCC-------CCCCCCCCCCCcEEEccC
Q 042568 323 --IPPHISN-LVNLTLLNLSSNLLNGTIP----HELCLMSKLERVYLSNNSLSGE-------IPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 323 --~p~~l~~-l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~ 388 (983)
++..+.. .++|++|+|++|.+++..+ ..+..+++|++|+|++|.+.+. ++..+..+++|+.||+++
T Consensus 214 ~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~ 293 (362)
T 3goz_A 214 AELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNG 293 (362)
T ss_dssp HHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTS
T ss_pred HHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCC
Confidence 2223333 2356666666666654433 2234456666666666664432 234566777777777777
Q ss_pred ccccCcCccc
Q 042568 389 NKLSGSIPDS 398 (983)
Q Consensus 389 N~l~~~~~~~ 398 (983)
|++.+..+..
T Consensus 294 N~l~~~~~~~ 303 (362)
T 3goz_A 294 KEIHPSHSIP 303 (362)
T ss_dssp CBCCGGGCHH
T ss_pred CcCCCcchHH
Confidence 7776554433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=225.95 Aligned_cols=204 Identities=25% Similarity=0.249 Sum_probs=121.6
Q ss_pred eeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC
Q 042568 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 309 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (983)
|+.|++++|.++. .+.+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..|+.+++|++|+|++
T Consensus 43 L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 118 (272)
T 3rfs_A 43 IDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118 (272)
T ss_dssp CCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred eeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCC
Confidence 4444444444431 12345555666666666665542 2455566666666666666655555566666666666666
Q ss_pred ccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCC
Q 042568 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL 468 (983)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 468 (983)
|++++..+..|+.+++|+.|++++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+. |++++|++++..
T Consensus 119 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~L~~N~l~~~~ 197 (272)
T 3rfs_A 119 NQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKD-LRLYQNQLKSVP 197 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCSCCC
T ss_pred CcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCE-EECCCCcCCccC
Confidence 6666555555666666666666666666555555566666666666666666555555566666664 666666666655
Q ss_pred ccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCC
Q 042568 469 PLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLP 524 (983)
Q Consensus 469 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 524 (983)
|..+..+++|+.|+|++|.+.+. +++|+.|+++.|.++|.+|.+++.+.
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 198 DGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred HHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 55566666666666666666543 33466666677777777776666544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=225.53 Aligned_cols=201 Identities=23% Similarity=0.201 Sum_probs=110.0
Q ss_pred CCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhc
Q 042568 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 330 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+++++++++++|.++ .+|..+. ++++.|+|++|.+++..|..|..+++|+.|+|++|+|++..+ .+.+++|+.|+
T Consensus 9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 83 (290)
T 1p9a_G 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLD 83 (290)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEE
T ss_pred cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEE
Confidence 334444444444444 2232221 344444444444444444444444444444444444443222 14445555555
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
+++|+++ .+|..+..+++|++|++++|++++..|..|..+++|+. |+|++|++++..+..|..+++|+.|+|++|+|+
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE-LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE-EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCE-EECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 5555554 44555555555666666666665555555555666654 666666666555555566666666666666666
Q ss_pred cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccC
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFG 538 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 538 (983)
+..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 444445566777777777777776 466666666677777777777653
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=221.44 Aligned_cols=191 Identities=26% Similarity=0.355 Sum_probs=156.5
Q ss_pred CCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCch
Q 042568 63 HVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIP 142 (983)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 142 (983)
+||.|.|++|... .+.++++++++. .+|..+. +.|++|+|++|.+++..|..|+++++|++|+|++|.|++..|
T Consensus 3 ~Cp~~~gC~C~~~---~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNEG---KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEGG---GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCCC---CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 4889999999643 346889999887 6776665 689999999999998888899999999999999999998888
Q ss_pred hhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhh
Q 042568 143 SQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALA 222 (983)
Q Consensus 143 ~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 222 (983)
..|..+++|++|+|++|+++ .+|...+ ..+++|++|+|++|.++ .+|...+..+++|++|+|++|++++..+..|+
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~--~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 152 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLA-SLPLGVF--DHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCC-CCCTTTT--TTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred hHhccCCcCCEEECCCCccc-ccChhHh--cccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcC
Confidence 88999999999999999998 4444333 47788888888888888 55656667788888888888888877777888
Q ss_pred ccCCcceecccccccccccchhhhcCCCCccEEEcccccccc
Q 042568 223 NSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVS 264 (983)
Q Consensus 223 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 264 (983)
.+++|++|+|++|+++ .++...+..+++|++|+|++|.+..
T Consensus 153 ~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp TCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCcCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeC
Confidence 8888888888888887 5666666777777777777777654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=230.75 Aligned_cols=224 Identities=23% Similarity=0.222 Sum_probs=176.3
Q ss_pred cccEEeccccccCCCCCc---ccccCCCCcEEEeeCCcccCCCCCCC--CCCCCCcEEEccCccccCcCc----ccccCc
Q 042568 332 NLTLLNLSSNLLNGTIPH---ELCLMSKLERVYLSNNSLSGEIPSAF--GDIPHLGLLDLSKNKLSGSIP----DSFANL 402 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~---~l~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l 402 (983)
.++.|.+.++.++..... .+..+++|++|++++|.+.+..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 355666666555421100 12234668888898888888888887 888899999999999887555 345678
Q ss_pred ccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc--C--CccccCCCccceeccccCCCCCCCCcc----cccc
Q 042568 403 SQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI--I--PSDVAGLRSLKLYLNLSSNHLDGPLPL----ELSK 474 (983)
Q Consensus 403 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~~L~l~~N~l~~~~p~----~~~~ 474 (983)
++|++|+|++|.+++..|..|..+++|++|+|++|++.+. + +..+..+++|+. |+|++|+++. +|. .+..
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~-L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQN-LALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCS-CBCCSSCCCC-HHHHHHHHHHH
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCE-EECCCCCCCc-hHHHHHHHHhc
Confidence 8999999999999888888899999999999999998652 2 233467888986 9999999973 333 2578
Q ss_pred ccccccccccccccccCCCcccccc---cccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcc
Q 042568 475 MDMVLAIDLSFNNLSGSIPPQLGSC---IALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLK 551 (983)
Q Consensus 475 l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 551 (983)
+++|++|||++|+|++..|..+..+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 8999999999999998888888777 69999999999999 6777764 7999999999999953 44 67889999
Q ss_pred eEeccCCcccc
Q 042568 552 QLNFSFNKFSG 562 (983)
Q Consensus 552 ~l~l~~N~l~~ 562 (983)
.|++++|+++.
T Consensus 298 ~L~L~~N~l~~ 308 (310)
T 4glp_A 298 NLTLDGNPFLV 308 (310)
T ss_dssp CEECSSTTTSC
T ss_pred EEECcCCCCCC
Confidence 99999999874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=227.62 Aligned_cols=226 Identities=20% Similarity=0.248 Sum_probs=154.6
Q ss_pred CccEEEccCCcccccCCcc---ccccccCeeEEEccCccccccCCCCC--CCCCcccEEeccccccCCCCC----ccccc
Q 042568 283 NFQELELAGNNLGGMIPSI---IGDLSTNLVQIHLDCNLIYGKIPPHI--SNLVNLTLLNLSSNLLNGTIP----HELCL 353 (983)
Q Consensus 283 ~L~~L~L~~n~l~~~~p~~---~~~l~~~L~~L~L~~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~l~~ 353 (983)
.++.+.++++.++...-.. .... ++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAY-SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHH-SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhccc-CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4556666666554211110 1111 358899999999998888888 889999999999999997655 34567
Q ss_pred CCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCc--C--cccccCcccchhhcccCccCCCCCcc----cccC
Q 042568 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGS--I--PDSFANLSQLRRLLLYGNHLSGTIPS----SLGK 425 (983)
Q Consensus 354 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~ 425 (983)
+++|++|+|++|.+.+..|..|+.+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 89999999999999988889999999999999999998652 2 223467888888888888886 3343 2467
Q ss_pred CCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceE
Q 042568 426 CVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL 505 (983)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 505 (983)
+++|++|+|++|++++..|..+..+. .+++|++|+|++|+|+ .+|..+. ++|+.|
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~----------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L 277 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCM----------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVL 277 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCC----------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred CCCCCEEECCCCCCCccchhhHHhcc----------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence 78888888888888876666655442 0123444455555554 4444443 456666
Q ss_pred EeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 506 NLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 506 ~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
+|++|+|++. |. +..+++|+.|+|++|+++
T Consensus 278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred ECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 6666666643 22 455566666666666664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.3e-25 Score=243.04 Aligned_cols=163 Identities=19% Similarity=0.229 Sum_probs=111.7
Q ss_pred CcceeeEEECCCCCeEEEEEcccCCcccccccccccC--CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCC-
Q 042568 64 VCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANL--SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK- 140 (983)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~- 140 (983)
|..|.++.|+.. .++.+|++++.+. +..+..+ +.++.|++++|.+++..|. +..+++|++|+|++|.+++.
T Consensus 36 c~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 36 CKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp CHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 567999988643 4778999988776 4566777 8999999999999876655 66789999999999998865
Q ss_pred chhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccC-cccc-ccc
Q 042568 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSN-RLVG-QVP 218 (983)
Q Consensus 141 ~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N-~l~~-~~p 218 (983)
+|..+..+++|++|+|++|++++..|..+. .+++|++|+|++| .+++ .++
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~----------------------------~~~~L~~L~L~~~~~l~~~~l~ 161 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLA----------------------------KNSNLVRLNLSGCSGFSEFALQ 161 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHT----------------------------TCTTCSEEECTTCBSCCHHHHH
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHh----------------------------cCCCCCEEECCCCCCCCHHHHH
Confidence 888889999999999999988765555443 3445555555555 3443 244
Q ss_pred hhhhccCCcceeccccc-ccccccchhhhcCCC-CccEEEcccc
Q 042568 219 QALANSSKLEWLDLESN-MFSGELPSEIISKMP-QLQFLYLSYN 260 (983)
Q Consensus 219 ~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~-~L~~L~Ls~N 260 (983)
..+.++++|++|+|++| .+++......+..++ +|++|+|++|
T Consensus 162 ~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 162 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp HHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred HHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 55566666666666666 555321122334444 5555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-25 Score=247.78 Aligned_cols=250 Identities=22% Similarity=0.159 Sum_probs=142.1
Q ss_pred EccCccccccCCCCCCCCCcccEEeccccccCCCCC----cccccCC-CCcEEEeeCCcccCCCCCCCCCC-----CCCc
Q 042568 313 HLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIP----HELCLMS-KLERVYLSNNSLSGEIPSAFGDI-----PHLG 382 (983)
Q Consensus 313 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~ 382 (983)
++++|.++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|+
T Consensus 4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~ 83 (362)
T 3goz_A 4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83 (362)
T ss_dssp ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence 344444444444444444445555555555554433 3444444 55555555555554444444433 5555
Q ss_pred EEEccCccccCcCcccccCc-----ccchhhcccCccCCCCCccccc----C-CCCCCEEEccCccccCcCC----cccc
Q 042568 383 LLDLSKNKLSGSIPDSFANL-----SQLRRLLLYGNHLSGTIPSSLG----K-CVNLEILDLSHNKISGIIP----SDVA 448 (983)
Q Consensus 383 ~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~l~----~-l~~L~~L~Ls~N~l~~~~p----~~~~ 448 (983)
+|+|++|++++..+..++.. ++|+.|+|++|.+++..+..+. . .++|++|+|++|++++..+ ..+.
T Consensus 84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~ 163 (362)
T 3goz_A 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163 (362)
T ss_dssp EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence 55555555554444433322 5556666666665544443322 2 2466666666666664322 2223
Q ss_pred CCC-ccceeccccCCCCCCCCccccccc-----cccccccccccccccC----CCccccc-ccccceEEeCCCccccccc
Q 042568 449 GLR-SLKLYLNLSSNHLDGPLPLELSKM-----DMVLAIDLSFNNLSGS----IPPQLGS-CIALESLNLSGNSLEGLLP 517 (983)
Q Consensus 449 ~l~-~L~~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~p 517 (983)
..+ +|+. |+|++|++++..+..+... ++|+.|||++|.|++. ++..+.. .++|+.|+|++|++++..+
T Consensus 164 ~~~~~L~~-L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 164 AIPANVNS-LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp TSCTTCCE-EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred cCCccccE-eeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 333 5664 6777777666555444433 4777777777777752 3444544 3478888888888876544
Q ss_pred ----ccccCCCCccEEecCCccccCC-------cCccccCCCCcceEeccCCccccc
Q 042568 518 ----VSVGQLPYLKQFDVSSNRLFGE-------IPQSFQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 518 ----~~~~~l~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~l~l~~N~l~~~ 563 (983)
..+..+++|+.|+|++|++.+. ++..+.++++|+.|++++|++...
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 3346667888888888875432 334677788888888888887654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-23 Score=215.51 Aligned_cols=199 Identities=18% Similarity=0.229 Sum_probs=109.9
Q ss_pred cccEEeccccccCCCCCcccccCCCCcEEEeeCCc-ccCCCCCCCCCCCCCcEEEccC-ccccCcCcccccCcccchhhc
Q 042568 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNS-LSGEIPSAFGDIPHLGLLDLSK-NKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+|++|++++|++++..+..+..+++|++|++++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 55566666665554444455555555555555554 5544444555555555555555 555544444444455555555
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCC-CCCCCCccccccccccc-cccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSN-HLDGPLPLELSKMDMVL-AIDLSFNN 487 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~ 487 (983)
+++|.+++ +|. |..+++|+ .|+. |++++| .+++..+..|.++++|+ .|++++|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~---------------------~L~~-L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~ 167 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTD---------------------IFFI-LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCC---------------------SEEE-EEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred CCCCCCcc-ccc-cccccccc---------------------cccE-EECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence 55554442 333 44444443 0013 555555 55544444555566666 66666666
Q ss_pred cccCCCcccccccccceEEeCCCc-ccccccccccCC-CCccEEecCCccccCCcCccccCCCCcceEeccCC
Q 042568 488 LSGSIPPQLGSCIALESLNLSGNS-LEGLLPVSVGQL-PYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558 (983)
Q Consensus 488 l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N 558 (983)
++ .+|......++|+.|+|++|+ +++..+..|..+ ++|+.|++++|+++ .+|.. .+++|+.|+++++
T Consensus 168 l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 168 FT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred Cc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 66 444433333667777777774 776556667777 77777777777776 44443 4666777777665
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=214.32 Aligned_cols=187 Identities=19% Similarity=0.209 Sum_probs=140.7
Q ss_pred ccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccc-cCCCCCcccccCCCCcEEEeeC-CcccCCC
Q 042568 294 LGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNL-LNGTIPHELCLMSKLERVYLSN-NSLSGEI 371 (983)
Q Consensus 294 l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~ 371 (983)
++ .+|. ++.+|++|++++|++++..+..|..+++|++|++++|+ ++...+..+..+++|++|++++ |.+++..
T Consensus 23 l~-~ip~----~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~ 97 (239)
T 2xwt_C 23 IQ-RIPS----LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97 (239)
T ss_dssp CS-SCCC----CCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC
T ss_pred cc-ccCC----CCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC
Confidence 44 4565 34589999999999998877799999999999999997 8877777899999999999999 9999888
Q ss_pred CCCCCCCCCCcEEEccCccccCcCcccccCcccch---hhcccCc-cCCCCCcccccCCCCCC-EEEccCccccCcCCcc
Q 042568 372 PSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLR---RLLLYGN-HLSGTIPSSLGKCVNLE-ILDLSHNKISGIIPSD 446 (983)
Q Consensus 372 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~ 446 (983)
+..|.++++|+.|++++|++++ +|. |..+++|+ .|++++| .+++..+..|..+++|+ .|++++|+++ .+|..
T Consensus 98 ~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 98 PDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174 (239)
T ss_dssp TTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred HHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence 8899999999999999999996 665 88888887 8888888 88866666788888888 8888888887 44433
Q ss_pred ccCCCccceeccccCCC-CCCCCccccccc-cccccccccccccc
Q 042568 447 VAGLRSLKLYLNLSSNH-LDGPLPLELSKM-DMVLAIDLSFNNLS 489 (983)
Q Consensus 447 ~~~l~~L~~~L~l~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~ 489 (983)
....++|+. |++++|+ +++..+..|..+ ++|+.|||++|+++
T Consensus 175 ~~~~~~L~~-L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 175 AFNGTKLDA-VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp TTTTCEEEE-EECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred hcCCCCCCE-EEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 222245553 5555552 443333334444 44444444444443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.8e-25 Score=252.24 Aligned_cols=188 Identities=20% Similarity=0.212 Sum_probs=128.9
Q ss_pred CCCCCCcEEEccCccccC----cCcccccCcccchhhcccCccCCCCCccc----ccCC---------CCCCEEEccCcc
Q 042568 376 GDIPHLGLLDLSKNKLSG----SIPDSFANLSQLRRLLLYGNHLSGTIPSS----LGKC---------VNLEILDLSHNK 438 (983)
Q Consensus 376 ~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~----l~~l---------~~L~~L~Ls~N~ 438 (983)
..+++|+.|+|++|++++ .+|..+..+++|+.|+|++|.+++..+.. +..+ ++|++|+|++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 344444445555544443 23444444455555555555443222222 2222 677777777777
Q ss_pred cc-CcCC---ccccCCCccceeccccCCCCC--C---CCccccccccccccccccccccc----cCCCcccccccccceE
Q 042568 439 IS-GIIP---SDVAGLRSLKLYLNLSSNHLD--G---PLPLELSKMDMVLAIDLSFNNLS----GSIPPQLGSCIALESL 505 (983)
Q Consensus 439 l~-~~~p---~~~~~l~~L~~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L 505 (983)
++ +.+| ..+..+++|+. |++++|+++ | ..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~-L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L 249 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHT-VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 249 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCE-EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE
T ss_pred CCcHHHHHHHHHHHhCCCcCE-EECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEE
Confidence 76 3334 34556677775 788888776 2 34447788888999999999886 5778888889999999
Q ss_pred EeCCCccccc----ccccc--cCCCCccEEecCCccccC----CcCccc-cCCCCcceEeccCCcccccc
Q 042568 506 NLSGNSLEGL----LPVSV--GQLPYLKQFDVSSNRLFG----EIPQSF-QASPTLKQLNFSFNKFSGNI 564 (983)
Q Consensus 506 ~Ls~N~l~~~----~p~~~--~~l~~L~~L~ls~N~l~~----~~p~~~-~~l~~L~~l~l~~N~l~~~~ 564 (983)
+|++|++++. +|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|++++|++++..
T Consensus 250 ~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 250 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 9999999876 56666 448999999999999987 488877 66899999999999987544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.9e-25 Score=248.47 Aligned_cols=252 Identities=18% Similarity=0.233 Sum_probs=125.5
Q ss_pred CCccccCCCCCCCEEeccCccCCCCch----hhhcccccccEEeccCc---ccccccCCcccccCCCcccceeecccccc
Q 042568 116 HIPAELGSLIRLKQLSLSWNSLQGKIP----SQLGSLHQLEYLDLGNN---KLVGEIPIPIFCSNSSTSLQYIDLSNNSL 188 (983)
Q Consensus 116 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p----~~~~~L~~L~~L~Ls~N---~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l 188 (983)
.++..+..+++|++|+|++|.|++..+ ..|.++++|++|+|++| ++++.+|..+..+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l---------------- 86 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL---------------- 86 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH----------------
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHH----------------
Confidence 466677777888888888888876533 34667788888888875 3444444433100
Q ss_pred cCCCCCcccccccccceeecccCcccc----ccchhhhccCCcceecccccccccccchhh---hcCC---------CCc
Q 042568 189 TGEIPLKNECELRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSGELPSEI---ISKM---------PQL 252 (983)
Q Consensus 189 ~~~ip~~~~~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~---~~~l---------~~L 252 (983)
...+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+++..+..+ +..+ ++|
T Consensus 87 -----~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L 161 (386)
T 2ca6_A 87 -----LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL 161 (386)
T ss_dssp -----HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred -----HHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC
Confidence 0112345666666666666655 355566666666666666666653222111 1122 555
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccc-----cCCccccccccCeeEEEccCcccc----ccC
Q 042568 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG-----MIPSIIGDLSTNLVQIHLDCNLIY----GKI 323 (983)
Q Consensus 253 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~-----~~p~~~~~l~~~L~~L~L~~N~l~----~~~ 323 (983)
++|+|++|++... .+..+...+..+++|++|+|++|+++. ..|..+..+ ++|++|+|++|.++ +.+
T Consensus 162 ~~L~L~~n~l~~~----~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~-~~L~~L~Ls~n~l~~~g~~~l 236 (386)
T 2ca6_A 162 RSIICGRNRLENG----SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC-QELKVLDLQDNTFTHLGSSAL 236 (386)
T ss_dssp CEEECCSSCCTGG----GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC-TTCCEEECCSSCCHHHHHHHH
T ss_pred cEEECCCCCCCcH----HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC-CCccEEECcCCCCCcHHHHHH
Confidence 5666655554311 111122334444555555555555541 112123222 23444444444443 233
Q ss_pred CCCCCCCCcccEEeccccccCCC----CCcccc--cCCCCcEEEeeCCcccC----CCCCCC-CCCCCCcEEEccCcccc
Q 042568 324 PPHISNLVNLTLLNLSSNLLNGT----IPHELC--LMSKLERVYLSNNSLSG----EIPSAF-GDIPHLGLLDLSKNKLS 392 (983)
Q Consensus 324 p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~--~l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~ 392 (983)
|..+..+++|++|+|++|.+++. +|..+. .+++|++|+|++|.+++ .+|..+ .++++|+.|+|++|+++
T Consensus 237 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 44444445555555555554433 233331 24445555555554443 233333 33444444444444444
Q ss_pred C
Q 042568 393 G 393 (983)
Q Consensus 393 ~ 393 (983)
+
T Consensus 317 ~ 317 (386)
T 2ca6_A 317 E 317 (386)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.3e-22 Score=208.70 Aligned_cols=180 Identities=21% Similarity=0.237 Sum_probs=102.8
Q ss_pred CCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEcc
Q 042568 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLS 435 (983)
Q Consensus 356 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls 435 (983)
..++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|+.|+|++|.+++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666766666 3444333 456666666666666555556666666666666666665555555555566666666
Q ss_pred CccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCccccc
Q 042568 436 HNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGL 515 (983)
Q Consensus 436 ~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 515 (983)
+|++++..+..+..+++ |+.|+|++|+|++..+..|..+++|+.|+|++|+|++.
T Consensus 92 ~n~l~~~~~~~~~~l~~-------------------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQ-------------------------LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp TSCCCCCCTTTTTTCTT-------------------------CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCcccccChhHhcccCC-------------------------CCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 66555444444444444 44555555555533334445555555555666655554
Q ss_pred ccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccc
Q 042568 516 LPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 516 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 563 (983)
.+..+..+++|+.|+|++|++++..|..|..+++|++|++++|++++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 444555566666666666666655555566666666666666666554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=6.7e-22 Score=216.42 Aligned_cols=206 Identities=21% Similarity=0.347 Sum_probs=121.3
Q ss_pred EccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCcccc
Q 042568 313 HLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS 392 (983)
Q Consensus 313 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 392 (983)
.+..+.+.+.+ .+..+++|++|++++|.++. +| .+..+++|++|+|++|.+.+..+ +..+++|+.|+|++|+++
T Consensus 25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC
Confidence 34444444322 24457778888888888774 44 57777788888888887775444 777777777777777776
Q ss_pred CcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccc
Q 042568 393 GSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLEL 472 (983)
Q Consensus 393 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~ 472 (983)
+. ..+..+++|+.|++++|.+++ ++. +..+++|+.|++++|++++..+ +..+++|+. |++++|++++..+ +
T Consensus 99 ~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~-L~l~~n~l~~~~~--l 169 (308)
T 1h6u_A 99 NV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQY-LSIGNAQVSDLTP--L 169 (308)
T ss_dssp CC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCE-EECCSSCCCCCGG--G
T ss_pred Cc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccE-EEccCCcCCCChh--h
Confidence 43 246667777777777777764 332 6666677777777776664332 555555554 5555555554222 4
Q ss_pred ccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 473 SKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 473 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
..+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..| +..+++|+.|++++|+++
T Consensus 170 ~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 170 ANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp TTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred cCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 555555555555555542 222 4445555555555555553332 444455555555555544
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.7e-24 Score=236.07 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=141.7
Q ss_pred CCccEEEccCCcccccCCcccccc-ccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCC-CCcccccCCCCcE
Q 042568 282 SNFQELELAGNNLGGMIPSIIGDL-STNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT-IPHELCLMSKLER 359 (983)
Q Consensus 282 ~~L~~L~L~~n~l~~~~p~~~~~l-~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~ 359 (983)
..++.+++++|.+. +..+..+ ..+++.|++++|.+.+..+. +..+++|++|++++|.+++. +|..+..+++|++
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~ 122 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQN 122 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCE
Confidence 34677777777765 2333332 13566777777776655443 44566666666666666544 5555555666666
Q ss_pred EEeeCCcccCCCCCCCCCCCCCcEEEccCc-cccCc-CcccccCcccchhhcccCc-cCCCC-CcccccCCC-CCCEEEc
Q 042568 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKN-KLSGS-IPDSFANLSQLRRLLLYGN-HLSGT-IPSSLGKCV-NLEILDL 434 (983)
Q Consensus 360 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~l~~l~-~L~~L~L 434 (983)
|+|++|.+++..|..++.+++|+.|+|++| .+++. ++..+.++++|+.|++++| .+++. ++..+..++ +|++|++
T Consensus 123 L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 123 LSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp EECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred EeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 666666655555555555555666666655 44431 3333444455555555555 44422 233344444 4444444
Q ss_pred cCccccCcCCccccCCCccceeccccCCCCC-CCCccccccccccccccccccc-cccCCCcccccccccceEEeCCCc-
Q 042568 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNHLD-GPLPLELSKMDMVLAIDLSFNN-LSGSIPPQLGSCIALESLNLSGNS- 511 (983)
Q Consensus 435 s~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~- 511 (983)
++|.+ .++ +.+|..+..+++|+.|+|++|. +++..+..+..+++|+.|++++|.
T Consensus 203 ~~~~~-----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~ 259 (336)
T 2ast_B 203 SGYRK-----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259 (336)
T ss_dssp CSCGG-----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred CCCcc-----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCC
Confidence 44421 232 2344455566666666666666 555566666677777777777774
Q ss_pred ccccccccccCCCCccEEecCCccccCCcCccccCC-CCcceEeccCCccccccCC
Q 042568 512 LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS-PTLKQLNFSFNKFSGNISN 566 (983)
Q Consensus 512 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~~~ 566 (983)
++......+..+++|+.|++++| ++. ..+..+ ..++.|++++|++++..|.
T Consensus 260 ~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~ 311 (336)
T 2ast_B 260 IIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARP 311 (336)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred CCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCC
Confidence 22222224666777777777777 332 233333 2356666777777776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-22 Score=237.32 Aligned_cols=208 Identities=25% Similarity=0.363 Sum_probs=155.1
Q ss_pred cCCCCCCCCCCc-----ceeeE-EECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCC
Q 042568 54 LESWNSTDVHVC-----NWSGV-KCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRL 127 (983)
Q Consensus 54 l~sw~~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (983)
+.+|.. +.++| .|.|+ .|.. ++++.|+|+++++.+ +|+.+. ++|++|+|++|.|+ .+| +.+++|
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHhc-cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 456654 34567 79999 7864 368999999999986 777663 88999999999998 777 567899
Q ss_pred CEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceee
Q 042568 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLL 207 (983)
Q Consensus 128 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~ 207 (983)
++|+|++|+|++ +|. +.+ +|++|+|++|++++ +|. .+++|++|+|++|.+++ +|. .+++|++|+
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~------~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~ 166 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE------LPALLEYINADNNQLTM-LPE----LPTSLEVLS 166 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC------CCTTCCEEECCSSCCSC-CCC----CCTTCCEEE
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC------cCccccEEeCCCCccCc-CCC----cCCCcCEEE
Confidence 999999999996 777 765 89999999999985 665 36889999999999885 664 568889999
Q ss_pred cccCccccccchhhhccCCcceecccccccccccchhhhcCCCCc-------cEEEccccccccCCCCCCCcccccccCC
Q 042568 208 LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQL-------QFLYLSYNDFVSHDGNTNLEPFFASLAN 280 (983)
Q Consensus 208 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~~~~~~l~~ 280 (983)
|++|+|++ +|. |. ++|++|+|++|+|+ .+|. + .. +| ++|+|++|+|+. ++..+..
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~-~~--~L~~~~~~L~~L~Ls~N~l~~---------lp~~l~~ 228 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-V-PV--RNHHSEETEIFFRCRENRITH---------IPENILS 228 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-C-C----------CCEEEECCSSCCCC---------CCGGGGG
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-H-HH--hhhcccccceEEecCCCccee---------cCHHHhc
Confidence 99998886 565 65 78888999988887 6776 3 22 45 677777766643 2234445
Q ss_pred CCCccEEEccCCcccccCCcccccc
Q 042568 281 SSNFQELELAGNNLGGMIPSIIGDL 305 (983)
Q Consensus 281 l~~L~~L~L~~n~l~~~~p~~~~~l 305 (983)
+++|++|+|++|.+++.+|..+..+
T Consensus 229 l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 229 LDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp SCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 6666666666666666655555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=213.92 Aligned_cols=190 Identities=23% Similarity=0.345 Sum_probs=113.1
Q ss_pred CeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
+|++|++++|.+.. +| .+..+++|++|++++|++++..+ +..+++|++|+|++|.+++. + .+..+++|+.|+|+
T Consensus 42 ~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLT 115 (308)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECT
T ss_pred CcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECC
Confidence 56666666666653 33 45666666666666666664333 66666666666666666642 2 46666666666666
Q ss_pred CccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
+|++++. + .+..+++|+.|++++|.+++. +. +..+++|+.|++++|++++..+ +..+++|+. |++++|++++.
T Consensus 116 ~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~-L~l~~n~l~~~ 188 (308)
T 1h6u_A 116 STQITDV-T-PLAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT-LKADDNKISDI 188 (308)
T ss_dssp TSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE-EECCSSCCCCC
T ss_pred CCCCCCc-h-hhcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCE-EECCCCccCcC
Confidence 6666643 2 266666666666666666633 22 5666666666666666664332 566666664 66666666643
Q ss_pred CccccccccccccccccccccccCCCcccccccccceEEeCCCcccc
Q 042568 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 514 (983)
.+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|++++
T Consensus 189 ~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred hh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 33 566666666666666666433 25666666666666666653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=217.00 Aligned_cols=242 Identities=18% Similarity=0.216 Sum_probs=120.6
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeC
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 364 (983)
++++.++++++ .+|..+ ++++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l---~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~--------------- 72 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA--------------- 72 (350)
T ss_dssp TEEEEESTTCC-SCCTTC---CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT---------------
T ss_pred CEEEecCCCCC-ccCcCc---CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh---------------
Confidence 45556666665 334332 23455555555555533333445555555555555554433332
Q ss_pred CcccCCCCCCCCCCCCCcE-EEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccC-ccccCc
Q 042568 365 NSLSGEIPSAFGDIPHLGL-LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSH-NKISGI 442 (983)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~ 442 (983)
.+|.++++|.. ++++.|+++...|..|..+++|+.|++++|+++...+..+....++..|++.+ |++...
T Consensus 73 --------~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l 144 (350)
T 4ay9_X 73 --------DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI 144 (350)
T ss_dssp --------TSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEE
T ss_pred --------hHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccc
Confidence 23444444332 33334444444444444444444444444444433333334444455555533 344433
Q ss_pred CCccccCCC-ccceeccccCCCCCCCCccccccccccccccccc-cccccCCC-cccccccccceEEeCCCccccccccc
Q 042568 443 IPSDVAGLR-SLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF-NNLSGSIP-PQLGSCIALESLNLSGNSLEGLLPVS 519 (983)
Q Consensus 443 ~p~~~~~l~-~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~ 519 (983)
.+..|..+. .++ .|+|++|+|+. +|.......+|+.|++++ |.++ .+| ..|..+++|+.|+|++|+|+...+..
T Consensus 145 ~~~~f~~~~~~l~-~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 145 ERNSFVGLSFESV-ILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp CTTSSTTSBSSCE-EEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred cccchhhcchhhh-hhccccccccC-CChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 334444443 233 36666666653 333333344566677764 4444 454 35677777777777777777544444
Q ss_pred ccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 520 VGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 520 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
+.+ |+.|.+.++.-...+| .+.++++|+.+++.++.-
T Consensus 222 ~~~---L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 222 LEN---LKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp CTT---CCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred hcc---chHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 443 4444433333233666 367777787777765543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.8e-22 Score=212.68 Aligned_cols=139 Identities=19% Similarity=0.243 Sum_probs=112.3
Q ss_pred HHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-----------------chhHHHHHHHHHHHhcCCC
Q 042568 662 LIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-----------------EITGSFKRECQILKRIRHR 724 (983)
Q Consensus 662 l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~ 724 (983)
+......|...+.||+|+||.||+|.+.+|+.||||.++..... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 33444556677999999999999999977999999998643211 12457899999999999
Q ss_pred CccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEe
Q 042568 725 NLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILL 804 (983)
Q Consensus 725 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl 804 (983)
| +++.+++.. +..++||||+++|+|.+ +.. .....++.|+++||+|||+.+ |+||||||+|||+
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 666665543 55699999999999988 431 124579999999999999996 9999999999999
Q ss_pred CCCCCEEEccccccc
Q 042568 805 DEDLTALVADFGIAK 819 (983)
Q Consensus 805 ~~~~~~kl~Dfgla~ 819 (983)
+ ++.+||+|||+|+
T Consensus 227 ~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV 240 (282)
T ss_dssp E-TTEEEECCCTTCE
T ss_pred E-CCcEEEEECCCCe
Confidence 9 9999999999986
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.9e-21 Score=213.13 Aligned_cols=199 Identities=20% Similarity=0.167 Sum_probs=129.5
Q ss_pred cEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCC-CCCCCC
Q 042568 253 QFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPP-HISNLV 331 (983)
Q Consensus 253 ~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~-~l~~l~ 331 (983)
++++.++++++.++ ..+ .+++++|+|++|+|+...+..|..+ ++|++|+|++|.+.+.+|. .|.+++
T Consensus 12 ~~v~C~~~~Lt~iP---------~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l-~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 12 RVFLCQESKVTEIP---------SDL--PRNAIELRFVLTKLRVIQKGAFSGF-GDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp TEEEEESTTCCSCC---------TTC--CTTCSEEEEESCCCSEECTTSSTTC-TTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred CEEEecCCCCCccC---------cCc--CCCCCEEEccCCcCCCcCHHHHcCC-CCCCEEECcCCCCCCccChhHhhcch
Confidence 67888888877643 223 2589999999999996656677777 5899999999999776665 578888
Q ss_pred cccE-EeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC-ccccCcCcccccCcc-cchhh
Q 042568 332 NLTL-LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK-NKLSGSIPDSFANLS-QLRRL 408 (983)
Q Consensus 332 ~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L 408 (983)
++++ +.++.|+++...|..|..+++|++|++++|.+....+..+....++..|++.+ |++....+..|..+. .++.|
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L 159 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL 159 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhh
Confidence 8775 66677889877778888888888888888888877776777777777888765 456544444454443 34455
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccC-ccccCcCCccccCCCccceeccccCCCCC
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSH-NKISGIIPSDVAGLRSLKLYLNLSSNHLD 465 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 465 (983)
+|++|+|+ .+|.......+|+.|++++ |.++...+..|..+++|+. |++++|+|+
T Consensus 160 ~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~-LdLs~N~l~ 215 (350)
T 4ay9_X 160 WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIH 215 (350)
T ss_dssp ECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSE-EECTTSCCC
T ss_pred cccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccch-hhcCCCCcC
Confidence 55555554 2333333334444444442 3333222223344444443 444444444
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-21 Score=226.16 Aligned_cols=188 Identities=23% Similarity=0.345 Sum_probs=107.8
Q ss_pred CeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|.|++ +|. +.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 57777777777765 565553 56777777777776 455 345666666666666665 444 443 66666666
Q ss_pred CccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
+|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. +
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l-------------------- 178 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-L-------------------- 178 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-C--------------------
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-h--------------------
Confidence 666664 333 34555555555555553 333 34455555555555553 333 3
Q ss_pred CccccccccccccccccccccccCCCccccccccc-------ceEEeCCCcccccccccccCCCCccEEecCCccccCCc
Q 042568 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIAL-------ESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI 540 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~ 540 (983)
. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+
T Consensus 179 -----~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 179 -----P--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp -----C--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred -----h--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence 2 44445555555554 4444 332 44 66666666666 35666666666666666666666666
Q ss_pred CccccCCC
Q 042568 541 PQSFQASP 548 (983)
Q Consensus 541 p~~~~~l~ 548 (983)
|..|..++
T Consensus 247 p~~l~~l~ 254 (571)
T 3cvr_A 247 RESLSQQT 254 (571)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 66665543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2e-20 Score=192.35 Aligned_cols=160 Identities=26% Similarity=0.304 Sum_probs=76.1
Q ss_pred cccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
+|++|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44444444444443333334444444444444444444444444445555555555555544444444444455555555
Q ss_pred CccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccC
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGS 491 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 491 (983)
+|.+++..+..|..+++|+.|++++|++++..+..+..+++|+. |++++|.+.+. ++.|++|+++.|+++|.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-IWLHDNPWDCT-------CPGIRYLSEWINKHSGV 180 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSCCBCCC-------TTTTHHHHHHHHHCTTT
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccE-EEecCCCeecC-------CCCHHHHHHHHHhCCce
Confidence 55554433334445555555555555555444434444444543 55555544322 22345555555555555
Q ss_pred CCcccccc
Q 042568 492 IPPQLGSC 499 (983)
Q Consensus 492 ~p~~~~~l 499 (983)
+|..++.+
T Consensus 181 ip~~~~~l 188 (208)
T 2o6s_A 181 VRNSAGSV 188 (208)
T ss_dssp BBCTTSSB
T ss_pred eeccCccc
Confidence 55544443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=194.02 Aligned_cols=181 Identities=20% Similarity=0.210 Sum_probs=103.7
Q ss_pred cEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCc
Q 042568 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 413 (983)
+.++++++.++ .+|..+ .++|++|++++|.+++..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 34555555555 334332 346677777777776655556666666777777666666555555555666666666666
Q ss_pred cCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCC
Q 042568 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIP 493 (983)
Q Consensus 414 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 493 (983)
.+++..+..|..+++|++|++++|++++..+..+ ..+++|+.|+|++|++++..+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------------~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVF-------------------------DKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-------------------------TTCTTCCEEECCSSCCSCCCT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHh-------------------------ccCCcCCEEECCCCccceeCH
Confidence 6654444445555555555555555554444444 444455555555555554444
Q ss_pred cccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCC
Q 042568 494 PQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549 (983)
Q Consensus 494 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 549 (983)
..|..+++|+.|++++|.+.+ .+++|+.|+++.|+++|.+|.+++.++.
T Consensus 142 ~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 142 GVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred HHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 445556666666666665553 2345666666666666666666665543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.9e-21 Score=232.61 Aligned_cols=232 Identities=21% Similarity=0.194 Sum_probs=82.0
Q ss_pred ccHHhHHHHHHHHHhccCCCccccCCCCCCCCCCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcC
Q 042568 31 QIIRDRASLVTFMSSIISAPEHALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSK 110 (983)
Q Consensus 31 ~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~ 110 (983)
....++++|+++..+...+....-..|.......+.|.+++++. .+++.|+|.++++.. ++.. .|+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQA-----LLQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chhh-----HhhcCccCc
Confidence 34568999999998875443344457866556678899998875 569999999988875 3332 244455555
Q ss_pred CcCCC---------CCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 111 NFFQG---------HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 111 n~l~~---------~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
|.|.+ ..|..+..+.+|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..+
T Consensus 201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~------------ 266 (727)
T 4b8c_D 201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI------------ 266 (727)
T ss_dssp ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG------------
T ss_pred ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh------------
Confidence 55442 23444455555555555555554 44444445555555555555554 444333
Q ss_pred ecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccc
Q 042568 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261 (983)
Q Consensus 182 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 261 (983)
..+++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..
T Consensus 267 ----------------~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~----------------- 311 (727)
T 4b8c_D 267 ----------------KNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWE----------------- 311 (727)
T ss_dssp ----------------GGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSS-----------------
T ss_pred ----------------hCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChh-----------------
Confidence 34444555555555544 34445555555555555555553 34332
Q ss_pred cccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEecccc
Q 042568 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341 (983)
Q Consensus 262 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 341 (983)
+.++++|++|+|++|.+++.+|..+......+..++|++|.+++.+|.. |+.|++++|
T Consensus 312 ----------------~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 312 ----------------FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp ----------------TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred ----------------hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 2333444444444444455555554443222334556666666665543 344555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=8.3e-20 Score=189.12 Aligned_cols=155 Identities=20% Similarity=0.188 Sum_probs=102.7
Q ss_pred hhcccCccCCCCCcccccCCCCCCEEEccCccccCcCC-ccccCCCccceeccccCCCCCCCCccccccccccccccccc
Q 042568 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIP-SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSF 485 (983)
Q Consensus 407 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 485 (983)
.+++++|.++ .+|..+. +.++.|+|++|+|++..| ..|..+++|+. |+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRK-INFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCE-EECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCE-EECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4444444444 3343332 234566666666665433 33556666664 66666666655555666667777777777
Q ss_pred cccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccC
Q 042568 486 NNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 486 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|++|++++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776666667777777777777777777777777777777788888887777667777777888888888888776554
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.2e-19 Score=183.81 Aligned_cols=157 Identities=29% Similarity=0.343 Sum_probs=103.3
Q ss_pred CCCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCc
Q 042568 62 VHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141 (983)
Q Consensus 62 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 141 (983)
.+.|+|.+|.|+.. ++. .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+|+...
T Consensus 16 ~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 80 (229)
T 3e6j_A 16 QCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80 (229)
T ss_dssp TCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence 56899999999753 222 4555443 78999999999999888888999999999999999998666
Q ss_pred hhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhh
Q 042568 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQAL 221 (983)
Q Consensus 142 p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l 221 (983)
+..|+.+++|++|+|++|+++ .+|...+ ..+++|++|+|++|+++ .+|.. +..+++|++|+|++|+|++..+..|
T Consensus 81 ~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~--~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~L~~N~l~~~~~~~~ 155 (229)
T 3e6j_A 81 VGVFDSLTQLTVLDLGTNQLT-VLPSAVF--DRLVHLKELFMCCNKLT-ELPRG-IERLTHLTHLALDQNQLKSIPHGAF 155 (229)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTT--TTCTTCCEEECCSSCCC-SCCTT-GGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred hhhcccCCCcCEEECCCCcCC-ccChhHh--CcchhhCeEeccCCccc-ccCcc-cccCCCCCEEECCCCcCCccCHHHH
Confidence 667888999999999999888 3443332 24555555555555555 33322 2344455555555555544444444
Q ss_pred hccCCcceecccccccc
Q 042568 222 ANSSKLEWLDLESNMFS 238 (983)
Q Consensus 222 ~~l~~L~~L~Ls~N~l~ 238 (983)
..+++|++|+|++|.+.
T Consensus 156 ~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 156 DRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp TTCTTCCEEECTTSCBC
T ss_pred hCCCCCCEEEeeCCCcc
Confidence 44444445555444444
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-19 Score=186.34 Aligned_cols=154 Identities=19% Similarity=0.252 Sum_probs=110.2
Q ss_pred hhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccc
Q 042568 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486 (983)
Q Consensus 407 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 486 (983)
.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+. |+|++|++++..|..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~-L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRR-IDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCE-EECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCE-EECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 4455555555 4444333 45677777777777666666667777774 777777777666777777777777777777
Q ss_pred ccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcccccc
Q 042568 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNI 564 (983)
Q Consensus 487 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 564 (983)
+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|++|++++|++.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 777544455677788888888888888777778888888888888888888766677888888888888888887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.7e-19 Score=212.42 Aligned_cols=190 Identities=26% Similarity=0.376 Sum_probs=110.3
Q ss_pred CccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEe
Q 042568 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362 (983)
Q Consensus 283 ~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 362 (983)
.+..+.++.+.+.+.++ +..+ .+|+.|++++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L-~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHH-TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHhccCCCcccccc--hhcC-CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 34445556665554333 2223 356667777776653 22 46666777777777777665433 666666777777
Q ss_pred eCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc
Q 042568 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
++|.+.+ +| .+..+++|+.|+|++|++++. +.+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++.
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~ 168 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 168 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence 7776664 22 566666666666666666642 3456666666666666666643 4456666666666666666654
Q ss_pred CCccccCCCccceeccccCCCCCCCCcccccccccccccccccccccc
Q 042568 443 IPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG 490 (983)
Q Consensus 443 ~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 490 (983)
.| +..+++|+. |+|++|+|++. ..+..+++|+.|+|++|++++
T Consensus 169 ~~--l~~l~~L~~-L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 169 VP--LAGLTKLQN-LYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp GG--GTTCTTCCE-EECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred hh--hccCCCCCE-EECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 44 555555554 66666655542 235555555555555555553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.7e-19 Score=210.32 Aligned_cols=197 Identities=23% Similarity=0.331 Sum_probs=135.7
Q ss_pred cccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
.+.++..+.++.+.+.+..+ +..+.+|+.|+|++|.++ .++. +..+++|++|+|++|++.... .+
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~----------~l 83 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIK----------PL 83 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCG----------GG
T ss_pred HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCCh----------hh
Confidence 45567777777777775544 567788888888888876 4442 455666666666666553311 13
Q ss_pred CCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCc
Q 042568 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358 (983)
Q Consensus 279 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 358 (983)
..++ +|+.|+|++|.+.+ ++.+..+++|+.|+|++|++++. ..+..+++|+
T Consensus 84 ~~l~-------------------------~L~~L~Ls~N~l~~--l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~ 134 (605)
T 1m9s_A 84 TNLK-------------------------NLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLE 134 (605)
T ss_dssp GGCT-------------------------TCCEEECCSSCCCC--CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCS
T ss_pred ccCC-------------------------CCCEEECcCCCCCC--ChhhccCCCCCEEEecCCCCCCC--ccccCCCccC
Confidence 3333 45555555555543 23567777888888888888753 3577788888
Q ss_pred EEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCcc
Q 042568 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438 (983)
Q Consensus 359 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 438 (983)
.|+|++|.+++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|+
T Consensus 135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQE 208 (605)
T ss_dssp EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEE
T ss_pred EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCc
Confidence 888888888764 467788888888888888886655 7788888888888888875 33 57888888888888888
Q ss_pred ccCcCCc
Q 042568 439 ISGIIPS 445 (983)
Q Consensus 439 l~~~~p~ 445 (983)
+.+....
T Consensus 209 l~~~p~~ 215 (605)
T 1m9s_A 209 CLNKPIN 215 (605)
T ss_dssp EECCCCC
T ss_pred CcCCccc
Confidence 8754333
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=195.52 Aligned_cols=170 Identities=25% Similarity=0.388 Sum_probs=77.1
Q ss_pred CCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 329 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
.+++|+.|++++|.++.. + .+..+++|++|+|++|.+++..+ +..+++|+.|+|++|++++
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--------------- 104 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD--------------- 104 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---------------
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC---------------
Confidence 445555555555555422 2 24444555555555555543322 4444444444444444442
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (983)
+| .+..+++|+.|++++|++++. ..+..+++|+. |++++|++++. ..+..+++|+.|+|++|++
T Consensus 105 ----------~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~-L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 105 ----------LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLES-LYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp ----------GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCE-EECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred ----------Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCE-EEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 11 244445555555555555432 22333444442 44444444332 2344444444444444444
Q ss_pred ccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 489 SGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 489 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
++..| +..+++|+.|++++|++++ +| .+..+++|+.|++++|+++
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred ccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence 43222 4445555555555555543 22 2444555555555555544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-21 Score=230.23 Aligned_cols=204 Identities=24% Similarity=0.232 Sum_probs=110.7
Q ss_pred CCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchh
Q 042568 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRR 407 (983)
Q Consensus 328 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 407 (983)
...++|+.|+|++|+++ .+|..++.+++|+.|++++|......|. .+..+.+.+..|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 44566666777777666 5566666666666666655431100000 00111234455666666777777
Q ss_pred hc-ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccc
Q 042568 408 LL-LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486 (983)
Q Consensus 408 L~-l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 486 (983)
|+ ++.|.+. .|+.+.+++|.++...+. .|+. |+|++|.|++ +|. ++.+++|+.|+|++|
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~-L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRV-LHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSE-EECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred Ccchhhcccc-----------hhhhhhhhcccccccCcc------CceE-EEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 66 5555432 233444455554432111 2343 5555555554 343 555555666666666
Q ss_pred ccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCc-CccccCCCCcceEeccCCccccccC
Q 042568 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEI-PQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 487 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..|..+++|+.|+|++|++++.+|
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 665 555566666666666666666664 44 5556666666666666665554 5566666666666666666665555
Q ss_pred C
Q 042568 566 N 566 (983)
Q Consensus 566 ~ 566 (983)
.
T Consensus 551 ~ 551 (567)
T 1dce_A 551 I 551 (567)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=5.6e-19 Score=197.93 Aligned_cols=176 Identities=26% Similarity=0.279 Sum_probs=92.6
Q ss_pred cEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCccccc-CcccchhhcccCccCCCCCcccccCCCCCCEEEccC
Q 042568 358 ERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFA-NLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSH 436 (983)
Q Consensus 358 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~ 436 (983)
+.+++++|.++. +|..+. +.++.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 456666666663 444332 2355666666666554444444 455555555555555544444444455555555555
Q ss_pred ccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccc
Q 042568 437 NKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLL 516 (983)
Q Consensus 437 N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 516 (983)
|+|++. .+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus 98 N~l~~~-------------------------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 98 NHLHTL-------------------------DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp SCCCEE-------------------------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred CcCCcC-------------------------CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 544433 3334444444555555555555444555555566666666666665433
Q ss_pred cccc---cCCCCccEEecCCccccCCcCccccCCCCc--ceEeccCCccc
Q 042568 517 PVSV---GQLPYLKQFDVSSNRLFGEIPQSFQASPTL--KQLNFSFNKFS 561 (983)
Q Consensus 517 p~~~---~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L--~~l~l~~N~l~ 561 (983)
+..+ ..+++|+.|+|++|+|++..+..|..++.+ +.|+|++|++.
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 3333 456666777777776664444556666553 55666655554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=178.91 Aligned_cols=153 Identities=23% Similarity=0.285 Sum_probs=91.7
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCC-CCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIP-PHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 363 (983)
+++++++|+++. +|..+. ..+++|+|++|.+++..| ..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~~-iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCccc-CccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 356666666653 444332 345566666666665543 235566666666666666665555556666666666666
Q ss_pred CCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccC
Q 042568 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 364 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
+|.+++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 666665555556666666666666666665556666666666666666666665555556666666666666666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=189.13 Aligned_cols=168 Identities=29% Similarity=0.392 Sum_probs=130.9
Q ss_pred cCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEc
Q 042568 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDL 386 (983)
Q Consensus 307 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 386 (983)
++|+.|++++|.+.+. + .+..+++|++|++++|++++..+ +..+++|++|++++|.+++. | .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEEEC
Confidence 5799999999999854 3 58899999999999999997654 89999999999999999863 3 4899999999999
Q ss_pred cCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCC
Q 042568 387 SKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 387 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 466 (983)
++|++++. +.+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..| +..+++|+. |++++|.+++
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~-L~L~~N~i~~ 192 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN-LYLSKNHISD 192 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCE-EECCSSCCCB
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCE-EECCCCcCCC
Confidence 99999864 4577888888888888888754 567788888888888888876544 666677764 7777776664
Q ss_pred CCccccccccccccccccccccc
Q 042568 467 PLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 467 ~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
. | .+..+++|+.|++++|+++
T Consensus 193 l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 193 L-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp C-G-GGTTCTTCSEEEEEEEEEE
T ss_pred C-h-hhccCCCCCEEECcCCccc
Confidence 2 2 2555555555555555555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-20 Score=223.05 Aligned_cols=202 Identities=20% Similarity=0.168 Sum_probs=120.8
Q ss_pred cccccceeecccCccccccchhhhccCCcceecccccc-------------cccccchhhhcCCCCccEEE-cccccccc
Q 042568 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM-------------FSGELPSEIISKMPQLQFLY-LSYNDFVS 264 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~~l~~L~~L~-Ls~N~l~~ 264 (983)
..++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+. ++..+..+++|+.|+ ++.|.+.
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~-~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-EKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGG-HHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccC-CHHHHHHHHhcccCcchhhcccc-
Confidence 5677777788888776 678888888888888887664 3322 234455666666666 5555432
Q ss_pred CCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccC
Q 042568 265 HDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLN 344 (983)
Q Consensus 265 ~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 344 (983)
+|+.+.+++|.+++..+ ..|+.|+|++|.|++ +|. ++.+++|+.|+|++|+|+
T Consensus 424 ------------------~L~~l~l~~n~i~~l~~-------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 424 ------------------DLRSKFLLENSVLKMEY-------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp ------------------HHHHHHHHHHHHHHHHH-------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC
T ss_pred ------------------hhhhhhhhcccccccCc-------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc
Confidence 23444455555543211 135666666666664 454 666666666666666666
Q ss_pred CCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcC-cccccCcccchhhcccCccCCCCCcc--
Q 042568 345 GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI-PDSFANLSQLRRLLLYGNHLSGTIPS-- 421 (983)
Q Consensus 345 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~-- 421 (983)
.+|..++.+++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|.+++..|.
T Consensus 477 -~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred -ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 556666666666666666666664 44 5666666666666666666554 55666666666666666666543332
Q ss_pred -cccCCCCCCEEE
Q 042568 422 -SLGKCVNLEILD 433 (983)
Q Consensus 422 -~l~~l~~L~~L~ 433 (983)
.+..+++|+.|+
T Consensus 554 ~l~~~lp~L~~L~ 566 (567)
T 1dce_A 554 RLAEMLPSVSSIL 566 (567)
T ss_dssp HHHHHCTTCSEEE
T ss_pred HHHHHCcccCccC
Confidence 122355555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=177.01 Aligned_cols=153 Identities=24% Similarity=0.315 Sum_probs=110.0
Q ss_pred cEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeC
Q 042568 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364 (983)
Q Consensus 285 ~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 364 (983)
+.+++++++++ .+|..+. .+++.|+|++|.|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 45677777776 3454332 4677777777777766666777777777777777777776677777777777777777
Q ss_pred CcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccC
Q 042568 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
|.|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++|++..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 77776666667777777777777777777777777777777777777777776666667777777777777777653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=195.68 Aligned_cols=129 Identities=29% Similarity=0.326 Sum_probs=77.2
Q ss_pred eEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccc-cCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC
Q 042568 310 VQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC-LMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 310 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (983)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..+..+. .+++|++|+|++|.|++..+..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45677777666 3555443 3466666666666655555555 666666666666666665556666666666666666
Q ss_pred ccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccC
Q 042568 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 150 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR 150 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe
Confidence 66665555555555555555555555555445555555555555555555553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-18 Score=177.93 Aligned_cols=153 Identities=22% Similarity=0.257 Sum_probs=91.4
Q ss_pred hcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccc
Q 042568 408 LLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487 (983)
Q Consensus 408 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 487 (983)
++.+++.++ .+|..+. ++|++|+|++|++++..|..+..+++|+. |+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 24 v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~-L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 24 VDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKE-LYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcE-EECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 444444443 3333222 45555555555555555555555555554 5555555554444455666666666666666
Q ss_pred cccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccC
Q 042568 488 LSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 488 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 100 l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 66544555566666677777777666 556666666777777777777765555566667777777777777665544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.1e-19 Score=218.89 Aligned_cols=183 Identities=23% Similarity=0.280 Sum_probs=76.0
Q ss_pred cCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccC
Q 042568 322 KIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN 401 (983)
Q Consensus 322 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 401 (983)
..|..+..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|+.|+|++|+|+ .+|..|++
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 34455555666666666666665 44544555555555555555555 45555555555555555555555 44555555
Q ss_pred cccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccc
Q 042568 402 LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAI 481 (983)
Q Consensus 402 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L 481 (983)
+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+... +..|
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~------------------------~~~l 346 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVT------------------------GLIF 346 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHH------------------------HHHH
T ss_pred CCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchh------------------------hhHH
Confidence 555555555555554 445555555555555555555555555444333211 1224
Q ss_pred cccccccccCCCcccccccccceEEeCCC--------cccccccccccCCCCccEEecCCccccC
Q 042568 482 DLSFNNLSGSIPPQLGSCIALESLNLSGN--------SLEGLLPVSVGQLPYLKQFDVSSNRLFG 538 (983)
Q Consensus 482 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 538 (983)
+|++|.++|.+|.. |+.|++++| .|.+..+..+..+..+....+++|-+.+
T Consensus 347 ~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 347 YLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp HHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred hhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence 45555555444432 223334433 3444455555666777777888887654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=5.9e-18 Score=171.15 Aligned_cols=109 Identities=23% Similarity=0.319 Sum_probs=56.9
Q ss_pred ccccCCCCCCCCcc-ccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcc
Q 042568 457 LNLSSNHLDGPLPL-ELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535 (983)
Q Consensus 457 L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 535 (983)
|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 34 L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 113 (192)
T 1w8a_A 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ 113 (192)
T ss_dssp EECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred EECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence 44444444433332 24445555555555555554445555555555555555555555555555555555555555555
Q ss_pred ccCCcCccccCCCCcceEeccCCccccccC
Q 042568 536 LFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 536 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
+++.+|..|..+++|++|++++|++++..+
T Consensus 114 l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 114 ISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 555555555555555555555555554443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.8e-18 Score=191.33 Aligned_cols=66 Identities=14% Similarity=0.171 Sum_probs=43.9
Q ss_pred CCCccccc--------ccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccc
Q 042568 192 IPLKNECE--------LRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSY 259 (983)
Q Consensus 192 ip~~~~~~--------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~ 259 (983)
||...|.+ +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++ .++...|..+.++..+.++.
T Consensus 84 I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~ 157 (329)
T 3sb4_A 84 VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGS 157 (329)
T ss_dssp ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTC
T ss_pred cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcc
Confidence 44555556 77777777777 666666667777777777777777776 66666666666666665554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=4.5e-18 Score=180.65 Aligned_cols=137 Identities=22% Similarity=0.264 Sum_probs=104.8
Q ss_pred CCCCCccccCCcEeEEEEEE-CCCcE--EEEEEeecccCc-----------------------chhHHHHHHHHHHHhcC
Q 042568 669 FCPSSLIGSGRFGHVYKGVL-QDNTR--IAVKVLDLTTTG-----------------------EITGSFKRECQILKRIR 722 (983)
Q Consensus 669 f~~~~~iG~G~~g~Vy~~~~-~~~~~--vAvK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 722 (983)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999997 67888 999987543211 01236889999999999
Q ss_pred CCCc--cceeeEEecCCceeEEEecccC-c----ccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCCeEe
Q 042568 723 HRNL--IRIITICSKPDFKALVLPLMSN-G----SLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH-HHSPIKVVH 794 (983)
Q Consensus 723 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH 794 (983)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|+++|+.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 8864 344432 356899999942 4 44433221 223457889999999999999 885 999
Q ss_pred ecCCCCCeEeCCCCCEEEccccccccc
Q 042568 795 CDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 795 ~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-18 Score=183.56 Aligned_cols=166 Identities=25% Similarity=0.339 Sum_probs=76.8
Q ss_pred CeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
++..++++.|.+++.. .+..+++|++|++++|+++ .++ .+..+++|++|+|++|.+++..+ +..+++|+.|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence 3445555555555322 3455555666666666555 233 45555555555555555554333 5555555555555
Q ss_pred CccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
+|++++. |. +.. ++|+.|++++|++++ ++ .+..+++|+.|++++|++++. + .+..+++|+. |++++|++++.
T Consensus 94 ~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~-L~L~~N~i~~~ 165 (263)
T 1xeu_A 94 RNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEV-LDLHGNEITNT 165 (263)
T ss_dssp SSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCE-EECTTSCCCBC
T ss_pred CCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCE-EECCCCcCcch
Confidence 5555532 21 111 444444444444442 22 244444444444444444432 1 2333444442 44444444332
Q ss_pred Cccccccccccccccccccccc
Q 042568 468 LPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
..+..+++|+.|++++|.++
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEE
T ss_pred --HHhccCCCCCEEeCCCCccc
Confidence 23333333333333333333
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.2e-18 Score=180.71 Aligned_cols=169 Identities=16% Similarity=0.231 Sum_probs=88.0
Q ss_pred CCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEc
Q 042568 355 SKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDL 434 (983)
Q Consensus 355 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L 434 (983)
.++..+++++|.+++.. .+..+++|+.|++++|+++. ++ .+..+++|+.|++++|++++. +. +..+++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEEC
Confidence 33444455555555322 34445555555555555542 22 344455555555555555432 22 444555555555
Q ss_pred cCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccc
Q 042568 435 SHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514 (983)
Q Consensus 435 s~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 514 (983)
++|++++. | .. .. .+|+.|+|++|++++ +| .+..+++|+.|+|++|++++
T Consensus 93 ~~N~l~~l-~-------------------------~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 93 NRNRLKNL-N-------------------------GI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp CSSCCSCC-T-------------------------TC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB
T ss_pred CCCccCCc-C-------------------------cc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC
Confidence 55554432 2 11 11 455555555555553 22 35566666666666666664
Q ss_pred cccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccc
Q 042568 515 LLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 515 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 563 (983)
. + .+..+++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 3 2 455666666666666666644 4566666666666666666554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=168.94 Aligned_cols=151 Identities=17% Similarity=0.254 Sum_probs=80.4
Q ss_pred cccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccc
Q 042568 402 LSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAI 481 (983)
Q Consensus 402 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L 481 (983)
+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|+. |++++|++++..|..+..+++|++|
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~-L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLER-LRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCE-EEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCE-EEeECCccCcccChhhcCCCCCCEE
Confidence 334444444444443 233 3444444444444444333 1123444444443 5555555544444555555555566
Q ss_pred cccccccccCCCcccccccccceEEeCCCc-ccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcc
Q 042568 482 DLSFNNLSGSIPPQLGSCIALESLNLSGNS-LEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560 (983)
Q Consensus 482 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l 560 (983)
+|++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 666666655556666666666666666666 44 344 46666677777777777663 33 566677777777777766
Q ss_pred c
Q 042568 561 S 561 (983)
Q Consensus 561 ~ 561 (983)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.9e-18 Score=186.07 Aligned_cols=298 Identities=17% Similarity=0.179 Sum_probs=172.2
Q ss_pred ccccccccc--CCCCcEEeCcCCcCCCCCccccCC-CCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCC
Q 042568 91 GTISPALAN--LSSLIVLDLSKNFFQGHIPAELGS-LIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPI 167 (983)
Q Consensus 91 g~~~~~l~~--l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~ 167 (983)
|+++..+.. +.+|+.|.++++ +.+.--..+.. +++|+.|||++|+|. .....-+.++.+..+++..|. +|.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~----I~~ 86 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANF----VPA 86 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTE----ECT
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCccccccccccccccccc----cCH
Confidence 444444443 778888988864 22111112333 788999999999998 111112233345666666663 444
Q ss_pred cccccCC--------CcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccc-
Q 042568 168 PIFCSNS--------STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFS- 238 (983)
Q Consensus 168 ~~~~~~~--------l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~- 238 (983)
..| .. +++|+.|+|.+ .++ .|+...|..+++|+.|++++|.+..+.+.+|.++.++.++.+..+...
T Consensus 87 ~aF--~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~ 162 (329)
T 3sb4_A 87 YAF--SNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR 162 (329)
T ss_dssp TTT--EEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH
T ss_pred HHh--cccccccccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh
Confidence 444 45 89999999999 776 788889999999999999999998888899999888888887764321
Q ss_pred --cccchhhhcCCCCcc-EEEccccccccCCCCCCCcc-cccccCCCCCccEEEccCCcccccCCccccccccCeeEEEc
Q 042568 239 --GELPSEIISKMPQLQ-FLYLSYNDFVSHDGNTNLEP-FFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL 314 (983)
Q Consensus 239 --~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L 314 (983)
..+....|..+..|+ .+.+....- +.. ++..-....+++.+.+.++-.. .....+.
T Consensus 163 ~~~~i~~~~f~~~~~L~~~i~~~~~~~--------l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~----------- 222 (329)
T 3sb4_A 163 FKNRWEHFAFIEGEPLETTIQVGAMGK--------LEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIR----------- 222 (329)
T ss_dssp TSTTTTTSCEEESCCCEEEEEECTTCC--------HHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHH-----------
T ss_pred ccccccccccccccccceeEEecCCCc--------HHHHHhhcccCccccceEEEeeeecH-HHHHHHH-----------
Confidence 122333344455555 333332210 000 0000011223333333322110 0000000
Q ss_pred cCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCc-EEEccCccccC
Q 042568 315 DCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG-LLDLSKNKLSG 393 (983)
Q Consensus 315 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~ 393 (983)
..+++|+.|+|++|+++.+.+..|.++++|+.|+|.+| +..+.+.+|.++++|+ .|++.+ .++.
T Consensus 223 -------------~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~ 287 (329)
T 3sb4_A 223 -------------DYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTA 287 (329)
T ss_dssp -------------HHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCE
T ss_pred -------------HhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceE
Confidence 12455666666666665444455666666666666665 5555555666666666 666666 5554
Q ss_pred cCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEE
Q 042568 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILD 433 (983)
Q Consensus 394 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 433 (983)
+.+.+|.++++|+.|++++|.++...+..|.++++|+.++
T Consensus 288 I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 288 IEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp ECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5556666666666666666666655555666666666665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.7e-17 Score=167.22 Aligned_cols=154 Identities=23% Similarity=0.317 Sum_probs=88.3
Q ss_pred ccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCE
Q 042568 352 CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431 (983)
Q Consensus 352 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 431 (983)
..+++|++|++++|.+. .+| .+..+++|+.|++++|.++. +..+..++ +|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~------------------------~L~~ 92 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLS------------------------NLER 92 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCT------------------------TCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCC------------------------CCCE
Confidence 45667777777777776 344 46666666666666665532 22344444 4555
Q ss_pred EEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCc
Q 042568 432 LDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNS 511 (983)
Q Consensus 432 L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 511 (983)
|++++|++++..|..+..+++|+. |++++|++++..|..+..+++|+.|+|++|++.+.+| .+..+++|+.|++++|+
T Consensus 93 L~l~~n~l~~~~~~~l~~l~~L~~-L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 93 LRIMGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170 (197)
T ss_dssp EEEECTTCBGGGSCCCTTCTTCCE-EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBC
T ss_pred EEeECCccCcccChhhcCCCCCCE-EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCC
Confidence 555555554444444455555553 5555555554445555555566666666665222444 46666777777777777
Q ss_pred ccccccccccCCCCccEEecCCcccc
Q 042568 512 LEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 512 l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
+++ ++ .+..+++|+.|++++|++.
T Consensus 171 i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 171 VHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CcC-hH-HhccCCCCCEEEeeCcccC
Confidence 764 33 5666777777777777764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=4.5e-17 Score=164.62 Aligned_cols=175 Identities=19% Similarity=0.215 Sum_probs=107.6
Q ss_pred hhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCc-cccCCCccceeccccCCCCCCCCcccccccccccccccc
Q 042568 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPS-DVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLS 484 (983)
Q Consensus 406 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 484 (983)
+.+++++|.++ .+|..+.. +|+.|++++|++++..+. .+..+++|+. |+|++|+|++..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVK-LELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCE-EECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCE-EECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 34455555554 44443322 566666666666654443 3566666664 6666666666666667777777777777
Q ss_pred ccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCcc-ccCCCCcceEeccCCccccc
Q 042568 485 FNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQS-FQASPTLKQLNFSFNKFSGN 563 (983)
Q Consensus 485 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~ 563 (983)
+|+|++..|..|..+++|+.|+|++|+|++.+|..+..+++|+.|+|++|++++..+.. +.. .++...+..+...+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~--~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE--WLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH--HHHHHCCSGGGCBBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH--HHHHcCCCCCCCCCC
Confidence 77777666666777777888888888887777777777888888888888877665521 111 122223334444333
Q ss_pred cCCCCCCcccccccccCCcCccCCC
Q 042568 564 ISNKGAFSSLTIASFQGNDGLCGEI 588 (983)
Q Consensus 564 ~~~~~~~~~~~~~~~~~N~~lc~~~ 588 (983)
.|. .+......++..+...|..+
T Consensus 165 ~P~--~l~~~~l~~l~~~~~~C~~~ 187 (192)
T 1w8a_A 165 APS--KVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp SST--TTTTSBGGGSCTTTCCCCCC
T ss_pred CCh--HHcCCChhhCcHhhcCcCCC
Confidence 332 34555556666676667654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=156.81 Aligned_cols=134 Identities=22% Similarity=0.211 Sum_probs=74.3
Q ss_pred CCCCcEEeCcCCcCC-CCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccc
Q 042568 100 LSSLIVLDLSKNFFQ-GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSL 178 (983)
Q Consensus 100 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 178 (983)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..++.+++|++|+|++|++++.+|..+. .+++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L 97 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAE---KLPNL 97 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHH---HCTTC
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHh---hCCCC
Confidence 356666666666666 56666666666666666666666643 5566666666666666666644443321 24444
Q ss_pred ceeecccccccCCCCCcccccccccceeecccCccccccc---hhhhccCCcceecccccccc
Q 042568 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP---QALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 179 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~ 238 (983)
++|+|++|.+++..+...+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 4444444444432111334455555555555555554433 34555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.5e-16 Score=157.22 Aligned_cols=130 Identities=23% Similarity=0.303 Sum_probs=95.4
Q ss_pred CEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCC
Q 042568 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509 (983)
Q Consensus 430 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 509 (983)
+.+++++|+++ .+|..+. +.++. |++++|+|+ .+|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~-L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTE-LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCE-EECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCE-EECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 45666666665 3444332 34554 677777776 5566777777777788888888766667788888888888888
Q ss_pred CcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcccccc
Q 042568 510 NSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNI 564 (983)
Q Consensus 510 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 564 (983)
|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 8888777778888888888888888888555567888888888888888887644
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.5e-16 Score=150.34 Aligned_cols=128 Identities=23% Similarity=0.260 Sum_probs=70.8
Q ss_pred CCCCcEEeCcCCcCC-CCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccc
Q 042568 100 LSSLIVLDLSKNFFQ-GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSL 178 (983)
Q Consensus 100 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L 178 (983)
.++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~--------- 84 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA--------- 84 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH---------
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh---------
Confidence 356667777777766 56666666677777777777776643 556666666666666666664344322
Q ss_pred ceeecccccccCCCCCcccccccccceeecccCccccc-cchhhhccCCcceecccccccccccch---hhhcCCCCccE
Q 042568 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQ-VPQALANSSKLEWLDLESNMFSGELPS---EIISKMPQLQF 254 (983)
Q Consensus 179 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~L~~ 254 (983)
..+++|++|++++|++++. .+..++.+++|++|++++|++++ +|. ..+..+++|++
T Consensus 85 -------------------~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 85 -------------------EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTY 144 (149)
T ss_dssp -------------------HHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG-STTHHHHHHHHCTTCCE
T ss_pred -------------------hhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc-hHHHHHHHHHHCCCccc
Confidence 1234444444444444432 22445555555555555555542 222 34455555555
Q ss_pred EEcc
Q 042568 255 LYLS 258 (983)
Q Consensus 255 L~Ls 258 (983)
|+++
T Consensus 145 L~l~ 148 (149)
T 2je0_A 145 LDGY 148 (149)
T ss_dssp ETTB
T ss_pred ccCC
Confidence 5544
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.8e-16 Score=151.61 Aligned_cols=136 Identities=24% Similarity=0.212 Sum_probs=107.1
Q ss_pred CCCCEEEccCcccc-CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceE
Q 042568 427 VNLEILDLSHNKIS-GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL 505 (983)
Q Consensus 427 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 505 (983)
++|+.|++++|+++ +.+|..+..+++|+. |++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~-L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEF-LSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCE-EEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCE-EeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 56778888888877 667777777777775 88888887765 677788888888888888887778777778888888
Q ss_pred EeCCCcccccc-cccccCCCCccEEecCCccccCCcC---ccccCCCCcceEeccCCccccccC
Q 042568 506 NLSGNSLEGLL-PVSVGQLPYLKQFDVSSNRLFGEIP---QSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 506 ~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
+|++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+...+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 88888888643 2678888889999999998885544 478888899999999888765543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=5.9e-16 Score=169.93 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=101.1
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-------------chhH--------HHHHHHHHHHhcCCCCc
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-------------EITG--------SFKRECQILKRIRHRNL 726 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-------------~~~~--------~~~~E~~~l~~l~h~ni 726 (983)
-|.+...||+|+||.||+|...+|+.||||+++..... .... ...+|...+.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 37788999999999999999989999999987532110 0011 12346667777755544
Q ss_pred cceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 727 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
....-+.. ...++||||++|+++.++... .....++.|++.++.|||+.| ||||||||.|||+++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 32221211 133799999999888765431 124568899999999999986 999999999999987
Q ss_pred CC----------CEEEccccccccc
Q 042568 807 DL----------TALVADFGIAKLV 821 (983)
Q Consensus 807 ~~----------~~kl~Dfgla~~~ 821 (983)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999987643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.8e-15 Score=149.65 Aligned_cols=127 Identities=28% Similarity=0.326 Sum_probs=96.1
Q ss_pred EEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCcc
Q 042568 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNK 390 (983)
Q Consensus 311 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 390 (983)
.+++++|.++ .+|..+. ++|++|+|++|+++ .+|..+..+++|++|+|++|.|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4566666665 4555443 46778888888877 566777888888888888888887777778888888888888888
Q ss_pred ccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccC
Q 042568 391 LSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 391 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
|++..|..|..+++|+.|+|++|.|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 887777778888888888888888876555567788888888888888764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-15 Score=147.34 Aligned_cols=128 Identities=23% Similarity=0.296 Sum_probs=86.5
Q ss_pred CCCCEEEccCcccc-CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceE
Q 042568 427 VNLEILDLSHNKIS-GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL 505 (983)
Q Consensus 427 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 505 (983)
++|+.|++++|.++ +.+|..+..+++|+. |++++|.+++. ..+..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~-L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEF-LSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCE-EECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcE-EECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 34555666666655 455555555556654 66666666544 556666677777777777776677777777778888
Q ss_pred EeCCCccccc-ccccccCCCCccEEecCCccccCCcC---ccccCCCCcceEeccC
Q 042568 506 NLSGNSLEGL-LPVSVGQLPYLKQFDVSSNRLFGEIP---QSFQASPTLKQLNFSF 557 (983)
Q Consensus 506 ~Ls~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~l~l~~ 557 (983)
++++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|++|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888887763 34677778888888888888875544 4677788888887763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.8e-15 Score=147.05 Aligned_cols=132 Identities=19% Similarity=0.216 Sum_probs=85.0
Q ss_pred CEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCC
Q 042568 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSG 509 (983)
Q Consensus 430 ~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 509 (983)
+.+++++|+++ .+|..+ .++++. |++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~-L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATR-LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSE-EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcE-EEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 44555555555 233222 134443 56666666555555556666666677777777655455567777777777777
Q ss_pred CcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccC
Q 042568 510 NSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 510 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
|++++..+..+..+++|+.|++++|++++..+..|..+++|++|++++|++++.+|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 77776666667777777777777777775555556777778888888887777655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.6e-15 Score=145.46 Aligned_cols=129 Identities=24% Similarity=0.287 Sum_probs=72.6
Q ss_pred EEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCcc
Q 042568 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNK 390 (983)
Q Consensus 311 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 390 (983)
.+++++|.++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|.+++..+..|..+++|+.|+|++|+
T Consensus 11 ~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 4444444444 2333222 455666666666654444445556666666666666665555555666666666666666
Q ss_pred ccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc
Q 042568 391 LSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 391 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 6655555555666666666666666544444455566666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-16 Score=162.86 Aligned_cols=156 Identities=26% Similarity=0.326 Sum_probs=104.2
Q ss_pred cccCCCCcEEeCcCCcCCCCCcc------ccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCccc
Q 042568 97 LANLSSLIVLDLSKNFFQGHIPA------ELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIF 170 (983)
Q Consensus 97 l~~l~~L~~L~Ls~n~l~~~~p~------~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~ 170 (983)
+.....++.++++.+.++|.+|. .++.+++|++|+|++|.|++ +| .++.+++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44555666666666666666665 67777777777777777774 55 6777777777777777776 5554332
Q ss_pred ccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccc-hhhhccCCcceecccccccccccch------
Q 042568 171 CSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP-QALANSSKLEWLDLESNMFSGELPS------ 243 (983)
Q Consensus 171 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~------ 243 (983)
.+++|++|+|++|.+++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.+|.
T Consensus 91 ---~~~~L~~L~L~~N~l~~-l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 164 (198)
T 1ds9_A 91 ---VADTLEELWISYNQIAS-LS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164 (198)
T ss_dssp ---HHHHCSEEEEEEEECCC-HH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHH
T ss_pred ---cCCcCCEEECcCCcCCc-CC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHH
Confidence 45667777777777664 33 35577788888888888775433 4677888888888888888755443
Q ss_pred ---hhhcCCCCccEEEccccccc
Q 042568 244 ---EIISKMPQLQFLYLSYNDFV 263 (983)
Q Consensus 244 ---~~~~~l~~L~~L~Ls~N~l~ 263 (983)
..+..+++|++|+ +|.+.
T Consensus 165 ~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 165 YRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHHHhCCCcEEEC--CcccC
Confidence 2456677777765 44443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.55 E-value=8.5e-14 Score=156.95 Aligned_cols=238 Identities=13% Similarity=0.131 Sum_probs=102.4
Q ss_pred cceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEc
Q 042568 178 LQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYL 257 (983)
Q Consensus 178 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 257 (983)
|+.+.+..| ++ .|+...|.+ .+|+.+.+.. .++.+.+.+|.++++|+.++|++|+++ .++...|. ..+|+.+.|
T Consensus 137 L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 137 IAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEEC
T ss_pred ccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-ecccCEEEe
Confidence 444444433 22 334444433 2455555543 444444455555555555555555555 45555444 345555555
Q ss_pred cccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEe
Q 042568 258 SYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337 (983)
Q Consensus 258 s~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 337 (983)
..+ +..+.. .+|.++++|+.+++..| ++..-...|.. ++|+.+.+ .+.++...+..|.++++|+.++
T Consensus 211 p~~-l~~I~~--------~aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~ 277 (401)
T 4fdw_A 211 PVT-LKEIGS--------QAFLKTSQLKTIEIPEN-VSTIGQEAFRE--SGITTVKL-PNGVTNIASRAFYYCPELAEVT 277 (401)
T ss_dssp CTT-CCEECT--------TTTTTCTTCCCEECCTT-CCEECTTTTTT--CCCSEEEE-ETTCCEECTTTTTTCTTCCEEE
T ss_pred CCc-hheehh--------hHhhCCCCCCEEecCCC-ccCcccccccc--CCccEEEe-CCCccEEChhHhhCCCCCCEEE
Confidence 432 322221 23444455555555442 22222222222 24444444 2333333344555555555555
Q ss_pred ccccccC-----CCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccC
Q 042568 338 LSSNLLN-----GTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYG 412 (983)
Q Consensus 338 Ls~N~l~-----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 412 (983)
+.+|.+. ...+..|.++++|+.++|.+ .+..+...+|.++++|+.++|..| ++.+...+|.++ +|+.+.+.+
T Consensus 278 l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~ 354 (401)
T 4fdw_A 278 TYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEG 354 (401)
T ss_dssp EESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECC
T ss_pred eCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcC
Confidence 5554443 12233344444444444442 233333444444444444444332 333333444444 444444444
Q ss_pred ccCCCCCcccccCCC-CCCEEEccCc
Q 042568 413 NHLSGTIPSSLGKCV-NLEILDLSHN 437 (983)
Q Consensus 413 N~l~~~~p~~l~~l~-~L~~L~Ls~N 437 (983)
|.+....+..|..++ +++.|++..+
T Consensus 355 n~~~~l~~~~F~~~~~~l~~l~vp~~ 380 (401)
T 4fdw_A 355 TTPPQVFEKVWYGFPDDITVIRVPAE 380 (401)
T ss_dssp SSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred CCCcccccccccCCCCCccEEEeCHH
Confidence 444333333333332 3444444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.7e-16 Score=161.30 Aligned_cols=154 Identities=20% Similarity=0.296 Sum_probs=114.7
Q ss_pred cCcccchhhcccCccCCCCCcc------cccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccc
Q 042568 400 ANLSQLRRLLLYGNHLSGTIPS------SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELS 473 (983)
Q Consensus 400 ~~l~~L~~L~l~~N~l~~~~p~------~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~ 473 (983)
.....++.++++.|.++|..|. .+..+++|++|++++|++++ +| .+..+++|+. |++++|+++ .+|..+.
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~-L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRI-LSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCE-EEEEEEEEC-SCSSHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCE-EECCCCCcc-cccchhh
Confidence 3445666666666666666665 77888888888888888875 55 7777777875 888888887 5677777
Q ss_pred cccccccccccccccccCCCcccccccccceEEeCCCccccccc-ccccCCCCccEEecCCccccCCcCcc---------
Q 042568 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLP-VSVGQLPYLKQFDVSSNRLFGEIPQS--------- 543 (983)
Q Consensus 474 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~--------- 543 (983)
.+++|+.|+|++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.|++++|++++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 77888888888888885 45 57788888888888888885333 46778888888888888887766653
Q ss_pred -ccCCCCcceEeccCCccc
Q 042568 544 -FQASPTLKQLNFSFNKFS 561 (983)
Q Consensus 544 -~~~l~~L~~l~l~~N~l~ 561 (983)
+..+++|+.|| +|+++
T Consensus 169 ~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 169 VVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHCSSCSEEC--CGGGT
T ss_pred HHHhCCCcEEEC--CcccC
Confidence 77788888776 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-14 Score=143.19 Aligned_cols=135 Identities=21% Similarity=0.266 Sum_probs=81.5
Q ss_pred cccccCCCCcEEeCcCCcCCCCCccccCCCC-CCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccC
Q 042568 95 PALANLSSLIVLDLSKNFFQGHIPAELGSLI-RLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173 (983)
Q Consensus 95 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~ 173 (983)
+.+.++++|++|+|++|.++ .+|. +..+. +|++|+|++|.|++ + ..|+.+++|++|+|++|+++ .+|..++ .
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~--~ 85 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLD--Q 85 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHH--H
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchh--h
Confidence 34566777778888888777 4443 44444 77778887777774 3 56777777777777777776 3444332 2
Q ss_pred CCcccceeecccccccCCCCC-cccccccccceeecccCccccccch----hhhccCCcceecccccccc
Q 042568 174 SSTSLQYIDLSNNSLTGEIPL-KNECELRNLRFLLLWSNRLVGQVPQ----ALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 174 ~l~~L~~L~Ls~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~ 238 (983)
.+++|++|+|++|.++ .+|. ..+..+++|++|++++|.++. +|. .+..+++|++||+++|.+.
T Consensus 86 ~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 86 ALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp HCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred cCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 4555666666666554 2332 344455566666666666552 333 2555666666666665554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.7e-13 Score=154.44 Aligned_cols=241 Identities=12% Similarity=0.115 Sum_probs=125.8
Q ss_pred CccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEe
Q 042568 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362 (983)
Q Consensus 283 ~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 362 (983)
+|+.+.+..+ ++..-...|.+ .+|+.+.+.. .+....+..|.++++|+.+++++|+++......|. ..+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~--~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN--STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT--CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred CccEEEeCCC-ccEECHHhcCC--CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence 4666665544 43333333333 2355555543 33333344455555555555555555432222333 344555555
Q ss_pred eCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCc
Q 042568 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 442 (983)
.++ +..+...+|.++++|+.++|..| ++.+...+|.+ .+|+.+.+ .|.++.+
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-------------------------~~L~~i~l-p~~i~~I 262 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-------------------------SGITTVKL-PNGVTNI 262 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-------------------------CCCSEEEE-ETTCCEE
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-------------------------CCccEEEe-CCCccEE
Confidence 422 33344444555555555555443 23233333433 34444444 2333333
Q ss_pred CCccccCCCccceeccccCCCCC-----CCCccccccccccccccccccccccCCCcccccccccceEEeCCCccccccc
Q 042568 443 IPSDVAGLRSLKLYLNLSSNHLD-----GPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLP 517 (983)
Q Consensus 443 ~p~~~~~l~~L~~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 517 (983)
.+..|.++.+|+. +++.+|.+. ...+..|.++.+|+.++|. |.++..-...|.++.+|+.++|..| ++.+-+
T Consensus 263 ~~~aF~~c~~L~~-l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~ 339 (401)
T 4fdw_A 263 ASRAFYYCPELAE-VTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINF 339 (401)
T ss_dssp CTTTTTTCTTCCE-EEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred ChhHhhCCCCCCE-EEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence 3444444444443 444444432 2344566667777777776 3455444556777777888777544 665566
Q ss_pred ccccCCCCccEEecCCccccCCcCccccCCC-CcceEeccCCcc
Q 042568 518 VSVGQLPYLKQFDVSSNRLFGEIPQSFQASP-TLKQLNFSFNKF 560 (983)
Q Consensus 518 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l 560 (983)
..|.++ +|+.+++++|.+....+..|..++ .++.|++..|.+
T Consensus 340 ~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 340 SAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred HhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 677777 788888888777655556677664 567777766554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=2.7e-14 Score=142.02 Aligned_cols=133 Identities=18% Similarity=0.142 Sum_probs=88.3
Q ss_pred ccCCCCCCEEEccCccccCcCCccccCCC-ccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccc
Q 042568 423 LGKCVNLEILDLSHNKISGIIPSDVAGLR-SLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA 501 (983)
Q Consensus 423 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 501 (983)
+.++++|+.|++++|+++. +|. +..+. +|+. |++++|.+++. ..+..+++|+.|+|++|+|++..|..+..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~-L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDA-IDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSE-EECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCE-EECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3445555666666665553 333 23332 5553 66666666543 45666677777777777777544444577788
Q ss_pred cceEEeCCCcccccccc--cccCCCCccEEecCCccccCCcCcc----ccCCCCcceEeccCCcccc
Q 042568 502 LESLNLSGNSLEGLLPV--SVGQLPYLKQFDVSSNRLFGEIPQS----FQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 502 L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~~ 562 (983)
|+.|+|++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|++|++++|....
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 888888888886 4554 6778888888888888887 55654 7888888888888887653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.9e-12 Score=145.13 Aligned_cols=311 Identities=13% Similarity=0.069 Sum_probs=157.4
Q ss_pred ccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccC
Q 042568 94 SPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173 (983)
Q Consensus 94 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~ 173 (983)
..++.++++|+.+.|.. .++..-..+|.++++|+.++|..+ ++..-..+|.++++|+.+.+..+ +. .+....| .
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~-~i~~~aF--~ 137 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LK-SIGVEAF--K 137 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CC-EECTTTT--T
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-ee-eecceee--e
Confidence 34688888899888875 366444567888889999988755 55455667888888888777655 32 3333333 2
Q ss_pred CCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCcc
Q 042568 174 SSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQ 253 (983)
Q Consensus 174 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~ 253 (983)
....+......... .+....|..+++|+.+.+.++. ..+...+|.++.+|+.+++..| ++ .++...+..+..|+
T Consensus 138 ~~~~~~~~~~~~~~---~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 138 GCDFKEITIPEGVT---VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLE 211 (394)
T ss_dssp TCCCSEEECCTTCC---EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCC
T ss_pred cccccccccCcccc---ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccc
Confidence 23222222222221 3445566777778888776553 3355667777778888877766 43 56666677777777
Q ss_pred EEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcc
Q 042568 254 FLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333 (983)
Q Consensus 254 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L 333 (983)
.+.+..+.... ........+|+.+.+..+ ++..-...+... ..++.+.+..+... .....|..+..+
T Consensus 212 ~i~~~~~~~~i----------~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~-~~l~~~~~~~~~~~-i~~~~F~~~~~l 278 (394)
T 4fs7_A 212 NMEFPNSLYYL----------GDFALSKTGVKNIIIPDS-FTELGKSVFYGC-TDLESISIQNNKLR-IGGSLFYNCSGL 278 (394)
T ss_dssp BCCCCTTCCEE----------CTTTTTTCCCCEEEECTT-CCEECSSTTTTC-SSCCEEEECCTTCE-ECSCTTTTCTTC
T ss_pred eeecCCCceEe----------ehhhcccCCCceEEECCC-ceeccccccccc-ccceeEEcCCCcce-eecccccccccc
Confidence 76665543211 111223345555554332 111111111111 23444444433222 233344444444
Q ss_pred cEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCc
Q 042568 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 413 (983)
+.+....+.+. ...+..+.+|+.+.+.++ +..+...+|.++++|+.++|.++ ++.+...+|.++++|+.+.+..|
T Consensus 279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred ceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 44444433221 123344444444444433 33333344444444444444322 33233344444444444444333
Q ss_pred cCCCCCcccccCCCCCCEEEcc
Q 042568 414 HLSGTIPSSLGKCVNLEILDLS 435 (983)
Q Consensus 414 ~l~~~~p~~l~~l~~L~~L~Ls 435 (983)
++..-..+|.++++|+.+++.
T Consensus 354 -l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 354 -LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp -CCEECTTTBTTCTTCCEEEEE
T ss_pred -ccEehHHHhhCCCCCCEEEEC
Confidence 332223344444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.5e-12 Score=147.42 Aligned_cols=60 Identities=10% Similarity=-0.009 Sum_probs=32.1
Q ss_pred CCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccc
Q 042568 173 NSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235 (983)
Q Consensus 173 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 235 (983)
.++++|+.+.+..+ ++ .|+...|.++++|+.+++.++ ++.+...+|.++++|+.+.+..+
T Consensus 68 ~~c~~L~~i~lp~~-i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~ 127 (394)
T 4fs7_A 68 QGCRKVTEIKIPST-VR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM 127 (394)
T ss_dssp TTCTTEEEEECCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hCCCCceEEEeCCC-cc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc
Confidence 34556666666533 33 455555555666666666543 44344455555566655555433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.42 E-value=3e-13 Score=133.40 Aligned_cols=106 Identities=20% Similarity=0.224 Sum_probs=65.8
Q ss_pred ccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccc
Q 042568 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536 (983)
Q Consensus 457 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 536 (983)
+++++|.++. +|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 14 l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 4444454442 333332 4556666666666655566666666666777777776665555566677777777777777
Q ss_pred cCCcCccccCCCCcceEeccCCccccccC
Q 042568 537 FGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 537 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
++..|..|..+++|++|+|++|++++..+
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 65555566677777777777777665544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=4.7e-13 Score=132.44 Aligned_cols=106 Identities=18% Similarity=0.229 Sum_probs=70.0
Q ss_pred ccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccc
Q 042568 457 LNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536 (983)
Q Consensus 457 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 536 (983)
+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 17 l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l 93 (174)
T 2r9u_A 17 VNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL 93 (174)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence 555555554 3444433 5566667777777666666677777777777777777765555567777777777777777
Q ss_pred cCCcCccccCCCCcceEeccCCccccccC
Q 042568 537 FGEIPQSFQASPTLKQLNFSFNKFSGNIS 565 (983)
Q Consensus 537 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 565 (983)
++..+..|..+++|++|+|++|++.+.++
T Consensus 94 ~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 94 KSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 75444557777777777777777765544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.40 E-value=7.6e-13 Score=130.49 Aligned_cols=105 Identities=25% Similarity=0.341 Sum_probs=65.0
Q ss_pred cEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCc
Q 042568 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 413 (983)
+.+++++|.++ .+|..+ .++|++|+|++|.|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45555555555 344433 255666666666666666666666666666666666666555555666666666666666
Q ss_pred cCCCCCcccccCCCCCCEEEccCccccC
Q 042568 414 HLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 414 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
+|++..+..|..+++|+.|+|++|++++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 6665555556667777777777777664
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=128.54 Aligned_cols=104 Identities=27% Similarity=0.378 Sum_probs=59.5
Q ss_pred cEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCc
Q 042568 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413 (983)
Q Consensus 334 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 413 (983)
+.+++++|+++ .+|..+. ++|++|+|++|.|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34555555554 3343332 45555555555555555555666666666666666666544444556666666666666
Q ss_pred cCCCCCcccccCCCCCCEEEccCcccc
Q 042568 414 HLSGTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 414 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
+|++..+..|..+++|+.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666444444666666666666666666
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.8e-12 Score=141.53 Aligned_cols=109 Identities=22% Similarity=0.266 Sum_probs=90.1
Q ss_pred cceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcC-CcCCCCCccccCCCCCCCEEeccCccCCCCchh
Q 042568 65 CNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSK-NFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPS 143 (983)
Q Consensus 65 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 143 (983)
|.|.+|.|++. +++. .+|. +..+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 88888887542 1565 4788 99999999999996 999987778999999999999999999998899
Q ss_pred hhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccC
Q 042568 144 QLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTG 190 (983)
Q Consensus 144 ~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~ 190 (983)
.|++|++|++|||++|+|+ .+|..++ ..++ |+.|+|++|.+..
T Consensus 75 ~~~~l~~L~~L~l~~N~l~-~~~~~~~--~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALE-SLSWKTV--QGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTT--CSCC-CCEEECCSSCCCC
T ss_pred HhcCCcCCCEEeCCCCccc-eeCHHHc--ccCC-ceEEEeeCCCccC
Confidence 9999999999999999998 5666554 2233 7777777777763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.1e-13 Score=154.51 Aligned_cols=168 Identities=20% Similarity=0.108 Sum_probs=76.6
Q ss_pred CCCcEEeCcCCcCCCCCcccc----C-CCCCCCEEeccCccCCCCchhhh-cccccccEEeccCcccccccCCcccccCC
Q 042568 101 SSLIVLDLSKNFFQGHIPAEL----G-SLIRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCSNS 174 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~----~-~l~~L~~L~Ls~n~l~~~~p~~~-~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~ 174 (983)
++|++|+|++|.++......+ . ..++|++|+|++|.|+......+ ..+++|++|+|++|.++......+..
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~--- 148 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRD--- 148 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHH---
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHH---
Confidence 456666666666654322222 1 12456666666666653322222 23455666666666554221111110
Q ss_pred CcccceeecccccccCCCCCccc-ccccccceeecccCcccc----ccchhhhccCCcceecccccccccccc---hhhh
Q 042568 175 STSLQYIDLSNNSLTGEIPLKNE-CELRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSGELP---SEII 246 (983)
Q Consensus 175 l~~L~~L~Ls~N~l~~~ip~~~~-~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~---~~~~ 246 (983)
.+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|.|++.-. ...+
T Consensus 149 ---------------------~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L 207 (372)
T 3un9_A 149 ---------------------LLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207 (372)
T ss_dssp ---------------------HHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG
T ss_pred ---------------------HHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH
Confidence 00 123445555555555543 223334555566666666666542110 1223
Q ss_pred cCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccc
Q 042568 247 SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296 (983)
Q Consensus 247 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~ 296 (983)
...++|++|+|++|.|.... ...+...+..+++|++|+|++|.+++
T Consensus 208 ~~~~~L~~L~Ls~N~i~~~g----~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 208 DRNRQLQELNVAYNGAGDTA----ALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp GGCSCCCEEECCSSCCCHHH----HHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred hcCCCcCeEECCCCCCCHHH----HHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 44455555555555543211 11222333344555555555555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.2e-13 Score=149.78 Aligned_cols=113 Identities=20% Similarity=0.197 Sum_probs=76.8
Q ss_pred CeEEEEEcccCCccccccccccc-----CCCCcEEeCcCCcCCCCCcccc-CCCCCCCEEeccCccCCCCchhhhc----
Q 042568 77 NKVVELDLSARSIYGTISPALAN-----LSSLIVLDLSKNFFQGHIPAEL-GSLIRLKQLSLSWNSLQGKIPSQLG---- 146 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~-----l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~p~~~~---- 146 (983)
..++.|+|++|.++......+.. .++|++|+|++|.++......+ ..+++|++|+|++|.|+......+.
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 35889999999998654444333 3799999999999985433333 3567899999999999865555553
Q ss_pred -ccccccEEeccCcccccccCCccc-ccCCCcccceeeccccccc
Q 042568 147 -SLHQLEYLDLGNNKLVGEIPIPIF-CSNSSTSLQYIDLSNNSLT 189 (983)
Q Consensus 147 -~L~~L~~L~Ls~N~l~~~~p~~~~-~~~~l~~L~~L~Ls~N~l~ 189 (983)
..++|++|+|++|.|+......+. .+..+++|++|+|++|.++
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 457899999999998732111111 1123455666666666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.1e-11 Score=137.79 Aligned_cols=103 Identities=20% Similarity=0.173 Sum_probs=54.3
Q ss_pred ccccCC-CCCCCCccccccccccccccccc-cccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCc
Q 042568 457 LNLSSN-HLDGPLPLELSKMDMVLAIDLSF-NNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534 (983)
Q Consensus 457 L~l~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 534 (983)
++++++ +|++ +|. +..+++|+.|+|++ |+|++..|..|+.+++|+.|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 444444 4442 444 55555555555553 5555444455555555555555555555555555555555555555555
Q ss_pred cccCCcCccccCCCCcceEeccCCcccc
Q 042568 535 RLFGEIPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 535 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
+|++..|..|..++ |+.|+|.+|+|.+
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 55543333444333 5555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-09 Score=122.80 Aligned_cols=308 Identities=13% Similarity=0.156 Sum_probs=143.3
Q ss_pred ccccCC-CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCcc---CCCCchhhhcccccccEEeccCcccccccCCcccc
Q 042568 96 ALANLS-SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS---LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFC 171 (983)
Q Consensus 96 ~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~---l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~ 171 (983)
++.+.. .|+.+.+..+ ++..-..+|.++++|+.+.++.|. ++..-..+|..+.+|+.+.+..+ ++ .++...+
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~aF- 133 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEAF- 133 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTTT-
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhhh-
Confidence 455553 4666666543 443344566666666666666553 44333455666666666555443 22 2333222
Q ss_pred cCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCC
Q 042568 172 SNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQ 251 (983)
Q Consensus 172 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 251 (983)
..+.+|+.+.+..+.- .++...|....+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-. .+....+..+..
T Consensus 134 -~~c~~L~~i~lp~~~~--~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~--~i~~~af~~c~~ 206 (394)
T 4gt6_A 134 -HHCEELDTVTIPEGVT--SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT--RIGTNAFSECFA 206 (394)
T ss_dssp -TTCTTCCEEECCTTCC--EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC--EECTTTTTTCTT
T ss_pred -hhhcccccccccceee--eecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc--ccccchhhhccc
Confidence 3445555555543221 334444444555555555433 22233333332 3444444443322 223333444444
Q ss_pred ccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCC
Q 042568 252 LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLV 331 (983)
Q Consensus 252 L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~ 331 (983)
++......+.....+... +. ........... .+. ...+..+.+. +.+.......|.++.
T Consensus 207 l~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~-------~~~-----~~~~~~~~ip-~~v~~i~~~aF~~c~ 265 (394)
T 4gt6_A 207 LSTITSDSESYPAIDNVL-----YE---KSANGDYALIR-------YPS-----QREDPAFKIP-NGVARIETHAFDSCA 265 (394)
T ss_dssp CCEEEECCSSSCBSSSCE-----EE---ECTTSCEEEEE-------CCT-----TCCCSEEECC-TTEEEECTTTTTTCS
T ss_pred cceeccccccccccccee-----ec---ccccccccccc-------ccc-----ccccceEEcC-CcceEcccceeeecc
Confidence 444443333222111100 00 00000000000 000 0111222221 122223344566667
Q ss_pred cccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
+|+.+.+.++..+ .....|.+++.|+.+.+. +.+..+...+|.++.+|+.++|..+ ++.+...+|.++++|+.+.+.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEC
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEEC
Confidence 7777777655433 444556666777777764 3444455566677777777777654 444445566666666666665
Q ss_pred CccCCCCCcccccCCCCCCEEEccCccc
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKI 439 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 439 (983)
.+ ++..-..+|.++++|+.+++.+|..
T Consensus 343 ~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 343 SS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred cc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 43 4434445666666666666666543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.9e-09 Score=121.81 Aligned_cols=108 Identities=18% Similarity=0.290 Sum_probs=50.5
Q ss_pred cccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccc
Q 042568 422 SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA 501 (983)
Q Consensus 422 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 501 (983)
.|.++++|+.+.+. +.++.+....|.++.+|+. +++..+ ++..-..+|.++.+|+.+.|..+ ++..-...|.++.+
T Consensus 283 aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~-i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~ 358 (394)
T 4gt6_A 283 AFMNCPALQDIEFS-SRITELPESVFAGCISLKS-IDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA 358 (394)
T ss_dssp TTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCE-EECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred ccccccccccccCC-CcccccCceeecCCCCcCE-EEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence 34444444444443 2233233344444445543 444432 33333445666666666666433 44233456777777
Q ss_pred cceEEeCCCcccccccccccCCCCccEEecCCccc
Q 042568 502 LESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRL 536 (983)
Q Consensus 502 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 536 (983)
|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 359 L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 359 LNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp CCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 7777777765432 3455666777777666644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.3e-10 Score=123.49 Aligned_cols=146 Identities=16% Similarity=0.128 Sum_probs=113.8
Q ss_pred HHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeE
Q 042568 663 IEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 663 ~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 741 (983)
...-++|......+.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++...+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 334457877888888999999999865 68899999864321 12356899999999995 6778899999988888999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc----------------------------------
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH---------------------------------- 787 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~---------------------------------- 787 (983)
||||++|.++.+.+.. ......++.+++++++.||+.
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999998775321 112347889999999999981
Q ss_pred ----------------------CCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 788 ----------------------SPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 788 ----------------------~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
.+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11348999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=2.3e-10 Score=121.56 Aligned_cols=137 Identities=16% Similarity=0.107 Sum_probs=102.2
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC--ccceeeEEecCCceeEEEec
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN--LIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 745 (983)
++....+.+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+++.+ +.+++++....+..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 34433333456669999998777888999997543 2356889999999996545 45688888887788999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC-------------------------------------
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS------------------------------------- 788 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------- 788 (983)
++|.++. ... .+ ...++.++++.++.||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 221 11 2367788888888888743
Q ss_pred ------------------CCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 789 ------------------PIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 789 ------------------~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+..++|+|++|.||+++++..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.5e-09 Score=119.20 Aligned_cols=143 Identities=13% Similarity=0.225 Sum_probs=107.8
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEee--cccCcchhHHHHHHHHHHHhcC--CCCccceeeEEecC---CceeEEEe
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLD--LTTTGEITGSFKRECQILKRIR--HRNLIRIITICSKP---DFKALVLP 744 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 744 (983)
.+.++.|.++.||+.... +..+++|+.. ..........+.+|+++++.++ +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 567899999999999876 4678888875 3222123457889999999997 45578889888766 44799999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC------------------------------------
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS------------------------------------ 788 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------ 788 (983)
|++|..+.+.. ...++...+..++.+++++|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998875422 123678888999999999999999721
Q ss_pred -------------------CCCeEeecCCCCCeEeCCCCC--EEEccccccccc
Q 042568 789 -------------------PIKVVHCDLKPSNILLDEDLT--ALVADFGIAKLV 821 (983)
Q Consensus 789 -------------------~~~ivH~Dikp~NiLl~~~~~--~kl~Dfgla~~~ 821 (983)
+..++|+|++|.||+++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997753 689999998754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.7e-11 Score=128.21 Aligned_cols=97 Identities=15% Similarity=0.133 Sum_probs=48.2
Q ss_pred CcceeeEEECCCCCeEEEEEccc---CCccccccc-ccccCCCCcEEeCcCCcCCCCCcc-ccCCCCCCCE--EeccCcc
Q 042568 64 VCNWSGVKCNNSRNKVVELDLSA---RSIYGTISP-ALANLSSLIVLDLSKNFFQGHIPA-ELGSLIRLKQ--LSLSWNS 136 (983)
Q Consensus 64 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~--L~Ls~n~ 136 (983)
.|.|.|+.|+....+|+.+...+ ..+.|.+.+ .+..++. .|...+|.-++.++- .+...+.|+. ++++.|.
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~ 154 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR 154 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence 58899999997666776666554 334444432 2222222 222333333322221 1333334444 5555553
Q ss_pred CCCCchh----hhcccccccEEeccCccccc
Q 042568 137 LQGKIPS----QLGSLHQLEYLDLGNNKLVG 163 (983)
Q Consensus 137 l~~~~p~----~~~~L~~L~~L~Ls~N~l~~ 163 (983)
.. .++. ...++++|++|+|++|+|++
T Consensus 155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~ 184 (267)
T 3rw6_A 155 RS-CMAATLRIIEENIPELLSLNLSNNRLYR 184 (267)
T ss_dssp HH-HHHHHHHHHHHHCTTCCEEECTTSCCCC
T ss_pred HH-HHHHHHHHHHhhCCCCCEEECCCCCCCC
Confidence 32 2222 22455666666666666664
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.89 E-value=5.4e-10 Score=123.46 Aligned_cols=212 Identities=11% Similarity=0.101 Sum_probs=99.4
Q ss_pred CeEEEEEcccCCccc-c-------cccccccCCCCcEEeCcCCcCC---------CCCccccCCCCCCCEEeccCccCCC
Q 042568 77 NKVVELDLSARSIYG-T-------ISPALANLSSLIVLDLSKNFFQ---------GHIPAELGSLIRLKQLSLSWNSLQG 139 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~Ls~n~l~---------~~~p~~~~~l~~L~~L~Ls~n~l~~ 139 (983)
.+|+.|.+...+..| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467777777665543 2 2345667788888888665331 123344455667777777666211
Q ss_pred CchhhhcccccccEEeccCcccccccCCcccccCCCcccceeeccc--ccccCCCCCcccccccccceeecccCcccccc
Q 042568 140 KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSN--NSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217 (983)
Q Consensus 140 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~--N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~ 217 (983)
.++. +. +++|++|+|..|.+.......+ +...+++|++|+|+. |...+... +.+ +
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l-~~~~lp~L~~L~L~~~~~~~~~~~~-------------------~~~-l 242 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDI-LGSDLPNLEKLVLYVGVEDYGFDGD-------------------MNV-F 242 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHH-HHSBCTTCCEEEEECBCGGGTCCSC-------------------GGG-T
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHH-HHccCCCCcEEEEeccccccccchh-------------------HHH-H
Confidence 2222 32 5666666666665542211111 112455555555542 11111100 000 0
Q ss_pred chhh--hccCCcceecccccccccccchhhh--cCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCc
Q 042568 218 PQAL--ANSSKLEWLDLESNMFSGELPSEII--SKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNN 293 (983)
Q Consensus 218 p~~l--~~l~~L~~L~Ls~N~l~~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~ 293 (983)
...+ ..+++|++|+|++|.+.+..+..++ ..+++|++|+|+.|.+.... ...++..+.++++|+.|+|++|.
T Consensus 243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G----~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG----ARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH----HHHHHTTHHHHTTCSEEECCSBB
T ss_pred HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH----HHHHHhhcccCCcceEEECCCCc
Confidence 0011 1244555555555555432222222 13555666666665543311 11222333455677777777776
Q ss_pred ccccCCccccccccCeeEEEccCcc
Q 042568 294 LGGMIPSIIGDLSTNLVQIHLDCNL 318 (983)
Q Consensus 294 l~~~~p~~~~~l~~~L~~L~L~~N~ 318 (983)
++...-..+... -...++++.++
T Consensus 319 i~d~~~~~l~~a--lg~~~~~~~~~ 341 (362)
T 2ra8_A 319 LSDEMKKELQKS--LPMKIDVSDSQ 341 (362)
T ss_dssp CCHHHHHHHHHH--CCSEEECCSBC
T ss_pred CCHHHHHHHHHH--cCCEEEecCCc
Confidence 664332222221 02446666665
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1.3e-09 Score=118.44 Aligned_cols=198 Identities=16% Similarity=0.134 Sum_probs=125.0
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCC--ccceeeEEecCC---ceeEEEec
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRN--LIRIITICSKPD---FKALVLPL 745 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~ 745 (983)
.+.++.|....||++. +.+++|+.... .....+.+|+++++.+. +.. +.+++.+..... ..|+||||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999873 56899986422 34577899999999984 333 344555443333 34889999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-------------------------------------- 787 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------------------------------------- 787 (983)
++|.++.+... ..++..++..++.++++.++.||+.
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865332 2366777888888888888888851
Q ss_pred -----------------CCCCeEeecCCCCCeEeCC--CCCEEEccccccccccCCcccccccCCCCccc-cccCccccc
Q 042568 788 -----------------SPIKVVHCDLKPSNILLDE--DLTALVADFGIAKLVKGIDESVNCANDSMSFT-STDGLLCGS 847 (983)
Q Consensus 788 -----------------~~~~ivH~Dikp~NiLl~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~-~~~~~~~gt 847 (983)
.+..++|+|++|.||++++ ...+.|+||+.+..-.+..+-.........+. .........
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1235899999999999998 45678999999876443211100000000000 000001111
Q ss_pred ccccc-ccccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 042568 848 VGYIA-PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884 (983)
Q Consensus 848 ~~y~a-PE~~~~~~~~~k~Dv~SlG~il~elltg~~p~ 884 (983)
.++.. |+.... .....+.|++|.++|.+.+|+.+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11222 222111 122368999999999999998775
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.4e-07 Score=103.95 Aligned_cols=121 Identities=15% Similarity=0.146 Sum_probs=59.2
Q ss_pred cccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccc
Q 042568 422 SLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIA 501 (983)
Q Consensus 422 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 501 (983)
.|..+..|+.+.+..+ ++......|.++..|+. +.+..+ ++......|.++.+|+.+++.++.++..-...|.++.+
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~-i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~ 311 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT-LNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVK 311 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE-EEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTT
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcc-cccccc-ceeccccccccccccccccccccccceehhhhhcCCCC
Confidence 3344444444444433 22233333444444443 444322 33233344555555556666555555333455666666
Q ss_pred cceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCC
Q 042568 502 LESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQAS 547 (983)
Q Consensus 502 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 547 (983)
|+.+.|..+ ++.+-...|.++.+|+.+.+..+ ++..-..+|.+.
T Consensus 312 L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 312 LSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 666666543 55444556666677776666544 432223445444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.76 E-value=3.3e-09 Score=117.11 Aligned_cols=158 Identities=16% Similarity=0.129 Sum_probs=96.8
Q ss_pred eEEEEEcccCCc---------ccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhc--
Q 042568 78 KVVELDLSARSI---------YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLG-- 146 (983)
Q Consensus 78 ~v~~l~l~~~~l---------~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-- 146 (983)
++..|.+..... .+.+.+.+..+++|+.|+|++|.-. .+|. +. +++|++|+|..|.+.......+.
T Consensus 140 ~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 140 HFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred hhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHc
Confidence 567777654322 2245566788999999999988311 3443 43 88999999999998755555555
Q ss_pred ccccccEEeccC--cccccccCC----cccccCCCcccceeecccccccCCCCCccc--ccccccceeecccCcccccc-
Q 042568 147 SLHQLEYLDLGN--NKLVGEIPI----PIFCSNSSTSLQYIDLSNNSLTGEIPLKNE--CELRNLRFLLLWSNRLVGQV- 217 (983)
Q Consensus 147 ~L~~L~~L~Ls~--N~l~~~~p~----~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~--~~l~~L~~L~L~~N~l~~~~- 217 (983)
.+++|++|+|+. |...|.... .+.....+++|++|+|++|.+.+..+...+ ..+++|++|+|+.|.+.+..
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 789999999964 322221100 011112456777777777776543221111 13567777777777766532
Q ss_pred ---chhhhccCCcceecccccccc
Q 042568 218 ---PQALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 218 ---p~~l~~l~~L~~L~Ls~N~l~ 238 (983)
+..+..+++|+.|+|++|.++
T Consensus 297 ~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 297 RLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp HHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHhhcccCCcceEEECCCCcCC
Confidence 333345567777777777665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.74 E-value=3.6e-07 Score=102.47 Aligned_cols=126 Identities=14% Similarity=0.145 Sum_probs=61.6
Q ss_pred CCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCccc
Q 042568 325 PHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQ 404 (983)
Q Consensus 325 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 404 (983)
..+....+|+.+.+..+ ++......+..+..|+.+.+..+ ++.+...+|.+..+|+.+.+..+ +.......|.++++
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence 34444455555555433 22233344555555555555544 33344455555556666655433 33333445555555
Q ss_pred chhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccc
Q 042568 405 LRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLK 454 (983)
Q Consensus 405 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 454 (983)
|+.+.+.++.++..-...|.++.+|+.++|..+ ++.+-...|.++.+|+
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 336 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS 336 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence 555555555554333445555555555555433 3323334444445444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.63 E-value=4.2e-09 Score=105.01 Aligned_cols=124 Identities=15% Similarity=0.085 Sum_probs=73.7
Q ss_pred cccccccccCCCCcEEeCcCC-cCCCC----CccccCCCCCCCEEeccCccCCCC----chhhhcccccccEEeccCccc
Q 042568 91 GTISPALANLSSLIVLDLSKN-FFQGH----IPAELGSLIRLKQLSLSWNSLQGK----IPSQLGSLHQLEYLDLGNNKL 161 (983)
Q Consensus 91 g~~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~L~~L~~L~Ls~N~l 161 (983)
..+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345566777888888888888 77642 344566677888888888887642 344455556777777777777
Q ss_pred ccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeec--ccCccccc----cchhhhccCCcceeccccc
Q 042568 162 VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLL--WSNRLVGQ----VPQALANSSKLEWLDLESN 235 (983)
Q Consensus 162 ~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N 235 (983)
....-..+. ..+...++|++|+| ++|.|... +...+...++|++|+|++|
T Consensus 106 ~~~g~~~l~------------------------~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n 161 (185)
T 1io0_A 106 SGSGILALV------------------------EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 161 (185)
T ss_dssp CHHHHHHHH------------------------HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred CHHHHHHHH------------------------HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCC
Confidence 632111111 11223445666666 55655533 2334444466666666666
Q ss_pred ccc
Q 042568 236 MFS 238 (983)
Q Consensus 236 ~l~ 238 (983)
.+.
T Consensus 162 ~i~ 164 (185)
T 1io0_A 162 QQG 164 (185)
T ss_dssp SHH
T ss_pred CCC
Confidence 664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=5.7e-08 Score=96.68 Aligned_cols=122 Identities=12% Similarity=0.111 Sum_probs=67.7
Q ss_pred CccccCCCCCCCEEeccCc-cCCC----CchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCC
Q 042568 117 IPAELGSLIRLKQLSLSWN-SLQG----KIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191 (983)
Q Consensus 117 ~p~~~~~l~~L~~L~Ls~n-~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ 191 (983)
+...+...++|++|+|++| .|.. .+...+...++|++|+|++|.+.......+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~--------------------- 86 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA--------------------- 86 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH---------------------
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHH---------------------
Confidence 3445667778888888887 7763 2344555567777777777777532111111
Q ss_pred CCCcccccccccceeecccCccccc----cchhhhccCCcceecc--cccccccccc---hhhhcCCCCccEEEcccccc
Q 042568 192 IPLKNECELRNLRFLLLWSNRLVGQ----VPQALANSSKLEWLDL--ESNMFSGELP---SEIISKMPQLQFLYLSYNDF 262 (983)
Q Consensus 192 ip~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L--s~N~l~~~~~---~~~~~~l~~L~~L~Ls~N~l 262 (983)
..+...++|++|+|++|.|... +..++...++|++|+| ++|.|+..-. ...+...++|++|+|++|.+
T Consensus 87 ---~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 87 ---EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp ---HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred ---HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 1122345666677777766543 3455566667777777 6677753211 11223334455555554443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=7.3e-08 Score=100.73 Aligned_cols=79 Identities=24% Similarity=0.333 Sum_probs=42.9
Q ss_pred ccccccccccccccccc--CCCcccccccccceEEeCCCcccccccccccCCC--CccEEecCCccccCCcCc-------
Q 042568 474 KMDMVLAIDLSFNNLSG--SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLP--YLKQFDVSSNRLFGEIPQ------- 542 (983)
Q Consensus 474 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~------- 542 (983)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+.+.+|.
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~ 245 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA 245 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence 34555566666666654 3344555566666666666666643 2233333 566666666666655442
Q ss_pred cccCCCCcceEe
Q 042568 543 SFQASPTLKQLN 554 (983)
Q Consensus 543 ~~~~l~~L~~l~ 554 (983)
.+..+|+|+.||
T Consensus 246 il~~~P~L~~LD 257 (267)
T 3rw6_A 246 IRERFPKLLRLD 257 (267)
T ss_dssp HHHHCTTCCEES
T ss_pred HHHHCcccCeEC
Confidence 245556665554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=3.2e-06 Score=91.47 Aligned_cols=136 Identities=16% Similarity=0.117 Sum_probs=95.9
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC---CccceeeEEe-cCCceeEEEeccc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR---NLIRIITICS-KPDFKALVLPLMS 747 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~ 747 (983)
.+.++.|....||+. ++.++||+.. .......+.+|.++++.+.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356788999999998 6778898852 223457889999999999753 3556677764 4456789999999
Q ss_pred CcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 042568 748 NGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH---------------------------------------- 787 (983)
Q Consensus 748 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~---------------------------------------- 787 (983)
|.++.+... ..++......++.++++.|+.||+.
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988865321 1234445555556666666555532
Q ss_pred -----------------CCCCeEeecCCCCCeEeCC---CCCE-EEcccccccc
Q 042568 788 -----------------SPIKVVHCDLKPSNILLDE---DLTA-LVADFGIAKL 820 (983)
Q Consensus 788 -----------------~~~~ivH~Dikp~NiLl~~---~~~~-kl~Dfgla~~ 820 (983)
.+..++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 4554 7999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3.5e-06 Score=89.48 Aligned_cols=134 Identities=18% Similarity=0.116 Sum_probs=97.2
Q ss_pred ccccCCcE-eEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEEEecccCcc
Q 042568 674 LIGSGRFG-HVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALVLPLMSNGS 750 (983)
Q Consensus 674 ~iG~G~~g-~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 750 (983)
.+..|..+ .||+.... ++..+++|+-... ....+.+|.++++.+. +--+.++++++...+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34556555 68998754 4667999986432 3466888999999884 3336788899988899999999999987
Q ss_pred cccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-------------------------------------------
Q 042568 751 LENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH------------------------------------------- 787 (983)
Q Consensus 751 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------------------------------------------- 787 (983)
+.+..... ......+..++++.|+.||..
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76644321 122345667777777777741
Q ss_pred ------------CCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 788 ------------SPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 788 ------------~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
.+..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 11237899999999999987777799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=8.4e-06 Score=90.42 Aligned_cols=82 Identities=7% Similarity=0.007 Sum_probs=57.9
Q ss_pred Ccc-ccCCcEeEEEEEEC-------CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcC-C--CCccceeeEEecC---
Q 042568 673 SLI-GSGRFGHVYKGVLQ-------DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIR-H--RNLIRIITICSKP--- 736 (983)
Q Consensus 673 ~~i-G~G~~g~Vy~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 736 (983)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+++++.+. + -.+.+++.++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 88989999998764 266789998643320 001256788999999884 3 3567788887655
Q ss_pred CceeEEEecccCcccccc
Q 042568 737 DFKALVLPLMSNGSLENH 754 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~ 754 (983)
+..++||||++|..+.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999999887653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.79 E-value=7.1e-06 Score=79.31 Aligned_cols=62 Identities=8% Similarity=0.100 Sum_probs=43.0
Q ss_pred CCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCcc-CCCCchhhhccc----ccccEEeccCcc-cc
Q 042568 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS-LQGKIPSQLGSL----HQLEYLDLGNNK-LV 162 (983)
Q Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~-l~~~~p~~~~~L----~~L~~L~Ls~N~-l~ 162 (983)
..|++|||++|.++..--..+..+++|++|+|++|. |++.--..++.+ ++|++|+|++|. ++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 467788888877776655667778888888888874 665444555554 367888887774 55
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=7.4e-05 Score=82.13 Aligned_cols=141 Identities=13% Similarity=0.080 Sum_probs=80.9
Q ss_pred CccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC--CCccceee------EEecCCceeEEEe
Q 042568 673 SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH--RNLIRIIT------ICSKPDFKALVLP 744 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e 744 (983)
+.|+.|..+.||++...+| .+++|+.... ..++..|+++++.+.. -.+.+++. +....+..+++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466677899999987654 5899988642 2344556666666631 12333333 1123556789999
Q ss_pred cccCccccc--------------ccccccC-c--C-------CCCCHHHH------------------------------
Q 042568 745 LMSNGSLEN--------------HLYPSHG-L--S-------HGLDLIQL------------------------------ 770 (983)
Q Consensus 745 ~~~~gsL~~--------------~l~~~~~-~--~-------~~l~~~~~------------------------------ 770 (983)
|++|..+.. .++.... . . ..-.|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999876531 0111000 0 0 01123211
Q ss_pred -HHHHHHHHHHHHHHhc----------cCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 771 -VKICSDVAEGVAYLHH----------HSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 771 -~~i~~~ia~aL~~LH~----------~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
..+..++.+++++|++ ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224445666653 123469999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=82.81 Aligned_cols=76 Identities=16% Similarity=0.133 Sum_probs=50.8
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccC------cchhHHHHHHHHHHHhcCC--CC-ccceeeEEecCCceeE
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT------GEITGSFKRECQILKRIRH--RN-LIRIITICSKPDFKAL 741 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 741 (983)
.+.+|.|..+.||++... +++.|+||....... .....++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 467899997642211 1234567889999998843 33 3455544 3455689
Q ss_pred EEecccCc
Q 042568 742 VLPLMSNG 749 (983)
Q Consensus 742 v~e~~~~g 749 (983)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.70 E-value=1.1e-05 Score=78.02 Aligned_cols=84 Identities=17% Similarity=0.181 Sum_probs=70.5
Q ss_pred CeEEEEEcccCCcccccccccccCCCCcEEeCcCC-cCCCCCccccCCC----CCCCEEeccCcc-CCCCchhhhccccc
Q 042568 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKN-FFQGHIPAELGSL----IRLKQLSLSWNS-LQGKIPSQLGSLHQ 150 (983)
Q Consensus 77 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n-~l~~~~p~~~~~l----~~L~~L~Ls~n~-l~~~~p~~~~~L~~ 150 (983)
-+++.||++++.++..--..+.++++|++|+|++| .+++.--..++.+ ++|++|+|++|. |+..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 36999999999988766677899999999999999 4886555566665 479999999985 88766677889999
Q ss_pred ccEEeccCcc
Q 042568 151 LEYLDLGNNK 160 (983)
Q Consensus 151 L~~L~Ls~N~ 160 (983)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999985
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.69 E-value=9.5e-06 Score=79.97 Aligned_cols=72 Identities=11% Similarity=0.121 Sum_probs=48.0
Q ss_pred ccccccccCCCCcEEeCcCC-cCCCC----CccccCCCCCCCEEeccCccCCC----CchhhhcccccccEEeccCcccc
Q 042568 92 TISPALANLSSLIVLDLSKN-FFQGH----IPAELGSLIRLKQLSLSWNSLQG----KIPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 92 ~~~~~l~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
.+...+.+-+.|++|+|++| .|... +-+.+..-+.|++|+|++|.|.. .+...+..-+.|++|+|++|.|.
T Consensus 32 ~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 32 CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34445666778888888875 66532 34456666778888888888773 34444555567777777777776
Q ss_pred c
Q 042568 163 G 163 (983)
Q Consensus 163 ~ 163 (983)
.
T Consensus 112 ~ 112 (197)
T 1pgv_A 112 P 112 (197)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00027 Score=75.93 Aligned_cols=139 Identities=14% Similarity=0.157 Sum_probs=93.0
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC---CCCccceeeEEecCCceeEEEecccC
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR---HRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
.+.|+.|....+|+.... ++.+++|+.... ....+.+|.+.++.+. ...+.++++++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456899999999999864 678899987532 2567889999999884 35688899988888889999999998
Q ss_pred ccccc-----------ccccccC---c---------------CCCCCHHHHH---HHHH----------------HHHHH
Q 042568 749 GSLEN-----------HLYPSHG---L---------------SHGLDLIQLV---KICS----------------DVAEG 780 (983)
Q Consensus 749 gsL~~-----------~l~~~~~---~---------------~~~l~~~~~~---~i~~----------------~ia~a 780 (983)
..+.. .++.... . ...-+|.... ++.. .+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76532 1221110 0 0012455432 1111 11111
Q ss_pred -HHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 781 -VAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 781 -L~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
...|.. ..++.++|+|+.+.|++++.++ +.|.||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2345799999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00048 Score=73.49 Aligned_cols=77 Identities=18% Similarity=0.197 Sum_probs=56.2
Q ss_pred CCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC---CccceeeEEecCCceeEEEecc
Q 042568 670 CPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR---NLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~ 746 (983)
...+.+|.|..+.||+....+|+.|+||+..... ......|.+|++.|+.+... -+.+++++. ..++||||+
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3456789999999999999999999999865332 22345688999999998422 344555543 348899999
Q ss_pred cCccc
Q 042568 747 SNGSL 751 (983)
Q Consensus 747 ~~gsL 751 (983)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00098 Score=72.32 Aligned_cols=160 Identities=13% Similarity=0.136 Sum_probs=89.7
Q ss_pred CCCHHHHHHHhCCCCCC-----CccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC--ccc
Q 042568 656 RVSYKQLIEATGGFCPS-----SLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN--LIR 728 (983)
Q Consensus 656 ~~~~~~l~~~~~~f~~~-----~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 728 (983)
.++.+++......|... +.|+.|....+|+....+| .+++|+..... ....+..|+++++.+.... +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 35556666655556542 3466788899999987655 68899885421 2345667888888774222 233
Q ss_pred eeeE------EecCCceeEEEecccCcccccc--------------ccccc-CcCCC----C---CHHHHHH--------
Q 042568 729 IITI------CSKPDFKALVLPLMSNGSLENH--------------LYPSH-GLSHG----L---DLIQLVK-------- 772 (983)
Q Consensus 729 l~~~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~-~~~~~----l---~~~~~~~-------- 772 (983)
++.. ....+..+++++|++|..+... ++... ....+ . .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 1123456899999998765321 11100 00000 1 1222110
Q ss_pred ----HHHHHHHHHHHHhcc----CCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 773 ----ICSDVAEGVAYLHHH----SPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 773 ----i~~~ia~aL~~LH~~----~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
+...+.+.+++++.. .+..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234445555421 23468999999999999987666899999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00089 Score=75.69 Aligned_cols=77 Identities=14% Similarity=0.116 Sum_probs=48.7
Q ss_pred CCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCcccc--ccccccccccCCC---CCCcc
Q 042568 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG--SVGYIAPEYGMGK---RASTH 864 (983)
Q Consensus 790 ~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~k 864 (983)
..++|+|++|.|||++.++ ++++||+.+..-.+..+- ....+ ...|.+|+..... .....
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--------------a~~l~~~~~~~~~~~~~~~~~~~~~~~~ 296 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--------------GAYLGNLILAFFAQDGHATQENDRKEYK 296 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--------------HHHHHHHHHHHHHGGGGCCSSCCSHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--------------HHHHHHHHHHHHhcccccccccchHHHH
Confidence 3599999999999999876 999999998754321110 00011 1346666654321 11233
Q ss_pred chhHHHHHHHHHHHhCC
Q 042568 865 GDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 865 ~Dv~SlG~il~elltg~ 881 (983)
.+++.....+|+.++++
T Consensus 297 ~~~~~~~~~~~~~y~~~ 313 (420)
T 2pyw_A 297 QWILRTIEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 56668888888887764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0012 Score=70.94 Aligned_cols=72 Identities=8% Similarity=0.097 Sum_probs=47.4
Q ss_pred CCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc-cceeeEEecCCceeEEEecc-cCc
Q 042568 672 SSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL-IRIITICSKPDFKALVLPLM-SNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g 749 (983)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+ .++++++ ++..++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 677899999999999 56889987543211 1234568888888853333 3555543 44458899999 665
Q ss_pred ccc
Q 042568 750 SLE 752 (983)
Q Consensus 750 sL~ 752 (983)
++.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00014 Score=71.65 Aligned_cols=45 Identities=11% Similarity=0.107 Sum_probs=30.6
Q ss_pred cccCCCCCCCEEeccCc-cCCC----CchhhhcccccccEEeccCccccc
Q 042568 119 AELGSLIRLKQLSLSWN-SLQG----KIPSQLGSLHQLEYLDLGNNKLVG 163 (983)
Q Consensus 119 ~~~~~l~~L~~L~Ls~n-~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~ 163 (983)
..+.+-+.|++|+|++| .|.. .+...+..-+.|++|+|++|+|..
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd 84 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISD 84 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCCh
Confidence 34456677888888875 7753 244556666778888888887763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0023 Score=72.31 Aligned_cols=74 Identities=16% Similarity=0.195 Sum_probs=51.7
Q ss_pred CCccccCCcEeEEEEEECC--------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc-cceeeEEecCCceeEE
Q 042568 672 SSLIGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL-IRIITICSKPDFKALV 742 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 742 (983)
.+.|+.|....||++...+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.. .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3567888899999998753 4789999884321 12456689999998854344 566766542 489
Q ss_pred EecccCcccc
Q 042568 743 LPLMSNGSLE 752 (983)
Q Consensus 743 ~e~~~~gsL~ 752 (983)
+||++|.++.
T Consensus 151 ~e~l~G~~l~ 160 (429)
T 1nw1_A 151 EEYIPSRPLS 160 (429)
T ss_dssp ECCCCEEECC
T ss_pred EEEeCCcccC
Confidence 9999876654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0026 Score=70.19 Aligned_cols=143 Identities=12% Similarity=0.196 Sum_probs=85.4
Q ss_pred CCccccCCcEeEEEEEEC--------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCceeEE
Q 042568 672 SSLIGSGRFGHVYKGVLQ--------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 742 (983)
.+.+..|-...+|++... +++.+++|+..... .......+|.++++.+. +.-..++++++.. .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 356777888999999864 24789999863221 13456678999999884 3333566666543 389
Q ss_pred EecccCcccccc-c----------------cccc-CcCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 042568 743 LPLMSNGSLENH-L----------------YPSH-GLSHGLD--LIQLVKICSDVAE-------------------GVAY 783 (983)
Q Consensus 743 ~e~~~~gsL~~~-l----------------~~~~-~~~~~l~--~~~~~~i~~~ia~-------------------aL~~ 783 (983)
|||++|.++..- + +... ...+... |.++.++..++.. .+++
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999998766421 1 1100 0111122 4455555544422 2233
Q ss_pred Hh----c-cCCCCeEeecCCCCCeEeCCC----CCEEEcccccccc
Q 042568 784 LH----H-HSPIKVVHCDLKPSNILLDED----LTALVADFGIAKL 820 (983)
Q Consensus 784 LH----~-~~~~~ivH~Dikp~NiLl~~~----~~~kl~Dfgla~~ 820 (983)
|. . ..+..++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 2 223468999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0075 Score=65.43 Aligned_cols=142 Identities=16% Similarity=0.178 Sum_probs=82.3
Q ss_pred ccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC--ccceeeE-----EecCCceeEEEecc
Q 042568 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN--LIRIITI-----CSKPDFKALVLPLM 746 (983)
Q Consensus 674 ~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~ 746 (983)
.++ |....||+....+|+.+++|....... ....+..|.++++.+.... +.+++.. ....+..++++||+
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 888899998877777899999853321 2456778888888884222 3444442 11234557899999
Q ss_pred cCcccccc--------------ccccc---C--cCCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 042568 747 SNGSLENH--------------LYPSH---G--LSHGLDLIQL----------------------VKICSDVAEGVAYLH 785 (983)
Q Consensus 747 ~~gsL~~~--------------l~~~~---~--~~~~l~~~~~----------------------~~i~~~ia~aL~~LH 785 (983)
+|..+... ++... . .....++... ...+..++..+.-..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98665320 11000 0 0111222211 011111222222221
Q ss_pred c-cCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 786 H-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 786 ~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
. ..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1233588999999999999 4 899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.002 Score=70.29 Aligned_cols=143 Identities=13% Similarity=0.066 Sum_probs=73.9
Q ss_pred CccccCCcEe-EEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC--CccceeeEEecCCceeEEEecccCc
Q 042568 673 SLIGSGRFGH-VYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR--NLIRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 673 ~~iG~G~~g~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g 749 (983)
+.|+.|+... +|+....+++.+++|...... ...+..|+++++.+... .+.+++.+.... -+++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence 4565565554 677765446777777653321 13345677887777432 345666664333 37899999776
Q ss_pred cccccccccc---------------------Cc-CCCCCHHHHH-------HH-------------HHHHHHHHHHHh--
Q 042568 750 SLENHLYPSH---------------------GL-SHGLDLIQLV-------KI-------------CSDVAEGVAYLH-- 785 (983)
Q Consensus 750 sL~~~l~~~~---------------------~~-~~~l~~~~~~-------~i-------------~~~ia~aL~~LH-- 785 (983)
++.+++.... .. ...++..... .+ ...+.+.++.+.
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 5543332110 00 0112211110 00 001112222221
Q ss_pred -ccCCCCeEeecCCCCCeEeCCC----CCEEEccccccccc
Q 042568 786 -HHSPIKVVHCDLKPSNILLDED----LTALVADFGIAKLV 821 (983)
Q Consensus 786 -~~~~~~ivH~Dikp~NiLl~~~----~~~kl~Dfgla~~~ 821 (983)
...+..++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1223469999999999999875 67899999988743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0036 Score=69.26 Aligned_cols=74 Identities=12% Similarity=0.147 Sum_probs=46.1
Q ss_pred CCccccCCcEeEEEEEECC---------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC-ccceeeEEecCCceeE
Q 042568 672 SSLIGSGRFGHVYKGVLQD---------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN-LIRIITICSKPDFKAL 741 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 741 (983)
.+.++.|....+|+....+ ++.+++|+...... .......|.++++.+...+ ..++++... -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 3457788889999998764 26788988743221 1123467888988885434 346665542 378
Q ss_pred EEecccCccc
Q 042568 742 VLPLMSNGSL 751 (983)
Q Consensus 742 v~e~~~~gsL 751 (983)
||||++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999998655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.01 Score=67.18 Aligned_cols=75 Identities=16% Similarity=0.167 Sum_probs=49.8
Q ss_pred CCccccCCcEeEEEEEECC-CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc-cceeeEEecCCceeEEEecccCc
Q 042568 672 SSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL-IRIITICSKPDFKALVLPLMSNG 749 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g 749 (983)
.+.|+.|-...+|++...+ +..+++|+...... . .-...+|..+++.+...++ .++++++. + ..|+||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 3568888899999999765 47788998743221 1 1123689999999965555 46676663 2 4699999986
Q ss_pred ccc
Q 042568 750 SLE 752 (983)
Q Consensus 750 sL~ 752 (983)
++.
T Consensus 187 ~l~ 189 (458)
T 2qg7_A 187 ALS 189 (458)
T ss_dssp ECC
T ss_pred cCC
Confidence 664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.013 Score=63.86 Aligned_cols=68 Identities=13% Similarity=0.187 Sum_probs=44.0
Q ss_pred ccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC---CCccceeeE------EecCCceeEEEecc
Q 042568 676 GSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH---RNLIRIITI------CSKPDFKALVLPLM 746 (983)
Q Consensus 676 G~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~e~~ 746 (983)
|.|....||+....+| .+++|+...... ..|+++++.+.. |.+.+++.. ....+..+++|+|+
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 3344689999987766 899998754321 356666666632 224444432 23346678999999
Q ss_pred cCccc
Q 042568 747 SNGSL 751 (983)
Q Consensus 747 ~~gsL 751 (983)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 98766
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0046 Score=56.73 Aligned_cols=57 Identities=18% Similarity=0.237 Sum_probs=35.5
Q ss_pred eEEeCCCccc-ccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCcccc
Q 042568 504 SLNLSGNSLE-GLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 504 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
.++.+++.|+ ..+|..+ .++|+.|+|++|+|+..-+..|..+++|+.|+|++|++..
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 5566666665 2344332 2357777777777775445567777777777777776653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0051 Score=56.46 Aligned_cols=35 Identities=26% Similarity=0.217 Sum_probs=15.5
Q ss_pred cceeecccCccccccchhhhccCCcceeccccccc
Q 042568 203 LRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMF 237 (983)
Q Consensus 203 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 237 (983)
|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433334444444444444444444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.13 E-value=0.014 Score=57.50 Aligned_cols=103 Identities=15% Similarity=0.117 Sum_probs=66.8
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
-||.+.|... ..+++++++|.++.|.+++|.-.-.+.. + ..+=+.|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 3777777654 5689999999999999999877621100 1 1222457889999999988764 2111
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP 883 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p 883 (983)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 ----------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122455888764 3557888999999999999975555
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.28 E-value=0.088 Score=58.76 Aligned_cols=143 Identities=14% Similarity=0.150 Sum_probs=86.7
Q ss_pred CCccccCCcEeEEEEEECC--------CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCC-ccceeeEEecCCceeEE
Q 042568 672 SSLIGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRN-LIRIITICSKPDFKALV 742 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 742 (983)
.+.+..|-...+|+....+ ++.+++|+..... +..-...+|.++++.+...+ ..++++.+. -+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 3457778889999998763 5789999864322 11223467999998885333 345565442 3789
Q ss_pred EecccCcccccc-cc----------------cccC---------cCCCCCHHHHHHHHHHHH------------------
Q 042568 743 LPLMSNGSLENH-LY----------------PSHG---------LSHGLDLIQLVKICSDVA------------------ 778 (983)
Q Consensus 743 ~e~~~~gsL~~~-l~----------------~~~~---------~~~~l~~~~~~~i~~~ia------------------ 778 (983)
+||++|.++..- +. .... ...+.-|..+.++..++-
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 999998765321 10 0000 011122444444443322
Q ss_pred -HHHHHHh---------------------ccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 779 -EGVAYLH---------------------HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 779 -~aL~~LH---------------------~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
+.+.+|. ...+..++|+|+.+.||+ +.++.+.++||..|..-
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~ 292 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN 292 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence 2233332 112345889999999999 88889999999988743
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.86 E-value=0.055 Score=60.33 Aligned_cols=30 Identities=30% Similarity=0.447 Sum_probs=25.4
Q ss_pred CeEeecCCCCCeEe------CCCCCEEEcccccccc
Q 042568 791 KVVHCDLKPSNILL------DEDLTALVADFGIAKL 820 (983)
Q Consensus 791 ~ivH~Dikp~NiLl------~~~~~~kl~Dfgla~~ 820 (983)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.43 E-value=3.6 Score=40.53 Aligned_cols=123 Identities=10% Similarity=0.093 Sum_probs=82.1
Q ss_pred CCCCccceeeEEecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCC
Q 042568 722 RHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSN 801 (983)
Q Consensus 722 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~N 801 (983)
.||+.+.. .+-...+...+.|+.-+ ....+-. -+.++...+++++.+|+....+++.. +|-=+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57888866 45555565555555443 2222222 23478889999999999988666543 677899999
Q ss_pred eEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCC
Q 042568 802 ILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR 881 (983)
Q Consensus 802 iLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~ 881 (983)
|+++.++.+++.=.|+...+ +|. ..++..=.-.+=+++..+++++
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------------------~P~-----~~~ee~fL~qyKAliiall~~K 154 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------------------DPL-----PVSEAEFLTRYKALVICAFNEK 154 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------------------SCC-----CCCHHHHHHHHHHHHHHHHCTT
T ss_pred EEEcCCCCEEEEEccCccCC------------------------------CCC-----CCCHHHHHHHHHHHHHHHHcCC
Confidence 99999999999877764433 222 1122223445778899999999
Q ss_pred CCCCcccCCCC
Q 042568 882 RPTDVLFHDGS 892 (983)
Q Consensus 882 ~p~~~~~~~~~ 892 (983)
..|+....+..
T Consensus 155 ~~Fe~l~~G~l 165 (215)
T 4ann_A 155 QSFDALVEGNL 165 (215)
T ss_dssp CCHHHHHHSCG
T ss_pred CCHHHHHcChH
Confidence 99876554443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.86 E-value=1.6 Score=30.69 Aligned_cols=10 Identities=30% Similarity=0.491 Sum_probs=4.1
Q ss_pred HHHhhhhhhc
Q 042568 620 FGNFLVLRSK 629 (983)
Q Consensus 620 ~~~~~~~~~~ 629 (983)
+.+++++|++
T Consensus 29 ~~~~~~~RRr 38 (44)
T 2ks1_B 29 LGIGLFMRRR 38 (44)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHhhhh
Confidence 3334444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 983 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-49 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-30 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-18 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-15 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-13 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-09 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-61
Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
IGSG FG VYKG + +AVK+L++T T + +FK E +L++ RH N++ +
Sbjct: 15 RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ P A+V SL +HL H + ++I+L+ I A+G+ YLH +
Sbjct: 73 STAPQL-AIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLHAK---SI 125
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DLK +NI L EDLT + DFG+A + S + L GS+ ++A
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVK-----------SRWSGSHQFEQLSGSILWMA 174
Query: 853 PEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
PE + + + DVY+FG++L E++TG+ P + + ++ + + L P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLSPD 230
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969
+ KV S+ + L C + RP + + L + L
Sbjct: 231 LS----------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 2e-56
Identities = 71/331 (21%), Positives = 135/331 (40%), Gaps = 54/331 (16%)
Query: 658 SYKQLIEATGGFCPS---------SLIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTT 704
+++ EA F +IG+G FG V G L+ + +A+K L T
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 705 GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG 764
+ F E I+ + H N+I + + +K ++ M NGSL++ L + G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---Q 124
Query: 765 LDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824
+IQLV + +A G+ YL VH DL NIL++ +L V+DFG+++ ++
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED- 180
Query: 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPT 884
+ S ++ + + APE ++ ++ DV+S+G+++ E+++
Sbjct: 181 -------DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER- 232
Query: 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLC 944
+ + + + P D L +L L C
Sbjct: 233 ---PYWDMTNQDVINAIEQDYRLPP--------------------PMDCPSALHQLMLDC 269
Query: 945 TQYNPSTRPSMLDVAHEMGRLKQYLSSPSSL 975
Q + + RP + + L + + +P+SL
Sbjct: 270 WQKDRNHRPKFGQIVNT---LDKMIRNPNSL 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-55
Identities = 73/298 (24%), Positives = 138/298 (46%), Gaps = 47/298 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G+G+FG V+ G +T++AVK L + +F E ++K+++H+ L+R+ +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
++ ++ M NGSL + L G L + +L+ + + +AEG+A++ +
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DL+ +NIL+ + L+ +ADFG+A+L++ N+ + + + AP
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED--------NEYTAREGA----KFPIKWTAP 179
Query: 854 EYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKA 913
E + DV+SFG+LL EIVT R + G + E ++ +E+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRI----PYPGMTNPEVIQN---------LERG 226
Query: 914 IAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971
P + P EL +L LC + P RP+ + L+ + ++
Sbjct: 227 YRMVRPDNCP-----------EELYQLMRLCWKERPEDRPTFDYLRS---VLEDFFTA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 47/298 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G G FG V+ G TR+A+K L T +F +E Q++K++RH L+++ + S
Sbjct: 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ +V MS GSL + L G L QLV + + +A G+AY+ VH
Sbjct: 83 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERM---NYVH 136
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL+ +NIL+ E+L VADFG+A+L++ + + + + APE
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG------------AKFPIKWTAPE 184
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAI 914
+ R + DV+SFG+LL E+ T R + G E + + P
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV----PYPGMVNREVLDQVERGYRMPC----- 235
Query: 915 AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972
+ L +L C + P RP+ + L+ Y +S
Sbjct: 236 ---------------PPECPESLHDLMCQCWRKEPEERPTFEYLQA---FLEDYFTST 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-52
Identities = 63/312 (20%), Positives = 112/312 (35%), Gaps = 46/312 (14%)
Query: 669 FCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
F S +G+G G V+K +A K++ L I RE Q+L ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
++ + M GSL+ L + + L K+ V +G+ YL
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKVSIAVIKGLTYLREK 123
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
I +H D+KPSNIL++ + DFG++ + DSM+ + G+
Sbjct: 124 HKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL----------IDSMANSF-----VGT 166
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP---------------------TDV 886
Y++PE G S D++S G+ L+E+ GR P +
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 887 LFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQ 946
+ R + + + + P + V+S + + C
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLI 283
Query: 947 YNPSTRPSMLDV 958
NP+ R + +
Sbjct: 284 KNPAERADLKQL 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 65/293 (22%), Positives = 119/293 (40%), Gaps = 44/293 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IGSG+FG V+ G + ++A+K + E F E +++ ++ H L+++ +C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
+ LV M +G L ++L L+ +C DV EG+AYL V+H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIH 124
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+ E+ V+DFG+ + V + + V + +PE
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG------------TKFPVKWASPE 172
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAI 914
R S+ DV+SFGVL+ E+ + + ++ S E V+ +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI----PYENRSNSEVVED---------ISTGF 219
Query: 915 AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
Y P+ + ++ C + P RP+ + ++ + +
Sbjct: 220 RLYKPRLAS-----------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 49/307 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTR---IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIIT 731
+G G FG V +GV + + +A+KVL T T RE QI+ ++ + ++R+I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+C LV+ + G L L G + + + ++ V+ G+ YL
Sbjct: 77 VCQAEAL-MLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 129
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
VH DL N+LL A ++DFG++K + S+ + + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKAL----------GADDSYYTARSAGKWPLKWY 179
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
APE ++ S+ DV+S+GV + E ++ G++P G + ++++ P
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK--KMKGPEVMAFIEQGKRMECPP-- 235
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970
+ EL L C Y RP L V R++
Sbjct: 236 ---------------------ECPPELYALMSDCWIYKWEDRPDFLTVEQ---RMRACYY 271
Query: 971 SPSSLIE 977
S +S +E
Sbjct: 272 SLASKVE 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-51
Identities = 62/308 (20%), Positives = 123/308 (39%), Gaps = 36/308 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
IG GRFG V++G +AVK+ + E + + E +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 735 KPDFKA----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH--- 787
K + LV +GSL ++L + + + ++K+ A G+A+LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 788 --SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
+ H DLK NIL+ ++ T +AD G+A ++++ A +
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR---------V 173
Query: 846 GSVGYIAPEYGMGKRASTHG------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899
G+ Y+APE H D+Y+ G++ EI + ++ V
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959
++ + + + ++P + + + + ++ C N + R + L +
Sbjct: 234 SDP--SVEEMRKVVCEQKLRPNIPNRWQ--SCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 960 HEMGRLKQ 967
+ +L Q
Sbjct: 290 KTLSQLSQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 48/307 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+IG+G FG VYKG+L+ ++ +A+K L T + F E I+ + H N+IR
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + SK ++ M NG+L+ L G ++QLV + +A G+ YL +
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM- 129
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
VH DL NIL++ +L V+DFG+++++ D T T +
Sbjct: 130 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVL----------EDDPEATYTTSGGKIPI 177
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
+ APE ++ ++ DV+SFG+++ E++T + S HE +K P
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEVMKAINDGFRLP 233
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968
D + +L + C Q + RP D+ L +
Sbjct: 234 T--------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI---LDKL 270
Query: 969 LSSPSSL 975
+ +P SL
Sbjct: 271 IRAPDSL 277
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-51
Identities = 80/296 (27%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 674 LIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
IG G FG V G ++AVK + T + +F E ++ ++RH NL++++ +
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVI 69
Query: 734 SKPDFK-ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ +V M+ GSL ++L L L+K DV E + YL +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NF 124
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
VH DL N+L+ ED A V+DFG+ K +ST V + A
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKE----------------ASSTQDTGKLPVKWTA 168
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE K+ ST DV+SFG+LL EI + R + L + V R VEK
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDVVPR---------VEK 215
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968
AP P + E+ C + + RPS L + ++ +K +
Sbjct: 216 GYKMDAPDGCP-----------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 58/284 (20%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICS 734
+G+G+FG V G + +A+K++ + E F E +++ + H L+++ +C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 735 KPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVH 794
K ++ M+NG L N+L H QL+++C DV E + YL + +H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 795 CDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPE 854
DL N L+++ V+DFG+++ V + + + + V + PE
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS------------KFPVRWSPPE 171
Query: 855 YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAI 914
M + S+ D+++FGVL+ EI + + F + + + +R
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--------- 222
Query: 915 AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
P ++ + C RP+ +
Sbjct: 223 ----PHLAS-----------EKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 78/299 (26%), Positives = 119/299 (39%), Gaps = 44/299 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
+IG G FG VY G L DN AVK L+ T F E I+K H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 730 ITICSKPDFKA-LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ IC + + +VLP M +G L N + +H + L+ VA+G+ +L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK- 149
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
K VH DL N +LDE T VADFG+A+ + + V
Sbjct: 150 --KFVHRDLAARNCMLDEKFTVKVADFGLARDM---------YDKEFDSVHNKTGAKLPV 198
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
++A E ++ +T DV+SFGVLL E++T P + + + R
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRRLL 254
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
P++ P L E+ L C RPS ++ + +
Sbjct: 255 Q---------PEYCP-----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (443), Expect = 2e-49
Identities = 70/319 (21%), Positives = 122/319 (38%), Gaps = 64/319 (20%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
IG G FG V++ + T +AVK+L + ++ F+RE ++ + N+++
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLY--------------------PSHGLSHGLDLI 768
++ +C+ L+ M+ G L L S L
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 769 QLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828
+ + I VA G+AYL K VH DL N L+ E++ +ADFG+++ +
Sbjct: 141 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI------- 190
Query: 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLF 888
S + DG + ++ PE R +T DV+++GV+L EI +
Sbjct: 191 ----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ----P 242
Query: 889 HDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYN 948
+ G + E + + E + LEL L LC
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPE--------------------NCPLELYNLMRLCWSKL 282
Query: 949 PSTRPSMLDVAHEMGRLKQ 967
P+ RPS + + R+ +
Sbjct: 283 PADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (438), Expect = 7e-49
Identities = 75/306 (24%), Positives = 136/306 (44%), Gaps = 45/306 (14%)
Query: 674 LIGSGRFGHVYKGVLQDNTR-IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G++G VY+GV + + +AVK L T F +E ++K I+H NL++++ +
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
C++ ++ M+ G+L ++L + + + L+ + + ++ + YL
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NF 136
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DL N L+ E+ VADFG+++L+ G + + + + A
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTG--------DTYTAHAGA----KFPIKWTA 184
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE + S DV++FGVLL EI T + G L + + ++EK
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQVYE---------LLEK 231
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSSP 972
P+ P ++ EL C Q+NPS RPS ++ + Q SS
Sbjct: 232 DYRMERPEGCPE-----------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-ESSI 279
Query: 973 SSLIEE 978
S +E+
Sbjct: 280 SDEVEK 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 43/287 (14%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G +G V V +AVK++D+ + + K+E I K + H N+++
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ + + L L S G L + + P G+ + + GV YLH +
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHGI---GI 124
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
H D+KP N+LLDE ++DFG+A + + N+ + +CG++ Y+A
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFR--------YNNRERLLNK---MCGTLPYVA 173
Query: 853 PEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
PE + DV+S G++L ++ G + + D E
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAG------------------ELPWDQPSDSCQE 215
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ K ++ W + + L NPS R ++ D+
Sbjct: 216 YSDWKEKKTYLNP-----WKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 48/293 (16%)
Query: 675 IGSGRFGHVYKGVLQD---NTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRII 730
+GSG FG V KG Q +AVK+L + E +++++ + ++R+I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
IC + LV+ + G L +L + + ++++ V+ G+ YL
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES--- 126
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DL N+LL A ++DFG++K ++ ++ V +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALR----------ADENYYKAQTHGKWPVKW 176
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
APE + S+ DV+SFGVL+ E + G++P Y
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP------------------YRGMKGSE 218
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
V + K P + E+ +L LC Y+ RP V +
Sbjct: 219 VTAMLEKGERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-48
Identities = 60/291 (20%), Positives = 104/291 (35%), Gaps = 44/291 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIIT 731
IG+G +G K D + K LD + T E +L+ ++H N++R
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 732 ICSKPDFKAL--VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
L V+ G L + + LD ++++ + + + H S
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 790 I--KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
V+H DLKP+N+ LD + DFG+A+++ N SF G+
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----------NHDTSFAKA---FVGT 177
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
Y++PE + D++S G LL E+ P S E + +
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAFSQKELAGKIREGKFR 232
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
I + +SD + E+I RPS+ ++
Sbjct: 233 RIPYR-----------------YSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-48
Identities = 59/322 (18%), Positives = 109/322 (33%), Gaps = 61/322 (18%)
Query: 674 LIGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNL 726
+G+G FG V + +AVK+L + + E ++L + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLYPSHG--------------LSHGLDLIQLVK 772
+ ++ C+ ++ G L N L LDL L+
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832
VA+G+A+L +H DL NILL + DFG+A+ +K V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK-- 204
Query: 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
G V ++APE + DV+S+G+ L E+ + S
Sbjct: 205 ---------GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
++ +K + E+ ++ C +P R
Sbjct: 256 KFYKMIKEGFRMLSPE-----------------------HAPAEMYDIMKTCWDADPLKR 292
Query: 953 PSMLDVAHEMGRLKQYLSSPSS 974
P+ + +++ +S ++
Sbjct: 293 PTFKQIVQ---LIEKQISESTN 311
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 8e-48
Identities = 70/291 (24%), Positives = 120/291 (41%), Gaps = 51/291 (17%)
Query: 675 IGSGRFGHVYKGVLQDNTR-IAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITI 732
IG G F VYKG+ + T +A L T FK E ++LK ++H N++R
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 733 C----SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
LV LM++G+L+ +L + + L C + +G+ +LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK----IKVLRSWCRQILKGLQFLHTRT 132
Query: 789 PIKVVHCDLKPSNILL-DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
P ++H DLK NI + + + D G+A L + SF + G+
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------------SFAKA---VIGT 176
Query: 848 VGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
++APE ++ DVY+FG+ +LE+ T P + + + + +
Sbjct: 177 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYR-------- 223
Query: 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ P ++KV V E+IE C + N R S+ D+
Sbjct: 224 --------RVTSGVKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-47
Identities = 59/312 (18%), Positives = 114/312 (36%), Gaps = 55/312 (17%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRIIT 731
IG G FG VY ++++ +A+K + + + E +E + L+++RH N I+
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV+ + + L +++ + +G+AYLH H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
++H D+K NILL E + DFG A + G+ ++
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSAS-----------------IMAPANSFVGTPYWM 178
Query: 852 APEYGMGKRASTHG---DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
APE + + DV+S G+ +E+ + P + +++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYH--------- 225
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV-AHEMGRLKQ 967
I + P + WS+ ++ C Q P RP+ + H ++
Sbjct: 226 IAQNES--------PALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLKHRFVLRER 274
Query: 968 YLSSPSSLIEEA 979
+ LI+
Sbjct: 275 PPTVIMDLIQRT 286
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-47
Identities = 65/313 (20%), Positives = 122/313 (38%), Gaps = 53/313 (16%)
Query: 675 IGSGRFGHVYKGVLQDNTRI-AVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITIC 733
+G G FG VYK ++ + + A KV+D + E+ + E IL H N+++++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 78
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
+ +++ + G+++ + L Q+ +C + + YLH + K++
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLK NIL D +ADFG++ ++ + G+ ++AP
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKN----------TRTIQRRDS---FIGTPYWMAP 179
Query: 854 EYGMGKRASTHG-----DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
E M + + DV+S G+ L+E+ P H + + +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLK-------- 226
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV-AHEMGRLKQ 967
IAK P + WS + ++ C + N R + + H +
Sbjct: 227 -----IAKSEPPTLAQPSR--WSSNFKDFLK---KCLEKNVDARWTTSQLLQHPF--VTV 274
Query: 968 YLSSP-SSLIEEA 979
+ P LI EA
Sbjct: 275 DSNKPIRELIAEA 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-47
Identities = 68/305 (22%), Positives = 119/305 (39%), Gaps = 58/305 (19%)
Query: 674 LIGSGRFGHVYKGVL-QDNTRIAVKVLDLT--TTGEITGSFKRECQILKRIRHRNLIRII 730
+G G+FG+VY Q +A+KVL + +RE +I +RH N++R+
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
L+L G++ L D + +++A ++Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSKF----DEQRTATYITELANALSYCHSK--- 125
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+V+H D+KP N+LL +ADFG + S LCG++ Y
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---------------SRRTTLCGTLDY 170
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
+ PE G+ D++S GVL E + G+ P + ++ E KR
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRI--------- 216
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV-AHEMGRLKQYL 969
+ + ++ +LI ++NPS RP + +V H ++
Sbjct: 217 ---------SRVEFTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVLEHP------WI 258
Query: 970 SSPSS 974
++ SS
Sbjct: 259 TANSS 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 62/344 (18%), Positives = 132/344 (38%), Gaps = 59/344 (17%)
Query: 640 ADLEDEEKEKE--EAKNPRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAV 696
+D E EK + +P+ Y + IG G G VY + + +A+
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRF----------EKIGQGASGTVYTAMDVATGQEVAI 50
Query: 697 KVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLY 756
+ ++L + E +++ ++ N++ + D +V+ ++ GSL + +
Sbjct: 51 RQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 757 PSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816
+D Q+ +C + + + +LH + +V+H D+K NILL D + + DFG
Sbjct: 110 -----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLE 876
+ + + G+ ++APE K D++S G++ +E
Sbjct: 162 FCAQITPEQSKRST-------------MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 208
Query: 877 IVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLE 936
++ G P + + + L + P + + S + +
Sbjct: 209 MIEGEPP----YLNENPLR-------------ALYLIATNGTP---ELQNPEKLSAIFRD 248
Query: 937 LIELGLLCTQYNPSTRPSMLDV-AHEMGRLKQYLSSPSSLIEEA 979
+ C + R S ++ H+ ++ + LSS + LI A
Sbjct: 249 FLN---RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-47
Identities = 55/316 (17%), Positives = 107/316 (33%), Gaps = 63/316 (19%)
Query: 674 LIGSGRFGHVYKGVLQDNTR------IAVKVLDLTTTGEITGSFKRECQILKRI-RHRNL 726
++GSG FG V ++ +AVK+L + E +++ ++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 727 IRIITICSKPDFKALVLPLMSNGSLENHLY-------------------PSHGLSHGLDL 767
+ ++ C+ L+ G L N+L + L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 768 IQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDES 827
L+ VA+G+ +L VH DL N+L+ + DFG+A+ +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 828 VNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVL 887
V N V ++APE + DV+S+G+LL EI +
Sbjct: 221 VVRGN-----------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 888 FHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQY 947
++ ++ ++ + + E+ + C +
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATE-----------------------EIYIIMQSCWAF 306
Query: 948 NPSTRPSMLDVAHEMG 963
+ RPS ++ +G
Sbjct: 307 DSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 8e-47
Identities = 70/342 (20%), Positives = 127/342 (37%), Gaps = 66/342 (19%)
Query: 655 PRVSYKQLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTR---IAVKVLDLTTTGEITGSF 711
P + + +IG G FG V K ++ + A+K + + + F
Sbjct: 5 PVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 57
Query: 712 KRECQILKRI-RHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSH------- 763
E ++L ++ H N+I ++ C + L + +G+L + L S L
Sbjct: 58 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 764 -----GLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818
L QL+ +DVA G+ YL + +H DL NIL+ E+ A +ADFG++
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 174
Query: 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIV 878
+ + V ++A E +T+ DV+S+GVLL EIV
Sbjct: 175 R--------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 220
Query: 879 TGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELI 938
+ + G + E ++ + E+
Sbjct: 221 SLGGT----PYCGMTCAELYEKLPQGYRLEK--------------------PLNCDDEVY 256
Query: 939 ELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS--PSSLIEE 978
+L C + P RPS + + R+ + + ++L E+
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEK 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 72/317 (22%), Positives = 133/317 (41%), Gaps = 51/317 (16%)
Query: 675 IGSGRFGHVYKGVL------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG VY+GV + TR+A+K ++ + F E ++K +++R
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHG------LDLIQLVKICSDVAEGVA 782
++ + S+ +++ LM+ G L+++L L +++++ ++A+G+A
Sbjct: 88 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147
Query: 783 YLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDG 842
YL+ + K VH DL N ++ ED T + DFG+ + + + G
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-----------YETDYYRKGG 193
Query: 843 LLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902
V +++PE +T+ DV+SFGV+L EI T + G S + ++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLRFVM 249
Query: 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962
L + + L EL +C QYNP RPS L++ +
Sbjct: 250 EGGLLDKPD--------------------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 963 -GRLKQYLSSPSSLIEE 978
++ S E
Sbjct: 290 KEEMEPGFREVSFYYSE 306
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-45
Identities = 63/304 (20%), Positives = 121/304 (39%), Gaps = 47/304 (15%)
Query: 669 FCPSSLIGSGRFGHVYKGVLQDNTR-----IAVKVLDLTTTGEITGSFKRECQILKRIRH 723
F ++GSG FG VYKG+ +A+K L T+ + E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
++ R++ IC + L+ LM G L +++ L+ C +A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGMNY 126
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
L ++VH DL N+L+ + DFG+AKL+ + + + G
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG---------AEEKEYHAEGG- 173
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
+ ++A E + + + DV+S+GV + E++T +DG E
Sbjct: 174 -KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISS---- 224
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMG 963
I+EK P I ++ + + C + +RP ++ E
Sbjct: 225 -----ILEKGERLPQPPICTI-----------DVYMIMVKCWMIDADSRPKFRELIIEFS 268
Query: 964 RLKQ 967
++ +
Sbjct: 269 KMAR 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 58/298 (19%), Positives = 122/298 (40%), Gaps = 47/298 (15%)
Query: 674 LIGSGRFGHVYKGVLQDNTR----IAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI 729
IG G+FG V++G+ +A+K T+ + F +E +++ H +++++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
I + ++ + +++ L + G L + L LDL L+ ++ +AYL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK-- 127
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+ VH D+ N+L+ + + DFG+++ + DS + ++ G +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKG--KLPIK 174
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
++APE +R ++ DV+ FGV + EI+ G ++ + R P+
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK----PFQGVKNNDVIGRIENGERLPM 230
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967
+ L L C Y+PS RP ++ ++ + +
Sbjct: 231 --------------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 65/290 (22%), Positives = 106/290 (36%), Gaps = 46/290 (15%)
Query: 675 IGSGRFGHVYKGVLQDNTR----IAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIR 728
+G G FG V +G + +AVK L D+ + E F RE + + HRNLIR
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
+ + P K +V L GSL + L G L L + VAEG+ YL
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+ +H DL N+LL + DFG+ + + +
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALP----------QNDDHYVMQEHRKVPF 178
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
+ APE + S D + FGV L E+ T + G + + + +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE----PWIGLNGSQILHKI------- 227
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ +P D ++ + + C + P RP+ + +
Sbjct: 228 -------DKEGERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (404), Expect = 1e-43
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 46/288 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G+G FG V++ A K + + + ++E Q + +RH L+ +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDA 91
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ ++ MS G L + H + + V+ V +G+ ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NY 145
Query: 793 VHCDLKPSNILL--DEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH DLKP NI+ + DFG+ + G+ +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--------------TGTAEF 191
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
APE GK + D++S GVL +++G P G + E ++ +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGENDDETLRNVKSCDWNMD- 245
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ +S + + + +P+TR ++
Sbjct: 246 ----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 6e-43
Identities = 53/302 (17%), Positives = 104/302 (34%), Gaps = 51/302 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDL--TTTGEITGSFKRECQILKRIRHRNLIRII 730
++G G F V L + A+K+L+ RE ++ R+ H +++
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ L NG L ++ D +++ + YLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK--- 127
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H DLKP NILL+ED+ + DFG AK+ + ++ G+ Y
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKV--------LSPESKQARANS---FVGTAQY 176
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
++PE K A D+++ G ++ ++V G P + + ++
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKI--------- 222
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLS 970
+ + + + +L+E + + R EM +
Sbjct: 223 ---------IKLEYDFPEKFFPKARDLVE---KLLVLDATKRLG----CEEMEGYGPLKA 266
Query: 971 SP 972
P
Sbjct: 267 HP 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-42
Identities = 64/306 (20%), Positives = 115/306 (37%), Gaps = 23/306 (7%)
Query: 661 QLIEATGGFCPSSLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILK 719
Q+ + + S IG G +G V + R+A+K + RE +IL
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 720 RIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAE 779
R RH N+I I I P + + + + LY + L + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILR 120
Query: 780 GVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTS 839
G+ Y+H V+H DLKPSN+LL+ + DFG+A++ + T
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA----------DPDHDHTG 167
Query: 840 TDGLLCGSVGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRP------TDVLFHDGS 892
+ Y APE + + T D++S G +L E+++ R D L H
Sbjct: 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
L + ++ + P + +N+++ + + ++L +NP R
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSL-PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286
Query: 953 PSMLDV 958
+
Sbjct: 287 IEVEQA 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 78/319 (24%), Positives = 121/319 (37%), Gaps = 60/319 (18%)
Query: 674 LIGSGRFGHVYKGVL--------QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHR 724
+G G FG V T++AVK+L T + E +++K I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 725 NLIRIITICSKPDFKALVLPLMSNGSLENHLY------------PSHGLSHGLDLIQLVK 772
N+I ++ C++ +++ S G+L +L PSH L LV
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 773 ICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAN 832
VA G+ YL K +H DL N+L+ ED +ADFG+A+ + ID N
Sbjct: 140 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 833 DSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGS 892
V ++APE + + DV+SFGVLL EI T + G
Sbjct: 197 G-----------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGV 241
Query: 893 SLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTR 952
+ E K S+ EL + C PS R
Sbjct: 242 PVEELFKLLKEGHRMDK--------------------PSNCTNELYMMMRDCWHAVPSQR 281
Query: 953 PSMLDVAHEMGRLKQYLSS 971
P+ + ++ R+ L+S
Sbjct: 282 PTFKQLVEDLDRIVA-LTS 299
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 1e-41
Identities = 57/309 (18%), Positives = 111/309 (35%), Gaps = 49/309 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+GSG FG V++ V K ++ + + K E I+ ++ H LI +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDA 94
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
L+L +S G L + + + + +++ EG+ ++H H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 793 VHCDLKPSNILLD--EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VH D+KP NI+ + + + + DFG+A + + + +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--------------TATAEF 194
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
APE + + D+++ GVL +++G P + D
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP------------------FAGEDDLET 236
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV-AHEMGRLKQYL 969
+ + + + +S V E + Q P R ++ D H LK
Sbjct: 237 LQNVKRCDWEFDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW--LKGDH 290
Query: 970 SSPSSLIEE 978
S+ +S I
Sbjct: 291 SNLTSRIPS 299
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (381), Expect = 2e-41
Identities = 60/300 (20%), Positives = 117/300 (39%), Gaps = 47/300 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
++G G V+ L+ + +AVKVL DL F+RE Q + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 731 TICSKPDFKA----LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH 786
+V+ + +L + ++ ++ + +++ +D + + + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT----PKRAIEVIADACQALNFSHQ 129
Query: 787 HSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+ ++H D+KP+NI++ V DFGIA+ DS + + + G
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIAR----------AIADSGNSVTQTAAVIG 176
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
+ Y++PE G DVYS G +L E++TG P G S +H
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHV---- 227
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-SMLDVAHEMGRL 965
+ PI + + +L + L NP R + ++ ++ R+
Sbjct: 228 -------------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-40
Identities = 55/286 (19%), Positives = 101/286 (35%), Gaps = 41/286 (14%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
++G+G F V + +A+K + GS + E +L +I+H N++ + I
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
L++ L+S G L + + + ++ V + V YLH +
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKGFYT----ERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
LDED +++DFG++K+ D S ST CG+ GY+A
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKME-----------DPGSVLST---ACGTPGYVA 177
Query: 853 PEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEK 912
PE K S D +S GV+ ++ G P + + ++ +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILKAEYEFDSPY 232
Query: 913 AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
W D+ + + +P R +
Sbjct: 233 -----------------WDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 66/314 (21%), Positives = 106/314 (33%), Gaps = 57/314 (18%)
Query: 674 LIGSGRFGHVYKGV------LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+G G FG V + +AVK+L T + E +IL I H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 728 RIIT--ICSKPDFKALVLPLMSNGSLENHLY------------PSHGLSHGLDLIQLVKI 773
+ +++ G+L +L P L L L+
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCAND 833
VA+G+ +L K +H DL NILL E + DFG+A+ + + V +
Sbjct: 140 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 195
Query: 834 SMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSS 893
+ ++APE + + DV+SFGVLL EI + + G
Sbjct: 196 ----------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVK 241
Query: 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953
+ E R + E+ + L C PS RP
Sbjct: 242 IDEEFCRRLKEGTRM-------------------RAPDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 954 SMLDVAHEMGRLKQ 967
+ ++ +G L Q
Sbjct: 283 TFSELVEHLGNLLQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 49/288 (17%), Positives = 104/288 (36%), Gaps = 47/288 (16%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G FG V++ V K + + T ++ K+E IL RHRN++ +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNILHLHES 69
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
+ ++ +S + + + + L+ ++V V E + +LH H +
Sbjct: 70 FESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 793 VHCDLKPSNILLDEDLTALV--ADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
H D++P NI+ ++ + +FG A+ + LL + Y
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--------------LKPGDNFRLLFTAPEY 169
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
APE ST D++S G L+ +++G P + + +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP------------------FLAETNQQI 211
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ I + + ++ +E ++ +R + +
Sbjct: 212 IENIMNAEYTFDE----EAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 2e-39
Identities = 50/287 (17%), Positives = 94/287 (32%), Gaps = 39/287 (13%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
IGSG FG +Y G + +A+K+ + T E +I K ++ I I
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRW 70
Query: 733 C-SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
C ++ D+ +V+ L+ + + S S L ++ + + + Y+H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFS----LKTVLLLADQMISRIEYIHSK---N 123
Query: 792 VVHCDLKPSNIL---LDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
+H D+KP N L + + DFG+AK + + + L G+
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR------DARTHQHIPYRENKNLTGTA 177
Query: 849 GYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDP 908
Y + +G S D+ S G +L+ G +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGS------------------LPWQGLKAA 219
Query: 909 IVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + + + M + E C +P
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 145 bits (366), Expect = 2e-39
Identities = 72/313 (23%), Positives = 119/313 (38%), Gaps = 62/313 (19%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG--------SFKRECQILKRIR-H 723
++G G V + + AVK++D+T G + + +E IL+++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 724 RNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAY 783
N+I++ F LV LM G L ++L LS + KI + E +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS----EKETRKIMRALLEVICA 125
Query: 784 LHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
LH +VH DLKP NILLD+D+ + DFG + + +
Sbjct: 126 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL----------DPGEKLREV--- 169
Query: 844 LCGSVGYIAPEYGMGKRASTHG------DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEW 897
CG+ Y+APE H D++S GV++ ++ G P
Sbjct: 170 -CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------------- 214
Query: 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957
+ HR ++ + I Q +SD V +L+ P R + +
Sbjct: 215 ----FWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEE 266
Query: 958 V-AHEMGRLKQYL 969
AH +QY+
Sbjct: 267 ALAHPF--FQQYV 277
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (350), Expect = 4e-37
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 33/293 (11%)
Query: 675 IGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITIC 733
IG G +G VYK A+K + L E I + RE ILK ++H N++++ +
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVV 793
LV + + GL + + G+AY H +V+
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLES----VTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 794 HCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAP 853
H DLKP N+L++ + +ADFG+A+ ++ Y AP
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-------------EIVTLWYRAP 169
Query: 854 EYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK----RHYPHRLDP 908
+ MG K+ ST D++S G + E+V G F S + ++ P+ +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRIFRILGTPNSKNW 225
Query: 909 IVEKAIAKYAPQ---HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ KY P + P+ + + I+L + +P+ R +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-37
Identities = 64/286 (22%), Positives = 108/286 (37%), Gaps = 50/286 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKR-IRHRNLIRI 729
++G G FG V+ + N A+K L D+ + E ++L H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 730 ITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
+ V+ ++ G L H+ H DL + +++ G+ +LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF----DLSRATFYAAEIILGLQFLHSK-- 122
Query: 790 IKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVG 849
+V+ DLK NILLD+D +ADFG+ K ++M + CG+
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCK-------------ENMLGDAKTNTFCGTPD 168
Query: 850 YIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPI 909
YIAPE +G++ + D +SFGVLL E++ G+ P G E
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP-----FHGQDEEELFHSI-------- 215
Query: 910 VEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ +Y + +L+ P R +
Sbjct: 216 ----------RMDNPFYPRWLEKEAKDLLV---KLFVREPEKRLGV 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 8e-37
Identities = 64/293 (21%), Positives = 111/293 (37%), Gaps = 28/293 (9%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE----ITGSFKRECQILKRIRHRNLIR 728
+G G+F VYK N +A+K + L E I + RE ++L+ + H N+I
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 729 IITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS 788
++ +LV M + S L + +G+ YLH H
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 789 PIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++H DLKP+N+LLDE+ +ADFG+AK + + +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-------------QVVTR 164
Query: 849 GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP--TDVLFHDGSSLHEWVKRHYPHR 905
Y APE G R G D+++ G +L E++ D + + E + +
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ I + ++S +L++L +NP R +
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 138 bits (348), Expect = 2e-36
Identities = 59/286 (20%), Positives = 109/286 (38%), Gaps = 52/286 (18%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
+G+G FG V+ + A+KVL ++ + E +L + H +IR+
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+++ + G L + L S + ++V + YLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVAKFYAAEVCLALEYLHSK--- 123
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
+++ DLKP NILLD++ + DFG AK V + ++ CG+ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----------------CGTPDY 167
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
IAPE K + D +SFG+L+ E++ G P S+ + ++
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKI--------- 213
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
+ + + +++ V +L+ + S R L
Sbjct: 214 ---------LNAELRFPPFFNEDVKDLLS---RLITRDLSQRLGNL 247
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 61/295 (20%), Positives = 106/295 (35%), Gaps = 53/295 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTT-----GEITGSFKRECQILKRIRHRNLI 727
+GSG+F V K + A K + T G +RE ILK I+H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ + L+L L++ G L + L L+ + + + GV YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTE----EEATEFLKQILNGVYYLHSL 132
Query: 788 SPIKVVHCDLKPSNILLDED----LTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGL 843
++ H DLKP NI+L + + DFG+A + F +
Sbjct: 133 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--------------KIDFGNEFKN 175
Query: 844 LCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
+ G+ ++APE + D++S GV+ +++G P G + E +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGDTKQETLANVSA 230
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ E +S+ + +P R ++ D
Sbjct: 231 VNYEFEDE-----------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 7e-36
Identities = 40/289 (13%), Positives = 86/289 (29%), Gaps = 41/289 (14%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI-RIIT 731
IG G FG +++G L +N ++A+K + + E + K + I +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYY 68
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ LV+ L+ + S + + V +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV----KTVAMAAKQMLARVQSIHEK---S 121
Query: 792 VVHCDLKPSNILLDEDLT-----ALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCG 846
+V+ D+KP N L+ + V DFG+ K + + L G
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR------DPVTKQHIPYREKKNLSG 175
Query: 847 SVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
+ Y++ +G+ S D+ + G + + + G +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS------------------LPWQGLK 217
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
++ + + ++ + E + P
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-36
Identities = 60/299 (20%), Positives = 110/299 (36%), Gaps = 34/299 (11%)
Query: 673 SLIGSGRFGHVYKG--VLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRI---RHRNL 726
+ IG G +G V+K + +A+K + + T + S RE +L+ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 727 IRIITICSKPDFKALVLPLMSNGSLEN--HLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
+R+ +C+ + ++ Y G+ + + + G+ +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H H +VVH DLKP NIL+ +ADFG+A++ +
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-------------- 175
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK----- 899
++ Y APE + +T D++S G + E+ + F S + + K
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILDVI 231
Query: 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
P + K +D+ +L L C +NP+ R S
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-35
Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 42/309 (13%)
Query: 669 FCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLI 727
+ + +IG+G FG VY+ L +A+K + RE QI++++ H N++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 728 RIITICSKPD------FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGV 781
R+ + LVL + + S L +I + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSL 135
Query: 782 AYLHHHSPIKVVHCDLKPSNILLDED-LTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
AY+H + H D+KP N+LLD D + DFG AK + + +V+
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---------- 182
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP------TDVLFHDGSS 893
S Y APE G T DV+S G +L E++ G+ D L
Sbjct: 183 ----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP 953
L + E + + + L +Y P+ R
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARL 295
Query: 954 SMLDV-AHE 961
+ L+ AH
Sbjct: 296 TPLEACAHS 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 65/295 (22%), Positives = 118/295 (40%), Gaps = 33/295 (11%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIIT 731
IG G +G VYK +A+K + L T E + + RE +LK + H N+++++
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ + LV + + + G+ L + + +G+A+ H H +
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
V+H DLKP N+L++ + +ADFG+A+ + ++ Y
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-------------EVVTLWYR 169
Query: 852 APE-YGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK----RHYPHRL 906
APE K ST D++S G + E+VT R F S + + + P +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRIFRTLGTPDEV 225
Query: 907 DPIVEKAIAKYA---PQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
++ Y P+ ++KV + + L Y+P+ R S
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 50/294 (17%), Positives = 103/294 (35%), Gaps = 52/294 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIIT 731
++G G G V + + + A+K+L +RE ++ R + +++RI+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 732 IC----SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ + +V+ + G L + + + +I + E + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130
Query: 788 SPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
+ H D+KP N+L + + DFG AK +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-------------- 173
Query: 845 CGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904
C + Y+APE ++ D++S GV++ ++ G P +
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP------------------FYS 215
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ + + N WS+V E+ L + P+ R ++ +
Sbjct: 216 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 64/295 (21%), Positives = 102/295 (34%), Gaps = 63/295 (21%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-----SFKRECQILKRIR--HRN 725
L+GSG FG VY G+ + DN +A+K ++ + E +LK++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+IR++ +PD L+L G L V E V + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTAL-VADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
+ V+H D+K NIL+D + L + DFG L+K +
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---------------F 169
Query: 845 CGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
G+ Y PE+ R V+S G+LL ++V G P F + + +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRG-QVFFR 224
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
R+ E L C PS RP+ ++
Sbjct: 225 QRVSS---------------------------ECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 56/294 (19%), Positives = 107/294 (36%), Gaps = 33/294 (11%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITI 732
IG G +G V+K + + +A+K + L E + S RE +LK ++H+N++R+ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 733 CSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKV 792
LV + + LD + + +G+ + H V
Sbjct: 70 LHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 793 VHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIA 852
+H DLKP N+L++ + +A+FG+A+ + ++ Y
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-------------EVVTLWYRP 169
Query: 853 PEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP-------TDVLFHDGSSLHEWVKRHYPH 904
P+ G + + D++S G + E+ RP D L L + +P
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
K Y + + +L++ + NP R S +
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-34
Identities = 53/301 (17%), Positives = 108/301 (35%), Gaps = 33/301 (10%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGE-ITGSFKRECQILKRIRHRNLIRIITI 732
IG G FG V+K + ++A+K + + E + RE +IL+ ++H N++ +I I
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 733 CSKPDFKA--------LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYL 784
C LV + + ++ ++ + G+ Y+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS----EIKRVMQMLLNGLYYI 133
Query: 785 HHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLL 844
H + K++H D+K +N+L+ D +ADFG+A+ S +
Sbjct: 134 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR--------- 181
Query: 845 CGSVGYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRP------TDVLFHDGSSLHEW 897
++ Y PE +G+R D++ G ++ E+ T L
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 898 VKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLD 957
+P+ + + + + Q + ++L +P+ R D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 958 V 958
Sbjct: 302 A 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 5e-34
Identities = 60/290 (20%), Positives = 97/290 (33%), Gaps = 52/290 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-----SFKRECQILKRIRHRNLI 727
+IG G FG VY A+K LD G + + ++ ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 728 RIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH 787
+ PD + +L LM+ G L HL + +++ G+ ++H+
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGLEHMHNR 126
Query: 788 SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGS 847
VV+ DLKP+NILLDE ++D G+A G+
Sbjct: 127 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFS---------------KKKPHASVGT 168
Query: 848 VGYIAPEYGMGKRASTH-GDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906
GY+APE A D +S G +L +++ G P H HE + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAV 226
Query: 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
+ EL L Q + + R L
Sbjct: 227 EL---------------------PDSFSPELRSLLEGLLQRDVNRRLGCL 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-34
Identities = 55/297 (18%), Positives = 110/297 (37%), Gaps = 35/297 (11%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-SFKRECQILKRIRHRNLIRIIT 731
+GSG +G V V + ++A+K L E+ RE ++LK +RH N+I ++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+ + + L ++ + + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---G 141
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
++H DLKP N+ ++ED + DFG+A+ + M+ + Y
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQA----------DSEMTGY------VVTRWYR 185
Query: 852 APEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK---------RH 901
APE + R + D++S G ++ E++TG+ F L + +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVTGTPPAE 241
Query: 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
+ RL K K P+ + + ++ + L + R + +
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 53/285 (18%), Positives = 93/285 (32%), Gaps = 49/285 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVL--DLTTTGEITGSFKRECQILKRIRHRNLIRII 730
L+G G FG V A+K+L ++ + E ++L+ RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
D V+ + G L HL + + +++ + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFT----EERARFYGAEIVSALEYLHSR--- 124
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
VV+ D+K N++LD+D + DFG+ K ++ CG+ Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-------------FCGTPEY 171
Query: 851 IAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIV 910
+APE D + GV++ E++ GR P +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-----FYNQDHERLFELI--------- 217
Query: 911 EKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
I + + S L+ + +P R
Sbjct: 218 ---------LMEEIRFPRTLSPEAKSLLA---GLLKKDPKQRLGG 250
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 1e-31
Identities = 54/307 (17%), Positives = 116/307 (37%), Gaps = 54/307 (17%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIIT 731
+G G++ V++ + + +N ++ VK+L + KRE +IL+ +R N+I +
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPNIITLAD 97
Query: 732 ICSKPDFK--ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP 789
I P + ALV ++N + L + ++ + + Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 790 IKVVHCDLKPSNILLD-EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSV 848
++H D+KP N+++D E + D+G+A+ E S
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--------------VASR 193
Query: 849 GYIAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLD 907
+ PE + + + D++S G +L ++ + P F G ++ + R
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP----FFHGHDNYDQLVRIAKVLGT 249
Query: 908 PIVEKAIAKYAPQHMPIY----------------YNKVWSDVVLELIELGLLCTQYNPST 951
+ I KY + P + +++ V E ++ +Y+ +
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
Query: 952 RPSMLDV 958
R + +
Sbjct: 310 RLTAREA 316
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 6e-31
Identities = 57/285 (20%), Positives = 103/285 (36%), Gaps = 52/285 (18%)
Query: 675 IGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG--SFKRECQILKRIRHRNLIRIIT 731
+G+G FG V + A+K+LD ++ E +IL+ + L+++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 732 ICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIK 791
+V+ ++ G + +HL S + + YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS----EPHARFYAAQIVLTFEYLHSL---D 161
Query: 792 VVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYI 851
+++ DLKP N+L+D+ V DFG AK VKG ++ CG+ +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----------------CGTPEAL 205
Query: 852 APEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVE 911
APE + K + D ++ GVL+ E+ G P + ++ ++
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP-----FFADQPIQIYEKIVSGKVRF--- 257
Query: 912 KAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956
P H +L +L Q + + R L
Sbjct: 258 -------PSHFSS-----------DLKDLLRNLLQVDLTKRFGNL 284
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 121 bits (304), Expect = 3e-30
Identities = 74/386 (19%), Positives = 146/386 (37%), Gaps = 42/386 (10%)
Query: 98 ANLSSLIVLDLSKNFFQGHIP-AELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDL 156
L+ + L K + +L + L+ L S+ G + L+ L ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73
Query: 157 GNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQ 216
NN+L P+ + +++ + + L N + + + +
Sbjct: 74 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 217 VPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFA 276
+ + +S+ + + S + S + S L+ + + N +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLL 336
+ +N + L N + + P I TNL ++ L+ N + +++L NLT L
Sbjct: 194 A--KLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIP--------------------SAFG 376
+L++N ++ P L ++KL + L N +S P S
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 377 DIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSH 436
++ +L L L N +S P ++L++L+RL N +S SSL N+ L H
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 437 NKISGIIPSDVAGLRSLKLYLNLSSN 462
N+IS + P +A L + L L+
Sbjct: 361 NQISDLTP--LANLTRIT-QLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 113 bits (282), Expect = 2e-27
Identities = 80/405 (19%), Positives = 140/405 (34%), Gaps = 24/405 (5%)
Query: 156 LGNNKLVGEIPIP-IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLV 214
LG+ + + PI IF + L ++T + +L + L +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGI- 56
Query: 215 GQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPF 274
+ + + L ++ +N + P + ++K+ + D TNL
Sbjct: 57 -KSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 115
Query: 275 FASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLT 334
++ L+ N + S + L + L +G + L NLT
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175
Query: 335 LLNLSSNLLNGTIPHELCL-MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393
L N + ++ LE + +NN +S P + +L L L+ N+L
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD 233
Query: 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSL 453
+ A+L+ L L L N +S P L L L L N+IS I P L L
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGL 284
Query: 454 KLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLE 513
NL N +S + + + L FNN+S P + S L+ L + N +
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS 342
Query: 514 GLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558
S+ L + N++ P + QL +
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (259), Expect = 2e-24
Identities = 67/391 (17%), Positives = 133/391 (34%), Gaps = 30/391 (7%)
Query: 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFL 206
+L + LG + + + + + + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDL-----DQVTTLQADRLGIKS---IDGVEYLNNLTQI 71
Query: 207 LLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHD 266
+N+L P L N +KL + + +N + P ++ + L D
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 267 GNTNLEPFFA---SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKI 323
TNL ++++ S L G + + L+ LD +
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 324 PPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGL 383
++ L NL L ++N ++ P +++ L+ + L+ N L + +L
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 384 LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGII 443
LDL+ N++S P + L++L L L N +S P L L + +
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLE 298
Query: 444 PSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALE 503
YL L N++ P+ S + + + + N +S L + +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 504 SLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
L+ N + L P + L + Q ++
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 52 HALESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKN 111
L++ ++ N S + +S K+ L + + + +LANL+++ L N
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHN 361
Query: 112 FFQGHIPAELGSLIRLKQLSLSWN 135
P L +L R+ QL L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 53/298 (17%), Positives = 102/298 (34%), Gaps = 35/298 (11%)
Query: 673 SLIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-SFKRECQILKRIRHRNLIRII 730
S +GSG +G V + R+AVK L I RE ++LK ++H N+I ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 731 TICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPI 790
+ + + L + L + + + G+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA--- 140
Query: 791 KVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGY 850
++H DLKPSN+ ++ED + DFG+A+ + Y
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----------------TRWY 184
Query: 851 IAPEYGMGKRASTHG-DVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK---------R 900
APE + D++S G ++ E++TGR F + +
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLILRLVGTPGA 240
Query: 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958
++ + + Q + + V+ ++L + R +
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 51/292 (17%)
Query: 674 LIGSGRFGHVYKGVL----QDNTRIAVKVLD---LTTTGEITGSFKRECQILKRIRHR-N 725
++G+G +G V+ A+KVL + + T + E Q+L+ IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 726 LIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
L+ + L+L ++ G L HL + ++ V E V L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT-------EHEVQIYVGEIVLALE 143
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
H + +++ D+K NILLD + ++ DFG++K + C
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF------------C 191
Query: 846 GSVGYIAPEYGMGKRA--STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903
G++ Y+AP+ G + D +S GVL+ E++TG P +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP------------------FT 233
Query: 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSM 955
+ + I++ + P Y ++ +L +P R
Sbjct: 234 VDGEKNSQAEISRRILKSEPPY----PQEMSALAKDLIQRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-28
Identities = 62/309 (20%), Positives = 112/309 (36%), Gaps = 48/309 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITG-SFKRECQILKRIRHRNLIRIIT 731
IGSG G V + +A+K L + RE ++K + H+N+I ++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 732 ICSKPDFK------ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLH 785
+ + LV+ LM + LD ++ + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH 136
Query: 786 HHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLC 845
I H DLKPSNI++ D T + DFG+A+ + +
Sbjct: 137 SAGII---HRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSFMMTPYV 179
Query: 846 GSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRP----------TDVLFHDGSSLH 895
+ Y APE +G + D++S G ++ E+V + V+ G+
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 896 EWVK------RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNP 949
E++K R+Y K P + ++ + +L +P
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299
Query: 950 STRPSMLDV 958
+ R S+ D
Sbjct: 300 AKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 5e-27
Identities = 50/320 (15%), Positives = 109/320 (34%), Gaps = 49/320 (15%)
Query: 674 LIGSGRFGHVYKGV-LQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITI 732
+G G F V+ + +NT +A+K++ T + + E ++L+R+ + + ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 733 CSKPDFKAL-----------VLPLMSNGSLENHLYPSHGLSHGL-DLIQLVKICSDVAEG 780
+ K L + ++ EN L H LI + +I + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 781 VAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTST 840
+ Y+H I +H D+KP N+L++ + I + ++ +
Sbjct: 138 LDYMHRRCGI--IHTDIKPENVLMEIVDSP----------ENLIQIKIADLGNACWYDEH 185
Query: 841 DGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD--------------- 885
+ Y +PE +G D++S L+ E++TG +
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKV-------WSDVVLELI 938
+ L ++ R+ + + + + + V D E+
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 939 ELGLLCTQYNPSTRPSMLDV 958
+ Q +P R +
Sbjct: 306 DFLSPMLQLDPRKRADAGGL 325
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.7 bits (244), Expect = 6e-23
Identities = 73/325 (22%), Positives = 119/325 (36%), Gaps = 24/325 (7%)
Query: 34 RDRASLVTFMSSIISAPEHALESWN-STDVHVCNWSGVKCNNSRN--KVVELDLSARSIY 90
+D+ +L+ + + L SW +TD W GV C+ +V LDLS ++
Sbjct: 6 QDKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 91 G--TISPALANLSSLIVLDLSKN-FFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGS 147
I +LANL L L + G IP + L +L L ++ ++ G IP L
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 148 LHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLL 207
+ L LD N L G +P I +L I N ++G IP + +
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISS---LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 208 LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDG 267
+ NRL G+ + + S + + N H
Sbjct: 181 ISRNRLTGK-----------IPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 268 NTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI 327
+L + S N L+L N + G +P + L L +++ N + G+IP
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL-KFLHSLNVSFNNLCGEIPQ-G 287
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELC 352
NL + ++N P C
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.6 bits (205), Expect = 7e-18
Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 5/258 (1%)
Query: 286 ELELAGNNLGGM--IPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLL 343
L+L+G NL IPS + +L N + G IPP I+ L L L ++ +
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 344 NGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLS 403
+G IP L + L + S N+LSG +P + +P+L + N++SG+IPDS+ + S
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 404 QLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNH 463
+L + + +NL +DLS N + G ++ + ++
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 464 LDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQL 523
+ LSK +DL N + G++P L L SLN+S N+L G +P G L
Sbjct: 234 AFDLGKVGLSKNLNG--LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290
Query: 524 PYLKQFDVSSNRLFGEIP 541
++N+ P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 83.3 bits (204), Expect = 9e-18
Identities = 70/284 (24%), Positives = 109/284 (38%), Gaps = 29/284 (10%)
Query: 306 STNLVQIHLDCNLIYGK--IPPHISNLVNLTLLNLSSNL-LNGTIPHELCLMSKLERVYL 362
+ + + L + IP ++NL L L + L G IP + +++L +Y+
Sbjct: 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108
Query: 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS 422
++ ++SG IP I L LD S N LSG++P S ++L L + GN +SG IP S
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 423 LGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAID 482
G L + + +L L S ++ L D
Sbjct: 169 YGSFSKLFTSMTISR--NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 483 LSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ 542
N ++G L L+L N + G LP + QL +L +VS N L GEIPQ
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 543 SFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCG 586
G ++++ N LCG
Sbjct: 287 G------------------------GNLQRFDVSAYANNKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 78.3 bits (191), Expect = 4e-16
Identities = 64/325 (19%), Positives = 107/325 (32%), Gaps = 31/325 (9%)
Query: 117 IPAELGSLIRLKQ-------LSLSWN--------SLQGKIPSQLGSLHQLEYLDLGNNKL 161
P + +L+++K+ LS SW + G + +++ LDL L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 162 VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQAL 221
PIP +N L ++ + + +L L +L + + G +P L
Sbjct: 63 PKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 222 ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANS 281
+ L LD N SG LP I S +P L + N ++
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISS-LPNLVGITFDGNRISGAIPDSYGSFS------- 173
Query: 282 SNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341
F + ++ N L G IP + + + + T +
Sbjct: 174 KLFTSMTISRNRLTGKIPPTF---ANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN 401
++ L L + L NN + G +P + L L++S N L G IP N
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289
Query: 402 LSQLRRLLLYGNHLSGTIPSSLGKC 426
L + N P L C
Sbjct: 290 LQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 59/306 (19%), Positives = 98/306 (32%), Gaps = 41/306 (13%)
Query: 169 IFCSNSSTS--LQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSK 226
+ C + + + +DLS +L P+ P +LAN
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYPI-----------------------PSSLANLPY 77
Query: 227 LEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQE 286
L +L + I+K+ QL +LY+++ + + + + S
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY--- 134
Query: 287 LELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTL-LNLSSNLLNG 345
N L G +P I L + D N I G IP + L + +S N L G
Sbjct: 135 -----NALSGTLPPSISSLPNLVGI-TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 346 TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
IP ++ + ++ S L
Sbjct: 189 KIPPTFANLNL--AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNL 246
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHL- 464
L L N + GT+P L + L L++S N + G IP L+ ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD-VSAYANNKCL 304
Query: 465 -DGPLP 469
PLP
Sbjct: 305 CGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 64.4 bits (155), Expect = 1e-11
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 107 DLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIP 166
DL N G +P L L L L++S+N+L G+IP G+L + + NNK + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
Query: 167 IPIFCS 172
+P C+
Sbjct: 309 LPA-CT 313
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.0 bits (227), Expect = 7e-21
Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 12/284 (4%)
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
+ DL + + L N I NL NL L L +N ++ P + KLER
Sbjct: 24 KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
+YLS N L + L + + K+ S+ + + + L SG
Sbjct: 84 LYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIE 142
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
+ L + ++ I+ I L L+L N + L ++ +
Sbjct: 143 NGAFQGMKKLSYIRIADTNITTIPQGLPPSLT----ELHLDGNKITKVDAASLKGLNNLA 198
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
+ LSFN++S L + L L+L+ N L +P + Y++ + +N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAI 257
Query: 540 IPQSFQ------ASPTLKQLNFSFNKFSGNISNKGAFSSLTIAS 577
F + ++ N F + + +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.5 bits (223), Expect = 3e-20
Identities = 58/330 (17%), Positives = 109/330 (33%), Gaps = 42/330 (12%)
Query: 65 CNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSL 124
C+ V+C++ + V DL +LDL N + +L
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLP---------------PDTALLDLQNNKITEIKDGDFKNL 54
Query: 125 IRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLS 184
L L L N + P L +LE L L N+L +P + L+ +
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE---LPEKMPKTLQELRVHENE 111
Query: 185 NNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSE 244
+ + N + L + G A KL ++ + + +P
Sbjct: 112 ITKVRKSVF--NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG 168
Query: 245 IISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD 304
+ P L L+L N D SL +N +L L+ N++ + + +
Sbjct: 169 L---PPSLTELHLDGNKITKVDAA--------SLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 305 LSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNG------TIPHELCLMSKLE 358
+ L+ +P +++ + ++ L +N ++ P +
Sbjct: 218 TPHLRELHLNNNKLVK--VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYS 275
Query: 359 RVYLSNNSLS-GEI-PSAFGDIPHLGLLDL 386
V L +N + EI PS F + + L
Sbjct: 276 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 1e-19
Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 10/252 (3%)
Query: 332 NLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391
+L ++ S L +P +L + L NN ++ F ++ +L L L NK+
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLR 451
S P +FA L +L RL L N L +P + L+ L + N+I+ + S GL
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 124
Query: 452 S-LKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGN 510
+ + L + G M + I ++ N++ +IP L +L L+L GN
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGN 181
Query: 511 SLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAF 570
+ + S+ L L + +S N + S +P L++L+ + NK
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
Query: 571 SSLTIASFQGND 582
+ + N+
Sbjct: 242 KYIQVVYLHNNN 253
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (222), Expect = 2e-20
Identities = 63/275 (22%), Positives = 103/275 (37%), Gaps = 16/275 (5%)
Query: 240 ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIP 299
+P I Q ++L N +++ AS N L L N L +
Sbjct: 25 AVPVGI---PAASQRIFLHGNRI------SHVPA--ASFRACRNLTILWLHSNVLARIDA 73
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLER 359
+ L+ D + P L L L+L L P ++ L+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133
Query: 360 VYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTI 419
+YL +N+L F D+ +L L L N++S +F L L RLLL+ N ++
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 420 PSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVL 479
P + L L L N +S + +A LR+L+ YL L+ N +
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWVCDCRA-RPLWAWLQ 251
Query: 480 AIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEG 514
S + + S+P +L + L+ N L+G
Sbjct: 252 KFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 50/278 (17%), Positives = 89/278 (32%), Gaps = 19/278 (6%)
Query: 116 HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSS 175
+P + + + ++ L N + + + L L L +N L
Sbjct: 25 AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
+ +DLS+N+ + L L L L L P + L++L L+ N
Sbjct: 83 ---EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
LP + + L L+L N S + + L L N +
Sbjct: 140 ALQA-LPDDTFRDLGNLTHLFLHGNRISSVPER--------AFRGLHSLDRLLLHQNRVA 190
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
+ P DL + N + ++ L L L L+ N L +
Sbjct: 191 HVHPHAFRDLGRLMTLYL-FANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWA 248
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393
L++ S++ + +P L L+ N L G
Sbjct: 249 WLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (173), Expect = 6e-14
Identities = 41/259 (15%), Positives = 74/259 (28%), Gaps = 29/259 (11%)
Query: 352 CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411
C L +P + L N++S SF L L L+
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 412 GN-------------------------HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSD 446
N L P++ L L L + + P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 447 VAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLN 506
GL +L+ L N L + + + L N +S +L+ L
Sbjct: 125 FRGLAALQYL-YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 507 LSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISN 566
L N + + P + L L + +N L ++ L+ L + N + +
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
Query: 567 KGAFSSLTIASFQGNDGLC 585
+ ++ L ++ C
Sbjct: 244 RPLWAWLQKFRGSSSEVPC 262
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 50/270 (18%), Positives = 75/270 (27%), Gaps = 43/270 (15%)
Query: 101 SSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI------------------- 141
++ + L N A + L L L N L
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 142 ------PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLK 195
P+ L +L L L + +LQY+ L +N+L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCG---LQELGPGLFRGLAALQYLYLQDNALQALPD-D 147
Query: 196 NECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
+L NL L L NR+ +A L+ L L N + P F
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH---------AFR 198
Query: 256 YLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLD 315
L + N +LA Q L L N + L L +
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR--PLWAWLQKFRGS 256
Query: 316 CNLIYGKIPPHISNLVNLTLLNLSSNLLNG 345
+ + +P L L L++N L G
Sbjct: 257 SSEVPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 29/185 (15%), Positives = 51/185 (27%), Gaps = 3/185 (1%)
Query: 418 TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDM 477
+P + + + L N+IS + + R+L + S+ +
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 478 VLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537
L P L +L+L L+ L P L L+ + N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 538 GEIPQSFQASPTLKQLNFSFNKFSGNISN-KGAFSSLTIASFQGNDGLCGEIKGLQTCKK 596
+F+ L L N+ S SL N + +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 597 EHTHH 601
T +
Sbjct: 203 LMTLY 207
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 35/135 (25%), Positives = 46/135 (34%), Gaps = 8/135 (5%)
Query: 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK 140
L L I A L SL L L +N P L RL L L N+L
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
L L L+YL L +N V + + LQ S++ + +P L
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRARPLWAW----LQKFRGSSSEVPCSLPQ----RL 268
Query: 201 RNLRFLLLWSNRLVG 215
L +N L G
Sbjct: 269 AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 9e-08
Identities = 41/210 (19%), Positives = 62/210 (29%), Gaps = 6/210 (2%)
Query: 54 LESWNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFF 113
L + + L L L L +
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 114 QGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSN 173
Q P L L+ L L N+LQ L L +L L N++ +P
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS---VPERAFR 174
Query: 174 SSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLE 233
SL + L N + P +L L L L++N L +ALA L++L L
Sbjct: 175 GLHSLDRLLLHQNRVAHVHP-HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 234 SNMFSGELPSEIISKMPQLQFLYLSYNDFV 263
N + + LQ S ++
Sbjct: 234 DNPWVCDCR--ARPLWAWLQKFRGSSSEVP 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 2e-18
Identities = 26/166 (15%), Positives = 51/166 (30%), Gaps = 25/166 (15%)
Query: 663 IEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEIT---------GSFKR 713
++A G L+G G+ V+ + VK + T F
Sbjct: 1 VDAIG-----KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 714 ECQILKRIRHRNLIRIITICSKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKI 773
R R L ++ + + G+ + + + ++
Sbjct: 56 LAIRSARNEFRALQKLQGLA-------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEV 108
Query: 774 CSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819
+ E VA +H +VH DL N+L+ + + DF +
Sbjct: 109 LDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (180), Expect = 7e-15
Identities = 42/274 (15%), Positives = 90/274 (32%), Gaps = 12/274 (4%)
Query: 130 LSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189
L L+ +L + +L S + + + P+ S +Q++DLSN+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQ----PLAEHFSPFRVQHMDLSNSVIE 59
Query: 190 GEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKM 249
+ L+ L L RL + LA +S L L+L E + + +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ--TLL 117
Query: 250 PQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQEL-ELAGNNLGGMIPSIIGDLSTN 308
L + +++ A ++ + L N + +++
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177
Query: 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSS-NLLNGTIPHELCLMSKLERVYLSNNSL 367
+ D ++ L L L+LS + EL + L+ + +
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237
Query: 368 SGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFAN 401
G + +PH L ++ + + + N
Sbjct: 238 DGTLQLLKEALPH---LQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 45/296 (15%), Positives = 94/296 (31%), Gaps = 34/296 (11%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK- 140
LDL+ ++++ ++ L + +I ++F + E S R++ + LS + ++
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 141 IPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECEL 200
+ L +L+ L L +L I + +++ L S S L + C
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 201 RNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYN 260
+ L + V A+A+ S+ SG + S + L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETIT----QLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 261 DFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIY 320
D F + Q L L+ C I
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR------------------------CYDII 214
Query: 321 GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFG 376
+ + + L L + + +GT+ L L + ++ + + G
Sbjct: 215 PETLLELGEIPTLKTLQVFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 6e-10
Identities = 45/276 (16%), Positives = 90/276 (32%), Gaps = 27/276 (9%)
Query: 179 QYIDLSNNSLTGEI---------------------PLKNECELRNLRFLLLWSNRL-VGQ 216
Q +DL+ +L ++ PL ++ + L ++ + V
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 217 VPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFA 276
+ L+ SKL+ L LE S + + ++K L L LS S L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNT-LAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLL 336
L + + ++ + + ++ + + + L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSN-NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSI 395
S +L E ++ L+ + LS + E G+IP L L + G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 396 PDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEI 431
L L + +H + ++G N EI
Sbjct: 242 QLL---KEALPHLQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 7e-10
Identities = 44/272 (16%), Positives = 79/272 (29%), Gaps = 17/272 (6%)
Query: 76 RNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQG-HIPAELGSLIRLKQLSLSW 134
V+ RS + + +DLS + + + L +L+ LSL
Sbjct: 22 SQGVIAFRCP-RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 135 NSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP- 193
L I + L L L+L E + S+ S + T +
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140
Query: 194 ---LKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMP 250
+ L N + + L LDL ++ + ++
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200
Query: 251 QLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLV 310
LQ L LS + + L + L++ G G + L L
Sbjct: 201 YLQHLSLSRCYDIIPET-------LLELGEIPTLKTLQVFGIVPDGTLQ----LLKEALP 249
Query: 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNL 342
+ ++C+ P I N N + + L
Sbjct: 250 HLQINCSHFTTIARPTIGNKKNQEIWGIKCRL 281
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 48/270 (17%), Positives = 95/270 (35%), Gaps = 16/270 (5%)
Query: 285 QELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLN 344
Q L+L G NL P + G L + V + + + ++LS++++
Sbjct: 3 QTLDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 345 G-TIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK--NKLSGSIPDSFAN 401
T+ L SKL+ + L LS I + +L L+LS ++ ++
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 402 LSQLRRLLLYGNHLSG------TIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKL 455
S+L L L + L + N + + V +L
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179
Query: 456 YLNLSSNHLDGPLPLELSKMDMVLAIDLSF-NNLSGSIPPQLGSCIALESLNLSGNSLEG 514
S L E +++ + + LS ++ +LG L++L + G +G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 515 LLPVSVGQLPYLKQFDVSSNRLFGEIPQSF 544
L + LP+L+ ++ + +
Sbjct: 240 TLQLLKEALPHLQ---INCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 45/262 (17%), Positives = 84/262 (32%), Gaps = 36/262 (13%)
Query: 334 TLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSG 393
L+L+ L+ + L L + + + + F + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 394 -SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRS 452
++ + S+L+ L L G LS I ++L K NL L+LS
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 453 LKLY-------------------------------LNLSSNHLDGPLPLELSKMDMVLAI 481
+L N L + + ++ +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 482 DLSFN-NLSGSIPPQLGSCIALESLNLSG-NSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
DLS + L + L+ L+LS + + +G++P LK V G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 540 IPQSFQASPTLKQLNFSFNKFS 561
+ +A P L+ F +
Sbjct: 241 LQLLKEALPHLQINCSHFTTIA 262
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 69.9 bits (169), Expect = 3e-13
Identities = 57/332 (17%), Positives = 99/332 (29%), Gaps = 23/332 (6%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNN 186
+L L+ L +P LE L N L E+P SL+ + + NN
Sbjct: 40 AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELP------ELPQSLKSLLVDNN 88
Query: 187 SLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQ---ALANSSKLEWLDLESNMFSGELPS 243
+L L E + L + +++ L+ L
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 244 EIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIG 303
+ + + + P S L +P +
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 304 DLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS 363
+ N + L + N + S + +S+L
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 364 NNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSL 423
N+ S EI S P L L++S NKL +P +L RL+ NHL+ +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP 323
Query: 424 GKCVNLEILDLSHNKISGIIPSDVAGLRSLKL 455
NL+ L + +N + P + L++
Sbjct: 324 Q---NLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 65.6 bits (158), Expect = 8e-12
Identities = 56/330 (16%), Positives = 99/330 (30%), Gaps = 17/330 (5%)
Query: 77 NKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
+ EL+L+ + ++ +L SL S N +P SL L + + +
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
L P + L + + SL+ + SL N
Sbjct: 93 LSDLPPLL--EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 197 ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
+ E L + + L+ + + +P L +Y
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
N + ++ EL + + I + L
Sbjct: 211 ADNNLLKTLPDLPPSLEALNV-RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFG 376
N +I +L LN+S+N L +P +LER+ S N L+ E+P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE--- 321
Query: 377 DIPHLGLLDLSKNKLSGSIPDSFANLSQLR 406
+L L + N L PD ++ LR
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 57/347 (16%), Positives = 100/347 (28%), Gaps = 41/347 (11%)
Query: 150 QLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLW 209
Q L+L N L +P L+ + S NSLT E+P ++L+ LL+
Sbjct: 39 QAHELELNNLGL-SSLP------ELPPHLESLVASCNSLT-ELP----ELPQSLKSLLVD 86
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
+N L L++ L SN +LP S ++ + + + +
Sbjct: 87 NNNLKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPS 141
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
+ + L + + L + +
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201
Query: 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGL------ 383
+ + N L T+P + L L S +
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 384 ---LDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440
N S I L L + N L +P+ LE L S N ++
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA 317
Query: 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNN 487
+ ++LK L++ N L P ++ DL N+
Sbjct: 318 EVPEL----PQNLK-QLHVEYNPLRE-FPDIPESVE-----DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 22/129 (17%), Positives = 45/129 (34%), Gaps = 15/129 (11%)
Query: 57 WNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGH 116
+ +++ + I SL L++S N
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 298
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176
+PA RL++L S+N L ++P + L+ L + N L E P +
Sbjct: 299 LPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFP------DIPE 344
Query: 177 SLQYIDLSN 185
S++ + +++
Sbjct: 345 SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 61/361 (16%), Positives = 113/361 (31%), Gaps = 57/361 (15%)
Query: 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN 235
++L+N L+ +P +L L+ N L ++P+ + L+ L +++N
Sbjct: 38 RQAHELELNNLGLS-SLP----ELPPHLESLVASCNSLT-ELPELPQS---LKSLLVDNN 88
Query: 236 MFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLG 295
+ P L++L +S N N ++++ ++L +L
Sbjct: 89 NLKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 296 GMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMS 355
+ +Q IY L N
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 356 KLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPD---------SFANLSQLR 406
++N+L +P + L + D L F+ LS+L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466
L Y N S I S +LE L++S+NK+ +P+ L L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL------------- 309
Query: 467 PLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYL 526
SFN+L+ +P + L+ L++ N L P + L
Sbjct: 310 ---------------IASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
Query: 527 K 527
+
Sbjct: 350 R 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 27/103 (26%), Positives = 43/103 (41%), Gaps = 16/103 (15%)
Query: 132 LSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGE 191
N+ +I S LE L++ NNKL+ E+P L+ + S N L E
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP------ALPPRLERLIASFNHLA-E 318
Query: 192 IPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLES 234
+P +NL+ L + N L + P + +E L + S
Sbjct: 319 VP----ELPQNLKQLHVEYNPLR-EFPDIPES---VEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 20/70 (28%), Positives = 28/70 (40%), Gaps = 5/70 (7%)
Query: 352 CLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411
CL + + L+N LS +P PHL L S N L+ +P+ +L L
Sbjct: 35 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 412 GNHLSGTIPS 421
LS P
Sbjct: 90 LKALSDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 5e-04
Identities = 24/88 (27%), Positives = 34/88 (38%), Gaps = 8/88 (9%)
Query: 475 MDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSN 534
+ + N S I +LE LN+S N L L P L++ S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLERLIASFN 314
Query: 535 RLFGEIPQSFQASPTLKQLNFSFNKFSG 562
L E+P+ Q LKQL+ +N
Sbjct: 315 HL-AEVPELPQ---NLKQLHVEYNPLRE 338
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 3e-11
Identities = 43/216 (19%), Positives = 75/216 (34%), Gaps = 13/216 (6%)
Query: 349 HELCLMSKLE---RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQL 405
H +C +SK+ V +L+ +P +L LS+N L + ++L
Sbjct: 1 HPICEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRL 57
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
+L +L + L L +L + + + G L + S +
Sbjct: 58 TQL-----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL 112
Query: 466 GPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESL-NLSGNSLEGLLPVSVGQLP 524
LPL + L N ++PP L + +L+ N+L L + L
Sbjct: 113 TSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLE 172
Query: 525 YLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKF 560
L + N L+ IP+ F S L N +
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 44/207 (21%), Positives = 66/207 (31%), Gaps = 27/207 (13%)
Query: 280 NSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLS 339
++ E+ NL ++ DL + +HL NL+Y + LT LNL
Sbjct: 8 KVASHLEVNCDKRNL----TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 340 SNLLNGTIPHEL---------------------CLMSKLERVYLSNNSLSGEIPSAFGDI 378
L + L + +S N L+ A +
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 379 PHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
L L L N+L P +L +L L N+L+ L NL+ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 439 ISGIIPSDVAGLRSLKLYLNLSSNHLD 465
+ IP G L + L N
Sbjct: 184 LY-TIPKGFFGSHLLP-FAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 45/229 (19%), Positives = 77/229 (33%), Gaps = 26/229 (11%)
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
+ ++ + +L+ +P L K + IL LS N + + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT-QL 60
Query: 458 NLSSN---------------------HLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQL 496
NL + LPL + + +D+SFN L+ L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 497 GSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556
L+ L L GN L+ L P + P L++ +++N L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 557 FNKFSGNISNKGAFSSLTIASFQGNDGLCG-EIKGLQTCKKEHTHHLVI 604
N L A GN LC EI + +++ ++ +
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYV 229
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 33/212 (15%), Positives = 59/212 (27%), Gaps = 28/212 (13%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158
++S + ++ K +P +L L LS N L + L +L L+L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 159 NKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLL----------- 207
+L + L + L + L G+ + L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 208 -----LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDF 262
+ +P L + +N ELP+ +++ + L L L N
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 263 VSHDGNTNLEPFFASLANSSNFQELELAGNNL 294
+ S L GN
Sbjct: 185 YT---------IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 34/223 (15%), Positives = 55/223 (24%), Gaps = 12/223 (5%)
Query: 79 VVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQ 138
L LS +Y L + L L+L + L L S
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-----GTLPVLGTLDLSHN 87
Query: 139 GKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNEC 198
L L + + N T L
Sbjct: 88 QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLS 258
L +N L L L+ L L+ N +P L F +L
Sbjct: 148 PKLEKLS--LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG-SHLLPFAFLH 203
Query: 259 YNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSI 301
N + N + F L +++ + G ++ M ++
Sbjct: 204 GNPW---LCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNV 243
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.8 bits (133), Expect = 4e-09
Identities = 39/237 (16%), Positives = 69/237 (29%), Gaps = 28/237 (11%)
Query: 200 LRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSY 259
L N + + + V QA + + L + E + + L L L
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKD 72
Query: 260 NDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLI 319
N NL + + + + + T++ + NL
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 320 YGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIP 379
+ + I + L YLS + + ++
Sbjct: 133 VLYLDLNQ-------------------ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS 173
Query: 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSH 436
L L NK+S P A+L L + L N +S P L NL I+ L++
Sbjct: 174 KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 40/242 (16%), Positives = 85/242 (35%), Gaps = 29/242 (11%)
Query: 169 IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228
IF + + I +++T + +L + L + + + + + L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLI 66
Query: 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELE 288
L+L+ N + P + ++K+ +L+ + + G +++ + ++ L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL- 125
Query: 289 LAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIP 348
S + L +L QI L ++S +
Sbjct: 126 --------AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA-----------QVSDL 166
Query: 349 HELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408
L +SKL + +N +S P +P+L + L N++S P AN S L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 409 LL 410
L
Sbjct: 223 TL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 7e-08
Identities = 37/222 (16%), Positives = 65/222 (29%), Gaps = 16/222 (7%)
Query: 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFL 206
+L + G + + + + + +T ++ L NL L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ-----ADLDGITTLSAFGTGVTTIEGVQY---LNNLIGL 68
Query: 207 LLWSNRLVGQVPQA-LANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSH 265
L N++ P L ++LE S + I +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 266 DGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL---STNLVQIHLDCNLIYGK 322
L + N S L G + L + D N I
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSN 364
P +++L NL ++L +N ++ P L S L V L+N
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 21/67 (31%), Positives = 31/67 (46%), Gaps = 5/67 (7%)
Query: 394 SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSL 453
S ANLS+L L N +S P L NL + L +N+IS + P +A +L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
Query: 454 KLYLNLS 460
+ L+
Sbjct: 220 F-IVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 28/216 (12%), Positives = 65/216 (30%), Gaps = 21/216 (9%)
Query: 354 MSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
++ ++ ++++ + A D+ + L ++ +I L+ L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 414 HLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSS------------ 461
++ P + L + K I + ++
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 462 -NHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520
+ + LS N S L + L +L N + + P+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL-- 191
Query: 521 GQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556
LP L + + +N++ P + L + +
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 32/242 (13%)
Query: 98 ANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLG 157
L++ I + K+ + L + LS + + L+ L L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELK 71
Query: 158 NNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV 217
+N I +L I S + L++++ L L S +
Sbjct: 72 DN--------QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ----- 118
Query: 218 PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFAS 277
+ L L ++ L+ ++S +
Sbjct: 119 --------ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-- 168
Query: 278 LANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLN 337
LAN S L+ N + + P + L NL+++HL N I P ++N NL ++
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASL-PNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 338 LS 339
L+
Sbjct: 224 LT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 25/217 (11%), Positives = 58/217 (26%), Gaps = 21/217 (9%)
Query: 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388
L N + + + T+ + + + ++ + +L L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQAD--LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVA 448
N+++ P L I + S++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 449 GLRSLKLYL-------------NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQ 495
L + LS + L+ + + + N +S P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 496 LGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVS 532
L S L ++L N + + P++ L ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 20/64 (31%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 95 PALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYL 154
LANLS L L N P L SL L ++ L N + P L + L +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 155 DLGN 158
L N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 43/222 (19%), Positives = 69/222 (31%), Gaps = 27/222 (12%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+++ ++ T++ A+L + L I + L L L L N +
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFC---------SNSSTSLQYIDLSNNSL 188
P + + L K V I T L +
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135
Query: 189 TGEIPLKNECELRNLRFLLLWSNRLVGQVPQ-ALANSSKLEWLDLESNMFSGELPSEIIS 247
+ N L L L S LAN SKL L + N S P ++
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP---LA 192
Query: 248 KMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELEL 289
+P L ++L N +++ P LAN+SN + L
Sbjct: 193 SLPNLIEVHLKNNQI------SDVSP----LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 33/244 (13%), Positives = 61/244 (25%), Gaps = 48/244 (19%)
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338
+N ++ +N+ + DL + + + + L NL L L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLD-GITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70
Query: 339 SSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDS 398
N + P + + + I + + +
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 399 FANLSQLRRLLLYGNHL--------------SGTIPSSLGKCVNLEILDLSHNKISGIIP 444
L + + L + + L L L NKIS I P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 445 SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALES 504
+A L +L + L N +S P L + L
Sbjct: 191 --LASLPNLI-------------------------EVHLKNNQISDVSP--LANTSNLFI 221
Query: 505 LNLS 508
+ L+
Sbjct: 222 VTLT 225
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 5e-09
Identities = 36/127 (28%), Positives = 55/127 (43%), Gaps = 10/127 (7%)
Query: 406 RRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
R L L L T+ L + + + LDLSHN++ + P+ L +L+ L ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNA 54
Query: 466 GPLPLELSKMDMVLAIDLSFNNLSGSIPPQ-LGSCIALESLNLSGNSL---EGLLPVSVG 521
++ + + + L N L S Q L SC L LNL GNSL EG+
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 522 QLPYLKQ 528
LP +
Sbjct: 115 MLPSVSS 121
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 7e-08
Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 9/128 (7%)
Query: 82 LDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141
L L+ + + T+ L L + LDLS N + P L +L L+ L + +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALEN 57
Query: 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE-- 199
+ +L +L+ L L NN+L I S L ++L NSL E ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSC--PRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 200 LRNLRFLL 207
L ++ +L
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEI 371
+HL + + H+ L+ +T L+LS N L P L L + + E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRC---LEVLQASDNALEN 57
Query: 372 PSAFGDIPHLGLLDLSKNKL-SGSIPDSFANLSQLRRLLLYGNHLSG 417
++P L L L N+L + + +L L L GN L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 28/131 (21%), Positives = 46/131 (35%), Gaps = 15/131 (11%)
Query: 179 QYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFS 238
+ + L++ LT L+ L + L L NRL P + L L++ +
Sbjct: 1 RVLHLAHKDLTVLCHLEQ---LLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDN 53
Query: 239 GELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMI 298
+ ++ +P+LQ L L N L + L L GN+L
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQS-------AAIQPLVSCPRLVLLNLQGNSLCQ-E 105
Query: 299 PSIIGDLSTNL 309
I L+ L
Sbjct: 106 EGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 25/116 (21%), Positives = 40/116 (34%), Gaps = 11/116 (9%)
Query: 153 YLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNR 212
L L + L + + ++DLS+N L P L LR L +
Sbjct: 2 VLHLAHKDLTVLCHLE-----QLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQAS 51
Query: 213 LVGQV-PQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDG 267
+AN +L+ L L +N + + P+L L L N +G
Sbjct: 52 DNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.3 bits (131), Expect = 8e-09
Identities = 39/251 (15%), Positives = 79/251 (31%), Gaps = 16/251 (6%)
Query: 171 CSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWL 230
C S+ + +T EIP RN L +L A + LE +
Sbjct: 6 CHCSNRV---FLCQESKVT-EIP---SDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKI 58
Query: 231 DLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELA 290
++ N + +++ S +P+L + + + + + + + ++
Sbjct: 59 EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-- 116
Query: 291 GNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHE 350
I L L+ I + N+ + + +L L+ N +
Sbjct: 117 ----HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 351 LCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLL 410
E NN+L F +LD+S+ ++ NL +LR
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 411 YGNHLSGTIPS 421
Y +P+
Sbjct: 233 YNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 1e-05
Identities = 29/229 (12%), Positives = 52/229 (22%), Gaps = 8/229 (3%)
Query: 210 SNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNT 269
V ++P L L + S L+ + +S ND +
Sbjct: 16 QESKVTEIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 270 NLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISN 329
L N + L + I ++ +
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389
+ N+ + L + ++L+ N + AF L N
Sbjct: 133 DIQDN-----INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNK 438
L D F S L + + L L + K
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 11/53 (20%), Positives = 19/53 (35%), Gaps = 3/53 (5%)
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE 471
ILD+S +I + + L+ L+ S+ +L LE
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 0.001
Identities = 31/240 (12%), Positives = 62/240 (25%), Gaps = 33/240 (13%)
Query: 348 PHELCLMSKLERVYLSNNSLSGEIPSAFGDIP-HLGLLDLSKNKLSGSIPDSFANLSQLR 406
H +C S + ++ EIPS D+P + L KL +F+ L
Sbjct: 2 HHRICHCSNRV-FLCQESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLE 56
Query: 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI--------------------------- 439
++ + N + I + + +
Sbjct: 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116
Query: 440 SGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC 499
+ L+ + L + + N + + + L+ N +
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 500 IALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNK 559
E N+LE L D+S R+ + L+ + K
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 13/104 (12%), Positives = 26/104 (25%)
Query: 57 WNSTDVHVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGH 116
++++ + V L L+ I + A + N +
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNK 160
L +S + L +L +L N K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.9 bits (125), Expect = 3e-08
Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 9/178 (5%)
Query: 323 IPPHISNLVNLTLLNLSSNLLNGTIPHELC-LMSKLERVYLSNNSLSGEIPSAFGDIPHL 381
IP I + T L L+ N L L + L ++ L N L+G P+AF H+
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 382 GLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441
L L +NK+ F L QL+ L LY N +S +P S +L L+L+ N +
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 442 IIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSC 499
+A +L+ P ++ + + DL + S C
Sbjct: 141 NCH--LAWFAEWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEFKCS-SENSEGC 192
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.9 bits (125), Expect = 3e-08
Identities = 35/167 (20%), Positives = 62/167 (37%), Gaps = 6/167 (3%)
Query: 300 SIIGDLSTNLVQIHLDCNLIYGKIPPHI-SNLVNLTLLNLSSNLLNGTIPHELCLMSKLE 358
I D+ + ++ L+ N + + L +L L L N L G P+ S ++
Sbjct: 22 EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81
Query: 359 RVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGT 418
+ L N + F + L L+L N++S +P SF +L+ L L L N +
Sbjct: 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLD 465
+ L L+ PS V ++ +L +
Sbjct: 142 CHLAWFAE-WLRKKSLNGGAARCGAPSKVRDVQ----IKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.2 bits (87), Expect = 0.002
Identities = 36/190 (18%), Positives = 63/190 (33%), Gaps = 18/190 (9%)
Query: 65 CNWSGVKCNNSR---------NKVVELDLSARSIYGTI-SPALANLSSLIVLDLSKNFFQ 114
C + V C EL L+ + L L+ L+L +N
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 115 GHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNS 174
G P +++L L N ++ LHQL+ L+L +N++ + F
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSF--EH 124
Query: 175 STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLES 234
SL ++L++N L LR L P + + ++ DL
Sbjct: 125 LNSLTSLNLASNPFNCNCHLA--WFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPH 179
Query: 235 NMFSGELPSE 244
+ F +
Sbjct: 180 SEFKCSSENS 189
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 7e-08
Identities = 20/89 (22%), Positives = 36/89 (40%), Gaps = 9/89 (10%)
Query: 384 LDLSKNKLSGS-IPDSFANLSQLRRLLLYGNHLSG----TIPSSLGKCVNLEILDLSHNK 438
LD+ +LS + + L Q + + L L+ I S+L L L+L N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 439 ISGIIPSDVA-GLRSLKL---YLNLSSNH 463
+ + V GL++ L+L +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 17/99 (17%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 175 STSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL----VGQVPQALANSSKLEWL 230
S +Q +D+ L+ + L+ + + L L + AL + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 231 DLESNMFSGELPSEII----SKMPQLQFLYLSYNDFVSH 265
+L SN ++ + ++Q L L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 10/94 (10%)
Query: 331 VNLTLLNLSSNLLNGTIPHELC-LMSKLERVYLSNNSLSGE----IPSAFGDIPHLGLLD 385
+++ L++ L+ EL L+ + + V L + L+ I SA P L L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 386 LSKNKLSGSIPDSFA-----NLSQLRRLLLYGNH 414
L N+L ++++L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 8/98 (8%)
Query: 224 SSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSN 283
S ++ LD++ S +E++ + Q Q + L + ++L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL----TEARCKDISSALRVNPA 56
Query: 284 FQELELAGNNLGGMIPSIIGDL----STNLVQIHLDCN 317
EL L N LG + + S + ++ L
Sbjct: 57 LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 20/92 (21%), Positives = 32/92 (34%), Gaps = 7/92 (7%)
Query: 102 SLIVLDLSKNFFQGHIPAELGSLIR-LKQLSLSWNSLQGK----IPSQLGSLHQLEYLDL 156
+ LD+ AEL L++ + + L L I S L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 157 GNNKLVGEIPIPIF--CSNSSTSLQYIDLSNN 186
+N+L + S +Q + L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 22/92 (23%), Positives = 31/92 (33%), Gaps = 9/92 (9%)
Query: 379 PHLGLLDLSKNKLSG----SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCV-----NL 429
L +L L+ +S S+ + LR L L N L L + V L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 430 EILDLSHNKISGIIPSDVAGLRSLKLYLNLSS 461
E L L S + + L K L + S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 15/87 (17%), Positives = 29/87 (33%), Gaps = 6/87 (6%)
Query: 113 FQGHIPAELGSLIRLKQLSLSWNSLQGK----IPSQLGSLHQLEYLDLGNNKLVGEIPIP 168
+ L+ L L+ + + + L + H L LDL NN L +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 169 IF--CSNSSTSLQYIDLSNNSLTGEIP 193
+ L+ + L + + E+
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 12/94 (12%), Positives = 34/94 (36%), Gaps = 11/94 (11%)
Query: 427 VNLEILDLSHNKISGIIPSDVA-GLRSLKLYLNLSSNHLDG----PLPLELSKMDMVLAI 481
++++ LD+ ++S +++ L+ + + L L + L + +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQ-VVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 482 DLSFNNLSGSIPPQLGSCIA-----LESLNLSGN 510
+L N L + + ++ L+L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 18/98 (18%), Positives = 33/98 (33%), Gaps = 13/98 (13%)
Query: 348 PHELCLMSKLERVYLSNNSLSGE----IPSAFGDIPHLGLLDLSKNKLSGSIPDSFA--- 400
S L ++L++ +S + + L LDLS N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 401 --NLSQLRRLLLYGNHLSGTIPSSLG----KCVNLEIL 432
L +L+LY + S + L +L ++
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 14/90 (15%), Positives = 32/90 (35%), Gaps = 9/90 (10%)
Query: 125 IRLKQLSLSWNSLQGKIPSQL-GSLHQLEYLDLGNNKLVGEIPIPIFCS-NSSTSLQYID 182
+ ++ L + L ++L L Q + + L + L I + + +L ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 183 LSNNSLTGEIP-------LKNECELRNLRF 205
L +N L C+++ L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 56/421 (13%), Positives = 114/421 (27%), Gaps = 28/421 (6%)
Query: 81 ELDLSARSI----YGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNS 136
+ L + IS AL +L L+L N + L+ S
Sbjct: 31 VVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG--LQTPSCKIQK 88
Query: 137 LQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196
L + G+ + L + E+ + + + + L+
Sbjct: 89 LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQL 148
Query: 197 ECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLY 256
E + ++ L + S + + + L
Sbjct: 149 EYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 208
Query: 257 LSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDC 316
+D + + ++ L + L T +
Sbjct: 209 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 268
Query: 317 NLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCL-----MSKLERVYLSNNSLSGEI 371
G + + +L L+L+ N L LC +LE +++ + S +
Sbjct: 269 AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 328
Query: 372 PSAFGDIPHLGLLDLSKNKLSGSIPDS---------FANLSQLRRLLLYGNHLSGT---- 418
S F + L + + D+ S LR L L +S +
Sbjct: 329 CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS 388
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVA-GLRSLKL---YLNLSSNHLDGPLPLELSK 474
+ ++L +L LDLS+N + + +R L L + + L
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
Query: 475 M 475
+
Sbjct: 449 L 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 18/104 (17%), Positives = 33/104 (31%), Gaps = 11/104 (10%)
Query: 163 GEIPIPIFCSNSSTSLQYIDLSNNSLTGEIP---LKNECELRNLRFLLLWSNRLVGQVPQ 219
G + + L+ + L++ ++ +LR L L +N L
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 220 ALA-----NSSKLEWLDLESNMFSGELPS---EIISKMPQLQFL 255
L LE L L +S E+ + P L+ +
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 17/93 (18%), Positives = 28/93 (30%), Gaps = 9/93 (9%)
Query: 326 HISNLVNLTLLNLSSNLLNGT----IPHELCLMSKLERVYLSNNSLSGEIPSAFGDI--- 378
L +L L+ ++ + + L L + LSNN L +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 379 --PHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409
L L L S + D L + + L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 18/93 (19%), Positives = 29/93 (31%), Gaps = 4/93 (4%)
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGK----IPPHISNLVNLTLL 336
S + Q L++ L + + L + LD + I + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG 369
NL SN L H + + + SL
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 26/156 (16%), Positives = 44/156 (28%), Gaps = 30/156 (19%)
Query: 235 NMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNL 294
F+ S S + Q +FL + E S + L LA ++
Sbjct: 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381
Query: 295 GGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELC-- 352
S + + +L L+LS+N L +L
Sbjct: 382 SDSSCSSLAAT---------------------LLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 353 ---LMSKLERVYLSNNSLSGEIPSAFGDI----PHL 381
LE++ L + S E+ + P L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 9/93 (9%)
Query: 65 CNWSGVKCNNSRNKVVELDLSARSIYGT----ISPALANLSSLIVLDLSKNFFQGHIPAE 120
+ + L L+ + + ++ L SL LDLS N +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 121 LGSLIR-----LKQLSLSWNSLQGKIPSQLGSL 148
L +R L+QL L ++ +L +L
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 13/86 (15%), Positives = 30/86 (34%), Gaps = 10/86 (11%)
Query: 481 IDLSFNNLSGSIPPQLGSCIA-LESLNLSGNSL--EGL--LPVSVGQLPYLKQFDVSSNR 535
+D+ LS + +L + + + L L + ++ P L + ++ SN
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 536 LFGEIPQSF-----QASPTLKQLNFS 556
L S +++L+
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 16/89 (17%), Positives = 27/89 (30%), Gaps = 10/89 (11%)
Query: 81 ELDLSARSIYGT-ISPALANLSSLIVLDLSKNFFQG----HIPAELGSLIRLKQLSLSWN 135
LD+ + + L L V+ L I + L L +L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 136 SLQGKIPSQLGSL-----HQLEYLDLGNN 159
L + +++ L L N
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 11/66 (16%), Positives = 24/66 (36%), Gaps = 5/66 (7%)
Query: 502 LESLNLSGNSLEGL-LPVSVGQLPYLKQFDVSSNRL----FGEIPQSFQASPTLKQLNFS 556
++SL++ L + L + + L +I + + +P L +LN
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 557 FNKFSG 562
N+
Sbjct: 64 SNELGD 69
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 33/135 (24%), Positives = 52/135 (38%), Gaps = 12/135 (8%)
Query: 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSL 367
+ Q LD + + P + +LN S++ T+ + +L + LSNN L
Sbjct: 21 DGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRL 77
Query: 368 SG--EIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSS--- 422
++ S P+L +L+LS N+L +L L L GN LS T
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137
Query: 423 ----LGKCVNLEILD 433
+ L LD
Sbjct: 138 ISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 8e-07
Identities = 30/147 (20%), Positives = 50/147 (34%), Gaps = 6/147 (4%)
Query: 322 KIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHL 381
++ +S + + L L +L + + ++ + + +IP L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 382 GLLDLSKNKLSG--SIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKI 439
L+LS N+L + L+ L L GN L K + LE L L N +
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 440 SGIIPSDVAGLRSLKLYLNLSSNHLDG 466
S D + S LDG
Sbjct: 128 SDTFR-DQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 4e-05
Identities = 24/146 (16%), Positives = 52/146 (35%), Gaps = 15/146 (10%)
Query: 419 IPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLS-SNHLDGPLPLELSKMDM 477
+ + K + L + L + + + L+ + + L + +
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRSD-----PDLVAQNIDVVLNRRSSMAATLRIIEENIPE 66
Query: 478 VLAIDLSFNNLSG--SIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNR 535
+L+++LS N L + + L+ LNLSGN L+ + + L++ + N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 536 LFGEIPQS-------FQASPTLKQLN 554
L + P L +L+
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 3/105 (2%)
Query: 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGT--IPHELCLMSKLERVYLSN 364
V ++ ++ + N+ L LNLS+N L + + L+ + LS
Sbjct: 42 NIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100
Query: 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409
N L E L L L N LS + D +S +R
Sbjct: 101 NELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 30/154 (19%), Positives = 50/154 (32%), Gaps = 25/154 (16%)
Query: 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKL 161
S LDL +L + L+ +S+ + ++ +L L+L NN+L
Sbjct: 23 SQQALDLKGL----RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRL 77
Query: 162 VGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQAL 221
+ + +L+ ++LS N L E L L+ L L N L
Sbjct: 78 YRLDDMSSIVQK-APNLKILNLSGNELKSERELDKIKGLKL-EELWLDGNSLSDTFRDQS 135
Query: 222 ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFL 255
S I + P+L L
Sbjct: 136 TYISA------------------IRERFPKLLRL 151
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.9 bits (118), Expect = 1e-07
Identities = 25/137 (18%), Positives = 49/137 (35%), Gaps = 8/137 (5%)
Query: 398 SFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYL 457
+ N + R L L G + I + + +D S N+I + LR LK L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLK-TL 68
Query: 458 NLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSG----SIPPQLGSCIALESLNLSGNSLE 513
+++N + + + + L+ N+L L S L L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 514 GLLPVSVGQLPYLKQFD 530
+ ++P ++ D
Sbjct: 129 HYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (111), Expect = 1e-06
Identities = 21/134 (15%), Positives = 48/134 (35%), Gaps = 8/134 (5%)
Query: 124 LIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDL 183
+R ++L L + I + +L Q + +D +N++ + L+ + +
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLKTLLV 70
Query: 184 SNNSLTGEIPLKNECELRNLRFLLLWSN--RLVGQVPQALANSSKLEWLDLESNMFSGEL 241
+NN + ++ +L ++ L P A S +
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 242 PSEIISKMPQLQFL 255
+I K+PQ++ L
Sbjct: 131 RLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 24/138 (17%), Positives = 40/138 (28%), Gaps = 3/138 (2%)
Query: 94 SPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEY 153
+ N LDL I +L + + S N ++ L +L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 154 LDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRL 213
L + NN++ T L + S L PL + L L L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 214 VGQVPQALANSSKLEWLD 231
+ ++ LD
Sbjct: 128 KHYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 24/133 (18%), Positives = 45/133 (33%), Gaps = 7/133 (5%)
Query: 307 TNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNS 366
++ L I I + L ++ S N + L+ +L+ + ++NN
Sbjct: 18 VRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNR 74
Query: 367 LSGEIPSAFGDIPHLGLLDLSKNKLSG-SIPDSFANLSQLRRLLLYG---NHLSGTIPSS 422
+ +P L L L+ N L D A+L L L + +
Sbjct: 75 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134
Query: 423 LGKCVNLEILDLS 435
+ K + +LD
Sbjct: 135 IYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 8/137 (5%)
Query: 276 ASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTL 335
A N+ +EL+L G + +I ++ L I N I L L
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATL-DQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 336 LNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSG----EIPSAFGDIPHLGLLDLSKNKL 391
L +++N + + L + L+NNSL + ++ + +L +L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 392 SGSIPDSFANLSQLRRL 408
+ Q+R L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 23/140 (16%), Positives = 45/140 (32%), Gaps = 8/140 (5%)
Query: 325 PHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLL 384
+N V L+L + I + + + + + S+N + F + L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 385 DLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSG----TIPSSLGKCVNLEILDLSHNKIS 440
++ N++ L L L+L N L +SL L IL
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 441 GIIPSDVAGLRSLKLYLNLS 460
+ + ++ L+
Sbjct: 129 HYRLYVIYKVPQVR-VLDFQ 147
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.2 bits (123), Expect = 1e-07
Identities = 44/333 (13%), Positives = 84/333 (25%), Gaps = 32/333 (9%)
Query: 93 ISPALANLSSLIVLDLSKNFFQG----HIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSL 148
+ L S+ + LS N + + S L+ S +L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 149 HQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLL 208
L L KL ++ LS ++ + L N L +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN-NGLGPQAGAKI 141
Query: 209 WSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGN 268
V + N+ L + N E + L+
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 269 TNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGD---LSTNLVQIHLDCNLIYGKIPP 325
LA + L+L N + S + NL ++ L+ L+ +
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 326 HISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDI-----PH 380
+ + L+ + L N + + + P
Sbjct: 262 AVVD------------------AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGN 413
L L+L+ N+ D + ++ G
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 48/351 (13%), Positives = 109/351 (31%), Gaps = 40/351 (11%)
Query: 127 LKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCS-NSSTSLQYIDLSN 185
LK +++ + + + L ++ + L N + E + + S L+ + S+
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 186 NS---LTGEIP------LKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNM 236
+ EIP L+ + L + L N + L + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 237 FSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGG 296
+ L + +K+ + + ++ L N S + + ++
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 297 MIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSK 356
++ + HL + + +L + N ++L + + L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD----NTFTHLGSSALAIALKSWPN 244
Query: 357 LERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS 416
L + L++ LS +A D S L+ L L N +
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAF------------------SKLENIGLQTLRLQYNEIE 286
Query: 417 GTIPSSL-----GKCVNLEILDLSHNKIS--GIIPSDVAGLRSLKLYLNLS 460
+L K +L L+L+ N+ S + ++ + S + L
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.6 bits (111), Expect = 5e-06
Identities = 44/334 (13%), Positives = 101/334 (30%), Gaps = 35/334 (10%)
Query: 252 LQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDL---STN 308
++ L + + + FA L + +E+ L+GN +G + + +
Sbjct: 5 IEGKSLKLDAI----TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 309 LVQIHLDCNLIY---GKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN 365
L +IP + L+ L + + + + +LS +
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 366 SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS----GTIPS 421
+ + + +++ ++ N LR ++ N L
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180
Query: 422 SLGKCVNLEILDLSHNKISGIIPS--------DVAGLRSLKLYLNLSSNHLDGPLPLELS 473
+ L + + N I L+ L L N ++ L + L
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240
Query: 474 KMDMVLAIDLSFNNLSGSIPPQLGSCIA------LESLNLSGNSLEG-----LLPVSVGQ 522
+ + L+ LS + + L++L L N +E L V +
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300
Query: 523 LPYLKQFDVSSNRL--FGEIPQSFQASPTLKQLN 554
+P L +++ NR ++ + + +
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 41/340 (12%), Positives = 79/340 (23%), Gaps = 26/340 (7%)
Query: 199 ELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI---ISKMPQLQFL 255
E ++L+ + + V L ++ + L N E + I+ L+
Sbjct: 6 EGKSLKLDAI-TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 256 YLSYNDF--VSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIH 313
S V + L +L + L+ N G + D + +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 314 LDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPS 373
G P + + L + + L + N L
Sbjct: 125 HLYLHNNGLGPQAGAKIAR--------ALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 176
Query: 374 AFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILD 433
+ L K+ + L L Y L
Sbjct: 177 EWAKTFQ-SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235
Query: 434 LSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIP 493
K + L + + + + L +N +
Sbjct: 236 AIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290
Query: 494 PQLGSCIA-----LESLNLSGNSLEGLLPVSVGQLPYLKQ 528
L + I L L L+GN V ++ +
Sbjct: 291 RTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFS 329
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 5e-05
Identities = 42/201 (20%), Positives = 68/201 (33%), Gaps = 26/201 (12%)
Query: 277 SLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLL 336
S + + L ++ + +L ++ QI + + I I L N+T L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 337 NLSSNLLNGTIPHELCLMSKLERV----------------YLSNNSLSGEIPSAFGDIPH 380
L+ N L P + S + I G +
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 381 LGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKIS 440
L L + + L++L L L N +S +P L L+ L LS N IS
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191
Query: 441 GIIPSDVAGLRSLKLYLNLSS 461
+ +AGL++L L L S
Sbjct: 192 DL--RALAGLKNLD-VLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 34/199 (17%), Positives = 64/199 (32%), Gaps = 16/199 (8%)
Query: 147 SLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFL 206
+ + +L + + N S+ I +N+ + ++ L N+ L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ-----NELNSIDQIIANNSDIKSVQGIQY---LPNVTKL 73
Query: 207 LLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHD 266
L N+L P A + +LD L K L+ +S + + H
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133
Query: 267 GNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLS-----TNLVQIHLDCNLIYG 321
+ + L + + + I D+ T L ++L N I
Sbjct: 134 PQLESLYLGNN-KITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI-- 190
Query: 322 KIPPHISNLVNLTLLNLSS 340
++ L NL +L L S
Sbjct: 191 SDLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 30/206 (14%), Positives = 62/206 (30%), Gaps = 17/206 (8%)
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387
NL + + ++ ++++ +N+ + +P++ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDV 447
NKL+ ANL L L L N + K + L+ + +
Sbjct: 77 GNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 448 AGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNL 507
++ + L + I L L++L L
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS---------DIVPLAGLTKLQNLYL 185
Query: 508 SGNSLEGLLPVSVGQLPYLKQFDVSS 533
S N + L ++ L L ++ S
Sbjct: 186 SKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 30/191 (15%), Positives = 62/191 (32%), Gaps = 17/191 (8%)
Query: 78 KVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSL 137
+ ++ +L +S+ ++ L+S+ + + + + + L + +L L+ N L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGNKL 80
Query: 138 QGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTS----------LQYIDLSNNS 187
P +LD K + + + S + L +
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 188 LTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIIS 247
L R + L LA +KL+ L L N S +L + ++
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLRA--LA 197
Query: 248 KMPQLQFLYLS 258
+ L L L
Sbjct: 198 GLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 30/202 (14%), Positives = 60/202 (29%), Gaps = 23/202 (11%)
Query: 99 NLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGN 158
+ I +L K + L + Q+ + + ++ + L + L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 159 NKLVGEIPI--------PIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWS 210
NKL P+ N L + + + ++ L L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 211 NRLVGQVPQALANSSKLEWLDLESNMFSGELPSEI-ISKMPQLQFLYLSYNDFVSHDGNT 269
+ +G ++ ++ + ++ + +LQ LYLS N +
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI------S 191
Query: 270 NLEPFFASLANSSNFQELELAG 291
+L A N LEL
Sbjct: 192 DLRAL----AGLKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 8e-05
Identities = 24/148 (16%), Positives = 46/148 (31%), Gaps = 3/148 (2%)
Query: 350 ELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP-DSFANLSQLRRL 408
+ C + + + + +L L + + + L +LR L
Sbjct: 3 DACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL 468
+ + L P + L L+LS N + + V GL +L L+ + H L
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 469 PLELSKMDMVLAIDLSFNNLSGSIPPQL 496
L + + + L L
Sbjct: 122 -RWLQRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 25/124 (20%), Positives = 42/124 (33%), Gaps = 3/124 (2%)
Query: 481 IDLSFNNLSGSIPPQLGSCIALESLNLSGN-SLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539
+ + + L L L + L+ L + L L+ + + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 540 IPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGNDGLCG-EIKGLQTCKKEH 598
P +F +P L +LN SFN SL GN C ++ LQ ++E
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 599 THHL 602
+
Sbjct: 132 LGGV 135
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 22/138 (15%), Positives = 36/138 (26%)
Query: 268 NTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHI 327
L + N EL + + L + + + + P
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 328 SNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387
L+ LNLS N L + +S E V N GL +
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVP 136
Query: 388 KNKLSGSIPDSFANLSQL 405
+ KL A++
Sbjct: 137 EQKLQCHGQGPLAHMPNA 154
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 27/200 (13%), Positives = 66/200 (33%), Gaps = 12/200 (6%)
Query: 164 EIPIP-IFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALA 222
+ PI IF + L ++T + +L + L + + +
Sbjct: 5 DTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGI--KSIDGVE 59
Query: 223 NSSKLEWLDLESNMFSGE--LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLAN 280
+ L ++ +N + L + + ++ +++ N F +
Sbjct: 60 YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119
Query: 281 SSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKI--PPHISNLVNLTLLNL 338
+ + N L +I + + + N ++ ++NL L L++
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI 179
Query: 339 SSNLLNGTIPHELCLMSKLE 358
SSN ++ L ++ LE
Sbjct: 180 SSNKVSD--ISVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 38/192 (19%), Positives = 63/192 (32%), Gaps = 25/192 (13%)
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNL 338
+ + L N+ + DL + + D I K + L NLT +N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS--QTDLD-QVTTLQADRLGI--KSIDGVEYLNNLTQINF 69
Query: 339 SSNLLNGTI----------------PHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLG 382
S+N L + +I
Sbjct: 70 SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129
Query: 383 LLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGI 442
L L + + S + + L+ L++L N ++ P L LE LD+S NK+S I
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDI 187
Query: 443 IPSDVAGLRSLK 454
S +A L +L+
Sbjct: 188 --SVLAKLTNLE 197
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 32/192 (16%), Positives = 63/192 (32%), Gaps = 12/192 (6%)
Query: 222 ANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGN---TNLEPFFASL 278
++ L + + + + Q+ L S DG NL S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSN 71
Query: 279 ANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHL--DCNLIYGKIPPHISNLVNLTLL 336
++ L+ + ++ + T L + L +I L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 337 NLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIP 396
L + + L ++ L+++ S+N ++ P ++ L LD+S NK+S
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--I 187
Query: 397 DSFANLSQLRRL 408
A L+ L L
Sbjct: 188 SVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 983 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.51 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.43 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.56 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.59 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.28 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.05 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=419.41 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=204.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|++.+.||+|+||+||+|++. +|+.||||+++.....+..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999975 68999999997765555567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999974 346999999999999999999999996 9999999999999999999999999998765332
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.. ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||............
T Consensus 158 ~~-----------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-------- 218 (271)
T d1nvra_ 158 RE-----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-------- 218 (271)
T ss_dssp EE-----------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH--------
T ss_pred cc-----------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH--------
Confidence 11 12234579999999999988776 57899999999999999999999643211111111
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.... ... ...+...+.++.+++.+|++.||++|||++|++++
T Consensus 219 --------~~~~-~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 219 --------WKEK-KTY------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --------HHTT-CTT------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --------HhcC-CCC------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 000 11123455778899999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=418.74 Aligned_cols=263 Identities=31% Similarity=0.450 Sum_probs=205.8
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||+||+|+++ ..||||+++... ..+..+.|.+|++++++++|||||++++++.. +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57888999999999999999865 359999986543 33456789999999999999999999998865 567999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++... ...+++..+..|+.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999998753 346999999999999999999999986 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||..... .
T Consensus 159 ~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~-------- 215 (276)
T d1uwha_ 159 GS-----------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----R-------- 215 (276)
T ss_dssp ------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----H--------
T ss_pred Cc-----------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----H--------
Confidence 11 12234579999999999864 3578999999999999999999999864211 0
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
..+...+...... +.......+++.++.+++.+||+.||++|||++|++++|+.+.+..
T Consensus 216 -----~~~~~~~~~~~~~---p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 216 -----DQIIFMVGRGYLS---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -----HHHHHHHHHTSCC---CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHhcCCCC---CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0111111111100 0111122345678999999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=422.37 Aligned_cols=262 Identities=25% Similarity=0.391 Sum_probs=200.3
Q ss_pred CCCCCCccccCCcEeEEEEEECC-Cc---EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQD-NT---RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~-~~---~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+|...++||+|+||+||+|.++. ++ .||||.+.........++|.+|++++++++|||||++++++...+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45567899999999999999752 32 589999876666556778999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... ...+++.++..|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988753 346899999999999999999999986 99999999999999999999999999987754
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
...... ........||+.|||||.+.+..++.++|||||||++|||+| |+.||.... ..
T Consensus 181 ~~~~~~--------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-----~~------- 240 (299)
T d1jpaa_ 181 DTSDPT--------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----NQ------- 240 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH-------
T ss_pred CCCcce--------eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-----HH-------
Confidence 322110 011122468999999999999999999999999999999998 899986321 11
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
++... +..... .+. ..+++.++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 241 -----~~~~~-i~~~~~--~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 -----DVINA-IEQDYR--LPP-----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----HHHHH-HHTTCC--CCC-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHH-HHcCCC--CCC-----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111 111111 110 123567889999999999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=411.16 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=201.9
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|.+.+++.||||+++.... ..++|.+|++++++++||||++++++|..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46778899999999999999998888999999875443 3578999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++... ...+++..++.++.|+|+||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999988653 456899999999999999999999996 99999999999999999999999999987653321
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
. ......||+.|+|||.+.+..++.++|||||||++|||+|++.|+.. .....+
T Consensus 157 ~------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~----~~~~~~---------- 210 (263)
T d1sm2a_ 157 T------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE----NRSNSE---------- 210 (263)
T ss_dssp --------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC----SCCHHH----------
T ss_pred e------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC----CCCHHH----------
Confidence 1 11234689999999999999999999999999999999996555321 111111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
+++. +........| ..++.++.+++.+||+.||++|||++||+++|+++.++
T Consensus 211 --~~~~-i~~~~~~~~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 211 --VVED-ISTGFRLYKP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --HHHH-HHHTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHH-HHhcCCCCCc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1111 1111111111 12456789999999999999999999999999998763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=408.33 Aligned_cols=250 Identities=19% Similarity=0.307 Sum_probs=207.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|+..+.||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999995 47899999999765433 357899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999987753 45899999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. .....+||+.|+|||.+.+..++.++||||+||++|||++|+.||.... . .
T Consensus 171 ~-------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~-~---------- 222 (293)
T d1yhwa1 171 S-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----P-L---------- 222 (293)
T ss_dssp C-------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H-H----------
T ss_pred c-------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC----H-H----------
Confidence 1 1233579999999999999999999999999999999999999985321 1 0
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...........+ .. ..+...+.++.+++.+||+.||++|||++|+++|
T Consensus 223 --~~~~~~~~~~~~-~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 223 --RALYLIATNGTP-EL-----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --HHHHHHHHHCSC-CC-----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --HHHHHHHhCCCC-CC-----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111111 00 1123356788999999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=410.24 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=197.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec--CCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK--PDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 742 (983)
++|++.+.||+|+||+||+|+.. +|+.||||.++.... +...+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999999999999965 688999999976543 3345779999999999999999999999864 4567899
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCC--CCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSP--IKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~--~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
|||+++|+|.+++.........+++..++.++.|+++||+|||+++. .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987554445679999999999999999999998642 2499999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... ......||+.|||||++.+..++.++|||||||++|||++|+.||... +..+
T Consensus 164 ~~~~~~-------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~~---- 221 (269)
T d2java1 164 LNHDTS-------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKE---- 221 (269)
T ss_dssp C------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHHH----
T ss_pred cccCCC-------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHHH----
Confidence 653221 122357999999999999999999999999999999999999998632 1111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ .....+ ..++.++.+++.+||+.||++|||++|+++|
T Consensus 222 --------~~~~i~~~-~~~~~~-------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 222 --------LAGKIREG-KFRRIP-------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --------HHHHHHHT-CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------HHHHHHcC-CCCCCC-------cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111111 111111 1245678999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-48 Score=413.75 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=211.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|++++++++|||||+++++|.+.+..++||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 46777889999999999999975 588899999865443 357899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.... ...+++..+..|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999987543 457899999999999999999999996 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ......
T Consensus 170 ~~------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~~-------- 225 (287)
T d1opja_ 170 YT------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQV-------- 225 (287)
T ss_dssp SE------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHH--------
T ss_pred ce------------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc----chHHHH--------
Confidence 11 112246899999999999999999999999999999999988776421 111111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.+.+........+ ..++.++.+++.+||+.||++|||++||++.|+.+.+..
T Consensus 226 -----~~~i~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 226 -----YELLEKDYRMERP-------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp -----HHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred -----HHHHhcCCCCCCC-------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 1111111111111 234578999999999999999999999999998886543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=407.95 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=207.3
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|...+.||+|+||.||+|.+++++.||||+++.... ..++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46777889999999999999998888999999975443 35789999999999999999999998865 5679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++.... ..++++..+++|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999876543 346999999999999999999999986 99999999999999999999999999997754321
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.......||+.|+|||++.+..++.++|||||||++|||+||+.|+... ....+
T Consensus 165 ------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----~~~~~---------- 218 (272)
T d1qpca_ 165 ------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNPE---------- 218 (272)
T ss_dssp ------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----CCHHH----------
T ss_pred ------------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----CCHHH----------
Confidence 1122346899999999999889999999999999999999977665321 11111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.... +........| ..++.++.+++.+||+.||++|||++||++.|+.+-.
T Consensus 219 --~~~~-i~~~~~~~~p-------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 219 --VIQN-LERGYRMVRP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --HHHH-HHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHH-HHhcCCCCCc-------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111 1111111111 2345678999999999999999999999999987643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=407.00 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 68899999986543 2234678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999875 345899999999999999999999996 99999999999999999999999999976542
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. .....||+.|||||++.+..++.++||||+||++|||++|+.||... ...+.
T Consensus 159 ~~---------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~------ 212 (263)
T d2j4za1 159 SR---------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQET------ 212 (263)
T ss_dssp CC---------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHH------
T ss_pred Cc---------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CHHHH------
Confidence 11 12357999999999999999999999999999999999999998632 11111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
..... ... ...| +..+.++.+++.+|++.||++|||++|+++|
T Consensus 213 ------~~~i~-~~~-~~~p-------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 213 ------YKRIS-RVE-FTFP-------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ------HHHHH-TTC-CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------HHHHH-cCC-CCCC-------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11111 111 0111 1245678999999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=398.70 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=210.9
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++++|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57889999999999999999998888999999976543 3578999999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|++.+++... ...+++..+++++.|+|+||+|||+.+ |+||||||+||++++++.+||+|||+|+.......
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999987654 356899999999999999999999996 99999999999999999999999999987654321
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 156 ~------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-----~~~--------- 209 (258)
T d1k2pa_ 156 T------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-----NSE--------- 209 (258)
T ss_dssp C------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----HHH---------
T ss_pred e------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-----HHH---------
Confidence 1 1122469999999999999999999999999999999998 899986431 111
Q ss_pred CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 906 LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
+. ..+........| ..++.++.+++.+||+.||++|||++|++++|.++
T Consensus 210 ---~~-~~i~~~~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 210 ---TA-EHIAQGLRLYRP-------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---HH-HHHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---HH-HHHHhCCCCCCc-------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11 112111111111 22456899999999999999999999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=408.13 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=209.0
Q ss_pred CCCCCC-ccccCCcEeEEEEEEC---CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 668 GFCPSS-LIGSGRFGHVYKGVLQ---DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 668 ~f~~~~-~iG~G~~g~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
+|...+ +||+|+||+||+|.++ ++..||||+++........++|.+|++++++++|||||++++++.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 444556 4999999999999864 3457999999776666667889999999999999999999999975 4679999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++... +..+++..+..++.|+|+||+|||+++ |+||||||+||+++.++.+||+|||+|+.+..
T Consensus 88 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp ECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999987543 356999999999999999999999996 99999999999999999999999999997754
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ...+..
T Consensus 162 ~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~------ 223 (285)
T d1u59a_ 162 DDSY----------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMA------ 223 (285)
T ss_dssp CSCE----------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHH------
T ss_pred cccc----------cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHH------
Confidence 3221 112233468999999999999999999999999999999998 899986421 111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.+........| ..++.++.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 224 ----------~i~~~~~~~~p-------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 224 ----------FIEQGKRMECP-------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----------HHHTTCCCCCC-------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------HHHcCCCCCCC-------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11111111111 235578899999999999999999999999998775443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=419.40 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=208.2
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.........++.+|++++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467889999999999999999965 6889999999876555567889999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhcc-CCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHH-SPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
|+++|+|.+++... ..+++..++.++.|+++||.|||++ + |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999753 4589999999999999999999974 5 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh--
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH-- 901 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~-- 901 (983)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .........
T Consensus 158 ~---------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~--~~~~~~~~~~~ 220 (322)
T d1s9ja_ 158 S---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK--ELELMFGCQVE 220 (322)
T ss_dssp H---------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT--HHHHHC-----
T ss_pred C---------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhc
Confidence 1 122358999999999999999999999999999999999999999642111 110000000
Q ss_pred ------------------------CCC-CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 042568 902 ------------------------YPH-RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML 956 (983)
Q Consensus 902 ------------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 956 (983)
.+. ...+..+. +....+...+ . ...+.++.+++.+|++.||++|||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~---~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY-IVNEPPPKLP---S---GVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp -------------------------CCCCHHHHHHH-HHTSCCCCCC---B---TTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCcccCCcccccccccccccccccccchhHHHHHhh-hhccCCccCc---c---ccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 000 00111111 1111111111 1 11346789999999999999999999
Q ss_pred HHHHH
Q 042568 957 DVAHE 961 (983)
Q Consensus 957 evl~~ 961 (983)
|+++|
T Consensus 294 e~L~H 298 (322)
T d1s9ja_ 294 QLMVH 298 (322)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=407.83 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=205.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCC-----cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDN-----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
+.|+..++||+|+||+||+|.+++. ..||||+++.....+...+|.+|++++++++|||||++++++...+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3567788999999999999996532 36999999766665566789999999999999999999999999999999
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
||||+.+|++.+.+... ...+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999998877643 356999999999999999999999986 999999999999999999999999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+... ....+
T Consensus 161 ~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~----~~~~~----- 221 (283)
T d1mqba_ 161 EDDPEAT----------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHE----- 221 (283)
T ss_dssp -----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHH-----
T ss_pred cCCCccc----------eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc----CCHHH-----
Confidence 5432210 1122346899999999999999999999999999999999977765321 11111
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
+.+ .+........ ..+++.++.+++.+||+.||++|||+.||++.|+++.+..++
T Consensus 222 -------~~~-~i~~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 222 -------VMK-AINDGFRLPT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp -------HHH-HHHTTCCCCC-------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -------HHH-HHhccCCCCC-------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 111 1111111111 123557789999999999999999999999999998775443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=405.60 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=205.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
+.|++.+.||+|+||+||+|++. +++.||||+++.... +..+++.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35778899999999999999965 688999999976543 3567899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999987643 346999999999999999999999996 9999999999999999999999999997654221
Q ss_pred ccccccCCCCccccccCccccccccccccccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGM-----GKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
.......||+.|+|||++. +..|+.++||||+||++|||++|+.||.....
T Consensus 165 -------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~----------- 220 (288)
T d2jfla1 165 -------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP----------- 220 (288)
T ss_dssp -------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----------
T ss_pred -------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----------
Confidence 1122357999999999874 45689999999999999999999999864211
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.+........+ ..+ .....+.++.+++.+||+.||++|||++|+++|
T Consensus 221 ------~~~~~~i~~~~~~-~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 221 ------MRVLLKIAKSEPP-TLA-----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------GGHHHHHHHSCCC-CCS-----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------HHHHHHHHcCCCC-CCC-----ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111211111111 000 112345788999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=413.18 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=205.2
Q ss_pred CCCCCCCccccCCcEeEEEEEECC-C-----cEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD-N-----TRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|...++||+|+||+||+|++.. + ..||||.+...........+.+|++++.++ +|||||++++++...+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 467788999999999999999642 2 259999987655555667899999999998 899999999999999999
Q ss_pred eEEEecccCcccccccccccC-------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCC
Q 042568 740 ALVLPLMSNGSLENHLYPSHG-------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPS 800 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~ 800 (983)
++||||+++|+|.+++..... ....+++..++.++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999875432 1235899999999999999999999996 999999999
Q ss_pred CeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-
Q 042568 801 NILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT- 879 (983)
Q Consensus 801 NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt- 879 (983)
||+++.++.+||+|||+|+........ .......||+.|||||.+.+..++.++|||||||++|||+|
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY-----------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS-----------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ccccccCCeEEEeeccccccccCCCce-----------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence 999999999999999999876543221 12234578999999999999999999999999999999998
Q ss_pred CCCCCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 042568 880 GRRPTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVA 959 (983)
Q Consensus 880 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 959 (983)
|+.||..... ...+. +.+........| ..++.++.+++.+||+.||++|||++||+
T Consensus 263 g~~Pf~~~~~-~~~~~----------------~~~~~~~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 263 GVNPYPGIPV-DANFY----------------KLIQNGFKMDQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp SCCSSTTCCC-SHHHH----------------HHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCCCH-HHHHH----------------HHHhcCCCCCCC-------CcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 8999864211 11111 222221111111 22457899999999999999999999999
Q ss_pred HHHH
Q 042568 960 HEMG 963 (983)
Q Consensus 960 ~~L~ 963 (983)
++|.
T Consensus 319 ~~L~ 322 (325)
T d1rjba_ 319 SFLG 322 (325)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 9986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=398.85 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=196.1
Q ss_pred CCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEec----CCceeEEE
Q 042568 670 CPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSK----PDFKALVL 743 (983)
Q Consensus 670 ~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 743 (983)
...++||+|+||+||+|.+. +++.||+|.+.... .....++|.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999975 67889999986654 33346789999999999999999999999854 34578999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC-CCCCEEEcccccccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD-EDLTALVADFGIAKLVK 822 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~-~~~~~kl~Dfgla~~~~ 822 (983)
||+++|+|.+++.. ...+++..++.++.||++||+|||++++ +|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999875 3468999999999999999999999852 499999999999997 57899999999998643
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
.. .....+||+.|||||++.+ .++.++||||+||++|||++|+.||... .......
T Consensus 167 ~~---------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~----~~~~~~~---- 222 (270)
T d1t4ha_ 167 AS---------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC----QNAAQIY---- 222 (270)
T ss_dssp TT---------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC----SSHHHHH----
T ss_pred CC---------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc----ccHHHHH----
Confidence 21 1223579999999999876 5899999999999999999999998532 1111111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+.... .+... ....+.++.+++.+||+.||++|||++|+++|
T Consensus 223 ---------~~i~~~~---~~~~~---~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 223 ---------RRVTSGV---KPASF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---------HHHTTTC---CCGGG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---------HHHHcCC---CCccc---CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111110 11111 12234678899999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-46 Score=407.18 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=191.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.+.|+..+.||+|+||+||+|+.. +++.||||++.........+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999975 6889999999766544455778899999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~Dfgla~~~ 821 (983)
|+++|+|.+++.. ...+++..+..++.|+++||+|||+++ |+||||||+||++. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999864 346999999999999999999999996 99999999999994 5789999999999865
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
.... .....+||+.|||||++.+..++.++||||+||++|||++|+.||.... ..
T Consensus 161 ~~~~--------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~~------ 215 (307)
T d1a06a_ 161 DPGS--------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-----DA------ 215 (307)
T ss_dssp --------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HH------
T ss_pred cCCC--------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-----HH------
Confidence 4321 1223579999999999999999999999999999999999999986321 11
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+............. ...+.+.+.++.+++.+|++.||++|||++|+++|
T Consensus 216 ------~~~~~i~~~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 216 ------KLFEQILKAEYEFD-----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ------HHHHHHHTTCCCCC-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHhccCCCCC-----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111111111111 11123456789999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=404.14 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999974 68999999986543 2234578999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998875 346999999999999999999999996 99999999999999999999999999987753
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||... +..
T Consensus 161 ~~~~-----------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~-------- 216 (288)
T d1uu3a_ 161 ESKQ-----------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEY-------- 216 (288)
T ss_dssp --------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH--------
T ss_pred CCcc-----------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CHH--------
Confidence 3211 1223357999999999999999999999999999999999999998632 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.......... ..| ...+.++.+++.+|++.||++|||++|++++
T Consensus 217 ----~~~~~i~~~~~--~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 217 ----LIFQKIIKLEY--DFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----HHHHHHHTTCC--CCC-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----HHHHHHHcCCC--CCC-------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111111111 111 1245678999999999999999999997554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=398.35 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=198.7
Q ss_pred CccccCCcEeEEEEEECC---CcEEEEEEeeccc-CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecccC
Q 042568 673 SLIGSGRFGHVYKGVLQD---NTRIAVKVLDLTT-TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLMSN 748 (983)
Q Consensus 673 ~~iG~G~~g~Vy~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 748 (983)
++||+|+||+||+|.+++ ++.||||+++... ..+..++|.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998643 4579999996543 33346789999999999999999999999965 457899999999
Q ss_pred cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcccc
Q 042568 749 GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDESV 828 (983)
Q Consensus 749 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~~~ 828 (983)
|+|.+++.. ...+++..+..|+.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.+......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~- 163 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY- 163 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc-
Confidence 999998874 346999999999999999999999986 999999999999999999999999999876543222
Q ss_pred cccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCCCCc
Q 042568 829 NCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPHRLD 907 (983)
Q Consensus 829 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 907 (983)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+
T Consensus 164 ---------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~----------- 218 (277)
T d1xbba_ 164 ---------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSE----------- 218 (277)
T ss_dssp ---------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH-----------
T ss_pred ---------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHH-----------
Confidence 122233579999999999999999999999999999999998 899986421 111
Q ss_pred HHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhH
Q 042568 908 PIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLK 966 (983)
Q Consensus 908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 966 (983)
+...+........| ..++.++.+++.+||+.||++|||++||++.|+..-
T Consensus 219 --~~~~i~~~~~~~~p-------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 219 --VTAMLEKGERMGCP-------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --HHHHHHTTCCCCCC-------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHHHcCCCCCCC-------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11111111111111 235578899999999999999999999999887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=398.38 Aligned_cols=259 Identities=28% Similarity=0.402 Sum_probs=204.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
++|++.+.||+|+||.||+|++++++.||||+++.... ..+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46788999999999999999998888899999975543 35789999999999999999999999854 5679999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|++..++.... ...++|..++.++.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999998887543 346999999999999999999999996 99999999999999999999999999987653221
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.......||+.|+|||++.++.++.++|||||||++|||++|+.|+... ....+
T Consensus 169 ------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~----~~~~~---------- 222 (285)
T d1fmka3 169 ------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----MVNRE---------- 222 (285)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----CCHHH----------
T ss_pred ------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC----CCHHH----------
Confidence 1122346999999999999999999999999999999999987775421 11111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
.++..... ..... ..+++.++.+++.+||+.||++|||+++|++.|+......
T Consensus 223 --~~~~i~~~-~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 223 --VLDQVERG-YRMPC-------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --HHHHHHTT-CCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --HHHHHHhc-CCCCC-------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11111111 11111 1235578999999999999999999999999998876544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-46 Score=402.98 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=200.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
.|+..+.||+|+||+||+|+.. +++.||||+++.... .+..+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4788899999999999999964 688899999976543 2345679999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+++|++..++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999766543 356999999999999999999999996 999999999999999999999999999865321
Q ss_pred cccccccCCCCccccccCccccccccccccccCC---CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG---KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... .
T Consensus 169 -----------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~-------- 219 (309)
T d1u5ra_ 169 -----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----A-------- 219 (309)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----H--------
T ss_pred -----------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC----H--------
Confidence 22479999999999864 468999999999999999999999985321 1
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+.+........+.. .. ...+.++.+++.+||+.||++|||++|+++|
T Consensus 220 -----~~~~~~i~~~~~~~~----~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 220 -----MSALYHIAQNESPAL----QS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----HHHHHHHHHSCCCCC----SC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----HHHHHHHHhCCCCCC----CC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111112221111111 11 1235678999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-46 Score=402.52 Aligned_cols=263 Identities=25% Similarity=0.390 Sum_probs=211.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCce
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFK 739 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 739 (983)
.++|+..+.||+|+||+||+|+.+ +++.||||+++.....+..++|.+|++++++++||||++++++|...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 457888999999999999999864 35679999997766655678899999999999999999999999999999
Q ss_pred eEEEecccCcccccccccccC--------------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCC
Q 042568 740 ALVLPLMSNGSLENHLYPSHG--------------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKP 799 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp 799 (983)
++||||+++|+|.+++..... ....+++..++.|+.|+|+||+|||+++ ||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 999999999999998864321 1235899999999999999999999986 99999999
Q ss_pred CCeEeCCCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh
Q 042568 800 SNILLDEDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT 879 (983)
Q Consensus 800 ~NiLl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt 879 (983)
+|||+++++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYY-----------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCB-----------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cceEECCCCcEEEccchhheeccCCccc-----------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 9999999999999999999876543221 12233568999999999999999999999999999999999
Q ss_pred CCC-CCCcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 042568 880 GRR-PTDVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDV 958 (983)
Q Consensus 880 g~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 958 (983)
|.. ||... ... ++... +........ ..+++.++.+++.+||+.+|++||||.||
T Consensus 238 ~~~~p~~~~-----~~~------------e~~~~-v~~~~~~~~-------p~~~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 238 YGLQPYYGM-----AHE------------EVIYY-VRDGNILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp TTCCTTTTS-----CHH------------HHHHH-HHTTCCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCCCCCC-----CHH------------HHHHH-HHcCCCCCC-------CccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 964 55432 111 11111 111111111 12355789999999999999999999999
Q ss_pred HHHHHHhHh
Q 042568 959 AHEMGRLKQ 967 (983)
Q Consensus 959 l~~L~~~~~ 967 (983)
+++|+++.+
T Consensus 293 ~~~L~~i~~ 301 (301)
T d1lufa_ 293 HRILQRMCE 301 (301)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHHhcC
Confidence 999998853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-45 Score=403.46 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=207.0
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 57999999999999999999964 688999999965533 2457889999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCCCEEEccccccccccC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDLTALVADFGIAKLVKG 823 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~~~kl~Dfgla~~~~~ 823 (983)
+++|+|.+++... ...+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999988643 346999999999999999999999996 99999999999996 468899999999987653
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||... ...
T Consensus 179 ~~~--------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~-------- 231 (350)
T d1koaa2 179 KQS--------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDD-------- 231 (350)
T ss_dssp TSC--------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHH--------
T ss_pred ccc--------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CHH--------
Confidence 221 12357999999999999999999999999999999999999998532 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+.......... + ...+..++.++.+++.+|++.||++|||++|+++|
T Consensus 232 ----~~~~~i~~~~~~~--~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 232 ----ETLRNVKSCDWNM--D---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----HHHHHHHHTCCCS--C---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHhCCCCC--C---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111110 0 11223456788999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=393.98 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=205.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-----cchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-----GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.+.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57889999999999999999974 789999999865432 224578999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----CEEEcccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL----TALVADFG 816 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~----~~kl~Dfg 816 (983)
+||||+++|+|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999998753 46999999999999999999999996 99999999999998776 59999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+|+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...+
T Consensus 163 ~a~~~~~~~~--------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~ 223 (293)
T d1jksa_ 163 LAHKIDFGNE--------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-----TKQE 223 (293)
T ss_dssp TCEECTTSCB--------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH
T ss_pred hhhhcCCCcc--------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC-----CHHH
Confidence 9987653221 12347999999999999999999999999999999999999998632 1111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. .......... .+ ...+...+.++.+++.+|++.||++|||++|+++|
T Consensus 224 ~------------~~~i~~~~~~--~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 224 T------------LANVSAVNYE--FE---DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp H------------HHHHHTTCCC--CC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred H------------HHHHHhcCCC--CC---chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1111111000 00 11122355778999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=389.49 Aligned_cols=251 Identities=29% Similarity=0.407 Sum_probs=197.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec-CCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-PDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 745 (983)
++|+..+.||+|+||.||+|+++ |+.||||+++.+. ..+.|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 34667889999999999999985 7899999996543 35789999999999999999999999854 4567999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+++|+|.+++.... ...+++..+++|+.||++||.|||+.+ |+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 99999999997542 335899999999999999999999985 999999999999999999999999999865422
Q ss_pred ccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
.....+|..|+|||++.+..+++++|||||||++|||+| |+.||... +...+...+..
T Consensus 157 ---------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~---- 215 (262)
T d1byga_ 157 ---------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEK---- 215 (262)
T ss_dssp --------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTT----
T ss_pred ---------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHc----
Confidence 122468899999999999999999999999999999998 67776532 11122222211
Q ss_pred CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 905 RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
. .....+ ..++.++.+++.+||+.||++|||+.|++++|++++.
T Consensus 216 -----------~-~~~~~~-------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 -----------G-YKMDAP-------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----------T-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------C-CCCCCC-------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1 111111 1244678999999999999999999999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.6e-45 Score=401.71 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=207.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|++++++++|||||++++++.+++..++||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 56889999999999999999964 7899999998765432 356788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC--CCCCEEEccccccccccC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD--EDLTALVADFGIAKLVKG 823 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~--~~~~~kl~Dfgla~~~~~ 823 (983)
+++|+|.+++... ..++++..++.|+.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 108 ~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999998877543 346999999999999999999999996 99999999999998 678999999999987754
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||... ...
T Consensus 182 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~-------- 234 (352)
T d1koba_ 182 DEI--------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDL-------- 234 (352)
T ss_dssp TSC--------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-----SHH--------
T ss_pred CCc--------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-----CHH--------
Confidence 221 12357999999999999999999999999999999999999998532 111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+.+.......... + ...+...+.++.+++.+|++.||++|||++|+++|
T Consensus 235 ----~~~~~i~~~~~~~--~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 235 ----ETLQNVKRCDWEF--D---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ----HHHHHHHHCCCCC--C---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHhCCCCC--C---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111110 0 11223456788999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=392.64 Aligned_cols=258 Identities=21% Similarity=0.362 Sum_probs=199.5
Q ss_pred CCCCCCCccccCCcEeEEEEEECC----CcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD----NTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|...+.||+|+||.||+|++.. +..||||.++........+.|.+|++++++++||||+++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 467788999999999999998653 34589998876655556788999999999999999999999996 4678999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|++.+++... ...+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999887643 346899999999999999999999996 9999999999999999999999999998765
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHhh
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~ 901 (983)
..... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 160 ~~~~~------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------------ 215 (273)
T d1mp8a_ 160 DSTYY------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------ 215 (273)
T ss_dssp -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------
T ss_pred CCcce------------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH------------
Confidence 32211 1223468999999999999999999999999999999998 8888864211
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQY 968 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 968 (983)
.++.......... .. +..++.++.+++.+||+.||++|||++||+++|+++.+.
T Consensus 216 -----~~~~~~i~~~~~~-~~-------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 216 -----NDVIGRIENGERL-PM-------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----GGHHHHHHTTCCC-CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCC-CC-------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1112221111111 11 123567899999999999999999999999999988654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=399.48 Aligned_cols=258 Identities=23% Similarity=0.406 Sum_probs=202.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc----EEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT----RIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKAL 741 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 741 (983)
.+|+..++||+|+||+||+|.+. +|+ +||||.++.....+..++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35888999999999999999964 444 58999887665555678899999999999999999999999875 5678
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLV 821 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~ 821 (983)
++||+.+|+|.+++... ...+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999998887653 456999999999999999999999996 999999999999999999999999999977
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~ 900 (983)
...... .......||+.|+|||.+.++.++.++|||||||++|||+| |+.||+... ...+...+.
T Consensus 162 ~~~~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~- 227 (317)
T d1xkka_ 162 GAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE- 227 (317)
T ss_dssp TTTCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHH-
T ss_pred cccccc-----------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH-
Confidence 543221 11223468999999999999999999999999999999999 788876421 111111111
Q ss_pred hCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 901 HYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
.......| ..++.++.+++.+||+.||++|||+.|++++|.++.+
T Consensus 228 ---------------~~~~~~~p-------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 228 ---------------KGERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---------------HTCCCCCC-------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------cCCCCCCC-------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11111111 2345778999999999999999999999999988753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=395.72 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=200.8
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecC-Cc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKP-DF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 738 (983)
++|...++||+|+||.||+|.+. +++.||||+++........+.+.+|++++.++ +|+||+.+++++..+ ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 46788899999999999999853 24579999997666555667888999988887 689999999988655 46
Q ss_pred eeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC
Q 042568 739 KALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE 806 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~ 806 (983)
.++||||+++|+|.+++..... ....+++..+..++.||++||+|||+++ |+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 7999999999999999865432 1345899999999999999999999996 999999999999999
Q ss_pred CCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 042568 807 DLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR-RPTD 885 (983)
Q Consensus 807 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~-~p~~ 885 (983)
++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDY-----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GGCEEECC------CCSCTTS-----------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCcEEEccCcchhhccccccc-----------cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999876543221 1223457999999999999999999999999999999999975 4664
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
... . .+.+...+........+ +.++.++.+++.+||+.||++|||++|++++|+++
T Consensus 239 ~~~-~----------------~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 239 GVK-I----------------DEEFCRRLKEGTRMRAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TCC-C----------------SHHHHHHHHHTCCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-H----------------HHHHHHHHhcCCCCCCC-------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 321 1 11111222221111111 22456789999999999999999999999999998
Q ss_pred Hhhc
Q 042568 966 KQYL 969 (983)
Q Consensus 966 ~~~~ 969 (983)
.+..
T Consensus 295 lq~n 298 (299)
T d1ywna1 295 LQAN 298 (299)
T ss_dssp HHHH
T ss_pred HhCC
Confidence 7653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=396.04 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=206.6
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|.+.+.||+|+||.||+|+. .+++.||||++++.. .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688899999999999999996 478999999997543 2234678899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999998875 346899999999999999999999996 99999999999999999999999999986543
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||... +.
T Consensus 158 ~~-------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~-----~~--------- 210 (337)
T d1o6la_ 158 DG-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DH--------- 210 (337)
T ss_dssp TT-------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-----SH---------
T ss_pred CC-------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc-----CH---------
Confidence 21 1223468999999999999999999999999999999999999998632 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
.+.......... ..| ...+.++.+++.+|++.||++||+ ++|+++|
T Consensus 211 ---~~~~~~i~~~~~--~~p-------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 211 ---ERLFELILMEEI--RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---HHHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---HHHHHHHhcCCC--CCC-------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112222221111 111 224567899999999999999995 8899875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=392.04 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=206.4
Q ss_pred CCccccCCcEeEEEEEECCC----cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEec-CCceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQDN----TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSK-PDFKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~----~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 746 (983)
.++||+|+||+||+|.+.++ ..||||+++........++|.+|++++++++||||++++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996532 25899999765555567889999999999999999999999865 45789999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
++|+|.+++... ....++..+.+++.|+|+||.|+|+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999988753 446788999999999999999999996 99999999999999999999999999997754332
Q ss_pred cccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHRL 906 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~ 906 (983)
.. ........||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ...+...+..
T Consensus 186 ~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~~~~~i~~------ 249 (311)
T d1r0pa_ 186 DS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQ------ 249 (311)
T ss_dssp CC---------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT------
T ss_pred cc---------ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHHHHHHHHc------
Confidence 21 1122234799999999999999999999999999999999998888753221 1111111111
Q ss_pred cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 907 DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
. .....| ..++.++.+++.+||+.||++||+|.||+++|+++.+..
T Consensus 250 ---------g-~~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 250 ---------G-RRLLQP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ---------T-CCCCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---------C-CCCCCc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1 111111 124567899999999999999999999999999997653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=392.62 Aligned_cols=246 Identities=26% Similarity=0.308 Sum_probs=204.6
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999974 68999999996542 2234678999999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||++||++..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999988875 345788999999999999999999996 99999999999999999999999999987643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||... +.
T Consensus 157 ~----------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~--------- 206 (316)
T d1fota_ 157 V----------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NT--------- 206 (316)
T ss_dssp C----------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SH---------
T ss_pred c----------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CH---------
Confidence 2 12357999999999999999999999999999999999999998632 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
.+.......... ..| ...+.++.+++.+|+..||++|| |++|+++|
T Consensus 207 ---~~~~~~i~~~~~--~~p-------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 207 ---MKTYEKILNAEL--RFP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHHHHHHHcCCC--CCC-------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111222221111 111 12346788999999999999996 89999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=390.03 Aligned_cols=279 Identities=22% Similarity=0.288 Sum_probs=203.2
Q ss_pred CCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHH--HHHHHHhcCCCCccceeeEEecCC----ceeE
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKR--ECQILKRIRHRNLIRIITICSKPD----FKAL 741 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 741 (983)
+|...+.||+|+||.||+|+++ |+.||||+++... ..++.+ |+..+.+++||||+++++++...+ ..++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566788999999999999974 8899999986432 233444 455556789999999999997554 5689
Q ss_pred EEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC-----CCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 742 VLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS-----PIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 742 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
||||+++|+|.++++. .+++|..+++++.|+|.||+|+|+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999974 45899999999999999999999731 1259999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCC------CCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR------ASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
+++......... ........||+.|+|||++.+.. ++.++|||||||++|||+||..||......
T Consensus 154 l~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 154 LAVRHDSATDTI---------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp TCEEEETTTTEE---------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred ccccccCCCcce---------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 999776433221 12233467999999999987642 577899999999999999999887543222
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
......... .........+...........+. .....+.+.++.+++.+||+.||++|||+.||+++|+++.+..
T Consensus 225 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 225 QLPYYDLVP--SDPSVEEMRKVVCEQKLRPNIPN--RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCTTTTTSC--SSCCHHHHHHHHTTSCCCCCCCG--GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhhccc--ccchHHHHHHHHhccccCCCCCc--ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 211111000 00111111111111111111111 1112456778999999999999999999999999999987653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-44 Score=386.59 Aligned_cols=262 Identities=20% Similarity=0.343 Sum_probs=203.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC--cchhHHHHHHHHHHHhcCCCCccceeeEEecCC----c
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT--GEITGSFKRECQILKRIRHRNLIRIITICSKPD----F 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 738 (983)
.++|.+.+.||+|+||+||+|.. .+++.||||+++.... .+...+|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36789999999999999999996 4788999999976543 234568999999999999999999999987554 3
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.|+||||+++|+|.+++.. ...+++.+++.++.|+++||+|||+++ |+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999988865 346899999999999999999999996 999999999999999999999999998
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
......... .......+||+.|+|||++.+..+++++||||+||++|||+||+.||... ...
T Consensus 159 ~~~~~~~~~----------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~--- 220 (277)
T d1o6ya_ 159 RAIADSGNS----------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPV--- 220 (277)
T ss_dssp EECC--------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---
T ss_pred hhhcccccc----------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-----CHH---
Confidence 765432211 12233457999999999999999999999999999999999999998632 111
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHhH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-SMLDVAHEMGRLK 966 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~ 966 (983)
+.....+..... .+ ...+.+.+.++.+++.+|++.||++|| |++++.+.|.+++
T Consensus 221 ---------~~~~~~~~~~~~--~~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 221 ---------SVAYQHVREDPI--PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---------HHHHHHHHCCCC--CG---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------HHHHHHHhcCCC--CC---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111122221111 01 111234567899999999999999999 8999999998774
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-45 Score=387.79 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=196.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC--CC--cEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ--DN--TRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~--~~--~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|+..+.||+|+||.||+|+.. ++ ..||||+++... ..+..++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999853 23 358999986543 23346789999999999999999999999976 4668
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++|++.+++... ...+++..+..++.|+|+||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999887654 345999999999999999999999985 99999999999999999999999999997
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~~~~~~~~~~l~~~~~ 899 (983)
........ .......||..|+|||.+.+..++.++|||||||++|||+| |+.||... ...+
T Consensus 161 ~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~~--- 222 (273)
T d1u46a_ 161 LPQNDDHY----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGSQ--- 222 (273)
T ss_dssp CCC-CCEE----------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHH---
T ss_pred cccCCCcc----------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHHH---
Confidence 75433221 22233568889999999999999999999999999999998 89998632 1111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
............ + ....++.++.+++.+||+.||++|||++||.+.|++.
T Consensus 223 ---------~~~~i~~~~~~~--~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 223 ---------ILHKIDKEGERL--P-----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------HHHHHHTSCCCC--C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHHHHhCCCCC--C-----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111111110 1 1123457899999999999999999999999988875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=392.52 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=212.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCce
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFK 739 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 739 (983)
++|+..++||+|+||.||+|++. +++.||||+++..........|.+|+++++++ +|||||+++++|...+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 46777889999999999999852 45679999998766655677899999999999 699999999999999999
Q ss_pred eEEEecccCcccccccccccC--------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 740 ALVLPLMSNGSLENHLYPSHG--------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
++||||+++|+|.+++..... ....+++..+..++.||++||+|||+++ |+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 999999999999999875431 1336899999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTD 885 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~ 885 (983)
.++.+|++|||.++........ .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTS-----------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ccCcccccccchheeccCCCcc-----------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 9999999999999876543222 22234579999999999999999999999999999999999555543
Q ss_pred cccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHh
Q 042568 886 VLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRL 965 (983)
Q Consensus 886 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 965 (983)
........+...+. .......+ ...+.++.+|+.+||+.||++|||++||+++|+++
T Consensus 249 ~~~~~~~~~~~~i~----------------~~~~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 249 PGMPVDSKFYKMIK----------------EGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTCCSSHHHHHHHH----------------HTCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHh----------------cCCCCCCc-------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22111111222222 11111111 12456799999999999999999999999999877
Q ss_pred Hhh
Q 042568 966 KQY 968 (983)
Q Consensus 966 ~~~ 968 (983)
...
T Consensus 306 i~~ 308 (311)
T d1t46a_ 306 ISE 308 (311)
T ss_dssp HHH
T ss_pred hcc
Confidence 554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=386.41 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=207.4
Q ss_pred CCCCCCCccccCCcEeEEEEEECC--------CcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQD--------NTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPD 737 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 737 (983)
++|...+.||+|+||.||+|+... +..||||+++.........++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467778999999999999998532 2469999998776666678899999999998 8999999999999999
Q ss_pred ceeEEEecccCcccccccccccC------------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC
Q 042568 738 FKALVLPLMSNGSLENHLYPSHG------------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD 805 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~ 805 (983)
..++||||+++|+|.+++..... ....+++..++.++.|+|+||+|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 99999999999999999975431 1346899999999999999999999996 99999999999999
Q ss_pred CCCCEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHh-CCCCC
Q 042568 806 EDLTALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVT-GRRPT 884 (983)
Q Consensus 806 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~ellt-g~~p~ 884 (983)
.++.+||+|||+++........ .......||+.|+|||.+.++.+++++|||||||++|||++ |+.||
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY-----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT-----------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCeEeccchhhccccccccc-----------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 9999999999999877543221 22234579999999999999999999999999999999998 67776
Q ss_pred CcccCCCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 042568 885 DVLFHDGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGR 964 (983)
Q Consensus 885 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 964 (983)
.... .. .+.+ .+........+ ..++.++.+++.+||+.||++|||+.||++.|++
T Consensus 239 ~~~~-----~~------------~~~~-~i~~~~~~~~p-------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 239 PGVP-----VE------------ELFK-LLKEGHRMDKP-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp TTCC-----HH------------HHHH-HHHTTCCCCCC-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC-----HH------------HHHH-HHHcCCCCCCC-------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 5321 11 1111 11111111111 1245678999999999999999999999999998
Q ss_pred hHhh
Q 042568 965 LKQY 968 (983)
Q Consensus 965 ~~~~ 968 (983)
+...
T Consensus 294 i~a~ 297 (299)
T d1fgka_ 294 IVAL 297 (299)
T ss_dssp HHHH
T ss_pred Hhhc
Confidence 8653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=391.28 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=205.3
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCc--EEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNT--RIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~--~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 742 (983)
++|+..++||+|+||+||+|.+. ++. .||||.++.....+..+.|.+|+++++++ +|||||+++++|...+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 46777899999999999999965 444 37888876555555677899999999999 799999999999999999999
Q ss_pred EecccCccccccccccc------------CcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCE
Q 042568 743 LPLMSNGSLENHLYPSH------------GLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTA 810 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~ 810 (983)
|||+++|+|.++++... .....+++..+.+++.|||+||.|+|+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999987542 22457999999999999999999999995 9999999999999999999
Q ss_pred EEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCC-CCCcccC
Q 042568 811 LVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRR-PTDVLFH 889 (983)
Q Consensus 811 kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~-p~~~~~~ 889 (983)
||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||...
T Consensus 167 kl~DfG~a~~~~~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-- 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-- 230 (309)
T ss_dssp EECCTTCEESSCEEC--------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--
T ss_pred EEccccccccccccc--------------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--
Confidence 999999998654221 1123468999999999999999999999999999999999765 55321
Q ss_pred CCCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc
Q 042568 890 DGSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL 969 (983)
Q Consensus 890 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 969 (983)
...+ +.+. +........ +..++.++.+++.+||+.||++||||+||+++|+++.+..
T Consensus 231 ---~~~~------------~~~~-i~~~~~~~~-------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 231 ---TCAE------------LYEK-LPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---CHHH------------HHHH-GGGTCCCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---CHHH------------HHHH-HHhcCCCCC-------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111 1111 111111111 1234578999999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6e-44 Score=380.40 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=205.1
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc--------chhHHHHHHHHHHHhcC-CCCccceeeEEecC
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG--------EITGSFKRECQILKRIR-HRNLIRIITICSKP 736 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 736 (983)
++|+..+.||+|+||+||+|+. .+++.||||+++..... ...+++.+|++++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999996 47889999999765422 13356889999999997 99999999999999
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
+..++||||+++|+|.+++.. ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999974 346999999999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCC------CCCCccchhHHHHHHHHHHHhCCCCCCcccCC
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG------KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHD 890 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~ 890 (983)
+|+....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 156 ~a~~~~~~~~--------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-- 219 (277)
T d1phka_ 156 FSCQLDPGEK--------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-- 219 (277)
T ss_dssp TCEECCTTCC--------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred heeEccCCCc--------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--
Confidence 9987653221 123579999999998753 356889999999999999999999986421
Q ss_pred CCchHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 891 GSSLHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 891 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. .............. ....+...+.++.+++.+|++.||++|||++|+++|
T Consensus 220 ---~------------~~~~~~i~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 220 ---Q------------MLMLRMIMSGNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---H------------HHHHHHHHHTCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---H------------HHHHHHHHhCCCCC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 11111111111111 111233466789999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-44 Score=393.83 Aligned_cols=246 Identities=25% Similarity=0.309 Sum_probs=205.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 743 (983)
++|++.+.||+|+||.||+|+++ +|+.||||+++... .....+.+.+|+++++.++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47899999999999999999975 78999999986543 2234578899999999999999999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccC
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKG 823 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~ 823 (983)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999988753 46899999999999999999999996 99999999999999999999999999987642
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .....||+.|||||++.+..++.++||||+||++|||++|+.||... ....
T Consensus 194 ~----------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~------- 245 (350)
T d1rdqe_ 194 R----------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQ------- 245 (350)
T ss_dssp C----------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH-------
T ss_pred c----------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CHHH-------
Confidence 1 12357999999999999999999999999999999999999998531 1111
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
........... .+ ...+.++.+++.+|++.||++|+ |++|+++|
T Consensus 246 -----~~~~i~~~~~~--~p-------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 246 -----IYEKIVSGKVR--FP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----HHHHHHHCCCC--CC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----HHHHHhcCCCC--CC-------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11111111111 11 12456789999999999999994 89999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=386.91 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=205.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|.+.+.||+|+||+||+|.+. +++.||||.++.... ....+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 57889999999999999999975 688899999976532 346788999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC--CCCEEEccccccccccC
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE--DLTALVADFGIAKLVKG 823 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~--~~~~kl~Dfgla~~~~~ 823 (983)
+++|+|.+++... ...+++.+++.|+.||++||+|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999998753 336899999999999999999999996 999999999999985 45899999999986643
Q ss_pred CcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 824 IDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......||+.|+|||...+..++.++||||+||++|+|++|+.||.... ..
T Consensus 157 ~~--------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~-------- 209 (321)
T d1tkia_ 157 GD--------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQ-------- 209 (321)
T ss_dssp TC--------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HH--------
T ss_pred CC--------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----HH--------
Confidence 21 1123578999999999999999999999999999999999999986321 11
Q ss_pred CCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
............ .....+.+.+.++.+++.+|++.||++|||++|+++|
T Consensus 210 ----~~~~~i~~~~~~-----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 210 ----QIIENIMNAEYT-----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHHHHHTCCC-----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHHHHHhCCCC-----CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111111 0111223356778999999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=389.17 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=198.6
Q ss_pred CCCCCCC-ccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhc-CCCCccceeeEEec----CCce
Q 042568 667 GGFCPSS-LIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRI-RHRNLIRIITICSK----PDFK 739 (983)
Q Consensus 667 ~~f~~~~-~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 739 (983)
++|.+.. +||+|+||+||+|++ .+++.||||+++. ...+.+|++++.++ +|||||+++++|.+ ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4677664 699999999999996 5789999999853 35678899997665 89999999999865 3567
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC---CCCEEEcccc
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE---DLTALVADFG 816 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~---~~~~kl~Dfg 816 (983)
|+|||||+||+|.+++.... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 99999999999999997532 346999999999999999999999996 999999999999985 5679999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+|+....... .....||+.|+|||++.+..|+.++||||+||++|+|+||+.||..... .....
T Consensus 160 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~--~~~~~ 223 (335)
T d2ozaa1 160 FAKETTSHNS--------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISP 223 (335)
T ss_dssp TCEECCCCCC--------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC--C----
T ss_pred eeeeccCCCc--------------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH--HHHHH
Confidence 9987653221 1235799999999999999999999999999999999999999964211 11000
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.+. ....... .......+...+.++.+++.+|++.||++|||+.|+++|
T Consensus 224 ~~~---------------~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 224 GMK---------------TRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -------------------CCCSCS-SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH---------------HHHhcCC-CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 0111000 001112345567889999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=389.14 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=210.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC------CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ------DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|...+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 46677889999999999999864 256799999976655555678999999999999999999999999999999
Q ss_pred EEEecccCcccccccccccC------cCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 741 LVLPLMSNGSLENHLYPSHG------LSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
+||||+++|+|.+++..... ....+++..+.+++.|+|+||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 99999999999998864321 1245799999999999999999999985 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCC-CCCCcccCCCCc
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGR-RPTDVLFHDGSS 893 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~-~p~~~~~~~~~~ 893 (983)
||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+||+ .||... .
T Consensus 177 FGla~~~~~~~~~-----------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~ 240 (308)
T d1p4oa_ 177 FGMTRDIYETDYY-----------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----S 240 (308)
T ss_dssp TTCCCGGGGGGCE-----------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----C
T ss_pred cccceeccCCcce-----------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----C
Confidence 9999876543221 2223347999999999999999999999999999999999986 555321 1
Q ss_pred hHHHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHh
Q 042568 894 LHEWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQ 967 (983)
Q Consensus 894 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 967 (983)
..+ .+........ ...+ ..++..+.+++.+||+.+|++|||++||+++|++..+
T Consensus 241 ~~~------------~~~~i~~~~~-~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 NEQ------------VLRFVMEGGL-LDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHH------------HHHHHHTTCC-CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHH------------HHHHHHhCCC-CCCc-------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1221111111 1111 2245679999999999999999999999999987644
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-43 Score=391.78 Aligned_cols=250 Identities=24% Similarity=0.278 Sum_probs=198.1
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC--cchhHHHHHH---HHHHHhcCCCCccceeeEEecCCcee
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT--GEITGSFKRE---CQILKRIRHRNLIRIITICSKPDFKA 740 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 740 (983)
++|.+.++||+|+||.||+|+.. +|+.||||+++.... ......+.+| +++++.++|||||++++++...+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57888999999999999999965 689999999864321 1122334444 66667778999999999999999999
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999875 345889999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .........
T Consensus 157 ~~~~~---------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~~~ 219 (364)
T d1omwa3 157 FSKKK---------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK--TKDKHEIDR 219 (364)
T ss_dssp CSSSC---------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC--SSCHHHHHH
T ss_pred cCCCc---------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence 65321 123479999999999875 568999999999999999999999996421 111111111
Q ss_pred hhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 042568 900 RHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPS-----MLDVAHE 961 (983)
Q Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 961 (983)
... . ..... +...+.++.+++.+|++.||++||| ++|+++|
T Consensus 220 ~~~-------------~-~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 MTL-------------T-MAVEL-------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HSS-------------S-CCCCC-------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred hcc-------------c-CCCCC-------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 110 0 00001 1124567899999999999999999 6888865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=386.74 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=201.7
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeeccc--CcchhHHHHHHHHHHH-hcCCCCccceeeEEecCCceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTT--TGEITGSFKRECQILK-RIRHRNLIRIITICSKPDFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 742 (983)
++|.+.+.||+|+||+||+|+.. +++.||||+++... ..+..+.+..|..++. .++|||||++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999975 68889999997542 2234566777887765 68999999999999999999999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVK 822 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~ 822 (983)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999875 345899999999999999999999996 9999999999999999999999999998654
Q ss_pred CCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhC
Q 042568 823 GIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHY 902 (983)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~ 902 (983)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||... ...
T Consensus 155 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~------- 209 (320)
T d1xjda_ 155 LGD-------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEE------- 209 (320)
T ss_dssp CTT-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH-------
T ss_pred ccc-------------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHH-------
Confidence 322 1123357999999999999999999999999999999999999998632 111
Q ss_pred CCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 042568 903 PHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSML-DVAH 960 (983)
Q Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~ 960 (983)
+........ . ...| ..++.++.+++.+|++.||++||++. |+++
T Consensus 210 -----~~~~~i~~~-~-~~~p-------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 210 -----ELFHSIRMD-N-PFYP-------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----HHHHHHHHC-C-CCCC-------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----HHHHHHHcC-C-CCCC-------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111111111 1 1111 12456789999999999999999995 7765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=386.08 Aligned_cols=269 Identities=22% Similarity=0.252 Sum_probs=195.5
Q ss_pred CCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc----chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEecc
Q 042568 672 SSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG----EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPLM 746 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 746 (983)
.++||+|+||+||+|+.. +|+.||||+++..... ...+++.+|++++++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 6899999998654322 23467899999999999999999999999999999999999
Q ss_pred cCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCcc
Q 042568 747 SNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGIDE 826 (983)
Q Consensus 747 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~~ 826 (983)
+++++..+... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 99887766543 446888999999999999999999996 99999999999999999999999999986543221
Q ss_pred cccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCCC
Q 042568 827 SVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPHR 905 (983)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 905 (983)
.....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...........
T Consensus 156 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 156 -------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPT 221 (299)
T ss_dssp -------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCC
T ss_pred -------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCC
Confidence 1223579999999998875 4679999999999999999999999853211 011111111111000
Q ss_pred CcHHHH--HHHhhcCCCCC-ccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 906 LDPIVE--KAIAKYAPQHM-PIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 906 ~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.....+ ........... .......+.....++.+++.+|++.||++|||++|+++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000 00000000000 000111122345679999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=384.33 Aligned_cols=277 Identities=24% Similarity=0.311 Sum_probs=203.0
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|.+.+.||+|+||+||+|++ .+++.||||+++..... ...+++.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 57899999999655432 246789999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
|+.++.+.. +.... ...+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~~~~-~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKF-MDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHH-HHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhh-hhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 998654443 33221 456999999999999999999999996 999999999999999999999999999876532
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
. .......||+.|+|||...... ++.++||||+||++|+|++|+.||..... ...+.........
T Consensus 156 ~-------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~ 221 (298)
T d1gz8a_ 156 V-------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGT 221 (298)
T ss_dssp S-------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCC
T ss_pred c-------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCC
Confidence 2 1222357999999999877655 57899999999999999999999964211 1111111111111
Q ss_pred CC--CcHHHHHHHhhcCCCCCccccc----cchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHh
Q 042568 904 HR--LDPIVEKAIAKYAPQHMPIYYN----KVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRL 965 (983)
Q Consensus 904 ~~--~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 965 (983)
.. ....... .... ....+.... ........++.+++.+|++.||++|||++|+++| ++++
T Consensus 222 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 222 PDEVVWPGVTS-MPDY-KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCTTTSTTGGG-STTC-CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred Cchhhcccccc-cccc-ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 10 0000000 0000 000011111 1112345678999999999999999999999987 4444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=376.25 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=195.5
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-----chhHHHHHHHHHHHhcC--CCCccceeeEEecCCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-----EITGSFKRECQILKRIR--HRNLIRIITICSKPDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 738 (983)
++|++.++||+|+||+||+|+.. +++.||||+++..... ....++.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57889999999999999999964 7899999998654321 12345778999999996 8999999999999999
Q ss_pred eeEEEecccC-cccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-CCCEEEcccc
Q 042568 739 KALVLPLMSN-GSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-DLTALVADFG 816 (983)
Q Consensus 739 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-~~~~kl~Dfg 816 (983)
.++||||+.+ +++.+++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 9999999976 566666654 346899999999999999999999996 999999999999985 4799999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCCCC-CccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRA-STHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .
T Consensus 157 ~a~~~~~~---------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~ 214 (273)
T d1xwsa_ 157 SGALLKDT---------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------E 214 (273)
T ss_dssp TCEECCSS---------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------H
T ss_pred cceecccc---------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------h
Confidence 99865421 1123579999999999987665 57789999999999999999998631 0
Q ss_pred HHHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 896 EWVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
+... ... ..+ ...+.++.+++.+|++.||++|||++|++++
T Consensus 215 ~i~~----------------~~~--~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 215 EIIR----------------GQV--FFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHH----------------CCC--CCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhh----------------ccc--CCC-------CCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111 100 011 1134678999999999999999999999886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-43 Score=377.57 Aligned_cols=274 Identities=22% Similarity=0.275 Sum_probs=203.8
Q ss_pred CCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEec
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLPL 745 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 745 (983)
++|...++||+|+||+||+|++++|+.||||+++.... ....+++.+|+.++++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999966532 23467899999999999999999999999999999999999
Q ss_pred ccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCCc
Q 042568 746 MSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGID 825 (983)
Q Consensus 746 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~~ 825 (983)
+.++.+..+... ...+++..++.++.||++||+|||+.+ ||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 998777666543 456999999999999999999999986 9999999999999999999999999998765322
Q ss_pred ccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCCC
Q 042568 826 ESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYPH 904 (983)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~ 904 (983)
. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..........
T Consensus 155 ~-------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 155 R-------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTP 220 (286)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCC
T ss_pred c-------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCC
Confidence 1 1223468999999999876 4568999999999999999999999964211 11111111111111
Q ss_pred C---CcHHHHH-HHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 905 R---LDPIVEK-AIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 905 ~---~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
. ....... ..........+............++.+++.+|++.||++|||++|+++|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 0000000000111111122345678999999999999999999999865
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.9e-42 Score=373.84 Aligned_cols=296 Identities=29% Similarity=0.453 Sum_probs=213.3
Q ss_pred cccHHhHHHHHHHHHhccCCCccccCCCCCCCCCCc--ceeeEEECCCC--CeEEEEEcccCCccc--ccccccccCCCC
Q 042568 30 DQIIRDRASLVTFMSSIISAPEHALESWNSTDVHVC--NWSGVKCNNSR--NKVVELDLSARSIYG--TISPALANLSSL 103 (983)
Q Consensus 30 ~~~~~~~~~ll~~k~~~~~~~~~~l~sw~~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L 103 (983)
.|+++|++||++||+++. || +.+++|.. +.||| .|.||+|++.+ +||+.|||+++++.| .+|+++++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 489999999999999996 55 46999985 46899 49999998754 489999999999988 477888888888
Q ss_pred cEEeCcC-CcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceee
Q 042568 104 IVLDLSK-NFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYID 182 (983)
Q Consensus 104 ~~L~Ls~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~ 182 (983)
++|+|++ |+++|.+|++|++|++|++|+|++|+|.+..|..+..+.+|+++++++|++.+.+|..+.
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~------------ 146 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS------------ 146 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG------------
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc------------
Confidence 8888886 788888888888888888888888888877777788888888888888877766655443
Q ss_pred cccccccCCCCCcccccccccceeecccCccccccchhhhccCCc-ceecccccccccccchhhhcCCCCccEEEccccc
Q 042568 183 LSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKL-EWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261 (983)
Q Consensus 183 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 261 (983)
.++.|+.+++++|.+.+.+|..+..+.++ +.+++++|+++|..|.
T Consensus 147 ----------------~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~------------------ 192 (313)
T d1ogqa_ 147 ----------------SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP------------------ 192 (313)
T ss_dssp ----------------GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCG------------------
T ss_pred ----------------cCcccceeeccccccccccccccccccccccccccccccccccccc------------------
Confidence 45556666666666666666666665554 5566666666544332
Q ss_pred cccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEecccc
Q 042568 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341 (983)
Q Consensus 262 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 341 (983)
.+..+ ....++++.|.+.+.+|..+..+++|+.|++++|
T Consensus 193 ---------------------------------------~~~~l--~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~ 231 (313)
T d1ogqa_ 193 ---------------------------------------TFANL--NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp ---------------------------------------GGGGC--CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred ---------------------------------------ccccc--cccccccccccccccccccccccccccccccccc
Confidence 22222 1234555555555566666666677777777777
Q ss_pred ccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCcc-CCC
Q 042568 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNH-LSG 417 (983)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~ 417 (983)
.+++.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|
T Consensus 232 ~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 232 SLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp EECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEES
T ss_pred ccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccC
Confidence 7765544 466677777777777777777777777777777777777777776664 5677777777777775 443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=379.96 Aligned_cols=276 Identities=21% Similarity=0.284 Sum_probs=202.8
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecCC----cee
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKPD----FKA 740 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 740 (983)
+++|++.+.||+|+||+||+|.. .+|+.||||+++........+++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45788999999999999999996 5799999999976655555678999999999999999999999996553 235
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
++++|+.+|+|.+++.. ..+++..++.++.|+++||+|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55667779999999863 35999999999999999999999996 99999999999999999999999999987
Q ss_pred ccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHH
Q 042568 821 VKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVK 899 (983)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~ 899 (983)
....... .......+||+.|+|||.+.. ..++.++||||+||++|||++|+.||...... ........
T Consensus 159 ~~~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-~~~~~~~~ 227 (345)
T d1pmea_ 159 ADPDHDH----------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILG 227 (345)
T ss_dssp CCGGGCB----------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred ccCCCcc----------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-HHHHHHhh
Confidence 6543221 122234579999999999854 56789999999999999999999998643211 01111111
Q ss_pred hhCCCC-------CcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 900 RHYPHR-------LDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 900 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... .............. ..+......+.....++.+++.+|++.||++|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 228 ILGSPSQEDLNCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCChhhhhhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110 00011111111111 11111122223345678999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=377.69 Aligned_cols=274 Identities=22% Similarity=0.262 Sum_probs=199.9
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-C-CcEEEEEEeecccCc-chhHHHHHHHHHHHhc---CCCCccceeeEEec----
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-D-NTRIAVKVLDLTTTG-EITGSFKRECQILKRI---RHRNLIRIITICSK---- 735 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~-~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 735 (983)
.++|++.+.||+|+||+||+|++. + ++.||||+++..... .....+.+|+++++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 567999998665432 2345677888888776 79999999999843
Q ss_pred -CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcc
Q 042568 736 -PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVAD 814 (983)
Q Consensus 736 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~D 814 (983)
....+++|||++++.+....... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 34678999999988775444322 456899999999999999999999996 99999999999999999999999
Q ss_pred ccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCch
Q 042568 815 FGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSL 894 (983)
Q Consensus 815 fgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l 894 (983)
||.++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... +...+
T Consensus 160 fg~~~~~~~~--------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~ 224 (305)
T d1blxa_ 160 FGLARIYSFQ--------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQL 224 (305)
T ss_dssp CCSCCCCCGG--------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHH
T ss_pred hhhhhhhccc--------------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHH
Confidence 9998865422 12234579999999999999999999999999999999999999996421 11111
Q ss_pred HHHHHhhCCCCCcHHHHHH--H-hhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 895 HEWVKRHYPHRLDPIVEKA--I-AKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 895 ~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.............. .... . ........+.............+.+|+.+|++.||++|||++|+++|
T Consensus 225 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 225 GKILDVIGLPGEED-WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHCCCCGGG-SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhCCCchhc-ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 12111111000000 0000 0 00000000111111223345678899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=376.93 Aligned_cols=273 Identities=21% Similarity=0.267 Sum_probs=198.6
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSKPD------ 737 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 737 (983)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.... ....+++.+|++++++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999964 689999999975433 334678899999999999999999999997654
Q ss_pred ceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccc
Q 042568 738 FKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGI 817 (983)
Q Consensus 738 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgl 817 (983)
..++||||+ +.++..+.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 556766654 346999999999999999999999996 99999999999999999999999999
Q ss_pred cccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 818 AKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
|+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.... ....+..
T Consensus 168 a~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-~~~~~~~ 230 (346)
T d1cm8a_ 168 ARQADSE----------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD-HLDQLKE 230 (346)
T ss_dssp CEECCSS----------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHH
T ss_pred eeccCCc----------------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC-hHHHHHH
Confidence 9865422 1235799999999998764 56899999999999999999999986421 1111111
Q ss_pred HHHhhCCCC------C-cHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHh
Q 042568 897 WVKRHYPHR------L-DPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRL 965 (983)
Q Consensus 897 ~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 965 (983)
......... . ............ ................++.+|+.+|+..||++|||++|+++| ++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLP-ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSC-CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhccCCCcHHHHhhhcchhhhhhhccCC-cccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 111111100 0 011111111111 111111112223345678999999999999999999999987 5444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=365.49 Aligned_cols=277 Identities=18% Similarity=0.199 Sum_probs=197.4
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccC-cchhHHHHHHHHHHHhcCCCCccceeeEEec--------C
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTT-GEITGSFKRECQILKRIRHRNLIRIITICSK--------P 736 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 736 (983)
++|.+.+.||+|+||+||+|++ .+|+.||||++..... +....++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999996 4789999999865533 2346788999999999999999999998855 3
Q ss_pred CceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccc
Q 042568 737 DFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFG 816 (983)
Q Consensus 737 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfg 816 (983)
+..++||||++++.+...... ...+++..++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 457899999998877655443 456899999999999999999999996 9999999999999999999999999
Q ss_pred ccccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchH
Q 042568 817 IAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLH 895 (983)
Q Consensus 817 la~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~ 895 (983)
+|+......... .......+||+.|+|||.+.+. .+++++||||+||++|||++|+.||..... .....
T Consensus 163 ~~~~~~~~~~~~---------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~ 232 (318)
T d3blha1 163 LARAFSLAKNSQ---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLA 232 (318)
T ss_dssp TCEECCC--------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH
T ss_pred eeeecccccccc---------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHH
Confidence 998765432211 1222335799999999998765 689999999999999999999999864211 11111
Q ss_pred HHHHhh--CCCC-----CcHHHHHHHhhcCCCCCccccccch--HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 042568 896 EWVKRH--YPHR-----LDPIVEKAIAKYAPQHMPIYYNKVW--SDVVLELIELGLLCTQYNPSTRPSMLDVAHEM 962 (983)
Q Consensus 896 ~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 962 (983)
...... .+.. ........+...... +......+ .....++.+|+.+|++.||++|||++|+++|=
T Consensus 233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQ--KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HHHHHHCCCCTTTSTTCCCC-------CCSSC--CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHhcCCCChhhccccchhhhhhhhcccccc--cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 111110 0000 000011111111100 00000000 11234678999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.3e-41 Score=362.80 Aligned_cols=272 Identities=18% Similarity=0.266 Sum_probs=210.3
Q ss_pred hCCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCC-CCccceeeEEecCCceeEEE
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRH-RNLIRIITICSKPDFKALVL 743 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 743 (983)
.++|.+.+.||+|+||+||+|++. +++.||||+++.... ...+.+|+++++.++| +|++.+++++......++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 367899999999999999999965 688999999865433 3567889999999975 89999999999999999999
Q ss_pred ecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCC-----CCCEEEcccccc
Q 042568 744 PLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDE-----DLTALVADFGIA 818 (983)
Q Consensus 744 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~-----~~~~kl~Dfgla 818 (983)
||+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence 999 67998887643 346899999999999999999999996 999999999999974 578999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+.+.......... .......+||+.|||||.+.+..+++++|||||||++|||++|+.||....... .....
T Consensus 154 ~~~~~~~~~~~~~------~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~--~~~~~ 225 (293)
T d1csna_ 154 KFYRDPVTKQHIP------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQKY 225 (293)
T ss_dssp EESBCTTTCCBCC------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHHHH
T ss_pred EEcccCcccccee------ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh--HHHHH
Confidence 9876443221111 122334689999999999999999999999999999999999999996432211 11110
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhcCC
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYLSS 971 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 971 (983)
.. +.+... . .+ .+.....++.++.+++..|++.+|++||+++.+.+.++++.+....
T Consensus 226 ~~--------i~~~~~-~-~~------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 226 ER--------IGEKKQ-S-TP------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HH--------HHHHHH-H-SC------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH--------HHhccC-C-CC------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 00 000000 0 00 0000122456789999999999999999999999999987655443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=371.61 Aligned_cols=274 Identities=24% Similarity=0.301 Sum_probs=197.7
Q ss_pred CCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccceeeEEecC------Ccee
Q 042568 668 GFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRIITICSKP------DFKA 740 (983)
Q Consensus 668 ~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 740 (983)
+|...++||+|+||+||+|++. +|+.||||++..... .+.+|++++++++||||+++++++... .+.+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 4777889999999999999975 689999999965432 234799999999999999999998433 3468
Q ss_pred EEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccc
Q 042568 741 LVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAK 819 (983)
Q Consensus 741 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~ 819 (983)
+||||++++.+..... .......+++..++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||+|+
T Consensus 96 lv~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998765444332 2222557999999999999999999999996 99999999999999775 89999999998
Q ss_pred cccCCcccccccCCCCccccccCccccccccccccccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 820 LVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMG-KRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+..++
T Consensus 172 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~ 236 (350)
T d1q5ka_ 172 QLVRGEP--------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEII 236 (350)
T ss_dssp ECCTTSC--------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHH
T ss_pred hccCCcc--------------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHH
Confidence 7653221 123479999999998775 5789999999999999999999999863211 11122222
Q ss_pred HhhCCCCCcHHHHHHHhhcCCCCCccc-----cccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHhH
Q 042568 899 KRHYPHRLDPIVEKAIAKYAPQHMPIY-----YNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE--MGRLK 966 (983)
Q Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~ 966 (983)
...-. ...+.+............+.. ..........++.+|+.+|++.||++|||+.|+++| ++++.
T Consensus 237 ~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 237 KVLGT-PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHCC-CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhCC-ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 21111 111222221111111111111 111123356678999999999999999999999975 44443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-41 Score=363.81 Aligned_cols=279 Identities=20% Similarity=0.277 Sum_probs=204.9
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCccce-eeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNLIRI-ITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e 744 (983)
++|++.+.||+|+||+||+|++ .+++.||||++..... ..++.+|+++++.++|++++.. .+++...+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5789999999999999999996 4688999999865433 3568899999999987765555 555577788899999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeC---CCCCEEEccccccccc
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLD---EDLTALVADFGIAKLV 821 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~---~~~~~kl~Dfgla~~~ 821 (983)
|+. +++.+.+... ...+++..+..++.|+++||+|||+++ |+||||||+|||++ .+..+|++|||+|+.+
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 995 4555554432 456999999999999999999999996 99999999999986 4567999999999987
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRH 901 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~ 901 (983)
......... .........||+.|+|||.+.+..+++++|||||||++|||++|+.||.......... . +.
T Consensus 157 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~-~~-- 226 (299)
T d1ckia_ 157 RDARTHQHI------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-K-YE-- 226 (299)
T ss_dssp BCTTTCCBC------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HH--
T ss_pred cccccccce------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-H-HH--
Confidence 654322111 0122344679999999999999999999999999999999999999996532211110 0 00
Q ss_pred CCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHhHhhc-CCCchhHHHh
Q 042568 902 YPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHEMGRLKQYL-SSPSSLIEEA 979 (983)
Q Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~-~~~~~~~~~~ 979 (983)
......... . .+.....++.++.+++.+|++.+|++||+++++.+.|+.+.... ....+.++|.
T Consensus 227 ------~~~~~~~~~-~-------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 227 ------RISEKKMST-P-------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp ------HHHHHHHHS-C-------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred ------HhhcccCCC-C-------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 000000000 0 00011235578999999999999999999999999998875433 2334444444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=360.59 Aligned_cols=274 Identities=21% Similarity=0.248 Sum_probs=205.2
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecCCceeEEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKPDFKALVLP 744 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 744 (983)
++|++.+.||+|+||+||+|++. +++.||||+++..... ....++.+|++++++++||||+++++++...+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57889999999999999999964 7888999999765433 356889999999999999999999999999999999999
Q ss_pred cccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEccccccccccCC
Q 042568 745 LMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIAKLVKGI 824 (983)
Q Consensus 745 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~~~~~ 824 (983)
++.++++..++.. ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998887754 346889999999999999999999996 999999999999999999999999999876533
Q ss_pred cccccccCCCCccccccCccccccccccccccCCCC-CCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHhhCC
Q 042568 825 DESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKR-ASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKRHYP 903 (983)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 903 (983)
.. ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.........+........+
T Consensus 155 ~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 155 VR-------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp CS-------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred Cc-------------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 21 112235788999999987655 6899999999999999999999974311111111111111111
Q ss_pred CC--CcHHHHHHHhhcCCC---CCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 904 HR--LDPIVEKAIAKYAPQ---HMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 904 ~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. ..+..... ...... ...............++.+++.+|++.||++|||++|+++|
T Consensus 222 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 222 PTEEQWPSMTKL-PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTTCTTGGGS-TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhhhhhhhhc-ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000 000000 00001111122345678899999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-40 Score=360.80 Aligned_cols=267 Identities=19% Similarity=0.290 Sum_probs=196.6
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecC--CceeEE
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKP--DFKALV 742 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 742 (983)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 5799999999999999999997 46889999998643 2467899999999995 99999999999744 568999
Q ss_pred EecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC-CEEEccccccccc
Q 042568 743 LPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL-TALVADFGIAKLV 821 (983)
Q Consensus 743 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~-~~kl~Dfgla~~~ 821 (983)
|||+++++|.+.. ..+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987654 24899999999999999999999996 99999999999998655 6899999999876
Q ss_pred cCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHHHh
Q 042568 822 KGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWVKR 900 (983)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~~~ 900 (983)
..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||................
T Consensus 181 ~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~ 246 (328)
T d3bqca1 181 HPGQE--------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246 (328)
T ss_dssp CTTCC--------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred cCCCc--------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence 53221 1235789999999998775 47999999999999999999999986422111111111110
Q ss_pred hC-----------CCCCcHHHHHHHhhcCCCCCc-cccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 901 HY-----------PHRLDPIVEKAIAKYAPQHMP-IYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 901 ~~-----------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
.. ....................+ ......+.....++.+|+.+|++.||++|||++|+++|
T Consensus 247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000000000000000000 00111123355778999999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=359.62 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred CCCCCCCccccCCcEeEEEEEEC----CCcEEEEEEeeccc---CcchhHHHHHHHHHHHhcCC-CCccceeeEEecCCc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ----DNTRIAVKVLDLTT---TGEITGSFKRECQILKRIRH-RNLIRIITICSKPDF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~----~~~~vAvK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 738 (983)
++|.+.+.||+|+||+||+|+.. +|+.||||.++... .....+++.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999852 47899999986542 22345778999999999977 899999999999999
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.++||||+.+|+|.+++... ..+++..+..++.|++.||+|+|+.+ |+||||||+||+++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998753 35788899999999999999999986 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC--CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK--RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE 896 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~ 896 (983)
+.+..... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ....
T Consensus 177 ~~~~~~~~------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~ 243 (322)
T d1vzoa_ 177 KEFVADET------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAE 243 (322)
T ss_dssp EECCGGGG------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHH
T ss_pred hhhccccc------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence 87653321 122335799999999998764 46889999999999999999999996532211 1111
Q ss_pred HHHhhCCCCCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 042568 897 WVKRHYPHRLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRP-----SMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 961 (983)
+......... ..+ .+++.++.+++.+|+++||++|| |++|+++|
T Consensus 244 ------------i~~~~~~~~~--~~~-------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 244 ------------ISRRILKSEP--PYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------------HHHHHHHCCC--CCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------------HHHhcccCCC--CCc-------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111111111 111 23567899999999999999999 48899875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=364.57 Aligned_cols=269 Identities=20% Similarity=0.243 Sum_probs=199.0
Q ss_pred hCCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC-----Cc
Q 042568 666 TGGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP-----DF 738 (983)
Q Consensus 666 ~~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 738 (983)
+++|++.+.||+|+||+||+|++ .+|+.||||+++..... ...+++.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999996 47899999999765432 3456789999999999999999999998643 34
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.+++++|+.+|+|.+++. ..++++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.|
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 467788888999999886 346999999999999999999999996 999999999999999999999999999
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCC-CCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHH-
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGK-RASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHE- 896 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~- 896 (983)
...... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||.... ......
T Consensus 169 ~~~~~~----------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~ 230 (348)
T d2gfsa1 169 RHTDDE----------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKL 230 (348)
T ss_dssp -CCTGG----------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH
T ss_pred cccCcc----------------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHH
Confidence 755321 2235799999999987765 46899999999999999999999986321 111111
Q ss_pred HHHhhCCC-------CCcHHHHHHHhhcCCCCCccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 897 WVKRHYPH-------RLDPIVEKAIAKYAPQHMPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 897 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
........ .............. ..........+.....++.+++.+|++.||++|||++|+++|
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLT-QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcc-cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 11111110 01111111111111 111111111223345778999999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-39 Score=359.07 Aligned_cols=270 Identities=21% Similarity=0.197 Sum_probs=193.9
Q ss_pred CCCCCCCccccCCcEeEEEEEEC-CCcEEEEEEeecccCc-chhHHHHHHHHHHHhcCCCCccceeeEEecC------Cc
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVLQ-DNTRIAVKVLDLTTTG-EITGSFKRECQILKRIRHRNLIRIITICSKP------DF 738 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~~-~~~~vAvK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 738 (983)
++|.+.++||+|+||+||+|++. +|+.||||+++..... ....++.+|++++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57889999999999999999975 6899999999765432 3456789999999999999999999999543 57
Q ss_pred eeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEcccccc
Q 042568 739 KALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVADFGIA 818 (983)
Q Consensus 739 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla 818 (983)
.|+||||+.++.+..+ . ..+++..++.++.|++.||+|||+.| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~~-~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-Q------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHHH-T------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHhh-h------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 7999999987655433 2 34899999999999999999999996 999999999999999999999999998
Q ss_pred ccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCcccCCCCchHHHH
Q 042568 819 KLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDVLFHDGSSLHEWV 898 (983)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~~~~~~~~l~~~~ 898 (983)
+...... ......||+.|+|||++.+..+++++||||+||++|||++|+.||.... ........+
T Consensus 167 ~~~~~~~--------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~ 231 (355)
T d2b1pa1 167 RTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVI 231 (355)
T ss_dssp ----------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH
T ss_pred hcccccc--------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHH
Confidence 8654321 2233579999999999999999999999999999999999999985321 011111111
Q ss_pred HhhCCC------CCcHHHHHHHhhcCCCC-----------CccccccchHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 042568 899 KRHYPH------RLDPIVEKAIAKYAPQH-----------MPIYYNKVWSDVVLELIELGLLCTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 899 ~~~~~~------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 961 (983)
...... ................. ..............++.+++.+|++.||++|||++|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111110 01111111111111000 0011111234467789999999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.3e-35 Score=324.65 Aligned_cols=273 Identities=18% Similarity=0.235 Sum_probs=190.0
Q ss_pred CCCCCCCccccCCcEeEEEEEE-CCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-----------CCCccceeeEEe
Q 042568 667 GGFCPSSLIGSGRFGHVYKGVL-QDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-----------HRNLIRIITICS 734 (983)
Q Consensus 667 ~~f~~~~~iG~G~~g~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 734 (983)
++|.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 4588999999999999999996 478999999996543 23467888999998875 578999998875
Q ss_pred c--CCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCC----
Q 042568 735 K--PDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDL---- 808 (983)
Q Consensus 735 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~---- 808 (983)
. ....+++++++..+......... .....+++..+..++.|+++||+|||+.. +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccc
Confidence 4 34556667666544332222221 12566899999999999999999999732 499999999999998655
Q ss_pred --CEEEccccccccccCCcccccccCCCCccccccCccccccccccccccCCCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 042568 809 --TALVADFGIAKLVKGIDESVNCANDSMSFTSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVTGRRPTDV 886 (983)
Q Consensus 809 --~~kl~Dfgla~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~SlG~il~elltg~~p~~~ 886 (983)
.++++|||.|...... ....+||+.|+|||.+.+..++.++||||+||++++|++|+.||..
T Consensus 168 ~~~~kl~dfg~s~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEEECCCTTCEETTBC----------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeeEeecccccccccc----------------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 3999999998755321 1235799999999999999999999999999999999999999964
Q ss_pred ccCCC-C----chHHHHHhhCCCCCcHHHHHH------Hhhc-CCCCCcc-----------ccccchHHHHHHHHHHHhh
Q 042568 887 LFHDG-S----SLHEWVKRHYPHRLDPIVEKA------IAKY-APQHMPI-----------YYNKVWSDVVLELIELGLL 943 (983)
Q Consensus 887 ~~~~~-~----~l~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~-----------~~~~~~~~~~~~l~~l~~~ 943 (983)
..... . .+...+...-. ...+..... .... ....... .....+.....++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 232 DEGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp -------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CccccccchhHHHHHHHHHhCC-CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 32211 1 11111111100 001111100 0000 0000000 0011235677889999999
Q ss_pred hcCCCCCCCCCHHHHHHH
Q 042568 944 CTQYNPSTRPSMLDVAHE 961 (983)
Q Consensus 944 cl~~dP~~RPs~~evl~~ 961 (983)
|+++||++|||++|+++|
T Consensus 311 mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGCSSTTTCBCHHHHHTC
T ss_pred HCCCChhHCcCHHHHhcC
Confidence 999999999999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.6e-33 Score=307.81 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=209.5
Q ss_pred cccEEeccccccCC--CCCcccccCCCCcEEEeeC-CcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 332 NLTLLNLSSNLLNG--TIPHELCLMSKLERVYLSN-NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 332 ~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
+++.|+|++|.++| .+|..++++++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 45556666666555 3556666666666666664 66666666667777777777777777776667677777777777
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (983)
++++|.+.+.+|..+..++.|+.+++++|++++.+|..+..+..+...+++++|++++..|..+..+..+ .+++++|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 7777777777777788888888888888888888888777777764458888888888888888777554 689999999
Q ss_pred ccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCC
Q 042568 489 SGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKG 568 (983)
Q Consensus 489 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~ 568 (983)
.+.+|..++.+++|+.|++++|.+++.+| .++.+++|+.|+|++|+++|.+|.+|+++++|++|+|++|+|+|.+|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999997665 68889999999999999999999999999999999999999999999988
Q ss_pred CCcccccccccCCcCccCCCCCcccc
Q 042568 569 AFSSLTIASFQGNDGLCGEIKGLQTC 594 (983)
Q Consensus 569 ~~~~~~~~~~~~N~~lc~~~~~~~~c 594 (983)
.+..+..+++.||+.+||.| +++|
T Consensus 289 ~L~~L~~l~l~~N~~l~g~p--lp~c 312 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSP--LPAC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTT--SSCC
T ss_pred cCCCCCHHHhCCCccccCCC--CCCC
Confidence 99999999999999999987 4577
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=5e-28 Score=272.10 Aligned_cols=191 Identities=26% Similarity=0.400 Sum_probs=98.0
Q ss_pred CCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccch
Q 042568 327 ISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLR 406 (983)
Q Consensus 327 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 406 (983)
+..+++++.+++++|.+++..| +..+++|+.|++++|.++.. ..+..+++|+.|++++|++++..+ +
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~------- 259 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L------- 259 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G-------
T ss_pred cccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--c-------
Confidence 3444555555555555554322 23344555555555554421 134444445555555544443221 3
Q ss_pred hhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccc
Q 042568 407 RLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFN 486 (983)
Q Consensus 407 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 486 (983)
..+++|+.|++++|++++.. .+..+..++. ++++.|.+++ +..+..+++++.|++++|
T Consensus 260 -----------------~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~-l~~~~n~l~~--~~~~~~~~~l~~L~ls~n 317 (384)
T d2omza2 260 -----------------SGLTKLTELKLGANQISNIS--PLAGLTALTN-LELNENQLED--ISPISNLKNLTYLTLYFN 317 (384)
T ss_dssp -----------------TTCTTCSEEECCSSCCCCCG--GGTTCTTCSE-EECCSSCCSC--CGGGGGCTTCSEEECCSS
T ss_pred -----------------cccccCCEeeccCcccCCCC--cccccccccc-cccccccccc--ccccchhcccCeEECCCC
Confidence 34444444444444444322 1333444442 4444454443 123445555556666666
Q ss_pred ccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCC
Q 042568 487 NLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFN 558 (983)
Q Consensus 487 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N 558 (983)
++++. + .+..+++|+.|++++|+|++ ++ .+.++++|+.|++++|++++..| +.++++|+.|++++|
T Consensus 318 ~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 318 NISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 66543 2 25566666666666666663 33 46666777777777777765443 666777777777665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=4.8e-28 Score=272.24 Aligned_cols=211 Identities=26% Similarity=0.373 Sum_probs=165.0
Q ss_pred cCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEE
Q 042568 353 LMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEIL 432 (983)
Q Consensus 353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 432 (983)
............|... .+..+..+++++.+++++|.+++..| +...++|+.|++++|.++. + +.+..+++|+.|
T Consensus 173 ~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 246 (384)
T d2omza2 173 NLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDL 246 (384)
T ss_dssp TCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred cccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchh
Confidence 3344444444444433 23345566677777777777775544 4556778888888888873 3 357889999999
Q ss_pred EccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcc
Q 042568 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSL 512 (983)
Q Consensus 433 ~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 512 (983)
++++|++++..+ +..+++|+. +++++|++++.. .+..+..++.+++++|++++ +..+..+.+++.|++++|++
T Consensus 247 ~l~~n~l~~~~~--~~~~~~L~~-L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l 319 (384)
T d2omza2 247 DLANNQISNLAP--LSGLTKLTE-LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNI 319 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSE-EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCC
T ss_pred ccccCccCCCCc--ccccccCCE-eeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCC
Confidence 999999996543 788899996 999999998654 37788999999999999985 34588899999999999999
Q ss_pred cccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccCCccccccCCCCCCcccccccccCC
Q 042568 513 EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSGNISNKGAFSSLTIASFQGN 581 (983)
Q Consensus 513 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~N 581 (983)
++..+ +..+++|+.|++++|+|++ +| .+.++++|++|++++|++++.+| ...++.+..+.+.+|
T Consensus 320 ~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 320 SDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 97543 7889999999999999984 55 69999999999999999999876 567778888888776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.1e-25 Score=244.04 Aligned_cols=271 Identities=21% Similarity=0.309 Sum_probs=155.1
Q ss_pred CCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCch
Q 042568 63 HVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIP 142 (983)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p 142 (983)
+-|.|++|.|++. +++ ++|+.+. +.+++|+|++|+|+...+..|.++++|++|++++|.+....|
T Consensus 8 c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~ 72 (305)
T d1xkua_ 8 CQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP 72 (305)
T ss_dssp CEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred CEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccch
Confidence 4478999999752 344 5666553 689999999999984444579999999999999999997778
Q ss_pred hhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhh
Q 042568 143 SQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALA 222 (983)
Q Consensus 143 ~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 222 (983)
..|.++++|++|++++|+++ .+|...+ ..|+.|++.+|.+.+..+..+.
T Consensus 73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~~------------------------------~~l~~L~~~~n~l~~l~~~~~~ 121 (305)
T d1xkua_ 73 GAFAPLVKLERLYLSKNQLK-ELPEKMP------------------------------KTLQELRVHENEITKVRKSVFN 121 (305)
T ss_dssp TTTTTCTTCCEEECCSSCCS-BCCSSCC------------------------------TTCCEEECCSSCCCBBCHHHHT
T ss_pred hhhhCCCccCEecccCCccC-cCccchh------------------------------hhhhhhhccccchhhhhhhhhh
Confidence 88999999999999999998 5665432 3344555555555555555555
Q ss_pred ccCCcceeccccccccc-ccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCcc
Q 042568 223 NSSKLEWLDLESNMFSG-ELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSI 301 (983)
Q Consensus 223 ~l~~L~~L~Ls~N~l~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~ 301 (983)
....++.++...|.... ......+..+++|+.+++++|.+..++. .-.++|++|++++|..+
T Consensus 122 ~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~-----------~~~~~L~~L~l~~n~~~------ 184 (305)
T d1xkua_ 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ-----------GLPPSLTELHLDGNKIT------ 184 (305)
T ss_dssp TCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS-----------SCCTTCSEEECTTSCCC------
T ss_pred ccccccccccccccccccCCCccccccccccCccccccCCccccCc-----------ccCCccCEEECCCCcCC------
Confidence 55566666666554321 1122234445555555555554432211 01233444444444444
Q ss_pred ccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCC
Q 042568 302 IGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHL 381 (983)
Q Consensus 302 ~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 381 (983)
+..+..+..++.++.|++++|.+++..+..+..+++|++|+|++|.|+ .+|.+|.++++|
T Consensus 185 -------------------~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L 244 (305)
T d1xkua_ 185 -------------------KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244 (305)
T ss_dssp -------------------EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred -------------------CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCC
Confidence 444444444444444444444444444444444444555555555444 234444445555
Q ss_pred cEEEccCccccCcCcccc------cCcccchhhcccCccCC
Q 042568 382 GLLDLSKNKLSGSIPDSF------ANLSQLRRLLLYGNHLS 416 (983)
Q Consensus 382 ~~L~Ls~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~ 416 (983)
+.|+|++|+|+......| ..+.+|+.|+|++|.++
T Consensus 245 ~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 555555555443322222 23445555555555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=8.9e-25 Score=236.90 Aligned_cols=268 Identities=22% Similarity=0.278 Sum_probs=210.9
Q ss_pred CccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEe
Q 042568 283 NFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYL 362 (983)
Q Consensus 283 ~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 362 (983)
..++++.++++++ .+|..+ ++++++|+|++|+|+...+..|.++++|++|++++|.+....|..|..+++|++|++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l---~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCC---CCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 4566777777777 456544 357888999999888655567888999999999999998777888888999999999
Q ss_pred eCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCC--CCCcccccCCCCCCEEEccCcccc
Q 042568 363 SNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLS--GTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 363 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
++|+++. +|..+ ...++.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|+++
T Consensus 87 ~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 87 SKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp CSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 9999884 44433 357888899999988777777777777888888777544 234556788888999999999887
Q ss_pred CcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccc
Q 042568 441 GIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSV 520 (983)
Q Consensus 441 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 520 (983)
.+|..+ .++++. |++++|.+++..+..|.+++.++.|++++|.+.+..|..+..+++|++|+|++|+|+ .+|..+
T Consensus 164 -~l~~~~--~~~L~~-L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l 238 (305)
T d1xkua_ 164 -TIPQGL--PPSLTE-LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238 (305)
T ss_dssp -SCCSSC--CTTCSE-EECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred -ccCccc--CCccCE-EECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccc
Confidence 445433 467775 889999988888888888899999999999998877888888999999999999998 567788
Q ss_pred cCCCCccEEecCCccccCCcCcc------ccCCCCcceEeccCCcccc
Q 042568 521 GQLPYLKQFDVSSNRLFGEIPQS------FQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 521 ~~l~~L~~L~ls~N~l~~~~p~~------~~~l~~L~~l~l~~N~l~~ 562 (983)
..+++|+.|+|++|+|+..-... +..+++|+.|++++|++..
T Consensus 239 ~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 88999999999999988432233 3456788889999998853
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.5e-25 Score=240.10 Aligned_cols=268 Identities=26% Similarity=0.263 Sum_probs=183.2
Q ss_pred EEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEee-C
Q 042568 286 ELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLS-N 364 (983)
Q Consensus 286 ~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~ 364 (983)
.++.++++++ .+|..+ ++++++|+|++|.|++..+..|.++++|++|++++|++....+..+..+..++.+... .
T Consensus 15 ~v~c~~~~L~-~iP~~i---p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCCC-ccCCCC---CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 4556666666 445433 3567788888888876656677888888888888888877777777777777777654 5
Q ss_pred CcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCC
Q 042568 365 NSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIP 444 (983)
Q Consensus 365 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 444 (983)
|.++...|..|+++++|++|++++|.+....+..+...++|+.+++++|.+++..+..|..+++|+.|++++|++++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 56666667777888888888888888776666677777777777888877776656667777777777777777777667
Q ss_pred ccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCC
Q 042568 445 SDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLP 524 (983)
Q Consensus 445 ~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 524 (983)
..|.++++|+. +++++|++++..|..|.++++|++||+++|++.+..|..|+.+.+|+.|+|++|++....+.. .-..
T Consensus 171 ~~f~~l~~L~~-l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~-~l~~ 248 (284)
T d1ozna_ 171 RAFRGLHSLDR-LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (284)
T ss_dssp TTTTTCTTCCE-EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred hhhccccccch-hhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch-HHHH
Confidence 77777777775 777777777777777777777777777777777666666777777777777777776543311 1122
Q ss_pred CccEEecCCccccCCcCccccCCCCcceEeccCCcccc
Q 042568 525 YLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 525 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
.++.+....+++....|..+.+ ....+++.+.|+|
T Consensus 249 ~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 249 WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred HHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 3455555556666666665543 2333344444443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.8e-25 Score=236.97 Aligned_cols=226 Identities=19% Similarity=0.184 Sum_probs=124.2
Q ss_pred EEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc-Cc
Q 042568 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS-KN 389 (983)
Q Consensus 311 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N 389 (983)
.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....+..+..++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4456666665 4555443 456666666666664444556666666666666666665555555555555555443 34
Q ss_pred cccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCc
Q 042568 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLP 469 (983)
Q Consensus 390 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p 469 (983)
.++...+..|.++++|+.|++++|.+....+..+...++|+.+++++|+++++.+
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~------------------------- 146 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD------------------------- 146 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-------------------------
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccCh-------------------------
Confidence 4444445555555555555555555544444444445555555555555554444
Q ss_pred cccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCC
Q 042568 470 LELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPT 549 (983)
Q Consensus 470 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 549 (983)
..|..+++|+.|+|++|+|++..|..|.++++|+.+++++|++++..|..|..+++|+.|++++|++.+..|..|.++++
T Consensus 147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~ 226 (284)
T d1ozna_ 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence 44444445555555555555444455555555555555555555555555555555555555555555555555555555
Q ss_pred cceEeccCCcccccc
Q 042568 550 LKQLNFSFNKFSGNI 564 (983)
Q Consensus 550 L~~l~l~~N~l~~~~ 564 (983)
|++|++++|++.+..
T Consensus 227 L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 227 LQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCEEECCSSCEECSG
T ss_pred cCEEEecCCCCCCCc
Confidence 555555555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.4e-23 Score=217.57 Aligned_cols=178 Identities=26% Similarity=0.260 Sum_probs=110.8
Q ss_pred CCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccc
Q 042568 380 HLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNL 459 (983)
Q Consensus 380 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l 459 (983)
+|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+| .++.+++|++|+|++|++++ .+..+..+++|+. |++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~-L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTV-LDV 107 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCE-EEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccccccccc-ccccccccccccc-ccc
Confidence 3445555555554444444555555555555555554 222 23455556666666666652 3445555556654 666
Q ss_pred cCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCC
Q 042568 460 SSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGE 539 (983)
Q Consensus 460 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 539 (983)
++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 666666555555666666667777777776555556666777777777777777766677777777888888888777 6
Q ss_pred cCccccCCCCcceEeccCCcccc
Q 042568 540 IPQSFQASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 540 ~p~~~~~l~~L~~l~l~~N~l~~ 562 (983)
+|..+..+++|+.|+|++|++.+
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCC
T ss_pred cChhHCCCCCCCEEEecCCCCCC
Confidence 77777777777777777766543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.4e-22 Score=214.28 Aligned_cols=198 Identities=26% Similarity=0.262 Sum_probs=112.3
Q ss_pred CeeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 308 NLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 308 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
.+.+++.+++.++ .+|+.+. ++|++|+|++|+|++..+..|..+++|++|+|++|.|+.. | .++.+++|+.|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccccccccc
Confidence 3455677777776 4565553 4567777777777655555666666677777777666632 2 24556666666666
Q ss_pred CccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGP 467 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 467 (983)
+|++++ .+..+.++++|+.|++++|.+.+..+..+..+.+++.|++++|.++..
T Consensus 86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l------------------------- 139 (266)
T d1p9ag_ 86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL------------------------- 139 (266)
T ss_dssp SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCC-------------------------
T ss_pred cccccc-cccccccccccccccccccccceeecccccccccccccccccccccee-------------------------
Confidence 666653 344455555555555555555544444444555555555555555544
Q ss_pred CccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCcccc
Q 042568 468 LPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLF 537 (983)
Q Consensus 468 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 537 (983)
.+..+..+++++.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus 140 ~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 4444444455555555555555444445555555555555555555 45555555556666666666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=4.5e-22 Score=198.87 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=105.2
Q ss_pred CCCccccCCcEeEEEEEECCCcEEEEEEeecccCc-----------------chhHHHHHHHHHHHhcCCCCccceeeEE
Q 042568 671 PSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTG-----------------EITGSFKRECQILKRIRHRNLIRIITIC 733 (983)
Q Consensus 671 ~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 733 (983)
+.++||+|+||+||+|...+|+.||||+++..... .......+|.+.+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999888999999987432110 1123455688899999999999988764
Q ss_pred ecCCceeEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecCCCCCeEeCCCCCEEEc
Q 042568 734 SKPDFKALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHSPIKVVHCDLKPSNILLDEDLTALVA 813 (983)
Q Consensus 734 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dikp~NiLl~~~~~~kl~ 813 (983)
. .+++|||++++.+.+ ++...+..++.|+++|++|||+++ |+||||||+|||++++ .++|+
T Consensus 84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 2 379999998765533 223345689999999999999996 9999999999999965 58999
Q ss_pred ccccccccc
Q 042568 814 DFGIAKLVK 822 (983)
Q Consensus 814 Dfgla~~~~ 822 (983)
|||.|....
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999997654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.84 E-value=1.6e-19 Score=199.21 Aligned_cols=219 Identities=29% Similarity=0.423 Sum_probs=110.4
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .++|++|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l-----p~~L~~L 103 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L-----PPLLEYL 103 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C-----CTTCCEE
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h-----ccccccc
Confidence 5667777777776 56643 356777777777777 666543 46677777777766 3331 1 1234444
Q ss_pred ecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccchhhhcCCCCccEEEccccc
Q 042568 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPSEIISKMPQLQFLYLSYND 261 (983)
Q Consensus 182 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 261 (983)
++++|.++ .+| . ++.+++|++|++++|.++ ..+ .....+..+.+..+.
T Consensus 104 ~L~~n~l~-~lp-------------------------~-~~~l~~L~~L~l~~~~~~-~~~----~~~~~l~~l~~~~~~ 151 (353)
T d1jl5a_ 104 GVSNNQLE-KLP-------------------------E-LQNSSFLKIIDVDNNSLK-KLP----DLPPSLEFIAAGNNQ 151 (353)
T ss_dssp ECCSSCCS-SCC-------------------------C-CTTCTTCCEEECCSSCCS-CCC----CCCTTCCEEECCSSC
T ss_pred cccccccc-ccc-------------------------c-hhhhccceeecccccccc-ccc----cccccccchhhcccc
Confidence 44444443 222 1 334444444444444443 111 112334444444433
Q ss_pred cccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcccEEecccc
Q 042568 262 FVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSN 341 (983)
Q Consensus 262 l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 341 (983)
.... ..+..++.++.+++++|..... +.. ....+.+..+++.+. .+ ..+..++.|+.+++++|
T Consensus 152 ~~~~----------~~l~~l~~l~~L~l~~n~~~~~-~~~----~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n 214 (353)
T d1jl5a_ 152 LEEL----------PELQNLPFLTAIYADNNSLKKL-PDL----PLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNN 214 (353)
T ss_dssp CSSC----------CCCTTCTTCCEEECCSSCCSSC-CCC----CTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSS
T ss_pred cccc----------ccccccccceeccccccccccc-ccc----ccccccccccccccc-cc-ccccccccccccccccc
Confidence 2211 1233455556666666655422 111 122344555555443 22 23556677777777777
Q ss_pred ccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCcccc
Q 042568 342 LLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLS 392 (983)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 392 (983)
.... ++. ...++..+.+.+|.+... +. ..+.+...++..|.+.
T Consensus 215 ~~~~-~~~---~~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~ 257 (353)
T d1jl5a_ 215 LLKT-LPD---LPPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFS 257 (353)
T ss_dssp CCSS-CCS---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS
T ss_pred cccc-ccc---cccccccccccccccccc-cc---cccccccccccccccc
Confidence 6652 332 234566666666666532 21 2334555555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=3.7e-19 Score=196.15 Aligned_cols=304 Identities=30% Similarity=0.365 Sum_probs=165.3
Q ss_pred ccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcc
Q 042568 149 HQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLE 228 (983)
Q Consensus 149 ~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 228 (983)
.+|++|||++|.++ .+|.. .++|++|+|++|+|+ .+|. .+.+|+.|++++|+++. ++.. .+.|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~------~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~-l~~l---p~~L~ 101 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL------PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKA-LSDL---PPLLE 101 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC------CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CCSC---CTTCC
T ss_pred cCCCEEEeCCCCCC-CCCCC------CCCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccch-hhhh---ccccc
Confidence 36888888888887 67742 356777777777776 4553 23566666666666652 2211 12455
Q ss_pred eecccccccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccC
Q 042568 229 WLDLESNMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTN 308 (983)
Q Consensus 229 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~ 308 (983)
+|++++|.++ .+|. +..+++|++|+++ +|.+.... .. ...
T Consensus 102 ~L~L~~n~l~-~lp~--~~~l~~L~~L~l~--------------------------------~~~~~~~~-~~----~~~ 141 (353)
T d1jl5a_ 102 YLGVSNNQLE-KLPE--LQNSSFLKIIDVD--------------------------------NNSLKKLP-DL----PPS 141 (353)
T ss_dssp EEECCSSCCS-SCCC--CTTCTTCCEEECC--------------------------------SSCCSCCC-CC----CTT
T ss_pred cccccccccc-cccc--hhhhccceeeccc--------------------------------cccccccc-cc----ccc
Confidence 6666666554 3442 2344444444444 44443221 11 123
Q ss_pred eeEEEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccC
Q 042568 309 LVQIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSK 388 (983)
Q Consensus 309 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 388 (983)
+..+.+..+... .+..+..++.++.|++++|.+... +. .....+.+...++.+. .+| .+..++.|+.+++++
T Consensus 142 l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-~~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~ 213 (353)
T d1jl5a_ 142 LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-PD---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADN 213 (353)
T ss_dssp CCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCS
T ss_pred ccchhhcccccc--ccccccccccceeccccccccccc-cc---cccccccccccccccc-ccc-ccccccccccccccc
Confidence 455555555443 345566777788888888777632 22 1233456666665555 333 356677788888888
Q ss_pred ccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCC
Q 042568 389 NKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPL 468 (983)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 468 (983)
|.... .+.. ..++..+.+.+|.+.. .+. ....+...++..|.+.+. ..+.......++..|.+.+.
T Consensus 214 n~~~~-~~~~---~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~~- 279 (353)
T d1jl5a_ 214 NLLKT-LPDL---PPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRSL- 279 (353)
T ss_dssp SCCSS-CCSC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSEE-
T ss_pred ccccc-cccc---cccccccccccccccc-ccc---cccccccccccccccccc-----ccccchhcccccccCccccc-
Confidence 77653 3332 3345555666666652 222 234566667666665532 11211111245555555421
Q ss_pred ccccccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCc
Q 042568 469 PLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ 542 (983)
Q Consensus 469 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 542 (983)
...+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|.
T Consensus 280 ---~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 280 ---CDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp ---CCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred ---cccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 223456666677766666 45543 345666666666666 34432 345666666666665 4554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.7e-23 Score=236.72 Aligned_cols=61 Identities=23% Similarity=0.168 Sum_probs=40.6
Q ss_pred CCcEEeCcCCcCCCC-CccccCCCCCCCEEeccCccCCC----CchhhhcccccccEEeccCcccc
Q 042568 102 SLIVLDLSKNFFQGH-IPAELGSLIRLKQLSLSWNSLQG----KIPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
.|++||+++|++++. +.+-+..+++|+.|+|++|.|+. .++..+..+++|++|||++|+|+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence 466777777777642 23345566777777777777762 34455667777888888877775
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.9e-21 Score=221.56 Aligned_cols=359 Identities=19% Similarity=0.172 Sum_probs=181.5
Q ss_pred cccccceeecccCcccc----ccchhhhccCCcceecccccccccc----cchhhhcCCCCccEEEccccccccCCCCCC
Q 042568 199 ELRNLRFLLLWSNRLVG----QVPQALANSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTN 270 (983)
Q Consensus 199 ~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 270 (983)
.+++++.|+|++|.++. .++.++..+++|++|||++|+|+.. +...+....++|++|+|++|+++...
T Consensus 25 ~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~---- 100 (460)
T d1z7xw1 25 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG---- 100 (460)
T ss_dssp HHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGG----
T ss_pred hCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccc----
Confidence 34555555555555442 2334445556666666666655411 11111112235666666666554321
Q ss_pred CcccccccCCCCCccEEEccCCcccccCCcccc----ccccCeeEEEccCcccccc----CCCCCCCCCcccEEeccccc
Q 042568 271 LEPFFASLANSSNFQELELAGNNLGGMIPSIIG----DLSTNLVQIHLDCNLIYGK----IPPHISNLVNLTLLNLSSNL 342 (983)
Q Consensus 271 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~----~l~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~ 342 (983)
...++..+..+++|++|++++|.++......+. ........+......+... .-..+.....++.++++++.
T Consensus 101 ~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~ 180 (460)
T d1z7xw1 101 CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 180 (460)
T ss_dssp HHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSB
T ss_pred cccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccc
Confidence 222334455566666666666665532111111 1111222233332222110 00111223456666666655
Q ss_pred cCCCCC----ccc-ccCCCCcEEEeeCCcccCCC----CCCCCCCCCCcEEEccCccccC-----cCcccccCcccchhh
Q 042568 343 LNGTIP----HEL-CLMSKLERVYLSNNSLSGEI----PSAFGDIPHLGLLDLSKNKLSG-----SIPDSFANLSQLRRL 408 (983)
Q Consensus 343 l~~~~p----~~l-~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L 408 (983)
+..... ..+ ........+++..+.+.... ...+...+.++.+++++|++.. ..+..+.....++.+
T Consensus 181 ~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l 260 (460)
T d1z7xw1 181 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 260 (460)
T ss_dssp CHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEE
T ss_pred cccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccc
Confidence 431100 001 11234555666665544211 1112344566777777776532 122333445667777
Q ss_pred cccCccCCCC----CcccccCCCCCCEEEccCccccCcCCccc-----cCCCccceeccccCCCCCCCCcccc----ccc
Q 042568 409 LLYGNHLSGT----IPSSLGKCVNLEILDLSHNKISGIIPSDV-----AGLRSLKLYLNLSSNHLDGPLPLEL----SKM 475 (983)
Q Consensus 409 ~l~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~~L~l~~N~l~~~~p~~~----~~l 475 (983)
++++|.+... ....+...+.++.+++++|.++......+ .....|+. +++++|.++......+ ...
T Consensus 261 ~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~-l~l~~~~l~~~~~~~l~~~~~~~ 339 (460)
T d1z7xw1 261 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES-LWVKSCSFTAACCSHFSSVLAQN 339 (460)
T ss_dssp ECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCE-EECTTSCCBGGGHHHHHHHHHHC
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhcccccccccccc-ccccccchhhhhhhhcccccccc
Confidence 7777766532 12234456777788888877753222111 12345664 7777777765433333 344
Q ss_pred cccccccccccccccC----CCcccc-cccccceEEeCCCccccc----ccccccCCCCccEEecCCccccCCcCccc--
Q 042568 476 DMVLAIDLSFNNLSGS----IPPQLG-SCIALESLNLSGNSLEGL----LPVSVGQLPYLKQFDVSSNRLFGEIPQSF-- 544 (983)
Q Consensus 476 ~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-- 544 (983)
.+|++|||++|+|++. ++..+. ..+.|+.|+|++|+|+.. ++..+..+++|+.|||++|+++......|
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred cchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHH
Confidence 5688888888887642 233332 345688888888888742 34455667888888888888864322222
Q ss_pred --c-CCCCcceEeccCCcccc
Q 042568 545 --Q-ASPTLKQLNFSFNKFSG 562 (983)
Q Consensus 545 --~-~l~~L~~l~l~~N~l~~ 562 (983)
. +...|+.|++.+|.+..
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCH
T ss_pred HHHhCCCccCEEECCCCCCCH
Confidence 2 33468888888888764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=7.7e-19 Score=180.55 Aligned_cols=188 Identities=18% Similarity=0.315 Sum_probs=106.9
Q ss_pred cCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEE
Q 042568 353 LMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEIL 432 (983)
Q Consensus 353 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 432 (983)
.+.+|+.|++.+|.|+.. ..+..+++|+.|++++|++++..| +..+++|+.+++++|.++ .++ .+..+++|+.+
T Consensus 39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l 112 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTL 112 (227)
T ss_dssp HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEE
T ss_pred HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccc
Confidence 344444444444444422 124444455555555555443222 445555555555555544 222 34555666666
Q ss_pred EccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccccCCCcccccccccceEEeCCCcc
Q 042568 433 DLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSL 512 (983)
Q Consensus 433 ~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 512 (983)
++++|...+.. .+.....+.. +.++++.+.... .+..+++|+.|++++|.+.+. ..++++++|+.|+|++|++
T Consensus 113 ~l~~~~~~~~~--~~~~~~~~~~-l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l 185 (227)
T d1h6ua2 113 DLTSTQITDVT--PLAGLSNLQV-LYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKI 185 (227)
T ss_dssp ECTTSCCCCCG--GGTTCTTCCE-EECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--hhccccchhh-hhchhhhhchhh--hhccccccccccccccccccc--hhhcccccceecccCCCcc
Confidence 66666554322 2333444443 556666555322 255666677777777777632 2367777888888888888
Q ss_pred cccccccccCCCCccEEecCCccccCCcCccccCCCCcceEeccC
Q 042568 513 EGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFSF 557 (983)
Q Consensus 513 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~~ 557 (983)
++. + .+..+++|+.|+|++|++++ +|. +.++++|+.|++++
T Consensus 186 ~~l-~-~l~~l~~L~~L~Ls~N~lt~-i~~-l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 186 SDI-S-PLASLPNLIEVHLKNNQISD-VSP-LANTSNLFIVTLTN 226 (227)
T ss_dssp CCC-G-GGGGCTTCCEEECTTSCCCB-CGG-GTTCTTCCEEEEEE
T ss_pred CCC-h-hhcCCCCCCEEECcCCcCCC-Ccc-cccCCCCCEEEeeC
Confidence 753 3 26777888888888888874 442 77888888888763
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=3.6e-18 Score=177.44 Aligned_cols=105 Identities=18% Similarity=0.226 Sum_probs=63.2
Q ss_pred cEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeec
Q 042568 104 IVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDL 183 (983)
Q Consensus 104 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L 183 (983)
+.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~----------------- 70 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE----------------- 70 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEEC-----------------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceee-----------------
Confidence 45666666666 5665542 456677777776663333456666666666666666553333
Q ss_pred ccccccCCCCCcccccccccceeecc-cCccccccchhhhccCCcceecccccccc
Q 042568 184 SNNSLTGEIPLKNECELRNLRFLLLW-SNRLVGQVPQALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 184 s~N~l~~~ip~~~~~~l~~L~~L~L~-~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 238 (983)
...|..++++++|.+. .|++....+..|.++++|++|++++|++.
T Consensus 71 ----------~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 71 ----------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp ----------SSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ----------ccccccccccccccccccccccccccccccccccccccccchhhhc
Confidence 3334456666666654 35565566666677777777777777665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=8.1e-18 Score=174.78 Aligned_cols=220 Identities=17% Similarity=0.170 Sum_probs=122.1
Q ss_pred cEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceeecccCcccccc-chhhhccCCccee
Q 042568 152 EYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV-PQALANSSKLEWL 230 (983)
Q Consensus 152 ~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L 230 (983)
+.++.+++.++ .+|..++ +++++|+|++|.++ .+|...|.++++|++|++++|.+...+ +.+|.+++++++|
T Consensus 11 ~~i~c~~~~l~-~iP~~l~-----~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP-----RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC-----SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CEEEEeCCCCC-CcCCCCC-----CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 56777777776 6676553 45666677766665 455555666666666666666665433 3455666666666
Q ss_pred cccc-cccccccchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCe
Q 042568 231 DLES-NMFSGELPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNL 309 (983)
Q Consensus 231 ~Ls~-N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L 309 (983)
++.. |++. .++...+..+++|++|++++|.+..... +..+..+. .+
T Consensus 84 ~~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~-------~~~~~~l~-------------------------~l 130 (242)
T d1xwdc1 84 RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPD-------VHKIHSLQ-------------------------KV 130 (242)
T ss_dssp EEECCTTCC-EECTTSEECCTTCCEEEEESCCCCSCCC-------CTTTCBSS-------------------------CE
T ss_pred ccccccccc-ccccccccccccccccccchhhhccccc-------cccccccc-------------------------cc
Confidence 6543 4444 4444555556666666666555433211 01112223 34
Q ss_pred eEEEccCccccccCCCCCCCCC-cccEEeccccccCCCCCcccccCCCCcEE-EeeCCcccCCCCCCCCCCCCCcEEEcc
Q 042568 310 VQIHLDCNLIYGKIPPHISNLV-NLTLLNLSSNLLNGTIPHELCLMSKLERV-YLSNNSLSGEIPSAFGDIPHLGLLDLS 387 (983)
Q Consensus 310 ~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls 387 (983)
..+..+++.+....+..+..++ .++.|++++|+++...+ ......+++.+ ++++|+++...+..|.++++|++|+|+
T Consensus 131 ~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~-~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls 209 (242)
T d1xwdc1 131 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN-CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 209 (242)
T ss_dssp EEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECT-TTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECT
T ss_pred ccccccccccccccccccccccccceeeeccccccccccc-ccccchhhhccccccccccccccHHHhcCCCCCCEEECC
Confidence 4444444444433344444432 45566666666653322 22333444333 355566665445567777777777777
Q ss_pred CccccCcCcccccCcccchhhcccC
Q 042568 388 KNKLSGSIPDSFANLSQLRRLLLYG 412 (983)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~l~~ 412 (983)
+|+|+...+..|.++++|+.+++.+
T Consensus 210 ~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 210 RTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TSCCCCCCSSSCTTCCEEESSSEES
T ss_pred CCcCCccCHHHHcCCcccccCcCCC
Confidence 7777755555677777777766643
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=6.4e-18 Score=173.53 Aligned_cols=203 Identities=21% Similarity=0.336 Sum_probs=127.1
Q ss_pred EEccCccccccCCCCCCCCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccc
Q 042568 312 IHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKL 391 (983)
Q Consensus 312 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 391 (983)
++++.+.+++.+ .+..+.+|++|++++|.++. + ..+..+++|++|++++|.+.+..| +..+++|+.+++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 344444444322 23445556666666666653 2 235566666666666666654332 56666666666666666
Q ss_pred cCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccc
Q 042568 392 SGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLE 471 (983)
Q Consensus 392 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~ 471 (983)
+. + ..+..+++|+.+.+++|...+. ..+...+.++.+.++.+.+.... .+...++|+. |++++|.+++.. .
T Consensus 98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~-L~l~~n~~~~~~--~ 168 (227)
T d1h6ua2 98 KN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQY-LSIGNAQVSDLT--P 168 (227)
T ss_dssp SC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCE-EECCSSCCCCCG--G
T ss_pred cc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhcccccccc-ccccccccccch--h
Confidence 52 2 2355666666666666665532 23455666777777777665332 3555666664 777777776432 3
Q ss_pred cccccccccccccccccccCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCC
Q 042568 472 LSKMDMVLAIDLSFNNLSGSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSS 533 (983)
Q Consensus 472 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 533 (983)
++++++|+.|||++|++++ +|+ +..+++|+.|+|++|++++..| +.++++|+.|++++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 6777888888888888874 443 7788889999999998886443 77888899988863
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=8.5e-18 Score=167.48 Aligned_cols=128 Identities=28% Similarity=0.373 Sum_probs=84.4
Q ss_pred EEEccCccccccCCCCCCCCCcccEEeccccccCCCC-CcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCc
Q 042568 311 QIHLDCNLIYGKIPPHISNLVNLTLLNLSSNLLNGTI-PHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKN 389 (983)
Q Consensus 311 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 389 (983)
.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|+|++|.+....+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555555555 4454442 45666666666665433 445566777777777777777666677777777777777777
Q ss_pred cccCcCcccccCcccchhhcccCccCCCCCcccccCCCCCCEEEccCccccC
Q 042568 390 KLSGSIPDSFANLSQLRRLLLYGNHLSGTIPSSLGKCVNLEILDLSHNKISG 441 (983)
Q Consensus 390 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 441 (983)
+|+...|.+|.++++|+.|+|++|+|++..|+.|..+++|++|+|++|.+..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 7776666667777777777777777776666667777777777777777764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=1.2e-17 Score=166.37 Aligned_cols=130 Identities=29% Similarity=0.425 Sum_probs=90.0
Q ss_pred ccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCC-CCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGE-IPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 333 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
.+.++.++++++ .+|..+. +++++|+|++|.|++. .+..|.++++|+.|+|++|++.+..+..|..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 456788888887 5665542 5677777777777653 34556777777777777777777777777777777777777
Q ss_pred CccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCC
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDG 466 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 466 (983)
+|+|+...|..|.++++|++|+|++|+|++..|..|..+++|+. ++|++|.+..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~-l~L~~N~~~~ 140 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-LNLASNPFNC 140 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE-EECTTCCBCC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccc-cccccccccc
Confidence 77777666666777777777777777777666666666666664 6666666653
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=3.7e-17 Score=165.31 Aligned_cols=56 Identities=20% Similarity=0.385 Sum_probs=27.6
Q ss_pred ccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceEecc
Q 042568 497 GSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQLNFS 556 (983)
Q Consensus 497 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l~l~ 556 (983)
..+++|+.+++++|++++..+ +.++++|+.|+|++|+++ .+| .|.++++|++|+|+
T Consensus 153 ~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred ccccccccccccccccccccc--ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence 334445555555555543221 445555555555555554 333 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=5.8e-17 Score=163.79 Aligned_cols=164 Identities=26% Similarity=0.378 Sum_probs=83.4
Q ss_pred CCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhc
Q 042568 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 330 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+.+|++|++++|.++.. + .+..+++|++|+|++|.|++.. .++.+++|+.|++++|++++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 44555555555555532 1 2445555555555555555422 24455555555555555553 22 344555555555
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
+++|.+. .+ ..+..++.++.+++++|.+++ +..+..+++|+.+++++|+++
T Consensus 119 l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~---------------------------~~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 119 LEHNGIS-DI-NGLVHLPQLESLYLGNNKITD---------------------------ITVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp CTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC---------------------------CGGGGGCTTCSEEECCSSCCC
T ss_pred ccccccc-cc-ccccccccccccccccccccc---------------------------ccccccccccccccccccccc
Confidence 5555543 12 234445555555555555442 112334444555555555555
Q ss_pred cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecC
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVS 532 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 532 (983)
+ +++ +.++++|+.|+|++|+++. +| .+..+++|+.|+|+
T Consensus 170 ~-i~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 170 D-IVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp C-CGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred c-ccc-ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 3 222 5556666666666666653 33 35666666666664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=1e-16 Score=160.48 Aligned_cols=183 Identities=23% Similarity=0.358 Sum_probs=112.2
Q ss_pred CCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhc
Q 042568 330 LVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLL 409 (983)
Q Consensus 330 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 409 (983)
+.++..+.++.+.+++.++ ...+.++++|++++|.+... +.+..+++|++|+|++|++++..| ++++++|+.|+
T Consensus 17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 90 (199)
T d2omxa2 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 90 (199)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence 3444556677777775443 34567888888888888743 246677777777777777775433 66777777777
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCccccccccccccccccccccc
Q 042568 410 LYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNLS 489 (983)
Q Consensus 410 l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 489 (983)
+++|.+. .++ .+..++.|+.|++++|.+... ..+. .+++|+.|++++|++.
T Consensus 91 l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~-------------------------~l~~L~~L~l~~n~l~ 141 (199)
T d2omxa2 91 MNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLK-------------------------NLTNLNRLELSSNTIS 141 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGT-------------------------TCTTCSEEECCSSCCC
T ss_pred ccccccc-ccc-ccccccccccccccccccccc--cccc-------------------------hhhhhHHhhhhhhhhc
Confidence 7777665 333 366666666666666666532 1233 3444555555555554
Q ss_pred cCCCcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCccccCCCCcceE
Q 042568 490 GSIPPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQSFQASPTLKQL 553 (983)
Q Consensus 490 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~l 553 (983)
.+| .+..+++|+.|++++|++++.. .++++++|+.|++++|++++ +| .+..+++|+.|
T Consensus 142 -~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 142 -DIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp -CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred -ccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 222 3556666666666666666432 25666777777777777663 43 35666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=2.1e-16 Score=158.25 Aligned_cols=148 Identities=29% Similarity=0.435 Sum_probs=89.4
Q ss_pred CCCcccEEeccccccCCCCCcccccCCCCcEEEeeCCcccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhh
Q 042568 329 NLVNLTLLNLSSNLLNGTIPHELCLMSKLERVYLSNNSLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRL 408 (983)
Q Consensus 329 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 408 (983)
.+.++++|++++|.++. + +.+..+++|++|++++|++++..| ++++++|+.|++++|.+... + .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-ccccccccccc
Confidence 45566666666666663 2 235666777777777777765433 66777777777777776532 2 36677777777
Q ss_pred cccCccCCCCCcccccCCCCCCEEEccCccccCcCCccccCCCccceeccccCCCCCCCCcccccccccccccccccccc
Q 042568 409 LLYGNHLSGTIPSSLGKCVNLEILDLSHNKISGIIPSDVAGLRSLKLYLNLSSNHLDGPLPLELSKMDMVLAIDLSFNNL 488 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 488 (983)
++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++++. |++++|++++.. .++++++|+.|++++|++
T Consensus 112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~-L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQ-LNFSSNQVTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSE-EECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred cccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccc-cccccccccCCc--cccCCCCCCEEECCCCCC
Confidence 7777776632 346677778888888777763 22 3555566654 666666555321 244444444444444444
Q ss_pred c
Q 042568 489 S 489 (983)
Q Consensus 489 ~ 489 (983)
+
T Consensus 185 ~ 185 (199)
T d2omxa2 185 S 185 (199)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=2e-16 Score=167.76 Aligned_cols=216 Identities=23% Similarity=0.259 Sum_probs=113.6
Q ss_pred cccceeecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceeccccc-ccccccchhhhcCCCCccE
Q 042568 176 TSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESN-MFSGELPSEIISKMPQLQF 254 (983)
Q Consensus 176 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~~l~~L~~ 254 (983)
.+|++||+++|.++.......+..+++|++|+|+++.+++..+..++.+++|++|+|+++ .++..--..+...+++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 344555555444443222233456777888888888777777777888888888888874 5542211233456777777
Q ss_pred EEccccccccCCCCCCCcccccccCC-CCCccEEEccCCc--ccccCCccccccccCeeEEEccCccccccCCCCCCCCC
Q 042568 255 LYLSYNDFVSHDGNTNLEPFFASLAN-SSNFQELELAGNN--LGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLV 331 (983)
Q Consensus 255 L~Ls~N~l~~~~~~~~~~~~~~~l~~-l~~L~~L~L~~n~--l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~ 331 (983)
|+++++..... ..+...+.. .++|+.|+++++. ++... +...+.+++
T Consensus 126 L~ls~c~~~~~------~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~------------------------l~~l~~~~~ 175 (284)
T d2astb2 126 LNLSWCFDFTE------KHVQVAVAHVSETITQLNLSGYRKNLQKSD------------------------LSTLVRRCP 175 (284)
T ss_dssp EECCCCTTCCH------HHHHHHHHHSCTTCCEEECCSCGGGSCHHH------------------------HHHHHHHCT
T ss_pred ccccccccccc------ccchhhhcccccccchhhhccccccccccc------------------------ccccccccc
Confidence 77777532110 011111111 2456666665431 22110 111122345
Q ss_pred cccEEecccc-ccCCCCCcccccCCCCcEEEeeCC-cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCc-ccchhh
Q 042568 332 NLTLLNLSSN-LLNGTIPHELCLMSKLERVYLSNN-SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANL-SQLRRL 408 (983)
Q Consensus 332 ~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L 408 (983)
+|++|++++| .+++..+..+..+++|++|+|++| .+++.....++++++|+.|+++++ ++. ..+..+ ..+..|
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L 251 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHL 251 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTS
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccc
Confidence 5666666654 345445555666666666666663 455444445666677777777665 221 111111 234445
Q ss_pred cccCccCCCCCcccccC
Q 042568 409 LLYGNHLSGTIPSSLGK 425 (983)
Q Consensus 409 ~l~~N~l~~~~p~~l~~ 425 (983)
.+..+++++..++.+++
T Consensus 252 ~i~~~~ls~~~~~~~~~ 268 (284)
T d2astb2 252 QINCSHFTTIARPTIGN 268 (284)
T ss_dssp EESCCCSCCTTCSSCSS
T ss_pred cccCccCCCCCCCccCc
Confidence 56666676555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=6.4e-15 Score=141.22 Aligned_cols=128 Identities=25% Similarity=0.237 Sum_probs=71.1
Q ss_pred cccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCc
Q 042568 97 LANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSST 176 (983)
Q Consensus 97 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~ 176 (983)
+.+...|++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .|+.+++|++|++++|+++ .+|.
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~--------- 80 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGE--------- 80 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECS---------
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCc---------
Confidence 445555666666666665 34544455566666666666665 332 3555666666666666655 3333
Q ss_pred ccceeecccccccCCCCCcccccccccceeecccCcccccc-chhhhccCCcceecccccccccccch---hhhcCCCCc
Q 042568 177 SLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV-PQALANSSKLEWLDLESNMFSGELPS---EIISKMPQL 252 (983)
Q Consensus 177 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~~---~~~~~l~~L 252 (983)
..+..+++|++|++++|+|+... ...+..+++|++|++++|.++ ..|. ..+..+++|
T Consensus 81 ------------------~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L 141 (162)
T d1a9na_ 81 ------------------GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 141 (162)
T ss_dssp ------------------CHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred ------------------cccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCc
Confidence 23334555556666666555321 134566666666666666665 3332 345666777
Q ss_pred cEEE
Q 042568 253 QFLY 256 (983)
Q Consensus 253 ~~L~ 256 (983)
++||
T Consensus 142 ~~LD 145 (162)
T d1a9na_ 142 RVLD 145 (162)
T ss_dssp SEET
T ss_pred CeeC
Confidence 7665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.7e-15 Score=157.92 Aligned_cols=126 Identities=19% Similarity=0.207 Sum_probs=70.0
Q ss_pred EEEcccCCcccccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCC-chhhhcccccccEEeccCc
Q 042568 81 ELDLSARSIYGTISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGK-IPSQLGSLHQLEYLDLGNN 159 (983)
Q Consensus 81 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~-~p~~~~~L~~L~~L~Ls~N 159 (983)
.+||+++.+.......+.. ..+..+.++...+...+ .......+|++|||++|.++.. ++..+.++++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5677777665433332222 23456666665555322 2334556788888888887643 4455677888888888888
Q ss_pred ccccccCCcccccCCCcccceeecccc-cccCCCCCcccccccccceeecccC
Q 042568 160 KLVGEIPIPIFCSNSSTSLQYIDLSNN-SLTGEIPLKNECELRNLRFLLLWSN 211 (983)
Q Consensus 160 ~l~~~~p~~~~~~~~l~~L~~L~Ls~N-~l~~~ip~~~~~~l~~L~~L~L~~N 211 (983)
.+++..+..+. .+++|++|++++| .+++..-......+++|++|+++++
T Consensus 82 ~l~~~~~~~l~---~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 82 RLSDPIVNTLA---KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp BCCHHHHHHHT---TCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCcHHHHHHh---cCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 77655444443 4566666666664 3331100011123455555555553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.51 E-value=2.7e-14 Score=129.94 Aligned_cols=119 Identities=28% Similarity=0.410 Sum_probs=69.2
Q ss_pred cEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeec
Q 042568 104 IVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDL 183 (983)
Q Consensus 104 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~L 183 (983)
|+|||++|+++ .+| .++.+++|++|+|++|+|+ .+|..|+.+++|++|++++|+|+ .+|. +
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~-------------- 61 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-V-------------- 61 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-G--------------
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc-c--------------
Confidence 46777777776 444 3677777777777777776 56666777777777777777776 3331 2
Q ss_pred ccccccCCCCCcccccccccceeecccCcccccc-chhhhccCCcceeccccccccc--ccchhhhcCCCCccEE
Q 042568 184 SNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQV-PQALANSSKLEWLDLESNMFSG--ELPSEIISKMPQLQFL 255 (983)
Q Consensus 184 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~~l~~L~~L 255 (983)
..+++|++|++++|+|+... ...+..+++|++|++++|++++ .++..+...+|+|+.|
T Consensus 62 --------------~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 62 --------------ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp --------------TTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred --------------ccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 23444444444444444322 2345555566666666666542 1234444556666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.3e-14 Score=138.97 Aligned_cols=133 Identities=19% Similarity=0.232 Sum_probs=101.1
Q ss_pred ccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCccccc
Q 042568 120 ELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECE 199 (983)
Q Consensus 120 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~ 199 (983)
.+.+..+|++|+|++|+|+ .+|..+..+++|++|||++|+|+ .++ .+..
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-----------------------------~~~~ 61 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-----------------------------GFPL 61 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-----------------------------CCCC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-----------------------------Cccc
Confidence 3556777888888888887 56666677778888888888776 332 1336
Q ss_pred ccccceeecccCccccccchhhhccCCcceecccccccccccch-hhhcCCCCccEEEccccccccCCCCCCCccccccc
Q 042568 200 LRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS-EIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASL 278 (983)
Q Consensus 200 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l 278 (983)
+++|++|++++|+++...+..+..+++|++|++++|+++ .++. ..+..+++|++|++++|.+...+.. -...+
T Consensus 62 l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~-----r~~~i 135 (162)
T d1a9na_ 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHY-----RLYVI 135 (162)
T ss_dssp CSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTH-----HHHHH
T ss_pred CcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchhhcCCCccccccch-----HHHHH
Confidence 788999999999998777777889999999999999998 5554 5678999999999999998764320 01235
Q ss_pred CCCCCccEEEc
Q 042568 279 ANSSNFQELEL 289 (983)
Q Consensus 279 ~~l~~L~~L~L 289 (983)
..+++|++||-
T Consensus 136 ~~lp~L~~LD~ 146 (162)
T d1a9na_ 136 YKVPQVRVLDF 146 (162)
T ss_dssp HHCTTCSEETT
T ss_pred HHCCCcCeeCC
Confidence 66889999873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.2e-14 Score=128.62 Aligned_cols=106 Identities=27% Similarity=0.355 Sum_probs=82.9
Q ss_pred CEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcccccccccceee
Q 042568 128 KQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLL 207 (983)
Q Consensus 128 ~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~ 207 (983)
|.|+|++|+|+ .++ .++.+++|++||+++|+|+ .+|..+ ..+++|+.|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~----------------------------~~l~~L~~L~ 49 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPAL----------------------------AALRCLEVLQ 49 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGG----------------------------GGCTTCCEEE
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhh----------------------------hhhhcccccc
Confidence 56788888887 554 3777888888888888876 455433 3677888888
Q ss_pred cccCccccccchhhhccCCcceecccccccccccc-hhhhcCCCCccEEEccccccccCCC
Q 042568 208 LWSNRLVGQVPQALANSSKLEWLDLESNMFSGELP-SEIISKMPQLQFLYLSYNDFVSHDG 267 (983)
Q Consensus 208 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~ 267 (983)
+++|+|++. | .++++++|++|++++|+++ .++ ...+..+++|++|++++|++...++
T Consensus 50 l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~ 107 (124)
T d1dcea3 50 ASDNALENV-D-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107 (124)
T ss_dssp CCSSCCCCC-G-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ccccccccc-C-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEECCCCcCCcCcc
Confidence 888888753 4 4899999999999999998 454 3567899999999999999987554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.45 E-value=2e-15 Score=165.31 Aligned_cols=251 Identities=21% Similarity=0.161 Sum_probs=137.2
Q ss_pred cccccccCCCCcEEeCcCCcCCCC----CccccCCCCCCCEEeccCccCCCC----------chhhhcccccccEEeccC
Q 042568 93 ISPALANLSSLIVLDLSKNFFQGH----IPAELGSLIRLKQLSLSWNSLQGK----------IPSQLGSLHQLEYLDLGN 158 (983)
Q Consensus 93 ~~~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----------~p~~~~~L~~L~~L~Ls~ 158 (983)
+..++.+.+.|++|+|++|.+... +...+...++|+.|+++++.+... +...+...++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 445567777788888888777542 334466677888888877654421 223345567788888888
Q ss_pred cccccccCCccc-ccCCCcccceeecccccccCCCCC------------cccccccccceeecccCccccc----cchhh
Q 042568 159 NKLVGEIPIPIF-CSNSSTSLQYIDLSNNSLTGEIPL------------KNECELRNLRFLLLWSNRLVGQ----VPQAL 221 (983)
Q Consensus 159 N~l~~~~p~~~~-~~~~l~~L~~L~Ls~N~l~~~ip~------------~~~~~l~~L~~L~L~~N~l~~~----~p~~l 221 (983)
|.+.......+. .+...++|++|++++|.+...-.. ......+.|+.|.+++|++... +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 777532111111 112456677777777765421000 0011345677777777776532 33345
Q ss_pred hccCCcceecccccccccc----cchhhhcCCCCccEEEccccccccCCCCCCCcccccccCCCCCccEEEccCCccccc
Q 042568 222 ANSSKLEWLDLESNMFSGE----LPSEIISKMPQLQFLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGM 297 (983)
Q Consensus 222 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~ 297 (983)
...+.|++|+|++|+++.. +....+..+++|+.|+|++|.+... ....+...+..+++|++|+|++|.+++.
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~----g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL----GSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHH----HHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccc----ccccccccccccccchhhhhhcCccCch
Confidence 5667777777777776521 1123345666777777777765331 1223334455666666667666666543
Q ss_pred CCccccccccCeeEEEccCccccccCCCCCC--CCCcccEEeccccccCCC----CCcccc-cCCCCcEEEeeCCccc
Q 042568 298 IPSIIGDLSTNLVQIHLDCNLIYGKIPPHIS--NLVNLTLLNLSSNLLNGT----IPHELC-LMSKLERVYLSNNSLS 368 (983)
Q Consensus 298 ~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~----~p~~l~-~l~~L~~L~L~~N~l~ 368 (983)
-...+.. .+. ..+.|++|++++|+++.. +...+. +.++|++|+|++|.+.
T Consensus 259 g~~~l~~---------------------~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 259 GAAAVVD---------------------AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHH---------------------HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred hhHHHHH---------------------HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 2222211 111 124466666666665532 122222 4566777777777765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.43 E-value=4.2e-15 Score=162.66 Aligned_cols=255 Identities=18% Similarity=0.178 Sum_probs=118.1
Q ss_pred CccccCCCCCCCEEeccCccCCCC----chhhhcccccccEEeccCccccc---ccCCcccccCCCcccceeeccccccc
Q 042568 117 IPAELGSLIRLKQLSLSWNSLQGK----IPSQLGSLHQLEYLDLGNNKLVG---EIPIPIFCSNSSTSLQYIDLSNNSLT 189 (983)
Q Consensus 117 ~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~L~~L~~L~Ls~N~l~~---~~p~~~~~~~~l~~L~~L~Ls~N~l~ 189 (983)
+...+.....|+.|+|++|.|... +...+...++|+.|+++++.... ..|..+..+
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l----------------- 85 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL----------------- 85 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHH-----------------
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHH-----------------
Confidence 445566677788888888877632 33445566778888887765431 111111000
Q ss_pred CCCCCcccccccccceeecccCccccc----cchhhhccCCcceecccccccccccch------------hhhcCCCCcc
Q 042568 190 GEIPLKNECELRNLRFLLLWSNRLVGQ----VPQALANSSKLEWLDLESNMFSGELPS------------EIISKMPQLQ 253 (983)
Q Consensus 190 ~~ip~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~------------~~~~~l~~L~ 253 (983)
...+...++|++|+|++|.+... +...+...++|++|++++|.+...-.. ......+.|+
T Consensus 86 ----~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~ 161 (344)
T d2ca6a1 86 ----LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR 161 (344)
T ss_dssp ----HHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred ----HHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccc
Confidence 01112344555555555555432 223344455666666666655311000 0112345566
Q ss_pred EEEccccccccCCCCCCCcccccccCCCCCccEEEccCCcccccCCccccccccCeeEEEccCccccccCCCCCCCCCcc
Q 042568 254 FLYLSYNDFVSHDGNTNLEPFFASLANSSNFQELELAGNNLGGMIPSIIGDLSTNLVQIHLDCNLIYGKIPPHISNLVNL 333 (983)
Q Consensus 254 ~L~Ls~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~~L~~L~L~~N~l~~~~p~~l~~l~~L 333 (983)
.|++++|.+... ....+...+...+.|++|+|++|+++..-.. ..+...+..+++|
T Consensus 162 ~l~l~~n~i~~~----~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~--------------------~~l~~~l~~~~~L 217 (344)
T d2ca6a1 162 SIICGRNRLENG----SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE--------------------HLLLEGLAYCQEL 217 (344)
T ss_dssp EEECCSSCCTGG----GHHHHHHHHHHCTTCCEEECCSSCCCHHHHH--------------------HHHHTTGGGCTTC
T ss_pred eeeccccccccc----ccccccchhhhhhhhcccccccccccccccc--------------------cchhhhhcchhhh
Confidence 666666655321 1222333344455566666666655421000 0012233344445
Q ss_pred cEEeccccccCCC----CCcccccCCCCcEEEeeCCcccCCCCCC----CC--CCCCCcEEEccCccccCcC----cccc
Q 042568 334 TLLNLSSNLLNGT----IPHELCLMSKLERVYLSNNSLSGEIPSA----FG--DIPHLGLLDLSKNKLSGSI----PDSF 399 (983)
Q Consensus 334 ~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~~----~~~~ 399 (983)
+.|+|++|.++.. +...+..+++|++|+|++|.|++..... +. ..+.|+.|+|++|+|+... ...+
T Consensus 218 ~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l 297 (344)
T d2ca6a1 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297 (344)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHH
Confidence 5555555544321 1223344455555555555544321111 11 1244666666666654321 1122
Q ss_pred c-CcccchhhcccCccCC
Q 042568 400 A-NLSQLRRLLLYGNHLS 416 (983)
Q Consensus 400 ~-~l~~L~~L~l~~N~l~ 416 (983)
. ++++|++|+|++|++.
T Consensus 298 ~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 298 DEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHCTTCCEEECTTSBSC
T ss_pred HccCCCCCEEECCCCcCC
Confidence 1 3455666666666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=1.9e-14 Score=142.90 Aligned_cols=113 Identities=30% Similarity=0.339 Sum_probs=59.0
Q ss_pred CccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCcccceeecccccccCCCCCcc
Q 042568 117 IPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLTGEIPLKN 196 (983)
Q Consensus 117 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~ 196 (983)
+|..++.+++|++|+|++|+|+ .++ .|+.+++|++|+|++|+++ .+|.... .+++|++|++++|+++. ++ .
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~---~~~~L~~L~l~~N~i~~-l~--~ 110 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDA---VADTLEELWISYNQIAS-LS--G 110 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHH---HHHHCCEEECSEEECCC-HH--H
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccc---ccccccccccccccccc-cc--c
Confidence 3444555555555555555555 333 3555555555555555554 3332111 22344444444444442 11 2
Q ss_pred cccccccceeecccCccccccc-hhhhccCCcceecccccccc
Q 042568 197 ECELRNLRFLLLWSNRLVGQVP-QALANSSKLEWLDLESNMFS 238 (983)
Q Consensus 197 ~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 238 (983)
+..+++|++|++++|+|+.... ..+..+++|++|+|++|++.
T Consensus 111 ~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 3456666666666666654321 35666777777777777665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=2.7e-14 Score=141.82 Aligned_cols=119 Identities=27% Similarity=0.292 Sum_probs=99.5
Q ss_pred ccccccccCCCCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccc
Q 042568 92 TISPALANLSSLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFC 171 (983)
Q Consensus 92 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~ 171 (983)
.++.++..|++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++ .++. +
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~-~-- 111 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-I-- 111 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHH-H--
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cccc-c--
Confidence 45678999999999999999998 555 5899999999999999998 77877777889999999999998 4432 2
Q ss_pred cCCCcccceeecccccccCCCCCcccccccccceeecccCccccccc
Q 042568 172 SNSSTSLQYIDLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVP 218 (983)
Q Consensus 172 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p 218 (983)
..+++|++|++++|+++.......+..+++|++|+|++|.+....+
T Consensus 112 -~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 112 -EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp -HHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred -cccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 4789999999999999853333567789999999999999875433
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=2.8e-12 Score=121.58 Aligned_cols=110 Identities=23% Similarity=0.235 Sum_probs=85.0
Q ss_pred CCcceeeEEECCCCCeEEEEEcccCCcccccccccccCCCCcEEeCcCC-cCCCCCccccCCCCCCCEEeccCccCCCCc
Q 042568 63 HVCNWSGVKCNNSRNKVVELDLSARSIYGTISPALANLSSLIVLDLSKN-FFQGHIPAELGSLIRLKQLSLSWNSLQGKI 141 (983)
Q Consensus 63 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~n-~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~ 141 (983)
.|+.+.+|+|... ++. .+|..+..+++|++|++++| .++..-+..|.++++|+.|+|++|+|+...
T Consensus 6 ~c~~~~~l~c~~~------------~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~ 72 (156)
T d2ifga3 6 CPHGSSGLRCTRD------------GAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72 (156)
T ss_dssp CCSSSSCEECCSS------------CCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEEC
T ss_pred CcCCCCeEEecCC------------CCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcc
Confidence 3445777888642 232 45667888899999999766 588555667999999999999999999777
Q ss_pred hhhhcccccccEEeccCcccccccCCcccccCCCcccceeeccccccc
Q 042568 142 PSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYIDLSNNSLT 189 (983)
Q Consensus 142 p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L~Ls~N~l~ 189 (983)
|.+|..+++|++|+|++|+|+ .+|...+ ...+|+.|+|++|.+.
T Consensus 73 ~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~---~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTV---QGLSLQELVLSGNPLH 116 (156)
T ss_dssp TTGGGSCSCCCEEECCSSCCS-CCCSTTT---CSCCCCEEECCSSCCC
T ss_pred cccccccccccceeccCCCCc-ccChhhh---ccccccccccCCCccc
Confidence 888999999999999999998 7777665 2335777777777654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=9.3e-12 Score=117.91 Aligned_cols=106 Identities=24% Similarity=0.191 Sum_probs=67.5
Q ss_pred ccEEeccccccCCCCCcccccCCCCcEEEeeCC-cccCCCCCCCCCCCCCcEEEccCccccCcCcccccCcccchhhccc
Q 042568 333 LTLLNLSSNLLNGTIPHELCLMSKLERVYLSNN-SLSGEIPSAFGDIPHLGLLDLSKNKLSGSIPDSFANLSQLRRLLLY 411 (983)
Q Consensus 333 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 411 (983)
.+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344556665555 34555566666666666544 3665555667777777777777777776666667777777777777
Q ss_pred CccCCCCCcccccCCCCCCEEEccCcccc
Q 042568 412 GNHLSGTIPSSLGKCVNLEILDLSHNKIS 440 (983)
Q Consensus 412 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 440 (983)
+|+|+ .+|.......+|+.|+|++|.+.
T Consensus 89 ~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 89 FNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCCc-ccChhhhccccccccccCCCccc
Confidence 77776 33333333346778888888775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=5e-09 Score=99.42 Aligned_cols=124 Identities=23% Similarity=0.123 Sum_probs=64.6
Q ss_pred CCcEEeCcCCcCCCCCccccCCCCCCCEEeccCccCCCCchhhhcccccccEEeccCcccccccCCcccccCCCccccee
Q 042568 102 SLIVLDLSKNFFQGHIPAELGSLIRLKQLSLSWNSLQGKIPSQLGSLHQLEYLDLGNNKLVGEIPIPIFCSNSSTSLQYI 181 (983)
Q Consensus 102 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~L~~L 181 (983)
+.+.||++++... +.+..+..+..|+..++.+. .++..+..+++|++|+|++|+|+. ++.-..
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~-l~~~~~----------- 85 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYR-LDDMSS----------- 85 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCC-CSGGGT-----------
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccC-CchhHH-----------
Confidence 3455666654432 23444555555666555554 555555677778888888887762 221111
Q ss_pred ecccccccCCCCCcccccccccceeecccCccccccchhhhccCCcceecccccccccccch------hhhcCCCCccEE
Q 042568 182 DLSNNSLTGEIPLKNECELRNLRFLLLWSNRLVGQVPQALANSSKLEWLDLESNMFSGELPS------EIISKMPQLQFL 255 (983)
Q Consensus 182 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~------~~~~~l~~L~~L 255 (983)
.+..+++|+.|+|++|+|+...+-.+....+|+.|++++|.++..... .++..+|+|+.|
T Consensus 86 --------------~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~L 151 (162)
T d1koha1 86 --------------IVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151 (162)
T ss_dssp --------------HHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEE
T ss_pred --------------HHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEE
Confidence 122344555555555555533332333334566666666666532221 235566777766
Q ss_pred E
Q 042568 256 Y 256 (983)
Q Consensus 256 ~ 256 (983)
|
T Consensus 152 D 152 (162)
T d1koha1 152 D 152 (162)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=1.3e-08 Score=96.58 Aligned_cols=86 Identities=22% Similarity=0.190 Sum_probs=52.6
Q ss_pred ccccccccccccccccccccccCC--CcccccccccceEEeCCCcccccccccccCCCCccEEecCCccccCCcCc----
Q 042568 469 PLELSKMDMVLAIDLSFNNLSGSI--PPQLGSCIALESLNLSGNSLEGLLPVSVGQLPYLKQFDVSSNRLFGEIPQ---- 542 (983)
Q Consensus 469 p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---- 542 (983)
+..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+++...+-.+....+|+.|++++|++.+....
T Consensus 58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y 137 (162)
T d1koha1 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137 (162)
T ss_dssp HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence 334455667777777777776421 23455677777777777777754333333445677777777777654432
Q ss_pred ---cccCCCCcceEe
Q 042568 543 ---SFQASPTLKQLN 554 (983)
Q Consensus 543 ---~~~~l~~L~~l~ 554 (983)
.+..+|+|+.||
T Consensus 138 ~~~i~~~~P~L~~LD 152 (162)
T d1koha1 138 ISAIRERFPKLLRLD 152 (162)
T ss_dssp HHHHHTTSTTCCEET
T ss_pred HHHHHHHCCCCCEEC
Confidence 255677777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.23 E-value=2.7e-06 Score=87.29 Aligned_cols=148 Identities=18% Similarity=0.166 Sum_probs=101.1
Q ss_pred HHHHHhCCCCCCCccccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcC-CCCccceeeEEecCCce
Q 042568 661 QLIEATGGFCPSSLIGSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIR-HRNLIRIITICSKPDFK 739 (983)
Q Consensus 661 ~l~~~~~~f~~~~~iG~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 739 (983)
++...-+.|+..+..+.++.+.||+... +++.++||+....... ....+.+|...++.+. +--+.+++++...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 3444445666555544455578999875 4667888887544322 3456788999988874 33356788888888889
Q ss_pred eEEEecccCcccccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhccC-------------------------------
Q 042568 740 ALVLPLMSNGSLENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHHHS------------------------------- 788 (983)
Q Consensus 740 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------- 788 (983)
++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998775543211 112345666677777777411
Q ss_pred -------------------------CCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 789 -------------------------PIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 789 -------------------------~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
+..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1e-05 Score=82.33 Aligned_cols=129 Identities=16% Similarity=0.122 Sum_probs=89.2
Q ss_pred cccCCc-EeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCC--CccceeeEEecCCceeEEEecccCccc
Q 042568 675 IGSGRF-GHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHR--NLIRIITICSKPDFKALVLPLMSNGSL 751 (983)
Q Consensus 675 iG~G~~-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL 751 (983)
+..|.. +.||+...+++..+++|...... ...+.+|.+.++.+... .+.+++++...++..++||+|++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444443 67999998888889999864332 34577888888887433 356778888888888999999998776
Q ss_pred ccccccccCcCCCCCHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 042568 752 ENHLYPSHGLSHGLDLIQLVKICSDVAEGVAYLHH--------------------------------------------- 786 (983)
Q Consensus 752 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~--------------------------------------------- 786 (983)
.+... . ....+.++++.++-||+
T Consensus 94 ~~~~~---------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSHL---------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSCC---------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccc---------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 44221 1 11223344455555552
Q ss_pred ----------cCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 787 ----------HSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 787 ----------~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
..+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 111237999999999999987667899999875
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.80 E-value=4.9e-06 Score=78.61 Aligned_cols=65 Identities=11% Similarity=0.142 Sum_probs=38.9
Q ss_pred ccCCCCcEEeCcCC-cCCCC----CccccCCCCCCCEEeccCccCCC----CchhhhcccccccEEeccCcccc
Q 042568 98 ANLSSLIVLDLSKN-FFQGH----IPAELGSLIRLKQLSLSWNSLQG----KIPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 98 ~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
.+.+.|++|+|+++ .++.. +-..+...++|++|+|++|.+.. .+...+...+.|++|+|++|.++
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 44567777777763 45432 22345566677777777777662 33334445566777777777665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.61 E-value=7.6e-05 Score=80.82 Aligned_cols=78 Identities=17% Similarity=0.152 Sum_probs=50.6
Q ss_pred CCccccCCcEeEEEEEECC-CcEEEEEEeecc------cCcchhHHHHHHHHHHHhcC-C--CCccceeeEEecCCceeE
Q 042568 672 SSLIGSGRFGHVYKGVLQD-NTRIAVKVLDLT------TTGEITGSFKRECQILKRIR-H--RNLIRIITICSKPDFKAL 741 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~-~~~vAvK~~~~~------~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 741 (983)
.+.||.|....||++...+ ++.|+||.-... .......+...|.++++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998654 667999965321 11223456677999888773 3 234555554 3456689
Q ss_pred EEecccCccc
Q 042568 742 VLPLMSNGSL 751 (983)
Q Consensus 742 v~e~~~~gsL 751 (983)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999986543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.59 E-value=1.7e-05 Score=74.73 Aligned_cols=40 Identities=13% Similarity=0.182 Sum_probs=22.9
Q ss_pred CCCCCCEEeccCc-cCCCC----chhhhcccccccEEeccCcccc
Q 042568 123 SLIRLKQLSLSWN-SLQGK----IPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 123 ~l~~L~~L~Ls~n-~l~~~----~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
+.++|++|+|+++ .++.. +-..+...++|++|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 4566777777653 45421 2334455566666666666665
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.28 E-value=2e-05 Score=74.26 Aligned_cols=67 Identities=15% Similarity=0.099 Sum_probs=38.0
Q ss_pred ccccCCCCcEEeCcC-CcCCCC----CccccCCCCCCCEEeccCccCCCC----chhhhcccccccEEeccCcccc
Q 042568 96 ALANLSSLIVLDLSK-NFFQGH----IPAELGSLIRLKQLSLSWNSLQGK----IPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 96 ~l~~l~~L~~L~Ls~-n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
...+.+.|++|+|++ +.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.+.
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344556777777776 445432 223345666677777777766532 2233444566666666666654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.02 E-value=0.00011 Score=68.85 Aligned_cols=42 Identities=7% Similarity=0.019 Sum_probs=26.1
Q ss_pred cCCCCCCCEEeccC-ccCCC----CchhhhcccccccEEeccCcccc
Q 042568 121 LGSLIRLKQLSLSW-NSLQG----KIPSQLGSLHQLEYLDLGNNKLV 162 (983)
Q Consensus 121 ~~~l~~L~~L~Ls~-n~l~~----~~p~~~~~L~~L~~L~Ls~N~l~ 162 (983)
..+.++|++|+|++ +.|+. .+-..+...++|++|+|++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 34567777777776 44552 23344456677777777777665
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.65 E-value=0.0038 Score=67.08 Aligned_cols=74 Identities=16% Similarity=0.205 Sum_probs=51.1
Q ss_pred CCccccCCcEeEEEEEECCC--------cEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc-cceeeEEecCCceeEE
Q 042568 672 SSLIGSGRFGHVYKGVLQDN--------TRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL-IRIITICSKPDFKALV 742 (983)
Q Consensus 672 ~~~iG~G~~g~Vy~~~~~~~--------~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 742 (983)
.+.|+.|-.-.+|++...++ +.|.+++.. ... ......+|..+++.+.-.++ .++++++.. ++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 45688899999999987543 456676664 222 23445689999998853344 577777743 789
Q ss_pred EecccCcccc
Q 042568 743 LPLMSNGSLE 752 (983)
Q Consensus 743 ~e~~~~gsL~ 752 (983)
+||++|.++.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEeccccCC
Confidence 9999986654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0022 Score=66.92 Aligned_cols=137 Identities=16% Similarity=0.173 Sum_probs=79.1
Q ss_pred cEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc--cceee-----EEecCCceeEEEecccCcccc
Q 042568 680 FGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL--IRIIT-----ICSKPDFKALVLPLMSNGSLE 752 (983)
Q Consensus 680 ~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 752 (983)
--.||++...+|+.|++|+...... ..+++..|.+.+..+....+ +..+. .....+..+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 3589999999999999999754322 35778889999888853222 11111 123445678899999875543
Q ss_pred ccc--------------cc----cc-CcCCCCCHH----------------------HHHHHHHHHHHHHHHH-hccCCC
Q 042568 753 NHL--------------YP----SH-GLSHGLDLI----------------------QLVKICSDVAEGVAYL-HHHSPI 790 (983)
Q Consensus 753 ~~l--------------~~----~~-~~~~~l~~~----------------------~~~~i~~~ia~aL~~L-H~~~~~ 790 (983)
..- +. .. ......++. .....+.++...+.-. ....+.
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 210 00 00 001111111 1122223333332222 122334
Q ss_pred CeEeecCCCCCeEeCCCCCEEEcccccccc
Q 042568 791 KVVHCDLKPSNILLDEDLTALVADFGIAKL 820 (983)
Q Consensus 791 ~ivH~Dikp~NiLl~~~~~~kl~Dfgla~~ 820 (983)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 68999999999999753 45899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.05 E-value=0.014 Score=60.37 Aligned_cols=160 Identities=13% Similarity=0.070 Sum_probs=84.7
Q ss_pred CCCHHHHHHHhCCCCCCCcc-----ccCCcEeEEEEEECCCcEEEEEEeecccCcchhHHHHHHHHHHHhcCCCCc--cc
Q 042568 656 RVSYKQLIEATGGFCPSSLI-----GSGRFGHVYKGVLQDNTRIAVKVLDLTTTGEITGSFKRECQILKRIRHRNL--IR 728 (983)
Q Consensus 656 ~~~~~~l~~~~~~f~~~~~i-----G~G~~g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 728 (983)
.++.+++.....+|...+.. ..|---+.|+....+| ++++|++..... .+.+..|++++..+...++ ..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccc
Confidence 35667777777888765543 4566678899988755 589998854322 3455667777777743222 11
Q ss_pred eee------EEecCCceeEEEecccCccccccccc------------------ccC-cCCCCC-----------------
Q 042568 729 IIT------ICSKPDFKALVLPLMSNGSLENHLYP------------------SHG-LSHGLD----------------- 766 (983)
Q Consensus 729 l~~------~~~~~~~~~lv~e~~~~gsL~~~l~~------------------~~~-~~~~l~----------------- 766 (983)
.+. +.........++.++.+......-.. ... ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111 11223344566666665433211100 000 000000
Q ss_pred -HHHHHHHHHHHHHHHHHHhc-cCCCCeEeecCCCCCeEeCCCCCEEEccccccc
Q 042568 767 -LIQLVKICSDVAEGVAYLHH-HSPIKVVHCDLKPSNILLDEDLTALVADFGIAK 819 (983)
Q Consensus 767 -~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dikp~NiLl~~~~~~kl~Dfgla~ 819 (983)
.......+......+...+. .-+.++||+|+.++||+++++...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111122222222332222 223369999999999999988777899999875
|